Citrus Sinensis ID: 038681

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330--
Protein Sequence
MELLKHRRDTERNDKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSCM
Secondary Structure (PSIPRED)
ccHHHHHHHHHHHHHHHHHHHHccHHHHHHHHHcccccccEEEEcHHHHHHHHcccccccccccccccEEEEEEEccccEEEEEEcccccHHHHHHHHHHHHHHHcccccccccEEEEEccccccHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccEEEEEEEcccccccccccccccccccccccHHHHHHHHHHHcccccccccccccccHHHHHHHHHccccccccccccHHHccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
cEEHHEcccccccccccccccccccccHHHccccccccccccEEcHHHHHHHHccccHHcccccccccEEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEEcccHcHEEccccccccHcHccHHEEccccccEEEEEEEEEccccccHHHccccEEcccHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHcccHHHHccccHcccccccccccHHHHHHHHHHHHHHccccHcccccHHHHHHHHHHHHHHcc
Coil and Loop (DISEMBL)
mellkhrrdterndkttFMMRNGERLLKELIAssngkynpyrifSAEELRIatnnydeqnivledpFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVgfsrpivyrdmkptnilfneqsdaklfdfslslsipdgethieldsvvgttgfiapenftTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVkrlsgqncrfkEMVDSIIIedksctctgkeQQLQAFKQLTLQcmdfspedrptMVDVAKQLRQMYRSCM
Flexible Loop (DISEMBL)
mellkhrrdterndkttfmmrngERLLKELiassngkynPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYeenvkrlsgqncrFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDfspedrptmvDVAKQLRQMYRSCM
Low Complexity Region (SEG)
MELLKHRRDTERNDKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSCM
Disordered region (IsUnstruct)
*************************LLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDF***********************
Disordered Region (DISOPRED)
MELL**************************************IFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEV************EENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS**
Disordered Region (DISEMBL)
********DTERNDKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSCM
Disordered Region (DISPRO)
MELLKHRR******************************NPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSC*
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MELLKHRRDTERNDKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSCM
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	332	2.2.26 [Sep-21-2011]
Q9LMP1	732	Wall-associated receptor	no	no	0.918	0.416	0.320	3e-37
Q9LSV3	433	Putative wall-associated	no	no	0.927	0.711	0.309	4e-37
O64798	389	Inactive serine/threonine	no	no	0.909	0.776	0.334	8e-36
O80795	372	Probable inactive recepto	no	no	0.921	0.822	0.324	2e-35
Q7X8C5	748	Wall-associated receptor	no	no	0.939	0.417	0.330	4e-35
Q9LMT9	764	Putative wall-associated	no	no	0.945	0.410	0.300	4e-35
Q9LMN6	738	Wall-associated receptor	no	no	0.936	0.421	0.299	6e-35
Q9S9M2	761	Wall-associated receptor	no	no	0.954	0.416	0.302	7e-35
Q9S9M5	730	Wall-associated receptor	no	no	0.942	0.428	0.315	8e-35
Q8RY17	751	Wall-associated receptor	no	no	0.900	0.398	0.319	9e-35

>sp|Q9LMP1|WAK2_ARATH Wall-associated receptor kinase 2 OS=Arabidopsis thaliana GN=WAK2 PE=1 SV=1

 Score =  155 bits (393), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 110/343 (32%), Positives = 189/343 (55%), Gaps = 38/343 (11%)

Query: 4   LKHRRDTERNDKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVL 63
           +KHR++TE   K  F  +NG  +L + ++ +       +IF+ + ++ ATN Y E  I+ 
Sbjct: 354 IKHRKNTELRQK--FFEQNGGGMLIQRVSGAGPSNVDVKIFTEKGMKEATNGYHESRILG 411

Query: 64  EDPFRKLYKGFWQKRSISLMKYN--GNRNQHALEWCINHIVYASRMSHKHIIK------- 114
           +     +YKG     SI  +K    GNR+Q  +E  IN ++  S+++H++++K       
Sbjct: 412 QGGQGTVYKGILPDNSIVAIKKARLGNRSQ--VEQFINEVLVLSQINHRNVVKVLGCCLE 469

Query: 115 ----LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVY 170
               L+V+E +  GTL D  H H   +  +L+   RL++A ++A ++AYLH   S PI++
Sbjct: 470 TEVPLLVYEFINSGTLFD--HLHGSLYDSSLTWEHRLRIATEVAGSLAYLHSSASIPIIH 527

Query: 171 RDMKPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVV-GTTGFIAPENFTT-LINE 227
           RD+K  NIL ++   AK+ DF  S  IP D E   +L ++V GT G++ PE + T L+NE
Sbjct: 528 RDIKTANILLDKNLTAKVADFGASRLIPMDKE---QLTTIVQGTLGYLDPEYYNTGLLNE 584

Query: 228 QCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRL---SGQNCRFKEMVDSIIIED 284
           + DVY FG  L ELL+ Q+    + FE R H  +N+      + +N RF E++D  ++ +
Sbjct: 585 KSDVYSFGVVLMELLSGQKA---LCFE-RPHCPKNLVSCFASATKNNRFHEIIDGQVMNE 640

Query: 285 KSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
            +      ++++Q   ++  +C     E+RP M +VA +L  +
Sbjct: 641 DN------QREIQEAARIAAECTRLMGEERPRMKEVAAELEAL 677

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9LSV3|WAKLS_ARATH Putative wall-associated receptor kinase-like 16 OS=Arabidopsis thaliana GN=WAKL16 PE=3 SV=1

 Score =  155 bits (392), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 105/339 (30%), Positives = 186/339 (54%), Gaps = 31/339 (9%)

Query: 5   KHRRDTERNDKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLE 64
           KH++DT +  +  F  +NG  +L E ++ +      ++IF+ E+++ ATN YD   I+ +
Sbjct: 58  KHQKDT-KIQRQLFFEKNGGGMLIERLSGAGSSNIDFKIFTEEDMKEATNGYDVSRILGQ 116

Query: 65  DPFRKLYKGFWQKRSISLMKYN--GNRNQHALEWCINHIVYASRMSHKHIIKLI------ 116
                +YKG     SI  +K    G+ NQ  +E  IN ++  S+++H++++KL+      
Sbjct: 117 GGQWTVYKGILPDNSIVAIKKTRLGDNNQ--VEQFINEVLVLSQINHRNVVKLLGCCLET 174

Query: 117 -----VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYR 171
                V+E +  G+L D  H H      +L+   RL++A+++A A+AYLH G S PI++R
Sbjct: 175 EVPLLVYEFITGGSLFD--HLHGSMFVSSLTWEHRLEIAIEVAGAIAYLHSGASIPIIHR 232

Query: 172 DMKPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVV-GTTGFIAPENFTT-LINEQ 228
           D+K  NIL +E   AK+ DF  S   P D E   +L ++V GT G++ PE +TT L+NE+
Sbjct: 233 DIKTENILLDENLTAKVADFGASKLKPMDKE---QLTTMVQGTLGYLDPEYYTTWLLNEK 289

Query: 229 CDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCT 288
            DVY FG  L EL++ Q+       E+  H        + +N R  E++D  ++ +++  
Sbjct: 290 SDVYSFGVVLMELISGQKALCFERPETSKHLVSYFVLATKEN-RLHEIIDDQVLNEEN-- 346

Query: 289 CTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
               ++++    ++ ++C     E+RP M++VA +L  +
Sbjct: 347 ----QREIHEAARVAVECTRLKGEERPRMIEVAAELETL 381

Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O64798|Y1747_ARATH Inactive serine/threonine-protein kinase At1g67470 OS=Arabidopsis thaliana GN=At1g67470 PE=2 SV=1

 Score =  151 bits (381), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 111/332 (33%), Positives = 177/332 (53%), Gaps = 30/332 (9%)

Query: 11  ERNDKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLE---DPF 67
           ++  K+      G +LLK+LI   +GK NP + FSA+E+R ATNN+   N+V E   D  
Sbjct: 7   KKKPKSEIASERGAKLLKDLIECCDGKSNPIKFFSADEIRKATNNFGVSNLVSELSHDFD 66

Query: 68  RKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKLIV----FESVQ 122
            K Y G  +   + L++   +++ +  +     I  +S +S HK+ +KLI     FE   
Sbjct: 67  YKWYSGKNENHDMILVRKAFSQSVYYKDTFFRDIAVSSMVSGHKNFLKLIGYCLEFEEPV 126

Query: 123 IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE 182
           +     + H+H E   +      R+K+A DIA A+AYLH  F RP VYR +  TNIL +E
Sbjct: 127 MVYHGVKKHYHLESSEQPWK--RRMKIAEDIATALAYLHTAFPRPFVYRCLSLTNILLDE 184

Query: 183 QSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFEL 241
              AKL DFS  +SIP+GET +++D + GT  ++ P      +++E+ DV+  G  +  L
Sbjct: 185 DGVAKLMDFSFCVSIPEGETFVQVDYIAGTVDYLKPNYLKHGVVSEETDVFAVGHSMQML 244

Query: 242 LTAQEVSDHV---SFE-SRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQ 297
           L  +++ D +    F  S+F  E  +  ++       EM +  I E++ C       Q++
Sbjct: 245 LMGEKIFDRIMRRPFPTSKFMEEPKMDEIAD-----PEMGE--ISEEELC-------QMK 290

Query: 298 AFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
           AF  L+L+C     E  PTMV+VAK+L+ + R
Sbjct: 291 AFLLLSLRCTGHVGE-VPTMVEVAKELKSIQR 321

Arabidopsis thaliana (taxid: 3702)

>sp|O80795|Y1652_ARATH Probable inactive receptor-like protein kinase At1g65250 OS=Arabidopsis thaliana GN=At1g65250 PE=2 SV=1

 Score =  150 bits (378), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 114/351 (32%), Positives = 185/351 (52%), Gaps = 45/351 (12%)

Query: 11  ERNDKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVL--EDPFR 68
           ++  K+      G +LL+ELI   +GK NP + FSA+E+  ATN++ + N VL  E PF 
Sbjct: 7   KKKPKSDIASERGAKLLEELIECCDGKSNPIKFFSADEILKATNDFSDSNFVLRLEVPF- 65

Query: 69  KLYKGFWQKRSISLMK-----YNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFESVQI 123
           K Y G  +   + L+K     ++G R       C +  V +    HK+ +KL+       
Sbjct: 66  KWYSGKNENHPMILIKKDVGWWSGLRVDRL---CRDIAVSSMVSGHKNFMKLV------- 115

Query: 124 GTLAD-----RIHHHCEQHFEALSLTD-----RLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
           G   +      ++H  ++H++ L +++     R+K+A DIA A+AYLH  F RP VYR +
Sbjct: 116 GCCLELDYPVMVYHSVKKHYK-LEISEQPWKKRMKIAEDIATALAYLHTAFPRPFVYRIL 174

Query: 174 KPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF--TTLINEQCDV 231
              NIL +E   AKL DFS  +SIP+GET + +D  VG   + A +N+  + L++++ DV
Sbjct: 175 SHWNILLDEDGVAKLTDFSHCVSIPEGETFVRVDRDVGLYSYFA-DNYVRSGLVSDKTDV 233

Query: 232 YGFGAFL-----------FELLTAQEVSDHVSFESRF-HYEENVKRLSGQNCRFKEMVDS 279
           + FG F+           FE    +E      F+S    +  N+     ++   +E+ DS
Sbjct: 234 FAFGIFMGHRLLLGYEYYFEHYRGEEEESEDGFDSLMKRHARNLLSTLKEDRPMEEIADS 293

Query: 280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
            +IE        +  Q++AF +L+L+C   S E+ PTMV+VAK+L ++ RS
Sbjct: 294 KMIEKMGQISEQERCQMKAFLKLSLRCTGPS-EEVPTMVEVAKELNKIQRS 343

Arabidopsis thaliana (taxid: 3702)

>sp|Q7X8C5|WAKLB_ARATH Wall-associated receptor kinase-like 2 OS=Arabidopsis thaliana GN=WAKL2 PE=2 SV=1

 Score =  148 bits (374), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 114/345 (33%), Positives = 186/345 (53%), Gaps = 33/345 (9%)

Query: 2   ELLKHRRDTERNDKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNI 61
           + ++ RR   R  K  F  RNG  LLK+ +A   G     RIFS+ EL  AT+N+++  +
Sbjct: 364 KFVQKRRKLIRMRK--FFRRNGGMLLKQQLARKEGNVEMSRIFSSHELEKATDNFNKNRV 421

Query: 62  VLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLI----- 116
           + +     +YKG      I  +K +   ++  +E  IN +V  ++++H++I+KL+     
Sbjct: 422 LGQGGQGTVYKGMLVDGRIVAVKRSKAVDEDRVEEFINEVVVLAQINHRNIVKLLGCCLE 481

Query: 117 ------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVY 170
                 V+E V  G L  R+H   + +   ++   RL +A++IA A++YLH   S PI +
Sbjct: 482 TEVPVLVYEFVPNGDLCKRLHDESDDY--TMTWEVRLHIAIEIAGALSYLHSAASFPIYH 539

Query: 171 RDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINEQC 229
           RD+K TNIL +E++ AK+ DF  S S+   +TH+    V GT G++ PE F ++   E+ 
Sbjct: 540 RDIKTTNILLDERNRAKVSDFGTSRSVTIDQTHLTTQ-VAGTFGYVDPEYFQSSKFTEKS 598

Query: 230 DVYGFGAFLFELLTAQEVSDHV-SFESR---FHYEENVKRLSGQNCRFKEMVDSIIIEDK 285
           DVY FG  L ELLT ++ S  V S E+R    H+ E VK    +N R  ++VD  I ++ 
Sbjct: 599 DVYSFGVVLVELLTGEKPSSRVRSEENRGLAAHFVEAVK----EN-RVLDIVDDRIKDE- 652

Query: 286 SCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
              C     Q+ +   L  +C++   + RP M +V+ +L +M RS
Sbjct: 653 ---C--NMDQVMSVANLARRCLNRKGKKRPNMREVSIEL-EMIRS 691

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMT9|WAKLL_ARATH Putative wall-associated receptor kinase-like 13 OS=Arabidopsis thaliana GN=WAKL13 PE=2 SV=1

 Score =  148 bits (374), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 102/339 (30%), Positives = 181/339 (53%), Gaps = 25/339 (7%)

Query: 2   ELLKHRRDTERNDKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNI 61
           +LL+ RR T R  K  F  RNG  LL++ + ++ G+    ++FS+ EL  AT+N+++  +
Sbjct: 402 KLLRKRRMTNRKRK--FFKRNGGLLLQQQLNTTQGRVEKTKLFSSRELEKATDNFNDNRV 459

Query: 62  VLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----- 115
           + +     +YKG     RS+++ K N   ++  L+  IN ++  S+++H+H++KL     
Sbjct: 460 IGQGGQGTVYKGMLVDGRSVAVKKSN-VVDEDKLQEFINEVIILSQINHRHVVKLLGCCL 518

Query: 116 ------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIV 169
                 +V+E +  G L   +H   + +     +  R+++A+DI+ A +YLH     PI 
Sbjct: 519 ETEVPILVYEFIPNGNLFQHLHEEFDDYTALWGV--RMRIAVDISGAFSYLHTAACSPIY 576

Query: 170 YRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINEQ 228
           +RD+K TNIL +E+  AK+ DF  S S+    TH     + GT G++ PE + ++   E+
Sbjct: 577 HRDIKSTNILLDEKYRAKVSDFGTSRSVSIDHTHWTT-VISGTVGYVDPEYYGSSHFTEK 635

Query: 229 CDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCT 288
            DVY FG  L EL+T ++    +S         +  RL+ +  R  E++D+ I  D  C 
Sbjct: 636 SDVYSFGVVLVELITGEKPVITLSETQEITGLADYFRLAMRENRLFEIIDARIRND--C- 692

Query: 289 CTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
              K +Q+ A   L L+C+  + + RP M +V+  L ++
Sbjct: 693 ---KLEQVIAVANLALRCLKKTGKTRPDMREVSTALERI 728

Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMN6|WAK4_ARATH Wall-associated receptor kinase 4 OS=Arabidopsis thaliana GN=WAK4 PE=2 SV=1

 Score =  148 bits (373), Expect = 6e-35,   Method: Compositional matrix adjust.
 Identities = 101/337 (29%), Positives = 177/337 (52%), Gaps = 26/337 (7%)

Query: 4   LKHRRDTERNDKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVL 63
           +K+ +DTE   +  F  +NG  +L + ++ +       +IF+ E ++ AT+ YDE  I+ 
Sbjct: 360 MKNTKDTEL--RQQFFEQNGGGMLMQRLSGAGPSNVDVKIFTEEGMKEATDGYDENRILG 417

Query: 64  EDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLI------- 116
           +     +YKG     SI  +K     +   +E  IN ++  S+++H++++KL+       
Sbjct: 418 QGGQGTVYKGILPDNSIVAIKKARLGDNSQVEQFINEVLVLSQINHRNVVKLLGCCLETE 477

Query: 117 ----VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRD 172
               V+E +  GTL D  H H      +L+   RL++A++IA  +AYLH   S PI++RD
Sbjct: 478 VPLLVYEFISSGTLFD--HLHGSMFDSSLTWEHRLRMAVEIAGTLAYLHSSASIPIIHRD 535

Query: 173 MKPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFTT-LINEQCD 230
           +K  NIL +E   AK+ DF  S  IP D E    +  V GT G++ PE + T L+NE+ D
Sbjct: 536 IKTANILLDENLTAKVADFGASRLIPMDKEDLATM--VQGTLGYLDPEYYNTGLLNEKSD 593

Query: 231 VYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCT 290
           VY FG  L ELL+ Q+       ++  H        + +N R  E++D  ++ + +    
Sbjct: 594 VYSFGVVLMELLSGQKALCFERPQTSKHIVSYFASATKEN-RLHEIIDGQVMNENN---- 648

Query: 291 GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
             ++++Q   ++ ++C   + E+RP M +VA +L  +
Sbjct: 649 --QREIQKAARIAVECTRLTGEERPGMKEVAAELEAL 683

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9S9M2|WAKLD_ARATH Wall-associated receptor kinase-like 4 OS=Arabidopsis thaliana GN=WAKL4 PE=2 SV=2

 Score =  148 bits (373), Expect = 7e-35,   Method: Compositional matrix adjust.
 Identities = 103/341 (30%), Positives = 177/341 (51%), Gaps = 24/341 (7%)

Query: 2   ELLKHRRDTERNDKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNI 61
           + +K +R + R     F  RNG  LLK+ +A   G     +IFS+ EL  AT+N++   +
Sbjct: 372 KFIKKQRRSSR--MRVFFRRNGGMLLKQQLARKEGNVEMSKIFSSNELEKATDNFNTNRV 429

Query: 62  VLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------ 115
           + +     +YKG      I  +K +   ++  +E  IN +V  ++++H++I+KL      
Sbjct: 430 LGQGGQGTVYKGMLVDGRIVAVKRSKAMDEDKVEEFINEVVVLAQINHRNIVKLLGCCLE 489

Query: 116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVY 170
                +V+E V  G L  R+   C+ +   ++   RL +A++IA A++YLH   S PI +
Sbjct: 490 TEVPVLVYEFVPNGDLCKRLRDECDDYI--MTWEVRLHIAIEIAGALSYLHSAASFPIYH 547

Query: 171 RDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINEQC 229
           RD+K TNIL +E+   K+ DF  S S+   +TH+    V GT G++ PE F ++   ++ 
Sbjct: 548 RDIKTTNILLDEKYQVKVSDFGTSRSVTIDQTHLTTQ-VAGTFGYVDPEYFQSSKFTDKS 606

Query: 230 DVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTC 289
           DVY FG  L EL+T +  S  V  E    +  +      +N RF ++VD  I ++  C  
Sbjct: 607 DVYSFGVVLVELITGKNPSSRVQSEENRGFAAHFVAAVKEN-RFLDIVDERIKDE--CNL 663

Query: 290 TGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
                Q+ A  +L  +C++   + RP M +V+ +L ++  S
Sbjct: 664 ----DQVMAVAKLAKRCLNRKGKKRPNMREVSVELERIRSS 700

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Plays a role in plant mineral nutrients response.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9S9M5|WAKLA_ARATH Wall-associated receptor kinase-like 1 OS=Arabidopsis thaliana GN=WAKL1 PE=1 SV=1

 Score =  147 bits (372), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 109/345 (31%), Positives = 184/345 (53%), Gaps = 32/345 (9%)

Query: 2   ELLKHRRDTERNDKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNI 61
           +L+K RR+  R+ K  F  RNG  LLK+ + + +G     +IFS++ELR AT+N+    +
Sbjct: 377 KLIKKRRNINRSKK--FFKRNGGLLLKQQLTTKDGNVEMSKIFSSKELRKATDNFSIDRV 434

Query: 62  VLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------ 115
           + +     +YKG     SI  +K +   ++  +E  IN IV  S+++H++I+KL      
Sbjct: 435 LGQGGQGTVYKGMLVDGSIVAVKRSKVVDEDKMEEFINEIVLLSQINHRNIVKLLGCCLE 494

Query: 116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVY 170
                +V+E +  G L  R+H   + +   ++   RL++A++IA A+ Y+H   S PI +
Sbjct: 495 TEVPILVYEYIPNGDLFKRLHDESDDY--TMTWEVRLRIAIEIAGALTYMHSAASFPIFH 552

Query: 171 RDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINEQC 229
           RD+K TNIL +E+  AK+ DF  S S+   +TH+    V GT G++ PE F ++    + 
Sbjct: 553 RDIKTTNILLDEKYRAKVSDFGTSRSVTLDQTHLT-TLVAGTFGYMDPEYFLSSQYTHKS 611

Query: 230 DVYGFGAFLFELLTAQEVSDHV-SFESR---FHYEENVKRLSGQNCRFKEMVDSIIIEDK 285
           DVY FG  L EL+T ++    V S E R    H+ E +K    +N     +   I  E K
Sbjct: 612 DVYSFGVVLVELITGEKPLSRVRSEEGRGLATHFLEAMK----ENRVIDIIDIRIKDESK 667

Query: 286 SCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
                   +Q+ A  +L  +C++   ++RP M +V+ +L ++  S
Sbjct: 668 L-------EQVMAVAKLARKCLNRKGKNRPNMKEVSNELERIRSS 705

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8RY17|WAKLI_ARATH Wall-associated receptor kinase-like 22 OS=Arabidopsis thaliana GN=WAKL22 PE=2 SV=1

 Score =  147 bits (372), Expect = 9e-35,   Method: Compositional matrix adjust.
 Identities = 105/329 (31%), Positives = 176/329 (53%), Gaps = 30/329 (9%)

Query: 18  FMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQK 77
           F  RNG  LLK+ + +  G     +IFS++EL  AT+N++   ++ +     +YKG    
Sbjct: 383 FFKRNGGLLLKQQLTTRGGNVQSSKIFSSKELEKATDNFNMNRVLGQGGQGTVYKGMLVD 442

Query: 78  RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTL 126
             I  +K +   ++  +E  IN +   S+++H++I+KL           +V+E +  G L
Sbjct: 443 GRIVAVKRSKVLDEDKVEEFINEVGVLSQINHRNIVKLMGCCLETEVPILVYEHIPNGDL 502

Query: 127 ADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA 186
             R+HH  + +   ++   RL+++++IA A+AYLH   S P+ +RD+K TNIL +E+  A
Sbjct: 503 FKRLHHDSDDY--TMTWDVRLRISVEIAGALAYLHSAASTPVYHRDVKTTNILLDEKYRA 560

Query: 187 KLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINEQCDVYGFGAFLFELLTAQ 245
           K+ DF  S SI   +TH+    V GT G++ PE F T+   ++ DVY FG  L EL+T +
Sbjct: 561 KVSDFGTSRSINVDQTHLT-TLVAGTFGYLDPEYFQTSQFTDKSDVYSFGVVLVELITGE 619

Query: 246 EVSDHVSFESR----FHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQ 301
           +    +  E       H+ E +K    QN R  ++VDS I E   CT     +Q+ A  +
Sbjct: 620 KPFSVMRPEENRGLVSHFNEAMK----QN-RVLDIVDSRIKE--GCTL----EQVLAVAK 668

Query: 302 LTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
           L  +C+    + RP M +V+ +L ++  S
Sbjct: 669 LARRCLSLKGKKRPNMREVSVELERIRSS 697

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Required during plant's response to pathogen infection.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	332
224123144	344	predicted protein [Populus trichocarpa]	0.960	0.927	0.457	3e-70
255582635	331	receptor protein kinase, putative [Ricin	0.909	0.912	0.439	7e-64
255542662	330	serine-threonine protein kinase, plant-t	0.927	0.933	0.425	4e-57
255542656	331	serine-threonine protein kinase, plant-t	0.909	0.912	0.415	2e-56
255542658	356	serine-threonine protein kinase, plant-t	0.912	0.851	0.380	2e-53
42566015	359	putative protein kinase [Arabidopsis tha	0.966	0.894	0.315	1e-41
4678275	356	putative protein [Arabidopsis thaliana]	0.966	0.901	0.315	1e-41
255542676	247	serine-threonine protein kinase, plant-t	0.662	0.890	0.431	5e-41
297817102	359	hypothetical protein ARALYDRAFT_907243 [	0.912	0.844	0.327	1e-40
255542668	307	serine-threonine protein kinase, plant-t	0.798	0.863	0.364	1e-40

>gi|224123144|ref|XP_002319005.1| predicted protein [Populus trichocarpa] gi|222857381|gb|EEE94928.1| predicted protein [Populus trichocarpa]

 Score =  271 bits (693), Expect = 3e-70,   Method: Compositional matrix adjust.
 Identities = 155/339 (45%), Positives = 218/339 (64%), Gaps = 20/339 (5%)

Query: 7   RRDTERNDKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLEDP 66
           ++D + N +T F+ +NG +LL++L+   +GK N  R FSA EL+ ATNNYD Q I+  D 
Sbjct: 8   KKDKKVNKETAFI-KNGSKLLEKLVDICDGKCNSIRSFSATELKKATNNYDPQKILTGDS 66

Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKLI--------- 116
             KLYKGF Q R +S+ K+  +  Q+  E+C N IVYAS+MS HK  +KL+         
Sbjct: 67  GYKLYKGFLQGRPVSVKKFKDDDEQY--EYCFNDIVYASKMSVHKSFMKLLGCCLEARIP 124

Query: 117 --VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
             VFE V   TL+D +    E   + L    R K+AMD+A+AVA+LH  FS+PIV+R++K
Sbjct: 125 ILVFEYVGDWTLSDFLWGSEEARCQPLLWIPRSKIAMDMANAVAFLHAAFSKPIVFRNIK 184

Query: 175 PTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTL-INEQCDVYG 233
           P NIL ++  +AKL DFS+S+SIP GE+H+  DSV G TG IAPE  TT   NE+ DV+ 
Sbjct: 185 PLNILLDDNHEAKLSDFSISISIPKGESHVR-DSVAGATGLIAPEYLTTGNFNEKQDVFN 243

Query: 234 FGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKE 293
           FG FL  LL+ Q V D    E     +++VK+   ++ RF +++DS II +   T  GKE
Sbjct: 244 FGVFLLVLLSGQMVVDFSRPEKEILLQDHVKKCI-EDDRFNKVIDSTIIAEG--TWPGKE 300

Query: 294 QQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSCM 332
           QQLQA+  L+L+C+    EDRPTM+DV+K+LR++Y S +
Sbjct: 301 QQLQAYTALSLRCISELAEDRPTMIDVSKELRKIYWSAI 339

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255582635|ref|XP_002532098.1| receptor protein kinase, putative [Ricinus communis] gi|223528232|gb|EEF30288.1| receptor protein kinase, putative [Ricinus communis]

 Score =  250 bits (638), Expect = 7e-64,   Method: Compositional matrix adjust.
 Identities = 142/323 (43%), Positives = 209/323 (64%), Gaps = 21/323 (6%)

Query: 20  MRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRS 79
           + NG  LL++LIAS +G+ NP RIFSA+EL  AT++YD + I+ +D   KLY G   +R+
Sbjct: 13  LMNGRMLLEKLIASCDGRCNPIRIFSADELSRATDDYDPRKIITQDSGYKLYNGLLHERT 72

Query: 80  ISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKLI-----------VFESVQIGTLA 127
           IS+ K+     Q+  ++C N I++A++MS HK+ +KL+           VFE ++ GTLA
Sbjct: 73  ISVKKFKDKSEQY--KYCYNDIMFATQMSKHKNFLKLLGCCLETQIPVLVFEPIEYGTLA 130

Query: 128 DRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAK 187
            R++   +  ++ L    RLK+A++IA+AV+YLH  FSRPIV+R++KP NI  +E   AK
Sbjct: 131 GRLYGPNKTLYQPLLWRHRLKIAVEIANAVSYLHTAFSRPIVFRNIKPLNIFLDECHVAK 190

Query: 188 LFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINEQCDVYGFGAFLFELLTAQE 246
           L DFSL++SIP+GE+H++ D + G  G IAPE   T+  NE  DVY FG FL  LLT Q+
Sbjct: 191 LSDFSLAVSIPEGESHVK-DMLAGAWGLIAPEYAKTSCFNESQDVYNFGVFLLMLLTGQK 249

Query: 247 VSDHVSFES--RFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTL 304
           V D    ++       ++VK+    + RF E VDSII+ + S     K+QQLQAF  L+ 
Sbjct: 250 VVDSYRPQAGEELGLVDHVKKFIADD-RFYETVDSIILGEGS--LPEKDQQLQAFTLLSF 306

Query: 305 QCMDFSPEDRPTMVDVAKQLRQM 327
           +C+  + EDRP M+DVAK+LR++
Sbjct: 307 RCISEADEDRPMMIDVAKELRKI 329

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255542662|ref|XP_002512394.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548355|gb|EEF49846.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  228 bits (580), Expect = 4e-57,   Method: Compositional matrix adjust.
 Identities = 141/331 (42%), Positives = 199/331 (60%), Gaps = 23/331 (6%)

Query: 15  KTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGF 74
           K  F++ NG +LL++ +A  NG+ NP R FS+EEL  AT NY+E+ ++  D + +LYKGF
Sbjct: 4   KEAFLI-NGSKLLEKSVAFCNGRCNPIRNFSSEELEKATRNYNEKQVLKLDGYFELYKGF 62

Query: 75  WQKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKLI-----------VFESVQ 122
            Q R + + K+         +  IN IVYAS MS H + IKL+           VFES +
Sbjct: 63  LQDRPVIVKKF---LEVGVEQLAINEIVYASAMSVHINSIKLLGCCLETPSPILVFESAK 119

Query: 123 IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE 182
             TLADRI    + HFE +    RLK+  DIA+ V Y+H  F RPIV+R++K +NIL +E
Sbjct: 120 EKTLADRIIDRNDDHFEPVKWKLRLKIVADIANVVVYIHTAFPRPIVHRNIKASNILLDE 179

Query: 183 QSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFEL 241
              AKL DFSL +SIP+G++ +  D + GT G IA E+  T   NE+ DVY FG  L  +
Sbjct: 180 DYVAKLSDFSLCVSIPEGKSRVR-DIMAGTMGLIASESLATGYFNEKSDVYSFGVVLLVV 238

Query: 242 LTAQEVSDHVSFES--RFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAF 299
           LT Q   D    E+  +F    +VK+   +   FKEMVD II+ +++    G  Q+L+ F
Sbjct: 239 LTGQRSFDFSRTETGEQFLLVNHVKK-HIETGGFKEMVDPIIVAEEAGNRKG--QELEDF 295

Query: 300 KQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
           + L L+C+  S E+RPTM++VAKQLR +Y S
Sbjct: 296 RDLALRCIHDSAEERPTMIEVAKQLRHIYLS 326

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255542656|ref|XP_002512391.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548352|gb|EEF49843.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  225 bits (574), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 136/327 (41%), Positives = 188/327 (57%), Gaps = 25/327 (7%)

Query: 19  MMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKR 78
           +MRNG  LL++ +A +NG+ NP R FS +EL+ ATN+Y + N+   D   +LYKG  + R
Sbjct: 14  LMRNGRSLLEKSVALNNGRGNPVRCFSVKELQNATNSYSQHNVFYIDGTCRLYKGLIRDR 73

Query: 79  SISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKLI-----------VFESVQIGTL 126
            + + KY+    +H  E  ++ IV AS MS H++++KL+           VFE  + GTL
Sbjct: 74  PVIVKKYD---YKHPSEDPVSDIVIASEMSVHRNVLKLLGCCLESEIPIPVFEYAEKGTL 130

Query: 127 ADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA 186
            D +         AL   DRLK+A+D+A  +AYLH  F RPIV+RD+   +IL +E   A
Sbjct: 131 EDYVQK------TALLWKDRLKIAVDVASVIAYLHTAFPRPIVHRDISLASILLDEDCAA 184

Query: 187 KLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQ 245
           K+  FSLS+SIP+GETHIE D V GT G++APE F   + NE+ DVY FG  L  LLT  
Sbjct: 185 KVTGFSLSISIPEGETHIE-DEVAGTIGYVAPEYFMKRMFNEKIDVYSFGVVLLVLLTGH 243

Query: 246 EVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQ 305
                    +  H          +N RF E++D  I+E+       KEQQL++F  L +Q
Sbjct: 244 GPILRSPTTNESHALVVFVEAKIKNERFNEIIDPAILEEGP--WPEKEQQLKSFLTLAMQ 301

Query: 306 CMDFSPEDRPTMVDVAKQLRQMYRSCM 332
           C     EDRP + DVAKQLR +Y S M
Sbjct: 302 CTRKDEEDRPEITDVAKQLRHIYHSLM 328

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255542658|ref|XP_002512392.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548353|gb|EEF49844.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  215 bits (548), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 137/360 (38%), Positives = 199/360 (55%), Gaps = 57/360 (15%)

Query: 13  NDKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYK 72
           ++  T +MRNG  LL++ IA +NG+ NP R FS +EL+ ATN+Y + N++ E  +  LYK
Sbjct: 10  DENETALMRNGGILLEKSIAFNNGRGNPIRWFSVDELQTATNSYSQNNVIYEGGWHTLYK 69

Query: 73  GFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKLI-----------VFES 120
           GF + R + + +Y  N ++      IN IV+AS MS HK+++KL+           VFE 
Sbjct: 70  GFLRDRPVIVKRYRNNIHERVCP--INDIVFASEMSRHKNVLKLLGCCLESEIPILVFEY 127

Query: 121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF 180
            + G L D I+      F  L    RLK+A+D A+ +AYLH    RP+V+RD+  +NI  
Sbjct: 128 AEKGKLQDYIYKTDSASFRPLLWKSRLKIAVDAANVIAYLHTACPRPVVHRDITLSNIWL 187

Query: 181 NEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINEQCDVYGFGAFLF 239
           +E   AK+ DF++S+SI +GETHIE D V+GT G+ APE   + + NE+ DV+ FG  L 
Sbjct: 188 DEDYVAKVTDFTVSMSILEGETHIE-DFVLGTCGYAAPEYVRSGIFNEKIDVFSFGVLLL 246

Query: 240 ELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIE---------------- 283
            LLT Q+      F+  +   EN+ +    + RF E++ S+I+E                
Sbjct: 247 VLLTDQK-----PFQGNW---ENILK----DARFDEIIGSLIVEKGLWSEKEQLETFLTR 294

Query: 284 ---------DKSCTCTG----KEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
                    D      G    KEQQL+AF  L +QC+D   E+RP + DVAKQLR  Y S
Sbjct: 295 TRQKLDLTIDPIIVEEGPWPEKEQQLKAFLMLGVQCIDPDEENRPEITDVAKQLRHFYLS 354

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|42566015|ref|NP_191331.2| putative protein kinase [Arabidopsis thaliana] gi|119360045|gb|ABL66751.1| At3g57720 [Arabidopsis thaliana] gi|332646169|gb|AEE79690.1| putative protein kinase [Arabidopsis thaliana]

 Score =  176 bits (446), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 107/339 (31%), Positives = 187/339 (55%), Gaps = 18/339 (5%)

Query: 4   LKHRRDTERN-DKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIV 62
           L+ R++ E++  +  + + NG   LKELIA  NGK  P R FS++++  AT+N+     V
Sbjct: 17  LEKRKEKEKDIQEEKWFLDNGSIFLKELIADCNGKSIPIRNFSSDQILKATSNFGSSCFV 76

Query: 63  LEDPFRKLYKGFWQKRSISLMKYNGNR-NQHALEWCINHIVYASRMS-HKHIIKLI---- 116
             + F   YKG  + RS  + +++  +  Q+ +    N IV ++RMS H + +KLI    
Sbjct: 77  TAEGFYVWYKGIIEDRSYMIKRFSEYKVTQYRVAEVYNEIVLSARMSNHNNFLKLIGFCL 136

Query: 117 -------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIV 169
                  VFE  + G L  R           L L+ RLK+  +IA+AV YLH+ F + ++
Sbjct: 137 EFSLPVLVFEYAEHGVLNHRGGVIVNGEEVILPLSLRLKIGKEIANAVTYLHMAFPKILI 196

Query: 170 YRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQ 228
           +R +KP N+  +E    KL DFS+S+++P+G++ IE++ V GT G++ P  +TT ++ E 
Sbjct: 197 HRHIKPRNVFLDENWTPKLSDFSISINLPEGKSRIEVECVQGTIGYLDPVYYTTKMVTEY 256

Query: 229 CDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCT 288
            DVY FG FL  +LT +      S +  + +  +  +   +N +   ++D  ++ED    
Sbjct: 257 TDVYSFGVFLMVILTGKPALASTSSDGDYKHIASYVKGFHENGQLDGVIDPKVMED---I 313

Query: 289 CTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
            + ++  ++A   L L+C +   E+RP M+ +AK+L+Q+
Sbjct: 314 TSAQKVHVEACVVLALRCCELRDENRPKMIQIAKELKQI 352

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|4678275|emb|CAB41183.1| putative protein [Arabidopsis thaliana]

 Score =  176 bits (446), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 107/339 (31%), Positives = 187/339 (55%), Gaps = 18/339 (5%)

Query: 4   LKHRRDTERN-DKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIV 62
           L+ R++ E++  +  + + NG   LKELIA  NGK  P R FS++++  AT+N+     V
Sbjct: 14  LEKRKEKEKDIQEEKWFLDNGSIFLKELIADCNGKSIPIRNFSSDQILKATSNFGSSCFV 73

Query: 63  LEDPFRKLYKGFWQKRSISLMKYNGNR-NQHALEWCINHIVYASRMS-HKHIIKLI---- 116
             + F   YKG  + RS  + +++  +  Q+ +    N IV ++RMS H + +KLI    
Sbjct: 74  TAEGFYVWYKGIIEDRSYMIKRFSEYKVTQYRVAEVYNEIVLSARMSNHNNFLKLIGFCL 133

Query: 117 -------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIV 169
                  VFE  + G L  R           L L+ RLK+  +IA+AV YLH+ F + ++
Sbjct: 134 EFSLPVLVFEYAEHGVLNHRGGVIVNGEEVILPLSLRLKIGKEIANAVTYLHMAFPKILI 193

Query: 170 YRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQ 228
           +R +KP N+  +E    KL DFS+S+++P+G++ IE++ V GT G++ P  +TT ++ E 
Sbjct: 194 HRHIKPRNVFLDENWTPKLSDFSISINLPEGKSRIEVECVQGTIGYLDPVYYTTKMVTEY 253

Query: 229 CDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCT 288
            DVY FG FL  +LT +      S +  + +  +  +   +N +   ++D  ++ED    
Sbjct: 254 TDVYSFGVFLMVILTGKPALASTSSDGDYKHIASYVKGFHENGQLDGVIDPKVMED---I 310

Query: 289 CTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
            + ++  ++A   L L+C +   E+RP M+ +AK+L+Q+
Sbjct: 311 TSAQKVHVEACVVLALRCCELRDENRPKMIQIAKELKQI 349

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255542676|ref|XP_002512401.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548362|gb|EEF49853.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  174 bits (441), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 104/241 (43%), Positives = 151/241 (62%), Gaps = 21/241 (8%)

Query: 19  MMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKR 78
           +MRNG  LL++ IA +NG+ NP R FS EEL+ ATN+Y + N++ E  +   YKGF ++R
Sbjct: 8   LMRNGGILLEKSIAFNNGRGNPIRCFSVEELQTATNSYSQNNVIYEGGWHTHYKGFLRER 67

Query: 79  SISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKLI-----------VFESVQIGTL 126
            + + +Y  N ++      IN IV+AS MS HK+++KL+           VFE  + G L
Sbjct: 68  PVIVKRYRTNIHERVCP--INDIVFASEMSRHKNVLKLLGCCLESEIPILVFEYAEKGNL 125

Query: 127 ADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA 186
            D I+       ++ S   RLK+A+D A+ +AYLH  F RP+V+R +  +N+  +E S A
Sbjct: 126 HDYIYKT-----DSASFRRRLKIAVDAANVIAYLHTAFPRPVVHRHITLSNVWLDEDSVA 180

Query: 187 KLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINEQCDVYGFGAFLFELLTAQ 245
           K+ DFSLS+SIP+GETHIE D V+GT G+ APE   + + NE+ DV+ FG  L  LLT Q
Sbjct: 181 KVTDFSLSMSIPEGETHIE-DFVMGTCGYAAPEYARSGIFNEKIDVFSFGVLLLVLLTGQ 239

Query: 246 E 246
           +
Sbjct: 240 K 240

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297817102|ref|XP_002876434.1| hypothetical protein ARALYDRAFT_907243 [Arabidopsis lyrata subsp. lyrata] gi|297322272|gb|EFH52693.1| hypothetical protein ARALYDRAFT_907243 [Arabidopsis lyrata subsp. lyrata]

 Score =  173 bits (439), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 106/324 (32%), Positives = 181/324 (55%), Gaps = 21/324 (6%)

Query: 20  MRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRS 79
           + NG   LKELIA  NGK  P R FS++++  AT+N+     V  + F   YKG  + RS
Sbjct: 34  LENGSIFLKELIADCNGKSIPIRSFSSDQILKATSNFGSSCFVTAEGFYVWYKGIIEDRS 93

Query: 80  ISLMKYNGNRNQH-ALEWCINHIVYASRMS-HKHIIKLI-----------VFESVQIGTL 126
             + K++  +  H  +    N IV ++RMS H + +KL+           VFE  + G L
Sbjct: 94  YMIKKFSEYKVTHYRVAEVYNEIVLSARMSNHNNFLKLVGFCLEFCLPVLVFEYAEHGVL 153

Query: 127 ADR--IHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS 184
             R  +  + E++   LSL  RLK+  +IA+AV YLH+ F + +++R + P N+  ++  
Sbjct: 154 NHRGGVMVNGEEYILPLSL--RLKIGKEIANAVTYLHMAFPKILIHRHINPRNVFLDKSW 211

Query: 185 DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT 243
            AKL DFS+S++IP+G++ IE++ V GT G++ P  +TT ++ E  DVY FG FL  +LT
Sbjct: 212 TAKLSDFSISINIPEGKSRIEVECVQGTIGYLDPVYYTTKMVTEYTDVYSFGVFLMVILT 271

Query: 244 AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLT 303
            +      S +  + +     +   +N +   ++DS +++D     + ++  ++A   L 
Sbjct: 272 GKPALASTSSDGDYKHIAGYVKGFHENGQLDGIIDSKVMKD---ITSAQKVLVEACVVLG 328

Query: 304 LQCMDFSPEDRPTMVDVAKQLRQM 327
           L+C +   E+RP M+ +AK+L+Q+
Sbjct: 329 LRCCELRDENRPKMIQIAKELKQI 352

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255542668|ref|XP_002512397.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223548358|gb|EEF49849.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  173 bits (439), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 120/329 (36%), Positives = 174/329 (52%), Gaps = 64/329 (19%)

Query: 17  TFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQ 76
           T ++RNG RLL++ IA +NG+    + + A ++              EDP          
Sbjct: 27  TVLLRNGSRLLEKSIALNNGRVIVKKYYWASDM--------------EDP---------- 62

Query: 77  KRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKLI-----------VFESVQIG 124
                                IN IV+AS MS HK+++KL+           VFE  Q G
Sbjct: 63  ---------------------INDIVFASEMSVHKNVLKLLGCCLESKIPILVFECAQKG 101

Query: 125 TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS 184
            L D  +   +    +L    RL++A+D+A  ++YLH  F RPIV+RD+  +NIL +E  
Sbjct: 102 ILKDYFY---KTDSASLLWQIRLRIAVDVASVISYLHSAFPRPIVHRDITLSNILLDEDY 158

Query: 185 DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLT 243
            AK+  FSLS+SIP+G+THIE D VVGT G++AP  F TL+ NE+ DVY FG  L  LLT
Sbjct: 159 IAKVTGFSLSMSIPEGKTHIE-DEVVGTPGYLAPAYFKTLMFNEKIDVYSFGVLLLVLLT 217

Query: 244 AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLT 303
            Q+   H    +  +   N  +   ++ RF E++D +I+E+       KE+QL+ F  L 
Sbjct: 218 GQQPILHSPTTTARYSLVNFVKEKIEDERFDEIIDPVILEEGP--WPEKERQLEIFLTLA 275

Query: 304 LQCMDFSPEDRPTMVDVAKQLRQMYRSCM 332
           +QC   + EDRP + DVAKQLR +Y S +
Sbjct: 276 MQCTHENEEDRPEITDVAKQLRHIYHSLI 304

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	332
TAIR|locus:2076681	359	AT3G57720 [Arabidopsis thalian	0.957	0.885	0.327	3.2e-42
TAIR|locus:2076586	351	AT3G57710 [Arabidopsis thalian	0.951	0.900	0.321	1.1e-39
TAIR|locus:2076671	355	AT3G57730 [Arabidopsis thalian	0.915	0.856	0.337	6.1e-39
TAIR|locus:2079959	351	AT3G52530 [Arabidopsis thalian	0.891	0.843	0.366	1.5e-37
TAIR|locus:2094468	433	AT3G25490 [Arabidopsis thalian	0.927	0.711	0.309	2.4e-37
TAIR|locus:2076596	340	AT3G57700 [Arabidopsis thalian	0.963	0.941	0.317	3.9e-37
TAIR|locus:2206235	372	AT1G65250 [Arabidopsis thalian	0.945	0.844	0.329	8e-37
TAIR|locus:2008818	389	AT1G67470 [Arabidopsis thalian	0.912	0.778	0.336	8e-37
TAIR|locus:2200375	396	AT1G65190 [Arabidopsis thalian	0.756	0.633	0.332	8.2e-37
TAIR|locus:2076646	334	AT3G57750 [Arabidopsis thalian	0.927	0.922	0.324	1e-36

TAIR|locus:2076681 AT3G57720 [Arabidopsis thaliana (taxid:3702)]

 Score = 447 (162.4 bits), Expect = 3.2e-42, P = 3.2e-42
 Identities = 112/342 (32%), Positives = 192/342 (56%)

Query:     4 LKHRRDTERN-DKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIV 62
             L+ R++ E++  +  + + NG   LKELIA  NGK  P R FS++++  AT+N+     V
Sbjct:    17 LEKRKEKEKDIQEEKWFLDNGSIFLKELIADCNGKSIPIRNFSSDQILKATSNFGSSCFV 76

Query:    63 LEDPFRKLYKGFWQKRSISLMKYNGNR-NQHALEWCINHIVYASRMS-HKHIIKLI---- 116
               + F   YKG  + RS  + +++  +  Q+ +    N IV ++RMS H + +KLI    
Sbjct:    77 TAEGFYVWYKGIIEDRSYMIKRFSEYKVTQYRVAEVYNEIVLSARMSNHNNFLKLIGFCL 136

Query:   117 -------VFESVQIGTLADR--IHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRP 167
                    VFE  + G L  R  +  + E+    LSL  RLK+  +IA+AV YLH+ F + 
Sbjct:   137 EFSLPVLVFEYAEHGVLNHRGGVIVNGEEVILPLSL--RLKIGKEIANAVTYLHMAFPKI 194

Query:   168 IVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LIN 226
             +++R +KP N+  +E    KL DFS+S+++P+G++ IE++ V GT G++ P  +TT ++ 
Sbjct:   195 LIHRHIKPRNVFLDENWTPKLSDFSISINLPEGKSRIEVECVQGTIGYLDPVYYTTKMVT 254

Query:   227 EQCDVYGFGAFLFELLTAQEVSDHVSFESRF-HYEENVKRLSGQNCRFKEMVDSIIIEDK 285
             E  DVY FG FL  +LT +      S +  + H    VK    +N +   ++D  ++ED 
Sbjct:   255 EYTDVYSFGVFLMVILTGKPALASTSSDGDYKHIASYVKGFH-ENGQLDGVIDPKVMEDI 313

Query:   286 SCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
             +   + ++  ++A   L L+C +   E+RP M+ +AK+L+Q+
Sbjct:   314 T---SAQKVHVEACVVLALRCCELRDENRPKMIQIAKELKQI 352

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2076586 AT3G57710 [Arabidopsis thaliana (taxid:3702)]

 Score = 423 (154.0 bits), Expect = 1.1e-39, P = 1.1e-39
 Identities = 108/336 (32%), Positives = 181/336 (53%)

Query:    11 ERNDKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLEDPFRKL 70
             E++    + + NG   L+EL+A  NGK  P R FS E++  ATNN+D    V +D + K 
Sbjct:    15 EKDKAKRWFLDNGSIFLRELVADCNGKSIPIRSFSPEQILKATNNFDSSCFVSQDVYYKW 74

Query:    71 YKGFWQKRSISLMKYNGNR---NQHALEWCINHIVYASRMS-HKHIIKLI---------- 116
             Y+G  + RS  + +++ +     +H ++   N IV ++RMS H + ++L+          
Sbjct:    75 YRGEIEDRSYMIKRFSEDEITGKRHRVKEVYNDIVLSARMSNHSNFLQLLGCCLEFPFPV 134

Query:   117 -VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
              VFE  + G +  R           L  + RLK+  +IA+AV YLH  F + I++RD+KP
Sbjct:   135 LVFEFAEHGAMNQRGGVIVNGEESLLPWSVRLKIGKEIANAVTYLHTAFPKIIIHRDVKP 194

Query:   176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAP-ENFTTLINEQCDVYGF 234
              ++  ++   AKL D S S+S+P+G++ IE + V+GT G+I P  + T  + E  DVY F
Sbjct:   195 MHVFLDKNWTAKLSDLSFSISLPEGKSRIEAEWVLGTFGYIDPLYHKTCFVTEYTDVYSF 254

Query:   235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
             G  L  ++T +     +S          V+ L  +N +  E++D  +++D +   +G+  
Sbjct:   255 GICLLVIITGKPAIMTISDGDLQGILSLVRELC-ENGKLDEVIDPRLMKDIT---SGQRL 310

Query:   295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
             Q++A   L L+C     EDRP M+ VAK+L+Q+  S
Sbjct:   311 QVEACVVLALRCCKERDEDRPKMIQVAKELKQIEAS 346

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2076671 AT3G57730 [Arabidopsis thaliana (taxid:3702)]

 Score = 416 (151.5 bits), Expect = 6.1e-39, P = 6.1e-39
 Identities = 112/332 (33%), Positives = 182/332 (54%)

Query:    15 KTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGF 74
             K  + + NG   LKELI   NGK  P R F++ ++R AT N+D    V E+ F   YKG 
Sbjct:    26 KERWFLENGSIFLKELIVDCNGKSIPIRSFTSSQIRKATKNFDLSCFVAEEGFYIWYKGV 85

Query:    75 WQKRSISLMKYNGNR-NQHALEWCINHIVYASRMS-HKHIIKLI-----------VFESV 121
              + RS  + +++  +   + +      IV ++RMS H + +KL+           VFE  
Sbjct:    86 IEDRSYMIKRFSEYKVTDYRVSEVYKDIVLSARMSNHNNFLKLLGCCLEFPFPVLVFEFA 145

Query:   122 QIGTLADR--IHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNIL 179
             + G L  R  I  + E+    LSL  RLK+  +IA+A+AYLH+ F + I+YRD+KP ++ 
Sbjct:   146 EHGVLNYRGGITVNGEESLLPLSL--RLKIGKEIANALAYLHMAFPKIIIYRDVKPLHVF 203

Query:   180 FNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFL 238
              +    AKL D S S+S+ +G++ IE + V+GT G++ P  F T ++ E  DVY FG FL
Sbjct:   204 LDNNWTAKLSDLSFSISLEEGKSQIEAEDVLGTYGYLDPLYFATRIVTEYTDVYSFGVFL 263

Query:   239 FELLTAQEVSDHVSFESRFHYEENVKR-LSG--QNCRFKEMVDSIIIEDKSCTCTGKEQQ 295
               ++T   +S  V F     Y   +   + G  +N +  E+V  +I+++ +   + +  Q
Sbjct:   264 MVVITG--IS--VYFTGSDGYPVGILGYMKGLAENGKLNEIVYPMIMKEMT---SAQRLQ 316

Query:   296 LQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
             ++A   L L+C +   EDRP M+ VAK+L+++
Sbjct:   317 VEACVLLALRCCEERVEDRPKMIQVAKELKRI 348

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2079959 AT3G52530 [Arabidopsis thaliana (taxid:3702)]

 Score = 403 (146.9 bits), Expect = 1.5e-37, P = 1.5e-37
 Identities = 117/319 (36%), Positives = 178/319 (55%)

Query:    21 RNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSI 80
             +NG  L +ELIA S+GKYNP R+FS++++  ATNN+D  +I+ +D F   YKG  ++R +
Sbjct:    17 KNGSLLHEELIACSDGKYNPIRMFSSDQILKATNNFDADHIIAKDRFI-WYKGTIEERRV 75

Query:    81 SLMKYNGNRNQHAL-EWCINHIVYASRMS-HKHIIKLI-----VFESVQIGTLADRIHHH 133
              + K+ G+    +  E     I   S MS HK+++KL+      ++ V +  LA++    
Sbjct:    76 LIKKWEGDYVLFSSPENVYRDIAVLSMMSSHKNVLKLLGCCVEFYKPVLVCELAEKGPLK 135

Query:   134 CEQ-HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS 192
              E      L  + RLK+  DIA+AVAYLH  F R I+ RD++P NI  +E   AKL  F 
Sbjct:   136 LEDMDGTPLPWSARLKIGKDIANAVAYLHTAFPRVIINRDVRPQNIFLDEDGTAKLSSFC 195

Query:   193 LSLSIPDGETHIELDSVV-GTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTAQEVSDH 250
             L +SIP+GE+ +  D VV G +  + PE N T L++E+ DVY FG  +  LL  +     
Sbjct:   196 LRISIPEGESSVYDDKVVYGVS--VDPEYNGTGLVSEKFDVYSFGVTMLFLLGGELGLTW 253

Query:   251 VSF---ESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCM 307
             +S    E  F +    + L+ Q   F  ++DS I   +S        Q++ F  L L+C+
Sbjct:   254 LSAIIGEFGFPFPGCGEELADQ---FMYVIDSNIWNGES---EASAVQVETFFGLALRCI 307

Query:   308 DFSP-EDRPTMVDVAKQLR 325
              F P +D  TM+DVAK+L+
Sbjct:   308 RFWPGQDVLTMIDVAKELK 326

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005739 "mitochondrion" evidence=IDA

TAIR|locus:2094468 AT3G25490 [Arabidopsis thaliana (taxid:3702)]

 Score = 401 (146.2 bits), Expect = 2.4e-37, P = 2.4e-37
 Identities = 105/339 (30%), Positives = 186/339 (54%)

Query:     5 KHRRDTERNDKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLE 64
             KH++DT +  +  F  +NG  +L E ++ +      ++IF+ E+++ ATN YD   I+ +
Sbjct:    58 KHQKDT-KIQRQLFFEKNGGGMLIERLSGAGSSNIDFKIFTEEDMKEATNGYDVSRILGQ 116

Query:    65 DPFRKLYKGFWQKRSISLMKYN--GNRNQHALEWCINHIVYASRMSHKHIIKLI------ 116
                  +YKG     SI  +K    G+ NQ  +E  IN ++  S+++H++++KL+      
Sbjct:   117 GGQWTVYKGILPDNSIVAIKKTRLGDNNQ--VEQFINEVLVLSQINHRNVVKLLGCCLET 174

Query:   117 -----VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYR 171
                  V+E +  G+L D  H H      +L+   RL++A+++A A+AYLH G S PI++R
Sbjct:   175 EVPLLVYEFITGGSLFD--HLHGSMFVSSLTWEHRLEIAIEVAGAIAYLHSGASIPIIHR 232

Query:   172 DMKPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVV-GTTGFIAPENFTT-LINEQ 228
             D+K  NIL +E   AK+ DF  S   P D E   +L ++V GT G++ PE +TT L+NE+
Sbjct:   233 DIKTENILLDENLTAKVADFGASKLKPMDKE---QLTTMVQGTLGYLDPEYYTTWLLNEK 289

Query:   229 CDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCT 288
              DVY FG  L EL++ Q+       E+  H        + +N R  E++D  ++ +++  
Sbjct:   290 SDVYSFGVVLMELISGQKALCFERPETSKHLVSYFVLATKEN-RLHEIIDDQVLNEEN-- 346

Query:   289 CTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
                 ++++    ++ ++C     E+RP M++VA +L  +
Sbjct:   347 ----QREIHEAARVAVECTRLKGEERPRMIEVAAELETL 381

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2076596 AT3G57700 [Arabidopsis thaliana (taxid:3702)]

 Score = 399 (145.5 bits), Expect = 3.9e-37, P = 3.9e-37
 Identities = 107/337 (31%), Positives = 181/337 (53%)

Query:     4 LKHRRDTERNDKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVL 63
             L  ++  ++ ++   + +NG  LL+ELIA+S G YNP R FS++++  ATN++D   ++ 
Sbjct:     4 LFRKKKKQKKEEEINLQKNGSLLLEELIATSGGIYNPIRTFSSDQILQATNHFDWNYVIS 63

Query:    64 EDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLI--VFESV 121
             ED F   YKG  + R + + K+       A  +  +  V +   SHK+++KL+    E  
Sbjct:    64 EDRF-VWYKGMIENRPVLIKKFQDCSVFDADNFYRDIAVSSLMSSHKNVLKLLGCCLEFP 122

Query:   122 QIGTLADRIHH---HC----EQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
             +   + +   H   +C    ++   +     RL++A +IA AVAYLH  F R I++RD+K
Sbjct:   123 RPVLVCEYPEHGALNCIRCGKEGVRSFPWNVRLRIAKEIADAVAYLHTEFPRTIIHRDLK 182

Query:   175 PTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYG 233
               NI  +E   AKL  FSLS+ +P+GET +  D V  T+ +I P+ F T L+ E  D+Y 
Sbjct:   183 LANIFLDENWSAKLSSFSLSIVLPEGETGVN-DMVCRTSSYIEPDYFNTGLVTENVDIYS 241

Query:   234 FGAFLFELLTAQ-EVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGK 292
              G  +  +LT + E +  V+           K L  +     E++D  I++  S      
Sbjct:   242 LGIIMLIILTGKSEYNSEVAVYLPVLPVYVGKFL--ERGLLTELIDPSILDSTSDDIPKH 299

Query:   293 EQ-QLQAFKQLTLQCMDFSP-EDRPTMVDVAKQLRQM 327
              + Q++AF +L  +C+ F P E+ P M+DVAK+L+++
Sbjct:   300 SRLQMEAFIELAFRCVRFRPGENVPRMIDVAKELKKI 336

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2206235 AT1G65250 [Arabidopsis thaliana (taxid:3702)]

 Score = 396 (144.5 bits), Expect = 8.0e-37, P = 8.0e-37
 Identities = 113/343 (32%), Positives = 187/343 (54%)

Query:    11 ERNDKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVL--EDPFR 68
             ++  K+      G +LL+ELI   +GK NP + FSA+E+  ATN++ + N VL  E PF 
Sbjct:     7 KKKPKSDIASERGAKLLEELIECCDGKSNPIKFFSADEILKATNDFSDSNFVLRLEVPF- 65

Query:    69 KLYKGFWQKRSISLMKYN-GNRNQHALEWCINHIVYASRMS-HKHIIKLIVFESVQIGTL 126
             K Y G  +   + L+K + G  +   ++     I  +S +S HK+ +KL+    +++   
Sbjct:    66 KWYSGKNENHPMILIKKDVGWWSGLRVDRLCRDIAVSSMVSGHKNFMKLVGC-CLELDYP 124

Query:   127 ADRIHHHCEQHFEALSLTD-----RLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN 181
                ++H  ++H++ L +++     R+K+A DIA A+AYLH  F RP VYR +   NIL +
Sbjct:   125 V-MVYHSVKKHYK-LEISEQPWKKRMKIAEDIATALAYLHTAFPRPFVYRILSHWNILLD 182

Query:   182 EQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFL- 238
             E   AKL DFS  +SIP+GET + +D  VG   + A +N+    L++++ DV+ FG F+ 
Sbjct:   183 EDGVAKLTDFSHCVSIPEGETFVRVDRDVGLYSYFA-DNYVRSGLVSDKTDVFAFGIFMG 241

Query:   239 ----------FELLTAQEVSDHVSFESRF-HYEENVKRLSGQNCRFKEMVDSIIIEDKSC 287
                       FE    +E      F+S    +  N+     ++   +E+ DS +IE    
Sbjct:   242 HRLLLGYEYYFEHYRGEEEESEDGFDSLMKRHARNLLSTLKEDRPMEEIADSKMIEKMGQ 301

Query:   288 TCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
                 +  Q++AF +L+L+C   S E+ PTMV+VAK+L ++ RS
Sbjct:   302 ISEQERCQMKAFLKLSLRCTGPS-EEVPTMVEVAKELNKIQRS 343

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2008818 AT1G67470 [Arabidopsis thaliana (taxid:3702)]

 Score = 396 (144.5 bits), Expect = 8.0e-37, P = 8.0e-37
 Identities = 113/336 (33%), Positives = 181/336 (53%)

Query:    11 ERNDKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLE---DPF 67
             ++  K+      G +LLK+LI   +GK NP + FSA+E+R ATNN+   N+V E   D  
Sbjct:     7 KKKPKSEIASERGAKLLKDLIECCDGKSNPIKFFSADEIRKATNNFGVSNLVSELSHDFD 66

Query:    68 RKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKLI----VFESVQ 122
              K Y G  +   + L++   +++ +  +     I  +S +S HK+ +KLI     FE   
Sbjct:    67 YKWYSGKNENHDMILVRKAFSQSVYYKDTFFRDIAVSSMVSGHKNFLKLIGYCLEFEEPV 126

Query:   123 IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE 182
             +     + H+H E   +      R+K+A DIA A+AYLH  F RP VYR +  TNIL +E
Sbjct:   127 MVYHGVKKHYHLESSEQPWKR--RMKIAEDIATALAYLHTAFPRPFVYRCLSLTNILLDE 184

Query:   183 QSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFE 240
                AKL DFS  +SIP+GET +++D + GT  ++ P N+    +++E+ DV+  G  +  
Sbjct:   185 DGVAKLMDFSFCVSIPEGETFVQVDYIAGTVDYLKP-NYLKHGVVSEETDVFAVGHSMQM 243

Query:   241 LLTAQEVSDHVS---FE-SRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQL 296
             LL  +++ D +    F  S+F  E  +  ++       EM +  I E++ C       Q+
Sbjct:   244 LLMGEKIFDRIMRRPFPTSKFMEEPKMDEIADP-----EMGE--ISEEELC-------QM 289

Query:   297 QAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSCM 332
             +AF  L+L+C     E  PTMV+VAK+L+ + R C+
Sbjct:   290 KAFLLLSLRCTGHVGEV-PTMVEVAKELKSIQR-CL 323

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2200375 AT1G65190 [Arabidopsis thaliana (taxid:3702)]

 Score = 320 (117.7 bits), Expect = 8.2e-37, Sum P(2) = 8.2e-37
 Identities = 87/262 (33%), Positives = 138/262 (52%)

Query:     8 RDTERNDKTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLEDPF 67
             R  ++N K    +  G +LL+ELI   +GK NP + FSA+E+R ATN +   N+V ++ F
Sbjct:     6 RKKKKNKKLE--LERGAKLLEELIECCDGKSNPIKFFSADEIRKATNIFSHSNLVHQEEF 63

Query:    68 R-KLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLI--VFESVQIG 124
               + Y G  +   + L++ + N     L  C N  V +    HK+ +KL+    E     
Sbjct:    64 YCQWYSGKNENHPMILIRKDSNVRGGDLV-CRNIAVSSMVSGHKNFMKLVGCCLELKYPV 122

Query:   125 TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS 184
             T+   +  H     +      R+K+A DIA A+AYLH  F RP+VY  +   NIL +E  
Sbjct:   123 TVYHGVKKHYGLEIDEKPWKRRMKIAEDIATALAYLHTAFPRPLVYMILSHRNILLDEDG 182

Query:   185 DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF--TTLINEQCDVYGFGAF--LFE 240
              AKL DFS  +SIP+GET + +++  G   + A +N+  + +++E+ DV+ FG F  L  
Sbjct:   183 VAKLTDFSHCVSIPEGETFVRVEAEDGFYSYFA-DNYVNSVVVSEKTDVFAFGIFMGLTL 241

Query:   241 LLTAQEVSDHVSFESRFHYEEN 262
             LL  +   +H   E +   EE+
Sbjct:   242 LLGYKSYFEHYRGEEKESEEED 263

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2076646 AT3G57750 [Arabidopsis thaliana (taxid:3702)]

 Score = 395 (144.1 bits), Expect = 1.0e-36, P = 1.0e-36
 Identities = 105/324 (32%), Positives = 175/324 (54%)

Query:    15 KTTFMMRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGF 74
             K  + ++NG  LL+ELIAS +GK NP R FS++++  AT+N+ E  I+    +   YKG 
Sbjct:     8 KRRWDLKNGGILLEELIASFDGKTNPIRCFSSDQILKATDNFSESRIISSWGYFIWYKGV 67

Query:    75 WQKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKLI-VFESVQIGTLADRIHH 132
              ++R +S+ K++ ++N  +       I  +S+MS HK+ +KLI       +  L      
Sbjct:    68 IEERQVSIKKWS-SQNLSSFTEAYRDISVSSQMSGHKNALKLIGCCLEFDLPALVCEYTE 126

Query:   133 HCEQHFEA-------LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD 185
             H   + +        L    RLK+A +IA +V YLH  F   IV+R++ PTNI  +E   
Sbjct:   127 HGPLNRDGGLSSGVVLPWKVRLKIAKEIASSVTYLHTAFPETIVHRNINPTNIFIDENWT 186

Query:   186 AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTA 244
             AKL DF   ++IP+GE ++E D V G  GF+ P+ + T+ + E+ D+Y FG  +  LL+ 
Sbjct:   187 AKLSDFWFCVAIPEGELYVE-DDVKGVIGFVDPDYYWTMKVTEKVDIYSFGVVMLVLLSG 245

Query:   245 QEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCT--CTGKEQQLQAFKQL 302
             +    +   E+     ++V  +  +   F E+VD  I  D         +  Q++AF +L
Sbjct:   246 RAAVFNGPDEAPMSLNDHVSEVMEKG-EFDEIVDKEIWNDLGGDDDLVLRRSQVKAFLRL 304

Query:   303 TLQCMDFSPEDRPT-MVDVAKQLR 325
              L+C+ +  ED  + M++VAK+L+
Sbjct:   305 ALRCVRYKKEDPVSGMLEVAKELK 328

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

GO:0015824 "proline transport" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	332
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	6e-23
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-23
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-21
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-17
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-17
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-16
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-15
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-15
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-15
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-14
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-14
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-14
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-12
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-11
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-10
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-10
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	3e-10
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-10
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-10
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	4e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-10
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	9e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-09
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-09
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-09
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-09
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-09
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-09
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-09
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-09
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	5e-09
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-09
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-08
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-08
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-08
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-08
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-08
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-08
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-08
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-08
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	6e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-08
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	6e-08
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	8e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-07
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-07
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-07
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-07
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-07
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-07
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-07
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-07
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-07
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-07
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-07
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-07
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	3e-07
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-07
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-07
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-07
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-07
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-07
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-07
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	7e-07
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-07
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	9e-07
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-06
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-06
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	1e-06
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-06
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-06
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-06
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-06
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	4e-06
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-06
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-06
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-06
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	6e-06
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-06
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	6e-06
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-06
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	7e-06
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-06
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	7e-06
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	8e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-06
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	8e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	9e-06
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	9e-06
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-05
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-05
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-05
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-05
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-05
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-05
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-05
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-05
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-05
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-05
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-05
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-05
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-05
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-05
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-05
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-05
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-05
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-05
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-05
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-05
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-05
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-05
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	3e-05
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-05
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-05
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-05
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-05
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	5e-05
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	6e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-05
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-05
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-05
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-05
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	7e-05
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-05
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-05
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-05
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	9e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-04
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-04
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-04
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-04
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-04
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-04
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-04
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-04
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-04
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-04
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-04
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-04
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-04
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-04
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-04
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-04
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-04
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-04
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-04
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-04
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-04
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-04
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-04
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-04
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-04
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	3e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-04
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-04
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-04
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-04
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-04
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-04
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-04
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-04
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-04
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-04
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-04
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	5e-04
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-04
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-04
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-04
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-04
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-04
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-04
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	8e-04
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-04
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	0.001
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	0.001
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	0.001
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	0.001
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	0.001
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	0.001
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	0.002
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	0.002
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	0.002
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	0.002
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	0.002
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	0.002
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	0.002
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	0.002
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	0.002
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	0.002
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.002
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.002
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	0.002
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.002
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.003
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	0.003
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.003
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	0.003
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	0.003
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	0.003
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	0.003
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	0.003
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	0.004
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	0.004
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 94.6 bits (236), Expect = 6e-23
 Identities = 44/157 (28%), Positives = 81/157 (51%), Gaps = 23/157 (14%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
            +++H +I+KL           +V E  + G+L D +    +++   LS  + L++ + I
Sbjct: 46  KKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLL----KENEGKLSEDEILRILLQI 101

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD-AKLFDFSLSLSIPDGETHIELDSVVGT 212
              + YLH   S  I++RD+KP NIL +  +   KL DF LS  +   ++   L ++VGT
Sbjct: 102 LEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156

Query: 213 TGFIAPE--NFTTLINEQCDVYGFGAFLFELLTAQEV 247
             ++APE        +E+ D++  G  L+EL   +++
Sbjct: 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYELPELKDL 193

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 95.3 bits (238), Expect = 7e-23
 Identities = 59/239 (24%), Positives = 92/239 (38%), Gaps = 55/239 (23%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
            ++ H +I++L           +V E  + G L D +          LS  +       I
Sbjct: 52  KKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR-----GRLSEDEARFYLRQI 106

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT 213
             A+ YLH   S+ IV+RD+KP NIL +E    KL DF L+  +  GE    L + VGT 
Sbjct: 107 LSALEYLH---SKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTP 160

Query: 214 GFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG 268
            ++APE    ++  +      D++  G  L+ELLT +       F       E  K++  
Sbjct: 161 EYMAPE----VLLGKGYGKAVDIWSLGVILYELLTGK-----PPFPGDDQLLELFKKI-- 209

Query: 269 QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
              +         I                 K L  + +   PE R T    A++  Q 
Sbjct: 210 GKPKPPFPPPEWDISP-------------EAKDLIRKLLVKDPEKRLT----AEEALQH 251

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 91.9 bits (229), Expect = 1e-21
 Identities = 59/236 (25%), Positives = 97/236 (41%), Gaps = 48/236 (20%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           R+SH +I++L           +V E  + G L D +          LS  +  K+A+ I 
Sbjct: 54  RLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG-----PLSEDEAKKIALQIL 108

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS--LSIPDGETHIELDSVVGT 212
             + YLH   S  I++RD+KP NIL +E    K+ DF L+  L            + VGT
Sbjct: 109 RGLEYLH---SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT----TFVGT 161

Query: 213 TGFIAPE--NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
             ++APE          + DV+  G  L+ELLT +      +   +              
Sbjct: 162 PWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQ------------ 209

Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQ 326
              + ++   +  D+    +G E      K L  +C++  P  RPT    A+++ Q
Sbjct: 210 -LIRRILGPPLEFDEPKWSSGSE----EAKDLIKKCLNKDPSKRPT----AEEILQ 256

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 79.9 bits (198), Expect = 2e-17
 Identities = 55/235 (23%), Positives = 92/235 (39%), Gaps = 48/235 (20%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
            ++ H +++KL           IV E ++ G L   +     ++   LSL+D L  A+ I
Sbjct: 56  RKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLR----KNRPKLSLSDLLSFALQI 111

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT 213
           A  + YL    S+  ++RD+   N L  E    K+ DF LS  + D + +       G  
Sbjct: 112 ARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY----RKRGGK 164

Query: 214 GFI---APENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
             I   APE+        + DV+ FG  L+E+ T            + +   + + +   
Sbjct: 165 LPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT---------LGEQPYPGMSNEEV--- 212

Query: 270 NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
                E + +     +   C            L LQC    PEDRPT  ++ + L
Sbjct: 213 ----LEYLKNGYRLPQPPNCP------PELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 79.1 bits (196), Expect = 4e-17
 Identities = 61/237 (25%), Positives = 97/237 (40%), Gaps = 51/237 (21%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
            ++SH +I++L           IV E +  G L D +     +H E L+L D L++A+ I
Sbjct: 56  KKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLR----KHGEKLTLKDLLQMALQI 111

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT 213
           A  + YL    S+  V+RD+   N L  E    K+ DF LS  I + + +          
Sbjct: 112 AKGMEYLE---SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYY-----RKRGG 163

Query: 214 GFI-----APENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS 267
           G +     APE+        + DV+ FG  L+E+ T               Y      +S
Sbjct: 164 GKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFT----------LGEQPYPG----MS 209

Query: 268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
             N    E+++      +   C           +L LQC  + PEDRPT  ++ + L
Sbjct: 210 --NEEVLELLEDGYRLPRPENCP------DELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 76.8 bits (190), Expect = 3e-16
 Identities = 44/159 (27%), Positives = 66/159 (41%), Gaps = 30/159 (18%)

Query: 105 SRMSHKHIIK-------------LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM 151
           S + H +I++              I  E V  G+L+  +       F  L      K   
Sbjct: 54  SSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-----FGKLPEPVIRKYTR 108

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
            I   +AYLH   S  IV+RD+K  NIL +     KL DF  +  + D ET     SV G
Sbjct: 109 QILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRG 165

Query: 212 TTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQ 245
           T  ++APE    +I  +      D++  G  + E+ T +
Sbjct: 166 TPYWMAPE----VIRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 75.3 bits (186), Expect = 1e-15
 Identities = 60/237 (25%), Positives = 91/237 (38%), Gaps = 51/237 (21%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLAD--RIHHHCEQHFEALSLTDRLKVAM 151
            ++ H +I+KL           IV E +  G L D  R +       + LSL+D L  A+
Sbjct: 56  RKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRP-----KELSLSDLLSFAL 110

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
            IA  + YL    S+  ++RD+   N L  E    K+ DF LS  + D + +     V G
Sbjct: 111 QIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY----KVKG 163

Query: 212 TTGFI---APENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS 267
               I   APE+        + DV+ FG  L+E+ T              +   +   + 
Sbjct: 164 GKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFT---------LGEEPYPGMSNAEV- 213

Query: 268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
                  E +       K   C           +L LQC    PEDRPT  ++ + L
Sbjct: 214 ------LEYLKKGYRLPKPPNCP------PELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 75.9 bits (185), Expect = 2e-15
 Identities = 59/236 (25%), Positives = 92/236 (38%), Gaps = 36/236 (15%)

Query: 108 SHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHA 156
              +I+KL           +V E V  G+L D +          LS ++ L +   I  A
Sbjct: 56  HPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKI--GRKGPLSESEALFILAQILSA 113

Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSD-AKLFDFSLSLSIPDGETH----IELDSVVG 211
           + YLH   S+ I++RD+KP NIL +      KL DF L+  +PD  +         + VG
Sbjct: 114 LEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170

Query: 212 TTGFIAPENFTTLINE----QCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS 267
           T G++APE    L         D++  G  L+ELLT             F  E+N    S
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTG---------LPPFEGEKNSSATS 221

Query: 268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ 323
                  E+    +    S +    E   +A   L  + +   P++R +       
Sbjct: 222 QTLKIILELPTPSLASPLSPSN--PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275

Length = 384

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 74.4 bits (183), Expect = 2e-15
 Identities = 63/242 (26%), Positives = 94/242 (38%), Gaps = 47/242 (19%)

Query: 98  INHIVYASRMSHKHIIK-----------LIVFESVQIGTLADRIHHHCEQHFEALSLTDR 146
           +N IV  S + H +II            LI  E    GTL D+I     Q FE     + 
Sbjct: 47  LNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE-----EE 101

Query: 147 LKVAM--DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHI 204
           + +     I  AV+Y+H      I++RD+K  NI   +    KL DF +S  +    +  
Sbjct: 102 MVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA 158

Query: 205 ELDSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENV 263
           E  +VVGT  +++PE    +  N + D++  G  L+ELLT +       F++       V
Sbjct: 159 E--TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRT-----FDATNPLNLVV 211

Query: 264 KRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ 323
           K + G        V S                      L    +   PE RPT  +V  Q
Sbjct: 212 KIVQGN----YTPVVS--------------VYSSELISLVHSLLQQDPEKRPTADEVLDQ 253

Query: 324 LR 325
             
Sbjct: 254 PL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 76.4 bits (188), Expect = 3e-15
 Identities = 75/282 (26%), Positives = 117/282 (41%), Gaps = 30/282 (10%)

Query: 58  EQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLI- 116
           E+N++        YKG   K  +  +    N          + I    ++ H +I+KLI 
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPS---SEIADMGKLQHPNIVKLIG 750

Query: 117 VFESVQIGTLADRIHHHCE-----QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYR 171
           +  S +   L   IH + E     +    LS   R K+A+ IA A+ +LH   S  +V  
Sbjct: 751 LCRSEKGAYL---IHEYIEGKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807

Query: 172 DMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTL-INEQCD 230
           ++ P  I+ + + +  L      LS+P G    +    + ++ ++APE   T  I E+ D
Sbjct: 808 NLSPEKIIIDGKDEPHL-----RLSLP-GLLCTDTKCFI-SSAYVAPETRETKDITEKSD 860

Query: 231 VYGFGAFLFELLTAQEVSDHVSFESRFHYEENVK--RLSGQNCRFKEMVDSIIIEDKSCT 288
           +YGFG  L ELLT +  +D    E   H    V+  R    +C     +D  I  D S  
Sbjct: 861 IYGFGLILIELLTGKSPAD---AEFGVH-GSIVEWARYCYSDCHLDMWIDPSIRGDVSV- 915

Query: 289 CTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
               + ++     L L C    P  RP   DV K L    RS
Sbjct: 916 ---NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS 954

Length = 968

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 71.9 bits (177), Expect = 2e-14
 Identities = 65/279 (23%), Positives = 109/279 (39%), Gaps = 64/279 (22%)

Query: 67  FRKLYKGFWQKRS-----ISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------ 115
           F ++YK    KR+     I ++K      +  +   IN I    +  H +I+K       
Sbjct: 13  FGEVYKA-RHKRTGKEVAIKVIKLESKEKKEKI---INEIQILKKCKHPNIVKYYGSYLK 68

Query: 116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVY 170
                IV E    G+L D +    +   E    +    V  ++   + YLH   S  I++
Sbjct: 69  KDELWIVMEFCSGGSLKDLLKSTNQTLTE----SQIAYVCKELLKGLEYLH---SNGIIH 121

Query: 171 RDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLIN---- 226
           RD+K  NIL     + KL DF LS  + D +     +++VGT  ++APE    +IN    
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAPE----VINGKPY 174

Query: 227 -EQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDK 285
             + D++  G    EL            +  +     +K L        ++  +     +
Sbjct: 175 DYKADIWSLGITAIELAEG---------KPPYSELPPMKAL-------FKIATNGPPGLR 218

Query: 286 SCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
           +      E     FK    +C+  +PE RPT    A+QL
Sbjct: 219 NPEKWSDE-----FKDFLKKCLQKNPEKRPT----AEQL 248

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 71.8 bits (177), Expect = 2e-14
 Identities = 58/253 (22%), Positives = 93/253 (36%), Gaps = 73/253 (28%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFE----ALSLTDRLKV 149
            ++ H ++++L           +V E ++ G L D +              LSL D L  
Sbjct: 51  KKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF 110

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A+ IA  + YL    S+  V+RD+   N L  E    K+ DF LS  + D + +      
Sbjct: 111 AIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY-----R 162

Query: 210 VGTTGFI-----APENFTTLI-NEQCDVYGFGAFLFELLT----------AQEVSDHVSF 253
             T G +     APE+    I   + DV+ FG  L+E+ T           +EV +++  
Sbjct: 163 KKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL-- 220

Query: 254 ESRFHYEENVKRLS-GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPE 312
                      RL   + C                             +L L C    PE
Sbjct: 221 -------RKGYRLPKPEYCP------------------------DELYELMLSCWQLDPE 249

Query: 313 DRPTMVDVAKQLR 325
           DRPT  ++ ++L 
Sbjct: 250 DRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 70.6 bits (174), Expect = 4e-14
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 14/97 (14%)

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ YLH   S  I+YRD+KP NIL +     KL DF L+  +    +    ++  G
Sbjct: 101 EIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRT--NTFCG 155

Query: 212 TTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLT 243
           T  ++APE    ++  +      D +  G  L+E+LT
Sbjct: 156 TPEYLAPE----VLLGKGYGKAVDWWSLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 1e-12
 Identities = 51/201 (25%), Positives = 84/201 (41%), Gaps = 43/201 (21%)

Query: 67  FRKLYKGFWQKRS----ISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIK-------- 114
           F  +YKG   +      I  +     + + AL+  +  I     + H +I+K        
Sbjct: 13  FGVVYKGLNLETGDFVAIKQISLEKIKEE-ALKSIMQEIDLLKNLKHPNIVKYIGSIETS 71

Query: 115 ---LIVFESVQIGTLADRIHHHCEQHF-EALSLTDRLKVAMDIA---HAVAYLHVGFSRP 167
               I+ E  + G+L   I       F E+L       VA+ +      +AYLH    + 
Sbjct: 72  DSLYIILEYAENGSLRQIIKKF--GPFPESL-------VAVYVYQVLQGLAYLH---EQG 119

Query: 168 IVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINE 227
           +++RD+K  NIL  +    KL DF ++  + D     +  SVVGT  ++APE    +I  
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLND--VSKDDASVVGTPYWMAPE----VIEM 173

Query: 228 Q-----CDVYGFGAFLFELLT 243
                  D++  G  + ELLT
Sbjct: 174 SGASTASDIWSLGCTVIELLT 194

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 65.9 bits (161), Expect = 2e-12
 Identities = 60/232 (25%), Positives = 95/232 (40%), Gaps = 41/232 (17%)

Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
            + H+++I+L          +V E   +G+L DR+      HF    ++     A+ IA+
Sbjct: 52  SLDHENLIRLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHF---LISTLCDYAVQIAN 108

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH--IELDSVVGTT 213
            + YL    S+  ++RD+   NIL       K+ DF L  ++P  E H  +E    V   
Sbjct: 109 GMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV-PF 164

Query: 214 GFIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR 272
            + APE+  T   +   DV+ FG  L+E+ T              + EE    LSG    
Sbjct: 165 AWCAPESLRTRTFSHASDVWMFGVTLWEMFT--------------YGEEPWAGLSGSQIL 210

Query: 273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
            K       I+ +       E   Q    + LQC   +P DRPT   + + L
Sbjct: 211 KK-------IDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 63.5 bits (155), Expect = 1e-11
 Identities = 29/92 (31%), Positives = 45/92 (48%), Gaps = 7/92 (7%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I  A+ YLH   S+ I++RD+KP NIL +EQ    + DF+++  +          S  GT
Sbjct: 109 IVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---LTTSTSGT 162

Query: 213 TGFIAPENFTT-LINEQCDVYGFGAFLFELLT 243
            G++APE       +   D +  G   +E L 
Sbjct: 163 PGYMAPEVLCRQGYSVAVDWWSLGVTAYECLR 194

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 46/169 (27%), Positives = 70/169 (41%), Gaps = 46/169 (27%)

Query: 109 HKHIIKLI-----------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAV 157
           H  IIKL            V E    G L   I       + +L        A +I  A+
Sbjct: 61  HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRK-----YGSLDEKCTRFYAAEILLAL 115

Query: 158 AYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF---------SLSLSIPDGETHIE--- 205
            YLH   S+ I++RD+KP NIL ++    K+ DF         S   S     T+I+   
Sbjct: 116 EYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQI 172

Query: 206 ------LDSVVGTTGFIAPENFTTLINEQC-----DVYGFGAFLFELLT 243
                   S VGT  +++PE    L+NE+      D++  G  ++++LT
Sbjct: 173 EKNRRRFASFVGTAEYVSPE----LLNEKPAGKSSDLWALGCIIYQMLT 217

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 47/196 (23%), Positives = 80/196 (40%), Gaps = 35/196 (17%)

Query: 76  QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLI------------VFESVQI 123
            + +I L++ +    +H            +R+ H +I+ L+            VFE V  
Sbjct: 4   HEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG 63

Query: 124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ 183
            TL + +         AL   +  ++ + +  A+A  H   ++ IV+RD+KP NI+ ++ 
Sbjct: 64  RTLREVL-----AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQT 115

Query: 184 SD---AKLFDFSLSLSIPDGETHIELD-----SVVGTTGFIAPENFTTLINE----QCDV 231
                AK+ DF +   +P               V+GT  + APE    L  E      D+
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQ---LRGEPVTPNSDL 172

Query: 232 YGFGAFLFELLTAQEV 247
           Y +G    E LT Q V
Sbjct: 173 YAWGLIFLECLTGQRV 188

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 60.6 bits (147), Expect = 1e-10
 Identities = 31/121 (25%), Positives = 55/121 (45%), Gaps = 14/121 (11%)

Query: 130 IHHHCEQHFEA-LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKL 188
           + +H     E        +  A  I   + +LH    R IVYRD+KP N+L ++  + ++
Sbjct: 80  LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRI 136

Query: 189 FDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQ----CDVYGFGAFLFELLTA 244
            D  L++ +  G+    +    GT G++APE    L  E      D +  G  L+E++  
Sbjct: 137 SDLGLAVELKGGKK---IKGRAGTPGYMAPE---VLQGEVYDFSVDWFALGCTLYEMIAG 190

Query: 245 Q 245
           +
Sbjct: 191 R 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 34/103 (33%), Positives = 50/103 (48%), Gaps = 20/103 (19%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS--------LSIPDGETHI 204
           I  A+ YLH   S  I++RD+KP NIL +     KL DF LS        +++ D E   
Sbjct: 102 IVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158

Query: 205 ELDSVVGTTGFIAPENFTTLINE----QCDVYGFGAFLFELLT 243
           +   +VGT  +IAPE    ++ +      D +  G  L+E L 
Sbjct: 159 K--RIVGTPDYIAPE---VILGQGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 59.6 bits (144), Expect = 4e-10
 Identities = 42/123 (34%), Positives = 64/123 (52%), Gaps = 29/123 (23%)

Query: 168 IVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINE 227
           IVYRD+KP NIL +++   ++ D  L++ IP+GET   +   VGT G++APE    + NE
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPE---VINNE 176

Query: 228 QC----DVYGFGAFLFELLTAQEVSDHVSFESRFH-YEENVKRLSGQNCRFKEMVDSIII 282
           +     D +G G  ++E++  Q         S F   +E VKR         E VD  + 
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQ---------SPFRKRKERVKR---------EEVDRRVK 218

Query: 283 EDK 285
           ED+
Sbjct: 219 EDQ 221

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 59.5 bits (144), Expect = 4e-10
 Identities = 44/140 (31%), Positives = 69/140 (49%), Gaps = 30/140 (21%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A +I   +  LH      IVYRD+KP NIL ++    ++ D  L++ IP+GET   +   
Sbjct: 108 AAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGR 161

Query: 210 VGTTGFIAPENFTTLINEQ----CDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKR 265
           VGT G++APE    + NE+     D +G G  ++E++  +       F  R   +E VKR
Sbjct: 162 VGTVGYMAPE---VVKNERYTFSPDWWGLGCLIYEMIEGKS-----PFRQR---KEKVKR 210

Query: 266 LSGQNCRFKEMVDSIIIEDK 285
                    E V+  + ED+
Sbjct: 211 ---------EEVERRVKEDQ 221

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 59.2 bits (144), Expect = 4e-10
 Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 21/96 (21%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE-THIELDSVVGTTG 214
           A  YLH   +R I+YRD+KP N+L +     KL DF  +  +  G+ T     +  GT  
Sbjct: 105 AFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW----TFCGTPE 157

Query: 215 FIAPE-------NFTTLINEQCDVYGFGAFLFELLT 243
           ++APE       +F+       D +  G  L+ELLT
Sbjct: 158 YVAPEIILNKGYDFS------VDYWSLGILLYELLT 187

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 59.2 bits (143), Expect = 5e-10
 Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 10/115 (8%)

Query: 130 IHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLF 189
           +H+H  QH    S  +    A +I   + ++H   +R +VYRD+KP NIL +E    ++ 
Sbjct: 84  LHYHLSQH-GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRIS 139

Query: 190 DFSLSLSIPDGETHIELDSVVGTTGFIAPENFT--TLINEQCDVYGFGAFLFELL 242
           D  L+      + H    + VGT G++APE     T  +   D +  G  LF+LL
Sbjct: 140 DLGLACDFSKKKPH----ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 58.4 bits (141), Expect = 9e-10
 Identities = 43/140 (30%), Positives = 68/140 (48%), Gaps = 30/140 (21%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A +I   +  LH       VYRD+KP NIL ++    ++ D  L++ IP+GE+   +   
Sbjct: 108 AAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGR 161

Query: 210 VGTTGFIAPENFTTLINEQC----DVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKR 265
           VGT G++APE    L N++     D +G G  ++E++  Q       F  R   +E VKR
Sbjct: 162 VGTVGYMAPE---VLNNQRYTLSPDYWGLGCLIYEMIEGQS-----PFRGR---KEKVKR 210

Query: 266 LSGQNCRFKEMVDSIIIEDK 285
                    E VD  ++E +
Sbjct: 211 ---------EEVDRRVLETE 221

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 35/115 (30%), Positives = 55/115 (47%), Gaps = 10/115 (8%)

Query: 130 IHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLF 189
           +H+H  QH    S  +    A +I   + ++H  F   +VYRD+KP NIL +E    ++ 
Sbjct: 84  LHYHLSQH-GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRIS 139

Query: 190 DFSLSLSIPDGETHIELDSVVGTTGFIAPENFT--TLINEQCDVYGFGAFLFELL 242
           D  L+      + H    + VGT G++APE        +   D +  G  LF+LL
Sbjct: 140 DLGLACDFSKKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 37/97 (38%), Positives = 54/97 (55%), Gaps = 14/97 (14%)

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           ++A A+ +LH   S  I+YRD+KP NIL +E+   KL DF LS    D E   +  S  G
Sbjct: 106 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCG 160

Query: 212 TTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLT 243
           T  ++APE    ++N +      D + FG  +FE+LT
Sbjct: 161 TVEYMAPE----VVNRRGHTQSADWWSFGVLMFEMLT 193

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 56/286 (19%), Positives = 105/286 (36%), Gaps = 79/286 (27%)

Query: 67  FRKLYKGFWQKRSISL--MKYNGNRNQHALEWCINHIVYASRMSHKHIIKL--------- 115
           F  +  G ++ + +++  +K +    Q  L          + + H ++++L         
Sbjct: 19  FGDVMLGDYRGQKVAVKCLKDDSTAAQAFLA----EASVMTTLRHPNLVQLLGVVLQGNP 74

Query: 116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
             IV E +  G+L D +          ++L  +L  A+D+   + YL     +  V+RD+
Sbjct: 75  LYIVTEYMAKGSLVDYLRSRGRAV---ITLAQQLGFALDVCEGMEYLE---EKNFVHRDL 128

Query: 174 KPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE-----NFTTLINEQ 228
              N+L +E   AK+ DF L+      E     DS      + APE      F+T    +
Sbjct: 129 AARNVLVSEDLVAKVSDFGLA-----KEASQGQDSGKLPVKWTAPEALREKKFST----K 179

Query: 229 CDVYGFGAFLFELLT----------AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD 278
            DV+ FG  L+E+ +           ++V  HV        E+  +  + + C       
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV--------EKGYRMEAPEGCP------ 225

Query: 279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
                                 ++   C +  P  RPT   + +QL
Sbjct: 226 ------------------PEVYKVMKDCWELDPAKRPTFKQLREQL 253

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 41/146 (28%), Positives = 64/146 (43%), Gaps = 27/146 (18%)

Query: 111 HIIKLIVF-ESVQIGTLADRIHH------HCEQHFEALSLTDRLKVAMDIAHAVAYLHVG 163
           H  K+ +F E    GTL + + H      H  + +  L L +           +AYLH  
Sbjct: 70  HREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVY-TLQLLE----------GLAYLH-- 116

Query: 164 FSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET--HIELDSVVGTTGFIAPENF 221
            S  IV+RD+KP NI  +     KL DF  ++ + +  T    E+ S+ GT  ++APE  
Sbjct: 117 -SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVI 175

Query: 222 T--TLINEQ--CDVYGFGAFLFELLT 243
           T           D++  G  + E+ T
Sbjct: 176 TGGKGKGHGRAADIWSLGCVVLEMAT 201

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 57.4 bits (138), Expect = 2e-09
 Identities = 48/160 (30%), Positives = 79/160 (49%), Gaps = 12/160 (7%)

Query: 138 FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI 197
           F+   +   LK   +I   + YLH   S   ++RD+K  N+L +EQ D KL DF ++  +
Sbjct: 98  FDEFQIATMLK---EILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQL 151

Query: 198 PDGETHIELDSVVGTTGFIAPENF-TTLINEQCDVYGFGAFLFELLTAQEV-SDHVSFES 255
            D  T I+ ++ VGT  ++APE    +  + + D++  G    EL   +   SD      
Sbjct: 152 TD--TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV 209

Query: 256 RFHYEE-NVKRLSGQNCR-FKEMVDSIIIEDKSCTCTGKE 293
            F   + N   L+G+  + FKE +D+ + +D S   T KE
Sbjct: 210 LFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKE 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 10/96 (10%)

Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD 207
           K+A  +   ++YLH   SR I++RD+KP+NIL   +   KL DF +S     GE    L 
Sbjct: 109 KIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLA 160

Query: 208 SV-VGTTGFIAPENFTTL-INEQCDVYGFGAFLFEL 241
               GT+ ++APE       +   DV+  G  L E+
Sbjct: 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 56.4 bits (137), Expect = 3e-09
 Identities = 46/157 (29%), Positives = 70/157 (44%), Gaps = 30/157 (19%)

Query: 105 SRMSHKHIIK-----------LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
            +++H +IIK            IV E    G L+ +I    ++  +       L   + +
Sbjct: 54  KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEG-KPFPEEQILDWFVQL 112

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS--LSIPDGETHIELDSVVG 211
             A+ YLH   SR I++RD+KP NI        KL DF +S  LS     T     +VVG
Sbjct: 113 CLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS----STVDLAKTVVG 165

Query: 212 TTGFIAPENFTTLI-----NEQCDVYGFGAFLFELLT 243
           T  +++PE    L      N + D++  G  L+EL T
Sbjct: 166 TPYYLSPE----LCQNKPYNYKSDIWSLGCVLYELCT 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 40/126 (31%), Positives = 63/126 (50%), Gaps = 16/126 (12%)

Query: 124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ 183
           G L   I+H  E  FE       +  A +I   +  LH      IVYRD+KP NIL ++ 
Sbjct: 85  GDLKFHIYHMGEAGFEE---GRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDH 138

Query: 184 SDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQC----DVYGFGAFLF 239
              ++ D  L++ +P+G+T   +   VGT G++APE    + NE+     D +  G  L+
Sbjct: 139 GHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPE---VVKNERYTFSPDWWALGCLLY 192

Query: 240 ELLTAQ 245
           E++  Q
Sbjct: 193 EMIAGQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 56.4 bits (136), Expect = 5e-09
 Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 11/98 (11%)

Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDS 208
           VA  I   +AYLH    R IV+RD+KP+N+L N   + K+ DF +S  +   +T    +S
Sbjct: 173 VARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL--AQTMDPCNS 227

Query: 209 VVGTTGFIAPENFTTLINE------QCDVYGFGAFLFE 240
            VGT  +++PE   T +N         D++  G  + E
Sbjct: 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265

Length = 353

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 55.6 bits (134), Expect = 6e-09
 Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 10/97 (10%)

Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD 207
           +   ++   V  LH    R I++RD+KP N+L ++    KL DF LS         +E  
Sbjct: 101 QYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLS------RNGLENK 151

Query: 208 SVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLT 243
             VGT  ++APE    +  ++  D +  G  +FE L 
Sbjct: 152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLF 188

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 52/239 (21%), Positives = 95/239 (39%), Gaps = 34/239 (14%)

Query: 106 RMSHKHIIKL-------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMD 152
            + H++I+K              ++ E +  G+L D +  H +Q    ++L   L  +  
Sbjct: 62  TLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQ----INLKRLLLFSSQ 117

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + YL    S+  ++RD+   NIL   +   K+ DF L+  +P+ + +  +     +
Sbjct: 118 ICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174

Query: 213 TGF-IAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
             F  APE   T   +   DV+ FG  L+EL T  + S     E  F     + +     
Sbjct: 175 PIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAE--FLRMIGIAQGQMIV 232

Query: 271 CRFKEMVDS--IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
            R  E++     +    SC              L   C +  P+DRP+  D+   + ++
Sbjct: 233 TRLLELLKEGERLPRPPSCPDE--------VYDLMKLCWEAEPQDRPSFADLILIVDRL 283

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 34/97 (35%), Positives = 53/97 (54%), Gaps = 10/97 (10%)

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGE-THIELDSV 209
           +I+ A+ +LH    + I+YRD+KP NIL + Q   KL DF L   SI +G  TH    + 
Sbjct: 108 EISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH----TF 160

Query: 210 VGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQ 245
            GT  ++APE    +   +  D +  GA ++++LT  
Sbjct: 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGA 197

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 54.8 bits (132), Expect = 1e-08
 Identities = 42/152 (27%), Positives = 75/152 (49%), Gaps = 26/152 (17%)

Query: 100 HIV--YASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAV 157
           +IV  Y + ++  +I   +  E +  G+L DRI+    +    + +    K+A+ +   +
Sbjct: 64  YIVSFYGAFLNENNIC--MCMEFMDCGSL-DRIY----KKGGPIPVEILGKIAVAVVEGL 116

Query: 158 AYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL-DSVVGTTGFI 216
            YL+      I++RD+KP+NIL N +   KL DF +S     GE    + D+ VGT+ ++
Sbjct: 117 TYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFVGTSTYM 169

Query: 217 APE-----NFTTLINEQCDVYGFGAFLFELLT 243
           +PE      +T     + DV+  G  + EL  
Sbjct: 170 SPERIQGGKYTV----KSDVWSLGISIIELAL 197

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 54.4 bits (131), Expect = 2e-08
 Identities = 64/308 (20%), Positives = 119/308 (38%), Gaps = 74/308 (24%)

Query: 53  TNNYDEQNIVLEDPFRKLYKG--FWQKRSISLMKYN--GNRNQHALEWCINHIVYASRMS 108
             N+  +  + +  F  +YK       R ++L K       +  A + C+  I    ++ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 109 HKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRL-------KVA 150
           H ++IK            IV E    G L+  I H  +Q         RL       K  
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQ--------KRLIPERTIWKYF 112

Query: 151 MDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS--LSIPDGETHIELDS 208
           + +  A+ ++H   S+ I++RD+KP N+        KL D  L    S      H    S
Sbjct: 113 VQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH----S 165

Query: 209 VVGTTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQEVSDHVSFESRFHYEE-N 262
           +VGT  +++PE     I+E       D++  G  L+E+          + +S F+ ++ N
Sbjct: 166 LVGTPYYMSPE----RIHENGYNFKSDIWSLGCLLYEM---------AALQSPFYGDKMN 212

Query: 263 VKRLSG--QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
           +  L    + C +  +                +   +  + L  +C++  PE RP +  V
Sbjct: 213 LYSLCKKIEKCDYPPL--------------PADHYSEELRDLVSRCINPDPEKRPDISYV 258

Query: 321 AKQLRQMY 328
            +  ++M+
Sbjct: 259 LQVAKEMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 38/121 (31%), Positives = 59/121 (48%), Gaps = 19/121 (15%)

Query: 134 CEQHFEALSLTDRLK------------VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN 181
           C +H +  SL   LK            V++ +   +AYL       I++RD+KP+NIL N
Sbjct: 81  CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVN 138

Query: 182 EQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFE 240
            + + KL DF +S  + D       +S VGT  +++PE    T  + Q D++  G  L E
Sbjct: 139 SRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 194

Query: 241 L 241
           L
Sbjct: 195 L 195

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 54.1 bits (131), Expect = 2e-08
 Identities = 43/192 (22%), Positives = 80/192 (41%), Gaps = 33/192 (17%)

Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLI---------- 116
           ++   +   ++ +I  M+          E  IN I+      H +I+             
Sbjct: 36  YKATDRATGKEVAIKKMRLRKQN----KELIINEILIMKDCKHPNIVDYYDSYLVGDELW 91

Query: 117 -VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
            V E +  G+L D I     Q+F  ++      V  ++   + YLH   S+ +++RD+K 
Sbjct: 92  VVMEYMDGGSLTDII----TQNFVRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKS 144

Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLI-----NEQCD 230
            NIL ++    KL DF  +  +   +   + +SVVGT  ++APE    +I       + D
Sbjct: 145 DNILLSKDGSVKLADFGFAAQL--TKEKSKRNSVVGTPYWMAPE----VIKRKDYGPKVD 198

Query: 231 VYGFGAFLFELL 242
           ++  G    E+ 
Sbjct: 199 IWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 54.1 bits (130), Expect = 2e-08
 Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 31/175 (17%)

Query: 87  GNRNQHALEWCINHIVYASRMSHKHIIK-------------LIVFESVQIGTLADRIHHH 133
               Q+   W    I     + H++I+K              ++ E V +G+L D +  H
Sbjct: 44  ECGQQNTSGW-KKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH 102

Query: 134 CEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL 193
                  L+L   L  A  I   +AYLH   S+  ++RD+   N+L +     K+ DF L
Sbjct: 103 ------KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGL 153

Query: 194 SLSIPDGETHIEL----DSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLT 243
           + ++P+G  +  +    DS V    + A E       +   DV+ FG  L+ELLT
Sbjct: 154 AKAVPEGHEYYRVREDGDSPV---FWYAVECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 53.8 bits (129), Expect = 3e-08
 Identities = 27/67 (40%), Positives = 41/67 (61%), Gaps = 6/67 (8%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + +LH   S  IVYRDMKP N+L ++Q + +L D  L++ + DG+T   +    GT
Sbjct: 104 ITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGT 157

Query: 213 TGFIAPE 219
            G++APE
Sbjct: 158 NGYMAPE 164

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 53.7 bits (129), Expect = 3e-08
 Identities = 53/269 (19%), Positives = 106/269 (39%), Gaps = 60/269 (22%)

Query: 78  RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTL 126
           + ++ ++   +  +  +E     I   +R++H HII++           +  E +  G++
Sbjct: 31  KQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSV 90

Query: 127 ADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS-D 185
           +  +       + A      +     +   ++YLH      I++RD+K  N+L +     
Sbjct: 91  SHLLS-----KYGAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQR 142

Query: 186 AKLFDFSLSLSIPDGETHIEL--DSVVGTTGFIAPENFTTLINEQ----CDVYGFGAFLF 239
            ++ DF  +  +    T        ++GT  F+APE    L  EQ    CDV+  G  + 
Sbjct: 143 LRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE---VLRGEQYGRSCDVWSVGCVII 199

Query: 240 ELLT------AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKE 293
           E+ T      A++ S+H++                    FK       I   +   +  E
Sbjct: 200 EMATAKPPWNAEKHSNHLAL------------------IFK-------IASATTAPSIPE 234

Query: 294 QQLQAFKQLTLQCMDFSPEDRPTMVDVAK 322
                 + +TL+C++  PEDRP   ++ K
Sbjct: 235 HLSPGLRDVTLRCLELQPEDRPPSRELLK 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 52.9 bits (127), Expect = 6e-08
 Identities = 51/233 (21%), Positives = 94/233 (40%), Gaps = 50/233 (21%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCE--QHFEALSLTDRL-KVAM 151
           ++ H +I++            IV + ++   L +  +   E  Q F      +R+  + +
Sbjct: 65  QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTE----ERIWNIFV 120

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
            +  A+ YLH    + IV+RD+ P NI+  E     + DF L+      +   +L SVVG
Sbjct: 121 QMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLA---KQKQPESKLTSVVG 175

Query: 212 TTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ- 269
           T  +  PE        E+ DV+ FG  L+++ T Q             Y  N+  L+ + 
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPP----------FYSTNMLSLATKI 225

Query: 270 -NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVA 321
               ++ + + +  ED +   T               C+    E RP ++ V+
Sbjct: 226 VEAVYEPLPEGMYSEDVTDVIT--------------SCLTPDAEARPDIIQVS 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 52.9 bits (127), Expect = 6e-08
 Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 12/97 (12%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + +LH    R I+YRD+KP N+L +   + ++ D  L++ + DG++  +     GT
Sbjct: 106 IISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK--GYAGT 160

Query: 213 TGFIAPENFTTLINEQ----CDVYGFGAFLFELLTAQ 245
            GF+APE    L  E+     D +  G  L+E++ A+
Sbjct: 161 PGFMAPE---LLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 52.7 bits (126), Expect = 6e-08
 Identities = 45/146 (30%), Positives = 72/146 (49%), Gaps = 9/146 (6%)

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I   + YLH   S   ++RD+K  N+L +EQ D KL DF ++  + D  T I+ ++ VG
Sbjct: 109 EILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVG 163

Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQ-EVSDHVSFESRFHYEENV-KRLSG 268
           T  ++APE    +  + + D++  G    EL   +   SD       F   +N    L G
Sbjct: 164 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEG 223

Query: 269 QNCR-FKEMVDSIIIEDKSCTCTGKE 293
           Q  + FKE V++ + +D     T KE
Sbjct: 224 QYSKPFKEFVEACLNKDPRFRPTAKE 249

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 52.1 bits (125), Expect = 8e-08
 Identities = 36/161 (22%), Positives = 69/161 (42%), Gaps = 20/161 (12%)

Query: 95  EWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSL 143
           E  I+     +++   +II+            IV E  + G L   +     Q    L  
Sbjct: 44  EEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLK---MQRGRPLPE 100

Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
               +  + I   +A+LH   S+ I++RD+K  N+  +   + K+ D  ++  +   +  
Sbjct: 101 DQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL--SDNT 155

Query: 204 IELDSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLT 243
              +++VGT  +++PE       NE+ DV+  G  L+E  T
Sbjct: 156 NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCT 196

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 53.1 bits (127), Expect = 8e-08
 Identities = 43/176 (24%), Positives = 79/176 (44%), Gaps = 27/176 (15%)

Query: 74  FWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHH 133
           FW++R I  M +  +       W +   ++ +    K++   +V E +  G L + + ++
Sbjct: 90  FWEERDI--MAFANS------PWVVQ--LFCAFQDDKYL--YMVMEYMPGGDLVNLMSNY 137

Query: 134 CEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL 193
                 A   T  + +A+D  H++  +H         RD+KP N+L ++    KL DF  
Sbjct: 138 DVPEKWAKFYTAEVVLALDAIHSMGLIH---------RDVKPDNMLLDKHGHLKLADFGT 188

Query: 194 SLSIPDGETHIELDSVVGTTGFIAPENFTT-----LINEQCDVYGFGAFLFELLTA 244
            + + D    +  D+ VGT  +I+PE   +         +CD +  G FLFE+L  
Sbjct: 189 CMKM-DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 30/106 (28%), Positives = 53/106 (50%), Gaps = 15/106 (14%)

Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
           T  + +A+D  H++ ++H         RD+KP N+L ++    KL DF   + + + E  
Sbjct: 148 TAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKM-NKEGM 197

Query: 204 IELDSVVGTTGFIAPENFTT-----LINEQCDVYGFGAFLFELLTA 244
           +  D+ VGT  +I+PE   +         +CD +  G FL+E+L  
Sbjct: 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 41/173 (23%), Positives = 70/173 (40%), Gaps = 30/173 (17%)

Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD 207
           K+ + I  A+ YL       +++RD+KP+NIL +   + KL DF +S  + D +      
Sbjct: 118 KMTVAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---T 172

Query: 208 SVVGTTGFIAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEEN 262
              G   ++APE     +     + + DV+  G  L EL T Q           F Y+  
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQ-----------FPYK-- 219

Query: 263 VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP 315
                  NC+ +  V + I++++  +    E     F      C+      RP
Sbjct: 220 -------NCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRP 265

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 52.1 bits (125), Expect = 1e-07
 Identities = 39/124 (31%), Positives = 58/124 (46%), Gaps = 21/124 (16%)

Query: 134 CEQHFEALSLTDRLKVAM--------DIAHAV----AYLHVGFSRPIVYRDMKPTNILFN 181
           C +H +  SL   LK A          I+ AV     YL       I++RD+KP+NIL N
Sbjct: 77  CMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVN 134

Query: 182 EQSDAKLFDFSLSLSIPDGETHIEL-DSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLF 239
            + + KL DF +S     G+    + +S VGT  +++PE    T    Q D++  G  L 
Sbjct: 135 SRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLV 189

Query: 240 ELLT 243
           E+  
Sbjct: 190 EMAI 193

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 31/125 (24%), Positives = 53/125 (42%), Gaps = 22/125 (17%)

Query: 137 HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS 196
             E  S+   L +   I   + Y+H   S+ +++RD+KP NIL     +  + D+  ++ 
Sbjct: 106 LAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIF 162

Query: 197 IPDGETHIELDS-----------------VVGTTGFIAPENFT-TLINEQCDVYGFGAFL 238
               E    LD                  +VGT  ++APE       +E  D+Y  G  L
Sbjct: 163 K-KLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVIL 221

Query: 239 FELLT 243
           +++LT
Sbjct: 222 YQMLT 226

Length = 932

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 45/175 (25%), Positives = 74/175 (42%), Gaps = 33/175 (18%)

Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD 207
           ++A+ +   + YL   +S  I++RD+KP+N+L N +   KL DF +S  + +        
Sbjct: 99  RIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIA----K 151

Query: 208 SVVGTTGFIAPENFTTLINEQ----CDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENV 263
           + VGT  ++APE    +  EQ     DV+  G    EL              RF Y +  
Sbjct: 152 TYVGTNAYMAPER---ISGEQYGIHSDVWSLGISFMELALG-----------RFPYPQ-- 195

Query: 264 KRLSGQNCRFK--EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
             +          +++  I+ ED      G  Q  + F     QCM   P++RP 
Sbjct: 196 --IQKNQGSLMPLQLLQCIVDEDPPVLPVG--QFSEKFVHFITQCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 41/152 (26%), Positives = 75/152 (49%), Gaps = 22/152 (14%)

Query: 105 SRMSHKHIIK-----------LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
             +SH +II+           +IV E    GTLA+ I   C    +  ++   L   + I
Sbjct: 54  KLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTI---LHFFVQI 110

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNE-QSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
             A+ ++H   ++ I++RD+K  NIL ++ +   K+ DF +S  +    +  +  +VVGT
Sbjct: 111 LLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGT 164

Query: 213 TGFIAPENFTTL-INEQCDVYGFGAFLFELLT 243
             +I+PE       N++ D++  G  L+EL +
Sbjct: 165 PCYISPELCEGKPYNQKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 51.4 bits (124), Expect = 2e-07
 Identities = 29/98 (29%), Positives = 48/98 (48%), Gaps = 17/98 (17%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  +  A+ YLH   S  IVYRD+KP N+L +     K+ DF  +  +    T+    ++
Sbjct: 107 AAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-TY----TL 158

Query: 210 VGTTGFIAPENFTTLI-----NEQCDVYGFGAFLFELL 242
            GT  ++APE    +I      +  D +  G  ++E+L
Sbjct: 159 CGTPEYLAPE----IILSKGYGKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 51.1 bits (122), Expect = 2e-07
 Identities = 41/172 (23%), Positives = 79/172 (45%), Gaps = 40/172 (23%)

Query: 105 SRMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           +++ HK++++L          IV E +  G L + +          +S+   L+ ++D+A
Sbjct: 54  TKLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRA---LVSVIQLLQFSLDVA 110

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
             + YL    S+ +V+RD+   NIL +E   AK+ DF L+     G     +D+      
Sbjct: 111 EGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-----VDNSKLPVK 162

Query: 215 FIAPE-----NFTTLINEQCDVYGFGAFLFEL----------LTAQEVSDHV 251
           + APE      F++    + DV+ +G  L+E+          ++ +EV + V
Sbjct: 163 WTAPEALKHKKFSS----KSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV 210

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 36/122 (29%), Positives = 57/122 (46%), Gaps = 14/122 (11%)

Query: 130 IHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLF 189
           +    + +  AL+ T   K    I   V YLH   S  IV+RD+K  NIL +   + KL 
Sbjct: 91  VKDQLKAY-GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLG 146

Query: 190 DFSLSLSIPDGETHIE-LDSVVGTTGFIAPENFTTLIN-----EQCDVYGFGAFLFELLT 243
           DF  S  +    +    + SV GT  +++PE    +I+      + DV+  G  + E+LT
Sbjct: 147 DFGASKRLQTICSSGTGMKSVTGTPYWMSPE----VISGEGYGRKADVWSVGCTVVEMLT 202

Query: 244 AQ 245
            +
Sbjct: 203 EK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 33/121 (27%), Positives = 58/121 (47%), Gaps = 15/121 (12%)

Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           IV E +  G+LAD +          +       +A  I   + YLH    R I++RD+KP
Sbjct: 76  IVLEYMDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKP 128

Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFG 235
           +N+L N + + K+ DF +S  + +     + ++ VGT  +++PE        Q + Y + 
Sbjct: 129 SNLLINSKGEVKIADFGISKVLENTLD--QCNTFVGTVTYMSPERI------QGESYSYA 180

Query: 236 A 236
           A
Sbjct: 181 A 181

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 29/130 (22%), Positives = 50/130 (38%), Gaps = 20/130 (15%)

Query: 101 IVYASRMSHKHIIKLI-----------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKV 149
           I       H +++KL+           V E +    L++ +    E+     +       
Sbjct: 50  IKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRD--EERPLPEAQVKSY-- 104

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
              +   VAY+H   +  I++RD+KP N+L +     K+ DF L+      E        
Sbjct: 105 MRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLF-SEEEPRLYSHQ 160

Query: 210 VGTTGFIAPE 219
           V T  + APE
Sbjct: 161 VATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 51.2 bits (122), Expect = 2e-07
 Identities = 38/101 (37%), Positives = 52/101 (51%), Gaps = 20/101 (19%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL---SLSIPDGETHIEL 206
           A +IA A+ YLH   S  IVYRD+KP NIL + Q    L DF L    ++  D  T    
Sbjct: 102 AAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTT---- 154

Query: 207 DSVVGTTGFIAPENFTTLINEQ-----CDVYGFGAFLFELL 242
            +  GT  ++APE    +I +Q      D +  GA L+E+L
Sbjct: 155 -TFCGTPEYLAPE----VIRKQPYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 50.5 bits (121), Expect = 3e-07
 Identities = 51/247 (20%), Positives = 89/247 (36%), Gaps = 45/247 (18%)

Query: 87  GNRNQHALEWCINHIVYASRMSHKHII----------KL-IVFESVQIGTLADRIHHHCE 135
           G+ +Q   E  +N I   + ++H +II          KL IV E    G L+  I     
Sbjct: 36  GSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISK--R 93

Query: 136 QHFEALSLTDRL-KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS 194
           +    L     + ++ + +   +  LH    + I++RD+K  NIL       K+ D    
Sbjct: 94  KKKRKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGD---- 146

Query: 195 LSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSF 253
           L I          + +GT  ++APE +     + + D++  G  L+E+ T         F
Sbjct: 147 LGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA-----PPF 201

Query: 254 ESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPED 313
           E+R   +   K   G+      +                 Q LQ         +   P+ 
Sbjct: 202 EARSMQDLRYKVQRGKYPPIPPIYS---------------QDLQ---NFIRSMLQVKPKL 243

Query: 314 RPTMVDV 320
           RP    +
Sbjct: 244 RPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 51.2 bits (122), Expect = 3e-07
 Identities = 36/96 (37%), Positives = 48/96 (50%), Gaps = 10/96 (10%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS--IPDGETHIELD 207
           A +IA A+ YLH   S  IVYRD+KP NIL + Q    L DF L       +G T     
Sbjct: 102 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT----S 154

Query: 208 SVVGTTGFIAPENF-TTLINEQCDVYGFGAFLFELL 242
           +  GT  ++APE       +   D +  GA L+E+L
Sbjct: 155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 50.3 bits (121), Expect = 3e-07
 Identities = 45/152 (29%), Positives = 70/152 (46%), Gaps = 28/152 (18%)

Query: 100 HIV--YASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFE---ALSLTDRLKVAMDIA 154
           +IV  Y S   +  +   IV E    G+++D +    +   E   A  L   LK      
Sbjct: 59  YIVKYYGSYFKNTDL--WIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLK------ 110

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
             + YLH   S   ++RD+K  NIL NE+  AKL DF +S  + D  T  + ++V+GT  
Sbjct: 111 -GLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD--TMAKRNTVIGTPF 164

Query: 215 FIAPENFTTLINEQ-----CDVYGFGAFLFEL 241
           ++APE    +I E       D++  G    E+
Sbjct: 165 WMAPE----VIQEIGYNNKADIWSLGITAIEM 192

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 50.7 bits (121), Expect = 3e-07
 Identities = 44/191 (23%), Positives = 83/191 (43%), Gaps = 28/191 (14%)

Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
            AL++ D +  A  I+  + YL       +V+RD+   N+L  E    K+ DF LS  + 
Sbjct: 122 RALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVY 178

Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT-AQEVSDHVSFESR 256
           + +++++         ++A E+ F  +   Q DV+ FG  L+E++T        ++ E  
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERL 238

Query: 257 FHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
           F+  +   R+                 ++   C+      +    L L C    P+ RPT
Sbjct: 239 FNLLKTGYRM-----------------ERPENCS------EEMYNLMLTCWKQEPDKRPT 275

Query: 317 MVDVAKQLRQM 327
             D++K+L +M
Sbjct: 276 FADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 50.8 bits (121), Expect = 3e-07
 Identities = 31/95 (32%), Positives = 51/95 (53%), Gaps = 7/95 (7%)

Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD 207
           KV++ +   + YL       I++RD+KP+NIL N + + KL DF +S  + D       +
Sbjct: 107 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 160

Query: 208 SVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFEL 241
           S VGT  +++PE    T  + Q D++  G  L E+
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 195

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 30/98 (30%), Positives = 46/98 (46%), Gaps = 8/98 (8%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL-SIPDGETHIELDS 208
           A +I   + +LH    R I+YRD+K  N+L + +   K+ DF +    I  G T     +
Sbjct: 102 AAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT---TST 155

Query: 209 VVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQ 245
             GT  +IAPE  +        D +  G  L+E+L  Q
Sbjct: 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 50.6 bits (122), Expect = 3e-07
 Identities = 30/106 (28%), Positives = 46/106 (43%), Gaps = 21/106 (19%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
            + H +I+KL           +VFE   +    D +  + ++    LS      +   + 
Sbjct: 54  ELKHPNIVKLLDVIHTERKLYLVFEYCDM----D-LKKYLDKRPGPLSPNLIKSIMYQLL 108

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS--LSIP 198
             +AY H   S  I++RD+KP NIL N     KL DF L+    IP
Sbjct: 109 RGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP 151

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 50.7 bits (121), Expect = 4e-07
 Identities = 34/96 (35%), Positives = 48/96 (50%), Gaps = 10/96 (10%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS--IPDGETHIELD 207
           A ++A A+ YLH   S  I+YRD+KP NIL + Q    L DF L      P+  T     
Sbjct: 102 AAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT----S 154

Query: 208 SVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELL 242
           +  GT  ++APE       +   D +  GA L+E+L
Sbjct: 155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 34/98 (34%), Positives = 49/98 (50%), Gaps = 14/98 (14%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A +IA A+ YLH   S  I+YRD+KP NIL + Q    L DF L     +        + 
Sbjct: 102 AAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTF 156

Query: 210 VGTTGFIAPENFTTLINEQ-----CDVYGFGAFLFELL 242
            GT  ++APE    ++ +Q      D +  GA L+E+L
Sbjct: 157 CGTPEYLAPE----VLRKQPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 33/116 (28%), Positives = 48/116 (41%), Gaps = 33/116 (28%)

Query: 156 AVAYLH-VGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG--------ETHIEL 206
           A+  +H +GF    ++RD+KP NIL +     KL DF L   +           ++H  L
Sbjct: 113 ALDSVHKLGF----IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLL 168

Query: 207 D-------------------SVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELL 242
                               S VGT  +IAPE    T    +CD +  G  L+E+L
Sbjct: 169 FRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 50.2 bits (121), Expect = 5e-07
 Identities = 37/152 (24%), Positives = 58/152 (38%), Gaps = 24/152 (15%)

Query: 107 MSHKHIIKL--IVFESVQIGT----------LADRIHHHCEQHFEALSLTDRLKVAM-DI 153
           + H +I++L  IV    +             L   +    E  F       ++K  M  +
Sbjct: 55  LRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLT-GLLDSPEVKFT----ESQIKCYMKQL 109

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT 213
              + YLH   S  I++RD+K +NIL N     KL DF L+          +  + V T 
Sbjct: 110 LEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPY-TKRNSADYTNRVITL 165

Query: 214 GFIAPENF--TTLINEQCDVYGFGAFLFELLT 243
            +  PE     T    + D++  G  L EL  
Sbjct: 166 WYRPPELLLGATRYGPEVDMWSVGCILAELFL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 50.5 bits (121), Expect = 5e-07
 Identities = 31/107 (28%), Positives = 54/107 (50%), Gaps = 21/107 (19%)

Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
           T  + +A+D  H++ ++H         RD+KP N+L ++    KL DF   + + D    
Sbjct: 148 TAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKM-DANGM 197

Query: 204 IELDSVVGTTGFIAPENFTTLINE--------QCDVYGFGAFLFELL 242
           +  D+ VGT  +I+PE    L ++        +CD +  G FL+E+L
Sbjct: 198 VRCDTAVGTPDYISPE---VLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 50.0 bits (119), Expect = 5e-07
 Identities = 56/245 (22%), Positives = 100/245 (40%), Gaps = 40/245 (16%)

Query: 97  CINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTD 145
           CI  I    +++H ++IK            IV E    G L+  I H  +Q    +    
Sbjct: 49  CIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK-RLIPEKT 107

Query: 146 RLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIE 205
             K  + +  A+ ++H   SR +++RD+KP N+        KL D  L        T   
Sbjct: 108 VWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164

Query: 206 LDSVVGTTGFIAPENF-TTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEE-NV 263
             S+VGT  +++PE       N + D++  G  L+E+          + +S F+ ++ N+
Sbjct: 165 --SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM---------AALQSPFYGDKMNL 213

Query: 264 KRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ 323
             L    C+  E  D   +          +   +  +QL   C++  PE RP +  V   
Sbjct: 214 YSL----CKKIEQCDYPPLP--------SDHYSEELRQLVNMCINPDPEKRPDITYVYDV 261

Query: 324 LRQMY 328
            ++M+
Sbjct: 262 AKRMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 129 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 180

Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 181 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 224

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 49.7 bits (119), Expect = 6e-07
 Identities = 41/212 (19%), Positives = 85/212 (40%), Gaps = 34/212 (16%)

Query: 67  FRKLYKGFWQ------KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLI---- 116
           F  +YKG W       K  +++       +  A +  ++     + + H H+++L+    
Sbjct: 20  FGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL 79

Query: 117 ------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVY 170
                 + + + +G L D    +   H + +     L   + IA  ++YL     + +V+
Sbjct: 80  SSQVQLITQLMPLGCLLD----YVRNHKDNIGSQYLLNWCVQIAKGMSYLE---EKRLVH 132

Query: 171 RDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLI-NEQC 229
           RD+   N+L       K+ DF L+  +   E     +       ++A E+    I   + 
Sbjct: 133 RDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKS 192

Query: 230 DVYGFGAFLFELLT----------AQEVSDHV 251
           DV+ +G  ++EL+T          A E+ D +
Sbjct: 193 DVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 49.7 bits (119), Expect = 7e-07
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 9/94 (9%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A +I  A+ YLH   S+ IVYRD+KP NIL +++   KL DF  +  + D  T     ++
Sbjct: 107 ASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-RTW----TL 158

Query: 210 VGTTGFIAPENF-TTLINEQCDVYGFGAFLFELL 242
            GT  ++APE   +   N+  D +  G  ++E+L
Sbjct: 159 CGTPEYLAPEVIQSKGHNKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 8e-07
 Identities = 30/92 (32%), Positives = 43/92 (46%), Gaps = 9/92 (9%)

Query: 158 AYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIA 217
           AYLH       ++RD+K  NIL  E  D KL DF +S  +    T  +  S +GT  ++A
Sbjct: 115 AYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQL--TATIAKRKSFIGTPYWMA 169

Query: 218 PE----NFTTLINEQCDVYGFGAFLFELLTAQ 245
           PE          + +CD++  G    EL   Q
Sbjct: 170 PEVAAVERKGGYDGKCDIWALGITAIELAELQ 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 49.3 bits (117), Expect = 9e-07
 Identities = 53/245 (21%), Positives = 93/245 (37%), Gaps = 42/245 (17%)

Query: 97  CINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTD 145
           C+  I    +++H ++IK            IV E    G L+  I +  +Q    +    
Sbjct: 49  CVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQK-RLIPERT 107

Query: 146 RLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIE 205
             K  + +  AV ++H   SR +++RD+KP N+        KL D  L        T   
Sbjct: 108 VWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 164

Query: 206 LDSVVGTTGFIAPENF-TTLINEQCDVYGFGAFLFELLTAQE--VSDHVSFESRFHYEEN 262
             S+VGT  +++PE       N + D++  G  L+E+   Q     D ++  S     E 
Sbjct: 165 --SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIE- 221

Query: 263 VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK 322
                   C +  +                E   +  ++L   C+   P+ RP +  V +
Sbjct: 222 -------QCDYPPL--------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260

Query: 323 QLRQM 327
             +QM
Sbjct: 261 IAKQM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 49.4 bits (118), Expect = 9e-07
 Identities = 31/97 (31%), Positives = 49/97 (50%), Gaps = 6/97 (6%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A +I   + +LH    + I+YRD+K  N+L ++    K+ DF +     +GE   +  + 
Sbjct: 102 AAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG--KASTF 156

Query: 210 VGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQ 245
            GT  +IAPE       NE  D + FG  L+E+L  Q
Sbjct: 157 CGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 54/243 (22%), Positives = 95/243 (39%), Gaps = 54/243 (22%)

Query: 105 SRMSHKHIIKLI----------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           +++ H  I++LI          V E   +G L   +     +      L    ++A  +A
Sbjct: 51  AQLDHPCIVRLIGVCKGEPLMLVMELAPLGPLLKYLKKR--REIPVSDL---KELAHQVA 105

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
             +AYL    S+  V+RD+   N+L   +  AK+ DF +S ++  G  +        TT 
Sbjct: 106 MGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR-----ATTA 157

Query: 215 ------FIAPE--NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRL 266
                 + APE  N+    + + DV+ +G  L+E           S+ ++  Y E    +
Sbjct: 158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEA---------FSYGAK-PYGE----M 202

Query: 267 SGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQ 326
            G       M++S     +   C       Q    + L C  + PEDRPT  ++    R+
Sbjct: 203 KGAE--VIAMLESGERLPRPEECP------QEIYSIMLSCWKYRPEDRPTFSELESTFRR 254

Query: 327 MYR 329
              
Sbjct: 255 DPE 257

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 41/149 (27%), Positives = 69/149 (46%), Gaps = 27/149 (18%)

Query: 109 HKHIIKLI----------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVA 158
           H HI+KLI          V E   +G L      + + +  +L L   +  +  ++ A+A
Sbjct: 66  HPHIVKLIGVITENPVWIVMELAPLGEL----RSYLQVNKYSLDLASLILYSYQLSTALA 121

Query: 159 YLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAP 218
           YL    S+  V+RD+   N+L +     KL DF LS  + D E++ +         ++AP
Sbjct: 122 YLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED-ESYYKASKGKLPIKWMAP 177

Query: 219 EN-----FTTLINEQCDVYGFGAFLFELL 242
           E+     FT+      DV+ FG  ++E+L
Sbjct: 178 ESINFRRFTS----ASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 48.6 bits (116), Expect = 1e-06
 Identities = 52/231 (22%), Positives = 87/231 (37%), Gaps = 57/231 (24%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           ++ H  +I+L           IV E ++ G+L + +     +    L L   + +A  +A
Sbjct: 57  KLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRA---LKLPQLIDMAAQVA 113

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
             +AYL    ++  ++RD+   N+L  E +  K+ DF L+  I +       ++  G   
Sbjct: 114 SGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKED----IYEAREGAKF 166

Query: 215 FI---APE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRL 266
            I   APE      F+     + DV+ FG  L E++T            R  Y       
Sbjct: 167 PIKWTAPEAALYNRFSI----KSDVWSFGILLTEIVT----------YGRMPY------- 205

Query: 267 SGQ-NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
            G  N    + VD          C       +    + L C    P+DRPT
Sbjct: 206 PGMTNAEVLQQVDQGYRMPCPPGCP------KELYDIMLDCWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 48.5 bits (116), Expect = 1e-06
 Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 15/103 (14%)

Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD 207
           K+A+ +   + YLH      I++RD+KP+NIL N +   KL DF +S     G+    ++
Sbjct: 104 KIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVS-----GQL---VN 153

Query: 208 SV----VGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQ 245
           S+    VGT+ ++APE       + + D++  G  L EL T +
Sbjct: 154 SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 20/106 (18%)

Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD 207
           K+A+ I  A+ YLH   S  +++RD+KP+N+L N     KL DF +S  +        +D
Sbjct: 107 KIAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL--------VD 156

Query: 208 SVV-----GTTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLT 243
           SV      G   ++APE     +N++      DV+  G  + EL T
Sbjct: 157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELAT 202

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 31/92 (33%), Positives = 46/92 (50%), Gaps = 7/92 (7%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG--ETHIELDSVVGTT 213
            + YLH   S   ++RD+K  NIL  E    K+ DF +S S+ DG   T     + VGT 
Sbjct: 114 GLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170

Query: 214 GFIAPENFTTL--INEQCDVYGFGAFLFELLT 243
            ++APE    +   + + D++ FG    EL T
Sbjct: 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELAT 202

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 48.0 bits (115), Expect = 2e-06
 Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 6/93 (6%)

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           ++   + YLH       ++RD+K  NIL +E+ D KL DF +S  +    T  + ++ VG
Sbjct: 106 EVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQL--TSTMSKRNTFVG 160

Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLT 243
           T  ++APE    +  +E+ D++  G    EL  
Sbjct: 161 TPFWMAPEVIKQSGYDEKADIWSLGITAIELAK 193

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 30/91 (32%), Positives = 45/91 (49%), Gaps = 13/91 (14%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
           A+ +LH      IVYRD+KP NIL +      L DF LS    +   +   ++  GTT +
Sbjct: 108 ALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEY 162

Query: 216 IAPENFTTLINE-----QCDVYGFGAFLFEL 241
           +APE    L++E       D +  G  +FE+
Sbjct: 163 LAPE---VLLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 47.5 bits (113), Expect = 3e-06
 Identities = 55/274 (20%), Positives = 104/274 (37%), Gaps = 45/274 (16%)

Query: 69  KLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IV 117
           ++Y+G W+K S+++       +   +E  +        + H ++++L           I+
Sbjct: 21  EVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80

Query: 118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTN 177
            E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++RD+   N
Sbjct: 81  TEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAARN 134

Query: 178 ILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGA 236
            L  E    K+ DF LS  +  G+T+           + APE+      + + DV+ FG 
Sbjct: 135 CLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGV 193

Query: 237 FLFELLT-AQEVSDHVSFESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQ 294
            L+E+ T        +     +   E   R+   + C  K                    
Sbjct: 194 LLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPK-------------------- 233

Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY 328
                 +L   C  ++P DRP+  ++ +    M+
Sbjct: 234 ----VYELMRACWQWNPSDRPSFAEIHQAFETMF 263

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 33/151 (21%), Positives = 67/151 (44%), Gaps = 29/151 (19%)

Query: 147 LKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL 206
           L +A+   H + Y+H         RD+KP N+L +     KL DF  +  +      +  
Sbjct: 111 LVLAIHSVHQMGYVH---------RDIKPENVLIDRTGHIKLADFGSAARL-TANKMVNS 160

Query: 207 DSVVGTTGFIAPENFTTLINE-------QCDVYGFGAFLFELLTAQ----EVSDHVSFES 255
              VGT  +IAPE  TT+  +       +CD +  G   +E++  +    E +   ++ +
Sbjct: 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNN 220

Query: 256 RFHYEENVK-----RLSGQNCRFKEMVDSII 281
             +++  +K     ++S     F +++ S++
Sbjct: 221 IMNFQRFLKFPEDPKVSSD---FLDLIQSLL 248

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 38/105 (36%), Positives = 49/105 (46%), Gaps = 25/105 (23%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS------LSIPDGETHIELDS- 208
           A+ YLH   +  IV+RD+KP N+L       KL DF LS      L+    E HIE D+ 
Sbjct: 113 ALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTR 169

Query: 209 ------VVGTTGFIAPENFTTLINEQ-----CDVYGFGAFLFELL 242
                 V GT  +IAPE    +I  Q      D +  G  L+E L
Sbjct: 170 EFLDKQVCGTPEYIAPE----VILRQGYGKPVDWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 47.5 bits (113), Expect = 4e-06
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 9/88 (10%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
           A  YLH   S+ I+YRD+KP N+L + +   K+ DF  +  +PD  T     ++ GT  +
Sbjct: 130 AFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD-RTF----TLCGTPEY 181

Query: 216 IAPENFTTL-INEQCDVYGFGAFLFELL 242
           +APE   +    +  D +  G  L+E +
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFI 209

Length = 329

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 46.9 bits (112), Expect = 5e-06
 Identities = 23/100 (23%), Positives = 47/100 (47%), Gaps = 5/100 (5%)

Query: 147 LKVAMDIAHAVAYLHVGF--SRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHI 204
            ++   +  A+   H        +++RD+KP NI  +  ++ KL DF L+  +       
Sbjct: 108 WRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD--SS 165

Query: 205 ELDSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLT 243
              + VGT  +++PE    +  +E+ D++  G  ++EL  
Sbjct: 166 FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCA 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 47.3 bits (113), Expect = 5e-06
 Identities = 30/98 (30%), Positives = 50/98 (51%), Gaps = 14/98 (14%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ P+ +    L   V 
Sbjct: 115 ILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171

Query: 212 TTGFIAPE------NFTTLINEQCDVYGFGAFLFELLT 243
           T  + APE       +T  I    D++  G  L E+L+
Sbjct: 172 TRWYRAPEIMLNSKGYTKAI----DIWSVGCILAEMLS 205

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.2 bits (112), Expect = 6e-06
 Identities = 50/203 (24%), Positives = 81/203 (39%), Gaps = 43/203 (21%)

Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI- 197
           E L+L D +  +  +A  + +L    SR  ++RD+   NIL +E +  K+ DF L+  I 
Sbjct: 168 EPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224

Query: 198 --PD----GETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT-AQEVSD 249
             PD    G+  + L        ++APE+ F  +   Q DV+ FG  L+E+ +       
Sbjct: 225 KDPDYVRKGDARLPLK-------WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYP 277

Query: 250 HVSFESRFHYEENVKRLSGQNC-RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMD 308
            V  +  F             C R KE                 E        + L C  
Sbjct: 278 GVQIDEEF-------------CRRLKEGT----------RMRAPEYATPEIYSIMLDCWH 314

Query: 309 FSPEDRPTMVDVAKQLRQMYRSC 331
            +PEDRPT  ++ + L  + +  
Sbjct: 315 NNPEDRPTFSELVEILGDLLQEN 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 46.8 bits (111), Expect = 6e-06
 Identities = 34/108 (31%), Positives = 52/108 (48%), Gaps = 13/108 (12%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
           A +I  A+ +LH    + I+YRD+K  N+L + +   KL DF +    I +G+T     +
Sbjct: 102 AAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT---TST 155

Query: 209 VVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFES 255
             GT  +IAPE     L     D +  G  L+E+L       H  FE+
Sbjct: 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEML-----CGHAPFEA 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 46.5 bits (111), Expect = 6e-06
 Identities = 29/105 (27%), Positives = 49/105 (46%), Gaps = 21/105 (20%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS--LSIPDGETHIELDSVV 210
               +AYLH      +++RD+K  NIL  + ++ KL DF +S  L    G  +    + +
Sbjct: 122 TLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN----TFI 174

Query: 211 GTTGFIAPE------NFTTLINEQCDVYGFGAFLFELLTAQEVSD 249
           GT  ++APE            + + DV+  G      +TA E++D
Sbjct: 175 GTPYWMAPEVIACDEQPDASYDARSDVWSLG------ITAIELAD 213

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 46.9 bits (111), Expect = 7e-06
 Identities = 33/108 (30%), Positives = 56/108 (51%), Gaps = 11/108 (10%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL--SIPDGETHIELDSVVGTT 213
            + Y H    R +++RD+KP N+L NE+ + KL DF L+   SIP   T    + VV T 
Sbjct: 116 GLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP---TKTYSNEVV-TL 168

Query: 214 GFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHY 259
            +  P+    +T  + Q D++G G   +E+ T + +    + E + H+
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHF 216

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 46.7 bits (111), Expect = 7e-06
 Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 13/104 (12%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  +V+RD+KP+NIL NE  D K+ DF L+  I D     ++   V T
Sbjct: 117 ILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLA-RIQDP----QMTGYVST 168

Query: 213 TGFIAPENFTTL--INEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE   T    + + D++  G    E+L  + +    DHV
Sbjct: 169 RYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHV 212

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 46.8 bits (112), Expect = 7e-06
 Identities = 33/95 (34%), Positives = 47/95 (49%), Gaps = 14/95 (14%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI-PDGETHIELDSVVGTTG 214
            + YLH   S  +++RD+KP+NIL N   D K+ DF L+  + PD +    L   V T  
Sbjct: 115 GLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171

Query: 215 FIAPE------NFTTLINEQCDVYGFGAFLFELLT 243
           + APE       +T  I    D++  G    ELLT
Sbjct: 172 YRAPELLLSSSRYTKAI----DIWSVGCIFAELLT 202

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 46.5 bits (110), Expect = 7e-06
 Identities = 34/110 (30%), Positives = 49/110 (44%), Gaps = 6/110 (5%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A +I   + +LH   S+ IVYRD+K  NIL +     K+ DF +      G+   +  + 
Sbjct: 102 AAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KTCTF 156

Query: 210 VGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFH 258
            GT  +IAPE       N   D + FG  L+E+L  Q        E  F 
Sbjct: 157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 46.5 bits (111), Expect = 8e-06
 Identities = 35/120 (29%), Positives = 46/120 (38%), Gaps = 41/120 (34%)

Query: 156 AVAYLHV-GFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI---------------PD 199
           A+ YLH+ G    IVYRD+KP NIL +E     L DF LS                    
Sbjct: 115 ALEYLHLLG----IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRR 170

Query: 200 GETHIELD------------SVVGTTGFIAPENFTTLINEQ-----CDVYGFGAFLFELL 242
              +                S VGT  +IAPE    +I+        D +  G  L+E+L
Sbjct: 171 SSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE----VISGDGHGSAVDWWTLGILLYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 46.9 bits (111), Expect = 8e-06
 Identities = 28/107 (26%), Positives = 49/107 (45%), Gaps = 4/107 (3%)

Query: 138 FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI 197
            E L+  D L     +A  + +L    S+  V+RD+   N+L  +    K+ DF L+  I
Sbjct: 231 SEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLARDI 287

Query: 198 PDGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
                ++   S      ++APE+ F  L     DV+ +G  L+E+ +
Sbjct: 288 MHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 46.5 bits (110), Expect = 8e-06
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 4/106 (3%)

Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E LS  D +  A  +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I 
Sbjct: 135 EQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 191

Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             + + +  +      ++APE  F  +   Q DV+ FG  L+E+ T
Sbjct: 192 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 46.5 bits (110), Expect = 9e-06
 Identities = 31/110 (28%), Positives = 54/110 (49%), Gaps = 4/110 (3%)

Query: 135 EQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS 194
           +   E LS  D +  A  +A  + YL    SR  ++RD+   N+L  E +  K+ DF L+
Sbjct: 125 KVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLA 181

Query: 195 LSIPDGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             + D + + +  +      ++APE  F  +   Q DV+ FG  ++E+ T
Sbjct: 182 RGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 46.2 bits (109), Expect = 9e-06
 Identities = 60/262 (22%), Positives = 105/262 (40%), Gaps = 53/262 (20%)

Query: 79  SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLA 127
           +I  M Y+G ++    +  I  + +  R+ H + I+            +V E   +G+ +
Sbjct: 54  AIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYC-LGSAS 112

Query: 128 DRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAK 187
           D +    E H + L   +   +       +AYLH   S  +++RD+K  NIL  E    K
Sbjct: 113 DLL----EVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVK 165

Query: 188 LFDF-SLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQ----CDVYGFGAFLFELL 242
           L DF S S++ P        +S VGT  ++APE    +   Q     DV+  G    EL 
Sbjct: 166 LADFGSASIASP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 218

Query: 243 TAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQL 302
             +    +++  S  ++                     I +++S T    E     F+  
Sbjct: 219 ERKPPLFNMNAMSALYH---------------------IAQNESPTLQSNEWS-DYFRNF 256

Query: 303 TLQCMDFSPEDRPTMVDVAKQL 324
              C+   P+DRPT  ++ K +
Sbjct: 257 VDSCLQKIPQDRPTSEELLKHM 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 46.3 bits (110), Expect = 9e-06
 Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 16/102 (15%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
           A +IA  + +LH   S+ I+YRD+K  N++ + +   K+ DF +   +I  G+T     +
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRT 160

Query: 209 VVGTTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQ 245
             GT  +IAPE    +I  Q      D + FG  L+E+L  Q
Sbjct: 161 FCGTPDYIAPE----IIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 45.7 bits (108), Expect = 1e-05
 Identities = 57/277 (20%), Positives = 110/277 (39%), Gaps = 57/277 (20%)

Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL--IVFESVQIG 124
           F  ++ G+W ++    +K        + E  I       ++SH  +++L  +  E   I 
Sbjct: 17  FGLVWLGYWLEKRKVAIK-TIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPIC 75

Query: 125 TLADRIHHHCEQHF-----EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNIL 179
            + + + H C   +        S    L + +D+   +AYL    S  +++RD+   N L
Sbjct: 76  LVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCL 132

Query: 180 FNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG------FIAPENFT-TLINEQCDVY 232
             E    K+ DF ++  + D       D    +TG      + +PE F+ +  + + DV+
Sbjct: 133 VGENQVVKVSDFGMTRFVLD-------DQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185

Query: 233 GFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSI-----IIEDKSC 287
            FG  ++E+ +          E +  YE         N    E+V++I     + + +  
Sbjct: 186 SFGVLMWEVFS----------EGKTPYE---------NRSNSEVVETINAGFRLYKPRLA 226

Query: 288 TCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
           +        Q+  +L   C    PEDRP+   +  QL
Sbjct: 227 S--------QSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 45.8 bits (109), Expect = 1e-05
 Identities = 57/252 (22%), Positives = 97/252 (38%), Gaps = 77/252 (30%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           +  H +II+L           I+ E ++ G+L   +  + +  F    L   L+    IA
Sbjct: 61  QFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN-DGKFTVGQLVGMLR---GIA 116

Query: 155 HAVAYL-HVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT 213
             + YL  + +    V+RD+   NIL N     K+ DF LS  + D       ++   T 
Sbjct: 117 SGMKYLSEMNY----VHRDLAARNILVNSNLVCKVSDFGLSRRLED------SEATYTTK 166

Query: 214 G------FIAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEEN 262
           G      + APE      FT+      DV+ FG  ++E++         S+  R +++  
Sbjct: 167 GGKIPIRWTAPEAIAYRKFTS----ASDVWSFGIVMWEVM---------SYGERPYWD-- 211

Query: 263 VKRLSGQNCRFKEMVDSIIIED-------KSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP 315
              +S Q     +++ +  +ED         C          A  QL L C      +RP
Sbjct: 212 ---MSNQ-----DVIKA--VEDGYRLPPPMDCP--------SALYQLMLDCWQKDRNERP 253

Query: 316 TMVDVAKQLRQM 327
           T   +   L +M
Sbjct: 254 TFSQIVSTLDKM 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 28/96 (29%), Positives = 49/96 (51%), Gaps = 8/96 (8%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS----LSIPDGETHIELDS 208
           I   + YLH   +R I++RD+K  NIL + +   K+ DF +S     +    +T+    S
Sbjct: 115 ILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS 171

Query: 209 VVGTTGFIAPENF-TTLINEQCDVYGFGAFLFELLT 243
           + G+  ++APE    T    + D++  G  + E+LT
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLT 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 30/111 (27%), Positives = 55/111 (49%), Gaps = 4/111 (3%)

Query: 134 CEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL 193
           C+   E L+  D +  A  +A  + YL    S+  ++RD+   N+L  E +  K+ DF L
Sbjct: 124 CKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGL 180

Query: 194 SLSIPDGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
           +  + + + + +  +      ++APE  F  +   Q DV+ FG  L+E+ T
Sbjct: 181 ARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 26/78 (33%), Positives = 41/78 (52%), Gaps = 5/78 (6%)

Query: 168 IVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDSVVGTTGFIAPENFTTLIN 226
           ++YRD+KP NIL + Q    L DF L  L++ D +     ++  GT  ++APE       
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK---TNTFCGTPEYLAPELLLGHGY 170

Query: 227 EQC-DVYGFGAFLFELLT 243
            +  D +  G  L+E+LT
Sbjct: 171 TKAVDWWTLGVLLYEMLT 188

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 29/104 (27%), Positives = 53/104 (50%), Gaps = 4/104 (3%)

Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           L++ D +  +  +A  + +L    SR  ++RD+   NIL +E +  K+ DF L+  I   
Sbjct: 171 LTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 227

Query: 201 ETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             ++   S      ++APE+ F  +   Q DV+ FG  L+E+ +
Sbjct: 228 PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 31/130 (23%), Positives = 61/130 (46%), Gaps = 7/130 (5%)

Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
           L++ E    G L + +    E     L+L D L  +  +A  +A+L    S+  ++RD+ 
Sbjct: 115 LVITEYCCYGDLLNFLRRKRESF---LTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLA 168

Query: 175 PTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYG 233
             N+L       K+ DF L+  I +   ++   +      ++APE+ F  +   + DV+ 
Sbjct: 169 ARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWS 228

Query: 234 FGAFLFELLT 243
           +G  L+E+ +
Sbjct: 229 YGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 42/172 (24%), Positives = 74/172 (43%), Gaps = 36/172 (20%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           ++SH+ +++L           IV E +  G L + +  H  + F+   L   L++  D+ 
Sbjct: 55  KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREH-GKRFQPSQL---LEMCKDVC 110

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT-- 212
             +AYL    S+  ++RD+   N L ++Q   K+ DF LS  + D     E  S VG+  
Sbjct: 111 EGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD----EYTSSVGSKF 163

Query: 213 -TGFIAPENFT-TLINEQCDVYGFGAFL----------FELLTAQEVSDHVS 252
              +  PE    +  + + DV+ FG  +          +E     E  + VS
Sbjct: 164 PVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS 215

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 41/173 (23%), Positives = 78/173 (45%), Gaps = 31/173 (17%)

Query: 89  RNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQH 137
           R Q   E   N +V      H++++ +           +V E ++ G L D I  H   +
Sbjct: 58  RKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMN 116

Query: 138 FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF----SL 193
            E ++      V + +  A++YLH   ++ +++RD+K  +IL       KL DF     +
Sbjct: 117 EEQIA-----TVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV 168

Query: 194 SLSIPDGETHIELDSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQ 245
           S  +P      +  S+VGT  ++APE  + L    + D++  G  + E++  +
Sbjct: 169 SKEVP------KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 24/79 (30%), Positives = 34/79 (43%), Gaps = 11/79 (13%)

Query: 158 AYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIA 217
            YLH    R  V+RD+K  NIL +     KL DF ++  +          S  G+  ++A
Sbjct: 116 EYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMA 169

Query: 218 PENFTTLINEQCDVYGFGA 236
           PE     +  Q   YG  A
Sbjct: 170 PE-----VIAQQGGYGLAA 183

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 38/169 (22%), Positives = 75/169 (44%), Gaps = 23/169 (13%)

Query: 89  RNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQH 137
           R Q   E   N +V      H++++++           +V E ++ G L D I  H   +
Sbjct: 56  RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMN 114

Query: 138 FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI 197
            E ++      V + +  A++ LH   ++ +++RD+K  +IL       KL DF     +
Sbjct: 115 EEQIA-----AVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166

Query: 198 PDGETHIELDSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQ 245
              +      S+VGT  ++APE  + L    + D++  G  + E++  +
Sbjct: 167 --SKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 45.4 bits (107), Expect = 2e-05
 Identities = 33/110 (30%), Positives = 56/110 (50%), Gaps = 11/110 (10%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL--SIPDGETHIELDSVV 210
           I   +AY H    R +++RD+KP N+L NE+ + KL DF L+   S+P   T    + VV
Sbjct: 113 ILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP---TKTYSNEVV 166

Query: 211 GTTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFH 258
            T  +  P+    ++  + Q D++G G   FE+ + + +    + E   H
Sbjct: 167 -TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELH 215

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 45.1 bits (106), Expect = 2e-05
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 21/152 (13%)

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I   + YLH   S   ++RD+K  N+L +E  + KL DF ++  + D  T I+ ++ VG
Sbjct: 109 EILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVG 163

Query: 212 TTGFIAPENF-TTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFH--------YEEN 262
           T  ++APE    +  + + D++  G      +TA E++      S  H         + N
Sbjct: 164 TPFWMAPEVIKQSAYDSKADIWSLG------ITAIELAKGEPPHSELHPMKVLFLIPKNN 217

Query: 263 VKRLSGQNCR-FKEMVDSIIIEDKSCTCTGKE 293
              L G   +  KE V++ + ++ S   T KE
Sbjct: 218 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKE 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 24/67 (35%), Positives = 34/67 (50%), Gaps = 4/67 (5%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           +  A+AY H   S  I++RD+KP NIL +E    KL DF  + ++        L   V T
Sbjct: 109 LLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVAT 164

Query: 213 TGFIAPE 219
             + APE
Sbjct: 165 RWYRAPE 171

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 38/131 (29%), Positives = 59/131 (45%), Gaps = 12/131 (9%)

Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           ++ + V  G L   ++    +HF    +  R+ +A +I  A+ +LH      I+YRD+K 
Sbjct: 82  LILDYVNGGELFTHLYQ--REHFTESEV--RVYIA-EIVLALDHLH---QLGIIYRDIKL 133

Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLI---NEQCDVY 232
            NIL + +    L DF LS      E      S  GT  ++APE         ++  D +
Sbjct: 134 ENILLDSEGHVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWW 192

Query: 233 GFGAFLFELLT 243
             G   FELLT
Sbjct: 193 SLGVLTFELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 32/101 (31%), Positives = 48/101 (47%), Gaps = 9/101 (8%)

Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDS 208
           V  +    +AYLH   S+  ++RD+K  NIL  +  D KL DF ++  I    T  +  S
Sbjct: 111 VCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT--ATIAKRKS 165

Query: 209 VVGTTGFIAPENFTTL----INEQCDVYGFGAFLFELLTAQ 245
            +GT  ++APE          N+ CD++  G    EL   Q
Sbjct: 166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQ 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 41/153 (26%), Positives = 67/153 (43%), Gaps = 27/153 (17%)

Query: 79  SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLA 127
           +I  M Y+G ++    +  I  + +  ++ H + I+            +V E   +G+ +
Sbjct: 44  AIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSAS 102

Query: 128 DRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAK 187
           D +    E H + L   +   +       +AYLH   S   ++RD+K  NIL  E    K
Sbjct: 103 DIL----EVHKKPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVK 155

Query: 188 LFDF-SLSLSIPDGETHIELDSVVGTTGFIAPE 219
           L DF S SL  P        +S VGT  ++APE
Sbjct: 156 LADFGSASLVSP-------ANSFVGTPYWMAPE 181

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 45.3 bits (108), Expect = 2e-05
 Identities = 24/67 (35%), Positives = 36/67 (53%), Gaps = 6/67 (8%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI---PDGETHIELDSVVGT 212
           A+ Y+H   S  +++RD+KP+NIL N     KL DF L+ S+    +   +  L   V T
Sbjct: 119 ALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVAT 175

Query: 213 TGFIAPE 219
             + APE
Sbjct: 176 RWYRAPE 182

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 44.8 bits (106), Expect = 2e-05
 Identities = 56/249 (22%), Positives = 91/249 (36%), Gaps = 64/249 (25%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEA--LSLTDRLKVAM 151
           S  +H +I+KL           I+ E ++ G L   +     + F    L+L + L + +
Sbjct: 54  SNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL 113

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA-----KLFDFSLSLSIPDGETHIEL 206
           D+A    YL        ++RD+   N L +E+        K+ DF L+  I   + + + 
Sbjct: 114 DVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE 170

Query: 207 DSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT----------AQEVSDHVSFES 255
              +    ++APE+        Q DV+ FG  ++E+LT           QEV  HV+   
Sbjct: 171 GEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG 230

Query: 256 RFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP 315
           R    EN                          C  K        QL   C    P +RP
Sbjct: 231 RLQKPEN--------------------------CPDK------IYQLMTNCWAQDPSERP 258

Query: 316 TMVDVAKQL 324
           T   + + L
Sbjct: 259 TFDRIQEIL 267

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 16/102 (15%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
           A +IA  + +LH   S+ I+YRD+K  N++ + +   K+ DF +   ++ DG T     +
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT---TKT 160

Query: 209 VVGTTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQ 245
             GT  +IAPE    +I  Q      D + FG  L+E+L  Q
Sbjct: 161 FCGTPDYIAPE----IIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 11/92 (11%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
           A+ YLH   S  I++RD+K  N+L     D KL DF +S    + +T    DS +GT  +
Sbjct: 122 ALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK--NVKTLQRRDSFIGTPYW 176

Query: 216 IAPENFT------TLINEQCDVYGFGAFLFEL 241
           +APE         T  + + D++  G  L E+
Sbjct: 177 MAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 42/156 (26%), Positives = 66/156 (42%), Gaps = 29/156 (18%)

Query: 168 IVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE------NF 221
           I++RD+K  NIL   +   KL DF +S  +    T +  ++ VGT  ++APE       +
Sbjct: 149 IIHRDVKGNNILLTTEGGVKLVDFGVSAQLT--STRLRRNTSVGTPFWMAPEVIACEQQY 206

Query: 222 TTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSII 281
               + +CDV+  G      +TA E+ D        H    VK L      FK      I
Sbjct: 207 DYSYDARCDVWSLG------ITAIELGDGDPPLFDMH---PVKTL------FK------I 245

Query: 282 IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTM 317
             +   T    E+  ++F     QC+    E RP++
Sbjct: 246 PRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSV 281

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 45.0 bits (107), Expect = 3e-05
 Identities = 33/109 (30%), Positives = 53/109 (48%), Gaps = 21/109 (19%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+NI  NE  + K+ DF L+       T  E+   V T
Sbjct: 127 ILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARH-----TDDEMTGYVAT 178

Query: 213 TGFIAPE------NFTTLINEQCDVYGFGAFLFELLTAQEV---SDHVS 252
             + APE      ++   +    D++  G  + ELLT + +   SDH+ 
Sbjct: 179 RWYRAPEIMLNWMHYNQTV----DIWSVGCIMAELLTGKTLFPGSDHID 223

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 57/229 (24%), Positives = 99/229 (43%), Gaps = 42/229 (18%)

Query: 113 IKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRD 172
           IKLI+ E +  G+L +    +  ++   ++L  +LK A+ I   + YL    SR  V+RD
Sbjct: 83  IKLIM-EFLPSGSLKE----YLPRNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRD 134

Query: 173 MKPTNILFNEQSDAKLFDFSLSLSIPDGETHI----ELDSVVGTTGFIAPENFTTLINEQ 228
           +   N+L   +   K+ DF L+ +I   + +     +LDS V    + APE    LI  +
Sbjct: 135 LAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV---FWYAPE---CLIQSK 188

Query: 229 ----CDVYGFGAFLFELLT-----AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS 279
                DV+ FG  L+ELLT     +  ++  +      H +  V RL             
Sbjct: 189 FYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-----------R 237

Query: 280 IIIEDKSCTCTGK-EQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
           ++ E K         +++    QL  +C +F P  R T  ++ +    +
Sbjct: 238 VLEEGKRLPRPPNCPEEVY---QLMRKCWEFQPSKRTTFQNLIEGFEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 28/104 (26%), Positives = 50/104 (48%), Gaps = 18/104 (17%)

Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI-PDGETHIELD 207
           +A+D  H + Y+H         RD+KP N+L ++    +L DF   L +  DG   ++ +
Sbjct: 113 LAIDSVHQLGYVH---------RDIKPDNVLLDKNGHIRLADFGSCLRLLADGT--VQSN 161

Query: 208 SVVGTTGFIAPENFTTL------INEQCDVYGFGAFLFELLTAQ 245
             VGT  +I+PE    +         +CD +  G  ++E+L  +
Sbjct: 162 VAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 4/105 (3%)

Query: 140 ALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD 199
           ALS  D +  +  +A+ + +L    S+  V+RD+   N+L  E    K+ DF L+  I  
Sbjct: 235 ALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFGLARDIMR 291

Query: 200 GETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
              +I   S      ++APE+ F  L     DV+ FG  L+E+ T
Sbjct: 292 DSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 56/262 (21%), Positives = 102/262 (38%), Gaps = 55/262 (20%)

Query: 79  SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLA 127
           ++  M Y+G +     +  I  + +  ++ H + I+            +V E   +G+ +
Sbjct: 50  AVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYC-LGSAS 108

Query: 128 DRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAK 187
           D +    E H + L   +   +       +AYLH   S  +++RD+K  NIL  E    K
Sbjct: 109 DLL----EVHKKPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVK 161

Query: 188 LFDF-SLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQ----CDVYGFGAFLFELL 242
           L DF S S S P        +S VGT  ++APE    +   Q     DV+  G    EL 
Sbjct: 162 LADFGSASKSSP-------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 214

Query: 243 TAQ-EVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQ 301
             +  + +  +  + +H  +N               DS  ++    T         +F+ 
Sbjct: 215 ERKPPLFNMNAMSALYHIAQN---------------DSPTLQSNEWT--------DSFRG 251

Query: 302 LTLQCMDFSPEDRPTMVDVAKQ 323
               C+   P++RP   ++ + 
Sbjct: 252 FVDYCLQKIPQERPASAELLRH 273

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 44.6 bits (105), Expect = 3e-05
 Identities = 30/99 (30%), Positives = 50/99 (50%), Gaps = 23/99 (23%)

Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL--SIPDGETHIEL-------- 206
           ++Y H    R I++RD+KP N+L NE+ + KL DF L+   S+P      E+        
Sbjct: 116 LSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPP 172

Query: 207 DSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQ 245
           D ++G+T +  P           D++G G  L+E+ T +
Sbjct: 173 DVLLGSTEYSTP----------IDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 44.4 bits (105), Expect = 3e-05
 Identities = 52/236 (22%), Positives = 91/236 (38%), Gaps = 55/236 (23%)

Query: 108 SHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHA 156
            H +I+KL           IV E V  G+L         +    L++   L++++D A  
Sbjct: 50  DHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT----FLRKKKNRLTVKKLLQMSLDAAAG 105

Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFI 216
           + YL    S+  ++RD+   N L  E +  K+ DF +S      E    + +V      I
Sbjct: 106 MEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQI 157

Query: 217 -----APENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
                APE         + DV+ +G  L+E  +  +                   +S Q 
Sbjct: 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTP--------------YPGMSNQQ 203

Query: 271 CRFKEMVDS--IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
            R  E ++S   +   + C         +   +L LQC  + PE+RP+  ++  +L
Sbjct: 204 TR--ERIESGYRMPAPQLCP--------EEIYRLMLQCWAYDPENRPSFSEIYNEL 249

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 44.3 bits (105), Expect = 3e-05
 Identities = 45/196 (22%), Positives = 84/196 (42%), Gaps = 34/196 (17%)

Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           F ++++G W+ R    +K   + +    +     +    R+ HKH+I L           
Sbjct: 19  FGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVY 78

Query: 116 IVFESVQIGTLADRIHHHCEQHF------EALSLTDRLKVAMDIAHAVAYLHVGFSRPIV 169
           I+ E ++ G+L           F      + L +   + +A  +A  +AYL     +  +
Sbjct: 79  IITELMEKGSL---------LAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQNSI 126

Query: 170 YRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE--NFTTLINE 227
           +RD+   NIL  E    K+ DF L+  I + + ++  D  +    + APE  +  T   +
Sbjct: 127 HRDLAARNILVGEDLVCKVADFGLARLIKE-DVYLSSDKKI-PYKWTAPEAASHGTFSTK 184

Query: 228 QCDVYGFGAFLFELLT 243
             DV+ FG  L+E+ T
Sbjct: 185 S-DVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 44.7 bits (105), Expect = 3e-05
 Identities = 28/103 (27%), Positives = 48/103 (46%), Gaps = 16/103 (15%)

Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDS 208
           +A+D  H + Y+H         RD+KP NIL +     +L DF   L + +  T ++   
Sbjct: 113 IAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSV 162

Query: 209 VVGTTGFIAPENFTTL------INEQCDVYGFGAFLFELLTAQ 245
            VGT  +I+PE    +         +CD +  G  ++E+L  +
Sbjct: 163 AVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 43.7 bits (103), Expect = 4e-05
 Identities = 40/151 (26%), Positives = 60/151 (39%), Gaps = 30/151 (19%)

Query: 109 HKHIIK----LIVFESVQIGTLAD------RIHHHCEQHFEALSLTDRLKVAMDIAHAVA 158
           HK+I+      +V +  + G L         I   C + + A      + VA+D  H   
Sbjct: 51  HKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAA-----EMVVALDALH--- 102

Query: 159 YLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAP 218
                    IV RD+ P NIL +++   +L  FS    + D       D       + AP
Sbjct: 103 ------REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYCAP 151

Query: 219 E-NFTTLINEQCDVYGFGAFLFELLTAQEVS 248
           E    +   E CD +  GA LFELLT + + 
Sbjct: 152 EVGGISEETEACDWWSLGAILFELLTGKTLV 182

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 44.4 bits (105), Expect = 4e-05
 Identities = 29/93 (31%), Positives = 48/93 (51%), Gaps = 8/93 (8%)

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDSVV 210
           +I  A+ YLH   S  +VYRD+K  N++ ++    K+ DF L    I DG T   + +  
Sbjct: 103 EIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFC 156

Query: 211 GTTGFIAPENFTTLINEQC-DVYGFGAFLFELL 242
           GT  ++APE        +  D +G G  ++E++
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 43.9 bits (104), Expect = 5e-05
 Identities = 28/96 (29%), Positives = 49/96 (51%), Gaps = 19/96 (19%)

Query: 158 AYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL--SIPDGETHIELDSVVGTTGF 215
           AY H    R +++RD+KP N+L +E+ + KL DF L+   S+P   +    + VV T  +
Sbjct: 117 AYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP---SKTYSNEVV-TLWY 169

Query: 216 IAPE------NFTTLINEQCDVYGFGAFLFELLTAQ 245
             P+       ++T      D++G G   +E+ T +
Sbjct: 170 RPPDVLLGSTEYST----SLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 44.3 bits (104), Expect = 5e-05
 Identities = 49/195 (25%), Positives = 83/195 (42%), Gaps = 26/195 (13%)

Query: 67  FRKLYKGFWQ------KRSISLMKYNGNRNQHA-LEWCINHIVYASRMSHKHIIKLI-VF 118
           F  +YKG W       K  +++   N      A +E+    ++ AS M H H+++L+ V 
Sbjct: 20  FGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMAS-MDHPHLVRLLGVC 78

Query: 119 ESVQIGTLADRIHHHC-----EQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
            S  I  +   + H C      +H + +     L   + IA  + YL     R +V+RD+
Sbjct: 79  LSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDL 135

Query: 174 KPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE-----NFTTLINEQ 228
              N+L    +  K+ DF L+  +   E     D       ++A E      FT     Q
Sbjct: 136 AARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT----HQ 191

Query: 229 CDVYGFGAFLFELLT 243
            DV+ +G  ++EL+T
Sbjct: 192 SDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 44.3 bits (104), Expect = 5e-05
 Identities = 27/89 (30%), Positives = 45/89 (50%), Gaps = 10/89 (11%)

Query: 159 YLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAP 218
           Y+H   S  I++RD+KP+N+  NE  + ++ DF L+    D     E+   V T  + AP
Sbjct: 133 YIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD-----EMTGYVATRWYRAP 184

Query: 219 ENFTTLI--NEQCDVYGFGAFLFELLTAQ 245
           E     +  N+  D++  G  + ELL  +
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 43.8 bits (104), Expect = 5e-05
 Identities = 30/90 (33%), Positives = 40/90 (44%), Gaps = 13/90 (14%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            V +LH   S  IV+RD+KP NIL       K+ DF L+         + L SVV T  +
Sbjct: 119 GVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY---SFEMALTSVVVTLWY 172

Query: 216 IAPENFTTLI----NEQCDVYGFGAFLFEL 241
            APE    L+        D++  G    EL
Sbjct: 173 RAPE---VLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 43.7 bits (104), Expect = 6e-05
 Identities = 27/90 (30%), Positives = 38/90 (42%), Gaps = 7/90 (7%)

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
             + YLH   S  I++RD+KP N+L       KL DF L+ S        ++   V T  
Sbjct: 113 RGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR--KMTHQVVTRW 167

Query: 215 FIAPENF--TTLINEQCDVYGFGAFLFELL 242
           + APE            D++  G    ELL
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELL 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 44.1 bits (104), Expect = 6e-05
 Identities = 39/132 (29%), Positives = 61/132 (46%), Gaps = 24/132 (18%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS------LSIPDGETHIELDSV 209
           AV ++H   S+ +++RD+K  NIL       KL DF  S      +S   G T       
Sbjct: 155 AVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT------F 205

Query: 210 VGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG 268
            GT  ++APE +     +++ D++  G  L+ELLT +   D  + E   H     K L+G
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH-----KTLAG 260

Query: 269 QNCRFKEMVDSI 280
              R+  +  SI
Sbjct: 261 ---RYDPLPPSI 269

Length = 496

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 43.5 bits (103), Expect = 6e-05
 Identities = 59/226 (26%), Positives = 87/226 (38%), Gaps = 53/226 (23%)

Query: 109 HKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAV 157
           H  +++L           IV E +  G+L D +        + L L   + +A  IA  +
Sbjct: 60  HDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLK---SGEGKKLRLPQLVDMAAQIAEGM 116

Query: 158 AYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE--THIELDSVVGTTGF 215
           AYL    SR  ++RD+   NIL  E    K+ DF L+  I D E          +  T  
Sbjct: 117 AYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT-- 171

Query: 216 IAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
            APE      FT     + DV+ FG  L E++T            R  Y     R     
Sbjct: 172 -APEAANYGRFTI----KSDVWSFGILLTEIVT----------YGRVPYPGMTNR----- 211

Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
               E+++ +    +        ++L     L LQC D  PE+RPT
Sbjct: 212 ----EVLEQVERGYRMPRPPNCPEELY---DLMLQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 44.0 bits (104), Expect = 6e-05
 Identities = 33/137 (24%), Positives = 50/137 (36%), Gaps = 47/137 (34%)

Query: 152 DIAHAVAYLH-VGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL----------------- 193
           ++  A+  +H +GF    ++RD+KP NIL +     KL DF L                 
Sbjct: 109 ELTCAIESVHKMGF----IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGD 164

Query: 194 -----SLSIPD-------------------GETHIELDSVVGTTGFIAPENFT-TLINEQ 228
                S+   +                           S+VGT  +IAPE    T   + 
Sbjct: 165 HHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 224

Query: 229 CDVYGFGAFLFELLTAQ 245
           CD +  G  L+E+L  Q
Sbjct: 225 CDWWSVGVILYEMLVGQ 241

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 43.9 bits (104), Expect = 6e-05
 Identities = 30/91 (32%), Positives = 43/91 (47%), Gaps = 15/91 (16%)

Query: 159 YLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAP 218
           Y+H   S  +++RD+KP+N+L N   D K+ DF L+      E    +   V T  + AP
Sbjct: 123 YIH---SANVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEKGDFMTEYVVTRWYRAP 177

Query: 219 E------NFTTLINEQCDVYGFGAFLFELLT 243
           E       +TT I    DV+  G    ELL 
Sbjct: 178 ELLLNCSEYTTAI----DVWSVGCIFAELLG 204

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 43.8 bits (103), Expect = 7e-05
 Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 8/93 (8%)

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDSVV 210
           +I  A+ YLH   SR +VYRD+K  N++ ++    K+ DF L    I DG T   + +  
Sbjct: 103 EIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFC 156

Query: 211 GTTGFIAPENFT-TLINEQCDVYGFGAFLFELL 242
           GT  ++APE           D +G G  ++E++
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 43.5 bits (102), Expect = 7e-05
 Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 7/96 (7%)

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDSVV 210
           +I  A+ YLH    + +VYRD+K  N++ ++    K+ DF L    I DG T   + +  
Sbjct: 103 EIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFC 157

Query: 211 GTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQ 245
           GT  ++APE           D +G G  ++E++  +
Sbjct: 158 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 43.5 bits (103), Expect = 7e-05
 Identities = 39/142 (27%), Positives = 60/142 (42%), Gaps = 43/142 (30%)

Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL-D 207
            A+D  H + Y+H         RD+KP N L +     KL DF LS  I      +   +
Sbjct: 112 EAVDALHELGYIH---------RDLKPENFLIDASGHIKLTDFGLSKGI------VTYAN 156

Query: 208 SVVGTTGFIAPE-------NFTTLINEQCDVYGFGAFLFELL---------TAQEVSDHV 251
           SVVG+  ++APE       +FT       D +  G  L+E L         T  E     
Sbjct: 157 SVVGSPDYMAPEVLRGKGYDFT------VDYWSLGCMLYEFLCGFPPFSGSTPNET---- 206

Query: 252 SFESRFHYEENVKRLSGQNCRF 273
            +E+  +++E ++R    + RF
Sbjct: 207 -WENLKYWKETLQRPVYDDPRF 227

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 43.1 bits (101), Expect = 8e-05
 Identities = 42/182 (23%), Positives = 71/182 (39%), Gaps = 28/182 (15%)

Query: 147 LKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL 206
           +K   DIA  + YL    S+  ++RD+   N + NE  +  + DF LS  I +G+ + + 
Sbjct: 115 VKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQG 171

Query: 207 DSVVGTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVK 264
                   +IA E+    +   + DV+ FG  ++E+ T  Q     V     + Y     
Sbjct: 172 RIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR--- 228

Query: 265 RLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
               Q  R K+  D                 L     L   C   +P+DRP+   +  +L
Sbjct: 229 ----QGNRLKQPPDC----------------LDGLYSLMSSCWLLNPKDRPSFETLRCEL 268

Query: 325 RQ 326
            +
Sbjct: 269 EK 270

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 43.5 bits (102), Expect = 8e-05
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 4/106 (3%)

Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E ++  D +     +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  + 
Sbjct: 132 EQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDVN 188

Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
           + + + +  +      ++APE  F  +   Q DV+ FG  ++E+ T
Sbjct: 189 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 43.1 bits (101), Expect = 9e-05
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 11/92 (11%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
           A+ YLH      I++RD+K  NILF    D KL DF +S    +  T    DS +GT  +
Sbjct: 115 ALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYW 169

Query: 216 IAPENFTTLINE------QCDVYGFGAFLFEL 241
           +APE      ++      + DV+  G  L E+
Sbjct: 170 MAPEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 43.5 bits (102), Expect = 9e-05
 Identities = 29/104 (27%), Positives = 51/104 (49%), Gaps = 4/104 (3%)

Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           L+L D +  +  +A  + +L    SR  ++RD+   NIL +E +  K+ DF L+  I   
Sbjct: 176 LTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232

Query: 201 ETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             ++          ++APE  F  +   Q DV+ FG  L+E+ +
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 43.1 bits (102), Expect = 9e-05
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 37/159 (23%)

Query: 106 RMSHKHIIKLIVFESVQIGTLADRIH---HHCEQHFEALSLTDRLK----------VAMD 152
            + H +I++L   + V +G   D I     +CEQ  +  SL D +           + + 
Sbjct: 62  NLRHPNIVEL---KEVVVGKHLDSIFLVMEYCEQ--DLASLLDNMPTPFSESQVKCLMLQ 116

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS--LSIPDGETHIELDSVV 210
           +   + YLH  F   I++RD+K +N+L  ++   K+ DF L+    +P       +   V
Sbjct: 117 LLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK----PMTPKV 169

Query: 211 GTTGFIAPE------NFTTLINEQCDVYGFGAFLFELLT 243
            T  + APE       +TT I    D++  G  L ELL 
Sbjct: 170 VTLWYRAPELLLGCTTYTTAI----DMWAVGCILAELLA 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 31/102 (30%), Positives = 51/102 (50%), Gaps = 16/102 (15%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
           A +I+  + +LH    R I+YRD+K  N++ + +   K+ DF +    + DG T     +
Sbjct: 107 AAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT---TRT 160

Query: 209 VVGTTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQ 245
             GT  +IAPE    +I  Q      D + +G  L+E+L  Q
Sbjct: 161 FCGTPDYIAPE----IIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 32/107 (29%), Positives = 50/107 (46%), Gaps = 16/107 (14%)

Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIE-- 205
           K    I   VAYLH   +  +V+RD+K  N++       KL DF  +  +     H    
Sbjct: 106 KYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHS 162

Query: 206 --LDSVVGTTGFIAPENFTTLINE-----QCDVYGFGAFLFELLTAQ 245
             L S+ GT  ++APE    +INE     + D++  G  +FE+ T +
Sbjct: 163 NMLKSMHGTPYWMAPE----VINESGYGRKSDIWSIGCTVFEMATGK 205

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 54/240 (22%), Positives = 95/240 (39%), Gaps = 63/240 (26%)

Query: 108 SHKHIIKLI-----------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHA 156
           SH +I++LI           V E VQ G     +     +    L + + +++  + A  
Sbjct: 51  SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPR----LKVKELIQMVENAAAG 106

Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG-- 214
           + YL    S+  ++RD+   N L  E++  K+ DF +S          E D V  +TG  
Sbjct: 107 MEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSRE--------EEDGVYASTGGM 155

Query: 215 ------FIAPE--NFTTLINEQCDVYGFGAFLFEL--LTAQEVSDHVSFESRFHYEENVK 264
                 + APE  N+    +E  DV+ FG  L+E   L A   ++  + ++R   E+ V+
Sbjct: 156 KQIPVKWTAPEALNYGRYSSES-DVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVR 214

Query: 265 RLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
               + C                          A  +L  +C ++ P  RP+   V ++L
Sbjct: 215 LPCPELCP------------------------DAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 37/150 (24%), Positives = 66/150 (44%), Gaps = 24/150 (16%)

Query: 105 SRMSHKHIIKL------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMD 152
           +++ H ++++L            IV E +  G+L D +            L   LK ++D
Sbjct: 54  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCL---LKFSLD 110

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           +  A+ YL    +   V+RD+   N+L +E + AK+ DF L+      E     D+    
Sbjct: 111 VCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLP 162

Query: 213 TGFIAPENF-TTLINEQCDVYGFGAFLFEL 241
             + APE       + + DV+ FG  L+E+
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 44/197 (22%), Positives = 77/197 (39%), Gaps = 47/197 (23%)

Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           + L     +K A+D A  +AYL    S+  ++RD+   N L  E +  K+ DF +S    
Sbjct: 88  DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQ-- 142

Query: 199 DGETHIELDSVVGTTG-------FIAPE--NFTTLINEQCDVYGFGAFLFEL--LTAQEV 247
                 E D +  ++G       + APE  N+    +E  DV+ +G  L+E   L     
Sbjct: 143 ------EDDGIYSSSGLKQIPIKWTAPEALNYGRYSSES-DVWSYGILLWETFSLGVCPY 195

Query: 248 SDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCM 307
               + ++R   E+  +    Q C                             ++  +C 
Sbjct: 196 PGMTNQQAREQVEKGYRMSCPQKCP------------------------DDVYKVMQRCW 231

Query: 308 DFSPEDRPTMVDVAKQL 324
           D+ PE+RP   ++ K+L
Sbjct: 232 DYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 42.5 bits (100), Expect = 1e-04
 Identities = 41/168 (24%), Positives = 72/168 (42%), Gaps = 40/168 (23%)

Query: 109 HKHIIKLI-----------VFESVQIGTLADRIHHH-----------------CEQHFEA 140
           H +I+KL+           +FE +  G L + + H                  C  +   
Sbjct: 67  HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLP 126

Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           LS T++L +A  +A  +AYL     R  V+RD+   N L  E    K+ DF LS +I   
Sbjct: 127 LSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 183

Query: 201 ETHIELDSVVGTTGFIAPEN-----FTTLINEQCDVYGFGAFLFELLT 243
           + +   ++      ++ PE+     +TT    + DV+ +G  L+E+ +
Sbjct: 184 DYYKASENDAIPIRWMPPESIFYNRYTT----ESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 42.8 bits (101), Expect = 1e-04
 Identities = 29/105 (27%), Positives = 54/105 (51%), Gaps = 4/105 (3%)

Query: 140 ALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD 199
           ALS    + +A+ IA  ++YLH    R ++++D+   N + +E+   K+ D +LS  +  
Sbjct: 113 ALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFP 169

Query: 200 GETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLT 243
            + H   D+      ++A E+      +   DV+ FG  L+EL+T
Sbjct: 170 MDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 42.7 bits (101), Expect = 1e-04
 Identities = 33/149 (22%), Positives = 61/149 (40%), Gaps = 15/149 (10%)

Query: 106 RMSHKHIIKL--IVFESVQIGTLADRIHHHCEQHFEALSL---TDRLKVAM-DIAHAVAY 159
            ++H +IIKL  +      +  + + +     +  +          +K  +  +   +A+
Sbjct: 54  ELNHPNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAF 113

Query: 160 LHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI-PDGETHIELDSVVGTTGFIAP 218
            H   S  I++RD+KP N+L N +   KL DF L+ S       +      V T  + AP
Sbjct: 114 CH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY---VVTRWYRAP 167

Query: 219 ENF--TTLINEQCDVYGFGAFLFELLTAQ 245
           E        +   D++  G    ELL+ +
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 31/110 (28%), Positives = 49/110 (44%), Gaps = 10/110 (9%)

Query: 145 DRLKVAMD---IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           DRL   M    IA  V  +H       V+RD+KP N+L +     +L DF   L +    
Sbjct: 97  DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156

Query: 202 THIELDSVVGTTGFIAPENFTTL------INEQCDVYGFGAFLFELLTAQ 245
           T ++    VGT  +I+PE    +         +CD +  G  ++E+L  +
Sbjct: 157 T-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 42.4 bits (100), Expect = 1e-04
 Identities = 49/216 (22%), Positives = 89/216 (41%), Gaps = 20/216 (9%)

Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +V E +  G+L D    + ++H E L     L  A  I   + YL    S+  V+RD+  
Sbjct: 84  LVMEYLPYGSLRD----YLQKHRERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLAT 136

Query: 176 TNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYG 233
            NIL   ++  K+ DF L+  +P D E +   +       + APE+ T +  +   DV+ 
Sbjct: 137 RNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWS 196

Query: 234 FGAFLFELLTAQEVSDHVS--FESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTG 291
           FG  L+EL T  + S      F      ++  + +        E++ +         C  
Sbjct: 197 FGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV---YHLIELLKNNGRLPAPPGCPA 253

Query: 292 KEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
           +         +  +C +  P  RP+  ++A Q+  +
Sbjct: 254 E------IYAIMKECWNNDPSQRPSFSELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 42.3 bits (99), Expect = 1e-04
 Identities = 56/226 (24%), Positives = 90/226 (39%), Gaps = 48/226 (21%)

Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          IV E +  G+L D +     +  + L L   + +A  IA 
Sbjct: 57  KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKG---EMGKYLRLPQLVDMAAQIAS 113

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +AY+        V+RD++  NIL  E    K+ DF L+  I D E +           +
Sbjct: 114 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKW 169

Query: 216 IAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
            APE      FT     + DV+ FG  L EL T          + R  Y   V R     
Sbjct: 170 TAPEAALYGRFTI----KSDVWSFGILLTELTT----------KGRVPYPGMVNR----- 210

Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
               E++D +   ++        +  ++   L  QC    PE+RPT
Sbjct: 211 ----EVLDQV---ERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 249

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 30/92 (32%), Positives = 44/92 (47%), Gaps = 8/92 (8%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV-VGTTG 214
            + YLH      IVYRD+K  N+L + +   K+ DF L     +G    +  S   GT  
Sbjct: 113 GLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLC---KEGMGFGDRTSTFCGTPE 166

Query: 215 FIAPENFT-TLINEQCDVYGFGAFLFELLTAQ 245
           F+APE  T T      D +G G  ++E+L  +
Sbjct: 167 FLAPEVLTETSYTRAVDWWGLGVLIYEMLVGE 198

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 37/135 (27%), Positives = 61/135 (45%), Gaps = 15/135 (11%)

Query: 115 LIVFESVQIGTLADRIHHHCEQH-----FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIV 169
           L++ E    G L  +I    ++H     +E   L  ++ +A+D  H         SR ++
Sbjct: 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVH---------SRKMM 191

Query: 170 YRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQ 228
           +RD+K  NI        KL DF  S    D  +     S  GT  ++APE +     +++
Sbjct: 192 HRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKK 251

Query: 229 CDVYGFGAFLFELLT 243
            D++  G  L+ELLT
Sbjct: 252 ADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 30/105 (28%), Positives = 49/105 (46%), Gaps = 19/105 (18%)

Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD 207
           K+A+    A+ YL       I++RD+KP+NIL +   + KL DF +S         +  D
Sbjct: 111 KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGIS-------GQLV-D 160

Query: 208 SV-----VGTTGFIAPENFTTLINE----QCDVYGFGAFLFELLT 243
           S+      G   ++APE       +    + DV+  G  L+E+ T
Sbjct: 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVAT 205

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 29/97 (29%), Positives = 46/97 (47%), Gaps = 6/97 (6%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A +I   + +LH   S+ I+YRD+K  N++ +     K+ DF +      G+      + 
Sbjct: 102 AAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDN--RASTF 156

Query: 210 VGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQ 245
            GT  +IAPE    L      D + FG  L+E+L  Q
Sbjct: 157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 42.4 bits (99), Expect = 2e-04
 Identities = 36/169 (21%), Positives = 70/169 (41%), Gaps = 23/169 (13%)

Query: 89  RNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQH 137
           + Q   E  IN I+    + + +I+             +V E +  G+L D +   C   
Sbjct: 55  QKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDE 114

Query: 138 FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI 197
            +  +      V  +   A+ +LH   +  +++RD+K  N+L       KL DF     I
Sbjct: 115 AQIAA------VCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQI 165

Query: 198 PDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQ 245
              ++  +  ++VGT  ++APE  T      + D++  G    E++  +
Sbjct: 166 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 34/130 (26%), Positives = 50/130 (38%), Gaps = 46/130 (35%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS--------------L 195
           A+D  H + Y+H         RD+KP N+L + +   KL DF L               L
Sbjct: 113 AIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRIL 163

Query: 196 SIPDGETHIELD----------------------SVVGTTGFIAPENFT-TLINEQCDVY 232
           S       ++                        S VGT  +IAPE F  T  N++CD +
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWW 223

Query: 233 GFGAFLFELL 242
             G  ++E+L
Sbjct: 224 SLGVIMYEML 233

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 42.4 bits (99), Expect = 2e-04
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 8/96 (8%)

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDSVV 210
           +I  A+ YLH G    IVYRD+K  N++ ++    K+ DF L    I D  T   + +  
Sbjct: 103 EIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT---MKTFC 156

Query: 211 GTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQ 245
           GT  ++APE           D +G G  ++E++  +
Sbjct: 157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 42.3 bits (100), Expect = 2e-04
 Identities = 27/104 (25%), Positives = 43/104 (41%), Gaps = 22/104 (21%)

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI---------PDGETHIE 205
             + YLH      I++RD+K  NIL + Q   K+ DF L+              G    +
Sbjct: 126 EGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182

Query: 206 LDSVVGTTGFIAPE------NFTTLINEQCDVYGFGAFLFELLT 243
             ++V T  +  PE       +TT +    D++G G    E+ T
Sbjct: 183 YTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFT 222

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 42.2 bits (99), Expect = 2e-04
 Identities = 44/204 (21%), Positives = 84/204 (41%), Gaps = 31/204 (15%)

Query: 63  LEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLI------ 116
           + +   K   G +QK ++ ++K +   +   +E  +          H ++IKLI      
Sbjct: 15  VREAQLKSEDGSFQKVAVKMLKADIFSSSD-IEEFLREAACMKEFDHPNVIKLIGVSLRS 73

Query: 117 -----------VFESVQIGTL-----ADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYL 160
                      +   ++ G L       RI    E+ F  L L   ++  +DIA  + YL
Sbjct: 74  RAKGRLPIPMVILPFMKHGDLHTFLLMSRIG---EEPFT-LPLQTLVRFMIDIASGMEYL 129

Query: 161 HVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPEN 220
               S+  ++RD+   N + NE     + DF LS  I  G+ + +  +      ++A E+
Sbjct: 130 S---SKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALES 186

Query: 221 FT-TLINEQCDVYGFGAFLFELLT 243
               +     DV+ FG  ++E++T
Sbjct: 187 LADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 46/191 (24%), Positives = 75/191 (39%), Gaps = 34/191 (17%)

Query: 140 ALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD 199
           +L  +D L +A+ IA  + YL    S   V+RD+   N L  E    K+ DF LS  I  
Sbjct: 120 SLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYS 176

Query: 200 GETHIELDSVVGTTGFIAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFE 254
            + +      +    ++ PE      FTT    + D++ FG  L+E+          S+ 
Sbjct: 177 ADYYRVQSKSLLPVRWMPPEAILYGKFTT----ESDIWSFGVVLWEIF---------SYG 223

Query: 255 SRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDR 314
            + +Y  +       N    EM+ S  +      C            L ++C +  P  R
Sbjct: 224 LQPYYGFS-------NQEVIEMIRSRQLLPCPEDCP------ARVYALMIECWNEIPARR 270

Query: 315 PTMVDVAKQLR 325
           P   D+  +LR
Sbjct: 271 PRFKDIHTRLR 281

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 41.8 bits (99), Expect = 2e-04
 Identities = 37/150 (24%), Positives = 62/150 (41%), Gaps = 25/150 (16%)

Query: 108 SHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHA 156
            H +I+KL            VFE ++ G L   +     + F    +   +     I   
Sbjct: 56  EHPNIVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKPFSESVIRSIIY---QILQG 111

Query: 157 VAYLH-VGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
           +A++H  GF     +RD+KP N+L +     K+ DF L+  I     + +    V T  +
Sbjct: 112 LAHIHKHGF----FHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY---VSTRWY 164

Query: 216 IAPENF--TTLINEQCDVYGFGAFLFELLT 243
            APE    +T  +   D++  G  + EL T
Sbjct: 165 RAPEILLRSTSYSSPVDIWALGCIMAELYT 194

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 42.0 bits (98), Expect = 2e-04
 Identities = 31/131 (23%), Positives = 56/131 (42%), Gaps = 12/131 (9%)

Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +V E +  G+L D +   C    +  ++      A+D  H         S  +++RD+K 
Sbjct: 93  VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLH---------SNQVIHRDIKS 143

Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            NIL       KL DF     I   ++  +  ++VGT  ++APE  T      + D++  
Sbjct: 144 DNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 201

Query: 235 GAFLFELLTAQ 245
           G    E++  +
Sbjct: 202 GIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 41.7 bits (98), Expect = 2e-04
 Identities = 32/101 (31%), Positives = 48/101 (47%), Gaps = 13/101 (12%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
           A+ +LH   S  +++RD+K  NIL     D KL DF +S       T  + D+ +GT  +
Sbjct: 115 ALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS--TLQKRDTFIGTPYW 169

Query: 216 IAP-----ENFT-TLINEQCDVYGFGAFLFELLTAQEVSDH 250
           +AP     E F     + + D++  G  L EL  AQ    H
Sbjct: 170 MAPEVVACETFKDNPYDYKADIWSLGITLIEL--AQMEPPH 208

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 24/79 (30%), Positives = 39/79 (49%), Gaps = 8/79 (10%)

Query: 169 VYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE------NFT 222
           ++RD+K  NIL   +   KL DF +S  +    T +  ++ VGT  ++APE         
Sbjct: 146 IHRDVKGNNILLTTEGGVKLVDFGVSAQLTS--TRLRRNTSVGTPFWMAPEVIACEQQLD 203

Query: 223 TLINEQCDVYGFGAFLFEL 241
           +  + +CDV+  G    EL
Sbjct: 204 STYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 41.9 bits (98), Expect = 3e-04
 Identities = 27/79 (34%), Positives = 44/79 (55%), Gaps = 12/79 (15%)

Query: 168 IVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLIN- 226
           IVYRD+KP N+L ++    K+ DF  +  + D  T+    ++ GT  +IAPE    L+N 
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFA-KVVDTRTY----TLCGTPEYIAPE---ILLNV 203

Query: 227 ---EQCDVYGFGAFLFELL 242
              +  D +  G F++E+L
Sbjct: 204 GHGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 7/94 (7%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVGTTG 214
           A+ Y+H   +  + +RD+KP NIL N     K+ DF L+ ++  D  T I     V T  
Sbjct: 115 ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 215 FIAPE---NFTTLINEQCDVYGFGAFLFELLTAQ 245
           + APE   +F +      D++  G    E+LT +
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 37/151 (24%), Positives = 63/151 (41%), Gaps = 16/151 (10%)

Query: 107 MSHKHIIKLI-VFESVQIGTLADRIHHHCE-----QHFEALSLTDRLKVAMDIAHAVAYL 160
           +SH+ II LI  +       +     + C+          L L   + +   +  A+AYL
Sbjct: 143 ISHRAIINLIHAYRWKSTVCMVMP-KYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYL 201

Query: 161 HVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPEN 220
           H    R I++RD+K  NI  +E  +A L DF  +  +       +     GT    +PE 
Sbjct: 202 H---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPE- 257

Query: 221 FTTLINEQC---DVYGFGAFLFELLTAQEVS 248
               ++  C   D++  G  LFE+   + V+
Sbjct: 258 -LLALDPYCAKTDIWSAGLVLFEMS-VKNVT 286

Length = 392

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 41.8 bits (98), Expect = 3e-04
 Identities = 39/169 (23%), Positives = 69/169 (40%), Gaps = 23/169 (13%)

Query: 89  RNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQH 137
           + Q   E  IN I+      H +I+             +V E +  G+L D +   C   
Sbjct: 55  QQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE 114

Query: 138 FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI 197
            +  +      V  +   A+ +LH   S  +++RD+K  NIL       KL DF     I
Sbjct: 115 GQIAA------VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165

Query: 198 PDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQ 245
              ++  +  ++VGT  ++APE  T      + D++  G    E++  +
Sbjct: 166 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 41.6 bits (97), Expect = 3e-04
 Identities = 33/132 (25%), Positives = 56/132 (42%), Gaps = 14/132 (10%)

Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +V E +  G+L D +   C    +  +      V  +   A+ +LH   S  +++RD+K 
Sbjct: 94  VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLH---SNQVIHRDIKS 144

Query: 176 TNILFNEQSDAKLFDFSLSLSI-PDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYG 233
            NIL       KL DF     I P+      +   VGT  ++APE  T      + D++ 
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSTM---VGTPYWMAPEVVTRKAYGPKVDIWS 201

Query: 234 FGAFLFELLTAQ 245
            G    E++  +
Sbjct: 202 LGIMAIEMIEGE 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 54/252 (21%), Positives = 97/252 (38%), Gaps = 64/252 (25%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQ----------HFEALSL 143
           +   H++I+K            +VFE ++ G L   +  H               E L+L
Sbjct: 63  TNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGE-LTL 121

Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
           +  L++A+ IA  + YL    S+  V+RD+   N L       K+ DF +S  +   + +
Sbjct: 122 SQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY 178

Query: 204 IELDSVVGTT----GFIAPEN-----FTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFE 254
                V G T     ++ PE+     FTT    + DV+ FG  L+E+ T         + 
Sbjct: 179 ----RVGGHTMLPIRWMPPESIMYRKFTT----ESDVWSFGVVLWEIFT---------YG 221

Query: 255 SRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDR 314
            +  Y  +       N    E +    +  +  TC            + L C    P+ R
Sbjct: 222 KQPWYGLS-------NEEVIECITQGRLLQRPRTCP------SEVYDIMLGCWKRDPQQR 268

Query: 315 PTMVDVAKQLRQ 326
             + D+ ++L++
Sbjct: 269 INIKDIHERLQK 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 32/107 (29%), Positives = 52/107 (48%), Gaps = 14/107 (13%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
           + +I+ A+ +LH    R I+YRD+K  N+L + +   KL D+ +    I  G+T     +
Sbjct: 102 SAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT---TST 155

Query: 209 VVGTTGFIAPENFTTLINEQ----CDVYGFGAFLFELLTAQEVSDHV 251
             GT  +IAPE    L  E      D +  G  +FE++  +   D V
Sbjct: 156 FCGTPNYIAPE---ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 41.6 bits (97), Expect = 3e-04
 Identities = 56/255 (21%), Positives = 100/255 (39%), Gaps = 55/255 (21%)

Query: 79  SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLA 127
           +I  M Y+G ++    +  I  + +  ++ H + I+            +V E   +G+ +
Sbjct: 44  AIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSAS 102

Query: 128 DRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAK 187
           D +    E H + L   +   V       +AYLH   S  +++RD+K  NIL +E    K
Sbjct: 103 DLL----EVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVK 155

Query: 188 LFDF-SLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQ----CDVYGFGAFLFELL 242
           L DF S S+  P        +  VGT  ++APE    +   Q     DV+  G    EL 
Sbjct: 156 LGDFGSASIMAP-------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208

Query: 243 TAQ-EVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQ 301
             +  + +  +  + +H  +N               +S  ++             + F+ 
Sbjct: 209 ERKPPLFNMNAMSALYHIAQN---------------ESPALQSG--------HWSEYFRN 245

Query: 302 LTLQCMDFSPEDRPT 316
               C+   P+DRPT
Sbjct: 246 FVDSCLQKIPQDRPT 260

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 41.2 bits (96), Expect = 3e-04
 Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 10/132 (7%)

Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I  E +  G++ D++     + + AL+ +   K    I   ++YLH   S  IV+RD+K 
Sbjct: 83  IFMEYMPGGSVKDQL-----KAYGALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKG 134

Query: 176 TNILFNEQSDAKLFDFSLSLSIPD-GETHIELDSVVGTTGFIAPENFTTL-INEQCDVYG 233
            NIL +   + KL DF  S  +     +   + SV GT  +++PE  +      + DV+ 
Sbjct: 135 ANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWS 194

Query: 234 FGAFLFELLTAQ 245
            G  + E+LT +
Sbjct: 195 LGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 28/98 (28%), Positives = 50/98 (51%), Gaps = 13/98 (13%)

Query: 159 YLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAP 218
           Y+H   +  I++RD+KP N+  NE  + K+ DF L+      +T  E+   V T  + AP
Sbjct: 133 YIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAP 184

Query: 219 ENFTTLIN--EQCDVYGFGAFLFELLTAQEV---SDHV 251
           E     ++  +  D++  G  + E+LT + +    DH+
Sbjct: 185 EVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL 222

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 33/98 (33%), Positives = 45/98 (45%), Gaps = 14/98 (14%)

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ +LH      IVYRD+K  NIL + +    L DF LS      E      S  G
Sbjct: 113 EIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTY-SFCG 168

Query: 212 TTGFIAPENFTTLINEQ------CDVYGFGAFLFELLT 243
           T  ++APE    +I  +       D +  G  +FELLT
Sbjct: 169 TIEYMAPE----IIRGKGGHGKAVDWWSLGILIFELLT 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 41.0 bits (96), Expect = 4e-04
 Identities = 30/105 (28%), Positives = 53/105 (50%), Gaps = 7/105 (6%)

Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           L++   + +A  IA  +A++     +  ++RD++  NIL +E    K+ DF L+  I D 
Sbjct: 99  LTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155

Query: 201 ETHIELDSVVGTTGFIAPE--NFTTLINEQCDVYGFGAFLFELLT 243
           E +   +       + APE  N+ T    + DV+ FG  L E++T
Sbjct: 156 E-YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 41.2 bits (96), Expect = 4e-04
 Identities = 31/101 (30%), Positives = 47/101 (46%), Gaps = 9/101 (8%)

Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDS 208
           V+ +    + YLH   S+  ++RD+K  NIL  +    KL DF +S  I    T  +  S
Sbjct: 111 VSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQI--TATIAKRKS 165

Query: 209 VVGTTGFIAPENFTTL----INEQCDVYGFGAFLFELLTAQ 245
            +GT  ++APE          N+ CD++  G    EL   Q
Sbjct: 166 FIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQ 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 41.1 bits (97), Expect = 4e-04
 Identities = 16/48 (33%), Positives = 27/48 (56%), Gaps = 5/48 (10%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL--SLSIP 198
           +   +AY H   S  +++RD+KP N+L + +   KL DF L  +  +P
Sbjct: 108 LLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP 152

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 41.2 bits (96), Expect = 4e-04
 Identities = 40/139 (28%), Positives = 67/139 (48%), Gaps = 19/139 (13%)

Query: 114 KLIVF-ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRD 172
           KL +F E +  G++ D++     + + AL+     +    I   V+YLH   S  IV+RD
Sbjct: 80  KLSIFVEYMPGGSIKDQL-----KAYGALTENVTRRYTRQILQGVSYLH---SNMIVHRD 131

Query: 173 MKPTNILFNEQSDAKLFDFSLSLSIPD-GETHIELDSVVGTTGFIAPENFTTLIN----- 226
           +K  NIL +   + KL DF  S  I     +   + SV GT  +++PE    +I+     
Sbjct: 132 IKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPE----VISGEGYG 187

Query: 227 EQCDVYGFGAFLFELLTAQ 245
            + DV+     + E+LT +
Sbjct: 188 RKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 41.1 bits (96), Expect = 4e-04
 Identities = 57/239 (23%), Positives = 98/239 (41%), Gaps = 46/239 (19%)

Query: 99  NHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRL 147
             ++  ++M H +I+             IV E    G L  RI+    Q     S    L
Sbjct: 48  KEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINR---QRGVLFSEDQIL 104

Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD-AKLFDFSLSLSIPDGETHIEL 206
              + I+  + ++H    R I++RD+K  NI  ++    AKL DF ++  + D    +EL
Sbjct: 105 SWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS---MEL 158

Query: 207 -DSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVK 264
             + VGT  +++PE       N + D++  G  L+EL T +       FE       N+ 
Sbjct: 159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKH-----PFEG-----NNLH 208

Query: 265 RLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ 323
           +L  + C+      S              + L++   L  Q    SP DRP++  + K+
Sbjct: 209 QLVLKICQGYFAPIS----------PNFSRDLRS---LISQLFKVSPRDRPSITSILKR 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 41.0 bits (96), Expect = 4e-04
 Identities = 26/83 (31%), Positives = 39/83 (46%), Gaps = 15/83 (18%)

Query: 168 IVYRDMKPTNILFNEQSDAKLFDFSLS--LSIPDGETHIELDSVVGTTGFIAPENFTTL- 224
           I++RD+KPTN+L N     KL DF +S  L     +T+I      G   ++APE   +  
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI------GCQSYMAPERIKSGG 177

Query: 225 ------INEQCDVYGFGAFLFEL 241
                    Q DV+  G  + E+
Sbjct: 178 PNQNPTYTVQSDVWSLGLSILEM 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 41.3 bits (97), Expect = 4e-04
 Identities = 41/170 (24%), Positives = 76/170 (44%), Gaps = 31/170 (18%)

Query: 89  RNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQH 137
           R Q   E   N +V      H +I+++           +V E ++ G L D I  H   +
Sbjct: 55  RKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMN 113

Query: 138 FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF----SL 193
            E ++      V + +  A+++LH   ++ +++RD+K  +IL       KL DF     +
Sbjct: 114 EEQIA-----TVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165

Query: 194 SLSIPDGETHIELDSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELL 242
           S  +P         S+VGT  ++APE  + L    + D++  G  + E++
Sbjct: 166 SKEVP------RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 41.1 bits (96), Expect = 5e-04
 Identities = 42/219 (19%), Positives = 87/219 (39%), Gaps = 31/219 (14%)

Query: 42  RIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFW------QKRSISLMKYNGNRNQHALE 95
           RI    ELR       +  ++    F  ++KG W       K  +++        +   +
Sbjct: 2   RILKETELR-------KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ 54

Query: 96  WCINHIVYASRMSHKHIIKLI----------VFESVQIGTLADRIHHHCEQHFEALSLTD 145
              +H++    + H +I++L+          V +   +G+L D    H  QH ++L    
Sbjct: 55  EITDHMLAMGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLD----HVRQHRDSLDPQR 110

Query: 146 RLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIE 205
            L   + IA  + YL       +V+R++   NIL    S  ++ DF ++  +   +    
Sbjct: 111 LLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYF 167

Query: 206 LDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLT 243
                    ++A E+        Q DV+ +G  ++E+++
Sbjct: 168 YSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 40.9 bits (96), Expect = 5e-04
 Identities = 24/89 (26%), Positives = 48/89 (53%), Gaps = 6/89 (6%)

Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFI 216
           +AYLH   S+ I++RD+K  N+L +     K+ DF +S    D   + +  S+ G+  ++
Sbjct: 121 LAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM 177

Query: 217 APE---NFTTLINEQCDVYGFGAFLFELL 242
           APE   +++   + + D++  G  + E+ 
Sbjct: 178 APEVIHSYSQGYSAKVDIWSLGCVVLEMF 206

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 41.2 bits (96), Expect = 5e-04
 Identities = 40/173 (23%), Positives = 74/173 (42%), Gaps = 31/173 (17%)

Query: 89  RNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQH 137
           R Q   E   N +V      H++++++           ++ E +Q G L D +       
Sbjct: 57  RKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----- 111

Query: 138 FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF----SL 193
              L+      V   +  A+ YLH   S+ +++RD+K  +IL       KL DF     +
Sbjct: 112 -TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167

Query: 194 SLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQ 245
           S  +P      +  S+VGT  ++APE  + T    + D++  G  + E++  +
Sbjct: 168 SKDVP------KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.2 bits (96), Expect = 5e-04
 Identities = 34/128 (26%), Positives = 54/128 (42%), Gaps = 43/128 (33%)

Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF----------------S 192
           +A+D  H + ++H         RD+KP N+L + +   KL DF                +
Sbjct: 112 LAIDSIHQLGFIH---------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRN 162

Query: 193 LSLSIPDGETHIELDS-----------------VVGTTGFIAPENFT-TLINEQCDVYGF 234
           L+ S+P   T   ++S                  VGT  +IAPE F  T  N+ CD +  
Sbjct: 163 LNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222

Query: 235 GAFLFELL 242
           G  ++E+L
Sbjct: 223 GVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 24/90 (26%), Positives = 46/90 (51%), Gaps = 7/90 (7%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
           A+ Y+H      +++RD+K  NIL     + KL DF ++  +    +  +  + VGT  +
Sbjct: 113 ALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--KRSTFVGTPYW 167

Query: 216 IAPENFT--TLINEQCDVYGFGAFLFELLT 243
           +APE  T     + + D++  G  ++E+ T
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMAT 197

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 40.7 bits (95), Expect = 6e-04
 Identities = 27/89 (30%), Positives = 44/89 (49%), Gaps = 10/89 (11%)

Query: 159 YLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAP 218
           Y+H   S  I++RD+KP N+  NE  + K+ DF L+          E+   V T  + AP
Sbjct: 132 YIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARH-----ADAEMTGYVVTRWYRAP 183

Query: 219 ENFTTLI--NEQCDVYGFGAFLFELLTAQ 245
           E     +  N+  D++  G  + E+LT +
Sbjct: 184 EVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 40.8 bits (95), Expect = 7e-04
 Identities = 32/117 (27%), Positives = 55/117 (47%), Gaps = 14/117 (11%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
           A +I  A+ +LH    R I+YRD+K  N+L +     KL D+ +    +  G+T     +
Sbjct: 102 AAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT---TST 155

Query: 209 VVGTTGFIAPENFTTLINEQ----CDVYGFGAFLFELLTAQEVSDHVSFESRFHYEE 261
             GT  +IAPE    L  E+     D +  G  +FE++  +   D ++     + E+
Sbjct: 156 FCGTPNYIAPE---ILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTED 209

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 40.4 bits (94), Expect = 7e-04
 Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 38/206 (18%)

Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           IV E +  G+L D +     ++ +   L D   +A  IA  +AY+        ++RD++ 
Sbjct: 77  IVTEFMGKGSLLDFLKEGDGKYLKLPQLVD---MAAQIADGMAYIE---RMNYIHRDLRA 130

Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE-----NFTTLINEQCD 230
            NIL  +    K+ DF L+  I D E +           + APE      FT     + D
Sbjct: 131 ANILVGDNLVCKIADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI----KSD 185

Query: 231 VYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCT 290
           V+ FG  L EL+T          + R  Y   V R         E+++ +   ++     
Sbjct: 186 VWSFGILLTELVT----------KGRVPYPGMVNR---------EVLEQV---ERGYRMP 223

Query: 291 GKEQQLQAFKQLTLQCMDFSPEDRPT 316
             +   ++  +L   C    P++RPT
Sbjct: 224 CPQGCPESLHELMKLCWKKDPDERPT 249

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 40.3 bits (95), Expect = 7e-04
 Identities = 26/90 (28%), Positives = 40/90 (44%), Gaps = 7/90 (7%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            VA+LH      I++RD+K +N+L N +   K+ DF L+              +V T  +
Sbjct: 118 GVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP--YTQLVVTLWY 172

Query: 216 IAPENF--TTLINEQCDVYGFGAFLFELLT 243
            APE        +   D++  G    ELLT
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLT 202

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 40.4 bits (94), Expect = 8e-04
 Identities = 32/107 (29%), Positives = 52/107 (48%), Gaps = 14/107 (13%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
           + +I+ A+ YLH    R I+YRD+K  N+L + +   KL D+ +    +  G+T     +
Sbjct: 102 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TST 155

Query: 209 VVGTTGFIAPENFTTLINE----QCDVYGFGAFLFELLTAQEVSDHV 251
             GT  +IAPE    L  E      D +  G  +FE++  +   D V
Sbjct: 156 FCGTPNYIAPE---ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 199

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 40.6 bits (95), Expect = 8e-04
 Identities = 34/140 (24%), Positives = 51/140 (36%), Gaps = 55/140 (39%)

Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL------------- 195
           +A++  H + ++H         RD+KP NIL +     KL DF LS              
Sbjct: 112 LAIEAVHKLGFIH---------RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQK 162

Query: 196 --------SIPDGETHIELDSV------------------------VGTTGFIAPENFTT 223
                   +  D    + +DS+                        VGT  +IAPE F  
Sbjct: 163 LLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ 222

Query: 224 L-INEQCDVYGFGAFLFELL 242
               ++CD +  GA +FE L
Sbjct: 223 QGYGQECDWWSLGAIMFECL 242

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 40.3 bits (95), Expect = 9e-04
 Identities = 43/170 (25%), Positives = 73/170 (42%), Gaps = 46/170 (27%)

Query: 107 MSHKHIIKL-------------IVFESV-----QIGTLADRIHHHCEQHFEALSLTDR-L 147
           + H++++ L             ++F+       QI      I  H  +  + +S+    +
Sbjct: 59  LKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQI------IKFH--RQAKRVSIPPSMV 110

Query: 148 KVAM-DIAHAVAYLHVGFSRPIVYRDMKPTNIL----FNEQSDAKLFDFSLS-LSIPDGE 201
           K  +  I + V YLH   S  +++RD+KP NIL      E+   K+ D  L+ L     +
Sbjct: 111 KSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLK 167

Query: 202 THIELDSVVGTTGFIAPE------NFTTLINEQCDVYGFGAFLFELLTAQ 245
              +LD VV T  + APE      ++T  I    D++  G    ELLT +
Sbjct: 168 PLADLDPVVVTIWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTLE 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 37/132 (28%), Positives = 63/132 (47%), Gaps = 10/132 (7%)

Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I  E +  G++ D++     + + AL+     K    I   V+YLH   S  IV+RD+K 
Sbjct: 83  IFMEHMPGGSIKDQL-----KSYGALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKG 134

Query: 176 TNILFNEQSDAKLFDFSLSLSIPD-GETHIELDSVVGTTGFIAPENFTTL-INEQCDVYG 233
            NIL +   + KL DF  S  +     +   + SV GT  +++PE  +      + D++ 
Sbjct: 135 ANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWS 194

Query: 234 FGAFLFELLTAQ 245
            G  + E+LT +
Sbjct: 195 VGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 26/105 (24%), Positives = 51/105 (48%), Gaps = 4/105 (3%)

Query: 140 ALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD 199
           AL   D L  +  +A  +++L    S+  ++RD+   NIL       K+ DF L+  I +
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266

Query: 200 GETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
              ++   +      ++APE+ F  +   + DV+ +G  L+E+ +
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 39.8 bits (93), Expect = 0.001
 Identities = 31/117 (26%), Positives = 48/117 (41%), Gaps = 36/117 (30%)

Query: 98  INHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQH--FEALSLTDRLKVAMDIA- 154
           I  I     ++H +I+KL+           D IH   + +  FE L     LK  MD + 
Sbjct: 47  IREISLLKELNHPNIVKLL-----------DVIHTENKLYLVFEFLH--QDLKKFMDASP 93

Query: 155 -----------------HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS 194
                              +A+ H   S  +++RD+KP N+L N +   KL DF L+
Sbjct: 94  LSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA 147

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 29/96 (30%), Positives = 44/96 (45%), Gaps = 7/96 (7%)

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ +LH      I+YRD+K  NIL +      L DF LS    + E      S  G
Sbjct: 113 EIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCG 168

Query: 212 TTGFIAPE---NFTTLINEQCDVYGFGAFLFELLTA 244
           T  ++AP+         ++  D +  G  ++ELLT 
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 43/163 (26%), Positives = 70/163 (42%), Gaps = 38/163 (23%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           + SH +II+L           I+ E ++ G L D+     +  F +  L   L+    IA
Sbjct: 62  QFSHHNIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLR---GIA 117

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
             + YL        V+RD+   NIL N   + K+ DF LS  + D     + +    T+G
Sbjct: 118 AGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLED-----DPEGTYTTSG 169

Query: 215 ------FIAPE-----NFTTLINEQCDVYGFGAFLFELLTAQE 246
                 + APE      FT+      DV+ FG  ++E+++  E
Sbjct: 170 GKIPIRWTAPEAIAYRKFTS----ASDVWSFGIVMWEVMSFGE 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 39.7 bits (93), Expect = 0.001
 Identities = 32/102 (31%), Positives = 43/102 (42%), Gaps = 11/102 (10%)

Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS--LSIPDGETHIE 205
           K+      AV + H       ++RD+KP NIL  +Q   KL DF  +  L+ P      +
Sbjct: 104 KIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD----D 156

Query: 206 LDSVVGTTGFIAPENFT--TLINEQCDVYGFGAFLFELLTAQ 245
               V T  + APE     T      DV+  G    ELLT Q
Sbjct: 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 34/130 (26%), Positives = 61/130 (46%), Gaps = 10/130 (7%)

Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G+L D +          + L   +  +  IA  +AY+     +  ++RD++ 
Sbjct: 78  IITEYMAKGSLLDFLK---SDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRA 131

Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE--NFTTLINEQCDVYG 233
            N+L +E    K+ DF L+  I D E +   +       + APE  NF +    + DV+ 
Sbjct: 132 ANVLVSESLMCKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWS 189

Query: 234 FGAFLFELLT 243
           FG  L+E++T
Sbjct: 190 FGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 39.4 bits (92), Expect = 0.002
 Identities = 29/102 (28%), Positives = 49/102 (48%), Gaps = 16/102 (15%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
           A ++  A+ +LH      ++YRD+K  NIL + +   KL DF +    I +G T     +
Sbjct: 102 AAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT---TTT 155

Query: 209 VVGTTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQ 245
             GT  +IAPE    ++ E       D +  G  ++E++  Q
Sbjct: 156 FCGTPDYIAPE----ILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 41/166 (24%), Positives = 69/166 (41%), Gaps = 34/166 (20%)

Query: 105 SRMSHKHIIK-----------LIVFESVQIGTLADRIHHHCE-----------QHFEALS 142
           + + H+HI+K           ++VFE ++ G L   +  H             Q    L 
Sbjct: 62  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 121

Query: 143 LTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET 202
           L+  L +A  IA  + YL    S+  V+RD+   N L       K+ DF +S  +   + 
Sbjct: 122 LSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 178

Query: 203 HIELDSVVGTTGFIAPEN-----FTTLINEQCDVYGFGAFLFELLT 243
           +      +    ++ PE+     FTT    + DV+ FG  L+E+ T
Sbjct: 179 YRVGGHTMLPIRWMPPESIMYRKFTT----ESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 23/63 (36%), Positives = 31/63 (49%), Gaps = 6/63 (9%)

Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFI 216
           + +LH   +  IV+RD+KP NIL       KL DF L+         + L  VV T  + 
Sbjct: 121 LDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYR 174

Query: 217 APE 219
           APE
Sbjct: 175 APE 177

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 39.0 bits (91), Expect = 0.002
 Identities = 36/153 (23%), Positives = 66/153 (43%), Gaps = 26/153 (16%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           ++SH ++++L           IV E +  G L +    +  +    L     L +  D+ 
Sbjct: 55  KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLN----YLRERKGKLGTEWLLDMCSDVC 110

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
            A+ YL    S   ++RD+   N L  E +  K+ DF L+  + D     +  S  GT  
Sbjct: 111 EAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD----QYTSSQGTKF 163

Query: 215 FI---APENFT-TLINEQCDVYGFGAFLFELLT 243
            +    PE F  +  + + DV+ FG  ++E+ +
Sbjct: 164 PVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 39.3 bits (92), Expect = 0.002
 Identities = 43/164 (26%), Positives = 65/164 (39%), Gaps = 38/164 (23%)

Query: 109 HKHIIKLI-----------VFESVQIGTLADRIHHH-----------CEQHFEALSLTDR 146
           HK+II L+           V E    G L D +                   E L+  D 
Sbjct: 75  HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 147 LKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL 206
           +  A  +A  + +L    S+  ++RD+   N+L  E    K+ DF L+  I     H  +
Sbjct: 135 VSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLARDI-----H-HI 185

Query: 207 DSVVGTTG------FIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
           D    TT       ++APE  F  +   Q DV+ FG  L+E+ T
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 56/226 (24%), Positives = 90/226 (39%), Gaps = 48/226 (21%)

Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H  +++L          IV E +  G+L D +    +    AL L + + +A  +A 
Sbjct: 57  KLRHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLK---DGEGRALKLPNLVDMAAQVAA 113

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +AY+        ++RD++  NIL  +    K+ DF L+  I D E +           +
Sbjct: 114 GMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE-YTARQGAKFPIKW 169

Query: 216 IAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
            APE      FT     + DV+ FG  L EL+T   V  +    +R    E V+R     
Sbjct: 170 TAPEAALYGRFTI----KSDVWSFGILLTELVTKGRVP-YPGMNNR-EVLEQVERGYRMP 223

Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
           C             + C  +          +L LQC    PE+RPT
Sbjct: 224 C------------PQDCPIS--------LHELMLQCWKKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 39/169 (23%), Positives = 72/169 (42%), Gaps = 24/169 (14%)

Query: 89  RNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQH 137
           ++  A+E      V  ++M H +I+             IV E    G L  +I     + 
Sbjct: 37  KSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKL 96

Query: 138 FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS--L 195
           F   ++   L+  + +   V ++H    + +++RD+K  NI   +    KL DF  +  L
Sbjct: 97  FPEDTI---LQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150

Query: 196 SIPDGETHIELDSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLT 243
           + P         + VGT  ++ PE +  +  N + D++  G  L+EL T
Sbjct: 151 TSPGAYAC----TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 38.9 bits (91), Expect = 0.002
 Identities = 38/134 (28%), Positives = 61/134 (45%), Gaps = 16/134 (11%)

Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +VFE V   T+ D +  +       L  +   K    I   + + H   S  I++RD+KP
Sbjct: 77  LVFEFVD-HTVLDDLEKYPN----GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKP 128

Query: 176 TNILFNEQSDAKL--FDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT--TLINEQCDV 231
            NIL ++    KL  F F+ +L+ P GE + +    V T  + APE     T      D+
Sbjct: 129 ENILVSQSGVVKLCDFGFARTLAAP-GEVYTDY---VATRWYRAPELLVGDTKYGRAVDI 184

Query: 232 YGFGAFLFELLTAQ 245
           +  G  + E+LT +
Sbjct: 185 WAVGCLVTEMLTGE 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 38.9 bits (90), Expect = 0.002
 Identities = 29/103 (28%), Positives = 55/103 (53%), Gaps = 9/103 (8%)

Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDS 208
           +  +I   +++LH      +++RD+K  N+L  E ++ KL DF +S  +    T    ++
Sbjct: 116 ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNT 170

Query: 209 VVGTTGFIAPENFTTLINEQCD-VYGFGAFLFEL-LTAQEVSD 249
            +GT  ++APE      +E  D  Y F + L+ L +TA E+++
Sbjct: 171 FIGTPYWMAPE--VIACDENPDATYDFKSDLWSLGITAIEMAE 211

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 37/186 (19%), Positives = 85/186 (45%), Gaps = 26/186 (13%)

Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           +L + +++A +IA  +AYL+   ++  V+RD+   N +       K+ DF ++  I + +
Sbjct: 117 TLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 173

Query: 202 THIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYE 260
            + +    +    ++APE+    +     D++ FG  L+E+ +                E
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLA--------------E 219

Query: 261 ENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
           +  + LS +    K ++D   + D+   C    +++    ++   C  F+P+ RPT +++
Sbjct: 220 QPYQGLSNEQV-LKFVMDGGYL-DQPDNC---PERVTDLMRM---CWQFNPKMRPTFLEI 271

Query: 321 AKQLRQ 326
              L+ 
Sbjct: 272 VNLLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 19/48 (39%), Positives = 29/48 (60%), Gaps = 3/48 (6%)

Query: 147 LKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS 194
           +K   ++A A+ YLH      I++RD+KP N+L + +   KL DF LS
Sbjct: 107 VKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 38.8 bits (90), Expect = 0.002
 Identities = 32/100 (32%), Positives = 50/100 (50%), Gaps = 11/100 (11%)

Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL--SLSIPDGETHIELDSVVGTTG 214
           +AY+H    + I++RD+KP N+L +   + KL DF L  + SIP  +T+    S V T  
Sbjct: 116 LAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP-SQTY---SSEVVTLW 168

Query: 215 FIAPENF--TTLINEQCDVYGFGAFLFELLTAQEVSDHVS 252
           +  P+     T  +   D++G G    E+L  Q     VS
Sbjct: 169 YRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 38.9 bits (90), Expect = 0.002
 Identities = 33/128 (25%), Positives = 49/128 (38%), Gaps = 43/128 (33%)

Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE------- 201
           +A+D  H + ++H         RD+KP N+L + +   KL DF L   +           
Sbjct: 112 LAIDAIHQLGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRN 162

Query: 202 -THIELD-------------------------SVVGTTGFIAPENFT-TLINEQCDVYGF 234
            TH                             S VGT  +IAPE F  T  N+ CD +  
Sbjct: 163 LTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSL 222

Query: 235 GAFLFELL 242
           G  ++E+L
Sbjct: 223 GVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 39.3 bits (91), Expect = 0.003
 Identities = 49/194 (25%), Positives = 81/194 (41%), Gaps = 40/194 (20%)

Query: 99  NHIVYASRMSHKHIIKL-IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAV 157
           N + Y  R  +K   KL I+ E    G L+  I   C + F  +     + +   + HA+
Sbjct: 73  NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQK-CYKMFGKIEEHAIVDITRQLLHAL 131

Query: 158 AYLHVGFSRP----IVYRDMKPTNIL-----------------FNEQSDAKLFDFSLSLS 196
           AY H     P    +++RD+KP NI                   N +  AK+ DF LS +
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191

Query: 197 IP-DGETHIELDSVVGTTGFIAPE---NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVS 252
           I  +   H    S VGT  + +PE   + T   +++ D++  G  ++EL + +       
Sbjct: 192 IGIESMAH----SCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK------- 240

Query: 253 FESRFHYEENVKRL 266
             + FH   N  +L
Sbjct: 241 --TPFHKANNFSQL 252

Length = 1021

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 38.6 bits (90), Expect = 0.003
 Identities = 47/199 (23%), Positives = 77/199 (38%), Gaps = 48/199 (24%)

Query: 145 DRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHI 204
           D +   + +A  + YL    S+  V+RD+   N + +E    K+ DF L+  I D     
Sbjct: 99  DLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDK---- 151

Query: 205 ELDSVVGTTGFIAP-----------ENFTTLINEQCDVYGFGAFLFELLT--AQEVSDHV 251
           E  SV   TG   P           + FTT    + DV+ FG  L+EL+T  A    D  
Sbjct: 152 EYYSVHNHTGAKLPVKWMALESLQTQKFTT----KSDVWSFGVLLWELMTRGAPPYPDVD 207

Query: 252 SFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSP 311
           SF+   +  +  + L  + C                             ++ L C    P
Sbjct: 208 SFDITVYLLQGRRLLQPEYCP------------------------DPLYEVMLSCWHPKP 243

Query: 312 EDRPTMVDVAKQLRQMYRS 330
           E RPT  ++  ++ Q++ +
Sbjct: 244 EMRPTFSELVSRIEQIFST 262

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.1 bits (91), Expect = 0.003
 Identities = 27/104 (25%), Positives = 53/104 (50%), Gaps = 4/104 (3%)

Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           L L D L+ +  +A  + +L    S+  ++RD+   N+L  +   AK+ DF L+  I + 
Sbjct: 209 LDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMND 265

Query: 201 ETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             ++   +      ++APE+ F  +   Q DV+ +G  L+E+ +
Sbjct: 266 SNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 38.5 bits (89), Expect = 0.003
 Identities = 30/110 (27%), Positives = 55/110 (50%), Gaps = 12/110 (10%)

Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           SL   +++A +IA  +AYL+   +   V+RD+   N +  E    K+ DF ++  I + +
Sbjct: 117 SLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173

Query: 202 THIELDSVVGTTGFIAPEN-----FTTLINEQCDVYGFGAFLFELLTAQE 246
            + +    +    +++PE+     FTT      DV+ FG  L+E+ T  E
Sbjct: 174 YYRKGGKGLLPVRWMSPESLKDGVFTT----YSDVWSFGVVLWEIATLAE 219

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 21/71 (29%), Positives = 39/71 (54%), Gaps = 5/71 (7%)

Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDS 208
           +  +I   +A+LH      +++RD+K  N+L  E ++ KL DF +S  +    T    ++
Sbjct: 126 ICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL--DRTVGRRNT 180

Query: 209 VVGTTGFIAPE 219
            +GT  ++APE
Sbjct: 181 FIGTPYWMAPE 191

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 38.6 bits (90), Expect = 0.003
 Identities = 27/98 (27%), Positives = 40/98 (40%), Gaps = 14/98 (14%)

Query: 160 LHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS---------IPDGETH---IELD 207
           L+V      ++RD+ P NI  N +   K+ DF L+           +   ET     E+ 
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMT 191

Query: 208 SVVGTTGFIAPENF--TTLINEQCDVYGFGAFLFELLT 243
           S V T  + APE        +   D++  G    ELLT
Sbjct: 192 SKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLT 229

Length = 335

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 38.4 bits (89), Expect = 0.003
 Identities = 31/114 (27%), Positives = 59/114 (51%), Gaps = 13/114 (11%)

Query: 135 EQHFEALSLTDR--LKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS 192
           ++H  A +LT +  L+ A D+A  + YL     +  ++RD+   N+L  E   +K+ DF 
Sbjct: 108 KEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFG 164

Query: 193 LSLSIPDGETHIELDSVVG--TTGFIAPENFT-TLINEQCDVYGFGAFLFELLT 243
           LS     GE  + +   +G     ++A E+   ++   + DV+ FG  L+E+++
Sbjct: 165 LS----RGE-EVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 38.8 bits (90), Expect = 0.003
 Identities = 30/110 (27%), Positives = 46/110 (41%), Gaps = 11/110 (10%)

Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           +++ D L +   +  A+ YLH      I++RD+K  NI  N   D  L DF  +    D 
Sbjct: 179 IAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD- 234

Query: 201 ETHIELDSVVGTTGFIAPENFTTLINE----QCDVYGFGAFLFELLTAQE 246
              I  +   G  G IA      L  +      D++  G  LFE+ T  +
Sbjct: 235 ---INANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD 281

Length = 391

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 38.5 bits (90), Expect = 0.004
 Identities = 28/92 (30%), Positives = 43/92 (46%), Gaps = 15/92 (16%)

Query: 159 YLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIE--LDSVVGTTGFI 216
           Y+H   S  +++RD+KP N+L N   + K+ DF L+    +        +   V T  + 
Sbjct: 120 YIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYR 176

Query: 217 APE------NFTTLINEQCDVYGFGAFLFELL 242
           APE      ++T  I    DV+  G  L ELL
Sbjct: 177 APEIMLSFQSYTKAI----DVWSVGCILAELL 204

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 38.1 bits (88), Expect = 0.004
 Identities = 41/208 (19%), Positives = 77/208 (37%), Gaps = 46/208 (22%)

Query: 133 HCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS 192
           +  ++ + +   D L   + IA  ++YL       +V+RD+   N+L    +  K+ DF 
Sbjct: 98  YVRENKDRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFG 154

Query: 193 LSLSIPDGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT-------- 243
           L+  +   ET    D       ++A E+        Q DV+ +G  ++EL+T        
Sbjct: 155 LARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214

Query: 244 --AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQ 301
             A+E+ D +         E  +RL                  +   CT           
Sbjct: 215 IPAREIPDLL---------EKGERLP-----------------QPPICT------IDVYM 242

Query: 302 LTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
           + ++C     E RP   ++  +  +M R
Sbjct: 243 IMVKCWMIDSECRPRFRELVDEFSRMAR 270

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 38.0 bits (88), Expect = 0.004
 Identities = 40/163 (24%), Positives = 68/163 (41%), Gaps = 33/163 (20%)

Query: 107 MSHKHIIK-----------LIVFESVQIGTLADRIHHHC----------EQHFEALSLTD 145
           + H+HI++           L+VFE ++ G L   +  H           +     L+L  
Sbjct: 64  LQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQ 123

Query: 146 RLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIE 205
            L +A  IA  + YL    S   V+RD+   N L  +    K+ DF +S  I   + +  
Sbjct: 124 MLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRV 180

Query: 206 LDSVVGTTGFIAPEN-----FTTLINEQCDVYGFGAFLFELLT 243
               +    ++ PE+     FTT    + D++ FG  L+E+ T
Sbjct: 181 GGRTMLPIRWMPPESILYRKFTT----ESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	332
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.92
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.91
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.89
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.89
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.88
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.88
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.86
PRK10345	210	hypothetical protein; Provisional	99.85
smart00090	237	RIO RIO-like kinase.	99.85
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.85
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.82
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.8
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.75
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.75
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.73
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.63
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.54
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.53
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.53
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.5
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.48
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.43
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.43
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.42
KOG3087	229	consensus Serine/threonine protein kinase [General	99.39
COG4248	637	Uncharacterized protein with protein kinase and he	99.34
KOG1243	690	consensus Protein kinase [General function predict	99.32
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.26
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.23
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.19
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.15
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.09
PRK09902	216	hypothetical protein; Provisional	98.98
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.93
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.91
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.79
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.7
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.68
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.62
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.52
PF01636	239	APH: Phosphotransferase enzyme family This family	98.45
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.41
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.34
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.27
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.22
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.06
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.02
PLN02876	822	acyl-CoA dehydrogenase	98.01
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.0
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.99
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.92
KOG2270	520	consensus Serine/threonine protein kinase involved	97.85
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.84
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.83
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.83
PRK05231	319	homoserine kinase; Provisional	97.8
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.78
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.78
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.73
PRK10593	297	hypothetical protein; Provisional	97.72
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.55
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.28
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.14
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	97.06
PLN02236	344	choline kinase	97.02
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.01
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.9
PLN02756	418	S-methyl-5-thioribose kinase	96.87
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.73
PRK12396	409	5-methylribose kinase; Reviewed	96.72
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.69
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.49
PRK11768	325	serine/threonine protein kinase; Provisional	96.25
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.19
PRK06148	1013	hypothetical protein; Provisional	96.19
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	96.0
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	95.9
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	95.61
PTZ00384	383	choline kinase; Provisional	95.6
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	95.11
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	95.01

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-54  Score=372.23  Aligned_cols=240  Identities=19%  Similarity=0.280  Sum_probs=206.9

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE------------EEEEe
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------------IVFES  120 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~------------lv~e~  120 (332)
                      +.+..+.||+|..|+||++.+  ++..+|+|.+....++...+++.+|++++..++||+||.+            |+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            456678999999999999999  7999999999877777778899999999999999999998            89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      |++|+|.+++...     +.+++.....++.++++||.|||+  .++||||||||+|||++..|.+||||||.|+.+.+.
T Consensus       160 MDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             cCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            9999999999876     679999999999999999999994  499999999999999999999999999999888766


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      .    ..+++||..|||||.+.+ .|+.++||||||++++|+++|+.||.....               ....+-++++.
T Consensus       233 ~----a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~---------------~~~~~~~Ll~~  293 (364)
T KOG0581|consen  233 I----ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP---------------PYLDIFELLCA  293 (364)
T ss_pred             h----cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC---------------CCCCHHHHHHH
Confidence            2    268899999999999998 999999999999999999999999976511               11233344444


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ++...++..+.  ..+++++.+|+..||+.||.+|||+.|+++
T Consensus       294 Iv~~ppP~lP~--~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  294 IVDEPPPRLPE--GEFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             HhcCCCCCCCc--ccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            44433222111  147799999999999999999999999986

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-53  Score=385.30  Aligned_cols=276  Identities=35%  Similarity=0.595  Sum_probs=228.4

Q ss_pred             CcccccHHHHHHHhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---
Q 038681           40 PYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---  115 (332)
Q Consensus        40 ~~~~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---  115 (332)
                      +.+.|++.|+..+|++|...+.||+|+||.||+|.. ++..||||++....... ..+|.+|+.++.+++|||+|++   
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEE
Confidence            788999999999999999999999999999999999 55899999888776543 4559999999999999999987   


Q ss_pred             ---------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCe
Q 038681          116 ---------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA  186 (332)
Q Consensus       116 ---------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  186 (332)
                               ||+||+++|+|.+++......   +++|..+++|+.++|.||+|||+.+...|+||||||+|||+|.+.++
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~a  216 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNA  216 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCE
Confidence                     899999999999999876321   78999999999999999999998766689999999999999999999


Q ss_pred             EEeecCCccccCC-CCceeecccc-ccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHH
Q 038681          187 KLFDFSLSLSIPD-GETHIELDSV-VGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENV  263 (332)
Q Consensus       187 kl~Dfg~a~~~~~-~~~~~~~~~~-~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~  263 (332)
                      ||+|||+|+..+. ....   ... .||.+|+|||.+.. ..+.++||||||+++.||+||+.|.+............+.
T Consensus       217 KlsDFGLa~~~~~~~~~~---~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~  293 (361)
T KOG1187|consen  217 KLSDFGLAKLGPEGDTSV---STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWA  293 (361)
T ss_pred             EccCccCcccCCccccce---eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHH
Confidence            9999999976654 3222   122 79999999999975 8999999999999999999999888754422222222222


Q ss_pred             hhhhccccchhhhhhhhhhc-ccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 038681          264 KRLSGQNCRFKEMVDSIIIE-DKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY  328 (332)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~  328 (332)
                      ... .....+.+++|+.+.. ...     .......+..+..+|++.+|.+||+|.+|++.|+.+.
T Consensus       294 ~~~-~~~~~~~eiiD~~l~~~~~~-----~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  294 KPL-LEEGKLREIVDPRLKEGEYP-----DEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             HHH-HHCcchhheeCCCccCCCCC-----hHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            111 1333788888887763 221     0146677999999999999999999999999997654

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.7e-55  Score=362.12  Aligned_cols=244  Identities=23%  Similarity=0.372  Sum_probs=204.0

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-------------EE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-------------IV  117 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-------------lv  117 (332)
                      .+|.+.++||+|+||+||++..  +|..||.|.+.... +....+.+..|+.+|++|+|||||++             ||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            4578889999999999999998  99999999998653 45557789999999999999999997             89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCC--CC--eeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFS--RP--IVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~--~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                      ||||.+|||.++++....+. ..+++..+++++.|++.||.++|   .  ..  |+||||||.||+++.+|.+||+|||+
T Consensus        99 mE~c~~GDLsqmIk~~K~qk-r~ipE~~Vwk~f~QL~~AL~~cH---~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL  174 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQK-RLIPEKTVWKYFVQLCRALYHCH---SKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL  174 (375)
T ss_pred             HHhhcccCHHHHHHHHHhcc-ccCchHHHHHHHHHHHHHHHHHh---ccccccceeeccCcchheEEcCCCceeeccchh
Confidence            99999999999998764433 67999999999999999999999   5  44  99999999999999999999999999


Q ss_pred             ccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          194 SLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       194 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      ++.+.......  .+.+|||.||+||.+.+ .|+.+|||||+||++|||+.-++||.+.+..+      +...+...  .
T Consensus       175 ~r~l~s~~tfA--~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~------L~~KI~qg--d  244 (375)
T KOG0591|consen  175 GRFLSSKTTFA--HSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS------LCKKIEQG--D  244 (375)
T ss_pred             HhHhcchhHHH--HhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH------HHHHHHcC--C
Confidence            99887765432  57899999999999988 99999999999999999999999998763322      22222211  1


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                      +              +.-....++.++..|+..|+..||..||+...++..+.
T Consensus       245 ~--------------~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  245 Y--------------PPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             C--------------CCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            1              11112467889999999999999999998555544443

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-53  Score=382.09  Aligned_cols=251  Identities=26%  Similarity=0.412  Sum_probs=206.5

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEeCCee-EEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE------------E
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFWQKRS-ISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL------------I  116 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~------------l  116 (332)
                      +...+....+.||.|+||+||+|.+.|.. ||||++..... ....+.|.+|+.+|.+++|||||++            |
T Consensus        38 i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i  117 (362)
T KOG0192|consen   38 IDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI  117 (362)
T ss_pred             cChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence            33444555666999999999999998888 99999987643 2326789999999999999999998            8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCC-eeecCCCCCCeeeCCCC-CeEEeecCCc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRP-IVYRDMKPTNILFNEQS-DAKLFDFSLS  194 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlkp~Nill~~~~-~~kl~Dfg~a  194 (332)
                      ||||+++|+|.+++...   ....+++..++.++.|||.||.|||   +++ ||||||||+|||++.++ ++||+|||++
T Consensus       118 VtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH---~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLH---SEGPIIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             EEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHh---cCCCeeecccChhhEEEcCCCCEEEECCCccc
Confidence            99999999999999873   1257999999999999999999999   888 99999999999999997 9999999999


Q ss_pred             cccCCCCceeeccccccCCCcccccccC--C-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFT--T-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      +........  .+...||+.|||||++.  . .|+.|+||||||+++|||+||+.||..........      .+     
T Consensus       192 r~~~~~~~~--~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~------~v-----  258 (362)
T KOG0192|consen  192 REKVISKTS--MTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVAS------AV-----  258 (362)
T ss_pred             eeecccccc--ccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHH------HH-----
Confidence            876654211  13468999999999999  4 69999999999999999999999999876522111      10     


Q ss_pred             chhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 038681          272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSC  331 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  331 (332)
                               .....  +.+.+..+++.+..|+.+||..||..||++.+++..|+.+...+
T Consensus       259 ---------~~~~~--Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~  307 (362)
T KOG0192|consen  259 ---------VVGGL--RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI  307 (362)
T ss_pred             ---------HhcCC--CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence                     00011  11222236688999999999999999999999999999887643

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-54  Score=372.40  Aligned_cols=240  Identities=21%  Similarity=0.308  Sum_probs=201.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChh------hHHHHHHHHHHHHhhcCCCcceE---------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQH------ALEWCINHIVYASRMSHKHIIKL---------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~------~~~~~~~E~~~l~~l~H~nIv~~---------  115 (332)
                      .+.|.+.+.||+|+||.|-+|..  +|+.||||++.......      ......+|+++|++|+|||||++         
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            45578899999999999999998  89999999998764322      13346799999999999999998         


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC---CCeEEee
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ---SDAKLFD  190 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~D  190 (332)
                        |||||+.||+|.+++-.+     +.+.+...+.++.|++.|+.|||   ++||+||||||+|||+..+   ..+||+|
T Consensus       251 ~YmVlE~v~GGeLfd~vv~n-----k~l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVAN-----KYLREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             eEEEEEEecCccHHHHHHhc-----cccccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecc
Confidence              999999999999999887     67889999999999999999999   9999999999999999765   7899999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccCC----CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhh
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFTT----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRL  266 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~  266 (332)
                      ||+|+........   .+.+||+.|.|||++.+    .+..++||||+||+||-+++|.+||.+......          
T Consensus       323 FGlAK~~g~~sfm---~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s----------  389 (475)
T KOG0615|consen  323 FGLAKVSGEGSFM---KTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS----------  389 (475)
T ss_pred             cchhhccccceeh---hhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc----------
Confidence            9999998755543   67899999999999975    344589999999999999999999986544321          


Q ss_pred             hccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          267 SGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                               +.++.....+....+.....+++..+||.+||..||++|||++|+++
T Consensus       390 ---------l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  390 ---------LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             ---------HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence                     12222333333333444577899999999999999999999999986

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-53  Score=366.61  Aligned_cols=193  Identities=23%  Similarity=0.414  Sum_probs=175.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      .++|...+.||+|+||+||+|++  ++..||||.+.... .....+.+..|+.+|+.++|||||++           |||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            46799999999999999999999  78999999998875 55557788999999999999999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC------CCeEEeecC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ------SDAKLFDFS  192 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~------~~~kl~Dfg  192 (332)
                      |||.||||.+|++.+     +.+++..++.++.||+.||++||   +++||||||||+|||++..      -.+||+|||
T Consensus        89 EyC~gGDLs~yi~~~-----~~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRR-----GRLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             EeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence            999999999999987     68999999999999999999999   9999999999999999765      458999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccch
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESR  256 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~  256 (332)
                      +|+.+......   .+.+||+.|||||++.. .|+.|+|+||+|+++|++++|+.||......+.
T Consensus       161 fAR~L~~~~~a---~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL  222 (429)
T KOG0595|consen  161 FARFLQPGSMA---ETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKEL  222 (429)
T ss_pred             hhhhCCchhHH---HHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHH
Confidence            99998866543   57899999999999965 999999999999999999999999997766553

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.8e-53  Score=382.10  Aligned_cols=235  Identities=20%  Similarity=0.349  Sum_probs=205.1

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ..|...++||+|||+.||++++  +|..||+|++.+..  .....+...+||++.+.|+|||||++           ||+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            4599999999999999999999  89999999998742  34557889999999999999999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      |+|+.|+|..++++.     .++++.+++.++.||+.||.|||   +++|+|||||..|+|++++.++||+|||+|..+.
T Consensus        98 ELC~~~sL~el~Krr-----k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le  169 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR-----KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE  169 (592)
T ss_pred             EecCCccHHHHHHhc-----CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceeeeec
Confidence            999999999999976     68999999999999999999999   9999999999999999999999999999999887


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      .+....  .+.+|||.|.|||++.. ..+..+||||+||++|-||+|++||......+..                    
T Consensus       170 ~~~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety--------------------  227 (592)
T KOG0575|consen  170 YDGERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY--------------------  227 (592)
T ss_pred             Cccccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH--------------------
Confidence            654322  57899999999999987 8999999999999999999999999876544332                    


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      +..-..++    ..+...+.++.+||.++|+.||.+|||+++|+.
T Consensus       228 ~~Ik~~~Y----~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  228 NKIKLNEY----SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             HHHHhcCc----ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            22222222    122355688999999999999999999999986

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=6.1e-53  Score=353.69  Aligned_cols=257  Identities=18%  Similarity=0.258  Sum_probs=206.6

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      +.|+...++|+|+||+||+|++  +|+.||||++....+ +...+..++|+++|++|+|||+|.+           ||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            3588899999999999999999  899999999987755 5556678999999999999999987           9999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      ||+. ++.+-+...    ...++...+.+++.|++.|+.|+|   +++|+||||||+||||+.+|.+||||||+|+.+..
T Consensus        82 ~~dh-TvL~eLe~~----p~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~  153 (396)
T KOG0593|consen   82 YCDH-TVLHELERY----PNGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA  153 (396)
T ss_pred             ecch-HHHHHHHhc----cCCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcC
Confidence            9987 666666554    256999999999999999999999   99999999999999999999999999999998875


Q ss_pred             CCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      +...+  +..+.|.+|+|||.+.+  .|+..+||||+||++.||++|.+.|.+.+.-++..  .+...+....+....++
T Consensus       154 pgd~Y--TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy--~I~ktLG~L~prhq~iF  229 (396)
T KOG0593|consen  154 PGDNY--TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLY--LIRKTLGNLIPRHQSIF  229 (396)
T ss_pred             Ccchh--hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHH--HHHHHHcccCHHHHHHh
Confidence            44332  56789999999999988  89999999999999999999999999887766543  12223333333333333


Q ss_pred             hhhhhc------ccCCCCCC---hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 DSIIIE------DKSCTCTG---KEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~~~~~~------~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .....-      ...-+.+.   -+..+.-+.+|++.||+.||.+|++.++++.
T Consensus       230 ~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  230 SSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            322110      00000010   1245567899999999999999999999875

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-52  Score=366.24  Aligned_cols=258  Identities=18%  Similarity=0.225  Sum_probs=206.4

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-CCCcceE------------E
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKL------------I  116 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~~------------l  116 (332)
                      ..++|...++||.|+||.||+|+.  ++..||||+++.....-..-.-++|+..|++|+ |||||++            +
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            346799999999999999999999  899999999987654322233478999999998 9999998            8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      |||||+. +|+++++.+.    ..+++..+..|+.||++||+|+|   .+|+.|||+||+|||+..+..+||+|||+|+.
T Consensus        88 VfE~Md~-NLYqLmK~R~----r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~iKiaDFGLARe  159 (538)
T KOG0661|consen   88 VFEFMDC-NLYQLMKDRN----RLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVIKIADFGLARE  159 (538)
T ss_pred             eHHhhhh-hHHHHHhhcC----CcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEecccceeEecccccccc
Confidence            9999976 9999998872    57999999999999999999999   99999999999999999889999999999999


Q ss_pred             cCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-cccch
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-QNCRF  273 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~  273 (332)
                      +......   +..+.|.+|+|||++..  .|+.+.||||+|||++|+.+-++.|.+.++.++..  .+-..+.. ....+
T Consensus       160 v~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~--KIc~VLGtP~~~~~  234 (538)
T KOG0661|consen  160 VRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY--KICEVLGTPDKDSW  234 (538)
T ss_pred             cccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH--HHHHHhCCCccccc
Confidence            8776654   56789999999999875  89999999999999999999999999988766533  11112211 11122


Q ss_pred             hh--hhhhhhhcccCC-CC-C---ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          274 KE--MVDSIIIEDKSC-TC-T---GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       274 ~~--~~~~~~~~~~~~-~~-~---~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .+  .+...+.-..+. .. .   .-+.++.++.++|.+|+.+||.+||||+++++
T Consensus       235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence            22  111111111110 00 0   11247789999999999999999999999986

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-51  Score=362.07  Aligned_cols=259  Identities=19%  Similarity=0.231  Sum_probs=205.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-------------E
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-------------I  116 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-------------l  116 (332)
                      .+.|+.+++||+|+||.||+|++  +|+.||+|++..+. .+.......+||.||++|+||||+++             |
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            34588899999999999999999  89999999998876 34446678899999999999999998             8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      |+|||++ ||.-++...    .-.+++.+++.++.||+.||+|||   .+||+|||||.+|||||.+|.+||+|||+|+.
T Consensus       196 VFeYMdh-DL~GLl~~p----~vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  196 VFEYMDH-DLSGLLSSP----GVKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARF  267 (560)
T ss_pred             EEecccc-hhhhhhcCC----CcccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceee
Confidence            9999987 999998763    146999999999999999999999   99999999999999999999999999999997


Q ss_pred             cCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc-h
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR-F  273 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~  273 (332)
                      +....... .+..+.|.+|+|||++.|  .|+.++|+||.||||.||++|+++|.+..+.++.+  .+.+........ |
T Consensus       268 y~~~~~~~-~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~--kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  268 YTPSGSAP-YTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLH--KIFKLCGSPTEDYW  344 (560)
T ss_pred             ccCCCCcc-cccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHH--HHHHHhCCCChhcc
Confidence            76655332 356788999999999998  89999999999999999999999999888766544  222222221111 1


Q ss_pred             h--hhhhhhh-hcccCCCC---CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          274 K--EMVDSII-IEDKSCTC---TGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       274 ~--~~~~~~~-~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .  .+-.... ....+...   ......+....+|+..+|..||.+|.||.++++
T Consensus       345 ~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  345 PVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1  0000000 00000000   001234567889999999999999999999875

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-50  Score=362.56  Aligned_cols=249  Identities=24%  Similarity=0.354  Sum_probs=206.5

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEeCCe-eEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           50 RIATNNYDEQNIVLEDPFRKLYKGFWQKR-SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        50 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      ++....+...+.||+|-||.||.|.+++. .||+|.++.....  .+.|.+|+++|++|+|+|||++           ||
T Consensus       202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~--~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV  279 (468)
T KOG0197|consen  202 EIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS--PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV  279 (468)
T ss_pred             eecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC--hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence            33334455678999999999999999665 9999999886432  4678899999999999999998           99


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||++.|+|.+||....   ...+...+.+.++.|||+|++||+   ++++|||||..+|||++++..+||+|||+|+..
T Consensus       280 tE~m~~GsLl~yLr~~~---~~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~  353 (468)
T KOG0197|consen  280 TEYMPKGSLLDYLRTRE---GGLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLI  353 (468)
T ss_pred             EEecccCcHHHHhhhcC---CCccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEccccccccc
Confidence            99999999999998731   257899999999999999999999   999999999999999999999999999999955


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      .++..... ....-...|.|||.+.. .++.||||||||++||||+| |+.||......+...      .          
T Consensus       354 ~d~~Y~~~-~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~------~----------  416 (468)
T KOG0197|consen  354 GDDEYTAS-EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLE------L----------  416 (468)
T ss_pred             CCCceeec-CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHH------H----------
Confidence            55443322 33445678999999986 99999999999999999998 888888766544322      1          


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                           +.  ...+.+.+..|+..+.++|..||+.+|++|||++.+...|+.+...
T Consensus       417 -----le--~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  417 -----LE--RGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             -----Hh--ccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence                 11  1123334456779999999999999999999999999999988753

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1e-49  Score=328.81  Aligned_cols=257  Identities=21%  Similarity=0.235  Sum_probs=207.1

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh-hhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ-HALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .+|...+.||+|.||.||+|++  +|+.||||+++..... .......+|++.|+.++|+||+.+           ||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4688899999999999999999  8999999999876543 224568999999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |++. ||+..++...    ..++..++..++.++++||+|||   .+.|+||||||.|+||+.+|.+||+|||+|+.+..
T Consensus        82 fm~t-dLe~vIkd~~----i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~  153 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDKN----IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS  153 (318)
T ss_pred             eccc-cHHHHhcccc----cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCC
Confidence            9986 9999998762    57999999999999999999999   99999999999999999999999999999998876


Q ss_pred             CCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-cccchhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-QNCRFKEM  276 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  276 (332)
                      .....  ...+-|.+|+|||.+-|  .|+..+||||.|||+.||+.|.+.|.+.+.-++..  ...+.+.. ....|+++
T Consensus       154 p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~--~If~~LGTP~~~~WP~~  229 (318)
T KOG0659|consen  154 PNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLS--KIFRALGTPTPDQWPEM  229 (318)
T ss_pred             CCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHH--HHHHHcCCCCcccCccc
Confidence            65443  33478999999999987  89999999999999999999999998877655433  23333332 22223332


Q ss_pred             ---hhhhhhcccCCC--CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 ---VDSIIIEDKSCT--CTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ---~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                         -|-.-....+.+  ...-..++.++.+|+..||.+||.+|+|++|+++
T Consensus       230 ~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~  280 (318)
T KOG0659|consen  230 TSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK  280 (318)
T ss_pred             cccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence               121111111111  1122355677899999999999999999999886

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-49  Score=347.86  Aligned_cols=241  Identities=23%  Similarity=0.311  Sum_probs=196.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-------------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-------------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-------------lv  117 (332)
                      ..+|...+.||+|+||.||++.+  +|...|||.+....... .+.+.+|+.+|++++|||||++             |.
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence            45688899999999999999999  57999999998875444 6778999999999999999998             79


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC-CCCeEEeecCCccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE-QSDAKLFDFSLSLS  196 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~  196 (332)
                      |||+++|+|.+++....    ..+++..+..+.+||++||.|||   ++|||||||||+|||++. ++.+||+|||+++.
T Consensus        95 mEy~~~GsL~~~~~~~g----~~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~  167 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYG----GKLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKK  167 (313)
T ss_pred             eeccCCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCccccc
Confidence            99999999999999872    26999999999999999999999   999999999999999999 79999999999987


Q ss_pred             cCCCCce-eeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCC-CccchhhhHHHHhhhhccccc
Q 038681          197 IPDGETH-IELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHV-SFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       197 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~-~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      ....... .......||+.|||||++.+  ....++|||||||++.||+||+.||... .....     ........  .
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~-----~~~ig~~~--~  240 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEA-----LLLIGRED--S  240 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHH-----HHHHhccC--C
Confidence            6631111 11245789999999999984  3345999999999999999999999864 11110     11110000  0


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                                     .+..+...+.++.+|+.+|+..||++||||+++++.
T Consensus       241 ---------------~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  241 ---------------LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             ---------------CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence                           112223456889999999999999999999999874

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-49  Score=347.40  Aligned_cols=257  Identities=20%  Similarity=0.300  Sum_probs=212.1

Q ss_pred             HHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE--------
Q 038681           46 AEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL--------  115 (332)
Q Consensus        46 ~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~--------  115 (332)
                      ..++....+.|++...||.|..++||+|+.  .+..||||++..+......+.+.+|+..++.++||||+++        
T Consensus        18 ~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~   97 (516)
T KOG0582|consen   18 EKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS   97 (516)
T ss_pred             cccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence            334455677899999999999999999999  8899999999987766658999999999999999999998        


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                         +||.||.+|++.+++.....   ..+++..+..|++++++||.|||   .+|.||||||+.||||+.+|.|||+|||
T Consensus        98 ~LWvVmpfMa~GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFg  171 (516)
T KOG0582|consen   98 ELWVVMPFMAGGSLLDIIKTYYP---DGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFG  171 (516)
T ss_pred             eeEEeehhhcCCcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCce
Confidence               89999999999999998754   35999999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCcee--eccccccCCCcccccccCC---CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhh
Q 038681          193 LSLSIPDGETHI--ELDSVVGTTGFIAPENFTT---LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS  267 (332)
Q Consensus       193 ~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  267 (332)
                      .+..+.+.....  ...++.||++|||||++..   .|+.|+||||||++..||.+|..||...++...     +...+.
T Consensus       172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv-----Ll~tLq  246 (516)
T KOG0582|consen  172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV-----LLLTLQ  246 (516)
T ss_pred             eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH-----HHHHhc
Confidence            986655433221  2256799999999999553   799999999999999999999999998876554     333333


Q ss_pred             ccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      +..+.+.-   .      ..+.......+..+.+++..||+.||.+||||+++++
T Consensus       247 n~pp~~~t---~------~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  247 NDPPTLLT---S------GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CCCCCccc---c------cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            33322110   0      0011112245568999999999999999999999986

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-49  Score=342.13  Aligned_cols=231  Identities=21%  Similarity=0.321  Sum_probs=195.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------E
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------I  116 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------l  116 (332)
                      ..++|++.+.||+|+||.||.++.  +++.+|+|++++..-  ....+...+|..+|.+++||.||++           |
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            356799999999999999999998  899999999987642  2336778999999999999999998           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      |+||+.||.|.-.|.+.     +.+++..+.-++..|+.||.|||   ++|||||||||+|||+|.+|+++|+|||+++.
T Consensus       103 Vld~~~GGeLf~hL~~e-----g~F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~  174 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQRE-----GRFSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKE  174 (357)
T ss_pred             EEeccCCccHHHHHHhc-----CCcchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchh
Confidence            99999999999999877     67999999999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      ........  .+++||+.|||||++.+ .|+.++|.||||+++|||++|.+||...+....                   
T Consensus       175 ~~~~~~~t--~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~-------------------  233 (357)
T KOG0598|consen  175 DLKDGDAT--RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKM-------------------  233 (357)
T ss_pred             cccCCCcc--ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHH-------------------
Confidence            55443322  56899999999999988 999999999999999999999999987654322                   


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP  315 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP  315 (332)
                       .+........   ..+.-.+.+..+++.++|+.||++|.
T Consensus       234 -~~~I~~~k~~---~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  234 -YDKILKGKLP---LPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             -HHHHhcCcCC---CCCccCCHHHHHHHHHHhccCHHHhc
Confidence             2222221100   01112457899999999999999995

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-49  Score=353.52  Aligned_cols=241  Identities=22%  Similarity=0.299  Sum_probs=202.2

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhh-cCCCcceE---------
Q 038681           50 RIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRM-SHKHIIKL---------  115 (332)
Q Consensus        50 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~~---------  115 (332)
                      .....+|..++.||+|+|++|++|+.  +++.+|||++.+.--  +...+.+..|-.+|.+| .||.|+++         
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            44567899999999999999999999  899999999876532  23355678899999999 79999998         


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        +|+||+++|+|.++|.+.     +.+++..++.++.+|+.||+|||   ++|||||||||+|||+|.+|++||+|||.
T Consensus       149 LYFvLe~A~nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH---~~GIIHRDlKPENILLd~dmhikITDFGs  220 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILLDKDGHIKITDFGS  220 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeEcCCCcEEEeeccc
Confidence              899999999999999988     78999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCce-----------eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHH
Q 038681          194 SLSIPDGETH-----------IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEE  261 (332)
Q Consensus       194 a~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~  261 (332)
                      |+.+......           ....+++||..|.+||++.. ..+..+|||+|||++|+|+.|.+||...++.-..+   
T Consensus       221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq---  297 (604)
T KOG0592|consen  221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ---  297 (604)
T ss_pred             cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHH---
Confidence            9887543221           11245899999999999998 88999999999999999999999998776543321   


Q ss_pred             HHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          262 NVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                       .++..++.    +++..++.+.+|+.+.|..||.+|+|+.+|-+
T Consensus       298 -----------------kI~~l~y~----fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~  337 (604)
T KOG0592|consen  298 -----------------KIQALDYE----FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA  337 (604)
T ss_pred             -----------------HHHHhccc----CCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence                             11112221    12233478899999999999999999988765

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-48  Score=352.09  Aligned_cols=236  Identities=25%  Similarity=0.355  Sum_probs=197.4

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC----hhhHHHHHHHHHHHHhhc-CCCcceE--------
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN----QHALEWCINHIVYASRMS-HKHIIKL--------  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~-H~nIv~~--------  115 (332)
                      ...++|.+.+.||+|+||.|+.|.+  ++..||+|.+.....    ....+.+.+|+.+++.++ ||||+++        
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4467899999999999999999998  889999997766411    133556778999999998 9999998        


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC-CCeEEeec
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ-SDAKLFDF  191 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Df  191 (332)
                         +|||||.||+|.+++...     +++.+.++..+++||++|++|||   ++||+||||||+|||++.+ +++||+||
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~-----g~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DF  165 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNK-----GRLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDF  165 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHc-----CCCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecc
Confidence               899999999999999985     67999999999999999999999   9999999999999999999 99999999


Q ss_pred             CCccccC-CCCceeeccccccCCCcccccccCC-C-C-ChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhh
Q 038681          192 SLSLSIP-DGETHIELDSVVGTTGFIAPENFTT-L-I-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS  267 (332)
Q Consensus       192 g~a~~~~-~~~~~~~~~~~~gt~~y~aPE~~~~-~-~-~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  267 (332)
                      |++.... ....   ..+.+||+.|+|||++.+ . | +.++||||+|++||.|++|..||.......      +...+.
T Consensus       166 G~s~~~~~~~~~---l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~------l~~ki~  236 (370)
T KOG0583|consen  166 GLSAISPGEDGL---LKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN------LYRKIR  236 (370)
T ss_pred             ccccccCCCCCc---ccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH------HHHHHh
Confidence            9998874 2222   267899999999999998 4 5 589999999999999999999998743221      111111


Q ss_pred             ccccchhhhhhhhhhcccCCCCCChHHH-HHHHHHHHHHcccCCCCCCCCHHHHH
Q 038681          268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQ-LQAFKQLTLQCMDFSPEDRPTMVDVA  321 (332)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~cl~~dP~~RPs~~evl  321 (332)
                      .....++.                  .. +.++.+|+.+||..||.+|+|+.+|+
T Consensus       237 ~~~~~~p~------------------~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  237 KGEFKIPS------------------YLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             cCCccCCC------------------CcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            11111111                  22 57899999999999999999999998

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2.8e-48  Score=352.70  Aligned_cols=255  Identities=18%  Similarity=0.327  Sum_probs=201.4

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-------
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-------  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-------  115 (332)
                      ...++|.+.+.||+|+||.||+|.+       .+..||+|++...........+.+|+.++.++ +||||+++       
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            4456799999999999999999975       34679999998665555567799999999999 89999987       


Q ss_pred             -----EEEEeccCCChHHHHhhhhcc------------------------------------------------------
Q 038681          116 -----IVFESVQIGTLADRIHHHCEQ------------------------------------------------------  136 (332)
Q Consensus       116 -----lv~e~~~~g~L~~~l~~~~~~------------------------------------------------------  136 (332)
                           +||||+++|+|.+++......                                                      
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence                 789999999999999753210                                                      


Q ss_pred             ---cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceeeccccccCC
Q 038681          137 ---HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT  213 (332)
Q Consensus       137 ---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~  213 (332)
                         ....+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...............+++
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence               0134788899999999999999999   9999999999999999999999999999998664433222223345678


Q ss_pred             CcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCC
Q 038681          214 GFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTG  291 (332)
Q Consensus       214 ~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      .|+|||++.+ .++.++|||||||++|||++ |..||........     ....+...               .  ....
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~-----~~~~~~~~---------------~--~~~~  298 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE-----FCQRLKDG---------------T--RMRA  298 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH-----HHHHHhcC---------------C--CCCC
Confidence            8999999877 88999999999999999997 9999976543221     11111100               0  0001


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          292 KEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       292 ~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      +...+..+.+|+.+||+.||.+|||+.+|++.|+.+.++
T Consensus       299 ~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         299 PENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            123346799999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-49  Score=355.40  Aligned_cols=261  Identities=23%  Similarity=0.366  Sum_probs=214.5

Q ss_pred             cccHHHHHHHhcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE------
Q 038681           43 IFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL------  115 (332)
Q Consensus        43 ~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~------  115 (332)
                      ..+.++|++..+...+...||+|+||+||+|.|.|. ||||+++... +.+..+.|.+|+.++++-+|.||+-|      
T Consensus       381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd-VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD-VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             CccccccccCHHHhhccceeccccccceeecccccc-eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            445578888888899999999999999999999764 8999987764 45568999999999999999999988      


Q ss_pred             ----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeec
Q 038681          116 ----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF  191 (332)
Q Consensus       116 ----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  191 (332)
                          ||+.||+|.+|+.+++...    ..++....+.|++||++|+.|||   .++|||||||..||++.++++|||+||
T Consensus       460 p~~AIiTqwCeGsSLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kVkIgDF  532 (678)
T KOG0193|consen  460 PPLAIITQWCEGSSLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKVKIGDF  532 (678)
T ss_pred             CceeeeehhccCchhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcEEEecc
Confidence                8999999999999998753    46899999999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCceeeccccccCCCcccccccCC----CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhh
Q 038681          192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTT----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS  267 (332)
Q Consensus       192 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  267 (332)
                      |++..-..-..........|+..|||||++..    +|++.+||||||||+|||+||..||.....+...       ++.
T Consensus       533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi-------fmV  605 (678)
T KOG0193|consen  533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII-------FMV  605 (678)
T ss_pred             cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE-------EEe
Confidence            99865433222223356678999999999852    8999999999999999999999999954443321       111


Q ss_pred             ccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      +...-..+.            .....++++++.+|+..||.+++++||.+.+|+..|+.+..+
T Consensus       606 GrG~l~pd~------------s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  606 GRGYLMPDL------------SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             cccccCccc------------hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            111111111            111236668999999999999999999999999999888753

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-48  Score=351.07  Aligned_cols=236  Identities=19%  Similarity=0.332  Sum_probs=203.4

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ..|....+||+|+.|.||.+..  ++..||||++....... .+-+.+|+.+|+..+|+|||++           .||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~-keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK-KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc-hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            4578888999999999999998  88899999998876655 6789999999999999999998           79999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      ++||+|.+.+...      .+++.++..|+++++.||+|||   .+||+|||||.+|||++.+|.+||+|||++..+...
T Consensus       352 m~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~  422 (550)
T KOG0578|consen  352 MEGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEE  422 (550)
T ss_pred             cCCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccc
Confidence            9999999999875      5999999999999999999999   999999999999999999999999999999877665


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      ...  ..+.+||++|||||++.. .|++++||||||++++||+-|++||-....-...     ...              
T Consensus       423 ~~K--R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl-----yLI--------------  481 (550)
T KOG0578|consen  423 QSK--RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-----YLI--------------  481 (550)
T ss_pred             cCc--cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH-----HHH--------------
Confidence            542  367899999999999988 9999999999999999999999999754332211     111              


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                        .....+....+...+..+.+|+.+||+.||.+||||.|+|+
T Consensus       482 --a~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  482 --ATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             --hhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence              11112233344567789999999999999999999999986

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.2e-49  Score=338.67  Aligned_cols=252  Identities=21%  Similarity=0.270  Sum_probs=200.3

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------------E
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------------I  116 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------------l  116 (332)
                      .|...+++|.|+||.||.|..  ++..||||+...+..-     -.+|+.+|+.++|||||++                +
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            377789999999999999999  7899999999887532     3589999999999999998                7


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC-CCeEEeecCCcc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ-SDAKLFDFSLSL  195 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~a~  195 (332)
                      ||||+|. +|.++++..... ...++...++-++.||.+||+|||   ..||+||||||.|+|+|.+ |.+||||||.|+
T Consensus       100 VleymP~-tL~~~~r~~~~~-~~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRA-NQRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhc-CCCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            9999987 999999864222 256899999999999999999999   9999999999999999977 899999999999


Q ss_pred             ccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc-ccc
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ-NCR  272 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~  272 (332)
                      .+..+...   .+...|..|+|||.+.+  .|+.+.||||.|||+.||+-|++.|.+.+..++  +....+.+... ...
T Consensus       175 ~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ--L~eIik~lG~Pt~e~  249 (364)
T KOG0658|consen  175 VLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ--LVEIIKVLGTPTRED  249 (364)
T ss_pred             eeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH--HHHHHHHhCCCCHHH
Confidence            88776654   45678999999999988  899999999999999999999999998665443  33333333221 111


Q ss_pred             hhhhhhh-------hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          273 FKEMVDS-------IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       273 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      +..+-..       .+....- ..-.....++++.+|+.++|.++|.+|.++.|++.
T Consensus       250 I~~mn~~y~~~~~p~ik~~~~-~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  250 IKSMNPNYTEFKFPQIKAHPW-HKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             HhhcCcccccccCcccccccc-eeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            1111111       1111110 00122345688999999999999999999999875

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.5e-48  Score=331.25  Aligned_cols=258  Identities=17%  Similarity=0.207  Sum_probs=202.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhh-HHHHHHHHHHHHhhcCCCcceE-------------E
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHA-LEWCINHIVYASRMSHKHIIKL-------------I  116 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~~-------------l  116 (332)
                      .++|+..+.|++|+||.||+|++  +++.||+|+++....... --..++||.+|.+++|||||.+             |
T Consensus        75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~  154 (419)
T KOG0663|consen   75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI  154 (419)
T ss_pred             HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence            35688899999999999999999  899999999987653221 2235899999999999999998             8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      |||||++ ||..++....    .++...+++.++.|+++||+|||   .+.|+||||||+|+|+...|.+||+|||+|+.
T Consensus       155 VMe~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  155 VMEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             eHHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhh
Confidence            9999987 9999998762    57999999999999999999999   99999999999999999999999999999998


Q ss_pred             cCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc-h
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR-F  273 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~  273 (332)
                      +......  .+..+-|.+|+|||++.+  .|+++.|+||+|||+.||+++++.|.+....++..  .+...+...... |
T Consensus       227 ygsp~k~--~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~--~If~llGtPte~iw  302 (419)
T KOG0663|consen  227 YGSPLKP--YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD--KIFKLLGTPSEAIW  302 (419)
T ss_pred             hcCCccc--CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH--HHHHHhCCCccccC
Confidence            8776432  256688999999999998  89999999999999999999999999887665433  233322221111 1


Q ss_pred             hhhhhhhhhc-----ccC---CCCCChH-HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          274 KEMVDSIIIE-----DKS---CTCTGKE-QQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       274 ~~~~~~~~~~-----~~~---~~~~~~~-~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      +.....-...     ..+   ....+.. ..++...+|+..+|.+||.+|.||+|.++
T Consensus       303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence            1111100000     000   0000110 14477899999999999999999999875

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-48  Score=333.84  Aligned_cols=259  Identities=19%  Similarity=0.242  Sum_probs=204.6

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCC-CChhhHHHHHHHHHHHHhhcCCCcceE-------------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGN-RNQHALEWCINHIVYASRMSHKHIIKL-------------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~~-------------  115 (332)
                      ....|...+.||.|+||.|..+.+  +|..||||++... ......++..+|+++|+.++|+||+.+             
T Consensus        20 i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~   99 (359)
T KOG0660|consen   20 IPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN   99 (359)
T ss_pred             ccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence            445577789999999999999999  8999999999843 334447889999999999999999987             


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                         +|+|+++ -+|.+.++..     ..++...+..++.||+.||.|+|   +.+|+||||||+|+|++.++.+||+|||
T Consensus       100 DvYiV~elMe-tDL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFG  170 (359)
T KOG0660|consen  100 DVYLVFELME-TDLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFG  170 (359)
T ss_pred             eeEEehhHHh-hHHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEecccc
Confidence               8999995 4999999876     45999999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-c
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-Q  269 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~  269 (332)
                      +|+...........+..+.|.+|+|||++..  .|+.+.||||+|||+.||++|++.|.+.+.-.+..   ++....+ .
T Consensus       171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~---lI~~~lGtP  247 (359)
T KOG0660|consen  171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQ---LILELLGTP  247 (359)
T ss_pred             ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHH---HHHHhcCCC
Confidence            9998865422222356788999999999876  89999999999999999999999999877655433   2222222 1


Q ss_pred             ccc-hhhhh----hhhhhcccCC-CCC---ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          270 NCR-FKEMV----DSIIIEDKSC-TCT---GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       270 ~~~-~~~~~----~~~~~~~~~~-~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ... +..+-    .+.+..-+.. +.+   .-+...+...+|+.+||..||.+|+|++|.++
T Consensus       248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            111 11111    1111111111 111   11355688999999999999999999999886

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-48  Score=341.96  Aligned_cols=236  Identities=21%  Similarity=0.317  Sum_probs=203.9

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ..|.....||+|+||.||+|.+  +++.||+|++.........+.+++|+.+|.+++++||.++           ++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            3477889999999999999999  8999999999998888778999999999999999999887           79999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      |.||++.+.+...     ..+++.++.-++++++.||.|||   .++.+|||||+.|||+..+|.+||+|||.+......
T Consensus        93 ~~gGsv~~lL~~~-----~~~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   93 CGGGSVLDLLKSG-----NILDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             hcCcchhhhhccC-----CCCccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeech
Confidence            9999999999875     45588999999999999999999   999999999999999999999999999999777665


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      ....  .+++||+.|||||++.+ .|+.++||||||++.+||++|.+|+....+.....     .               
T Consensus       165 ~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf-----l---------------  222 (467)
T KOG0201|consen  165 VKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF-----L---------------  222 (467)
T ss_pred             hhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE-----e---------------
Confidence            4432  67899999999999998 99999999999999999999999998776543221     0               


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                       +....  ++.....+++.+++|+..||+.||+.||||.++++
T Consensus       223 -Ipk~~--PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  223 -IPKSA--PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             -ccCCC--CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence             00001  11111256688999999999999999999999987

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.8e-46  Score=332.44  Aligned_cols=251  Identities=15%  Similarity=0.271  Sum_probs=202.7

Q ss_pred             CCcccccHHHHHHHhcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-
Q 038681           39 NPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-  115 (332)
Q Consensus        39 ~~~~~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-  115 (332)
                      ...+.++.++++     ......||+|++|.||+|.++|+.||||.+.....  ....+.+.+|+.++.+++||||+++ 
T Consensus        10 ~~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~   84 (283)
T PHA02988         10 NDIKCIESDDID-----KYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY   84 (283)
T ss_pred             CcceecCHHHcC-----CCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence            345566666662     33346799999999999999999999999976532  2225678899999999999999987 


Q ss_pred             --------------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeeecCCCCCCeee
Q 038681          116 --------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFS-RPIVYRDMKPTNILF  180 (332)
Q Consensus       116 --------------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill  180 (332)
                                    +||||+++|+|.+++...     ..+++.....++.|++.||.|||   . .+++||||||+|||+
T Consensus        85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~Hrdlkp~nill  156 (283)
T PHA02988         85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLY---KYTNKPYKNLTSVSFLV  156 (283)
T ss_pred             eeEEecccCCCceEEEEEeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHH---hcCCCCCCcCChhhEEE
Confidence                          799999999999999865     56899999999999999999999   6 589999999999999


Q ss_pred             CCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC---CCChhhhHHHHHHHHHHHHhCCccCCCCCccchh
Q 038681          181 NEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT---LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRF  257 (332)
Q Consensus       181 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~  257 (332)
                      +.++.+||+|||+++......     ....||..|+|||++.+   .++.++|||||||++|||++|..||......+..
T Consensus       157 ~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~  231 (283)
T PHA02988        157 TENYKLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY  231 (283)
T ss_pred             CCCCcEEEcccchHhhhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            999999999999998654432     23468899999999864   7899999999999999999999999865432211


Q ss_pred             hhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          258 HYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                            ...              ......  ...+..++..+.+|+.+||+.||++|||++++++.|+.++.
T Consensus       232 ------~~i--------------~~~~~~--~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        232 ------DLI--------------INKNNS--LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             ------HHH--------------HhcCCC--CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence                  111              001100  11112345789999999999999999999999999998864

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.8e-47  Score=343.87  Aligned_cols=234  Identities=24%  Similarity=0.364  Sum_probs=202.0

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      ++|.+.+.||+|+||+||+|+.  +.+.||+|.+.+.. .+...+.+.+|+++++.++|||||.+           +|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            4688899999999999999998  78899999997764 45568889999999999999999987           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      ||.| +|..++...     +.++++.+..++.|+++||.|||   +++|+|||+||.|||++..|.+|+||||+|+....
T Consensus        82 ~a~g-~L~~il~~d-----~~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~  152 (808)
T KOG0597|consen   82 YAVG-DLFTILEQD-----GKLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST  152 (808)
T ss_pred             hhhh-hHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhccc
Confidence            9986 999999987     78999999999999999999999   99999999999999999999999999999998776


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      +...  .+...|||.|||||++.+ .|+..+|.||+||++||+++|++||.....                    ..++.
T Consensus       153 ~t~v--ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si--------------------~~Lv~  210 (808)
T KOG0597|consen  153 NTSV--LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI--------------------TQLVK  210 (808)
T ss_pred             Ccee--eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH--------------------HHHHH
Confidence            5433  257789999999999998 999999999999999999999999975322                    22222


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .+..++...+    ...+..+..|+...|..||.+|.|..+++.
T Consensus       211 ~I~~d~v~~p----~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  211 SILKDPVKPP----STASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             HHhcCCCCCc----ccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            3333322222    256688999999999999999999999875

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=6e-48  Score=363.18  Aligned_cols=253  Identities=20%  Similarity=0.289  Sum_probs=213.2

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------  115 (332)
                      ...+....+.||+|.||.||+|+.       ....||||.++...+....++|.+|++++..|+|||||++         
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P  563 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP  563 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe
Confidence            345566678999999999999987       3456999999999988789999999999999999999998         


Q ss_pred             --EEEEeccCCChHHHHhhhhccc---------ccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQH---------FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS  184 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~---------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  184 (332)
                        +|+|||..|||.+||..+....         ..+++..+.+.|+.|||.|++||-   ++.+|||||-.+|+||+++.
T Consensus       564 ~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENL  640 (774)
T ss_pred             eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccce
Confidence              8999999999999998654321         234889999999999999999999   99999999999999999999


Q ss_pred             CeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHH
Q 038681          185 DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEEN  262 (332)
Q Consensus       185 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~  262 (332)
                      .|||+|||+++..-..+.........-..+|||||.+.. +|+++||||||||+|||+++ |..||.+....+.......
T Consensus       641 ~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~  720 (774)
T KOG1026|consen  641 VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRA  720 (774)
T ss_pred             EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHc
Confidence            999999999998766554433234456789999998875 99999999999999999998 9999998876654331111


Q ss_pred             HhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          263 VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      -                      . -.+.+.+++.++++||..||+.+|++|||++||-.+|++.-++
T Consensus       721 g----------------------~-lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  721 G----------------------Q-LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             C----------------------C-cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            0                      0 1223357779999999999999999999999999999987654

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-48  Score=348.68  Aligned_cols=238  Identities=24%  Similarity=0.346  Sum_probs=202.4

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           49 LRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        49 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      |++........+-||.|+-|.||+|+..++.||||+++.-.        ..+|+-|++|+||||+.|           ||
T Consensus       119 WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIi  190 (904)
T KOG4721|consen  119 WEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPCYCII  190 (904)
T ss_pred             ccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence            44444445556789999999999999999999999986432        357888999999999998           99


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      ||||+.|.|...|+..     .++.......|..+||.|+.|||   .+.|||||||.-||||+.+..|||+|||.++..
T Consensus       191 MEfCa~GqL~~VLka~-----~~itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~  262 (904)
T KOG4721|consen  191 MEFCAQGQLYEVLKAG-----RPITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKISDFGTSKEL  262 (904)
T ss_pred             eeccccccHHHHHhcc-----CccCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEeccccchHhh
Confidence            9999999999999887     67899999999999999999999   999999999999999999999999999999988


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      .+..+.   ..+.||..|||||++.+ +.++|+|||||||||||||||..||...+....+         .+..      
T Consensus       263 ~~~STk---MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAII---------wGVG------  324 (904)
T KOG4721|consen  263 SDKSTK---MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAII---------WGVG------  324 (904)
T ss_pred             hhhhhh---hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeE---------Eecc------
Confidence            776543   67899999999999998 8999999999999999999999999876543321         1100      


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                             ......+.+..+++.+.-|++.||+..|..|||+.+++..|+-.
T Consensus       325 -------sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  325 -------SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             -------CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence                   11122333456778899999999999999999999999988643

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-46  Score=333.36  Aligned_cols=232  Identities=22%  Similarity=0.261  Sum_probs=191.7

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|++.+.||+|+||.||+|.+  +++.||+|.+....  .....+.+.+|+.++++++||||+++           +||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            4688999999999999999999  68999999986542  22335678899999999999999987           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++|+|.+++...     ..+++..+..++.||+.||+|||   ++||+||||||+|||++.++.+||+|||+++...
T Consensus        81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~  152 (291)
T cd05612          81 EYVPGGELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR  152 (291)
T ss_pred             eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhcc
Confidence            999999999999765     56899999999999999999999   9999999999999999999999999999997664


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ...     ....||+.|+|||++.+ .++.++|||||||++|+|++|..||........      ..........     
T Consensus       153 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~------~~~i~~~~~~-----  216 (291)
T cd05612         153 DRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI------YEKILAGKLE-----  216 (291)
T ss_pred             CCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCcC-----
Confidence            432     24568999999999987 789999999999999999999999976543221      1111100000     


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT-----MVDVAK  322 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~  322 (332)
                                   .+...+..+.+|+.+||+.||.+||+     ++++++
T Consensus       217 -------------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         217 -------------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             -------------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence                         11122467899999999999999995     888775

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.3e-46  Score=322.50  Aligned_cols=261  Identities=19%  Similarity=0.224  Sum_probs=201.3

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCC-cceE--------------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKH-IIKL--------------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~n-Iv~~--------------  115 (332)
                      ..|...++||+|+||+||+|+.  +|+.||+|++..... +..-....+|+.+++.|+|+| ||++              
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            4477778899999999999999  899999999987754 344556799999999999999 9987              


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                         +|+||+.. +|..++....... ..++...++.++.||+.||+|||   +++|+||||||+||||+.+|.+||+|||
T Consensus        91 ~l~lvfe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   91 KLYLVFEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             eEEEEEEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccc
Confidence               79999975 9999998763211 35778999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-c
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-Q  269 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~  269 (332)
                      +|+...-+...  .+..++|.+|+|||++.+  .|++..||||+|||++||++++..|.+....+...  .....+.. .
T Consensus       166 lAra~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~--~If~~lGtP~  241 (323)
T KOG0594|consen  166 LARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLF--RIFRLLGTPN  241 (323)
T ss_pred             hHHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHH--HHHHHcCCCC
Confidence            99976644332  256789999999999987  79999999999999999999999999887744322  12222222 1


Q ss_pred             ccchhhhhhhhhhcccCCCCCCh-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          270 NCRFKEMVDSIIIEDKSCTCTGK-------EQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                      ...|+....-.-..........+       +.......+++.+||+++|.+|.|++.++..
T Consensus       242 e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  242 EKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             ccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            22222221100000000111101       1122478999999999999999999998874

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.9e-46  Score=331.71  Aligned_cols=254  Identities=21%  Similarity=0.244  Sum_probs=194.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEe------------------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcce
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW------------------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIK  114 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~------------------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~  114 (332)
                      .++|.+.+.||+|+||.||+|.+                  ++..||+|.+...........+.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            35788999999999999999985                  233699999987655555678999999999999999999


Q ss_pred             E-----------EEEEeccCCChHHHHhhhhc--------------ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 038681          115 L-----------IVFESVQIGTLADRIHHHCE--------------QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIV  169 (332)
Q Consensus       115 ~-----------lv~e~~~~g~L~~~l~~~~~--------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  169 (332)
                      +           +||||+++|+|.+++.....              .....+++..+..++.||+.||.|||   +.+|+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCcc
Confidence            7           89999999999999865321              01134788899999999999999999   99999


Q ss_pred             ecCCCCCCeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh--CCc
Q 038681          170 YRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT--AQE  246 (332)
Q Consensus       170 H~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt--g~~  246 (332)
                      ||||||+|||++.++.+||+|||+++...............++..|+|||++.+ .++.++|||||||++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999986654433222234456889999999876 89999999999999999987  556


Q ss_pred             cCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          247 VSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       247 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                      ||..........  ........           .....   ....+..++..+.+|+.+||+.||++|||+.+|.+.|+
T Consensus       241 p~~~~~~~~~~~--~~~~~~~~-----------~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDEQVIE--NAGEFFRD-----------QGRQV---YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHHHHHH--HHHHHhhh-----------ccccc---cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            776544322111  00000000           00000   00011133477999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.8e-46  Score=341.78  Aligned_cols=254  Identities=18%  Similarity=0.280  Sum_probs=198.4

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----
Q 038681           49 LRIATNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----  115 (332)
Q Consensus        49 l~~~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----  115 (332)
                      +....++|++.+.||+|+||.||+|.+       ++..||||++.........+.+.+|+.++..+ +||||+++     
T Consensus        30 ~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~  109 (375)
T cd05104          30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACT  109 (375)
T ss_pred             cccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeec
Confidence            344456799999999999999999974       35689999997655444467789999999999 89999998     


Q ss_pred             ------EEEEeccCCChHHHHhhhhcc-----------------------------------------------------
Q 038681          116 ------IVFESVQIGTLADRIHHHCEQ-----------------------------------------------------  136 (332)
Q Consensus       116 ------lv~e~~~~g~L~~~l~~~~~~-----------------------------------------------------  136 (332)
                            +||||+++|+|.+++......                                                     
T Consensus       110 ~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~  189 (375)
T cd05104         110 VGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSV  189 (375)
T ss_pred             cCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccc
Confidence                  899999999999999753210                                                     


Q ss_pred             -----------------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          137 -----------------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       137 -----------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                                       ....+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~  266 (375)
T cd05104         190 RSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRN  266 (375)
T ss_pred             ccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence                             0124788999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ...........++..|+|||++.+ .++.++|||||||++|||++ |..||........     ....+...        
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~-----~~~~~~~~--------  333 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-----FYKMIKEG--------  333 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH-----HHHHHHhC--------
Confidence            432221123345678999999987 89999999999999999998 8888876543221     11111100        


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                         ..      ...+...+.++.+|+.+||+.||++|||+.+|++.|++.
T Consensus       334 ---~~------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         334 ---YR------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             ---cc------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence               00      000112236799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.2e-46  Score=329.92  Aligned_cols=257  Identities=18%  Similarity=0.273  Sum_probs=193.7

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ++|.+.+.||.|+||.||+|..  ++..||+|.+...........+.+|+.++++++||||+++           +||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            5699999999999999999998  7889999998765444445677899999999999999997           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++ +|.+++....    ..+++..+..++.||+.||+|||   ++||+||||||+|||++.++.+||+|||+++.....
T Consensus        85 ~~~-~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~  156 (288)
T cd07871          85 LDS-DLKQYLDNCG----NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP  156 (288)
T ss_pred             CCc-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCC
Confidence            975 9999887541    35789999999999999999999   999999999999999999999999999999765433


Q ss_pred             CceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-cccchhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-QNCRFKEMV  277 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  277 (332)
                      ...  .....+|+.|+|||++.+  .++.++|||||||++|+|++|..||......+...  ........ ....+....
T Consensus       157 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  232 (288)
T cd07871         157 TKT--YSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH--LIFRLLGTPTEETWPGIT  232 (288)
T ss_pred             Ccc--ccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCChHHhhccc
Confidence            221  134568999999999865  68999999999999999999999998765433221  11111111 011111110


Q ss_pred             hh-----hhhcccCC--CCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 DS-----IIIEDKSC--TCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~~-----~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ..     ........  ........+.++.+|+.+||+.||.+|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00     00000000  00000123467899999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.2e-46  Score=337.60  Aligned_cols=243  Identities=17%  Similarity=0.252  Sum_probs=199.2

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE----------
Q 038681           50 RIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        50 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~----------  115 (332)
                      ....++|++...||+|+||.||+|+-  +|..+|+|++++..-  ....+.+..|-.+|...++|.||++          
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            45678899999999999999999998  899999999988642  3346778899999999999999998          


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       |||||+||||+..+|...     ..|++.++..++.+++.|++.||   ..|+|||||||+|+|||..|++||+|||++
T Consensus       217 YLiMEylPGGD~mTLL~~~-----~~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs  288 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRK-----DTLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLS  288 (550)
T ss_pred             EEEEEecCCccHHHHHHhc-----CcCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeecccccc
Confidence             899999999999999887     78999999999999999999999   999999999999999999999999999998


Q ss_pred             cccCC---------------------CCcee------------------------eccccccCCCcccccccCC-CCChh
Q 038681          195 LSIPD---------------------GETHI------------------------ELDSVVGTTGFIAPENFTT-LINEQ  228 (332)
Q Consensus       195 ~~~~~---------------------~~~~~------------------------~~~~~~gt~~y~aPE~~~~-~~~~~  228 (332)
                      ..+..                     .....                        .....+|||.|+|||++.+ .|+..
T Consensus       289 ~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~  368 (550)
T KOG0605|consen  289 TGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE  368 (550)
T ss_pred             chhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc
Confidence            53311                     00000                        0124689999999999998 89999


Q ss_pred             hhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHccc
Q 038681          229 CDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMD  308 (332)
Q Consensus       229 sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  308 (332)
                      +|.||||||+||||.|-+||......+...  .+..|-..                  ...+.....+.++.+||.+|+.
T Consensus       369 cDwWSLG~ImyEmLvGyPPF~s~tp~~T~r--kI~nwr~~------------------l~fP~~~~~s~eA~DLI~rll~  428 (550)
T KOG0605|consen  369 CDWWSLGCIMYEMLVGYPPFCSETPQETYR--KIVNWRET------------------LKFPEEVDLSDEAKDLITRLLC  428 (550)
T ss_pred             ccHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhhh------------------ccCCCcCcccHHHHHHHHHHhc
Confidence            999999999999999999999887665422  11111100                  1112223445889999999999


Q ss_pred             CCCCCCCC---HHHHH
Q 038681          309 FSPEDRPT---MVDVA  321 (332)
Q Consensus       309 ~dP~~RPs---~~evl  321 (332)
                       ||++|.-   ++||-
T Consensus       429 -d~~~RLG~~G~~EIK  443 (550)
T KOG0605|consen  429 -DPENRLGSKGAEEIK  443 (550)
T ss_pred             -CHHHhcCcccHHHHh
Confidence             9999964   55553

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.2e-45  Score=332.70  Aligned_cols=254  Identities=19%  Similarity=0.234  Sum_probs=198.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|++.+.||+|+||.||++.+  ++..+|+|.+.........+.+.+|+.++.+++||||+++           +|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            46799999999999999999999  6888999998876555556789999999999999999997           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFS-RPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      |+++|+|.+++...     ..+++..+..++.|++.||.|||   + ++|+||||||+|||++.++.+||+|||++....
T Consensus        84 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  155 (331)
T cd06649          84 HMDGGSLDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLR---EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  155 (331)
T ss_pred             cCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence            99999999999765     46899999999999999999999   6 469999999999999999999999999997664


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhh-cc-------
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS-GQ-------  269 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~-------  269 (332)
                      ....    ....||+.|+|||++.+ .++.++|||||||++|||++|+.||......+...   ...... ..       
T Consensus       156 ~~~~----~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~  228 (331)
T cd06649         156 DSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA---IFGRPVVDGEEGEPHS  228 (331)
T ss_pred             cccc----ccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HhcccccccccCCccc
Confidence            4322    34578999999999987 89999999999999999999999997554322111   000000 00       


Q ss_pred             ---------------------ccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          270 ---------------------NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       270 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                                           .....+..+.......  +.......+.++.+|+.+||+.||++|||+.++++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPP--PKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cCcccccccccccccccccccchhHHHHHHHHHhCCC--cCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                 0000011111111111  111112355789999999999999999999999873

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-46  Score=343.71  Aligned_cols=235  Identities=19%  Similarity=0.240  Sum_probs=201.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      .+-|+.++.||.|+-|.|-.|++  +|+.+|||++.+..  .......+.+|+.+|+.+.||||+++           +|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            45689999999999999999999  99999999998763  23335668899999999999999998           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      +||+++|-|.+++-..     +++++.++..+++||+.|+.|+|   ..+|+||||||+|+|+|.++++||+|||+|..-
T Consensus        91 lEyv~gGELFdylv~k-----G~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe  162 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVRK-----GPLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLE  162 (786)
T ss_pred             EEecCCchhHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecc
Confidence            9999999999999988     78999999999999999999999   999999999999999999999999999999776


Q ss_pred             CCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      ..+...   .+.+|+++|+|||++.|  +.+.++||||.|||||.||||+.||++.+...      +...+.        
T Consensus       163 ~~gklL---eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~------LLlKV~--------  225 (786)
T KOG0588|consen  163 VPGKLL---ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV------LLLKVQ--------  225 (786)
T ss_pred             cCCccc---cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH------HHHHHH--------
Confidence            655543   57799999999999999  45889999999999999999999998554322      111111        


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                            .+.+    ..+...+.++.+|+.+||..||+.|.|..||++
T Consensus       226 ------~G~f----~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k  262 (786)
T KOG0588|consen  226 ------RGVF----EMPSNISSEAQDLLRRMLDVDPSTRITTEEILK  262 (786)
T ss_pred             ------cCcc----cCCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence                  1111    122355688999999999999999999999986

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-46  Score=312.81  Aligned_cols=224  Identities=20%  Similarity=0.293  Sum_probs=193.5

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|+..+.||.|+||.|.+++.  +|..+|+|.+....-  ....+...+|..+|+.+.||.++++           |||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            4577889999999999999999  889999999987643  3346678899999999999999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||++||.|..++++.     +++++..++.++.||+.||+|||   +.+|++|||||+|||+|.+|.+||+|||+|+...
T Consensus       124 eyv~GGElFS~Lrk~-----~rF~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~  195 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKS-----GRFSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS  195 (355)
T ss_pred             eccCCccHHHHHHhc-----CCCCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEec
Confidence            999999999999987     68999999999999999999999   9999999999999999999999999999999887


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ...     .+.+|||.|+|||++.. .++.++|.||||+++|||+.|.+||........      ...+......++   
T Consensus       196 ~rT-----~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~i------Y~KI~~~~v~fP---  261 (355)
T KOG0616|consen  196 GRT-----WTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQI------YEKILEGKVKFP---  261 (355)
T ss_pred             CcE-----EEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHH------HHHHHhCcccCC---
Confidence            652     56799999999999998 899999999999999999999999987765332      222222222222   


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCC
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDR  314 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R  314 (332)
                                     ...+.++.+|+...|+.|-.+|
T Consensus       262 ---------------~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  262 ---------------SYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ---------------cccCHHHHHHHHHHHhhhhHhh
Confidence                           2344789999999999999888

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-47  Score=308.95  Aligned_cols=256  Identities=19%  Similarity=0.277  Sum_probs=206.3

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------  115 (332)
                      .+.++.++|.+.+.||+|||+-||.+..  +++.+|+|++.....+ ..+..++|++..++++||||+++          
T Consensus        15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~-~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D   93 (302)
T KOG2345|consen   15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQE-DIEEALREIDNHRKFNSPNVLRLVDHQLREEKD   93 (302)
T ss_pred             cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchH-HHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence            3456678899999999999999999998  8999999999887744 48889999999999999999986          


Q ss_pred             ------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCCeeeCCCCCeE
Q 038681          116 ------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRP--IVYRDMKPTNILFNEQSDAK  187 (332)
Q Consensus       116 ------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~k  187 (332)
                            |+++|...|+|.+.+...... ...+++.+++.|+.+|++||++||   +..  ++||||||.|||+.+++.++
T Consensus        94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~k-g~~~sE~~iL~if~gic~gL~~lH---~~~~~yAH~DiKP~NILls~~~~~v  169 (302)
T KOG2345|consen   94 GKHEAYLLLPYYKRGSLLDEIERLKIK-GNFVSEAQILWIFLGICRGLEALH---EKEPPYAHRDIKPANILLSDSGLPV  169 (302)
T ss_pred             CceeEEEEeehhccccHHHHHHHHhhc-CCccCHHHHHHHHHHHHHHHHHHh---ccCCcccccCCCcceeEecCCCceE
Confidence                  899999999999999876332 246999999999999999999999   665  99999999999999999999


Q ss_pred             EeecCCccccCCCCc-------eeeccccccCCCcccccccCC----CCChhhhHHHHHHHHHHHHhCCccCCCCCccch
Q 038681          188 LFDFSLSLSIPDGET-------HIELDSVVGTTGFIAPENFTT----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESR  256 (332)
Q Consensus       188 l~Dfg~a~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~  256 (332)
                      |.|||.+....-...       .........|..|+|||.+.-    ..++++|||||||+||+|+.|..||+...... 
T Consensus       170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-  248 (302)
T KOG2345|consen  170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-  248 (302)
T ss_pred             EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-
Confidence            999999865432111       111123467999999999863    67899999999999999999999997432211 


Q ss_pred             hhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 038681          257 FHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY  328 (332)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~  328 (332)
                                    .++.-.+     .......+.....++.+.++++.||+.||.+||++.+++..++.+.
T Consensus       249 --------------gSlaLAv-----~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  249 --------------GSLALAV-----QNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             --------------CeEEEee-----eccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                          1111000     0011122222346789999999999999999999999999998874

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-46  Score=330.47  Aligned_cols=248  Identities=22%  Similarity=0.292  Sum_probs=196.3

Q ss_pred             cHHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh-------------hhHHHHHHHHHHHHhhcC
Q 038681           45 SAEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ-------------HALEWCINHIVYASRMSH  109 (332)
Q Consensus        45 ~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~l~~l~H  109 (332)
                      ...+=....++|+++..||+|.||.|-+|++  +++.||||++.+....             .-.+...+||.+|+++.|
T Consensus        88 ~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H  167 (576)
T KOG0585|consen   88 DDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHH  167 (576)
T ss_pred             cCcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCC
Confidence            3334445578899999999999999999999  8999999998754221             114689999999999999


Q ss_pred             CCcceE-------------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 038681          110 KHIIKL-------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPT  176 (332)
Q Consensus       110 ~nIv~~-------------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~  176 (332)
                      ||||++             ||+|||..|.+...=-.     ...+++.++++++++++.||+|||   .+||+||||||+
T Consensus       168 ~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~d-----~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPs  239 (576)
T KOG0585|consen  168 PNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPPD-----KPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPS  239 (576)
T ss_pred             cCeeEEEEeecCcccCceEEEEEeccCCccccCCCC-----cccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchh
Confidence            999998             89999998877432211     123899999999999999999999   999999999999


Q ss_pred             CeeeCCCCCeEEeecCCccccCCCC---ceeeccccccCCCcccccccCC-----CCChhhhHHHHHHHHHHHHhCCccC
Q 038681          177 NILFNEQSDAKLFDFSLSLSIPDGE---THIELDSVVGTTGFIAPENFTT-----LINEQCDVYGFGAFLFELLTAQEVS  248 (332)
Q Consensus       177 Nill~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~-----~~~~~sDiwSlG~~l~elltg~~p~  248 (332)
                      |+|++.+|++||+|||.+..+..+.   .........|||.|+|||.+.+     ..+.+.||||+||+||.|+.|+.||
T Consensus       240 NLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF  319 (576)
T KOG0585|consen  240 NLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPF  319 (576)
T ss_pred             heEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCc
Confidence            9999999999999999997663321   1112345789999999999875     3477999999999999999999999


Q ss_pred             CCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          249 DHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ......+                    ..+.++...  ...+..++..+.+.+||.+||+.||++|.+..+|..
T Consensus       320 ~~~~~~~--------------------l~~KIvn~p--L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~  371 (576)
T KOG0585|consen  320 FDDFELE--------------------LFDKIVNDP--LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKL  371 (576)
T ss_pred             ccchHHH--------------------HHHHHhcCc--ccCCCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence            7654322                    222222211  122223356688999999999999999999988864

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1e-45  Score=339.87  Aligned_cols=255  Identities=18%  Similarity=0.329  Sum_probs=200.0

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----
Q 038681           49 LRIATNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----  115 (332)
Q Consensus        49 l~~~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----  115 (332)
                      +....++|++.+.||+|+||.||+|.+       ++..||+|.+.........+.+.+|+.+++.+ +|||||++     
T Consensus        33 ~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          33 WEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             ccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            344556799999999999999999986       23479999998765555567789999999999 89999997     


Q ss_pred             ------EEEEeccCCChHHHHhhhhc------------------------------------------------------
Q 038681          116 ------IVFESVQIGTLADRIHHHCE------------------------------------------------------  135 (332)
Q Consensus       116 ------lv~e~~~~g~L~~~l~~~~~------------------------------------------------------  135 (332)
                            +||||+++|+|.+++.....                                                      
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence                  89999999999999865321                                                      


Q ss_pred             -----------ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCcee
Q 038681          136 -----------QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHI  204 (332)
Q Consensus       136 -----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  204 (332)
                                 .....+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.........
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCccee
Confidence                       00124788899999999999999999   9999999999999999999999999999997665443322


Q ss_pred             eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhh
Q 038681          205 ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIII  282 (332)
Q Consensus       205 ~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (332)
                      ......++..|+|||++.+ .++.++|||||||++|||++ |..||.........     .......             
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~-----~~~~~~~-------------  331 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF-----YKMVKRG-------------  331 (374)
T ss_pred             eccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH-----HHHHHcc-------------
Confidence            2223345678999999876 89999999999999999997 99999765332210     0100000             


Q ss_pred             cccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 038681          283 EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY  328 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~  328 (332)
                        .  ....+...+.++.+++.+||+.||.+|||+.+|++.|+++.
T Consensus       332 --~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         332 --Y--QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             --c--CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence              0  00001122477999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-46  Score=351.53  Aligned_cols=248  Identities=21%  Similarity=0.306  Sum_probs=205.4

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe-CC-eeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-CCCcceE------------
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW-QK-RSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKL------------  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~~------------  115 (332)
                      +...++.+.+.|.+|||+.||.|.+ .+ ..+|+|++... ++..++.+.+|+.+|++|+ |+|||.+            
T Consensus        34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            4455678899999999999999999 44 89999999887 6667999999999999996 9999998            


Q ss_pred             ------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEe
Q 038681          116 ------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLF  189 (332)
Q Consensus       116 ------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  189 (332)
                            |.||||+||.|-+++..+..   ..|++.++++|+.|+++|+.+||.. ..+|||||||-+||||+.+|+.|||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq---~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQ---TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHh---ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeC
Confidence                  79999999999999997744   3499999999999999999999943 5669999999999999999999999


Q ss_pred             ecCCccccCCCCc-ee------eccccccCCCcccccccC---C-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhh
Q 038681          190 DFSLSLSIPDGET-HI------ELDSVVGTTGFIAPENFT---T-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFH  258 (332)
Q Consensus       190 Dfg~a~~~~~~~~-~~------~~~~~~gt~~y~aPE~~~---~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~  258 (332)
                      |||.+........ ..      ..-....|+.|+|||++.   + .+++|+|||||||+||-|+....||+....-... 
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl-  267 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL-  267 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE-
Confidence            9999865433221 10      011235799999999864   4 8999999999999999999999999865322111 


Q ss_pred             hHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          259 YEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                                             ...  ...+..+.++..+.+||..||+.||.+||++-+|+..+..|..
T Consensus       268 -----------------------ng~--Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~  313 (738)
T KOG1989|consen  268 -----------------------NGN--YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN  313 (738)
T ss_pred             -----------------------ecc--ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence                                   111  1222234788999999999999999999999999999988864

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.2e-45  Score=324.32  Aligned_cols=244  Identities=17%  Similarity=0.244  Sum_probs=196.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-----CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------E
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------I  116 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------l  116 (332)
                      ..+|.+.+.||+|+||.||+|.+     .+..||+|.+...........+.+|+.++.+++||||+++           +
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            45689999999999999999986     3568999999877655556779999999999999999997           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ||||+++|+|.+++....    ..+++..++.++.||+.||+|||   +++++||||||+||+++.++.++++|||.+..
T Consensus        84 v~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          84 VTEYMSNGALDSFLRKHE----GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEEeCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            999999999999997641    46899999999999999999999   99999999999999999999999999998765


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ....... ......++..|+|||.+.+ .++.++|||||||++||+++ |..||........      ......      
T Consensus       157 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~------~~~~~~------  223 (266)
T cd05064         157 DKSEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV------IKAVED------  223 (266)
T ss_pred             ccccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH------HHHHHC------
Confidence            4322211 1122345678999999876 89999999999999999775 9999976543221      111110      


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                               ..  ..+.+..++..+.+++.+||+.+|.+|||+++|++.|.++
T Consensus       224 ---------~~--~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         224 ---------GF--RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ---------CC--CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                     00  0111224457899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.2e-45  Score=325.19  Aligned_cols=247  Identities=22%  Similarity=0.318  Sum_probs=199.3

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CC-----eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QK-----RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      ++|++.+.||+|+||.||+|..  .+     ..|++|.+...........+.+|+.++.+++||||+++           
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            4688899999999999999987  22     56999998876655556779999999999999999997           


Q ss_pred             EEEEeccCCChHHHHhhhhcccc-----------cCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC
Q 038681          116 IVFESVQIGTLADRIHHHCEQHF-----------EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS  184 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~-----------~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  184 (332)
                      ++|||+++|+|.+++........           ..+++..++.++.|++.||.|||   +.+++|+||||+||+++.++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCC
Confidence            79999999999999976422111           45889999999999999999999   99999999999999999999


Q ss_pred             CeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHH
Q 038681          185 DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEEN  262 (332)
Q Consensus       185 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~  262 (332)
                      .++|+|||+++...............+++.|+|||.+.+ .++.++|||||||++|||++ |..||......+..     
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~-----  236 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI-----  236 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-----
Confidence            999999999976544332222234567889999998876 89999999999999999998 99999765433211     


Q ss_pred             HhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 038681          263 VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQ  326 (332)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~  326 (332)
                       ..+..               ..  ....+..++.++.+|+.+||+.||.+||++.+|++.|++
T Consensus       237 -~~i~~---------------~~--~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 -EMIRS---------------RQ--LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -HHHHc---------------CC--cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence             11100               00  011123455889999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.1e-45  Score=330.73  Aligned_cols=246  Identities=18%  Similarity=0.348  Sum_probs=198.7

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCe----eEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------EE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKR----SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IV  117 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv  117 (332)
                      .+|+..+.||+|+||.||+|.+  ++.    .||+|.+.........+.+.+|+.+++.++||||+++          +|
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v   86 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   86 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence            4699999999999999999987  343    3899998866555557789999999999999999998          79


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      +||+++|+|.+++....    ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus        87 ~e~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          87 TQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             eecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccc
Confidence            99999999999998642    35889999999999999999999   999999999999999999999999999999877


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      .............++..|+|||.+.+ .++.++|||||||++|||++ |..||........      ......       
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~------~~~~~~-------  226 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI------SSILEK-------  226 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHhC-------
Confidence            55433222223345678999999887 88999999999999999998 9999976543221      111100       


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                              ..  ..+.+..++..+.+++.+||..||.+|||+.+++..|.++.+
T Consensus       227 --------~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         227 --------GE--RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             --------CC--CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence                    00  001111234678999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.1e-45  Score=327.76  Aligned_cols=239  Identities=21%  Similarity=0.329  Sum_probs=191.0

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .|+..+.||+|+||.||+|.+  +++.||+|.+.....  ......+.+|+.++.+++|+||+++           +|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            377889999999999999998  789999999875432  2224567899999999999999987           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++|+|.+++.....   ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.++|+|||++.....
T Consensus        81 ~~~~g~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~  154 (285)
T cd05631          81 IMNGGDLKFHIYNMGN---PGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE  154 (285)
T ss_pred             ecCCCcHHHHHHhhCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC
Confidence            9999999988865321   35899999999999999999999   99999999999999999999999999999987644


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      ....   ....||..|+|||++.+ .++.++|||||||++|||++|+.||..........  .....             
T Consensus       155 ~~~~---~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~--~~~~~-------------  216 (285)
T cd05631         155 GETV---RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE--EVDRR-------------  216 (285)
T ss_pred             CCee---cCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH--HHHHH-------------
Confidence            3322   34578999999999987 89999999999999999999999998654321100  01110             


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT-----MVDVAK  322 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~  322 (332)
                        +...   ....+...+..+.+|+.+||+.||.+||+     ++++++
T Consensus       217 --~~~~---~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         217 --VKED---QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             --hhcc---cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence              0000   00111234578899999999999999997     788776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=4.1e-46  Score=337.18  Aligned_cols=233  Identities=17%  Similarity=0.271  Sum_probs=191.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|.+....  .....+.+.+|+.++.+++||||+++           +|
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   96 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL   96 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence            35689999999999999999999  78899999987542  22335678999999999999999987           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+++|+|.+++...     ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus        97 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  168 (329)
T PTZ00263         97 LEFVVGGELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV  168 (329)
T ss_pred             EcCCCCChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEc
Confidence            9999999999999865     56899999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ....     ....||+.|+|||++.+ .++.++|||||||++|+|++|..||........      ...+......++  
T Consensus       169 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~------~~~i~~~~~~~p--  235 (329)
T PTZ00263        169 PDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRI------YEKILAGRLKFP--  235 (329)
T ss_pred             CCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHH------HHHHhcCCcCCC--
Confidence            4432     24578999999999987 789999999999999999999999976443211      111111111111  


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT-----MVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~  322 (332)
                                      ...+..+.+|+.+||+.||.+||+     +.+++.
T Consensus       236 ----------------~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        236 ----------------NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             ----------------CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                            123367889999999999999997     577664

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.3e-46  Score=335.62  Aligned_cols=239  Identities=23%  Similarity=0.314  Sum_probs=205.7

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE------------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL------------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~------------lv~  118 (332)
                      ++|...+.+|+|+||.++.+++  .+..+++|++.... +....+...+|+.+++++.|||||.+            |||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            5799999999999999999988  77889999988764 33445678999999999999999998            899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      +||+||++.+.+.+..+   ..++++.+..|+.|++.|+.|||   +++|+|||||+.||+++.++.|+|+|||+|+...
T Consensus        84 ~Y~eGg~l~~~i~~~k~---~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKG---VLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             eecCCCCHHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcC
Confidence            99999999999988742   56999999999999999999999   9999999999999999999999999999999987


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ......  .+.+||+.|++||++.+ +|+.|+|||||||++|||++-+++|...+....                    +
T Consensus       158 ~~~~~a--~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~L--------------------i  215 (426)
T KOG0589|consen  158 PEDSLA--STVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSEL--------------------I  215 (426)
T ss_pred             Cchhhh--heecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHH--------------------H
Confidence            765222  56799999999999999 999999999999999999999999987654332                    1


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                      .......   ..+.+..++.++..++..||..+|..||++.+++..
T Consensus       216 ~ki~~~~---~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  216 LKINRGL---YSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHHhhcc---CCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            1111111   123334677899999999999999999999999985

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8.8e-46  Score=334.19  Aligned_cols=229  Identities=17%  Similarity=0.247  Sum_probs=186.9

Q ss_pred             CccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCC
Q 038681           60 NIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIG  124 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g  124 (332)
                      +.||+|+||.||+|.+  +++.||+|++....  .......+.+|+.++.+++||||+++           +||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999998  78899999987542  23335678899999999999999987           899999999


Q ss_pred             ChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCcee
Q 038681          125 TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHI  204 (332)
Q Consensus       125 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  204 (332)
                      +|.+++...     ..+++..+..++.||+.||+|||   ++||+||||||+|||++.++.+||+|||+++........ 
T Consensus        81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-  151 (323)
T cd05571          81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGAT-  151 (323)
T ss_pred             cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCc-
Confidence            999999765     56899999999999999999999   999999999999999999999999999998754322211 


Q ss_pred             eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhc
Q 038681          205 ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIE  283 (332)
Q Consensus       205 ~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (332)
                       .....||+.|+|||++.+ .++.++|||||||++|||++|..||........      ..........           
T Consensus       152 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~------~~~~~~~~~~-----------  213 (323)
T cd05571         152 -MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELILMEEIR-----------  213 (323)
T ss_pred             -ccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHH------HHHHHcCCCC-----------
Confidence             134579999999999987 899999999999999999999999976443221      1111111100           


Q ss_pred             ccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038681          284 DKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAK  322 (332)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~  322 (332)
                             .+...+.++.+|+.+||+.||++||     ++.++++
T Consensus       214 -------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         214 -------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             -------CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence                   1123447789999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.7e-45  Score=326.66  Aligned_cols=258  Identities=18%  Similarity=0.227  Sum_probs=192.7

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      ++|++.+.||+|+||.||+|++  ++..||+|++..... ....+.+.+|+.+++.++||||+++           +|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            4689999999999999999999  678999999876532 3335678899999999999999987           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |++++.+..+....     ..+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  152 (287)
T cd07848          81 YVEKNMLELLEEMP-----NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSE  152 (287)
T ss_pred             cCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence            99987776554332     46899999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh-
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV-  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  277 (332)
                      ..... .....||+.|+|||++.+ .++.++|||||||++|||++|+.||..........  ................. 
T Consensus       153 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  229 (287)
T cd07848         153 GSNAN-YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF--TIQKVLGPLPAEQMKLFY  229 (287)
T ss_pred             ccccc-ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhhCCCCHHHHHhhh
Confidence            33221 134578999999999987 88999999999999999999999998755432211  01111110000000000 


Q ss_pred             -hhhhhcc--cCCC------CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 -DSIIIED--KSCT------CTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 -~~~~~~~--~~~~------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                       ++.....  ....      .......+..+.+|+.+||+.||++|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence             0000000  0000      0001124577999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.3e-46  Score=323.45  Aligned_cols=234  Identities=23%  Similarity=0.333  Sum_probs=201.4

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      .+|++.+.||+|+||.|-+|..  .|+.||||.+.++.  ++..+-.+.+||+||+.|+||||+++           |||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4589999999999999999988  89999999998764  34446778999999999999999997           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||..+|.|++|+...     +.+++.++..+++||++|+.|+|   .++++|||||.+|||+|.++++||+|||++-.+.
T Consensus       133 EYaS~GeLYDYiSer-----~~LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~  204 (668)
T KOG0611|consen  133 EYASGGELYDYISER-----GSLSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA  204 (668)
T ss_pred             EecCCccHHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhc
Confidence            999999999999988     68999999999999999999999   9999999999999999999999999999998877


Q ss_pred             CCCceeeccccccCCCcccccccCC-C-CChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-L-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      +....   .+++|++-|.+||++.+ + -++.+|-||||++||-|+.|..||++.+...                    +
T Consensus       205 ~~kfL---qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~--------------------l  261 (668)
T KOG0611|consen  205 DKKFL---QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR--------------------L  261 (668)
T ss_pred             cccHH---HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH--------------------H
Confidence            76654   67899999999999998 4 4789999999999999999999999875432                    1


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                      +.++....+. .    +..+....-||+.||-.||+.|.|+.+|...
T Consensus       262 vrQIs~GaYr-E----P~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  262 VRQISRGAYR-E----PETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             HHHhhccccc-C----CCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence            2222112111 1    1223567789999999999999999999764

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=3.5e-45  Score=327.42  Aligned_cols=259  Identities=18%  Similarity=0.250  Sum_probs=191.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|.+.+.||+|+||.||+|..  +++.||+|++...........+.+|+.+++.++||||+++           +|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            36799999999999999999999  7889999998765443334567899999999999999987           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |++ ++|.+++....    ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++.....
T Consensus        84 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          84 YVH-TDLCQYMDKHP----GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             CCC-cCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            996 58888886541    45899999999999999999999   99999999999999999999999999999875443


Q ss_pred             CCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-cccchhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-QNCRFKEM  276 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  276 (332)
                      ....  .....+|+.|+|||++.+  .++.++|||||||++|+|++|..||........ ........... ....+...
T Consensus       156 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  232 (303)
T cd07869         156 PSHT--YSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD-QLERIFLVLGTPNEDTWPGV  232 (303)
T ss_pred             CCcc--CCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHHHHHHHhCCCChhhccch
Confidence            2211  134568999999999865  688999999999999999999999986543211 11111111100 00000000


Q ss_pred             hh-hhhh-cccCC-CCCC------hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VD-SIII-EDKSC-TCTG------KEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~-~~~~-~~~~~-~~~~------~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .. +... ..... ....      ....+..+.+|+.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         233 HSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             hhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            00 0000 00000 0000      0012356889999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.6e-45  Score=346.79  Aligned_cols=251  Identities=16%  Similarity=0.208  Sum_probs=202.4

Q ss_pred             cHHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE------
Q 038681           45 SAEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL------  115 (332)
Q Consensus        45 ~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~------  115 (332)
                      +..+.....++|.+.+.||+|+||+||+|.+  +++.||||.+.... .......+.+|+.++..++|+||+++      
T Consensus        23 d~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~  102 (496)
T PTZ00283         23 DEATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAK  102 (496)
T ss_pred             CcccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence            3345556678999999999999999999998  78999999987653 34446678999999999999999973      


Q ss_pred             -------------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC
Q 038681          116 -------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE  182 (332)
Q Consensus       116 -------------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~  182 (332)
                                   +||||+++|+|.+++...... ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.
T Consensus       103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~-~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~  178 (496)
T PTZ00283        103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKT-NRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCS  178 (496)
T ss_pred             ccccCcccceEEEEEEeCCCCCcHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeC
Confidence                         799999999999999764322 246899999999999999999999   999999999999999999


Q ss_pred             CCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHH
Q 038681          183 QSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEE  261 (332)
Q Consensus       183 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~  261 (332)
                      ++.+||+|||+++...............||+.|+|||++.+ .++.++|||||||++|||++|+.||........     
T Consensus       179 ~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~-----  253 (496)
T PTZ00283        179 NGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV-----  253 (496)
T ss_pred             CCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-----
Confidence            99999999999987654322222245679999999999987 899999999999999999999999976443221     


Q ss_pred             HHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          262 NVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                     +........   .+.+...++++.+++.+||+.||.+|||+.++++
T Consensus       254 ---------------~~~~~~~~~---~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~  296 (496)
T PTZ00283        254 ---------------MHKTLAGRY---DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN  296 (496)
T ss_pred             ---------------HHHHhcCCC---CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence                           111111000   0111234578999999999999999999999986

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-47  Score=311.07  Aligned_cols=239  Identities=23%  Similarity=0.351  Sum_probs=198.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      +++|++.+.||+|.|+.||++.+  +|+.+|+|.+.... .....+.+.+|++|.+.|+|||||++           ||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            45688889999999999999999  89999988876442 23347889999999999999999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC---CCCeEEeecCCcc
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE---QSDAKLFDFSLSL  195 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~a~  195 (332)
                      |++.||+|..-+-.+     ..+++..+-..++||++||.|+|   .++|||||+||+|+|+..   ..-+||+|||+|.
T Consensus        90 e~m~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             ecccchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEE
Confidence            999999997776655     46889999999999999999999   999999999999999953   3458999999999


Q ss_pred             ccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      .+.++..   .....|||.|||||++.. +|+..+||||.|++||-|+.|.+||.+.+...                   
T Consensus       162 ~l~~g~~---~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r-------------------  219 (355)
T KOG0033|consen  162 EVNDGEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------------------  219 (355)
T ss_pred             EeCCccc---cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH-------------------
Confidence            8874332   256789999999999988 99999999999999999999999998754322                   


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                       +...+....+..+.+.-...+++.++|+++||..||.+|.|+.|.++
T Consensus       220 -lye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  220 -LYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             -HHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence             22222333333333344466789999999999999999999999875

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.9e-45  Score=330.03  Aligned_cols=254  Identities=20%  Similarity=0.350  Sum_probs=200.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE--------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL--------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~--------  115 (332)
                      ..++|++.+.||+|+||.||+|..       +++.||+|++.........+.+.+|+.++.++ +||||+++        
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            345799999999999999999975       24689999998665544467788999999999 89999987        


Q ss_pred             ----EEEEeccCCChHHHHhhhhcc-------------------------------------------------------
Q 038681          116 ----IVFESVQIGTLADRIHHHCEQ-------------------------------------------------------  136 (332)
Q Consensus       116 ----lv~e~~~~g~L~~~l~~~~~~-------------------------------------------------------  136 (332)
                          +++||+++|+|.+++......                                                       
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence                789999999999998653210                                                       


Q ss_pred             -cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCc
Q 038681          137 -HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF  215 (332)
Q Consensus       137 -~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y  215 (332)
                       ....+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.++|+|||+++.+.............++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence             0125889999999999999999999   999999999999999999999999999999876543322222344567789


Q ss_pred             ccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChH
Q 038681          216 IAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKE  293 (332)
Q Consensus       216 ~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (332)
                      +|||++.+ .++.++|||||||++|||++ |..||......+.     ....+...           .      ....+.
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~-----~~~~~~~~-----------~------~~~~~~  299 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE-----FCRRLKEG-----------T------RMRAPE  299 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH-----HHHHHhcc-----------C------CCCCCc
Confidence            99998877 89999999999999999998 9999975433221     11111000           0      000111


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          294 QQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       294 ~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      ..+.++.+++.+||+.+|++||++.+|++.|+++++.
T Consensus       300 ~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~~  336 (337)
T cd05054         300 YATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQE  336 (337)
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            3346799999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=6.9e-45  Score=336.22  Aligned_cols=256  Identities=18%  Similarity=0.331  Sum_probs=202.0

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEeC-------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-CCCcceE-----
Q 038681           49 LRIATNNYDEQNIVLEDPFRKLYKGFWQ-------KRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKL-----  115 (332)
Q Consensus        49 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~~-----  115 (332)
                      +....++|.+.++||+|+||.||+|.+.       +..||||++.........+.+.+|+.++.++. ||||+++     
T Consensus        32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            3445678999999999999999999871       24699999977655555678999999999996 9999998     


Q ss_pred             ------EEEEeccCCChHHHHhhhhcc-----------------------------------------------------
Q 038681          116 ------IVFESVQIGTLADRIHHHCEQ-----------------------------------------------------  136 (332)
Q Consensus       116 ------lv~e~~~~g~L~~~l~~~~~~-----------------------------------------------------  136 (332)
                            ||||||++|+|.+++......                                                     
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence                  899999999999998754210                                                     


Q ss_pred             --------------------------------------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCe
Q 038681          137 --------------------------------------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNI  178 (332)
Q Consensus       137 --------------------------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  178 (332)
                                                            ....+++..+..++.||+.||.|||   ..+|+||||||+||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Ni  268 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhE
Confidence                                                  0124788889999999999999999   99999999999999


Q ss_pred             eeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccch
Q 038681          179 LFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESR  256 (332)
Q Consensus       179 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~  256 (332)
                      |++.++.+||+|||+++...............++..|+|||.+.+ .++.++|||||||++|||++ |..||........
T Consensus       269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~  348 (400)
T cd05105         269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST  348 (400)
T ss_pred             EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence            999999999999999986644332222234457788999999877 88999999999999999997 8899875432221


Q ss_pred             hhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          257 FHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                      .     ......               ..  ..+.+...+..+.+++.+||+.||++|||+.+|.+.|+++.+
T Consensus       349 ~-----~~~~~~---------------~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         349 F-----YNKIKS---------------GY--RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             H-----HHHHhc---------------CC--CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            1     111100               00  011112345789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-45  Score=329.55  Aligned_cols=227  Identities=19%  Similarity=0.274  Sum_probs=183.8

Q ss_pred             cccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCCCh
Q 038681           62 VLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTL  126 (332)
Q Consensus        62 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g~L  126 (332)
                      ||+|+||.||+|.+  ++..||+|.+....  .......+.+|+.++.+++||||+++           +||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999999  68899999987532  23335678899999999999999987           89999999999


Q ss_pred             HHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceeec
Q 038681          127 ADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL  206 (332)
Q Consensus       127 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  206 (332)
                      .+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.++|+|||+++........  .
T Consensus        81 ~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~--~  150 (312)
T cd05585          81 FHHLQRE-----GRFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--T  150 (312)
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCc--c
Confidence            9999765     56899999999999999999999   999999999999999999999999999999764332221  1


Q ss_pred             cccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhccc
Q 038681          207 DSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDK  285 (332)
Q Consensus       207 ~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ....||+.|+|||++.+ .++.++|||||||++|||++|..||........      ......              ...
T Consensus       151 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~------~~~~~~--------------~~~  210 (312)
T cd05585         151 NTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM------YRKILQ--------------EPL  210 (312)
T ss_pred             ccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH------HHHHHc--------------CCC
Confidence            34579999999999988 889999999999999999999999976433221      111110              000


Q ss_pred             CCCCCChHHHHHHHHHHHHHcccCCCCCCCC---HHHHHH
Q 038681          286 SCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT---MVDVAK  322 (332)
Q Consensus       286 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~evl~  322 (332)
                          ..+...+..+.+++.+||+.||.+||+   +.+++.
T Consensus       211 ----~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         211 ----RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             ----CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence                111234477899999999999999985   555543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.7e-44  Score=317.02  Aligned_cols=247  Identities=17%  Similarity=0.316  Sum_probs=196.5

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCe----eEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------EE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKR----SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IV  117 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv  117 (332)
                      ++|++.+.||+|+||.||+|.+  ++.    .+++|.+...........+..|+..+++++||||+++          ++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i   86 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV   86 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence            4578889999999999999998  444    4778887655444446778889999999999999997          89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      +||+++|+|.+++....    ..+++..+..++.||+.||.|||   +++++||||||+||+++.++.+||+|||+++..
T Consensus        87 ~e~~~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          87 TQLSPLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEeCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            99999999999997642    46899999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      .............++..|+|||.+.+ .++.++|||||||++||+++ |..||........      ...+....     
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------~~~~~~~~-----  228 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV------PDLLEKGE-----  228 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHCCC-----
Confidence            54332222234557788999999876 89999999999999999998 9999976543221      11111000     


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                                .  .+.+..++..+.+++.+||..||++|||+.++++.|..+.+.
T Consensus       229 ----------~--~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         229 ----------R--LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             ----------c--CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence                      0  000012235678899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-45  Score=357.37  Aligned_cols=252  Identities=22%  Similarity=0.367  Sum_probs=209.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEe---CCe----eEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW---QKR----SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~---~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------  115 (332)
                      ..+....+.||+|.||.||+|..   .+.    .||||.+....+......|++|..+|++++|||||++          
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            44566788999999999999998   333    4999999999888889999999999999999999998          


Q ss_pred             -EEEEeccCCChHHHHhhhhccc--ccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          116 -IVFESVQIGTLADRIHHHCEQH--FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                       |++|||++|||..||++.+...  ...+...+.+.++.|||+|+.||+   ++++|||||..+|+|++....+||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccc
Confidence             8999999999999999763221  246889999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccc
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      +|+.+.............-...|||||.+.. .++.|+|||||||++||++| |..||......+...     ..+.+  
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~-----~~~~g--  920 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLL-----DVLEG--  920 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHH-----HHHhC--
Confidence            9996655544333222234568999999986 99999999999999999999 889998776544322     11111  


Q ss_pred             cchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                                   .   +.+.+..++..++++|..||+.+|++||++..|++++.++.+.
T Consensus       921 -------------g---RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  921 -------------G---RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             -------------C---ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence                         1   2223346668899999999999999999999999999988765

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.8e-44  Score=326.94  Aligned_cols=254  Identities=18%  Similarity=0.239  Sum_probs=195.8

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ..++|++.++||+|+||.||++.+  ++..+|+|.+.........+.+.+|++++++++||||+++           +||
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            347899999999999999999999  6888999988776555556779999999999999999997           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFS-RPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      ||+++|+|.+++...     ..+++..+..++.|++.||.|||   + ++|+|+||||+|||++.++.+||+|||++...
T Consensus        83 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  154 (333)
T cd06650          83 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (333)
T ss_pred             ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence            999999999999765     56899999999999999999999   6 57999999999999999999999999998765


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhh-hhccc-----
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKR-LSGQN-----  270 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~-----  270 (332)
                      .....    ....||..|+|||++.+ .++.++|||||||++|+|++|..||..........   .... .....     
T Consensus       155 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~  227 (333)
T cd06650         155 IDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL---MFGCPVEGDPAESET  227 (333)
T ss_pred             hhhcc----ccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHH---HhcCcccCCcccccc
Confidence            43221    34568999999999987 78999999999999999999999997544321110   0000 00000     


Q ss_pred             ---------------------cchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          271 ---------------------CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       271 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                           .......+....... ... .....+.++.+|+.+||+.||++|||+.|++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         228 SPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPP-PKL-PSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             CcccCCccchhhhhcccccccccHHHHHHHHhcCCC-ccC-CCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence                                 000001111111110 000 00123467899999999999999999999975

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-45  Score=333.07  Aligned_cols=241  Identities=17%  Similarity=0.208  Sum_probs=194.9

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|.+.+.||+|+||.||+|.+  +++.||+|++.....  ......+.+|+.++..++||||+++           |||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            4689999999999999999999  688999999875432  2335678899999999999999987           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++....
T Consensus        81 e~~~g~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~  152 (333)
T cd05600          81 EYVPGGDFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIV  152 (333)
T ss_pred             eCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence            999999999999765     56899999999999999999999   9999999999999999999999999999997654


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ...     ....||+.|+|||++.+ .++.++|||||||++|||++|..||......+....  ...+..        .+
T Consensus       153 ~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~--i~~~~~--------~~  217 (333)
T cd05600         153 TYA-----NSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN--LKYWKE--------TL  217 (333)
T ss_pred             ccc-----CCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH--HHhccc--------cc
Confidence            421     45679999999999987 899999999999999999999999986544332110  000000        00


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                      .      .+.........+.++.+|+.+||..+|.+|||+.++++.
T Consensus       218 ~------~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         218 Q------RPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             c------CCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            0      000000001345789999999999999999999999863

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=336.74  Aligned_cols=259  Identities=20%  Similarity=0.345  Sum_probs=210.5

Q ss_pred             cccccHHHHHHHhcCCCCCCccccCCCceEEEEEe--C-C--ee-EEEEEEcC--CCChhhHHHHHHHHHHHHhhcCCCc
Q 038681           41 YRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFW--Q-K--RS-ISLMKYNG--NRNQHALEWCINHIVYASRMSHKHI  112 (332)
Q Consensus        41 ~~~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~-~--~~-vavK~~~~--~~~~~~~~~~~~E~~~l~~l~H~nI  112 (332)
                      ...+..+.|+...++-...++||+|+||.||+|.+  . +  .. ||||..+.  .........+++|++++++++||||
T Consensus       144 ~~PI~r~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NV  223 (474)
T KOG0194|consen  144 KRPIPRQKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNV  223 (474)
T ss_pred             cccccccccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCE
Confidence            44456667777888888889999999999999999  2 2  23 89999986  3456668899999999999999999


Q ss_pred             ceE-----------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeC
Q 038681          113 IKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN  181 (332)
Q Consensus       113 v~~-----------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  181 (332)
                      |++           ||||+|+||+|.++|.+..    ..++..+...++.+.|.||+|||   +++++||||-.+|+|++
T Consensus       224 Vr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~  296 (474)
T KOG0194|consen  224 VRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYS  296 (474)
T ss_pred             EEEEEEEcCCCccEEEEEecCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheec
Confidence            998           8999999999999999872    25999999999999999999999   99999999999999999


Q ss_pred             CCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhh
Q 038681          182 EQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHY  259 (332)
Q Consensus       182 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~  259 (332)
                      .++.+||+|||+++....-..  ......-...|+|||.+.. .|++++|||||||++||+++ |..||.+........ 
T Consensus       297 ~~~~vKISDFGLs~~~~~~~~--~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~-  373 (474)
T KOG0194|consen  297 KKGVVKISDFGLSRAGSQYVM--KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKA-  373 (474)
T ss_pred             CCCeEEeCccccccCCcceee--ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHH-
Confidence            999999999999876541111  1012235689999999987 89999999999999999999 888998776543211 


Q ss_pred             HHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          260 EENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                           ++              .....  +.+.+...+..+..++.+||..||++||||.++.+.|+.+...
T Consensus       374 -----kI--------------~~~~~--r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~  423 (474)
T KOG0194|consen  374 -----KI--------------VKNGY--RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKK  423 (474)
T ss_pred             -----HH--------------HhcCc--cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhc
Confidence                 11              11111  1112224557888999999999999999999999999988753

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.4e-45  Score=330.43  Aligned_cols=257  Identities=19%  Similarity=0.259  Sum_probs=190.3

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE----------------
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL----------------  115 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~----------------  115 (332)
                      +|++.+.||+|+||.||+|.+  ++..||||++.... .......+.+|+.++++++||||+++                
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            488889999999999999998  78999999987532 22234568899999999999999864                


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      +||||++ ++|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        81 lv~e~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~  151 (338)
T cd07859          81 VVFELME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLAR  151 (338)
T ss_pred             EEEecCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCcccc
Confidence            8999995 6899998765     46899999999999999999999   9999999999999999999999999999997


Q ss_pred             ccCCCCce-eeccccccCCCcccccccCC---CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          196 SIPDGETH-IELDSVVGTTGFIAPENFTT---LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       196 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      ........ .......||+.|+|||++.+   .++.++|||||||++|||++|+.||..........  ...........
T Consensus       152 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~--~~~~~~~~~~~  229 (338)
T cd07859         152 VAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD--LITDLLGTPSP  229 (338)
T ss_pred             ccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH--HHHHHhCCCCH
Confidence            65332211 11134578999999998764   68899999999999999999999997654322211  01111100000


Q ss_pred             c---------hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          272 R---------FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       272 ~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .         ....+...............+..+..+.+++.+||+.||++|||++++++
T Consensus       230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            0         00000000000000000000123467889999999999999999999986

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.2e-44  Score=318.36  Aligned_cols=247  Identities=19%  Similarity=0.317  Sum_probs=198.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCe----eEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------E
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKR----SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------I  116 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------l  116 (332)
                      ..+|+..+.||+|+||+||+|.+  ++.    .||+|.+.........+.+.+|+.++..+.||||+++          +
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l   85 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQL   85 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEE
Confidence            45688899999999999999987  444    4899999876666657789999999999999999986          8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ++||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~~~~~~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~  158 (279)
T cd05109          86 VTQLMPYGCLLDYVRENK----DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (279)
T ss_pred             EEEcCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceee
Confidence            999999999999997641    46899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ..............+++.|+|||.+.+ .++.++|||||||++|||++ |..||........      ...+...     
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~------~~~~~~~-----  227 (279)
T cd05109         159 LDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI------PDLLEKG-----  227 (279)
T ss_pred             cccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHCC-----
Confidence            654433222123345678999999877 88999999999999999998 8899865432211      1111100     


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                                .  ..+.+...+..+.+++.+||+.||++||++.++++.|..+.+
T Consensus       228 ----------~--~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         228 ----------E--RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             ----------C--cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                      0  001112344678999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=3.2e-45  Score=332.46  Aligned_cols=234  Identities=17%  Similarity=0.238  Sum_probs=190.8

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--C-CeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--Q-KRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~-~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      ..++|.+.+.||+|+||.||+|.+  . +..||+|.+....  .....+.+.+|+.++..++||||+++           
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            345699999999999999999987  2 3689999986532  22335678899999999999999987           


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      +||||+++|+|.+++...     ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus       108 lv~Ey~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~  179 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAK  179 (340)
T ss_pred             EEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCe
Confidence            899999999999999875     56899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ......     ....||+.|+|||++.+ .++.++|||||||++|||++|..||........      ...+......  
T Consensus       180 ~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~------~~~i~~~~~~--  246 (340)
T PTZ00426        180 VVDTRT-----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI------YQKILEGIIY--  246 (340)
T ss_pred             ecCCCc-----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH------HHHHhcCCCC--
Confidence            764322     34579999999999987 789999999999999999999999976543211      1111111000  


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAK  322 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~  322 (332)
                                      .+...+..+.+++.+||+.||.+|+     +++++++
T Consensus       247 ----------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        247 ----------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             ----------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence                            0112336788999999999999995     8888875

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-44  Score=333.86  Aligned_cols=253  Identities=17%  Similarity=0.197  Sum_probs=188.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      ..+|++.+.||+|+||.||+|.+  +++.||+|...       ...+.+|+.++++++|||||++           +|+|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e  163 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ-------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP  163 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh-------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence            36799999999999999999999  78899999643       2346799999999999999998           7899


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      ++. ++|..++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus       164 ~~~-~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        164 RYK-TDLYCYLAAK-----RNIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             cCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence            985 6899888765     46899999999999999999999   99999999999999999999999999999975433


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCcc-----chhhhHHHHhhhhccccch
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFE-----SRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~  273 (332)
                      .... ......||+.|+|||++.+ .++.++|||||||++|||++|..||......     ...............+..+
T Consensus       235 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~  313 (391)
T PHA03212        235 INAN-KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF  313 (391)
T ss_pred             cccc-ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence            2211 1134679999999999987 8999999999999999999999887543211     1111111111111111110


Q ss_pred             ----hhhhhhhh----hcccCC-----CCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          274 ----KEMVDSII----IEDKSC-----TCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       274 ----~~~~~~~~----~~~~~~-----~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                          ...++...    ......     ........+.++.+|+.+||+.||.+|||++|+++
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence                00011000    000000     00111234568999999999999999999999986

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.7e-44  Score=318.72  Aligned_cols=250  Identities=23%  Similarity=0.338  Sum_probs=198.3

Q ss_pred             CCCCCCccccCCCceEEEEEeC-------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------E
Q 038681           55 NYDEQNIVLEDPFRKLYKGFWQ-------KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------I  116 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------l  116 (332)
                      +|.+.+.||+|+||.||+|...       ...+++|.+.........+.+.+|+.+++.++||||+++           +
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4788899999999999999872       246888888766655556789999999999999999997           7


Q ss_pred             EEEeccCCChHHHHhhhhc-------------------ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 038681          117 VFESVQIGTLADRIHHHCE-------------------QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTN  177 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  177 (332)
                      |+||+++|+|.+++.....                   .....+++..++.++.|++.||.|||   +++|+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhhe
Confidence            9999999999999875311                   11135889999999999999999999   9999999999999


Q ss_pred             eeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccc
Q 038681          178 ILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFES  255 (332)
Q Consensus       178 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~  255 (332)
                      ||+++++.++|+|||+++...............++..|+|||.+.+ .++.++||||||+++|||++ |..||.......
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999976644332222233456778999998876 78999999999999999998 999997654322


Q ss_pred             hhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          256 RFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      .      ......           ..      ....+...+.++.+++.+||+.||++||++.++++.|+++..+
T Consensus       238 ~------~~~~~~-----------~~------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~  289 (290)
T cd05045         238 L------FNLLKT-----------GY------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK  289 (290)
T ss_pred             H------HHHHhC-----------CC------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence            1      111110           00      0011123446899999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.4e-44  Score=340.74  Aligned_cols=240  Identities=20%  Similarity=0.227  Sum_probs=192.6

Q ss_pred             CCCCCCccccCCCceEEEEEe--C-CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--Q-KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      .|.+.+.||+|+||.||+|..  + +..||+|.+..... .....+.+|+.+++.++|||||++           |||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~-~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE-RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            388999999999999999988  4 67788887755433 335678889999999999999997           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++|+|.+++...... ..++++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       147 ~~gg~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKE-HLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             CCCCCHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            9999999998754221 246899999999999999999999   999999999999999999999999999999876544


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      ..........||+.|+|||++.+ .++.++|||||||++|||++|..||.........                    ..
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~--------------------~~  282 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM--------------------QQ  282 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH--------------------HH
Confidence            32222245679999999999987 8999999999999999999999999754332211                    11


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .......   +.+...+..+.+|+.+||..||++|||+.+++.
T Consensus       283 ~~~~~~~---~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        283 VLYGKYD---PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             HHhCCCC---CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            1111000   011133467999999999999999999999875

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.3e-44  Score=317.12  Aligned_cols=247  Identities=20%  Similarity=0.299  Sum_probs=197.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-C------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-Q------KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------  115 (332)
                      .++|.+.+.||+|+||.||+|.+ .      +..||+|.+.........+.+.+|+.++..++||||+++          
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            35688899999999999999987 2      468999999877665557889999999999999999987          


Q ss_pred             -EEEEeccCCChHHHHhhhhc---------ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCC
Q 038681          116 -IVFESVQIGTLADRIHHHCE---------QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD  185 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  185 (332)
                       +||||+++|+|.+++.....         .....+++..+..++.|++.||.|||   +++++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCe
Confidence             89999999999999976421         11235789999999999999999999   999999999999999999999


Q ss_pred             eEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHH
Q 038681          186 AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENV  263 (332)
Q Consensus       186 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~  263 (332)
                      ++|+|||++................+++.|+|||++.+ .++.++|||||||++|||++ |..||.........      
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~------  234 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI------  234 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH------
Confidence            99999999976543322111133456788999999887 89999999999999999998 99998755432211      


Q ss_pred             hhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          264 KRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                      .....              ..   ....+...+..+.+++.+||+.||++|||+.||++.|+
T Consensus       235 ~~~~~--------------~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         235 ECITQ--------------GR---LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHHHc--------------CC---cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            11100              00   00011134477999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.1e-44  Score=327.08  Aligned_cols=229  Identities=18%  Similarity=0.262  Sum_probs=186.0

Q ss_pred             CccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCC
Q 038681           60 NIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIG  124 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g  124 (332)
                      +.||+|+||.||++..  ++..||+|.+....  .......+.+|+.+++.++||||+++           +||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999998  78999999987642  22335667899999999999999987           899999999


Q ss_pred             ChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCcee
Q 038681          125 TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHI  204 (332)
Q Consensus       125 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  204 (332)
                      +|..++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++........ 
T Consensus        81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-  151 (323)
T cd05595          81 ELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-  151 (323)
T ss_pred             cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCc-
Confidence            999988765     56899999999999999999999   999999999999999999999999999998754332211 


Q ss_pred             eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhc
Q 038681          205 ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIE  283 (332)
Q Consensus       205 ~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (332)
                       .....||+.|+|||++.+ .++.++|||||||++|||++|..||.........      ......              
T Consensus       152 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~------~~~~~~--------------  210 (323)
T cd05595         152 -MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF------ELILME--------------  210 (323)
T ss_pred             -cccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH------HHHhcC--------------
Confidence             134579999999999987 8899999999999999999999999765432211      111000              


Q ss_pred             ccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038681          284 DKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAK  322 (332)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~  322 (332)
                      ..    ..+...++.+.+++.+||+.||.+||     ++.++++
T Consensus       211 ~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         211 EI----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CC----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            00    01113347789999999999999998     7888775

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.3e-44  Score=317.96  Aligned_cols=249  Identities=18%  Similarity=0.315  Sum_probs=195.0

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEeC-------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE--------
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFWQ-------KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL--------  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~--------  115 (332)
                      ...++|++.+.||+|+||.||+|.+.       +..||+|++...........+.+|+.+++.++||||+++        
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            45678999999999999999999862       457999998765444445678999999999999999988        


Q ss_pred             ---EEEEeccCCChHHHHhhhhcc-----cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeE
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQ-----HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAK  187 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  187 (332)
                         +||||+++|+|.+++......     ....+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEE
Confidence               899999999999999754211     0124678889999999999999999   99999999999999999999999


Q ss_pred             EeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhh
Q 038681          188 LFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKR  265 (332)
Q Consensus       188 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~  265 (332)
                      |+|||+++...............+++.|+|||.+.+ .++.++|||||||++|||++ |..||........      ...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~------~~~  233 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQV------LRF  233 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHH
Confidence            999999976654433222123345778999999887 88999999999999999999 7888875543221      111


Q ss_pred             hhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          266 LSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                      ...              ...   ...+...+..+.+++.+||+.||++|||+.++++.|+
T Consensus       234 ~~~--------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         234 VME--------------GGL---LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHc--------------CCc---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            000              000   0001123467899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.1e-44  Score=327.65  Aligned_cols=229  Identities=18%  Similarity=0.243  Sum_probs=186.5

Q ss_pred             CccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCC
Q 038681           60 NIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIG  124 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g  124 (332)
                      +.||+|+||.||++..  ++..||+|++....  .......+.+|+.+++.++||||+++           +||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999998  78999999997642  23335678899999999999999987           899999999


Q ss_pred             ChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCcee
Q 038681          125 TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHI  204 (332)
Q Consensus       125 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  204 (332)
                      +|.+++...     ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++........ 
T Consensus        81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~-  151 (328)
T cd05593          81 ELFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAAT-  151 (328)
T ss_pred             CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccc-
Confidence            999988765     56899999999999999999999   999999999999999999999999999998754332211 


Q ss_pred             eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhc
Q 038681          205 ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIE  283 (332)
Q Consensus       205 ~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (332)
                       .....||+.|+|||++.+ .++.++|||||||++|+|++|..||........      ........             
T Consensus       152 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~------~~~~~~~~-------------  211 (328)
T cd05593         152 -MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FELILMED-------------  211 (328)
T ss_pred             -cccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHH------HHHhccCC-------------
Confidence             134579999999999987 889999999999999999999999976443221      11111000             


Q ss_pred             ccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038681          284 DKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAK  322 (332)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~  322 (332)
                       .    ..+...+.++.+|+.+||+.||++||     ++.++++
T Consensus       212 -~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         212 -I----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             -c----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence             0    01112346789999999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.1e-43  Score=312.61  Aligned_cols=246  Identities=20%  Similarity=0.289  Sum_probs=192.6

Q ss_pred             CCCCCccccCCCceEEEEEe--CCe--eEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE---------------
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKR--SISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL---------------  115 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~--~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~---------------  115 (332)
                      |.+.+.||+|+||.||+|.+  .+.  .+|+|.++... .....+.+.+|+.+++.++||||+++               
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            45678999999999999998  332  58999887653 33446788999999999999999986               


Q ss_pred             --EEEEeccCCChHHHHhhhh-cccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          116 --IVFESVQIGTLADRIHHHC-EQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                        +++||+++|+|.+++.... ......+++..+..++.|++.||+|||   .++|+||||||+|||++.++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCC
Confidence              6899999999999885432 122245899999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccc
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      +++...............+++.|+|||.+.+ .++.++|||||||++|||++ |..||........      ........
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~------~~~~~~~~  231 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEI------YDYLRQGN  231 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHcCC
Confidence            9987654432222123346778999999887 78999999999999999999 7888876433211      11111100


Q ss_pred             cchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                                    .   .......+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       232 --------------~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 --------------R---LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             --------------C---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                          0   001113346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=6.9e-44  Score=316.70  Aligned_cols=251  Identities=20%  Similarity=0.275  Sum_probs=198.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------  115 (332)
                      ..+|.+.+.||+|+||.||++..       ++..+|+|.+..... .....+.+|+.++.+++||||+++          
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH-HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            45789999999999999999985       345688888876543 336779999999999999999998          


Q ss_pred             -EEEEeccCCChHHHHhhhhc--------ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCe
Q 038681          116 -IVFESVQIGTLADRIHHHCE--------QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA  186 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  186 (332)
                       +||||+++|+|.+++.....        .....+++..++.++.|++.||+|||   ++|++||||||+||+++.++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcE
Confidence             89999999999999975421        11235899999999999999999999   9999999999999999999999


Q ss_pred             EEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHh
Q 038681          187 KLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVK  264 (332)
Q Consensus       187 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~  264 (332)
                      +|+|||+++...............++..|+|||++.+ .++.++|||||||++|+|++ |..||.........      .
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~------~  233 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI------E  233 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH------H
Confidence            9999999986644332222233446788999999987 78999999999999999998 89998765432211      1


Q ss_pred             hhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          265 RLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      .....              ..   ...+...+..+.+|+.+||+.||.+|||+.++++.|+++.++
T Consensus       234 ~i~~~--------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         234 CITQG--------------RV---LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             HHHcC--------------Cc---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            11000              00   000112336799999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=8.4e-45  Score=317.76  Aligned_cols=238  Identities=27%  Similarity=0.442  Sum_probs=187.2

Q ss_pred             CCCccccCCCceEEEEEeC------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           58 EQNIVLEDPFRKLYKGFWQ------KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        58 ~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      +.+.||.|.||.||+|.+.      +..|+||.+.........+.+.+|++.+++++||||+++           +|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            3568999999999999996      688999999776666668899999999999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++|+|.+++....   ...+++..+..|+.||+.||.|||   +.+++|+||+|+||+++.++.+||+|||++......
T Consensus        83 ~~~g~L~~~L~~~~---~~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~  156 (259)
T PF07714_consen   83 CPGGSLDDYLKSKN---KEPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEK  156 (259)
T ss_dssp             -TTEBHHHHHHHTC---TTTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTS
T ss_pred             cccccccccccccc---cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccc
Confidence            99999999998751   146899999999999999999999   899999999999999999999999999999877443


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      ..............|+|||.+.+ .++.++||||||+++||+++ |..||.........      ..+..          
T Consensus       157 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~------~~~~~----------  220 (259)
T PF07714_consen  157 SKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEII------EKLKQ----------  220 (259)
T ss_dssp             SSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHH------HHHHT----------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccc----------
Confidence            33333244567789999999876 78999999999999999999 67888765332211      11100          


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL  324 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L  324 (332)
                           ..  ....+..++..+.+++.+||+.||.+|||+.+|++.|
T Consensus       221 -----~~--~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  221 -----GQ--RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             -----TE--ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             -----cc--cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                 00  0011123347799999999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-44  Score=313.53  Aligned_cols=245  Identities=20%  Similarity=0.298  Sum_probs=198.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-----CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------E
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFWQ-----KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------I  116 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------l  116 (332)
                      .++|++.+.||+|+||.||+|.+.     ...||+|.+...........+.+|+.++++++||||+++           +
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            457999999999999999999982     347899998876665556789999999999999999997           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ||||+++|+|.+++....    ..+++..+..++.|++.||.|||   +++|+|+||||+||+++.++.++|+|||++..
T Consensus        83 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~  155 (266)
T cd05033          83 ITEYMENGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRR  155 (266)
T ss_pred             EEEcCCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhc
Confidence            999999999999997642    36899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ..............++..|+|||.+.+ .++.++||||||+++|+|++ |..||........      ......      
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~------~~~~~~------  223 (266)
T cd05033         156 LEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV------IKAVED------  223 (266)
T ss_pred             ccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH------HHHHHc------
Confidence            753222222123345678999999887 88999999999999999998 9999865432211      111100      


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                               ..  ..+.+...+..+.+++.+||+.+|++||++.+|++.|.++
T Consensus       224 ---------~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         224 ---------GY--RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---------CC--CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                     00  0001123447789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.8e-44  Score=337.98  Aligned_cols=255  Identities=19%  Similarity=0.280  Sum_probs=189.0

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE--------------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL--------------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~--------------  115 (332)
                      ...+|.+.+.||+|+||.||+|.+  +++.||||++....     ....+|+.+++.++|||||++              
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            346799999999999999999998  78899999986542     223579999999999999974              


Q ss_pred             -----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC-CeEEe
Q 038681          116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS-DAKLF  189 (332)
Q Consensus       116 -----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~  189 (332)
                           +||||+++ +|.+++..... ....+++..++.++.||+.||.|||   +++|+||||||+|||++.++ .+||+
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYAR-NNHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeee
Confidence                 69999985 78887764322 1256999999999999999999999   99999999999999998665 69999


Q ss_pred             ecCCccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhh
Q 038681          190 DFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS  267 (332)
Q Consensus       190 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  267 (332)
                      |||+|+........   ....||+.|+|||++.+  .++.++|||||||++|||++|.+||.+........  .....+.
T Consensus       214 DFGla~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~--~i~~~~~  288 (440)
T PTZ00036        214 DFGSAKNLLAGQRS---VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV--RIIQVLG  288 (440)
T ss_pred             ccccchhccCCCCc---ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHHHhC
Confidence            99999876543322   34578999999999865  68999999999999999999999998765433211  1111111


Q ss_pred             cccc-chhhhhhhhhhc-ccC------CCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          268 GQNC-RFKEMVDSIIIE-DKS------CTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       268 ~~~~-~~~~~~~~~~~~-~~~------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .... .+.. ..+.... ..+      .....+...+.++.+|+.+||+.||.+|||+.|+++
T Consensus       289 ~p~~~~~~~-~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        289 TPTEDQLKE-MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             CCCHHHHHH-hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            1000 0000 0000000 000      000011123468999999999999999999999985

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.1e-44  Score=316.18  Aligned_cols=254  Identities=22%  Similarity=0.314  Sum_probs=196.1

Q ss_pred             CCCCCccccCCCceEEEEEe------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-------------E
Q 038681           56 YDEQNIVLEDPFRKLYKGFW------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-------------I  116 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-------------l  116 (332)
                      |...+.||+|+||+||++.+      .+..||+|.+...........+.+|+.++++++||||+++             +
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            38889999999999988753      5678999999876544446778999999999999999987             8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ||||+++|+|.+++...      .+++..+..++.|++.||.|||   +++|+|+||||+||+++.++.++|+|||+++.
T Consensus        86 v~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~  156 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  156 (283)
T ss_pred             EecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccc
Confidence            99999999999999753      5999999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCceee-ccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc--cccc
Q 038681          197 IPDGETHIE-LDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG--QNCR  272 (332)
Q Consensus       197 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~  272 (332)
                      ......... .....++..|+|||.+.+ .++.++|||||||++|||++|..||.........    ......+  ....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~----~~~~~~~~~~~~~  232 (283)
T cd05080         157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEE----MIGPKQGQMTVVR  232 (283)
T ss_pred             cCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhh----hhcccccccchhh
Confidence            654332111 122345677999999876 8899999999999999999999998654321110    0000000  0011


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY  328 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~  328 (332)
                      +.+..+...      ..+.+...+..+.+++.+||+.||++|||++++++.|+++.
T Consensus       233 ~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         233 LIELLERGM------RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhhcCC------CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            111111111      11112244578999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=6e-44  Score=315.67  Aligned_cols=254  Identities=18%  Similarity=0.297  Sum_probs=203.8

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe-C-----CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW-Q-----KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------  115 (332)
                      +..++|.+.+.||+|+||.||+|.+ .     +..|++|.+.........+.+.+|+.++++++||||+++         
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            3456799999999999999999998 3     578999998876666667889999999999999999997         


Q ss_pred             ---EEEEeccCCChHHHHhhhhcc---cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEe
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQ---HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLF  189 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  189 (332)
                         +++||+++|+|.+++......   ....+++..+..++.|++.||+|||   +++++|+||||+||+++.++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEEC
Confidence               789999999999999764221   1135899999999999999999999   9999999999999999999999999


Q ss_pred             ecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhh
Q 038681          190 DFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLS  267 (332)
Q Consensus       190 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  267 (332)
                      |||+++.+.............++..|+|||++.+ .++.++|||||||++||+++ |..||.......      ......
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~  233 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE------MAAYLK  233 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH------HHHHHH
Confidence            9999986654432222123456778999999887 78999999999999999999 999997643322      111111


Q ss_pred             ccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      ..               .  .......++..+.+++.+||..||++|||+.++++.|+.+.+.
T Consensus       234 ~~---------------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         234 DG---------------Y--RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             cC---------------C--CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            10               0  0001112346789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.3e-44  Score=318.64  Aligned_cols=255  Identities=22%  Similarity=0.322  Sum_probs=202.0

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEeC-------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE----
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGFWQ-------KRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL----  115 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~----  115 (332)
                      ++....++|++.+.||+|+||.||++.+.       ...+|+|.+...........+.+|+.++.++ +||||+++    
T Consensus         6 ~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   85 (293)
T cd05053           6 EWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVC   85 (293)
T ss_pred             ccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            44556677999999999999999999872       2678999988765555567789999999999 89999987    


Q ss_pred             -------EEEEeccCCChHHHHhhhhc-----------ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 038681          116 -------IVFESVQIGTLADRIHHHCE-----------QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTN  177 (332)
Q Consensus       116 -------lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  177 (332)
                             ++|||+++|+|.+++.....           .....+++..++.++.|++.||.|||   +++|+||||||+|
T Consensus        86 ~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~N  162 (293)
T cd05053          86 TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARN  162 (293)
T ss_pred             cCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceee
Confidence                   89999999999999975321           12246899999999999999999999   9999999999999


Q ss_pred             eeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccc
Q 038681          178 ILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFES  255 (332)
Q Consensus       178 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~  255 (332)
                      |+++.++.+||+|||+++...............++..|+|||.+.+ .++.++|||||||++|||++ |..||.......
T Consensus       163 il~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         163 VLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             EEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            9999999999999999987655432222123345678999999876 88999999999999999997 999987554322


Q ss_pred             hhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 038681          256 RFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY  328 (332)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~  328 (332)
                      ..      .....               ..  ....+...+..+.+|+.+||..||++|||+.++++.|+++.
T Consensus       243 ~~------~~~~~---------------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 LF------KLLKE---------------GY--RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HH------HHHHc---------------CC--cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            11      11100               00  00111133467899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=6.1e-44  Score=312.85  Aligned_cols=243  Identities=19%  Similarity=0.334  Sum_probs=195.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      ..+|.+.+.||+|+||.||+|.+  .+..||+|.+.....  ....+.+|+.++..++||||+++           +|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   82 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch--HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence            44588889999999999999998  688999999875432  25678999999999999999997           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++|+|.+++....   ...+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus        83 ~~~~~~L~~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          83 FMTYGNLLDYLRECN---RQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             eCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            999999999997542   135899999999999999999999   99999999999999999999999999999977654


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ...... ....++..|+|||.+.+ .++.++|||||||++|||++ |..||........      .......        
T Consensus       157 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~------~~~~~~~--------  221 (263)
T cd05052         157 DTYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV------YELLEKG--------  221 (263)
T ss_pred             ceeecc-CCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHCC--------
Confidence            332211 22334668999999877 88999999999999999998 9999876543221      1111100        


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                         .      ....+...+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       222 ---~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         222 ---Y------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ---C------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence               0      0011123447899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3.5e-44  Score=318.71  Aligned_cols=257  Identities=20%  Similarity=0.259  Sum_probs=189.2

Q ss_pred             cCCCCCCccccCCCceEEEEEe---CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhh---cCCCcceE-----------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW---QKRSISLMKYNGNRN-QHALEWCINHIVYASRM---SHKHIIKL-----------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~H~nIv~~-----------  115 (332)
                      ++|++.+.||+|+||.||+|.+   .+..||+|.+..... ......+.+|+.+++.+   +||||+++           
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            3689999999999999999987   467899998875432 22234566788877766   69999986           


Q ss_pred             -----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEee
Q 038681          116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFD  190 (332)
Q Consensus       116 -----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  190 (332)
                           +||||++ ++|.+++.....   ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~D  153 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLAD  153 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEcc
Confidence                 7999997 599999875421   35899999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-  268 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-  268 (332)
                      ||+++.......   .....||+.|+|||++.+ .++.++|||||||++|||++|..||......+...  ........ 
T Consensus       154 fg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~--~i~~~~~~~  228 (290)
T cd07862         154 FGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG--KILDVIGLP  228 (290)
T ss_pred             ccceEeccCCcc---cccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHH--HHHHHhCCC
Confidence            999976654321   135578999999999877 88999999999999999999999998765433221  11111100 


Q ss_pred             cccchhhhh---hhhhhcccC-CCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          269 QNCRFKEMV---DSIIIEDKS-CTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       269 ~~~~~~~~~---~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ....+....   ......... ......+..+..+.+|+.+||+.||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            011111000   000000000 000000134467889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.3e-43  Score=308.65  Aligned_cols=236  Identities=20%  Similarity=0.305  Sum_probs=188.0

Q ss_pred             CccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCCCh
Q 038681           60 NIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTL  126 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g~L  126 (332)
                      +.||+|+||.||+|.+  +++.+|+|.+...........+.+|+.++++++||||+++           +||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            4699999999999998  7889999998766555556789999999999999999997           89999999999


Q ss_pred             HHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceeec
Q 038681          127 ADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL  206 (332)
Q Consensus       127 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  206 (332)
                      .+++....    ..+++..++.++.|++.||.|||   +++|+|+||||+||+++.++.+||+|||++............
T Consensus        81 ~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          81 LTFLRTEG----PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence            99997541    35899999999999999999999   999999999999999999999999999998765432211111


Q ss_pred             cccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcc
Q 038681          207 DSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIED  284 (332)
Q Consensus       207 ~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      .....+..|+|||.+.+ .++.++|||||||++|||++ |..||.........      ...           ....   
T Consensus       154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~------~~~-----------~~~~---  213 (252)
T cd05084         154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR------EAI-----------EQGV---  213 (252)
T ss_pred             CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH------HHH-----------HcCC---
Confidence            11123457999999877 88999999999999999998 88888654322110      000           0000   


Q ss_pred             cCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          285 KSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       285 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                         ....+...+..+.+|+.+||+.||++|||+.++++.|+
T Consensus       214 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         214 ---RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ---CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence               00111233478999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.2e-44  Score=330.20  Aligned_cols=241  Identities=16%  Similarity=0.244  Sum_probs=187.1

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|++.+.||+|+||+||+|.+  +++.||+|++....  .......+.+|+.++.+++||||+++           |||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4689999999999999999998  78899999997542  22335678899999999999999987           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++|+|.+++...     ..+++..+..++.|++.||+|||   ++||+||||||+|||++.++.+||+|||+++...
T Consensus        81 E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~  152 (363)
T cd05628          81 EFLPGGDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK  152 (363)
T ss_pred             cCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence            999999999999865     57999999999999999999999   9999999999999999999999999999987543


Q ss_pred             CCCce---------------------------------eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhC
Q 038681          199 DGETH---------------------------------IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTA  244 (332)
Q Consensus       199 ~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg  244 (332)
                      .....                                 .......||+.|+|||++.+ .++.++|||||||++|||++|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G  232 (363)
T cd05628         153 KAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG  232 (363)
T ss_pred             ccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhC
Confidence            21100                                 00123579999999999987 899999999999999999999


Q ss_pred             CccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCC---CCCCHHHHH
Q 038681          245 QEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPE---DRPTMVDVA  321 (332)
Q Consensus       245 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~---~RPs~~evl  321 (332)
                      ..||.........      ..+.....              ....+.....+.++.+++.+|+. +|.   .||+++||+
T Consensus       233 ~~Pf~~~~~~~~~------~~i~~~~~--------------~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~  291 (363)
T cd05628         233 YPPFCSETPQETY------KKVMNWKE--------------TLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIK  291 (363)
T ss_pred             CCCCCCCCHHHHH------HHHHcCcC--------------cccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence            9999765433221      11100000              00000001233677888888654 444   468999998


Q ss_pred             HH
Q 038681          322 KQ  323 (332)
Q Consensus       322 ~~  323 (332)
                      +.
T Consensus       292 ~h  293 (363)
T cd05628         292 TN  293 (363)
T ss_pred             CC
Confidence            63

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-45  Score=333.61  Aligned_cols=240  Identities=16%  Similarity=0.255  Sum_probs=190.3

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|++.+.||+|+||.||+|.+  +++.||||++....  .......+.+|+.++..++||||+++           |||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4789999999999999999999  78899999997542  22335668899999999999999997           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++|+|.+++...     ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.++|+|||+++...
T Consensus        81 E~~~~g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  152 (364)
T cd05599          81 EYLPGGDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK  152 (364)
T ss_pred             CCCCCcHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceecc
Confidence            999999999999765     56999999999999999999999   9999999999999999999999999999987543


Q ss_pred             CCCcee------------------------------------eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHH
Q 038681          199 DGETHI------------------------------------ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFEL  241 (332)
Q Consensus       199 ~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~el  241 (332)
                      ......                                    ......||+.|+|||++.+ .++.++|||||||++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el  232 (364)
T cd05599         153 KSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM  232 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHh
Confidence            221000                                    0012469999999999887 889999999999999999


Q ss_pred             HhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC---HH
Q 038681          242 LTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT---MV  318 (332)
Q Consensus       242 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~  318 (332)
                      ++|..||..........     ..... .              .....+.....++.+.+|+.+|+. +|.+|++   +.
T Consensus       233 ~~G~~Pf~~~~~~~~~~-----~i~~~-~--------------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~  291 (364)
T cd05599         233 LVGYPPFCSDNPQETYR-----KIINW-K--------------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVN  291 (364)
T ss_pred             hcCCCCCCCCCHHHHHH-----HHHcC-C--------------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHH
Confidence            99999997654322110     00000 0              000001111234678899999997 9999998   88


Q ss_pred             HHHH
Q 038681          319 DVAK  322 (332)
Q Consensus       319 evl~  322 (332)
                      ++++
T Consensus       292 ~ll~  295 (364)
T cd05599         292 EIKS  295 (364)
T ss_pred             HHhc
Confidence            8875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=6.1e-45  Score=334.44  Aligned_cols=243  Identities=18%  Similarity=0.275  Sum_probs=193.7

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE----------
Q 038681           50 RIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        50 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~----------  115 (332)
                      ....++|++.+.||+|+||.||+|.+  ++..||+|.+....  .....+.+.+|+.+++.++||||+++          
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~  118 (370)
T cd05596          39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYL  118 (370)
T ss_pred             CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            34567899999999999999999998  78899999986532  12224567899999999999999997          


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       +||||+++|+|.+++...      .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       119 ~lv~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~  189 (370)
T cd05596         119 YMVMEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (370)
T ss_pred             EEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccce
Confidence             899999999999998653      5889999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCceeeccccccCCCcccccccCC-----CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFTT-----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ  269 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  269 (332)
                      .......... .....||+.|+|||++.+     .++.++|||||||++|||++|..||.........      ..+.  
T Consensus       190 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~i~--  260 (370)
T cd05596         190 MKMDANGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIM--  260 (370)
T ss_pred             eeccCCCccc-CCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH------HHHH--
Confidence            7664432211 134579999999999864     3788999999999999999999999865432211      1110  


Q ss_pred             ccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 038681          270 NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPED--RPTMVDVAK  322 (332)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~evl~  322 (332)
                                  ........+.....+.++.+|+.+||+.+|.+  |||++++++
T Consensus       261 ------------~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~  303 (370)
T cd05596         261 ------------DHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKS  303 (370)
T ss_pred             ------------cCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence                        00000111111234578999999999999988  999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.1e-44  Score=312.83  Aligned_cols=244  Identities=18%  Similarity=0.306  Sum_probs=196.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      ..++|++.++||+|+||.||+|.+ .+..||+|.+.....  ..+.+.+|+.+++.++||||+++           ++||
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM--SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE   81 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch--hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence            456799999999999999999998 677899998765432  25778999999999999999997           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++|+|.+++....   ...+++..+..++.|++.||+|||   ..+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          82 YMAKGSLLDFLKSDE---GGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             cCCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCC
Confidence            999999999997642   145889999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ...... ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||.........      ..+...        
T Consensus       156 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~------~~~~~~--------  220 (261)
T cd05072         156 NEYTAR-EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM------SALQRG--------  220 (261)
T ss_pred             Cceecc-CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH------HHHHcC--------
Confidence            432211 23346778999999876 78999999999999999998 99999764432211      111000        


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                             .  ..+.....+.++.+++.+||+.+|++|||++++.+.|+++
T Consensus       221 -------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         221 -------Y--RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -------C--CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                   0  0011113346789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.1e-44  Score=332.42  Aligned_cols=240  Identities=18%  Similarity=0.207  Sum_probs=188.0

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .|+..+.||+|+||+||+|.+  ++..||+|++....  .....+.+.+|+.++.+++||||+++           +|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            588899999999999999998  78899999997542  23346678999999999999999997           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++|+|.+++...     ..+++..+..++.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~  153 (381)
T cd05626          82 YIPGGDMMSLLIRM-----EVFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRW  153 (381)
T ss_pred             cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCccccc
Confidence            99999999999765     56899999999999999999999   99999999999999999999999999999754311


Q ss_pred             CCc---------------------------------------------eeeccccccCCCcccccccCC-CCChhhhHHH
Q 038681          200 GET---------------------------------------------HIELDSVVGTTGFIAPENFTT-LINEQCDVYG  233 (332)
Q Consensus       200 ~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwS  233 (332)
                      ...                                             ........||+.|+|||++.+ .++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  233 (381)
T cd05626         154 THNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWS  233 (381)
T ss_pred             ccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceee
Confidence            000                                             000123579999999999987 7899999999


Q ss_pred             HHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHH--cccCCC
Q 038681          234 FGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQ--CMDFSP  311 (332)
Q Consensus       234 lG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~--cl~~dP  311 (332)
                      |||++|||++|..||..........     .....               ......+.....+.++.+|+.+  |+..+|
T Consensus       234 lG~il~elltG~~Pf~~~~~~~~~~-----~i~~~---------------~~~~~~~~~~~~s~~~~dli~~ll~~~~~~  293 (381)
T cd05626         234 VGVILFEMLVGQPPFLAPTPTETQL-----KVINW---------------ENTLHIPPQVKLSPEAVDLITKLCCSAEER  293 (381)
T ss_pred             hhhHHHHHHhCCCCCcCCCHHHHHH-----HHHcc---------------ccccCCCCCCCCCHHHHHHHHHHccCcccc
Confidence            9999999999999997654322110     00000               0000011111234778899988  455666


Q ss_pred             CCCCCHHHHHH
Q 038681          312 EDRPTMVDVAK  322 (332)
Q Consensus       312 ~~RPs~~evl~  322 (332)
                      ..||++.++++
T Consensus       294 ~~R~~~~~~l~  304 (381)
T cd05626         294 LGRNGADDIKA  304 (381)
T ss_pred             cCCCCHHHHhc
Confidence            67999999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=9.1e-44  Score=328.65  Aligned_cols=256  Identities=18%  Similarity=0.288  Sum_probs=201.4

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEeC-------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-CCCcceE----
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGFWQ-------KRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKL----  115 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~~----  115 (332)
                      ++....++|.+.+.||+|+||.||+|.+.       +..||+|++.........+.+.+|+.++.++. |||||++    
T Consensus        31 ~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          31 AWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             cceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            35566677889999999999999999862       35799999987655554567899999999997 9999998    


Q ss_pred             -------EEEEeccCCChHHHHhhhhc-----------------------------------------------------
Q 038681          116 -------IVFESVQIGTLADRIHHHCE-----------------------------------------------------  135 (332)
Q Consensus       116 -------lv~e~~~~g~L~~~l~~~~~-----------------------------------------------------  135 (332)
                             +||||+++|+|.+++.....                                                     
T Consensus       111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (401)
T cd05107         111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV  190 (401)
T ss_pred             ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence                   89999999999999975421                                                     


Q ss_pred             ----------------------------------------ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 038681          136 ----------------------------------------QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP  175 (332)
Q Consensus       136 ----------------------------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  175 (332)
                                                              .....+++..++.++.||+.||.|||   +.+|+||||||
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp  267 (401)
T cd05107         191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAA  267 (401)
T ss_pred             chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCc
Confidence                                                    01124677888999999999999999   99999999999


Q ss_pred             CCeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCc
Q 038681          176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSF  253 (332)
Q Consensus       176 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~  253 (332)
                      +|||++.++.+||+|||+++...............++..|+|||.+.+ .++.++|||||||++|||++ |..||.....
T Consensus       268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~  347 (401)
T cd05107         268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM  347 (401)
T ss_pred             ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence            999999999999999999986543322111133457889999999887 78999999999999999998 8889875443


Q ss_pred             cchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 038681          254 ESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY  328 (332)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~  328 (332)
                      .+.     ....+...               .  ....+...+.++.+|+.+||..+|.+||++++|++.|+.+.
T Consensus       348 ~~~-----~~~~~~~~---------------~--~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         348 NEQ-----FYNAIKRG---------------Y--RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             hHH-----HHHHHHcC---------------C--CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            221     11111100               0  00111233478999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5e-45  Score=302.24  Aligned_cols=240  Identities=22%  Similarity=0.320  Sum_probs=203.9

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-------hhhHHHHHHHHHHHHhh-cCCCcceE------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-------QHALEWCINHIVYASRM-SHKHIIKL------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l-~H~nIv~~------  115 (332)
                      .-.+|...+.||.|..++|-++.+  ++...|+|++.....       ....+.-.+|+.+|+++ -||+|+.+      
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            345688899999999999999998  888999999875432       22355678899999999 59999998      


Q ss_pred             -----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEee
Q 038681          116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFD  190 (332)
Q Consensus       116 -----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  190 (332)
                           +|+|.|+.|.|.|++...     ..+++.+...|++|+.+|+.|||   ..+||||||||+|||++++.++||+|
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEec
Confidence                 899999999999999887     67999999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccCC-------CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHH
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-------LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENV  263 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~  263 (332)
                      ||+|..+..+...   ...+|||+|.|||.+..       .|+..+|+||+|+++|-|+.|.+||.+....         
T Consensus       167 FGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm---------  234 (411)
T KOG0599|consen  167 FGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM---------  234 (411)
T ss_pred             cceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH---------
Confidence            9999998877654   56799999999998752       5888999999999999999999999753211         


Q ss_pred             hhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          264 KRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                 -++..++...+....+.-.+.+...++||.+||+.||.+|.|++|++.
T Consensus       235 -----------lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  235 -----------LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             -----------HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence                       122223334444455555677889999999999999999999999986

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.3e-44  Score=327.80  Aligned_cols=235  Identities=20%  Similarity=0.291  Sum_probs=186.0

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ++|+..+.||+|+||.||+|.+  +++.||||.+.........+.+.+|+.+++.++|+||+++           +||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            4567788999999999999998  6899999999776555556789999999999999999997           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++|+|.+.         ...++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       154 ~~~~~L~~~---------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~  221 (353)
T PLN00034        154 MDGGSLEGT---------HIADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT  221 (353)
T ss_pred             CCCCccccc---------ccCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccc
Confidence            999998653         23567788899999999999999   999999999999999999999999999999876433


Q ss_pred             CceeeccccccCCCcccccccCC------CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT------LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~------~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ...  .....||..|+|||++..      ..+.++|||||||++|||++|+.||..........   .....        
T Consensus       222 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---~~~~~--------  288 (353)
T PLN00034        222 MDP--CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWAS---LMCAI--------  288 (353)
T ss_pred             ccc--ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHH---HHHHH--------
Confidence            211  134578999999998743      34568999999999999999999997332211100   11000        


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                            ....   ........+.++.+||.+||+.||++|||+.|+++
T Consensus       289 ------~~~~---~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        289 ------CMSQ---PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             ------hccC---CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  0000   01111234578999999999999999999999986

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.1e-43  Score=309.85  Aligned_cols=238  Identities=20%  Similarity=0.285  Sum_probs=190.5

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEec
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESV  121 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~  121 (332)
                      ++|++.+.||+|+||.||++.+ .+..+|+|.+......  .+.+.+|+.++++++||||+++           +||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS--EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc--HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            4588889999999999999999 6668999987654322  4678899999999999999997           899999


Q ss_pred             cCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCC
Q 038681          122 QIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE  201 (332)
Q Consensus       122 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  201 (332)
                      ++|+|.+++....    ..+++..+..++.|++.||.|||   +++|+|+||||+||+++.++.+||+|||.++......
T Consensus        82 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05114          82 ENGCLLNYLRQRQ----GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE  154 (256)
T ss_pred             CCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCc
Confidence            9999999987541    35899999999999999999999   9999999999999999999999999999997664433


Q ss_pred             ceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          202 THIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       202 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      .... ....++..|+|||.+.+ .++.++||||||+++|||++ |+.||........      .........        
T Consensus       155 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~------~~~i~~~~~--------  219 (256)
T cd05114         155 YTSS-SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEV------VEMISRGFR--------  219 (256)
T ss_pred             eecc-CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHHHCCCC--------
Confidence            2211 23345678999999886 88999999999999999999 8999876543221      111111000        


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL  324 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L  324 (332)
                               ...+...+..+.+++.+||+.||.+|||+.++++.|
T Consensus       220 ---------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         220 ---------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                     000112236789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.5e-44  Score=325.95  Aligned_cols=239  Identities=19%  Similarity=0.230  Sum_probs=188.7

Q ss_pred             CCCCCCccccCCCceEEEEEe-----CCeeEEEEEEcCCC---ChhhHHHHHHHHHHHHhh-cCCCcceE----------
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW-----QKRSISLMKYNGNR---NQHALEWCINHIVYASRM-SHKHIIKL----------  115 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~~----------  115 (332)
                      +|++.+.||+|+||.||++..     ++..||+|.+....   .....+.+.+|+.++..+ .||||+++          
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            488899999999999999886     57889999987532   223356688999999999 59999987          


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       +||||+++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus        81 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~  152 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLS  152 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCC
Confidence             899999999999999765     56899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      +.......... ....||+.|+|||++.+  .++.++|||||||++|||++|..||..........  .......     
T Consensus       153 ~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~--~~~~~~~-----  224 (332)
T cd05614         153 KEFLSEEKERT-YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS--EVSRRIL-----  224 (332)
T ss_pred             ccccccCCCcc-ccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH--HHHHHHh-----
Confidence            76543322111 34579999999999876  47889999999999999999999997543221110  0111110     


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAK  322 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~  322 (332)
                               ....    ..+...+..+.+++.+||+.||++||     +++++++
T Consensus       225 ---------~~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         225 ---------KCDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             ---------cCCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence                     0010    11123347789999999999999999     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.7e-43  Score=310.38  Aligned_cols=249  Identities=22%  Similarity=0.344  Sum_probs=198.8

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|++.+.||+|+||.||+|.+  ++..||+|.+....  .......+.+|+.+++.++||||+++           +|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5799999999999999999998  78999999876532  33445678999999999999999987           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++|+|.+++...... ...+++..+..++.||+.||.|||   +++++|+||||+||+++.++.++|+|||++....
T Consensus        82 e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~  157 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQ-KRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCcHHHHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceecc
Confidence            999999999998653221 145889999999999999999999   9999999999999999999999999999987765


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      .....  .....+++.|+|||.+.+ .++.++||||||+++|||++|..||........ .   ....+..         
T Consensus       158 ~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~---~~~~~~~---------  222 (267)
T cd08228         158 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-S---LCQKIEQ---------  222 (267)
T ss_pred             chhHH--HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-H---HHHHHhc---------
Confidence            43321  124568899999999877 788999999999999999999999865332111 0   1111100         


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY  328 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~  328 (332)
                           ..  .+.......+..+.+++.+||..+|++|||+.+|++.|+++.
T Consensus       223 -----~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         223 -----CD--YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -----CC--CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                 00  011111244577999999999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.5e-44  Score=326.47  Aligned_cols=229  Identities=18%  Similarity=0.262  Sum_probs=185.5

Q ss_pred             CccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCC
Q 038681           60 NIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIG  124 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g  124 (332)
                      +.||+|+||.||++.+  ++..||+|.+....  .......+.+|+.++..++||||+++           +||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999998  78999999997642  22335677899999999999999987           899999999


Q ss_pred             ChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCce
Q 038681          125 TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFS-RPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH  203 (332)
Q Consensus       125 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  203 (332)
                      +|.+++...     ..+++..+..++.||+.||.|||   + .+|+||||||+|||++.++.+||+|||+++........
T Consensus        81 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH---~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  152 (325)
T cd05594          81 ELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT  152 (325)
T ss_pred             cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcc
Confidence            999988765     56899999999999999999999   7 79999999999999999999999999998754322211


Q ss_pred             eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhh
Q 038681          204 IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIII  282 (332)
Q Consensus       204 ~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (332)
                        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.........      .........          
T Consensus       153 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~------~~i~~~~~~----------  214 (325)
T cd05594         153 --MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF------ELILMEEIR----------  214 (325)
T ss_pred             --cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH------HHHhcCCCC----------
Confidence              134579999999999987 8899999999999999999999999765432211      111110000          


Q ss_pred             cccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038681          283 EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAK  322 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~  322 (332)
                              .+...++++.+|+.+||+.||++|+     ++.++++
T Consensus       215 --------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         215 --------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             --------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence                    0112346789999999999999996     8988875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.9e-43  Score=310.79  Aligned_cols=244  Identities=17%  Similarity=0.217  Sum_probs=185.1

Q ss_pred             CccccCCCceEEEEEe----CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCC
Q 038681           60 NIVLEDPFRKLYKGFW----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIG  124 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g  124 (332)
                      +.||+|+||.||+|.+    .+..+++|.+...........+.+|+.++++++||||+++           +||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            4699999999999986    3457899998776554445678999999999999999997           899999999


Q ss_pred             ChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCcee
Q 038681          125 TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHI  204 (332)
Q Consensus       125 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  204 (332)
                      +|.+++...........++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||+++.........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999997653222235677888899999999999999   9999999999999999999999999999997654433222


Q ss_pred             eccccccCCCcccccccCC--------CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          205 ELDSVVGTTGFIAPENFTT--------LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       205 ~~~~~~gt~~y~aPE~~~~--------~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      ......++..|+|||++.+        .++.++|||||||++|||++ |..||..........     .........+. 
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~-----~~~~~~~~~~~-  231 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT-----YTVREQQLKLP-  231 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH-----HHhhcccCCCC-
Confidence            2234467888999998853        25789999999999999996 999997554322111     00000000000 


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                        +          .......+..+.+++.+|| .+|++|||+++|+..|+
T Consensus       232 --~----------~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 --K----------PRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             --C----------CccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence              0          0000122356889999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.5e-43  Score=322.28  Aligned_cols=253  Identities=18%  Similarity=0.322  Sum_probs=197.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE---------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL---------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~---------  115 (332)
                      .++|++.+.||+|+||.||+|.+       .++.||||.+...........+.+|+.++.++ +||||+++         
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            45799999999999999999974       46789999998765444467789999999999 68999976         


Q ss_pred             ---EEEEeccCCChHHHHhhhhcc--------------------------------------------------------
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQ--------------------------------------------------------  136 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~--------------------------------------------------------  136 (332)
                         +||||+++|+|.+++......                                                        
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence               799999999999998753210                                                        


Q ss_pred             ------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceeeccccc
Q 038681          137 ------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV  210 (332)
Q Consensus       137 ------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~  210 (332)
                            ....+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||++................
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                  0124678889999999999999999   9999999999999999999999999999997654433222212344


Q ss_pred             cCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCC
Q 038681          211 GTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCT  288 (332)
Q Consensus       211 gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (332)
                      ++..|+|||.+.+ .++.++||||||+++|+|++ |..||........     ........               .  .
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~-----~~~~~~~~---------------~--~  300 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE-----FCRRLKEG---------------T--R  300 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH-----HHHHHhcc---------------C--C
Confidence            5678999999877 88999999999999999997 8999875432211     11111000               0  0


Q ss_pred             CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          289 CTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       289 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      ...+...++.+.+++.+||+.||++|||+.+|++.|+.+.++
T Consensus       301 ~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         301 MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            000111235789999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.8e-43  Score=314.49  Aligned_cols=250  Identities=20%  Similarity=0.280  Sum_probs=197.5

Q ss_pred             cCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      .+|.+.+.||+|+||.||+|.+       .+..+++|.+...... ..+.+.+|+.++++++||||+++           
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA-ARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHH-HHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            4588889999999999999985       2345888887654432 25678999999999999999997           


Q ss_pred             EEEEeccCCChHHHHhhhhc-----------ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC
Q 038681          116 IVFESVQIGTLADRIHHHCE-----------QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS  184 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  184 (332)
                      +||||+++++|.+++.....           .....+++..++.++.||+.||+|||   +++|+||||||+||+++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCC
Confidence            89999999999999976421           11134899999999999999999999   99999999999999999999


Q ss_pred             CeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHH
Q 038681          185 DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEEN  262 (332)
Q Consensus       185 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~  262 (332)
                      .++|+|||++................++..|+|||.+.+ .++.++|||||||++|||++ |..||.........     
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-----  235 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI-----  235 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----
Confidence            999999999976654332222234557889999999887 88999999999999999999 99998765432211     


Q ss_pred             HhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          263 VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                       ......  .               ........+..+.+++.+||+.||++|||+.+|++.|.++.+.
T Consensus       236 -~~~~~~--~---------------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         236 -ECITQG--R---------------VLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             -HHHhCC--C---------------CCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence             111000  0               0000112346799999999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.7e-43  Score=313.26  Aligned_cols=247  Identities=21%  Similarity=0.305  Sum_probs=195.8

Q ss_pred             cCCCCCCccccCCCceEEEEEe------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------E
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------I  116 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------l  116 (332)
                      ++|++.+.||+|+||.||+|.+      .+..|++|.+...........+.+|+.+++.++||||+++           +
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4688889999999999999985      4578999999876555556788999999999999999987           8


Q ss_pred             EEEeccCCChHHHHhhhhc------------ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC
Q 038681          117 VFESVQIGTLADRIHHHCE------------QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS  184 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  184 (332)
                      ||||+++|+|.+++.....            .....+++..++.++.|++.||.|||   +++|+|+||||+|||++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCC
Confidence            9999999999999864311            00134788999999999999999999   99999999999999999999


Q ss_pred             CeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHH
Q 038681          185 DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEEN  262 (332)
Q Consensus       185 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~  262 (332)
                      .+||+|||+++...............++..|+|||.+.+ .++.++|||||||++|||++ |..||........      
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~------  235 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEV------  235 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH------
Confidence            999999999987644332222234456778999999876 88999999999999999998 8889875432211      


Q ss_pred             HhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 038681          263 VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQ  326 (332)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~  326 (332)
                      .......               .  ..+.+..++..+.+++.+||+.||.+||++.+|++.|.+
T Consensus       236 ~~~~~~~---------------~--~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         236 IEMVRKR---------------Q--LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHHcC---------------C--cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1111000               0  001112334778999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-44  Score=330.74  Aligned_cols=240  Identities=17%  Similarity=0.279  Sum_probs=193.8

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|.+.+.||+|+||.||+|.+  +++.||+|++....  .......+.+|+.++..++||||+++           +||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            4689999999999999999999  68999999987542  12335678899999999999999987           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++|+|.+++...     ..+++..+..++.||+.||+|||   .+||+||||||+|||++.++.+||+|||++....
T Consensus        81 e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~  152 (350)
T cd05573          81 EYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMN  152 (350)
T ss_pred             cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCc
Confidence            999999999999875     56999999999999999999999   9999999999999999999999999999997665


Q ss_pred             CCC---------------------------ceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCC
Q 038681          199 DGE---------------------------THIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDH  250 (332)
Q Consensus       199 ~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~  250 (332)
                      ...                           .........||+.|+|||++.+ .++.++|||||||++|||++|..||..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~  232 (350)
T cd05573         153 KAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYS  232 (350)
T ss_pred             ccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCC
Confidence            433                           0011134579999999999987 899999999999999999999999986


Q ss_pred             CCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 038681          251 VSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT-MVDVAK  322 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-~~evl~  322 (332)
                      ........  ....+.  ..                ...+.....++.+.+|+.+||. ||.+||+ ++++++
T Consensus       233 ~~~~~~~~--~i~~~~--~~----------------~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         233 DTLQETYN--KIINWK--ES----------------LRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             CCHHHHHH--HHhccC--Cc----------------ccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            55322110  000000  00                0000011135789999999998 9999999 999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4e-44  Score=322.95  Aligned_cols=224  Identities=20%  Similarity=0.266  Sum_probs=181.8

Q ss_pred             CccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhh-cCCCcceE-----------EEEEeccC
Q 038681           60 NIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRM-SHKHIIKL-----------IVFESVQI  123 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv~e~~~~  123 (332)
                      +.||+|+||.||+|.+  +++.||+|.+....  .....+.+..|..++..+ +||||+++           +||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999998  68899999987542  223356778899998877 69999987           89999999


Q ss_pred             CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCce
Q 038681          124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH  203 (332)
Q Consensus       124 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  203 (332)
                      |+|.+++...     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++........
T Consensus        81 g~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~  152 (320)
T cd05590          81 GDLMFHIQKS-----RRFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT  152 (320)
T ss_pred             chHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCc
Confidence            9999998765     56999999999999999999999   999999999999999999999999999998754322211


Q ss_pred             eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhh
Q 038681          204 IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIII  282 (332)
Q Consensus       204 ~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (332)
                        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||........      ...+......          
T Consensus       153 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~~~----------  214 (320)
T cd05590         153 --TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL------FEAILNDEVV----------  214 (320)
T ss_pred             --ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHH------HHHHhcCCCC----------
Confidence              134579999999999987 889999999999999999999999976543221      1111110000          


Q ss_pred             cccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCH
Q 038681          283 EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTM  317 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~  317 (332)
                              .+...+.++.+|+.+||+.||.+||++
T Consensus       215 --------~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         215 --------YPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             --------CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence                    111234678999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3e-43  Score=313.99  Aligned_cols=248  Identities=19%  Similarity=0.279  Sum_probs=194.2

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CC--eeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----------EE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QK--RSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----------IV  117 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv  117 (332)
                      ++|++.+.||+|+||.||+|..  ++  ..+++|.++........+.+.+|+.++.++ +||||+++           +|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            5789999999999999999988  33  347888887554444467789999999999 79999987           89


Q ss_pred             EEeccCCChHHHHhhhhcc-----------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCe
Q 038681          118 FESVQIGTLADRIHHHCEQ-----------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA  186 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  186 (332)
                      +||+++|+|.+++......           ....+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeE
Confidence            9999999999999754210           1135889999999999999999999   9999999999999999999999


Q ss_pred             EEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHh
Q 038681          187 KLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVK  264 (332)
Q Consensus       187 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~  264 (332)
                      ||+|||++.........   .....+..|+|||.+.+ .++.++|||||||++|||++ |..||.........      .
T Consensus       159 kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~------~  229 (297)
T cd05089         159 KIADFGLSRGEEVYVKK---TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY------E  229 (297)
T ss_pred             EECCcCCCccccceecc---CCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH------H
Confidence            99999998643221110   12233567999999877 78999999999999999997 99999765432211      1


Q ss_pred             hhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          265 RLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      ....           ..      ....+..++..+.+|+.+||+.||.+|||++++++.|..+.+.
T Consensus       230 ~~~~-----------~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~  278 (297)
T cd05089         230 KLPQ-----------GY------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA  278 (297)
T ss_pred             HHhc-----------CC------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            0000           00      0001113446789999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.4e-43  Score=307.17  Aligned_cols=238  Identities=16%  Similarity=0.292  Sum_probs=189.8

Q ss_pred             ccccCCCceEEEEEe----CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------EEEEeccCCCh
Q 038681           61 IVLEDPFRKLYKGFW----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IVFESVQIGTL  126 (332)
Q Consensus        61 ~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv~e~~~~g~L  126 (332)
                      .||+|+||.||+|.+    .+..||+|.+.........+.+.+|+.++++++||||+++          +||||+++|+|
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L   81 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPL   81 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCH
Confidence            489999999999987    3456999998876555556779999999999999999987          89999999999


Q ss_pred             HHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceee-
Q 038681          127 ADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIE-  205 (332)
Q Consensus       127 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-  205 (332)
                      .+++....    ..+++..++.++.|++.||.|||   .++++|+||||+||+++.++.+||+|||++........... 
T Consensus        82 ~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          82 NKFLSGKK----DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            99987531    46899999999999999999999   99999999999999999999999999999976544332211 


Q ss_pred             ccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhc
Q 038681          206 LDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIE  283 (332)
Q Consensus       206 ~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (332)
                      .....++..|+|||.+.+ .++.++|||||||++||+++ |..||........      ...+....             
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~-------------  215 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEV------MSFIEQGK-------------  215 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHH------HHHHHCCC-------------
Confidence            112233578999999876 88999999999999999996 9999976543221      11111000             


Q ss_pred             ccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 038681          284 DKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY  328 (332)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~  328 (332)
                          ....+..++.++.+++.+||..||++||++.+|.+.|+.++
T Consensus       216 ----~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~~  256 (257)
T cd05115         216 ----RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTYY  256 (257)
T ss_pred             ----CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhhc
Confidence                00111233478999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-44  Score=332.46  Aligned_cols=240  Identities=17%  Similarity=0.222  Sum_probs=188.1

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|.+.+.||+|+||.||++..  +++.||+|++....  .....+.+.+|+.++.+++||||+++           +||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            3688999999999999999998  88999999986542  23345678899999999999999987           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++|+|.+++...     ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~  152 (377)
T cd05629          81 EFLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFH  152 (377)
T ss_pred             eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeecccccccc
Confidence            999999999999765     56899999999999999999999   9999999999999999999999999999986432


Q ss_pred             CCCce------------e---------------------------------eccccccCCCcccccccCC-CCChhhhHH
Q 038681          199 DGETH------------I---------------------------------ELDSVVGTTGFIAPENFTT-LINEQCDVY  232 (332)
Q Consensus       199 ~~~~~------------~---------------------------------~~~~~~gt~~y~aPE~~~~-~~~~~sDiw  232 (332)
                      .....            .                                 ......||+.|+|||++.+ .++.++|||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw  232 (377)
T cd05629         153 KQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW  232 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeE
Confidence            11000            0                                 0012469999999999987 899999999


Q ss_pred             HHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCC
Q 038681          233 GFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPE  312 (332)
Q Consensus       233 SlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~  312 (332)
                      ||||++|||++|..||..........  ....+.  ..                ...+.....+.++.+|+.+||. +|.
T Consensus       233 SlGvil~elltG~~Pf~~~~~~~~~~--~i~~~~--~~----------------~~~p~~~~~s~~~~dli~~lL~-~~~  291 (377)
T cd05629         233 SLGAIMFECLIGWPPFCSENSHETYR--KIINWR--ET----------------LYFPDDIHLSVEAEDLIRRLIT-NAE  291 (377)
T ss_pred             ecchhhhhhhcCCCCCCCCCHHHHHH--HHHccC--Cc----------------cCCCCCCCCCHHHHHHHHHHhc-CHh
Confidence            99999999999999997654322111  000000  00                0001111234678999999998 777


Q ss_pred             CC---CCHHHHHH
Q 038681          313 DR---PTMVDVAK  322 (332)
Q Consensus       313 ~R---Ps~~evl~  322 (332)
                      +|   +|+.+++.
T Consensus       292 ~r~~r~~~~~~l~  304 (377)
T cd05629         292 NRLGRGGAHEIKS  304 (377)
T ss_pred             hcCCCCCHHHHhc
Confidence            75   59998876

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=6.3e-44  Score=321.12  Aligned_cols=228  Identities=20%  Similarity=0.285  Sum_probs=182.0

Q ss_pred             CccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhh-cCCCcceE-----------EEEEeccC
Q 038681           60 NIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRM-SHKHIIKL-----------IVFESVQI  123 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv~e~~~~  123 (332)
                      +.||+|+||.||+|.+  +++.||+|.+....  .....+.+..|..++..+ +||||+++           +||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999998  67889999987542  222345567777777755 89999987           89999999


Q ss_pred             CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCce
Q 038681          124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH  203 (332)
Q Consensus       124 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  203 (332)
                      |+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++........
T Consensus        81 g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~  152 (316)
T cd05592          81 GDLMFHIQSS-----GRFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK  152 (316)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCc
Confidence            9999998765     56999999999999999999999   999999999999999999999999999999765433221


Q ss_pred             eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhh
Q 038681          204 IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIII  282 (332)
Q Consensus       204 ~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (332)
                        .....||+.|+|||++.+ .++.++|||||||++|||++|..||........      ...+......          
T Consensus       153 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~------~~~i~~~~~~----------  214 (316)
T cd05592         153 --ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDEL------FDSILNDRPH----------  214 (316)
T ss_pred             --cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHH------HHHHHcCCCC----------
Confidence              135579999999999987 889999999999999999999999986543221      1111111000          


Q ss_pred             cccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 038681          283 EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMV-DVA  321 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~-evl  321 (332)
                              .+...+.++.+|+.+||+.||.+||++. +++
T Consensus       215 --------~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         215 --------FPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             --------CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                    1112346788999999999999999875 454

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.7e-43  Score=315.10  Aligned_cols=254  Identities=20%  Similarity=0.264  Sum_probs=197.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC------------------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcce
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFWQ------------------KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIK  114 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~  114 (332)
                      .++|++.+.||+|+||.||+|.+.                  +..||+|.+.........+.+.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            457999999999999999999872                  14589999887766666788999999999999999998


Q ss_pred             E-----------EEEEeccCCChHHHHhhhhccc------ccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 038681          115 L-----------IVFESVQIGTLADRIHHHCEQH------FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTN  177 (332)
Q Consensus       115 ~-----------lv~e~~~~g~L~~~l~~~~~~~------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  177 (332)
                      +           +|+||+++++|.+++.......      ...+++..++.++.|++.||.|||   +.+|+|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhc
Confidence            7           8999999999999997753111      126899999999999999999999   9999999999999


Q ss_pred             eeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh--CCccCCCCCcc
Q 038681          178 ILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT--AQEVSDHVSFE  254 (332)
Q Consensus       178 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt--g~~p~~~~~~~  254 (332)
                      |+++.++.++|+|||+++...............+++.|+|||.+.+ .++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999976544432222234456789999999877 89999999999999999998  67777654432


Q ss_pred             chhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          255 SRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                      ....  .........              ......+.+...+.++.+++.+||+.||.+|||+.+|++.|+
T Consensus       241 ~~~~--~~~~~~~~~--------------~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 QVIE--NAGHFFRDD--------------GRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHH--HHHhccccc--------------cccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            2111  000000000              000000111233468999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.1e-44  Score=321.76  Aligned_cols=229  Identities=19%  Similarity=0.266  Sum_probs=184.5

Q ss_pred             CccccCCCceEEEEEe-----CCeeEEEEEEcCCC---ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           60 NIVLEDPFRKLYKGFW-----QKRSISLMKYNGNR---NQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      +.||+|+||.||++..     .++.||+|.+....   .......+.+|+.+++.++||||+++           +||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            6799999999999986     57789999987542   22234567899999999999999987           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (323)
T cd05584          82 LSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE  153 (323)
T ss_pred             CCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence            9999999999765     56889999999999999999999   999999999999999999999999999998754332


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      ...  .....||+.|+|||++.+ .++.++|||||||++|||++|..||........      ...+..           
T Consensus       154 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~------~~~~~~-----------  214 (323)
T cd05584         154 GTV--THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT------IDKILK-----------  214 (323)
T ss_pred             CCc--ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH------HHHHHc-----------
Confidence            221  134578999999999987 788999999999999999999999976543221      111100           


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAK  322 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~  322 (332)
                         ...    ..+...+..+.+|+.+||+.||++||     ++.++++
T Consensus       215 ---~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         215 ---GKL----NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ---CCC----CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence               000    01112346789999999999999999     7887765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7.2e-44  Score=319.76  Aligned_cols=257  Identities=19%  Similarity=0.278  Sum_probs=193.7

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ++|.+.+.||+|+||.||+|.+  ++..||+|.+...........+.+|+.++++++||||+++           +||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            5689999999999999999998  7888999998766544445567899999999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++ +|.+++....    ..+++..+..++.||+.||+|||   +++|+||||||+||+++.++.+||+|||++......
T Consensus        86 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  157 (309)
T cd07872          86 LDK-DLKQYMDDCG----NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVP  157 (309)
T ss_pred             CCC-CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCC
Confidence            975 8988886541    35889999999999999999999   999999999999999999999999999999765433


Q ss_pred             CceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc-ccchhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ-NCRFKEMV  277 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  277 (332)
                      ....  ....+|+.|+|||++.+  .++.++|||||||++|+|++|+.||......+....  ........ ...+....
T Consensus       158 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  233 (309)
T cd07872         158 TKTY--SNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHL--IFRLLGTPTEETWPGIS  233 (309)
T ss_pred             cccc--ccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHHHhCCCCHHHHhhhc
Confidence            2211  34467899999998865  689999999999999999999999987654332211  11111111 00111110


Q ss_pred             hhhhhc--ccCC-----CCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 DSIIIE--DKSC-----TCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~~~~~~--~~~~-----~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ......  ..+.     ........+.++.+|+.+||+.||.+|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            000000  0000     00011234567899999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.2e-44  Score=327.89  Aligned_cols=240  Identities=16%  Similarity=0.200  Sum_probs=192.4

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|.+.+.||+|+||.||+|.+  +++.||+|.+.....  ....+.+.+|+.++..++||||+++           +||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4689999999999999999998  788999999976432  3335678899999999999999987           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++|+|.+++....    ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++....
T Consensus        81 e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~  153 (330)
T cd05601          81 EYQPGGDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLT  153 (330)
T ss_pred             CCCCCCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECC
Confidence            9999999999997651    46899999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCCceeeccccccCCCcccccccC------C-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          199 DGETHIELDSVVGTTGFIAPENFT------T-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~------~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      ....... ....||+.|+|||++.      + .++.++|||||||++|||++|..||..........     .....   
T Consensus       154 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~-----~i~~~---  224 (330)
T cd05601         154 ANKMVNS-KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN-----NIMNF---  224 (330)
T ss_pred             CCCceee-ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH-----HHHcC---
Confidence            4433211 3457899999999986      2 57889999999999999999999997654322110     00000   


Q ss_pred             chhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                  ......+.....+..+.+|+..||. ||.+|||+.+++.
T Consensus       225 ------------~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         225 ------------QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             ------------CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence                        0000011111344778999999998 9999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.5e-44  Score=330.19  Aligned_cols=246  Identities=17%  Similarity=0.285  Sum_probs=193.0

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE--------
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL--------  115 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~--------  115 (332)
                      ++....++|++.+.||+|+||.||++.+  +++.+|+|.+....  .....+.+.+|+.+++.++||||+++        
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            4444567899999999999999999999  68899999986532  22234568899999999999999997        


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                         +||||+++|+|.+++...      .+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG  187 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFG  187 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecc
Confidence               899999999999999653      5899999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC-----CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhh
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT-----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS  267 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  267 (332)
                      ++......... ......||+.|+|||++.+     .++.++|||||||++|||++|..||.........      ..+ 
T Consensus       188 ~a~~~~~~~~~-~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~------~~i-  259 (370)
T cd05621         188 TCMKMDETGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY------SKI-  259 (370)
T ss_pred             cceecccCCce-ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH------HHH-
Confidence            99876443321 1135679999999999864     3788999999999999999999999765432211      000 


Q ss_pred             ccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 038681          268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPED--RPTMVDVAKQ  323 (332)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~evl~~  323 (332)
                               .    ........+.....+..+.+++.+||..+|..  |||+.++++.
T Consensus       260 ---------~----~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         260 ---------M----DHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ---------H----hCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                     0    00000111111234577899999999855543  8899998763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9e-45  Score=332.95  Aligned_cols=231  Identities=21%  Similarity=0.311  Sum_probs=195.3

Q ss_pred             ccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCCChH
Q 038681           61 IVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLA  127 (332)
Q Consensus        61 ~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g~L~  127 (332)
                      .||+|+||+||-|++  +...+|||.+....+.. .+-+..||.+.++|+|.|||++           |.||-+|||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~-~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSRE-VQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchh-hccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            589999999999999  66778999987766544 6778899999999999999998           899999999999


Q ss_pred             HHHhhhhcccccCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeC-CCCCeEEeecCCccccCCCCcee
Q 038681          128 DRIHHHCEQHFEAL--SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN-EQSDAKLFDFSLSLSIPDGETHI  204 (332)
Q Consensus       128 ~~l~~~~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~  204 (332)
                      ++++..+    +++  .+...-.+..||++||.|||   .+.|||||||.+|+|++ ..|.+||+|||.++.+..-....
T Consensus       661 sLLrskW----GPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~T  733 (1226)
T KOG4279|consen  661 SLLRSKW----GPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCT  733 (1226)
T ss_pred             HHHHhcc----CCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhccCCccc
Confidence            9998875    455  78889999999999999999   99999999999999995 67899999999998876544332


Q ss_pred             eccccccCCCcccccccCC---CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhh
Q 038681          205 ELDSVVGTTGFIAPENFTT---LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSII  281 (332)
Q Consensus       205 ~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (332)
                        .++.||..|||||++..   .|+.++|||||||++.||.||++||-.........+                  .   
T Consensus       734 --ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF------------------k---  790 (1226)
T KOG4279|consen  734 --ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF------------------K---  790 (1226)
T ss_pred             --cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh------------------h---
Confidence              57889999999999975   799999999999999999999999976544322110                  0   


Q ss_pred             hcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          282 IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ..-+...++.+...+.+...+|.+|+.+||.+||||+++++
T Consensus       791 VGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  791 VGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             hcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            11122344556688899999999999999999999999985

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.2e-43  Score=317.50  Aligned_cols=253  Identities=18%  Similarity=0.294  Sum_probs=200.5

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe---------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW---------QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----  115 (332)
                      ....+|.+.+.||+|+||.||+|.+         .+..||+|.+.........+.+.+|+.+++.+ +||||+++     
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            4456789999999999999999975         23479999987665455567899999999999 89999997     


Q ss_pred             ------EEEEeccCCChHHHHhhhhcc-----------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCe
Q 038681          116 ------IVFESVQIGTLADRIHHHCEQ-----------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNI  178 (332)
Q Consensus       116 ------lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  178 (332)
                            +||||+++|+|.+++......           ....+++..+..++.||+.||.|||   ++||+||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceE
Confidence                  899999999999999864211           1135788999999999999999999   99999999999999


Q ss_pred             eeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccch
Q 038681          179 LFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESR  256 (332)
Q Consensus       179 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~  256 (332)
                      +++.++.+||+|||+++...............+++.|+|||++.+ .++.++||||||+++|++++ |..||...+....
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~  248 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  248 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH
Confidence            999999999999999987654332222223446778999999877 78999999999999999998 7888865443221


Q ss_pred             hhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          257 FHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                            ...+...               .  ....+..++..+.+|+.+||..+|.+|||+.++++.|+++..
T Consensus       249 ------~~~~~~~---------------~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         249 ------FKLLKEG---------------H--RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             ------HHHHHcC---------------C--cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence                  1111100               0  001112345789999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.4e-43  Score=324.47  Aligned_cols=255  Identities=18%  Similarity=0.266  Sum_probs=191.7

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-------------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-------------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-------------  115 (332)
                      ..++|.+.+.||+|+||.||+|.+  ++..||+|++.... .......+.+|+.+++.++||||+++             
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            457899999999999999999998  78999999987543 23335678899999999999999976             


Q ss_pred             ----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeec
Q 038681          116 ----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF  191 (332)
Q Consensus       116 ----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  191 (332)
                          +||||+++ +|.+.+..       .+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+||
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Df  167 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF  167 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecC
Confidence                79999975 67776643       4889999999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc
Q 038681          192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       192 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      |+++........   ....||+.|+|||++.+ .++.++|||||||++|+|++|..||........  +......+....
T Consensus       168 g~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~--~~~~~~~~~~~~  242 (359)
T cd07876         168 GLARTACTNFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ--WNKVIEQLGTPS  242 (359)
T ss_pred             CCccccccCccC---CCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCc
Confidence            999765433221   34578999999999987 899999999999999999999999986643221  111111111111


Q ss_pred             cchhhh----hhhhhhcccCC----------------CCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          271 CRFKEM----VDSIIIEDKSC----------------TCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       271 ~~~~~~----~~~~~~~~~~~----------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ..+...    ...........                ........+..+.+|+.+||..||++|||+.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence            000000    00000000000                00011123467899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7e-44  Score=321.96  Aligned_cols=229  Identities=19%  Similarity=0.260  Sum_probs=184.1

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCC-cceE-----------EEE
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKH-IIKL-----------IVF  118 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~n-Iv~~-----------lv~  118 (332)
                      +|++.+.||+|+||.||+|.+  +++.||+|++....  .....+.+..|..++..++|++ |+++           +||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            488899999999999999998  67789999987542  2233567889999999997765 6655           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++....
T Consensus        81 E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05587          81 EYVNGGDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENI  152 (324)
T ss_pred             cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecC
Confidence            999999999999765     56899999999999999999999   9999999999999999999999999999986533


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      .....  .....||+.|+|||++.+ .++.++|||||||++|||++|+.||........      ...+......     
T Consensus       153 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~------~~~i~~~~~~-----  219 (324)
T cd05587         153 FGGKT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL------FQSIMEHNVS-----  219 (324)
T ss_pred             CCCCc--eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHHcCCCC-----
Confidence            22211  134578999999999987 789999999999999999999999976543221      1111111100     


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTM  317 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~  317 (332)
                                   .+...+..+.+++.+||..||.+||+.
T Consensus       220 -------------~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         220 -------------YPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             -------------CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence                         111234678999999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-43  Score=308.19  Aligned_cols=246  Identities=22%  Similarity=0.305  Sum_probs=194.5

Q ss_pred             CCCCCccccCCCceEEEEEe--C---CeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE--------------
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--Q---KRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL--------------  115 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~---~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~--------------  115 (332)
                      |.+.+.||+|+||.||+|..  +   +..||+|.+..... ......+.+|+..++.++||||+++              
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            56788999999999999987  2   36799999876532 3346779999999999999999986              


Q ss_pred             ---EEEEeccCCChHHHHhhhhc-ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeec
Q 038681          116 ---IVFESVQIGTLADRIHHHCE-QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF  191 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  191 (332)
                         +|+||+++|+|..++..... .....+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCc
Confidence               78999999999999865421 12246899999999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhcc
Q 038681          192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQ  269 (332)
Q Consensus       192 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  269 (332)
                      |+++...............++..|+|||.+.+ .++.++|||||||++|||++ |..||........      .......
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~------~~~~~~~  231 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEI------YDYLRHG  231 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHcC
Confidence            99987654432222122345678999999876 78999999999999999999 8888865443221      1111100


Q ss_pred             ccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          270 NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                                    .   ....+...+..+.+++.+||+.||++|||+.++++.|+++
T Consensus       232 --------------~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         232 --------------N---RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             --------------C---CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                          0   0011123457899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-44  Score=329.56  Aligned_cols=233  Identities=20%  Similarity=0.303  Sum_probs=198.3

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhc-CCCcceE---------
Q 038681           50 RIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMS-HKHIIKL---------  115 (332)
Q Consensus        50 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~~---------  115 (332)
                      ....++|...++||+|+||.|+++..  +++.+|||.++++.  ..+..+..+.|.+|+...+ ||.++++         
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            44567899999999999999999999  78899999999874  2445788899999998885 9999998         


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        +||||+.||++..+.+.      ..+++..+..++..|+.||.|||   ++|||+||||.+|||+|.+|.+||+|||+
T Consensus       444 l~fvmey~~Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGl  514 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGL  514 (694)
T ss_pred             EEEEEEecCCCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEeccccc
Confidence              89999999995444432      47999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          194 SLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       194 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      ++..-....  ..++++|||.|+|||++.+ .|+.++|.|||||+||||+.|+.||.+.++++                 
T Consensus       515 cKe~m~~g~--~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-----------------  575 (694)
T KOG0694|consen  515 CKEGMGQGD--RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-----------------  575 (694)
T ss_pred             ccccCCCCC--ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-----------------
Confidence            987653332  2278999999999999998 99999999999999999999999999877644                 


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTM  317 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~  317 (332)
                         ++|.++..+...+    ...+.+..++++++|..||++|.-+
T Consensus       576 ---~FdsI~~d~~~yP----~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  576 ---VFDSIVNDEVRYP----RFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             ---HHHHHhcCCCCCC----CcccHHHHHHHHHHhccCcccccCC
Confidence               3444444444332    2455889999999999999999754

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.4e-43  Score=316.96  Aligned_cols=248  Identities=20%  Similarity=0.262  Sum_probs=194.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCe--eEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----------E
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKR--SISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----------I  116 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------l  116 (332)
                      .++|++.+.||+|+||.||+|.+  ++.  .+++|.+...........+.+|+.++.++ +||||+++           +
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            45788999999999999999997  443  46777776655455567889999999999 89999987           8


Q ss_pred             EEEeccCCChHHHHhhhhc-----------ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCC
Q 038681          117 VFESVQIGTLADRIHHHCE-----------QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD  185 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  185 (332)
                      ||||+++|+|.+++.....           .....+++..++.++.||+.||+|||   ++||+||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCc
Confidence            9999999999999976421           11135889999999999999999999   999999999999999999999


Q ss_pred             eEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHH
Q 038681          186 AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENV  263 (332)
Q Consensus       186 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~  263 (332)
                      +||+|||++.........   ....++..|+|||.+.+ .++.++|||||||++|||+| |..||......+.      .
T Consensus       163 ~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~  233 (303)
T cd05088         163 AKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------Y  233 (303)
T ss_pred             EEeCccccCcccchhhhc---ccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH------H
Confidence            999999998643221110   12234667999998876 78999999999999999998 9999975443221      1


Q ss_pred             hhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          264 KRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                      ......               .  ....+...+..+.+|+.+||+.+|++||++.+++..|..+.+
T Consensus       234 ~~~~~~---------------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~  282 (303)
T cd05088         234 EKLPQG---------------Y--RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  282 (303)
T ss_pred             HHHhcC---------------C--cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            111000               0  000111234678999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.5e-43  Score=313.14  Aligned_cols=255  Identities=18%  Similarity=0.306  Sum_probs=198.3

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-------
Q 038681           50 RIATNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-------  115 (332)
Q Consensus        50 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-------  115 (332)
                      +...++|++.+.||+|+||.||+|..       .+..||+|.+...........+.+|+.+++.++||||+++       
T Consensus         2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            34567899999999999999999975       2457999988766544445668899999999999999988       


Q ss_pred             ----EEEEeccCCChHHHHhhhhcc-----cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCe
Q 038681          116 ----IVFESVQIGTLADRIHHHCEQ-----HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA  186 (332)
Q Consensus       116 ----lv~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  186 (332)
                          +||||+++|+|.+++......     ....++...+..++.|++.||.|||   +++|+||||||+||+++.++.+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~  158 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTV  158 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcE
Confidence                899999999999999764211     1134567889999999999999999   9999999999999999999999


Q ss_pred             EEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHh
Q 038681          187 KLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVK  264 (332)
Q Consensus       187 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~  264 (332)
                      +|+|||+++...............++..|+|||.+.+ .++.++|||||||++|||++ |..||........      ..
T Consensus       159 ~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~------~~  232 (288)
T cd05061         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV------LK  232 (288)
T ss_pred             EECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHH------HH
Confidence            9999999976544332222123345678999999876 88999999999999999998 7888865433221      11


Q ss_pred             hhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          265 RLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      ....              ...   ...+...+..+.+++.+||+.||++|||+.++++.|++....
T Consensus       233 ~~~~--------------~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  281 (288)
T cd05061         233 FVMD--------------GGY---LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP  281 (288)
T ss_pred             HHHc--------------CCC---CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence            1100              000   000112346899999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6.1e-44  Score=321.94  Aligned_cols=229  Identities=17%  Similarity=0.250  Sum_probs=184.7

Q ss_pred             CccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhh-cCCCcceE-----------EEEEeccC
Q 038681           60 NIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRM-SHKHIIKL-----------IVFESVQI  123 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv~e~~~~  123 (332)
                      +.||+|+||.||+|.+  +++.||+|.+....  .....+.+..|..++..+ +||||+++           +||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999998  67899999987642  223356678899999876 79999987           89999999


Q ss_pred             CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCce
Q 038681          124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH  203 (332)
Q Consensus       124 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  203 (332)
                      |+|..++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++.........
T Consensus        81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  152 (321)
T cd05591          81 GDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT  152 (321)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccCCcc
Confidence            9999998765     56899999999999999999999   999999999999999999999999999998754332221


Q ss_pred             eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhh
Q 038681          204 IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIII  282 (332)
Q Consensus       204 ~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (332)
                        .....||+.|+|||++.+ .++.++|||||||++|||++|..||.........      ..+..              
T Consensus       153 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~------~~i~~--------------  210 (321)
T cd05591         153 --TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF------ESILH--------------  210 (321)
T ss_pred             --ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH------HHHHc--------------
Confidence              134578999999999987 8999999999999999999999999865433221      11110              


Q ss_pred             cccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHH
Q 038681          283 EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-------TMVDVAK  322 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-------s~~evl~  322 (332)
                      ....    .+...+.++.+++.+||+.||++||       ++.++++
T Consensus       211 ~~~~----~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         211 DDVL----YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCCC----CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            0000    0112346789999999999999999       7777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.4e-43  Score=315.44  Aligned_cols=250  Identities=19%  Similarity=0.320  Sum_probs=199.2

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE------
Q 038681           50 RIATNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL------  115 (332)
Q Consensus        50 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~------  115 (332)
                      ....++|.+.+.||+|+||.||+|.+       .+..||+|.+.........+.+.+|+.+++++ +||||+++      
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            34456799999999999999999975       34579999988765555567899999999999 79999987      


Q ss_pred             -----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEee
Q 038681          116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFD  190 (332)
Q Consensus       116 -----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  190 (332)
                           +||||+++|+|.+++.....   ..+++..+..++.|++.||.|||   +++|+|+||||+|||++.++.++|+|
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~~---~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~d  184 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKRE---SFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICD  184 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECC
Confidence                 89999999999999975421   23899999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhc
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSG  268 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  268 (332)
                      ||+++...............++..|+|||.+.+ .++.++|||||||++|||++ |..||.........     ......
T Consensus       185 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~-----~~~~~~  259 (302)
T cd05055         185 FGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF-----YKLIKE  259 (302)
T ss_pred             CcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH-----HHHHHc
Confidence            999986654432222233456788999999876 88999999999999999998 99998765432211     111100


Q ss_pred             cccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          269 QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                                 ..      ....+...+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       260 -----------~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         260 -----------GY------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -----------CC------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                       00      0000112346799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5.2e-43  Score=305.91  Aligned_cols=236  Identities=17%  Similarity=0.294  Sum_probs=189.8

Q ss_pred             ccccCCCceEEEEEe----CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE----------EEEEeccCCC
Q 038681           61 IVLEDPFRKLYKGFW----QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL----------IVFESVQIGT  125 (332)
Q Consensus        61 ~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~----------lv~e~~~~g~  125 (332)
                      .||+|+||.||+|.+    ++..+|+|++..... ....+.+.+|+.+++.+.||||+++          +||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~   81 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP   81 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence            699999999999976    578899999875543 3446778999999999999999987          8999999999


Q ss_pred             hHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceee
Q 038681          126 LADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIE  205 (332)
Q Consensus       126 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  205 (332)
                      |.+++...     ..+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||++...........
T Consensus        82 L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          82 LNKFLQKN-----KHVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            99999765     46899999999999999999999   99999999999999999999999999999987654432211


Q ss_pred             -ccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhh
Q 038681          206 -LDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIII  282 (332)
Q Consensus       206 -~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (332)
                       .....++..|+|||.+.. .++.++|||||||++|||++ |..||........      ...+..           .. 
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~------~~~i~~-----------~~-  215 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV------TQMIES-----------GE-  215 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHC-----------CC-
Confidence             122234678999999876 78899999999999999998 9999976543221      111110           00 


Q ss_pred             cccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          283 EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                           ..+.+...+.++.++|.+||+.||++||++++|...|+..
T Consensus       216 -----~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         216 -----RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             -----CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence                 0011123447899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.2e-43  Score=324.46  Aligned_cols=256  Identities=18%  Similarity=0.253  Sum_probs=193.1

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE------------
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL------------  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~------------  115 (332)
                      ...++|.+.+.||+|+||.||++.+  .++.||+|++.... .......+.+|+.+++.++||||+++            
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            3457899999999999999999998  78899999987643 23345678899999999999999876            


Q ss_pred             -----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEee
Q 038681          116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFD  190 (332)
Q Consensus       116 -----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  190 (332)
                           +||||+++ +|.+.+..       .+++..+..++.|++.||.|||   ++||+||||||+|||++.++.+||+|
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~D  162 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEee
Confidence                 78999975 67777653       3889999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ  269 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  269 (332)
                      ||+++........   ....||+.|+|||++.+ .++.++|||||||++|+|++|+.||..........  .....+...
T Consensus       163 fg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~  237 (355)
T cd07874         163 FGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN--KVIEQLGTP  237 (355)
T ss_pred             CcccccCCCcccc---CCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCC
Confidence            9999765443221   34578999999999987 88999999999999999999999998665332211  111111111


Q ss_pred             ccchhhh----hhhhhhcc----------------cCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          270 NCRFKEM----VDSIIIED----------------KSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       270 ~~~~~~~----~~~~~~~~----------------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ...+...    ........                .+............+.+|+.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~  310 (355)
T cd07874         238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ  310 (355)
T ss_pred             CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence            0000000    00000000                00001111223467899999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=3.3e-43  Score=309.12  Aligned_cols=244  Identities=16%  Similarity=0.230  Sum_probs=183.2

Q ss_pred             CccccCCCceEEEEEe----CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCC
Q 038681           60 NIVLEDPFRKLYKGFW----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIG  124 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g  124 (332)
                      +.||+|+||.||+|..    ....+++|.+...........+.+|+.+++.++||||+++           +||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            3699999999999976    3456888887665555546678999999999999999997           899999999


Q ss_pred             ChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCcee
Q 038681          125 TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHI  204 (332)
Q Consensus       125 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  204 (332)
                      +|.+++...........++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            9999998753322234567888999999999999999   9999999999999999999999999999986543332221


Q ss_pred             eccccccCCCcccccccCC--------CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          205 ELDSVVGTTGFIAPENFTT--------LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       205 ~~~~~~gt~~y~aPE~~~~--------~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      ......++..|+|||++..        .++.++|||||||++|||++ |..||........     ...........+. 
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-----~~~~~~~~~~~~~-  231 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-----LKQVVREQDIKLP-  231 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH-----HHHHhhccCccCC-
Confidence            1133456778999998632        56889999999999999999 7788865433221     1111111100000 


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                                  ........+..+.+++..|| .||++|||+++|++.|.
T Consensus       232 ------------~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         232 ------------KPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             ------------CCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence                        00011234467788999999 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.2e-43  Score=318.08  Aligned_cols=254  Identities=20%  Similarity=0.295  Sum_probs=199.1

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEeC---------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFWQ---------KRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----  115 (332)
                      ...++|.+.+.||+|+||.||++.+.         ...+|+|.+...........+.+|+.++..+ +||||+++     
T Consensus        15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (307)
T cd05098          15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   94 (307)
T ss_pred             eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            33467999999999999999999862         2469999998765444467789999999999 79999998     


Q ss_pred             ------EEEEeccCCChHHHHhhhhcc-----------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCe
Q 038681          116 ------IVFESVQIGTLADRIHHHCEQ-----------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNI  178 (332)
Q Consensus       116 ------lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  178 (332)
                            +||||+++|+|.+++......           ....+++..++.++.|++.||+|||   ++|++||||||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Ni  171 (307)
T cd05098          95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV  171 (307)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHhe
Confidence                  899999999999999764211           1135889999999999999999999   99999999999999


Q ss_pred             eeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccch
Q 038681          179 LFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESR  256 (332)
Q Consensus       179 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~  256 (332)
                      +++.++.++|+|||.++...............+++.|+|||.+.+ .++.++|||||||++|||++ |..||...+....
T Consensus       172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~  251 (307)
T cd05098         172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  251 (307)
T ss_pred             EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence            999999999999999876643322111122234578999999887 78999999999999999998 8888865433221


Q ss_pred             hhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          257 FHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                            ...+..               ..  ....+...+.++.+|+.+||..+|.+|||+.+|++.|.++.+.
T Consensus       252 ------~~~~~~---------------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         252 ------FKLLKE---------------GH--RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             ------HHHHHc---------------CC--CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence                  111110               00  0011123447889999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.9e-43  Score=309.58  Aligned_cols=244  Identities=22%  Similarity=0.312  Sum_probs=195.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------EEEEec
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IVFESV  121 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv~e~~  121 (332)
                      .++|.+.++||+|+||.||+|.+ ....||+|++......  .+.+.+|+.+++.++||||+++          +||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC--HHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcC
Confidence            46699999999999999999998 5557999998764332  4578999999999999999986          899999


Q ss_pred             cCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCC
Q 038681          122 QIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE  201 (332)
Q Consensus       122 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  201 (332)
                      ++|+|.+++.....   ..+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||.++......
T Consensus        83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          83 SKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             CCCcHHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            99999999976421   35789999999999999999999   9999999999999999999999999999997665443


Q ss_pred             ceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          202 THIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       202 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      .... ....++..|+|||...+ .++.++|||||||++|+|++ |..||.........      .....           
T Consensus       157 ~~~~-~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~------~~~~~-----------  218 (262)
T cd05071         157 YTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL------DQVER-----------  218 (262)
T ss_pred             cccc-cCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH------HHHhc-----------
Confidence            2211 23456778999998876 88999999999999999999 88888754332211      00000           


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY  328 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~  328 (332)
                          ..  ..+.....+..+.+++.+||+.||++|||+.++++.|+...
T Consensus       219 ----~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         219 ----GY--RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             ----CC--CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence                00  00111244577899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-44  Score=326.02  Aligned_cols=243  Identities=23%  Similarity=0.345  Sum_probs=208.4

Q ss_pred             CCCCCccccCCCceEEEEEeC----C--eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------EEEE
Q 038681           56 YDEQNIVLEDPFRKLYKGFWQ----K--RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IVFE  119 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~~----~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv~e  119 (332)
                      ....++||.|-||.||+|.+.    |  -.||||..+.+...+..+.|+.|..++++++|||||++          ||||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmE  470 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVME  470 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEe
Confidence            345678999999999999992    2  35899999998888779999999999999999999998          8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      +++.|.|..|+..+.    ..++......++.||+.||+|||   +.++|||||-.+|||+.....+||+|||+++.+.+
T Consensus       471 L~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  471 LAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             cccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            999999999998763    46899999999999999999999   99999999999999999999999999999999887


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ...... +...-...|||||.+.- +++.+||||-|||.+||++. |..||.+....+...                   
T Consensus       544 ~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-------------------  603 (974)
T KOG4257|consen  544 DAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-------------------  603 (974)
T ss_pred             cchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-------------------
Confidence            664432 33345678999999986 89999999999999999986 999998876554321                   


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                          .-+.+-+.+.++.|++.++.|+.+||.+||.+||.+.++...|..+++
T Consensus       604 ----~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  604 ----HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             ----EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence                111122344456788999999999999999999999999999998876

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.5e-43  Score=313.52  Aligned_cols=247  Identities=18%  Similarity=0.282  Sum_probs=195.0

Q ss_pred             cCCCCCCccccCCCceEEEEEeC-------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFWQ-------KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      .+|.+.+.||+|+||.||+|.+.       +..||+|.+.........+.+.+|+.++..++||||+++           
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            44777889999999999999872       467999999876555546778999999999999999987           


Q ss_pred             EEEEeccCCChHHHHhhhhc-----------ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC
Q 038681          116 IVFESVQIGTLADRIHHHCE-----------QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS  184 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  184 (332)
                      +++||+++++|.+++.....           .....+++..+..++.|++.||.|||   +++|+||||||+||+++.++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCC
Confidence            68999999999999864211           11135888999999999999999999   99999999999999999999


Q ss_pred             CeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHH
Q 038681          185 DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEEN  262 (332)
Q Consensus       185 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~  262 (332)
                      .+||+|||+++...............+++.|+|||.+.+ .++.++|||||||++|||++ |..||........      
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~------  235 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV------  235 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH------
Confidence            999999999887654433222234456789999999876 88999999999999999998 8888865433211      


Q ss_pred             HhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 038681          263 VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQ  326 (332)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~  326 (332)
                      .......              ..   .+.+..++..+.+|+.+||+.+|.+||++++|+..|+.
T Consensus       236 ~~~i~~~--------------~~---~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         236 IEMIRNR--------------QV---LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHHcC--------------Cc---CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1111110              00   01112345779999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-44  Score=293.65  Aligned_cols=236  Identities=17%  Similarity=0.273  Sum_probs=198.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      .++|++++.||+|.||.||.|+.  ++..||+|++.+..-  ......+.+|+++-+.|+||||+++           |+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            35688999999999999999999  788899999876542  2224568899999999999999997           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      +||.+.|+|...+.....   ..+++..+..++.|+|.||.|+|   .++|+||||||+|+|++..+.+||+|||-+-..
T Consensus       101 lEya~~gel~k~L~~~~~---~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~  174 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGRM---KRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHA  174 (281)
T ss_pred             EEecCCchHHHHHHhccc---ccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence            999999999999984421   56899999999999999999999   999999999999999999999999999998665


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      +.+..    .+.+||..|.+||+..+ .++..+|+|++|++.||++.|.+||......+.      .+.+....      
T Consensus       175 p~~kR----~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~et------YkrI~k~~------  238 (281)
T KOG0580|consen  175 PSNKR----KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSET------YKRIRKVD------  238 (281)
T ss_pred             CCCCc----eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHH------HHHHHHcc------
Confidence            53332    57899999999999998 899999999999999999999999987764332      22221111      


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                  ...+...+..+.++|.+|+..+|.+|.+..|+++
T Consensus       239 ------------~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~  272 (281)
T KOG0580|consen  239 ------------LKFPSTISGGAADLISRLLVKNPIERLALTEVMD  272 (281)
T ss_pred             ------------ccCCcccChhHHHHHHHHhccCccccccHHHHhh
Confidence                        1112345578999999999999999999999876

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.9e-44  Score=321.63  Aligned_cols=232  Identities=21%  Similarity=0.280  Sum_probs=183.8

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHH---HhhcCCCcceE-----------EE
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYA---SRMSHKHIIKL-----------IV  117 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l---~~l~H~nIv~~-----------lv  117 (332)
                      |.+.+.||+|+||.||+|.+  +++.||||.+....  .....+.+.+|+.++   +.++||||+++           +|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            66788999999999999998  78999999997542  222345677777665   45679999987           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+++|+|..++..      ..+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++..
T Consensus        81 ~E~~~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~  151 (324)
T cd05589          81 MEYAAGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEG  151 (324)
T ss_pred             EcCCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence            999999999988864      36899999999999999999999   999999999999999999999999999998754


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ......  .....||+.|+|||++.+ .++.++|||||||++|||++|..||.........      ..+          
T Consensus       152 ~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~------~~i----------  213 (324)
T cd05589         152 MGFGDR--TSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF------DSI----------  213 (324)
T ss_pred             CCCCCc--ccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH------HHH----------
Confidence            332211  135679999999999987 8899999999999999999999999765432211      111          


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~  322 (332)
                          ......    .+...+..+.+++.+||+.||.+||     ++.++++
T Consensus       214 ----~~~~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         214 ----VNDEVR----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             ----HhCCCC----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence                000000    1112346789999999999999999     4666654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-43  Score=308.69  Aligned_cols=244  Identities=19%  Similarity=0.321  Sum_probs=195.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      ..++|++.+.||+|+||.||+|.+ .+..||+|.+.....  ..+.+.+|+.++++++||||+++           +|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM--DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc--cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            456799999999999999999998 667899999876532  24668899999999999999987           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++++|.+++....   ...+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.++|+|||+++....
T Consensus        82 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05068          82 LMKYGSLLEYLQGGA---GRALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKE  155 (261)
T ss_pred             cccCCcHHHHHhccC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccC
Confidence            999999999997642   135899999999999999999999   99999999999999999999999999999987653


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ...... .....+..|+|||.+.+ .++.++||||||+++|||++ |+.||.........      .....         
T Consensus       156 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~------~~~~~---------  219 (261)
T cd05068         156 DIYEAR-EGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL------QQVDQ---------  219 (261)
T ss_pred             Cccccc-CCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH------HHHHc---------
Confidence            322111 12223457999999887 88999999999999999999 99999765432211      11100         


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                            ..  ..+.+...+..+.+++.+||+.||.+||++.++++.|+.+
T Consensus       220 ------~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         220 ------GY--RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ------CC--CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                  00  0011123447799999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.4e-43  Score=318.88  Aligned_cols=228  Identities=22%  Similarity=0.298  Sum_probs=182.3

Q ss_pred             CccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhh-cCCCcceE-----------EEEEeccC
Q 038681           60 NIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRM-SHKHIIKL-----------IVFESVQI  123 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv~e~~~~  123 (332)
                      +.||+|+||.||+|.+  ++..||+|.+....  .....+.+..|..++..+ +||||+++           +||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999998  67889999987642  122345677788888765 89999987           89999999


Q ss_pred             CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCce
Q 038681          124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH  203 (332)
Q Consensus       124 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  203 (332)
                      |+|.+++...     ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++........
T Consensus        81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  152 (316)
T cd05619          81 GDLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK  152 (316)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCc
Confidence            9999999765     46899999999999999999999   999999999999999999999999999998754322211


Q ss_pred             eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhh
Q 038681          204 IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIII  282 (332)
Q Consensus       204 ~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (332)
                        .....||+.|+|||++.+ .++.++|||||||++|||++|..||........      ...+......          
T Consensus       153 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~------~~~i~~~~~~----------  214 (316)
T cd05619         153 --TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEEL------FQSIRMDNPC----------  214 (316)
T ss_pred             --eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCC----------
Confidence              134578999999999987 889999999999999999999999976543221      1111110000          


Q ss_pred             cccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 038681          283 EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMV-DVA  321 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~-evl  321 (332)
                              .+...+.++.+|+.+||+.||++||++. ++.
T Consensus       215 --------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         215 --------YPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             --------CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence                    0112346789999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.4e-43  Score=309.75  Aligned_cols=248  Identities=18%  Similarity=0.332  Sum_probs=194.7

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFWQ-------KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------  115 (332)
                      ..++|.+.+.||+|+||.||+|.+.       +..|++|.+...........+.+|+.+++.++|+||+++         
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            3567999999999999999999983       467889988766555546679999999999999999998         


Q ss_pred             --EEEEeccCCChHHHHhhhhc--ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC---CeEE
Q 038681          116 --IVFESVQIGTLADRIHHHCE--QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS---DAKL  188 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl  188 (332)
                        +||||+++|+|.+++.....  .....+++..++.++.||+.||+|||   +++++|+||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEe
Confidence              89999999999999976532  11235899999999999999999999   99999999999999998765   5899


Q ss_pred             eecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhh
Q 038681          189 FDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRL  266 (332)
Q Consensus       189 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~  266 (332)
                      +|||+++................+..|+|||++.+ .++.++|||||||++|||++ |..||.........      ...
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~------~~~  234 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM------EFV  234 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH------HHH
Confidence            99999987643322211122334568999999876 89999999999999999997 99999765432211      111


Q ss_pred             hccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          267 SGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                      ....                 ....+...+..+.+++.+||+.||++|||+.+|++.|.
T Consensus       235 ~~~~-----------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         235 TGGG-----------------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             HcCC-----------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            0000                 00011133467899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.7e-43  Score=312.96  Aligned_cols=235  Identities=21%  Similarity=0.299  Sum_probs=185.2

Q ss_pred             cccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCCCh
Q 038681           62 VLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTL  126 (332)
Q Consensus        62 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g~L  126 (332)
                      ||+|+||+||++.+  +++.+|+|++.....  ....+.+..|+.+++.++||||+++           +||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999998  788999999875432  2234667899999999999999987           89999999999


Q ss_pred             HHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceeec
Q 038681          127 ADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL  206 (332)
Q Consensus       127 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  206 (332)
                      .+++..... ....+++..+..++.||+.||.|||   +++|+||||||+||+++.++.++|+|||++.........  .
T Consensus        81 ~~~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~  154 (280)
T cd05608          81 RYHIYNVDE-ENPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--T  154 (280)
T ss_pred             HHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc--c
Confidence            988864321 1246899999999999999999999   999999999999999999999999999999766543322  1


Q ss_pred             cccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhccc
Q 038681          207 DSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDK  285 (332)
Q Consensus       207 ~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ....||+.|+|||++.+ .++.++|||||||++|||++|+.||..........  .....              ....  
T Consensus       155 ~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~--------------~~~~--  216 (280)
T cd05608         155 KGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQR--------------ILND--  216 (280)
T ss_pred             cccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHHHh--------------hccc--
Confidence            34578999999999987 88999999999999999999999997543221100  00000              0000  


Q ss_pred             CCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038681          286 SCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAK  322 (332)
Q Consensus       286 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~  322 (332)
                        ....+...+..+.+++.+||+.||++||     +++++++
T Consensus       217 --~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         217 --SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             --CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence              0011123457899999999999999999     6677775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-43  Score=311.91  Aligned_cols=248  Identities=20%  Similarity=0.337  Sum_probs=197.0

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeC-------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFWQ-------KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------  115 (332)
                      ..++|.+.+.||+|+||.||+|.+.       +..||+|.+...........+.+|+.++..++||||+++         
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            4567899999999999999999872       267999998766554546678999999999999999998         


Q ss_pred             --EEEEeccCCChHHHHhhhhcc-----cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEE
Q 038681          116 --IVFESVQIGTLADRIHHHCEQ-----HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKL  188 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  188 (332)
                        +||||+++|+|.+++......     ....+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEE
Confidence              899999999999999764221     1134788999999999999999999   999999999999999999999999


Q ss_pred             eecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhh
Q 038681          189 FDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRL  266 (332)
Q Consensus       189 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~  266 (332)
                      +|||+++...............++..|+|||.+.+ .++.++|||||||++||+++ |..||.........      ...
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~------~~~  234 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL------KFV  234 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH------HHH
Confidence            99999976654432222233456789999999876 88999999999999999998 89898654432211      111


Q ss_pred             hccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          267 SGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                      ..               ..  ....+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       235 ~~---------------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         235 ID---------------GG--HLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             hc---------------CC--CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            00               00  00011123478999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-43  Score=314.57  Aligned_cols=239  Identities=21%  Similarity=0.308  Sum_probs=190.9

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      +|++.+.||+|+||.||++.+  +++.||+|++.....  ......+.+|+.+++.++||||+++           +|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            478889999999999999998  688999999875432  2224557889999999999999987           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++|+|.+++....   ...+++..+..++.|++.||.|||   +.+|+||||||+||++++++.++|+|||++.....
T Consensus        81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  154 (285)
T cd05605          81 LMNGGDLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE  154 (285)
T ss_pred             ccCCCcHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            999999998886532   145899999999999999999999   99999999999999999999999999999987644


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      ....   ....|++.|+|||++.+ .++.++|||||||++||+++|..||..........  .....+...         
T Consensus       155 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~--~~~~~~~~~---------  220 (285)
T cd05605         155 GETI---RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKRE--EVERRVKED---------  220 (285)
T ss_pred             CCcc---ccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHH--HHHHHhhhc---------
Confidence            3321   34578999999999987 88999999999999999999999997644322110  010111000         


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAK  322 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~  322 (332)
                               ....+...+..+.+|+.+||..||++||     ++.++++
T Consensus       221 ---------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         221 ---------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ---------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence                     0011123457789999999999999999     8888865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=2.6e-43  Score=324.10  Aligned_cols=254  Identities=20%  Similarity=0.221  Sum_probs=192.0

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE----------------
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL----------------  115 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~----------------  115 (332)
                      +|++.+.||+|+||.||+|.+  +++.||+|++.... .....+.+.+|+.+++.++||||+++                
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            488899999999999999998  78999999987542 23335678999999999999999865                


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      +|+||+. ++|.+++...     ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++
T Consensus        81 lv~e~~~-~~l~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~  151 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP-----QPLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLAR  151 (372)
T ss_pred             EEeeccc-cCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEecccccee
Confidence            7999996 5888888654     56999999999999999999999   9999999999999999999999999999997


Q ss_pred             ccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      ......... .....+|+.|+|||++.+  .++.++|||||||++|||++|+.||..........  .....+..  +..
T Consensus       152 ~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~i~~~~g~--~~~  226 (372)
T cd07853         152 VEEPDESKH-MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD--LITDLLGT--PSL  226 (372)
T ss_pred             ecccCcccc-CCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHH--HHHHHcCC--CCH
Confidence            654332211 134467899999999876  57999999999999999999999998765433211  11111111  001


Q ss_pred             hhhh------hhhhhcccCCCC------CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          274 KEMV------DSIIIEDKSCTC------TGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       274 ~~~~------~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .++.      ...+........      ......++++.+|+.+||+.||.+|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         227 EAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             HHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            1100      000000000000      011123577899999999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.3e-44  Score=330.49  Aligned_cols=239  Identities=18%  Similarity=0.205  Sum_probs=187.1

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .|+..+.||+|+||.||+|..  ++..||+|++....  .....+.+.+|+.++++++|||||++           +|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            588899999999999999998  78899999987542  23335678899999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++|+|.+++...     ..+++..+..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++..+..
T Consensus        82 ~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~  153 (382)
T cd05625          82 YIPGGDMMSLLIRM-----GIFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (382)
T ss_pred             CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccc
Confidence            99999999999765     46899999999999999999999   99999999999999999999999999999753211


Q ss_pred             CCc---------------------------------------------eeeccccccCCCcccccccCC-CCChhhhHHH
Q 038681          200 GET---------------------------------------------HIELDSVVGTTGFIAPENFTT-LINEQCDVYG  233 (332)
Q Consensus       200 ~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwS  233 (332)
                      ...                                             ........||+.|+|||++.+ .++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwS  233 (382)
T cd05625         154 THDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWS  233 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEe
Confidence            000                                             000123468999999999987 8999999999


Q ss_pred             HHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCC
Q 038681          234 FGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPED  313 (332)
Q Consensus       234 lG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~  313 (332)
                      |||++|||++|..||..........     ....               .......+.....++++.+++.+|+ .||.+
T Consensus       234 lGvil~elltG~~Pf~~~~~~~~~~-----~i~~---------------~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~  292 (382)
T cd05625         234 VGVILYEMLVGQPPFLAQTPLETQM-----KVIN---------------WQTSLHIPPQAKLSPEASDLIIKLC-RGPED  292 (382)
T ss_pred             chHHHHHHHhCCCCCCCCCHHHHHH-----HHHc---------------cCCCcCCCCcccCCHHHHHHHHHHc-cCHhH
Confidence            9999999999999998654322110     1000               0000011111233467888888876 59999


Q ss_pred             CCC---HHHHHH
Q 038681          314 RPT---MVDVAK  322 (332)
Q Consensus       314 RPs---~~evl~  322 (332)
                      |++   +.++++
T Consensus       293 R~~~~~~~ei~~  304 (382)
T cd05625         293 RLGKNGADEIKA  304 (382)
T ss_pred             cCCCCCHHHHhc
Confidence            987   777764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=6e-44  Score=327.83  Aligned_cols=248  Identities=17%  Similarity=0.286  Sum_probs=194.1

Q ss_pred             HHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE------
Q 038681           46 AEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL------  115 (332)
Q Consensus        46 ~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~------  115 (332)
                      ..++....++|++.+.||+|+||.||+|.+  +++.+|+|.+....  .....+.+.+|+.++..++||||+++      
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            445556678899999999999999999999  78899999986532  22234567899999999999999997      


Q ss_pred             -----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEee
Q 038681          116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFD  190 (332)
Q Consensus       116 -----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  190 (332)
                           +||||+++|+|.+++...      .+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~D  185 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLAD  185 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEe
Confidence                 899999999999998653      5889999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccCC-----CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhh
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKR  265 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~  265 (332)
                      ||+++......... .....||+.|+|||++.+     .++.++|||||||++|||++|..||.........      ..
T Consensus       186 fG~a~~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~  258 (371)
T cd05622         186 FGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SK  258 (371)
T ss_pred             CCceeEcCcCCccc-ccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH------HH
Confidence            99998765433221 135679999999999864     3788999999999999999999999865432211      11


Q ss_pred             hhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 038681          266 LSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPED--RPTMVDVAKQ  323 (332)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~evl~~  323 (332)
                      +              .........+.....+..+.+++..||..++.+  ||++.++++.
T Consensus       259 i--------------~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         259 I--------------MNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             H--------------HcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            1              000001111112244578899999999844433  6789888763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.1e-43  Score=319.53  Aligned_cols=228  Identities=18%  Similarity=0.282  Sum_probs=182.3

Q ss_pred             CccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhh-cCCCcceE-----------EEEEeccC
Q 038681           60 NIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRM-SHKHIIKL-----------IVFESVQI  123 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv~e~~~~  123 (332)
                      +.||+|+||.||+|.+  ++..||+|.+.....  ....+.+..|..++..+ +||||+++           +||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4699999999999999  788999999976421  22345677888888765 89999987           89999999


Q ss_pred             CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCce
Q 038681          124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH  203 (332)
Q Consensus       124 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  203 (332)
                      |+|.+++...     ..+++..+..++.||+.||+|||   ++||+||||||+|||++.++.++|+|||+++........
T Consensus        81 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  152 (316)
T cd05620          81 GDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR  152 (316)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCc
Confidence            9999998765     56899999999999999999999   999999999999999999999999999998754322211


Q ss_pred             eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhh
Q 038681          204 IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIII  282 (332)
Q Consensus       204 ~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (332)
                        .....||+.|+|||++.+ .++.++|||||||++|||++|..||........      ...+......+         
T Consensus       153 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~------~~~~~~~~~~~---------  215 (316)
T cd05620         153 --ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL------FESIRVDTPHY---------  215 (316)
T ss_pred             --eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHHhCCCCC---------
Confidence              135678999999999987 899999999999999999999999976543221      11111110000         


Q ss_pred             cccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 038681          283 EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMV-DVA  321 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~-evl  321 (332)
                               +...+.++.+|+.+||+.||++||++. +++
T Consensus       216 ---------~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         216 ---------PRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             ---------CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                     112346789999999999999999984 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.2e-43  Score=313.46  Aligned_cols=254  Identities=20%  Similarity=0.238  Sum_probs=193.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC----------------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFWQ----------------KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~~----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-  115 (332)
                      .++|++.+.||+|+||.||+|...                ...||+|.+.........+.+.+|++++++++||||+++ 
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            357999999999999999998762                235899998876555556789999999999999999998 


Q ss_pred             ----------EEEEeccCCChHHHHhhhhcc-------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCe
Q 038681          116 ----------IVFESVQIGTLADRIHHHCEQ-------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNI  178 (332)
Q Consensus       116 ----------lv~e~~~~g~L~~~l~~~~~~-------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  178 (332)
                                +||||+++++|.+++......       ....+++..++.++.|++.||.|||   +.+++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhE
Confidence                      899999999999999653110       1124788999999999999999999   99999999999999


Q ss_pred             eeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh--CCccCCCCCccc
Q 038681          179 LFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT--AQEVSDHVSFES  255 (332)
Q Consensus       179 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt--g~~p~~~~~~~~  255 (332)
                      +++.++.+||+|||++................++..|+|||.+.+ .++.++|||||||++|+|++  |..||.......
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999976544332222233445778999998876 88999999999999999998  666776544322


Q ss_pred             hhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          256 RFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                      ....  ...           .........   ....+...+..+.+|+.+||+.||++|||+++|++.|+
T Consensus       241 ~~~~--~~~-----------~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 VIEN--TGE-----------FFRNQGRQI---YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHH--HHH-----------hhhhccccc---cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            1110  000           000000000   00011123468999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.8e-43  Score=323.03  Aligned_cols=255  Identities=17%  Similarity=0.245  Sum_probs=192.6

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-------------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-------------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-------------  115 (332)
                      ..++|.+.+.||+|+||.||+|.+  .++.||||++.... .......+.+|+.+++.++||||+++             
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            357899999999999999999998  78899999987643 23335678899999999999999865             


Q ss_pred             ----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeec
Q 038681          116 ----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF  191 (332)
Q Consensus       116 ----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  191 (332)
                          +||||+++ +|.+++..       .+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+||
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Df  170 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF  170 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeC
Confidence                89999975 78877753       3788999999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc
Q 038681          192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       192 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      |+++........   ....+|+.|+|||++.+ .++.++|||||||++|+|++|+.||..........  ..........
T Consensus       171 G~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~  245 (364)
T cd07875         171 GLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN--KVIEQLGTPC  245 (364)
T ss_pred             CCccccCCCCcc---cCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcCCCC
Confidence            999765443221   34578999999999987 88999999999999999999999998665432211  1111111111


Q ss_pred             cchhhhhhhh----hhcccC----------------CCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          271 CRFKEMVDSI----IIEDKS----------------CTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       271 ~~~~~~~~~~----~~~~~~----------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      +.+...+.+.    ....+.                ............+.+|+.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            1111111000    000000                000011122457899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-45  Score=327.67  Aligned_cols=231  Identities=20%  Similarity=0.310  Sum_probs=197.1

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      |...+.||.|+||.||-|++  +...||||++.....  ......++.|+.+|.+++|||+|.+           |||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY  107 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY  107 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence            77778999999999999999  889999999987643  3447789999999999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      |- |+-.|++.-+.    .++.+-++..|+.+.+.||+|||   +++.||||||..|||+++.|.|||+|||.|......
T Consensus       108 Cl-GSAsDlleVhk----KplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA  179 (948)
T KOG0577|consen  108 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA  179 (948)
T ss_pred             Hh-ccHHHHHHHHh----ccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence            95 58888887653    57999999999999999999999   999999999999999999999999999999765543


Q ss_pred             CceeeccccccCCCcccccccC----CCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFT----TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                            ++++|||+|||||++.    |.|+-++||||||++..||.-.++|+..++.....     ........+     
T Consensus       180 ------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL-----YHIAQNesP-----  243 (948)
T KOG0577|consen  180 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----YHIAQNESP-----  243 (948)
T ss_pred             ------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH-----HHHHhcCCC-----
Confidence                  5789999999999885    38999999999999999999999999877665432     111111111     


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                  .....+++..+..|+..||+.-|.+|||.++++.
T Consensus       244 ------------tLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  244 ------------TLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             ------------CCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence                        1123478899999999999999999999999875

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.6e-43  Score=318.79  Aligned_cols=229  Identities=20%  Similarity=0.276  Sum_probs=184.9

Q ss_pred             CccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhh-cCCCcceE-----------EEEEeccC
Q 038681           60 NIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRM-SHKHIIKL-----------IVFESVQI  123 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv~e~~~~  123 (332)
                      +.||+|+||.||+|.+  ++..||+|.+....  .......+.+|..++..+ +||||+++           +||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999  67899999987642  223356678899999888 69999997           89999999


Q ss_pred             CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCce
Q 038681          124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH  203 (332)
Q Consensus       124 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  203 (332)
                      |+|..++...     ..+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++........
T Consensus        81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  152 (318)
T cd05570          81 GDLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT  152 (318)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCc
Confidence            9999998765     56999999999999999999999   999999999999999999999999999998753322211


Q ss_pred             eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhh
Q 038681          204 IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIII  282 (332)
Q Consensus       204 ~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (332)
                        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||........      ..........          
T Consensus       153 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~------~~~i~~~~~~----------  214 (318)
T cd05570         153 --TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL------FQSILEDEVR----------  214 (318)
T ss_pred             --ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH------HHHHHcCCCC----------
Confidence              134568999999999987 899999999999999999999999976543221      1111110000          


Q ss_pred             cccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 038681          283 EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTM-----VDVAK  322 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~-----~evl~  322 (332)
                              .+...+..+.+|+.+||+.||.+|||+     .++++
T Consensus       215 --------~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         215 --------YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             --------CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence                    111234678999999999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.2e-43  Score=306.25  Aligned_cols=238  Identities=19%  Similarity=0.344  Sum_probs=194.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE------------EEEEe
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------------IVFES  120 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~------------lv~e~  120 (332)
                      ..+|.+.+.||+|+||.||++...+..|++|.......   .+.+.+|+.++++++|+||+++            +|+||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDAT---AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCch---HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            45789999999999999999999999999999865432   4678899999999999999996            89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++|+|.+++.....   ..+++..++.++.|++.||+|||   +++++||||||+||+++.++.+||+|||++......
T Consensus        82 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  155 (256)
T cd05082          82 MAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST  155 (256)
T ss_pred             CCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceecccc
Confidence            999999999976421   34889999999999999999999   999999999999999999999999999998765433


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      .     ....++..|+|||++.+ .++.++|||||||++|+|++ |..||........      .......         
T Consensus       156 ~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~------~~~~~~~---------  215 (256)
T cd05082         156 Q-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKG---------  215 (256)
T ss_pred             C-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHhcC---------
Confidence            2     22345678999999887 78999999999999999998 9999875433221      1111100         


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                            .  .......++..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       216 ------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         216 ------Y--KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             ------C--CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                  0  0011123447899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=2.7e-44  Score=331.22  Aligned_cols=240  Identities=16%  Similarity=0.193  Sum_probs=188.0

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|++.+.||+|+||.||+|.+  +++.||+|.+.....  ......+.+|+.++.+++||||+++           +||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            4699999999999999999998  789999999865321  2235668899999999999999997           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++|+|.+++...     ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|..+.
T Consensus        81 E~~~~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~  152 (376)
T cd05598          81 DYIPGGDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  152 (376)
T ss_pred             eCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccc
Confidence            999999999999775     56899999999999999999999   9999999999999999999999999999975321


Q ss_pred             CCC-----------------------------------------ceeeccccccCCCcccccccCC-CCChhhhHHHHHH
Q 038681          199 DGE-----------------------------------------THIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGA  236 (332)
Q Consensus       199 ~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~  236 (332)
                      ...                                         .........||+.|+|||++.+ .++.++|||||||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv  232 (376)
T cd05598         153 WTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  232 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccc
Confidence            000                                         0000123479999999999987 8899999999999


Q ss_pred             HHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-
Q 038681          237 FLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-  315 (332)
Q Consensus       237 ~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-  315 (332)
                      ++|||++|..||..........      .......              ....+.....+..+.+++.+|+ .+|.+|+ 
T Consensus       233 ilyell~G~~Pf~~~~~~~~~~------~i~~~~~--------------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~  291 (376)
T cd05598         233 ILYEMLVGQPPFLADTPAETQL------KVINWET--------------TLHIPSQAKLSREASDLILRLC-CGAEDRLG  291 (376)
T ss_pred             eeeehhhCCCCCCCCCHHHHHH------HHhccCc--------------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCC
Confidence            9999999999998655432211      0000000              0000111133467888999876 4999999 


Q ss_pred             --CHHHHHH
Q 038681          316 --TMVDVAK  322 (332)
Q Consensus       316 --s~~evl~  322 (332)
                        |+.++++
T Consensus       292 ~~t~~ell~  300 (376)
T cd05598         292 KNGADEIKA  300 (376)
T ss_pred             CCCHHHHhC
Confidence              8888875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=3.8e-43  Score=307.20  Aligned_cols=243  Identities=21%  Similarity=0.320  Sum_probs=194.8

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------EEEEe
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IVFES  120 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv~e~  120 (332)
                      ..++|++.+.||+|+||.||+|.+ .+..+|+|.+......  .+.+.+|+.++++++||||+++          ++|||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~   81 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS--PESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEY   81 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC--HHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEe
Confidence            345789999999999999999988 6678999998765432  4568999999999999999987          89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++++|.+++....   ...+++..+..++.|++.||.|||   +++|+|+||||+||+++.++.++|+|||.+......
T Consensus        82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05070          82 MSKGSLLDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN  155 (260)
T ss_pred             cCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence            99999999997541   135899999999999999999999   999999999999999999999999999999776543


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      ..... ....++..|+|||.+.+ .++.++||||||+++|+|++ |..||......+.      .......         
T Consensus       156 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~------~~~~~~~---------  219 (260)
T cd05070         156 EYTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREV------LEQVERG---------  219 (260)
T ss_pred             ccccc-cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH------HHHHHcC---------
Confidence            32211 23345678999999876 88999999999999999999 8889875432221      1111000         


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQ  326 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~  326 (332)
                            .  ..+.+...+..+.+|+.+||..||++|||+.++.+.|+.
T Consensus       220 ------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         220 ------Y--RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ------C--CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                  0  001112344779999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2e-43  Score=319.54  Aligned_cols=232  Identities=18%  Similarity=0.280  Sum_probs=180.9

Q ss_pred             CccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhh-cCCCcceE-----------EEEEeccC
Q 038681           60 NIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRM-SHKHIIKL-----------IVFESVQI  123 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv~e~~~~  123 (332)
                      +.||+|+||.||+|.+  +++.||+|.+....  .......+.+|+.++.++ +||||+++           +||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999998  77899999998642  233356688899998887 79999987           89999999


Q ss_pred             CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCce
Q 038681          124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH  203 (332)
Q Consensus       124 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  203 (332)
                      |+|..++...     ..+++..+..++.||+.||.|||   +++|+||||||+||+++.++.+||+|||+++........
T Consensus        81 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~  152 (329)
T cd05618          81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT  152 (329)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCc
Confidence            9999988765     56999999999999999999999   999999999999999999999999999998754322211


Q ss_pred             eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh-hhhh
Q 038681          204 IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV-DSII  281 (332)
Q Consensus       204 ~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  281 (332)
                        .....||+.|+|||++.+ .++.++|||||||++|||++|..||..........            ......+ ....
T Consensus       153 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~------------~~~~~~~~~~i~  218 (329)
T cd05618         153 --TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPD------------QNTEDYLFQVIL  218 (329)
T ss_pred             --cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcc------------cccHHHHHHHHh
Confidence              134578999999999987 88999999999999999999999996432211100            0000000 0000


Q ss_pred             hcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCH
Q 038681          282 IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTM  317 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~  317 (332)
                      ....    ..+...+..+.+++.+||+.||.+||++
T Consensus       219 ~~~~----~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         219 EKQI----RIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             cCCC----CCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence            1111    1112344678999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.4e-43  Score=304.85  Aligned_cols=238  Identities=20%  Similarity=0.352  Sum_probs=191.7

Q ss_pred             CccccCCCceEEEEEe--CC---eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------EEEEeccCC
Q 038681           60 NIVLEDPFRKLYKGFW--QK---RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IVFESVQIG  124 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv~e~~~~g  124 (332)
                      ++||+|+||.||+|.+  .+   ..+|+|.+.........+.+.+|+.+++.++||||+++          +||||+++|
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~   80 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLG   80 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCC
Confidence            4799999999999987  33   67999998877654456789999999999999999998          899999999


Q ss_pred             ChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCcee
Q 038681          125 TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHI  204 (332)
Q Consensus       125 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  204 (332)
                      +|.+++...     ..+++..+..++.|++.||.|||   ..+++|+||||+||+++.++.+||+|||+++.........
T Consensus        81 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          81 PLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             cHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            999999875     46899999999999999999999   9999999999999999999999999999998664433221


Q ss_pred             e-ccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhh
Q 038681          205 E-LDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSII  281 (332)
Q Consensus       205 ~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (332)
                      . .....++..|+|||.+.+ .++.++|||||||++|++++ |..||........      ........           
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~------~~~~~~~~-----------  215 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV------IAMLESGE-----------  215 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH------HHHHHcCC-----------
Confidence            1 011223567999999877 88999999999999999998 9999976543221      11111100           


Q ss_pred             hcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 038681          282 IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY  328 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~  328 (332)
                            ..+.+...+..+.+++.+||..||++|||+.++++.|+++.
T Consensus       216 ------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 ------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             ------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                  00111233467899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1e-43  Score=321.49  Aligned_cols=238  Identities=18%  Similarity=0.291  Sum_probs=184.1

Q ss_pred             CccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhh-cCCCcceE-----------EEEEeccC
Q 038681           60 NIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRM-SHKHIIKL-----------IVFESVQI  123 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv~e~~~~  123 (332)
                      +.||+|+||.||+|.+  ++..||+|.+....  .......+..|..++..+ +||||+++           +||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999998  78899999997642  233356688999999998 79999987           89999999


Q ss_pred             CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCce
Q 038681          124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH  203 (332)
Q Consensus       124 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  203 (332)
                      |+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++........
T Consensus        81 g~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~  152 (329)
T cd05588          81 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT  152 (329)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCc
Confidence            9999988765     57999999999999999999999   999999999999999999999999999998753222211


Q ss_pred             eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhh
Q 038681          204 IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIII  282 (332)
Q Consensus       204 ~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (332)
                        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..........            ....+.....+.
T Consensus       153 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~------------~~~~~~~~~~~~  218 (329)
T cd05588         153 --TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPD------------QNTEDYLFQVIL  218 (329)
T ss_pred             --cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccccccccc------------ccchHHHHHHHH
Confidence              134678999999999987 88999999999999999999999996432211000            000000000111


Q ss_pred             cccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC------HHHHHH
Q 038681          283 EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT------MVDVAK  322 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs------~~evl~  322 (332)
                      ...   ...+...+..+.+++.+||+.||.+|||      +.++++
T Consensus       219 ~~~---~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         219 EKQ---IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             cCC---CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            100   0111133467899999999999999998      566653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.8e-43  Score=309.55  Aligned_cols=256  Identities=20%  Similarity=0.316  Sum_probs=195.2

Q ss_pred             cCCCCCCccccCCCceEEEEEe------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE------------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~------------  115 (332)
                      .+|++.+.||+|+||.||+|..      ++..||+|.+..... ...+.+.+|+.++++++||||+++            
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            4688899999999999999974      577899999876543 336788999999999999999987            


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       +|+||+++|+|.+++....    ..+++..+..++.|++.||.|||   .+||+||||||+||+++.++.++|+|||++
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~  155 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLT  155 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCccc
Confidence             7999999999999997541    35899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCceeec-cccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc---
Q 038681          195 LSIPDGETHIEL-DSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ---  269 (332)
Q Consensus       195 ~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---  269 (332)
                      ............ ....++..|+|||++.+ .++.++|||||||++|||++|..|+.......       .......   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~-------~~~~~~~~~~  228 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEF-------MRMMGNDKQG  228 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhh-------hhhccccccc
Confidence            876544322111 12234456999999887 78999999999999999999987764432110       0000000   


Q ss_pred             ccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          270 NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                      ......+. ..+....  ..+.....+..+.+|+.+||..+|++|||+.+|++.|+++
T Consensus       229 ~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         229 QMIVYHLI-ELLKNNG--RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             ccchHHHH-HHHhcCC--cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            00000111 1111111  1112224457899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=6.7e-43  Score=314.19  Aligned_cols=254  Identities=22%  Similarity=0.318  Sum_probs=199.4

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEe---------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE----
Q 038681           50 RIATNNYDEQNIVLEDPFRKLYKGFW---------QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL----  115 (332)
Q Consensus        50 ~~~~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~----  115 (332)
                      ....++|.+.+.||+|+||.||+|..         ....+|+|.+...........+.+|+.++.++ +||||+++    
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            34456788999999999999999975         24568999988665555567889999999999 69999998    


Q ss_pred             -------EEEEeccCCChHHHHhhhhcc-----------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 038681          116 -------IVFESVQIGTLADRIHHHCEQ-----------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTN  177 (332)
Q Consensus       116 -------lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  177 (332)
                             +||||+++|+|.+++......           ....+++..+..++.||+.||.|||   ++||+||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~N  164 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARN  164 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeecccccee
Confidence                   899999999999999764211           1135889999999999999999999   9999999999999


Q ss_pred             eeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccc
Q 038681          178 ILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFES  255 (332)
Q Consensus       178 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~  255 (332)
                      |+++.++.+||+|||+++...............++..|+|||++.+ .++.++|||||||++|+|++ |..||.......
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999986654322111122234568999999877 78999999999999999999 888887654322


Q ss_pred             hhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          256 RFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                      ..      ......               .  ....+..++.++.+++.+||..||++|||+.++++.|.++..
T Consensus       245 ~~------~~~~~~---------------~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~  295 (314)
T cd05099         245 LF------KLLREG---------------H--RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA  295 (314)
T ss_pred             HH------HHHHcC---------------C--CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence            11      111100               0  000112334678899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.1e-43  Score=308.90  Aligned_cols=244  Identities=20%  Similarity=0.362  Sum_probs=197.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      ...+|.+.+.||.|+||.||+|.+ .+..+++|.+....... ...+.+|+.+++.++||||+++           +|||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLK-QQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhh-HHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            345689999999999999999999 77889999987654423 5678899999999999999997           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++|+|.+++.....   ..+++..+..++.||+.||.|||   +++|+|+||||+||+++.++.+||+|||.+.....
T Consensus        83 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~  156 (261)
T cd05148          83 LMEKGSLLAFLRSPEG---QVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKE  156 (261)
T ss_pred             ecccCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCC
Confidence            9999999999976421   45899999999999999999999   99999999999999999999999999999977644


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      .....  ....++..|+|||.+.+ .++.++||||||+++|+|++ |..||......+...      ....         
T Consensus       157 ~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~------~~~~---------  219 (261)
T cd05148         157 DVYLS--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD------QITA---------  219 (261)
T ss_pred             ccccc--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHH------HHHh---------
Confidence            32221  23345778999999876 88999999999999999998 899997654322111      1100         


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                            ..  ..+.+...+..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       220 ------~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         220 ------GY--RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ------CC--cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                  00  0111123447789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.9e-43  Score=310.06  Aligned_cols=257  Identities=21%  Similarity=0.302  Sum_probs=197.0

Q ss_pred             cCCCCCCccccCCCceEEEEEe------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE------------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~------------  115 (332)
                      ..|.+.+.||+|+||.||.+.+      .+..||+|.+.........+.+.+|+.+++.++||||+++            
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            3478899999999999999974      5778999998866555556789999999999999999976            


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       +||||+++++|.+++....    ..+++..+..++.|++.||+|||   ++|++||||||+||+++.++.++|+|||++
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~----~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~  156 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK----NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT  156 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccc
Confidence             8999999999999996541    35899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCcee-eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc--cc
Q 038681          195 LSIPDGETHI-ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG--QN  270 (332)
Q Consensus       195 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~  270 (332)
                      +......... ......++..|+|||.+.+ .++.++|||||||++|||+++..|+.......       ......  ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~-------~~~~~~~~~~  229 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF-------LKMIGPTHGQ  229 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh-------hhhccccccc
Confidence            8765433211 1123456778999999877 78999999999999999999877654321100       000000  00


Q ss_pred             cchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                      ........ .+....  ..+.+..++..+.+|+.+||+.||++|||+.++++.|+++
T Consensus       230 ~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         230 MTVTRLVR-VLEEGK--RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             ccHHHHHH-HHHcCc--cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            00111110 011111  1111223557899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.6e-43  Score=319.41  Aligned_cols=229  Identities=19%  Similarity=0.258  Sum_probs=184.2

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhh-cCCCcceE-----------EEE
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRM-SHKHIIKL-----------IVF  118 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv~  118 (332)
                      +|.+.+.||+|+||.||+|.+  ++..||+|.+.....  ....+.+..|..++..+ .|++|+++           +||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            488899999999999999998  678999999876432  22345677888888887 57888866           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++|+|.+++...     ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        81 E~~~~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~  152 (323)
T cd05616          81 EYVNGGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENM  152 (323)
T ss_pred             cCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecC
Confidence            999999999998765     56899999999999999999999   9999999999999999999999999999997543


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      .....  .....||+.|+|||++.+ .++.++|||||||++|||++|..||.........      ..+.....      
T Consensus       153 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~------~~i~~~~~------  218 (323)
T cd05616         153 WDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF------QSIMEHNV------  218 (323)
T ss_pred             CCCCc--cccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHH------HHHHhCCC------
Confidence            22211  134578999999999987 8999999999999999999999999765433221      11111000      


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTM  317 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~  317 (332)
                                  ..+...+.++.+++.+||+.||.+|++.
T Consensus       219 ------------~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         219 ------------AYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ------------CCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence                        0111334778999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-45  Score=340.56  Aligned_cols=247  Identities=18%  Similarity=0.288  Sum_probs=211.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-----CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------E
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------I  116 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------l  116 (332)
                      .+...+.+.||.|.||.|++|+.     ....||||.++....+.....|+.|+.||.+++||||+++           |
T Consensus       628 ~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMI  707 (996)
T KOG0196|consen  628 PSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMI  707 (996)
T ss_pred             hhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEE
Confidence            34456789999999999999999     3467999999999988889999999999999999999998           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      |.|||++|+|..||+.+.    +.+.+.+...++++|+.|+.||-   +.++|||||-.+|||++.+-.+|++|||+++.
T Consensus       708 iTEyMENGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLs---dm~YVHRDLAARNILVNsnLvCKVsDFGLSRv  780 (996)
T KOG0196|consen  708 ITEYMENGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLS---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRV  780 (996)
T ss_pred             EhhhhhCCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHh---hcCchhhhhhhhheeeccceEEEeccccceee
Confidence            999999999999999874    45888999999999999999999   99999999999999999999999999999998


Q ss_pred             cCCCCceeeccccc--cCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          197 IPDGETHIELDSVV--GTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       197 ~~~~~~~~~~~~~~--gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      +.++..... ++..  -..+|.|||.+.- +++.+|||||||++|||.++ |..||-.....+.+.              
T Consensus       781 ledd~~~~y-tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIk--------------  845 (996)
T KOG0196|consen  781 LEDDPEAAY-TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIK--------------  845 (996)
T ss_pred             cccCCCccc-cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHH--------------
Confidence            876653221 2222  3578999999987 99999999999999999876 999998776544322              


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                            . +...+  +.+.+.+++..|.+||..||+.|-.+||.+.+|+..|.+|.++
T Consensus       846 ------a-Ie~gy--RLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  846 ------A-IEQGY--RLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             ------H-HHhcc--CCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence                  1 11222  3344457889999999999999999999999999999999853

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=8.3e-43  Score=312.78  Aligned_cols=253  Identities=18%  Similarity=0.254  Sum_probs=195.3

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ++|++.+.||+|+||.||++.+  ++..+|+|.+...........+.+|++++.+++||||+++           +||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            3689999999999999999998  6788999988766555556778999999999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFS-RPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      +++|+|.+++...     ..+++..+..++.|++.||.|||   + .+++|+||||+|||++.++.++|+|||++.....
T Consensus        81 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (308)
T cd06615          81 MDGGSLDQVLKKA-----GRIPENILGKISIAVLRGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  152 (308)
T ss_pred             cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hhCCEEECCCChHHEEEecCCcEEEccCCCcccccc
Confidence            9999999999765     56899999999999999999999   6 6999999999999999999999999999876543


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-c--------
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-Q--------  269 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~--------  269 (332)
                      ...    ....++..|+|||.+.+ .++.++|||||||++|+|++|..||..........   ....... .        
T Consensus       153 ~~~----~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~  225 (308)
T cd06615         153 SMA----NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA---MFGRPVSEGEAKESHRP  225 (308)
T ss_pred             ccc----ccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHH---hhcCccccccccCCccc
Confidence            322    34578999999999877 78899999999999999999999996543221110   0000000 0        


Q ss_pred             ----------ccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          270 ----------NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       270 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                                .....+..+....... ... .....+.++.+|+.+||..||++|||+.+|++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         226 VSGHPPDSPRPMAIFELLDYIVNEPP-PKL-PSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             ccCCCCCccchhhHHHHHHHHhcCCC-ccC-cCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                      0000111111111110 000 011245679999999999999999999999874

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=6e-43  Score=312.96  Aligned_cols=247  Identities=21%  Similarity=0.357  Sum_probs=196.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCe----eEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------E
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKR----SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------I  116 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------l  116 (332)
                      ..+|+..+.||+|+||.||+|.+  ++.    .||+|.+...........+.+|+.+++.++||||+++          +
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~   85 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQL   85 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCcee
Confidence            34578889999999999999987  443    5788888766555545678999999999999999997          7


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ++||+++|+|.+++....    ..+++..+..++.|++.||.|||   +++|+|+||||+||+++.++.+||+|||+++.
T Consensus        86 v~e~~~~g~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          86 VTQLMPHGCLLDYVHEHK----DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             eehhcCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEcccccccc
Confidence            999999999999987641    35899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ..............++..|+|||.+.+ .++.++|||||||++||+++ |..||........      ...+....    
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~------~~~~~~~~----  228 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI------PDLLEKGE----  228 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHHCCC----
Confidence            654333222233446778999999887 88999999999999999997 8999876532221      11111000    


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                                   ..+.+..++..+.+++.+||..+|++||++.++++.|.++.+
T Consensus       229 -------------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         229 -------------RLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             -------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                         000011233678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=8.1e-43  Score=306.80  Aligned_cols=247  Identities=21%  Similarity=0.345  Sum_probs=199.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-C----CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-Q----KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv  117 (332)
                      .++|.+.+.||+|+||.||+|.+ .    ...|++|...........+.+.+|+.++++++||||+++          +|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv   84 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIV   84 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEE
Confidence            45688899999999999999987 2    246899998877655557789999999999999999998          89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+++|+|.+++....    ..+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||+++..
T Consensus        85 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~  157 (270)
T cd05056          85 MELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL  157 (270)
T ss_pred             EEcCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeec
Confidence            99999999999997641    35899999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      ........ ....++..|+|||.+.. .++.++|||||||++||+++ |..||.........      ......      
T Consensus       158 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~------~~~~~~------  224 (270)
T cd05056         158 EDESYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI------GRIENG------  224 (270)
T ss_pred             ccccceec-CCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH------HHHHcC------
Confidence            55432211 23334568999999876 78999999999999999986 99999765433211      111000      


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                              .   ..+.+...+..+.+++.+||..+|.+|||+.++++.|.++..+
T Consensus       225 --------~---~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         225 --------E---RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             --------C---cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                    0   0011123447899999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.7e-43  Score=306.08  Aligned_cols=244  Identities=19%  Similarity=0.318  Sum_probs=196.6

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------EEEE
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IVFE  119 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv~e  119 (332)
                      +..++|.+.++||+|+||.||+|.. ++..||+|.+......  .+.+.+|+.++++++||||+++          ++||
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e   80 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS--PEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITE   80 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc--HHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEE
Confidence            3456799999999999999999998 7788999998765432  4678899999999999999987          8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++|+|.+++....   ...+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05067          81 YMENGSLVDFLKTPE---GIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIED  154 (260)
T ss_pred             cCCCCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence            999999999987542   145899999999999999999999   99999999999999999999999999999977653


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ...... ....++..|+|||.+.+ .++.++||||||+++||+++ |..||........      ...+..         
T Consensus       155 ~~~~~~-~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~---------  218 (260)
T cd05067         155 NEYTAR-EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV------IQNLER---------  218 (260)
T ss_pred             CCcccc-cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH------HHHHHc---------
Confidence            322111 23346778999999876 78999999999999999999 9999975443221      111100         


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQ  326 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~  326 (332)
                            ..  ..+.+...+.++.+++.+||+.+|++|||+++++..|+.
T Consensus       219 ------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         219 ------GY--RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ------CC--CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                  00  000111234679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.9e-43  Score=320.38  Aligned_cols=254  Identities=16%  Similarity=0.232  Sum_probs=189.9

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-------------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-------------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-------------  115 (332)
                      ..++|.+.+.||+|+||.||+|.+  ++..||||++..... ....+.+.+|+.++++++||||+++             
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            457799999999999999999998  778999999876432 2234567899999999999999975             


Q ss_pred             ----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeec
Q 038681          116 ----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF  191 (332)
Q Consensus       116 ----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  191 (332)
                          +++|++ +++|.+++..      ..+++..+..++.||+.||.|||   +++|+||||||+||+++.++.+||+||
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Df  162 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDF  162 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCC
Confidence                678877 6799888754      35999999999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc
Q 038681          192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ  269 (332)
Q Consensus       192 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  269 (332)
                      |+++......     ....||+.|+|||++.+  .++.++|||||||++|+|++|..||..........  .........
T Consensus       163 g~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~  235 (343)
T cd07878         163 GLARQADDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLK--RIMEVVGTP  235 (343)
T ss_pred             ccceecCCCc-----CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH--HHHHHhCCC
Confidence            9998765432     34578999999999876  68999999999999999999999997654322211  011111111


Q ss_pred             ccchhhhhh-----hhhhcccCCCCCC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          270 NCRFKEMVD-----SIIIEDKSCTCTG----KEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       270 ~~~~~~~~~-----~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .......+.     .........+...    .....+.+.+|+.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000000000     0000000000000    0012356789999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=9.2e-43  Score=308.26  Aligned_cols=246  Identities=19%  Similarity=0.255  Sum_probs=193.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------  115 (332)
                      ..+|...++||+|+||.||++..       ++..+++|.+.... ....+.+.+|+.+++.++||||+++          
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL   82 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence            45688899999999999999964       45678888877554 3336789999999999999999998          


Q ss_pred             -EEEEeccCCChHHHHhhhhcc----------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC
Q 038681          116 -IVFESVQIGTLADRIHHHCEQ----------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS  184 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  184 (332)
                       +||||+++|+|.+++......          ....+++..++.++.||+.||+|||   +.+++|+||||+|||+++++
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCC
Confidence             899999999999999764210          1134889999999999999999999   99999999999999999999


Q ss_pred             CeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHH
Q 038681          185 DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEEN  262 (332)
Q Consensus       185 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~  262 (332)
                      .++|+|||++................+++.|+|||.+.+ .++.++|||||||++|||++ |..||..........    
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~----  235 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE----  235 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH----
Confidence            999999999976544332222233445788999999887 88999999999999999998 899986544322111    


Q ss_pred             HhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          263 VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                        ..              ....   ....+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus       236 --~~--------------~~~~---~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         236 --CI--------------TQGR---ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             --HH--------------HcCc---cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence              00              0000   00111133467899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-42  Score=306.23  Aligned_cols=246  Identities=18%  Similarity=0.346  Sum_probs=198.1

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCe----eEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------EE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKR----SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IV  117 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv  117 (332)
                      .+|.+.+.||+|+||.||+|.+  ++.    .+|+|.............+.+|+.++.+++||||+++          +|
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v   86 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI   86 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence            5678889999999999999987  333    5899988777655556789999999999999999987          79


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      +||+++|+|.+++....    ..+++..+..++.||+.||+|||   +.+|+|+||||+||+++.++.+||+|||.++..
T Consensus        87 ~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~  159 (279)
T cd05057          87 TQLMPLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (279)
T ss_pred             EecCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccc
Confidence            99999999999997642    35899999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      .............++..|+|||.+.. .++.++|||||||++||+++ |..||......+..      ..+..       
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~------~~~~~-------  226 (279)
T cd05057         160 DVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP------DLLEK-------  226 (279)
T ss_pred             cCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH------HHHhC-------
Confidence            54433222122334678999998876 88999999999999999998 99999765432211      11100       


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                             . .  ..+.+..++..+.+++.+||..||++||++.++++.|.++.+
T Consensus       227 -------~-~--~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         227 -------G-E--RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             -------C-C--CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                   0 0  001111233678899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=6.8e-43  Score=305.09  Aligned_cols=239  Identities=19%  Similarity=0.303  Sum_probs=190.9

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEec
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESV  121 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~  121 (332)
                      ++|.+.+.||+|+||.||.|.+ .+..+|+|.+.....  ..+.+.+|+.++.+++||||+++           +||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM--SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc--cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            4588889999999999999998 445699998875432  24678999999999999999998           899999


Q ss_pred             cCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCC
Q 038681          122 QIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE  201 (332)
Q Consensus       122 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  201 (332)
                      ++|+|.+++....    ..+++..++.++.||+.||.|||   +.+++|+||||+||+++.++.+||+|||.++......
T Consensus        82 ~~~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  154 (256)
T cd05113          82 SNGCLLNYLREHG----KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE  154 (256)
T ss_pred             CCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence            9999999997641    35899999999999999999999   9999999999999999999999999999987665443


Q ss_pred             ceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          202 THIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       202 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      .... ....++..|+|||.+.+ .++.++|||||||++|+|++ |..||........      .......          
T Consensus       155 ~~~~-~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~------~~~~~~~----------  217 (256)
T cd05113         155 YTSS-VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSET------VEKVSQG----------  217 (256)
T ss_pred             eeec-CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH------HHHHhcC----------
Confidence            2211 23345678999999986 88999999999999999998 9999875443221      0111000          


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                          ..   ...+...+..+.+++.+||+.||.+|||+.+|++.|+
T Consensus       218 ----~~---~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         218 ----LR---LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ----CC---CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                00   0001122478899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=5.4e-43  Score=305.28  Aligned_cols=238  Identities=20%  Similarity=0.306  Sum_probs=193.9

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEec
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESV  121 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~  121 (332)
                      +|++.+.||+|+||.||++.+  ++..+|+|.+.........+.+.+|+.+++.++||||+++           +|+||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            478889999999999999998  7889999998765544556788999999999999999987           899999


Q ss_pred             cCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCC
Q 038681          122 QIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE  201 (332)
Q Consensus       122 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  201 (332)
                      ++|+|.+++.....   ..+++..++.++.|++.||.|||   +++|+|+||||+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  154 (255)
T cd08219          81 DGGDLMQKIKLQRG---KLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG  154 (255)
T ss_pred             CCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccc
Confidence            99999999875321   35889999999999999999999   9999999999999999999999999999997665433


Q ss_pred             ceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhh
Q 038681          202 THIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSI  280 (332)
Q Consensus       202 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (332)
                      ...  ....+++.|+|||++.+ .++.++||||||+++|+|++|..||.........     ........          
T Consensus       155 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~-----~~~~~~~~----------  217 (255)
T cd08219         155 AYA--CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI-----LKVCQGSY----------  217 (255)
T ss_pred             ccc--ccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHH-----HHHhcCCC----------
Confidence            211  34568899999999987 7899999999999999999999999754322110     00000000          


Q ss_pred             hhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          281 IIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                              .+.+...+..+.+|+.+||+.||++|||+.+++.+
T Consensus       218 --------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 --------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                    00112344678999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9e-43  Score=304.08  Aligned_cols=239  Identities=20%  Similarity=0.367  Sum_probs=196.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEec
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESV  121 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~  121 (332)
                      .++|++.+.||.|+||.||+|...++.||+|.+.....  ..+.+.+|+.+++.++|+||+++           +||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            45789999999999999999999999999999987654  36789999999999999999987           899999


Q ss_pred             cCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCC
Q 038681          122 QIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE  201 (332)
Q Consensus       122 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  201 (332)
                      ++++|.+++.....   ..+++..+..++.|++.||.|||   ..+++|+||||+||+++.++.++|+|||.++......
T Consensus        83 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          83 AKGSLVDYLRSRGR---AVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             CCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            99999999976521   25899999999999999999999   9999999999999999999999999999998764322


Q ss_pred             ceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          202 THIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       202 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      .     ....+..|+|||.+.+ .++.++||||||+++|++++ |..||........      ......           
T Consensus       157 ~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~-----------  214 (256)
T cd05039         157 D-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV------VPHVEK-----------  214 (256)
T ss_pred             c-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH------HHHHhc-----------
Confidence            1     2334668999998876 88899999999999999997 9999875543221      111100           


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                          ..  ....+...+..+.+++.+||..+|++|||++++++.|+.+
T Consensus       215 ----~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         215 ----GY--RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ----CC--CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                00  0001113347899999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=2e-42  Score=303.45  Aligned_cols=249  Identities=23%  Similarity=0.354  Sum_probs=198.5

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|++.+.||+|+||.||+|..  +++.||+|.+....  .....+.+.+|+.++++++|+||+++           +||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            5799999999999999999999  78999999886432  23336678999999999999999987           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++|+|.+++..... ....+++..+..++.|++.||.|||   +.||+|+||+|+||+++.++.++|+|||++....
T Consensus        82 e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~  157 (267)
T cd08224          82 ELADAGDLSRMIKHFKK-QKRLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             ecCCCCCHHHHHHHhcc-cCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeecc
Confidence            99999999999875322 1245899999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      .....  .....++..|+|||.+.+ .++.++|||||||++|+|++|..||........                  +..
T Consensus       158 ~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------------------~~~  217 (267)
T cd08224         158 SKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY------------------SLC  217 (267)
T ss_pred             CCCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHH------------------HHH
Confidence            43221  134568899999999877 789999999999999999999999864432110                  000


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY  328 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~  328 (332)
                      +.......  ........+..+.+++.+||..+|++|||+.+|++.|+.+.
T Consensus       218 ~~~~~~~~--~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         218 KKIEKCDY--PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             hhhhcCCC--CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            10000000  00011144568999999999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.1e-42  Score=305.27  Aligned_cols=249  Identities=23%  Similarity=0.340  Sum_probs=198.8

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|.+.+.||+|+||.||+|.+  ++..++||.+....  .......+.+|+.+++.++||||+++           ++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688999999999999999997  88999999886532  23335678999999999999999986           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++++|.+++..... ....+++..++.++.||+.||.|||   +.+++|+||||+||+++.++.++|+|||++....
T Consensus        82 e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd08229          82 ELADAGDLSRMIKHFKK-QKRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  157 (267)
T ss_pred             EecCCCCHHHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence            99999999999875322 1246899999999999999999999   9999999999999999999999999999987664


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ......  ....++..|+|||.+.+ .++.++||||||+++|+|++|..||.........    ......          
T Consensus       158 ~~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~----------  221 (267)
T cd08229         158 SKTTAA--HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS----LCKKIE----------  221 (267)
T ss_pred             cCCccc--ccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHH----Hhhhhh----------
Confidence            433211  34568899999999877 7889999999999999999999998654321110    111100          


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY  328 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~  328 (332)
                          ....  +.......+..+.+++.+||+.||++|||+.+|++.++++.
T Consensus       222 ----~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         222 ----QCDY--PPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             ----cCCC--CCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence                0000  00111245578999999999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-43  Score=317.44  Aligned_cols=238  Identities=25%  Similarity=0.341  Sum_probs=201.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh--hhHHHHHHHHHHHHhhc-CCCcceE-----------E
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ--HALEWCINHIVYASRMS-HKHIIKL-----------I  116 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~-H~nIv~~-----------l  116 (332)
                      ...|++.+.||+|.||.||+++.  +|+.+|+|.+.+....  ...+.+.+|+.+|+++. |||||.+           +
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            45689999999999999999999  7999999999876543  23578999999999998 9999998           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC----CCeEEeecC
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ----SDAKLFDFS  192 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~kl~Dfg  192 (332)
                      |||+|.||.|.+.+...      .+++..+..++.|++.|+.|||   +.||+||||||+|+|+...    +.+|++|||
T Consensus       114 vmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFG  184 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFG  184 (382)
T ss_pred             EEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence            99999999999999875      2999999999999999999999   9999999999999999543    579999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      +|........   ....+||+.|+|||++.. .|+..+||||+|+++|.|++|.+||..........     ..      
T Consensus       185 la~~~~~~~~---~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----~i------  250 (382)
T KOG0032|consen  185 LAKFIKPGER---LHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----AI------  250 (382)
T ss_pred             CceEccCCce---EeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----HH------
Confidence            9988877332   267899999999999996 99999999999999999999999998876544322     11      


Q ss_pred             chhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                               .........+.....+..+.+++.+|+..||..|+|+.++++
T Consensus       251 ---------~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  251 ---------LRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             ---------HcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence                     111111222223466788999999999999999999999987

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=7.8e-43  Score=311.16  Aligned_cols=254  Identities=20%  Similarity=0.251  Sum_probs=194.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEe------------------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcce
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW------------------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIK  114 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~------------------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~  114 (332)
                      .++|++.+.||+|+||.||++.+                  ++..+|+|.+...........+.+|+.+++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            35699999999999999999864                  234689999886655555678999999999999999998


Q ss_pred             E-----------EEEEeccCCChHHHHhhhhcc------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 038681          115 L-----------IVFESVQIGTLADRIHHHCEQ------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTN  177 (332)
Q Consensus       115 ~-----------lv~e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  177 (332)
                      +           +||||+++|+|.+++......      ....+++..+..++.|++.||+|||   +.+++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhe
Confidence            7           899999999999999764221      1124778899999999999999999   9999999999999


Q ss_pred             eeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh--CCccCCCCCcc
Q 038681          178 ILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT--AQEVSDHVSFE  254 (332)
Q Consensus       178 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt--g~~p~~~~~~~  254 (332)
                      ||++.++.++|+|||+++...............++..|+|||...+ .++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            9999999999999999976644332211123345678999998765 89999999999999999998  77888654432


Q ss_pred             chhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          255 SRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                      ....      ..       ...........   ..+.+..++..+.+|+.+||+.||.+|||+.+|++.|+
T Consensus       241 ~~~~------~~-------~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 QVIE------NT-------GEFFRDQGRQV---YLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHH------HH-------HHHHhhccccc---cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            2211      00       00000000000   00111234478999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.5e-43  Score=309.97  Aligned_cols=249  Identities=20%  Similarity=0.305  Sum_probs=196.1

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------  115 (332)
                      ..++|++.+.||+|+||.||+|.+       ++..||+|.+...........+.+|+.++++++||||+++         
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            356799999999999999999986       3578999998876655556779999999999999999987         


Q ss_pred             --EEEEeccCCChHHHHhhhhc-----------------ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 038681          116 --IVFESVQIGTLADRIHHHCE-----------------QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPT  176 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~  176 (332)
                        +|+||+++|+|.+++.....                 .....+++..++.++.|++.||.|||   ..+++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHh
Confidence              89999999999999975321                 11134788999999999999999999   999999999999


Q ss_pred             CeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCcc
Q 038681          177 NILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFE  254 (332)
Q Consensus       177 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~  254 (332)
                      ||+++.++.++|+|||++.................+..|+|||.+.+ .++.++|||||||++|||++ |..||......
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999876543322111123345678999999876 89999999999999999998 88888654332


Q ss_pred             chhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 038681          255 SRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQ  326 (332)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~  326 (332)
                      +.      ........                 ..+.+...+..+.+|+.+||+.||.+|||+.|+++.|++
T Consensus       240 ~~------~~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 EV------IYYVRDGN-----------------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HH------HHHHhcCC-----------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            21      11111000                 000111334779999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2e-42  Score=302.78  Aligned_cols=240  Identities=22%  Similarity=0.335  Sum_probs=186.9

Q ss_pred             CccccCCCceEEEEEe-----CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE------------EEEEecc
Q 038681           60 NIVLEDPFRKLYKGFW-----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------------IVFESVQ  122 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~------------lv~e~~~  122 (332)
                      +.||+|+||.||+|.+     .+..||+|.+.........+.+.+|+.+++.++||||+++            +|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            4689999999999987     2357999998765554556788999999999999999987            7999999


Q ss_pred             CCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCc
Q 038681          123 IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET  202 (332)
Q Consensus       123 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  202 (332)
                      +|+|.+++....    ..+++..+..++.|++.||.|||   ..+++||||||+|||++.++.+||+|||+++.......
T Consensus        81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          81 HGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            999999997541    34677888999999999999999   99999999999999999999999999999976543221


Q ss_pred             ee--eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhC-CccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          203 HI--ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTA-QEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       203 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      ..  ......++..|+|||.+.+ .++.++|||||||++|||++| .+||.......      ........         
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~------~~~~~~~~---------  218 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD------ITVYLLQG---------  218 (262)
T ss_pred             eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH------HHHHHhcC---------
Confidence            11  1123345778999999876 889999999999999999995 55565432211      11111000         


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                           .   ....+...+..+.+++.+||..+|++||++.+|++.|+++..
T Consensus       219 -----~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         219 -----R---RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             -----C---CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence                 0   000111234678999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.4e-43  Score=307.90  Aligned_cols=241  Identities=22%  Similarity=0.293  Sum_probs=191.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|++.+.||+|+||.||+|.+  ++..||+|++....... ...+.+|+.++.+++||||+++           +|||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~-~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDD-FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccch-HHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            35699999999999999999998  78899999987554332 4568899999999999999987           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++|+|.+++...     ..+++..+..++.|++.||.|||   +.+|+|+||+|+||+++.++.++|+|||++.....
T Consensus        87 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          87 YCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             CCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            99999999998765     56899999999999999999999   99999999999999999999999999999976643


Q ss_pred             CCceeeccccccCCCcccccccCC----CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      ....  .....++..|+|||.+..    .++.++|||||||++|||++|..||..........      ....  ..+. 
T Consensus       159 ~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~------~~~~--~~~~-  227 (267)
T cd06646         159 TIAK--RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMSK--SNFQ-  227 (267)
T ss_pred             cccc--cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe------eeec--CCCC-
Confidence            2211  134568899999998742    57889999999999999999999986443221100      0000  0000 


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                                ..........+..+.+++.+||..||++|||++++++.
T Consensus       228 ----------~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         228 ----------PPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             ----------CCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence                      00000111344789999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5e-43  Score=313.11  Aligned_cols=257  Identities=18%  Similarity=0.282  Sum_probs=193.7

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ++|.+.+.||+|+||.||+|.+  ++..||+|.+...........+.+|+.+++.++||||+++           +||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            5689999999999999999998  6889999998765544445667899999999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      ++ ++|.+++....    ..+++..+..++.||+.||.|||   +.+|+|+||||+||+++.++.++|+|||++......
T Consensus        86 ~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  157 (301)
T cd07873          86 LD-KDLKQYLDDCG----NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIP  157 (301)
T ss_pred             cc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCC
Confidence            97 59999887541    45889999999999999999999   999999999999999999999999999999765433


Q ss_pred             CceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-cccchhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-QNCRFKEMV  277 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  277 (332)
                      ...  .....+++.|+|||++.+  .++.++|||||||++|+|++|+.||......+...  .....+.. ....+....
T Consensus       158 ~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  233 (301)
T cd07873         158 TKT--YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH--FIFRILGTPTEETWPGIL  233 (301)
T ss_pred             CCc--ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHcCCCChhhchhhh
Confidence            221  123467899999999865  67899999999999999999999998665432211  01111111 111111111


Q ss_pred             hhhhhcccCCC-------CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 DSIIIEDKSCT-------CTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      +.........+       .......+..+.+|+.+||+.||.+|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11000000000       0001134567899999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.9e-44  Score=322.15  Aligned_cols=226  Identities=22%  Similarity=0.255  Sum_probs=182.9

Q ss_pred             CccccCCCceEEEEEe-----CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEecc
Q 038681           60 NIVLEDPFRKLYKGFW-----QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQ  122 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~  122 (332)
                      +.||+|+||.||++..     ++..+|+|++..... ......+.+|+.++++++||||+++           +||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999875     578899999976432 2224567889999999999999998           8999999


Q ss_pred             CCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCc
Q 038681          123 IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET  202 (332)
Q Consensus       123 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  202 (332)
                      +|+|.+++...     ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~  153 (318)
T cd05582          82 GGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK  153 (318)
T ss_pred             CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence            99999999765     56899999999999999999999   99999999999999999999999999999976544322


Q ss_pred             eeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhh
Q 038681          203 HIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSII  281 (332)
Q Consensus       203 ~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (332)
                      .  .....||+.|+|||++.+ .++.++|||||||++|||++|+.||.........      ..+....           
T Consensus       154 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~------~~i~~~~-----------  214 (318)
T cd05582         154 K--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM------TMILKAK-----------  214 (318)
T ss_pred             c--eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH------HHHHcCC-----------
Confidence            1  134578999999999987 7899999999999999999999999765432211      1110000           


Q ss_pred             hcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 038681          282 IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVD  319 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e  319 (332)
                         .    ..+...+..+.+|+.+||+.||.+|||+.+
T Consensus       215 ---~----~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 ---L----GMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             ---C----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence               0    011123467899999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.8e-43  Score=324.72  Aligned_cols=190  Identities=23%  Similarity=0.325  Sum_probs=167.2

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-C-----CCcceE-----------
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS-H-----KHIIKL-----------  115 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H-----~nIv~~-----------  115 (332)
                      +|.+.+.||+|+||.|.+|.+  +++.||||+++....  ...+...|+.+|..|+ |     -|+|++           
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~--f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR--FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH--HHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            678899999999999999999  899999999987743  3567789999999997 4     378887           


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC--CCeEEeecCC
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ--SDAKLFDFSL  193 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl~Dfg~  193 (332)
                      ||+|.+.. +|+++++.+   .+..++...++.++.||+.||.+||   ..+|||+||||+|||+...  ..+||+|||.
T Consensus       265 iVfELL~~-NLYellK~n---~f~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGS  337 (586)
T KOG0667|consen  265 IVFELLST-NLYELLKNN---KFRGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGS  337 (586)
T ss_pred             eeehhhhh-hHHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccc
Confidence            89999965 999999976   3467999999999999999999999   9999999999999999643  4799999999


Q ss_pred             ccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhh
Q 038681          194 SLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFH  258 (332)
Q Consensus       194 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~  258 (332)
                      |.......     .+.+.+..|+|||++.| +|+.+.||||||||++||++|.+.|.+.++.++..
T Consensus       338 Sc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~  398 (586)
T KOG0667|consen  338 SCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLA  398 (586)
T ss_pred             ccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHH
Confidence            98766544     25578999999999999 99999999999999999999999999988776544

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.4e-42  Score=303.74  Aligned_cols=242  Identities=20%  Similarity=0.294  Sum_probs=193.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------EEEEec
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IVFESV  121 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv~e~~  121 (332)
                      .++|.+...||+|+||.||+|.+ .+..+|+|.+.....  ..+.+.+|+.++++++||||+++          +||||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~   82 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM--MPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFM   82 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc--cHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcC
Confidence            35688999999999999999998 555799998765432  24678899999999999999987          899999


Q ss_pred             cCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCC
Q 038681          122 QIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE  201 (332)
Q Consensus       122 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  201 (332)
                      ++|+|.+++....   ...+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        83 ~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          83 GKGSLLDFLKEGD---GKYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCCHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            9999999997642   134789999999999999999999   9999999999999999999999999999997664433


Q ss_pred             ceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          202 THIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       202 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      .... ....++..|+|||...+ .++.++||||||+++|+|++ |..||.........      .....           
T Consensus       157 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~------~~~~~-----------  218 (260)
T cd05069         157 YTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL------EQVER-----------  218 (260)
T ss_pred             cccc-CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHc-----------
Confidence            2111 23346778999998876 88999999999999999999 89998764432211      11100           


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQ  326 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~  326 (332)
                          ..  ..+.+...+..+.+++.+||..||++||++++|++.|++
T Consensus       219 ----~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         219 ----GY--RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ----CC--CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                00  001112345789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.2e-42  Score=307.33  Aligned_cols=238  Identities=21%  Similarity=0.293  Sum_probs=189.2

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ++|++.+.||+|+||.||+|.+  ++..||+|.+...........+.+|+.++.+++||||+++           +||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3578889999999999999998  7889999998766545546779999999999999999997           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++|+|..+         ..+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~l~~~---------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~  148 (279)
T cd06619          81 MDGGSLDVY---------RKIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS  148 (279)
T ss_pred             CCCCChHHh---------hcCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc
Confidence            999999654         24788899999999999999999   999999999999999999999999999999766443


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhh-hHHHHhhhhccccchhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFH-YEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  278 (332)
                      ..    ....+|..|+|||.+.+ .++.++|||||||++|+|++|..||.......... ........            
T Consensus       149 ~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------  212 (279)
T cd06619         149 IA----KTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI------------  212 (279)
T ss_pred             cc----cCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH------------
Confidence            22    34578999999999987 88999999999999999999999997543221100 00000000            


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                        .....  ........+.++.+++.+||+.||++||+++++++.
T Consensus       213 --~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         213 --VDEDP--PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             --hccCC--CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence              00000  000011234678999999999999999999999763

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-42  Score=302.88  Aligned_cols=238  Identities=21%  Similarity=0.296  Sum_probs=190.0

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEec
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESV  121 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~  121 (332)
                      .+|++.+.||+|+||.||+|.+ .+..+|+|.+......  ...+.+|+.+++.++||||+++           +||||+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS--EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            3588899999999999999998 5668999988654322  3568899999999999999987           899999


Q ss_pred             cCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCC
Q 038681          122 QIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE  201 (332)
Q Consensus       122 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  201 (332)
                      ++++|.+++....    ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++......
T Consensus        82 ~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~  154 (256)
T cd05059          82 ANGCLLNYLRERK----GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ  154 (256)
T ss_pred             CCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceeccccc
Confidence            9999999997641    35899999999999999999999   9999999999999999999999999999997664432


Q ss_pred             ceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          202 THIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       202 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      .... ....++..|+|||.+.+ .++.++||||||+++|++++ |..||......+.      .......          
T Consensus       155 ~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~~----------  217 (256)
T cd05059         155 YTSS-QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEV------VESVSAG----------  217 (256)
T ss_pred             cccc-CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHH------HHHHHcC----------
Confidence            2111 22234567999999887 88999999999999999999 8899875433221      1111000          


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL  324 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L  324 (332)
                           .  ....+...+..+.+++.+||..+|++|||+.++++.|
T Consensus       218 -----~--~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         218 -----Y--RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -----C--cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                 0  0011113457899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.8e-43  Score=317.88  Aligned_cols=225  Identities=20%  Similarity=0.251  Sum_probs=178.7

Q ss_pred             CccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHH-HHHhhcCCCcceE-----------EEEEeccC
Q 038681           60 NIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIV-YASRMSHKHIIKL-----------IVFESVQI  123 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~H~nIv~~-----------lv~e~~~~  123 (332)
                      +.||+|+||.||+|.+  +++.||+|.+.....  ......+..|.. +++.++||||+++           +||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4699999999999999  789999999875421  222344556655 4577899999987           89999999


Q ss_pred             CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCce
Q 038681          124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH  203 (332)
Q Consensus       124 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  203 (332)
                      |+|..++...     ..+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+++........
T Consensus        81 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  152 (323)
T cd05575          81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT  152 (323)
T ss_pred             CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCc
Confidence            9999998765     56899999999999999999999   999999999999999999999999999998754332211


Q ss_pred             eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhh
Q 038681          204 IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIII  282 (332)
Q Consensus       204 ~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (332)
                        .....||+.|+|||++.+ .++.++|||||||++|||++|..||........      ....              ..
T Consensus       153 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~------~~~i--------------~~  210 (323)
T cd05575         153 --TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM------YDNI--------------LN  210 (323)
T ss_pred             --cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHH------HHHH--------------Hc
Confidence              134578999999999987 889999999999999999999999976543221      1111              10


Q ss_pred             cccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHH
Q 038681          283 EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMV  318 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~  318 (332)
                      ....    .....+..+.+++.+||+.||.+||++.
T Consensus       211 ~~~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         211 KPLR----LKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCCC----CCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            0000    0112347789999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.8e-42  Score=299.86  Aligned_cols=235  Identities=21%  Similarity=0.330  Sum_probs=188.6

Q ss_pred             CccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCCChH
Q 038681           60 NIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLA  127 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g~L~  127 (332)
                      +.||+|+||.||+|.. .+..+|+|.+...........+.+|+.+++.++||||+++           +||||+++|+|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            3699999999999988 7788999998876655556678999999999999999987           899999999999


Q ss_pred             HHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceeecc
Q 038681          128 DRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD  207 (332)
Q Consensus       128 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  207 (332)
                      +++....    ..+++..+..++.|++.||.|||   .++++|+||||+||+++.++.++|+|||++........... .
T Consensus        81 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~-~  152 (250)
T cd05085          81 SFLRKKK----DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSS-G  152 (250)
T ss_pred             HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccC-C
Confidence            9986541    35789999999999999999999   99999999999999999999999999999875543322111 2


Q ss_pred             ccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhccc
Q 038681          208 SVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDK  285 (332)
Q Consensus       208 ~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ...++..|+|||++.+ .++.++||||||+++|++++ |..||.........      ......               .
T Consensus       153 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~------~~~~~~---------------~  211 (250)
T cd05085         153 LKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR------EQVEKG---------------Y  211 (250)
T ss_pred             CCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH------HHHHcC---------------C
Confidence            2244677999999886 78999999999999999998 99999755332211      111000               0


Q ss_pred             CCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          286 SCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       286 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                        ....+...+..+.+++.+||..+|++|||+.++++.|.
T Consensus       212 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         212 --RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence              00011123478999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-42  Score=302.62  Aligned_cols=240  Identities=21%  Similarity=0.283  Sum_probs=192.5

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC----hhhHHHHHHHHHHHHhhcCCCcceE-----------E
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN----QHALEWCINHIVYASRMSHKHIIKL-----------I  116 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~~-----------l  116 (332)
                      ++|.+.+.||+|++|.||.|..  ++..|++|.+.....    ......+.+|+.++++++||||+++           +
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5799999999999999999988  789999999865432    1224578899999999999999998           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      |+||+++++|.+++...     ..+++..+..++.|++.||.|||   +.+|+|+||+|+||+++.++.++|+|||+++.
T Consensus        82 v~e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~  153 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKR  153 (263)
T ss_pred             EEEECCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccccee
Confidence            99999999999999765     56899999999999999999999   99999999999999999999999999999876


Q ss_pred             cCCCCceee-ccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          197 IPDGETHIE-LDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       197 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ......... .....++..|+|||++.+ .++.++||||||+++|||++|+.||..........     . .....    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-----~-~~~~~----  223 (263)
T cd06625         154 LQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-----K-IATQP----  223 (263)
T ss_pred             ccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHH-----H-HhccC----
Confidence            543221111 023457889999999987 78999999999999999999999997543221110     0 00000    


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                                  .....+...+..+.+++.+||..+|.+|||+.++++.
T Consensus       224 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         224 ------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             ------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                        0011112344678999999999999999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-45  Score=307.52  Aligned_cols=234  Identities=22%  Similarity=0.326  Sum_probs=204.0

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEecc
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQ  122 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~  122 (332)
                      |.+..+||+|+||.||++.+  .|..||||++....+   ++++.+|+.++.++..|++|++           ||||||.
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD---LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD---LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch---HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            78889999999999999999  899999999987754   7889999999999999999998           8999999


Q ss_pred             CCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCc
Q 038681          123 IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET  202 (332)
Q Consensus       123 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  202 (332)
                      .|++.+.++.+.    .++.+.++..++++.++||+|||   ...-+|||||..|||++.+|.+||+|||.|..+.+.-.
T Consensus       112 AGSiSDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH---~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA  184 (502)
T KOG0574|consen  112 AGSISDIMRARR----KPLSEQEISAVLRDTLKGLQYLH---DLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA  184 (502)
T ss_pred             CCcHHHHHHHhc----CCccHHHHHHHHHHHHhHHHHHH---HHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH
Confidence            999999998763    67999999999999999999999   99999999999999999999999999999977655332


Q ss_pred             eeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhh
Q 038681          203 HIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSII  281 (332)
Q Consensus       203 ~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (332)
                        ..++..||+.|||||++.. .|+.++||||||++..||.-|++||....+.....                     .+
T Consensus       185 --KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF---------------------MI  241 (502)
T KOG0574|consen  185 --KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF---------------------MI  241 (502)
T ss_pred             --hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE---------------------ec
Confidence              2367899999999999998 99999999999999999999999998765533211                     01


Q ss_pred             hcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          282 IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ...+++....++.++.++.++++.||...|++|-||.++++
T Consensus       242 PT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  242 PTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             cCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            11222334455688899999999999999999999999886

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.1e-42  Score=311.26  Aligned_cols=187  Identities=23%  Similarity=0.311  Sum_probs=153.3

Q ss_pred             CCccccCCCceEEEEEe----CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-------------EEEEec
Q 038681           59 QNIVLEDPFRKLYKGFW----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-------------IVFESV  121 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-------------lv~e~~  121 (332)
                      ..+||+|+||.||+|.+    ++..+|+|.+.....   ...+.+|+.++++++||||+++             +|+||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC---cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc
Confidence            56899999999999986    457899999876532   3456789999999999999986             789998


Q ss_pred             cCCChHHHHhhhhc----ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee----CCCCCeEEeecCC
Q 038681          122 QIGTLADRIHHHCE----QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF----NEQSDAKLFDFSL  193 (332)
Q Consensus       122 ~~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfg~  193 (332)
                      + ++|.+++.....    .....+++..+..++.||+.||.|||   +++|+||||||+|||+    +.++.+||+|||+
T Consensus        83 ~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07868          83 E-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             C-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence            6 489888764321    11235899999999999999999999   9999999999999999    4567899999999


Q ss_pred             ccccCCCCce-eeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCC
Q 038681          194 SLSIPDGETH-IELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVS  252 (332)
Q Consensus       194 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~  252 (332)
                      ++........ .......||+.|+|||++.+  .++.++||||+||++|+|++|..||....
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            9876543211 11234678999999999876  58999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.9e-43  Score=330.34  Aligned_cols=258  Identities=16%  Similarity=0.223  Sum_probs=187.1

Q ss_pred             HHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCC------cceE---
Q 038681           47 EELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKH------IIKL---  115 (332)
Q Consensus        47 ~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~~---  115 (332)
                      +++....++|.+.++||+|+||.||+|.+  .+..||||++.....  ....+..|+.++..++|.+      |+++   
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~--~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK--YTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh--hHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            34555678899999999999999999998  788999999865322  2345667888888876554      5543   


Q ss_pred             ---------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeeecCCCCCCeeeCCCC-
Q 038681          116 ---------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFS-RPIVYRDMKPTNILFNEQS-  184 (332)
Q Consensus       116 ---------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~~-  184 (332)
                               +|||++ +++|.+++...     ..+++..+..++.||+.||+|||   . .||+||||||+|||++.++ 
T Consensus       200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH---~~~gIiHrDlKP~NILl~~~~~  270 (467)
T PTZ00284        200 FQNETGHMCIVMPKY-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFH---TELHLMHTDLKPENILMETSDT  270 (467)
T ss_pred             EEcCCceEEEEEecc-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hcCCeecCCCCHHHEEEecCCc
Confidence                     788887 67899988765     57999999999999999999999   7 5999999999999998765 


Q ss_pred             ---------------CeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccC
Q 038681          185 ---------------DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVS  248 (332)
Q Consensus       185 ---------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~  248 (332)
                                     .+||+|||.+.......     ....||+.|+|||++.+ .++.++|||||||++|||++|+.||
T Consensus       271 ~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~~-----~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf  345 (467)
T PTZ00284        271 VVDPVTNRALPPDPCRVRICDLGGCCDERHSR-----TAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY  345 (467)
T ss_pred             ccccccccccCCCCceEEECCCCccccCcccc-----ccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence                           49999999875432221     35679999999999988 8999999999999999999999999


Q ss_pred             CCCCccchhhhHHHHhhhhccccchh---------hhhhhhhhccc-----------CCCCCChHHHHHHHHHHHHHccc
Q 038681          249 DHVSFESRFHYEENVKRLSGQNCRFK---------EMVDSIIIEDK-----------SCTCTGKEQQLQAFKQLTLQCMD  308 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~li~~cl~  308 (332)
                      ......+....  ....+...+..+.         ++++.......           .............+.+||.+||+
T Consensus       346 ~~~~~~~~~~~--i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~  423 (467)
T PTZ00284        346 DTHDNLEHLHL--MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH  423 (467)
T ss_pred             CCCChHHHHHH--HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCC
Confidence            87654332211  1111110000000         00000000000           00000000123568899999999


Q ss_pred             CCCCCCCCHHHHHH
Q 038681          309 FSPEDRPTMVDVAK  322 (332)
Q Consensus       309 ~dP~~RPs~~evl~  322 (332)
                      +||.+|||+.|+++
T Consensus       424 ~dP~~R~ta~e~L~  437 (467)
T PTZ00284        424 YDRQKRLNARQMTT  437 (467)
T ss_pred             cChhhCCCHHHHhc
Confidence            99999999999986

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-42  Score=303.21  Aligned_cols=241  Identities=20%  Similarity=0.270  Sum_probs=187.4

Q ss_pred             CccccCCCceEEEEEe--CCe--eEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----------EEEEeccC
Q 038681           60 NIVLEDPFRKLYKGFW--QKR--SISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----------IVFESVQI  123 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv~e~~~~  123 (332)
                      +.||+|+||.||+|.+  ++.  .+++|.+.........+.+.+|+.++.++ +||||+++           +||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            3689999999999998  333  46888887655555567889999999999 79999987           89999999


Q ss_pred             CChHHHHhhhhc-----------ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          124 GTLADRIHHHCE-----------QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       124 g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                      |+|.+++.....           .....+++..+..++.|++.||+|||   +++++|+||||+||+++.++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCC
Confidence            999999976421           11134789999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccc
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      ++.........   .....+..|+|||++.+ .++.++|||||||++|||++ |..||........      ......  
T Consensus       158 l~~~~~~~~~~---~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~------~~~~~~--  226 (270)
T cd05047         158 LSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEKLPQ--  226 (270)
T ss_pred             Cccccchhhhc---cCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH------HHHHhC--
Confidence            98643221110   12234567999999876 88999999999999999997 9999975433221      111100  


Q ss_pred             cchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                                   ..  ....+...+.++.+++.+||..||.+|||+.+++..|.++++
T Consensus       227 -------------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~~  270 (270)
T cd05047         227 -------------GY--RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE  270 (270)
T ss_pred             -------------CC--CCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhhC
Confidence                         00  000111234678999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.2e-42  Score=307.03  Aligned_cols=234  Identities=21%  Similarity=0.309  Sum_probs=183.0

Q ss_pred             cccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCCCh
Q 038681           62 VLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTL  126 (332)
Q Consensus        62 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g~L  126 (332)
                      ||+|+||.||++..  +|+.+|+|.+.....  ......+..|+.++.+++||||+++           +||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999998  789999999865322  1123445679999999999999998           89999999999


Q ss_pred             HHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceeec
Q 038681          127 ADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL  206 (332)
Q Consensus       127 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  206 (332)
                      .+++.....   ..+++..+..++.||+.||+|||   +.+|+||||||+||+++.++.++|+|||++.........   
T Consensus        81 ~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~---  151 (277)
T cd05607          81 KYHIYNVGE---RGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---  151 (277)
T ss_pred             HHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCcee---
Confidence            998865421   35889999999999999999999   999999999999999999999999999998776543322   


Q ss_pred             cccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhccc
Q 038681          207 DSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDK  285 (332)
Q Consensus       207 ~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ....||..|+|||++.+ .++.++|||||||++|||++|..||..........  ......              .....
T Consensus       152 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~--~~~~~~--------------~~~~~  215 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE--ELKRRT--------------LEDEV  215 (277)
T ss_pred             eccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHH--HHHHHh--------------hcccc
Confidence            34568999999999987 88999999999999999999999997543211100  010100              00000


Q ss_pred             CCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          286 SCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       286 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                      ..   .....+.++.+|+.+||+.||++||++.|+++.
T Consensus       216 ~~---~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         216 KF---EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             cc---ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence            00   001344778999999999999999999776543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.4e-42  Score=301.02  Aligned_cols=237  Identities=21%  Similarity=0.312  Sum_probs=193.4

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      +|...+.||+|++|.||+|.+  ++..|++|.+.... .....+.+.+|+.++++++||||+++           +||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            478889999999999999998  78999999987542 33446778999999999999999987           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++++|.+++....   ...+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++.....
T Consensus        81 ~~~~~L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~  154 (256)
T cd08529          81 AENGDLHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN  154 (256)
T ss_pred             CCCCcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCc
Confidence            99999999997642   146899999999999999999999   999999999999999999999999999998876544


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      ....  ....|++.|+|||++.+ .++.++|||||||++|+|++|..||........      .....            
T Consensus       155 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~------------  214 (256)
T cd08529         155 TNFA--NTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL------ILKII------------  214 (256)
T ss_pred             cchh--hccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHH------------
Confidence            3221  34568899999999887 788999999999999999999999976542211      11100            


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                        ...   ........+..+.+++.+||+.+|++||++.++++
T Consensus       215 --~~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         215 --RGV---FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             --cCC---CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence              000   00111134477999999999999999999999986

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-43  Score=312.70  Aligned_cols=235  Identities=20%  Similarity=0.319  Sum_probs=203.7

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      +-|.+.+.||+|.|+.|-+|++  +|..||||++.+..- .-....+.+|++.|+.++|||||++           ||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4488889999999999999999  999999999988753 3345678999999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee-CCCCCeEEeecCCccccC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF-NEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill-~~~~~~kl~Dfg~a~~~~  198 (332)
                      +-.+|+|.+||.++.    ..+.+..+.+++.||+.|+.|+|   ...+|||||||+||++ ..-|-+||.|||++-.+.
T Consensus        98 LGD~GDl~DyImKHe----~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~  170 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHE----EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ  170 (864)
T ss_pred             ecCCchHHHHHHhhh----ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence            999999999998873    56999999999999999999999   9999999999999876 567889999999998877


Q ss_pred             CCCceeeccccccCCCcccccccCC-CC-ChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      .+...   .+.+|+..|-|||++.+ .| .+++||||||||||-|++|+.||...+..+...                -+
T Consensus       171 PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT----------------mI  231 (864)
T KOG4717|consen  171 PGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT----------------MI  231 (864)
T ss_pred             Ccchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh----------------hh
Confidence            76543   67899999999999998 44 678999999999999999999999877655421                11


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      +|        |..+.+...+.+..+||..||..||.+|.|.++|..
T Consensus       232 mD--------CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  232 MD--------CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             hc--------ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            11        334455678899999999999999999999999875

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.5e-42  Score=313.12  Aligned_cols=255  Identities=19%  Similarity=0.290  Sum_probs=199.4

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEeC---------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE---
Q 038681           49 LRIATNNYDEQNIVLEDPFRKLYKGFWQ---------KRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL---  115 (332)
Q Consensus        49 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~---  115 (332)
                      ++....+|.+.+.||+|+||.||+|.+.         +..||+|.+.........+.+.+|+.++.++ +||||+++   
T Consensus         7 ~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           7 WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             cccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            3444456999999999999999999861         2368999888665555577899999999999 79999987   


Q ss_pred             --------EEEEeccCCChHHHHhhhhc-----------ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 038681          116 --------IVFESVQIGTLADRIHHHCE-----------QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPT  176 (332)
Q Consensus       116 --------lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~  176 (332)
                              +++||+++|+|.+++.....           .....+++..+..++.|++.||.|||   +++|+||||||+
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~  163 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAAR  163 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccc
Confidence                    89999999999999976421           11235788999999999999999999   999999999999


Q ss_pred             CeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCcc
Q 038681          177 NILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFE  254 (332)
Q Consensus       177 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~  254 (332)
                      ||+++.++.+||+|||+++...............++..|+|||++.+ .++.++|||||||++|||++ |..||......
T Consensus       164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  243 (334)
T cd05100         164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE  243 (334)
T ss_pred             eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999999976654332211122334568999999977 78999999999999999998 88888765432


Q ss_pred             chhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          255 SRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                      ..      ...+...               .  ....+...+..+.+++.+||+.+|.+|||+.++++.|+++..
T Consensus       244 ~~------~~~~~~~---------------~--~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         244 EL------FKLLKEG---------------H--RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             HH------HHHHHcC---------------C--CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            21      1111100               0  000111334679999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.4e-43  Score=317.66  Aligned_cols=228  Identities=20%  Similarity=0.262  Sum_probs=179.1

Q ss_pred             CccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHH-HHHhhcCCCcceE-----------EEEEeccC
Q 038681           60 NIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIV-YASRMSHKHIIKL-----------IVFESVQI  123 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~H~nIv~~-----------lv~e~~~~  123 (332)
                      +.||+|+||.||+|.+  ++..||+|.+.....  ......+..|.. +++.++||||+++           +||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4699999999999999  678899999875421  122334455544 4677899999987           89999999


Q ss_pred             CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCce
Q 038681          124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH  203 (332)
Q Consensus       124 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  203 (332)
                      |+|.+++...     ..+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+++........
T Consensus        81 ~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~  152 (325)
T cd05602          81 GELFYHLQRE-----RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT  152 (325)
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCC
Confidence            9999999765     56889999999999999999999   999999999999999999999999999999754332211


Q ss_pred             eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhh
Q 038681          204 IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIII  282 (332)
Q Consensus       204 ~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (332)
                        .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.........      .....              
T Consensus       153 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~i~~--------------  210 (325)
T cd05602         153 --TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY------DNILN--------------  210 (325)
T ss_pred             --cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH------HHHHh--------------
Confidence              135579999999999987 8899999999999999999999999765432211      11100              


Q ss_pred             cccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 038681          283 EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVA  321 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl  321 (332)
                      ...    ......+..+.+++.+||+.||.+||++.+.+
T Consensus       211 ~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         211 KPL----QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             CCc----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            000    01113347789999999999999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.6e-42  Score=304.85  Aligned_cols=244  Identities=19%  Similarity=0.285  Sum_probs=193.9

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CC---eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QK---RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      ++|++.+.||+|+||.||+|.+  ++   ..||+|.+.........+.+.+|+.+++.++||||+++           +|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            4588899999999999999998  33   36999998876555557789999999999999999998           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+++|+|.+++....    ..+++..++.++.|++.||.|||   +.|++|+||||+||+++.++.++|+|||++...
T Consensus        84 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~  156 (269)
T cd05065          84 TEFMENGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  156 (269)
T ss_pred             EecCCCCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCcccccc
Confidence            99999999999987641    45899999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCceeeccccc---cCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          198 PDGETHIELDSVV---GTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       198 ~~~~~~~~~~~~~---gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      .............   .+..|+|||.+.+ .++.++|||||||++||+++ |..||........      ......    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~------~~~i~~----  226 (269)
T cd05065         157 EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV------INAIEQ----  226 (269)
T ss_pred             ccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH------HHHHHc----
Confidence            4433211111111   2457999999987 88999999999999999886 9999875443221      111100    


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                                 ..  ..+.+..++..+.+++.+||..+|.+||++.+|+..|+++
T Consensus       227 -----------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         227 -----------DY--RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             -----------CC--cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                       00  0011123446789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=8.9e-43  Score=309.33  Aligned_cols=256  Identities=19%  Similarity=0.225  Sum_probs=187.2

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh-hhHHHHHHHHHHHHhh---cCCCcceE-------------
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ-HALEWCINHIVYASRM---SHKHIIKL-------------  115 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~H~nIv~~-------------  115 (332)
                      +|++.+.||+|+||.||+|.+  +++.||+|.+...... .....+.+|+.+++.+   +||||+++             
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            488899999999999999999  7889999998764322 1233456777777665   69999986             


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                         +|+||+++ +|.+++.....   ..+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg  153 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPP---PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFG  153 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccC
Confidence               79999974 89998876421   35899999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-cc
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-QN  270 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~  270 (332)
                      ++.........   ....+|..|+|||++.+ .++.++|||||||++|+|++|.+||..........  ........ ..
T Consensus       154 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~--~~~~~~~~~~~  228 (288)
T cd07863         154 LARIYSCQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG--KIFDLIGLPPE  228 (288)
T ss_pred             ccccccCcccC---CCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHH--HHHHHhCCCCh
Confidence            99766543221   34568999999999977 88999999999999999999999997654432211  11111100 00


Q ss_pred             cchhhhhh---hhhhc-ccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          271 CRFKEMVD---SIIIE-DKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       271 ~~~~~~~~---~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ..+.....   ..... .........+..+..+.+++.+||+.||++|||+.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00000000   00000 000000001134467899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3e-42  Score=302.81  Aligned_cols=245  Identities=21%  Similarity=0.319  Sum_probs=194.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CC---eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------E
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QK---RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------I  116 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------l  116 (332)
                      .++|+..+.||+|+||.||+|..  ++   ..+++|.+.........+.+.+|+.++++++||||+++           +
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            45788899999999999999998  33   36899998766555556779999999999999999988           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ||||+++++|.+++....    ..+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++..
T Consensus        84 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~  156 (268)
T cd05063          84 ITEYMENGALDKYLRDHD----GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRV  156 (268)
T ss_pred             EEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCcccee
Confidence            999999999999997541    46899999999999999999999   99999999999999999999999999999976


Q ss_pred             cCCCCceee-ccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          197 IPDGETHIE-LDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       197 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      ......... ......+..|+|||.+.+ .++.++|||||||++||+++ |..||........      ...+...    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~------~~~i~~~----  226 (268)
T cd05063         157 LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV------MKAINDG----  226 (268)
T ss_pred             cccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH------HHHHhcC----
Confidence            654322111 011223457999999876 78999999999999999997 9999965433221      1111100    


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                                 .  ..+.....+..+.+++.+||+.+|++||++.+|++.|.++
T Consensus       227 -----------~--~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 -----------F--RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -----------C--CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                       0  0011113347789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.6e-43  Score=306.86  Aligned_cols=240  Identities=26%  Similarity=0.457  Sum_probs=190.2

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhh-HHHHHHHHHHHHhhcCCCcceE-----------EEEEec
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHA-LEWCINHIVYASRMSHKHIIKL-----------IVFESV  121 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~  121 (332)
                      |++.+.||+|+||+||++..  ++..+|+|.+........ .....+|+.++.+++||||+++           +||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            56788999999999999999  677899999988765432 2344669999999999999987           899999


Q ss_pred             cCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCC
Q 038681          122 QIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE  201 (332)
Q Consensus       122 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  201 (332)
                      ++++|.+++...     ..+++..+..++.||+.||.+||   +.+|+|+||||+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~  152 (260)
T PF00069_consen   81 PGGSLQDYLQKN-----KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENN  152 (260)
T ss_dssp             TTEBHHHHHHHH-----SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTT
T ss_pred             cccccccccccc-----ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            999999999844     57899999999999999999999   8999999999999999999999999999997642222


Q ss_pred             ceeeccccccCCCcccccccC-C-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          202 THIELDSVVGTTGFIAPENFT-T-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       202 ~~~~~~~~~gt~~y~aPE~~~-~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      .  ......+|..|+|||++. + .++.++||||+|+++|+|++|..||..........   .....          ...
T Consensus       153 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~---~~~~~----------~~~  217 (260)
T PF00069_consen  153 E--NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE---IIEKI----------LKR  217 (260)
T ss_dssp             S--EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH---HHHHH----------HHT
T ss_pred             c--ccccccccccccccccccccccccccccccccccccccccccccccccccchhhhh---hhhhc----------ccc
Confidence            1  124567899999999998 4 88999999999999999999999998762222111   00000          000


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ......    .........+.+++.+||+.||++|||+.++++
T Consensus       218 ~~~~~~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  218 PLPSSS----QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHHT----TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cccccc----cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000000    000011278999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.1e-43  Score=316.16  Aligned_cols=231  Identities=18%  Similarity=0.279  Sum_probs=181.8

Q ss_pred             CccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhh-cCCCcceE-----------EEEEeccC
Q 038681           60 NIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRM-SHKHIIKL-----------IVFESVQI  123 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv~e~~~~  123 (332)
                      +.||+|+||.||+|..  +++.||+|++.....  ....+.+.+|+.++.++ +||||+++           +||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999998  778999999986532  23356788999999998 69999987           89999999


Q ss_pred             CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCce
Q 038681          124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH  203 (332)
Q Consensus       124 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  203 (332)
                      |+|..++...     ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++........
T Consensus        81 ~~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  152 (327)
T cd05617          81 GDLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT  152 (327)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCc
Confidence            9999988765     56999999999999999999999   999999999999999999999999999998753322211


Q ss_pred             eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhh
Q 038681          204 IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIII  282 (332)
Q Consensus       204 ~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (332)
                        .....||+.|+|||++.+ .++.++|||||||++|||++|..||...........              .+.+...+.
T Consensus       153 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~--------------~~~~~~~~~  216 (327)
T cd05617         153 --TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT--------------EDYLFQVIL  216 (327)
T ss_pred             --eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCccccc--------------HHHHHHHHH
Confidence              134679999999999987 889999999999999999999999965432211110              000000111


Q ss_pred             cccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCH
Q 038681          283 EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTM  317 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~  317 (332)
                      ..   +...+...+..+.+++.+||+.||.+||++
T Consensus       217 ~~---~~~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         217 EK---PIRIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             hC---CCCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence            00   001112334678999999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.9e-43  Score=323.61  Aligned_cols=240  Identities=16%  Similarity=0.256  Sum_probs=187.1

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|+..+.||+|+||.||++..  +++.||+|++....  .......+.+|+.++..++||||+++           +||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4688999999999999999998  78899999987532  23335678899999999999999987           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++|+|.+++...     ..+++..+..++.|++.||+|||   ++||+||||||+|||++.++.++|+|||+++...
T Consensus        81 E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~  152 (360)
T cd05627          81 EFLPGGDMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK  152 (360)
T ss_pred             eCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence            999999999999765     56899999999999999999999   9999999999999999999999999999987543


Q ss_pred             CCCce---------------------------------eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhC
Q 038681          199 DGETH---------------------------------IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTA  244 (332)
Q Consensus       199 ~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg  244 (332)
                      .....                                 .......||+.|+|||++.+ .++.++|||||||++|||++|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG  232 (360)
T cd05627         153 KAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG  232 (360)
T ss_pred             cccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccC
Confidence            21100                                 00123479999999999987 899999999999999999999


Q ss_pred             CccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC---HHHHH
Q 038681          245 QEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT---MVDVA  321 (332)
Q Consensus       245 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~evl  321 (332)
                      ..||..........      .+...              ......+.....+.++.+|+.+|+. ||.+|++   +.+++
T Consensus       233 ~~Pf~~~~~~~~~~------~i~~~--------------~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~  291 (360)
T cd05627         233 YPPFCSETPQETYR------KVMNW--------------KETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIK  291 (360)
T ss_pred             CCCCCCCCHHHHHH------HHHcC--------------CCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHh
Confidence            99997654432211      00000              0000000001234678899998774 9999985   56655


Q ss_pred             H
Q 038681          322 K  322 (332)
Q Consensus       322 ~  322 (332)
                      +
T Consensus       292 ~  292 (360)
T cd05627         292 S  292 (360)
T ss_pred             c
Confidence            4

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2e-42  Score=308.65  Aligned_cols=236  Identities=19%  Similarity=0.318  Sum_probs=192.3

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      .+|...+.||+|+||.||+|..  ++..|++|.+....... .+.+.+|+.+++.++||||+++           +||||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~-~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~   98 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch-HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence            4688899999999999999997  78899999987655443 5778999999999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++|+|.+++...      .+++.++..++.|++.||.|||   +.+|+|+||||+||+++.++.++|+|||++......
T Consensus        99 ~~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          99 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             cCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            9999999998643      5889999999999999999999   999999999999999999999999999998765433


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      ...  .....+++.|+|||.+.+ .++.++|||||||++|+|++|..||.........     ........         
T Consensus       170 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~-----~~~~~~~~---------  233 (296)
T cd06654         170 QSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-----YLIATNGT---------  233 (296)
T ss_pred             ccc--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH-----HHHhcCCC---------
Confidence            211  134468899999999887 7889999999999999999999999755432211     00000000         


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                             .....+...+..+.+++.+||..||++|||+.++++
T Consensus       234 -------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         234 -------PELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             -------CCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence                   001111234467899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=9.2e-43  Score=314.48  Aligned_cols=229  Identities=17%  Similarity=0.254  Sum_probs=183.5

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcC-CCcceE-----------EEE
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSH-KHIIKL-----------IVF  118 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H-~nIv~~-----------lv~  118 (332)
                      +|+..+.||+|+||.||+|.+  +++.||+|++....  .....+.+..|..++..+.| ++|+++           +||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            477789999999999999998  78899999987542  22335667889999988865 666655           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus        81 Ey~~~g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~  152 (323)
T cd05615          81 EYVNGGDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHM  152 (323)
T ss_pred             cCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccC
Confidence            999999999999765     56999999999999999999999   9999999999999999999999999999987543


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      .....  .....||+.|+|||++.+ .++.++|||||||++|||++|..||........      ...+...        
T Consensus       153 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~------~~~i~~~--------  216 (323)
T cd05615         153 VDGVT--TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL------FQSIMEH--------  216 (323)
T ss_pred             CCCcc--ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH------HHHHHhC--------
Confidence            32221  134568999999999987 789999999999999999999999976543221      1111100        


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTM  317 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~  317 (332)
                            ..    ..+...+.++.+++.+||+.||.+|++.
T Consensus       217 ------~~----~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         217 ------NV----SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ------CC----CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence                  00    0111234678999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-42  Score=321.72  Aligned_cols=255  Identities=20%  Similarity=0.238  Sum_probs=190.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEe----CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      ..+|.+.+.||+|+||.||+|..    .+..|++|.+....      ...+|+.++++++|||||++           +|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK------TPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            45699999999999999999976    45779999876542      34689999999999999987           79


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      ||++. ++|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.++|+|||++...
T Consensus       165 ~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~  235 (392)
T PHA03207        165 MPKYK-CDLFTYVDRS-----GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKL  235 (392)
T ss_pred             ehhcC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCcccccc
Confidence            99986 6899988544     57999999999999999999999   999999999999999999999999999999766


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchh-hhHHHHhhhhccccchh-
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRF-HYEENVKRLSGQNCRFK-  274 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~-  274 (332)
                      .............||+.|+|||++.+ .++.++|||||||++|||++|+.||......... .+......+......+. 
T Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~  315 (392)
T PHA03207        236 DAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ  315 (392)
T ss_pred             CcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC
Confidence            55433322245679999999999987 8999999999999999999999999765443211 11111111111111110 


Q ss_pred             -------hhhhhhhhcc-cCCCCC---ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          275 -------EMVDSIIIED-KSCTCT---GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       275 -------~~~~~~~~~~-~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                             ..+....... .....+   .......++.++|.+||..||++|||+.+++.
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~  374 (392)
T PHA03207        316 NGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILS  374 (392)
T ss_pred             ccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence                   0111100000 000000   00123467889999999999999999999986

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1e-42  Score=341.86  Aligned_cols=246  Identities=19%  Similarity=0.294  Sum_probs=192.2

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           50 RIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        50 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      ....++|.+.+.||+|+||+||+|.+  .+..||+|.+.... .......+..|+.++.+|+|||||++           
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            34457899999999999999999999  77889999987543 33446778999999999999999987           


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcC----CCCeeecCCCCCCeeeCC-------
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGF----SRPIVYRDMKPTNILFNE-------  182 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----~~~ivH~Dlkp~Nill~~-------  182 (332)
                        |||||+++|+|.++|...... ...+++..++.|+.||+.||.|||+..    ..+||||||||+|||++.       
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~-~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence              899999999999999764221 246999999999999999999999310    145999999999999964       


Q ss_pred             ----------CCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC---CCChhhhHHHHHHHHHHHHhCCccCC
Q 038681          183 ----------QSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT---LINEQCDVYGFGAFLFELLTAQEVSD  249 (332)
Q Consensus       183 ----------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~p~~  249 (332)
                                .+.+||+|||++.........   ....||+.|+|||++.+   .++.++|||||||++|||++|..||.
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~---~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~  244 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMA---HSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH  244 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccccc---cccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence                      234899999999866443321   34579999999999854   58899999999999999999999997


Q ss_pred             CCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          250 HVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .......     ....+...               ...+.   ...+.++.+||..||..+|.+||++.+++.
T Consensus       245 ~~~~~~q-----li~~lk~~---------------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        245 KANNFSQ-----LISELKRG---------------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             cCCcHHH-----HHHHHhcC---------------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            5432211     11111100               00000   123467999999999999999999999984

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.1e-42  Score=301.93  Aligned_cols=245  Identities=19%  Similarity=0.281  Sum_probs=195.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--C---CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------E
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--Q---KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------I  116 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------l  116 (332)
                      ..+|.+.+.||+|+||.||+|.+  +   +..+|+|.+.........+.+.+|+.++.+++||||+++           +
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            35688999999999999999987  2   236999998766555556789999999999999999998           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ||||+++|+|.+++....    ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++..
T Consensus        83 v~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~  155 (267)
T cd05066          83 VTEYMENGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRV  155 (267)
T ss_pred             EEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccc
Confidence            999999999999997641    35899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCceee-ccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          197 IPDGETHIE-LDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       197 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      ......... .....++..|+|||.+.+ .++.++|||||||++||+++ |..||......+.      ...+...    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~------~~~~~~~----  225 (267)
T cd05066         156 LEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV------IKAIEEG----  225 (267)
T ss_pred             cccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH------HHHHhCC----
Confidence            654332211 112233568999999987 88999999999999999886 9999876543221      1111100    


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                                 .  ..+.....+..+.+++.+||+.+|.+|||+.++++.|.++
T Consensus       226 -----------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         226 -----------Y--RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -----------C--cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                       0  0011113346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.4e-42  Score=305.51  Aligned_cols=240  Identities=18%  Similarity=0.256  Sum_probs=191.0

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE------------
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL------------  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~------------  115 (332)
                      .+.+.|+..+.||+|+||.||+|.+  .++.||+|.+......  ...+.+|+.++.++ +||||+++            
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc--HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            3567799999999999999999998  7889999998765432  45688999999998 69999975            


Q ss_pred             -----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEee
Q 038681          116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFD  190 (332)
Q Consensus       116 -----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  190 (332)
                           +||||+++|+|.+++....   ...+++..+..++.|++.||+|||   +++|+|+||||+||+++.++.++|+|
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~D  154 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVD  154 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEcc
Confidence                 7999999999999997642   135899999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccC-----C-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHh
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFT-----T-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVK  264 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~  264 (332)
                      ||++........  ......|+..|+|||++.     + .++.++|||||||++|||++|..||..........     .
T Consensus       155 fg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~-----~  227 (272)
T cd06637         155 FGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----L  227 (272)
T ss_pred             CCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH-----H
Confidence            999976543221  113467899999999985     2 57889999999999999999999996543221110     0


Q ss_pred             hhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          265 RLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ....                 ..........+..+.+|+.+||..||.+|||+.++++
T Consensus       228 ~~~~-----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         228 IPRN-----------------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HhcC-----------------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            0000                 0000011133467899999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-42  Score=298.73  Aligned_cols=240  Identities=25%  Similarity=0.394  Sum_probs=195.1

Q ss_pred             CccccCCCceEEEEEeC-----CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccC
Q 038681           60 NIVLEDPFRKLYKGFWQ-----KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQI  123 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~  123 (332)
                      +.||+|+||.||+|.+.     +..|++|.+.........+.+.+|+.++..++|+||+++           +||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            46999999999999993     788999999877655457889999999999999999997           89999999


Q ss_pred             CChHHHHhhhhcc----cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          124 GTLADRIHHHCEQ----HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       124 g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+|.+++......    ....+++..+..++.|++.||+|||   +++++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999874211    0256899999999999999999999   99999999999999999999999999999987765


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ...........++..|+|||.+.+ .++.++|||||||++|+|++ |..||........      ......         
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~~~---------  222 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV------LEYLRK---------  222 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH------HHHHHc---------
Confidence            432222244567889999999887 88999999999999999999 6999976633221      111110         


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                            ..  ....+...+.++.+++.+||+.||.+|||+.++++.|+
T Consensus       223 ------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 ------GY--RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ------CC--CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                  00  11111234578999999999999999999999998873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-44  Score=324.82  Aligned_cols=248  Identities=22%  Similarity=0.296  Sum_probs=201.9

Q ss_pred             CCCcccccHHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE
Q 038681           38 YNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL  115 (332)
Q Consensus        38 ~~~~~~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~  115 (332)
                      .+.++-+++.+.      |.++..||.|+||.||+|..  ++-..|.|.+.... ...++.++-||.||..+.||+||++
T Consensus        22 ehv~rdlnP~d~------WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks-eEELEDylVEIeILa~CdHP~ivkL   94 (1187)
T KOG0579|consen   22 EHVYRDLNPRDH------WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS-EEELEDYLVEIEILAECDHPVIVKL   94 (1187)
T ss_pred             HHHhccCCHHHH------HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc-hhHHhhhhhhhhhhhcCCChHHHHH
Confidence            445666666665      77788999999999999999  44445666666554 4448999999999999999999997


Q ss_pred             -----------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC
Q 038681          116 -----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS  184 (332)
Q Consensus       116 -----------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  184 (332)
                                 |..|||+||-+...+-.-.    .++.+.++..+++|++.||.|||   +++|||||||..|||++-+|
T Consensus        95 l~ayy~enkLwiliEFC~GGAVDaimlEL~----r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldG  167 (1187)
T KOG0579|consen   95 LSAYYFENKLWILIEFCGGGAVDAIMLELG----RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDG  167 (1187)
T ss_pred             HHHHhccCceEEEEeecCCchHhHHHHHhc----cccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecC
Confidence                       7899999999998887652    57999999999999999999999   99999999999999999999


Q ss_pred             CeEEeecCCccccCCCCceeeccccccCCCcccccccCC------CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhh
Q 038681          185 DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT------LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFH  258 (332)
Q Consensus       185 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~  258 (332)
                      .++|+|||.+......  .....+++|||+|||||+...      +|+.++||||||++|.||..+.+|....+....  
T Consensus       168 dirLADFGVSAKn~~t--~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV--  243 (1187)
T KOG0579|consen  168 DIRLADFGVSAKNKST--RQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--  243 (1187)
T ss_pred             cEeeecccccccchhH--HhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH--
Confidence            9999999998543322  222367899999999998742      799999999999999999999999876654332  


Q ss_pred             hHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          259 YEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                         +.....                ..++....+..++..+.+|+.+||..||..||+++++++
T Consensus       244 ---llKiaK----------------SePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  244 ---LLKIAK----------------SEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ---HHHHhh----------------cCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence               111111                112223344578899999999999999999999999986

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=2.7e-42  Score=337.62  Aligned_cols=252  Identities=18%  Similarity=0.285  Sum_probs=195.5

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|++.++||+|+||.||+|.+  +++.||+|++....  .....+++.+|+.++++++||||+++           +||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            5799999999999999999998  68999999997643  23345679999999999999999987           899


Q ss_pred             EeccCCChHHHHhhhhcc------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          119 ESVQIGTLADRIHHHCEQ------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                      ||++||+|.+++......      .....++..++.++.||+.||+|||   ++||+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecC
Confidence            999999999999753211      1134567788999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCc----------------eeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccc
Q 038681          193 LSLSIPDGET----------------HIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFES  255 (332)
Q Consensus       193 ~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~  255 (332)
                      +++.......                ........||+.|+|||++.+ .++.++|||||||++|||+||..||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9976521110                001123469999999999987 88999999999999999999999997643221


Q ss_pred             hhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHHHH
Q 038681          256 RFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-TMVDVAKQLRQMYR  329 (332)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-s~~evl~~L~~l~~  329 (332)
                      ...    ....          .++.       ........+..+.+++.+||+.||++|| +++++++.|+...+
T Consensus       239 i~~----~~~i----------~~P~-------~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        239 ISY----RDVI----------LSPI-------EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hhh----hhhc----------cChh-------hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            100    0000          0000       0000113446789999999999999995 57778888887654

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=9.1e-42  Score=299.97  Aligned_cols=243  Identities=17%  Similarity=0.213  Sum_probs=180.2

Q ss_pred             CccccCCCceEEEEEe-CC---eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCC
Q 038681           60 NIVLEDPFRKLYKGFW-QK---RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIG  124 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~-~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g  124 (332)
                      +.||+|+||.||+|.. ++   ..+++|.+.........+.+.+|+.+++.++||||+++           +||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999986 32   34667776665544456789999999999999999987           899999999


Q ss_pred             ChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCcee
Q 038681          125 TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHI  204 (332)
Q Consensus       125 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  204 (332)
                      +|.+++...... ....++..+..++.||+.||+|||   +.+++||||||+|||++.++.++|+|||++..........
T Consensus        81 ~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          81 DLKSYLSQEQWH-RRNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             cHHHHHHhhhcc-cccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            999999764221 234677888999999999999999   9999999999999999999999999999986433222111


Q ss_pred             eccccccCCCcccccccCC--------CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          205 ELDSVVGTTGFIAPENFTT--------LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       205 ~~~~~~gt~~y~aPE~~~~--------~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      ......++..|+|||++..        .++.++|||||||++|||++ |..||......+...     ........   .
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-----~~~~~~~~---~  228 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN-----HVIKDQQV---K  228 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----HHHhhccc---c
Confidence            1134567899999998742        35779999999999999997 566776543322111     11111000   0


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                      ..++          .........+.+++..|| .+|.+||++.+|++.|.
T Consensus       229 ~~~~----------~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         229 LFKP----------QLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cCCC----------ccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            0010          011123467888999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.4e-42  Score=304.09  Aligned_cols=241  Identities=17%  Similarity=0.300  Sum_probs=192.2

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ++|++.+.||+|+||.||++.+  .+..||+|.+...........+.+|+.++.+++||||+++           +||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            3688899999999999999999  6899999998765555546789999999999999999987           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++++|..++....  ....+++..+..++.||+.||.|||+  ..+|+|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          81 MDAGSLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             cCCCCHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            99999999887531  11368999999999999999999993  369999999999999999999999999998765433


Q ss_pred             CceeeccccccCCCcccccccCC-------CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-------LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      ..    ....+++.|+|||.+.+       .++.++|||||||++|+|++|..||..........   .           
T Consensus       157 ~~----~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~---~-----------  218 (286)
T cd06622         157 LA----KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA---Q-----------  218 (286)
T ss_pred             cc----ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH---H-----------
Confidence            22    33468889999998854       35789999999999999999999996543221110   0           


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                         +.......   ....+...+.++.+|+.+||+.+|++||++.++++
T Consensus       219 ---~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         219 ---LSAIVDGD---PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             ---HHHHhhcC---CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence               00000000   11112245678999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.9e-42  Score=303.92  Aligned_cols=239  Identities=21%  Similarity=0.278  Sum_probs=189.9

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ++|.+.+.||+|+||.||+|.+  ++..||+|.+....... ...+.+|+.+++.++||||+++           +|+||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED-FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhH-HHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            4688889999999999999998  78899999987654333 5568899999999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++++|.+++...     ..+++.+++.++.|++.||.|||   ..|++|+||||+||+++.++.++|+|||++......
T Consensus        88 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          88 CGGGSLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence            9999999998765     56899999999999999999999   999999999999999999999999999998765432


Q ss_pred             CceeeccccccCCCcccccccC---C-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFT---T-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~---~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ..  ......|+..|+|||++.   . .++.++|||||||++|+|++|..||..........     ..... .....  
T Consensus       160 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~-----~~~~~-~~~~~--  229 (267)
T cd06645         160 IA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-----LMTKS-NFQPP--  229 (267)
T ss_pred             cc--ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH-----hhhcc-CCCCC--
Confidence            21  113457899999999874   2 68899999999999999999999986543221110     00000 00000  


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                 ........+..+.+++.+||+.||++|||+++|++
T Consensus       230 -----------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         230 -----------KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             -----------cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence                       00000123467889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-42  Score=300.58  Aligned_cols=244  Identities=23%  Similarity=0.346  Sum_probs=195.5

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ...++|.+.+.||+|+||.||+|.+ .+..||+|.+......  .+.+.+|+.++++++||||+++           +||
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS--PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC--HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence            4457899999999999999999998 6678999998765432  4678999999999999999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++++|.+++.....   ..+++..+..++.|++.||.|||   +++++|+||||+||+++.++.++|+|||++....
T Consensus        81 e~~~~~~L~~~i~~~~~---~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          81 EYMSKGSLLDFLKSGEG---KKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIE  154 (261)
T ss_pred             eccCCCCHHHHHhcccc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceecc
Confidence            99999999999976421   35899999999999999999999   9999999999999999999999999999997765


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ....... ....++..|+|||.+.+ .++.++|||||||++|++++ |..||.........      ......       
T Consensus       155 ~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~------~~~~~~-------  220 (261)
T cd05034         155 DDEYTAR-EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL------EQVERG-------  220 (261)
T ss_pred             chhhhhh-hccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHcC-------
Confidence            4321111 22335678999999887 78999999999999999998 99998654332211      111000       


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQ  326 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~  326 (332)
                              .  ..+.+...+..+.+++.+||..+|++||+++++.+.|+.
T Consensus       221 --------~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         221 --------Y--RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             --------C--CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                    0  000111224679999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=9.3e-43  Score=314.24  Aligned_cols=225  Identities=20%  Similarity=0.245  Sum_probs=177.7

Q ss_pred             CccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHH-HHHhhcCCCcceE-----------EEEEeccC
Q 038681           60 NIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIV-YASRMSHKHIIKL-----------IVFESVQI  123 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~-~l~~l~H~nIv~~-----------lv~e~~~~  123 (332)
                      +.||+|+||.||+|.+  ++..||+|.+.....  ......+..|.. +++.++||||+++           +||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999  788999999875421  222344556654 5788899999997           89999999


Q ss_pred             CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCce
Q 038681          124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH  203 (332)
Q Consensus       124 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  203 (332)
                      |+|..++...     ..+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+++........
T Consensus        81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  152 (321)
T cd05603          81 GELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET  152 (321)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCc
Confidence            9999888764     56899999999999999999999   999999999999999999999999999998754322211


Q ss_pred             eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhh
Q 038681          204 IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIII  282 (332)
Q Consensus       204 ~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (332)
                        .....||+.|+|||++.+ .++.++|||||||++|||++|..||...+....      ...+.              .
T Consensus       153 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i~--------------~  210 (321)
T cd05603         153 --TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM------YDNIL--------------H  210 (321)
T ss_pred             --cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH------HHHHh--------------c
Confidence              134578999999999987 889999999999999999999999976543211      11110              0


Q ss_pred             cccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHH
Q 038681          283 EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMV  318 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~  318 (332)
                      ...    ..+...+..+.+++.+||+.||.+||++.
T Consensus       211 ~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         211 KPL----QLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCC----CCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence            000    11112346789999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.2e-42  Score=300.34  Aligned_cols=236  Identities=21%  Similarity=0.361  Sum_probs=192.4

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------EEEEeccC
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IVFESVQI  123 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv~e~~~~  123 (332)
                      ++|.+.+.||+|+||.||+|...++.||+|.+.....   .+.+.+|+.++++++||||+++          +||||+++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~~---~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~   82 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDVT---AQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSK   82 (254)
T ss_pred             HHceeeeeeccCCCCceEecccCCCceEEEeecCcch---HHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCC
Confidence            5689999999999999999999999999999875432   4678899999999999999998          89999999


Q ss_pred             CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCce
Q 038681          124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH  203 (332)
Q Consensus       124 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  203 (332)
                      |+|.+++....   ...+++..+..++.|++.||.|||   +.|++||||||+||+++.++.++|+|||++.......  
T Consensus        83 ~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--  154 (254)
T cd05083          83 GNLVNFLRTRG---RALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--  154 (254)
T ss_pred             CCHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccC--
Confidence            99999997642   135899999999999999999999   9999999999999999999999999999987644322  


Q ss_pred             eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhh
Q 038681          204 IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSII  281 (332)
Q Consensus       204 ~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (332)
                         .....+..|+|||.+.+ .++.++|||||||++|+|++ |..||.........      .....             
T Consensus       155 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~------~~~~~-------------  212 (254)
T cd05083         155 ---DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK------ECVEK-------------  212 (254)
T ss_pred             ---CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHH------HHHhC-------------
Confidence               22344678999999876 88999999999999999998 99998765432211      11100             


Q ss_pred             hcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 038681          282 IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQ  326 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~  326 (332)
                        ..  ........+..+.+++.+||+.+|++||++++++..|+.
T Consensus       213 --~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         213 --GY--RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             --CC--CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence              00  000112344778999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1e-42  Score=314.49  Aligned_cols=226  Identities=19%  Similarity=0.258  Sum_probs=178.8

Q ss_pred             CccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHH-HHHhhcCCCcceE-----------EEEEeccC
Q 038681           60 NIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIV-YASRMSHKHIIKL-----------IVFESVQI  123 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~H~nIv~~-----------lv~e~~~~  123 (332)
                      +.||+|+||.||+|.+  +++.+|+|++....  .......+..|.. +++.++||||+++           +||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999998  78999999987542  1222345566665 4677899999987           89999999


Q ss_pred             CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCce
Q 038681          124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH  203 (332)
Q Consensus       124 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  203 (332)
                      |+|..++...     ..+++..+..++.||+.||+|||   +.||+||||||+|||++.++.+||+|||+++........
T Consensus        81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~  152 (325)
T cd05604          81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT  152 (325)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC
Confidence            9999988765     56899999999999999999999   999999999999999999999999999998754322211


Q ss_pred             eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhh
Q 038681          204 IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIII  282 (332)
Q Consensus       204 ~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (332)
                        .....||+.|+|||++.+ .++.++|||||||++|||++|..||........      ....              ..
T Consensus       153 --~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~------~~~~--------------~~  210 (325)
T cd05604         153 --TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM------YDNI--------------LH  210 (325)
T ss_pred             --cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHH------HHHH--------------Hc
Confidence              134579999999999987 889999999999999999999999976543221      1111              10


Q ss_pred             cccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 038681          283 EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVD  319 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e  319 (332)
                      .....    .+..+..+.+++.+||+.||.+||++.+
T Consensus       211 ~~~~~----~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         211 KPLVL----RPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             CCccC----CCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            00000    1123467889999999999999998864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-42  Score=300.54  Aligned_cols=284  Identities=21%  Similarity=0.335  Sum_probs=214.5

Q ss_pred             hhhchHHHHHHHHhcCCCCCCcccccHHHHHHHhcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHH
Q 038681           20 MRNGERLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCIN   99 (332)
Q Consensus        20 ~~~~~~~~~~~~~s~~~~~~~~~~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~   99 (332)
                      ...+++.+++++.....+.+. +-.++---.....+..+.+.||+|.||.||+|.|.|+.||||++....    ...+.+
T Consensus       178 ~~~~~stl~Dll~~~~tSGSG-SGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd----E~SWfr  252 (513)
T KOG2052|consen  178 TLAGDSTLKDLLDDLETSGSG-SGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD----ERSWFR  252 (513)
T ss_pred             cccCCccHHHHHHhhccCCCC-CCchhHhHHhhhheeEEEEEecCccccceeeccccCCceEEEEecccc----hhhhhh
Confidence            366778888887433211111 222222222334567889999999999999999999999999998764    345677


Q ss_pred             HHHHHHh--hcCCCcceE---------------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhh
Q 038681          100 HIVYASR--MSHKHIIKL---------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHV  162 (332)
Q Consensus       100 E~~~l~~--l~H~nIv~~---------------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~  162 (332)
                      |.++...  |+|+||+.|               ||++|-+.|+|.|||...      .++....++++..+|.||+|||.
T Consensus       253 EtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~  326 (513)
T KOG2052|consen  253 ETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHM  326 (513)
T ss_pred             HHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHH
Confidence            8777766  599999998               899999999999999885      69999999999999999999993


Q ss_pred             -----cCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCC--ceeeccccccCCCcccccccCCCCC-------hh
Q 038681          163 -----GFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE--THIELDSVVGTTGFIAPENFTTLIN-------EQ  228 (332)
Q Consensus       163 -----~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-------~~  228 (332)
                           .....|.|||||+.|||+..++.+.|+|+|+|-......  .....+..+||.+|||||++....+       ..
T Consensus       327 eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~  406 (513)
T KOG2052|consen  327 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKR  406 (513)
T ss_pred             HHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhH
Confidence                 336789999999999999999999999999996554432  1222356789999999999976332       25


Q ss_pred             hhHHHHHHHHHHHHhCC----------ccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCC---ChHHH
Q 038681          229 CDVYGFGAFLFELLTAQ----------EVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCT---GKEQQ  295 (332)
Q Consensus       229 sDiwSlG~~l~elltg~----------~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  295 (332)
                      +||||||.|+||++...          .||...-+               ..+++.++.+-.......+..+   .....
T Consensus       407 ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp---------------~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~  471 (513)
T KOG2052|consen  407 ADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVP---------------SDPSFEEMRKVVCVQKLRPNIPNRWKSDPA  471 (513)
T ss_pred             HHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCC---------------CCCCHHHHhcceeecccCCCCCcccccCHH
Confidence            89999999999998632          44443322               3344555554444333322222   22466


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          296 LQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       296 ~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                      ...+.+||+.||..||.-|-||--|-+.|.++.+
T Consensus       472 l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  472 LRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             HHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            6788999999999999999999999999998874

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.3e-42  Score=305.25  Aligned_cols=249  Identities=16%  Similarity=0.239  Sum_probs=196.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|++.+.||+|+||+||++.+  ++..||+|.+.........+.+.+|+++++.++||||+++           +|+|
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            35688889999999999999998  5889999988766555556789999999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++|+|.+++...     +.+++..+..++.+++.||.|||+  .++++|+||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          84 FMDCGSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             cCCCCCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence            99999999998765     568999999999999999999993  36899999999999999999999999999865533


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      ...    ....|+..|+|||++.+ .++.++|||||||++|++++|..||..........         .....+.+.+.
T Consensus       157 ~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~---------~~~~~~~~~~~  223 (284)
T cd06620         157 SIA----DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ---------DDPMGILDLLQ  223 (284)
T ss_pred             hcc----CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh---------hhhhHHHHHHH
Confidence            221    34578999999999876 88899999999999999999999998654321100         00001111111


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                      ........ .. .....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus       224 ~~~~~~~~-~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         224 QIVQEPPP-RL-PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             HHhhccCC-CC-CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            11111110 00 111245779999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-42  Score=301.37  Aligned_cols=236  Identities=20%  Similarity=0.300  Sum_probs=193.7

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ++|++.+.||.|+||.||+|.+  ++..|++|.+...........+.+|+.+++.++||||+++           +|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            3688899999999999999998  7889999999776544446778999999999999999987           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++++|.+++...      .+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||+++.....
T Consensus        81 ~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  151 (274)
T cd06609          81 CGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTST  151 (274)
T ss_pred             eCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence            9999999998753      6899999999999999999999   999999999999999999999999999999876544


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      ...  .....+++.|+|||.+.+ .++.++|||||||++|+|++|..||..........     ........        
T Consensus       152 ~~~--~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~-----~~~~~~~~--------  216 (274)
T cd06609         152 MSK--RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF-----LIPKNNPP--------  216 (274)
T ss_pred             ccc--cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH-----HhhhcCCC--------
Confidence            221  134578889999999987 88999999999999999999999997544221100     00000000        


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                              ... ....+..+.+++.+||..||++|||++++++
T Consensus       217 --------~~~-~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         217 --------SLE-GNKFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             --------CCc-ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                    000 0014467899999999999999999999976

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.3e-42  Score=305.35  Aligned_cols=252  Identities=18%  Similarity=0.241  Sum_probs=197.7

Q ss_pred             cccHHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE----
Q 038681           43 IFSAEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL----  115 (332)
Q Consensus        43 ~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~----  115 (332)
                      .+.++.+....++|++.+.||+|+||.||+|.+  +++.+|+|........  ...+.+|+.++..+ +||||+++    
T Consensus         7 ~~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~   84 (286)
T cd06638           7 TIIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI--DEEIEAEYNILKALSDHPNVVKFYGMY   84 (286)
T ss_pred             eEEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch--HHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence            355567777889999999999999999999998  7889999987654322  35678899999999 69999985    


Q ss_pred             ------------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC
Q 038681          116 ------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ  183 (332)
Q Consensus       116 ------------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  183 (332)
                                  +||||+++|+|.+++...... ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~  160 (286)
T cd06638          85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTE  160 (286)
T ss_pred             eecccCCCCeEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCC
Confidence                        899999999999988653211 246889999999999999999999   9999999999999999999


Q ss_pred             CCeEEeecCCccccCCCCceeeccccccCCCcccccccCC------CCChhhhHHHHHHHHHHHHhCCccCCCCCccchh
Q 038681          184 SDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT------LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRF  257 (332)
Q Consensus       184 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~  257 (332)
                      +.++|+|||++.........  .....|++.|+|||++..      .++.++|||||||++|||++|..||........ 
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-  237 (286)
T cd06638         161 GGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-  237 (286)
T ss_pred             CCEEEccCCceeecccCCCc--cccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-
Confidence            99999999999766443221  134568999999998752      478899999999999999999999975432211 


Q ss_pred             hhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          258 HYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                          .........                .....+...+..+.+|+.+||+.||++|||+.+|++.
T Consensus       238 ----~~~~~~~~~----------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         238 ----LFKIPRNPP----------------PTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             ----HhhccccCC----------------CcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence                100000000                0000111234679999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=8.5e-42  Score=303.82  Aligned_cols=239  Identities=21%  Similarity=0.269  Sum_probs=190.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .+.|++.+.||.|+||.||+|.+  ++..+++|.+..... ...+.+.+|+.+++.++||||+++           +|||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   89 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE-EELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE   89 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence            35699999999999999999998  678999999876543 336778999999999999999997           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++++|..++....    ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||++.....
T Consensus        90 ~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          90 FCPGGAVDAIMLELD----RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             cCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            999999998876531    45899999999999999999999   99999999999999999999999999999865433


Q ss_pred             CCceeeccccccCCCcccccccC-----C-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          200 GETHIELDSVVGTTGFIAPENFT-----T-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~-----~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      ....  .....++..|+|||.+.     . .++.++|||||||++|+|++|..||........     .........   
T Consensus       163 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~-----~~~~~~~~~---  232 (292)
T cd06644         163 TLQR--RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LLKIAKSEP---  232 (292)
T ss_pred             cccc--cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH-----HHHHhcCCC---
Confidence            2211  13456889999999884     2 568899999999999999999999875432211     111110000   


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                   .....+...+.++.+++.+||..||++||++.++++
T Consensus       233 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         233 -------------PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             -------------ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                         011111234467899999999999999999999976

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6e-42  Score=303.27  Aligned_cols=236  Identities=22%  Similarity=0.271  Sum_probs=188.3

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEecc
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQ  122 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~  122 (332)
                      |++.+.||+|+||.||+|.+  ++..+++|.+..... ...+.+.+|+.+++.++||||+++           +|+||++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE-EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH-HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            67788999999999999999  677888988865543 336778999999999999999988           8999999


Q ss_pred             CCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCc
Q 038681          123 IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET  202 (332)
Q Consensus       123 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  202 (332)
                      +|+|..++....    ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++........
T Consensus        86 ~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  158 (282)
T cd06643          86 GGAVDAVMLELE----RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ  158 (282)
T ss_pred             CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccc
Confidence            999999876531    46899999999999999999999   99999999999999999999999999999876543221


Q ss_pred             eeeccccccCCCcccccccC-----C-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          203 HIELDSVVGTTGFIAPENFT-----T-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       203 ~~~~~~~~gt~~y~aPE~~~-----~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      .  .....++..|+|||++.     + .++.++|||||||++|+|++|..||........     .........      
T Consensus       159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-----~~~~~~~~~------  225 (282)
T cd06643         159 R--RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV-----LLKIAKSEP------  225 (282)
T ss_pred             c--cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH-----HHHHhhcCC------
Confidence            1  13456899999999874     2 577899999999999999999999976543221     111110000      


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                .....+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       226 ----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         226 ----------PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             ----------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                      000111234478999999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=307.35  Aligned_cols=262  Identities=20%  Similarity=0.311  Sum_probs=207.9

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh--cCCCcceE---------------E
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRM--SHKHIIKL---------------I  116 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~H~nIv~~---------------l  116 (332)
                      ......++||+|+||.||+|..+++.||||++....    .+.|.+|-.|.+..  .|+||++|               |
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~~~----kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPEQE----KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhccCceeEEEecCHHH----HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            345556789999999999999999999999998653    57788998887764  89999998               8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhc------CCCCeeecCCCCCCeeeCCCCCeEEee
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVG------FSRPIVYRDMKPTNILFNEQSDAKLFD  190 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~------~~~~ivH~Dlkp~Nill~~~~~~kl~D  190 (332)
                      |+||.+.|+|.+||..+      .++|.+..+++..+++||+|||+.      .+.+|+|||||..|||+..|+++.|+|
T Consensus       286 Vt~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD  359 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD  359 (534)
T ss_pred             EeeeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence            99999999999999986      699999999999999999999963      256899999999999999999999999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccCC--CCC-----hhhhHHHHHHHHHHHHhCCccCC-CCCccchhhhHHH
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFTT--LIN-----EQCDVYGFGAFLFELLTAQEVSD-HVSFESRFHYEEN  262 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~-----~~sDiwSlG~~l~elltg~~p~~-~~~~~~~~~~~~~  262 (332)
                      ||+|..+..+.........+||.+|||||++.+  .+.     .+.||||+|.|||||++...-+. +.......    .
T Consensus       360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yql----p  435 (534)
T KOG3653|consen  360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQL----P  435 (534)
T ss_pred             cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccC----c
Confidence            999998876655544456799999999999988  333     25899999999999999876654 22221111    2


Q ss_pred             HhhhhccccchhhhhhhhhhcccCCCCCCh---HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          263 VKRLSGQNCRFKEMVDSIIIEDKSCTCTGK---EQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                      ...--+..+.+.++.+-.+.....+..+..   ......+++.+..||..||+.|.|+.-+-+++.++..
T Consensus       436 fe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~  505 (534)
T KOG3653|consen  436 FEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM  505 (534)
T ss_pred             hhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence            222223455566665555544433222211   2445779999999999999999999999999988763

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-43  Score=321.09  Aligned_cols=232  Identities=22%  Similarity=0.392  Sum_probs=194.3

Q ss_pred             CCCCccccCCCceEEEEEe--CCeeEE---EEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-------------EEE
Q 038681           57 DEQNIVLEDPFRKLYKGFW--QKRSIS---LMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-------------IVF  118 (332)
Q Consensus        57 ~~~~~lg~G~~g~Vy~~~~--~~~~va---vK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-------------lv~  118 (332)
                      ....+||+|+|-+||+|.+  +|-.||   ||.-+....+..+++|..|+.+|+.|+|||||++             +|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            3456799999999999999  566665   4554555566778999999999999999999998             899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC-CCCeEEeecCCcccc
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE-QSDAKLFDFSLSLSI  197 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~  197 (332)
                      |.+..|+|..|..++     +.++...++.|++||++||.|||+. ..+|+|||||-+||+|+. -|.|||+|+|+|...
T Consensus       123 EL~TSGtLr~Y~kk~-----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~  196 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKH-----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL  196 (632)
T ss_pred             ecccCCcHHHHHHHh-----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence            999999999999998     6799999999999999999999975 789999999999999964 589999999999887


Q ss_pred             CCCCceeeccccccCCCcccccccCCCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc--cccchhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG--QNCRFKE  275 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  275 (332)
                      .....    ...+|||.|||||++...|++.+||||||++++||+|+.+||..-.....     +++.+..  .+..+..
T Consensus       197 r~s~a----ksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ-----IYKKV~SGiKP~sl~k  267 (632)
T KOG0584|consen  197 RKSHA----KSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ-----IYKKVTSGIKPAALSK  267 (632)
T ss_pred             hcccc----ceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH-----HHHHHHcCCCHHHhhc
Confidence            66554    34689999999999999999999999999999999999999976544332     3333222  2222222


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      +-|                  +++++||.+||.. .++|||+.|+|+
T Consensus       268 V~d------------------Pevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  268 VKD------------------PEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             cCC------------------HHHHHHHHHHhcC-chhccCHHHHhh
Confidence            222                  6799999999999 999999999986

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=5.1e-42  Score=304.31  Aligned_cols=238  Identities=20%  Similarity=0.313  Sum_probs=189.0

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      |+..+.||+|+||.||++.+  +++.||+|.+.....  ......+.+|+.++++++|+||+++           +||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            77788999999999999999  788999999875432  2224567889999999999999987           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++|+|.+++.....   ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++......
T Consensus        82 ~~g~~L~~~l~~~~~---~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          82 MNGGDLKFHIYHMGE---AGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             cCCCcHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            999999999865421   35899999999999999999999   999999999999999999999999999998765443


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      ...   ....||..|+|||++.+ .++.++|||||||++|+|++|..||..........  ..........         
T Consensus       156 ~~~---~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~--~~~~~~~~~~---------  221 (285)
T cd05630         156 QTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--EVERLVKEVQ---------  221 (285)
T ss_pred             ccc---cCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHH--HHHhhhhhhh---------
Confidence            321   23478999999999987 88999999999999999999999997643221100  0000000000         


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT-----MVDVAK  322 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~  322 (332)
                               .......+..+.+|+.+||+.||++|||     +.|+++
T Consensus       222 ---------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         222 ---------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             ---------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                     0001123467899999999999999999     888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.8e-42  Score=322.71  Aligned_cols=255  Identities=16%  Similarity=0.195  Sum_probs=186.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      ..+|.+.+.||+|+||.||+|.+  .++.||||...       ...+.+|+.++++++|||||++           +|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW-------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc-------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            34699999999999999999999  67889999643       2335789999999999999988           7999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      ++. ++|.+++....    ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.++|+|||+++....
T Consensus       241 ~~~-~~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~  312 (461)
T PHA03211        241 KYR-SDLYTYLGARL----RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARG  312 (461)
T ss_pred             ccC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceeccc
Confidence            995 69998886541    36999999999999999999999   99999999999999999999999999999986644


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCcc-ch----hhhHHHHhhhhccccch
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFE-SR----FHYEENVKRLSGQNCRF  273 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~-~~----~~~~~~~~~~~~~~~~~  273 (332)
                      ...........||+.|+|||++.+ .++.++|||||||++|||++|..|+...... ..    ......+.........+
T Consensus       313 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~  392 (461)
T PHA03211        313 SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEF  392 (461)
T ss_pred             ccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccC
Confidence            332211134579999999999987 8999999999999999999988765433211 00    01111111111100111


Q ss_pred             hh-----hhhhh---hhcccCCC-----CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          274 KE-----MVDSI---IIEDKSCT-----CTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       274 ~~-----~~~~~---~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ..     +....   ........     +.........+.+|+.+||+.||.+|||+.|+++
T Consensus       393 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        393 PQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             CCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence            10     00000   00000000     0000122357889999999999999999999986

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.7e-42  Score=304.56  Aligned_cols=238  Identities=19%  Similarity=0.302  Sum_probs=188.2

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      |+..+.||+|+||+||+|.+  +++.+|+|.+.....  ......+.+|+.+++.++|+||+++           +||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            66778899999999999999  788999999865432  2224557889999999999999987           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++|+|.+++....   ...+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++......
T Consensus        82 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05632          82 MNGGDLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG  155 (285)
T ss_pred             ccCccHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence            99999999886542   135999999999999999999999   999999999999999999999999999998765433


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      ...   ....|+..|+|||.+.+ .++.++|||||||++|+|++|..||..........  ...........        
T Consensus       156 ~~~---~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~--~~~~~~~~~~~--------  222 (285)
T cd05632         156 ESI---RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKRE--EVDRRVLETEE--------  222 (285)
T ss_pred             Ccc---cCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhhhcccc--------
Confidence            221   34578999999999977 88999999999999999999999997653322110  01110000000        


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT-----MVDVAK  322 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~  322 (332)
                                ......+..+.+|+.+||+.||++||+     +.+++.
T Consensus       223 ----------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         223 ----------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             ----------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence                      011133467899999999999999999     666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.9e-42  Score=306.08  Aligned_cols=236  Identities=17%  Similarity=0.320  Sum_probs=192.3

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      .+|...+.||.|+||.||+|.+  +++.|++|.+....... .+.+.+|+.+++.++||||+++           +|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPK-KELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCch-HHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEe
Confidence            4588899999999999999997  78999999987654333 5778999999999999999987           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++++|..++...      .+++.++..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++......
T Consensus        98 ~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          98 LAGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             cCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            9999999998653      5899999999999999999999   999999999999999999999999999998765443


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      ...  .....++..|+|||.+.+ .++.++|||||||++|+|++|..||..........     .......         
T Consensus       169 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~-----~~~~~~~---------  232 (296)
T cd06655         169 QSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNGT---------  232 (296)
T ss_pred             ccc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhcCC---------
Confidence            221  134568899999999887 78999999999999999999999997654322211     0000000         


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                             .....+...+..+.+++.+||..||.+|||+.+++.
T Consensus       233 -------~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         233 -------PELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             -------cccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                   000111234467899999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.2e-41  Score=296.96  Aligned_cols=237  Identities=18%  Similarity=0.287  Sum_probs=192.1

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE------------EEEE
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL------------IVFE  119 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~------------lv~e  119 (332)
                      +|++.+.||+|++|.||++.+  +++.||+|++.... .....+.+.+|+.++++++||||+++            +|+|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            588899999999999999998  67889999987543 23345678999999999999999986            7999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++++|.+++.....   ..+++.++..++.|++.||+|||   +.+|+|+||||+||+++.++.++|+|||++.....
T Consensus        81 ~~~~~~l~~~l~~~~~---~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~  154 (257)
T cd08223          81 FCEGGDLYHKLKEQKG---KLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN  154 (257)
T ss_pred             ccCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecc
Confidence            9999999999976421   35899999999999999999999   99999999999999999999999999999976643


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      ....  .....+++.|+|||++.+ .++.++|||||||++|+|++|+.||.........     ........        
T Consensus       155 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~-----~~~~~~~~--------  219 (257)
T cd08223         155 QCDM--ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV-----YRIIEGKL--------  219 (257)
T ss_pred             cCCc--cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH-----HHHHhcCC--------
Confidence            3221  134568999999999887 7899999999999999999999999754322110     00000000        


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                ...+...+..+.+++.+||+.||++|||+.++++
T Consensus       220 ----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         220 ----------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ----------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence                      0111234578999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.7e-42  Score=301.02  Aligned_cols=244  Identities=20%  Similarity=0.318  Sum_probs=195.3

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------EEEE
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IVFE  119 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv~e  119 (332)
                      +..++|.+.+.||+|+||.||+|.+ .+..+++|.+....  ...+.+.+|+.+++.++|+||+++          ++||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e   80 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITE   80 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEE
Confidence            3456799999999999999999988 66779999887543  235678999999999999999998          8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++|+|.+++....   ...+++..+..++.|++.||.|||   ..+++|+||||+||+++.++.++|+|||.+.....
T Consensus        81 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  154 (260)
T cd05073          81 FMAKGSLLDFLKSDE---GSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIED  154 (260)
T ss_pred             eCCCCcHHHHHHhCC---ccccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence            999999999997642   135788999999999999999999   99999999999999999999999999999976654


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ...... ....++..|+|||.+.+ .++.++|||||||++|++++ |..||........      .......        
T Consensus       155 ~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~------~~~~~~~--------  219 (260)
T cd05073         155 NEYTAR-EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEV------IRALERG--------  219 (260)
T ss_pred             CCcccc-cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHH------HHHHhCC--------
Confidence            332211 23345678999999886 78999999999999999999 8999975433221      1111100        


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQ  326 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~  326 (332)
                             .  ..+.....+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus       220 -------~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         220 -------Y--RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -------C--CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                   0  001112334679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-41  Score=298.47  Aligned_cols=237  Identities=19%  Similarity=0.282  Sum_probs=190.3

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh--------hhHHHHHHHHHHHHhhcCCCcceE---------
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ--------HALEWCINHIVYASRMSHKHIIKL---------  115 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~--------~~~~~~~~E~~~l~~l~H~nIv~~---------  115 (332)
                      +|.+...||+|+||.||+|.+  .+..+|+|.+......        ...+.+.+|+.++++++||||+++         
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            477889999999999999998  6789999988654321        123568899999999999999998         


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        +|+||+++++|.+++...     ..+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~  152 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGI  152 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCC
Confidence              899999999999999765     56899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCcee----eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc
Q 038681          194 SLSIPDGETHI----ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG  268 (332)
Q Consensus       194 a~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  268 (332)
                      ++.........    ......|+..|+|||.+.+ .++.++|||||||++|+|++|..||.........     ......
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~  227 (267)
T cd06628         153 SKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI-----FKIGEN  227 (267)
T ss_pred             CcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH-----HHHhcc
Confidence            98765322111    1123458899999999887 7889999999999999999999999764322110     000000


Q ss_pred             cccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          269 QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                        .....+...+..+.+++.+||+.||.+||++.+|++
T Consensus       228 ------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         228 ------------------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             ------------------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence                              001111234478899999999999999999999976

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.7e-41  Score=299.66  Aligned_cols=236  Identities=21%  Similarity=0.327  Sum_probs=194.3

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ..|+..+.||.|+||.||+|.+  ++..||+|.+...........+.+|+.++++++||||+++           +||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            3478889999999999999998  6889999998866555557789999999999999999987           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++|+|.+++..      ..+++..+..++.|++.||+|||   +.+++|+||+|+||+++.++.++|+|||++......
T Consensus        84 ~~~~~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          84 LGGGSALDLLRA------GPFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             CCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            999999999864      35889999999999999999999   999999999999999999999999999999766543


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      ...  .....++..|+|||.+.+ .++.++|+|||||++|||++|..||..........      ...            
T Consensus       155 ~~~--~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~~~------------  214 (277)
T cd06640         155 QIK--RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF------LIP------------  214 (277)
T ss_pred             ccc--cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh------hhh------------
Confidence            321  133467889999999877 78999999999999999999999997543322110      000            


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                           ...........+..+.+++.+||+.+|++||++.+++..
T Consensus       215 -----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         215 -----KNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             -----cCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence                 000111223556789999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.6e-42  Score=311.90  Aligned_cols=254  Identities=17%  Similarity=0.231  Sum_probs=183.8

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      ....+|.+.+.||+|+||.||+|.+  ++..||+|.....       ....|+.++++++||||+++           +|
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            3456799999999999999999999  6678999975432       23569999999999999987           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      +|++. |+|.+++....    ..+++..+..++.||+.||.|||   .++|+||||||+|||++.++.+||+|||+++..
T Consensus       136 ~e~~~-~~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  207 (357)
T PHA03209        136 LPHYS-SDLYTYLTKRS----RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFP  207 (357)
T ss_pred             EEccC-CcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCcccccc
Confidence            99995 58998886541    46899999999999999999999   999999999999999999999999999999754


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccc-hh-------hhHHHHhhhhc
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFES-RF-------HYEENVKRLSG  268 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~-~~-------~~~~~~~~~~~  268 (332)
                      ......   ....||+.|+|||++.+ .++.++|||||||++|||+++..|+....... ..       ........+..
T Consensus       208 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~  284 (357)
T PHA03209        208 VVAPAF---LGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKV  284 (357)
T ss_pred             ccCccc---ccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhcc
Confidence            332221   34568999999999987 89999999999999999998665543322211 00       01111111111


Q ss_pred             cccchh-----hhhhhhhhcccC--CC-----CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          269 QNCRFK-----EMVDSIIIEDKS--CT-----CTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       269 ~~~~~~-----~~~~~~~~~~~~--~~-----~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .+..+.     ......+.....  .+     .......+..+.+||.+||+.||.+|||+.|+++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        285 HPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             ChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence            111111     000000000000  00     0001123456778999999999999999999986

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-43  Score=322.49  Aligned_cols=267  Identities=18%  Similarity=0.241  Sum_probs=204.5

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------------  115 (332)
                      ..|...+.||+|+||.||+|++  +|+.||||.+.......-.+...+|+++|++|+|||||++                
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            3466778899999999999998  9999999999987766668889999999999999999987                


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee--CCCCC--eEEee
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF--NEQSD--AKLFD  190 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill--~~~~~--~kl~D  190 (332)
                       +|||||.+|||...+.+..+  -..+++.+.+.++.+++.||.|||   .+||+||||||.||++  +.+|+  .||+|
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN--~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtD  167 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPEN--AYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTD  167 (732)
T ss_pred             eEEEeecCCCcHHHHhcCccc--ccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeec
Confidence             89999999999999987532  246999999999999999999999   9999999999999987  34444  69999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccC--CCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFT--TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG  268 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  268 (332)
                      ||.|+.++++...   .+.+||+.|.+||++.  ..|+..+|.|||||++|+.+||..||.......... .........
T Consensus       168 fG~Arel~d~s~~---~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~-~~~~~~~tk  243 (732)
T KOG4250|consen  168 FGAARELDDNSLF---TSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNK-EIMWHIITK  243 (732)
T ss_pred             ccccccCCCCCee---eeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccc-hhhhhhhcc
Confidence            9999999888743   6789999999999998  389999999999999999999999997554332100 001111111


Q ss_pred             cccchhhhhhhhhh----c--ccCCCCCChHHHHHHHHHHHHHcccCCCCCCC--CHHHHHHHHHHHHH
Q 038681          269 QNCRFKEMVDSIII----E--DKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP--TMVDVAKQLRQMYR  329 (332)
Q Consensus       269 ~~~~~~~~~~~~~~----~--~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP--s~~evl~~L~~l~~  329 (332)
                      .+....-...+...    .  ..+.+..........+-..+..+|..+|.+|-  .+.+....+..+++
T Consensus       244 kp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~  312 (732)
T KOG4250|consen  244 KPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILN  312 (732)
T ss_pred             CCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHh
Confidence            11111000011000    0  01112222234445666788889999999998  77777777777664

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.1e-41  Score=298.73  Aligned_cols=239  Identities=18%  Similarity=0.261  Sum_probs=190.4

Q ss_pred             CCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCC-----hhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRN-----QHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      +|...+.||.|+||.||+|.. +++.+|+|.+.....     ......+.+|+.++++++|+||+++           +|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            478899999999999999988 888999998875432     2234568899999999999999987           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      +||+++++|.+++...     ..+++..+..++.|++.||+|||   +.+|+|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  152 (265)
T cd06631          81 MEFVPGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRL  152 (265)
T ss_pred             EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence            9999999999999765     46899999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCc----eeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          198 PDGET----HIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       198 ~~~~~----~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      .....    ........++..|+|||.+.+ .++.++|||||||++|+|++|..||..........     .... ....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~-----~~~~-~~~~  226 (265)
T cd06631         153 AWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-----YIGA-HRGL  226 (265)
T ss_pred             hhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH-----Hhhh-ccCC
Confidence            32111    111134568999999999987 78999999999999999999999997543222110     0000 0000


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                     ....+...+.++.+++.+||+.+|.+||++.++++
T Consensus       227 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         227 ---------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                           00011134477899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8.8e-42  Score=300.94  Aligned_cols=246  Identities=20%  Similarity=0.301  Sum_probs=193.9

Q ss_pred             cCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      ++|++...||+|+||.||+|..       ....|++|.+.........+.+.+|+.++++++||||+++           
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            5688999999999999999996       2456899988766555456789999999999999999988           


Q ss_pred             EEEEeccCCChHHHHhhhhccc----ccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeec
Q 038681          116 IVFESVQIGTLADRIHHHCEQH----FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF  191 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~----~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  191 (332)
                      +||||+++|+|.+++.......    ...+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEccc
Confidence            8999999999999997652111    125899999999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhcc
Q 038681          192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQ  269 (332)
Q Consensus       192 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  269 (332)
                      |++......... ......++..|+|||.+.+ .++.++||||||+++|+|++ |..||........      .......
T Consensus       162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~------~~~~~~~  234 (275)
T cd05046         162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV------LNRLQAG  234 (275)
T ss_pred             ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH------HHHHHcC
Confidence            998754332211 1133456778999998876 78899999999999999999 7888865432211      1111100


Q ss_pred             ccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          270 NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                      ..                ..+.....+..+.+++.+||+.||.+|||+.+++..|.
T Consensus       235 ~~----------------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         235 KL----------------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             Cc----------------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            00                00111133468999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.2e-41  Score=298.06  Aligned_cols=246  Identities=20%  Similarity=0.296  Sum_probs=192.3

Q ss_pred             CCCCCccccCCCceEEEEEe-----CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE--------------
Q 038681           56 YDEQNIVLEDPFRKLYKGFW-----QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL--------------  115 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~--------------  115 (332)
                      |.+.+.||+|+||.||+|.+     ++..||+|.+.... .....+.+.+|+.+++.++||||+++              
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            56788999999999999986     36789999987653 23346778999999999999999887              


Q ss_pred             ---EEEEeccCCChHHHHhhhh-cccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeec
Q 038681          116 ---IVFESVQIGTLADRIHHHC-EQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF  191 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  191 (332)
                         +++||+++|+|.+++.... ......+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECcc
Confidence               5678999999999876432 112235789999999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhcc
Q 038681          192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQ  269 (332)
Q Consensus       192 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  269 (332)
                      |+++...............+++.|++||.+.+ .++.++|||||||++|+|++ |..||........      .......
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~------~~~~~~~  231 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI------YNYLIKG  231 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHH------HHHHHcC
Confidence            99987654332222233445678999999876 78899999999999999999 8888875433221      1111000


Q ss_pred             ccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          270 NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                      . .                .......+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       232 ~-~----------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         232 N-R----------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             C-c----------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0 0                000112346899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.4e-41  Score=296.62  Aligned_cols=238  Identities=23%  Similarity=0.397  Sum_probs=190.7

Q ss_pred             CccccCCCceEEEEEe-C--C--eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------EEEEeccCC
Q 038681           60 NIVLEDPFRKLYKGFW-Q--K--RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IVFESVQIG  124 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~-~--~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv~e~~~~g  124 (332)
                      +.||+|++|.||+|.+ .  +  ..||+|.+.........+.+.+|+.++++++||||+++          +|+||+++|
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~   80 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLG   80 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCC
Confidence            4689999999999998 2  2  36899999877654557789999999999999999987          899999999


Q ss_pred             ChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCcee
Q 038681          125 TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHI  204 (332)
Q Consensus       125 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  204 (332)
                      +|.+++.....   ..+++..+..++.|++.||+|||   .++++|+||||+||+++.++.+||+|||++..........
T Consensus        81 ~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          81 SLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             cHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            99999987521   35899999999999999999999   9999999999999999999999999999998775533221


Q ss_pred             e-ccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhh
Q 038681          205 E-LDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSII  281 (332)
Q Consensus       205 ~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (332)
                      . .....++..|+|||.+.+ .++.++|||||||++|+|++ |..||..........      ......           
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~------~~~~~~-----------  217 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILK------KIDKEG-----------  217 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HHHhcC-----------
Confidence            1 123456789999999887 88999999999999999998 999997554322111      000000           


Q ss_pred             hcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          282 IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                         .  ....+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       218 ---~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         218 ---E--RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ---C--cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence               0  00111133477999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=6.2e-42  Score=303.39  Aligned_cols=258  Identities=17%  Similarity=0.207  Sum_probs=189.9

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      +|++.+.||+|++|.||+|..  ++..||+|++..... ......+.+|+.++.+++||||+++           +||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            488889999999999999998  788999999875432 2234678899999999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      ++ ++|.+++.....  ...+++..+..++.||+.||.|||   +.+|+|+||||+||+++.++.++|+|||++......
T Consensus        81 ~~-~~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  154 (285)
T cd07861          81 LS-MDLKKYLDSLPK--GQYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP  154 (285)
T ss_pred             CC-CCHHHHHhcCCC--CCcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC
Confidence            97 689988865421  145899999999999999999999   999999999999999999999999999998765433


Q ss_pred             CceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-cccchh---
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-QNCRFK---  274 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~---  274 (332)
                      ...  .....+++.|+|||.+.+  .++.++|||||||++|+|++|+.||..........  ........ ....+.   
T Consensus       155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  230 (285)
T cd07861         155 VRV--YTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF--RIFRILGTPTEDVWPGVT  230 (285)
T ss_pred             ccc--ccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHHHHhCCCChhhhhcch
Confidence            211  123467889999998865  57899999999999999999999997654322111  01010000 000000   


Q ss_pred             hhhhhhhh--c-ccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          275 EMVDSIII--E-DKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       275 ~~~~~~~~--~-~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ...+....  . ............+.++.+++.+||+.||.+|||+.+|++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00000000  0 000000001124577889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7.8e-42  Score=304.91  Aligned_cols=237  Identities=18%  Similarity=0.310  Sum_probs=192.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|.+.+.||+|+||.||+|..  ++..||+|.+....... .+.+.+|+.+++.++||||+++           +|||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            36799999999999999999997  78999999997654433 5678899999999999999997           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++++|.+++...      .+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.++|+|||++.....
T Consensus        97 ~~~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          97 YLAGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             ccCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            99999999998653      5889999999999999999999   99999999999999999999999999999876544


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      ....  .....+++.|+|||.+.+ .++.++|||||||++|++++|..||..........     ......         
T Consensus       168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~-----~~~~~~---------  231 (297)
T cd06656         168 EQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNG---------  231 (297)
T ss_pred             CccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee-----eeccCC---------
Confidence            3221  134568899999999887 78999999999999999999999997543322110     000000         


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                             ......+...+..+.+|+.+||..||++||++.++++
T Consensus       232 -------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         232 -------TPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             -------CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                   0001111234467889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-43  Score=316.64  Aligned_cols=252  Identities=19%  Similarity=0.372  Sum_probs=210.0

Q ss_pred             HHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------
Q 038681           47 EELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------  115 (332)
Q Consensus        47 ~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------  115 (332)
                      ++|+....+....++||-|.||.||.|.|  ..-.||||.++.+..+  .++|+.|..+|+.+.|||+|++         
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe--veEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh--HHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            45555566677789999999999999999  6778999999877544  6899999999999999999998         


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        ||+|||.+|+|.+||++...   ..++.-..++++.||++|++||.   .+++|||||-.+|+|++++..+|++|||+
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr---~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGL  411 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNR---SEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGL  411 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhch---hhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccch
Confidence              89999999999999998633   45777788999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          194 SLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       194 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      ++....+..... ....-.+.|.|||.+.- .++.|+|||+|||+|||+.| |..||.+.+......+            
T Consensus       412 sRlMtgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~L------------  478 (1157)
T KOG4278|consen  412 SRLMTGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGL------------  478 (1157)
T ss_pred             hhhhcCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHH------------
Confidence            998866543221 22234678999998876 89999999999999999998 8899988765443221            


Q ss_pred             chhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                           +.      ...+...+..|++.+++||+.||+++|.+||++.|+-+.++.|..+
T Consensus       479 -----LE------kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  479 -----LE------KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             -----Hh------ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence                 11      1112223346668999999999999999999999999999998754

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-41  Score=294.37  Aligned_cols=236  Identities=21%  Similarity=0.344  Sum_probs=189.1

Q ss_pred             CccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCCChH
Q 038681           60 NIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLA  127 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g~L~  127 (332)
                      ++||+|+||.||++.+ .++.|++|.+.........+.+.+|+.++++++||||+++           +|+||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            4799999999999998 5899999998876555456789999999999999999987           899999999999


Q ss_pred             HHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceeecc
Q 038681          128 DRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD  207 (332)
Q Consensus       128 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~  207 (332)
                      +++....    ..+++..+..++.+++.||.|||   +++++||||||+||+++.++.++|+|||++.............
T Consensus        81 ~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          81 TFLRKKK----NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence            9997541    35889999999999999999999   9999999999999999999999999999997654322211111


Q ss_pred             ccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhccc
Q 038681          208 SVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDK  285 (332)
Q Consensus       208 ~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ...++..|+|||.+.+ .++.++|||||||++|||++ |..||.........      ......               .
T Consensus       154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~------~~~~~~---------------~  212 (251)
T cd05041         154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR------ERIESG---------------Y  212 (251)
T ss_pred             cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH------HHHhcC---------------C
Confidence            2234567999999876 88999999999999999999 88888655432211      111000               0


Q ss_pred             CCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          286 SCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       286 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                        ..+.+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       213 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         213 --RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             --CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence              00111234468999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.5e-41  Score=298.48  Aligned_cols=244  Identities=19%  Similarity=0.260  Sum_probs=191.6

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------  115 (332)
                      |++.+++++.....||+|+||.||+|.+  ++..|++|.+....... .+.+.+|+.++++++|+||+++          
T Consensus         2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~-~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (268)
T cd06624           2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRY-VQPLHEEIALHSYLKHRNIVQYLGSDSENGFF   80 (268)
T ss_pred             CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHH-HHHHHHHHHHHHhcCCCCeeeeeeeeccCCEE
Confidence            3556677787788999999999999998  67789999887654433 5678999999999999999998          


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCC--CHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC-CCCeEEeec
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEAL--SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE-QSDAKLFDF  191 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l--~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Df  191 (332)
                       +|+||+++++|.+++....    ..+  ++..+..++.||+.||+|||   +.+|+||||||+||+++. ++.++|+||
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~df  153 (268)
T cd06624          81 KIFMEQVPGGSLSALLRSKW----GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDF  153 (268)
T ss_pred             EEEEecCCCCCHHHHHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecc
Confidence             8999999999999997642    234  78889999999999999999   999999999999999976 678999999


Q ss_pred             CCccccCCCCceeeccccccCCCcccccccCC---CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc
Q 038681          192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTT---LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG  268 (332)
Q Consensus       192 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  268 (332)
                      |.+.........  .....++..|+|||.+.+   .++.++||||||+++|+|++|..||..........   .......
T Consensus       154 g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~~~~~~~  228 (268)
T cd06624         154 GTSKRLAGINPC--TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---FKVGMFK  228 (268)
T ss_pred             hhheecccCCCc--cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---hhhhhhc
Confidence            998765432221  123467899999999865   47899999999999999999999986543211100   0000000


Q ss_pred             cccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          269 QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .                  ....+.....++.+|+.+||+.+|.+|||+.+++.
T Consensus       229 ~------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         229 I------------------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             c------------------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            0                  00111234477899999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=9.3e-42  Score=308.49  Aligned_cols=254  Identities=16%  Similarity=0.230  Sum_probs=186.4

Q ss_pred             CCCccccC--CCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEec
Q 038681           58 EQNIVLED--PFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFESV  121 (332)
Q Consensus        58 ~~~~lg~G--~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~  121 (332)
                      +.++||+|  +|++||++..  ++..||+|.+..... ....+.+.+|+.+++.++||||+++           +||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  6889999998  789999999976543 3335667889999999999999987           899999


Q ss_pred             cCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCC
Q 038681          122 QIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE  201 (332)
Q Consensus       122 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  201 (332)
                      ++|+|.+++.....   ..+++..++.++.|++.||+|||   +++|+||||||+|||++.++.++++|||.+.......
T Consensus        82 ~~~~l~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~  155 (327)
T cd08227          82 AYGSAKDLICTHFM---DGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHG  155 (327)
T ss_pred             CCCcHHHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccc
Confidence            99999999976421   35899999999999999999999   9999999999999999999999999998754432211


Q ss_pred             cee-----eccccccCCCcccccccCC---CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          202 THI-----ELDSVVGTTGFIAPENFTT---LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       202 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      ...     ......++..|+|||++.+   .++.++|||||||++|||++|..||..........     ..........
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-----~~~~~~~~~~  230 (327)
T cd08227         156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-----EKLNGTVPCL  230 (327)
T ss_pred             ccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHH-----HHhcCCcccc
Confidence            100     0122356788999999874   58899999999999999999999997644322110     0000000000


Q ss_pred             --------hhh--------hhhhhhc-----------ccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          274 --------KEM--------VDSIIIE-----------DKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       274 --------~~~--------~~~~~~~-----------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                              .+.        .+.....           ......+.....++.+.+|+.+||+.||++|||++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         231 LDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             ccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                    000        0000000           000001112244578999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.6e-42  Score=302.08  Aligned_cols=259  Identities=20%  Similarity=0.295  Sum_probs=198.0

Q ss_pred             cCCCCCCccccCCCceEEEEEe------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE------------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~------------  115 (332)
                      ..|...+.||+|+||.||+|.+      .+..+|+|.+.........+.+.+|+.+++.++||||+++            
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            4577889999999999999986      2678999999876554446789999999999999999986            


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       +||||+++++|.+++....    ..+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||.+
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  156 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLA  156 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence             8999999999999997652    35899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCceee-ccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          195 LSIPDGETHIE-LDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       195 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      ........... .....++..|+|||.+.+ .++.++|||||||++|||++|..|+..........    .. .......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~----~~-~~~~~~~  231 (284)
T cd05038         157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRM----IG-IAQGQMI  231 (284)
T ss_pred             cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccc----cc-ccccccc
Confidence            87764332211 112345667999998876 88999999999999999999999986543221100    00 0000000


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                      ...+ ...+....  ..+.+..++.++.+++.+||+.+|.+|||+.+|++.|+++
T Consensus       232 ~~~~-~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         232 VTRL-LELLKEGE--RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHH-HHHHHcCC--cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            1111 11111111  1111223447899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.7e-41  Score=305.32  Aligned_cols=187  Identities=22%  Similarity=0.311  Sum_probs=152.8

Q ss_pred             CCccccCCCceEEEEEe----CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-------------EEEEec
Q 038681           59 QNIVLEDPFRKLYKGFW----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-------------IVFESV  121 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-------------lv~e~~  121 (332)
                      ..+||+|+||.||+|..    ++..||+|.+.....   ...+.+|+.++++++||||+++             +|+||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI---SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC---cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence            46899999999999997    347899998876532   3457899999999999999987             789998


Q ss_pred             cCCChHHHHhhhhc----ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee----CCCCCeEEeecCC
Q 038681          122 QIGTLADRIHHHCE----QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF----NEQSDAKLFDFSL  193 (332)
Q Consensus       122 ~~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfg~  193 (332)
                      ++ +|.+++.....    .....+++..+..++.||+.||.|||   +.+|+||||||+|||+    +.++.+||+|||+
T Consensus        83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~  158 (317)
T cd07867          83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGF  158 (317)
T ss_pred             CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence            75 88888764311    11235889999999999999999999   9999999999999999    5667899999999


Q ss_pred             ccccCCCCce-eeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCC
Q 038681          194 SLSIPDGETH-IELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVS  252 (332)
Q Consensus       194 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~  252 (332)
                      ++........ .......+|+.|+|||++.+  .++.++|||||||++|||+||..||....
T Consensus       159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            9876543221 11234578999999999876  58999999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=313.96  Aligned_cols=253  Identities=19%  Similarity=0.245  Sum_probs=205.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC-CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFWQ-KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      .+...+.++||+|-||.|.+|... +..||||.++.....+....|.+|+++|.+|+|||||++           +++||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            344567889999999999999995 499999999999888878999999999999999999998           79999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++|+|.+|+..+..   ..+.-.....|+.||++|++||.   +.++|||||.+.|+|+|.++++||+|||+++.+..+
T Consensus       617 mEnGDLnqFl~ahea---pt~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  617 MENGDLNQFLSAHEL---PTAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HhcCcHHHHHHhccC---cccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccC
Confidence            999999999988722   12345566789999999999999   999999999999999999999999999999987776


Q ss_pred             CceeeccccccCCCcccccccC-CCCChhhhHHHHHHHHHHHHh--CCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLT--AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~sDiwSlG~~l~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      .........+-...|||||.+. ++++++||||+||+++||+++  ...||.....+....   ....+....+      
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vve---n~~~~~~~~~------  761 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVE---NAGEFFRDQG------  761 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHH---hhhhhcCCCC------
Confidence            6554445667789999999765 599999999999999999865  778887765544322   1111111000      


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                          .   ..-...+.-++..++++|.+||..|-.+|||++++...|++.
T Consensus       762 ----~---~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  762 ----R---QVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ----c---ceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence                0   001122335668899999999999999999999999988764

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=6.7e-42  Score=304.28  Aligned_cols=251  Identities=19%  Similarity=0.232  Sum_probs=198.5

Q ss_pred             cccHHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE----
Q 038681           43 IFSAEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL----  115 (332)
Q Consensus        43 ~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~----  115 (332)
                      .+++.++...+++|.+.+.||+|+||.||++..  +++.+|+|.+.....  ....+.+|+.++.++ +||||+++    
T Consensus        11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~e~~~l~~l~~h~ni~~~~~~~   88 (291)
T cd06639          11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD--VDEEIEAEYNILQSLPNHPNVVKFYGMF   88 (291)
T ss_pred             hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc--HHHHHHHHHHHHHHhcCCCCeEEEEEEE
Confidence            466677777899999999999999999999998  788999999865432  245678899999999 79999985    


Q ss_pred             ------------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC
Q 038681          116 ------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ  183 (332)
Q Consensus       116 ------------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  183 (332)
                                  +|+||+++|+|.+++...... ...+++..++.++.|++.||.|||   ..+++|+||||+||+++.+
T Consensus        89 ~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~  164 (291)
T cd06639          89 YKADKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTE  164 (291)
T ss_pred             EeccccCCCeeEEEEEECCCCcHHHHHHHhhhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCC
Confidence                        799999999999998753221 246899999999999999999999   9999999999999999999


Q ss_pred             CCeEEeecCCccccCCCCceeeccccccCCCcccccccCC------CCChhhhHHHHHHHHHHHHhCCccCCCCCccchh
Q 038681          184 SDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT------LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRF  257 (332)
Q Consensus       184 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~  257 (332)
                      +.++|+|||++..........  ....|+..|+|||.+..      .++.++|||||||++|||++|+.||........ 
T Consensus       165 ~~~kl~dfg~~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~-  241 (291)
T cd06639         165 GGVKLVDFGVSAQLTSTRLRR--NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT-  241 (291)
T ss_pred             CCEEEeecccchhcccccccc--cCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH-
Confidence            999999999987655432211  34568899999998754      368899999999999999999999976433211 


Q ss_pred             hhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          258 HYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                          ..........                ....+......+.+++.+||+.||++||++.++++
T Consensus       242 ----~~~~~~~~~~----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         242 ----LFKIPRNPPP----------------TLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             ----HHHHhcCCCC----------------CCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence                1111100000                00111234467999999999999999999999985

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=8.6e-42  Score=301.47  Aligned_cols=233  Identities=23%  Similarity=0.341  Sum_probs=190.7

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEecc
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQ  122 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~  122 (332)
                      |+..+.||+|+||.||+|.+  ++..||+|.+.........+.+.+|+.++++++||||+++           +|+||++
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG   85 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence            66678899999999999988  6889999998866544556789999999999999999987           8999999


Q ss_pred             CCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCc
Q 038681          123 IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET  202 (332)
Q Consensus       123 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  202 (332)
                      +++|.+++..      ..+++..+..++.|++.||.|||   .++++|+||+|+||+++.++.++|+|||++........
T Consensus        86 ~~~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06642          86 GGSALDLLKP------GPLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcch
Confidence            9999998864      35899999999999999999999   99999999999999999999999999999976654322


Q ss_pred             eeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhh
Q 038681          203 HIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSII  281 (332)
Q Consensus       203 ~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (332)
                      .  .....++..|+|||.+.+ .++.++|||||||++|||++|..||..........      .....            
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~------~~~~~------------  216 (277)
T cd06642         157 K--RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF------LIPKN------------  216 (277)
T ss_pred             h--hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh------hhhcC------------
Confidence            1  133468899999999987 78999999999999999999999986543222110      00000            


Q ss_pred             hcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          282 IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                         .  ........+..+.+++.+||+.+|++|||+.++++
T Consensus       217 ---~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         217 ---S--PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             ---C--CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence               0  00111234467899999999999999999999997

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.8e-42  Score=302.45  Aligned_cols=247  Identities=18%  Similarity=0.249  Sum_probs=196.3

Q ss_pred             ccHHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----
Q 038681           44 FSAEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----  115 (332)
Q Consensus        44 ~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----  115 (332)
                      .++.++....+.|++.+.||.|+||.||+|.+  .+..+|+|.+.....  ....+..|+.++.++ +||||+++     
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~   83 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED--EEEEIKLEINMLKKYSHHRNIATYYGAFI   83 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH--HHHHHHHHHHHHHHhcCCCcEEEEeeehh
Confidence            46677777788999999999999999999999  778999999865432  245688899999998 79999975     


Q ss_pred             ------------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC
Q 038681          116 ------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ  183 (332)
Q Consensus       116 ------------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  183 (332)
                                  ++|||+++|+|.+++.....   ..+++..+..++.||+.||.|||   +.+|+|+||+|+||+++.+
T Consensus        84 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~  157 (282)
T cd06636          84 KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTEN  157 (282)
T ss_pred             cccccCCCCEEEEEEEeCCCCcHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCC
Confidence                        89999999999999976421   35889999999999999999999   9999999999999999999


Q ss_pred             CCeEEeecCCccccCCCCceeeccccccCCCcccccccC-----C-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchh
Q 038681          184 SDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-----T-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRF  257 (332)
Q Consensus       184 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~  257 (332)
                      +.++|+|||++.........  .....|++.|+|||.+.     + .++.++|||||||++|||++|..||.........
T Consensus       158 ~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~  235 (282)
T cd06636         158 AEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL  235 (282)
T ss_pred             CCEEEeeCcchhhhhccccC--CCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh
Confidence            99999999998765432211  13457899999999875     2 5788999999999999999999999654322111


Q ss_pred             hhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          258 HYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .     ......                 ........++..+.+|+.+||..||.+|||+.++++
T Consensus       236 ~-----~~~~~~-----------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         236 F-----LIPRNP-----------------PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             h-----hHhhCC-----------------CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            0     000000                 000011234578999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=8.6e-42  Score=299.96  Aligned_cols=240  Identities=21%  Similarity=0.343  Sum_probs=188.8

Q ss_pred             CccccCCCceEEEEEeCC--------eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           60 NIVLEDPFRKLYKGFWQK--------RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~~~--------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      +.||+|+||.||+|.+..        ..+++|.+...........+.+|+.+++.++||||+++           +||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            469999999999998722        57899988765544446788999999999999999987           89999


Q ss_pred             ccCCChHHHHhhhhcc--cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC-----CeEEeecCC
Q 038681          121 VQIGTLADRIHHHCEQ--HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS-----DAKLFDFSL  193 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-----~~kl~Dfg~  193 (332)
                      +++|+|.+++......  ....+++..++.++.|++.||.|||   +.+++|+||||+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999999999764221  1234789999999999999999999   99999999999999999877     899999999


Q ss_pred             ccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          194 SLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       194 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      +................++..|+|||.+.+ .++.++|||||||++|||++ |..||........      ......   
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~------~~~~~~---  228 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEV------LQHVTA---  228 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHH------HHHHhc---
Confidence            976544332222123356788999999887 88999999999999999998 9999875432211      111100   


Q ss_pred             chhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                                  .  .....+...+..+.+++.+||..+|.+||+++++++.|+
T Consensus       229 ------------~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         229 ------------G--GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ------------C--CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                        0  000111234578899999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-41  Score=298.09  Aligned_cols=226  Identities=20%  Similarity=0.333  Sum_probs=177.1

Q ss_pred             CccccCCCceEEEEEeC--------------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------
Q 038681           60 NIVLEDPFRKLYKGFWQ--------------KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~~--------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------  115 (332)
                      +.||+|+||.||+|.+.              ...|++|.+..... .....+.+|+.++..++||||+++          
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR-DISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh-hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            46899999999999861              22488888765432 335678899999999999999998          


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCC-------eE
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD-------AK  187 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-------~k  187 (332)
                       +||||+++|+|..++....    ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.       ++
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~~  152 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKS----DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIK  152 (262)
T ss_pred             EEEEecccCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCceeE
Confidence             8999999999999886531    45899999999999999999999   999999999999999987664       89


Q ss_pred             EeecCCccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHH-hCCccCCCCCccchhhhHHHHh
Q 038681          188 LFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELL-TAQEVSDHVSFESRFHYEENVK  264 (332)
Q Consensus       188 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~ell-tg~~p~~~~~~~~~~~~~~~~~  264 (332)
                      ++|||++......      ....++..|+|||.+.+  .++.++|||||||++|||+ +|..||......+...      
T Consensus       153 l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~------  220 (262)
T cd05077         153 LSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER------  220 (262)
T ss_pred             eCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH------
Confidence            9999998655332      23467889999998863  7899999999999999998 5888876543221100      


Q ss_pred             hhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038681          265 RLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL  324 (332)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L  324 (332)
                       ....              ......    .....+.+|+.+||+.||.+||++.+|++.|
T Consensus       221 -~~~~--------------~~~~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         221 -FYEG--------------QCMLVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             -HHhc--------------CccCCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence             0000              000000    1235789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-41  Score=300.06  Aligned_cols=226  Identities=19%  Similarity=0.288  Sum_probs=176.4

Q ss_pred             ccccCCCceEEEEEe--C------------------------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcce
Q 038681           61 IVLEDPFRKLYKGFW--Q------------------------KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIK  114 (332)
Q Consensus        61 ~lg~G~~g~Vy~~~~--~------------------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~  114 (332)
                      .||+|+||.||+|.+  +                        ...|++|.+..... .....+.+|+.+++.++||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence            699999999999985  1                        13488888865433 23567889999999999999999


Q ss_pred             E-----------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC
Q 038681          115 L-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ  183 (332)
Q Consensus       115 ~-----------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  183 (332)
                      +           +||||+++|+|..++....    ..+++..+..++.||+.||+|||   +.+|+||||||+|||++..
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~  153 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEK----GRVPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARL  153 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEecc
Confidence            7           8999999999999986531    46899999999999999999999   9999999999999999764


Q ss_pred             C-------CeEEeecCCccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHH-hCCccCCCCCc
Q 038681          184 S-------DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELL-TAQEVSDHVSF  253 (332)
Q Consensus       184 ~-------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~ell-tg~~p~~~~~~  253 (332)
                      +       .++++|||++......      ....++..|+|||.+.+  .++.++|||||||++||++ +|..||.....
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             CcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence            4       3799999988654322      22357888999998865  6899999999999999995 68998875433


Q ss_pred             cchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          254 ESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                      .....      ..           ..    ....+    ......+.+++.+||+.+|++|||+.+|++.|+
T Consensus       228 ~~~~~------~~-----------~~----~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         228 SEKER------FY-----------EK----KHRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHHHH------HH-----------Hh----ccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            22110      00           00    00000    011256899999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-42  Score=302.31  Aligned_cols=240  Identities=23%  Similarity=0.299  Sum_probs=192.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|++.+.||.|+||.||+|.+  ++..+|+|.+..... ...+.+.+|+.++++++||||+++           +|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE-EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH-HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            35689999999999999999998  688999999876543 336778999999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++|+|.+++....    ..+++..+..++.|++.||.|||   +.+|+|+||+|+||+++.++.++|+|||++.....
T Consensus        83 ~~~~~~L~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          83 FCDGGALDSIMLELE----RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             ccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            999999999987642    46899999999999999999999   99999999999999999999999999999866543


Q ss_pred             CCceeeccccccCCCcccccccC-----C-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          200 GETHIELDSVVGTTGFIAPENFT-----T-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~-----~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      ....  .....+++.|+|||.+.     . .++.++|||||||++|+|++|..||........     .........   
T Consensus       156 ~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~---  225 (280)
T cd06611         156 TLQK--RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV-----LLKILKSEP---  225 (280)
T ss_pred             cccc--cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH-----HHHHhcCCC---
Confidence            3221  13456899999999874     2 567899999999999999999999976533211     111110000   


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                                   .....+...+..+.+++.+||+.||.+|||+.++++.
T Consensus       226 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         226 -------------PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             -------------CCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                         0011112345678999999999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.7e-41  Score=295.75  Aligned_cols=237  Identities=22%  Similarity=0.346  Sum_probs=193.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|+..+.||+|+||.||+|.+  ++..+++|.+.....   .+.+.+|+.++++++||||+++           +++|
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e   78 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED---LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME   78 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH---HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence            36799999999999999999999  478999999876532   6789999999999999999997           7999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++++|.+++....    ..+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 ~~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          79 YCGAGSVSDIMKITN----KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             cCCCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            999999999996542    46899999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      ....  .....++..|+|||++.+ .++.++||||||+++|+|++|..||..........     ....           
T Consensus       152 ~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-----~~~~-----------  213 (256)
T cd06612         152 TMAK--RNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-----MIPN-----------  213 (256)
T ss_pred             Cccc--cccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-----hhcc-----------
Confidence            4321  134457899999999887 88999999999999999999999997543322110     0000           


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                           ........+...+..+.+++.+||+.||++|||+.++++
T Consensus       214 -----~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         214 -----KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             -----CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence                 000011112244578999999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1e-42  Score=293.16  Aligned_cols=268  Identities=19%  Similarity=0.264  Sum_probs=200.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe----C--CeeEEEEEEcCCCCh-hhHHHHHHHHHHHHhhcCCCcceE---------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW----Q--KRSISLMKYNGNRNQ-HALEWCINHIVYASRMSHKHIIKL---------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~----~--~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~~---------  115 (332)
                      ....|+....||+|+||.||+|..    .  ...+|+|+++...+. .......+|+.+++.++||||+.+         
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~  101 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDK  101 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence            345699999999999999999966    2  236899999887542 234568999999999999999987         


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC----CCeEE
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ----SDAKL  188 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~kl  188 (332)
                         +++||+++ +|.+.|+.+.......++...++.|+.||+.|+.|||   ++=|+||||||.|||+..+    |.|||
T Consensus       102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKI  177 (438)
T KOG0666|consen  102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKI  177 (438)
T ss_pred             eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEe
Confidence               89999987 9999999876655567999999999999999999999   9999999999999999877    89999


Q ss_pred             eecCCccccCCCCc-eeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccc----hhhhHH
Q 038681          189 FDFSLSLSIPDGET-HIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFES----RFHYEE  261 (332)
Q Consensus       189 ~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~----~~~~~~  261 (332)
                      +|||+++.+.++-. .......+-|.+|+|||++.+  .|+.+.||||+|||+.||+|-++.|.+.....    ..+...
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            99999998866432 223355678999999999998  79999999999999999999999997654321    112222


Q ss_pred             HHhhhhc----cccchhhhh---hh-hhhc----ccCCCCCCh------HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          262 NVKRLSG----QNCRFKEMV---DS-IIIE----DKSCTCTGK------EQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       262 ~~~~~~~----~~~~~~~~~---~~-~~~~----~~~~~~~~~------~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                      +.+.+.-    ....|+.+.   +- ....    ....+....      ..-++...+|+.++|++||.+|.|+++.++.
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            2222211    111121111   00 0000    000000000      0112347899999999999999999998763

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=313.90  Aligned_cols=228  Identities=20%  Similarity=0.284  Sum_probs=178.1

Q ss_pred             cccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhh---cCCCcceE-----------EEEEeccC
Q 038681           62 VLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRM---SHKHIIKL-----------IVFESVQI  123 (332)
Q Consensus        62 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l---~H~nIv~~-----------lv~e~~~~  123 (332)
                      ||+|+||.||+|.+  ++..||+|++.....  ......+..|..++..+   .||||+++           +||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999998  789999999865321  22234556677777765   69999986           89999999


Q ss_pred             CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCce
Q 038681          124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH  203 (332)
Q Consensus       124 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  203 (332)
                      |+|.+++...     ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.++|+|||++.........
T Consensus        81 g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~  152 (330)
T cd05586          81 GELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT  152 (330)
T ss_pred             ChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence            9999998765     56999999999999999999999   999999999999999999999999999998754332221


Q ss_pred             eeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhh
Q 038681          204 IELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSII  281 (332)
Q Consensus       204 ~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (332)
                        .....||+.|+|||++.+  .++.++|||||||++|+|++|..||........      ...+......+        
T Consensus       153 --~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~------~~~i~~~~~~~--------  216 (330)
T cd05586         153 --TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM------YRNIAFGKVRF--------  216 (330)
T ss_pred             --ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH------HHHHHcCCCCC--------
Confidence              135679999999999875  589999999999999999999999976543221      11111100000        


Q ss_pred             hcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 038681          282 IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT----MVDVAK  322 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs----~~evl~  322 (332)
                            +   ....+..+.+|+.+||+.||.+||+    +.++++
T Consensus       217 ------~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         217 ------P---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             ------C---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence                  0   0123467889999999999999984    555554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.5e-41  Score=296.80  Aligned_cols=238  Identities=20%  Similarity=0.280  Sum_probs=188.0

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC----ChhhHHHHHHHHHHHHhhcCCCcceE------------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR----NQHALEWCINHIVYASRMSHKHIIKL------------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~H~nIv~~------------  115 (332)
                      .+|...+.||+|+||.||+|..  ++..|++|.+....    .....+.+.+|+.++++++||||+++            
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4699999999999999999998  78899999886442    12335678899999999999999987            


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       +++||+++++|.+++...     ..+++..++.++.|++.||+|||   +.+|+|+||+|+||+++.++.++|+|||++
T Consensus        82 ~l~~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~  153 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS  153 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCc
Confidence             699999999999999765     46899999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCce-eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          195 LSIPDGETH-IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       195 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      ......... .......++..|+|||.+.+ .++.++|||||||++|||++|+.||.........     .......   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~-----~~~~~~~---  225 (266)
T cd06651         154 KRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI-----FKIATQP---  225 (266)
T ss_pred             cccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH-----HHHhcCC---
Confidence            765432111 11123458899999999987 7899999999999999999999999754322211     0000000   


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                    .....+....+.+.+++ +||..+|++||+++||++
T Consensus       226 --------------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 --------------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             --------------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence                          00111123346677887 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.2e-41  Score=299.40  Aligned_cols=249  Identities=20%  Similarity=0.218  Sum_probs=194.6

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-------------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-------------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-------------lv~  118 (332)
                      ++|+..+.||.|++|.||+|.+  ++..+|+|.+...........+.+|++++++++||||+++             +||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            3688889999999999999999  7889999999866554556779999999999999999986             799


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++++|.+++..... ....+++..+..++.||+.||.|||   ..+++|+||+|+||+++.++.++|+|||++....
T Consensus        81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          81 EYCEGGSLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EecCCCCHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            99999999998865422 2246899999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ....    ....++..|+|||.+.+ .++.++|||||||++|+|++|..||.......... ............      
T Consensus       157 ~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~------  225 (287)
T cd06621         157 NSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP-IELLSYIVNMPN------  225 (287)
T ss_pred             cccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCCh-HHHHHHHhcCCc------
Confidence            3322    23457889999999887 88999999999999999999999997653210000 001111111000      


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                       ..+.    .........++.+.+++.+||..||.+|||+.|+++
T Consensus       226 -~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         226 -PELK----DEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             -hhhc----cCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence             0000    000111134578999999999999999999999987

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-42  Score=311.27  Aligned_cols=243  Identities=16%  Similarity=0.227  Sum_probs=186.9

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|++.+.||+|+||.||++..  +++.||+|.+....  .....+.+.+|+.++..++||||+++           +||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4689999999999999999998  68899999987532  22235568899999999999999987           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++|+|.+++....    ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++....
T Consensus        81 e~~~g~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  153 (331)
T cd05597          81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLL  153 (331)
T ss_pred             ecCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecC
Confidence            9999999999997631    46899999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCceeeccccccCCCcccccccCC------CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT------LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      ....... ....||+.|+|||++..      .++.++|||||||++|+|++|..||.........      ..+......
T Consensus       154 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~------~~i~~~~~~  226 (331)
T cd05597         154 ADGTVQS-NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHKEH  226 (331)
T ss_pred             CCCCccc-cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHH------HHHHcCCCc
Confidence            4332211 23468999999999862      5788999999999999999999999765432211      111000000


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPED--RPTMVDVAKQ  323 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~evl~~  323 (332)
                      +            ..+ ......+..+.+++.+||..+++.  ||++.++++.
T Consensus       227 ~------------~~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         227 F------------QFP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             c------------cCC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            0            000 001124577899999988654433  7899888763

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.3e-41  Score=301.16  Aligned_cols=257  Identities=17%  Similarity=0.209  Sum_probs=187.9

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      +|+..+.||+|+||.||+|.+  +|..||+|.+..... ......+.+|+.++++++||||+++           +|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            478889999999999999999  788999999875432 2223567889999999999999986           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      ++ ++|.+++....    ..+++..++.++.||+.||.|||   ..+|+|+||||+||+++.++.++|+|||+++.....
T Consensus        81 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  152 (284)
T cd07839          81 CD-QDLKKYFDSCN----GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP  152 (284)
T ss_pred             CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC
Confidence            97 58888876531    46899999999999999999999   999999999999999999999999999999765433


Q ss_pred             CceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc-chhh--
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC-RFKE--  275 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--  275 (332)
                      ...  .....++..|+|||++.+  .++.++|||||||++|+|++|..|+........ .............. .+..  
T Consensus       153 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07839         153 VRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEESWPGVS  229 (284)
T ss_pred             CCC--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HHHHHHHHhCCCChHHhHHhh
Confidence            221  123467899999999876  578999999999999999999998654332111 11111111111000 0000  


Q ss_pred             -hhhhhhhcccCCC---CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          276 -MVDSIIIEDKSCT---CTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       276 -~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                       ..+..........   .......+.++.+|+.+||+.||.+|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         230 KLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             hcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence             0000000000000   0001134578899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.8e-41  Score=297.15  Aligned_cols=241  Identities=19%  Similarity=0.259  Sum_probs=193.7

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ++|+..+.||+|+||.||++.+  +++.+++|.+...........+.+|+.++++++||||+++           +|+||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            3688889999999999999999  5889999998877655556789999999999999999986           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFS-RPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      +++++|.+++....    ..+++..+..++.|++.||+|||   + .+++|+||||+||+++.++.++|+|||.+.....
T Consensus        81 ~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~  153 (265)
T cd06605          81 MDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVN  153 (265)
T ss_pred             cCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHH
Confidence            99999999997642    46899999999999999999999   8 9999999999999999999999999999876543


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      ...    ....++..|+|||.+.+ .++.++|||||||++|+|++|..||..........               .+...
T Consensus       154 ~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---------------~~~~~  214 (265)
T cd06605         154 SLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGI---------------FELLQ  214 (265)
T ss_pred             HHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccH---------------HHHHH
Confidence            322    12568889999999887 88999999999999999999999997543211110               01111


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ....... ... .....+.++.++|.+||..||++|||+.+++.
T Consensus       215 ~~~~~~~-~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         215 YIVNEPP-PRL-PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             HHhcCCC-CCC-ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            1111000 000 00115577999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=3.4e-41  Score=293.98  Aligned_cols=239  Identities=22%  Similarity=0.365  Sum_probs=190.2

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEec
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESV  121 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~  121 (332)
                      .+|++.+.||+|+||.||+|.+ .+..+|+|.+......  ...+.+|+.++++++||||+++           +|+||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~--~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS--EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC--HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            4688889999999999999998 5888999988754322  3568899999999999999988           899999


Q ss_pred             cCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCC
Q 038681          122 QIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE  201 (332)
Q Consensus       122 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  201 (332)
                      ++|+|.+++....    ..+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||.+.......
T Consensus        82 ~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  154 (256)
T cd05112          82 EHGCLSDYLRAQR----GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ  154 (256)
T ss_pred             CCCcHHHHHHhCc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCc
Confidence            9999999987541    35889999999999999999999   9999999999999999999999999999987654332


Q ss_pred             ceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          202 THIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       202 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      .... ....++..|+|||.+.+ .++.++||||||+++|||++ |..||........      ...+...          
T Consensus       155 ~~~~-~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~----------  217 (256)
T cd05112         155 YTSS-TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV------VETINAG----------  217 (256)
T ss_pred             cccc-CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH------HHHHhCC----------
Confidence            2111 23345678999999886 88999999999999999998 9999875443221      1111000          


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                          ...   ..+...+..+.+|+.+||+.+|++|||+.++++.|.
T Consensus       218 ----~~~---~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         218 ----FRL---YKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             ----CCC---CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                000   000112367999999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.1e-41  Score=300.01  Aligned_cols=257  Identities=19%  Similarity=0.263  Sum_probs=192.4

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      ++|+....||+|+||.||+|.+  +++.||+|++..... ....+.+.+|+.++++++||||+++           +|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            4688999999999999999999  689999999865432 2234567899999999999999987           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++++|..++...     ..+++..++.++.||+.||.|||   +.+++|+||||+||+++.++.++|+|||++.....
T Consensus        81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07847          81 YCDHTVLNELEKNP-----RGVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTG  152 (286)
T ss_pred             ccCccHHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCC
Confidence            99998888877544     46899999999999999999999   99999999999999999999999999999987655


Q ss_pred             CCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ....  .....++..|+|||.+.+  .++.++|||||||++|+|++|..||......+....  ................
T Consensus       153 ~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  228 (286)
T cd07847         153 PGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYL--IRKTLGDLIPRHQQIF  228 (286)
T ss_pred             Cccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHHHhCCCChHHhhhc
Confidence            4321  124467889999999865  578999999999999999999999986654332110  1111111000000000


Q ss_pred             hhhh------hcccCCCCC---ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 DSII------IEDKSCTCT---GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~~~~------~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      +...      ........+   .....+..+.+|+.+||+.||++|||+.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0000      000000000   00123577899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=9.9e-42  Score=297.20  Aligned_cols=241  Identities=22%  Similarity=0.261  Sum_probs=196.9

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      +.|+..+.||.|.-|+||++..  ++..+|+|++.+..-  .....++..|-+||+.++||.+..+           |||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            4577788999999999999999  558899999987643  3446788999999999999999987           999


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      |||+||+|..+.+++   ....+++..++.++..++-||+|||   -.|||.|||||+||||.++|++-|+||.++....
T Consensus       157 eyCpGGdL~~LrqkQ---p~~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~~~~  230 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQ---PGKRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSLRCP  230 (459)
T ss_pred             ecCCCccHHHHHhhC---CCCccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccccCC
Confidence            999999999998765   2367999999999999999999999   9999999999999999999999999998864321


Q ss_pred             C---------------------------------CCc---------------------eeeccccccCCCcccccccCC-
Q 038681          199 D---------------------------------GET---------------------HIELDSVVGTTGFIAPENFTT-  223 (332)
Q Consensus       199 ~---------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~-  223 (332)
                      -                                 ...                     ......++||-.|.|||++.+ 
T Consensus       231 ~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~  310 (459)
T KOG0610|consen  231 VSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGE  310 (459)
T ss_pred             CCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecC
Confidence            0                                 000                     011245789999999999999 


Q ss_pred             CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHH
Q 038681          224 LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLT  303 (332)
Q Consensus       224 ~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  303 (332)
                      ..+.++|.|+||+++|||+.|..||.+.+..+...     ..+.               .+  ...+..+..+..+.+||
T Consensus       311 GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~-----NIv~---------------~~--l~Fp~~~~vs~~akDLI  368 (459)
T KOG0610|consen  311 GHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLR-----NIVG---------------QP--LKFPEEPEVSSAAKDLI  368 (459)
T ss_pred             CCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHH-----HHhc---------------CC--CcCCCCCcchhHHHHHH
Confidence            89999999999999999999999999887665422     1111               11  11222235668899999


Q ss_pred             HHcccCCCCCCCC----HHHHHH
Q 038681          304 LQCMDFSPEDRPT----MVDVAK  322 (332)
Q Consensus       304 ~~cl~~dP~~RPs----~~evl~  322 (332)
                      ++.|..||++|..    |.||-+
T Consensus       369 r~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  369 RKLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             HHHhccChhhhhccccchHHhhc
Confidence            9999999999987    666643

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-41  Score=294.37  Aligned_cols=241  Identities=23%  Similarity=0.309  Sum_probs=193.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|++.+.||.|+||.||+|.+  ++..+++|.+...... ..+.+.+|+.++++++||||+++           ++||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD-DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh-hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence            35789999999999999999998  6788999998866544 36789999999999999999997           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++++|.+++....    ..+++..+..++.|++.||.|||   +.+|+|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~~~~~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          81 YCGGGSLQDIYQVTR----GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             CCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            999999999987642    46899999999999999999999   99999999999999999999999999999876544


Q ss_pred             CCceeeccccccCCCcccccccCC----CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      ....  .....++..|+|||.+.+    .++.++|||||||++|+|++|..||..........     ..... .  +  
T Consensus       154 ~~~~--~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~-----~~~~~-~--~--  221 (262)
T cd06613         154 TIAK--RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF-----LISKS-N--F--  221 (262)
T ss_pred             hhhc--cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhc-c--C--
Confidence            3211  134568889999998864    57889999999999999999999997654322111     00000 0  0  


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                               ...........+.++.+++.+||..||.+|||+++|+.
T Consensus       222 ---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         222 ---------PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             ---------CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                     00011112345678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.5e-41  Score=294.94  Aligned_cols=238  Identities=20%  Similarity=0.264  Sum_probs=189.3

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC----ChhhHHHHHHHHHHHHhhcCCCcceE------------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR----NQHALEWCINHIVYASRMSHKHIIKL------------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~H~nIv~~------------  115 (332)
                      .+|.+.+.||+|+||.||+|.+  ++..||+|.+....    .....+.+.+|+.++.+++||||+++            
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            4689999999999999999998  68899999886432    12335678899999999999999986            


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       +||||+++|+|.+++...     ..+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.++|+|||++
T Consensus        82 ~~v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~  153 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGAS  153 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccc
Confidence             799999999999999765     45889999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCce-eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          195 LSIPDGETH-IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       195 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      ......... .......++..|+|||++.+ .++.++|||||||++|+|++|+.||.........     ......    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~-----~~~~~~----  224 (265)
T cd06652         154 KRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAI-----FKIATQ----  224 (265)
T ss_pred             cccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHH-----HHHhcC----
Confidence            765432111 11133468899999999877 7899999999999999999999999754322110     000000    


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                   ......+...+..+.+++.+||. +|++||++++|++
T Consensus       225 -------------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         225 -------------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             -------------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence                         00111123445778899999995 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.1e-41  Score=295.70  Aligned_cols=246  Identities=20%  Similarity=0.327  Sum_probs=196.3

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ++|++.+.||.|+||+||+|..  ++..+++|++...........+.+|+.+++.++|+||+++           +|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            4689999999999999999998  7788999998765544457889999999999999999987           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++++|.+++.....  ...+++..+..++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++......
T Consensus        81 ~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~  155 (267)
T cd06610          81 LSGGSLLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADG  155 (267)
T ss_pred             cCCCcHHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccC
Confidence            999999999976421  135899999999999999999999   999999999999999999999999999998766554


Q ss_pred             Ccee--eccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          201 ETHI--ELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       201 ~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ....  ......|+..|+|||.+..  .++.++|+|||||++|+|++|..||........     ...........+.. 
T Consensus       156 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~-  229 (267)
T cd06610         156 GDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV-----LMLTLQNDPPSLET-  229 (267)
T ss_pred             ccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh-----HHHHhcCCCCCcCC-
Confidence            3321  1134468999999998875  588999999999999999999999976543221     11111111100000 


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                  .......+..+.+++.+||..||++|||+.+|++
T Consensus       230 ------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         230 ------------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             ------------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                        0001244578899999999999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-42  Score=310.60  Aligned_cols=244  Identities=20%  Similarity=0.290  Sum_probs=193.6

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcC-CCChhhHHHHHHHHHHHHhhc-CCCcceE-----------
Q 038681           50 RIATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNG-NRNQHALEWCINHIVYASRMS-HKHIIKL-----------  115 (332)
Q Consensus        50 ~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~-H~nIv~~-----------  115 (332)
                      .+....|++.++||+||.+.||++.. +.+.+|+|++.. ..+.....-|.+|+..|.+|+ |.+||++           
T Consensus       357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lY  436 (677)
T KOG0596|consen  357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLY  436 (677)
T ss_pred             EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEE
Confidence            34456699999999999999999999 667788877654 456666889999999999994 9999998           


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      |||||-+ .||..+|.+..    ..++...++.+..|++.|+.++|   .+||||.||||.|+|+- .|.+||+|||.|.
T Consensus       437 mvmE~Gd-~DL~kiL~k~~----~~~~~~~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~  507 (677)
T KOG0596|consen  437 MVMECGD-IDLNKILKKKK----SIDPDWFLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIAN  507 (677)
T ss_pred             EEeeccc-ccHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhc
Confidence            8999775 49999998873    23444588999999999999999   99999999999999984 5789999999999


Q ss_pred             ccCCCCceeeccccccCCCcccccccCC------------CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHH
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFTT------------LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENV  263 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------------~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~  263 (332)
                      .+..+.........+||+.|||||.+..            ..+.+|||||||||||+|+.|+.||......        +
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~--------~  579 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ--------I  579 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH--------H
Confidence            8887776665578899999999998852            2567999999999999999999999754321        1


Q ss_pred             hhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          264 KRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .       .+..+.++...-.++.....     .++.++++.||.+||.+|||..++|+
T Consensus       580 a-------Kl~aI~~P~~~Iefp~~~~~-----~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  580 A-------KLHAITDPNHEIEFPDIPEN-----DELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             H-------HHHhhcCCCccccccCCCCc-----hHHHHHHHHHHhcCcccCCCcHHHhc
Confidence            1       11222222221111111111     33999999999999999999999986

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.5e-41  Score=293.23  Aligned_cols=238  Identities=24%  Similarity=0.283  Sum_probs=193.6

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      +|+..+.||.|+||.||.+..  ++..+++|.+.... .......+.+|+.++++++|+||+++           ++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            488899999999999998888  78899999987543 34446778999999999999999998           79999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++|+|.+++....   ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~  154 (256)
T cd08221          81 ANGGTLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE  154 (256)
T ss_pred             cCCCcHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence            99999999997642   145899999999999999999999   999999999999999999999999999999766444


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      ...  .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.........      ...             
T Consensus       155 ~~~--~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~------~~~-------------  213 (256)
T cd08221         155 YSM--AETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV------VKI-------------  213 (256)
T ss_pred             ccc--ccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH------HHH-------------
Confidence            321  134568999999999887 7889999999999999999999999754332211      000             


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                       .....   .+.....+..+.+++.+||..+|.+|||+.++++.
T Consensus       214 -~~~~~---~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         214 -VQGNY---TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             -HcCCC---CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence             00000   00112344779999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=317.26  Aligned_cols=240  Identities=22%  Similarity=0.360  Sum_probs=200.4

Q ss_pred             CCCCCccccCCCceEEEEEe---CC--eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------EEEEe
Q 038681           56 YDEQNIVLEDPFRKLYKGFW---QK--RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IVFES  120 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~---~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv~e~  120 (332)
                      ....++||+|.||.|++|.|   .|  -.||||.+..+........|++|+.+|.+|+|||+|++          +|+|+
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~EL  191 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFEL  191 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhh
Confidence            44567899999999999999   33  45899999988766568999999999999999999998          79999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      ++.|+|.+.|++.   ....+.....-.++.|||.|+.||.   .+++|||||-.+|+|+-....|||+|||+.+.+..+
T Consensus       192 aplGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  192 APLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             cccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            9999999999873   2256888889999999999999999   999999999999999999999999999999998877


Q ss_pred             Cceeeccc-cccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          201 ETHIELDS-VVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       201 ~~~~~~~~-~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ...+.... ..-...|+|||.+.. .++.+||||+|||++|||+| |+.||.+........                 .+
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~-----------------~i  328 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILK-----------------NI  328 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHH-----------------hc
Confidence            66544222 234668999999997 99999999999999999998 788998766544322                 11


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL  324 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L  324 (332)
                      |.      .-..+.++.|+++++++++.||..+|++|||+..|.+.+
T Consensus       329 D~------~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  329 DA------GERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             cc------cccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            11      112233457789999999999999999999999997543

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.7e-42  Score=312.69  Aligned_cols=240  Identities=20%  Similarity=0.253  Sum_probs=204.1

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE---------
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL---------  115 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~---------  115 (332)
                      ......+.|.+...||+|.|+.|..|++  ++..||||.+.+... ....+.+.+|++++..|+|||||++         
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEAT  129 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence            3344567899999999999999999999  999999999988753 4445779999999999999999998         


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        +||||+.+|.+.+|+..+     +...+..+..++.|+++|++|||   +++|||||||++|||++.+.++||+|||+
T Consensus       130 lylV~eya~~ge~~~yl~~~-----gr~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgf  201 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKH-----GRMKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGF  201 (596)
T ss_pred             eEEEEEeccCchhHHHHHhc-----ccchhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeecccc
Confidence              899999999999999988     56778999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          194 SLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       194 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      +..+......   .+++|++.|+|||++.+  ..++.+|+||+|+++|-|+.|..||++....+.               
T Consensus       202 S~~~~~~~~l---qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~L---------------  263 (596)
T KOG0586|consen  202 STFFDYGLML---QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKEL---------------  263 (596)
T ss_pred             ceeecccccc---cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccc---------------
Confidence            9888755433   67899999999999998  568899999999999999999999987654332               


Q ss_pred             chhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                           -+..+......+.    -.+.+..++|+++|..+|.+|++.+++.+
T Consensus       264 -----r~rvl~gk~rIp~----~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  264 -----RPRVLRGKYRIPF----YMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             -----cchheeeeecccc----eeechhHHHHHHhhccCccccCCHHHhhh
Confidence                 1222222222121    22356789999999999999999999875

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=7.9e-41  Score=291.56  Aligned_cols=239  Identities=26%  Similarity=0.405  Sum_probs=191.6

Q ss_pred             CCCCCccccCCCceEEEEEeC--C----eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           56 YDEQNIVLEDPFRKLYKGFWQ--K----RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~~--~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      +.+.+.||.|+||.||+|.+.  +    ..||+|.+.........+.+.+|+.++..++||||+++           ++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            456789999999999999993  3    88999999777655457789999999999999999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++++|.+++.....   ..+++..+..++.|++.||+|||   +.+++|+||||+||+++.++.++|+|||++....
T Consensus        81 e~~~~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~  154 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLY  154 (258)
T ss_pred             eccCCCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceecc
Confidence            99999999999976521   12899999999999999999999   9999999999999999999999999999998766


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ....... ....+++.|+|||.+.+ .++.++|||||||++|+|++ |..||........      .......       
T Consensus       155 ~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~------~~~~~~~-------  220 (258)
T smart00219      155 DDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV------LEYLKKG-------  220 (258)
T ss_pred             ccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH------HHHHhcC-------
Confidence            5432211 12336789999999876 78999999999999999998 7888865432221      1111000       


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL  324 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L  324 (332)
                              .  ....+...+.++.+++.+||..||++|||+.++++.|
T Consensus       221 --------~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      221 --------Y--RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --------C--CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                    0  0011112457899999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=3.3e-41  Score=301.97  Aligned_cols=243  Identities=21%  Similarity=0.248  Sum_probs=190.1

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|+..+.||+|+||.||++.+  .++.|++|.+.....  ......+.+|+.+++.++||||+++           +||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            4688999999999999999999  778999999876532  2335678899999999999999997           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++|+|.+++...     ..+++..+..++.|++.||.|||   +.+++||||||+||+++.++.++|+|||+++...
T Consensus        81 e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~  152 (305)
T cd05609          81 EYVEGGDCATLLKNI-----GALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGL  152 (305)
T ss_pred             ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccC
Confidence            999999999999765     56899999999999999999999   9999999999999999999999999999986421


Q ss_pred             CCCc-------------eeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHh
Q 038681          199 DGET-------------HIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVK  264 (332)
Q Consensus       199 ~~~~-------------~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~  264 (332)
                      ....             ........++..|+|||.+.+ .++.++|||||||++||+++|..||.........      .
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~------~  226 (305)
T cd05609         153 MSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF------G  226 (305)
T ss_pred             cCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------H
Confidence            1100             001122457889999999876 8899999999999999999999999754332211      1


Q ss_pred             hhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          265 RLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                      .              ........+. .....+..+.+++.+||+.||++||++.++.+.|+
T Consensus       227 ~--------------~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         227 Q--------------VISDDIEWPE-GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             H--------------HHhcccCCCC-ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            0              0000000000 01134467899999999999999999766655554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.6e-42  Score=299.17  Aligned_cols=226  Identities=20%  Similarity=0.377  Sum_probs=177.2

Q ss_pred             CccccCCCceEEEEEe--CC-------eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           60 NIVLEDPFRKLYKGFW--QK-------RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      +.||+|+||.||+|..  .+       ..+++|.+.... ....+.+.+|+.+++.++||||+++           +|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence            4699999999999987  22       247888876543 2335678899999999999999987           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCC--------eEEeec
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD--------AKLFDF  191 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--------~kl~Df  191 (332)
                      |+++|+|.+++....    ..+++..++.++.||+.||+|||   +++|+||||||+||+++.++.        ++++||
T Consensus        80 ~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~  152 (258)
T cd05078          80 YVKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDP  152 (258)
T ss_pred             cCCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEeccc
Confidence            999999999997652    35899999999999999999999   999999999999999987765        699999


Q ss_pred             CCccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCC-ccCCCCCccchhhhHHHHhhhhc
Q 038681          192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQ-EVSDHVSFESRFHYEENVKRLSG  268 (332)
Q Consensus       192 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~-~p~~~~~~~~~~~~~~~~~~~~~  268 (332)
                      |.+......      ....+++.|+|||++.+  .++.++|||||||++|+|++|. .||..........      ... 
T Consensus       153 g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~------~~~-  219 (258)
T cd05078         153 GISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ------FYE-  219 (258)
T ss_pred             ccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH------HHH-
Confidence            998655432      23467889999999976  5789999999999999999995 5554332211100      000 


Q ss_pred             cccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038681          269 QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL  324 (332)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L  324 (332)
                                    .....+    .....++.+|+.+||+.||++|||++++++.|
T Consensus       220 --------------~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         220 --------------DRHQLP----APKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             --------------ccccCC----CCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                          000001    11235789999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.5e-41  Score=302.43  Aligned_cols=235  Identities=18%  Similarity=0.303  Sum_probs=187.2

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEecc
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQ  122 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~  122 (332)
                      |.....||+|+||.||++..  ++..||||.+...... ..+.+.+|+.+++.++||||+++           +||||++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~  102 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQ-RRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLE  102 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHH-HHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCC
Confidence            44456799999999999998  7889999998654433 36678999999999999999986           8999999


Q ss_pred             CCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCc
Q 038681          123 IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET  202 (332)
Q Consensus       123 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  202 (332)
                      +++|.+++..      ..+++..+..++.||+.||.|||   +++|+||||||+||+++.++.++|+|||++........
T Consensus       103 ~~~L~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~  173 (292)
T cd06658         103 GGALTDIVTH------TRMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP  173 (292)
T ss_pred             CCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc
Confidence            9999998854      35899999999999999999999   99999999999999999999999999999875543322


Q ss_pred             eeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhh
Q 038681          203 HIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSII  281 (332)
Q Consensus       203 ~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (332)
                      .  .....++..|+|||.+.+ .++.++||||||+++|||++|..||..........      ....       ....  
T Consensus       174 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~------~~~~-------~~~~--  236 (292)
T cd06658         174 K--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR------RIRD-------NLPP--  236 (292)
T ss_pred             c--CceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHh-------cCCC--
Confidence            1  134568999999999887 88999999999999999999999997543322110      0000       0000  


Q ss_pred             hcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          282 IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                            ........+..+.+++.+||..||.+|||+.++++.
T Consensus       237 ------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         237 ------RVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ------ccccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                  000111334678899999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5.7e-42  Score=310.37  Aligned_cols=242  Identities=17%  Similarity=0.218  Sum_probs=187.3

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|.+.+.||+|+||.||++.+  +++.||+|.+....  .......+.+|+.++..++|+||+++           +||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4689999999999999999998  77889999987532  22234567889999999999999987           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++|+|.+++....    ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||++....
T Consensus        81 Ey~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~  153 (331)
T cd05624          81 DYYVGGDLLTLLSKFE----DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMN  153 (331)
T ss_pred             eCCCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999997631    46899999999999999999999   9999999999999999999999999999997665


Q ss_pred             CCCceeeccccccCCCcccccccCC------CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT------LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      ....... ....||+.|+|||++.+      .++.++|||||||++|+|++|+.||........      ...+......
T Consensus       154 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~~  226 (331)
T cd05624         154 QDGTVQS-SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHEER  226 (331)
T ss_pred             CCCceee-ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------HHHHHcCCCc
Confidence            4332211 34569999999998863      478899999999999999999999976543221      1111000000


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPED--RPTMVDVAK  322 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~evl~  322 (332)
                      +            .. .......+..+.+++.+||..++.+  |++++++++
T Consensus       227 ~------------~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         227 F------------QF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             c------------cC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            0            00 0001133478999999999876554  467887765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.1e-41  Score=308.70  Aligned_cols=243  Identities=16%  Similarity=0.218  Sum_probs=187.5

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|.+.+.||+|+||.||++.+  .++.+|+|.+....  .......+.+|+.++..++|+||+++           +||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            3688999999999999999998  67889999986432  12224457889999999999999987           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++|+|.+++....    ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++....
T Consensus        81 ey~~~g~L~~~l~~~~----~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~  153 (332)
T cd05623          81 DYYVGGDLLTLLSKFE----DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLM  153 (332)
T ss_pred             eccCCCcHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecc
Confidence            9999999999997631    46899999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCceeeccccccCCCcccccccC------CCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          199 DGETHIELDSVVGTTGFIAPENFT------TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      ...... .....||+.|+|||++.      +.++.++|||||||++|||++|+.||.........      ..+......
T Consensus       154 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~------~~i~~~~~~  226 (332)
T cd05623         154 EDGTVQ-SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMNHKER  226 (332)
T ss_pred             cCCcce-ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH------HHHhCCCcc
Confidence            332221 13457999999999885      25788999999999999999999999765432211      111100000


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPED--RPTMVDVAKQ  323 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~evl~~  323 (332)
                      +          .   ........+.++.+|+.+|+..+|..  |+++.++++.
T Consensus       227 ~----------~---~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         227 F----------Q---FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             c----------c---CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            0          0   00011234578899999999765544  6889988764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.1e-40  Score=291.65  Aligned_cols=242  Identities=16%  Similarity=0.267  Sum_probs=195.4

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-------------EEE
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-------------IVF  118 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-------------lv~  118 (332)
                      +|++.+.||.|+||.||++.+  ++..+|+|.+.... .....+.+.+|+.++++++||||+++             +++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            488889999999999999998  77889999987543 34446778999999999999999986             799


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGF--SRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ||+++++|.+++..... ....+++..++.++.||+.||.|||...  +.+++|+||+|+||+++.++.+||+|||++..
T Consensus        81 e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          81 EYCEGGDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             hhccCCCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            99999999999976522 2256899999999999999999999432  56899999999999999999999999999987


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      ........  ....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.......      ........      
T Consensus       160 ~~~~~~~~--~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~------  225 (265)
T cd08217         160 LGHDSSFA--KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ------LASKIKEG------  225 (265)
T ss_pred             ccCCcccc--cccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH------HHHHHhcC------
Confidence            76544211  34568999999999987 78899999999999999999999997654211      11111100      


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                              .   ....+...+..+.+++.+||+.+|++|||+.+|++
T Consensus       226 --------~---~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         226 --------K---FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             --------C---CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                    0   00111244578999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.2e-41  Score=295.57  Aligned_cols=241  Identities=16%  Similarity=0.231  Sum_probs=189.2

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC---------hhhHHHHHHHHHHHHhhcCCCcceE--------
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN---------QHALEWCINHIVYASRMSHKHIIKL--------  115 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---------~~~~~~~~~E~~~l~~l~H~nIv~~--------  115 (332)
                      +|...+.||.|+||.||+|..  ++..+|+|.+.....         ....+.+.+|+.+++.++||||+++        
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            477889999999999999987  788999998864211         1123567889999999999999988        


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                         +|+||+++|+|.+++...     ..+++..+..++.||+.||.|||   +++++|+||+|+||+++.++.++|+|||
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~  153 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFG  153 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeecc
Confidence               899999999999999775     56899999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC---CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT---LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-  268 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-  268 (332)
                      ++................++..|+|||.+.+   .++.++|+||||+++|++++|..||........     ....... 
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~  228 (272)
T cd06629         154 ISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA-----MFKLGNKR  228 (272)
T ss_pred             ccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH-----HHHhhccc
Confidence            9976544322211234568899999999875   378999999999999999999999964332111     0000000 


Q ss_pred             cccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          269 QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ....+              ........+..+.+++.+||..||.+|||+++|++
T Consensus       229 ~~~~~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         229 SAPPI--------------PPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             cCCcC--------------CccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            00000              00111234578999999999999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-41  Score=297.95  Aligned_cols=258  Identities=18%  Similarity=0.292  Sum_probs=188.4

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ++|++.+.||+|++|.||+|..  +++.||+|.+...........+.+|+.++++++||||+++           +||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            5789999999999999999998  7889999998765433334457789999999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++ +|.+++....    ..+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.++|+|||+++.....
T Consensus        85 ~~~-~L~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          85 LDT-DLKQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             CCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            985 9999887642    36899999999999999999999   999999999999999999999999999998754332


Q ss_pred             CceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc-ccchhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ-NCRFKEMV  277 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  277 (332)
                      ....  ....++..|+|||++.+  .++.++|||||||++|+|++|..||........ ........+... ...+....
T Consensus       157 ~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         157 SKTY--SNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED-QLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             Cccc--cccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH-HHHHHHHhcCCCChhhhhhhh
Confidence            2111  23356889999999865  588999999999999999999999975542111 111111111110 00000000


Q ss_pred             hhhhhccc--C-CCCC------ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 DSIIIEDK--S-CTCT------GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~~~~~~~~--~-~~~~------~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ........  . ....      ........+.+++.+||+.||.+|||+.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             hccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            00000000  0 0000      00011267789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.6e-42  Score=330.90  Aligned_cols=243  Identities=22%  Similarity=0.331  Sum_probs=190.8

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE------------
Q 038681           50 RIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------------  115 (332)
Q Consensus        50 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~------------  115 (332)
                      .....+|+....||+||||.||++++  +|+.+|||++....+......+.+|+.+|++|+|||||++            
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            34566789999999999999999999  9999999999888766668889999999999999999998            


Q ss_pred             --------------------------------------------------------------------------------
Q 038681          116 --------------------------------------------------------------------------------  115 (332)
Q Consensus       116 --------------------------------------------------------------------------------  115 (332)
                                                                                                      
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------------EEEEeccCCChHHHHhhhhcccccCC-CHHHHHHHHHHHHHH
Q 038681          116 --------------------------------------IVFESVQIGTLADRIHHHCEQHFEAL-SLTDRLKVAMDIAHA  156 (332)
Q Consensus       116 --------------------------------------lv~e~~~~g~L~~~l~~~~~~~~~~l-~~~~~~~i~~~i~~~  156 (332)
                                                            |-||||+.-+|.+++..+     ... .....+.++++|++|
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N-----~~~~~~d~~wrLFreIlEG  709 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN-----HFNSQRDEAWRLFREILEG  709 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc-----ccchhhHHHHHHHHHHHHH
Confidence                                                  678999987777777765     112 477889999999999


Q ss_pred             HHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC----------------CCCceeeccccccCCCcccccc
Q 038681          157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP----------------DGETHIELDSVVGTTGFIAPEN  220 (332)
Q Consensus       157 L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE~  220 (332)
                      |.|+|   +.|||||||||.||+++.++.|||+|||+|+...                .+......+..+||.-|+|||+
T Consensus       710 LaYIH---~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl  786 (1351)
T KOG1035|consen  710 LAYIH---DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL  786 (1351)
T ss_pred             HHHHH---hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence            99999   9999999999999999999999999999997721                0111112356789999999999


Q ss_pred             cCC----CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHH
Q 038681          221 FTT----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQL  296 (332)
Q Consensus       221 ~~~----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  296 (332)
                      +.+    .|+.|+|+||||+|++||+.   ||....  +...   ....+..  +.++.-            ........
T Consensus       787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM--ERa~---iL~~LR~--g~iP~~------------~~f~~~~~  844 (1351)
T KOG1035|consen  787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM--ERAS---ILTNLRK--GSIPEP------------ADFFDPEH  844 (1351)
T ss_pred             hcccccccccchhhhHHHHHHHHHHhc---cCCchH--HHHH---HHHhccc--CCCCCC------------cccccccc
Confidence            976    49999999999999999985   454322  1111   2222221  111110            00111233


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          297 QAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       297 ~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      +.-..+|.+|++.||++||||.|+++
T Consensus       845 ~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  845 PEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             hHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            55678999999999999999999986

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.7e-41  Score=298.82  Aligned_cols=232  Identities=19%  Similarity=0.263  Sum_probs=190.9

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|.+.+.||+|+||.||++.+  .++.||+|.+....  .....+.+.+|+.++++++||||+++           +||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            4688999999999999999999  68999999987543  22335678999999999999999987           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++|+|.+++...     ..+++..+..++.||+.||.|||   +.+|+|+||+|+||+++.++.+||+|||++....
T Consensus        81 e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~  152 (290)
T cd05580          81 EYVPGGELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVK  152 (290)
T ss_pred             ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccC
Confidence            999999999999776     56899999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ...     ....+++.|+|||.+.+ ..+.++||||||+++|+|++|..||........      ..........     
T Consensus       153 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~~~~~~-----  216 (290)
T cd05580         153 GRT-----YTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI------YEKILEGKVR-----  216 (290)
T ss_pred             CCC-----CCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHhcCCcc-----
Confidence            542     34568999999999877 788999999999999999999999976542211      1111010000     


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAK  322 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~  322 (332)
                                   .+...+..+.+++.+||..||.+||     +++++++
T Consensus       217 -------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         217 -------------FPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             -------------CCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence                         1112247789999999999999998     7777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.7e-41  Score=298.58  Aligned_cols=257  Identities=21%  Similarity=0.304  Sum_probs=191.6

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh-hhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ-HALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      ++|+..+.||+|+||.||+|.+  +++.||+|.+...... ...+.+.+|+.+++.++||||+++           +|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            3688899999999999999999  6889999988654332 235668899999999999999986           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++++|..+....     ..+++..++.++.||+.||+|||   +.+|+|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~  152 (286)
T cd07846          81 FVDHTVLDDLEKYP-----NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA  152 (286)
T ss_pred             cCCccHHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence            99999998877554     45899999999999999999999   99999999999999999999999999999876644


Q ss_pred             CCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ....  .....++..|+|||.+.+  .++.++|||||||++|||++|..||......+.  ...................
T Consensus       153 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07846         153 PGEV--YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ--LYHIIKCLGNLIPRHQEIF  228 (286)
T ss_pred             Cccc--cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH--HHHHHHHhCCCchhhHHHh
Confidence            3321  134567899999999875  578899999999999999999999875443211  1111111111000001111


Q ss_pred             hhhh------hcccCCCC---CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 DSII------IEDKSCTC---TGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~~~~------~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      +...      ........   ...+..+..+.+|+.+||+.||++||++.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            0000      00000000   001134577999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.4e-41  Score=293.01  Aligned_cols=226  Identities=24%  Similarity=0.365  Sum_probs=179.1

Q ss_pred             CccccCCCceEEEEEeC--C----------eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------EE
Q 038681           60 NIVLEDPFRKLYKGFWQ--K----------RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IV  117 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~~--~----------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv  117 (332)
                      +.||+|+||.||+|.+.  +          ..+++|.+......  ...+.+|+.++++++||||+++          +|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD--SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh--HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEE
Confidence            46999999999999992  3          24777776654332  5778999999999999999987          79


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC-------CeEEee
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS-------DAKLFD  190 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-------~~kl~D  190 (332)
                      |||+++|+|.+++....    ..+++..+..++.||+.||.|||   +++|+||||||+||+++.++       .+||+|
T Consensus        79 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D  151 (259)
T cd05037          79 EEYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD  151 (259)
T ss_pred             EEcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEeCC
Confidence            99999999999998752    26899999999999999999999   99999999999999999887       799999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccCC---CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhh
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFTT---LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRL  266 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~  266 (332)
                      ||++......      ....++..|+|||++.+   .++.++|||||||++|+|++ |..||..........      ..
T Consensus       152 fg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~------~~  219 (259)
T cd05037         152 PGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER------FY  219 (259)
T ss_pred             CCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH------HH
Confidence            9999765442      23456788999999875   58899999999999999999 577776543221110      00


Q ss_pred             hccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          267 SGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                      ..               ....+.+    ....+.+++.+||..+|.+|||+.+|++.|.
T Consensus       220 ~~---------------~~~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         220 QD---------------QHRLPMP----DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             hc---------------CCCCCCC----CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00               0000000    1167899999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3e-41  Score=301.17  Aligned_cols=234  Identities=20%  Similarity=0.301  Sum_probs=187.4

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEecc
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQ  122 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~  122 (332)
                      |.....||+|+||.||+|..  ++..||+|.+....... .+.+.+|+.++..++||||+++           +|+||++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~  101 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR-RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQ  101 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch-HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCC
Confidence            44456799999999999998  78999999986544332 5678899999999999999987           8999999


Q ss_pred             CCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCc
Q 038681          123 IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET  202 (332)
Q Consensus       123 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  202 (332)
                      +++|.+++..      ..+++..++.++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++........
T Consensus       102 ~~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659         102 GGALTDIVSQ------TRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             CCCHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            9999998754      35899999999999999999999   99999999999999999999999999999875543322


Q ss_pred             eeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhh
Q 038681          203 HIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSII  281 (332)
Q Consensus       203 ~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (332)
                      .  .....++..|+|||.+.+ .++.++|||||||++|||++|..||.........      ..+......         
T Consensus       173 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~~~~---------  235 (297)
T cd06659         173 K--RKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------KRLRDSPPP---------  235 (297)
T ss_pred             c--ccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHhccCCC---------
Confidence            1  134568999999999987 8899999999999999999999999754332211      111110000         


Q ss_pred             hcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          282 IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                            ........+..+.+++.+||+.+|.+||+++++++
T Consensus       236 ------~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~  270 (297)
T cd06659         236 ------KLKNAHKISPVLRDFLERMLTREPQERATAQELLD  270 (297)
T ss_pred             ------CccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence                  00011123467899999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.3e-40  Score=293.98  Aligned_cols=233  Identities=21%  Similarity=0.333  Sum_probs=190.9

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEecc
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQ  122 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~  122 (332)
                      |...+.||+|+||.||+|.+  ++..||+|.............+.+|+.++.+++||||+++           +||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            77889999999999999987  7789999998765544446778999999999999999987           8999999


Q ss_pred             CCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCc
Q 038681          123 IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET  202 (332)
Q Consensus       123 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  202 (332)
                      +|+|.+++..      ..+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++........
T Consensus        86 ~~~l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06641          86 GGSALDLLEP------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchh
Confidence            9999999864      35899999999999999999999   99999999999999999999999999999876544321


Q ss_pred             eeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhh
Q 038681          203 HIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSII  281 (332)
Q Consensus       203 ~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (332)
                      .  .....++..|+|||.+.+ .++.++|||||||++|+|++|..||........      ........           
T Consensus       157 ~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~-----------  217 (277)
T cd06641         157 K--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKV------LFLIPKNN-----------  217 (277)
T ss_pred             h--hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHH------HHHHhcCC-----------
Confidence            1  134568889999999877 788999999999999999999999975432211      00010000           


Q ss_pred             hcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          282 IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                            ........+..+.+++.+||..+|.+||++.++++
T Consensus       218 ------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  252 (277)
T cd06641         218 ------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLK  252 (277)
T ss_pred             ------CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                  00111234477899999999999999999999998

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-43  Score=341.14  Aligned_cols=242  Identities=21%  Similarity=0.301  Sum_probs=200.4

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------E
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------I  116 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------l  116 (332)
                      ..+-+|....+||.|.||.||.|.+  +|...|+|-+..... ......+.+|..++..++|||+|++           |
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~I 1311 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYI 1311 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHH
Confidence            3455688899999999999999999  899999998876543 3446678899999999999999998           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      .||||.+|+|.+++...     ...++.....+..|++.|+.|||   .+|||||||||.||+++.+|.+|++|||.|..
T Consensus      1312 FMEyC~~GsLa~ll~~g-----ri~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEHG-----RIEDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred             HHHHhccCcHHHHHHhc-----chhhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeE
Confidence            99999999999999876     45778888889999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCce--eeccccccCCCcccccccCC----CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc
Q 038681          197 IPDGETH--IELDSVVGTTGFIAPENFTT----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       197 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      +..+...  .......||+.|||||++.+    ...-++||||+|||+.||+||+.||...+..-...+    ....+..
T Consensus      1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy----~V~~gh~ 1459 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY----HVAAGHK 1459 (1509)
T ss_pred             ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh----HHhccCC
Confidence            7665321  12346789999999999986    356689999999999999999999987765443332    1112222


Q ss_pred             cchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      +                  +.+...+.+..+|+.+||+.||+.|.++.|+++
T Consensus      1460 P------------------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1460 P------------------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             C------------------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            2                  223346688999999999999999999998876

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=7.7e-41  Score=297.49  Aligned_cols=260  Identities=21%  Similarity=0.231  Sum_probs=189.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++++|.+.+.||+|+||.||+|..  ++..|++|.+...........+.+|+.+++.++|+||+++           +|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            356799999999999999999988  7889999998765444434567899999999999999987           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||++ ++|.+++....    ..+++..+..++.|++.||.|||   +.+|+|+||||+||+++.++.++|+|||+++...
T Consensus        83 e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~  154 (291)
T cd07870          83 EYMH-TDLAQYMIQHP----GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKS  154 (291)
T ss_pred             eccc-CCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccC
Confidence            9996 68887775431    35788899999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch---
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF---  273 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~---  273 (332)
                      .....  .....+++.|+|||.+.+  .++.++|||||||++|+|++|..||........ ........+.......   
T Consensus       155 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~  231 (291)
T cd07870         155 IPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWTVLGVPTEDTWPG  231 (291)
T ss_pred             CCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHHHcCCCChhhhhh
Confidence            33221  133457899999999875  578899999999999999999999976543211 1111111110000000   


Q ss_pred             ----hhhhhhhhhcccCCCC---CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          274 ----KEMVDSIIIEDKSCTC---TGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       274 ----~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                          +...............   .........+.+++.+||..||.+|||+.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence                0000000000000000   000011367889999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1e-40  Score=290.80  Aligned_cols=236  Identities=23%  Similarity=0.360  Sum_probs=190.7

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      +|+..+.||+|+||.||++..  ++..+|+|.+.... .......+.+|+.+++.++||||+++           +|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            588899999999999999998  78889999987653 33346778999999999999999987           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC-CeEEeecCCccccCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS-DAKLFDFSLSLSIPD  199 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~~  199 (332)
                      +++++|.+++....   ...+++..+..++.|++.||.|||   +++++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (256)
T cd08220          81 APGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS  154 (256)
T ss_pred             CCCCCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence            99999999997642   135899999999999999999999   99999999999999998654 579999999987654


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      ....   ....++..|+|||.+.+ .++.++||||||+++|+|++|..||.........     ........        
T Consensus       155 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~-----~~~~~~~~--------  218 (256)
T cd08220         155 KSKA---YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV-----LKIMSGTF--------  218 (256)
T ss_pred             Cccc---cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH-----HHHHhcCC--------
Confidence            4322   23568899999999987 7889999999999999999999999765432211     00000000        


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                .+.+...+..+.+++.+||..||.+|||+.++++
T Consensus       219 ----------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         219 ----------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ----------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                      0011124477999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-41  Score=295.72  Aligned_cols=243  Identities=19%  Similarity=0.258  Sum_probs=193.2

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE------------
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL------------  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~------------  115 (332)
                      ..+++|++.+.||+|+||.||+|.+  +++.+++|.+.....  ..+.+.+|+.+++++ .||||+++            
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN   80 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence            3568899999999999999999999  678899999876543  246789999999999 79999875            


Q ss_pred             -----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEee
Q 038681          116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFD  190 (332)
Q Consensus       116 -----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  190 (332)
                           +||||+++++|.+++...... ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d  156 (275)
T cd06608          81 DDQLWLVMELCGGGSVTDLVKGLRKK-GKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVD  156 (275)
T ss_pred             ceEEEEEEEcCCCCcHHHHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECC
Confidence                 799999999999998764211 246899999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccCC------CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHh
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFTT------LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVK  264 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~  264 (332)
                      ||++.........  .....++..|+|||++..      .++.++|||||||++|+|++|..||........     ...
T Consensus       157 ~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~  229 (275)
T cd06608         157 FGVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA-----LFK  229 (275)
T ss_pred             Cccceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH-----HHH
Confidence            9998765433221  134568999999998753      467899999999999999999999975432211     111


Q ss_pred             hhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          265 RLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ....                .......+...+..+.+|+.+||..||++|||+.++++
T Consensus       230 ~~~~----------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         230 IPRN----------------PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hhcc----------------CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1000                00011112235578999999999999999999999975

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-41  Score=295.08  Aligned_cols=235  Identities=18%  Similarity=0.327  Sum_probs=191.0

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc---CCCcceE-----------EEE
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS---HKHIIKL-----------IVF  118 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~~-----------lv~  118 (332)
                      .|+..+.||+|+||.||+|.+  ++..|++|.+.........+.+.+|+.+++.+.   ||||+++           +||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            478889999999999999998  789999999876655555677889999999996   9999987           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++++|.+++...      .+++..+..++.|++.||.|||   ..+|+|+||+|+||+++.++.++|+|||++....
T Consensus        82 e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06917          82 EYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN  152 (277)
T ss_pred             ecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecC
Confidence            999999999998643      6899999999999999999999   9999999999999999999999999999997765


Q ss_pred             CCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      .....  .....|+..|+|||.+.+  .++.++|||||||++|+|++|..||..........      .....       
T Consensus       153 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~------~~~~~-------  217 (277)
T cd06917         153 QNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM------LIPKS-------  217 (277)
T ss_pred             CCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh------ccccC-------
Confidence            54321  134578999999998865  57899999999999999999999997543321100      00000       


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                              ...... ....+.++.+++.+||+.||++||++.+++.
T Consensus       218 --------~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         218 --------KPPRLE-DNGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             --------CCCCCC-cccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                    000000 0013467999999999999999999999976

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.9e-41  Score=298.24  Aligned_cols=244  Identities=18%  Similarity=0.262  Sum_probs=186.0

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-CCCcceE-----------EEEEe
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKL-----------IVFES  120 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~~-----------lv~e~  120 (332)
                      +|...+.||+|+||.||++.+  ++..+|+|.+...........+.+|+.++.++. ||||+++           ++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            466678899999999999999  789999999986654455677899999999996 9999997           78999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      ++. ++.++...........+++..+..++.|++.||+|||+  ..+|+||||||+||+++.++.++|+|||++......
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            864 66655432111112568999999999999999999993  359999999999999999999999999999765443


Q ss_pred             CceeeccccccCCCcccccccCC----CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ...   ....|++.|+|||++.+    .++.++|||||||++|+|++|+.||.....  .  ............+.    
T Consensus       162 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~--~~~~~~~~~~~~~~----  230 (288)
T cd06616         162 IAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--V--FDQLTQVVKGDPPI----  230 (288)
T ss_pred             Ccc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--H--HHHHhhhcCCCCCc----
Confidence            221   23468899999999875    478899999999999999999999975431  0  00011111110000    


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                .........+.++.+|+.+||+.||++|||+.+|+.
T Consensus       231 ----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         231 ----------LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             ----------CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                      011111235578999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1e-40  Score=295.61  Aligned_cols=257  Identities=18%  Similarity=0.218  Sum_probs=193.4

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      +|.+.+.||+|+||.||+|.+  ++..|++|++..... ....+.+.+|+.++++++||||+++           +|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            488899999999999999998  788999999876543 3335678999999999999999987           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      + +++|.+++....    ..+++..+..++.||+.||.|||   +.+++|+||||+||+++.++.++|+|||++......
T Consensus        81 ~-~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~  152 (286)
T cd07832          81 M-PSDLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEE  152 (286)
T ss_pred             c-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence            9 999999987642    46899999999999999999999   999999999999999999999999999999876554


Q ss_pred             CceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc-ccchhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ-NCRFKEMV  277 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  277 (332)
                      ... ......++..|+|||.+.+  .++.++||||+||++|+|++|.+||..........  ......... ...+.+..
T Consensus       153 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  229 (286)
T cd07832         153 EPR-LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLA--IVFRTLGTPNEETWPGLT  229 (286)
T ss_pred             CCC-ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHH--HHHHHcCCCChHHHhhcc
Confidence            321 1134578999999999865  57899999999999999999988886654322211  111111100 00011000


Q ss_pred             h-----hhhh-cccCCC-CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 D-----SIII-EDKSCT-CTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~-----~~~~-~~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      +     .... ...... .......+..+.+++.+||..||++|||+++++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            0     0000 000000 0000133478999999999999999999999975

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=9.7e-41  Score=304.97  Aligned_cols=255  Identities=17%  Similarity=0.249  Sum_probs=192.2

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-------------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-------------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-------------  115 (332)
                      ..++|+..+.||+|+||.||+|.+  +++.||+|.+.... .......+.+|+.++++++||||+++             
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            357799999999999999999998  78999999986532 23335677899999999999999864             


Q ss_pred             ----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeec
Q 038681          116 ----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF  191 (332)
Q Consensus       116 ----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  191 (332)
                          +||||++ ++|.+.+...       +++..+..++.|++.||+|||   ..||+||||||+||+++.++.+||+||
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~-------l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Df  162 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD-------LDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF  162 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc-------CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccC
Confidence                8999996 4888887542       889999999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc
Q 038681          192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       192 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      |+++........   ....++..|+|||.+.+ .++.++|||||||++|+|++|+.||...+....  +......+....
T Consensus       163 g~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~  237 (353)
T cd07850         163 GLARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQ--WNKIIEQLGTPS  237 (353)
T ss_pred             ccceeCCCCCCC---CCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHhcCCCC
Confidence            999866443221   34567899999999987 889999999999999999999999976543221  111111111111


Q ss_pred             cchhhhhhhh----hhcccC-----------------CCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          271 CRFKEMVDSI----IIEDKS-----------------CTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       271 ~~~~~~~~~~----~~~~~~-----------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ..+...++..    ......                 .........+..+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1111111100    000000                 000001134567899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-41  Score=305.85  Aligned_cols=259  Identities=19%  Similarity=0.238  Sum_probs=192.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  ++..||+|.+...........+.+|+.++++++||||+++               
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46799999999999999999998  7899999998754444446678899999999999999886               


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       +|+||+++ +|.+++..      ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++
T Consensus        84 ~lv~e~~~~-~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          84 YIVQELMET-DLYKLIKT------QHLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             EEEehhccc-CHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccce
Confidence             78999964 88887754      36899999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCcee-eccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-cc
Q 038681          195 LSIPDGETHI-ELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-QN  270 (332)
Q Consensus       195 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~  270 (332)
                      .......... ......||..|+|||.+.+  .++.++|||||||++|+|++|+.||..........  .....+.. ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~--~~~~~~~~~~~  231 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLN--LILGVLGTPSQ  231 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHcCCCCH
Confidence            7654332211 1123568999999998754  68999999999999999999999997654322111  01111110 00


Q ss_pred             cchhhhhhhhh----hcc-cCCCCC---ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          271 CRFKEMVDSII----IED-KSCTCT---GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       271 ~~~~~~~~~~~----~~~-~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                      ..+....+...    ... .....+   ..+..+.++.+++.+||+.||++|||+.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11111111000    000 000000   001235678999999999999999999999874

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.8e-40  Score=290.57  Aligned_cols=240  Identities=22%  Similarity=0.349  Sum_probs=192.4

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      +|...+.||+|+||.||+|..  ++..|++|.+..... ....+.+.+|+.+++.++|+||+++           +|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            488889999999999999998  788999999876643 2457789999999999999999987           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++++|.+++...     ..+++..+..++.|++.||.|||   +.+|+|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~  152 (264)
T cd06626          81 CSGGTLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN  152 (264)
T ss_pred             CCCCcHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCC
Confidence            9999999999765     45889999999999999999999   999999999999999999999999999999876544


Q ss_pred             Cceee--ccccccCCCcccccccCC-C---CChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          201 ETHIE--LDSVVGTTGFIAPENFTT-L---INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       201 ~~~~~--~~~~~gt~~y~aPE~~~~-~---~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      .....  .....++..|+|||.+.+ .   ++.++||||||+++|++++|..||..........    .........   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~---  225 (264)
T cd06626         153 TTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIM----FHVGAGHKP---  225 (264)
T ss_pred             CCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHH----HHHhcCCCC---
Confidence            33211  123567889999999876 4   7889999999999999999999997543211110    000000000   


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                   ..+.....+..+.+++.+||+.||.+|||+.+++.
T Consensus       226 -------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         226 -------------PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             -------------CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                         00111123577889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=299.96  Aligned_cols=241  Identities=20%  Similarity=0.281  Sum_probs=191.9

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh--hhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ--HALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|...+.||+|+||.||+|..  ++..+|+|.+......  ...+.+.+|+.++..++||||+++           +||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            3688899999999999999999  6899999999765432  246678999999999999999987           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+.+++|.+++....   ...+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++....
T Consensus        81 e~~~~~~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~  154 (316)
T cd05574          81 DYCPGGELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSD  154 (316)
T ss_pred             EecCCCCHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence            9999999999987531   146899999999999999999999   9999999999999999999999999999986543


Q ss_pred             CCCce---------------------------eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCC
Q 038681          199 DGETH---------------------------IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDH  250 (332)
Q Consensus       199 ~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~  250 (332)
                      .....                           .......||..|+|||++.+ .++.++||||||+++|+|++|..||..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~  234 (316)
T cd05574         155 VEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKG  234 (316)
T ss_pred             ccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCC
Confidence            22110                           01123468899999999987 789999999999999999999999976


Q ss_pred             CCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC----HHHHHH
Q 038681          251 VSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT----MVDVAK  322 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs----~~evl~  322 (332)
                      .......     ..           ....    ..  ..+.....+..+.+++.+||+.||++|||    +.++++
T Consensus       235 ~~~~~~~-----~~-----------~~~~----~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         235 SNRDETF-----SN-----------ILKK----EV--TFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             CchHHHH-----HH-----------HhcC----Cc--cCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            5432211     00           0000    00  01111124578999999999999999999    777765

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.2e-40  Score=290.49  Aligned_cols=237  Identities=21%  Similarity=0.289  Sum_probs=191.6

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      +|++.+.||+|+||.||.+..  +++.|++|.+.... .......+.+|+.++++++||||+++           +|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            488899999999999999998  78899999987542 23335678999999999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++++|.+++.....   ..+++..++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~  154 (256)
T cd08218          81 CEGGDLYKKINAQRG---VLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNST  154 (256)
T ss_pred             CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcc
Confidence            999999999875421   35789999999999999999999   999999999999999999999999999999766543


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      ....  ....|++.|+|||++.+ .++.++|+|||||++|+|++|..||......+.                    ...
T Consensus       155 ~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~--------------------~~~  212 (256)
T cd08218         155 VELA--RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL--------------------VLK  212 (256)
T ss_pred             hhhh--hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH--------------------HHH
Confidence            3211  23468889999999887 788999999999999999999999875432211                    111


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ......   .+.+...+..+.+++.+||+.+|.+||++.+|++
T Consensus       213 ~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         213 IIRGSY---PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             HhcCCC---CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            111110   0111234477999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=8.4e-41  Score=295.82  Aligned_cols=240  Identities=18%  Similarity=0.263  Sum_probs=185.7

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHH-HHhhcCCCcceE-----------EEEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVY-ASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~H~nIv~~-----------lv~e  119 (332)
                      ++|++.+.||+|+||.||+|.+  ++..||+|.+...........+..|+.+ ++.++||||+++           +|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            4688999999999999999999  7899999999876443334556667766 555689999986           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSR-PIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      |++ |+|.+++....... ..+++..++.++.||+.||.|||   ++ +++||||||+||+++.++.+||+|||++....
T Consensus        81 ~~~-~~l~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKG-LTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhc-ccHHHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            997 68998887643222 46899999999999999999999   76 99999999999999999999999999997654


Q ss_pred             CCCceeeccccccCCCcccccccCC-----CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      .....   ....++..|+|||.+.+     .++.++|+|||||++|+|++|+.||........    ...........  
T Consensus       156 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~--  226 (283)
T cd06617         156 DSVAK---TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ----QLKQVVEEPSP--  226 (283)
T ss_pred             ccccc---ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH----HHHHHHhcCCC--
Confidence            33221   23468899999998854     467899999999999999999999964321100    01111100000  


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                    . ......+.++.+++.+||..+|.+|||+.++++
T Consensus       227 --------------~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         227 --------------Q-LPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             --------------C-CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                          0 001134578999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.1e-40  Score=296.86  Aligned_cols=238  Identities=19%  Similarity=0.318  Sum_probs=192.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|.+.+.||+|+||.||+|..  ++..|++|.+....... .+.+.+|+.++++++||||+++           +|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK-KELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchH-HHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence            36799999999999999999987  77889999986544333 5678999999999999999987           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++|+|.+++...      .+++..+..++.|++.||.|||   +++++|+||+|+||+++.++.++|+|||++.....
T Consensus        97 ~~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~  167 (293)
T cd06647          97 YLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (293)
T ss_pred             cCCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence            99999999999753      5789999999999999999999   99999999999999999999999999999876544


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      ....  .....+++.|+|||.+.+ .++.++|||||||++|++++|..||..........     .......        
T Consensus       168 ~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~-----~~~~~~~--------  232 (293)
T cd06647         168 EQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-----LIATNGT--------  232 (293)
T ss_pred             cccc--cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee-----ehhcCCC--------
Confidence            3321  134568899999999876 78899999999999999999999997654322110     0000000        


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                              .........+..+.+++.+||..+|++||++.+++..
T Consensus       233 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         233 --------PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             --------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    0111112344678999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2e-40  Score=291.03  Aligned_cols=241  Identities=20%  Similarity=0.357  Sum_probs=191.3

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-----hhhHHHHHHHHHHHHhhcCCCcceE-----------E
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-----QHALEWCINHIVYASRMSHKHIIKL-----------I  116 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~~-----------l  116 (332)
                      +|+..+.||+|+||.||+|..  ++..||+|.+.....     ....+.+.+|+.++++++||||+++           +
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            588899999999999999998  788999999875432     1235678999999999999999987           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC-CeEEeecCCcc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS-DAKLFDFSLSL  195 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~  195 (332)
                      |+||+++++|.+++...     ..+++..+..++.||+.||.|||   +++++|+||+|+||+++.++ .++|+|||.+.
T Consensus        81 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~  152 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAA  152 (268)
T ss_pred             EEeccCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccccccc
Confidence            99999999999999765     56899999999999999999999   99999999999999998776 59999999987


Q ss_pred             ccCCCCcee--eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          196 SIPDGETHI--ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       196 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      .........  ......+|..|+|||.+.+ .++.++||||+||++|+|++|..||..........   .....      
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~------  223 (268)
T cd06630         153 RLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIFKI------  223 (268)
T ss_pred             ccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHHHH------
Confidence            665432110  1123468899999999887 78999999999999999999999996543321111   00000      


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                              ...  ......+...+.++.+++.+||..+|.+|||+.++++
T Consensus       224 --------~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         224 --------ASA--TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             --------hcc--CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence                    000  0011122345578999999999999999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.9e-41  Score=320.02  Aligned_cols=266  Identities=17%  Similarity=0.201  Sum_probs=180.8

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe---CCeeEEEEEEc--------------C--CCChhhHHHHHHHHHHHHhhcCCCc
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW---QKRSISLMKYN--------------G--NRNQHALEWCINHIVYASRMSHKHI  112 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~--------------~--~~~~~~~~~~~~E~~~l~~l~H~nI  112 (332)
                      ..++|.+.+.||+|+||.||+|..   .+...++|.+.              .  .........+.+|+.++.+++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            457899999999999999999876   22222222110              0  0112234568899999999999999


Q ss_pred             ceE-----------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeC
Q 038681          113 IKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN  181 (332)
Q Consensus       113 v~~-----------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  181 (332)
                      |++           +|+|++. ++|.+++...............+..++.||+.||.|||   +++|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH---~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH---DKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEC
Confidence            987           7888885 57888876532211123446778899999999999999   99999999999999999


Q ss_pred             CCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCC-CCccchhhh
Q 038681          182 EQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDH-VSFESRFHY  259 (332)
Q Consensus       182 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~-~~~~~~~~~  259 (332)
                      .++.+||+|||+++.+........ ....||..|+|||++.+ .++.++|||||||++|||++|..++.. .........
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFD-YGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCEEEEeCCCceecCccccccc-ccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            999999999999987655432211 34679999999999987 899999999999999999998865432 222221121


Q ss_pred             HHHHhhhhccccchh-------hhhhhhhhcccCCCCC---ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          260 EENVKRLSGQNCRFK-------EMVDSIIIEDKSCTCT---GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       260 ~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ......+......+.       +.++...........+   .....+..+.+++.+||++||.+|||+.|++.
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            112211111111111       1111100000000000   00012356788999999999999999999986

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.2e-40  Score=288.85  Aligned_cols=235  Identities=20%  Similarity=0.291  Sum_probs=190.8

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC----hhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN----QHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      +|...+.||+|+||.||+|..  ++..|++|.+.....    ....+.+.+|+.+++.++||||+++           +|
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            477889999999999999998  688999998865432    2346778999999999999999987           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      +||+++++|.+++...     ..+++..+..++.||+.||.|||   +.+|+|+||+|+||+++.++.+||+|||.+...
T Consensus        81 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~  152 (258)
T cd06632          81 LELVPGGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQV  152 (258)
T ss_pred             EEecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceec
Confidence            9999999999999765     45899999999999999999999   999999999999999999999999999998766


Q ss_pred             CCCCceeeccccccCCCcccccccCC-C-CChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-L-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      .....   .....++..|+|||.+.. . ++.++|+|||||++|+|++|..||........     ........  .   
T Consensus       153 ~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~--~---  219 (258)
T cd06632         153 VEFSF---AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA-----VFKIGRSK--E---  219 (258)
T ss_pred             ccccc---ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH-----HHHHHhcc--c---
Confidence            44331   134568999999999876 4 89999999999999999999999976542111     11100000  0   


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                  ....+...+..+.+++.+||+.+|.+||++.+++.
T Consensus       220 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         220 ------------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             ------------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence                        00011133477899999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.5e-40  Score=288.58  Aligned_cols=239  Identities=19%  Similarity=0.308  Sum_probs=196.8

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ++|++.+.||+|++|.||+|.+  ++..|++|++...........+.+|+..+.+++||||+++           +|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            3688899999999999999999  6899999999877654456789999999999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFS-RPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      +++++|.+++...     ..+++..++.++.|++.||.|||   + .+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~  152 (264)
T cd06623          81 MDGGSLADLLKKV-----GKIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN  152 (264)
T ss_pred             cCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            9999999999875     56899999999999999999999   8 9999999999999999999999999999987654


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      .....  ....++..|+|||.+.+ .++.++||||||+++|+|++|..||..........   .......          
T Consensus       153 ~~~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~---~~~~~~~----------  217 (264)
T cd06623         153 TLDQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFE---LMQAICD----------  217 (264)
T ss_pred             CCCcc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHH---HHHHHhc----------
Confidence            43321  24568899999999887 78899999999999999999999997654211100   1111110          


Q ss_pred             hhhhcccCCCCCChHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQ-QLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                          ..   ....... .+..+.+++.+||..+|++|||+.++++
T Consensus       218 ----~~---~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         218 ----GP---PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             ----CC---CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                00   0011112 4578999999999999999999999987

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=280.84  Aligned_cols=239  Identities=19%  Similarity=0.287  Sum_probs=192.5

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-CCCcceE-----------EEEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKL-----------IVFE  119 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~~-----------lv~e  119 (332)
                      ++.+....||.|+.|.|+++++  +|...|||.+....+....++++..+.++.+.. .|.||+.           |.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            3445567899999999999999  789999999999888777889999999887764 8999997           4566


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      .+.- .+..++....    .++|+..+-++...+++||.||-+  .++|+|||+||+|||+|+.|++||||||.+..+.+
T Consensus       172 lMs~-C~ekLlkrik----~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd  244 (391)
T KOG0983|consen  172 LMST-CAEKLLKRIK----GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVD  244 (391)
T ss_pred             HHHH-HHHHHHHHhc----CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeec
Confidence            6532 4555555542    569999999999999999999986  89999999999999999999999999999988776


Q ss_pred             CCceeeccccccCCCcccccccCC----CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      ....   +...|.+.|||||.+.-    .|+..+||||||++++||.||+.||.....+-.                   
T Consensus       245 SkAh---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-------------------  302 (391)
T KOG0983|consen  245 SKAH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-------------------  302 (391)
T ss_pred             cccc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH-------------------
Confidence            6554   45689999999999863    689999999999999999999999987543221                   


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ++...+...+ +..+.....++.+.+|+..||..|+.+||...++++
T Consensus       303 ~ltkvln~eP-P~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  303 VLTKVLNEEP-PLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             HHHHHHhcCC-CCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            1111222222 111222236789999999999999999999998875

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.7e-40  Score=296.25  Aligned_cols=256  Identities=20%  Similarity=0.212  Sum_probs=190.6

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh----hhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ----HALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      +|...+.||+|+||.||+|.+  +++.|++|.+......    .....+.+|+.++++++|+||+++           +|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            478889999999999999998  6889999999765432    224557789999999999999987           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+ +|+|.+++....    ..+++..+..++.||++||.|||   +++|+|+||+|+||+++.++.++|+|||+++..
T Consensus        81 ~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~  152 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSF  152 (298)
T ss_pred             Eccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeec
Confidence            9999 889999997651    26899999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc-ccchh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ-NCRFK  274 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~  274 (332)
                      .......  ....+++.|+|||.+.+  .++.++|||||||++|||++|.+||.........  .......... ...+.
T Consensus       153 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  228 (298)
T cd07841         153 GSPNRKM--THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL--GKIFEALGTPTEENWP  228 (298)
T ss_pred             cCCCccc--cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH--HHHHHHcCCCchhhhh
Confidence            5443211  23456889999998865  6789999999999999999998887654432211  1111111000 00000


Q ss_pred             h---hhhhhhhcccCC--CCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          275 E---MVDSIIIEDKSC--TCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       275 ~---~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .   ..+.........  ........+..+.+++.+||+.||++|||+.++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            0   000000000000  00011234578899999999999999999999987

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.3e-40  Score=296.57  Aligned_cols=248  Identities=12%  Similarity=0.139  Sum_probs=175.9

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--C---CeeEEEEEEcCCCChhhHH----------HHHHHHHHHHhhcCCCcceE-
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--Q---KRSISLMKYNGNRNQHALE----------WCINHIVYASRMSHKHIIKL-  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~---~~~vavK~~~~~~~~~~~~----------~~~~E~~~l~~l~H~nIv~~-  115 (332)
                      ..++|.+.+.||+|+||.||+|.+  +   +..+++|...........+          ....+...+..+.|+||+++ 
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            346799999999999999999998  3   3456666543332211111          12233344556689999875 


Q ss_pred             --------------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeC
Q 038681          116 --------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN  181 (332)
Q Consensus       116 --------------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  181 (332)
                                    +++|++. .++.+.+...     ...++..+..++.|++.||+|||   +.+|+||||||+|||++
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~  160 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVD  160 (294)
T ss_pred             EeeeEecCCceEEEEEEehhc-cCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEc
Confidence                          4556553 3666666543     34678889999999999999999   99999999999999999


Q ss_pred             CCCCeEEeecCCccccCCCCce-----eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccc
Q 038681          182 EQSDAKLFDFSLSLSIPDGETH-----IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFES  255 (332)
Q Consensus       182 ~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~  255 (332)
                      .++.++|+|||+|+........     .......||+.|+|||++.+ .++.++|||||||++|||++|..||.......
T Consensus       161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~  240 (294)
T PHA02882        161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG  240 (294)
T ss_pred             CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence            9999999999999866432211     11123469999999999987 89999999999999999999999998764322


Q ss_pred             hhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038681          256 RFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL  324 (332)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L  324 (332)
                      ........           +.+.........     ....+..+.+++..||..+|++||++.++++.|
T Consensus       241 ~~~~~~~~-----------~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        241 NLIHAAKC-----------DFIKRLHEGKIK-----IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHhHH-----------HHHHHhhhhhhc-----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            21100000           000000000000     012347799999999999999999999999876

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=7.8e-41  Score=292.16  Aligned_cols=235  Identities=19%  Similarity=0.259  Sum_probs=192.0

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      +|++.+.||.|+||.||+|.+  ++..||+|.+....  .....+.+.+|+.++++++||||+++           +|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            588899999999999999999  68999999997543  22346789999999999999999976           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++++|.+++...     ..+++..+..++.||++||.|||   +++++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~  152 (258)
T cd05578          81 LLLGGDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP  152 (258)
T ss_pred             CCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence            99999999999765     46899999999999999999999   99999999999999999999999999999877654


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      ....   ....|+..|+|||.+.+ .++.++|+||||+++|+|++|..||..........   .......          
T Consensus       153 ~~~~---~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~----------  216 (258)
T cd05578         153 DTLT---TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ---IRAKQET----------  216 (258)
T ss_pred             Cccc---cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH---HHHHhcc----------
Confidence            4321   34568889999999887 78999999999999999999999998654321111   1110000          


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCH--HHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTM--VDVA  321 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~--~evl  321 (332)
                              .....+...+..+.+++.+||..||.+||++  +|++
T Consensus       217 --------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 --------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             --------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                    0111112344789999999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.3e-40  Score=294.74  Aligned_cols=257  Identities=19%  Similarity=0.228  Sum_probs=189.7

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      +|+..+.||.|++|.||+|.+  ++..||||.+..... ......+.+|++++++++||||+++           +||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            588899999999999999998  788999998875432 2234578899999999999999997           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      ++ ++|.+++....   ...+++..+..++.|++.||+|||   ..+++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~-~~l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~  153 (284)
T cd07860          81 LH-QDLKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  153 (284)
T ss_pred             cc-cCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            96 58999886542   146899999999999999999999   999999999999999999999999999998765433


Q ss_pred             CceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      ...  .....++..|+|||.+.+  .++.++|||||||++|+|+||+.||.........  ...................
T Consensus       154 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07860         154 VRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL--FRIFRTLGTPDEVVWPGVT  229 (284)
T ss_pred             ccc--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCChhhhhhhh
Confidence            221  123456889999998876  4688999999999999999999999765433221  1111111111100000000


Q ss_pred             hhh--hcccCC-CCC----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          279 SII--IEDKSC-TCT----GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       279 ~~~--~~~~~~-~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ...  ...... ...    .....+..+.+++.+||+.||.+|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            000  000000 000    00123467889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-40  Score=295.22  Aligned_cols=258  Identities=20%  Similarity=0.250  Sum_probs=192.0

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      ++|++.+.||+|+||.||+|.+  ++..|++|.+.... .....+.+.+|+.++++++|+||+++           +|+|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            3688999999999999999998  67899999987543 23335778999999999999999987           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |++++.+..+....     ..+++..+..++.||+.||.|||   ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~  152 (288)
T cd07833          81 YVERTLLELLEASP-----GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRA  152 (288)
T ss_pred             cCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCC
Confidence            99987776665443     45899999999999999999999   99999999999999999999999999999977655


Q ss_pred             CCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ...... ....++..|+|||++.+  .++.++||||||+++|+|++|..||......+...  .................
T Consensus       153 ~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  229 (288)
T cd07833         153 RPASPL-TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLY--LIQKCLGPLPPSHQELF  229 (288)
T ss_pred             Cccccc-cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCCHHHhhhc
Confidence            442111 34567899999999875  67899999999999999999999997654322111  01111111010000000


Q ss_pred             h--hhhhccc--CCC------CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 D--SIIIEDK--SCT------CTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~--~~~~~~~--~~~------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .  .......  ...      ...+...+.++.+|+.+||..||++|||++++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0  0000000  000      0001123578999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=5e-40  Score=288.81  Aligned_cols=242  Identities=20%  Similarity=0.329  Sum_probs=190.6

Q ss_pred             CCCCCCccccCCCceEEEEEe---CCeeEEEEEEcCCC---------ChhhHHHHHHHHHHHHh-hcCCCcceE------
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW---QKRSISLMKYNGNR---------NQHALEWCINHIVYASR-MSHKHIIKL------  115 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~-l~H~nIv~~------  115 (332)
                      +|++.+.||+|+||.||+|.+   .+..+|+|.+....         .......+.+|+.++.+ ++||||+++      
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            488899999999999999999   35789999875321         22335667889998875 799999998      


Q ss_pred             -----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeeecCCCCCCeeeCCCCCeEEe
Q 038681          116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFS-RPIVYRDMKPTNILFNEQSDAKLF  189 (332)
Q Consensus       116 -----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~~~~kl~  189 (332)
                           +||||+++++|.+++..... ....+++..++.++.|++.||.|||   . .+++|+||+|+||+++.++.++|+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh---~~~~i~H~dl~~~nil~~~~~~~~l~  156 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLH---KEKRIVHRDLTPNNIMLGEDDKVTIT  156 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhc---cCCceeecCCCHHHEEECCCCcEEEe
Confidence                 89999999999999865321 1246899999999999999999999   6 689999999999999999999999


Q ss_pred             ecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc
Q 038681          190 DFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG  268 (332)
Q Consensus       190 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  268 (332)
                      |||.+........   .....++..|+|||.+.+ .++.++||||||+++|+|++|..||........      ......
T Consensus       157 dfg~~~~~~~~~~---~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~------~~~~~~  227 (269)
T cd08528         157 DFGLAKQKQPESK---LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL------ATKIVE  227 (269)
T ss_pred             cccceeecccccc---cccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH------HHHHhh
Confidence            9999977654431   145578999999999987 789999999999999999999999865432211      000000


Q ss_pred             cccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          269 QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                                    ...  ........+..+.+++.+||+.||++||++.|+...+.
T Consensus       228 --------------~~~--~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         228 --------------AVY--EPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             --------------ccC--CcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                          000  00001123467999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=4.7e-40  Score=291.16  Aligned_cols=258  Identities=18%  Similarity=0.248  Sum_probs=192.7

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEec
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESV  121 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~  121 (332)
                      +|+..+.||.|++|.||+|.+  ++..||+|.+...........+.+|+.++++++||||+++           +||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            588899999999999999999  7889999999876544445678899999999999999998           899999


Q ss_pred             cCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCC
Q 038681          122 QIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE  201 (332)
Q Consensus       122 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  201 (332)
                      ++ +|.+++.....  ...+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~~-~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          81 DK-DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV  154 (284)
T ss_pred             Cc-cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence            85 89998875421  135899999999999999999999   9999999999999999999999999999997654332


Q ss_pred             ceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-cccchhhhhh
Q 038681          202 THIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-QNCRFKEMVD  278 (332)
Q Consensus       202 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  278 (332)
                      ..  .....++..|+|||.+.+  .++.++|||||||++|+|++|..||......+...  ........ ....+..+.+
T Consensus       155 ~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07836         155 NT--FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL--KIFRIMGTPTESTWPGISQ  230 (284)
T ss_pred             cc--cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH--HHHHHhCCCChhhHHHHhc
Confidence            21  123457889999998865  57899999999999999999999998665432211  11111100 0001110000


Q ss_pred             hh-hhcccCCC-----CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          279 SI-IIEDKSCT-----CTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       279 ~~-~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .. .....+..     ....+..+..+.+++.+||+.||.+||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00 00000000     0001133577899999999999999999999875

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3e-40  Score=293.00  Aligned_cols=234  Identities=19%  Similarity=0.300  Sum_probs=187.4

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEecc
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQ  122 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~  122 (332)
                      |...+.||+|++|.||++..  .+..+++|++...... ..+.+.+|+.+++.++||||+++           +|+||++
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ-RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh-HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            55567999999999999987  7788999988654333 25668899999999999999998           8999999


Q ss_pred             CCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCc
Q 038681          123 IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET  202 (332)
Q Consensus       123 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  202 (332)
                      +++|.+++...      .+++..+..++.|++.||+|||   +++|+||||+|+||+++.++.++|+|||.+........
T Consensus       100 ~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~  170 (285)
T cd06648         100 GGALTDIVTHT------RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP  170 (285)
T ss_pred             CCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc
Confidence            99999998763      5899999999999999999999   99999999999999999999999999998875543322


Q ss_pred             eeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhh
Q 038681          203 HIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSII  281 (332)
Q Consensus       203 ~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (332)
                      .  .....|+..|+|||.+.+ .++.++|||||||++|+|++|..||........      ........           
T Consensus       171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~~~~~~~~-----------  231 (285)
T cd06648         171 R--RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------MKRIRDNL-----------  231 (285)
T ss_pred             c--cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHHHhcC-----------
Confidence            1  133568999999999887 789999999999999999999999875432211      11111000           


Q ss_pred             hcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          282 IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                          ..........+..+.+++.+||+.||++|||+.++++
T Consensus       232 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         232 ----PPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ----CCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence                0000011123467999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.9e-40  Score=294.18  Aligned_cols=261  Identities=16%  Similarity=0.160  Sum_probs=189.6

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhc-CCCcceE--------------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMS-HKHIIKL--------------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-H~nIv~~--------------  115 (332)
                      ++|++.+.||+|+||.||+|.+  ++..||+|....... ......+.+|+.+++.++ ||||+++              
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4688999999999999999998  788999998866532 222456889999999995 6999876              


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC-CCCeEEeecC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE-QSDAKLFDFS  192 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg  192 (332)
                        +||||+++ +|.+++..........+++..++.++.||+.||.|||   +++|+||||+|+||+++. ++.++|+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecc
Confidence              79999985 8999987653322246899999999999999999999   999999999999999998 8899999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-c
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-Q  269 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~  269 (332)
                      ++..........  ....+++.|+|||.+.+  .++.++||||||+++|+|++|..||.........  ......... .
T Consensus       157 ~~~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~~~~~~~~~  232 (295)
T cd07837         157 LGRAFSIPVKSY--THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHIFKLLGTPT  232 (295)
T ss_pred             cceecCCCcccc--CCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHHHhCCCC
Confidence            987654332111  23356889999998865  5789999999999999999999999765432211  111111100 0


Q ss_pred             ccchhhhhhhhh---hcccC--CCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          270 NCRFKEMVDSII---IEDKS--CTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       270 ~~~~~~~~~~~~---~~~~~--~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ...+........   .....  ......+..+..+.+||.+||..||.+|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            000000000000   00000  000001234577999999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=4.5e-40  Score=290.95  Aligned_cols=229  Identities=19%  Similarity=0.294  Sum_probs=177.5

Q ss_pred             ccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHh---hcCCCcceE-----------EEEEecc
Q 038681           61 IVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASR---MSHKHIIKL-----------IVFESVQ  122 (332)
Q Consensus        61 ~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~---l~H~nIv~~-----------lv~e~~~  122 (332)
                      .||+|+||.||++..  +++.+|+|.+.....  ......+.+|..++..   .+||||+.+           +||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999998  688999998865432  1212334555544444   479999876           8999999


Q ss_pred             CCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCc
Q 038681          123 IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET  202 (332)
Q Consensus       123 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  202 (332)
                      +|+|.+++...     ..+++..+..++.|++.||.|||   +.+|+|+||||+|||++.++.++|+|||++........
T Consensus        81 ~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~  152 (279)
T cd05633          81 GGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  152 (279)
T ss_pred             CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc
Confidence            99999998765     56999999999999999999999   99999999999999999999999999999876543322


Q ss_pred             eeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhh
Q 038681          203 HIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSI  280 (332)
Q Consensus       203 ~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (332)
                          ....||..|+|||.+.+  .++.++|||||||++|+|++|..||..........   .......            
T Consensus       153 ----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~---~~~~~~~------------  213 (279)
T cd05633         153 ----HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTLT------------  213 (279)
T ss_pred             ----cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHH---HHHHhhc------------
Confidence                23468999999999863  68999999999999999999999997543322111   0000000            


Q ss_pred             hhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038681          281 IIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAK  322 (332)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~  322 (332)
                            .....+...+.++.+++.+||..||++||     |+.++++
T Consensus       214 ------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         214 ------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             ------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence                  00111123457899999999999999999     5888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.9e-40  Score=291.32  Aligned_cols=253  Identities=18%  Similarity=0.200  Sum_probs=186.8

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-CCCcceE-------------EEEE
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKL-------------IVFE  119 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~~-------------lv~e  119 (332)
                      |.+.+.||+|+||.||+|..  ++..||+|.+.............+|+.++.++. ||||+++             +|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            66788999999999999998  788999999876533322344568999999985 9999987             8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |++ |+|.+++....    ..+++..+..++.|++.||.|||   ..+++|+||+|+||+++. +.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~  151 (282)
T cd07831          81 LMD-MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS  151 (282)
T ss_pred             cCC-ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence            997 58888876531    46899999999999999999999   999999999999999999 9999999999987654


Q ss_pred             CCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ....   ....++..|+|||.+.+  .++.++|||||||++|||++|..||...+..+...  ............+....
T Consensus       152 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  226 (282)
T cd07831         152 KPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIA--KIHDVLGTPDAEVLKKF  226 (282)
T ss_pred             CCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHH--HHHHHcCCCCHHHHHhh
Confidence            3322   23467899999997653  67889999999999999999999997655432211  11111111111110000


Q ss_pred             hhhhhcccCCC-------CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 DSIIIEDKSCT-------CTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ...-......+       .......+..+.+|+.+||+.||++|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            00000000000       0001234688999999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.1e-40  Score=293.92  Aligned_cols=257  Identities=18%  Similarity=0.208  Sum_probs=191.1

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh-hhHHHHHHHHHHHHhhcCCCcceE-------------EE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ-HALEWCINHIVYASRMSHKHIIKL-------------IV  117 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~~-------------lv  117 (332)
                      ++|+..+.||.|+||.||+|.+  +++.+++|.+...... .....+.+|+.++.+++||||+++             +|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            5799999999999999999999  6889999998755332 223457789999999999999987             89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      +||+++ +|.+++....    ..+++..++.++.||+.||+|||   +.+++|+||||+||+++.++.++|+|||++...
T Consensus        85 ~e~~~~-~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~  156 (293)
T cd07843          85 MEYVEH-DLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREY  156 (293)
T ss_pred             ehhcCc-CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeec
Confidence            999974 9999987642    35899999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc-chh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC-RFK  274 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~  274 (332)
                      ......  .....+++.|+|||.+.+  .++.++||||||+++|+|++|..||..........  ........... .+.
T Consensus       157 ~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~--~~~~~~~~~~~~~~~  232 (293)
T cd07843         157 GSPLKP--YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLN--KIFKLLGTPTEKIWP  232 (293)
T ss_pred             cCCccc--cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHHHhCCCchHHHH
Confidence            554221  134467889999999876  46899999999999999999999997655432211  11111110000 000


Q ss_pred             hhhh---hh---hhcc-c-CCCCCChHH-HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          275 EMVD---SI---IIED-K-SCTCTGKEQ-QLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       275 ~~~~---~~---~~~~-~-~~~~~~~~~-~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ....   ..   .... . ......+.. .++.+.+++.+||+.||++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence            0000   00   0000 0 000000011 3577899999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.6e-40  Score=296.68  Aligned_cols=259  Identities=18%  Similarity=0.209  Sum_probs=191.4

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh-hhHHHHHHHHHHHHhhcCCCcceE-------------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ-HALEWCINHIVYASRMSHKHIIKL-------------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~~-------------  115 (332)
                      ..++|++.+.||+|+||.||+|.+  ++..||+|.+...... .....+.+|+.++.+++|+||+++             
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            356799999999999999999998  7899999998754322 223346789999999999999976             


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      +||||+.+ +|.+++....    ..+++..+..++.||+.||.|||   +.+++||||||+||+++.++.+||+|||.+.
T Consensus        85 lv~e~~~~-~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~  156 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR  156 (309)
T ss_pred             EEEecCCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceee
Confidence            89999974 8988887542    46899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      .........  ....++..|+|||.+.+  .++.++|||||||++|||++|..||..........  ............+
T Consensus       157 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~--~~~~~~~~~~~~~  232 (309)
T cd07845         157 TYGLPAKPM--TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLD--LIIQLLGTPNESI  232 (309)
T ss_pred             ecCCccCCC--CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcCCCChhh
Confidence            765432211  23346888999999865  67899999999999999999999998655433211  1111111110000


Q ss_pred             hhhhhhhh-hcccC---CCCCC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          274 KEMVDSII-IEDKS---CTCTG----KEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       274 ~~~~~~~~-~~~~~---~~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ...++... .....   .....    ....++.+.++|.+||+.||++|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         233 WPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             chhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00000000 00000   00000    0123577899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-40  Score=295.67  Aligned_cols=264  Identities=19%  Similarity=0.276  Sum_probs=190.7

Q ss_pred             CCCCCCccccCCCceEEEEEe----CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-------------
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW----QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-------------  115 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-------------  115 (332)
                      +|.+.+.||+|+||.||+|..    .+..||+|.+....  .....+.+.+|+.++.+++||||+++             
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            478889999999999999999    46899999998743  12224667889999999999999987             


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC----CCCeEEeec
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE----QSDAKLFDF  191 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl~Df  191 (332)
                      +||||+++ +|.+++..........+++..++.++.||+.||.|||   +.+|+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            89999975 7888776543333246899999999999999999999   999999999999999999    899999999


Q ss_pred             CCccccCCCCc-eeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchh-------hhHH
Q 038681          192 SLSLSIPDGET-HIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRF-------HYEE  261 (332)
Q Consensus       192 g~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~-------~~~~  261 (332)
                      |++........ ........+|..|+|||++.+  .++.++|||||||++|+|++|..||.........       ....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99986644332 111234567899999998865  5789999999999999999999999766543310       0111


Q ss_pred             HHhhhhccccc-h------hhhhhhh-hhcccCCCCCCh-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          262 NVKRLSGQNCR-F------KEMVDSI-IIEDKSCTCTGK-------EQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       262 ~~~~~~~~~~~-~------~~~~~~~-~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ....+...... +      .+..... .......+....       ...+..+.+++.+||+.||++|||+.++++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11111100000 0      0000000 000000000000       023457899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.9e-40  Score=291.07  Aligned_cols=239  Identities=21%  Similarity=0.333  Sum_probs=194.1

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ..++|+....||+|+||.||+|.+  .+..+++|.+.....  ..+.+.+|+.+++.++|+||+++           +|+
T Consensus        17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            456688899999999999999999  588999999976544  36778899999999999999987           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++++|.+++....    ..+++..+..++.|++.||.|||   ..||+|+||+|+||+++.++.++|+|||++....
T Consensus        95 e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          95 EYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             eccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            9999999999998762    26999999999999999999999   9999999999999999999999999999986654


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      .....  .....++..|+|||.+.+ .++.++|||||||++|+|++|..||..........     ......        
T Consensus       168 ~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~-----~~~~~~--------  232 (286)
T cd06614         168 KEKSK--RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF-----LITTKG--------  232 (286)
T ss_pred             cchhh--hccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhcC--------
Confidence            43221  133457889999999887 78999999999999999999999987543322110     000000        


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                              .........++..+.+++.+||+.+|.+|||+.++++
T Consensus       233 --------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         233 --------IPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             --------CCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                    0011111224578999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-41  Score=282.67  Aligned_cols=240  Identities=21%  Similarity=0.264  Sum_probs=198.4

Q ss_pred             HhcCCCC-CCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE------------
Q 038681           52 ATNNYDE-QNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL------------  115 (332)
Q Consensus        52 ~~~~y~~-~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~------------  115 (332)
                      .+++|.+ .++||-|-.|.|-.+.+  +++.+|+|++...      ....+|+++.-.. .|||||.+            
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            3556765 46799999999999999  8999999998764      4567899987777 59999997            


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeC---CCCCeEEe
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN---EQSDAKLF  189 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~  189 (332)
                         +|||+++||.|.+.+..+..   ..+++.++..|+.||+.|+.|||   +.+|.||||||+|+|.+   .|..+||+
T Consensus       133 cLLiVmE~meGGeLfsriq~~g~---~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLt  206 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDRGD---QAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLT  206 (400)
T ss_pred             eeEeeeecccchHHHHHHHHccc---ccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEec
Confidence               89999999999999988743   46999999999999999999999   99999999999999996   45579999


Q ss_pred             ecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc
Q 038681          190 DFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG  268 (332)
Q Consensus       190 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  268 (332)
                      |||+|+........   .+.+.|+.|.|||++.. +|+...|+||+||++|-|++|-+||.+.......           
T Consensus       207 DfGFAK~t~~~~~L---~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais-----------  272 (400)
T KOG0604|consen  207 DFGFAKETQEPGDL---MTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------  272 (400)
T ss_pred             ccccccccCCCccc---cCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC-----------
Confidence            99999887654433   56788999999999987 8999999999999999999999999876542111           


Q ss_pred             cccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          269 QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                           +.+-..+....+..+.+.-.+.++..+++|+.+|..+|.+|.|+.++++
T Consensus       273 -----pgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  273 -----PGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             -----hhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence                 1122222233344444555688899999999999999999999999875

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-40  Score=286.75  Aligned_cols=238  Identities=21%  Similarity=0.245  Sum_probs=189.8

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCC----CChhhHHHHHHHHHHHHhhcCCCcceE------------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGN----RNQHALEWCINHIVYASRMSHKHIIKL------------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~H~nIv~~------------  115 (332)
                      .+|.+.+.||+|+||.||+|.+  ++..||+|.+...    ........+.+|+.++++++||||+++            
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4689999999999999999998  7889999987543    123345678999999999999999987            


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       +|+||+++++|.+++...     ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++
T Consensus        82 ~~v~e~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~  153 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGAS  153 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccc
Confidence             799999999999999765     45889999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCce-eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          195 LSIPDGETH-IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       195 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      +........ .......++..|+|||.+.+ .++.++|||||||++|+|++|+.||........     .......    
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~----  224 (264)
T cd06653         154 KRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA-----IFKIATQ----  224 (264)
T ss_pred             cccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH-----HHHHHcC----
Confidence            765432110 11123568899999999987 788999999999999999999999975432211     1111000    


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                   +.....+...++.+.+++.+||. +|..||++.+++.
T Consensus       225 -------------~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         225 -------------PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             -------------CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence                         00111123455789999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=9.5e-40  Score=292.78  Aligned_cols=233  Identities=21%  Similarity=0.330  Sum_probs=187.0

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ..|...+.||+|+||.||+|..  ++..||+|.+....  .....+.+.+|+.+++.++||||+++           +|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            4588899999999999999998  78999999986543  23335678999999999999999997           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||++ |+|.+++....    ..+++..+..++.|++.||.|||   +.+|+|+||+|+||+++.++.++|+|||++....
T Consensus        95 e~~~-g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~  166 (307)
T cd06607          95 EYCL-GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVS  166 (307)
T ss_pred             HhhC-CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecC
Confidence            9997 57877776431    45899999999999999999999   9999999999999999999999999999987654


Q ss_pred             CCCceeeccccccCCCcccccccC----CCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFT----TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ..      ....++..|+|||++.    +.++.++||||||+++|||++|..||..........      ....      
T Consensus       167 ~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~------~~~~------  228 (307)
T cd06607         167 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQ------  228 (307)
T ss_pred             CC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH------HHhc------
Confidence            33      2346788999999874    268889999999999999999999987554322100      0000      


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                              ..  .+......++..+.+++.+||..||++||++.+|+.
T Consensus       229 --------~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  266 (307)
T cd06607         229 --------ND--SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK  266 (307)
T ss_pred             --------CC--CCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence                    00  000111235578999999999999999999999987

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.3e-40  Score=300.32  Aligned_cols=258  Identities=16%  Similarity=0.262  Sum_probs=192.9

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE---------------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL---------------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~---------------  115 (332)
                      ++|++.+.||+|+||.||+|..  ++..||+|++..... ......+.+|+.++++++||||+++               
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   84 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY   84 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence            6799999999999999999998  789999999876532 2335677899999999999999874               


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      +|+||+. |+|.+++...     ..+++..+..++.||+.||.|||   .++|+||||||+||+++.++.+||+|||++.
T Consensus        85 lv~e~~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~  155 (334)
T cd07855          85 VVMDLME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMAR  155 (334)
T ss_pred             EEEehhh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccce
Confidence            8999996 6899988654     46899999999999999999999   9999999999999999999999999999997


Q ss_pred             ccCCCCcee--eccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          196 SIPDGETHI--ELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       196 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      .........  ......++..|+|||.+.+  .++.++|||||||++|||++|+.||..........  ...........
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~--~~~~~~g~~~~  233 (334)
T cd07855         156 GLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLK--LILSVLGSPSE  233 (334)
T ss_pred             eecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHH--HHHHHhCCChh
Confidence            654332211  1124578999999998865  68899999999999999999999997654432211  01111111100


Q ss_pred             ch-hhhhhhhhh---cccCCCCC-----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          272 RF-KEMVDSIII---EDKSCTCT-----GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       272 ~~-~~~~~~~~~---~~~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .+ .......+.   ........     .....+..+.+++.+||+.||.+|||+++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         234 EVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             HhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            00 000000000   00000000     01234578999999999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-40  Score=290.58  Aligned_cols=256  Identities=17%  Similarity=0.205  Sum_probs=188.5

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEec
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFESV  121 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~  121 (332)
                      |++.+.||.|++|.||+|.+  +|..||+|++..... ....+.+.+|+.+++.++||||+++           +++||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            67788999999999999998  789999999875532 2224568899999999999999987           899999


Q ss_pred             cCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCC
Q 038681          122 QIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE  201 (332)
Q Consensus       122 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  201 (332)
                      + ++|.+++.....   ..+++..+..++.|++.||+|||   +++++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~-~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~  153 (283)
T cd07835          81 D-LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV  153 (283)
T ss_pred             C-cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc
Confidence            5 699999876521   35899999999999999999999   9999999999999999999999999999997654332


Q ss_pred             ceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc-h-----
Q 038681          202 THIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR-F-----  273 (332)
Q Consensus       202 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~-----  273 (332)
                      ...  ....++..|+|||++.+  .++.++||||||+++|+|++|..||..........  ............ +     
T Consensus       154 ~~~--~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07835         154 RTY--THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF--RIFRTLGTPDEDVWPGVTS  229 (283)
T ss_pred             ccc--CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCChHHhhhhhh
Confidence            111  23356889999998865  57899999999999999999999997654322111  011111000000 0     


Q ss_pred             -hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          274 -KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       274 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                       .+....................+..+.+++.+||+.||.+|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence             0000000000000000011133467899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.6e-40  Score=300.23  Aligned_cols=258  Identities=18%  Similarity=0.259  Sum_probs=192.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE--------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL--------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~--------------  115 (332)
                      ..+|.+.+.||+|+||.||+|.+  ++..||+|.+.... .......+.+|+.+++.++||||+++              
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            35699999999999999999998  78999999987542 22234567889999999999999864              


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        +|+||+. ++|.+++...     ..+++..+..++.|++.||.|||   +++++|+||||+||+++.++.+||+|||+
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~  154 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGL  154 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCcc
Confidence              8999996 6899888765     56999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc-
Q 038681          194 SLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN-  270 (332)
Q Consensus       194 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  270 (332)
                      +.........  .....++..|+|||.+.+  .++.++|||||||++|+|++|..||...+......  .......... 
T Consensus       155 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~  230 (337)
T cd07858         155 ARTTSEKGDF--MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLK--LITELLGSPSE  230 (337)
T ss_pred             ccccCCCccc--ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHH--HHHHHhCCCCh
Confidence            9876543211  134567899999998764  68899999999999999999999997654322111  0111111000 


Q ss_pred             c--------chhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          271 C--------RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       271 ~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                      .        .....+..................+..+.+++.+||+.||++|||+.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            0        0000000000000000000012345778999999999999999999999874

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.2e-40  Score=298.90  Aligned_cols=260  Identities=22%  Similarity=0.304  Sum_probs=191.9

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhh-cCCCcceE------------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRM-SHKHIIKL------------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~~------------  115 (332)
                      ..++|++.+.||+|+||.||+|.+  ++..+|+|++.... .......+.+|+.++.++ +||||+++            
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            356799999999999999999998  68899999886532 223355678899999999 99999987            


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       +||||++ ++|.+++...      .+++..+..++.||+.||.|||   ++||+|+||||+||+++.++.+||+|||++
T Consensus        85 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~  154 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLA  154 (337)
T ss_pred             EEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccch
Confidence             8999997 5999888653      5788999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCce---eeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc
Q 038681          195 LSIPDGETH---IELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ  269 (332)
Q Consensus       195 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  269 (332)
                      .........   .......||..|+|||.+.+  .++.++|||||||++|+|++|+.||..........  .........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~--~~~~~~~~~  232 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLE--KIIEVIGPP  232 (337)
T ss_pred             hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHHHhCCC
Confidence            866543321   11234568999999998765  67899999999999999999999997654332211  011110000


Q ss_pred             c-cchh--------hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          270 N-CRFK--------EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       270 ~-~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                      . ..+.        ..++.................+.++.+++.+||+.||++|||+.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            0 0000        0011000000000000111245789999999999999999999999873

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.4e-39  Score=284.92  Aligned_cols=230  Identities=22%  Similarity=0.269  Sum_probs=185.7

Q ss_pred             cccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCCCh
Q 038681           62 VLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTL  126 (332)
Q Consensus        62 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g~L  126 (332)
                      ||.|+||.||+|.+  ++..+++|.+.....  ....+.+.+|+.+++.++||||+++           +|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            79999999999999  489999999876432  2345779999999999999999997           89999999999


Q ss_pred             HHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceeec
Q 038681          127 ADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL  206 (332)
Q Consensus       127 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  206 (332)
                      .+++...     ..+++..+..++.||+.||.|||   +.+++|+||+|+||+++.++.++|+|||++.........   
T Consensus        81 ~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~---  149 (262)
T cd05572          81 WTILRDR-----GLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT---  149 (262)
T ss_pred             HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccc---
Confidence            9999775     45899999999999999999999   999999999999999999999999999999876554311   


Q ss_pred             cccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhccc
Q 038681          207 DSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDK  285 (332)
Q Consensus       207 ~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ....++..|+|||.+.+ .++.++|+||||+++|+|++|..||.........    ....              ......
T Consensus       150 ~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~--------------~~~~~~  211 (262)
T cd05572         150 WTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPME----IYND--------------ILKGNG  211 (262)
T ss_pred             ccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHH----HHHH--------------HhccCC
Confidence            33468899999999876 7899999999999999999999999765421110    0000              000000


Q ss_pred             CCCCCChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 038681          286 SCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT-----MVDVAK  322 (332)
Q Consensus       286 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~  322 (332)
                        ....+...+..+.+++.+||..||++||+     +.|+++
T Consensus       212 --~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         212 --KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             --CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence              00111122578999999999999999999     777765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=7.6e-40  Score=289.11  Aligned_cols=232  Identities=20%  Similarity=0.316  Sum_probs=182.6

Q ss_pred             cccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCCCh
Q 038681           62 VLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTL  126 (332)
Q Consensus        62 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g~L  126 (332)
                      ||+|+||+||+|..  +++.+|+|.+....  .......+.+|+.++++++||||+++           +||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999988  78899999986542  12234567889999999999999987           89999999999


Q ss_pred             HHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceeec
Q 038681          127 ADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL  206 (332)
Q Consensus       127 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  206 (332)
                      .+++.....   ..+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||.+.........   
T Consensus        81 ~~~l~~~~~---~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~---  151 (277)
T cd05577          81 KYHIYNVGE---PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKI---  151 (277)
T ss_pred             HHHHHHcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCcc---
Confidence            999976521   36899999999999999999999   999999999999999999999999999998765442221   


Q ss_pred             cccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhccc
Q 038681          207 DSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDK  285 (332)
Q Consensus       207 ~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ....++..|+|||.+.+ .++.++|||||||++|+|++|+.||..........  ........                 
T Consensus       152 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~~~~~~~~-----------------  212 (277)
T cd05577         152 KGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--ELKRRTLE-----------------  212 (277)
T ss_pred             ccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--HHHhcccc-----------------
Confidence            34567889999999877 78899999999999999999999997554311100  00000000                 


Q ss_pred             CCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038681          286 SCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAK  322 (332)
Q Consensus       286 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~  322 (332)
                       .....+...+..+.+++.+||+.||.+||     ++.+++.
T Consensus       213 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         213 -MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             -ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence             00111123357889999999999999999     6666654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.4e-39  Score=291.63  Aligned_cols=259  Identities=18%  Similarity=0.222  Sum_probs=188.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE--------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL--------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~--------------  115 (332)
                      .++|++.+.||+|+||.||+|..  ++..||+|.+..... ......+.+|+.++++++||||+++              
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            45799999999999999999998  789999999865432 2223456789999999999999875              


Q ss_pred             -----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEee
Q 038681          116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFD  190 (332)
Q Consensus       116 -----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  190 (332)
                           +||||+.+ +|.+++....    ..+++.+++.++.||+.||.|||   +++++|+||||+||+++.++.+||+|
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNKN----VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECc
Confidence                 78999964 8888876531    35899999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCce--eeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhh
Q 038681          191 FSLSLSIPDGETH--IELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRL  266 (332)
Q Consensus       191 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~  266 (332)
                      ||++.........  .......++..|+|||.+.+  .++.++||||||+++|||++|..||..........   ....+
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~---~~~~~  239 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT---LISQL  239 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHH
Confidence            9999766443221  11123457889999998866  47889999999999999999999997654332211   11111


Q ss_pred             hc-cccc-hhhhhhhhhhcccCCCCC----C-----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          267 SG-QNCR-FKEMVDSIIIEDKSCTCT----G-----KEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       267 ~~-~~~~-~~~~~~~~~~~~~~~~~~----~-----~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .+ .... ++...+.........+..    .     .......+.+|+.+||..||.+|||++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            11 0000 000000000000000000    0     0012356789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-40  Score=259.56  Aligned_cols=256  Identities=17%  Similarity=0.238  Sum_probs=197.1

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      +|...++||+|+||+||+|++  +++.||+|.+..+.+ +..-....+|+-+++.+.|.|||++           +|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            577788999999999999998  889999999987654 3335668999999999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      |.. +|..|....    .+.++...+..++.|++.||.|+|   ++++.||||||.|.||..+|.+||+|||+++.+.-+
T Consensus        83 cdq-dlkkyfdsl----ng~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgip  154 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSL----NGDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP  154 (292)
T ss_pred             hhH-HHHHHHHhc----CCcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence            975 898888664    256999999999999999999999   999999999999999999999999999999987665


Q ss_pred             CceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhc-cccchhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSG-QNCRFKEM  276 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  276 (332)
                      ....  +..+.|.+|++|.++-+  -|++..|+||.||++.|+.. |++.|.+.+..++..  .+...+.. ....|+.+
T Consensus       155 vrcy--saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlk--rif~~lg~p~ed~wps~  230 (292)
T KOG0662|consen  155 VRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK--RIFRLLGTPTEDQWPSM  230 (292)
T ss_pred             eEee--eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHH--HHHHHhCCCccccCCcc
Confidence            4322  45578999999999988  79999999999999999986 777787766555432  12222211 12222221


Q ss_pred             ---hhhhhhcccCCCCC---ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 ---VDSIIIEDKSCTCT---GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ---~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                         -|-.....++....   .-+.....-.+++.+.|.-+|.+|.++++.++
T Consensus       231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence               11111111111100   01233345679999999999999999998775

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.6e-39  Score=292.19  Aligned_cols=253  Identities=19%  Similarity=0.230  Sum_probs=187.0

Q ss_pred             CCCCccccCCCceEEEEEeCCeeEEEEEEcCC-CChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCC
Q 038681           57 DEQNIVLEDPFRKLYKGFWQKRSISLMKYNGN-RNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIG  124 (332)
Q Consensus        57 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g  124 (332)
                      .+.+.+|.|+++.|+++..++..||+|++... ......+.+.+|+.+++.++||||+++           ++|||+++|
T Consensus         5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            34455566666666666668999999999765 344456789999999999999999987           899999999


Q ss_pred             ChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCc--
Q 038681          125 TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET--  202 (332)
Q Consensus       125 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--  202 (332)
                      +|.+++.....   ..+++..+..++.|++.||.|||   +++|+||||||+||+++.++.++|+|||.+........  
T Consensus        85 ~l~~~l~~~~~---~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          85 SCEDLLKTHFP---EGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             CHHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            99999986522   35889999999999999999999   99999999999999999999999999998865533221  


Q ss_pred             ---eeeccccccCCCcccccccCC---CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc-----
Q 038681          203 ---HIELDSVVGTTGFIAPENFTT---LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC-----  271 (332)
Q Consensus       203 ---~~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  271 (332)
                         ........++..|+|||++.+   .++.++|||||||++|||++|..||........     ......+...     
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~  233 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-----LLEKVRGTVPCLLDK  233 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-----HHHHHhccCcccccc
Confidence               011123457788999999865   478999999999999999999999986543221     1111110000     


Q ss_pred             --------chhh----hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          272 --------RFKE----MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       272 --------~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                              ....    ..+...  ............+.++.+|+.+||+.||++|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         234 STYPLYEDSMSQSRSSNEHPNN--RDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             CchhhhcCCcCcccccccccch--hhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence                    0000    000000  001111222355678999999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-41  Score=311.26  Aligned_cols=244  Identities=20%  Similarity=0.348  Sum_probs=208.4

Q ss_pred             CCCCCccccCCCceEEEEEe--CC----eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------EEEE
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QK----RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IVFE  119 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv~e  119 (332)
                      ....++||+|+||+||+|.|  .+    -+||||++.......+..+++.|+-+|.+++|||++++          ||++
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq  777 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQ  777 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHH
Confidence            44567899999999999999  43    46899999888887778999999999999999999998          7999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+|+|+|.+|++.+.    ..+.....+.|..|||+|+.|||   .+++|||||-.+|||+.....+||.|||+++....
T Consensus       778 ~mP~G~LlDyvr~hr----~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREHR----DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             hcccchHHHHHHHhh----ccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            999999999999864    56888999999999999999999   99999999999999999999999999999998877


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      +..........-.+.|||-|.+.. .|+.++|||||||++||++| |..||.+.+..+.....+.-.             
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge-------------  917 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE-------------  917 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc-------------
Confidence            665544344445678999998886 89999999999999999998 999999877655432111111             


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                                +.+.++.++-+++-++.+||..|+..||+++++...+.++.+
T Consensus       918 ----------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  918 ----------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             ----------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence                      123345677889999999999999999999999999998765

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-39  Score=286.43  Aligned_cols=255  Identities=18%  Similarity=0.206  Sum_probs=188.5

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-CCCcceE-----------EEEEec
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKL-----------IVFESV  121 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~~-----------lv~e~~  121 (332)
                      |.+.+.||+|+||.||+|..  +++.|++|++.............+|+..+.+++ ||||+++           +||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            66788999999999999999  678899999876543322344567999999998 9999987           899999


Q ss_pred             cCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCC
Q 038681          122 QIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE  201 (332)
Q Consensus       122 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  201 (332)
                       +|+|.+++....   ...+++..+..++.|++.||.|||   +++++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 -~~~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (283)
T cd07830          81 -EGNLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP  153 (283)
T ss_pred             -CCCHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC
Confidence             789999987652   136899999999999999999999   9999999999999999999999999999997665433


Q ss_pred             ceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc-cchhhhh-
Q 038681          202 THIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN-CRFKEMV-  277 (332)
Q Consensus       202 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-  277 (332)
                      ..   ....++..|+|||++.+  .++.++||||||+++|+|++|..||..........  .....+.... ..+.+.. 
T Consensus       154 ~~---~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07830         154 PY---TDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY--KICSVLGTPTKQDWPEGYK  228 (283)
T ss_pred             Cc---CCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHH--HHHHhcCCCChhhhhhHhh
Confidence            22   34567889999998854  67899999999999999999999997664432211  0111111000 0000000 


Q ss_pred             -hhhhhcccCCCC-----CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 -DSIIIEDKSCTC-----TGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 -~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                       +.......+...     ......+..+.+++.+||+.||++|||+.|++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence             000000000000     000112467999999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-39  Score=284.76  Aligned_cols=231  Identities=19%  Similarity=0.210  Sum_probs=179.0

Q ss_pred             CccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHH-HhhcCCCcceE-----------EEEEeccC
Q 038681           60 NIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYA-SRMSHKHIIKL-----------IVFESVQI  123 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l-~~l~H~nIv~~-----------lv~e~~~~  123 (332)
                      +.||+|+||.||+|.+  .++.||+|.+.....  ......+..|..++ ...+||||+++           +|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5699999999999998  788999999875432  12233445555544 44589999997           89999999


Q ss_pred             CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCce
Q 038681          124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH  203 (332)
Q Consensus       124 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  203 (332)
                      ++|.+++...     ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++......   
T Consensus        82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  150 (260)
T cd05611          82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLEN---  150 (260)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceecccc---
Confidence            9999999765     56899999999999999999999   999999999999999999999999999998765432   


Q ss_pred             eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhh
Q 038681          204 IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIII  282 (332)
Q Consensus       204 ~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (332)
                         ....++..|+|||.+.+ .++.++||||||+++|+|++|..||.........      ......             
T Consensus       151 ---~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~-------------  208 (260)
T cd05611         151 ---KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF------DNILSR-------------  208 (260)
T ss_pred             ---ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHHhc-------------
Confidence               34468899999999887 7799999999999999999999999755432211      111000             


Q ss_pred             cccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038681          283 EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL  324 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L  324 (332)
                       ............+..+.+++.+||+.||++||++.++.+.|
T Consensus       209 -~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l  249 (260)
T cd05611         209 -RINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK  249 (260)
T ss_pred             -ccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence             00001111113457899999999999999999876554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.2e-39  Score=284.16  Aligned_cols=237  Identities=24%  Similarity=0.356  Sum_probs=188.9

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      +|...+.||+|+||.||+|..  ++..+|+|.+..... ....+.+.+|+.+++.++||||+++           +|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            478889999999999999999  678899999876422 2235678899999999999999987           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCC-eEEeecCCccccCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD-AKLFDFSLSLSIPD  199 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-~kl~Dfg~a~~~~~  199 (332)
                      +++++|.+++.....   ..+++..+..++.|++.||.|||   +.+++|+||||+||+++.++. ++|+|||.+.....
T Consensus        81 ~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~  154 (257)
T cd08225          81 CDGGDLMKRINRQRG---VLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND  154 (257)
T ss_pred             CCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence            999999999976421   35799999999999999999999   999999999999999988864 69999999977654


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      .....  ....|++.|+|||.+.+ .++.++|+||||+++|++++|..||.........     ......   .+     
T Consensus       155 ~~~~~--~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----~~~~~~---~~-----  219 (257)
T cd08225         155 SMELA--YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLV-----LKICQG---YF-----  219 (257)
T ss_pred             Ccccc--cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHH-----HHHhcc---cC-----
Confidence            33221  23468999999999876 7899999999999999999999999754322110     000000   00     


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                .+.....+..+.+++.+||..+|++|||+.++++
T Consensus       220 ----------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         220 ----------APISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                      0001123467999999999999999999999976

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-39  Score=295.94  Aligned_cols=265  Identities=18%  Similarity=0.219  Sum_probs=195.6

Q ss_pred             cccccHHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE--
Q 038681           41 YRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL--  115 (332)
Q Consensus        41 ~~~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~--  115 (332)
                      ++.....++....++|.+.+.||+|+||.||+|..  ++..||+|++.... .....+.+.+|+.++.+++||||+++  
T Consensus         4 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~   83 (345)
T cd07877           4 YRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD   83 (345)
T ss_pred             chhhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceee
Confidence            34455667777889999999999999999999987  78899999987643 22235668899999999999999986  


Q ss_pred             ---------------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee
Q 038681          116 ---------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF  180 (332)
Q Consensus       116 ---------------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  180 (332)
                                     ++++++ +++|.+++...      .+++..+..++.|++.||.|||   +.+|+||||||+||++
T Consensus        84 ~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll  153 (345)
T cd07877          84 VFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAV  153 (345)
T ss_pred             eeeecccccccccEEEEehhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEE
Confidence                           455655 77998887643      5899999999999999999999   9999999999999999


Q ss_pred             CCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhh
Q 038681          181 NEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFH  258 (332)
Q Consensus       181 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~  258 (332)
                      +.++.++|+|||++.......     ....++..|+|||.+.+  .++.++|||||||++|+|++|..||..........
T Consensus       154 ~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~  228 (345)
T cd07877         154 NEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK  228 (345)
T ss_pred             cCCCCEEEecccccccccccc-----cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999999987654322     34567899999998865  67889999999999999999999997544322111


Q ss_pred             hHHHHhhhhccccchhhhhhhh-----hhcccCCCCC----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          259 YEENVKRLSGQNCRFKEMVDSI-----IIEDKSCTCT----GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                        ............+...+...     +......+..    .....+..+.+++.+||+.||.+|||+.++++
T Consensus       229 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  299 (345)
T cd07877         229 --LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  299 (345)
T ss_pred             --HHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence              11111111111110000000     0000000000    00013467899999999999999999999886

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-39  Score=295.06  Aligned_cols=252  Identities=17%  Similarity=0.247  Sum_probs=186.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE--------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL--------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~--------------  115 (332)
                      .++|...+.||+|+||.||+|.+  ++..||+|++.... .......+.+|+.+++.++||||+++              
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            37899999999999999999998  78999999987543 22334568899999999999999965              


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                         +|+||+.. +|..++.       ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++|+|||
T Consensus        94 ~~~lv~e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg  162 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFG  162 (342)
T ss_pred             eEEEEeccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCC
Confidence               68888864 6766552       25899999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      +++......     ....++..|+|||.+.+  .++.++|||||||++|||++|+.||..........  ..........
T Consensus       163 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~  235 (342)
T cd07879         163 LARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT--QILKVTGVPG  235 (342)
T ss_pred             CCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcCCCC
Confidence            987653322     23467889999999865  68899999999999999999999998654322111  1111111111


Q ss_pred             cchhhhhhhhhh----cc-cCCCCC----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          271 CRFKEMVDSIII----ED-KSCTCT----GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       271 ~~~~~~~~~~~~----~~-~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      +.+.+.......    .. ......    ..+..+..+.+|+.+||+.||.+||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            111111110000    00 000000    00123467889999999999999999999985

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.7e-39  Score=281.65  Aligned_cols=237  Identities=18%  Similarity=0.279  Sum_probs=193.6

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      +|++.+.||+|+||.||++.+  ++..+++|.+.... .......+.+|+.+++.++||||+++           +|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            488899999999999999988  78899999987643 33346678899999999999999987           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++++|.+++...... ...+++..+..++.|++.||.|||   +.|++|+||+|+||+++.++.+||+|||++......
T Consensus        81 ~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          81 APFGDLSKAISKRKKK-RKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             cCCCCHHHHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            9999999999774221 246899999999999999999999   999999999999999999999999999999877654


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      ..    ....++..|+|||.+.+ .++.++|+||||+++|+|++|..||.........      .....           
T Consensus       157 ~~----~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~-----------  215 (256)
T cd08530         157 MA----KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR------YKVQR-----------  215 (256)
T ss_pred             Cc----ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHhc-----------
Confidence            22    33568899999999987 7889999999999999999999999765432110      00000           


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                         ..   ..+.+...+.++.+++.+||+.+|++|||+.++++
T Consensus       216 ---~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         216 ---GK---YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             ---CC---CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence               00   01111245578999999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-39  Score=285.95  Aligned_cols=256  Identities=18%  Similarity=0.212  Sum_probs=189.7

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-------------EEEE
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-------------IVFE  119 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-------------lv~e  119 (332)
                      |++.+.||+|+||.||+|.+  ++..+|+|.+.... .......+.+|+.+++.++||||+++             +|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            66788999999999999998  57899999998764 22334668899999999999999976             8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++ +|.+++....    ..+++..++.++.||+.||+|||   ..+++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~  152 (287)
T cd07840          81 YMDH-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTK  152 (287)
T ss_pred             cccc-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccC
Confidence            9975 8988886541    36899999999999999999999   99999999999999999999999999999987655


Q ss_pred             CCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc-ccchhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ-NCRFKEM  276 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  276 (332)
                      ..... .....++..|+|||.+.+  .++.++||||||+++|||++|..||..........  ......... ...+...
T Consensus       153 ~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  229 (287)
T cd07840         153 RNSAD-YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE--KIFELCGSPTDENWPGV  229 (287)
T ss_pred             CCccc-ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHHHhCCCchhhcccc
Confidence            43211 133456889999998765  67899999999999999999999997655432211  111111110 0000000


Q ss_pred             hh----hhhhcccCCCC----CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VD----SIIIEDKSCTC----TGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~----~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .+    ...........    ......+..+.+++.+||..||.+||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            00    00000000000    000012578999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.3e-39  Score=279.91  Aligned_cols=236  Identities=24%  Similarity=0.378  Sum_probs=192.9

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEec
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESV  121 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~  121 (332)
                      +|...+.||+|++|.||++.+  ++..+++|++..... .....+.+|+.++++++||||+++           +++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence            478889999999999999999  588899999987654 336789999999999999999987           899999


Q ss_pred             cCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCC
Q 038681          122 QIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE  201 (332)
Q Consensus       122 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  201 (332)
                      ++++|.+++....    ..+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        80 ~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  152 (253)
T cd05122          80 SGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK  152 (253)
T ss_pred             CCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeeccccccccccc
Confidence            9999999987642    46899999999999999999999   9999999999999999999999999999997765543


Q ss_pred             ceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhh
Q 038681          202 THIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSI  280 (332)
Q Consensus       202 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (332)
                      .   .....++..|+|||.+.+ .++.++||||||+++|+|++|..||..........   ....  ...   .      
T Consensus       153 ~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~--~~~---~------  215 (253)
T cd05122         153 A---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF---KIAT--NGP---P------  215 (253)
T ss_pred             c---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH---HHHh--cCC---C------
Confidence            2   134578899999999887 78899999999999999999999997653322111   0000  000   0      


Q ss_pred             hhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          281 IIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                             .......++..+.+++.+||+.||++|||+.++++
T Consensus       216 -------~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         216 -------GLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             -------CcCcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                   00011122477999999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=3.2e-39  Score=281.07  Aligned_cols=239  Identities=23%  Similarity=0.337  Sum_probs=194.2

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      +|.+.+.||.|+||.||++.+  ++..+++|.+..... ......+.+|+++++.++|||++++           +|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            478889999999999999999  589999999986543 3446778999999999999999987           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++++|.+++..... ....+++..+..++.+++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          81 ADGGDLSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             cCCCcHHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            999999999987521 1256899999999999999999999   999999999999999999999999999999776554


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      ...  .....|++.|+|||.+.+ .++.++||||+|+++|+|++|..||........      ......           
T Consensus       157 ~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~-----------  217 (258)
T cd08215         157 VDL--AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL------ALKILK-----------  217 (258)
T ss_pred             cce--ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH------HHHHhc-----------
Confidence            321  134578899999999877 788999999999999999999999975542211      111000           


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                         ..   ..+.+...+..+.+++.+||..+|++|||+.++++
T Consensus       218 ---~~---~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         218 ---GQ---YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             ---CC---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence               00   00011133477899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.5e-39  Score=285.14  Aligned_cols=229  Identities=19%  Similarity=0.297  Sum_probs=177.5

Q ss_pred             ccccCCCceEEEEEe--CCeeEEEEEEcCCCCh--hhHHHHHHHHHH---HHhhcCCCcceE-----------EEEEecc
Q 038681           61 IVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ--HALEWCINHIVY---ASRMSHKHIIKL-----------IVFESVQ  122 (332)
Q Consensus        61 ~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~---l~~l~H~nIv~~-----------lv~e~~~  122 (332)
                      .||+|+||.||+|.+  +++.||+|.+......  .....+..|..+   ++...||||+++           +||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999988  6889999998754321  112234445444   344579999976           8999999


Q ss_pred             CCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCc
Q 038681          123 IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET  202 (332)
Q Consensus       123 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  202 (332)
                      +|+|.+++...     ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++|+|||++........
T Consensus        81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~  152 (278)
T cd05606          81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  152 (278)
T ss_pred             CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC
Confidence            99999988765     56999999999999999999999   99999999999999999999999999999876543322


Q ss_pred             eeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhh
Q 038681          203 HIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSI  280 (332)
Q Consensus       203 ~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (332)
                          ....|+..|+|||.+.+  .++.++||||+||++|+|++|..||..........   ........           
T Consensus       153 ----~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~~~-----------  214 (278)
T cd05606         153 ----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTLTM-----------  214 (278)
T ss_pred             ----cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH---HHHHhhcc-----------
Confidence                34578999999999874  68999999999999999999999997653221111   00000000           


Q ss_pred             hhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038681          281 IIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAK  322 (332)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~  322 (332)
                             ....+...+..+.+++.+||..||.+||     ++.++++
T Consensus       215 -------~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         215 -------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             -------CCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence                   0011112347899999999999999999     9999885

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.3e-39  Score=330.42  Aligned_cols=250  Identities=25%  Similarity=0.378  Sum_probs=192.6

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ..|...+.||+|+||.||+|.+  ++..||||++......     ...|+..+++++|||||++           +||||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            4578889999999999999997  7899999998754322     2356889999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++|+|.+++.        .+++..+..++.||+.||+|||+.+..+|+||||||+||+++.++.+++. ||.+......
T Consensus       765 ~~~g~L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~  835 (968)
T PLN00113        765 IEGKNLSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD  835 (968)
T ss_pred             CCCCcHHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence            99999999994        37899999999999999999996556799999999999999999888876 6655433221


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                            ....+|+.|+|||++.+ .++.++|||||||++|||+||+.||....... .....+.... ........++++
T Consensus       836 ------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~  907 (968)
T PLN00113        836 ------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVH-GSIVEWARYC-YSDCHLDMWIDP  907 (968)
T ss_pred             ------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCC-CcHHHHHHHh-cCccchhheeCc
Confidence                  23367899999999987 89999999999999999999999995432211 1111111111 111222333343


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                      .+...    .........++.+++.+||+.||++|||+.||++.|+++.+
T Consensus       908 ~~~~~----~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        908 SIRGD----VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             cccCC----CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            33221    12233556778999999999999999999999999999875

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-39  Score=279.64  Aligned_cols=235  Identities=23%  Similarity=0.349  Sum_probs=193.0

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      +|++.+.||+|++|.||++.+  .+..+++|.+..... ....+.+.+|++++++++|||++++           +|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            478889999999999999988  678999999987643 2346789999999999999999987           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++++|.+++...     ..+++..+..++.|++.||.|||   +.||+|+||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  152 (254)
T cd06627          81 AENGSLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV  152 (254)
T ss_pred             CCCCcHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCC
Confidence            9999999999765     56899999999999999999999   999999999999999999999999999999876554


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      ...  .....++..|+|||.+.+ .++.++||||||+++|+|++|..||........     ........          
T Consensus       153 ~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~-----~~~~~~~~----------  215 (254)
T cd06627         153 SKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA-----LFRIVQDD----------  215 (254)
T ss_pred             ccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH-----HHHHhccC----------
Confidence            332  134568899999999876 788999999999999999999999975442111     10000000          


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                              ....+...+..+.+++.+||..+|++|||+.+++.
T Consensus       216 --------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         216 --------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence                    00111233478899999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.8e-39  Score=288.94  Aligned_cols=231  Identities=17%  Similarity=0.278  Sum_probs=184.7

Q ss_pred             CCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCCC
Q 038681           59 QNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGT  125 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g~  125 (332)
                      ..+||+|+||.||++..  ++..||+|++..... .....+.+|+.+++.++||||+++           +||||+++++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ-QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch-hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            35799999999999988  789999999865433 336678999999999999999987           8999999999


Q ss_pred             hHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceee
Q 038681          126 LADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIE  205 (332)
Q Consensus       126 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  205 (332)
                      |.+++..      ..+++..+..++.|++.||+|||   +.|++|+||+|+||+++.++.++|+|||++.........  
T Consensus       104 L~~~~~~------~~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~--  172 (292)
T cd06657         104 LTDIVTH------TRMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR--  172 (292)
T ss_pred             HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceeccccccc--
Confidence            9998754      35899999999999999999999   999999999999999999999999999998765433211  


Q ss_pred             ccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcc
Q 038681          206 LDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIED  284 (332)
Q Consensus       206 ~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (332)
                      .....++..|+|||.+.+ .++.++||||||+++|+|++|..||..........      ....       ....     
T Consensus       173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~------~~~~-------~~~~-----  234 (292)
T cd06657         173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK------MIRD-------NLPP-----  234 (292)
T ss_pred             ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHh-------hCCc-----
Confidence            133568899999999876 78999999999999999999999997543322110      0000       0000     


Q ss_pred             cCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          285 KSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       285 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                         ........+..+.+++.+||..||.+||++.++++
T Consensus       235 ---~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         235 ---KLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             ---ccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence               00011123467889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=7e-39  Score=281.55  Aligned_cols=237  Identities=19%  Similarity=0.224  Sum_probs=182.7

Q ss_pred             HHHHHHHhcCCCCCCcc--ccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----
Q 038681           46 AEELRIATNNYDEQNIV--LEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----  115 (332)
Q Consensus        46 ~~el~~~~~~y~~~~~l--g~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----  115 (332)
                      ..++....++|++.+.+  |+|+||.||++..  ++..+|+|.+.......      .|+.....+ +||||+++     
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~e~~~~~~~~~h~~iv~~~~~~~   79 (267)
T PHA03390          6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------IEPMVHQLMKDNPNFIKLYYSVT   79 (267)
T ss_pred             HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------hhHHHHHHhhcCCCEEEEEEEEe
Confidence            34444556678887777  9999999999998  78889999986543211      122222222 79999987     


Q ss_pred             ------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC-CeEE
Q 038681          116 ------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS-DAKL  188 (332)
Q Consensus       116 ------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl  188 (332)
                            +||||+++|+|.+++...     ..+++..+..++.|+++||.|||   +.+++||||||+||+++.++ .++|
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l  151 (267)
T PHA03390         80 TLKGHVLIMDYIKDGDLFDLLKKE-----GKLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYL  151 (267)
T ss_pred             cCCeeEEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEE
Confidence                  899999999999999765     47999999999999999999999   99999999999999999988 9999


Q ss_pred             eecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhh
Q 038681          189 FDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS  267 (332)
Q Consensus       189 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  267 (332)
                      +|||++......      ....++..|+|||++.+ .++.++||||||+++|+|++|..||........ ......... 
T Consensus       152 ~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-  223 (267)
T PHA03390        152 CDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKRQ-  223 (267)
T ss_pred             ecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHhh-
Confidence            999998765433      23468899999999987 889999999999999999999999974432211 100010000 


Q ss_pred             ccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 038681          268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT-MVDVAK  322 (332)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-~~evl~  322 (332)
                      .                  .........+..+.+++.+||+.||.+||+ ++++++
T Consensus       224 ~------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        224 Q------------------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             c------------------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            0                  011111245578999999999999999996 588874

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=4e-39  Score=291.44  Aligned_cols=252  Identities=15%  Similarity=0.212  Sum_probs=184.3

Q ss_pred             CccccC--CCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccC
Q 038681           60 NIVLED--PFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQI  123 (332)
Q Consensus        60 ~~lg~G--~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~  123 (332)
                      ..||.|  +||+||++.+  .++.||+|.+.... .....+.+.+|+.+++.++||||+++           +|+||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456766  8999999998  89999999987653 33446788999999999999999987           79999999


Q ss_pred             CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCce
Q 038681          124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH  203 (332)
Q Consensus       124 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  203 (332)
                      |+|.+++.....   ..+++..+..++.|++.||+|||   +.+|+||||||+||+++.++.++++||+.+.........
T Consensus        84 ~~l~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          84 GSANSLLKTYFP---EGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             CCHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            999999886522   35899999999999999999999   999999999999999999999999999865332221110


Q ss_pred             e-----eccccccCCCcccccccCC---CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc-cc--
Q 038681          204 I-----ELDSVVGTTGFIAPENFTT---LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN-CR--  272 (332)
Q Consensus       204 ~-----~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~--  272 (332)
                      .     ......++..|+|||++.+   .++.++|||||||++|+|++|..||........     ......... ..  
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-----~~~~~~~~~~~~~~  232 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-----LLQKLKGPPYSPLD  232 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-----HHHHhcCCCCCCcc
Confidence            0     0011235677999999875   478999999999999999999999976543221     111110000 00  


Q ss_pred             -----------------hhh-hhhhhh-------hcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          273 -----------------FKE-MVDSII-------IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       273 -----------------~~~-~~~~~~-------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                       +.. ..+...       ........+.....+..+.+|+.+||+.||++|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         233 ITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             ccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence                             000 000000       00001112223456788999999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.9e-39  Score=282.66  Aligned_cols=233  Identities=21%  Similarity=0.249  Sum_probs=185.0

Q ss_pred             cccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCCCh
Q 038681           62 VLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTL  126 (332)
Q Consensus        62 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g~L  126 (332)
                      ||.|+||.||++.+  ++..+++|.+.....  ....+.+.+|+.++.+++||||+++           +|+||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999  589999999876533  2446778999999999999999986           89999999999


Q ss_pred             HHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCc----
Q 038681          127 ADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET----  202 (332)
Q Consensus       127 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~----  202 (332)
                      .+++...     ..+++..+..++.||+.||.|||   ..+++|+||+|+||+++.++.++|+|||++........    
T Consensus        81 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  152 (265)
T cd05579          81 ASLLENV-----GSLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN  152 (265)
T ss_pred             HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence            9999865     46899999999999999999999   99999999999999999999999999999876543321    


Q ss_pred             --eeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          203 --HIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       203 --~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                        ........++..|+|||.+.+ ..+.++||||||+++|++++|..||.........      .........       
T Consensus       153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~~~~~-------  219 (265)
T cd05579         153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF------QNILNGKIE-------  219 (265)
T ss_pred             cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHhcCCcC-------
Confidence              011134567889999999877 7888999999999999999999999755432211      111000000       


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL  324 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L  324 (332)
                               .+.....+..+.+++.+||+.+|.+|||+.++.+.|
T Consensus       220 ---------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         220 ---------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             ---------CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence                     000011247889999999999999999995554444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-39  Score=294.34  Aligned_cols=255  Identities=17%  Similarity=0.221  Sum_probs=190.4

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE------------
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL------------  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~------------  115 (332)
                      ...++|.+.+.||+|+||.||+|..  ++..||+|++.... .....+.+.+|+.++++++||||+++            
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            3467799999999999999999998  78999999986543 23335668899999999999999875            


Q ss_pred             -----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEee
Q 038681          116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFD  190 (332)
Q Consensus       116 -----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  190 (332)
                           +|+||+ +++|.+++..      ..+++..+..++.||+.||.|||   +.||+||||||+||+++.++.++|+|
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEee
Confidence                 789998 6799888864      35899999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG  268 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  268 (332)
                      ||++.......     ....+++.|+|||.+.+  .++.++|||||||++|++++|..||.........  .........
T Consensus       162 fg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~--~~~~~~~~~  234 (343)
T cd07880         162 FGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQL--MEIMKVTGT  234 (343)
T ss_pred             cccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhcCC
Confidence            99997654332     23467899999999875  5889999999999999999999999765432211  011110000


Q ss_pred             cccchhhhhhhh-----hhcccCCCC----CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          269 QNCRFKEMVDSI-----IIEDKSCTC----TGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       269 ~~~~~~~~~~~~-----~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ....+...+...     ...-.....    ......+..+.+++.+||+.||++|||+.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         235 PSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             CCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            010111110000     000000000    000133467899999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.7e-39  Score=287.11  Aligned_cols=242  Identities=18%  Similarity=0.228  Sum_probs=188.7

Q ss_pred             CCCCCCccccCCCceEEEEEe-----CCeeEEEEEEcCCCC---hhhHHHHHHHHHHHHhh-cCCCcceE----------
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW-----QKRSISLMKYNGNRN---QHALEWCINHIVYASRM-SHKHIIKL----------  115 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~~----------  115 (332)
                      +|.+.+.||+|+||.||++..     ++..||+|.+.....   ....+.+.+|+.++.++ +||||+++          
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            477889999999999999986     467899999875421   22356688999999999 59999987          


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       +||||+++|+|.+++...     ..+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++
T Consensus        81 ~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~  152 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLS  152 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccc
Confidence             899999999999998764     46899999999999999999999   999999999999999999999999999998


Q ss_pred             cccCCCCceeeccccccCCCcccccccCC-C--CChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFTT-L--INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~--~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      +.......... ....|+..|+|||.+.+ .  .+.++||||||+++|+|++|..||.........  .......     
T Consensus       153 ~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~--~~~~~~~-----  224 (288)
T cd05583         153 KEFLAEEEERA-YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ--SEISRRI-----  224 (288)
T ss_pred             ccccccccccc-ccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH--HHHHHHH-----
Confidence            76544332211 23468899999999876 3  688999999999999999999999643221110  0011110     


Q ss_pred             chhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                               .....    +.+...+..+.+++.+||+.||++|||+.++.+.|.
T Consensus       225 ---------~~~~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~  265 (288)
T cd05583         225 ---------LKSKP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN  265 (288)
T ss_pred             ---------HccCC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence                     01111    111123467899999999999999999888877664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-41  Score=279.37  Aligned_cols=259  Identities=17%  Similarity=0.254  Sum_probs=198.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE--------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL--------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~--------------  115 (332)
                      .+.|+...+||+|.||.||+|+.  +++.||+|++...+. +..-...++|+++|..|.|+|++.+              
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            35578888999999999999998  788899887655332 2223457899999999999999876              


Q ss_pred             -----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEee
Q 038681          116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFD  190 (332)
Q Consensus       116 -----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  190 (332)
                           +||.+|+. +|..++....    ..++..++..++.++..||.|+|   +..|+|||+||+|+||+.+|.+||+|
T Consensus        96 r~t~ylVf~~ceh-DLaGlLsn~~----vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklAD  167 (376)
T KOG0669|consen   96 RATFYLVFDFCEH-DLAGLLSNRK----VRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLAD  167 (376)
T ss_pred             cceeeeeHHHhhh-hHHHHhcCcc----ccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeec
Confidence                 89999987 8999987642    56999999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCce--eeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhh
Q 038681          191 FSLSLSIPDGETH--IELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRL  266 (332)
Q Consensus       191 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~  266 (332)
                      ||+++.+......  ...+..+.|.+|++||.+.+  .|+++.|||+.||++.||+||.+.+.+.......+   ++..+
T Consensus       168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~---~Is~L  244 (376)
T KOG0669|consen  168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLH---LISQL  244 (376)
T ss_pred             cccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHH---HHHHH
Confidence            9999876544322  12234567999999999998  89999999999999999999999999887766554   33333


Q ss_pred             hc--cccchhhhhhhhhhccc---CCCCCC---hHHH------HHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          267 SG--QNCRFKEMVDSIIIEDK---SCTCTG---KEQQ------LQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       267 ~~--~~~~~~~~~~~~~~~~~---~~~~~~---~~~~------~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .+  ....|+.+..--+...-   +.+...   -++.      .++..+|+..++..||.+|++++++++
T Consensus       245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            32  11222221111111000   000000   0111      247889999999999999999999886

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5e-39  Score=285.69  Aligned_cols=239  Identities=18%  Similarity=0.248  Sum_probs=186.6

Q ss_pred             CCCCCCccccCCCceEEEEEe-----CCeeEEEEEEcCCCC---hhhHHHHHHHHHHHHhh-cCCCcceE----------
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW-----QKRSISLMKYNGNRN---QHALEWCINHIVYASRM-SHKHIIKL----------  115 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l-~H~nIv~~----------  115 (332)
                      +|++.+.||.|+||.||++..     +|..||+|.+.....   ....+.+.+|+.++.++ +|+||+++          
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            478889999999999999987     578899999875422   22346788999999999 59999987          


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       +|+||+++++|.+++...     ..+++..+..++.|++.||.|||   +.+++||||+|+|||++.++.++|+|||++
T Consensus        81 ~lv~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  152 (290)
T cd05613          81 HLILDYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLS  152 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccc
Confidence             899999999999999765     46889999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCceeeccccccCCCcccccccCC---CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFTT---LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      .......... .....|+..|+|||.+.+   .++.++||||||+++|+|++|..||.........              
T Consensus       153 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--------------  217 (290)
T cd05613         153 KEFHEDEVER-AYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--------------  217 (290)
T ss_pred             eecccccccc-cccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH--------------
Confidence            7664432211 134568999999999864   4678999999999999999999998643221110              


Q ss_pred             chhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038681          272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAK  322 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~  322 (332)
                        .++.........    +.+...+..+.+++.+||..||++||     ++.+++.
T Consensus       218 --~~~~~~~~~~~~----~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         218 --AEISRRILKSEP----PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             --HHHHHHhhccCC----CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence              011111111111    11123346789999999999999997     6676654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.7e-39  Score=278.68  Aligned_cols=239  Identities=23%  Similarity=0.302  Sum_probs=194.8

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-------------EEE
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-------------IVF  118 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-------------lv~  118 (332)
                      +|...+.||+|++|.||+|..  ++..|++|.+..... ....+.+.+|+.++++++||||+++             +|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            477889999999999999999  588999999876643 3446788999999999999999987             799


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++++|.+++...     ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||.+....
T Consensus        81 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~  152 (260)
T cd06606          81 EYVSGGSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLG  152 (260)
T ss_pred             EecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEecc
Confidence            999999999999875     47999999999999999999999   9999999999999999999999999999998776


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ............++..|+|||.+.+ ..+.++||||||+++|+|++|..||........     .......         
T Consensus       153 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~---------  218 (260)
T cd06606         153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA-----ALYKIGS---------  218 (260)
T ss_pred             cccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH-----HHHhccc---------
Confidence            6543111134578899999999887 689999999999999999999999976551111     0000000         


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                             .......+...+..+.+++.+||+.||++||++.+++.
T Consensus       219 -------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         219 -------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             -------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                   00001111233578999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3e-39  Score=287.65  Aligned_cols=258  Identities=19%  Similarity=0.207  Sum_probs=186.9

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      ++|++.+.||+|++|.||+|.+  +++.||+|.+..... ....+.+.+|+.++++++||||+++           +|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            5789999999999999999998  688999999865432 2334668899999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC-CCCeEEeecCCccccC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE-QSDAKLFDFSLSLSIP  198 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~  198 (332)
                      |++ ++|.+++....   ...+++..+..++.||+.||+|||   +++++|+||+|+||+++. ++.+||+|||++....
T Consensus        82 ~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~  154 (294)
T PLN00009         82 YLD-LDLKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFG  154 (294)
T ss_pred             ccc-ccHHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence            996 58888876541   123678889999999999999999   999999999999999985 4579999999997654


Q ss_pred             CCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc-ccc---
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ-NCR---  272 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~~~---  272 (332)
                      .....  .....+++.|+|||.+.+  .++.++|||||||++|+|+||..||......+...  ......... ...   
T Consensus       155 ~~~~~--~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~  230 (294)
T PLN00009        155 IPVRT--FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF--KIFRILGTPNEETWPG  230 (294)
T ss_pred             CCccc--cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCChhhccc
Confidence            33211  123467889999998865  57899999999999999999999997654322211  011100000 000   


Q ss_pred             ---hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          273 ---FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       273 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                         +.+.................+..+..+.+++.+||+.||++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence               00000000000000000001123467899999999999999999999986

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=7.6e-39  Score=288.26  Aligned_cols=233  Identities=21%  Similarity=0.326  Sum_probs=186.6

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      |...+.||+|+||.||+|.+  ++..+|+|.+....  .......+.+|+.++++++|||++++           +||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            77889999999999999998  78899999987542  23335678899999999999999987           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      ++ |+|.+++....    ..+++..+..++.|++.||.|||   ..+|+|+||+|+||+++.++.++|+|||++......
T Consensus       107 ~~-g~l~~~~~~~~----~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (317)
T cd06635         107 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA  178 (317)
T ss_pred             CC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence            97 48888776541    46899999999999999999999   999999999999999999999999999998654432


Q ss_pred             CceeeccccccCCCcccccccC----CCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFT----TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                            ....+++.|+|||.+.    +.++.++|||||||++|+|++|..||........     ........       
T Consensus       179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-----~~~~~~~~-------  240 (317)
T cd06635         179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNE-------  240 (317)
T ss_pred             ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-----HHHHHhcc-------
Confidence                  2346889999999873    2688899999999999999999999875432211     11111000       


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL  324 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L  324 (332)
                              .  ........+..+.+++.+||+.+|.+||++.++++.+
T Consensus       241 --------~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         241 --------S--PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             --------C--CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence                    0  0011123456789999999999999999999999753

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=4.2e-39  Score=284.17  Aligned_cols=237  Identities=21%  Similarity=0.316  Sum_probs=191.9

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhc-CCCcceE-----------EE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMS-HKHIIKL-----------IV  117 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-H~nIv~~-----------lv  117 (332)
                      ++|.+.+.||+|+||.||+|..  ++..|++|.+....  .....+.+.+|+.++.+++ ||||+++           +|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4688999999999999999998  78999999987632  2333567889999999998 9999987           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+++++|.+++...     ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~  152 (280)
T cd05581          81 LEYAPNGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVL  152 (280)
T ss_pred             EcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCcccccc
Confidence            9999999999999875     47999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCce------------------eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhh
Q 038681          198 PDGETH------------------IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFH  258 (332)
Q Consensus       198 ~~~~~~------------------~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~  258 (332)
                      ......                  .......++..|+|||++.+ .++.++||||||++++++++|..||......... 
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-  231 (280)
T cd05581         153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTF-  231 (280)
T ss_pred             CCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHH-
Confidence            443210                  11234567899999999877 7899999999999999999999999865422110 


Q ss_pred             hHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCH----HHHHH
Q 038681          259 YEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTM----VDVAK  322 (332)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~----~evl~  322 (332)
                           .....              .    ....+...++.+.+++.+||+.||.+|||+    .++++
T Consensus       232 -----~~~~~--------------~----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         232 -----QKILK--------------L----EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             -----HHHHh--------------c----CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                 11000              0    001111234778999999999999999999    77654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.8e-39  Score=295.37  Aligned_cols=254  Identities=17%  Similarity=0.212  Sum_probs=187.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------------  115 (332)
                      .++|.+.+.||.|+||.||+|..  ++..||+|++..... ...+.+.+|+.++++++||||+++               
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~-~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP-QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV   82 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC-chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence            36799999999999999999998  788999999876544 336778899999999999999963               


Q ss_pred             ----------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC-CC
Q 038681          116 ----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE-QS  184 (332)
Q Consensus       116 ----------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~  184 (332)
                                +|+||++ ++|.+++..      ..+++..+..++.||+.||.|||   +.||+||||||+||+++. ++
T Consensus        83 ~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~  152 (342)
T cd07854          83 GSLTELNSVYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDL  152 (342)
T ss_pred             ccccccceEEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCc
Confidence                      7999997 589888854      35899999999999999999999   999999999999999974 55


Q ss_pred             CeEEeecCCccccCCCCcee-eccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHH
Q 038681          185 DAKLFDFSLSLSIPDGETHI-ELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEE  261 (332)
Q Consensus       185 ~~kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~  261 (332)
                      .++|+|||.++......... ......++..|+|||.+.+  .++.++|||||||++|+|++|+.||..........   
T Consensus       153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~---  229 (342)
T cd07854         153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ---  229 (342)
T ss_pred             eEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---
Confidence            78999999997654322111 1123357889999998754  68889999999999999999999997654322211   


Q ss_pred             HHhhhhccccc-------hhhhhhhhhh-cccCCCCC---ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          262 NVKRLSGQNCR-------FKEMVDSIII-EDKSCTCT---GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       262 ~~~~~~~~~~~-------~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                        ......+..       +......... .......+   .....+.++.+|+.+||+.||.+|||+.+++.
T Consensus       230 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         230 --LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             --HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence              111100000       0000000000 00000000   00123467889999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-39  Score=282.75  Aligned_cols=255  Identities=20%  Similarity=0.223  Sum_probs=192.2

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh-hhHHHHHHHHHHHHhhcCCCcceE-----------EEEEec
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ-HALEWCINHIVYASRMSHKHIIKL-----------IVFESV  121 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~  121 (332)
                      |.+.+.||+|++|.||+|..  ++..+++|.+...... .....+.+|+.++++++||||+++           +|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            66788999999999999998  7888999998765432 345678899999999999999987           899999


Q ss_pred             cCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCC
Q 038681          122 QIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE  201 (332)
Q Consensus       122 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  201 (332)
                      ++ +|.+++....    ..+++..+..++.||+.||.|||   ..+|+|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~-~l~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~  152 (283)
T cd05118          81 DT-DLYKLIKDRQ----RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV  152 (283)
T ss_pred             CC-CHHHHHHhhc----ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc
Confidence            75 8988887641    46899999999999999999999   9999999999999999999999999999997765543


Q ss_pred             ceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc-chhhhhh
Q 038681          202 THIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC-RFKEMVD  278 (332)
Q Consensus       202 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  278 (332)
                      ..  .....++..|+|||.+.+  .++.++||||||+++|+|++|+.||...+..+...  .....+..... .+....+
T Consensus       153 ~~--~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  228 (283)
T cd05118         153 RP--YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF--KIFRTLGTPDPEVWPKFTS  228 (283)
T ss_pred             cc--ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHcCCCchHhcccchh
Confidence            11  133567889999998875  67899999999999999999999997655432211  11111111000 0111110


Q ss_pred             ---hhhhccc-CCC---CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          279 ---SIIIEDK-SCT---CTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       279 ---~~~~~~~-~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                         ....... ...   .......+.++.+++.+||+.||.+||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence               0000000 000   0111245688999999999999999999999975

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.5e-39  Score=292.25  Aligned_cols=257  Identities=17%  Similarity=0.221  Sum_probs=187.3

Q ss_pred             CCCCCCccccCCCceEEEEEe--C--CeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhh-cCCCcceE-------------
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--Q--KRSISLMKYNGNRN-QHALEWCINHIVYASRM-SHKHIIKL-------------  115 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~--~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~~-------------  115 (332)
                      +|.+.+.||+|+||.||++.+  .  +..||+|++..... ....+.+.+|+.++.++ .||||+++             
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            478889999999999999999  4  67899999875432 22356688999999999 59999987             


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        +++||+. ++|.+++...     ..+++..++.++.||+.||.|||   ..||+||||||+||+++.++.++|+|||+
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCC
Confidence              5667775 6899988754     56899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCce--eeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc
Q 038681          194 SLSIPDGETH--IELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ  269 (332)
Q Consensus       194 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  269 (332)
                      ++........  .......||..|+|||.+.+  .++.++|||||||++|++++|..||..........  .....+...
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~  229 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLN--QILQVLGTP  229 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHH--HHHHHhCCC
Confidence            9866433221  11133568999999998765  68999999999999999999999997654322111  111111110


Q ss_pred             cc-chhhhhhhhh----h---cccCCC-CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          270 NC-RFKEMVDSII----I---EDKSCT-CTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       270 ~~-~~~~~~~~~~----~---~~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .. .+..+.++..    .   ...... .......+..+.+++.+||+.||.+|||+.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         230 DEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             CHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00 0000000000    0   000000 0000122467999999999999999999999875

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.5e-39  Score=291.72  Aligned_cols=257  Identities=19%  Similarity=0.204  Sum_probs=191.4

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE----------
Q 038681           49 LRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        49 l~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~----------  115 (332)
                      +...+++|.+.+.||.|+||.||+|..  ++..||+|++.... .....+.+.+|+.++..++||||+++          
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            344678899999999999999999988  78899999886532 22335678899999999999999997          


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        +|+||+ +++|.+++...      .+++..+..++.|+++||.|||   ..+|+|+||+|+||+++.++.++|+|||.
T Consensus        85 ~~lv~e~~-~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~  154 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGL  154 (328)
T ss_pred             EEEEeehh-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCcccc
Confidence              899998 56898888643      5788889999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          194 SLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       194 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      +.......     ....++..|+|||.+.+  .++.++|||||||++|+|++|..||.........  ......+.....
T Consensus       155 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~--~~~~~~~~~~~~  227 (328)
T cd07856         155 ARIQDPQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF--SIITDLLGTPPD  227 (328)
T ss_pred             ccccCCCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCH
Confidence            87543322     23467889999998765  6899999999999999999999999765432211  111111111111


Q ss_pred             chhhh-hhh-------hhhcccCCCC-CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          272 RFKEM-VDS-------IIIEDKSCTC-TGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       272 ~~~~~-~~~-------~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .+... .+.       ........+. ......+..+.+++.+||+.+|++|||+++++.
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             HHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            11000 000       0000000000 000123478999999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=6e-39  Score=286.08  Aligned_cols=243  Identities=19%  Similarity=0.261  Sum_probs=187.7

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-CCCcceE-----------
Q 038681           50 RIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKL-----------  115 (332)
Q Consensus        50 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~~-----------  115 (332)
                      ....++|++.+.||+|+||.||+|.+  ++..||||.+...........+..|+.++.+.. ||||+++           
T Consensus        11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~   90 (296)
T cd06618          11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVF   90 (296)
T ss_pred             cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEE
Confidence            34456789999999999999999999  489999999986654444566778888777774 9999987           


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFS-RPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                      +||||++ ++|.+++....    ..+++..+..++.||+.||+|||   + ++|+||||+|+||+++.++.++|+|||++
T Consensus        91 ~v~e~~~-~~l~~l~~~~~----~~l~~~~~~~i~~~i~~~l~~lH---~~~~i~H~dl~p~nill~~~~~~kL~dfg~~  162 (296)
T cd06618          91 ICMELMS-TCLDKLLKRIQ----GPIPEDILGKMTVAIVKALHYLK---EKHGVIHRDVKPSNILLDASGNVKLCDFGIS  162 (296)
T ss_pred             EEeeccC-cCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hhCCEecCCCcHHHEEEcCCCCEEECccccc
Confidence            7999985 47877776531    46899999999999999999999   6 69999999999999999999999999998


Q ss_pred             cccCCCCceeeccccccCCCcccccccCC-C----CChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFTT-L----INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ  269 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~----~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  269 (332)
                      .........   ....++..|+|||.+.+ .    ++.++||||||+++|+|++|+.||........    .........
T Consensus       163 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~~~  235 (296)
T cd06618         163 GRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE----VLTKILQEE  235 (296)
T ss_pred             hhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH----HHHHHhcCC
Confidence            766443322   23457889999999875 2    78899999999999999999999965322110    011111110


Q ss_pred             ccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          270 NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                      ...                .+.....+.++.+|+.+||..||.+||++.+++..
T Consensus       236 ~~~----------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         236 PPS----------------LPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCC----------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            000                00011234679999999999999999999999763

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.7e-39  Score=291.76  Aligned_cols=257  Identities=21%  Similarity=0.255  Sum_probs=193.1

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE----------------
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL----------------  115 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~----------------  115 (332)
                      +|.+.+.||.|+||.||+|..  ++..||+|++..... ....+.+.+|+.+++.++||||+++                
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            488899999999999999998  589999999876542 3345778999999999999999865                


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      +||||++ ++|.+++...     ..+++..+..++.||+.||.|||   ++||+|+||||+||+++.++.++|+|||++.
T Consensus        81 lv~e~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~  151 (330)
T cd07834          81 IVTELME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLAR  151 (330)
T ss_pred             EEecchh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceE
Confidence            7999997 4899888765     47999999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCce-eeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc-
Q 038681          196 SIPDGETH-IELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC-  271 (332)
Q Consensus       196 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  271 (332)
                      ........ .......++..|+|||.+.+  .++.++||||||+++|+|++|..||..........  ........... 
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~--~i~~~~~~~~~~  229 (330)
T cd07834         152 GVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLN--LIVEVLGTPSEE  229 (330)
T ss_pred             eecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHH--HHHHhcCCCChh
Confidence            76554310 11134567899999999876  68899999999999999999999998765432211  11111110000 


Q ss_pred             --------chhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          272 --------RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       272 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                              .....+..................+..+.+++.+||+.||.+|||+.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                    000000000000000000001124578899999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.7e-39  Score=287.34  Aligned_cols=261  Identities=18%  Similarity=0.203  Sum_probs=191.2

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE------------
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL------------  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~------------  115 (332)
                      ...++|++.+.||+|+||.||+|.+  ++..||+|.+..... ......+.+|+.+++.++||||+++            
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            4567899999999999999999999  688999999875432 2224567789999999999999984            


Q ss_pred             ---------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCe
Q 038681          116 ---------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA  186 (332)
Q Consensus       116 ---------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  186 (332)
                               +|+||+++ ++.+++...    ...+++..+..++.||+.||.|||   +.+|+|+||||+||+++.++.+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~  155 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQI  155 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcE
Confidence                     79999986 777777643    146899999999999999999999   9999999999999999999999


Q ss_pred             EEeecCCccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHh
Q 038681          187 KLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVK  264 (332)
Q Consensus       187 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~  264 (332)
                      ||+|||++........... ....++..|+|||.+.+  .++.++|||||||++|+|++|+.||........  ......
T Consensus       156 kl~dfg~~~~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~--~~~~~~  232 (302)
T cd07864         156 KLADFGLARLYNSEESRPY-TNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ--LELISR  232 (302)
T ss_pred             EeCcccccccccCCccccc-ccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHH
Confidence            9999999977654432111 22356788999998865  578999999999999999999999975443221  111111


Q ss_pred             hhhcc-ccchhhhhhhhhhc----ccC---CCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          265 RLSGQ-NCRFKEMVDSIIIE----DKS---CTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       265 ~~~~~-~~~~~~~~~~~~~~----~~~---~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ..... ...++++.......    ...   .........+..+.+++.+||+.||.+|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11111 11111110000000    000   000000123477999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-39  Score=310.45  Aligned_cols=256  Identities=21%  Similarity=0.330  Sum_probs=206.5

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEe-----C----CeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE--
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGFW-----Q----KRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL--  115 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~--  115 (332)
                      .++....+..+.+.||+|.||.|++|..     .    ...||||..+........+.+..|+.+|..+ .||||+.+  
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            4666666777778999999999999986     1    4579999999887777788999999999999 69999987  


Q ss_pred             ---------EEEEeccCCChHHHHhhhh---------cccc--cCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 038681          116 ---------IVFESVQIGTLADRIHHHC---------EQHF--EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP  175 (332)
Q Consensus       116 ---------lv~e~~~~g~L~~~l~~~~---------~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  175 (332)
                               +|+||+..|+|.++++...         ....  ..++....+.++.|||.|++||+   +.++|||||-.
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhh
Confidence                     7999999999999999875         1111  13889999999999999999999   99999999999


Q ss_pred             CCeeeCCCCCeEEeecCCccccCCCCceeecccccc--CCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCC
Q 038681          176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG--TTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHV  251 (332)
Q Consensus       176 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~  251 (332)
                      +|||++.+..+||+|||+|+.......... ....+  ...|||||.+.. .|+.+|||||||++|||++| |..||.+.
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~  525 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI  525 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence            999999999999999999997666544332 12222  345999999998 89999999999999999998 88888764


Q ss_pred             CccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          252 SFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                      .....     ....+..               .  .....+..+..+++++|+.||+.+|++||++.++.+.|..++.
T Consensus       526 ~~~~~-----l~~~l~~---------------G--~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  526 PPTEE-----LLEFLKE---------------G--NRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             CcHHH-----HHHHHhc---------------C--CCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            32211     1111111               1  1222233556899999999999999999999999999998653

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=292.05  Aligned_cols=244  Identities=23%  Similarity=0.351  Sum_probs=199.2

Q ss_pred             ccHHHHHHHh-cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE---
Q 038681           44 FSAEELRIAT-NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL---  115 (332)
Q Consensus        44 ~~~~el~~~~-~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~---  115 (332)
                      +..-|+...+ +.|..-+.||+||||.||-++.  +|+-+|.|++.+...  .......++|-.+|.+++.+.||.+   
T Consensus       174 WK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYA  253 (591)
T KOG0986|consen  174 WKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYA  253 (591)
T ss_pred             HHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeee
Confidence            3333443333 4588889999999999999988  899999998765432  2234568899999999999999988   


Q ss_pred             --------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeE
Q 038681          116 --------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAK  187 (332)
Q Consensus       116 --------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  187 (332)
                              +|+..|.||||.-+|....+   ..+++..++.++.+|+-||++||   ..+||.|||||+|||+|+.|+++
T Consensus       254 feTkd~LClVLtlMNGGDLkfHiyn~g~---~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvR  327 (591)
T KOG0986|consen  254 FETKDALCLVLTLMNGGDLKFHIYNHGN---PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVR  327 (591)
T ss_pred             ecCCCceEEEEEeecCCceeEEeeccCC---CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeE
Confidence                    89999999999999987633   47999999999999999999999   99999999999999999999999


Q ss_pred             EeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhh
Q 038681          188 LFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRL  266 (332)
Q Consensus       188 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~  266 (332)
                      |+|+|+|..+..+...   ...+||.+|||||++.+ .|+...|.|||||++|||+.|+.||........          
T Consensus       328 ISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk----------  394 (591)
T KOG0986|consen  328 ISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK----------  394 (591)
T ss_pred             eeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh----------
Confidence            9999999998887765   34589999999999998 899999999999999999999999976544322          


Q ss_pred             hccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC
Q 038681          267 SGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT  316 (332)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs  316 (332)
                             .+-+|..+..+.   ...+...++++.+|....|+.||++|.-
T Consensus       395 -------~eEvdrr~~~~~---~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  395 -------REEVDRRTLEDP---EEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             -------HHHHHHHHhcch---hhcccccCHHHHHHHHHHHccCHHHhcc
Confidence                   112222222221   1122356688999999999999999953

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=9e-39  Score=286.64  Aligned_cols=233  Identities=21%  Similarity=0.311  Sum_probs=184.9

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCC--CChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGN--RNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .|...+.||+|+||.||+|.+  ++..+++|.+...  ........+.+|+.+++.++|+|++++           +|+|
T Consensus        16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   95 (308)
T cd06634          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (308)
T ss_pred             HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence            377788999999999999998  7788999998643  223335678899999999999999987           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+. |+|.+++....    ..+++..+..++.|++.||.|||   ..+++|+||+|+||+++.++.++|+|||++.....
T Consensus        96 ~~~-~~l~~~~~~~~----~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  167 (308)
T cd06634          96 YCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (308)
T ss_pred             ccC-CCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence            997 58888776431    45899999999999999999999   99999999999999999999999999999876543


Q ss_pred             CCceeeccccccCCCcccccccC----CCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFT----TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      .      ....+++.|+|||.+.    +.++.++|||||||++|+|++|..||.........     ........     
T Consensus       168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----~~~~~~~~-----  231 (308)
T cd06634         168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----YHIAQNES-----  231 (308)
T ss_pred             c------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH-----HHHhhcCC-----
Confidence            2      2346788999999874    26788999999999999999999998654322111     00000000     


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                                  +.......+..+.+|+.+||..+|++||++.+++..
T Consensus       232 ------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         232 ------------PALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             ------------CCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence                        000112345778999999999999999999998864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.8e-38  Score=277.55  Aligned_cols=238  Identities=19%  Similarity=0.249  Sum_probs=184.2

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC----ChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR----NQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      +|.+.+.||+|+||.||++.+  .+..+++|..+...    .......+..|+.++++++||||+++           +|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            488889999999999999998  44455555554321    12224457789999999999999987           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      +||+++++|.+++...... ...+++..++.++.|++.||.|||   +.+++|+||+|+||+++. +.++|+|||++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~  155 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHT-GKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLL  155 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhc-ccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeec
Confidence            9999999999998754221 246899999999999999999999   999999999999999975 56999999998766


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      .......  ....+++.|+|||.+.+ .++.++|+||||+++|+|++|..||........     ........       
T Consensus       156 ~~~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~-----~~~~~~~~-------  221 (260)
T cd08222         156 MGSCDLA--TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV-----VLRIVEGP-------  221 (260)
T ss_pred             CCCcccc--cCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH-----HHHHHcCC-------
Confidence            4433211  34567889999999876 788899999999999999999999864332111     00000000       


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                 ....+...+.++.+++.+||..||++||++.++++
T Consensus       222 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         222 -----------TPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -----------CCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence                       01112245578999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-38  Score=281.06  Aligned_cols=255  Identities=21%  Similarity=0.250  Sum_probs=187.0

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh-hhHHHHHHHHHHHHhh---cCCCcceE--------------
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ-HALEWCINHIVYASRM---SHKHIIKL--------------  115 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~H~nIv~~--------------  115 (332)
                      |++.+.||+|+||.||+|.+  ++..+|+|.+...... .....+.+|+.++.++   +||||+++              
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            66788999999999999999  5899999999754332 2234567788887776   59999987              


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        ++|||+++ +|.+++.....   ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||+
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~---~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~  153 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPK---PGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGL  153 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCc
Confidence              78899974 89998876421   35899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-ccc
Q 038681          194 SLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-QNC  271 (332)
Q Consensus       194 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~  271 (332)
                      +.........   ....++..|+|||.+.+ .++.++|||||||++|+|++|..||..........  ........ ...
T Consensus       154 ~~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  228 (287)
T cd07838         154 ARIYSFEMAL---TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD--KIFDVIGLPSEE  228 (287)
T ss_pred             ceeccCCccc---ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH--HHHHHcCCCChH
Confidence            9776544322   23457889999999987 88999999999999999999999997655432211  11111100 000


Q ss_pred             chhhhh--hhhhhcc--cCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          272 RFKEMV--DSIIIED--KSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       272 ~~~~~~--~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .+....  .......  ...........+..+.+++.+||+.||.+||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            000000  0000000  00001111244578899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.6e-39  Score=287.41  Aligned_cols=260  Identities=18%  Similarity=0.205  Sum_probs=188.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh-hhHHHHHHHHHHHHhhcCCCcceE--------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ-HALEWCINHIVYASRMSHKHIIKL--------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~H~nIv~~--------------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  ++..+|+|++...... .....+.+|+.+++.++||||+++              
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            47899999999999999999998  6889999998654322 223456789999999999999975              


Q ss_pred             -----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEee
Q 038681          116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFD  190 (332)
Q Consensus       116 -----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  190 (332)
                           +|+||+.+ +|.+.+...    ...+++..+..++.|+++||.|||   +.+|+|+||||+||+++.++.++|+|
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~d  158 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP----SVKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIAD  158 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECc
Confidence                 68899865 777776543    146999999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCcee---------eccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhh
Q 038681          191 FSLSLSIPDGETHI---------ELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHY  259 (332)
Q Consensus       191 fg~a~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~  259 (332)
                      ||++..........         ......+++.|+|||.+.+  .++.++|||||||++|||++|..||.......... 
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~-  237 (311)
T cd07866         159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLH-  237 (311)
T ss_pred             CccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHH-
Confidence            99997654322111         1123456888999998865  58899999999999999999999997655432211 


Q ss_pred             HHHHhhhhcc-ccchhh------hhhhhhhcccCCCC-CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          260 EENVKRLSGQ-NCRFKE------MVDSIIIEDKSCTC-TGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       260 ~~~~~~~~~~-~~~~~~------~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                       ......... ...+..      ..+........... .........+.+++.+||+.||.+|||+.+++.
T Consensus       238 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         238 -LIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             -HHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence             111111110 000000      00000000000000 000122367889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.4e-38  Score=288.57  Aligned_cols=258  Identities=17%  Similarity=0.182  Sum_probs=187.6

Q ss_pred             cCCC-CCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChh-------------hHHHHHHHHHHHHhhcCCCcceE--
Q 038681           54 NNYD-EQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQH-------------ALEWCINHIVYASRMSHKHIIKL--  115 (332)
Q Consensus        54 ~~y~-~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~H~nIv~~--  115 (332)
                      ++|. +.+.||.|+||.||+|.+  .++.||+|++.......             ....+.+|+.+++.++||||+++  
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            4565 457799999999999998  78899999986543221             01247799999999999999987  


Q ss_pred             ---------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCe
Q 038681          116 ---------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA  186 (332)
Q Consensus       116 ---------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  186 (332)
                               +||||++ |+|.+++...     ..+++..+..++.|++.||.|||   +.+|+|+||+|+||+++.++.+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~  158 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGIC  158 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCE
Confidence                     8999997 5999998764     46899999999999999999999   9999999999999999999999


Q ss_pred             EEeecCCccccCCCCc------------eeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCC
Q 038681          187 KLFDFSLSLSIPDGET------------HIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVS  252 (332)
Q Consensus       187 kl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~  252 (332)
                      +|+|||++........            ........++..|+|||.+.+  .++.++|||||||++|+|++|..||....
T Consensus       159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        159 KIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             EECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999876541110            011123356889999999876  57899999999999999999999998665


Q ss_pred             ccchhhhHHHHhhhhc-cccchhhhhhhhhhcc-----cCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          253 FESRFHYEENVKRLSG-QNCRFKEMVDSIIIED-----KSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       253 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ......  ........ ....+.....-.....     ...........+..+.+++.+||+.||++|||+++++.
T Consensus       239 ~~~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        239 EIDQLG--RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HHHHHH--HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            432211  11111111 1111111100000000     00000001123467899999999999999999999985

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-39  Score=292.73  Aligned_cols=254  Identities=19%  Similarity=0.257  Sum_probs=189.9

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-------------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-------------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-------------  115 (332)
                      ..++|.+.+.||+|+||.||+|.+  ++..||+|++.... .....+.+.+|+.++++++||||+++             
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            456799999999999999999999  67899999987542 22335667899999999999999753             


Q ss_pred             ----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeec
Q 038681          116 ----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF  191 (332)
Q Consensus       116 ----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  191 (332)
                          +|+||+ +++|.+++..      ..+++..+..++.|++.||.|||   +.||+|+||||+||+++.++.++|+||
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~df  162 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDF  162 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccc
Confidence                899998 5699998875      36899999999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc
Q 038681          192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ  269 (332)
Q Consensus       192 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  269 (332)
                      |++.......     ....++..|+|||.+.+  .++.++|||||||++|++++|..||..........  .........
T Consensus       163 g~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~--~i~~~~~~~  235 (343)
T cd07851         163 GLARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLK--RIMNLVGTP  235 (343)
T ss_pred             cccccccccc-----cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHHhcCCC
Confidence            9997664432     34467889999998865  67899999999999999999999997654322111  111111100


Q ss_pred             ccchhhhh-----hhhhhcccCCCC----CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          270 NCRFKEMV-----DSIIIEDKSCTC----TGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       270 ~~~~~~~~-----~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ...+...+     ...+........    ......+..+.+++.+||+.||++|||+.+|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         236 DEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             CHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            00000000     000000000000    000123578999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=4e-38  Score=283.09  Aligned_cols=231  Identities=20%  Similarity=0.318  Sum_probs=184.0

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      |...+.||+|+||.||+|.+  ++..|++|++....  .....+.+.+|+.+++.++|||++++           +||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            66678899999999999998  78899999987543  23335678899999999999999987           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      ++ |+|.+++....    ..+++.++..++.||+.||.|||   +.|++|+||+|+||+++.++.++|+|||++......
T Consensus       103 ~~-~~l~~~l~~~~----~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~  174 (313)
T cd06633         103 CL-GSASDLLEVHK----KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPA  174 (313)
T ss_pred             CC-CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECCCCCEEEeecCCCcccCCC
Confidence            96 58888876531    46899999999999999999999   999999999999999999999999999998643221


Q ss_pred             CceeeccccccCCCcccccccC----CCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFT----TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                            ....|+..|+|||.+.    +.++.++|||||||++|+|++|..||..........     .......      
T Consensus       175 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~-----~~~~~~~------  237 (313)
T cd06633         175 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-----HIAQNDS------  237 (313)
T ss_pred             ------CCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH-----HHHhcCC------
Confidence                  3456889999999974    268889999999999999999999987654322111     0000000      


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                 +.......+..+.+|+.+||+.+|.+||++.+++.
T Consensus       238 -----------~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         238 -----------PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             -----------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                       00001123356899999999999999999999986

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-38  Score=271.43  Aligned_cols=224  Identities=22%  Similarity=0.297  Sum_probs=182.5

Q ss_pred             cccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCCCh
Q 038681           62 VLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTL  126 (332)
Q Consensus        62 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g~L  126 (332)
                      ||.|+||.||++..  .+..+++|.+.....  ......+.+|+.++++++||||+++           +||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            69999999999999  588999999876533  2246678999999999999999986           89999999999


Q ss_pred             HHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceeec
Q 038681          127 ADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL  206 (332)
Q Consensus       127 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~  206 (332)
                      .+++...     ..+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++.........  .
T Consensus        81 ~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~--~  150 (250)
T cd05123          81 FSHLSKE-----GRFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR--T  150 (250)
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCc--c
Confidence            9999765     46899999999999999999999   999999999999999999999999999999776543211  1


Q ss_pred             cccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhccc
Q 038681          207 DSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDK  285 (332)
Q Consensus       207 ~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ....++..|+|||...+ ..+.++|+||||+++|++++|..||.......      ..........              
T Consensus       151 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~~~~--------------  210 (250)
T cd05123         151 NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE------IYEKILKDPL--------------  210 (250)
T ss_pred             cCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH------HHHHHhcCCC--------------
Confidence            34568889999999887 78889999999999999999999997654311      1111110000              


Q ss_pred             CCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 038681          286 SCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVD  319 (332)
Q Consensus       286 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e  319 (332)
                          +.+...+..+.+++.+||..||++||++.+
T Consensus       211 ----~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         211 ----RFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             ----CCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence                111122477899999999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=273.49  Aligned_cols=243  Identities=18%  Similarity=0.242  Sum_probs=190.8

Q ss_pred             CCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----------EEEEecc
Q 038681           57 DEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----------IVFESVQ  122 (332)
Q Consensus        57 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv~e~~~  122 (332)
                      +....||.|+||+|++-.+  .|+..|||++.....+....+++.|.++..+- +.||||++           |.||++.
T Consensus        67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd  146 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD  146 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh
Confidence            3346799999999999999  89999999999988877788899999887666 68999998           8999996


Q ss_pred             CCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCc
Q 038681          123 IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET  202 (332)
Q Consensus       123 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  202 (332)
                      - +|..+...-..-....+++...-.|....+.||.||-+  ...|+|||+||+|||++..|.+||||||.+..+.++-.
T Consensus       147 ~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA  223 (361)
T KOG1006|consen  147 I-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA  223 (361)
T ss_pred             h-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH
Confidence            4 77666544322233579999999999999999999986  78999999999999999999999999999977655433


Q ss_pred             eeeccccccCCCcccccccCC---CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          203 HIELDSVVGTTGFIAPENFTT---LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       203 ~~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      .   +.-.|..+|||||.+..   .|+.+|||||||++|||+.||..||.....    .++.+-....+.++.+.     
T Consensus       224 k---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s----vfeql~~Vv~gdpp~l~-----  291 (361)
T KOG1006|consen  224 K---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS----VFEQLCQVVIGDPPILL-----  291 (361)
T ss_pred             h---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH----HHHHHHHHHcCCCCeec-----
Confidence            2   44578999999999975   589999999999999999999999975432    11111111111111110     


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                              ......+.+..+..++..||..|-++||...++.+
T Consensus       292 --------~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  292 --------FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             --------CcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence                    00011246688999999999999999999998865

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=312.04  Aligned_cols=247  Identities=19%  Similarity=0.274  Sum_probs=200.0

Q ss_pred             cHHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----
Q 038681           45 SAEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----  115 (332)
Q Consensus        45 ~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----  115 (332)
                      ...++....++|.+.+.||+|+||.|..+++  +++.+|.|++.+..-  .....-|+.|-.+|..-+.+-|+++     
T Consensus        66 ~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQ  145 (1317)
T KOG0612|consen   66 KVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQ  145 (1317)
T ss_pred             HHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhc
Confidence            3445666678899999999999999999999  889999999877321  1224568899999999899999987     


Q ss_pred             ------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEe
Q 038681          116 ------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLF  189 (332)
Q Consensus       116 ------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  189 (332)
                            +||||++||||..++.+.     .++|+..++.++..|+.||+-||   +.|+|||||||+|||+|..|++||+
T Consensus       146 D~~~LYlVMdY~pGGDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLA  217 (1317)
T KOG0612|consen  146 DERYLYLVMDYMPGGDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLA  217 (1317)
T ss_pred             CccceEEEEecccCchHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeec
Confidence                  999999999999999887     57999999999999999999999   9999999999999999999999999


Q ss_pred             ecCCccccCCCCceeeccccccCCCcccccccC------CCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHH
Q 038681          190 DFSLSLSIPDGETHIELDSVVGTTGFIAPENFT------TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENV  263 (332)
Q Consensus       190 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~  263 (332)
                      |||.+-....++.... ...+|||.|.+||++.      +.|+..+|.||+||++|||+.|..||......+..      
T Consensus       218 DFGsClkm~~dG~V~s-~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY------  290 (1317)
T KOG0612|consen  218 DFGSCLKMDADGTVRS-SVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY------  290 (1317)
T ss_pred             cchhHHhcCCCCcEEe-ccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH------
Confidence            9999988776555443 6779999999999985      26899999999999999999999999765433221      


Q ss_pred             hhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC---HHHHH
Q 038681          264 KRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT---MVDVA  321 (332)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~evl  321 (332)
                      ..          +.+.    ......|.....++++.+||.+.+. +|+.|..   ++++-
T Consensus       291 ~K----------Im~h----k~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik  336 (1317)
T KOG0612|consen  291 GK----------IMNH----KESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK  336 (1317)
T ss_pred             HH----------Hhch----hhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence            11          1111    0011112223567889999998876 7788876   66654

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=275.02  Aligned_cols=255  Identities=20%  Similarity=0.225  Sum_probs=189.9

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEec
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-----------IVFESV  121 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~  121 (332)
                      |+..+.||+|+||.||+|..  +++.+++|.+.... .....+.+.+|+.++++++||||+++           +|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            56678899999999999999  68999999998764 23335678899999999999999987           899999


Q ss_pred             cCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCC
Q 038681          122 QIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE  201 (332)
Q Consensus       122 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  201 (332)
                      + ++|.+++....    ..+++..+..++.|++.||.|||   +.+|+|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~-~~l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~  152 (282)
T cd07829          81 D-MDLKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL  152 (282)
T ss_pred             C-cCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc
Confidence            8 59999998652    36899999999999999999999   9999999999999999999999999999997765433


Q ss_pred             ceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc-hhhhhh
Q 038681          202 THIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR-FKEMVD  278 (332)
Q Consensus       202 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  278 (332)
                      ..  .....++..|+|||.+.+  .++.++|||||||++||+++|..||..........  ............ +....+
T Consensus       153 ~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07829         153 RT--YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLF--KIFQILGTPTEESWPGVTK  228 (282)
T ss_pred             cc--cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH--HHHHHhCCCcHHHHHhhcc
Confidence            21  123456788999998865  78899999999999999999999997655332211  111111110000 000000


Q ss_pred             -----hhhhcccCCCC-CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          279 -----SIIIEDKSCTC-TGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       279 -----~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                           ........... ...+..+..+.+++.+||..||++||++.+++.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                 00000000000 000122567999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=7.2e-38  Score=306.55  Aligned_cols=135  Identities=22%  Similarity=0.294  Sum_probs=121.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      .++|.+.++||+|+||.||+|.+  .++.||+|++....  .......+..|+.++..++||||+++           ||
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            36799999999999999999999  68999999987543  23335778999999999999999997           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      |||+++|+|.+++...     ..+++..++.++.||+.||.|||   .++|+||||||+|||++.++.+||+|||+++
T Consensus        83 mEy~~g~~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIY-----GYFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999765     46899999999999999999999   8999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-38  Score=298.39  Aligned_cols=248  Identities=17%  Similarity=0.254  Sum_probs=208.2

Q ss_pred             ccHHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----
Q 038681           44 FSAEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----  115 (332)
Q Consensus        44 ~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----  115 (332)
                      ..++.+...++-|++...||.|.+|.||++..  +++.+|+|+.....+.+  +++..|..+|+.+ .|||++.+     
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d--eEiE~eynil~~~~~hpnv~~fyg~~~   86 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE--EEIELEYNMLKKYSHHPNVATFYGAFI   86 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc--HHHHHHHHHHHhccCCCCcceEEEEEE
Confidence            44455556677899999999999999999998  88899999988876554  6677899999988 69999987     


Q ss_pred             -----------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC
Q 038681          116 -----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS  184 (332)
Q Consensus       116 -----------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  184 (332)
                                 ||||||.+|+..|+++...   ...+.|..+..|++.++.||.+||   .+.++|||||-.|||++.++
T Consensus        87 k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~  160 (953)
T KOG0587|consen   87 KKDPGNGDQLWLVMEFCGGGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENA  160 (953)
T ss_pred             EecCCCCCeEEEEeeccCCccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccC
Confidence                       8999999999999999875   357999999999999999999999   99999999999999999999


Q ss_pred             CeEEeecCCccccCCCCceeeccccccCCCcccccccCC------CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhh
Q 038681          185 DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT------LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFH  258 (332)
Q Consensus       185 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~  258 (332)
                      .|||+|||.+..+.....  ...+++||+.|||||++..      .|+..+|+||||++..||.-|.+|+..+.+.-...
T Consensus       161 ~VKLvDFGvSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF  238 (953)
T KOG0587|consen  161 EVKLVDFGVSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF  238 (953)
T ss_pred             cEEEeeeeeeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc
Confidence            999999999977655432  2367899999999999863      46778999999999999999999998776533211


Q ss_pred             hHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          259 YEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                           .                +...+++....+..+++++.++|..||..|-.+||+..++++
T Consensus       239 -----~----------------IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  239 -----L----------------IPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             -----c----------------CCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                 1                112222333345688899999999999999999999999875

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-38  Score=266.62  Aligned_cols=247  Identities=22%  Similarity=0.331  Sum_probs=199.8

Q ss_pred             CccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-CCCcceE-----------EEEEeccCCC
Q 038681           60 NIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKL-----------IVFESVQIGT  125 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~~-----------lv~e~~~~g~  125 (332)
                      +.||+|+|+.|-.+..  ++..+|||++.+.. .....++.+|++++.+.+ |+||+++           ||||-+.||+
T Consensus        84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~-gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP-GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHhcCccceeeeeeeeeccchhhhhhhhhcCC-chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            5799999999999998  99999999999884 445888999999999995 9999987           9999999999


Q ss_pred             hHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCC---eEEeecCCccccCC---
Q 038681          126 LADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPD---  199 (332)
Q Consensus       126 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~Dfg~a~~~~~---  199 (332)
                      |...|.++     ..+++.++..++.+|+.||.|||   .+||.||||||+|||-.....   +|||||.+..-...   
T Consensus       163 lLshI~~~-----~~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~  234 (463)
T KOG0607|consen  163 LLSHIQKR-----KHFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND  234 (463)
T ss_pred             HHHHHHHh-----hhccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence            99999987     67999999999999999999999   999999999999999865543   79999987643322   


Q ss_pred             --CCceeeccccccCCCcccccccC---C---CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          200 --GETHIELDSVVGTTGFIAPENFT---T---LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       200 --~~~~~~~~~~~gt~~y~aPE~~~---~---~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                        ........+++|+..|||||+..   +   .|+.+.|.||||+|+|-|++|.+||.+.-..+-       .|-.+..+
T Consensus       235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC-------GWdrGe~C  307 (463)
T KOG0607|consen  235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC-------GWDRGEVC  307 (463)
T ss_pred             CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC-------CccCCCcc
Confidence              22233446788999999999763   2   689999999999999999999999987654321       12222222


Q ss_pred             ch--hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          272 RF--KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       272 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      +.  ..++.++-...+..+...-...+.+..+++...|..|+.+|.++.++++
T Consensus       308 r~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  308 RVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            21  2334444444444455555678899999999999999999999998876

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-39  Score=271.80  Aligned_cols=229  Identities=21%  Similarity=0.273  Sum_probs=190.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      .++|...++||+|.||.|-+++-  +++.+|+|++++.-.  .+....-+.|-++|...+||.+..+           +|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            45788899999999999999998  899999999987632  2334556789999999999998866           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+.||.|.-.+.+.     ..+++.....+-..|+.||.|||   +++||.||||.+|.|+|.+|++||+|||+++.-
T Consensus       247 MeyanGGeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  247 MEYANGGELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             EEEccCceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhc
Confidence            9999999999988876     67999999999999999999999   999999999999999999999999999999754


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      -.....  ..+++|||.|+|||++.. .|+.++|.|.+||++|||++|+.||...+......      .           
T Consensus       319 I~~g~t--~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFe------L-----------  379 (516)
T KOG0690|consen  319 IKYGDT--TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFE------L-----------  379 (516)
T ss_pred             ccccce--eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHH------H-----------
Confidence            333222  267899999999999998 99999999999999999999999998765433211      1           


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP  315 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP  315 (332)
                         ++..+.    .++...+++...|+...|..||.+|.
T Consensus       380 ---Il~ed~----kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  380 ---ILMEDL----KFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ---HHhhhc----cCCccCCHHHHHHHHHHhhcChHhhc
Confidence               111111    12224457899999999999999994

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-38  Score=274.46  Aligned_cols=260  Identities=20%  Similarity=0.328  Sum_probs=195.0

Q ss_pred             ccccHHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc--CCC----cc
Q 038681           42 RIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS--HKH----II  113 (332)
Q Consensus        42 ~~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--H~n----Iv  113 (332)
                      .+|...++.  +++|.+..++|+|+||.|-.+.+  ++..||||+++....  ..+...-|+++|.++.  .|+    +|
T Consensus        79 ~v~~~gD~l--~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k--YreAa~iEi~vLqki~~~DP~g~~rcv  154 (415)
T KOG0671|consen   79 YVYQVGDIL--TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK--YREAALIEIEVLQKINESDPNGKFRCV  154 (415)
T ss_pred             EEEEecccc--ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH--HhhHHHHHHHHHHHHHhcCCCCceEEE
Confidence            444444443  77899999999999999999998  778999999887643  2466788999999994  233    33


Q ss_pred             eE-----------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC
Q 038681          114 KL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE  182 (332)
Q Consensus       114 ~~-----------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~  182 (332)
                      ++           ||+|.+ |-++.+++..+   +..+++...+..++.|++++++|||   +.+++|-||||+|||+..
T Consensus       155 ~m~~wFdyrghiCivfell-G~S~~dFlk~N---~y~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvs  227 (415)
T KOG0671|consen  155 QMRDWFDYRGHICIVFELL-GLSTFDFLKEN---NYIPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVS  227 (415)
T ss_pred             eeehhhhccCceEEEEecc-ChhHHHHhccC---CccccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEec
Confidence            33           799988 45999999875   3467999999999999999999999   999999999999999832


Q ss_pred             --------------------CCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHH
Q 038681          183 --------------------QSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFEL  241 (332)
Q Consensus       183 --------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~el  241 (332)
                                          +..++|+|||.|+......     ...+.|..|+|||++.+ .++.++||||+||||+|+
T Consensus       228 s~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~El  302 (415)
T KOG0671|consen  228 SEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVEL  302 (415)
T ss_pred             cceEEEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEe
Confidence                                2348999999998765554     45678999999999999 999999999999999999


Q ss_pred             HhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhh----------h-------hc--c---cCCCC-----CChHH
Q 038681          242 LTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSI----------I-------IE--D---KSCTC-----TGKEQ  294 (332)
Q Consensus       242 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~-------~~--~---~~~~~-----~~~~~  294 (332)
                      .||...|...+..+-.   ...+.+.+..+  ..++...          +       ..  .   ..|..     .....
T Consensus       303 ytG~~LFqtHen~EHL---aMMerIlGp~P--~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~  377 (415)
T KOG0671|consen  303 YTGETLFQTHENLEHL---AMMERILGPIP--SRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDL  377 (415)
T ss_pred             eccceecccCCcHHHH---HHHHHhhCCCc--HHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcH
Confidence            9999999877643322   12222222111  1111111          0       00  0   00000     01123


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          295 QLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       295 ~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ...++.+|+.+||.+||.+|+|+.|++.
T Consensus       378 e~~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  378 EHVQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             HHhHHHHHHHHHHccCccccccHHHHhc
Confidence            4467999999999999999999999885

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-39  Score=281.86  Aligned_cols=246  Identities=23%  Similarity=0.342  Sum_probs=194.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC------hhhHHHHHHHHHHHHhhcCCCcceE---------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN------QHALEWCINHIVYASRMSHKHIIKL---------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~H~nIv~~---------  115 (332)
                      .++|-..++||+|||+.||+|.+  ..+.||||+-....+      ....+...+|.+|.+.|.||.||++         
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            35577889999999999999999  778889988654322      2223457899999999999999998         


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeC---CCCCeEEe
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN---EQSDAKLF  189 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~  189 (332)
                         -|+|||+|.+|.-|++.+     ..+++.++..|+.||+.||.||.+- +.+|+|-||||.|||+-   ..|.+||.
T Consensus       542 sFCTVLEYceGNDLDFYLKQh-----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQH-----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             cceeeeeecCCCchhHHHHhh-----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEee
Confidence               599999999999999988     6799999999999999999999854 68999999999999993   56789999


Q ss_pred             ecCCccccCCCCcee-----eccccccCCCcccccccC-C----CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhh
Q 038681          190 DFSLSLSIPDGETHI-----ELDSVVGTTGFIAPENFT-T----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHY  259 (332)
Q Consensus       190 Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~-~----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~  259 (332)
                      |||++++..+.....     -.....||.+|++||.|. +    .++.++||||+|||+|..+.|+.||...........
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq  695 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ  695 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence            999999887654321     124568999999999885 2    578999999999999999999999987654332111


Q ss_pred             HHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          260 EENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ...                  +........+..+..+.+..+||++||++.-++|....++..
T Consensus       696 eNT------------------IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  696 ENT------------------ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             hhc------------------hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence            100                  111111122333456688999999999999999988877654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-38  Score=288.01  Aligned_cols=226  Identities=22%  Similarity=0.275  Sum_probs=188.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----------EEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----------IVF  118 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv~  118 (332)
                      +..|.....+|.|+|+.|-.+.+  ++...++|++.....     ...+|+.++... +||||+++           +||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc-----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            56788888999999999999999  888999999987732     235778777776 79999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee-CCCCCeEEeecCCcccc
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF-NEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill-~~~~~~kl~Dfg~a~~~  197 (332)
                      |.+.+|-+.+.+...      +....++..|+.+|+.|+.|||   ++|+|||||||+|||+ +..++++|+|||.++..
T Consensus       396 e~l~g~ell~ri~~~------~~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~  466 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSK------PEFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL  466 (612)
T ss_pred             hhccccHHHHHHHhc------chhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence            999999888887664      2333788899999999999999   9999999999999999 69999999999999887


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ...     ..+.+-|..|.|||++.. .|++++||||||++||+|++|+.||...+....     +...+..        
T Consensus       467 ~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e-----i~~~i~~--------  528 (612)
T KOG0603|consen  467 ERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE-----IHTRIQM--------  528 (612)
T ss_pred             chh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH-----HHHhhcC--------
Confidence            665     145577999999999987 999999999999999999999999987665411     2222211        


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                  .+.....+..+++|+..||+.||.+||++.++..
T Consensus       529 ------------~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  529 ------------PKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ------------CccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                        1112466789999999999999999999999864

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.8e-37  Score=266.65  Aligned_cols=206  Identities=22%  Similarity=0.238  Sum_probs=166.1

Q ss_pred             CCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCCChHHHHh
Q 038681           65 DPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIH  131 (332)
Q Consensus        65 G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g~L~~~l~  131 (332)
                      |.+|.||++.+  +++.+|+|.+....      .+.+|...+....||||+++           +||||+++|+|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence            89999999999  88999999987653      22345555566679999987           8999999999999997


Q ss_pred             hhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceeecccccc
Q 038681          132 HHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG  211 (332)
Q Consensus       132 ~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g  211 (332)
                      ..     ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.++++|||.+.......     ....+
T Consensus        78 ~~-----~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~  144 (237)
T cd05576          78 KF-----LNIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAV  144 (237)
T ss_pred             Hh-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCc
Confidence            65     46899999999999999999999   9999999999999999999999999999876654432     23456


Q ss_pred             CCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCC
Q 038681          212 TTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCT  290 (332)
Q Consensus       212 t~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (332)
                      +..|+|||.+.+ .++.++||||+||++|||++|..|+.........          ..                  ...
T Consensus       145 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~~----------~~------------------~~~  196 (237)
T cd05576         145 ENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINT----------HT------------------TLN  196 (237)
T ss_pred             CccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhccc----------cc------------------ccC
Confidence            778999999876 7899999999999999999999887533211000          00                  000


Q ss_pred             ChHHHHHHHHHHHHHcccCCCCCCCCH
Q 038681          291 GKEQQLQAFKQLTLQCMDFSPEDRPTM  317 (332)
Q Consensus       291 ~~~~~~~~~~~li~~cl~~dP~~RPs~  317 (332)
                      .+...+..+.+++.+||+.||++||++
T Consensus       197 ~~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         197 IPEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             CcccCCHHHHHHHHHHccCCHHHhcCC
Confidence            111234678999999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.9e-37  Score=296.91  Aligned_cols=257  Identities=19%  Similarity=0.176  Sum_probs=164.4

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--C----CeeEEEEEEcCCCChhhHHHHHHHH----------HHHHhhcCC-----
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--Q----KRSISLMKYNGNRNQHALEWCINHI----------VYASRMSHK-----  110 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~----~~~vavK~~~~~~~~~~~~~~~~E~----------~~l~~l~H~-----  110 (332)
                      ..++|.+.+.||+|+||.||+|.+  +    +..||+|++......   +...+|.          .....+.++     
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~---e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~  206 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV---EIWMNERVRRACPNSCADFVYGFLEPVSSKK  206 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh---HHHHHHHHHhhchhhHHHHHHhhhccccccc
Confidence            567899999999999999999999  4    689999998654321   1111111          001111111     


Q ss_pred             CcceEEEEEeccCCChHHHHhhhhcc---------------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 038681          111 HIIKLIVFESVQIGTLADRIHHHCEQ---------------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP  175 (332)
Q Consensus       111 nIv~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  175 (332)
                      .--.+||+||+++++|.+++......               .........+..++.||+.||.|||   +++|+||||||
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP  283 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKP  283 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCH
Confidence            11234999999999999998753110               0001123456789999999999999   99999999999


Q ss_pred             CCeeeCC-CCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-----------------------CCChhhhH
Q 038681          176 TNILFNE-QSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-----------------------LINEQCDV  231 (332)
Q Consensus       176 ~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------------------~~~~~sDi  231 (332)
                      +|||++. ++.+||+|||+|+.......... ....+|+.|+|||.+..                       .++.++||
T Consensus       284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~-~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        284 QNIIFSEGSGSFKIIDLGAAADLRVGINYIP-KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHEEEeCCCCcEEEEeCCCccccccccccCC-cccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            9999985 57899999999986644332221 45678999999997632                       12345699


Q ss_pred             HHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh---hhhhhhhcccCCCCCChHHHHHHHHHHHHHccc
Q 038681          232 YGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE---MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMD  308 (332)
Q Consensus       232 wSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~  308 (332)
                      |||||++|||+++..++....    ..   ....+......+..   ...+.....................+|+.+||+
T Consensus       363 wSlGviL~el~~~~~~~~~~~----~~---~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSNL----IQ---FNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchHH----HH---HHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            999999999999776644221    11   11111111111111   111100000000000000112346689999999


Q ss_pred             CCCCCCCCHHHHHH
Q 038681          309 FSPEDRPTMVDVAK  322 (332)
Q Consensus       309 ~dP~~RPs~~evl~  322 (332)
                      .||++|||+.++++
T Consensus       436 ~dP~kR~ta~e~L~  449 (566)
T PLN03225        436 FKGRQRISAKAALA  449 (566)
T ss_pred             CCcccCCCHHHHhC
Confidence            99999999999986

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-38  Score=282.21  Aligned_cols=232  Identities=19%  Similarity=0.229  Sum_probs=187.5

Q ss_pred             CCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCC
Q 038681           59 QNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIG  124 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g  124 (332)
                      .+.||+|.||+||-|.+  +|+.||||++.+.. .......+.+|+.||.++.||.||.+           .|||-+.| 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-
Confidence            57899999999999999  89999999998754 33335778999999999999999998           79999865 


Q ss_pred             ChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC---CCeEEeecCCccccCCCC
Q 038681          125 TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ---SDAKLFDFSLSLSIPDGE  201 (332)
Q Consensus       125 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~a~~~~~~~  201 (332)
                      +..+.|-..   ..+.+++.....++.||+.||.|||   .++|+|+||||+|||+...   -++||||||+|+.+....
T Consensus       648 DMLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks  721 (888)
T KOG4236|consen  648 DMLEMILSS---EKGRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS  721 (888)
T ss_pred             hHHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence            555555432   1367999999999999999999999   9999999999999999643   479999999999988766


Q ss_pred             ceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhh
Q 038681          202 THIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSI  280 (332)
Q Consensus       202 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (332)
                      ..   .+.+||+.|.|||++.+ .|+..-|+||.|+++|--++|..||........                      ++
T Consensus       722 FR---rsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd----------------------QI  776 (888)
T KOG4236|consen  722 FR---RSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND----------------------QI  776 (888)
T ss_pred             hh---hhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH----------------------Hh
Confidence            43   56799999999999998 899999999999999999999999975433111                      11


Q ss_pred             hhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          281 IIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      -....-.+...-.+.+....+||...|+..-.+|-|.+..+.
T Consensus       777 QNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  777 QNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             hccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhcc
Confidence            001111111122356688999999999999999999887654

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=5.8e-37  Score=248.44  Aligned_cols=252  Identities=17%  Similarity=0.230  Sum_probs=193.6

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-CCCcceE-------------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKL-------------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~~-------------  115 (332)
                      ..++|++.+++|+|.|+.||.|..  +++.++||.++...    .+.+.+|+.+|..|+ ||||+.+             
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa  111 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS  111 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence            356799999999999999999997  88899999998754    567899999999997 9999998             


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC-CCCeEEeecCCc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE-QSDAKLFDFSLS  194 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a  194 (332)
                      ||+||+.+-+...+.        +.++...+..++.+++.||.|+|   +.||.|||+||.|++||. ...++|+|+|+|
T Consensus       112 LiFE~v~n~Dfk~ly--------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLA  180 (338)
T KOG0668|consen  112 LIFEYVNNTDFKQLY--------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLA  180 (338)
T ss_pred             hHhhhhccccHHHHh--------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchH
Confidence            899999988777665        45788889999999999999999   999999999999999985 457999999999


Q ss_pred             cccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHh--------
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVK--------  264 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~--------  264 (332)
                      .....+...   +-.+.+..|-.||++..  .|+..-|+|||||++..|+..+.||..-..... ++..+..        
T Consensus       181 EFYHp~~eY---nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVkIakVLGt~el~  256 (338)
T KOG0668|consen  181 EFYHPGKEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVKIAKVLGTDELY  256 (338)
T ss_pred             hhcCCCcee---eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHHHHHHhChHHHH
Confidence            888776654   34567889999999986  788899999999999999999999865443221 1111211        


Q ss_pred             -hhhc----cccchhhhhhhhhhcccC--CCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          265 -RLSG----QNCRFKEMVDSIIIEDKS--CTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       265 -~~~~----~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                       .+..    .++.+.+++.........  .......-.++++.+|+.+.|.+|..+||||.|.+.
T Consensus       257 ~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  257 AYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence             1111    112222222211111100  011111223488999999999999999999999875

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-37  Score=264.73  Aligned_cols=257  Identities=18%  Similarity=0.299  Sum_probs=211.3

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----  115 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----  115 (332)
                      |+.....++....++.+|.||.||+|.|       +.+.|.+|.++...++-....++.|.-.+..+.|||+.++     
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            4445566788888999999999999977       3345788888888887778889999999999999999987     


Q ss_pred             -------EEEEeccCCChHHHHhhhhcc---cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCC
Q 038681          116 -------IVFESVQIGTLADRIHHHCEQ---HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD  185 (332)
Q Consensus       116 -------lv~e~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  185 (332)
                             .++.+..-|+|..|+......   ....+...+...++.|++.|++|||   .+++||.||-.+|++||+.-+
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhhee
Confidence                   567788889999999854322   2245777788899999999999999   999999999999999999999


Q ss_pred             eEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHH
Q 038681          186 AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENV  263 (332)
Q Consensus       186 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~  263 (332)
                      +||+|=.+++.+...+...-.........||+||.+.+ .|+.++||||||+++|||+| |+.||...++.+...+.   
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl---  511 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL---  511 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH---
Confidence            99999999998877665544344456789999999988 99999999999999999998 99999887766543321   


Q ss_pred             hhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          264 KRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                                        +..+  +...+-++++++..+|..||..+|++||+++++...|.+....
T Consensus       512 ------------------kdGy--RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~q  558 (563)
T KOG1024|consen  512 ------------------KDGY--RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQ  558 (563)
T ss_pred             ------------------hccc--eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHH
Confidence                              1111  2222346779999999999999999999999999999887643

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-37  Score=265.97  Aligned_cols=230  Identities=19%  Similarity=0.260  Sum_probs=188.2

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhh-cCCCcceE-----------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRM-SHKHIIKL-----------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~~-----------  115 (332)
                      ...+|.....||+|+||.|.+|..  +.+.+|||+++++--  .+..+--+.|-++|... +-|.++++           
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            345688899999999999999998  667899999887621  22244456777888776 46677765           


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      +||||+.||+|.-.+.+-     +.+.+..+..++..|+-||-|||   ++||+.||||.+||++|.+|.+||+|||+++
T Consensus       427 FVMEyvnGGDLMyhiQQ~-----GkFKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK  498 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQV-----GKFKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK  498 (683)
T ss_pred             eEEEEecCchhhhHHHHh-----cccCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccc
Confidence            899999999999888876     67999999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      .---+....  .+++|||.|+|||++.- +|+.++|.||||++||||+.|++||++.++.+...      .+...+.   
T Consensus       499 Eni~~~~TT--kTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~------aI~ehnv---  567 (683)
T KOG0696|consen  499 ENIFDGVTT--KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ------AIMEHNV---  567 (683)
T ss_pred             ccccCCcce--eeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH------HHHHccC---
Confidence            654433322  57899999999999886 99999999999999999999999999887765322      1111111   


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP  315 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP  315 (332)
                                     ..+...+.+..++.+..|...|.+|.
T Consensus       568 ---------------syPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  568 ---------------SYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             ---------------cCcccccHHHHHHHHHHhhcCCcccc
Confidence                           12235557889999999999999994

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=5.9e-35  Score=251.44  Aligned_cols=226  Identities=26%  Similarity=0.351  Sum_probs=182.1

Q ss_pred             CCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCCChHHHHhh
Q 038681           66 PFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHH  132 (332)
Q Consensus        66 ~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g~L~~~l~~  132 (332)
                      +||.||+|.+  ++..+++|.+.........+.+.+|+..+++++|+||+++           +++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            5899999999  5799999999876554336789999999999999999976           89999999999999876


Q ss_pred             hhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceeeccccccC
Q 038681          133 HCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT  212 (332)
Q Consensus       133 ~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt  212 (332)
                      .     ..+++..+..++.+++.|+.|||   ..+++|+||+|+||+++.++.++|+|||.+.........   ....++
T Consensus        81 ~-----~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~  149 (244)
T smart00220       81 R-----GRLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLL---TTFVGT  149 (244)
T ss_pred             c-----cCCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeecccccc---ccccCC
Confidence            5     33899999999999999999999   899999999999999999999999999999876654311   345688


Q ss_pred             CCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCC
Q 038681          213 TGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTG  291 (332)
Q Consensus       213 ~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      ..|+|||.+.+ .++.++||||||+++|++++|..||........     ............               ...
T Consensus       150 ~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~-----~~~~~~~~~~~~---------------~~~  209 (244)
T smart00220      150 PEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE-----LFKKIGKPKPPF---------------PPP  209 (244)
T ss_pred             cCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-----HHHHHhccCCCC---------------ccc
Confidence            89999999876 788899999999999999999999976322111     111111100000               000


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          292 KEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       292 ~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ....+.++.+++.+||..+|++||++.++++
T Consensus       210 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      210 EWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             cccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            0014478999999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-37  Score=287.22  Aligned_cols=235  Identities=25%  Similarity=0.384  Sum_probs=180.7

Q ss_pred             CCCCCccccCCCce-EEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----------EEEEecc
Q 038681           56 YDEQNIVLEDPFRK-LYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----------IVFESVQ  122 (332)
Q Consensus        56 y~~~~~lg~G~~g~-Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv~e~~~  122 (332)
                      |...+.+|.|+.|+ ||+|.+.|+.||||++....    ...+.+|+..|..- .|||||++           |..|.|.
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~  586 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA  586 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence            45566789999886 89999999999999987553    56688999999998 69999998           8899997


Q ss_pred             CCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC---C--CCeEEeecCCcccc
Q 038681          123 IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE---Q--SDAKLFDFSLSLSI  197 (332)
Q Consensus       123 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~--~~~kl~Dfg~a~~~  197 (332)
                      . +|.+++... ............+.++.|+++||++||   +.+||||||||.||||+.   +  ..++|+|||+++.+
T Consensus       587 ~-sL~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  587 C-SLQDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             h-hHHHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence            5 999999874 111111222456789999999999999   999999999999999975   3  46899999999988


Q ss_pred             CCCCcee-eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhC-CccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          198 PDGETHI-ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTA-QEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       198 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ..+.... ...+..||-+|+|||++.. .-+.++||||+||++|..++| ..||......+.       ..+.+ ...+.
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-------NIl~~-~~~L~  733 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-------NILTG-NYTLV  733 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-------hhhcC-cccee
Confidence            7655332 2356789999999999987 677799999999999999986 889976433211       11111 11111


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .+.             ...++  ++.+||.+|+++||..||+|.+|+.
T Consensus       734 ~L~-------------~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  734 HLE-------------PLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             eec-------------cCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            000             00122  7899999999999999999999974

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=256.44  Aligned_cols=255  Identities=18%  Similarity=0.244  Sum_probs=193.2

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE----------------
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL----------------  115 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~----------------  115 (332)
                      +.+..+.||-|+||.||.+++  +|+.||.|++.... +-.+.+++.+|+++|..++|.|++..                
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            456788999999999999999  89999999987653 33446789999999999999999875                


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      .++|.+.. +|...+-..     ..++...++-++.||+.||.|||   +.+|.||||||.|.|++.|..+||||||+++
T Consensus       134 V~TELmQS-DLHKIIVSP-----Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLAR  204 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVSP-----QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLAR  204 (449)
T ss_pred             HHHHHHHh-hhhheeccC-----CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEeccccccc
Confidence            35566643 677666543     67999999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      ..+.+..... +..+-|..|+|||++.+  .|+.+.||||.||++.||+..+-.|....+.+...   ++..+.+ .+..
T Consensus       205 vee~d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~---lItdLLG-TPs~  279 (449)
T KOG0664|consen  205 TWDQRDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQ---MIIDLLG-TPSQ  279 (449)
T ss_pred             ccchhhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHH---HHHHHhC-CCcH
Confidence            8766544322 44567899999999998  89999999999999999999999998766654433   3322222 1111


Q ss_pred             hhhh-------hhhhhcccCC-------CCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          274 KEMV-------DSIIIEDKSC-------TCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       274 ~~~~-------~~~~~~~~~~-------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                      ..+.       ...+......       ....+.....+...++..++..||.+|.+..+.+..
T Consensus       280 EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~  343 (449)
T KOG0664|consen  280 EAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH  343 (449)
T ss_pred             HHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence            1111       1111111100       111222344567788999999999999998887653

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-36  Score=271.58  Aligned_cols=231  Identities=19%  Similarity=0.273  Sum_probs=193.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCee--EEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFWQKRS--ISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~--vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      ..++.....||-||||.|=++..++..  +|+|++++..  +....+.+..|-.+|..++.|.||++           +.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            455677788999999999999884443  7888877653  23446778999999999999999997           78


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      ||-|-||.|...++.+     +.++...+..++..+++|++|||   ++|||.|||||+|.+++.+|-+||.|||+|+.+
T Consensus       499 mEaClGGElWTiLrdR-----g~Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki  570 (732)
T KOG0614|consen  499 MEACLGGELWTILRDR-----GSFDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKI  570 (732)
T ss_pred             HHhhcCchhhhhhhhc-----CCcccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeeccCCceEEeehhhHHHh
Confidence            9999999999999987     78999999999999999999999   999999999999999999999999999999998


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ..+...   -+++|||.|.|||++.+ ..+.++|.||||+++|||++|.+||.+.+.....+.     .+.+        
T Consensus       571 ~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~-----ILkG--------  634 (732)
T KOG0614|consen  571 GSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNL-----ILKG--------  634 (732)
T ss_pred             ccCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHH-----HHhh--------
Confidence            887755   57899999999999987 889999999999999999999999998876544221     1111        


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT  316 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs  316 (332)
                      +|         ....+........+|+++....+|.+|.-
T Consensus       635 id---------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  635 ID---------KIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             hh---------hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence            00         11122345577889999999999999964

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-36  Score=239.31  Aligned_cols=197  Identities=17%  Similarity=0.254  Sum_probs=168.1

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE---------
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL---------  115 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~---------  115 (332)
                      .++...+....+..||+|++|.|=+-++  +|...|+|.+...-+.....+.++|+.+..+. ..|.+|.|         
T Consensus        40 ~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd  119 (282)
T KOG0984|consen   40 NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD  119 (282)
T ss_pred             ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence            3556666677788999999999988887  89999999999887766678889999987776 68999998         


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        |.||.+.- +|..+..+-...+ ..+++..+-+|+..+..||.|||+  ...++|||+||+||||+.+|++|+||||.
T Consensus       120 vwIcME~M~t-Sldkfy~~v~~~g-~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGI  195 (282)
T KOG0984|consen  120 VWICMELMDT-SLDKFYRKVLKKG-GTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGI  195 (282)
T ss_pred             EEEeHHHhhh-hHHHHHHHHHhcC-CcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEccccc
Confidence              89999864 7877766543332 679999999999999999999996  78999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccccCCCcccccccCC-----CCChhhhHHHHHHHHHHHHhCCccCCCC
Q 038681          194 SLSIPDGETHIELDSVVGTTGFIAPENFTT-----LINEQCDVYGFGAFLFELLTAQEVSDHV  251 (332)
Q Consensus       194 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~sDiwSlG~~l~elltg~~p~~~~  251 (332)
                      +..+.++-..   +-..|...|||||.+..     .|+.+|||||||+++.||.+++.||+..
T Consensus       196 sG~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  196 SGYLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             ceeehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            9887765432   23568899999998863     6889999999999999999999999754

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.1e-34  Score=269.84  Aligned_cols=256  Identities=15%  Similarity=0.211  Sum_probs=174.2

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe------------------CCeeEEEEEEcCCCChh-------------hHHHHHHH
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW------------------QKRSISLMKYNGNRNQH-------------ALEWCINH  100 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~------------------~~~~vavK~~~~~~~~~-------------~~~~~~~E  100 (332)
                      ..++|++.++||+|+||.||+|..                  .++.||||++.......             ..+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            467899999999999999999964                  34579999987543221             11233457


Q ss_pred             HHHHHhhcCCCcc------------------------eEEEEEeccCCChHHHHhhhhcc-------------------c
Q 038681          101 IVYASRMSHKHII------------------------KLIVFESVQIGTLADRIHHHCEQ-------------------H  137 (332)
Q Consensus       101 ~~~l~~l~H~nIv------------------------~~lv~e~~~~g~L~~~l~~~~~~-------------------~  137 (332)
                      +.++.+++|.+++                        .+||+||+++|+|.+++......                   .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            7778888776551                        23999999999999998753110                   0


Q ss_pred             ccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCccc
Q 038681          138 FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIA  217 (332)
Q Consensus       138 ~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  217 (332)
                      ...+++..++.++.|++.||.|||   ..+|+||||||+|||++.++.+||+|||++........... ....+|+.|+|
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~-~~g~~tp~Y~a  378 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNP-LYGMLDPRYSP  378 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCc-cccCCCcceeC
Confidence            123567889999999999999999   99999999999999999999999999999976543322111 22345889999


Q ss_pred             ccccCC-C--------------------C--ChhhhHHHHHHHHHHHHhCCc-cCCCCCccchhhhHHHHhhhhccccch
Q 038681          218 PENFTT-L--------------------I--NEQCDVYGFGAFLFELLTAQE-VSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       218 PE~~~~-~--------------------~--~~~sDiwSlG~~l~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      ||.+.. .                    +  ..+.||||+||++|+|++|.. ||.........     ..........+
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-----~~~~~~~~~~~  453 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-----LRQYDNDLNRW  453 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-----HhhccchHHHH
Confidence            998753 1                    1  124699999999999999875 66432211100     00000000000


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCC---CCCCCHHHHHH
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSP---EDRPTMVDVAK  322 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP---~~RPs~~evl~  322 (332)
                      ...      .............+....+|+.+||..+|   .+|+|++|+++
T Consensus       454 r~~------~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        454 RMY------KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             Hhh------cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            000      00000111112345789999999999866   68999999985

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-35  Score=258.45  Aligned_cols=121  Identities=21%  Similarity=0.345  Sum_probs=104.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-----CC---CcceE-------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS-----HK---HIIKL-------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----H~---nIv~~-------  115 (332)
                      .++|.+.++||.|.|++||+|.+  ..+.||+|+.+...  ...+..+.||++|++++     |+   +||++       
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs  154 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS  154 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence            36799999999999999999999  77889999998763  33577899999999984     33   48887       


Q ss_pred             --------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeC
Q 038681          116 --------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN  181 (332)
Q Consensus       116 --------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  181 (332)
                              +|+|++ |-+|..+|...   ....++...+++|++||+.||.|||.  ..||+|-||||+|||+.
T Consensus       155 GpNG~HVCMVfEvL-GdnLLklI~~s---~YrGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  155 GPNGQHVCMVFEVL-GDNLLKLIKYS---NYRGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCCcEEEEEehhh-hhHHHHHHHHh---CCCCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeee
Confidence                    899998 55899998865   23679999999999999999999997  78999999999999983

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-35  Score=251.24  Aligned_cols=237  Identities=17%  Similarity=0.292  Sum_probs=189.9

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCC--CChhhHHHHHHHHHHHHhh-cCCCcceE-----------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGN--RNQHALEWCINHIVYASRM-SHKHIIKL-----------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------  115 (332)
                      ..++|...+.||+|+|+.|..+++  +.+.+|+|++++.  +..+.+...+.|-.++.+. +||.+|-+           
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            356799999999999999999999  8889999998865  3334477888898888887 79999976           


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      +|.||++||+|.-.+.+.     ..+|++.+..+...|+.||.|||   +.||+.||||.+|+|+|..|.+||+|+|+++
T Consensus       328 fvieyv~ggdlmfhmqrq-----rklpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmck  399 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK  399 (593)
T ss_pred             EEEEEecCcceeeehhhh-----hcCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhh
Confidence            899999999999888776     67999999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      .--.+...  .++++|||.|.|||++.+ .|+..+|.|+||++++||+.|+.||+.........             +-.
T Consensus       400 e~l~~gd~--tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~-------------nte  464 (593)
T KOG0695|consen  400 EGLGPGDT--TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDM-------------NTE  464 (593)
T ss_pred             cCCCCCcc--cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCccc-------------chh
Confidence            65443332  267899999999999999 99999999999999999999999998554221111             111


Q ss_pred             hhhhhhhh-cccCCCCCChHHHHHHHHHHHHHcccCCCCCCC
Q 038681          275 EMVDSIII-EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP  315 (332)
Q Consensus       275 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP  315 (332)
                      +.+=+.+. .....    +...+.....+++.-|+.||.+|.
T Consensus       465 dylfqvilekqiri----prslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  465 DYLFQVILEKQIRI----PRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             HHHHHHHhhhcccc----cceeehhhHHHHHHhhcCCcHHhc
Confidence            11111111 11111    112335566788899999999984

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=245.71  Aligned_cols=252  Identities=19%  Similarity=0.272  Sum_probs=193.8

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCC-CChhhHHHHHHHHHHHHhhcCCCcceE---------------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGN-RNQHALEWCINHIVYASRMSHKHIIKL---------------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~H~nIv~~---------------  115 (332)
                      .+|.-...+|.|.- .|-.+.+  .+++||+|+.... .+....++..+|..++..++|+||+++               
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45777888999988 7777777  8999999997654 223346788999999999999999997               


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        +|||++. ++|.+.+...       ++-..+..++.|++.|+.|||   +.||+||||||+||++..++.+||.|||+
T Consensus        96 ~y~v~e~m~-~nl~~vi~~e-------lDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~  164 (369)
T KOG0665|consen   96 VYLVMELMD-ANLCQVILME-------LDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGL  164 (369)
T ss_pred             HHHHHHhhh-hHHHHHHHHh-------cchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchh
Confidence              7999996 4999998743       788889999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          194 SLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       194 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      |+.-...-   ..+..+.|..|.|||++.+ .+.+.+||||+||++.||++|+..|.+...-+  ++......+......
T Consensus       165 ar~e~~~~---~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~id--Q~~ki~~~lgtpd~~  239 (369)
T KOG0665|consen  165 ARTEDTDF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHID--QWNKIIEQLGTPDPS  239 (369)
T ss_pred             hcccCccc---ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHH--HHHHHHHHhcCCCHH
Confidence            97655441   2256688999999999998 89999999999999999999999998654332  233333333333333


Q ss_pred             hhhhhhhhhhc-----------c---------cCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          273 FKEMVDSIIIE-----------D---------KSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       273 ~~~~~~~~~~~-----------~---------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      +.+-+.+....           .         .+.....++-....+.+++.+||..||++|.|+.++|+
T Consensus       240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence            32222111100           0         00111112234467889999999999999999999985

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-34  Score=263.89  Aligned_cols=219  Identities=16%  Similarity=0.260  Sum_probs=175.1

Q ss_pred             HHHHHHHHhcCCCCCCcccccHHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHH
Q 038681           25 RLLKELIASSNGKYNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINH  100 (332)
Q Consensus        25 ~~~~~~~~s~~~~~~~~~~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E  100 (332)
                      ..|+.++-..++.+.-++.-.+     ..+-|..++.||-|+||.|.++.-  +...+|.|.+.+..-  .........|
T Consensus       605 ~qMrkmL~QKESnYiRLkRaKM-----dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAE  679 (1034)
T KOG0608|consen  605 NQMRKMLQQKESNYIRLKRAKM-----DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAE  679 (1034)
T ss_pred             HHHHHHHHhhhhhHHHHHHhhc-----cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhh
Confidence            3444555444444433222222     234488899999999999999987  677789998876532  2234557789


Q ss_pred             HHHHHhhcCCCcceE-----------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 038681          101 IVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIV  169 (332)
Q Consensus       101 ~~~l~~l~H~nIv~~-----------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  169 (332)
                      -.||...+++-||++           +||+|++||++..+|.+.     +.+++..+..++..+..|+++.|   ..|+|
T Consensus       680 RDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrm-----gIFeE~LARFYIAEltcAiesVH---kmGFI  751 (1034)
T KOG0608|consen  680 RDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM-----GIFEEDLARFYIAELTCAIESVH---KMGFI  751 (1034)
T ss_pred             hhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHh-----ccCHHHHHHHHHHHHHHHHHHHH---hccce
Confidence            999999999999998           899999999999999887     78999999999999999999999   99999


Q ss_pred             ecCCCCCCeeeCCCCCeEEeecCCccccC---------CCC-------------------------------ceeecccc
Q 038681          170 YRDMKPTNILFNEQSDAKLFDFSLSLSIP---------DGE-------------------------------THIELDSV  209 (332)
Q Consensus       170 H~Dlkp~Nill~~~~~~kl~Dfg~a~~~~---------~~~-------------------------------~~~~~~~~  209 (332)
                      ||||||+|||||.+|.+||.|||++.-+.         .+.                               ........
T Consensus       752 HRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahsl  831 (1034)
T KOG0608|consen  752 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSL  831 (1034)
T ss_pred             ecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhh
Confidence            99999999999999999999999985431         000                               00011346


Q ss_pred             ccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccch
Q 038681          210 VGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESR  256 (332)
Q Consensus       210 ~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~  256 (332)
                      +||+.|+|||++.. .|+..+|.||.|||||||+.|+.||-.....+.
T Consensus       832 vgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~t  879 (1034)
T KOG0608|consen  832 VGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGET  879 (1034)
T ss_pred             cCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence            79999999999987 899999999999999999999999977665543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-35  Score=267.72  Aligned_cols=240  Identities=22%  Similarity=0.265  Sum_probs=198.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|+....+|.|+||.||++++  +++..|+|.++.....+ ..-.++|+-+++..+|||||.+           |+||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd-~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD-FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc-ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            45799999999999999999999  89999999998876655 6778899999999999999987           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      ||.+|+|.+..+-.     +++++.++...++..+.||+|||   +.|-+|||||-.|||+++.|.+|++|||.+..+..
T Consensus        93 ycgggslQdiy~~T-----gplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVT-----GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             ecCCCcccceeeec-----ccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhh
Confidence            99999999988876     78999999999999999999999   99999999999999999999999999999866544


Q ss_pred             CCceeeccccccCCCcccccccC----CCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFT----TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      .-.  ....+.||+.|||||+..    +.|+..+|||++|++..|+---++|-..........   +...          
T Consensus       165 ti~--KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~---LmTk----------  229 (829)
T KOG0576|consen  165 TIA--KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF---LMTK----------  229 (829)
T ss_pred             hhh--hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH---Hhhc----------
Confidence            322  225789999999999863    489999999999999999988887765443322211   0000          


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                            ..-.++.......+++.+.+|++.||..+|++|||++.++.
T Consensus       230 ------S~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  230 ------SGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ------cCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence                  00011122233467788999999999999999999988765

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-34  Score=235.46  Aligned_cols=243  Identities=22%  Similarity=0.261  Sum_probs=191.1

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE------------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL------------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~------------lv~  118 (332)
                      +.|.+.+.||+|.||.+-++++  .+..+++|.+......  ...|.+|...--.| .|.||+.-            +++
T Consensus        24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt--~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT--QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh--HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            4599999999999999999999  6778899988776433  67899999887777 48999864            899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeC--CCCCeEEeecCCccc
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN--EQSDAKLFDFSLSLS  196 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~Dfg~a~~  196 (332)
                      ||+|.|+|..-+...      .+-+.....++.|+++|+.|||   +.++||||||.+||||-  +...+||||||+++.
T Consensus       102 E~aP~gdL~snv~~~------GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k  172 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAA------GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADFYRVKLCDFGLTRK  172 (378)
T ss_pred             ccCccchhhhhcCcc------cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCccEEEeeecccccc
Confidence            999999999888653      5888999999999999999999   99999999999999982  345799999999876


Q ss_pred             cCCCCceeeccccccCCCcccccccCC------CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT------LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      ......     ....+..|.+||.+..      ...+.+|||.||+++|.++||+.||...... ...+.....|.....
T Consensus       173 ~g~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~-d~~Y~~~~~w~~rk~  246 (378)
T KOG1345|consen  173 VGTTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM-DKPYWEWEQWLKRKN  246 (378)
T ss_pred             cCceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc-CchHHHHHHHhcccC
Confidence            544321     2334678999997753      4577899999999999999999999844333 334455666666655


Q ss_pred             cchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 038681          271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY  328 (332)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~  328 (332)
                      ...+..+.               ..++.+..+.++-|..+|++|--..++.+.-..++
T Consensus       247 ~~~P~~F~---------------~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w  289 (378)
T KOG1345|consen  247 PALPKKFN---------------PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW  289 (378)
T ss_pred             ccCchhhc---------------ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence            55555444               23367888999999999999965555555544444

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.7e-33  Score=251.66  Aligned_cols=255  Identities=18%  Similarity=0.221  Sum_probs=194.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcC------CCcceE---------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSH------KHIIKL---------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H------~nIv~~---------  115 (332)
                      .+.|.+....|+|-||+|.+|.+  .|..||||++.....  ..+.-+.|+++|++|+.      -|++++         
T Consensus       431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~--M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV--MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH--HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            45688888899999999999999  788999999987633  34556889999999852      356655         


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC-CCeEEeecC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ-SDAKLFDFS  192 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg  192 (332)
                        ||+|-+. .+|.++|......  ..|....+..++.|+.-||..|-   ..||+|.||||+|||+.+. ..+||||||
T Consensus       509 LClVFE~Ls-lNLRevLKKyG~n--vGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  509 LCLVFEPLS-LNLREVLKKYGRN--VGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             eEEEehhhh-chHHHHHHHhCcc--cceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCc
Confidence              8999885 5999999987432  45888999999999999999999   9999999999999999865 457999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc-
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN-  270 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  270 (332)
                      .|.....+..    +....+..|.|||++.| +|+...|+||+||+||||.||+..|++........   +...+.+.. 
T Consensus       583 SA~~~~enei----tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLr---l~me~KGk~p  655 (752)
T KOG0670|consen  583 SASFASENEI----TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLR---LFMELKGKFP  655 (752)
T ss_pred             cccccccccc----cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHH---HHHHhcCCCc
Confidence            9988776654    34567889999999999 99999999999999999999999999877654332   111111110 


Q ss_pred             -------cchhhhhhhhhh-----------cc--------c------------CCCCCChHHHHHHHHHHHHHcccCCCC
Q 038681          271 -------CRFKEMVDSIII-----------ED--------K------------SCTCTGKEQQLQAFKQLTLQCMDFSPE  312 (332)
Q Consensus       271 -------~~~~~~~~~~~~-----------~~--------~------------~~~~~~~~~~~~~~~~li~~cl~~dP~  312 (332)
                             ......+|..+.           ..        .            +...........++.+|+..||..||+
T Consensus       656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~  735 (752)
T KOG0670|consen  656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE  735 (752)
T ss_pred             HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence                   001111111110           00        0            001112245677899999999999999


Q ss_pred             CCCCHHHHHH
Q 038681          313 DRPTMVDVAK  322 (332)
Q Consensus       313 ~RPs~~evl~  322 (332)
                      +|.|..+.|.
T Consensus       736 KRit~nqAL~  745 (752)
T KOG0670|consen  736 KRITVNQALK  745 (752)
T ss_pred             hcCCHHHHhc
Confidence            9999999875

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=3.3e-31  Score=222.71  Aligned_cols=198  Identities=28%  Similarity=0.502  Sum_probs=172.7

Q ss_pred             cccCCCceEEEEEeC--CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCCChHH
Q 038681           62 VLEDPFRKLYKGFWQ--KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLAD  128 (332)
Q Consensus        62 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g~L~~  128 (332)
                      ||+|++|.||++...  +..+++|.+.........+.+.+|+..+..++|++|+++           +++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999994  899999999887654345779999999999999999987           8999999999999


Q ss_pred             HHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC-CCCeEEeecCCccccCCCCceeecc
Q 038681          129 RIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE-QSDAKLFDFSLSLSIPDGETHIELD  207 (332)
Q Consensus       129 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~  207 (332)
                      ++....    ..+++..+..++.+++.+|.+||   ..+++|+||+|.||+++. ++.++|+|||.+........  ...
T Consensus        81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~  151 (215)
T cd00180          81 LLKENE----GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLK  151 (215)
T ss_pred             HHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhh
Confidence            987641    35899999999999999999999   899999999999999999 89999999999977655431  113


Q ss_pred             ccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhccc
Q 038681          208 SVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDK  285 (332)
Q Consensus       208 ~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  285 (332)
                      ...++..|++||.+..  .++.++|+||+|++++++                                            
T Consensus       152 ~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------  187 (215)
T cd00180         152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------  187 (215)
T ss_pred             cccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------------
Confidence            4567889999999876  778899999999999999                                            


Q ss_pred             CCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          286 SCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       286 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                                 ..+.+++..|++.||++||++.++++.
T Consensus       188 -----------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -----------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -----------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                       136789999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-32  Score=246.43  Aligned_cols=186  Identities=20%  Similarity=0.293  Sum_probs=160.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-------hhhHHHHHHHHHHHHhhc---CCCcceE-----
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-------QHALEWCINHIVYASRMS---HKHIIKL-----  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~---H~nIv~~-----  115 (332)
                      ..+|...+.+|+|+||.|+.|.+  +...|+||.+.+..-       ...+..+-.||+||..|+   |+||+++     
T Consensus       560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE  639 (772)
T KOG1152|consen  560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE  639 (772)
T ss_pred             cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence            34588999999999999999999  667788998876532       111334678999999997   9999998     


Q ss_pred             ------EEEEe-ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEE
Q 038681          116 ------IVFES-VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKL  188 (332)
Q Consensus       116 ------lv~e~-~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  188 (332)
                            |+||- -++-+|.++|..+     ..+++.++..|+.|++.|+++||   +.||||||||-+|+.++.+|-+||
T Consensus       640 ddd~yyl~te~hg~gIDLFd~IE~k-----p~m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~kl  711 (772)
T KOG1152|consen  640 DDDYYYLETEVHGEGIDLFDFIEFK-----PRMDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKL  711 (772)
T ss_pred             cCCeeEEEecCCCCCcchhhhhhcc-----CccchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEE
Confidence                  66665 3466899999887     67999999999999999999999   999999999999999999999999


Q ss_pred             eecCCccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCC
Q 038681          189 FDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDH  250 (332)
Q Consensus       189 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~  250 (332)
                      +|||.|.....+..    ..++||..|+|||++.+  ..+..-|||++|++||-++....||..
T Consensus       712 idfgsaa~~ksgpf----d~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  712 IDFGSAAYTKSGPF----DVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             eeccchhhhcCCCc----ceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            99999977766543    57899999999999998  558889999999999999999999863

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.5e-30  Score=220.41  Aligned_cols=186  Identities=29%  Similarity=0.377  Sum_probs=161.5

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEecc
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQ  122 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~  122 (332)
                      |...+.||.|++|.||+|..  ++..+++|.+.........+.+.+|+..+.+++|+|++++           +++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            56778999999999999999  4789999999876544246789999999999999999986           8999999


Q ss_pred             CCChHHHHhhhhcccccC-CCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCC
Q 038681          123 IGTLADRIHHHCEQHFEA-LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE  201 (332)
Q Consensus       123 ~g~L~~~l~~~~~~~~~~-l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  201 (332)
                      +++|.+++...     .. +++..+..++.+++.+|.+||   ..+++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~L~~~~~~~-----~~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~  152 (225)
T smart00221       81 GGDLFDYLRKK-----GGKLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL  152 (225)
T ss_pred             CCCHHHHHHhc-----ccCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc
Confidence            99999999875     23 889999999999999999999   8999999999999999999999999999998776543


Q ss_pred             ceeeccccccCCCccccccc-CC-CCChhhhHHHHHHHHHHHHhCCccCCC
Q 038681          202 THIELDSVVGTTGFIAPENF-TT-LINEQCDVYGFGAFLFELLTAQEVSDH  250 (332)
Q Consensus       202 ~~~~~~~~~gt~~y~aPE~~-~~-~~~~~sDiwSlG~~l~elltg~~p~~~  250 (332)
                      .. ......++..|++||.+ .. .++.++||||||+++++|++|+.||..
T Consensus       153 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      153 AA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            11 11345678899999998 44 778899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=2.2e-31  Score=233.28  Aligned_cols=257  Identities=24%  Similarity=0.298  Sum_probs=187.0

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe-----CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-CCCcceE---------
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW-----QKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKL---------  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~~---------  115 (332)
                      ...+.|...++||+|+|++||++.+     ..+.||+|.+......   .++.+|++.|..+. +.||+++         
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p---~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP---SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc---hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            3456699999999999999999988     3578999999887654   56899999999994 8888887         


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC-CCeEEeecC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ-SDAKLFDFS  192 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg  192 (332)
                        +|+||+++-+..++...        ++..++..+++.++.||.++|   .+|||||||||+|+|.+.. +.-.|.|||
T Consensus       110 v~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             eEEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEech
Confidence              89999999999988853        778999999999999999999   9999999999999999754 567899999


Q ss_pred             CccccCCC---------------------------------Cc---------eeeccccccCCCcccccccCC--CCChh
Q 038681          193 LSLSIPDG---------------------------------ET---------HIELDSVVGTTGFIAPENFTT--LINEQ  228 (332)
Q Consensus       193 ~a~~~~~~---------------------------------~~---------~~~~~~~~gt~~y~aPE~~~~--~~~~~  228 (332)
                      +|......                                 ..         ........||++|+|||++..  ..+++
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            98621100                                 00         000123569999999999986  78899


Q ss_pred             hhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhh-----------cc--------ccchhhhhhhhhhc----cc
Q 038681          229 CDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS-----------GQ--------NCRFKEMVDSIIIE----DK  285 (332)
Q Consensus       229 sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------~~--------~~~~~~~~~~~~~~----~~  285 (332)
                      +||||.|+|+.-++++..||.....+-... ..+...+.           +.        .+.+.+........    -.
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~al-~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~  337 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADAL-AEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY  337 (418)
T ss_pred             cceeeccceeehhhccccccccCccccchH-HHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence            999999999999999999997554432211 11111000           00        00111111111000    00


Q ss_pred             C-----C-CCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          286 S-----C-TCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       286 ~-----~-~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .     . ........+..+.+|+.+||+.||.+|.||++.|+
T Consensus       338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk  380 (418)
T KOG1167|consen  338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK  380 (418)
T ss_pred             cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence            0     0 11111233457899999999999999999999875

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=5e-30  Score=211.05  Aligned_cols=169  Identities=20%  Similarity=0.222  Sum_probs=127.3

Q ss_pred             CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCce
Q 038681          124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH  203 (332)
Q Consensus       124 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  203 (332)
                      |+|.+++....    ..+++..++.++.||+.||.|||   +.+      ||+|||++.++.+++  ||++.......  
T Consensus         1 GsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~lH---~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~--   63 (176)
T smart00750        1 VSLADILEVRG----RPLNEEEIWAVCLQCLRALRELH---RQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ--   63 (176)
T ss_pred             CcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH---hcC------CcccEeEcCccceee--ccceEeecccc--
Confidence            68999997641    46999999999999999999999   666      999999999999999  99987654422  


Q ss_pred             eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhh
Q 038681          204 IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIII  282 (332)
Q Consensus       204 ~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (332)
                           ..||+.|+|||++.+ .++.++|||||||++|||++|..||.........     ...+          ......
T Consensus        64 -----~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~-----~~~~----------~~~~~~  123 (176)
T smart00750       64 -----SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI-----LEIL----------LNGMPA  123 (176)
T ss_pred             -----CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH-----HHHH----------HHHhcc
Confidence                 258899999999987 8999999999999999999999999654321110     0000          000000


Q ss_pred             cccCCCCCChHHHHH--HHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          283 EDKSCTCTGKEQQLQ--AFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~--~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                       ..............  .+.+++.+||..||.+|||+.++++.+..+..+
T Consensus       124 -~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~~  172 (176)
T smart00750      124 -DDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFAE  172 (176)
T ss_pred             -CCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHHH
Confidence             00000011122333  699999999999999999999999988777543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=1e-29  Score=254.51  Aligned_cols=174  Identities=17%  Similarity=0.184  Sum_probs=123.3

Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC------------
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ------------  183 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~------------  183 (332)
                      .++||+ +++|.+++...    ...+++.+++.++.||+.||.|||   ++||+||||||+|||++..            
T Consensus        57 ~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~  128 (793)
T PLN00181         57 RALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAH---SQGIVVHNVRPSCFVMSSFNHVSFIESASCS  128 (793)
T ss_pred             hhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHH---hCCeeeccCCchhEEEcccCcEEEeeccccC
Confidence            567877 56999999753    146999999999999999999999   9999999999999999654            


Q ss_pred             -------CCeEEeecCCccccCCCCc--------------eeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHH
Q 038681          184 -------SDAKLFDFSLSLSIPDGET--------------HIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFEL  241 (332)
Q Consensus       184 -------~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~el  241 (332)
                             +.+|++|||+++.......              ........||+.|+|||++.+ .++.++|||||||+||||
T Consensus       129 ~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~EL  208 (793)
T PLN00181        129 DSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFEL  208 (793)
T ss_pred             cccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHH
Confidence                   4456666666653211000              000012357899999999887 899999999999999999


Q ss_pred             HhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 038681          242 LTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVA  321 (332)
Q Consensus       242 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl  321 (332)
                      ++|..|+.....        ....+..      ....+.           .........+++.+||+.||.+|||+.|++
T Consensus       209 l~~~~~~~~~~~--------~~~~~~~------~~~~~~-----------~~~~~~~~~~~~~~~L~~~P~~Rps~~eil  263 (793)
T PLN00181        209 FCPVSSREEKSR--------TMSSLRH------RVLPPQ-----------ILLNWPKEASFCLWLLHPEPSCRPSMSELL  263 (793)
T ss_pred             hhCCCchhhHHH--------HHHHHHH------hhcChh-----------hhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence            998887653211        0000000      000000           001124456889999999999999999997


Q ss_pred             H
Q 038681          322 K  322 (332)
Q Consensus       322 ~  322 (332)
                      +
T Consensus       264 ~  264 (793)
T PLN00181        264 Q  264 (793)
T ss_pred             h
Confidence            5

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=7.3e-28  Score=217.03  Aligned_cols=163  Identities=16%  Similarity=0.197  Sum_probs=129.2

Q ss_pred             HHHHHHHhcCCCCCCccccCCCceEEEEEe---CCeeEEEEEEcCCC----ChhhHHHHHHHHHHHHhhcCCCcce-E--
Q 038681           46 AEELRIATNNYDEQNIVLEDPFRKLYKGFW---QKRSISLMKYNGNR----NQHALEWCINHIVYASRMSHKHIIK-L--  115 (332)
Q Consensus        46 ~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~H~nIv~-~--  115 (332)
                      .+.+....++|.+.+.||+|+||+||+|.+   ++..||||+.....    .....+.+.+|+.+|.+++|+||+. +  
T Consensus        10 ~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~   89 (365)
T PRK09188         10 GDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA   89 (365)
T ss_pred             ccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE
Confidence            344556678899999999999999999988   46778999875431    2333567999999999999999984 3  


Q ss_pred             -----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCCCeeeCCCCCeEEe
Q 038681          116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM-KPTNILFNEQSDAKLF  189 (332)
Q Consensus       116 -----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~  189 (332)
                           |||||++|++|.. +..        ..   ...++.|+++||.|||   ++||+|||| ||+|||++.++.+||+
T Consensus        90 ~~~~~LVmE~~~G~~L~~-~~~--------~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLi  154 (365)
T PRK09188         90 TGKDGLVRGWTEGVPLHL-ARP--------HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVI  154 (365)
T ss_pred             cCCcEEEEEccCCCCHHH-hCc--------cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEE
Confidence                 9999999999963 211        11   1467899999999999   999999999 9999999999999999


Q ss_pred             ecCCccccCCCCceee------ccccccCCCcccccccCC
Q 038681          190 DFSLSLSIPDGETHIE------LDSVVGTTGFIAPENFTT  223 (332)
Q Consensus       190 Dfg~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~  223 (332)
                      |||+|+.+........      .....+++.|+|||.+..
T Consensus       155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9999987755432211      134568889999999863

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=1.2e-27  Score=229.00  Aligned_cols=242  Identities=15%  Similarity=0.160  Sum_probs=180.3

Q ss_pred             CCCCccccCCCceEEEEEe--CCeeEEEEEEc----CCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           57 DEQNIVLEDPFRKLYKGFW--QKRSISLMKYN----GNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        57 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~----~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      .....+|.|++|.|+....  .....+.|.+.    .... ......+..|+-+-..+.|||++..           -+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            4578899999998887776  44444444432    2222 2222236778888888999998876           368


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      |||++ +|..++...     ..+...++-.++.|++.|+.|||   ..||.|||+||+|++++.+|.+||+|||.+..+.
T Consensus       401 E~~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFR  471 (601)
T ss_pred             hcccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHH---hcCceeccCccccEEEecCCceEEeecCcceeec
Confidence            99999 999999875     46889999999999999999999   9999999999999999999999999999997665


Q ss_pred             CCCce--eeccccccCCCcccccccCC-CCC-hhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          199 DGETH--IELDSVVGTTGFIAPENFTT-LIN-EQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       199 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~-~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      .+...  ......+|+.+|+|||++.+ .|. ...||||.|++++.|.+|+.||......+....    ...........
T Consensus       472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~----~~~~~~~~~~~  547 (601)
T KOG0590|consen  472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK----TNNYSDQRNIF  547 (601)
T ss_pred             cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh----hhccccccccc
Confidence            44432  33467889999999999988 665 478999999999999999999976655433210    00000000000


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .-           +.......+..-..+|.+||+.||.+|.|+++|++
T Consensus       548 ~~-----------~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  548 EG-----------PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cC-----------hHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            00           00011244467789999999999999999999986

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.4e-27  Score=197.31  Aligned_cols=238  Identities=19%  Similarity=0.253  Sum_probs=184.5

Q ss_pred             CCCCCccccCCCceEEEEEeCCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccC
Q 038681           56 YDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQI  123 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~  123 (332)
                      .....+|.+...|..|+|+|.|..+++|++.... +....+.|..|.-.|+-+.||||+.+           ++..|+|.
T Consensus       192 lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~  271 (448)
T KOG0195|consen  192 LNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPF  271 (448)
T ss_pred             hhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccc
Confidence            3456678999999999999999988888876543 33445678999999999999999987           89999999


Q ss_pred             CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEe--ecCCccccCCCC
Q 038681          124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLF--DFSLSLSIPDGE  201 (332)
Q Consensus       124 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~--Dfg~a~~~~~~~  201 (332)
                      |+|+..++....   -.++..++.+++.+++.|++|||+- ..-|.---|....++||++.+++|+  |--++...    
T Consensus       272 gslynvlhe~t~---vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe----  343 (448)
T KOG0195|consen  272 GSLYNVLHEQTS---VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE----  343 (448)
T ss_pred             hHHHHHHhcCcc---EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeec----
Confidence            999999987632   4578899999999999999999964 3445556799999999999887764  33222111    


Q ss_pred             ceeeccccccCCCcccccccCC----CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          202 THIELDSVVGTTGFIAPENFTT----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       202 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                           ....-++.||+||.++.    .--.++|+|||++++|||.|...||...+..+.....    .+.+         
T Consensus       344 -----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki----aleg---------  405 (448)
T KOG0195|consen  344 -----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI----ALEG---------  405 (448)
T ss_pred             -----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh----hhcc---------
Confidence                 22345789999999986    2345899999999999999999999987765542210    0111         


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY  328 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~  328 (332)
                               .+...++..+.....|+.-|++.||.+||.++.|+-.|+++.
T Consensus       406 ---------lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  406 ---------LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ---------ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                     112223355578889999999999999999999999999874

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=8.7e-25  Score=196.90  Aligned_cols=249  Identities=17%  Similarity=0.166  Sum_probs=182.7

Q ss_pred             CCCCCCccccCCCceEEEEEeCC---eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcC----CCcce------------E
Q 038681           55 NYDEQNIVLEDPFRKLYKGFWQK---RSISLMKYNGNRNQHALEWCINHIVYASRMSH----KHIIK------------L  115 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~------------~  115 (332)
                      +|.+.++||+|+||.||.|....   ..+|+|........... .+..|..++..+..    +++..            +
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~   97 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNF   97 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeE
Confidence            79999999999999999999822   46888887765433322 67788888888862    23333            3


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC-----CCeEEee
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ-----SDAKLFD  190 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-----~~~kl~D  190 (332)
                      |||+.+ |.+|.++.....   ...++...++.++.|++.+|.+||   +.|++||||||+|++++..     ..+.|.|
T Consensus        98 iVM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   98 IVMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             EEEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence            899988 679999886552   257999999999999999999999   9999999999999999865     4689999


Q ss_pred             cCCcc--ccCCCCc----eee--ccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHH
Q 038681          191 FSLSL--SIPDGET----HIE--LDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEE  261 (332)
Q Consensus       191 fg~a~--~~~~~~~----~~~--~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~  261 (332)
                      ||+++  .......    ...  ...+.||..|+++.+..+ ..+.+.|+||++-++.+++.|..||...........  
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~--  248 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK--  248 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH--
Confidence            99998  3322221    111  134569999999999988 899999999999999999999999966543222110  


Q ss_pred             HHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          262 NVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      .....           .......      .....+..+.++...+-..+..++|....+...|+.+..+
T Consensus       249 ~~~~~-----------~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~  300 (322)
T KOG1164|consen  249 FEKDP-----------RKLLTDR------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDS  300 (322)
T ss_pred             HHHHh-----------hhhcccc------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHh
Confidence            00000           0000000      0012235566777777779999999999999998877653

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=1e-24  Score=195.24  Aligned_cols=250  Identities=25%  Similarity=0.355  Sum_probs=188.4

Q ss_pred             CCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChh--hHHHHHHHHHHHHhhcCC-CcceE-----------EEEEec
Q 038681           56 YDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQH--ALEWCINHIVYASRMSHK-HIIKL-----------IVFESV  121 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~H~-nIv~~-----------lv~e~~  121 (332)
                      |.....||.|+||.||++.+. ..+++|.+.......  ....+.+|+.++..+.|+ +|+++           ++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~   80 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV   80 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence            677789999999999999988 888999988765543  477899999999999988 79887           899999


Q ss_pred             cCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC-CeEEeecCCccccCCC
Q 038681          122 QIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS-DAKLFDFSLSLSIPDG  200 (332)
Q Consensus       122 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~  200 (332)
                      .++++.+++......  ..++......++.|++.++.|+|   ..+++|||+||+||+++..+ .++++|||.++.....
T Consensus        81 ~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          81 DGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            999999777654111  26899999999999999999999   99999999999999999988 6999999999865544


Q ss_pred             Ccee----eccccccCCCcccccccCC----CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          201 ETHI----ELDSVVGTTGFIAPENFTT----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       201 ~~~~----~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      ....    ......||..|+|||.+.+    .++...|+||+|++++++++|..||........  .......+......
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~  233 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA--TSQTLKIILELPTP  233 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcccc--HHHHHHHHHhcCCc
Confidence            3221    2256789999999999875    678899999999999999999999765543100  00011111110000


Q ss_pred             -hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          273 -FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       273 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                       .....          ...........+.+++..|+..+|..|.+..+....
T Consensus       234 ~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 SLASPL----------SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccccc----------CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence             00000          000001223578899999999999999988876653

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=4.3e-24  Score=182.39  Aligned_cols=248  Identities=14%  Similarity=0.206  Sum_probs=189.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-CCCcceE-----------EEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKL-----------IVF  118 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~~-----------lv~  118 (332)
                      .-+|.++++||+|+||.+|.|.+  ++..||||.-.....   .-.+..|.+..+.|. .++|.++           ||+
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~---APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE---APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCC---cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            34699999999999999999999  999999998766543   234567888888774 5677665           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC-----CeEEeecCC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS-----DAKLFDFSL  193 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-----~~kl~Dfg~  193 (332)
                      |++ |.+|+|+..-..    ..++...+..++.|++.-++|+|   ++.+|.|||||+|+||+..+     .+.++|||+
T Consensus       104 dLL-GPSLEDLFD~Cg----R~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm  175 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCG----RRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM  175 (449)
T ss_pred             hhh-CcCHHHHHHHhc----CcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccc
Confidence            988 669999987663    46999999999999999999999   99999999999999997554     478999999


Q ss_pred             ccccCCCCce-----eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhh
Q 038681          194 SLSIPDGETH-----IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS  267 (332)
Q Consensus       194 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  267 (332)
                      |+...++.+.     .+.....||..||+--...+ ..+...|+=|||-++...|-|..||.+........   ..+.+.
T Consensus       176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~---kYeKIG  252 (449)
T KOG1165|consen  176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE---KYEKIG  252 (449)
T ss_pred             hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH---HHHHhc
Confidence            9988765532     12345679999999988888 78999999999999999999999998876544322   111111


Q ss_pred             c--cccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          268 G--QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       268 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                      .  ...++.++..               ..+.++..-+.-.-..+-.+-|..+-+...+..+++
T Consensus       253 e~Kr~T~i~~Lc~---------------g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvld  301 (449)
T KOG1165|consen  253 ETKRSTPIEVLCE---------------GFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLD  301 (449)
T ss_pred             cccccCCHHHHHh---------------cCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence            1  1111222211               234566666666666777788888777777766654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=7.5e-25  Score=179.43  Aligned_cols=252  Identities=15%  Similarity=0.229  Sum_probs=188.8

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcC----CCcceE--------EE
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSH----KHIIKL--------IV  117 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~~--------lv  117 (332)
                      ..++|.+.++||+|+||.+|.|..  .|..||||.-......   -.+..|..+...|++    |+|-.+        +|
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h---pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH---PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC---cchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            346799999999999999999999  8999999998765432   235678888888864    555544        99


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC---CCCeEEeecCCc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE---QSDAKLFDFSLS  194 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~a  194 (332)
                      |+.+ |.+|+++..-..    ..++...++-++-|++.-++|+|   .++++||||||+|+|.+-   ...+.|+|||+|
T Consensus        90 MdLL-GPsLEdLfnfC~----R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa  161 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFCS----RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA  161 (341)
T ss_pred             eecc-CccHHHHHHHHh----hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccch
Confidence            9998 669999887552    46899999999999999999999   999999999999999863   346889999999


Q ss_pred             cccCCCCce-----eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc
Q 038681          195 LSIPDGETH-----IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG  268 (332)
Q Consensus       195 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  268 (332)
                      +.+-+..+.     .......||..|++--...+ ..+...|+=|+|-+|..+.-|..||.+.......+..+.+...  
T Consensus       162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek--  239 (341)
T KOG1163|consen  162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK--  239 (341)
T ss_pred             hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh--
Confidence            877554321     22345789999999888777 7788999999999999999999999987655443311111100  


Q ss_pred             cccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          269 QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                         .+...+....           ...+.++.-.+.-|-..--++-|.-.-+.+.+.-|.+.
T Consensus       240 ---K~s~~ie~LC-----------~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~  287 (341)
T KOG1163|consen  240 ---KMSTPIEVLC-----------KGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRT  287 (341)
T ss_pred             ---hcCCCHHHHh-----------CCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence               0000001000           02236677788888888888888887777776666544

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.92  E-value=1.5e-25  Score=216.11  Aligned_cols=238  Identities=19%  Similarity=0.198  Sum_probs=174.2

Q ss_pred             CCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHH---HHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           55 NYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCI---NHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~---~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      +|...+.||++.|=.|.+|.+....|+||++.+....-.++.+.   .|++ ...++|||++++           ||=+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            57778899999999999999966669999998776543344444   4444 555689999998           66677


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC-
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD-  199 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~-  199 (332)
                      ..+ +|+|.+..+     +.+..-+.+.|+.|++.||.-+|   ..||+|||||.+||||+.=..+.|+||..-+..-- 
T Consensus       103 vkh-nLyDRlSTR-----PFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen  103 VKH-NLYDRLSTR-----PFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             Hhh-hhhhhhccc-----hHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCC
Confidence            766 899999876     56888899999999999999999   99999999999999999888899999987654321 


Q ss_pred             -CC---ceeeccccccCCCcccccccCC------------CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHH
Q 038681          200 -GE---THIELDSVVGTTGFIAPENFTT------------LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEEN  262 (332)
Q Consensus       200 -~~---~~~~~~~~~gt~~y~aPE~~~~------------~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~  262 (332)
                       +.   ......+...-..|.|||.+..            ..+++.||||+||+++||++ |++||.-.         .+
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---------QL  244 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---------QL  244 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---------HH
Confidence             11   1111122233457999998742            15678999999999999998 67777521         11


Q ss_pred             HhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          263 VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                      ..+-.+.. ...+.+-..+.             ...++.++..|++.||++|.||++.++.-+
T Consensus       245 ~aYr~~~~-~~~e~~Le~Ie-------------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  245 LAYRSGNA-DDPEQLLEKIE-------------DVSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             HhHhccCc-cCHHHHHHhCc-------------CccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence            11111111 11111111111             135889999999999999999999998743

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=1.2e-24  Score=180.58  Aligned_cols=132  Identities=14%  Similarity=0.168  Sum_probs=105.8

Q ss_pred             CCccccCCCceEEEEEe-CCeeEEEEEEcCCCChh-h------------------------HHHHHHHHHHHHhhcCCCc
Q 038681           59 QNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQH-A------------------------LEWCINHIVYASRMSHKHI  112 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-~------------------------~~~~~~E~~~l~~l~H~nI  112 (332)
                      ...||+|+||.||+|.. +|+.||||++....... .                        .....+|+.++.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            56899999999999998 79999999997642210 0                        1223459999999976554


Q ss_pred             ce---------EEEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeeecCCCCCCeeeCC
Q 038681          113 IK---------LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYL-HVGFSRPIVYRDMKPTNILFNE  182 (332)
Q Consensus       113 v~---------~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlkp~Nill~~  182 (332)
                      ..         +|||||++++++.......     ..++...+..++.|++.+|.|+ |   ..||+||||||+|||++ 
T Consensus        82 ~~p~~~~~~~~~iVmE~i~g~~l~~~~~~~-----~~~~~~~~~~i~~qi~~~L~~l~H---~~giiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILLKSHVLVMEFIGDDGWAAPRLKD-----APLSESKARELYLQVIQIMRILYQ---DCRLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEecCCEEEEEEeCCCCCcchhhhc-----CCCCHHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEE-
Confidence            22         3999999998776554332     4689999999999999999999 7   88999999999999998 


Q ss_pred             CCCeEEeecCCccccCC
Q 038681          183 QSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       183 ~~~~kl~Dfg~a~~~~~  199 (332)
                      ++.++|+|||+|.....
T Consensus       153 ~~~v~LiDFG~a~~~~~  169 (190)
T cd05147         153 DGKLYIIDVSQSVEHDH  169 (190)
T ss_pred             CCcEEEEEccccccCCC
Confidence            47899999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.91  E-value=6.2e-26  Score=204.87  Aligned_cols=170  Identities=29%  Similarity=0.420  Sum_probs=124.9

Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      |.|++|.-.+|.+|+.....  ....++...+.++.|++.|++|      ++.+|+|+||.||+...+..+||.|||+..
T Consensus       333 I~Mn~c~~~tledWl~rr~~--~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  333 IQMNLCEKETLEDWLRRRRT--GEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             hhhhhhhhhhHHHHhhCCCc--ccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhee
Confidence            57888999999999975422  2457788899999999999997      689999999999999999999999999987


Q ss_pred             ccCCCC----ceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhcc
Q 038681          196 SIPDGE----THIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQ  269 (332)
Q Consensus       196 ~~~~~~----~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  269 (332)
                      ......    .....+...||..||+||++.+ .|+.++||||||++|+|+++ -...|....                 
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~-----------------  467 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA-----------------  467 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH-----------------
Confidence            665544    1122256789999999999998 99999999999999999997 222222111                 


Q ss_pred             ccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 038681          270 NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVD  319 (332)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e  319 (332)
                        .+.++-+..+...      + ....+.-..|+.+++...|.+||++.+
T Consensus       468 --t~~d~r~g~ip~~------~-~~d~p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  468 --TLTDIRDGIIPPE------F-LQDYPEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             --hhhhhhcCCCChH------H-hhcCcHHHHHHHHhcCCCcccCchHHH
Confidence              0111111111000      0 011145568999999999999995443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=2.8e-24  Score=180.82  Aligned_cols=160  Identities=15%  Similarity=0.119  Sum_probs=125.8

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCC--hhhHHH------HHHHHHHHHhhcCCCcceE--------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRN--QHALEW------CINHIVYASRMSHKHIIKL--------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~--~~~~~~------~~~E~~~l~~l~H~nIv~~--------  115 (332)
                      ..++|...+.+|.|+||.||++..++..+|+|.+.....  +...+.      +.+|+..+.++.||+|..+        
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~  108 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE  108 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence            467899999999999999999777888999999976533  222233      5799999999999997754        


Q ss_pred             -----------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC
Q 038681          116 -----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS  184 (332)
Q Consensus       116 -----------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  184 (332)
                                 |||||++|.+|.++..         +++    ....+++.+|..+|   ..|++|||+||+||+++.+|
T Consensus       109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g  172 (232)
T PRK10359        109 RKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG  172 (232)
T ss_pred             cccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC
Confidence                       7999999999988732         222    24669999999999   99999999999999999988


Q ss_pred             CeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHH
Q 038681          185 DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELL  242 (332)
Q Consensus       185 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ell  242 (332)
                       ++|+|||.+.........              ...+.. .++.++||||||+++.-+.
T Consensus       173 -i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 -LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             -EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence             999999988665332211              002222 5668999999999987654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=2.9e-23  Score=172.87  Aligned_cols=132  Identities=11%  Similarity=0.167  Sum_probs=107.8

Q ss_pred             CCccccCCCceEEEEEe-CCeeEEEEEEcCCCCh-------------------------hhHHHHHHHHHHHHhhcCCCc
Q 038681           59 QNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQ-------------------------HALEWCINHIVYASRMSHKHI  112 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-------------------------~~~~~~~~E~~~l~~l~H~nI  112 (332)
                      ...||+|+||.||+|.+ +|+.||||.+......                         .....+.+|...+.++.|++|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            57899999999999998 7999999998765311                         002234689999999998887


Q ss_pred             ce---------EEEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeeecCCCCCCeeeCC
Q 038681          113 IK---------LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFS-RPIVYRDMKPTNILFNE  182 (332)
Q Consensus       113 v~---------~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~  182 (332)
                      ..         +|||||++++++.......     ..++...+..++.|++.+|.+||   . .||+||||||+||+++ 
T Consensus        82 ~~p~~~~~~~~~lVmE~~~g~~~~~~~l~~-----~~~~~~~~~~i~~~l~~~l~~lH---~~~givHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLKKNVLVMEFIGDDGSPAPRLKD-----VPLEEEEAEELYEQVVEQMRRLY---QEAGLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEecCCEEEEEEecCCCchhhhhhh-----ccCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCChhhEEEE-
Confidence            43         4999999988654432222     35788899999999999999999   7 9999999999999998 


Q ss_pred             CCCeEEeecCCccccCC
Q 038681          183 QSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       183 ~~~~kl~Dfg~a~~~~~  199 (332)
                      ++.++|+|||++.....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            88999999999977654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=3.4e-23  Score=180.83  Aligned_cols=178  Identities=19%  Similarity=0.222  Sum_probs=127.0

Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee--CCCC--CeEEeec
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF--NEQS--DAKLFDF  191 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill--~~~~--~~kl~Df  191 (332)
                      +||.-.+. +|.+|+...      ..+.....-++.|+++|+.|||   .+||.|||+|.+|||+  |+++  .+.|+||
T Consensus       320 lvMkrY~~-tLr~yl~~~------~~s~r~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDF  389 (598)
T KOG4158|consen  320 LVMKRYRQ-TLREYLWTR------HRSYRTGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADF  389 (598)
T ss_pred             Eehhcchh-hHHHHHhcC------CCchHHHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEccc
Confidence            67777765 899999764      4677778889999999999999   9999999999999998  4444  4678999


Q ss_pred             CCccccCCCCce----eeccccccCCCcccccccCCCC-------ChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhH
Q 038681          192 SLSLSIPDGETH----IELDSVVGTTGFIAPENFTTLI-------NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYE  260 (332)
Q Consensus       192 g~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-------~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~  260 (332)
                      |++-........    .......|.-.-||||+.....       -.++|.|+.|.+.||+++...||........    
T Consensus       390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L----  465 (598)
T KOG4158|consen  390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL----  465 (598)
T ss_pred             ceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee----
Confidence            997443321110    0113446788899999987522       2489999999999999999999986332111    


Q ss_pred             HHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          261 ENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                                       +.....+. .-++.+..+++.+.+++...|+.||++|||..-..+.|.
T Consensus       466 -----------------~~r~Yqe~-qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  466 -----------------DTRTYQES-QLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             -----------------chhhhhhh-hCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence                             00000000 011122355578899999999999999999876666553

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1.9e-22  Score=166.29  Aligned_cols=183  Identities=11%  Similarity=0.049  Sum_probs=137.4

Q ss_pred             CCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCC---hhhHHHHHHHHHHHHhhc-CCCcceE-------EEEEeccCC
Q 038681           56 YDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRN---QHALEWCINHIVYASRMS-HKHIIKL-------IVFESVQIG  124 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~-H~nIv~~-------lv~e~~~~g  124 (332)
                      +.+...|++|+||+||.+...+..++.+.+.....   .-....+.+|+++|.+|. |++|.++       ++|||+.|.
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~~~~lvmeyI~G~   83 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWDGRHLDRSYLAGA   83 (218)
T ss_pred             cccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEcCEEEEEeeecCc
Confidence            34567899999999998887888898888776643   112335889999999995 4556655       899999999


Q ss_pred             ChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC-CCCCeeeCCCCCeEEeecCCccccCCCCce
Q 038681          125 TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM-KPTNILFNEQSDAKLFDFSLSLSIPDGETH  203 (332)
Q Consensus       125 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  203 (332)
                      +|.+.+..            ....++.|++.+|.++|   .+||+|||| ||+|||++.++.++|+|||+|.........
T Consensus        84 ~L~~~~~~------------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~  148 (218)
T PRK12274         84 AMYQRPPR------------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARW  148 (218)
T ss_pred             cHHhhhhh------------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchH
Confidence            88654321            11357889999999999   999999999 799999999999999999999865543310


Q ss_pred             ----e-e------ccccccCCCcccccccC--CCCC-hhhhHHHHHHHHHHHHhCCccCCCCCc
Q 038681          204 ----I-E------LDSVVGTTGFIAPENFT--TLIN-EQCDVYGFGAFLFELLTAQEVSDHVSF  253 (332)
Q Consensus       204 ----~-~------~~~~~gt~~y~aPE~~~--~~~~-~~sDiwSlG~~l~elltg~~p~~~~~~  253 (332)
                          . .      ......++.|++|+.-.  ...+ ...+.++-|+-+|.++|+..|+.+..+
T Consensus       149 ~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        149 MRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence                0 0      01123577888887543  2444 567777999999999999988765543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.89  E-value=3.9e-23  Score=179.03  Aligned_cols=222  Identities=18%  Similarity=0.237  Sum_probs=145.4

Q ss_pred             CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcC-----------CC-----cceE
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSH-----------KH-----IIKL  115 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H-----------~n-----Iv~~  115 (332)
                      +...+.||.|+++.||.+++  +++.+|+|.+.....  ....+.+.+|.-....+.+           .-     ++++
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            45577899999999999999  789999999865442  3346666666644444222           01     1111


Q ss_pred             ----------------------EEEEeccCCChHHHHhhhhccc--ccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeec
Q 038681          116 ----------------------IVFESVQIGTLADRIHHHCEQH--FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYR  171 (332)
Q Consensus       116 ----------------------lv~e~~~~g~L~~~l~~~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~  171 (332)
                                            ++|+-+ .+||.+++..-....  ...+.....+.+..|+++.+++||   ..|++|+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHg  169 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLH---SYGLVHG  169 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEES
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHh---hcceEec
Confidence                                  466666 458888865421111  112334455677899999999999   9999999


Q ss_pred             CCCCCCeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC---------CCChhhhHHHHHHHHHHHH
Q 038681          172 DMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT---------LINEQCDVYGFGAFLFELL  242 (332)
Q Consensus       172 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~sDiwSlG~~l~ell  242 (332)
                      ||+|+|++++.+|.+.|+||+..........     ....+..|.+||....         .++.+.|.|+||+++|.|+
T Consensus       170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~-----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYR-----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             T-SGGGEEE-TTS-EEE--GGGEEETTEEEE-----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             ccceeeEEEcCCCCEEEcChHHHeecCceee-----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            9999999999999999999987655433221     1344578999997632         4788999999999999999


Q ss_pred             hCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCC
Q 038681          243 TAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDR  314 (332)
Q Consensus       243 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R  314 (332)
                      +|..||...........            .+           ..|.     +.++.+..||..+|+.||.+|
T Consensus       245 C~~lPf~~~~~~~~~~~------------~f-----------~~C~-----~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW------------DF-----------SRCR-----DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG------------GG-----------TTSS--------HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc------------cc-----------hhcC-----CcCHHHHHHHHHHccCCcccC
Confidence            99999986644332110            00           0111     455889999999999999988

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.88  E-value=2e-22  Score=197.41  Aligned_cols=247  Identities=15%  Similarity=0.189  Sum_probs=175.5

Q ss_pred             ccccHHHHHHHhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc---CCCcce---
Q 038681           42 RIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMS---HKHIIK---  114 (332)
Q Consensus        42 ~~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~---  114 (332)
                      +.-+..+++.....|.+.+.||+|+||.||+|.. +|+.||+|.-+....=+    |.-=.+++.+|+   -+.|..   
T Consensus       686 ~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~  761 (974)
T KOG1166|consen  686 KLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISS  761 (974)
T ss_pred             ccCccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHH
Confidence            3344456667778899999999999999999999 89999999987654311    011112233333   111222   


Q ss_pred             --------EEEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC----
Q 038681          115 --------LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE----  182 (332)
Q Consensus       115 --------~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~----  182 (332)
                              +||+||.+.|+|.+++...     ..+++..+..++.|++.-+++||   ..+|||+||||+|+||..    
T Consensus       762 a~~~~~~S~lv~ey~~~Gtlld~~N~~-----~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~  833 (974)
T KOG1166|consen  762 AHVFQNASVLVSEYSPYGTLLDLINTN-----KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICA  833 (974)
T ss_pred             HHccCCcceeeeeccccccHHHhhccC-----CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCC
Confidence                    2899999999999999854     67999999999999999999999   999999999999999942    


Q ss_pred             ---CCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhh
Q 038681          183 ---QSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFH  258 (332)
Q Consensus       183 ---~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~  258 (332)
                         +..++|+|||.|.....-.........++|-.+-.+|+..| .++..+|.|.|+.+++-||.|++.= ..+      
T Consensus       834 ~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-~~~------  906 (974)
T KOG1166|consen  834 DSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-VKN------  906 (974)
T ss_pred             CCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-hcC------
Confidence               34589999999854432222223366788999999999999 8999999999999999999997432 000      


Q ss_pred             hHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          259 YEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                         -..|.  ....+...++.                 ....+|...+|+.|-..=|...++...|+..+.
T Consensus       907 ---g~~~~--~~~~~~Ry~~~-----------------~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~  955 (974)
T KOG1166|consen  907 ---GSSWM--VKTNFPRYWKR-----------------DMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA  955 (974)
T ss_pred             ---Cccee--ccccchhhhhH-----------------HHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence               00000  00011222221                 334567777787554445788888888777654

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.88  E-value=2.1e-22  Score=185.14  Aligned_cols=205  Identities=21%  Similarity=0.343  Sum_probs=152.0

Q ss_pred             HHhhcCCCcceE-----------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCe-eec
Q 038681          104 ASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPI-VYR  171 (332)
Q Consensus       104 l~~l~H~nIv~~-----------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~i-vH~  171 (332)
                      |+.+.|.|+.++           +|.+||..|+|.+.+...    ...+++.....++++|+.||.|||+   ..| .|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg   73 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHN---SPIGYHG   73 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhc---Ccceeee
Confidence            356789999988           689999999999999874    2568899999999999999999994   444 999


Q ss_pred             CCCCCCeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCCC--------CChhhhHHHHHHHHHHHHh
Q 038681          172 DMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTL--------INEQCDVYGFGAFLFELLT  243 (332)
Q Consensus       172 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~sDiwSlG~~l~ellt  243 (332)
                      .+++.|+++|....+||+|||+.................-...|.|||.+.+.        .+.+.||||||++++|+++
T Consensus        74 ~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~  153 (484)
T KOG1023|consen   74 ALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILF  153 (484)
T ss_pred             eeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHh
Confidence            99999999999999999999998776431111111222345679999998751        4667999999999999999


Q ss_pred             CCccCCCCCccchhhhHHHHhhhhc-cccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          244 AQEVSDHVSFESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       244 g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ...||.........  .+....+.. ....+...+..            .....+++..++.+||..+|.+||++++|-.
T Consensus       154 r~~~~~~~~~~~~~--~eii~~~~~~~~~~~rP~i~~------------~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  154 RSGPFDLRNLVEDP--DEIILRVKKGGSNPFRPSIEL------------LNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccCccccccccCCh--HHHHHHHHhcCCCCcCcchhh------------hhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            99999875544332  112222222 11111111110            0123347899999999999999999999999


Q ss_pred             HHHHHHH
Q 038681          323 QLRQMYR  329 (332)
Q Consensus       323 ~L~~l~~  329 (332)
                      .++.+..
T Consensus       220 ~~~~~~~  226 (484)
T KOG1023|consen  220 KLLTINK  226 (484)
T ss_pred             hhhhhcc
Confidence            8877654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.86  E-value=6.4e-23  Score=188.85  Aligned_cols=214  Identities=21%  Similarity=0.227  Sum_probs=170.1

Q ss_pred             ccccCCCceEEEEEe-----CCeeEEEEEEcCCCCh-hhHHHHHHHHHHHHhhc-CCCcceE-----------EEEEecc
Q 038681           61 IVLEDPFRKLYKGFW-----QKRSISLMKYNGNRNQ-HALEWCINHIVYASRMS-HKHIIKL-----------IVFESVQ  122 (332)
Q Consensus        61 ~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~-H~nIv~~-----------lv~e~~~  122 (332)
                      .+|+|.||.|+++.-     .+..+|.|..++.... ........|..++...+ ||.+|++           ++++|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999997754     5666788777654321 11224567888888886 9999998           7889999


Q ss_pred             CCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCc
Q 038681          123 IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET  202 (332)
Q Consensus       123 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  202 (332)
                      +|+|...+...     ..+.+.....+...++-|++++|   +.+|+|||+|++||+++.+|.+++.|||+++..-....
T Consensus        81 gg~lft~l~~~-----~~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~  152 (612)
T KOG0603|consen   81 GGDLFTRLSKE-----VMFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI  152 (612)
T ss_pred             cchhhhccccC-----CchHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhh
Confidence            99998888765     56788888899999999999999   99999999999999999999999999999987655442


Q ss_pred             eeeccccccCCCcccccccCCCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhh
Q 038681          203 HIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIII  282 (332)
Q Consensus       203 ~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (332)
                            .+||..|||||++. ....++|.||||++++||+||..||...          ....+..              
T Consensus       153 ------~cgt~eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~~----------~~~~Il~--------------  201 (612)
T KOG0603|consen  153 ------ACGTYEYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGGD----------TMKRILK--------------  201 (612)
T ss_pred             ------cccchhhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCchH----------HHHHHhh--------------
Confidence                  27899999999998 4667899999999999999999999861          1111110              


Q ss_pred             cccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCH
Q 038681          283 EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTM  317 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~  317 (332)
                          .....+...+..+.+++..++..+|..|--.
T Consensus       202 ----~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  202 ----AELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             ----hccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence                1122334666788999999999999999654

>PRK10345 hypothetical protein; Provisional

Probab=99.85  E-value=7.7e-21  Score=159.42  Aligned_cols=126  Identities=15%  Similarity=0.106  Sum_probs=98.2

Q ss_pred             CCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-----cCCCcceE---------------
Q 038681           56 YDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRM-----SHKHIIKL---------------  115 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~~---------------  115 (332)
                      +.....||+|+||.||.-..++. .+||++...... ..+.+.+|+.+++.+     +||||+++               
T Consensus         4 L~~~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~~-~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGDG-GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEECCCCcC-eEEEEEeccccc-hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            45567899999999996222433 468888764333 256789999999999     57999998               


Q ss_pred             EEEEe--ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHH-HHhhhcCCCCeeecCCCCCCeeeCC----CCCeEE
Q 038681          116 IVFES--VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAV-AYLHVGFSRPIVYRDMKPTNILFNE----QSDAKL  188 (332)
Q Consensus       116 lv~e~--~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L-~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl  188 (332)
                      +|+||  +++|+|.+++.+.      .+++.  ..++.|++.++ +|||   +++|+||||||+|||++.    ++.++|
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~L  150 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVV  150 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEE
Confidence            57899  5689999999653      35555  35688888888 9999   999999999999999974    347999


Q ss_pred             eecCCc
Q 038681          189 FDFSLS  194 (332)
Q Consensus       189 ~Dfg~a  194 (332)
                      +||+.+
T Consensus       151 iDg~G~  156 (210)
T PRK10345        151 CDNIGE  156 (210)
T ss_pred             EECCCC
Confidence            995444

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=8.3e-21  Score=162.92  Aligned_cols=135  Identities=14%  Similarity=0.166  Sum_probs=108.4

Q ss_pred             CCCCCCccccCCCceEEEEE-e--CCeeEEEEEEcCCCCh-----------------------hhHHHHHHHHHHHHhhc
Q 038681           55 NYDEQNIVLEDPFRKLYKGF-W--QKRSISLMKYNGNRNQ-----------------------HALEWCINHIVYASRMS  108 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~-~--~~~~vavK~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~  108 (332)
                      .|.+.+.||+|+||.||+|. +  +|+.||+|.+......                       .....+.+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48899999999999999998 3  8999999998754310                       01134678999999997


Q ss_pred             CCCc--ce-------EEEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCC-eeecCCCCCCe
Q 038681          109 HKHI--IK-------LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRP-IVYRDMKPTNI  178 (332)
Q Consensus       109 H~nI--v~-------~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-ivH~Dlkp~Ni  178 (332)
                      +.++  .+       +|||||+++++|..+....     ..+....+..++.||+.+|.+||   ..| |+||||||+||
T Consensus       109 ~~~i~~p~~~~~~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI  180 (237)
T smart00090      109 EAGVPVPKPIAWRRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI  180 (237)
T ss_pred             hcCCCCCeeeEecCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence            6332  22       2999999998887765332     34566677899999999999999   999 99999999999


Q ss_pred             eeCCCCCeEEeecCCccccC
Q 038681          179 LFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       179 ll~~~~~~kl~Dfg~a~~~~  198 (332)
                      +++ ++.++|+|||.+....
T Consensus       181 li~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEE-CCCEEEEEChhhhccC
Confidence            999 8899999999986543

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.85  E-value=1e-21  Score=189.60  Aligned_cols=209  Identities=22%  Similarity=0.296  Sum_probs=148.9

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceEEEEEeccCCChHH
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFESVQIGTLAD  128 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~lv~e~~~~g~L~~  128 (332)
                      ....+|..+++|..|+||.||.+++  +.+.+|+ ++.+.+.      +.+-  ++.....|.+|          ||=..
T Consensus        80 p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l------ilRn--ilt~a~npfvv----------gDc~t  140 (1205)
T KOG0606|consen   80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL------ILRN--ILTFAGNPFVV----------GDCAT  140 (1205)
T ss_pred             CCccccceeEeeccCCCCceeeeeccccccchhh-cccccch------hhhc--cccccCCccee----------chhhh
Confidence            3456899999999999999999988  5788888 4433321      1111  33333455544          45555


Q ss_pred             HHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCce-----
Q 038681          129 RIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH-----  203 (332)
Q Consensus       129 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-----  203 (332)
                      .++..     ++++..        ++.+++|||   ..||+|||+||+|.+|+.-|.+|+.|||+++........     
T Consensus       141 llk~~-----g~lPvd--------mvla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg  204 (1205)
T KOG0606|consen  141 LLKNI-----GPLPVD--------MVLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEG  204 (1205)
T ss_pred             hcccC-----CCCcch--------hhHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhc
Confidence            55543     344433        288999999   999999999999999999999999999998654221110     


Q ss_pred             --------eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          204 --------IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       204 --------~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                              ......+||+.|.|||++.. .|+..+|.|++|+++||.+.|+.||.+...++...      .+......|.
T Consensus       205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg------~visd~i~wp  278 (1205)
T KOG0606|consen  205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG------QVISDDIEWP  278 (1205)
T ss_pred             chHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh------hhhhhhcccc
Confidence                    11134589999999999876 89999999999999999999999999876654321      1111111111


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP  315 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP  315 (332)
                      +-               ......++.+++.+.|+.+|..|-
T Consensus       279 E~---------------dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  279 EE---------------DEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             cc---------------CcCCCHHHHHHHHHHHHhChHhhc
Confidence            11               123347899999999999999993

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.82  E-value=9.1e-20  Score=153.01  Aligned_cols=121  Identities=21%  Similarity=0.214  Sum_probs=100.8

Q ss_pred             ccccCCCceEEEEEeCCeeEEEEEEcCCCC--h-----hhHHHHHHHHHHHHhhcCCCcce-----------EEEEEecc
Q 038681           61 IVLEDPFRKLYKGFWQKRSISLMKYNGNRN--Q-----HALEWCINHIVYASRMSHKHIIK-----------LIVFESVQ  122 (332)
Q Consensus        61 ~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~--~-----~~~~~~~~E~~~l~~l~H~nIv~-----------~lv~e~~~  122 (332)
                      .||+|+||.||+|.+.+..|++|.......  .     ....++.+|+.++..+.|+++..           ++||||++
T Consensus         1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~   80 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE   80 (199)
T ss_pred             CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence            489999999999999999999998664321  1     11356789999999998876432           18999999


Q ss_pred             CCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          123 IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       123 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |++|.+++...     ..       .++.+++.+|.+||   ..+++|+|++|.||+++ ++.++++|||++...
T Consensus        81 g~~l~~~~~~~-----~~-------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        81 GKPLKDVIEEG-----ND-------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CccHHHHHhhc-----HH-------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            99999987543     11       78999999999999   99999999999999999 889999999998663

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.82  E-value=1.7e-19  Score=151.27  Aligned_cols=141  Identities=13%  Similarity=0.043  Sum_probs=110.4

Q ss_pred             HHHHHHHhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCCh---------------------hhHHHHHHHHHH
Q 038681           46 AEELRIATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQ---------------------HALEWCINHIVY  103 (332)
Q Consensus        46 ~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~---------------------~~~~~~~~E~~~  103 (332)
                      ..++......|.+.+.||+|+||.||+|.. +|+.||||++......                     .....+..|+.+
T Consensus         7 ~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   86 (198)
T cd05144           7 LHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAA   86 (198)
T ss_pred             HHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHH
Confidence            344444444588899999999999999998 7999999987653210                     011236789999


Q ss_pred             HHhhcCCCc--ce-------EEEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 038681          104 ASRMSHKHI--IK-------LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK  174 (332)
Q Consensus       104 l~~l~H~nI--v~-------~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  174 (332)
                      +..+.|+++  ..       ++||||+++++|......           .....++.+++.++.++|   ..||+|+|||
T Consensus        87 l~~l~~~~i~v~~~~~~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~  152 (198)
T cd05144          87 LKALYEEGFPVPKPIDWNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAY---KHGIIHGDLS  152 (198)
T ss_pred             HHHHHHcCCCCCceeecCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHH---HCCCCcCCCC
Confidence            999987743  22       289999999998765421           235678899999999999   9999999999


Q ss_pred             CCCeeeCCCCCeEEeecCCccccCCC
Q 038681          175 PTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       175 p~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      |+||+++.++.++|+|||.+......
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~~~~  178 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVSTDHP  178 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccCCCc
Confidence            99999999999999999999665543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.4e-19  Score=153.20  Aligned_cols=124  Identities=20%  Similarity=0.242  Sum_probs=104.8

Q ss_pred             CccccCCCceEEEEEeCCeeEEEEEEcCCCC--h-----hhHHHHHHHHHHHHhhcCCCcceE-----------EEEEec
Q 038681           60 NIVLEDPFRKLYKGFWQKRSISLMKYNGNRN--Q-----HALEWCINHIVYASRMSHKHIIKL-----------IVFESV  121 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~--~-----~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~  121 (332)
                      +.||+|++|.||+|.+.+..|++|+......  .     .....+.+|+.++..+.|++|...           +||||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            5799999999999999889999998764322  1     113467899999999998876532           899999


Q ss_pred             cCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          122 QIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       122 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      +|++|.+++...        .. ....++.+++.+|.+||   ..+++|+|++|+|||++ ++.++|+|||.+..
T Consensus        82 ~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         82 EGEPLKDLINSN--------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999998643        12 78899999999999999   99999999999999999 78899999999865

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.80  E-value=2.8e-19  Score=171.63  Aligned_cols=128  Identities=17%  Similarity=0.166  Sum_probs=104.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCC--C-----hhhHHHHHHHHHHHHhhcCCCcceE----------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNR--N-----QHALEWCINHIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~--~-----~~~~~~~~~E~~~l~~l~H~nIv~~----------  115 (332)
                      ...|...+.||+|+||.||+|.+.+..+++|+.....  .     ....+++.+|+.++..++|++|+..          
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            4455678999999999999999966666665543221  1     1123568899999999999998753          


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       +||||+++++|.+++.             ....++.+++.+|.|||   +.+++||||||+|||+ .++.++|+|||++
T Consensus       412 ~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             EEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCccc
Confidence             8999999999999885             24578999999999999   9999999999999999 6788999999999


Q ss_pred             ccc
Q 038681          195 LSI  197 (332)
Q Consensus       195 ~~~  197 (332)
                      +..
T Consensus       475 ~~~  477 (535)
T PRK09605        475 KYS  477 (535)
T ss_pred             ccC
Confidence            653

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.75  E-value=7.8e-18  Score=139.78  Aligned_cols=130  Identities=14%  Similarity=0.158  Sum_probs=96.2

Q ss_pred             CCccccCCCceEEEEEe-CCeeEEEEEEcCCCCh-hhHHH----------------------HHHHHHHHHhhcCCC--c
Q 038681           59 QNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQ-HALEW----------------------CINHIVYASRMSHKH--I  112 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-~~~~~----------------------~~~E~~~l~~l~H~n--I  112 (332)
                      .+.||+|+||.||+|.. +++.||||.+...... .....                      ...|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            56899999999999999 6999999998754221 11111                      145677777765443  2


Q ss_pred             ce-------EEEEEeccCCChHHH-HhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeeecCCCCCCeeeCCC
Q 038681          113 IK-------LIVFESVQIGTLADR-IHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFS-RPIVYRDMKPTNILFNEQ  183 (332)
Q Consensus       113 v~-------~lv~e~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~  183 (332)
                      .+       ++||||++++++... +...      ... ..+..++.+++.++.++|   . .+|+|+||||+||+++ +
T Consensus        82 ~~~~~~~~~~lv~e~~~g~~~~~~~l~~~------~~~-~~~~~~~~~~~~~l~~lh---~~~~ivH~Dl~p~Nili~-~  150 (187)
T cd05119          82 PKPIDLNRHVLVMEFIGGDGIPAPRLKDV------RLL-EDPEELYDQILELMRKLY---REAGLVHGDLSEYNILVD-D  150 (187)
T ss_pred             CceEecCCCEEEEEEeCCCCccChhhhhh------hhc-ccHHHHHHHHHHHHHHHh---hccCcCcCCCChhhEEEE-C
Confidence            22       289999999654322 2111      011 667889999999999999   7 9999999999999999 8


Q ss_pred             CCeEEeecCCccccCC
Q 038681          184 SDAKLFDFSLSLSIPD  199 (332)
Q Consensus       184 ~~~kl~Dfg~a~~~~~  199 (332)
                      +.++|+|||.+.....
T Consensus       151 ~~~~liDfg~a~~~~~  166 (187)
T cd05119         151 GKVYIIDVPQAVEIDH  166 (187)
T ss_pred             CcEEEEECcccccccC
Confidence            9999999999966544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=1e-19  Score=174.63  Aligned_cols=245  Identities=18%  Similarity=0.236  Sum_probs=185.0

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe---CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhc-CCCcceE-----------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW---QKRSISLMKYNGNR-NQHALEWCINHIVYASRMS-HKHIIKL-----------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-H~nIv~~-----------  115 (332)
                      ....|.+.+.||+|+|+.|-....   ....+|+|.+.... .....+....|..+-..++ |+|++.+           
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            345688888999999999998877   44456666665543 3344556667888888887 9999987           


Q ss_pred             EEEEeccCCChHHHH-hhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC-CeEEeecCC
Q 038681          116 IVFESVQIGTLADRI-HHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS-DAKLFDFSL  193 (332)
Q Consensus       116 lv~e~~~~g~L~~~l-~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~  193 (332)
                      ++++|..+|++.+.+ ...    ....+...+..++.|+..|+.|+|.  ..++.|+|+||+|.+++..+ ..+++|||+
T Consensus        98 ~~~~~s~g~~~f~~i~~~~----~~~~~~~~~~~~~~ql~s~l~~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~  171 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPD----STGTSSSSASRYLPQLNSGLSYLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGL  171 (601)
T ss_pred             cccCcccccccccccccCC----ccCCCCcchhhhhhhhccCccccCc--ccccccCCCCCccchhccCCCcccCCCchh
Confidence            799999999999888 333    1256777888999999999999995  68999999999999999999 999999999


Q ss_pred             ccccCC-CCceeecccccc-CCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc
Q 038681          194 SLSIPD-GETHIELDSVVG-TTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ  269 (332)
Q Consensus       194 a~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  269 (332)
                      |..+.. ...........| ++.|+|||.+.+  ...+..|+||.|+++.-+++|..|+..........    ..+....
T Consensus       172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~----~~~~~~~  247 (601)
T KOG0590|consen  172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY----SSWKSNK  247 (601)
T ss_pred             hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc----eeecccc
Confidence            987766 444444456678 999999999987  56889999999999999999999997655433211    0111000


Q ss_pred             ccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 038681          270 NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVA  321 (332)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl  321 (332)
                       ..+              .............+++.+++..+|..|.+.+++-
T Consensus       248 -~~~--------------~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~  284 (601)
T KOG0590|consen  248 -GRF--------------TQLPWNSISDQAHDLLHKILKENPSNRLSIEELK  284 (601)
T ss_pred             -ccc--------------ccCccccCChhhhhcccccccCCchhcccccccc
Confidence             000              0001112335678899999999999999987764

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.73  E-value=4.6e-17  Score=139.99  Aligned_cols=126  Identities=14%  Similarity=0.100  Sum_probs=101.1

Q ss_pred             CCccc-cCCCceEEEEEeCCeeEEEEEEcCCCC------------hhhHHHHHHHHHHHHhhcCCCc--ceE--------
Q 038681           59 QNIVL-EDPFRKLYKGFWQKRSISLMKYNGNRN------------QHALEWCINHIVYASRMSHKHI--IKL--------  115 (332)
Q Consensus        59 ~~~lg-~G~~g~Vy~~~~~~~~vavK~~~~~~~------------~~~~~~~~~E~~~l~~l~H~nI--v~~--------  115 (332)
                      ...|| .||.|+||.+...+..+++|.+.....            .....++.+|+.++.+|.|++|  ++.        
T Consensus        36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~  115 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH  115 (239)
T ss_pred             CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence            34687 899999999999899999998854211            1223568899999999998775  211        


Q ss_pred             -------EEEEeccC-CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeE
Q 038681          116 -------IVFESVQI-GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAK  187 (332)
Q Consensus       116 -------lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k  187 (332)
                             +|+|+++| .+|.+++...      .++..    .+.+|+.+|.+||   ..||+|+||||.|||++.++.++
T Consensus       116 ~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        116 GLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             CcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEE
Confidence                   89999997 6899887542      34543    3678999999999   99999999999999999989999


Q ss_pred             EeecCCcccc
Q 038681          188 LFDFSLSLSI  197 (332)
Q Consensus       188 l~Dfg~a~~~  197 (332)
                      |+|||.+...
T Consensus       183 LIDfg~~~~~  192 (239)
T PRK01723        183 LIDFDRGELR  192 (239)
T ss_pred             EEECCCcccC
Confidence            9999988653

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=1.3e-16  Score=127.10  Aligned_cols=124  Identities=15%  Similarity=0.107  Sum_probs=101.2

Q ss_pred             CCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcC--CCcceE-----------EEEEeccCC
Q 038681           58 EQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSH--KHIIKL-----------IVFESVQIG  124 (332)
Q Consensus        58 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H--~nIv~~-----------lv~e~~~~g  124 (332)
                      +.+.||+|.++.||++...+..+++|.......   ...+.+|+.++..+.|  .++.++           +++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            457899999999999999778999999866543   4568899999999976  366554           799999887


Q ss_pred             ChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          125 TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       125 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ++..+            +......++.+++.+|.+||.....+++|+|++|+||+++..+.++++|||.+..
T Consensus        79 ~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77543            4455677899999999999932225799999999999999989999999998854

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.63  E-value=3.9e-14  Score=132.16  Aligned_cols=130  Identities=12%  Similarity=0.133  Sum_probs=95.8

Q ss_pred             CCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhH---------------------------------------HHHH
Q 038681           59 QNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHAL---------------------------------------EWCI   98 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~---------------------------------------~~~~   98 (332)
                      .+.||.|++|.||+|+. +|+.||||+..........                                       -.+.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            46799999999999999 8999999998654211100                                       0245


Q ss_pred             HHHHHHHhhc-----CCCcc-----------eEEEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHH-HHHHhh
Q 038681           99 NHIVYASRMS-----HKHII-----------KLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH-AVAYLH  161 (332)
Q Consensus        99 ~E~~~l~~l~-----H~nIv-----------~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~-~L~~LH  161 (332)
                      +|...+.++.     +++|.           ++|||||++|++|.++.....    ...+   ...++..++. .+..+|
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~----~~~~---~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE----AGLD---RKALAENLARSFLNQVL  274 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh----cCCC---HHHHHHHHHHHHHHHHH
Confidence            5666666662     34432           129999999999998875421    1122   3456666665 478889


Q ss_pred             hcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          162 VGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       162 ~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                         ..|++|+|++|.||+++.++.++++|||++..+.
T Consensus       275 ---~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       275 ---RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ---hCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence               8999999999999999999999999999986654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.54  E-value=1.1e-14  Score=125.02  Aligned_cols=192  Identities=20%  Similarity=0.264  Sum_probs=129.9

Q ss_pred             HHHhhcCCCcceE----------------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 038681          103 YASRMSHKHIIKL----------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSR  166 (332)
Q Consensus       103 ~l~~l~H~nIv~~----------------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~  166 (332)
                      .|-++.|.|||++                ++.||+..|++.++|++..... ..+....-.+|+-||+.||.|||+. ..
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~-~a~~~~~wkkw~tqIlsal~yLhs~-~P  197 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQ-KALFQKAWKKWCTQILSALSYLHSC-DP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhh-hhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence            3555678898887                7899999999999999864333 4577888889999999999999965 89


Q ss_pred             CeeecCCCCCCeeeCCCCCeEEeecCCccccCC--CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh
Q 038681          167 PIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD--GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT  243 (332)
Q Consensus       167 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt  243 (332)
                      .|+|+++..+-|++..+|-+|+.--.-...-..  ...........+-++|.|||.=.. ..+.++|||+||....||..
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            999999999999999998888753222111110  000111122346788999996554 67779999999999999988


Q ss_pred             CCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          244 AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       244 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      +..-....... ...               .+.+...+....          ...-.+++.+|++..|..||+|.+++-
T Consensus       278 lEiq~tnseS~-~~~---------------ee~ia~~i~~le----------n~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  278 LEIQSTNSESK-VEV---------------EENIANVIIGLE----------NGLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             heeccCCCcce-eeh---------------hhhhhhheeecc----------CccccCcCcccccCCCCCCcchhhhhc
Confidence            75432111100 000               000000000000          011246888999999999999998764

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.53  E-value=7.9e-13  Score=125.05  Aligned_cols=134  Identities=12%  Similarity=0.117  Sum_probs=90.2

Q ss_pred             cCCCCCCccccCCCceEEEEEe-C-CeeEEEEEEcCCCCh---------------------------------hhHH---
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW-Q-KRSISLMKYNGNRNQ---------------------------------HALE---   95 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~-~-~~~vavK~~~~~~~~---------------------------------~~~~---   95 (332)
                      ..|+. +.||+|++|.||+|+. + |+.||||+.......                                 +..+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            35776 7899999999999999 4 999999999754211                                 0011   


Q ss_pred             ---HHHHHHHHHHhhc----CCCcce------------EEEEEeccCCChHHHHhhhh-cccccCCCHHHHHHHHHHHHH
Q 038681           96 ---WCINHIVYASRMS----HKHIIK------------LIVFESVQIGTLADRIHHHC-EQHFEALSLTDRLKVAMDIAH  155 (332)
Q Consensus        96 ---~~~~E~~~l~~l~----H~nIv~------------~lv~e~~~~g~L~~~l~~~~-~~~~~~l~~~~~~~i~~~i~~  155 (332)
                         .+.+|+..+.++.    +.+.+.            +|||||++|+++.++-.-.. +.....+....+..++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence               2455666666653    333333            29999999999987532110 0000112233333333333  


Q ss_pred             HHHHhhhcCCCCeeecCCCCCCeeeCCCC----CeEEeecCCccccC
Q 038681          156 AVAYLHVGFSRPIVYRDMKPTNILFNEQS----DAKLFDFSLSLSIP  198 (332)
Q Consensus       156 ~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Dfg~a~~~~  198 (332)
                           .   ..|++|+|+||.||+++.++    .++++|||++..+.
T Consensus       277 -----f---~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 -----F---RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -----H---hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                 4   68999999999999999888    99999999986654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.53  E-value=1.6e-14  Score=133.55  Aligned_cols=237  Identities=19%  Similarity=0.208  Sum_probs=171.2

Q ss_pred             CCCCCCcccc--CCCceEEEEEe----CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhh-cCCCcceE-----------
Q 038681           55 NYDEQNIVLE--DPFRKLYKGFW----QKRSISLMKYNGNRN-QHALEWCINHIVYASRM-SHKHIIKL-----------  115 (332)
Q Consensus        55 ~y~~~~~lg~--G~~g~Vy~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~~-----------  115 (332)
                      .|.+...+|.  |.+|.||.+..    .+..+|+|+-+.... .....+-.+|+....++ .|+|.++.           
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4677888999  99999999877    677889988544332 11123345677777777 49999985           


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHH----HHHHhhhcCCCCeeecCCCCCCeeeCCC-CCeEEee
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH----AVAYLHVGFSRPIVYRDMKPTNILFNEQ-SDAKLFD  190 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~----~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~D  190 (332)
                      +-+|+|. .+|.++.....    ..++...++..+.+...    ||.++|   ..+++|-|+||.||++..+ ...+++|
T Consensus       195 iqtE~~~-~sl~~~~~~~~----~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~d  266 (524)
T KOG0601|consen  195 IQTELCG-ESLQSYCHTPC----NFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTD  266 (524)
T ss_pred             eeecccc-chhHHhhhccc----ccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCC
Confidence            5667774 68888877652    34788888889999888    999999   9999999999999999999 8899999


Q ss_pred             cCCccccCCCCceee---ccccccCCCcccccccCCCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhh
Q 038681          191 FSLSLSIPDGETHIE---LDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS  267 (332)
Q Consensus       191 fg~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  267 (332)
                      ||+...+.+......   .....|...|++||...+.++..+||||+|.++.+..++..++........         ..
T Consensus       267 f~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W---------~~  337 (524)
T KOG0601|consen  267 FGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSW---------SQ  337 (524)
T ss_pred             cceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCc---------cc
Confidence            999887766542211   122357788999999999999999999999999999998766543311111         00


Q ss_pred             ccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ....-++   +..      +     ...+.++...+..|++.+|-.|+++..+.+
T Consensus       338 ~r~~~ip---~e~------~-----~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  338 LRQGYIP---LEF------C-----EGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cccccCc---hhh------h-----cCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            0000000   000      0     012244556889999999999999877654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.50  E-value=1.6e-13  Score=111.84  Aligned_cols=118  Identities=16%  Similarity=0.096  Sum_probs=92.1

Q ss_pred             CCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------EEEEeccCCChHH
Q 038681           59 QNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IVFESVQIGTLAD  128 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv~e~~~~g~L~~  128 (332)
                      .+.|+.|.++.||++...+..+++|........  ...+.+|+.++..+.+.++++-          +||||++|.++.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~~--~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTEL--LINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLT   80 (170)
T ss_pred             eeecCCcccCceEEEEECCeEEEEEeCCCCccc--ccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccc
Confidence            357899999999999999999999997655321  2345789999999865554432          8999999988764


Q ss_pred             HHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCC-----eeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          129 RIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRP-----IVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       129 ~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      .  .        .   ....++.+++.+|+.||   ..+     ++|+|++|.||+++ ++.++++|||.+.
T Consensus        81 ~--~--------~---~~~~~~~~l~~~l~~LH---~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          81 E--D--------F---SDPENLEKIAKLLKKLH---SSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             c--c--------c---cCHHHHHHHHHHHHHHh---CCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            3  0        0   11245689999999999   776     59999999999998 6789999999874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.48  E-value=9.6e-13  Score=108.65  Aligned_cols=131  Identities=11%  Similarity=0.178  Sum_probs=95.5

Q ss_pred             CCccccCCCceEEEEEeC--------CeeEEEEEEcCCCC---------------------hhhHH----HHHHHHHHHH
Q 038681           59 QNIVLEDPFRKLYKGFWQ--------KRSISLMKYNGNRN---------------------QHALE----WCINHIVYAS  105 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~~~---------------------~~~~~----~~~~E~~~l~  105 (332)
                      ...||.|--+.||.|...        +..+|||+++....                     .....    ...+|++.|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            457999999999999873        37899998653211                     01112    2348999999


Q ss_pred             hhcC-----CCcceE----EEEEeccCCChHH-HHhhhhcccccCCCHHHHHHHHHHHHHHHHHh-hhcCCCCeeecCCC
Q 038681          106 RMSH-----KHIIKL----IVFESVQIGTLAD-RIHHHCEQHFEALSLTDRLKVAMDIAHAVAYL-HVGFSRPIVYRDMK  174 (332)
Q Consensus       106 ~l~H-----~nIv~~----lv~e~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L-H~~~~~~ivH~Dlk  174 (332)
                      ++..     |.++-+    |||||+.++.+.. .+..      ..++......+..+++.+|..| |   ..||||+||+
T Consensus        82 rl~~~Gv~vP~pi~~~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H---~~glVHGDLs  152 (197)
T cd05146          82 RMQKAGIPCPEVVVLKKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYK---ECNLVHADLS  152 (197)
T ss_pred             HHHHcCCCCCeEEEecCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHH---hCCeecCCCC
Confidence            9853     333333    9999997654422 2222      2355566778899999999999 8   8999999999


Q ss_pred             CCCeeeCCCCCeEEeecCCccccCC
Q 038681          175 PTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       175 p~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |.||+++ ++.+.|+|||.+-....
T Consensus       153 ~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         153 EYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             HHHEEEE-CCcEEEEECCCceeCCC
Confidence            9999996 47899999999865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.43  E-value=3.2e-14  Score=138.42  Aligned_cols=239  Identities=17%  Similarity=0.156  Sum_probs=168.5

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      ...+++.+.+-+-+|.++.++.+.-  .+...++|.......  ....+....+-.++-...||-++..           
T Consensus       801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~  880 (1205)
T KOG0606|consen  801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP  880 (1205)
T ss_pred             CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence            4567788888999999999998877  444444444332211  1113333444444444456766644           


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      ||++|..+++|...++..     +..+..-+...+..+..+++|||   ...+.|+|++|.|+++..++..+++|||...
T Consensus       881 L~~~~~~~~~~~Skl~~~-----~~~saepaRs~i~~~vqs~e~L~---s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~  952 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNS-----GCLSAEPARSPILERVQSLESLH---SSLRKHRDLKPDSLLIAYDGHRPLTDFGTLS  952 (1205)
T ss_pred             hhhHHhccCCchhhhhcC-----CCcccccccchhHHHHhhhhccc---cchhhcccccccchhhcccCCcccCcccccc
Confidence            899999999999999876     45677777888899999999999   7789999999999999999999999998432


Q ss_pred             ccCC------C---------------C---c-----eeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCC
Q 038681          196 SIPD------G---------------E---T-----HIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQ  245 (332)
Q Consensus       196 ~~~~------~---------------~---~-----~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~  245 (332)
                      ....      .               .   .     ........||+.|.+||...+ .....+|.|++|++++|.++|.
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence            2110      0               0   0     001234678999999999998 8888999999999999999999


Q ss_pred             ccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHH
Q 038681          246 EVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMV  318 (332)
Q Consensus       246 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~  318 (332)
                      +||.........                    +..+.... .....+...+....+++.+.+..+|.+|-.+.
T Consensus      1033 pp~na~tpq~~f--------------------~ni~~~~~-~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQIF--------------------ENILNRDI-PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCcchhhhh--------------------hccccCCC-CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            999876544321                    11111111 11112234457788999999999999997654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.43  E-value=7.5e-14  Score=129.11  Aligned_cols=246  Identities=16%  Similarity=0.183  Sum_probs=172.7

Q ss_pred             CcccccHHH-HHHHhcCCCCCCccccCCCceEEEEEe---CCeeEEEEEEcCCCChh-hHHHHHHHHHHHHhh-cCCCcc
Q 038681           40 PYRIFSAEE-LRIATNNYDEQNIVLEDPFRKLYKGFW---QKRSISLMKYNGNRNQH-ALEWCINHIVYASRM-SHKHII  113 (332)
Q Consensus        40 ~~~~~~~~e-l~~~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l-~H~nIv  113 (332)
                      +..+|...+ ......+|.....||.|.|+.|+....   ++..+++|......... ....-..|+.+...+ .|.+++
T Consensus       250 p~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~  329 (524)
T KOG0601|consen  250 PANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSV  329 (524)
T ss_pred             hhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccC
Confidence            344455555 444567789999999999999999876   67888988877654322 123345666666666 588888


Q ss_pred             eE-----------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC
Q 038681          114 KL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE  182 (332)
Q Consensus       114 ~~-----------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~  182 (332)
                      ++           |-.|||.++++...+.-.     ..+++...+.+..|++.|+.++|   +..++|+|+||+||++..
T Consensus       330 g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~-----~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~  401 (524)
T KOG0601|consen  330 GKNSSWSQLRQGYIPLEFCEGGSSSLRSVTS-----QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISN  401 (524)
T ss_pred             CCCCCccccccccCchhhhcCcchhhhhHHH-----HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeecc
Confidence            74           778999999887776433     45888999999999999999999   999999999999999987


Q ss_pred             C-CCeEEeecCCccccCCCCceeeccccccCCCcc-ccccc-CC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhh
Q 038681          183 Q-SDAKLFDFSLSLSIPDGETHIELDSVVGTTGFI-APENF-TT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFH  258 (332)
Q Consensus       183 ~-~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~-aPE~~-~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~  258 (332)
                      + +..++.|||+...+.-..     ....+.-++. .+|.+ .. .+..++|++|||..+.+.+++.........     
T Consensus       402 ~~~~~~~~~~~~~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-----  471 (524)
T KOG0601|consen  402 DGFFSKLGDFGCWTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-----  471 (524)
T ss_pred             chhhhhccccccccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc-----
Confidence            6 788999999986532221     1223333444 24444 44 788899999999999999998654332111     


Q ss_pred             hHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          259 YEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                            +......                ..+........+..+.+.+...++..||++.++.....
T Consensus       472 ------~~~i~~~----------------~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  472 ------SLTIRSG----------------DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             ------ceeeecc----------------cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence                  0000000                00011122366778899999999999999988765443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.42  E-value=5.5e-12  Score=100.96  Aligned_cols=122  Identities=16%  Similarity=0.179  Sum_probs=95.9

Q ss_pred             CccccCCCceEEEEEeCCeeEEEEEEcCCCC--h-----hhHHHHHHHHHHHHhhc-----CCCcceE------EEEEec
Q 038681           60 NIVLEDPFRKLYKGFWQKRSISLMKYNGNRN--Q-----HALEWCINHIVYASRMS-----HKHIIKL------IVFESV  121 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~--~-----~~~~~~~~E~~~l~~l~-----H~nIv~~------lv~e~~  121 (332)
                      ..+++|+-+.+|.+.+-|.++++|.-.....  +     -..++..+|+.++.++.     -|-+..+      |+|||+
T Consensus         2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            4688999999999988777777776544321  1     12456789999999985     3444443      999999


Q ss_pred             cCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          122 QIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       122 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      +|-.|.+++...            ...++..+-.-+.-||   ..||+|+||.++||++...+ +.++|||++...
T Consensus        82 ~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          82 EGELLKDALEEA------------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             CChhHHHHHHhc------------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            999999888754            2457778888889999   99999999999999997654 999999999643

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.39  E-value=9.2e-12  Score=99.32  Aligned_cols=134  Identities=17%  Similarity=0.209  Sum_probs=103.4

Q ss_pred             CCCccccCCCceEEEEEeCCeeEEEEEEcCCCC-------hhhHHHHHHHHHHHHhhc-----CCCcceE------EEEE
Q 038681           58 EQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRN-------QHALEWCINHIVYASRMS-----HKHIIKL------IVFE  119 (332)
Q Consensus        58 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~-----H~nIv~~------lv~e  119 (332)
                      ....|-+|+-+.|+++.+.|+...||.-.....       .-...+..+|++.|.++.     -|-++-+      |+||
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME   90 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME   90 (229)
T ss_pred             cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence            567889999999999999999998887544321       112456889999999985     4555443      9999


Q ss_pred             eccC-CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC---CeEEeecCCcc
Q 038681          120 SVQI-GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS---DAKLFDFSLSL  195 (332)
Q Consensus       120 ~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~a~  195 (332)
                      |++| .++.+++......   .....-...++..|-+.+.-||   .++|+|+||..+||++..++   .+.++|||++.
T Consensus        91 ~~~g~~~vk~~i~~~~~~---~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   91 FIDGASTVKDFILSTMED---ESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             eccchhHHHHHHHHHccC---cccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEeecchh
Confidence            9976 4889999876432   1222233688999999999999   99999999999999996554   35899999985


Q ss_pred             cc
Q 038681          196 SI  197 (332)
Q Consensus       196 ~~  197 (332)
                      ..
T Consensus       165 ~s  166 (229)
T KOG3087|consen  165 VS  166 (229)
T ss_pred             cc
Confidence            54

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.34  E-value=1.1e-10  Score=104.29  Aligned_cols=262  Identities=16%  Similarity=0.101  Sum_probs=165.7

Q ss_pred             CCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcce-E-----------------E
Q 038681           56 YDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIK-L-----------------I  116 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~-~-----------------l  116 (332)
                      ....+.||+|+-+.+|-.-.-+. .+.|++.........    +-+..|... .||-+.. +                 +
T Consensus        13 i~~gr~LgqGgea~ly~l~e~~d-~VAKIYh~Pppa~~a----qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          13 IPPGRPLGQGGEADLYTLGEVRD-QVAKIYHAPPPAAQA----QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             cCCCccccCCccceeeecchhhc-hhheeecCCCchHHH----HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            34578899999999997544333 344666554432211    122233333 4554433 1                 5


Q ss_pred             EEEeccCC-ChHHHHhh-hhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          117 VFESVQIG-TLADRIHH-HCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       117 v~e~~~~g-~L~~~l~~-~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                      .|..+++. .+..+++- +.+++....+|...++.++.++.+.+-||   .+|.+-+|++++|+|+++++.+.|.|=..-
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccce
Confidence            56665543 23334332 23445567889999999999999999999   999999999999999999999999985443


Q ss_pred             cccCCCCceeeccccccCCCcccccccC-----C-CCChhhhHHHHHHHHHHHHhC-CccCCCCCccchhhhHHHHhhhh
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFT-----T-LINEQCDVYGFGAFLFELLTA-QEVSDHVSFESRFHYEENVKRLS  267 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~-~~~~~sDiwSlG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~  267 (332)
                      ....++...   ...+|...|.+||.-.     + .-+...|.|.||+++++++.| +.||.+........-......  
T Consensus       165 qi~~ng~~~---~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I--  239 (637)
T COG4248         165 QINANGTLH---LCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI--  239 (637)
T ss_pred             eeccCCceE---ecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh--
Confidence            333222222   4568999999999754     3 456789999999999999887 999987654322110000000  


Q ss_pred             ccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCC--CCCCCCHHHHHHHHHHHHHhh
Q 038681          268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFS--PEDRPTMVDVAKQLRQMYRSC  331 (332)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d--P~~RPs~~evl~~L~~l~~~~  331 (332)
                       ....+...-+...-....+....-.-.++.+..|..+|+...  +.-|||++.-+..|.++.+++
T Consensus       240 -a~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L  304 (637)
T COG4248         240 -AHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL  304 (637)
T ss_pred             -hcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence             001111111111111111111112345577889999999743  568999999999888887664

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.32  E-value=6.4e-11  Score=111.14  Aligned_cols=153  Identities=18%  Similarity=0.244  Sum_probs=116.5

Q ss_pred             CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCCChHHHHhhhhcccccCCCHH
Q 038681           76 QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLT  144 (332)
Q Consensus        76 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~  144 (332)
                      .+.+|.|...+.... ...+...+-++.|+.++||||+++           ||+|-+.  .|..++.+.        ...
T Consensus        36 ~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--------~~~  104 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--------GKE  104 (690)
T ss_pred             cCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh--------HHH
Confidence            788888888887765 445667888899999999999998           8999874  688888764        366


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCCC
Q 038681          145 DRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTL  224 (332)
Q Consensus       145 ~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  224 (332)
                      .+...+.||+.||.|||+  +.+++|++|.-+.|+++..|..||++|-.+..........  ....--..|..|+.... 
T Consensus       105 ~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~--~~~~~~~s~~~P~~~~~-  179 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPA--KSLYLIESFDDPEEIDP-  179 (690)
T ss_pred             HHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCccc--ccchhhhcccChhhcCc-
Confidence            677789999999999985  7899999999999999999999999998775443322100  11122233555654332 


Q ss_pred             CChhhhHHHHHHHHHHHHhC
Q 038681          225 INEQCDVYGFGAFLFELLTA  244 (332)
Q Consensus       225 ~~~~sDiwSlG~~l~elltg  244 (332)
                      -....|.|-|||+++|++.|
T Consensus       180 s~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  180 SEWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cccchhhhhHHHHHHHHhCc
Confidence            11346999999999999999

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.26  E-value=8.5e-11  Score=96.71  Aligned_cols=119  Identities=20%  Similarity=0.278  Sum_probs=79.6

Q ss_pred             eEEEEEe-CCeeEEEEEEcCCCC-------------------------hhhHHHHHHHHHHHHhhcCCCc--ce---E--
Q 038681           69 KLYKGFW-QKRSISLMKYNGNRN-------------------------QHALEWCINHIVYASRMSHKHI--IK---L--  115 (332)
Q Consensus        69 ~Vy~~~~-~~~~vavK~~~~~~~-------------------------~~~~~~~~~E~~~l~~l~H~nI--v~---~--  115 (332)
                      .||.|.. +|..+|+|.......                         ........+|.+.|.++...+|  .+   +  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~   80 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYNR   80 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEET
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEeC
Confidence            4899998 899999999764311                         0113457899999999975532  22   2  


Q ss_pred             --EEEEecc--CCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHH-hhhcCCCCeeecCCCCCCeeeCCCCCeEEee
Q 038681          116 --IVFESVQ--IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAY-LHVGFSRPIVYRDMKPTNILFNEQSDAKLFD  190 (332)
Q Consensus       116 --lv~e~~~--~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~-LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  190 (332)
                        |||||++  |..+..+....       ++......++.+++..+.. +|   ..||+|+||.+.||+++.+ .+.|+|
T Consensus        81 ~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~---~~givHGDLs~~NIlv~~~-~~~iID  149 (188)
T PF01163_consen   81 NVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLH---KAGIVHGDLSEYNILVDDG-KVYIID  149 (188)
T ss_dssp             TEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHH---CTTEEESS-STTSEEEETT-CEEE--
T ss_pred             CEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHH---hcCceecCCChhhEEeecc-eEEEEe
Confidence              9999998  65555443322       2244456777888885555 57   9999999999999999877 899999


Q ss_pred             cCCccccC
Q 038681          191 FSLSLSIP  198 (332)
Q Consensus       191 fg~a~~~~  198 (332)
                      ||.+....
T Consensus       150 f~qav~~~  157 (188)
T PF01163_consen  150 FGQAVDSS  157 (188)
T ss_dssp             GTTEEETT
T ss_pred             cCcceecC
Confidence            99886554

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.23  E-value=2.1e-10  Score=99.93  Aligned_cols=131  Identities=14%  Similarity=0.047  Sum_probs=98.7

Q ss_pred             CccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHH----------HHHHHHHHHHhhc-----CCCcceE---------
Q 038681           60 NIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALE----------WCINHIVYASRMS-----HKHIIKL---------  115 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~----------~~~~E~~~l~~l~-----H~nIv~~---------  115 (332)
                      +.+-......|+++.+.|+.+.||...........+          .+.+|...+.+|.     -|.+|-+         
T Consensus        28 e~v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~  107 (268)
T PRK15123         28 EVFRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT  107 (268)
T ss_pred             cEEecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence            445555555678888899999999885544221122          3789999988873     3444322         


Q ss_pred             ----EEEEeccCC-ChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC-------C
Q 038681          116 ----IVFESVQIG-TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE-------Q  183 (332)
Q Consensus       116 ----lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-------~  183 (332)
                          ||+|++++- +|.+++.....   ...+......++.+++..+.-||   ..||+|+|++++|||++.       +
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~---~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWAT---NPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcc---cCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCC
Confidence                899999875 79999864211   34567778899999999999999   999999999999999975       4


Q ss_pred             CCeEEeecCCccc
Q 038681          184 SDAKLFDFSLSLS  196 (332)
Q Consensus       184 ~~~kl~Dfg~a~~  196 (332)
                      +.+.|+||+.+..
T Consensus       182 ~~~~LIDl~r~~~  194 (268)
T PRK15123        182 LKLSVIDLHRAQI  194 (268)
T ss_pred             ceEEEEECCcccc
Confidence            6789999998753

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.19  E-value=2.4e-10  Score=97.17  Aligned_cols=131  Identities=18%  Similarity=0.152  Sum_probs=98.3

Q ss_pred             CccccCCCceEEEEEeCC-eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcC-----CCcce-----------EEEEEecc
Q 038681           60 NIVLEDPFRKLYKGFWQK-RSISLMKYNGNRNQHALEWCINHIVYASRMSH-----KHIIK-----------LIVFESVQ  122 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-----~nIv~-----------~lv~e~~~  122 (332)
                      +.|+.|..+.||++...+ ..+++|.............+.+|..++..+.+     |.++.           ++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            568999999999999854 89999997654332224567899999999864     33332           28999999


Q ss_pred             CCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhc---------------------------------------
Q 038681          123 IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVG---------------------------------------  163 (332)
Q Consensus       123 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------------------------------------  163 (332)
                      |+++.+.+..      ..++......++.+++.+|..||+.                                       
T Consensus        84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            9888776531      2366777777888888888888731                                       


Q ss_pred             --------------CCCCeeecCCCCCCeeeCC--CCCeEEeecCCccc
Q 038681          164 --------------FSRPIVYRDMKPTNILFNE--QSDAKLFDFSLSLS  196 (332)
Q Consensus       164 --------------~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~a~~  196 (332)
                                    ....++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          1356899999999999998  56689999988753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.15  E-value=5.1e-10  Score=95.03  Aligned_cols=144  Identities=17%  Similarity=0.105  Sum_probs=102.9

Q ss_pred             cccccHHHHHHHhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCC---------------------hhhHHHHH
Q 038681           41 YRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRN---------------------QHALEWCI   98 (332)
Q Consensus        41 ~~~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---------------------~~~~~~~~   98 (332)
                      +..+.+..+.....-+.++..||-|--|.||.|.. .|.++|||.-....+                     .-+...+.
T Consensus        78 yD~LAL~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~  157 (304)
T COG0478          78 YDALALHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAE  157 (304)
T ss_pred             hhHHHHHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHH
Confidence            34444555544444467889999999999999999 799999997543211                     01234578


Q ss_pred             HHHHHHHhhcCC--CcceE-------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 038681           99 NHIVYASRMSHK--HIIKL-------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIV  169 (332)
Q Consensus        99 ~E~~~l~~l~H~--nIv~~-------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  169 (332)
                      +|.++|.+|...  .|.+.       +||||++|-.|...-          ++....-.++..|+.-+.-+-   ..|||
T Consensus       158 rEf~~L~~L~~~G~~VP~P~~~nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~---~~GiV  224 (304)
T COG0478         158 REFEALQRLYPEGVKVPKPIAWNRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAY---RRGIV  224 (304)
T ss_pred             HHHHHHHHhhhcCCCCCCccccccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHH---HcCcc
Confidence            999999999543  44433       899999986664322          234444555566666655555   68999


Q ss_pred             ecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          170 YRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       170 H~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |+|+.+-||+++++|.+.++||-.+...
T Consensus       225 HGDlSefNIlV~~dg~~~vIDwPQ~v~~  252 (304)
T COG0478         225 HGDLSEFNILVTEDGDIVVIDWPQAVPI  252 (304)
T ss_pred             ccCCchheEEEecCCCEEEEeCcccccC
Confidence            9999999999999999999999766443

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.09  E-value=8.4e-09  Score=94.48  Aligned_cols=159  Identities=16%  Similarity=0.182  Sum_probs=119.8

Q ss_pred             CCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------------EEEEeccC-CChH
Q 038681           66 PFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------------IVFESVQI-GTLA  127 (332)
Q Consensus        66 ~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------------lv~e~~~~-g~L~  127 (332)
                      --.+.|++..  +|..+++|++....... ......=++.++++.|+|||++               +|++|.|+ ++|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~-~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQS-TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccC-cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence            4557899988  89999999995543322 2233455788999999999998               79999885 5777


Q ss_pred             HHHhhhhc----------ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          128 DRIHHHCE----------QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       128 ~~l~~~~~----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      ++.-....          ......++..+|.++.|+..||.++|   +.|+.=+-|.|.+||++.+.+++|+.-|....+
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl  443 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVL  443 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeee
Confidence            76543211          11235788999999999999999999   899999999999999999888998877776555


Q ss_pred             CCCCceeeccccccCCCcccccccCCCCChhhhHHHHHHHHHHHHhCCc
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQE  246 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~  246 (332)
                      ..+..                |.+  .--.+-|.=.||.+++.|.||..
T Consensus       444 ~~d~~----------------~~l--e~~Qq~D~~~lG~ll~aLAt~~~  474 (655)
T KOG3741|consen  444 QEDPT----------------EPL--ESQQQNDLRDLGLLLLALATGTE  474 (655)
T ss_pred             cCCCC----------------cch--hHHhhhhHHHHHHHHHHHhhccc
Confidence            44331                001  11235688999999999999963

>PRK09902 hypothetical protein; Provisional

Probab=98.98  E-value=1e-08  Score=85.10  Aligned_cols=143  Identities=13%  Similarity=0.079  Sum_probs=106.8

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCC-----hhhHHHHHHHHHHHHhhcCCCcc--eE-----
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRN-----QHALEWCINHIVYASRMSHKHII--KL-----  115 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv--~~-----  115 (332)
                      .+-.....+...=--|+||.+-|++....|..+-+|.......     +.....|.+|...+.+|..-+|.  +.     
T Consensus        12 ~~w~~~~~wve~pN~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~   91 (216)
T PRK09902         12 HWWATEGDWVEEPNYRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEA   91 (216)
T ss_pred             HHHhCCCceecCCCcCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeee
Confidence            3333344454444567899999999988888899998762211     22356799999999998543322  21     


Q ss_pred             ----------EEEEeccC-CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC
Q 038681          116 ----------IVFESVQI-GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS  184 (332)
Q Consensus       116 ----------lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  184 (332)
                                ||+|-+++ -||.+++....   ..+.+......++.+++..+.-||   ..|+.|+|+.+.||+++.++
T Consensus        92 ~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g  165 (216)
T PRK09902         92 VKIEGEWRALLVTEDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEG  165 (216)
T ss_pred             eccCCceEEEEEEEeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCC
Confidence                      89997653 58888886531   134677888899999999999999   99999999999999998777


Q ss_pred             C--eEEeecCCccc
Q 038681          185 D--AKLFDFSLSLS  196 (332)
Q Consensus       185 ~--~kl~Dfg~a~~  196 (332)
                      .  ++++||--++.
T Consensus       166 ~~~v~lIDlEk~r~  179 (216)
T PRK09902        166 KAEAGFLDLEKSRR  179 (216)
T ss_pred             CeeEEEEEhhccch
Confidence            7  99999976643

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.93  E-value=2.2e-10  Score=108.03  Aligned_cols=150  Identities=17%  Similarity=0.229  Sum_probs=102.3

Q ss_pred             HHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceee-------ccccccCCCcccccccCC
Q 038681          151 MDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIE-------LDSVVGTTGFIAPENFTT  223 (332)
Q Consensus       151 ~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~  223 (332)
                      .+++.||.|+|.  +.++||++|.|++|.++.++..||+.|+++-....+.....       .........|.|||.+.+
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            345599999996  78999999999999999999999999998755444221110       011234568999999988


Q ss_pred             -CCChhhhHHHHHHHHHHHH-hCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHH
Q 038681          224 -LINEQCDVYGFGAFLFELL-TAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQ  301 (332)
Q Consensus       224 -~~~~~sDiwSlG~~l~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (332)
                       ..+.++|+||+||++|.+. .|+..+...............    ....                ........+.++.+
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~----~~~~----------------~~~~s~~~p~el~~  243 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL----LNAG----------------AFGYSNNLPSELRE  243 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc----cccc----------------cccccccCcHHHHH
Confidence             7888999999999999999 555555433222111100000    0000                00001245578899


Q ss_pred             HHHHcccCCCCCCCCHHHHHH
Q 038681          302 LTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       302 li~~cl~~dP~~RPs~~evl~  322 (332)
                      =+.+++..++..||++.++..
T Consensus       244 ~l~k~l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  244 SLKKLLNGDSAVRPTLDLLLS  264 (700)
T ss_pred             HHHHHhcCCcccCcchhhhhc
Confidence            999999999999997776653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.91  E-value=5.9e-09  Score=87.79  Aligned_cols=114  Identities=18%  Similarity=0.182  Sum_probs=85.3

Q ss_pred             CCeeEEEEEEcCCCCh------hhHHHHHHHHHHHHhhcC-----CCcceE------------EEEEeccCC-ChHHHHh
Q 038681           76 QKRSISLMKYNGNRNQ------HALEWCINHIVYASRMSH-----KHIIKL------------IVFESVQIG-TLADRIH  131 (332)
Q Consensus        76 ~~~~vavK~~~~~~~~------~~~~~~~~E~~~l~~l~H-----~nIv~~------------lv~e~~~~g-~L~~~l~  131 (332)
                      .++.+.+|........      -...++.+|...+..|..     |..+-+            ||+|++++. +|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            4556666654322111      123467888888888743     333332            899999874 7999987


Q ss_pred             hhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC---CeEEeecCCcccc
Q 038681          132 HHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS---DAKLFDFSLSLSI  197 (332)
Q Consensus       132 ~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~a~~~  197 (332)
                      ..     ...+......++.+++..+.-||   ..||+|+|++|.|||++.++   .+.++||+-++..
T Consensus       111 ~~-----~~~~~~~~~~ll~~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  111 QW-----EQLDPSQRRELLRALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             hh-----cccchhhHHHHHHHHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            64     23667778899999999999999   99999999999999998887   7999999887653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.79  E-value=5.4e-08  Score=82.03  Aligned_cols=150  Identities=16%  Similarity=0.205  Sum_probs=103.2

Q ss_pred             cccccHHHHHHHhcCCCCCCc---cccCCCceEEEEEe-CCeeEEEEEEcCCCChh-----------------------h
Q 038681           41 YRIFSAEELRIATNNYDEQNI---VLEDPFRKLYKGFW-QKRSISLMKYNGNRNQH-----------------------A   93 (332)
Q Consensus        41 ~~~~~~~el~~~~~~y~~~~~---lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-----------------------~   93 (332)
                      +...+...+....++..+...   |..|.-+.||+|.. .+..+|+|++......-                       .
T Consensus        32 ~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv  111 (268)
T COG1718          32 FDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLV  111 (268)
T ss_pred             hhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHH
Confidence            334556666666666655444   55777789999988 79999999987543210                       1


Q ss_pred             HHHHHHHHHHHHhhcCCCc--ce-------EEEEEeccCC-ChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhc
Q 038681           94 LEWCINHIVYASRMSHKHI--IK-------LIVFESVQIG-TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVG  163 (332)
Q Consensus        94 ~~~~~~E~~~l~~l~H~nI--v~-------~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~  163 (332)
                      .....+|+..|.++....|  .+       +|||||+... .-.-.|..      ..+...++..+..++++++.-|-. 
T Consensus       112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~nVLvMEfIg~~g~pAP~LkD------v~~e~~e~~~~~~~~v~~~~~l~~-  184 (268)
T COG1718         112 FAWARKEFRNLKRAYEAGVRVPEPIAFRNNVLVMEFIGDDGLPAPRLKD------VPLELEEAEGLYEDVVEYMRRLYK-  184 (268)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCCceeecCCeEEEEeccCCCCCCCCccc------CCcCchhHHHHHHHHHHHHHHHHH-
Confidence            1245678888888854332  11       2999998653 11112221      123344788888999999988872 


Q ss_pred             CCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          164 FSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       164 ~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                       ..++||+||..=|||+. ++.+.|+|||.|.....
T Consensus       185 -~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h  218 (268)
T COG1718         185 -EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             -hcCcccccchhhheEEE-CCeEEEEECccccccCC
Confidence             49999999999999998 88999999999865543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.70  E-value=2.4e-07  Score=77.30  Aligned_cols=129  Identities=16%  Similarity=0.118  Sum_probs=90.3

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChh--hHHH------HHHHHHHHHhhc-----CCCcceE--
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQH--ALEW------CINHIVYASRMS-----HKHIIKL--  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~--~~~~------~~~E~~~l~~l~-----H~nIv~~--  115 (332)
                      ...++|...+.+-......|.+...+|..+++|.........  ....      ..+++..+.++.     .++-+-+  
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            346778888888888888999988899999999887654321  1111      123333333332     1211111  


Q ss_pred             ------------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC
Q 038681          116 ------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ  183 (332)
Q Consensus       116 ------------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  183 (332)
                                  |+|||++|..|.++..         +++    .+...+.+++.-||   ..|+.|+|..|.|++++.+
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNN  171 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECC
Confidence                        7999999988876542         222    24566778899999   9999999999999999865


Q ss_pred             CCeEEeecCCccc
Q 038681          184 SDAKLFDFSLSLS  196 (332)
Q Consensus       184 ~~~kl~Dfg~a~~  196 (332)
                      + ++++||+..+.
T Consensus       172 ~-i~iID~~~k~~  183 (229)
T PF06176_consen  172 G-IRIIDTQGKRM  183 (229)
T ss_pred             c-EEEEECccccc
Confidence            4 99999987654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.68  E-value=2e-07  Score=88.08  Aligned_cols=131  Identities=10%  Similarity=0.135  Sum_probs=88.2

Q ss_pred             CccccCCCceEEEEEe-CCeeEEEEEEcCCCChhh-----------------------------H----H------HHHH
Q 038681           60 NIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHA-----------------------------L----E------WCIN   99 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~-----------------------------~----~------~~~~   99 (332)
                      ..|+.++-|.||+|+. +|+.||||+....-.+..                             .    +      .+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            6899999999999999 799999999765432110                             0    0      1345


Q ss_pred             HHHHHHhhc-----CCCcc-----------eEEEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhc
Q 038681          100 HIVYASRMS-----HKHII-----------KLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVG  163 (332)
Q Consensus       100 E~~~l~~l~-----H~nIv-----------~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~  163 (332)
                      |...+.+++     .|+|.           ++|+|||++|-.+.+......    ..++.+.+.....++.  +..+=  
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d~k~ia~~~~~~f--~~q~~--  282 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGIDRKELAELLVRAF--LRQLL--  282 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCCHHHHHHHHHHHH--HHHHH--
Confidence            555555542     23221           129999999998988854321    2355333333222221  22222  


Q ss_pred             CCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          164 FSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       164 ~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                       ..|+.|.|..|.||+++.+|.+.+.|||+...+..
T Consensus       283 -~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         283 -RDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             -hcCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence             57999999999999999999999999999877654

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.62  E-value=3.7e-07  Score=72.99  Aligned_cols=124  Identities=10%  Similarity=0.079  Sum_probs=89.8

Q ss_pred             CCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcce----E----EEEEeccCCChH
Q 038681           56 YDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIK----L----IVFESVQIGTLA  127 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~----~----lv~e~~~~g~L~  127 (332)
                      ....+.||+|++|.||+|.+.|..+|+|+-..++.   ...+..|+++|..+.-.++.+    +    +.|||+.|-+|.
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds~---r~~l~kEakiLeil~g~~~~p~vy~yg~~~i~me~i~G~~L~  100 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDSP---RRNLEKEAKILEILAGEGVTPEVYFYGEDFIRMEYIDGRPLG  100 (201)
T ss_pred             hhhhhhhhcccccEEEEeeccCceEEEEEecCCcc---hhhHHHHHHHHHHhhhcCCCceEEEechhhhhhhhhcCcchh
Confidence            34567899999999999999999999999887765   567889999999987655543    3    789999987887


Q ss_pred             HHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC-CCCeeeCCCCCeEEeecCCcccc
Q 038681          128 DRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK-PTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       128 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk-p~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      +.-...        +..    -+..++++---|-   ..||-|+.|. |...++..++.+.|+||-.|+.-
T Consensus       101 ~~~~~~--------~rk----~l~~vlE~a~~LD---~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112         101 KLEIGG--------DRK----HLLRVLEKAYKLD---RLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             hhhhcc--------cHH----HHHHHHHHHHHHH---HhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            765421        222    2333444433344   7788898886 44445555568999999988643

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.52  E-value=1.2e-06  Score=82.63  Aligned_cols=133  Identities=14%  Similarity=0.117  Sum_probs=89.0

Q ss_pred             CCccccCCCceEEEEEe-CCeeEEEEEEcCCCChh------------------------------hHH------HHHHHH
Q 038681           59 QNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQH------------------------------ALE------WCINHI  101 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~------------------------------~~~------~~~~E~  101 (332)
                      .+.||.-+.|.||+|+. +|+.||||+-+..-...                              ..+      .|.+|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            46899999999999999 89999999976542211                              001      245555


Q ss_pred             HHHHhh----cCCC------cceE---------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhh
Q 038681          102 VYASRM----SHKH------IIKL---------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHV  162 (332)
Q Consensus       102 ~~l~~l----~H~n------Iv~~---------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~  162 (332)
                      +...++    .|-+      |.++         |+|||++|..+.+.-.-..    ..++...+..-+.+...-.-+   
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~----~gi~~~~i~~~l~~~~~~qIf---  318 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK----RGISPHDILNKLVEAYLEQIF---  318 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH----cCCCHHHHHHHHHHHHHHHHH---
Confidence            554443    3444      2222         9999999988876643221    246665444444443332323   


Q ss_pred             cCCCCeeecCCCCCCeeeCC----CCCeEEeecCCccccCCC
Q 038681          163 GFSRPIVYRDMKPTNILFNE----QSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       163 ~~~~~ivH~Dlkp~Nill~~----~~~~kl~Dfg~a~~~~~~  200 (332)
                        ..|++|+|-.|.||+++.    ++.+.+-|||+.......
T Consensus       319 --~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  319 --KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             --hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence              467999999999999983    678999999998766543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.45  E-value=1.6e-06  Score=73.98  Aligned_cols=133  Identities=13%  Similarity=0.151  Sum_probs=77.2

Q ss_pred             CccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcC-----CCcceE-----------EEEEeccC
Q 038681           60 NIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSH-----KHIIKL-----------IVFESVQI  123 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-----~nIv~~-----------lv~e~~~~  123 (332)
                      +.|+.|..+.||+....+..+++|.....   .....+.+|..++..+..     |.++..           ++|++++|
T Consensus         3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~---~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP---DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEESSSSEEEEEEETTSEEEEEEESSH---HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             ccCCCCCeeeEEEEEECCcEEEEEEeCCC---CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            56899999999999997789999997665   335677889999888843     334431           79999998


Q ss_pred             CChHH----------------HHhhhhcc--cccCCCHHH---------HHHH------------HHHHHH-HHHHhhh-
Q 038681          124 GTLAD----------------RIHHHCEQ--HFEALSLTD---------RLKV------------AMDIAH-AVAYLHV-  162 (332)
Q Consensus       124 g~L~~----------------~l~~~~~~--~~~~l~~~~---------~~~i------------~~~i~~-~L~~LH~-  162 (332)
                      .++..                .+..--..  .........         ....            ...+.. .+..++. 
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            87777                11110000  000011000         0000            111222 2222221 


Q ss_pred             ---cCCCCeeecCCCCCCeeeC-CCCCeEEeecCCcc
Q 038681          163 ---GFSRPIVYRDMKPTNILFN-EQSDAKLFDFSLSL  195 (332)
Q Consensus       163 ---~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~a~  195 (332)
                         .....++|+|+.|.||+++ .++.+-|+||+.+.
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence               1257899999999999999 55666799998763

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.41  E-value=6.2e-06  Score=70.36  Aligned_cols=130  Identities=12%  Similarity=0.089  Sum_probs=74.6

Q ss_pred             CccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-----CCCcceE--------EEEEeccCCC-
Q 038681           60 NIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMS-----HKHIIKL--------IVFESVQIGT-  125 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----H~nIv~~--------lv~e~~~~g~-  125 (332)
                      ..||.|..+.||+.  .+..+++|.......   .....+|.+++..+.     .|.++.+        +|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~~---~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH--KTGKWMLKLYNPGFD---KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe--cCCCEEEEeCCCCCC---HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57899999999984  355677888765432   344688999998874     3444444        8999999863 


Q ss_pred             hHHHH--------------hhh---hcc-cccCCCHHHHH-HHHH----------HHHHH-HHHhhh-cCCCCeeecCCC
Q 038681          126 LADRI--------------HHH---CEQ-HFEALSLTDRL-KVAM----------DIAHA-VAYLHV-GFSRPIVYRDMK  174 (332)
Q Consensus       126 L~~~l--------------~~~---~~~-~~~~l~~~~~~-~i~~----------~i~~~-L~~LH~-~~~~~ivH~Dlk  174 (332)
                      +...+              ...   ... .....+..... .+..          .+... ..+|.. .....++|+|+.
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~  161 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ  161 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence            21111              110   000 00011111100 0000          00111 111110 114567999999


Q ss_pred             CCCeeeCCCCCeEEeecCCcc
Q 038681          175 PTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       175 p~Nill~~~~~~kl~Dfg~a~  195 (332)
                      |.||+++.++ +.|+||+.+.
T Consensus       162 ~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       162 IGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCcEEEcCCC-cEEEechhcC
Confidence            9999999888 9999998774

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.34  E-value=3e-06  Score=84.96  Aligned_cols=184  Identities=16%  Similarity=0.229  Sum_probs=125.1

Q ss_pred             HHHHHHHHHHhhcCCCcceEEEE---------------EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHh
Q 038681           96 WCINHIVYASRMSHKHIIKLIVF---------------ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYL  160 (332)
Q Consensus        96 ~~~~E~~~l~~l~H~nIv~~lv~---------------e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~L  160 (332)
                      ...-|...+.+..|+|++.+.++               |+|..-++...+..-     ..++....+.+..++.+||.|+
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v-----~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV-----GSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc-----cccCHHHHHHHHHHHhhhHHHH
Confidence            34456667788899999998433               445555555555544     6788999999999999999999


Q ss_pred             hhcCCCCeeecCCCCC---CeeeCCCCCeEEe--ecCCccccCCCCceeeccccccCCCcccccccCC---CCChhhhHH
Q 038681          161 HVGFSRPIVYRDMKPT---NILFNEQSDAKLF--DFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT---LINEQCDVY  232 (332)
Q Consensus       161 H~~~~~~ivH~Dlkp~---Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~sDiw  232 (332)
                      |   +....|.-+..+   +-..+.++.+.++  ||+.++...+....   .....+..|.+||....   ..+...|+|
T Consensus       303 h---~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~  376 (1351)
T KOG1035|consen  303 H---SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLW  376 (1351)
T ss_pred             H---HhccceeEEecccccccccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHH
Confidence            9   665555544444   3344556667766  99888877665432   23455667888888776   334457999


Q ss_pred             HHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCC
Q 038681          233 GFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPE  312 (332)
Q Consensus       233 SlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~  312 (332)
                      .+|.....+..|..+-......                   ....+.              .......+...+|+..+++
T Consensus       377 ~lgll~~~~~~~~~i~~~~~~~-------------------~~~l~~--------------~~~~~~~d~~~~~~~~~~~  423 (1351)
T KOG1035|consen  377 CLGLLLLQLSQGEDISEKSAVP-------------------VSLLDV--------------LSTSELLDALPKCLDEDSE  423 (1351)
T ss_pred             HHHHHHhhhhhcCcccccccch-------------------hhhhcc--------------ccchhhhhhhhhhcchhhh
Confidence            9999999999886553211100                   001100              0112567888999999999


Q ss_pred             CCCCHHHHHHH
Q 038681          313 DRPTMVDVAKQ  323 (332)
Q Consensus       313 ~RPs~~evl~~  323 (332)
                      +|+++.+++..
T Consensus       424 ~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  424 ERLSALELLTH  434 (1351)
T ss_pred             hccchhhhhhc
Confidence            99999998763

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.27  E-value=1.8e-07  Score=87.98  Aligned_cols=174  Identities=17%  Similarity=0.103  Sum_probs=121.8

Q ss_pred             CCCCCccccCCCceEEEEEeCCe-eEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCC-cceE-----------EEEEecc
Q 038681           56 YDEQNIVLEDPFRKLYKGFWQKR-SISLMKYNGNRNQHALEWCINHIVYASRMSHKH-IIKL-----------IVFESVQ  122 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n-Iv~~-----------lv~e~~~  122 (332)
                      +...+-.++|+++.+++.+...+ ....+.+...      ....-++++|.+++||| .+..           ++++++.
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~h~fvs~~------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s  317 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS  317 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhheeceeeccc------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence            33445678999999999988333 3334444332      33456789999999999 5544           6777776


Q ss_pred             CC-ChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCC
Q 038681          123 IG-TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE  201 (332)
Q Consensus       123 ~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  201 (332)
                      .| +-...+...    ...+...+...+.+.-+++|+++|   +-.=+|+|    ||+..+ +..+..||+....+....
T Consensus       318 ~~rs~~~~~~~s----e~~~~~~~~~~~~r~et~~l~~l~---~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  318 TGRSSALEMTVS----EIALEQYQFAYPLRKETRPLAELH---SSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             CCccccccCChh----hHhhhhhhhhhhhhhhcccccccc---cccccCcc----cccccc-cccccccccCCcccCccc
Confidence            65 221111110    012444556667888889999999   66568888    777654 679999999987766554


Q ss_pred             ceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCC
Q 038681          202 THIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDH  250 (332)
Q Consensus       202 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~  250 (332)
                         ......+|+.++|||+... .+....|.||+|.-..++.-|.+|-..
T Consensus       386 ---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  386 ---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             ---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence               2256789999999997766 889999999999887788888777654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.22  E-value=5e-05  Score=62.79  Aligned_cols=95  Identities=21%  Similarity=0.208  Sum_probs=75.9

Q ss_pred             HHHHHHHHhhcC-CCcceE-------EEEEeccCCChHHH---HhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCC
Q 038681           98 INHIVYASRMSH-KHIIKL-------IVFESVQIGTLADR---IHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSR  166 (332)
Q Consensus        98 ~~E~~~l~~l~H-~nIv~~-------lv~e~~~~g~L~~~---l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~  166 (332)
                      .+|.-++..+.+ +++.++       +|.||.+.+++...   +.+.     ...+|..+.+|+.++++.+.+++++...
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~~~v~E~~~~~~~~~~~~~l~~~-----~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGRFYVVEYVGAGSLYGIYRPLSQF-----LQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCCEEEEEeecCccccccccccccc-----cccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            468888888876 577777       89999987766432   1111     2468999999999999999999965556


Q ss_pred             CeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          167 PIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       167 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      .+.-.|++|+|+-+++++++|++|...+...
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            7888999999999999999999999876443

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.06  E-value=7.3e-05  Score=64.57  Aligned_cols=130  Identities=11%  Similarity=-0.043  Sum_probs=74.5

Q ss_pred             cccCCC-ceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc----CCCcce--------EEEEEeccCCChHH
Q 038681           62 VLEDPF-RKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMS----HKHIIK--------LIVFESVQIGTLAD  128 (332)
Q Consensus        62 lg~G~~-g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----H~nIv~--------~lv~e~~~~g~L~~  128 (332)
                      |-.|.. +.||+....+..+.+|......    .....+|+.++..+.    .|.++.        ++|||+++|.+|..
T Consensus         6 ~~~g~~~~~v~~~~~~~~~~~vk~~~~~~----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   81 (244)
T cd05150           6 VTEGQSGATVYRLDGKNPGLYLKIAPSGP----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA   81 (244)
T ss_pred             cCCCCCcCeEEEEcCCCCcEEEEecCCCc----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence            444555 7899998876778888876543    234567888887773    344443        28999999877764


Q ss_pred             HHh----------------hhhccc--ccCCCHH--HHHHH-----------------------HHHHHHHHHHhh-hcC
Q 038681          129 RIH----------------HHCEQH--FEALSLT--DRLKV-----------------------AMDIAHAVAYLH-VGF  164 (332)
Q Consensus       129 ~l~----------------~~~~~~--~~~l~~~--~~~~i-----------------------~~~i~~~L~~LH-~~~  164 (332)
                      ...                .--...  ..++...  .....                       ..++...|.... ...
T Consensus        82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence            321                000000  0011100  00000                       111111111110 011


Q ss_pred             CCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          165 SRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       165 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      ...++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            4569999999999999987778899998763

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.02  E-value=6.5e-05  Score=62.11  Aligned_cols=140  Identities=18%  Similarity=0.171  Sum_probs=88.1

Q ss_pred             CCcccccHHHHHHHhcCCCCCCccccCCC-ceEEEEEeCCeeEEEEEEcC---CCC-------h----------hhHHHH
Q 038681           39 NPYRIFSAEELRIATNNYDEQNIVLEDPF-RKLYKGFWQKRSISLMKYNG---NRN-------Q----------HALEWC   97 (332)
Q Consensus        39 ~~~~~~~~~el~~~~~~y~~~~~lg~G~~-g~Vy~~~~~~~~vavK~~~~---~~~-------~----------~~~~~~   97 (332)
                      +.+..|+.     -+.+++..+.||.|.- |.||++...|+.+|+|.+..   ...       .          ....-|
T Consensus        27 PKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF  101 (207)
T PF13095_consen   27 PKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPF  101 (207)
T ss_pred             CCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChH
Confidence            33445554     2277899999999999 99999999999999999322   111       0          112358


Q ss_pred             HHHHHHHHhhc---CCCc--ceEEEEEeccCCChHHHHhhh---hccc-----------ccCCCHHHHHHHHHHHHHHHH
Q 038681           98 INHIVYASRMS---HKHI--IKLIVFESVQIGTLADRIHHH---CEQH-----------FEALSLTDRLKVAMDIAHAVA  158 (332)
Q Consensus        98 ~~E~~~l~~l~---H~nI--v~~lv~e~~~~g~L~~~l~~~---~~~~-----------~~~l~~~~~~~i~~~i~~~L~  158 (332)
                      ..|.+...+|+   +.++  |+.  +-|+-- +..+-+...   ....           ....+......-+.+|.+-|.
T Consensus       102 ~~ECRAfgRLke~~~e~~~Avkc--~Gyl~L-~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~~~~~~~~~~~~~dl~  178 (207)
T PF13095_consen  102 NCECRAFGRLKEAGREGLWAVKC--HGYLLL-TEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDPPLQIRDIPQMLRDLK  178 (207)
T ss_pred             HHHHHhhHHHHhccccCceEEEe--eEEEEE-chHHHHHHhhcccccCCCCccEEEEEeecCCccccchhHHHHHHHHHH
Confidence            88999988885   4455  454  111100 101111100   0000           000111223445677888899


Q ss_pred             HhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          159 YLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       159 ~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                      .+|   ..||+-+|+++.|..     .-+|+|||.+
T Consensus       179 ~~~---k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILH---KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHH---HCCeeeccCcccccc-----CCEEEecccC
Confidence            999   999999999999986     3589999865

>PLN02876 acyl-CoA dehydrogenase

Probab=98.01  E-value=8e-05  Score=75.61  Aligned_cols=67  Identities=7%  Similarity=-0.046  Sum_probs=46.7

Q ss_pred             CCccccCCCceEEEEEeCC----eeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-CCCc--ce--------------EEE
Q 038681           59 QNIVLEDPFRKLYKGFWQK----RSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHI--IK--------------LIV  117 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nI--v~--------------~lv  117 (332)
                      ...++.|.+..+|+....+    ..+++|+............+.+|+.+++.+. |++|  .+              ++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            5668999999999988733    4677777654332222356789999999985 6554  22              289


Q ss_pred             EEeccCCC
Q 038681          118 FESVQIGT  125 (332)
Q Consensus       118 ~e~~~~g~  125 (332)
                      |||++|..
T Consensus       123 ME~v~G~~  130 (822)
T PLN02876        123 MEYLEGRI  130 (822)
T ss_pred             EEecCCcc
Confidence            99998754

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.00  E-value=0.00018  Score=59.80  Aligned_cols=124  Identities=20%  Similarity=0.322  Sum_probs=81.8

Q ss_pred             CCCCccccCCCceEEEEEeCCeeEEEEEEcCCC---------------ChhhHHHHHHHHHHHHhhc------CCCcceE
Q 038681           57 DEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNR---------------NQHALEWCINHIVYASRMS------HKHIIKL  115 (332)
Q Consensus        57 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---------------~~~~~~~~~~E~~~l~~l~------H~nIv~~  115 (332)
                      +....||+|+.-.||.-- .+...+||+.....               .........+|+.....+.      +.+|.++
T Consensus         4 ~~~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CCCcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            345789999999999632 55566778776655               1122456777877777766      5566665


Q ss_pred             -----------EEEEeccC------CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCe
Q 038681          116 -----------IVFESVQI------GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNI  178 (332)
Q Consensus       116 -----------lv~e~~~~------g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  178 (332)
                                 +|+|.+.+      -+|.+++...      .++. .....+.++.   .||-   .++|+.+|++|.||
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~------~~~~-~~~~~L~~f~---~~l~---~~~Iv~~dl~~~NI  149 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG------GLTE-ELRQALDEFK---RYLL---DHHIVIRDLNPHNI  149 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC------CccH-HHHHHHHHHH---HHHH---HcCCeecCCCcccE
Confidence                       77777643      3678888543      4555 4444555444   4555   77899999999999


Q ss_pred             eeCCCC----CeEEee-cCCc
Q 038681          179 LFNEQS----DAKLFD-FSLS  194 (332)
Q Consensus       179 ll~~~~----~~kl~D-fg~a  194 (332)
                      ++....    .+.|+| ||..
T Consensus       150 v~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  150 VVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             EEEecCCCceEEEEEeCCCCc
Confidence            995332    467777 4543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.99  E-value=5.2e-05  Score=66.05  Aligned_cols=134  Identities=11%  Similarity=0.015  Sum_probs=76.3

Q ss_pred             ccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcC----CCcceE----EEEEeccCCChHH----
Q 038681           61 IVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSH----KHIIKL----IVFESVQIGTLAD----  128 (332)
Q Consensus        61 ~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~~----lv~e~~~~g~L~~----  128 (332)
                      .+..|-.+.+|+...++..+++|........-. -...+|..+++.+..    |.++-.    +|+||++|..+..    
T Consensus         3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~i~~~~~~~v~e~i~G~~~~~~~~~   81 (256)
T TIGR02721         3 TLSGGLTNRSWRIEHPGISFVWRPQSPVCKALG-VDRQREYQILQALSALGLAPKPILVNEHWLLVEWLEGEVITLDQFV   81 (256)
T ss_pred             cCCCcCcCCeEEEEeCCccEEEeeCCccccccc-CcHHHHHHHHHHHHhcCCCCceEEEeCCEEEEEeccCccccccccc
Confidence            356688889999988888888887544322110 124678888888853    444443    8999999866532    


Q ss_pred             ----------HHhhh-h-cccccCCCHH-HHHHHHHHH---------HHHHHHhhh-----cCCCCeeecCCCCCCeeeC
Q 038681          129 ----------RIHHH-C-EQHFEALSLT-DRLKVAMDI---------AHAVAYLHV-----GFSRPIVYRDMKPTNILFN  181 (332)
Q Consensus       129 ----------~l~~~-~-~~~~~~l~~~-~~~~i~~~i---------~~~L~~LH~-----~~~~~ivH~Dlkp~Nill~  181 (332)
                                .+.+- . .....+++.. .+..+..++         ..-+..+-.     .....++|+|+.|.||+++
T Consensus        82 ~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~  161 (256)
T TIGR02721        82 ALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVT  161 (256)
T ss_pred             CchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEe
Confidence                      11110 0 0000112221 111211111         111111110     1134689999999999999


Q ss_pred             CCCCeEEeecCCccc
Q 038681          182 EQSDAKLFDFSLSLS  196 (332)
Q Consensus       182 ~~~~~kl~Dfg~a~~  196 (332)
                      .++ +.|+||..|..
T Consensus       162 ~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       162 PQG-LKLIDWEYASD  175 (256)
T ss_pred             CCC-CEEEeccccCc
Confidence            877 78999987743

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.92  E-value=9.4e-05  Score=65.84  Aligned_cols=133  Identities=13%  Similarity=0.111  Sum_probs=78.6

Q ss_pred             CCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCC--cceE-----------------EEEE
Q 038681           59 QNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKH--IIKL-----------------IVFE  119 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~~-----------------lv~e  119 (332)
                      .+.|..|....+|+....+..+++|..... .   ......|+.++..+.+.+  +.++                 .|++
T Consensus        19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~-~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV-S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCCCcEEEEEcCCC-C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            456777888899998877778888887652 1   345677888888874322  2221                 6899


Q ss_pred             eccCCChHH----H----------Hhhhhcccc------cCCCHHHHH----------HHHHHHHHHHHHhhh----cCC
Q 038681          120 SVQIGTLAD----R----------IHHHCEQHF------EALSLTDRL----------KVAMDIAHAVAYLHV----GFS  165 (332)
Q Consensus       120 ~~~~g~L~~----~----------l~~~~~~~~------~~l~~~~~~----------~i~~~i~~~L~~LH~----~~~  165 (332)
                      |++|.++..    .          ++.......      ....+....          .....+..++.++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            998866422    1          111000000      000111100          011112333444431    113


Q ss_pred             CCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          166 RPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       166 ~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      .+++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            679999999999999987777899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.85  E-value=0.00019  Score=64.27  Aligned_cols=134  Identities=15%  Similarity=0.210  Sum_probs=96.7

Q ss_pred             CCCCccccCCCceEEEEEe-CCeeEEEEEEcCCC-----------------------Chh--hHHHHHHHHHHHHhhcCC
Q 038681           57 DEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNR-----------------------NQH--ALEWCINHIVYASRMSHK  110 (332)
Q Consensus        57 ~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-----------------------~~~--~~~~~~~E~~~l~~l~H~  110 (332)
                      .+...|..|--+.||.++. +|..+|||+++...                       ++.  ..-++..|++.|.+++..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            4567788999999999999 88899999876321                       011  122466789999998754


Q ss_pred             Ccc-------e--EEEEEeccCCC-hHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee
Q 038681          111 HII-------K--LIVFESVQIGT-LADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF  180 (332)
Q Consensus       111 nIv-------~--~lv~e~~~~g~-L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  180 (332)
                      .|.       +  +|||+|+.... ..-.|..      ..++...+..+-.|++.-+.-|-+  ..++||.||.-=|+|+
T Consensus       227 GIP~PePIlLk~hVLVM~FlGrdgw~aPkLKd------~~ls~~ka~~~Y~~~v~~MR~lY~--~c~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  227 GIPCPEPILLKNHVLVMEFLGRDGWAAPKLKD------ASLSTSKARELYQQCVRIMRRLYQ--KCRLVHADLSEFNLLY  298 (520)
T ss_pred             CCCCCCceeeecceEeeeeccCCCCcCccccc------ccCChHHHHHHHHHHHHHHHHHHH--HhceeccchhhhhheE
Confidence            432       1  29999985321 1222222      357777888888888888888764  7899999999999998


Q ss_pred             CCCCCeEEeecCCccccCC
Q 038681          181 NEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       181 ~~~~~~kl~Dfg~a~~~~~  199 (332)
                       .+|.+.|+|.+.|-....
T Consensus       299 -hdG~lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  299 -HDGKLYIIDVSQSVEHDH  316 (520)
T ss_pred             -ECCEEEEEEccccccCCC
Confidence             467899999988755433

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.84  E-value=0.00025  Score=60.79  Aligned_cols=65  Identities=12%  Similarity=0.068  Sum_probs=43.6

Q ss_pred             CccccCCCceEEEEEeC---CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcC----CCcceE----EEEEeccCCCh
Q 038681           60 NIVLEDPFRKLYKGFWQ---KRSISLMKYNGNRNQHALEWCINHIVYASRMSH----KHIIKL----IVFESVQIGTL  126 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~~----lv~e~~~~g~L  126 (332)
                      +.|..|-...+|+....   +..+++|........  .-...+|+.++..+..    |.+...    ++|||++|.++
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~--~~d~~~E~~~~~~l~~~gl~P~v~~~~~~~~l~e~i~G~~l   79 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL--IIDRERELRIHKLLSKHGLAPKLYATFQNGLIYEFIPGRTL   79 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc--eecHHHHHHHHHHHHhCCCCCeEEEEeCCcEEEEeeCCCcC
Confidence            45777888899999874   578888876543221  1223478888888853    333222    89999998665

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.83  E-value=0.00079  Score=60.31  Aligned_cols=151  Identities=18%  Similarity=0.191  Sum_probs=85.9

Q ss_pred             ccccHHHHHHHhcCCCC-----CCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcC-----CC
Q 038681           42 RIFSAEELRIATNNYDE-----QNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSH-----KH  111 (332)
Q Consensus        42 ~~~~~~el~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-----~n  111 (332)
                      ...+.+++......|.+     ...++.|....+|+...++..+++|.......   .+....|..++..|..     |.
T Consensus         5 ~~~~~~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~~---~~~i~~e~~~l~~L~~~g~pvp~   81 (307)
T TIGR00938         5 TSVSDEEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVGRYILTLYEKRVK---AEELPFFLALTTHLAARGLPVPK   81 (307)
T ss_pred             ccCCHHHHHHHHHhcCCCCceeccccCCccccceEEEEeCCCcEEEEEecCCCC---HHHHHHHHHHHHHHHHCCCCCCc
Confidence            34555666555555644     45677777789999887666788888765322   2344566777777632     22


Q ss_pred             cce--------------EEEEEeccCCChH-----------HH---HhhhhcccccC------C-CHHHHH---------
Q 038681          112 IIK--------------LIVFESVQIGTLA-----------DR---IHHHCEQHFEA------L-SLTDRL---------  147 (332)
Q Consensus       112 Iv~--------------~lv~e~~~~g~L~-----------~~---l~~~~~~~~~~------l-~~~~~~---------  147 (332)
                      +++              ++++||++|.++.           ..   ++.........      . .|....         
T Consensus        82 ~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~  161 (307)
T TIGR00938        82 PVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQ  161 (307)
T ss_pred             cccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccc
Confidence            222              1689999885432           11   11110000000      0 011000         


Q ss_pred             ---HHHHHHHHHHHHhhh----cCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          148 ---KVAMDIAHAVAYLHV----GFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       148 ---~i~~~i~~~L~~LH~----~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                         .....+...++++..    ....+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       162 l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       162 LEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence               011123334555531    125789999999999999988767899998773

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.83  E-value=0.00026  Score=60.78  Aligned_cols=31  Identities=19%  Similarity=0.248  Sum_probs=25.8

Q ss_pred             CCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          165 SRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       165 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      ..+++|+|+.|.||+++.++..-|+||+.+.
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~  193 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLG  193 (235)
T ss_pred             CceEEeCCCCCCcEEEECCCEEEEEeCcccC
Confidence            4569999999999999876555699999874

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK05231 homoserine kinase; Provisional

Probab=97.80  E-value=0.00092  Score=60.19  Aligned_cols=150  Identities=13%  Similarity=0.092  Sum_probs=81.5

Q ss_pred             ccccHHHHHHHhcCCCC-----CCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-----CCC
Q 038681           42 RIFSAEELRIATNNYDE-----QNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMS-----HKH  111 (332)
Q Consensus        42 ~~~~~~el~~~~~~y~~-----~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----H~n  111 (332)
                      ..++.+++......|.+     .+.|+.|....+|+...++..+++|++. ...   .+....|+.++..|.     -|.
T Consensus         5 t~ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g~~vLK~~~-~~~---~~~l~~~~~~l~~L~~~glpvP~   80 (319)
T PRK05231          5 TDVSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQGEYVLTLFE-RLT---AEDLPFFLGLMQHLAARGVPVPA   80 (319)
T ss_pred             ccCCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCCcEEEEEec-cCC---hHHhHHHHHHHHHHHHCCCCCCc
Confidence            44566666555555644     3456677778999988766678899876 222   233344556665553     344


Q ss_pred             cce--------------EEEEEeccCCChH-----------HHHh---hhhccc------ccCCCH-HHHHH--------
Q 038681          112 IIK--------------LIVFESVQIGTLA-----------DRIH---HHCEQH------FEALSL-TDRLK--------  148 (332)
Q Consensus       112 Iv~--------------~lv~e~~~~g~L~-----------~~l~---~~~~~~------~~~l~~-~~~~~--------  148 (332)
                      ++.              ++++||++|..+.           ..+.   ......      ...+.+ .....        
T Consensus        81 ~i~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (319)
T PRK05231         81 PVARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLAD  160 (319)
T ss_pred             ceeCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccCh
Confidence            342              1789999886431           1111   110000      000111 11110        


Q ss_pred             ----HHHH-HHHHHHHhhh----cCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          149 ----VAMD-IAHAVAYLHV----GFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       149 ----i~~~-i~~~L~~LH~----~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                          .+.+ +...++.+-.    ....+++|+|+.|.||+++.+...-|+||+.+.
T Consensus       161 ~~~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        161 EQAALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             hHHHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence                1111 1111222221    024689999999999999866555799998874

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.78  E-value=5.3e-06  Score=85.27  Aligned_cols=178  Identities=11%  Similarity=-0.037  Sum_probs=123.1

Q ss_pred             ceEEEEEe-CC--eeEEEEEEcCCCCh----hhHHHHHHHHHHHHhhcCCCcceE-------------EEEEeccCCChH
Q 038681           68 RKLYKGFW-QK--RSISLMKYNGNRNQ----HALEWCINHIVYASRMSHKHIIKL-------------IVFESVQIGTLA  127 (332)
Q Consensus        68 g~Vy~~~~-~~--~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~H~nIv~~-------------lv~e~~~~g~L~  127 (332)
                      +.-+++.+ ..  ..+.+++.+...-+    ...+....|..-++...|+++...             .+++|+.+|++.
T Consensus      1240 ~~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f 1319 (2724)
T KOG1826|consen 1240 HFHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLF 1319 (2724)
T ss_pred             ceeeccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHH
Confidence            34456666 22  22345554433221    113334555556666789998876             789999999999


Q ss_pred             HHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhc--CCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceee
Q 038681          128 DRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVG--FSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIE  205 (332)
Q Consensus       128 ~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~--~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~  205 (332)
                      +.+.+.... ...++..-+.....+.+.+..-+|..  .++--+|++||+-|.+|..+.++|++++|+.+........  
T Consensus      1320 ~iIikg~ee-~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf-- 1396 (2724)
T KOG1826|consen 1320 SIIIKGLEE-SPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSF-- 1396 (2724)
T ss_pred             HHHHhcccc-CCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhh--
Confidence            998765332 23455555555555546666666632  2455799999999999999999999999999843332221  


Q ss_pred             ccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccC
Q 038681          206 LDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVS  248 (332)
Q Consensus       206 ~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~  248 (332)
                      .....+++.|++|++... .++.++|+|+.|+-+|+...|..+|
T Consensus      1397 ~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1397 FGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             hhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            245678889999999888 8888899999999999998777665

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.78  E-value=4.1e-05  Score=67.25  Aligned_cols=129  Identities=13%  Similarity=0.066  Sum_probs=90.3

Q ss_pred             CCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCC-----------------h----hhHHHHHHHHHHHHhhc-CCC
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRN-----------------Q----HALEWCINHIVYASRMS-HKH  111 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-----------------~----~~~~~~~~E~~~l~~l~-H~n  111 (332)
                      -+.+++.||-|.-+.||.+.+ .|++.++|.-.....                 .    -+.-.+.+|...|+.|. |..
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            478899999999999999999 788888886332111                 0    01223678999998884 322


Q ss_pred             cce--------EEEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC
Q 038681          112 IIK--------LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ  183 (332)
Q Consensus       112 Iv~--------~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  183 (332)
                      =|+        ++|||++.+-+|.+.-+        ..+...+..-+..+..   -|.   .+|+||+|..-=||+++++
T Consensus       173 pVPkpiD~~RH~Vvmelv~g~Pl~~v~~--------v~d~~~ly~~lm~~Iv---~la---~~GlIHgDFNEFNimv~dd  238 (465)
T KOG2268|consen  173 PVPKPIDHNRHCVVMELVDGYPLRQVRH--------VEDPPTLYDDLMGLIV---RLA---NHGLIHGDFNEFNIMVKDD  238 (465)
T ss_pred             CCCCcccccceeeHHHhhcccceeeeee--------cCChHHHHHHHHHHHH---HHH---HcCceecccchheeEEecC
Confidence            221        28999998888766542        2334444444444433   344   8999999999999999999


Q ss_pred             CCeEEeecCCcccc
Q 038681          184 SDAKLFDFSLSLSI  197 (332)
Q Consensus       184 ~~~kl~Dfg~a~~~  197 (332)
                      +.++++||-..-..
T Consensus       239 ~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  239 DKIVVIDFPQMVST  252 (465)
T ss_pred             CCEEEeechHhhcc
Confidence            99999999765433

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.73  E-value=0.00066  Score=62.59  Aligned_cols=66  Identities=6%  Similarity=-0.046  Sum_probs=45.9

Q ss_pred             CCccccCCCceEEEEEe-CC-eeEEEEEEcCC------CChhhHHHHHHHHHHHHhhc-C-----CCcceE------EEE
Q 038681           59 QNIVLEDPFRKLYKGFW-QK-RSISLMKYNGN------RNQHALEWCINHIVYASRMS-H-----KHIIKL------IVF  118 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~-~~-~~vavK~~~~~------~~~~~~~~~~~E~~~l~~l~-H-----~nIv~~------lv~  118 (332)
                      .+.||.|.+..||++.. +| +.|+||.-...      ..+-..+++..|.+.|..+. +     |.|+.+      +||
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~~~lVM  110 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEELAVTVM  110 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCCCEEEE
Confidence            35799999999999999 44 48999985421      11223677888888888863 1     333332      999


Q ss_pred             EeccCC
Q 038681          119 ESVQIG  124 (332)
Q Consensus       119 e~~~~g  124 (332)
                      ||+++.
T Consensus       111 E~L~~~  116 (401)
T PRK09550        111 EDLSDH  116 (401)
T ss_pred             ecCCCc
Confidence            999863

>PRK10593 hypothetical protein; Provisional

Probab=97.72  E-value=0.00061  Score=60.69  Aligned_cols=67  Identities=7%  Similarity=0.077  Sum_probs=47.6

Q ss_pred             CCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc------CCCcc-----------eEEEEE
Q 038681           57 DEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMS------HKHII-----------KLIVFE  119 (332)
Q Consensus        57 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------H~nIv-----------~~lv~e  119 (332)
                      ...+.||.|..+.||+....+..+.+|..+....   ...+..|...|+.|.      .|.|+           .+||||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQGNPMPLMARSFST---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCCCEEEEEeccccc---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            3456799999999999987555677777544212   246788888887663      45555           239999


Q ss_pred             eccCCCh
Q 038681          120 SVQIGTL  126 (332)
Q Consensus       120 ~~~~g~L  126 (332)
                      +++++++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998765

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.55  E-value=0.00054  Score=61.19  Aligned_cols=66  Identities=18%  Similarity=0.133  Sum_probs=43.8

Q ss_pred             CccccCCCceEEEEEeC--------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcC----CCcceE----EEEEeccC
Q 038681           60 NIVLEDPFRKLYKGFWQ--------KRSISLMKYNGNRNQHALEWCINHIVYASRMSH----KHIIKL----IVFESVQI  123 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~~----lv~e~~~~  123 (332)
                      +.+..|-...||+....        ++.+++|........  .....+|..++..+..    |.++-.    +|+||++|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~--~~~r~~E~~~~~~l~~~g~~P~~~~~~~~~~v~e~i~G   81 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL--LIDRERELVVFARLSERNLGPKLYGIFPNGRIEEFIPS   81 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc--eechHHHHHHHHHHHhCCCCCceEEEeCCCchhheeCC
Confidence            34556667789998873        478888886654321  2345788888888853    343333    78999988


Q ss_pred             CChH
Q 038681          124 GTLA  127 (332)
Q Consensus       124 g~L~  127 (332)
                      .++.
T Consensus        82 ~~l~   85 (302)
T cd05156          82 RTLT   85 (302)
T ss_pred             CcCC
Confidence            6654

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.28  E-value=0.0024  Score=56.30  Aligned_cols=32  Identities=25%  Similarity=0.440  Sum_probs=26.0

Q ss_pred             CCCeeecCCCCCCeeeCCCCCe-EEeecCCccc
Q 038681          165 SRPIVYRDMKPTNILFNEQSDA-KLFDFSLSLS  196 (332)
Q Consensus       165 ~~~ivH~Dlkp~Nill~~~~~~-kl~Dfg~a~~  196 (332)
                      ...++|+|+.|.||+++.++.+ -|+||+.+..
T Consensus       184 ~~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         184 HTVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CCeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            3468999999999999875654 5999998744

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.14  E-value=0.0064  Score=55.11  Aligned_cols=63  Identities=13%  Similarity=0.081  Sum_probs=42.8

Q ss_pred             ccccCCCceEEEEEeCC--eeEEEEEEcC------CCChhhHHHHHHHHHHHHhhc--CCC-cceE---------EEEEe
Q 038681           61 IVLEDPFRKLYKGFWQK--RSISLMKYNG------NRNQHALEWCINHIVYASRMS--HKH-IIKL---------IVFES  120 (332)
Q Consensus        61 ~lg~G~~g~Vy~~~~~~--~~vavK~~~~------~~~~~~~~~~~~E~~~l~~l~--H~n-Iv~~---------lv~e~  120 (332)
                      .||.|....||++...+  +.|+||.-..      ...+-..++..-|...|....  -|. +.++         +|||+
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~~~~vMEd   81 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEMAVTVMED   81 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccccceehHhh
Confidence            58999999999999843  6899987431      122333667778888887763  232 2233         89999


Q ss_pred             ccC
Q 038681          121 VQI  123 (332)
Q Consensus       121 ~~~  123 (332)
                      ++.
T Consensus        82 L~~   84 (370)
T TIGR01767        82 LSH   84 (370)
T ss_pred             Ccc
Confidence            854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=97.06  E-value=0.0028  Score=53.03  Aligned_cols=109  Identities=17%  Similarity=0.087  Sum_probs=69.0

Q ss_pred             CCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------EEEEeccCCChHHHHhhhhc
Q 038681           65 DPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------IVFESVQIGTLADRIHHHCE  135 (332)
Q Consensus        65 G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------lv~e~~~~g~L~~~l~~~~~  135 (332)
                      |+.++.-.+.-+-.+..+|++....-.-...-+.++.++++++.  .|+++         ++.|.|-.-..         
T Consensus        73 ~gNsTl~~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~NDn~~~yGvIlE~Cy~~~i---------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKNDNNYKYGVILERCYKIKI---------  141 (308)
T ss_pred             CCceEEEEeccccchhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecCCCceeEEEEeeccCccc---------
Confidence            34444444443334555666654432212455788899988864  34554         78888743111         


Q ss_pred             ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          136 QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       136 ~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                           .+    ..++..=+.+|.-.|++ ..+.+|+|-.|+||+-|..|.+||.|-+..
T Consensus       142 -----~~----~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  142 -----NF----SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             -----ch----hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence                 11    11222224667778855 788999999999999999999999998764

The function of this family is unknown.

>PLN02236 choline kinase

Probab=97.02  E-value=0.0066  Score=55.30  Aligned_cols=134  Identities=13%  Similarity=0.117  Sum_probs=75.4

Q ss_pred             CccccCCCceEEEEEeC------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcC----CCcceE----EEEEeccCCC
Q 038681           60 NIVLEDPFRKLYKGFWQ------KRSISLMKYNGNRNQHALEWCINHIVYASRMSH----KHIIKL----IVFESVQIGT  125 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~~----lv~e~~~~g~  125 (332)
                      ..|-.|-...+|++...      ++.|+++...... ..... -.+|..++..+..    |.++-.    .|.||+++.+
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t-~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g~v~efi~g~~  119 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV-ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNGRVEEFIHART  119 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC-Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCceEEEeeCCCC
Confidence            34555778889998752      2578888776543 22222 2678888888853    444433    7899998766


Q ss_pred             hHHH--------------H---hhhhccccc-CCCHHHHHHHHHHH-----------------HHHHHHh----hh-cCC
Q 038681          126 LADR--------------I---HHHCEQHFE-ALSLTDRLKVAMDI-----------------AHAVAYL----HV-GFS  165 (332)
Q Consensus       126 L~~~--------------l---~~~~~~~~~-~l~~~~~~~i~~~i-----------------~~~L~~L----H~-~~~  165 (332)
                      |..-              +   +........ ...+..+..+..++                 ...+..|    .. ...
T Consensus       120 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~  199 (344)
T PLN02236        120 LSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQE  199 (344)
T ss_pred             CCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCC
Confidence            5321              0   000000000 11123332332211                 1111111    11 114


Q ss_pred             CCeeecCCCCCCeeeCC-CCCeEEeecCCcc
Q 038681          166 RPIVYRDMKPTNILFNE-QSDAKLFDFSLSL  195 (332)
Q Consensus       166 ~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~  195 (332)
                      ..++|+|+++.||++++ ++.+.++||..+.
T Consensus       200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        200 IGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             ceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            57999999999999976 4679999998774

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.01  E-value=0.014  Score=52.29  Aligned_cols=29  Identities=24%  Similarity=0.418  Sum_probs=25.5

Q ss_pred             CCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          165 SRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       165 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                      ..+++|+|+.+.||+++. +.+.|+||+.+
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~  214 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYC  214 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECccc
Confidence            468999999999999987 67899999865

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.90  E-value=0.0027  Score=59.35  Aligned_cols=83  Identities=12%  Similarity=0.157  Sum_probs=49.8

Q ss_pred             hhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHc
Q 038681          227 EQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQC  306 (332)
Q Consensus       227 ~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c  306 (332)
                      +|+||||+|.++.|+..|...+......+...   ........+..........         .....+...+..+...|
T Consensus       110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~---~i~k~~~~d~~~~~~a~e~---------~~~~~~d~~~~~~~~~c  177 (725)
T KOG1093|consen  110 PKSDVWSLGFIILELYLGISLEAELTESEYLE---ILLKYYTDDQELLSTAMEH---------LIQLLADKKRLPLLKKC  177 (725)
T ss_pred             cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHH---HHHHhccCchhHHHHHHHH---------HHHHhhhHhHHHHhccC
Confidence            49999999999999999987776554433221   1111111111111110000         11124557788999999


Q ss_pred             ccCCCCCCCCHHHHH
Q 038681          307 MDFSPEDRPTMVDVA  321 (332)
Q Consensus       307 l~~dP~~RPs~~evl  321 (332)
                      +-..|..||...++.
T Consensus       178 ~~~~~~ir~l~~~~~  192 (725)
T KOG1093|consen  178 LWLEPIIRPLPMELS  192 (725)
T ss_pred             CccccccccchhHHh
Confidence            999999998665544

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.87  E-value=0.02  Score=52.84  Aligned_cols=65  Identities=8%  Similarity=-0.070  Sum_probs=44.5

Q ss_pred             CCccccCCCceEEEEEeCCeeEEEEEEcCC-----C-ChhhHHHHHHHHHHHHhhc------CCCcceE------EEEEe
Q 038681           59 QNIVLEDPFRKLYKGFWQKRSISLMKYNGN-----R-NQHALEWCINHIVYASRMS------HKHIIKL------IVFES  120 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~-~~~~~~~~~~E~~~l~~l~------H~nIv~~------lv~e~  120 (332)
                      .+.||.|....||+....+..++||.-...     . .+....+...|...|..+.      .|.|..+      ++||+
T Consensus        37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~vlvME~  116 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMALIGMRY  116 (418)
T ss_pred             EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCCEEEEee
Confidence            567899999999999887778999986521     1 1123455566677776652      3444444      89999


Q ss_pred             ccC
Q 038681          121 VQI  123 (332)
Q Consensus       121 ~~~  123 (332)
                      +++
T Consensus       117 L~~  119 (418)
T PLN02756        117 LEP  119 (418)
T ss_pred             cCC
Confidence            976

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.73  E-value=0.011  Score=53.60  Aligned_cols=30  Identities=20%  Similarity=0.351  Sum_probs=25.6

Q ss_pred             CeeecCCCCCCeeeCC-CCCeEEeecCCccc
Q 038681          167 PIVYRDMKPTNILFNE-QSDAKLFDFSLSLS  196 (332)
Q Consensus       167 ~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~  196 (332)
                      -++|+|+.+.|||+++ ++.++++||..|..
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            4899999999999974 57899999987743

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.72  E-value=0.021  Score=52.45  Aligned_cols=65  Identities=6%  Similarity=-0.021  Sum_probs=45.6

Q ss_pred             CCccccCCCceEEEEEeC--CeeEEEEEEcC-----CCChhhHHHHHHHHHHHHhhc--CCC-cceE---------EEEE
Q 038681           59 QNIVLEDPFRKLYKGFWQ--KRSISLMKYNG-----NRNQHALEWCINHIVYASRMS--HKH-IIKL---------IVFE  119 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~-----~~~~~~~~~~~~E~~~l~~l~--H~n-Iv~~---------lv~e  119 (332)
                      .+.||.|.-..||++.+.  ++.|+||.-..     ...+-..++..-|...|+.+.  -|. +.++         +|||
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e~~~~vME  113 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSVMNCCVME  113 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcHHhhHHHH
Confidence            457899999999999983  67899987431     222334778888888888763  233 3333         7889


Q ss_pred             eccC
Q 038681          120 SVQI  123 (332)
Q Consensus       120 ~~~~  123 (332)
                      +++.
T Consensus       114 dL~~  117 (409)
T PRK12396        114 DLSD  117 (409)
T ss_pred             hCcc
Confidence            8854

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.69  E-value=0.0062  Score=55.54  Aligned_cols=60  Identities=17%  Similarity=0.063  Sum_probs=45.2

Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ  183 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  183 (332)
                      |+-+|.+|-++..++...      ..++....+++.-.+.||.-|--  -.+++|.|+.|.||++..+
T Consensus       322 l~E~~~~Gl~v~~~v~~~------~~pe~l~kkva~lg~~AllkMl~--vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  322 LVETYERGLSVLRFVKWK------SQPEALVKKVAKLGVNALLKMLI--VDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             eeeeccccccHHhhhhcc------cChHHHHHHHHHHHHHHHHHHHH--hhcceecccCCCcEEEEec
Confidence            667888888999998765      35566677777777777655442  5789999999999999543

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.49  E-value=0.012  Score=49.55  Aligned_cols=31  Identities=32%  Similarity=0.528  Sum_probs=21.8

Q ss_pred             CCCeeecCCCCCCeee-CCCCCeEEeecCCcc
Q 038681          165 SRPIVYRDMKPTNILF-NEQSDAKLFDFSLSL  195 (332)
Q Consensus       165 ~~~ivH~Dlkp~Nill-~~~~~~kl~Dfg~a~  195 (332)
                      ...++|+|+.|.|||+ +.++.++++||-.|.
T Consensus       142 ~~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  142 PLVFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             GEEEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             CceEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            3578999999999999 888999999998763

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.25  E-value=0.17  Score=45.69  Aligned_cols=69  Identities=12%  Similarity=0.121  Sum_probs=44.2

Q ss_pred             CCCcccccHHHHHHHhcCCCCC---C-ccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc
Q 038681           38 YNPYRIFSAEELRIATNNYDEQ---N-IVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMS  108 (332)
Q Consensus        38 ~~~~~~~~~~el~~~~~~y~~~---~-~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~  108 (332)
                      .+++..++.+.+..+...+-+.   + ..-.+.-..||+... ++..+++|.......  ....+..|+..+..|.
T Consensus         5 ~~~~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~~--~~~~i~~E~~~l~~L~   78 (325)
T PRK11768          5 AFPFQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPERW--SDAQILEEHAFALELA   78 (325)
T ss_pred             CCCCCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcccC--CHHHHHHHHHHHHHHH
Confidence            4678888888887776655331   1 122344567899887 567888888754321  2455667887777763

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.19  E-value=0.086  Score=47.14  Aligned_cols=34  Identities=18%  Similarity=0.324  Sum_probs=29.5

Q ss_pred             CCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          165 SRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       165 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ...++|+|+.+.|++++..+-+=+.||+++..-.
T Consensus       197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGD  230 (321)
T COG3173         197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGD  230 (321)
T ss_pred             CceeeeCCcccCCEEEeCCCeeEEEeccccccCC
Confidence            4579999999999999998889999999986543

>PRK06148 hypothetical protein; Provisional

Probab=96.19  E-value=0.088  Score=54.93  Aligned_cols=32  Identities=22%  Similarity=0.380  Sum_probs=26.9

Q ss_pred             CCCeeecCCCCCCeeeCCCC--CeE-EeecCCccc
Q 038681          165 SRPIVYRDMKPTNILFNEQS--DAK-LFDFSLSLS  196 (332)
Q Consensus       165 ~~~ivH~Dlkp~Nill~~~~--~~k-l~Dfg~a~~  196 (332)
                      ..++||+|+.+.|||++.++  .+. |+|||-+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            57899999999999998775  555 999998744

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=96.00  E-value=0.05  Score=47.66  Aligned_cols=46  Identities=15%  Similarity=0.234  Sum_probs=34.2

Q ss_pred             HHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       149 i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      .+..+-.++.-.+.. ..-++|+|+.|.|+|.++.+.+.|+||--|.
T Consensus       137 ~~~~l~~~l~~~~~~-~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg  182 (269)
T COG0510         137 KLKELRRALEEVPKD-DLVPCHNDLNPGNLLLTDKGGLFLIDWEYAG  182 (269)
T ss_pred             HHHHHHHHhhhcCCC-ceeeecCCCCccceEEcCCCcEEEEecccCC
Confidence            444455555555521 1369999999999999998999999997664

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=95.90  E-value=0.089  Score=47.11  Aligned_cols=31  Identities=13%  Similarity=0.304  Sum_probs=27.7

Q ss_pred             CCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          165 SRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       165 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      ..+++|+|+.+.|+|++.++.+.++||..+.
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            4589999999999999999999999997663

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=95.61  E-value=0.032  Score=49.36  Aligned_cols=63  Identities=10%  Similarity=0.056  Sum_probs=39.3

Q ss_pred             CCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc--C----CCcceE--------EEEEeccC
Q 038681           58 EQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMS--H----KHIIKL--------IVFESVQI  123 (332)
Q Consensus        58 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--H----~nIv~~--------lv~e~~~~  123 (332)
                      ..+.++-|....+|+...+++.+.||.-....    ...|..|..-|+.|.  .    |.++.+        ||+||++.
T Consensus        21 ~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~   96 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLDTDGGSYFVKVNSESG----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEM   96 (288)
T ss_dssp             EEEEE--SSSSEEEEEETTS-EEEEEEEEGGG----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE----
T ss_pred             eeEecCCCChhheEEEECCCccEEEEecChhh----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecC
Confidence            35568889999999988889999999887322    355778888888883  2    333332        89999886


Q ss_pred             C
Q 038681          124 G  124 (332)
Q Consensus       124 g  124 (332)
                      +
T Consensus        97 ~   97 (288)
T PF03881_consen   97 G   97 (288)
T ss_dssp             -
T ss_pred             C
Confidence            6

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PTZ00384 choline kinase; Provisional

Probab=95.60  E-value=0.14  Score=47.24  Aligned_cols=29  Identities=24%  Similarity=0.164  Sum_probs=24.1

Q ss_pred             CCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          166 RPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       166 ~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      ...+|.|+-+.||+.++ +.+.++||-.|.
T Consensus       227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~  255 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAG  255 (383)
T ss_pred             eeeeeccCCcccEEecC-CCEEEEEecccc
Confidence            57899999999999765 459999997663

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=95.11  E-value=0.11  Score=44.94  Aligned_cols=67  Identities=7%  Similarity=-0.048  Sum_probs=48.4

Q ss_pred             CCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHH---HHHHhhcCCCcceE---------EEEEec-cC
Q 038681           58 EQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHI---VYASRMSHKHIIKL---------IVFESV-QI  123 (332)
Q Consensus        58 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~---~~l~~l~H~nIv~~---------lv~e~~-~~  123 (332)
                      ....+..|..+.|+.++. +|.++++|........      ..|.   ..|+..+-...|++         |.+|.+ ++
T Consensus         6 ~~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~------~~E~~g~~~L~~w~G~GaVrll~~d~~~~AlLLErl~~g   79 (253)
T PF04655_consen    6 PDGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEA------EHEARGEAALRWWNGRGAVRLLAADPERGALLLERLDPG   79 (253)
T ss_pred             cCCCCCCCcceEEEEEEcCCCCeEEEEecCCcccc------hhhhhHHhHhheeCCCCceeeeccccccchhhhhhccCC
Confidence            345677899999999988 8899999998754321      2333   55777777778888         788988 55


Q ss_pred             CChHHHH
Q 038681          124 GTLADRI  130 (332)
Q Consensus       124 g~L~~~l  130 (332)
                      -+|.++.
T Consensus        80 ~~L~~~~   86 (253)
T PF04655_consen   80 RSLASLP   86 (253)
T ss_pred             Cchhhcc
Confidence            5676554

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=95.01  E-value=0.057  Score=48.79  Aligned_cols=84  Identities=19%  Similarity=0.239  Sum_probs=59.1

Q ss_pred             CCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccc
Q 038681          141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPEN  220 (332)
Q Consensus       141 l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  220 (332)
                      -.++++..++++-+.-++-+..  .-..-|||+.-.||||+ +|++.|+||-+++........       .....--|-.
T Consensus       318 ~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl~~~q~~i-------sy~rldhp~l  387 (488)
T COG5072         318 DRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSYSQGII-------SYNRLDHPDL  387 (488)
T ss_pred             ccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeecccCCcee-------eccccCchhh
Confidence            4577888888887777776663  66889999999999999 999999999999854332211       1112234555


Q ss_pred             cCCCCChhhhHHHH
Q 038681          221 FTTLINEQCDVYGF  234 (332)
Q Consensus       221 ~~~~~~~~sDiwSl  234 (332)
                      +.|.-+..-|||-+
T Consensus       388 F~G~dd~QFeIYrl  401 (488)
T COG5072         388 FNGVDDYQFEIYRL  401 (488)
T ss_pred             hcCccceeeeHHHH
Confidence            66644556677764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	332
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-23
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		8e-23
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-20
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-19
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-16
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-16
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-16
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-16
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		9e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-11
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-11
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-11
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-10
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		9e-10
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-09
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-09
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-09
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-09
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-09
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-09
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-09
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-09
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-09
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-09
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-09
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		5e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-09
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		6e-09
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-09
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-09
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		7e-09
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-09
4h58_A	275	Braf In Complex With Compound 3 Length = 275		7e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		7e-09
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		7e-09
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		8e-09
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		8e-09
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		8e-09
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-08
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-08
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-08
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-08
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-08
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-08
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-08
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-08
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-08
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-08
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-08
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-08
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-08
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-08
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-08
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-08
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-08
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-08
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-08
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-08
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-08
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-08
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-08
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-08
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-08
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-08
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-08
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		3e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-08
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-08
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-08
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-08
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-08
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-08
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-08
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		5e-08
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		5e-08
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-08
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		6e-08
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-08
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-08
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		6e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		6e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		6e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-08
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		7e-08
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-08
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		8e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		9e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		9e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		1e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-07
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-07
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-07
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-07
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-07
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-07
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-07
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		1e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-07
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-07
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-07
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-07
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-07
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-07
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-07
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-07
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-07
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-07
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		3e-07
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		3e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		3e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		3e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-07
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-07
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		3e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-07
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		3e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		3e-07
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-07
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-07
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-07
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-07
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-07
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-07
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-07
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-07
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-07
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-07
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-07
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-07
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		4e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		4e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		4e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-07
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-07
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		5e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		5e-07
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		5e-07
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-07
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-07
2oza_A	356	Structure Of P38alpha Complex Length = 356		5e-07
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		6e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-07
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		6e-07
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-07
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		6e-07
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		6e-07
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		6e-07
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		7e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-07
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		7e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-07
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		7e-07
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		7e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		7e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		8e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		9e-07
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-06
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-06
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-06
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-06
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-06
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-06
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-06
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-06
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-06
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-06
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-06
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-06
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-06
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-06
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-06
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-06
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-06
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-06
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-06
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-06
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-06
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-06
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-06
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-06
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-06
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-06
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		3e-06
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-06
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-06
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-06
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-06
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-06
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-06
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-06
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-06
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-06
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-06
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-06
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-06
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-06
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		4e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-06
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-06
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-06
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-06
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-06
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-06
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-06
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-06
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		4e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-06
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-06
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		4e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-06
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-06
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-06
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-06
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-06
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-06
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-06
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-06
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-06
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		5e-06
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-06
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-06
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-06
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-06
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-06
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-06
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		6e-06
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		6e-06
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		6e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-06
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		6e-06
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		6e-06
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-06
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-06
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-06
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-06
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-06
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-06
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		7e-06
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		7e-06
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-06
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		7e-06
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		7e-06
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		8e-06
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-06
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-06
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-06
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		8e-06
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		8e-06
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-06
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		9e-06
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-06
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-06
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-06
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-06
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		9e-06
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		9e-06
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-06
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-05
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-05
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-05
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-05
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-05
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-05
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-05
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-05
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-05
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-05
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-05
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-05
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-05
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-05
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-05
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		2e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-05
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-05
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-05
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-05
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-05
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		2e-05
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-05
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-05
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-05
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-05
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-05
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-05
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-05
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-05
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-05
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-05
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-05
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-05
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-05
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-05
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-05
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-05
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-05
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-05
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-05
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-05
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-05
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-05
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-05
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		3e-05
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-05
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-05
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-05
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-05
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		3e-05
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-05
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-05
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-05
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-05
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-05
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-05
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-05
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-05
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		4e-05
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		4e-05
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-05
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-05
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-05
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-05
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-05
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-05
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-05
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-05
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		4e-05
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-05
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		4e-05
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-05
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-05
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-05
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-05
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		5e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-05
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-05
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-05
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		6e-05
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		6e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-05
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-05
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-05
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-05
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		7e-05
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		7e-05
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		7e-05
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		7e-05
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		7e-05
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		7e-05
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		7e-05
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		8e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		8e-05
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		8e-05
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-05
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-05
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-05
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		8e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		8e-05
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-05
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		9e-05
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		9e-05
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-05
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-05
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-05
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-05
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-04
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-04
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-04
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-04
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-04
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-04
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		1e-04
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-04
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		1e-04
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-04
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-04
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-04
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-04
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-04
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-04
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-04
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-04
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-04
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-04
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-04
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-04
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-04
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-04
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-04
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-04
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-04
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-04
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-04
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-04
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-04
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-04
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-04
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-04
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-04
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-04
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-04
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-04
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-04
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-04
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-04
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-04
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-04
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-04
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-04
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-04
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-04
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-04
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-04
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-04
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-04
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-04
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-04
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-04
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-04
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-04
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		2e-04
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-04
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-04
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-04
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-04
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-04
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-04
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-04
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-04
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-04
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		2e-04
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-04
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-04
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-04
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-04
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-04
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-04
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-04
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-04
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-04
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-04
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-04
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-04
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-04
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-04
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-04
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-04
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-04
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-04
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-04
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-04
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-04
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-04
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-04
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-04
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-04
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-04
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-04
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-04
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-04
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-04
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-04
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-04
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-04
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-04
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-04
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		3e-04
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-04
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-04
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-04
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-04
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-04
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-04
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-04
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-04
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-04
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-04
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-04
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-04
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-04
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		4e-04
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-04
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		4e-04
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-04
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		4e-04
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-04
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-04
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-04
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-04
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-04
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-04
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		5e-04
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		5e-04
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-04
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		5e-04
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-04
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-04
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-04
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-04
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-04
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-04
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		5e-04
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-04
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-04
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-04
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-04
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		6e-04
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-04
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		6e-04
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		6e-04
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-04
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-04
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-04
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-04
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		7e-04
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		7e-04
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		7e-04
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		7e-04
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-04
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-04
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		7e-04
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-04
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		8e-04
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-04
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-04
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		8e-04
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		8e-04
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-04
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 142/294 (48%), Gaps = 20/294 (6%)
Query: 44  FSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRS-ISLMKYNGNRNQHALEWCINHIV 102
           FS  EL++A++N+  +NI+    F K+YKG     + +++ +    R Q         + 
Sbjct: 28  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVE 87
Query: 103 YASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM 151
             S   H+++++L           +V+  +  G++A  +    E     L    R ++A+
Sbjct: 88  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-PPLDWPKRQRIAL 146
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
             A  +AYLH      I++RD+K  NIL +E+ +A + DF L+  +   + H+   +V G
Sbjct: 147 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX-AVRG 205
Query: 212 TTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
           T G IAPE  +T   +E+ DV+G+G  L EL+T Q   D     +R   +++V  L    
Sbjct: 206 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL----ARLANDDDVMLLDWVK 261
Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
              KE     ++ D       K+++++   Q+ L C   SP +RP M +V + L
Sbjct: 262 GLLKEKKLEALV-DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 314

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  104 bits (259), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 140/294 (47%), Gaps = 20/294 (6%)
Query: 44  FSAEELRIATNNYDEQNIVLEDPFRKLYKG-FWQKRSISLMKYNGNRNQHALEWCINHIV 102
           FS  EL++A++N+  +NI+    F K+YKG       +++ +    R Q         + 
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVE 79
Query: 103 YASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM 151
             S   H+++++L           +V+  +  G++A  +    E     L    R ++A+
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-PPLDWPKRQRIAL 138
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
             A  +AYLH      I++RD+K  NIL +E+ +A + DF L+  +   + H+   +V G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXX-AVRG 197
Query: 212 TTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
             G IAPE  +T   +E+ DV+G+G  L EL+T Q   D     +R   +++V  L    
Sbjct: 198 XIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL----ARLANDDDVMLLDWVK 253
Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
              KE     ++ D       K+++++   Q+ L C   SP +RP M +V + L
Sbjct: 254 GLLKEKKLEALV-DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/306 (27%), Positives = 146/306 (47%), Gaps = 28/306 (9%)
Query: 38  YNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWC 97
           +  YR+    +L  ATNN+D + ++    F K+YKG  +  +   +K     +   +E  
Sbjct: 24  FESYRV-PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEF 82
Query: 98  INHIVYASRMSHKHIIKLI-----------VFESVQIGTLADRIHHHCEQHFEALSLTDR 146
              I   S   H H++ LI           +++ ++ G L   + +  +    ++S   R
Sbjct: 83  ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL-YGSDLPTMSMSWEQR 141
Query: 147 LKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD-GETHIE 205
           L++ +  A  + YLH   +R I++RD+K  NIL +E    K+ DF +S    + G+TH+ 
Sbjct: 142 LEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLX 198
Query: 206 LDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQE-VSDHVSFESRFHYEENV 263
              V GT G+I PE F    + E+ DVY FG  LFE+L A+  +   +  E     E  V
Sbjct: 199 -XVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
Query: 264 KRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ 323
           +  S  N + +++VD  + +        + + L+ F    ++C+  S EDRP+M DV  +
Sbjct: 258 E--SHNNGQLEQIVDPNLADKI------RPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309
Query: 324 LRQMYR 329
           L    R
Sbjct: 310 LEYALR 315

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 84/306 (27%), Positives = 145/306 (47%), Gaps = 28/306 (9%)
Query: 38  YNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWC 97
           +  YR+    +L  ATNN+D + ++    F K+YKG  +  +   +K     +   +E  
Sbjct: 24  FESYRV-PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEF 82
Query: 98  INHIVYASRMSHKHIIKLI-----------VFESVQIGTLADRIHHHCEQHFEALSLTDR 146
              I   S   H H++ LI           +++ ++ G L   + +  +    ++S   R
Sbjct: 83  ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHL-YGSDLPTMSMSWEQR 141
Query: 147 LKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD-GETHIE 205
           L++ +  A  + YLH   +R I++RD+K  NIL +E    K+ DF +S    +  +TH+ 
Sbjct: 142 LEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLX 198
Query: 206 LDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQE-VSDHVSFESRFHYEENV 263
              V GT G+I PE F    + E+ DVY FG  LFE+L A+  +   +  E     E  V
Sbjct: 199 X-VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
Query: 264 KRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ 323
           +  S  N + +++VD  + +        + + L+ F    ++C+  S EDRP+M DV  +
Sbjct: 258 E--SHNNGQLEQIVDPNLADKI------RPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309
Query: 324 LRQMYR 329
           L    R
Sbjct: 310 LEYALR 315

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 103/226 (45%), Gaps = 25/226 (11%)
Query: 44  FSAEELRIATNNYDEQNIVL------EDPFRKLYKGFWQKRSISLMKYNGNRN---QHAL 94
           FS  EL+  TNN+DE+ I +      E  F  +YKG+    ++++ K     +   +   
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 65
Query: 95  EWCINHIVYASRMSHKHIIKLIVFES-----------VQIGTLADRIHHHCEQHFEALSL 143
           +     I   ++  H+++++L+ F S              G+L DR+   C      LS 
Sbjct: 66  QQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLS--CLDGTPPLSW 123
Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
             R K+A   A+ + +LH       ++RD+K  NIL +E   AK+ DF L+ +       
Sbjct: 124 HXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 204 IELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSD 249
           +    +VGTT + APE     I  + D+Y FG  L E++T     D
Sbjct: 181 VXXSRIVGTTAYXAPEALRGEITPKSDIYSFGVVLLEIITGLPAVD 226

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 44  FSAEELRIATNNYDEQNIVL------EDPFRKLYKGFWQKRSISLMKYNGNRN---QHAL 94
           FS  EL+  TNN+DE+ I +      E  F  +YKG+    ++++ K     +   +   
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 95  EWCINHIVYASRMSHKHIIKLIVFES-----------VQIGTLADRIHHHCEQHFEALSL 143
           +     I   ++  H+++++L+ F S           +  G+L DR+   C      LS 
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS--CLDGTPPLSW 132
Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
             R K+A   A+ + +LH       ++RD+K  NIL +E   AK+ DF L+ +       
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 204 IELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSD 249
           +    +VGTT ++APE     I  + D+Y FG  L E++T     D
Sbjct: 190 VMXSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVD 235

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 44  FSAEELRIATNNYDEQNIVL------EDPFRKLYKGFWQKRSISLMKYNGNRN---QHAL 94
           FS  EL+  TNN+DE+ I +      E  F  +YKG+    ++++ K     +   +   
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 68
Query: 95  EWCINHIVYASRMSHKHIIKLIVFES-----------VQIGTLADRIHHHCEQHFEALSL 143
           +     I   ++  H+++++L+ F S           +  G+L DR+   C      LS 
Sbjct: 69  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS--CLDGTPPLSW 126
Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
             R K+A   A+ + +LH       ++RD+K  NIL +E   AK+ DF L+ +       
Sbjct: 127 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 204 IELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSD 249
           +    +VGTT ++APE     I  + D+Y FG  L E++T     D
Sbjct: 184 VMXXRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVD 229

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 25/226 (11%)
Query: 44  FSAEELRIATNNYDEQNIVL------EDPFRKLYKGFWQKRSISLMKYNGNRN---QHAL 94
           FS  EL+  TNN+DE+ I +      E  F  +YKG+    ++++ K     +   +   
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 95  EWCINHIVYASRMSHKHIIKLIVFES-----------VQIGTLADRIHHHCEQHFEALSL 143
           +     I   ++  H+++++L+ F S           +  G+L DR+   C      LS 
Sbjct: 75  QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLS--CLDGTPPLSW 132
Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
             R K+A   A+ + +LH       ++RD+K  NIL +E   AK+ DF L+ +       
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 204 IELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSD 249
           +    +VGTT ++APE     I  + D+Y FG  L E++T     D
Sbjct: 190 VMXXRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVD 235

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 47/132 (35%), Positives = 69/132 (52%), Gaps = 6/132 (4%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           IV E +  G+L   +H    +  E L    RL +A D+A  + YLH   + PIV+R++K 
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAR--EQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRNLKS 167
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINEQCDVYGF 234
            N+L +++   K+ DF LS       T +   S  GT  ++APE       NE+ DVY F
Sbjct: 168 PNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSF 225
Query: 235 GAFLFELLTAQE 246
           G  L+EL T Q+
Sbjct: 226 GVILWELATLQQ 237

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/283 (20%), Positives = 123/283 (43%), Gaps = 44/283 (15%)
Query: 59  QNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL--- 115
           + +V    F  + K  W+ + +++ +      + A    I  +   SR++H +I+KL   
Sbjct: 13  EEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAF---IVELRQLSRVNHPNIVKLYGA 69
Query: 116 ------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIV 169
                 +V E  + G+L + +H    +     +    +   +  +  VAYLH    + ++
Sbjct: 70  CLNPVCLVMEYAEGGSLYNVLHG--AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 170 YRDMKPTNILFNEQSDA-KLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINE 227
           +RD+KP N+L        K+ DF  +  I   +TH+  +   G+  ++APE F  +  +E
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK--GSAAWMAPEVFEGSNYSE 182
Query: 228 QCDVYGFGAFLFELLTAQEVSDHVSFES-RFHYEENVKRLSGQNCRFKEMVDSIIIEDKS 286
           +CDV+ +G  L+E++T ++  D +   + R  +       +  N     ++ ++      
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW-------AVHNGTRPPLIKNLP----- 230
Query: 287 CTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
                     +  + L  +C    P  RP+M ++ K +  + R
Sbjct: 231 ----------KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/283 (20%), Positives = 123/283 (43%), Gaps = 44/283 (15%)
Query: 59  QNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL--- 115
           + +V    F  + K  W+ + +++ +      + A    I  +   SR++H +I+KL   
Sbjct: 14  EEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAF---IVELRQLSRVNHPNIVKLYGA 70
Query: 116 ------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIV 169
                 +V E  + G+L + +H    +     +    +   +  +  VAYLH    + ++
Sbjct: 71  CLNPVCLVMEYAEGGSLYNVLHG--AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 170 YRDMKPTNILFNEQSDA-KLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINE 227
           +RD+KP N+L        K+ DF  +  I   +TH+  +   G+  ++APE F  +  +E
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNNK--GSAAWMAPEVFEGSNYSE 183
Query: 228 QCDVYGFGAFLFELLTAQEVSDHVSFES-RFHYEENVKRLSGQNCRFKEMVDSIIIEDKS 286
           +CDV+ +G  L+E++T ++  D +   + R  +       +  N     ++ ++      
Sbjct: 184 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW-------AVHNGTRPPLIKNLP----- 231
Query: 287 CTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
                     +  + L  +C    P  RP+M ++ K +  + R
Sbjct: 232 ----------KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 264

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 46/132 (34%), Positives = 67/132 (50%), Gaps = 6/132 (4%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           IV E +  G+L   +H    +  E L    RL +A D+A  + YLH   + PIV+RD+K 
Sbjct: 111 IVTEYLSRGSLYRLLHKSGAR--EQLDERRRLSMAYDVAKGMNYLH-NRNPPIVHRDLKS 167
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINEQCDVYGF 234
            N+L +++   K+ DF LS         +      GT  ++APE       NE+ DVY F
Sbjct: 168 PNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSF 225
Query: 235 GAFLFELLTAQE 246
           G  L+EL T Q+
Sbjct: 226 GVILWELATLQQ 237

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/262 (26%), Positives = 109/262 (41%), Gaps = 34/262 (12%)
Query: 96  WCINHIVYA-SRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLK------ 148
           W   + VY+   M H++I++ I  E  + GT  D          E  SL+D LK      
Sbjct: 63  WQNEYEVYSLPGMKHENILQFIGAE--KRGTSVDVDLWLITAFHEKGSLSDFLKANVVSW 120
Query: 149 -----VAMDIAHAVAYLHV-------GFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS 196
                +A  +A  +AYLH        G    I +RD+K  N+L      A + DF L+L 
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180
Query: 197 IPDGETHIELDSVVGTTGFIAPENFTTLINEQ------CDVYGFGAFLFELLTAQEVSDH 250
              G++  +    VGT  ++APE     IN Q       D+Y  G  L+EL +    +D 
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
Query: 251 VSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQL---TLQCM 307
              E    +EE +    GQ+   ++M + ++ + K        Q+      L     +C 
Sbjct: 241 PVDEYMLPFEEEI----GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECW 296
Query: 308 DFSPEDRPTMVDVAKQLRQMYR 329
           D   E R +   V +++ QM R
Sbjct: 297 DHDAEARLSAGCVGERITQMQR 318

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/173 (28%), Positives = 83/173 (47%), Gaps = 21/173 (12%)
Query: 86  NGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHC 134
           N +R+Q  +E     I     + H +IIK+           IV E+ + G L +RI    
Sbjct: 56  NKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVS-A 114
Query: 135 EQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE---QSDAKLFDF 191
           +   +ALS     ++   + +A+AY H   S+ +V++D+KP NILF +    S  K+ DF
Sbjct: 115 QARGKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDF 171
Query: 192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTA 244
            L+      E      +  GT  ++APE F   +  +CD++  G  ++ LLT 
Sbjct: 172 GLAELFKSDEHST---NAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 72/155 (46%), Gaps = 29/155 (18%)
Query: 108 SHKHIIKLI-----------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHA 156
            H HII LI           VF+ ++ G L D +         ALS  +   +   +  A
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV-----ALSEKETRSIMRSLLEA 212
Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFI 216
           V++LH   +  IV+RD+KP NIL ++    +L DF  S  +  GE   +L  + GT G++
Sbjct: 213 VSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYL 266
Query: 217 APENFTTLINE-------QCDVYGFGAFLFELLTA 244
           APE     ++E       + D++  G  LF LL  
Sbjct: 267 APEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/236 (21%), Positives = 116/236 (49%), Gaps = 21/236 (8%)
Query: 104 ASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRL--------KVAMD-IA 154
           A+ ++H  I+   V+++ +  T A  + +   ++ + ++L D +        K A++ IA
Sbjct: 66  AAALNHPAIVA--VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 123
Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD-GETHIELDSVVGTT 213
            A   L+      I++RD+KP NI+ +  +  K+ DF ++ +I D G +  +  +V+GT 
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 214 GFIAPENF-TTLINEQCDVYGFGAFLFELLTAQ-----EVSDHVSFESRFHYEENVKRLS 267
            +++PE      ++ + DVY  G  L+E+LT +     +  D V+++   H  E+    S
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQ---HVREDPIPPS 240
Query: 268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ 323
            ++      +D+++++  +     + Q     +   ++  +  P + P ++  A++
Sbjct: 241 ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAER 296

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 89/181 (49%), Gaps = 25/181 (13%)
Query: 83  MKYNGNRNQHALEWCINH--IVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEA 140
           M+ N  +   AL+ C  H  IV    + H  +   +V E +  G L +RI    ++HF  
Sbjct: 48  MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKK--KKHF-- 103
Query: 141 LSLTDRLKVAMDIAHAVAYLH-VGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLS-L 195
            S T+   +   +  AV+++H VG    +V+RD+KP N+LF +++D    K+ DF  + L
Sbjct: 104 -SETEASYIMRKLVSAVSHMHDVG----VVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158
Query: 196 SIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFE 254
             PD +    L +   T  + APE       +E CD++  G  L+ +L+ Q     V F+
Sbjct: 159 KPPDNQP---LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ-----VPFQ 210
Query: 255 S 255
           S
Sbjct: 211 S 211

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 70/152 (46%), Gaps = 25/152 (16%)
Query: 107 MSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           + H +I+KL           +V E  + G L D I H  +      +  D   +   +  
Sbjct: 93  LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK-----FNEVDAAVIIKQVLS 147
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILF-NEQSDA--KLFDFSLSLSIPDGETHIELDSVVGT 212
            V YLH      IV+RD+KP N+L  +++ DA  K+ DF LS      E   ++   +GT
Sbjct: 148 GVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF---ENQKKMKERLGT 201
Query: 213 TGFIAPENFTTLINEQCDVYGFGAFLFELLTA 244
             +IAPE      +E+CDV+  G  LF LL  
Sbjct: 202 AYYIAPEVLRKKYDEKCDVWSIGVILFILLAG 233

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 50/233 (21%), Positives = 112/233 (48%), Gaps = 15/233 (6%)
Query: 104 ASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRL--------KVAMD-IA 154
           A+ ++H  I+   V+++ +  T A  + +   ++ + ++L D +        K A++ IA
Sbjct: 66  AAALNHPAIVA--VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 123
Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD-GETHIELDSVVGTT 213
            A   L+      I++RD+KP NIL +  +  K+ DF ++ +I D G +  +  +V+GT 
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTA 183
Query: 214 GFIAPENF-TTLINEQCDVYGFGAFLFELLTAQE--VSDHVSFESRFHYEENVKRLSGQN 270
            +++PE      ++ + DVY  G  L+E+LT +     D     +  H  E+    S ++
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ 323
                 +D+++++  +     + Q     +   ++  +  P + P ++  A++
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAER 296

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 81/156 (51%), Gaps = 25/156 (16%)
Query: 104 ASRMSHKHIIKLI-----------VFESVQIGTLADRIHHHCEQHFE-ALSLTDRLKVAM 151
           +S++SH++I+ +I           V E ++  TL++ I  H     + A++ T+++   +
Sbjct: 65  SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGI 124
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHI-ELDSVV 210
             AH +          IV+RD+KP NIL +     K+FDF ++ ++   ET + + + V+
Sbjct: 125 KHAHDMR---------IVHRDIKPQNILIDSNKTLKIFDFGIAKAL--SETSLTQTNHVL 173
Query: 211 GTTGFIAPENFTTLINEQC-DVYGFGAFLFELLTAQ 245
           GT  + +PE       ++C D+Y  G  L+E+L  +
Sbjct: 174 GTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 87/193 (45%), Gaps = 21/193 (10%)
Query: 67  FRKLYKGFWQKR-SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFESV-QIG 124
           F  +YKG W    ++ ++       Q  L+   N +    +  H +I+  + + +  Q+ 
Sbjct: 37  FGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYSTAPQLA 95
Query: 125 TL-----ADRIHHH---CEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPT 176
            +        ++HH    E  FE   L D   +A   A  + YLH   ++ I++RD+K  
Sbjct: 96  IVTQWCEGSSLYHHLHASETKFEMKKLID---IARQTARGMDYLH---AKSIIHRDLKSN 149
Query: 177 NILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF----TTLINEQCDVY 232
           NI  +E +  K+ DF L+          + + + G+  ++APE      +   + Q DVY
Sbjct: 150 NIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVY 209
Query: 233 GFGAFLFELLTAQ 245
            FG  L+EL+T Q
Sbjct: 210 AFGIVLYELMTGQ 222

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/233 (21%), Positives = 112/233 (48%), Gaps = 15/233 (6%)
Query: 104 ASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRL--------KVAMD-IA 154
           A+ ++H  I+   V+++ +  T A  + +   ++ + ++L D +        K A++ IA
Sbjct: 66  AAALNHPAIVA--VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 123
Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD-GETHIELDSVVGTT 213
            A   L+      I++RD+KP NI+ +  +  K+ DF ++ +I D G +  +  +V+GT 
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 214 GFIAPENF-TTLINEQCDVYGFGAFLFELLTAQE--VSDHVSFESRFHYEENVKRLSGQN 270
            +++PE      ++ + DVY  G  L+E+LT +     D     +  H  E+    S ++
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ 323
                 +D+++++  +     + Q     +   ++  +  P + P ++  A++
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAER 296

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/233 (21%), Positives = 112/233 (48%), Gaps = 15/233 (6%)
Query: 104 ASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRL--------KVAMD-IA 154
           A+ ++H  I+   V+++ +  T A  + +   ++ + ++L D +        K A++ IA
Sbjct: 66  AAALNHPAIVA--VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 123
Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD-GETHIELDSVVGTT 213
            A   L+      I++RD+KP NI+ +  +  K+ DF ++ +I D G +  +  +V+GT 
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 214 GFIAPENF-TTLINEQCDVYGFGAFLFELLTAQE--VSDHVSFESRFHYEENVKRLSGQN 270
            +++PE      ++ + DVY  G  L+E+LT +     D     +  H  E+    S ++
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARH 243
Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ 323
                 +D+++++  +     + Q     +   ++  +  P + P ++  A++
Sbjct: 244 EGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAER 296

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 82/153 (53%), Gaps = 13/153 (8%)
Query: 104 ASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRL--------KVAMD-IA 154
           A+ ++H  I+   V+++ +  T A  + +   ++ + ++L D +        K A++ IA
Sbjct: 83  AAALNHPAIVA--VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 140
Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD-GETHIELDSVVGTT 213
            A   L+      I++RD+KP NI+ +  +  K+ DF ++ +I D G +  +  +V+GT 
Sbjct: 141 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 200
Query: 214 GFIAPENF-TTLINEQCDVYGFGAFLFELLTAQ 245
            +++PE      ++ + DVY  G  L+E+LT +
Sbjct: 201 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/241 (22%), Positives = 108/241 (44%), Gaps = 14/241 (5%)
Query: 89  RNQHALEWCINHIVYASRMSHKHIIKL--IVFESVQIGTLADRIHHHCEQHFEALSLTDR 146
           +N  AL       VYA+  +      L  IV E V   TL D +H           +T +
Sbjct: 64  QNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-------PMTPK 116
Query: 147 LKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD-GETHIE 205
             + + IA A   L+      I++RD+KP NI+ +  +  K+ DF ++ +I D G +  +
Sbjct: 117 RAIEV-IADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 206 LDSVVGTTGFIAPENF-TTLINEQCDVYGFGAFLFELLTAQE--VSDHVSFESRFHYEEN 262
             +V+GT  +++PE      ++ + DVY  G  L+E+LT +     D     +  H  E+
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED 235
Query: 263 VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK 322
               S ++      +D+++++  +     + Q     +   ++  +  P + P ++  A+
Sbjct: 236 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNGEPPEAPKVLTDAE 295
Query: 323 Q 323
           +
Sbjct: 296 R 296

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 58/118 (49%), Gaps = 10/118 (8%)
Query: 132 HHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF 191
           H  E  FE   L D   +A   A  + YLH   ++ I++RD+K  NI  +E +  K+ DF
Sbjct: 111 HASETKFEMKKLID---IARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDF 164
Query: 192 SLSLSIPDGETHIELDSVVGTTGFIAPENF----TTLINEQCDVYGFGAFLFELLTAQ 245
            L+          + + + G+  ++APE      +   + Q DVY FG  L+EL+T Q
Sbjct: 165 GLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A ++  A+ YLH   S+ I+YRD+KP NIL ++    K+ DF  +  +PD    +     
Sbjct: 112 AAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXL----- 163
Query: 210 VGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTA 244
            GT  +IAPE  +T   N+  D + FG  ++E+L  
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 37/118 (31%), Positives = 58/118 (49%), Gaps = 10/118 (8%)
Query: 132 HHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF 191
           H  E  FE   L D   +A   A  + YLH   ++ I++RD+K  NI  +E +  K+ DF
Sbjct: 99  HASETKFEMKKLID---IARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDF 152
Query: 192 SLSLSIPDGETHIELDSVVGTTGFIAPENF----TTLINEQCDVYGFGAFLFELLTAQ 245
            L+          + + + G+  ++APE      +   + Q DVY FG  L+EL+T Q
Sbjct: 153 GLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 94/221 (42%), Gaps = 40/221 (18%)
Query: 142 SLTDRLK-----------VAMDIAHAVAYLHV--------GFSRPIVYRDMKPTNILFNE 182
           SLTD LK           VA  ++  ++YLH         G    I +RD K  N+L   
Sbjct: 99  SLTDYLKGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKS 158
Query: 183 QSDAKLFDFSLSLSI----PDGETHIELDSVVGTTGFIAPENFTTLINEQ------CDVY 232
              A L DF L++      P G+TH +    VGT  ++APE     IN Q       D+Y
Sbjct: 159 DLTAVLADFGLAVRFEPGKPPGDTHGQ----VGTRRYMAPEVLEGAINFQRDAFLRIDMY 214
Query: 233 GFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGK 292
             G  L+EL++  + +D    E    +EE +    GQ+   +E+ + ++ +    T    
Sbjct: 215 AMGLVLWELVSRCKAADGPVDEYMLPFEEEI----GQHPSLEELQEVVVHKKMRPTIKDH 270
Query: 293 EQQLQAFKQLTL---QCMDFSPEDRPTMVDVAKQLRQMYRS 330
             +     QL +   +C D   E R +   V +++  + RS
Sbjct: 271 WLKHPGLAQLCVTIEECWDHDAEARLSAGCVEERVSLIRRS 311

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 21/193 (10%)
Query: 67  FRKLYKGFWQKR-SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFES-VQIG 124
           F  +YKG W    ++ ++       Q  L+   N +    +  H +I+  + + +  Q+ 
Sbjct: 49  FGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA 107
Query: 125 TL-----ADRIHHH---CEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPT 176
            +        ++HH    E  FE + L D   +A   A  + YLH   ++ I++RD+K  
Sbjct: 108 IVTQWCEGSSLYHHLHIIETKFEMIKLID---IARQTAQGMDYLH---AKSIIHRDLKSN 161
Query: 177 NILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF----TTLINEQCDVY 232
           NI  +E    K+ DF L+          + + + G+  ++APE          + Q DVY
Sbjct: 162 NIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 221
Query: 233 GFGAFLFELLTAQ 245
            FG  L+EL+T Q
Sbjct: 222 AFGIVLYELMTGQ 234

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 21/193 (10%)
Query: 67  FRKLYKGFWQKR-SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFES-VQIG 124
           F  +YKG W    ++ ++       Q  L+   N +    +  H +I+  + + +  Q+ 
Sbjct: 41  FGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA 99
Query: 125 TL-----ADRIHHH---CEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPT 176
            +        ++HH    E  FE + L D   +A   A  + YLH   ++ I++RD+K  
Sbjct: 100 IVTQWCEGSSLYHHLHIIETKFEMIKLID---IARQTAQGMDYLH---AKSIIHRDLKSN 153
Query: 177 NILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF----TTLINEQCDVY 232
           NI  +E    K+ DF L+          + + + G+  ++APE          + Q DVY
Sbjct: 154 NIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 213
Query: 233 GFGAFLFELLTAQ 245
            FG  L+EL+T Q
Sbjct: 214 AFGIVLYELMTGQ 226

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 86/188 (45%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 115
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P        D++ 
Sbjct: 116 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DTLC 168
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQETYKRISRV 222
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 223 EFTFPDFV 230

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/278 (21%), Positives = 114/278 (41%), Gaps = 39/278 (14%)
Query: 67  FRKLYKGFWQKR-SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFESV-QIG 124
           F  +YKG W    ++ ++       Q  L+   N +    +  H +I+  + + +  Q+ 
Sbjct: 21  FGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYSTAPQLA 79
Query: 125 TL-----ADRIHHH---CEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPT 176
            +        ++HH    E  FE + L D   +A   A  + YLH   ++ I++RD+K  
Sbjct: 80  IVTQWCEGSSLYHHLHIIETKFEMIKLID---IARQTAQGMDYLH---AKSIIHRDLKSN 133
Query: 177 NILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF----TTLINEQCDVY 232
           NI  +E    K+ DF L+          + + + G+  ++APE          + Q DVY
Sbjct: 134 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 193
Query: 233 GFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGK 292
            FG  L+EL+T Q    +++   +  +      LS    + +           +C     
Sbjct: 194 AFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS----------NCP---- 239
Query: 293 EQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
               +A K+L  +C+    ++RP    +   +  + RS
Sbjct: 240 ----KAMKRLMAECLKKKRDERPLFPQILASIELLARS 273

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 29/82 (35%), Positives = 48/82 (58%), Gaps = 10/82 (12%)
Query: 168 IVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINE 227
           IVYRD+KP NIL ++    ++ D  L++ +P+G+T   +   VGT G++APE    + NE
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPE---VVKNE 360
Query: 228 Q----CDVYGFGAFLFELLTAQ 245
           +     D +  G  L+E++  Q
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 21/193 (10%)
Query: 67  FRKLYKGFWQKR-SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFES-VQIG 124
           F  +YKG W    ++ ++       Q  L+   N +    +  H +I+  + + +  Q+ 
Sbjct: 48  FGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA 106
Query: 125 TL-----ADRIHHH---CEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPT 176
            +        ++HH    E  FE + L D   +A   A  + YLH   ++ I++RD+K  
Sbjct: 107 IVTQWCEGSSLYHHLHIIETKFEMIKLID---IARQTAQGMDYLH---AKSIIHRDLKSN 160
Query: 177 NILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF----TTLINEQCDVY 232
           NI  +E    K+ DF L+          + + + G+  ++APE          + Q DVY
Sbjct: 161 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 220
Query: 233 GFGAFLFELLTAQ 245
            FG  L+EL+T Q
Sbjct: 221 AFGIVLYELMTGQ 233

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 29/82 (35%), Positives = 48/82 (58%), Gaps = 10/82 (12%)
Query: 168 IVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINE 227
           IVYRD+KP NIL ++    ++ D  L++ +P+G+T   +   VGT G++APE    + NE
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPE---VVKNE 360
Query: 228 Q----CDVYGFGAFLFELLTAQ 245
           +     D +  G  L+E++  Q
Sbjct: 361 RYTFSPDWWALGCLLYEMIAGQ 382

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 57/117 (48%), Gaps = 10/117 (8%)
Query: 130 IHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLF 189
           +H+H  QH    S  D    A +I   + ++H   +R +VYRD+KP NIL +E    ++ 
Sbjct: 278 LHYHLSQH-GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRIS 333
Query: 190 DFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLI--NEQCDVYGFGAFLFELLTA 244
           D  L+      + H    + VGT G++APE     +  +   D +  G  LF+LL  
Sbjct: 334 DLGLACDFSKKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 21/193 (10%)
Query: 67  FRKLYKGFWQKR-SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFES-VQIG 124
           F  +YKG W    ++ ++       Q  L+   N +    +  H +I+  + + +  Q+ 
Sbjct: 49  FGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA 107
Query: 125 TL-----ADRIHHH---CEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPT 176
            +        ++HH    E  FE + L D   +A   A  + YLH   ++ I++RD+K  
Sbjct: 108 IVTQWCEGSSLYHHLHIIETKFEMIKLID---IARQTAQGMDYLH---AKSIIHRDLKSN 161
Query: 177 NILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF----TTLINEQCDVY 232
           NI  +E    K+ DF L+          + + + G+  ++APE          + Q DVY
Sbjct: 162 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 221
Query: 233 GFGAFLFELLTAQ 245
            FG  L+EL+T Q
Sbjct: 222 AFGIVLYELMTGQ 234

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 10/115 (8%)
Query: 130 IHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLF 189
           +H+H  QH    S  D    A +I   + ++H   +R +VYRD+KP NIL +E    ++ 
Sbjct: 279 LHYHLSQH-GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRIS 334
Query: 190 DFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLI--NEQCDVYGFGAFLFELL 242
           D  L+      + H    + VGT G++APE     +  +   D +  G  LF+LL
Sbjct: 335 DLGLACDFSKKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 75/143 (52%), Gaps = 22/143 (15%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +VFE ++ G++   IH    +HF  L  +    V  D+A A+ +LH   ++ I +RD+KP
Sbjct: 88  LVFEKMRGGSILSHIHKR--RHFNELEAS---VVVQDVASALDFLH---NKGIAHRDLKP 139
Query: 176 TNILF---NEQSDAKLFDFSLSLSIP-DGE----THIELDSVVGTTGFIAPENF------ 221
            NIL    N+ S  K+ DF L   I  +G+    +  EL +  G+  ++APE        
Sbjct: 140 ENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEE 199
Query: 222 TTLINEQCDVYGFGAFLFELLTA 244
            ++ +++CD++  G  L+ LL+ 
Sbjct: 200 ASIYDKRCDLWSLGVILYILLSG 222

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 21/193 (10%)
Query: 67  FRKLYKGFWQKR-SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFES-VQIG 124
           F  +YKG W    ++ ++       Q  L+   N +    +  H +I+  + + +  Q+ 
Sbjct: 21  FGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA 79
Query: 125 TL-----ADRIHHH---CEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPT 176
            +        ++HH    E  FE + L D   +A   A  + YLH   ++ I++RD+K  
Sbjct: 80  IVTQWCEGSSLYHHLHIIETKFEMIKLID---IARQTAQGMDYLH---AKSIIHRDLKSN 133
Query: 177 NILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF----TTLINEQCDVY 232
           NI  +E    K+ DF L+          + + + G+  ++APE          + Q DVY
Sbjct: 134 NIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 193
Query: 233 GFGAFLFELLTAQ 245
            FG  L+EL+T Q
Sbjct: 194 AFGIVLYELMTGQ 206

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 10/115 (8%)
Query: 130 IHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLF 189
           +H+H  QH    S  D    A +I   + ++H   +R +VYRD+KP NIL +E    ++ 
Sbjct: 279 LHYHLSQH-GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRIS 334
Query: 190 DFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLI--NEQCDVYGFGAFLFELL 242
           D  L+      + H    + VGT G++APE     +  +   D +  G  LF+LL
Sbjct: 335 DLGLACDFSKKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 36/115 (31%), Positives = 57/115 (49%), Gaps = 10/115 (8%)
Query: 130 IHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLF 189
           +H+H  QH    S  D    A +I   + ++H   +R +VYRD+KP NIL +E    ++ 
Sbjct: 279 LHYHLSQH-GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRIS 334
Query: 190 DFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLI--NEQCDVYGFGAFLFELL 242
           D  L+      + H    + VGT G++APE     +  +   D +  G  LF+LL
Sbjct: 335 DLGLACDFSKKKPH----ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 84/182 (46%), Gaps = 15/182 (8%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G+  D +       F+  ++   +   +D      YLH   S   ++RD+K 
Sbjct: 98  IIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLD------YLH---SEKKIHRDIKA 148
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINEQCDVYGF 234
            N+L +EQ D KL DF ++  + D  T I+ ++ VGT  ++APE    +  + + D++  
Sbjct: 149 ANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSL 206
Query: 235 GAFLFELLTAQEV-SDHVSFESRFHYEE-NVKRLSGQNCR-FKEMVDSIIIEDKSCTCTG 291
           G    EL   +   SD       F   + N   L G   + FKE +D+ + +D S   T 
Sbjct: 207 GITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDPSFRPTA 266
Query: 292 KE 293
           KE
Sbjct: 267 KE 268

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 69/153 (45%), Gaps = 25/153 (16%)
Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           ++ H +I+KL           IV E    G L D I        +  S  D  ++   + 
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVF 131
Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQS---DAKLFDFSLSLSIPDGETHIELDSVVG 211
             + Y+H      IV+RD+KP NIL   +    D K+ DF LS      + + ++   +G
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIG 185
Query: 212 TTGFIAPENFTTLINEQCDVYGFGAFLFELLTA 244
           T  +IAPE      +E+CDV+  G  L+ LL+ 
Sbjct: 186 TAYYIAPEVLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/143 (30%), Positives = 75/143 (52%), Gaps = 22/143 (15%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +VFE ++ G++   IH    +HF  L  +    V  D+A A+ +LH   ++ I +RD+KP
Sbjct: 88  LVFEKMRGGSILSHIHKR--RHFNELEAS---VVVQDVASALDFLH---NKGIAHRDLKP 139
Query: 176 TNILF---NEQSDAKLFDFSLSLSIP-DGE----THIELDSVVGTTGFIAPENF------ 221
            NIL    N+ S  K+ DF L   I  +G+    +  EL +  G+  ++APE        
Sbjct: 140 ENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEE 199
Query: 222 TTLINEQCDVYGFGAFLFELLTA 244
            ++ +++CD++  G  L+ LL+ 
Sbjct: 200 ASIYDKRCDLWSLGVILYILLSG 222

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 69/153 (45%), Gaps = 25/153 (16%)
Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           ++ H +I+KL           IV E    G L D I        +  S  D  ++   + 
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVF 131
Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQS---DAKLFDFSLSLSIPDGETHIELDSVVG 211
             + Y+H      IV+RD+KP NIL   +    D K+ DF LS      + + ++   +G
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIG 185
Query: 212 TTGFIAPENFTTLINEQCDVYGFGAFLFELLTA 244
           T  +IAPE      +E+CDV+  G  L+ LL+ 
Sbjct: 186 TAYYIAPEVLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 85/188 (45%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 140
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P        D + 
Sbjct: 141 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DDLC 193
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 194 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEANT-YQETYKRISRV 247
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 248 EFTFPDFV 255

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/278 (21%), Positives = 114/278 (41%), Gaps = 39/278 (14%)
Query: 67  FRKLYKGFWQKR-SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFES-VQIG 124
           F  +YKG W    ++ ++       Q  L+   N +    +  H +I+  + + +  Q+ 
Sbjct: 21  FGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA 79
Query: 125 TL-----ADRIHHH---CEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPT 176
            +        ++HH    E  FE + L D   +A   A  + YLH   ++ I++RD+K  
Sbjct: 80  IVTQWCEGSSLYHHLHIIETKFEMIKLID---IARQTAQGMDYLH---AKSIIHRDLKSN 133
Query: 177 NILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF----TTLINEQCDVY 232
           NI  +E    K+ DF L+          + + + G+  ++APE          + Q DVY
Sbjct: 134 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 193
Query: 233 GFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGK 292
            FG  L+EL+T Q    +++   +  +      LS    + +           +C     
Sbjct: 194 AFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRS----------NCP---- 239
Query: 293 EQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
               +A K+L  +C+    ++RP    +   +  + RS
Sbjct: 240 ----KAMKRLMAECLKKKRDERPLFPQILASIELLARS 273

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 95/215 (44%), Gaps = 31/215 (14%)
Query: 99  NHIVYASRMSHKHIIKLI-VFESVQIGTLADRIHHHCEQHFEAL------SLTDRLKVAM 151
           N I     + H +IIKL  VFE  +   L    +   E  FE +         D   +  
Sbjct: 95  NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL-FEQIINRHKFDECDAANIMK 153
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS---DAKLFDFSLSLSIPDGETHIELDS 208
            I   + YLH      IV+RD+KP NIL   ++   + K+ DF LS          +L  
Sbjct: 154 QILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS---KDYKLRD 207
Query: 209 VVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTA---------QEVSDHVSFESRFHY 259
            +GT  +IAPE      NE+CDV+  G  ++ LL           Q++   V  + ++++
Sbjct: 208 RLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE-KGKYYF 266
Query: 260 EEN-VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKE 293
           + N  K +S +    KE++  ++  D +  CT +E
Sbjct: 267 DFNDWKNISDEA---KELIKLMLTYDYNKRCTAEE 298

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 21/193 (10%)
Query: 67  FRKLYKGFWQKR-SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFES-VQIG 124
           F  +YKG W    ++ ++       Q  L+   N +    +  H +I+  + + +  Q+ 
Sbjct: 26  FGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA 84
Query: 125 TL-----ADRIHHH---CEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPT 176
            +        ++HH    E  FE + L D   +A   A  + YLH   ++ I++RD+K  
Sbjct: 85  IVTQWCEGSSLYHHLHIIETKFEMIKLID---IARQTAQGMDYLH---AKSIIHRDLKSN 138
Query: 177 NILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF----TTLINEQCDVY 232
           NI  +E    K+ DF L+          + + + G+  ++APE          + Q DVY
Sbjct: 139 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 198
Query: 233 GFGAFLFELLTAQ 245
            FG  L+EL+T Q
Sbjct: 199 AFGIVLYELMTGQ 211

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 21/193 (10%)
Query: 67  FRKLYKGFWQKR-SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFES-VQIG 124
           F  +YKG W    ++ ++       Q  L+   N +    +  H +I+  + + +  Q+ 
Sbjct: 26  FGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA 84
Query: 125 TL-----ADRIHHH---CEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPT 176
            +        ++HH    E  FE + L D   +A   A  + YLH   ++ I++RD+K  
Sbjct: 85  IVTQWCEGSSLYHHLHIIETKFEMIKLID---IARQTAQGMDYLH---AKSIIHRDLKSN 138
Query: 177 NILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF----TTLINEQCDVY 232
           NI  +E    K+ DF L+          + + + G+  ++APE          + Q DVY
Sbjct: 139 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 198
Query: 233 GFGAFLFELLTAQ 245
            FG  L+EL+T Q
Sbjct: 199 AFGIVLYELMTGQ 211

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 73/156 (46%), Gaps = 26/156 (16%)
Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           R+SH +IIKL           +V E V  G L DRI    + ++      D +K    I 
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVE--KGYYSERDAADAVK---QIL 158
Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILF-NEQSDA--KLFDFSLSLSIPDGETHIELDSVVG 211
            AVAYLH      IV+RD+KP N+L+     DA  K+ DF LS  +   E  + + +V G
Sbjct: 159 EAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCG 212
Query: 212 TTGFIAPENF-TTLINEQCDVYGFGAFLFELLTAQE 246
           T G+ APE         + D++  G   + LL   E
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFE 248

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 86/193 (44%), Gaps = 21/193 (10%)
Query: 67  FRKLYKGFWQKR-SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFES-VQIG 124
           F  +YKG W    ++ ++       Q  L+   N +    +  H +I+  + + +  Q+ 
Sbjct: 23  FGTVYKGKWHGDVAVKMLNVTAPTPQQ-LQAFKNEVGVLRKTRHVNILLFMGYSTKPQLA 81
Query: 125 TL-----ADRIHHH---CEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPT 176
            +        ++HH    E  FE + L D   +A   A  + YLH   ++ I++RD+K  
Sbjct: 82  IVTQWCEGSSLYHHLHIIETKFEMIKLID---IARQTAQGMDYLH---AKSIIHRDLKSN 135
Query: 177 NILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF----TTLINEQCDVY 232
           NI  +E    K+ DF L+          + + + G+  ++APE          + Q DVY
Sbjct: 136 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVY 195
Query: 233 GFGAFLFELLTAQ 245
            FG  L+EL+T Q
Sbjct: 196 AFGIVLYELMTGQ 208

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 57.8 bits (138), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 69/153 (45%), Gaps = 25/153 (16%)
Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           ++ H +I+KL           IV E    G L D I        +  S  D  ++   + 
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR-----KRFSEHDAARIIKQVF 131
Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQS---DAKLFDFSLSLSIPDGETHIELDSVVG 211
             + Y+H      IV+RD+KP NIL   +    D K+ DF LS      + + ++   +G
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF---QQNTKMKDRIG 185
Query: 212 TTGFIAPENFTTLINEQCDVYGFGAFLFELLTA 244
           T  +IAPE      +E+CDV+  G  L+ LL+ 
Sbjct: 186 TAYYIAPEVLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/188 (24%), Positives = 85/188 (45%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 117
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P        D + 
Sbjct: 118 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DDLC 170
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQETYKRISRV 224
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 225 EFTFPDFV 232

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 25/202 (12%)
Query: 67  FRKLYKGFWQKR-SISLMK--------YNGNRNQHALEWCINHI---VYASRMSHKHIIK 114
           F  +YKG W    ++ ++K        +   RN+ A+     H+   ++   M+  ++  
Sbjct: 49  FGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLA- 107
Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
            IV +  +  +L   +H   E  F+   L D   +A   A  + YLH   ++ I++RDMK
Sbjct: 108 -IVTQWCEGSSLYKHLHVQ-ETKFQMFQLID---IARQTAQGMDYLH---AKNIIHRDMK 159
Query: 175 PTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINE----QCD 230
             NI  +E    K+ DF L+          +++   G+  ++APE      N     Q D
Sbjct: 160 SNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSD 219
Query: 231 VYGFGAFLFELLTAQEVSDHVS 252
           VY +G  L+EL+T +    H++
Sbjct: 220 VYSYGIVLYELMTGELPYSHIN 241

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 69/148 (46%), Gaps = 15/148 (10%)
Query: 106 RMSHKHIIKLI-VFESVQIGTLADRIHHHCEQHFEALSL-----TDRLKVAMDIAHAVAY 159
           ++ H +I+KL   FE      L   ++   E   E +S       D  ++   +   + Y
Sbjct: 88  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 147
Query: 160 LHVGFSRPIVYRDMKPTNILFNEQS---DAKLFDFSLSLSIPDGETHIELDSVVGTTGFI 216
           +H      IV+RD+KP N+L   +S   + ++ DF LS      E   ++   +GT  +I
Sbjct: 148 MH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKKMKDKIGTAYYI 201
Query: 217 APENFTTLINEQCDVYGFGAFLFELLTA 244
           APE      +E+CDV+  G  L+ LL+ 
Sbjct: 202 APEVLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           ++A A+ +LH   S  I+YRD+KP NIL +E+   KL DF LS    D E   +  S  G
Sbjct: 135 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCG 189
Query: 212 TTGFIAPENFTTLINEQ-CDVYGFGAFLFELLTA 244
           T  ++APE      + Q  D + FG  +FE+LT 
Sbjct: 190 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           ++A A+ +LH   S  I+YRD+KP NIL +E+   KL DF LS    D E   +  S  G
Sbjct: 134 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCG 188
Query: 212 TTGFIAPENFTTLINEQ-CDVYGFGAFLFELLTA 244
           T  ++APE      + Q  D + FG  +FE+LT 
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 64/135 (47%), Gaps = 15/135 (11%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +V E +  G L + + ++      A   T  + +A+D  H++ ++H         RD+KP
Sbjct: 151 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH---------RDVKP 201
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-----LINEQCD 230
            N+L ++    KL DF   + + + E  +  D+ VGT  +I+PE   +         +CD
Sbjct: 202 DNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 260
Query: 231 VYGFGAFLFELLTAQ 245
            +  G FL+E+L   
Sbjct: 261 WWSVGVFLYEMLVGD 275

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 24/223 (10%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +V E +  G L D +    ++H   L  +  L  +  I   + YL    SR  V+RD+  
Sbjct: 91  LVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAA 143
Query: 176 TNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYG 233
            NIL   ++  K+ DF L+  +P D + ++  +       + APE+ +  + + Q DV+ 
Sbjct: 144 RNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWS 203
Query: 234 FGAFLFELLTA--QEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTG 291
           FG  L+EL T   +  S    F      E +V  L    CR  E+++          C  
Sbjct: 204 FGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL----CRLLELLEEGQRLPAPPACPA 259
Query: 292 KEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY---RSC 331
           +  +L         C   SP+DRP+   +  QL  ++   R C
Sbjct: 260 EVHELMKL------CWAPSPQDRPSFSALGPQLDMLWSGSRGC 296

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/245 (24%), Positives = 99/245 (40%), Gaps = 52/245 (21%)
Query: 107 MSHKHIIKLI-----------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           + H +++K I           + E ++ GTL   I     Q+      + R+  A DIA 
Sbjct: 64  LEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQY----PWSQRVSFAKDIAS 119
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIE---------- 205
            +AYLH   S  I++RD+   N L  E  +  + DF L+  + D +T  E          
Sbjct: 120 GMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 206 --LDSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEEN 262
               +VVG   ++APE       +E+ DV+ FG  L E++  +  +D         +  N
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNADPDYLPRTMDFGLN 235
Query: 263 VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK 322
           V+    + C              +C          +F  +T++C D  PE RP+ V +  
Sbjct: 236 VRGFLDRYC------------PPNCP--------PSFFPITVRCCDLDPEKRPSFVKLEH 275
Query: 323 QLRQM 327
            L  +
Sbjct: 276 WLETL 280

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 64/135 (47%), Gaps = 15/135 (11%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +V E +  G L + + ++      A   T  + +A+D  H++ ++H         RD+KP
Sbjct: 146 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH---------RDVKP 196
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-----LINEQCD 230
            N+L ++    KL DF   + + + E  +  D+ VGT  +I+PE   +         +CD
Sbjct: 197 DNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 255
Query: 231 VYGFGAFLFELLTAQ 245
            +  G FL+E+L   
Sbjct: 256 WWSVGVFLYEMLVGD 270

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 68/150 (45%), Gaps = 26/150 (17%)
Query: 109 HKHIIKL-----------IVFESVQIGTLADRIHHHCE-QHFEALSLTDRLKVAMDIAHA 156
           H HIIKL           +V E V  G L D I  H   +  EA  L  ++  A+D  H 
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH- 128
Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFI 216
                      +V+RD+KP N+L +   +AK+ DF LS  + DGE    L +  G+  + 
Sbjct: 129 --------RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYA 177
Query: 217 APENFTTLI--NEQCDVYGFGAFLFELLTA 244
           APE  +  +    + D++  G  L+ LL  
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 64/135 (47%), Gaps = 15/135 (11%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +V E +  G L + + ++      A   T  + +A+D  H++ ++H         RD+KP
Sbjct: 151 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIH---------RDVKP 201
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-----LINEQCD 230
            N+L ++    KL DF   + + + E  +  D+ VGT  +I+PE   +         +CD
Sbjct: 202 DNMLLDKSGHLKLADFGTCMKM-NKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 260
Query: 231 VYGFGAFLFELLTAQ 245
            +  G FL+E+L   
Sbjct: 261 WWSVGVFLYEMLVGD 275

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 95  EWCINHIVYASRMSHKHIIKLI-VFESVQIGTLADRIHHHCEQHFEALSL-----TDRLK 148
           E  +  +    ++ H +I+KL   FE      L   ++   E   E +S       D  +
Sbjct: 94  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR 153
Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS-DA--KLFDFSLSLSIPDGETHIE 205
           +   +   + Y+H      IV+RD+KP N+L   +S DA  ++ DF LS      E   +
Sbjct: 154 IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKK 207
Query: 206 LDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTA 244
           +   +GT  +IAPE      +E+CDV+  G  L+ LL+ 
Sbjct: 208 MKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 95  EWCINHIVYASRMSHKHIIKLI-VFESVQIGTLADRIHHHCEQHFEALSL-----TDRLK 148
           E  +  +    ++ H +I+KL   FE      L   ++   E   E +S       D  +
Sbjct: 95  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR 154
Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS-DA--KLFDFSLSLSIPDGETHIE 205
           +   +   + Y+H      IV+RD+KP N+L   +S DA  ++ DF LS      E   +
Sbjct: 155 IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKK 208
Query: 206 LDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTA 244
           +   +GT  +IAPE      +E+CDV+  G  L+ LL+ 
Sbjct: 209 MKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 83/185 (44%), Gaps = 31/185 (16%)
Query: 77  KRSISLMKYNG---NRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQ 122
           +R+I ++K +      N  AL   ++ +    ++ H +I+KL           +V E  +
Sbjct: 31  ERAIKIIKKSSVTTTSNSGAL---LDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYR 87
Query: 123 IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE 182
            G L D I     Q F   S  D   +   +     YLH      IV+RD+KP N+L   
Sbjct: 88  GGELFDEII--LRQKF---SEVDAAVIMKQVLSGTTYLH---KHNIVHRDLKPENLLLES 139
Query: 183 QS-DA--KLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLF 239
           +S DA  K+ DF LS      E   ++   +GT  +IAPE      +E+CDV+  G  L+
Sbjct: 140 KSRDALIKIVDFGLSAHF---EVGGKMKERLGTAYYIAPEVLRKKYDEKCDVWSCGVILY 196
Query: 240 ELLTA 244
            LL  
Sbjct: 197 ILLCG 201

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 85/188 (45%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSRFDEQRTATYI 118
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P        D++ 
Sbjct: 119 TELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----DTLC 171
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L          FE+   Y+E  +R+S  
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMP-----PFEAH-TYQETYRRISRV 225
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 226 EFTFPDFV 233

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 15/159 (9%)
Query: 95  EWCINHIVYASRMSHKHIIKLI-VFESVQIGTLADRIHHHCEQHFEALSL-----TDRLK 148
           E  +  +    ++ H +I+KL   FE      L   ++   E   E +S       D  +
Sbjct: 71  ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR 130
Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS-DA--KLFDFSLSLSIPDGETHIE 205
           +   +   + Y+H      IV+RD+KP N+L   +S DA  ++ DF LS      E   +
Sbjct: 131 IIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF---EASKK 184
Query: 206 LDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTA 244
           +   +GT  +IAPE      +E+CDV+  G  L+ LL+ 
Sbjct: 185 MKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 40/224 (17%)
Query: 107 MSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHA 156
           + H+++I+L          +V E   +G+L DR+  H + HF   +L+   + A+ +A  
Sbjct: 72  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLS---RYAVQVAEG 127
Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT-GF 215
           + YL    S+  ++RD+   N+L   +   K+ DF L  ++P  + H  +         +
Sbjct: 128 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 216 IAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK 274
            APE+  T   +   D + FG  L+E+ T              + +E    L+G     K
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFT--------------YGQEPWIGLNGSQILHK 230
Query: 275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMV 318
                  I+ +       E   Q    + +QC    PEDRPT V
Sbjct: 231 -------IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 267

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/94 (39%), Positives = 52/94 (55%), Gaps = 6/94 (6%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           ++A A+ +LH   S  I+YRD+KP NIL +E+   KL DF LS    D E   +  S  G
Sbjct: 134 ELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCG 188
Query: 212 TTGFIAPENFTTLINEQ-CDVYGFGAFLFELLTA 244
           T  ++APE      + Q  D + FG  +FE+LT 
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 40/224 (17%)
Query: 107 MSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHA 156
           + H+++I+L          +V E   +G+L DR+  H + HF   +L+   + A+ +A  
Sbjct: 68  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLS---RYAVQVAEG 123
Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT-GF 215
           + YL    S+  ++RD+   N+L   +   K+ DF L  ++P  + H  +         +
Sbjct: 124 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 216 IAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK 274
            APE+  T   +   D + FG  L+E+ T              + +E    L+G     K
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFT--------------YGQEPWIGLNGSQILHK 226
Query: 275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMV 318
                  I+ +       E   Q    + +QC    PEDRPT V
Sbjct: 227 -------IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 263

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 40/224 (17%)
Query: 107 MSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHA 156
           + H+++I+L          +V E   +G+L DR+  H + HF   +L+   + A+ +A  
Sbjct: 72  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLS---RYAVQVAEG 127
Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT-GF 215
           + YL    S+  ++RD+   N+L   +   K+ DF L  ++P  + H  +         +
Sbjct: 128 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 216 IAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK 274
            APE+  T   +   D + FG  L+E+ T              + +E    L+G     K
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFT--------------YGQEPWIGLNGSQILHK 230
Query: 275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMV 318
                  I+ +       E   Q    + +QC    PEDRPT V
Sbjct: 231 -------IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 267

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 40/224 (17%)
Query: 107 MSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHA 156
           + H+++I+L          +V E   +G+L DR+  H + HF   +L+   + A+ +A  
Sbjct: 68  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLS---RYAVQVAEG 123
Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT-GF 215
           + YL    S+  ++RD+   N+L   +   K+ DF L  ++P  + H  +         +
Sbjct: 124 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 180
Query: 216 IAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK 274
            APE+  T   +   D + FG  L+E+ T              + +E    L+G     K
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFT--------------YGQEPWIGLNGSQILHK 226
Query: 275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMV 318
                  I+ +       E   Q    + +QC    PEDRPT V
Sbjct: 227 -------IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 263

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 67/150 (44%), Gaps = 25/150 (16%)
Query: 107 MSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           + H +II+L           +V E    G L +R+ H           +D  ++  D+  
Sbjct: 80  LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK-----RVFRESDAARIMKDVLS 134
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           AVAY H      + +RD+KP N LF   +  S  KL DF L+     G+    + + VGT
Sbjct: 135 AVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGT 188
Query: 213 TGFIAPENFTTLINEQCDVYGFGAFLFELL 242
             +++P+    L   +CD +  G  ++ LL
Sbjct: 189 PYYVSPQVLEGLYGPECDEWSAGVMMYVLL 218

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 67/150 (44%), Gaps = 25/150 (16%)
Query: 107 MSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           + H +II+L           +V E    G L +R+ H           +D  ++  D+  
Sbjct: 63  LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK-----RVFRESDAARIMKDVLS 117
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           AVAY H      + +RD+KP N LF   +  S  KL DF L+     G+    + + VGT
Sbjct: 118 AVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGT 171
Query: 213 TGFIAPENFTTLINEQCDVYGFGAFLFELL 242
             +++P+    L   +CD +  G  ++ LL
Sbjct: 172 PYYVSPQVLEGLYGPECDEWSAGVMMYVLL 201

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 40/224 (17%)
Query: 107 MSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHA 156
           + H+++I+L          +V E   +G+L DR+  H + HF   +L+   + A+ +A  
Sbjct: 78  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLS---RYAVQVAEG 133
Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT-GF 215
           + YL    S+  ++RD+   N+L   +   K+ DF L  ++P  + H  +         +
Sbjct: 134 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 190
Query: 216 IAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK 274
            APE+  T   +   D + FG  L+E+ T              + +E    L+G     K
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFT--------------YGQEPWIGLNGSQILHK 236
Query: 275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMV 318
                  I+ +       E   Q    + +QC    PEDRPT V
Sbjct: 237 -------IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 273

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 80/182 (43%), Gaps = 25/182 (13%)
Query: 77  KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGT 125
           +R+I ++K +           ++ +    ++ H +I+KL           +V E  + G 
Sbjct: 48  ERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGE 107
Query: 126 LADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS- 184
           L D I     Q F   S  D   +   +     YLH      IV+RD+KP N+L   +S 
Sbjct: 108 LFDEII--LRQKF---SEVDAAVIMKQVLSGTTYLH---KHNIVHRDLKPENLLLESKSR 159
Query: 185 DA--KLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELL 242
           DA  K+ DF LS      E   ++   +GT  +IAPE      +E+CDV+  G  L+ LL
Sbjct: 160 DALIKIVDFGLSAHF---EVGGKMKERLGTAYYIAPEVLRKKYDEKCDVWSCGVILYILL 216
Query: 243 TA 244
Sbjct: 217 CG 218

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 40/224 (17%)
Query: 107 MSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHA 156
           + H+++I+L          +V E   +G+L DR+  H + HF   +L+   + A+ +A  
Sbjct: 68  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLS---RYAVQVAEG 123
Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT-GF 215
           + YL    S+  ++RD+   N+L   +   K+ DF L  ++P  + H  +         +
Sbjct: 124 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 216 IAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK 274
            APE+  T   +   D + FG  L+E+ T              + +E    L+G     K
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFT--------------YGQEPWIGLNGSQILHK 226
Query: 275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMV 318
                  I+ +       E   Q    + +QC    PEDRPT V
Sbjct: 227 -------IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 263

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 21/217 (9%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +V E +  G L D +    ++H   L  +  L  +  I   + YL    SR  V+RD+  
Sbjct: 87  LVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAA 139
Query: 176 TNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYG 233
            NIL   ++  K+ DF L+  +P D +  +  +       + APE+ +  + + Q DV+ 
Sbjct: 140 RNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWS 199
Query: 234 FGAFLFELLT--AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTG 291
           FG  L+EL T   +  S    F      E +V  L    CR  E+++          C  
Sbjct: 200 FGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPAL----CRLLELLEEGQRLPAPPACPA 255
Query: 292 KEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY 328
           +  +L         C   SP+DRP+   +  QL  ++
Sbjct: 256 EVHELMKL------CWAPSPQDRPSFSALGPQLDMLW 286

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 67/150 (44%), Gaps = 26/150 (17%)
Query: 109 HKHIIKL-----------IVFESVQIGTLADRIHHHCE-QHFEALSLTDRLKVAMDIAHA 156
           H HIIKL           +V E V  G L D I  H   +  EA  L  ++  A+D  H 
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCH- 128
Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFI 216
                      +V+RD+KP N+L +   +AK+ DF LS  + DGE    L    G+  + 
Sbjct: 129 --------RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRDSCGSPNYA 177
Query: 217 APENFTTLI--NEQCDVYGFGAFLFELLTA 244
           APE  +  +    + D++  G  L+ LL  
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/224 (24%), Positives = 94/224 (41%), Gaps = 40/224 (17%)
Query: 107 MSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHA 156
           + H+++I+L          +V E   +G+L DR+  H + HF   +L+   + A+ +A  
Sbjct: 78  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKH-QGHFLLGTLS---RYAVQVAEG 133
Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT-GF 215
           + YL    S+  ++RD+   N+L   +   K+ DF L  ++P  + H  +         +
Sbjct: 134 MGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 216 IAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK 274
            APE+  T   +   D + FG  L+E+ T              + +E    L+G     K
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFT--------------YGQEPWIGLNGSQILHK 236
Query: 275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMV 318
                  I+ +       E   Q    + +QC    PEDRPT V
Sbjct: 237 -------IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV 273

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 85/188 (45%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 80  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 131
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P         ++ 
Sbjct: 132 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLC 184
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 185 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEANT-YQETYKRISRV 238
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 239 EFTFPDFV 246

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 85/188 (45%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 119
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P         ++ 
Sbjct: 120 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLC 172
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQETYKRISRV 226
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 227 EFTFPDFV 234

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 85/188 (45%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 89  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 140
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P         ++ 
Sbjct: 141 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLC 193
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 194 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEANT-YQETYKRISRV 247
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 248 EFTFPDFV 255

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 85/188 (45%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 117
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P         ++ 
Sbjct: 118 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLC 170
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQETYKRISRV 224
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 225 EFTFPDFV 232

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 85/188 (45%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 114
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P         ++ 
Sbjct: 115 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLC 167
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQETYKRISRV 221
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 222 EFTFPDFV 229

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 70/155 (45%), Gaps = 30/155 (19%)
Query: 107 MSHKHIIKL-------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
           + H+HI+K              +V E V +G+L D +  HC      + L   L  A  I
Sbjct: 68  LYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC------VGLAQLLLFAQQI 121
Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL----DSV 209
              +AYLH   ++  ++R +   N+L +     K+ DF L+ ++P+G  +  +    DS 
Sbjct: 122 CEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 178
Query: 210 VGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLT 243
           V    + APE           DV+ FG  L+ELLT
Sbjct: 179 V---FWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 85/188 (45%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 117
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P         ++ 
Sbjct: 118 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLC 170
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQETYKRISRV 224
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 225 EFTFPDFV 232

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 73/149 (48%), Gaps = 9/149 (6%)
Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDS 208
           +  +I   + YLH   S   ++RD+K  N+L +EQ D KL DF ++  + D  T I+ + 
Sbjct: 121 ILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNX 175
Query: 209 VVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEV-SDHVSFESRFHYEEN-VKR 265
            VGT  ++APE    +  + + D++  G    EL   +   SD       F   +N    
Sbjct: 176 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT 235
Query: 266 LSGQNCR-FKEMVDSIIIEDKSCTCTGKE 293
           L GQ+ + FKE V++ + +D     T KE
Sbjct: 236 LEGQHSKPFKEFVEACLNKDPRFRPTAKE 264

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 70/155 (45%), Gaps = 30/155 (19%)
Query: 107 MSHKHIIKL-------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
           + H+HI+K              +V E V +G+L D +  HC      + L   L  A  I
Sbjct: 67  LYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHC------VGLAQLLLFAQQI 120
Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL----DSV 209
              +AYLH   ++  ++R +   N+L +     K+ DF L+ ++P+G  +  +    DS 
Sbjct: 121 CEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 177
Query: 210 VGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLT 243
           V    + APE           DV+ FG  L+ELLT
Sbjct: 178 V---FWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 85/188 (45%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 60  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 111
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P         ++ 
Sbjct: 112 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLC 164
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 165 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQETYKRISRV 218
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 219 EFTFPDFV 226

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 85/188 (45%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 62  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 113
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P         ++ 
Sbjct: 114 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLC 166
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 167 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQETYKRISRV 220
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 221 EFTFPDFV 228

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 85/188 (45%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 118
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P         ++ 
Sbjct: 119 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLC 171
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQETYKRISRV 225
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 226 EFTFPDFV 233

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/176 (24%), Positives = 79/176 (44%), Gaps = 27/176 (15%)
Query: 74  FWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHH 133
           FW++R I  M +  +       W +   ++ +    K++   +V E +  G L + + ++
Sbjct: 122 FWEERDI--MAFANS------PWVVQ--LFCAFQDDKYL--YMVMEYMPGGDLVNLMSNY 169
Query: 134 CEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL 193
                 A   T  + +A+D  H++  +H         RD+KP N+L ++    KL DF  
Sbjct: 170 DVPEKWAKFYTAEVVLALDAIHSMGLIH---------RDVKPDNMLLDKHGHLKLADFGT 220
Query: 194 SLSIPDGETHIELDSVVGTTGFIAPENFTT-----LINEQCDVYGFGAFLFELLTA 244
            + + D    +  D+ VGT  +I+PE   +         +CD +  G FLFE+L  
Sbjct: 221 CMKM-DETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 84/188 (44%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 119
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P         ++ 
Sbjct: 120 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLC 172
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE       +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 173 GTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKP-----PFEANT-YQETYKRISRV 226
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 227 EFTFPDFV 234

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 82/190 (43%), Gaps = 28/190 (14%)
Query: 140 ALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD 199
           AL++ D +  A  I+  + YL       +V+RD+   NIL  E    K+ DF LS  + +
Sbjct: 146 ALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 200 GETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRF 257
            +++++         ++A E+ F  +   Q DV+ FG  L+E++T        +  E  F
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262
Query: 258 HYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTM 317
           +  +   R+                 ++   C+      +   +L LQC    P+ RP  
Sbjct: 263 NLLKTGHRM-----------------ERPDNCS------EEMYRLMLQCWKQEPDKRPVF 299
Query: 318 VDVAKQLRQM 327
            D++K L +M
Sbjct: 300 ADISKDLEKM 309

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 10/96 (10%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGE-THIELDSV 209
           +I+ A+ +LH    + I+YRD+KP NI+ N Q   KL DF L   SI DG  TH    + 
Sbjct: 129 EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH----TF 181
Query: 210 VGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE    +  N   D +  GA ++++LT 
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 85/188 (45%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 114
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P         ++ 
Sbjct: 115 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALC 167
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQETYKRISRV 221
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 222 EFTFPDFV 229

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 85/188 (45%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 117
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P         ++ 
Sbjct: 118 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALC 170
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQETYKRISRV 224
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 225 EFTFPDFV 232

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 24/223 (10%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +V E +  G L D +    ++H   L  +  L  +  I   + YL    SR  V+RD+  
Sbjct: 103 LVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAA 155
Query: 176 TNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYG 233
            NIL   ++  K+ DF L+  +P D + ++  +       + APE+ +  + + Q DV+ 
Sbjct: 156 RNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWS 215
Query: 234 FGAFLFELLTA--QEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTG 291
           FG  L+EL T   +  S    F      E +V  LS    R  E+++          C  
Sbjct: 216 FGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS----RLLELLEEGQRLPAPPACPA 271
Query: 292 KEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY---RSC 331
           +  +L         C   SP+DRP+   +  QL  ++   R C
Sbjct: 272 EVHELMKL------CWAPSPQDRPSFSALGPQLDMLWSGSRGC 308

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/98 (36%), Positives = 53/98 (54%), Gaps = 14/98 (14%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           ++A  + +LH   S  I+YRD+KP NIL +E+   KL DF LS    D E   +  S  G
Sbjct: 138 ELALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEK--KAYSFCG 192
Query: 212 TTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTA 244
           T  ++APE    ++N Q      D + +G  +FE+LT 
Sbjct: 193 TVEYMAPE----VVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 95/223 (42%), Gaps = 24/223 (10%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +V E +  G L D +    ++H   L  +  L  +  I   + YL    SR  V+RD+  
Sbjct: 90  LVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAA 142
Query: 176 TNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYG 233
            NIL   ++  K+ DF L+  +P D + ++  +       + APE+ +  + + Q DV+ 
Sbjct: 143 RNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWS 202
Query: 234 FGAFLFELLTA--QEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTG 291
           FG  L+EL T   +  S    F      E +V  LS    R  E+++          C  
Sbjct: 203 FGVVLYELFTYCDKSCSPSAEFLRMMGSERDVPALS----RLLELLEEGQRLPAPPACPA 258
Query: 292 KEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY---RSC 331
           +  +L         C   SP+DRP+   +  QL  ++   R C
Sbjct: 259 EVHELMKL------CWAPSPQDRPSFSALGPQLDMLWSGSRGC 295

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 84/188 (44%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 114
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P          + 
Sbjct: 115 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLC 167
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQETYKRISRV 221
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 222 EFTFPDFV 229

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 84/188 (44%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 68  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 119
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P          + 
Sbjct: 120 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLC 172
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEANT-YQETYKRISRV 226
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 227 EFTFPDFV 234

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 84/188 (44%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 115
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P          + 
Sbjct: 116 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLC 168
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQETYKRISRV 222
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 223 EFTFPDFV 230

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 84/188 (44%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 114
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P          + 
Sbjct: 115 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TELC 167
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQETYKRISRV 221
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 222 EFTFPDFV 229

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 84/188 (44%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 114
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P          + 
Sbjct: 115 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TDLC 167
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQETYKRISRV 221
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 222 EFTFPDFV 229

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 84/188 (44%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 116
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P          + 
Sbjct: 117 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLC 169
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQETYKRISRV 223
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 224 EFTFPDFV 231

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 69/152 (45%), Gaps = 24/152 (15%)
Query: 107 MSHKHIIKL-------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
           + H+HIIK              +V E V +G+L D +  H      ++ L   L  A  I
Sbjct: 73  LYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQI 126
Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT 213
              +AYLH   S+  ++R++   N+L +     K+ DF L+ ++P+G  +  +     + 
Sbjct: 127 CEGMAYLH---SQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 183
Query: 214 GF-IAPENFTTL-INEQCDVYGFGAFLFELLT 243
            F  APE           DV+ FG  L+ELLT
Sbjct: 184 VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 84/188 (44%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 117
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P          + 
Sbjct: 118 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLC 170
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQETYKRISRV 224
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 225 EFTFPDFV 232

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 84/188 (44%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 114
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P          + 
Sbjct: 115 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLC 167
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQETYKRISRV 221
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 222 EFTFPDFV 229

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 84/188 (44%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 63  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 114
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P          + 
Sbjct: 115 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TXLC 167
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQETYKRISRV 221
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 222 EFTFPDFV 229

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + +LH    R I+YRD+KP N+L ++  + ++ D  L++ +  G+T  +     GT
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK--GYAGT 352
Query: 213 TGFIAPENFTTLINEQ----CDVYGFGAFLFELLTAQ 245
            GF+APE    L+ E+     D +  G  L+E++ A+
Sbjct: 353 PGFMAPE---LLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/146 (26%), Positives = 70/146 (47%), Gaps = 17/146 (11%)
Query: 136 QHFEALSLTDRLKVAM---DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS 192
           +  + LS  D  + A    ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF 
Sbjct: 102 KELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG 158
Query: 193 LSLSIPDGETHIELDSVVGTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHV 251
            S+  P         ++ GT  ++ PE     + +E+ D++  G   +E L  +      
Sbjct: 159 WSVHAPSSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP----- 209
Query: 252 SFESRFHYEENVKRLSGQNCRFKEMV 277
            FE+   Y+E  KR+S     F + V
Sbjct: 210 PFEAN-TYQETYKRISRVEFTFPDFV 234

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + +LH    R I+YRD+KP N+L ++  + ++ D  L++ +  G+T  +     GT
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK--GYAGT 352
Query: 213 TGFIAPENFTTLINEQ----CDVYGFGAFLFELLTAQ 245
            GF+APE    L+ E+     D +  G  L+E++ A+
Sbjct: 353 PGFMAPE---LLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + +LH    R I+YRD+KP N+L ++  + ++ D  L++ +  G+T  +     GT
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK--GYAGT 352
Query: 213 TGFIAPENFTTLINEQ----CDVYGFGAFLFELLTAQ 245
            GF+APE    L+ E+     D +  G  L+E++ A+
Sbjct: 353 PGFMAPE---LLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/97 (30%), Positives = 53/97 (54%), Gaps = 12/97 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + +LH    R I+YRD+KP N+L ++  + ++ D  L++ +  G+T  +     GT
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTK--GYAGT 352
Query: 213 TGFIAPENFTTLINEQ----CDVYGFGAFLFELLTAQ 245
            GF+APE    L+ E+     D +  G  L+E++ A+
Sbjct: 353 PGFMAPE---LLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/96 (37%), Positives = 52/96 (54%), Gaps = 10/96 (10%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGE-THIELDSV 209
           +I+ A+ +LH    + I+YRD+KP NI+ N Q   KL DF L   SI DG  TH      
Sbjct: 129 EISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH----XF 181
Query: 210 VGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE    +  N   D +  GA ++++LT 
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 85/188 (45%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 63  SHLRHPNILRLYGYFHDSTRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 114
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P         ++ 
Sbjct: 115 TELANALSYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----AALC 167
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y++  KR+S  
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQDTYKRISRV 221
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 222 EFTFPDFV 229

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 70/142 (49%), Gaps = 23/142 (16%)
Query: 116 IVFESVQIGTLADRIH-HHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
           I  E  + GTL D IH  +  Q  +     +  ++   I  A++Y+H   S+ I++RD+K
Sbjct: 92  IQMEYCENGTLYDLIHSENLNQQRD-----EYWRLFRQILEALSYIH---SQGIIHRDLK 143
Query: 175 PTNILFNEQSDAKLFDFSLSLSIPDGETHIELD------------SVVGTTGFIAPE--N 220
           P NI  +E  + K+ DF L+ ++      ++LD            S +GT  ++A E  +
Sbjct: 144 PMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLD 203
Query: 221 FTTLINEQCDVYGFGAFLFELL 242
            T   NE+ D+Y  G   FE++
Sbjct: 204 GTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 45/188 (23%), Positives = 84/188 (44%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 115
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S   P         ++ 
Sbjct: 116 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRR----TTLS 168
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQETYKRISRV 222
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 223 EFTFPDFV 230

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 81/190 (42%), Gaps = 28/190 (14%)
Query: 140 ALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD 199
           AL++ D +  A  I+  + YL       +V+RD+   NIL  E    K+ DF LS  + +
Sbjct: 146 ALTMGDLISFAWQISQGMQYLA---EMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 200 GETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRF 257
            ++ ++         ++A E+ F  +   Q DV+ FG  L+E++T        +  E  F
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262
Query: 258 HYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTM 317
           +  +   R+                 ++   C+      +   +L LQC    P+ RP  
Sbjct: 263 NLLKTGHRM-----------------ERPDNCS------EEMYRLMLQCWKQEPDKRPVF 299
Query: 318 VDVAKQLRQM 327
            D++K L +M
Sbjct: 300 ADISKDLEKM 309

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE S+ K+ DF L+    D     E+   V T
Sbjct: 140 ILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD-----EMTGYVAT 191
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 235

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 81/190 (42%), Gaps = 28/190 (14%)
Query: 140 ALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD 199
           AL++ D +  A  I+  + YL       +V+RD+   NIL  E    K+ DF LS  + +
Sbjct: 146 ALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202
Query: 200 GETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRF 257
            ++ ++         ++A E+ F  +   Q DV+ FG  L+E++T        +  E  F
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF 262
Query: 258 HYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTM 317
           +  +   R+                 ++   C+      +   +L LQC    P+ RP  
Sbjct: 263 NLLKTGHRM-----------------ERPDNCS------EEMYRLMLQCWKQEPDKRPVF 299
Query: 318 VDVAKQLRQM 327
            D++K L +M
Sbjct: 300 ADISKDLEKM 309

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 54/104 (51%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE S+ K+ DF L+    D     E+   V T
Sbjct: 136 ILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD-----EMTGYVAT 187
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 231

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 73/143 (51%), Gaps = 22/143 (15%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +VFE +Q G++   I    ++HF     +   +V  D+A A+ +LH   ++ I +RD+KP
Sbjct: 88  LVFEKLQGGSILAHIQK--QKHFNEREAS---RVVRDVAAALDFLH---TKGIAHRDLKP 139
Query: 176 TNILFNEQ---SDAKLFDFSL--SLSIPDGETHI---ELDSVVGTTGFIAPE------NF 221
            NIL       S  K+ DF L   + + +  T I   EL +  G+  ++APE      + 
Sbjct: 140 ENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQ 199
Query: 222 TTLINEQCDVYGFGAFLFELLTA 244
            T  +++CD++  G  L+ +L+ 
Sbjct: 200 ATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 84/188 (44%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 67  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSRFDEQRTATYI 118
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P         ++ 
Sbjct: 119 TELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----TTLC 171
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L          FE+   Y+E  +R+S  
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMP-----PFEAH-TYQETYRRISRV 225
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 226 EFTFPDFV 233

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 85/188 (45%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 65  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 116
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ +F  S+  P         ++ 
Sbjct: 117 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLC 169
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQETYKRISRV 223
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 224 EFTFPDFV 231

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 24/152 (15%)
Query: 107 MSHKHIIKL-------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
           + H+HIIK              +V E V +G+L D +  H      ++ L   L  A  I
Sbjct: 73  LYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQI 126
Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT 213
              +AYLH   ++  ++R++   N+L +     K+ DF L+ ++P+G  +  +     + 
Sbjct: 127 CEGMAYLH---AQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 183
Query: 214 GF-IAPENFTTL-INEQCDVYGFGAFLFELLT 243
            F  APE           DV+ FG  L+ELLT
Sbjct: 184 VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/188 (23%), Positives = 85/188 (45%), Gaps = 36/188 (19%)
Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM-- 151
           S + H +I++L           ++ E   +GT+         +  + LS  D  + A   
Sbjct: 66  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVY--------RELQKLSKFDEQRTATYI 117
Query: 152 -DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            ++A+A++Y H   S+ +++RD+KP N+L     + K+ +F  S+  P         ++ 
Sbjct: 118 TELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLC 170
Query: 211 GTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
           GT  ++ PE     + +E+ D++  G   +E L  +       FE+   Y+E  KR+S  
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP-----PFEAN-TYQETYKRISRV 224
Query: 270 NCRFKEMV 277
              F + V
Sbjct: 225 EFTFPDFV 232

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/275 (21%), Positives = 111/275 (40%), Gaps = 41/275 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           F ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 24  FGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 83
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++RD+  
Sbjct: 84  IITEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQISSAMEYLE---KKNFIHRDLAA 137
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T            + APE+      + + DV+ F
Sbjct: 138 RNCLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 196
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE     L  ++ R           ++   C  K  
Sbjct: 197 GVLLWEIATYG-MSPYPGIDPSQVYE-----LLEKDYRM----------ERPEGCPEK-- 238
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
                 +L   C  ++P DRP+  ++ +    M++
Sbjct: 239 ----VYELMRACWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 17/104 (16%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD----- 207
           I  A++Y+H   S+ I++RD+KP NI  +E  + K+ DF L+ ++      ++LD     
Sbjct: 125 ILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 208 -------SVVGTTGFIAPE--NFTTLINEQCDVYGFGAFLFELL 242
                  S +GT  ++A E  + T   NE+ D+Y  G   FE++
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 70/155 (45%), Gaps = 30/155 (19%)
Query: 107 MSHKHIIKL-------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
           + H+HIIK              +V E V +G+L D +  H      ++ L   L  A  I
Sbjct: 90  LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQI 143
Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL----DSV 209
              +AYLH   ++  ++RD+   N+L +     K+ DF L+ ++P+G     +    DS 
Sbjct: 144 CEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSP 200
Query: 210 VGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLT 243
           V    + APE           DV+ FG  L+ELLT
Sbjct: 201 V---FWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 9/107 (8%)
Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS-DA--KLFDFSLSLSI 197
            S  D  ++   +   + Y H      IV+RD+KP N+L   +S DA  ++ DF LS   
Sbjct: 123 FSEVDAARIIRQVLSGITYXH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF 179
Query: 198 PDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTA 244
              E   +    +GT  +IAPE      +E+CDV+  G  L+ LL+ 
Sbjct: 180 ---EASKKXKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/146 (26%), Positives = 69/146 (47%), Gaps = 17/146 (11%)
Query: 136 QHFEALSLTDRLKVAM---DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS 192
           +  + LS  D  + A    ++A+A++Y H   S+ +++RD+KP N+L     + K+ DF 
Sbjct: 102 KELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFG 158
Query: 193 LSLSIPDGETHIELDSVVGTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHV 251
            S+  P          + GT  ++ PE     + +E+ D++  G   +E L  +      
Sbjct: 159 WSVHAPSSRR----XXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKP----- 209
Query: 252 SFESRFHYEENVKRLSGQNCRFKEMV 277
            FE+   Y+E  KR+S     F + V
Sbjct: 210 PFEAN-TYQETYKRISRVEFTFPDFV 234

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/275 (21%), Positives = 112/275 (40%), Gaps = 41/275 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 26  YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++RD+  
Sbjct: 86  IIIEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQISSAMEYLE---KKNFIHRDLAA 139
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T+           + APE+      + + DV+ F
Sbjct: 140 RNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 198
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE     L  ++ R           ++   C  K  
Sbjct: 199 GVLLWEIATYG-MSPYPGIDLSQVYE-----LLEKDYRM----------ERPEGCPEK-- 240
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
                 +L   C  ++P DRP+  ++ +    M++
Sbjct: 241 ----VYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/275 (21%), Positives = 112/275 (40%), Gaps = 41/275 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 26  YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++RD+  
Sbjct: 86  IIIEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQISSAMEYLE---KKNFIHRDLAA 139
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T+           + APE+      + + DV+ F
Sbjct: 140 RNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 198
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE     L  ++ R           ++   C  K  
Sbjct: 199 GVLLWEIATYG-MSPYPGIDLSQVYE-----LLEKDYRM----------ERPEGCPEK-- 240
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
                 +L   C  ++P DRP+  ++ +    M++
Sbjct: 241 ----VYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/275 (21%), Positives = 112/275 (40%), Gaps = 41/275 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 27  YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 86
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++RD+  
Sbjct: 87  IITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAA 140
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T+           + APE+      + + DV+ F
Sbjct: 141 RNCLVGENHLVKVADFGLS-RLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAF 199
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE     L  ++ R           ++   C  K  
Sbjct: 200 GVLLWEIATYG-MSPYPGIDLSQVYE-----LLEKDYRM----------ERPEGCPEK-- 241
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
                 +L   C  ++P DRP+  ++ +    M++
Sbjct: 242 ----VYELMRACWQWNPSDRPSFAEIHQAFETMFQ 272

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/275 (20%), Positives = 109/275 (39%), Gaps = 41/275 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 31  YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 90
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++RD+  
Sbjct: 91  IIIEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAA 144
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T+           + APE+      + + DV+ F
Sbjct: 145 RNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 203
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE                     + +K       E 
Sbjct: 204 GVLLWEIATYG-MSPYPGIDLSQVYE---------------------LLEKDYRMERPEG 241
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
             +   +L   C  ++P DRP+  ++ +    M++
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/125 (31%), Positives = 60/125 (48%), Gaps = 19/125 (15%)
Query: 134 CEQHFEALSLTDRLK------------VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN 181
           C +H +  SL   LK            V++ +   +AYL       I++RD+KP+NIL N
Sbjct: 92  CMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVN 149
Query: 182 EQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINEQCDVYGFGAFLFE 240
            + + KL DF +S  + D       +S VGT  ++APE    T  + Q D++  G  L E
Sbjct: 150 SRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVE 205
Query: 241 LLTAQ 245
           L   +
Sbjct: 206 LAVGR 210

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/275 (21%), Positives = 112/275 (40%), Gaps = 41/275 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 28  YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 87
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++RD+  
Sbjct: 88  IITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAA 141
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T+           + APE+      + + DV+ F
Sbjct: 142 RNCLVGENHLVKVADFGLS-RLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKSDVWAF 200
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE     L  ++ R           ++   C  K  
Sbjct: 201 GVLLWEIATYG-MSPYPGIDLSQVYE-----LLEKDYRM----------ERPEGCPEK-- 242
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
                 +L   C  ++P DRP+  ++ +    M++
Sbjct: 243 ----VYELMRACWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/275 (21%), Positives = 111/275 (40%), Gaps = 41/275 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 24  YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 83
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++RD+  
Sbjct: 84  IIIEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQISSAMEYLE---KKNFIHRDLAA 137
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T            + APE+      + + DV+ F
Sbjct: 138 RNCLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 196
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE     L  ++ R           ++   C  K  
Sbjct: 197 GVLLWEIATYG-MSPYPGIDPSQVYE-----LLEKDYRM----------ERPEGCPEK-- 238
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
                 +L   C  ++P DRP+  ++ +    M++
Sbjct: 239 ----VYELMRACWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE S+ K+ DF L     D     E+   V T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDD-----EMTGYVAT 185
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/149 (30%), Positives = 66/149 (44%), Gaps = 24/149 (16%)
Query: 109 HKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAV 157
           H HIIKL           +V E V  G L D I   C+     L   +  ++   I   V
Sbjct: 75  HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYI---CKN--GRLDEKESRRLFQQILSGV 129
Query: 158 AYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIA 217
            Y H      +V+RD+KP N+L +   +AK+ DF LS  + DGE    L    G+  + A
Sbjct: 130 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRXSCGSPNYAA 183
Query: 218 PENFTTLI--NEQCDVYGFGAFLFELLTA 244
           PE  +  +    + D++  G  L+ LL  
Sbjct: 184 PEVISGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/244 (23%), Positives = 101/244 (41%), Gaps = 43/244 (17%)
Query: 97  CINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTD 145
           CI  I    +++H ++IK            IV E    G L+  I H  +Q    +    
Sbjct: 79  CIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK-RLIPERT 137
Query: 146 RLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIE 205
             K  + +  A+ ++H   SR +++RD+KP N+        KL D  L        T   
Sbjct: 138 VWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH 194
Query: 206 LDSVVGTTGFIAPENF-TTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEE-NV 263
             S+VGT  +++PE       N + D++  G  L+E+          + +S F+ ++ N+
Sbjct: 195 --SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM---------AALQSPFYGDKMNL 243
Query: 264 KRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMV---DV 320
             L    C+  E  D   +          +   +  +QL   C++  PE RP +    DV
Sbjct: 244 YSL----CKKIEQCDYPPLPS--------DHYSEELRQLVNMCINPDPEKRPDVTYVYDV 291
Query: 321 AKQL 324
           AK++
Sbjct: 292 AKRM 295

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 64/137 (46%), Gaps = 18/137 (13%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
            +VF+ ++ G L D +          LS  +  K+   +   +  LH      IV+RD+K
Sbjct: 100 FLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALH---KLNIVHRDLK 151
Query: 175 PTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINE------- 227
           P NIL ++  + KL DF  S  +  GE   +L SV GT  ++APE     +N+       
Sbjct: 152 PENILLDDDMNIKLTDFGFSCQLDPGE---KLRSVCGTPSYLAPEIIECSMNDNHPGYGK 208
Query: 228 QCDVYGFGAFLFELLTA 244
           + D++  G  ++ LL  
Sbjct: 209 EVDMWSTGVIMYTLLAG 225

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/275 (21%), Positives = 112/275 (40%), Gaps = 41/275 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 39  YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 98
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++RD+  
Sbjct: 99  IITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAA 152
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T+           + APE+      + + DV+ F
Sbjct: 153 RNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 211
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE     L  ++ R           ++   C  K  
Sbjct: 212 GVLLWEIATYG-MSPYPGIDLSQVYE-----LLEKDYRM----------ERPEGCPEK-- 253
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
                 +L   C  ++P DRP+  ++ +    M++
Sbjct: 254 ----VYELMRACWQWNPSDRPSFAEIHQAFETMFQ 284

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/275 (20%), Positives = 109/275 (39%), Gaps = 41/275 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 26  YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++RD+  
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQISSAMEYLE---KKNFIHRDLAA 139
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T+           + APE+      + + DV+ F
Sbjct: 140 RNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 198
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE                     + +K       E 
Sbjct: 199 GVLLWEIATYG-MSPYPGIDLSQVYE---------------------LLEKDYRMERPEG 236
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
             +   +L   C  ++P DRP+  ++ +    M++
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 59/291 (20%), Positives = 120/291 (41%), Gaps = 35/291 (12%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYAS-RMSHKHIIKLIVFE------ 119
           + ++++G W   S+++  ++    Q    W     +Y +  + H +I+  I  +      
Sbjct: 21  YGEVWRGLWHGESVAVKIFSSRDEQ---SWFRETEIYNTVLLRHDNILGFIASDMTSRNS 77
Query: 120 SVQIGTLADRIHHHCEQHF---EALSLTDRLKVAMDIAHAVAYLHVGF----SRP-IVYR 171
           S Q+  +     H     F   + L     L++A+  A  +A+LHV       +P I +R
Sbjct: 78  STQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEIFGTQGKPAIAHR 137
Query: 172 DMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL--DSVVGTTGFIAPENFTTLINEQC 229
           D K  N+L        + D  L++    G  ++++  +  VGT  ++APE     I   C
Sbjct: 138 DFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQIRTDC 197
Query: 230 -------DVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIII 282
                  D++ FG  L+E+     V+  V       Y      +   +  F++M   + +
Sbjct: 198 FESYKWTDIWAFGLVLWEIARRTIVNGIVE-----DYRPPFYDVVPNDPSFEDMKKVVCV 252
Query: 283 EDKSCTCTGK---EQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
           + ++ T   +   +  L    Q+  +C   +P  R T + + K L+++  S
Sbjct: 253 DQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQKISNS 303

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/275 (21%), Positives = 112/275 (40%), Gaps = 41/275 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 26  YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++RD+  
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQISSAMEYLE---KKNFIHRDLAA 139
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T+           + APE+      + + DV+ F
Sbjct: 140 RNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 198
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE     L  ++ R           ++   C  K  
Sbjct: 199 GVLLWEIATYG-MSPYPGIDLSQVYE-----LLEKDYRM----------ERPEGCPEK-- 240
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
                 +L   C  ++P DRP+  ++ +    M++
Sbjct: 241 ----VYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 81/185 (43%), Gaps = 37/185 (20%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD--------AKLFDFSLSLSIPDGE 201
           A+ IA  + YLH     PI++RD+K +NIL  ++ +         K+ DF L+      E
Sbjct: 111 AVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----E 165
Query: 202 THIELD-SVVGTTGFIAPENF-TTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHY 259
            H     S  G   ++APE    ++ ++  DV+ +G  L+ELLT +     V F      
Sbjct: 166 WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE-----VPF------ 214
Query: 260 EENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVD 319
               + + G    +   ++ + +   S TC       + F +L   C +  P  RP+  +
Sbjct: 215 ----RGIDGLAVAYGVAMNKLALPIPS-TCP------EPFAKLMEDCWNPDPHSRPSFTN 263
Query: 320 VAKQL 324
           +  QL
Sbjct: 264 ILDQL 268

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/275 (21%), Positives = 112/275 (40%), Gaps = 41/275 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 28  YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 87
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++RD+  
Sbjct: 88  IITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAA 141
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T+           + APE+      + + DV+ F
Sbjct: 142 RNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 200
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE     L  ++ R           ++   C  K  
Sbjct: 201 GVLLWEIATYG-MSPYPGIDLSQVYE-----LLEKDYRM----------ERPEGCPEK-- 242
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
                 +L   C  ++P DRP+  ++ +    M++
Sbjct: 243 ----VYELMRACWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/275 (21%), Positives = 112/275 (40%), Gaps = 41/275 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 31  YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 90
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++RD+  
Sbjct: 91  IITEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQISSAMEYLE---KKNFIHRDLAA 144
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T+           + APE+      + + DV+ F
Sbjct: 145 RNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 203
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE     L  ++ R           ++   C  K  
Sbjct: 204 GVLLWEIATYG-MSPYPGIDLSQVYE-----LLEKDYRM----------ERPEGCPEK-- 245
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
                 +L   C  ++P DRP+  ++ +    M++
Sbjct: 246 ----VYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/275 (21%), Positives = 112/275 (40%), Gaps = 41/275 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 31  YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 90
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++RD+  
Sbjct: 91  IITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAA 144
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T+           + APE+      + + DV+ F
Sbjct: 145 RNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 203
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE     L  ++ R           ++   C  K  
Sbjct: 204 GVLLWEIATYG-MSPYPGIDLSQVYE-----LLEKDYRM----------ERPEGCPEK-- 245
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
                 +L   C  ++P DRP+  ++ +    M++
Sbjct: 246 ----VYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVAT 192
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 236

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/275 (21%), Positives = 111/275 (40%), Gaps = 41/275 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 27  YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 86
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++RD+  
Sbjct: 87  IIIEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAA 140
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T            + APE+      + + DV+ F
Sbjct: 141 RNCLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 199
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE     L  ++ R           ++   C  K  
Sbjct: 200 GVLLWEIATYG-MSPYPGIDLSQVYE-----LLEKDYRM----------ERPEGCPEK-- 241
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
                 +L   C  ++P DRP+  ++ +    M++
Sbjct: 242 ----VYELMRACWQWNPSDRPSFAEIHQAFETMFQ 272

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVAT 192
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 236

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/275 (20%), Positives = 109/275 (39%), Gaps = 41/275 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 26  YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++RD+  
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAA 139
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T+           + APE+      + + DV+ F
Sbjct: 140 RNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 198
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE                     + +K       E 
Sbjct: 199 GVLLWEIATYG-MSPYPGIDLSQVYE---------------------LLEKDYRMERPEG 236
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
             +   +L   C  ++P DRP+  ++ +    M++
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 271

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVAT 192
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 236

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 145 ILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMTGYVAT 196
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 197 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 240

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/275 (20%), Positives = 109/275 (39%), Gaps = 41/275 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 30  YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++RD+  
Sbjct: 90  IITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAA 143
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T+           + APE+      + + DV+ F
Sbjct: 144 RNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 202
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE                     + +K       E 
Sbjct: 203 GVLLWEIATYG-MSPYPGIDLSQVYE---------------------LLEKDYRMERPEG 240
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
             +   +L   C  ++P DRP+  ++ +    M++
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/275 (21%), Positives = 112/275 (40%), Gaps = 41/275 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 28  YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 87
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++RD+  
Sbjct: 88  IITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAA 141
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T+           + APE+      + + DV+ F
Sbjct: 142 RNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 200
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE     L  ++ R           ++   C  K  
Sbjct: 201 GVLLWEIATYG-MSPYPGIDLSQVYE-----LLEKDYRM----------ERPEGCPEK-- 242
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
                 +L   C  ++P DRP+  ++ +    M++
Sbjct: 243 ----VYELMRACWQWNPSDRPSFAEIHQAFETMFQ 273

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/275 (20%), Positives = 109/275 (39%), Gaps = 41/275 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 31  YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 90
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++RD+  
Sbjct: 91  IITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAA 144
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T+           + APE+      + + DV+ F
Sbjct: 145 RNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 203
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE                     + +K       E 
Sbjct: 204 GVLLWEIATYG-MSPYPGIDLSQVYE---------------------LLEKDYRMERPEG 241
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
             +   +L   C  ++P DRP+  ++ +    M++
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/275 (21%), Positives = 111/275 (40%), Gaps = 41/275 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 24  YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 83
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++RD+  
Sbjct: 84  IITEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQISSAMEYLE---KKNFIHRDLAA 137
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T            + APE+      + + DV+ F
Sbjct: 138 RNCLVGENHLVKVADFGLS-RLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 196
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE     L  ++ R           ++   C  K  
Sbjct: 197 GVLLWEIATYG-MSPYPGIDPSQVYE-----LLEKDYRM----------ERPEGCPEK-- 238
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
                 +L   C  ++P DRP+  ++ +    M++
Sbjct: 239 ----VYELMRACWQWNPSDRPSFAEIHQAFETMFQ 269

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMTGYVAT 185
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 145 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 196
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 197 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 240

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 154 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMXGXVAT 205
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 249

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 140 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 191
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 235

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 139 ILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMTGYVAT 190
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 234

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 140 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 191
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 235

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 139 ILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD-----EMTGYVAT 190
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 234

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 27/166 (16%)
Query: 105 SRMSHKHIIKL---------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           S ++H +I+KL         +V E V  G L    +H        +  + +L++ +DIA 
Sbjct: 78  SNLNHPNIVKLYGLMHNPPRMVMEFVPCGDL----YHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILF-----NEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            + Y+    + PIV+RD++  NI       N    AK+ DFSLS        H  +  ++
Sbjct: 134 GIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQ----SVH-SVSGLL 187
Query: 211 GTTGFIAPENFTT---LINEQCDVYGFGAFLFELLTAQEVSDHVSF 253
           G   ++APE          E+ D Y F   L+ +LT +   D  S+
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 185
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 157 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 208
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 209 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 252

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 146 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 197
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 198 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 241

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 146 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 197
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 198 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 241

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 146 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 197
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 198 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 241

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 185
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 136 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 187
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 231

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 185
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGXVAT 185
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 154 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 205
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 249

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 140 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 191
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 192 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 235

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 185
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 144 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 195
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 196 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 239

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 154 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 205
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 206 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 249

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 192
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 193 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 236

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 136 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 187
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 231

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 185
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 153 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 204
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 205 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 248

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 153 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 204
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 205 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 248

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMAGFVAT 185
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 139 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 190
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 234

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 185
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMAGFVAT 185
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 181
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 185
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 136 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 187
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 188 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 231

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 139 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 190
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 191 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 234

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 133 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 184
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 185 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 228

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 185
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 181
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 131 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 182
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 183 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 226

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 131 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 182
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 183 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 226

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 68/142 (47%), Gaps = 14/142 (9%)
Query: 107 MSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSR 166
           M H     LI+ E ++ G L  RI    +Q F   +  +  ++  DI  A+ +LH   S 
Sbjct: 75  MHHGKRCLLIIMECMEGGELFSRIQERGDQAF---TEREAAEIMRDIGTAIQFLH---SH 128
Query: 167 PIVYRDMKPTNILF-NEQSDA--KLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT 223
            I +RD+KP N+L+ +++ DA  KL DF  +       T   L +   T  ++APE    
Sbjct: 129 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQTPCYTPYYVAPEVLGP 184
Query: 224 -LINEQCDVYGFGAFLFELLTA 244
              ++ CD++  G  ++ LL  
Sbjct: 185 EKYDKSCDMWSLGVIMYILLCG 206

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 185
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 132 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 183
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 184 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 227

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/274 (20%), Positives = 108/274 (39%), Gaps = 41/274 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 26  YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 85
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++RD+  
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAA 139
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T+           + APE+      + + DV+ F
Sbjct: 140 RNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 198
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE                     + +K       E 
Sbjct: 199 GVLLWEIATYG-MSPYPGIDLSQVYE---------------------LLEKDYRMERPEG 236
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY 328
             +   +L   C  ++P DRP+  ++ +    M+
Sbjct: 237 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF 270

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 181
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 157 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMXGYVAT 208
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 209 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 252

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMAGFVAT 181
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 182 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 225

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 185
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 186 RWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 68/142 (47%), Gaps = 14/142 (9%)
Query: 107 MSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSR 166
           M H     LI+ E ++ G L  RI    +Q F   +  +  ++  DI  A+ +LH   S 
Sbjct: 94  MHHGKRCLLIIMECMEGGELFSRIQERGDQAF---TEREAAEIMRDIGTAIQFLH---SH 147
Query: 167 PIVYRDMKPTNILF-NEQSDA--KLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT 223
            I +RD+KP N+L+ +++ DA  KL DF  +       T   L +   T  ++APE    
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQTPCYTPYYVAPEVLGP 203
Query: 224 -LINEQCDVYGFGAFLFELLTA 244
              ++ CD++  G  ++ LL  
Sbjct: 204 EKYDKSCDMWSLGVIMYILLCG 225

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
           LIV E +  G L  RI    +Q F     ++ +K    I  A+ YLH   S  I +RD+K
Sbjct: 135 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMK---SIGEAIQYLH---SINIAHRDVK 188
Query: 175 PTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCD 230
           P N+L+  +      KL DF  +    +  +H  L +   T  ++APE       ++ CD
Sbjct: 189 PENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 245
Query: 231 VYGFGAFLFELL 242
           ++  G  ++ LL
Sbjct: 246 MWSLGVIMYILL 257

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
           LIV E +  G L  RI    +Q F     ++ +K    I  A+ YLH   S  I +RD+K
Sbjct: 141 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMK---SIGEAIQYLH---SINIAHRDVK 194
Query: 175 PTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCD 230
           P N+L+  +      KL DF  +    +  +H  L +   T  ++APE       ++ CD
Sbjct: 195 PENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 251
Query: 231 VYGFGAFLFELL 242
           ++  G  ++ LL
Sbjct: 252 MWSLGVIMYILL 263

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/219 (21%), Positives = 90/219 (41%), Gaps = 31/219 (14%)
Query: 42  RIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQ------KRSISLMKYNGNRNQHALE 95
           RIF   ELR       +  ++    F  ++KG W       K  + +        + + +
Sbjct: 26  RIFKETELR-------KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQ 78
Query: 96  WCINHIVYASRMSHKHIIKLI----------VFESVQIGTLADRIHHHCEQHFEALSLTD 145
              +H++    + H HI++L+          V + + +G+L D    H  QH  AL    
Sbjct: 79  AVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLD----HVRQHRGALGPQL 134
Query: 146 RLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIE 205
            L   + IA  + YL       +V+R++   N+L    S  ++ DF ++  +P  +  + 
Sbjct: 135 LLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 191
Query: 206 LDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLT 243
                    ++A E+        Q DV+ +G  ++EL+T
Sbjct: 192 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
           LIV E +  G L  RI    +Q F     ++ +K    I  A+ YLH   S  I +RD+K
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMK---SIGEAIQYLH---SINIAHRDVK 144
Query: 175 PTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCD 230
           P N+L+  +      KL DF  +    +  +H  L +   T  ++APE       ++ CD
Sbjct: 145 PENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 201
Query: 231 VYGFGAFLFELL 242
           ++  G  ++ LL
Sbjct: 202 MWSLGVIMYILL 213

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 47/219 (21%), Positives = 90/219 (41%), Gaps = 31/219 (14%)
Query: 42  RIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQ------KRSISLMKYNGNRNQHALE 95
           RIF   ELR       +  ++    F  ++KG W       K  + +        + + +
Sbjct: 8   RIFKETELR-------KLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQ 60
Query: 96  WCINHIVYASRMSHKHIIKLI----------VFESVQIGTLADRIHHHCEQHFEALSLTD 145
              +H++    + H HI++L+          V + + +G+L D    H  QH  AL    
Sbjct: 61  AVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLD----HVRQHRGALGPQL 116
Query: 146 RLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIE 205
            L   + IA  + YL       +V+R++   N+L    S  ++ DF ++  +P  +  + 
Sbjct: 117 LLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLL 173
Query: 206 LDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLT 243
                    ++A E+        Q DV+ +G  ++EL+T
Sbjct: 174 YSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/155 (27%), Positives = 69/155 (44%), Gaps = 29/155 (18%)
Query: 108 SHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHA 156
            H +II+L           +VF+ ++ G L D +          LS  +  K+   +   
Sbjct: 69  GHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEV 123
Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFI 216
           +  LH      IV+RD+KP NIL ++  + KL DF  S  +  GE   +L  V GT  ++
Sbjct: 124 ICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYL 177
Query: 217 APENFTTLINE-------QCDVYGFGAFLFELLTA 244
           APE     +N+       + D++  G  ++ LL  
Sbjct: 178 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
           LIV E +  G L  RI    +Q F     ++ +K    I  A+ YLH   S  I +RD+K
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMK---SIGEAIQYLH---SINIAHRDVK 142
Query: 175 PTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCD 230
           P N+L+  +      KL DF  +    +  +H  L +   T  ++APE       ++ CD
Sbjct: 143 PENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 199
Query: 231 VYGFGAFLFELL 242
           ++  G  ++ LL
Sbjct: 200 MWSLGVIMYILL 211

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 56/275 (20%), Positives = 108/275 (39%), Gaps = 41/275 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 31  YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 90
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++RD+  
Sbjct: 91  IITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRDLAA 144
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T            + APE+      + + DV+ F
Sbjct: 145 RNCLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 203
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE                     + +K       E 
Sbjct: 204 GVLLWEIATYG-MSPYPGIDLSQVYE---------------------LLEKDYRMERPEG 241
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
             +   +L   C  ++P DRP+  ++ +    M++
Sbjct: 242 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 276

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
           LIV E +  G L  RI    +Q F     ++ +K    I  A+ YLH   S  I +RD+K
Sbjct: 90  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMK---SIGEAIQYLH---SINIAHRDVK 143
Query: 175 PTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCD 230
           P N+L+  +      KL DF  +    +  +H  L +   T  ++APE       ++ CD
Sbjct: 144 PENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 200
Query: 231 VYGFGAFLFELL 242
           ++  G  ++ LL
Sbjct: 201 MWSLGVIMYILL 212

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 27/94 (28%), Positives = 49/94 (52%), Gaps = 4/94 (4%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         +S VG
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 196
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
           T  +++PE  T    ++  D++  G  +++L+  
Sbjct: 197 TAQYVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
           LIV E +  G L  RI    +Q F     ++ +K    I  A+ YLH   S  I +RD+K
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMK---SIGEAIQYLH---SINIAHRDVK 144
Query: 175 PTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCD 230
           P N+L+  +      KL DF  +    +  +H  L +   T  ++APE       ++ CD
Sbjct: 145 PENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 201
Query: 231 VYGFGAFLFELL 242
           ++  G  ++ LL
Sbjct: 202 MWSLGVIMYILL 213

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
           LIV E +  G L  RI    +Q F     ++ +K    I  A+ YLH   S  I +RD+K
Sbjct: 97  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMK---SIGEAIQYLH---SINIAHRDVK 150
Query: 175 PTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCD 230
           P N+L+  +      KL DF  +    +  +H  L +   T  ++APE       ++ CD
Sbjct: 151 PENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 207
Query: 231 VYGFGAFLFELL 242
           ++  G  ++ LL
Sbjct: 208 MWSLGVIMYILL 219

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDD-----EMTGYVAT 185
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
           LIV E +  G L  RI    +Q F     ++ +K    I  A+ YLH   S  I +RD+K
Sbjct: 96  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMK---SIGEAIQYLH---SINIAHRDVK 149
Query: 175 PTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCD 230
           P N+L+  +      KL DF  +    +  +H  L +   T  ++APE       ++ CD
Sbjct: 150 PENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 206
Query: 231 VYGFGAFLFELL 242
           ++  G  ++ LL
Sbjct: 207 MWSLGVIMYILL 218

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 60/129 (46%), Gaps = 14/129 (10%)
Query: 123 IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE 182
           +GT A+++    +       + +R+   M +A   A  ++     +++RD+KP+NIL +E
Sbjct: 106 MGTCAEKLKKRMQG-----PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE 160
Query: 183 QSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTL------INEQCDVYGFGA 236
           +   KL DF +S  + D +     D   G   ++APE            + + DV+  G 
Sbjct: 161 RGQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGI 217
Query: 237 FLFELLTAQ 245
            L EL T Q
Sbjct: 218 SLVELATGQ 226

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
           LIV E +  G L  RI    +Q F     ++ +K    I  A+ YLH   S  I +RD+K
Sbjct: 105 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMK---SIGEAIQYLH---SINIAHRDVK 158
Query: 175 PTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCD 230
           P N+L+  +      KL DF  +    +  +H  L +   T  ++APE       ++ CD
Sbjct: 159 PENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 215
Query: 231 VYGFGAFLFELL 242
           ++  G  ++ LL
Sbjct: 216 MWSLGVIMYILL 227

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 62/132 (46%), Gaps = 13/132 (9%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
           LIV E +  G L  RI    +Q F     ++ +K    I  A+ YLH   S  I +RD+K
Sbjct: 95  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMK---SIGEAIQYLH---SINIAHRDVK 148
Query: 175 PTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCD 230
           P N+L+  +      KL DF  +    +  +H  L +   T  ++APE       ++ CD
Sbjct: 149 PENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 205
Query: 231 VYGFGAFLFELL 242
           ++  G  ++ LL
Sbjct: 206 MWSLGVIMYILL 217

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 59/290 (20%), Positives = 130/290 (44%), Gaps = 39/290 (13%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKLIVFE------ 119
           + ++++G WQ  ++++ K   +R++ +  W     +Y + M  H++I+  I  +      
Sbjct: 21  YGEVWRGSWQGENVAV-KIFSSRDEKS--WFRETELYNTVMLRHENILGFIASDMTSRHS 77
Query: 120 SVQIGTLADRIHHHCEQHFEALSLTDR-----LKVAMDIAHAVAYLHVGF----SRP-IV 169
           S Q+  +    +H     ++ L LT       L++ + IA  +A+LH+       +P I 
Sbjct: 78  STQLWLITH--YHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIA 135
Query: 170 YRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL--DSVVGTTGFIAPENFTTLINE 227
           +RD+K  NIL  +     + D  L++        +++  +  VGT  ++APE     I  
Sbjct: 136 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195
Query: 228 QC-------DVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSI 280
            C       D++ FG  L+E +  + VS+ +  + +  + + V      +  F++M   +
Sbjct: 196 DCFDSYKRVDIWAFGLVLWE-VARRMVSNGIVEDYKPPFYDVVP----NDPSFEDMRKVV 250
Query: 281 IIEDKSCTCTGK---EQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
            ++ +      +   +  L +  +L  +C   +P  R T + + K L ++
Sbjct: 251 CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 63/137 (45%), Gaps = 18/137 (13%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
            +VF+ ++ G L D +          LS  +  K+   +   +  LH      IV+RD+K
Sbjct: 100 FLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALH---KLNIVHRDLK 151
Query: 175 PTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINE------- 227
           P NIL ++  + KL DF  S  +  GE   +L  V GT  ++APE     +N+       
Sbjct: 152 PENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGK 208
Query: 228 QCDVYGFGAFLFELLTA 244
           + D++  G  ++ LL  
Sbjct: 209 EVDMWSTGVIMYTLLAG 225

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 53/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ D+ L+    D     E+   V T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDD-----EMTGYVAT 185
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 59/290 (20%), Positives = 130/290 (44%), Gaps = 39/290 (13%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKLIVFE------ 119
           + ++++G WQ  ++++ K   +R++ +  W     +Y + M  H++I+  I  +      
Sbjct: 21  YGEVWRGSWQGENVAV-KIFSSRDEKS--WFRETELYNTVMLRHENILGFIASDMTSRHS 77
Query: 120 SVQIGTLADRIHHHCEQHFEALSLTDR-----LKVAMDIAHAVAYLHVGF----SRP-IV 169
           S Q+  +    +H     ++ L LT       L++ + IA  +A+LH+       +P I 
Sbjct: 78  STQLWLITH--YHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIA 135
Query: 170 YRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL--DSVVGTTGFIAPENFTTLINE 227
           +RD+K  NIL  +     + D  L++        +++  +  VGT  ++APE     I  
Sbjct: 136 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 195
Query: 228 QC-------DVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSI 280
            C       D++ FG  L+E +  + VS+ +  + +  + + V      +  F++M   +
Sbjct: 196 DCFDSYKRVDIWAFGLVLWE-VARRMVSNGIVEDYKPPFYDVVP----NDPSFEDMRKVV 250
Query: 281 IIEDKSCTCTGK---EQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
            ++ +      +   +  L +  +L  +C   +P  R T + + K L ++
Sbjct: 251 CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 73/166 (43%), Gaps = 27/166 (16%)
Query: 105 SRMSHKHIIKL---------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           S ++H +I+KL         +V E V  G L    +H        +  + +L++ +DIA 
Sbjct: 78  SNLNHPNIVKLYGLMHNPPRMVMEFVPCGDL----YHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILF-----NEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            + Y+    + PIV+RD++  NI       N    AK+ DF LS        H  +  ++
Sbjct: 134 GIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVH-SVSGLL 187
Query: 211 GTTGFIAPENFTT---LINEQCDVYGFGAFLFELLTAQEVSDHVSF 253
           G   ++APE          E+ D Y F   L+ +LT +   D  S+
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 59/290 (20%), Positives = 130/290 (44%), Gaps = 39/290 (13%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKLIVFE------ 119
           + ++++G WQ  ++++ K   +R++ +  W     +Y + M  H++I+  I  +      
Sbjct: 50  YGEVWRGSWQGENVAV-KIFSSRDEKS--WFRETELYNTVMLRHENILGFIASDMTSRHS 106
Query: 120 SVQIGTLADRIHHHCEQHFEALSLTDR-----LKVAMDIAHAVAYLHVGF----SRP-IV 169
           S Q+  +    +H     ++ L LT       L++ + IA  +A+LH+       +P I 
Sbjct: 107 STQLWLITH--YHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIA 164
Query: 170 YRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL--DSVVGTTGFIAPENFTTLINE 227
           +RD+K  NIL  +     + D  L++        +++  +  VGT  ++APE     I  
Sbjct: 165 HRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQV 224
Query: 228 QC-------DVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSI 280
            C       D++ FG  L+E +  + VS+ +  + +  + + V      +  F++M   +
Sbjct: 225 DCFDSYKRVDIWAFGLVLWE-VARRMVSNGIVEDYKPPFYDVVP----NDPSFEDMRKVV 279
Query: 281 IIEDKSCTCTGK---EQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
            ++ +      +   +  L +  +L  +C   +P  R T + + K L ++
Sbjct: 280 CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 329

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/105 (30%), Positives = 53/105 (50%), Gaps = 13/105 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T
Sbjct: 163 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-----EMTGYVAT 214
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHVS 252
             + APE     +  N   D++  G  + ELLT + +   +DH++
Sbjct: 215 RWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHIN 259

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 61/132 (46%), Gaps = 13/132 (9%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
           LIV E +  G L  RI    +Q F     ++ +K    I  A+ YLH   S  I +RD+K
Sbjct: 89  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMK---SIGEAIQYLH---SINIAHRDVK 142
Query: 175 PTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCD 230
           P N+L+  +      KL DF  +    +  +H  L     T  ++APE       ++ CD
Sbjct: 143 PENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTEPCYTPYYVAPEVLGPEKYDKSCD 199
Query: 231 VYGFGAFLFELL 242
           ++  G  ++ LL
Sbjct: 200 MWSLGVIMYILL 211

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 59/125 (47%), Gaps = 19/125 (15%)
Query: 134 CEQHFEALSLTDRLK------------VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN 181
           C +H +  SL   LK            V++ +   + YL       I++RD+KP+NIL N
Sbjct: 101 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVN 158
Query: 182 EQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINEQCDVYGFGAFLFE 240
            + + KL DF +S  + D       +S VGT  +++PE    T  + Q D++  G  L E
Sbjct: 159 SRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 214
Query: 241 LLTAQ 245
           +   +
Sbjct: 215 MAVGR 219

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 72/159 (45%), Gaps = 26/159 (16%)
Query: 99  NHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRL 147
           N I    ++ H++I+ L           +V + V  G L DRI    E+ F   +  D  
Sbjct: 69  NEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRI---VEKGF--YTEKDAS 123
Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHI 204
            +   +  AV YLH      IV+RD+KP N+L+   +E+S   + DF LS     G+   
Sbjct: 124 TLIRQVLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDV-- 178
Query: 205 ELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELL 242
            + +  GT G++APE       ++  D +  G   + LL
Sbjct: 179 -MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 216

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 77/174 (44%), Gaps = 31/174 (17%)
Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD 207
           K+A+ I  A+ +LH   S  +++RD+KP+N+L N     K+ DF +S  + D    +  D
Sbjct: 113 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVD---DVAKD 167
Query: 208 SVVGTTGFIAPENFTTLINE-----QCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEEN 262
              G   ++APE     +N+     + D++  G  + EL              RF Y+  
Sbjct: 168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAIL-----------RFPYDS- 215
Query: 263 VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
                     F+++    ++E+ S      +   + F   T QC+  + ++RPT
Sbjct: 216 ------WGTPFQQLKQ--VVEEPSPQLPADKFSAE-FVDFTSQCLKKNSKERPT 260

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 53/104 (50%), Gaps = 17/104 (16%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD----- 207
           I  A++Y+H   S+ I++R++KP NI  +E  + K+ DF L+ ++      ++LD     
Sbjct: 125 ILEALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181
Query: 208 -------SVVGTTGFIAPE--NFTTLINEQCDVYGFGAFLFELL 242
                  S +GT  ++A E  + T   NE+ D Y  G   FE +
Sbjct: 182 GSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/98 (37%), Positives = 50/98 (51%), Gaps = 14/98 (14%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A +IA A+ YLH   S  IVYRD+KP NIL + Q    L DF L       + +IE +S 
Sbjct: 145 AAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLC------KENIEHNST 195
Query: 210 V----GTTGFIAPENF-TTLINEQCDVYGFGAFLFELL 242
                GT  ++APE       +   D +  GA L+E+L
Sbjct: 196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 233

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 8/96 (8%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         +S VG
Sbjct: 137 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 193
Query: 212 TTGFIAPENFTTLINEQC---DVYGFGAFLFELLTA 244
           T  +++PE  T      C   D++  G  +++L+  
Sbjct: 194 TAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAG 227

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/275 (20%), Positives = 109/275 (39%), Gaps = 41/275 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 233 YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 292
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++R++  
Sbjct: 293 IITEFMTYGNLLDYLRECNRQEVSAVVL---LYMATQISSAMEYLE---KKNFIHRNLAA 346
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T+           + APE+      + + DV+ F
Sbjct: 347 RNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 405
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE                     + +K       E 
Sbjct: 406 GVLLWEIATYG-MSPYPGIDLSQVYE---------------------LLEKDYRMERPEG 443
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
             +   +L   C  ++P DRP+  ++ +    M++
Sbjct: 444 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 478

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/275 (20%), Positives = 104/275 (37%), Gaps = 43/275 (15%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 45  YGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFY 104
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           IV E +  G L D +     +   A+ L   L +A  I+ A+ YL     +  ++RD+  
Sbjct: 105 IVTEYMPYGNLLDYLRECNREEVTAVVL---LYMATQISSAMEYLE---KKNFIHRDLAA 158
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T+           + APE+      + + DV+ F
Sbjct: 159 RNCLVGENHVVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAF 217
Query: 235 GAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKE 293
           G  L+E+ T        +     +   E   R+                 ++   C  K 
Sbjct: 218 GVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRM-----------------EQPEGCPPK- 259
Query: 294 QQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY 328
                  +L   C  +SP DRP+  +  +    M+
Sbjct: 260 -----VYELMRACWKWSPADRPSFAETHQAFETMF 289

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/94 (28%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         +S VG
Sbjct: 141 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 197
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
           T  +++PE  T     +  D++  G  +++L+  
Sbjct: 198 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 90/218 (41%), Gaps = 40/218 (18%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
            I  E    GTL   I    ++  E L     L++   I   V Y+H   S+ +++RD+K
Sbjct: 110 FIQMEFCDKGTLEQWIE---KRRGEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLK 163
Query: 175 PTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFTTL-INEQCDVY 232
           P+NI   +    K+ DF L  S+  DG+         GT  +++PE  ++    ++ D+Y
Sbjct: 164 PSNIFLVDTKQVKIGDFGLVTSLKNDGKRT----RSKGTLRYMSPEQISSQDYGKEVDLY 219
Query: 233 GFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGK 292
             G  L ELL    V D     S+F               F ++ D II    S     K
Sbjct: 220 ALGLILAELL---HVCDTAFETSKF---------------FTDLRDGII----SDIFDKK 257
Query: 293 EQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
           E      K L  + +   PEDRP   ++ + L    +S
Sbjct: 258 E------KTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 289

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 97/247 (39%), Gaps = 49/247 (19%)
Query: 98  INHIVYASRMSHKHIIKLI----------VFESVQIGTLADRIHHHCEQHFEALSLTDRL 147
           ++  V    + H HI+KLI          + E    G L     H+ E++  +L +   +
Sbjct: 61  MSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLV 116
Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD 207
             ++ I  A+AYL    S   V+RD+   NIL       KL DF LS  I D E + +  
Sbjct: 117 LYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED-EDYYKAS 172
Query: 208 SVVGTTGFIAPEN-----FTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEEN 262
                  +++PE+     FTT      DV+ F   ++E+L+          +  F + EN
Sbjct: 173 VTRLPIKWMSPESINFRRFTT----ASDVWMFAVCMWEILSFG--------KQPFFWLEN 220
Query: 263 VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK 322
                          D I + +K       +        L  +C D+ P DRP   ++  
Sbjct: 221 --------------KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVC 266
Query: 323 QLRQMYR 329
            L  +Y+
Sbjct: 267 SLSDVYQ 273

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 97/247 (39%), Gaps = 49/247 (19%)
Query: 98  INHIVYASRMSHKHIIKLI----------VFESVQIGTLADRIHHHCEQHFEALSLTDRL 147
           ++  V    + H HI+KLI          + E    G L     H+ E++  +L +   +
Sbjct: 73  MSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLV 128
Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD 207
             ++ I  A+AYL    S   V+RD+   NIL       KL DF LS  I D E + +  
Sbjct: 129 LYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED-EDYYKAS 184
Query: 208 SVVGTTGFIAPEN-----FTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEEN 262
                  +++PE+     FTT      DV+ F   ++E+L+          +  F + EN
Sbjct: 185 VTRLPIKWMSPESINFRRFTT----ASDVWMFAVCMWEILSFG--------KQPFFWLEN 232
Query: 263 VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK 322
                          D I + +K       +        L  +C D+ P DRP   ++  
Sbjct: 233 --------------KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVC 278
Query: 323 QLRQMYR 329
            L  +Y+
Sbjct: 279 SLSDVYQ 285

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 97/247 (39%), Gaps = 49/247 (19%)
Query: 98  INHIVYASRMSHKHIIKLI----------VFESVQIGTLADRIHHHCEQHFEALSLTDRL 147
           ++  V    + H HI+KLI          + E    G L     H+ E++  +L +   +
Sbjct: 57  MSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLV 112
Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD 207
             ++ I  A+AYL    S   V+RD+   NIL       KL DF LS  I D E + +  
Sbjct: 113 LYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIED-EDYYKAS 168
Query: 208 SVVGTTGFIAPEN-----FTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEEN 262
                  +++PE+     FTT      DV+ F   ++E+L+          +  F + EN
Sbjct: 169 VTRLPIKWMSPESINFRRFTT----ASDVWMFAVCMWEILSFG--------KQPFFWLEN 216
Query: 263 VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK 322
                          D I + +K       +        L  +C D+ P DRP   ++  
Sbjct: 217 --------------KDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVC 262
Query: 323 QLRQMYR 329
            L  +Y+
Sbjct: 263 SLSDVYQ 269

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 103/259 (39%), Gaps = 55/259 (21%)
Query: 80  ISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIK------LIVFESVQIGTLADRIHHH 133
           ++++ YNG         C +   Y    S K+  +       I  E    GTL   I   
Sbjct: 64  VNIVHYNG---------CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE-- 112
Query: 134 CEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL 193
            ++  E L     L++   I   V Y+H   S+ ++ RD+KP+NI   +    K+ DF L
Sbjct: 113 -KRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGL 168
Query: 194 SLSIP-DGETHIELDSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHV 251
             S+  DG+         GT  +++PE  ++    ++ D+Y  G  L ELL    V D  
Sbjct: 169 VTSLKNDGKRX----RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL---HVCDTA 221
Query: 252 SFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSP 311
              S+F               F ++ D II    S     KE      K L  + +   P
Sbjct: 222 FETSKF---------------FTDLRDGII----SDIFDKKE------KTLLQKLLSKKP 256
Query: 312 EDRPTMVDVAKQLRQMYRS 330
           EDRP   ++ + L    +S
Sbjct: 257 EDRPNTSEILRTLTVWKKS 275

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/275 (20%), Positives = 109/275 (39%), Gaps = 41/275 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           + ++Y+G W+K S+++       +   +E  +        + H ++++L           
Sbjct: 272 YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 331
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L D +     Q   A+ L   L +A  I+ A+ YL     +  ++R++  
Sbjct: 332 IITEFMTYGNLLDYLRECNRQEVNAVVL---LYMATQISSAMEYLE---KKNFIHRNLAA 385
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            N L  E    K+ DF LS  +  G+T+           + APE+      + + DV+ F
Sbjct: 386 RNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 444
Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  L+E+ T   +S +   +    YE                     + +K       E 
Sbjct: 445 GVLLWEIATYG-MSPYPGIDLSQVYE---------------------LLEKDYRMERPEG 482
Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
             +   +L   C  ++P DRP+  ++ +    M++
Sbjct: 483 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 517

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 59/125 (47%), Gaps = 19/125 (15%)
Query: 134 CEQHFEALSLTDRLK------------VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN 181
           C +H +  SL   LK            V++ +   + YL       I++RD+KP+NIL N
Sbjct: 109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVN 166
Query: 182 EQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINEQCDVYGFGAFLFE 240
            + + KL DF +S  + D       +S VGT  +++PE    T  + Q D++  G  L E
Sbjct: 167 SRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 222
Query: 241 LLTAQ 245
           +   +
Sbjct: 223 MAVGR 227

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/169 (26%), Positives = 73/169 (43%), Gaps = 33/169 (19%)
Query: 105 SRMSHKHIIKL---------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           S ++H +I+KL         +V E V  G L    +H        +  + +L++ +DIA 
Sbjct: 78  SNLNHPNIVKLYGLMHNPPRMVMEFVPCGDL----YHRLLDKAHPIKWSVKLRLMLDIAL 133
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILF-----NEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
            + Y+    + PIV+RD++  NI       N    AK+ DF        G +   + SV 
Sbjct: 134 GIEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF--------GTSQQSVHSVS 184
Query: 211 GTTG---FIAPENFTT---LINEQCDVYGFGAFLFELLTAQEVSDHVSF 253
           G  G   ++APE          E+ D Y F   L+ +LT +   D  S+
Sbjct: 185 GLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY 233

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 59/108 (54%), Gaps = 11/108 (10%)
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL--SIPDGETHIELDSVVGTT 213
            +AY H    + +++RD+KP N+L NE+ + KL DF L+   SIP  +T+   D+ V T 
Sbjct: 112 GLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTY---DNEVVTL 164
Query: 214 GFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHY 259
            +  P+    +T  + Q D++G G   +E+ T + +    + E + H+
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHF 212

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 19/152 (12%)
Query: 101 IVYASRMSHKHIIKL--IVFESVQIGTLADRIHHHCEQHFEALSLTDRL------KVAMD 152
           I Y   + H HIIKL  ++    +I  +   I +   + F+ +   D++      +    
Sbjct: 65  ISYLRLLRHPHIIKLYDVIKSKDEIIMV---IEYAGNELFDYIVQRDKMSEQEARRFFQQ 121
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I  AV Y H      IV+RD+KP N+L +E  + K+ DF LS  + DG     L +  G+
Sbjct: 122 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF---LKTSCGS 175
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELL 242
             + APE  +  +    + DV+  G  L+ +L
Sbjct: 176 PNYAAPEVISGKLYAGPEVDVWSCGVILYVML 207

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 70/161 (43%), Gaps = 26/161 (16%)
Query: 99  NHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRL 147
           N I    ++ H +I+ L           ++ + V  G L DRI    E+ F   +  D  
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGF--YTERDAS 119
Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHI 204
           ++   +  AV YLH      IV+RD+KP N+L+   +E S   + DF LS     G    
Sbjct: 120 RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV-- 174
Query: 205 ELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
            L +  GT G++APE       ++  D +  G   + LL  
Sbjct: 175 -LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 19/152 (12%)
Query: 101 IVYASRMSHKHIIKL--IVFESVQIGTLADRIHHHCEQHFEALSLTDRL------KVAMD 152
           I Y   + H HIIKL  ++    +I  +   I +   + F+ +   D++      +    
Sbjct: 64  ISYLRLLRHPHIIKLYDVIKSKDEIIMV---IEYAGNELFDYIVQRDKMSEQEARRFFQQ 120
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I  AV Y H      IV+RD+KP N+L +E  + K+ DF LS  + DG     L +  G+
Sbjct: 121 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF---LKTSCGS 174
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELL 242
             + APE  +  +    + DV+  G  L+ +L
Sbjct: 175 PNYAAPEVISGKLYAGPEVDVWSCGVILYVML 206

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/171 (23%), Positives = 70/171 (40%), Gaps = 30/171 (17%)
Query: 93  ALEWCINHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM- 151
            +E     I    ++ H +++KL+         L D    H    FE ++    ++V   
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLV-------EVLDDPNEDHLYMVFELVNQGPVMEVPTL 131
Query: 152 -------------DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
                        D+   + YLH    + I++RD+KP+N+L  E    K+ DF +S    
Sbjct: 132 KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 199 DGETHIELDSVVGTTGFIAPENFT----TLINEQCDVYGFGAFLFELLTAQ 245
             +    L + VGT  F+APE+ +        +  DV+  G  L+  +  Q
Sbjct: 189 GSDAL--LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 19/152 (12%)
Query: 101 IVYASRMSHKHIIKL--IVFESVQIGTLADRIHHHCEQHFEALSLTDRL------KVAMD 152
           I Y   + H HIIKL  ++    +I  +   I +   + F+ +   D++      +    
Sbjct: 55  ISYLRLLRHPHIIKLYDVIKSKDEIIMV---IEYAGNELFDYIVQRDKMSEQEARRFFQQ 111
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I  AV Y H      IV+RD+KP N+L +E  + K+ DF LS  + DG     L +  G+
Sbjct: 112 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF---LKTSCGS 165
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELL 242
             + APE  +  +    + DV+  G  L+ +L
Sbjct: 166 PNYAAPEVISGKLYAGPEVDVWSCGVILYVML 197

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 59/125 (47%), Gaps = 19/125 (15%)
Query: 134 CEQHFEALSLTDRLK------------VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN 181
           C +H +  SL   LK            V++ +   + YL       I++RD+KP+NIL N
Sbjct: 82  CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVN 139
Query: 182 EQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINEQCDVYGFGAFLFE 240
            + + KL DF +S  + D       +S VGT  +++PE    T  + Q D++  G  L E
Sbjct: 140 SRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 195
Query: 241 LLTAQ 245
           +   +
Sbjct: 196 MAVGR 200

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 59/125 (47%), Gaps = 19/125 (15%)
Query: 134 CEQHFEALSLTDRLK------------VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN 181
           C +H +  SL   LK            V++ +   + YL       I++RD+KP+NIL N
Sbjct: 82  CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVN 139
Query: 182 EQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINEQCDVYGFGAFLFE 240
            + + KL DF +S  + D       +S VGT  +++PE    T  + Q D++  G  L E
Sbjct: 140 SRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 195
Query: 241 LLTAQ 245
           +   +
Sbjct: 196 MAVGR 200

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 70/159 (44%), Gaps = 26/159 (16%)
Query: 99  NHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRL 147
           N I    ++ H +I+ L           ++ + V  G L DRI    E+ F   +  D  
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGF--YTERDAS 119
Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHI 204
           ++   +  AV YLH      IV+RD+KP N+L+   +E S   + DF LS     G    
Sbjct: 120 RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV-- 174
Query: 205 ELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELL 242
            L +  GT G++APE       ++  D +  G   + LL
Sbjct: 175 -LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 212

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 52/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+  F L+    D     E+   V T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDD-----EMTGYVAT 185
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 70/159 (44%), Gaps = 26/159 (16%)
Query: 99  NHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRL 147
           N I    ++ H +I+ L           ++ + V  G L DRI    E+ F   +  D  
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGF--YTERDAS 119
Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHI 204
           ++   +  AV YLH      IV+RD+KP N+L+   +E S   + DF LS     G    
Sbjct: 120 RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV-- 174
Query: 205 ELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELL 242
            L +  GT G++APE       ++  D +  G   + LL
Sbjct: 175 -LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 212

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 63/133 (47%), Gaps = 26/133 (19%)
Query: 126 LADRIHHHCEQHFEALSLTDR-----LKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF 180
           L D ++  C       SL DR     L + + IA AV +LH   S+ +++RD+KP+NI F
Sbjct: 148 LKDWMNRRC-------SLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFF 197
Query: 181 NEQSDAKLFDFSLSLSI-PDGETHIELDSV---------VGTTGFIAPENF-TTLINEQC 229
                 K+ DF L  ++  D E    L  +         VGT  +++PE       + + 
Sbjct: 198 TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSHKV 257
Query: 230 DVYGFGAFLFELL 242
           D++  G  LFELL
Sbjct: 258 DIFSLGLILFELL 270

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 62/137 (45%), Gaps = 13/137 (9%)
Query: 116 IVFESVQIGTLADRIHHHCEQ--HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
           ++ E +  G+L D +  H E+  H + L  T ++   M+      Y+H         RD+
Sbjct: 93  LIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRYIH---------RDL 143
Query: 174 KPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFT-TLINEQCDV 231
              NIL   ++  K+ DF L+  +P D E     +       + APE+ T +  +   DV
Sbjct: 144 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDV 203
Query: 232 YGFGAFLFELLTAQEVS 248
           + FG  L+EL T  E S
Sbjct: 204 WSFGVVLYELFTYIEKS 220

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 59/125 (47%), Gaps = 19/125 (15%)
Query: 134 CEQHFEALSLTDRLK------------VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN 181
           C +H +  SL   LK            V++ +   + YL       I++RD+KP+NIL N
Sbjct: 82  CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVN 139
Query: 182 EQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINEQCDVYGFGAFLFE 240
            + + KL DF +S  + D       +S VGT  +++PE    T  + Q D++  G  L E
Sbjct: 140 SRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 195
Query: 241 LLTAQ 245
           +   +
Sbjct: 196 MAVGR 200

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/154 (27%), Positives = 70/154 (45%), Gaps = 17/154 (11%)
Query: 101 IVYASRMSHKHIIKLIVFESVQIGT-LADRIHHHCEQHFEALSLTDRL------KVAMDI 153
           I Y   + H HIIKL  ++ +   T +   I +   + F+ +    R+      +    I
Sbjct: 60  ISYLKLLRHPHIIKL--YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQI 117
Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT 213
             A+ Y H      IV+RD+KP N+L ++  + K+ DF LS  + DG     L +  G+ 
Sbjct: 118 ICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSP 171
Query: 214 GFIAPE--NFTTLINEQCDVYGFGAFLFELLTAQ 245
            + APE  N       + DV+  G  L+ +L  +
Sbjct: 172 NYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 51/110 (46%), Gaps = 6/110 (5%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A +I   + +LH   S+ IVYRD+K  NIL ++    K+ DF +      G+   + +  
Sbjct: 125 AAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNEF 179
Query: 210 VGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFH 258
            GT  +IAPE       N   D + FG  L+E+L  Q        E  FH
Sbjct: 180 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 229

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 71/152 (46%), Gaps = 19/152 (12%)
Query: 101 IVYASRMSHKHIIKL--IVFESVQIGTLADRIHHHCEQHFEALSLTDRL------KVAMD 152
           I Y   + H HIIKL  ++    +I  +   I +   + F+ +   D++      +    
Sbjct: 59  ISYLRLLRHPHIIKLYDVIKSKDEIIMV---IEYAGNELFDYIVQRDKMSEQEARRFFQQ 115
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I  AV Y H      IV+RD+KP N+L +E  + K+ DF LS  + DG     L +  G+
Sbjct: 116 IISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF---LKTSCGS 169
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELL 242
             + APE  +  +    + DV+  G  L+ +L
Sbjct: 170 PNYAAPEVISGKLYAGPEVDVWSCGVILYVML 201

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 70/161 (43%), Gaps = 26/161 (16%)
Query: 99  NHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRL 147
           N I    ++ H +I+ L           ++ + V  G L DRI    E+ F   +  D  
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGF--YTERDAS 119
Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHI 204
           ++   +  AV YLH      IV+RD+KP N+L+   +E S   + DF LS     G    
Sbjct: 120 RLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV-- 174
Query: 205 ELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
            L +  GT G++APE       ++  D +  G   + LL  
Sbjct: 175 -LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 59/125 (47%), Gaps = 19/125 (15%)
Query: 134 CEQHFEALSLTDRLK------------VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN 181
           C +H +  SL   LK            V++ +   + YL       I++RD+KP+NIL N
Sbjct: 82  CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVN 139
Query: 182 EQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINEQCDVYGFGAFLFE 240
            + + KL DF +S  + D       +S VGT  +++PE    T  + Q D++  G  L E
Sbjct: 140 SRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 195
Query: 241 LLTAQ 245
           +   +
Sbjct: 196 MAVGR 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 59/125 (47%), Gaps = 19/125 (15%)
Query: 134 CEQHFEALSLTDRLK------------VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN 181
           C +H +  SL   LK            V++ +   + YL       I++RD+KP+NIL N
Sbjct: 82  CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVN 139
Query: 182 EQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINEQCDVYGFGAFLFE 240
            + + KL DF +S  + D       +S VGT  +++PE    T  + Q D++  G  L E
Sbjct: 140 SRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 195
Query: 241 LLTAQ 245
           +   +
Sbjct: 196 MAVGR 200

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 62/137 (45%), Gaps = 13/137 (9%)
Query: 116 IVFESVQIGTLADRIHHHCEQ--HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
           ++ E +  G+L D +  H E+  H + L  T ++   M+      Y+H         RD+
Sbjct: 89  LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH---------RDL 139
Query: 174 KPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFT-TLINEQCDV 231
              NIL   ++  K+ DF L+  +P D E     +       + APE+ T +  +   DV
Sbjct: 140 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDV 199
Query: 232 YGFGAFLFELLTAQEVS 248
           + FG  L+EL T  E S
Sbjct: 200 WSFGVVLYELFTYIEKS 216

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 36/125 (28%), Positives = 59/125 (47%), Gaps = 19/125 (15%)
Query: 134 CEQHFEALSLTDRLK------------VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN 181
           C +H +  SL   LK            V++ +   + YL       I++RD+KP+NIL N
Sbjct: 144 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVN 201
Query: 182 EQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINEQCDVYGFGAFLFE 240
            + + KL DF +S  + D       +S VGT  +++PE    T  + Q D++  G  L E
Sbjct: 202 SRGEIKLCDFGVSGQLIDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 257
Query: 241 LLTAQ 245
           +   +
Sbjct: 258 MAVGR 262

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 21/152 (13%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I   + YLH   S   ++RD+K  N+L +E  + KL DF ++  + D  T I+ ++ VG
Sbjct: 112 EILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVG 166
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFH--------YEEN 262
           T  ++APE    +  + + D++  G      +TA E++      S  H         + N
Sbjct: 167 TPFWMAPEVIKQSAYDSKADIWSLG------ITAIELARGEPPHSELHPMKVLFLIPKNN 220
Query: 263 VKRLSGQNCR-FKEMVDSIIIEDKSCTCTGKE 293
              L G   +  KE V++ + ++ S   T KE
Sbjct: 221 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKE 252

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 62/137 (45%), Gaps = 13/137 (9%)
Query: 116 IVFESVQIGTLADRIHHHCEQ--HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
           ++ E +  G+L D +  H E+  H + L  T ++   M+      Y+H         RD+
Sbjct: 94  LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH---------RDL 144
Query: 174 KPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFT-TLINEQCDV 231
              NIL   ++  K+ DF L+  +P D E     +       + APE+ T +  +   DV
Sbjct: 145 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDV 204
Query: 232 YGFGAFLFELLTAQEVS 248
           + FG  L+EL T  E S
Sbjct: 205 WSFGVVLYELFTYIEKS 221

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         ++ VG
Sbjct: 138 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVG 194
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
           T  +++PE  T     +  D++  G  +++L+  
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/110 (31%), Positives = 51/110 (46%), Gaps = 6/110 (5%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A +I   + +LH   S+ IVYRD+K  NIL ++    K+ DF +      G+   + +  
Sbjct: 124 AAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNXF 178
Query: 210 VGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFH 258
            GT  +IAPE       N   D + FG  L+E+L  Q        E  FH
Sbjct: 179 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 228

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 63/124 (50%), Gaps = 11/124 (8%)
Query: 126 LADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD 185
           L   + +H +Q+      T +L +  ++  A+ YL    ++ I++RDMKP NIL +E   
Sbjct: 98  LGGDLRYHLQQNVHFKEETVKLFIC-ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGH 153
Query: 186 AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINE----QCDVYGFGAFLFEL 241
             + DF+++  +P  ET I   ++ GT  ++APE F++          D +  G   +EL
Sbjct: 154 VHITDFNIAAMLP-RETQIT--TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYEL 210
Query: 242 LTAQ 245
           L  +
Sbjct: 211 LRGR 214

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 62/137 (45%), Gaps = 13/137 (9%)
Query: 116 IVFESVQIGTLADRIHHHCEQ--HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
           ++ E +  G+L D +  H E+  H + L  T ++   M+      Y+H         RD+
Sbjct: 90  LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH---------RDL 140
Query: 174 KPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFT-TLINEQCDV 231
              NIL   ++  K+ DF L+  +P D E     +       + APE+ T +  +   DV
Sbjct: 141 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDV 200
Query: 232 YGFGAFLFELLTAQEVS 248
           + FG  L+EL T  E S
Sbjct: 201 WSFGVVLYELFTYIEKS 217

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 62/137 (45%), Gaps = 13/137 (9%)
Query: 116 IVFESVQIGTLADRIHHHCEQ--HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
           ++ E +  G+L D +  H E+  H + L  T ++   M+      Y+H         RD+
Sbjct: 108 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH---------RDL 158
Query: 174 KPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFT-TLINEQCDV 231
              NIL   ++  K+ DF L+  +P D E     +       + APE+ T +  +   DV
Sbjct: 159 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDV 218
Query: 232 YGFGAFLFELLTAQEVS 248
           + FG  L+EL T  E S
Sbjct: 219 WSFGVVLYELFTYIEKS 235

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 62/137 (45%), Gaps = 13/137 (9%)
Query: 116 IVFESVQIGTLADRIHHHCEQ--HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
           ++ E +  G+L D +  H E+  H + L  T ++   M+      Y+H         RD+
Sbjct: 95  LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH---------RDL 145
Query: 174 KPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFT-TLINEQCDV 231
              NIL   ++  K+ DF L+  +P D E     +       + APE+ T +  +   DV
Sbjct: 146 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDV 205
Query: 232 YGFGAFLFELLTAQEVS 248
           + FG  L+EL T  E S
Sbjct: 206 WSFGVVLYELFTYIEKS 222

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 14/107 (13%)
Query: 147 LKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI-PDGETHIE 205
           L + + IA AV +LH   S+ +++RD+KP+NI F      K+ DF L  ++  D E    
Sbjct: 121 LHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 206 LDSV---------VGTTGFIAPENF-TTLINEQCDVYGFGAFLFELL 242
           L  +         VGT  +++PE       + + D++  G  LFELL
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 62/137 (45%), Gaps = 13/137 (9%)
Query: 116 IVFESVQIGTLADRIHHHCEQ--HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
           ++ E +  G+L D +  H E+  H + L  T ++   M+      Y+H         RD+
Sbjct: 88  LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH---------RDL 138
Query: 174 KPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFT-TLINEQCDV 231
              NIL   ++  K+ DF L+  +P D E     +       + APE+ T +  +   DV
Sbjct: 139 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDV 198
Query: 232 YGFGAFLFELLTAQEVS 248
           + FG  L+EL T  E S
Sbjct: 199 WSFGVVLYELFTYIEKS 215

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 62/137 (45%), Gaps = 13/137 (9%)
Query: 116 IVFESVQIGTLADRIHHHCEQ--HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
           ++ E +  G+L D +  H E+  H + L  T ++   M+      Y+H         RD+
Sbjct: 93  LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH---------RDL 143
Query: 174 KPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFT-TLINEQCDV 231
              NIL   ++  K+ DF L+  +P D E     +       + APE+ T +  +   DV
Sbjct: 144 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDV 203
Query: 232 YGFGAFLFELLTAQEVS 248
           + FG  L+EL T  E S
Sbjct: 204 WSFGVVLYELFTYIEKS 220

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 29/99 (29%), Positives = 52/99 (52%), Gaps = 10/99 (10%)
Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD 207
           K+A+ I  A+ +LH   S  +++RD+KP+N+L N     K+ DF +S  + D      +D
Sbjct: 157 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKT-ID 213
Query: 208 SVVGTTGFIAPENFTTLINE-----QCDVYGFGAFLFEL 241
           +  G   ++APE     +N+     + D++  G  + EL
Sbjct: 214 A--GCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 52/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ D  L+    D     E+   V T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDD-----EMTGYVAT 185
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 62/137 (45%), Gaps = 13/137 (9%)
Query: 116 IVFESVQIGTLADRIHHHCEQ--HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
           ++ E +  G+L D +  H E+  H + L  T ++   M+      Y+H         RD+
Sbjct: 108 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH---------RDL 158
Query: 174 KPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFT-TLINEQCDV 231
              NIL   ++  K+ DF L+  +P D E     +       + APE+ T +  +   DV
Sbjct: 159 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDV 218
Query: 232 YGFGAFLFELLTAQEVS 248
           + FG  L+EL T  E S
Sbjct: 219 WSFGVVLYELFTYIEKS 235

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 62/137 (45%), Gaps = 13/137 (9%)
Query: 116 IVFESVQIGTLADRIHHHCEQ--HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
           ++ E +  G+L D +  H E+  H + L  T ++   M+      Y+H         RD+
Sbjct: 96  LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH---------RDL 146
Query: 174 KPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFT-TLINEQCDV 231
              NIL   ++  K+ DF L+  +P D E     +       + APE+ T +  +   DV
Sbjct: 147 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDV 206
Query: 232 YGFGAFLFELLTAQEVS 248
           + FG  L+EL T  E S
Sbjct: 207 WSFGVVLYELFTYIEKS 223

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 62/137 (45%), Gaps = 13/137 (9%)
Query: 116 IVFESVQIGTLADRIHHHCEQ--HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
           ++ E +  G+L D +  H E+  H + L  T ++   M+      Y+H         RD+
Sbjct: 90  LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH---------RDL 140
Query: 174 KPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFT-TLINEQCDV 231
              NIL   ++  K+ DF L+  +P D E     +       + APE+ T +  +   DV
Sbjct: 141 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDV 200
Query: 232 YGFGAFLFELLTAQEVS 248
           + FG  L+EL T  E S
Sbjct: 201 WSFGVVLYELFTYIEKS 217

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 58/130 (44%), Gaps = 12/130 (9%)
Query: 170 YRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQ 228
           +RD+KP NIL +    A L DF ++ +  D E   +L + VGT  + APE F+ +    +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTD-EKLTQLGNTVGTLYYXAPERFSESHATYR 215
Query: 229 CDVYGFGAFLFELLTAQEV--SDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIII---- 282
            D+Y     L+E LT       D +S     H  + + R S          D++I     
Sbjct: 216 ADIYALTCVLYECLTGSPPYQGDQLSVXG-AHINQAIPRPSTVRPGIPVAFDAVIARGXA 274
Query: 283 ---EDKSCTC 289
              ED+  TC
Sbjct: 275 KNPEDRYVTC 284

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 62/137 (45%), Gaps = 13/137 (9%)
Query: 116 IVFESVQIGTLADRIHHHCEQ--HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
           ++ E +  G+L D +  H E+  H + L  T ++   M+      Y+H         RD+
Sbjct: 97  LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH---------RDL 147
Query: 174 KPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFT-TLINEQCDV 231
              NIL   ++  K+ DF L+  +P D E     +       + APE+ T +  +   DV
Sbjct: 148 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDV 207
Query: 232 YGFGAFLFELLTAQEVS 248
           + FG  L+EL T  E S
Sbjct: 208 WSFGVVLYELFTYIEKS 224

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 13/137 (9%)
Query: 116 IVFESVQIGTLADRIHHHCEQ--HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
           ++ E +  G+L D +  H E+  H + L  T ++   M+      Y+H         RD+
Sbjct: 90  LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH---------RDL 140
Query: 174 KPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF-IAPENFT-TLINEQCDV 231
              NIL   ++  K+ DF L+  +P  +   ++     +  F  APE+ T +  +   DV
Sbjct: 141 ATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDV 200
Query: 232 YGFGAFLFELLTAQEVS 248
           + FG  L+EL T  E S
Sbjct: 201 WSFGVVLYELFTYIEKS 217

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         +  VG
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
           T  +++PE  T     +  D++  G  +++L+  
Sbjct: 197 TAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 62/137 (45%), Gaps = 13/137 (9%)
Query: 116 IVFESVQIGTLADRIHHHCEQ--HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
           ++ E +  G+L D +  H E+  H + L  T ++   M+      Y+H         RD+
Sbjct: 121 LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH---------RDL 171
Query: 174 KPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFT-TLINEQCDV 231
              NIL   ++  K+ DF L+  +P D E     +       + APE+ T +  +   DV
Sbjct: 172 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDV 231
Query: 232 YGFGAFLFELLTAQEVS 248
           + FG  L+EL T  E S
Sbjct: 232 WSFGVVLYELFTYIEKS 248

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 52/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ D  L+    D     E+   V T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDD-----EMTGYVAT 185
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         +  VG
Sbjct: 116 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 172
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
           T  +++PE  T     +  D++  G  +++L+  
Sbjct: 173 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 58/116 (50%), Gaps = 12/116 (10%)
Query: 139 EALSLTDRLKVAMDIAHAV-AYLHVGFSRPIVYRDMKPTNILF--NEQSDAKLFDFSLS- 194
           E+L    R K+  +I   + + LH   ++ I +RD+KP N LF  N+  + KL DF LS 
Sbjct: 159 ESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSK 218
Query: 195 --LSIPDGETHIELDSVVGTTGFIAPENFTTLINE----QCDVYGFGAFLFELLTA 244
               + +GE +  + +  GT  F+APE   T  NE    +CD +  G  L  LL  
Sbjct: 219 EFYKLNNGE-YYGMTTKAGTPYFVAPEVLNT-TNESYGPKCDAWSAGVLLHLLLMG 272

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         +  VG
Sbjct: 117 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 173
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
           T  +++PE  T     +  D++  G  +++L+  
Sbjct: 174 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         +  VG
Sbjct: 115 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 171
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
           T  +++PE  T     +  D++  G  +++L+  
Sbjct: 172 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 52/104 (50%), Gaps = 13/104 (12%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + Y+H   S  I++RD+KP+N+  NE  + K+ D  L+    D     E+   V T
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDD-----EMTGYVAT 185
Query: 213 TGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
             + APE     +  N+  D++  G  + ELLT + +   +DH+
Sbjct: 186 RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI 229

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 52/101 (51%), Gaps = 13/101 (12%)
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            + Y+H   S  I++RD+KP+N+  NE S+ ++ DF L+    +     E+   V T  +
Sbjct: 143 GLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADE-----EMTGYVATRWY 194
Query: 216 IAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
            APE     +  N+  D++  G  + ELL  + +   SD++
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYI 235

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 29/101 (28%), Positives = 52/101 (51%), Gaps = 13/101 (12%)
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            + Y+H   S  I++RD+KP+N+  NE S+ ++ DF L+    +     E+   V T  +
Sbjct: 143 GLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADE-----EMTGYVATRWY 194
Query: 216 IAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
            APE     +  N+  D++  G  + ELL  + +   SD++
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYI 235

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 68/154 (44%), Gaps = 26/154 (16%)
Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           ++ H +I++L           +VF+ V  G L + I        E  S  D       I 
Sbjct: 84  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQIL 138
Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA---KLFDFSLSLSIPDGETHIELDSVVG 211
            ++AY H   S  IV+R++KP N+L   ++     KL DF L++ + D E         G
Sbjct: 139 ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAG 192
Query: 212 TTGFIAPENFTT-LINEQCDVYGFGAFLFELLTA 244
           T G+++PE       ++  D++  G  L+ LL  
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         +  VG
Sbjct: 118 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 174
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
           T  +++PE  T     +  D++  G  +++L+  
Sbjct: 175 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/128 (25%), Positives = 59/128 (46%), Gaps = 4/128 (3%)
Query: 116 IVFESVQIGTLADRIHHHC-EQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
           IV E  + G LA  I     E+ +       R+   + +A    +        +++RD+K
Sbjct: 84  IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 175 PTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTL-INEQCDVYG 233
           P N+  + + + KL DF L+  +   E   +    VGT  +++PE    +  NE+ D++ 
Sbjct: 144 PANVFLDGKQNVKLGDFGLARILNHDEDFAK--EFVGTPYYMSPEQMNRMSYNEKSDIWS 201
Query: 234 FGAFLFEL 241
            G  L+EL
Sbjct: 202 LGCLLYEL 209

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         +  VG
Sbjct: 122 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 178
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
           T  +++PE  T     +  D++  G  +++L+  
Sbjct: 179 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         +  VG
Sbjct: 137 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 193
Query: 212 TTGFIAPENFTTLINEQC---DVYGFGAFLFELLTA 244
           T  +++PE  T      C   D++  G  +++L+  
Sbjct: 194 TAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAG 227

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 21/152 (13%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I   + YLH   S   ++RD+K  N+L +E  + KL DF ++  + D  T I+ +  VG
Sbjct: 127 EILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNXFVG 181
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFH--------YEEN 262
           T  ++APE    +  + + D++  G      +TA E++      S  H         + N
Sbjct: 182 TPFWMAPEVIKQSAYDSKADIWSLG------ITAIELARGEPPHSELHPMKVLFLIPKNN 235
Query: 263 VKRLSGQNCR-FKEMVDSIIIEDKSCTCTGKE 293
              L G   +  KE V++ + ++ S   T KE
Sbjct: 236 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKE 267

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 36/137 (26%), Positives = 64/137 (46%), Gaps = 13/137 (9%)
Query: 116 IVFESVQIGTLADRIHHHCEQ--HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
           ++ E +  G+L D +  H E+  H + L  T ++   M+      Y+H         R++
Sbjct: 91  LIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH---------RNL 141
Query: 174 KPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF-IAPENFT-TLINEQCDV 231
              NIL   ++  K+ DF L+  +P  + + ++     +  F  APE+ T +  +   DV
Sbjct: 142 ATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDV 201
Query: 232 YGFGAFLFELLTAQEVS 248
           + FG  L+EL T  E S
Sbjct: 202 WSFGVVLYELFTYIEKS 218

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 61/128 (47%), Gaps = 4/128 (3%)
Query: 116 IVFESVQIGTLADRIHHHC-EQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
           IV E  + G LA  I     E+ +       R+   + +A    +        +++RD+K
Sbjct: 84  IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 175 PTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTL-INEQCDVYG 233
           P N+  + + + KL DF L+  I + +T     + VGT  +++PE    +  NE+ D++ 
Sbjct: 144 PANVFLDGKQNVKLGDFGLA-RILNHDTSFA-KTFVGTPYYMSPEQMNRMSYNEKSDIWS 201
Query: 234 FGAFLFEL 241
            G  L+EL
Sbjct: 202 LGCLLYEL 209

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 59/132 (44%), Gaps = 13/132 (9%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
           LIV E +  G L  RI    +Q F     ++   +   I  A+ YLH   S  I +RD+K
Sbjct: 135 LIVXECLDGGELFSRIQDRGDQAFTEREASE---IXKSIGEAIQYLH---SINIAHRDVK 188
Query: 175 PTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCD 230
           P N+L+  +      KL DF  +    +  +H  L +   T  ++APE       ++ CD
Sbjct: 189 PENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCD 245
Query: 231 VYGFGAFLFELL 242
            +  G   + LL
Sbjct: 246 XWSLGVIXYILL 257

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 21/152 (13%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I   + YLH   S   ++RD+K  N+L +E  + KL DF ++  + D  T I+ +  VG
Sbjct: 112 EILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNXFVG 166
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFH--------YEEN 262
           T  ++APE    +  + + D++  G      +TA E++      S  H         + N
Sbjct: 167 TPFWMAPEVIKQSAYDSKADIWSLG------ITAIELARGEPPHSELHPMKVLFLIPKNN 220
Query: 263 VKRLSGQNCR-FKEMVDSIIIEDKSCTCTGKE 293
              L G   +  KE V++ + ++ S   T KE
Sbjct: 221 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKE 252

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         +  VG
Sbjct: 138 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
           T  +++PE  T     +  D++  G  +++L+  
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         +  VG
Sbjct: 138 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
           T  +++PE  T     +  D++  G  +++L+  
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/128 (26%), Positives = 61/128 (47%), Gaps = 4/128 (3%)
Query: 116 IVFESVQIGTLADRIHHHC-EQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
           IV E  + G LA  I     E+ +       R+   + +A    +        +++RD+K
Sbjct: 84  IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLK 143
Query: 175 PTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTL-INEQCDVYG 233
           P N+  + + + KL DF L+  I + +T     + VGT  +++PE    +  NE+ D++ 
Sbjct: 144 PANVFLDGKQNVKLGDFGLA-RILNHDTSFA-KAFVGTPYYMSPEQMNRMSYNEKSDIWS 201
Query: 234 FGAFLFEL 241
            G  L+EL
Sbjct: 202 LGCLLYEL 209

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         +  VG
Sbjct: 145 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 201
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
           T  +++PE  T     +  D++  G  +++L+  
Sbjct: 202 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 72/152 (47%), Gaps = 21/152 (13%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I   + YLH   S   ++RD+K  N+L +E  + KL DF ++  + D  T I+ ++ VG
Sbjct: 132 EILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVG 186
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFH--------YEEN 262
           T  ++APE    +  + + D++  G      +TA E++      S  H         + N
Sbjct: 187 TPFWMAPEVIKQSAYDSKADIWSLG------ITAIELARGEPPHSELHPMKVLFLIPKNN 240
Query: 263 VKRLSGQNCR-FKEMVDSIIIEDKSCTCTGKE 293
              L G   +  KE V++ + ++ S   T KE
Sbjct: 241 PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKE 272

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         +  VG
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
           T  +++PE  T     +  D++  G  +++L+  
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         +  VG
Sbjct: 138 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 194
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
           T  +++PE  T     +  D++  G  +++L+  
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         +  VG
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
           T  +++PE  T     +  D++  G  +++L+  
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 68/154 (44%), Gaps = 26/154 (16%)
Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           ++ H +I++L           +VF+ V  G L + I        E  S  D       I 
Sbjct: 60  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQIL 114
Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA---KLFDFSLSLSIPDGETHIELDSVVG 211
            ++AY H   S  IV+R++KP N+L   ++     KL DF L++ + D E         G
Sbjct: 115 ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAG 168
Query: 212 TTGFIAPENFTT-LINEQCDVYGFGAFLFELLTA 244
           T G+++PE       ++  D++  G  L+ LL  
Sbjct: 169 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         +  VG
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
           T  +++PE  T     +  D++  G  +++L+  
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         +  VG
Sbjct: 141 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 197
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
           T  +++PE  T     +  D++  G  +++L+  
Sbjct: 198 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 68/154 (44%), Gaps = 26/154 (16%)
Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           ++ H +I++L           +VF+ V  G L + I        E  S  D       I 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQIL 115
Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA---KLFDFSLSLSIPDGETHIELDSVVG 211
            ++AY H   S  IV+R++KP N+L   ++     KL DF L++ + D E         G
Sbjct: 116 ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAG 169
Query: 212 TTGFIAPENFTT-LINEQCDVYGFGAFLFELLTA 244
           T G+++PE       ++  D++  G  L+ LL  
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         +  VG
Sbjct: 140 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 196
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
           T  +++PE  T     +  D++  G  +++L+  
Sbjct: 197 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/245 (22%), Positives = 102/245 (41%), Gaps = 58/245 (23%)
Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           ++SH  +++L           +VFE ++ G L+D +       F A +L   L + +D+ 
Sbjct: 58  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETL---LGMCLDVC 113
Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
             +AYL       +++RD+   N L  E    K+ DF ++  + D       D    +TG
Sbjct: 114 EGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTG 163
Query: 215 ------FIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS 267
                 + +PE F+ +  + + DV+ FG  ++E+ +          E +  YE       
Sbjct: 164 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS----------EGKIPYENR----- 208
Query: 268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQA--FKQLTLQCMDFSPEDRPTMVDVAKQLR 325
                     +S ++ED S      + +L +    Q+   C    PEDRP    + +QL 
Sbjct: 209 ---------SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 259
Query: 326 QMYRS 330
           ++  S
Sbjct: 260 EIAES 264

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 41/154 (26%), Positives = 68/154 (44%), Gaps = 26/154 (16%)
Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           ++ H +I++L           +VF+ V  G L + I        E  S  D       I 
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR-----EFYSEADASHCIQQIL 115
Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA---KLFDFSLSLSIPDGETHIELDSVVG 211
            ++AY H   S  IV+R++KP N+L   ++     KL DF L++ + D E         G
Sbjct: 116 ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAG 169
Query: 212 TTGFIAPENFTT-LINEQCDVYGFGAFLFELLTA 244
           T G+++PE       ++  D++  G  L+ LL  
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/245 (22%), Positives = 102/245 (41%), Gaps = 58/245 (23%)
Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           ++SH  +++L           +VFE ++ G L+D +       F A +L   L + +D+ 
Sbjct: 61  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETL---LGMCLDVC 116
Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
             +AYL       +++RD+   N L  E    K+ DF ++  + D       D    +TG
Sbjct: 117 EGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTG 166
Query: 215 ------FIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS 267
                 + +PE F+ +  + + DV+ FG  ++E+ +          E +  YE       
Sbjct: 167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS----------EGKIPYENR----- 211
Query: 268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQA--FKQLTLQCMDFSPEDRPTMVDVAKQLR 325
                     +S ++ED S      + +L +    Q+   C    PEDRP    + +QL 
Sbjct: 212 ---------SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLA 262
Query: 326 QMYRS 330
           ++  S
Sbjct: 263 EIAES 267

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 26/94 (27%), Positives = 47/94 (50%), Gaps = 4/94 (4%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I  A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         +  VG
Sbjct: 143 EIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVG 199
Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
           T  +++PE  T     +  D++  G  +++L+  
Sbjct: 200 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 48.1 bits (113), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 55/245 (22%), Positives = 102/245 (41%), Gaps = 58/245 (23%)
Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           ++SH  +++L           +VFE ++ G L+D +       F A +L   L + +D+ 
Sbjct: 56  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETL---LGMCLDVC 111
Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
             +AYL       +++RD+   N L  E    K+ DF ++  + D       D    +TG
Sbjct: 112 EGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTG 161
Query: 215 ------FIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS 267
                 + +PE F+ +  + + DV+ FG  ++E+ +          E +  YE       
Sbjct: 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS----------EGKIPYENR----- 206
Query: 268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQA--FKQLTLQCMDFSPEDRPTMVDVAKQLR 325
                     +S ++ED S      + +L +    Q+   C    PEDRP    + +QL 
Sbjct: 207 ---------SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 257
Query: 326 QMYRS 330
           ++  S
Sbjct: 258 EIAES 262

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
             +I  A+ YLH   SR +VYRD+K  N++ ++    K+ DF L    I DG T   + +
Sbjct: 111 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKT 164
Query: 209 VVGTTGFIAPENF-TTLINEQCDVYGFGAFLFELLTAQ 245
             GT  ++APE           D +G G  ++E++  +
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 55/245 (22%), Positives = 102/245 (41%), Gaps = 58/245 (23%)
Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           ++SH  +++L           +VFE ++ G L+D +       F A +L   L + +D+ 
Sbjct: 78  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETL---LGMCLDVC 133
Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
             +AYL       +++RD+   N L  E    K+ DF ++  + D       D    +TG
Sbjct: 134 EGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTG 183
Query: 215 ------FIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS 267
                 + +PE F+ +  + + DV+ FG  ++E+ +          E +  YE       
Sbjct: 184 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS----------EGKIPYENR----- 228
Query: 268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQA--FKQLTLQCMDFSPEDRPTMVDVAKQLR 325
                     +S ++ED S      + +L +    Q+   C    PEDRP    + +QL 
Sbjct: 229 ---------SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 279
Query: 326 QMYRS 330
           ++  S
Sbjct: 280 EIAES 284

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/113 (27%), Positives = 59/113 (52%), Gaps = 18/113 (15%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI- 197
           E +++ D +  +  +A  + +L    SR  ++RD+   NIL +E +  K+ DF L+  I 
Sbjct: 194 EPITMEDLISYSFQVARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIY 250
Query: 198 --PD----GETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             PD    G+T + L        ++APE+ F  + + + DV+ +G  L+E+ +
Sbjct: 251 KNPDYVRKGDTRLPLK-------WMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
             +I  A+ YLH   SR +VYRD+K  N++ ++    K+ DF L    I DG T   + +
Sbjct: 114 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKT 167
Query: 209 VVGTTGFIAPENF-TTLINEQCDVYGFGAFLFELLTAQ 245
             GT  ++APE           D +G G  ++E++  +
Sbjct: 168 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
             +I  A+ YLH   SR +VYRD+K  N++ ++    K+ DF L    I DG T   + +
Sbjct: 111 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKT 164
Query: 209 VVGTTGFIAPENF-TTLINEQCDVYGFGAFLFELLTAQ 245
             GT  ++APE           D +G G  ++E++  +
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 70/171 (40%), Gaps = 26/171 (15%)
Query: 95  EWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSL 143
           E CIN +     ++H++++K            +  E    G L DRI          +  
Sbjct: 53  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPE 102
Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
            D  +    +   V YLH G    I +RD+KP N+L +E+ + K+ DF L+         
Sbjct: 103 PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159
Query: 204 IELDSVVGTTGFIAPENFT--TLINEQCDVYGFGAFLFELLTAQEVSDHVS 252
             L+ + GT  ++APE         E  DV+  G  L  +L  +   D  S
Sbjct: 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 210

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 70/171 (40%), Gaps = 26/171 (15%)
Query: 95  EWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSL 143
           E CIN +     ++H++++K            +  E    G L DRI          +  
Sbjct: 55  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPE 104
Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
            D  +    +   V YLH G    I +RD+KP N+L +E+ + K+ DF L+         
Sbjct: 105 PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 204 IELDSVVGTTGFIAPENFT--TLINEQCDVYGFGAFLFELLTAQEVSDHVS 252
             L+ + GT  ++APE         E  DV+  G  L  +L  +   D  S
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 70/171 (40%), Gaps = 26/171 (15%)
Query: 95  EWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSL 143
           E CIN +     ++H++++K            +  E    G L DRI          +  
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPE 103
Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
            D  +    +   V YLH G    I +RD+KP N+L +E+ + K+ DF L+         
Sbjct: 104 PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 204 IELDSVVGTTGFIAPENFT--TLINEQCDVYGFGAFLFELLTAQEVSDHVS 252
             L+ + GT  ++APE         E  DV+  G  L  +L  +   D  S
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 52/98 (53%), Gaps = 6/98 (6%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N  SD K+ DF L+ ++ PD +    L   V 
Sbjct: 135 ILRGLKYIH---SANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 212 TTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEV 247
           T  + APE    +    +  D++  G  L E+L+ + +
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 229

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 70/171 (40%), Gaps = 26/171 (15%)
Query: 95  EWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSL 143
           E CIN +     ++H++++K            +  E    G L DRI          +  
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPE 103
Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
            D  +    +   V YLH G    I +RD+KP N+L +E+ + K+ DF L+         
Sbjct: 104 PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 204 IELDSVVGTTGFIAPENFT--TLINEQCDVYGFGAFLFELLTAQEVSDHVS 252
             L+ + GT  ++APE         E  DV+  G  L  +L  +   D  S
Sbjct: 161 RLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 64/268 (23%), Positives = 104/268 (38%), Gaps = 55/268 (20%)
Query: 67  FRKLYKGFWQ---KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-------- 115
           F +++ G W    + +I  +K  GN +  A    +       ++ H+ +++L        
Sbjct: 198 FGEVWMGTWNGTTRVAIKTLK-PGNMSPEAF---LQEAQVMKKLRHEKLVQLYAVVSEEP 253
Query: 116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
             IV E +  G+L D +     ++     L D   +A  IA  +AY+        V+RD+
Sbjct: 254 IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD---MAAQIASGMAYVE---RMNYVHRDL 307
Query: 174 KPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE-----NFTTLINEQ 228
           +  NIL  E    K+ DF L   I D E +           + APE      FT     +
Sbjct: 308 RAANILVGENLVCKVADFGLGRLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI----K 362
Query: 229 CDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCT 288
            DV+ FG  L EL T          + R  Y   V R         E++D +   ++   
Sbjct: 363 SDVWSFGILLTELTT----------KGRVPYPGMVNR---------EVLDQV---ERGYR 400
Query: 289 CTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
                +  ++   L  QC    PE+RPT
Sbjct: 401 MPCPPECPESLHDLMCQCWRKDPEERPT 428

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 70/171 (40%), Gaps = 26/171 (15%)
Query: 95  EWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSL 143
           E CIN +     ++H++++K            +  E    G L DRI          +  
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPE 103
Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
            D  +    +   V YLH G    I +RD+KP N+L +E+ + K+ DF L+         
Sbjct: 104 PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 204 IELDSVVGTTGFIAPENFT--TLINEQCDVYGFGAFLFELLTAQEVSDHVS 252
             L+ + GT  ++APE         E  DV+  G  L  +L  +   D  S
Sbjct: 161 RLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 70/171 (40%), Gaps = 26/171 (15%)
Query: 95  EWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSL 143
           E CIN +     ++H++++K            +  E    G L DRI          +  
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPE 103
Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
            D  +    +   V YLH G    I +RD+KP N+L +E+ + K+ DF L+         
Sbjct: 104 PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 204 IELDSVVGTTGFIAPENFT--TLINEQCDVYGFGAFLFELLTAQEVSDHVS 252
             L+ + GT  ++APE         E  DV+  G  L  +L  +   D  S
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 70/171 (40%), Gaps = 26/171 (15%)
Query: 95  EWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSL 143
           E CIN +     ++H++++K            +  E    G L DRI          +  
Sbjct: 55  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPE 104
Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
            D  +    +   V YLH G    I +RD+KP N+L +E+ + K+ DF L+         
Sbjct: 105 PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 204 IELDSVVGTTGFIAPENFT--TLINEQCDVYGFGAFLFELLTAQEVSDHVS 252
             L+ + GT  ++APE         E  DV+  G  L  +L  +   D  S
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 70/171 (40%), Gaps = 26/171 (15%)
Query: 95  EWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSL 143
           E CIN +     ++H++++K            +  E    G L DRI          +  
Sbjct: 55  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPE 104
Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
            D  +    +   V YLH G    I +RD+KP N+L +E+ + K+ DF L+         
Sbjct: 105 PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 204 IELDSVVGTTGFIAPENFT--TLINEQCDVYGFGAFLFELLTAQEVSDHVS 252
             L+ + GT  ++APE         E  DV+  G  L  +L  +   D  S
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 70/171 (40%), Gaps = 26/171 (15%)
Query: 95  EWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSL 143
           E CIN +     ++H++++K            +  E    G L DRI          +  
Sbjct: 55  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPE 104
Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
            D  +    +   V YLH G    I +RD+KP N+L +E+ + K+ DF L+         
Sbjct: 105 PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 204 IELDSVVGTTGFIAPENFT--TLINEQCDVYGFGAFLFELLTAQEVSDHVS 252
             L+ + GT  ++APE         E  DV+  G  L  +L  +   D  S
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 70/171 (40%), Gaps = 26/171 (15%)
Query: 95  EWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSL 143
           E CIN +     ++H++++K            +  E    G L DRI          +  
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPE 103
Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
            D  +    +   V YLH G    I +RD+KP N+L +E+ + K+ DF L+         
Sbjct: 104 PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 204 IELDSVVGTTGFIAPENFT--TLINEQCDVYGFGAFLFELLTAQEVSDHVS 252
             L+ + GT  ++APE         E  DV+  G  L  +L  +   D  S
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/247 (22%), Positives = 102/247 (41%), Gaps = 58/247 (23%)
Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           ++SH  +++L           +VFE ++ G L+D +       F A +L   L + +D+ 
Sbjct: 58  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETL---LGMCLDVC 113
Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
             +AYL       +++RD+   N L  E    K+ DF ++  + D       D    +TG
Sbjct: 114 EGMAYLE---EASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTG 163
Query: 215 ------FIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS 267
                 + +PE F+ +  + + DV+ FG  ++E+ +          E +  YE       
Sbjct: 164 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS----------EGKIPYENR----- 208
Query: 268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQA--FKQLTLQCMDFSPEDRPTMVDVAKQLR 325
                     +S ++ED S      + +L +    Q+   C    PEDRP    + +QL 
Sbjct: 209 ---------SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLA 259
Query: 326 QMYRSCM 332
            +  S +
Sbjct: 260 AIAASGL 266

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA---KLFDFSLSLSIPDGETHIELDSV 209
           I  A+ Y H      I++RD+KP N+L   + ++   KL DF +++ +  GE+ +     
Sbjct: 139 ILEALRYCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAGGR 193
Query: 210 VGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
           VGT  F+APE        +  DV+G G  LF LL+ 
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 70/171 (40%), Gaps = 26/171 (15%)
Query: 95  EWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSL 143
           E CIN +     ++H++++K            +  E    G L DRI          +  
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPE 103
Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
            D  +    +   V YLH G    I +RD+KP N+L +E+ + K+ DF L+         
Sbjct: 104 PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 204 IELDSVVGTTGFIAPENFT--TLINEQCDVYGFGAFLFELLTAQEVSDHVS 252
             L+ + GT  ++APE         E  DV+  G  L  +L  +   D  S
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          IV E +  G+L D +     ++     L D   +A  IA 
Sbjct: 69  KLRHEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVD---MAAQIAS 125
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +AY+        V+RD++  NIL  E    K+ DF L+  I D E +           +
Sbjct: 126 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKW 181
Query: 216 IAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
            APE      FT     + DV+ FG  L EL T          + R  Y   V R     
Sbjct: 182 TAPEAALYGRFTI----KSDVWSFGILLTELTT----------KGRVPYPGMVNR----- 222
Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
               E++D +   ++        +  ++   L  QC    PE+RPT
Sbjct: 223 ----EVLDQV---ERGYRMPCPPECPESLHDLMCQCWRKDPEERPT 261

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 70/171 (40%), Gaps = 26/171 (15%)
Query: 95  EWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSL 143
           E CIN +     ++H++++K            +  E    G L DRI          +  
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPE 103
Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
            D  +    +   V YLH G    I +RD+KP N+L +E+ + K+ DF L+         
Sbjct: 104 PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 204 IELDSVVGTTGFIAPENFT--TLINEQCDVYGFGAFLFELLTAQEVSDHVS 252
             L+ + GT  ++APE         E  DV+  G  L  +L  +   D  S
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 8/98 (8%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
             +I  A+ YLH   SR +VYRD+K  N++ ++    K+ DF L    I DG T   +  
Sbjct: 111 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKX 164
Query: 209 VVGTTGFIAPENF-TTLINEQCDVYGFGAFLFELLTAQ 245
             GT  ++APE           D +G G  ++E++  +
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 70/171 (40%), Gaps = 26/171 (15%)
Query: 95  EWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSL 143
           E CIN +     ++H++++K            +  E    G L DRI          +  
Sbjct: 55  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPE 104
Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
            D  +    +   V YLH G    I +RD+KP N+L +E+ + K+ DF L+         
Sbjct: 105 PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 204 IELDSVVGTTGFIAPENFT--TLINEQCDVYGFGAFLFELLTAQEVSDHVS 252
             L+ + GT  ++APE         E  DV+  G  L  +L  +   D  S
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 70/171 (40%), Gaps = 26/171 (15%)
Query: 95  EWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSL 143
           E CIN +     ++H++++K            +  E    G L DRI          +  
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPE 103
Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
            D  +    +   V YLH G    I +RD+KP N+L +E+ + K+ DF L+         
Sbjct: 104 PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 204 IELDSVVGTTGFIAPENFT--TLINEQCDVYGFGAFLFELLTAQEVSDHVS 252
             L+ + GT  ++APE         E  DV+  G  L  +L  +   D  S
Sbjct: 161 RLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          IV E +  G+L D +     ++     L D   +A  IA 
Sbjct: 69  KLRHEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVD---MAAQIAS 125
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +AY+        V+RD++  NIL  E    K+ DF L+  I D E      +      +
Sbjct: 126 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKW 181
Query: 216 IAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
            APE      FT     + DV+ FG  L EL T          + R  Y   V R     
Sbjct: 182 TAPEAALYGRFTI----KSDVWSFGILLTELTT----------KGRVPYPGMVNR----- 222
Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
               E++D +   ++        +  ++   L  QC    PE+RPT
Sbjct: 223 ----EVLDQV---ERGYRMPCPPECPESLHDLMCQCWRKDPEERPT 261

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 71/172 (41%), Gaps = 28/172 (16%)
Query: 95  EWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSL 143
           E CIN +     ++H++++K            +  E    G L DRI          +  
Sbjct: 55  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPE 104
Query: 144 TDRLKVAMDIAHAVAYLH-VGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET 202
            D  +    +   V YLH +G    I +RD+KP N+L +E+ + K+ DF L+        
Sbjct: 105 PDAQRFFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160
Query: 203 HIELDSVVGTTGFIAPENFT--TLINEQCDVYGFGAFLFELLTAQEVSDHVS 252
              L+ + GT  ++APE         E  DV+  G  L  +L  +   D  S
Sbjct: 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/172 (25%), Positives = 71/172 (41%), Gaps = 28/172 (16%)
Query: 95  EWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSL 143
           E CIN +     ++H++++K            +  E    G L DRI          +  
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPE 103
Query: 144 TDRLKVAMDIAHAVAYLH-VGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET 202
            D  +    +   V YLH +G    I +RD+KP N+L +E+ + K+ DF L+        
Sbjct: 104 PDAQRFFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 159
Query: 203 HIELDSVVGTTGFIAPENFT--TLINEQCDVYGFGAFLFELLTAQEVSDHVS 252
              L+ + GT  ++APE         E  DV+  G  L  +L  +   D  S
Sbjct: 160 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 70/171 (40%), Gaps = 26/171 (15%)
Query: 95  EWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSL 143
           E CIN     + ++H++++K            +  E    G L DRI          +  
Sbjct: 55  EICIN-----AMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPE 104
Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
            D  +    +   V YLH G    I +RD+KP N+L +E+ + K+ DF L+         
Sbjct: 105 PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161
Query: 204 IELDSVVGTTGFIAPENFT--TLINEQCDVYGFGAFLFELLTAQEVSDHVS 252
             L+ + GT  ++APE         E  DV+  G  L  +L  +   D  S
Sbjct: 162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 212

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 70/171 (40%), Gaps = 26/171 (15%)
Query: 95  EWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSL 143
           E CIN +     ++H++++K            +  E    G L DRI          +  
Sbjct: 54  EICINKM-----LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI-----GMPE 103
Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
            D  +    +   V YLH G    I +RD+KP N+L +E+ + K+ DF L+         
Sbjct: 104 PDAQRFFHQLMAGVVYLH-GIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 160
Query: 204 IELDSVVGTTGFIAPENFT--TLINEQCDVYGFGAFLFELLTAQEVSDHVS 252
             L+ + GT  ++APE         E  DV+  G  L  +L  +   D  S
Sbjct: 161 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPS 211

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 59/142 (41%), Gaps = 10/142 (7%)
Query: 113 IKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRD 172
           I+ +  E    G L DRI          +   D  +    +   V YLH G    I +RD
Sbjct: 78  IQYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLH-GIG--ITHRD 129
Query: 173 MKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT--TLINEQCD 230
           +KP N+L +E+ + K+ DF L+           L+ + GT  ++APE         E  D
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 189
Query: 231 VYGFGAFLFELLTAQEVSDHVS 252
           V+  G  L  +L  +   D  S
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPS 211

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/241 (20%), Positives = 97/241 (40%), Gaps = 50/241 (20%)
Query: 106 RMSHKHIIKL--IVFESVQIGTLADRIHHHCEQHF-----EALSLTDRLKVAMDIAHAVA 158
           ++SH  +++L  +  E   I  + + + H C   +        +    L + +D+   +A
Sbjct: 59  KLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 118
Query: 159 YLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG---- 214
           YL       +++RD+   N L  E    K+ DF ++  + D       D    +TG    
Sbjct: 119 YLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSSTGTKFP 168
Query: 215 --FIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC 271
             + +PE F+ +  + + DV+ FG  ++E+ +          E +  YE           
Sbjct: 169 VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFS----------EGKIPYENR--------- 209
Query: 272 RFKEMVDSIIIEDKSCTCTGKEQQLQA--FKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
                 +S ++ED S      + +L +    Q+   C    PEDRP    + +QL ++  
Sbjct: 210 -----SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE 264
Query: 330 S 330
           S
Sbjct: 265 S 265

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 87/195 (44%), Gaps = 24/195 (12%)
Query: 134 CEQHFEALSLTDRLK------------VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN 181
           C +H +  SL   LK            V++ +   + YL       I++RD+KP+NIL N
Sbjct: 85  CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVN 142
Query: 182 EQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINEQCDVYGFGAFLFE 240
            + + KL DF +S  + D       +  VGT  +++PE    T  + Q D++  G  L E
Sbjct: 143 SRGEIKLCDFGVSGQLIDEMA----NEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVE 198
Query: 241 LLTAQEVSDHVSFESRFHY--EENVKRLSGQ--NCRFKEMVDSIIIEDKSCTCTGKEQQL 296
           +   +     ++      Y   E   +L     +  F++ V+  +I++ +     K+  +
Sbjct: 199 MAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAERADLKQLMV 258
Query: 297 QAF-KQLTLQCMDFS 310
            AF K+   + +DF+
Sbjct: 259 HAFIKRSDAEEVDFA 273

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 8/98 (8%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
             +I  A+ YLH   SR +VYRD+K  N++ ++    K+ DF L    I DG T   +  
Sbjct: 111 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKX 164
Query: 209 VVGTTGFIAPENF-TTLINEQCDVYGFGAFLFELLTAQ 245
             GT  ++APE           D +G G  ++E++  +
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 8/98 (8%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
             +I  A+ YLH   SR +VYRD+K  N++ ++    K+ DF L    I DG T   +  
Sbjct: 116 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKX 169
Query: 209 VVGTTGFIAPENF-TTLINEQCDVYGFGAFLFELLTAQ 245
             GT  ++APE           D +G G  ++E++  +
Sbjct: 170 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 59/142 (41%), Gaps = 10/142 (7%)
Query: 113 IKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRD 172
           I+ +  E    G L DRI          +   D  +    +   V YLH G    I +RD
Sbjct: 78  IQYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLH-GIG--ITHRD 129
Query: 173 MKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT--TLINEQCD 230
           +KP N+L +E+ + K+ DF L+           L+ + GT  ++APE         E  D
Sbjct: 130 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVD 189
Query: 231 VYGFGAFLFELLTAQEVSDHVS 252
           V+  G  L  +L  +   D  S
Sbjct: 190 VWSCGIVLTAMLAGELPWDQPS 211

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 83/195 (42%), Gaps = 26/195 (13%)
Query: 67  FRKLYKGFWQ------KRSISLMKYNGNRNQHA-LEWCINHIVYASRMSHKHIIKLI-VF 118
           F  +YKG W       K  +++   N      A +E+    ++ AS M H H+++L+ V 
Sbjct: 28  FGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMAS-MDHPHLVRLLGVC 86
Query: 119 ESVQIGTLADRIHHHC-----EQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
            S  I  +   + H C      +H + +     L   + IA  + YL     R +V+RD+
Sbjct: 87  LSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDL 143
Query: 174 KPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE-----NFTTLINEQ 228
              N+L    +  K+ DF L+  +   E     D       ++A E      FT     Q
Sbjct: 144 AARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT----HQ 199
Query: 229 CDVYGFGAFLFELLT 243
            DV+ +G  ++EL+T
Sbjct: 200 SDVWSYGVTIWELMT 214

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 8/98 (8%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
             +I  A+ YLH   SR +VYRD+K  N++ ++    K+ DF L    I DG T   +  
Sbjct: 111 GAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKX 164
Query: 209 VVGTTGFIAPENF-TTLINEQCDVYGFGAFLFELLTAQ 245
             GT  ++APE           D +G G  ++E++  +
Sbjct: 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/142 (27%), Positives = 59/142 (41%), Gaps = 10/142 (7%)
Query: 113 IKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRD 172
           I+ +  E    G L DRI          +   D  +    +   V YLH G    I +RD
Sbjct: 79  IQYLFLEYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLH-GIG--ITHRD 130
Query: 173 MKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT--TLINEQCD 230
           +KP N+L +E+ + K+ DF L+           L+ + GT  ++APE         E  D
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVD 190
Query: 231 VYGFGAFLFELLTAQEVSDHVS 252
           V+  G  L  +L  +   D  S
Sbjct: 191 VWSCGIVLTAMLAGELPWDQPS 212

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 53/110 (48%), Gaps = 12/110 (10%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE---QSDAKLFDFSLSL 195
           E +S  D +++   I   V YLH      IV+ D+KP NIL +      D K+ DF +S 
Sbjct: 126 EMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR 182
Query: 196 SIPDGETHIELDSVVGTTGFIAPE--NFTTLINEQCDVYGFGAFLFELLT 243
            I       EL  ++GT  ++APE  N+   I    D++  G   + LLT
Sbjct: 183 KIGHA---CELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLT 228

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 42/163 (25%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRI-------HHHCEQHFEALSLTDRLK 148
           +++H  IIK+          IV E ++ G L D++          C+ +F  + L     
Sbjct: 71  KLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL----- 125
Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIE 205
                  AV YLH      I++RD+KP N+L + Q +    K+ DF  S  +  GET + 
Sbjct: 126 -------AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL- 172
Query: 206 LDSVVGTTGFIAPENFTTL----INEQCDVYGFGAFLFELLTA 244
           + ++ GT  ++APE   ++     N   D +  G  LF  L+ 
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 67/159 (42%), Gaps = 27/159 (16%)
Query: 99  NHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRL 147
           N I    ++ H++I+ L           +V + V  G L DRI           +  D  
Sbjct: 55  NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG-----VYTEKDAS 109
Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHI 204
            V   +  AV YLH      IV+RD+KP N+L+    E S   + DF LS    +G    
Sbjct: 110 LVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---- 162
Query: 205 ELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELL 242
            + +  GT G++APE       ++  D +  G   + LL
Sbjct: 163 IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          IV E +  G+L D +     ++     L D   +A  IA 
Sbjct: 62  KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD---MAAQIAS 118
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +AY+        V+RD++  NIL  E    K+ DF L+  I D E +           +
Sbjct: 119 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKW 174
Query: 216 IAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
            APE      FT     + DV+ FG  L EL T          + R  Y   V R     
Sbjct: 175 TAPEAALYGRFTI----KSDVWSFGILLTELTT----------KGRVPYPGMVNR----- 215
Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
               E++D +   ++        +  ++   L  QC    PE+RPT
Sbjct: 216 ----EVLDQV---ERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 254

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 83/195 (42%), Gaps = 26/195 (13%)
Query: 67  FRKLYKGFWQ------KRSISLMKYNGNRNQHA-LEWCINHIVYASRMSHKHIIKLI-VF 118
           F  +YKG W       K  +++   N      A +E+    ++ AS M H H+++L+ V 
Sbjct: 51  FGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMAS-MDHPHLVRLLGVC 109
Query: 119 ESVQIGTLADRIHHHC-----EQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
            S  I  +   + H C      +H + +     L   + IA  + YL     R +V+RD+
Sbjct: 110 LSPTIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDL 166
Query: 174 KPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE-----NFTTLINEQ 228
              N+L    +  K+ DF L+  +   E     D       ++A E      FT     Q
Sbjct: 167 AARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT----HQ 222
Query: 229 CDVYGFGAFLFELLT 243
            DV+ +G  ++EL+T
Sbjct: 223 SDVWSYGVTIWELMT 237

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 42/163 (25%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRI-------HHHCEQHFEALSLTDRLK 148
           +++H  IIK+          IV E ++ G L D++          C+ +F  + L     
Sbjct: 71  KLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL----- 125
Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIE 205
                  AV YLH      I++RD+KP N+L + Q +    K+ DF  S  +  GET + 
Sbjct: 126 -------AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL- 172
Query: 206 LDSVVGTTGFIAPENFTTL----INEQCDVYGFGAFLFELLTA 244
           + ++ GT  ++APE   ++     N   D +  G  LF  L+ 
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 42/163 (25%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRI-------HHHCEQHFEALSLTDRLK 148
           +++H  IIK+          IV E ++ G L D++          C+ +F  + L     
Sbjct: 71  KLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL----- 125
Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIE 205
                  AV YLH      I++RD+KP N+L + Q +    K+ DF  S  +  GET + 
Sbjct: 126 -------AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL- 172
Query: 206 LDSVVGTTGFIAPENFTTL----INEQCDVYGFGAFLFELLTA 244
           + ++ GT  ++APE   ++     N   D +  G  LF  L+ 
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          IV E +  G+L D +     ++     L D   +A  IA 
Sbjct: 235 KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD---MAAQIAS 291
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +AY+        V+RD++  NIL  E    K+ DF L+  I D E +           +
Sbjct: 292 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKW 347
Query: 216 IAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
            APE      FT     + DV+ FG  L EL T          + R  Y   V R     
Sbjct: 348 TAPEAALYGRFTI----KSDVWSFGILLTELTT----------KGRVPYPGMVNR----- 388
Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
               E++D +   ++        +  ++   L  QC    PE+RPT
Sbjct: 389 ----EVLDQV---ERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 427

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 52/108 (48%), Gaps = 13/108 (12%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL-SIPDGETHIELDS 208
           A +I  A+ +LH    + I+YRD+K  N+L + +   KL DF +    I +G T     +
Sbjct: 130 AAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA---T 183
Query: 209 VVGTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFES 255
             GT  +IAPE    ++     D +  G  L+E+L       H  FE+
Sbjct: 184 FCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG-----HAPFEA 226

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 47.0 bits (110), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 42/163 (25%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRI-------HHHCEQHFEALSLTDRLK 148
           +++H  IIK+          IV E ++ G L D++          C+ +F  + L     
Sbjct: 70  KLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL----- 124
Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIE 205
                  AV YLH      I++RD+KP N+L + Q +    K+ DF  S  +  GET + 
Sbjct: 125 -------AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL- 171
Query: 206 LDSVVGTTGFIAPENFTTL----INEQCDVYGFGAFLFELLTA 244
           + ++ GT  ++APE   ++     N   D +  G  LF  L+ 
Sbjct: 172 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          IV E +  G+L D +     ++     L D   +A  IA 
Sbjct: 60  KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD---MAAQIAS 116
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +AY+        V+RD++  NIL  E    K+ DF L+  I D E +           +
Sbjct: 117 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKW 172
Query: 216 IAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
            APE      FT     + DV+ FG  L EL T          + R  Y   V R     
Sbjct: 173 TAPEAALYGRFTI----KSDVWSFGILLTELTT----------KGRVPYPGMVNR----- 213
Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
               E++D +   ++        +  ++   L  QC    PE+RPT
Sbjct: 214 ----EVLDQV---ERGYRMPCPPECPESLHDLMCQCWRKDPEERPT 252

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 62/137 (45%), Gaps = 13/137 (9%)
Query: 116 IVFESVQIGTLADRIHHHCEQ--HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
           ++ E +  G+L + +  H E+  H + L  T ++   M+      Y+H         RD+
Sbjct: 93  LIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH---------RDL 143
Query: 174 KPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFT-TLINEQCDV 231
              NIL   ++  K+ DF L+  +P D E     +       + APE+ T +  +   DV
Sbjct: 144 ATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDV 203
Query: 232 YGFGAFLFELLTAQEVS 248
           + FG  L+EL T  E S
Sbjct: 204 WSFGVVLYELFTYIEKS 220

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/106 (28%), Positives = 53/106 (50%), Gaps = 4/106 (3%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E LS  D L  +  +A  +A+L    S+  ++RD+   N+L      AK+ DF L+  I 
Sbjct: 161 EQLSSRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 217
Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
           +   +I   +      ++APE+ F  +   Q DV+ +G  L+E+ +
Sbjct: 218 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 48/103 (46%), Gaps = 16/103 (15%)
Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDS 208
           +A+D  H + Y+H         RD+KP N+L +     +L DF   L + D  T ++   
Sbjct: 202 LAIDSIHQLHYVH---------RDIKPDNVLLDVNGHIRLADFGSCLKMNDDGT-VQSSV 251
Query: 209 VVGTTGFIAPENFTTL------INEQCDVYGFGAFLFELLTAQ 245
            VGT  +I+PE    +         +CD +  G  ++E+L  +
Sbjct: 252 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 48/103 (46%), Gaps = 16/103 (15%)
Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDS 208
           +A+D  H + Y+H         RD+KP N+L +     +L DF   L + D  T ++   
Sbjct: 186 LAIDSIHQLHYVH---------RDIKPDNVLLDVNGHIRLADFGSCLKMNDDGT-VQSSV 235
Query: 209 VVGTTGFIAPENFTTL------INEQCDVYGFGAFLFELLTAQ 245
            VGT  +I+PE    +         +CD +  G  ++E+L  +
Sbjct: 236 AVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 42/163 (25%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRI-------HHHCEQHFEALSLTDRLK 148
           +++H  IIK+          IV E ++ G L D++          C+ +F  + L     
Sbjct: 77  KLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL----- 131
Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIE 205
                  AV YLH      I++RD+KP N+L + Q +    K+ DF  S  +  GET + 
Sbjct: 132 -------AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL- 178
Query: 206 LDSVVGTTGFIAPENFTTL----INEQCDVYGFGAFLFELLTA 244
           + ++ GT  ++APE   ++     N   D +  G  LF  L+ 
Sbjct: 179 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          IV E +  G+L D +     ++     L D   +A  IA 
Sbjct: 235 KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD---MAAQIAS 291
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +AY+        V+RD++  NIL  E    K+ DF L+  I D E +           +
Sbjct: 292 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKW 347
Query: 216 IAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
            APE      FT     + DV+ FG  L EL T          + R  Y   V R     
Sbjct: 348 TAPEAALYGRFTI----KSDVWSFGILLTELTT----------KGRVPYPGMVNR----- 388
Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
               E++D +   ++        +  ++   L  QC    PE+RPT
Sbjct: 389 ----EVLDQV---ERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 427

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 42/163 (25%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRI-------HHHCEQHFEALSLTDRLK 148
           +++H  IIK+          IV E ++ G L D++          C+ +F  + L     
Sbjct: 196 KLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL----- 250
Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIE 205
                  AV YLH      I++RD+KP N+L + Q +    K+ DF  S  +  GET + 
Sbjct: 251 -------AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL- 297
Query: 206 LDSVVGTTGFIAPENFTTL----INEQCDVYGFGAFLFELLTA 244
           + ++ GT  ++APE   ++     N   D +  G  LF  L+ 
Sbjct: 298 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 88/226 (38%), Gaps = 48/226 (21%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          IV E +  G L D +     ++     L D   +A  IA 
Sbjct: 69  KLRHEKLVQLYAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVD---MAAQIAS 125
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +AY+        V+RD++  NIL  E    K+ DF L+  I D E +           +
Sbjct: 126 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKW 181
Query: 216 IAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
            APE      FT     + DV+ FG  L EL T          + R  Y   V R     
Sbjct: 182 TAPEAALYGRFTI----KSDVWSFGILLTELTT----------KGRVPYPGMVNR----- 222
Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
               E++D +   ++        +  ++   L  QC    PE+RPT
Sbjct: 223 ----EVLDQV---ERGYRMPCPPECPESLHDLMCQCWRKDPEERPT 261

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          IV E +  G+L D +     ++     L D   +A  IA 
Sbjct: 235 KLRHEKLVQLYAVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVD---MAAQIAS 291
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +AY+        V+RD++  NIL  E    K+ DF L+  I D E +           +
Sbjct: 292 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKW 347
Query: 216 IAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
            APE      FT     + DV+ FG  L EL T          + R  Y   V R     
Sbjct: 348 TAPEAALYGRFTI----KSDVWSFGILLTELTT----------KGRVPYPGMVNR----- 388
Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
               E++D +   ++        +  ++   L  QC    PE+RPT
Sbjct: 389 ----EVLDQV---ERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 427

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 73/163 (44%), Gaps = 42/163 (25%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRI-------HHHCEQHFEALSLTDRLK 148
           +++H  IIK+          IV E ++ G L D++          C+ +F  + L     
Sbjct: 210 KLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL----- 264
Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIE 205
                  AV YLH      I++RD+KP N+L + Q +    K+ DF  S  +  GET + 
Sbjct: 265 -------AVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSL- 311
Query: 206 LDSVVGTTGFIAPENFTTL----INEQCDVYGFGAFLFELLTA 244
           + ++ GT  ++APE   ++     N   D +  G  LF  L+ 
Sbjct: 312 MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          IV E +  G+L D +     ++     L D   +A  IA 
Sbjct: 59  KLRHEKLVQLYAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVD---MAAQIAS 115
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +AY+        V+RD++  NIL  E    K+ DF L+  I D E      +      +
Sbjct: 116 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKF-PIKW 171
Query: 216 IAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
            APE      FT     + DV+ FG  L EL T          + R  Y   V R     
Sbjct: 172 TAPEAALYGRFTI----KSDVWSFGILLTELTT----------KGRVPYPGMVNR----- 212
Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
               E++D +   ++        +  ++   L  QC    PE+RPT
Sbjct: 213 ----EVLDQV---ERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 251

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL-SIPDGETHIELDS 208
           A +IA  + +L    S+ I+YRD+K  N++ + +   K+ DF +   +I DG T      
Sbjct: 448 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKX 501
Query: 209 VVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQ 245
             GT  +IAPE        +  D + FG  L+E+L  Q
Sbjct: 502 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          IV E +  G+L D +     ++     L D   +A  IA 
Sbjct: 69  KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD---MAAQIAS 125
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +AY+        V+RD++  NIL  E    K+ DF L+  I D E +           +
Sbjct: 126 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKW 181
Query: 216 IAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
            APE      FT     + DV+ FG  L EL T          + R  Y   V R     
Sbjct: 182 TAPEAALYGRFTI----KSDVWSFGILLTELTT----------KGRVPYPGMVNR----- 222
Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
               E++D +   ++        +  ++   L  QC    PE+RPT
Sbjct: 223 ----EVLDQV---ERGYRMPCPPECPESLHDLMCQCWRKDPEERPT 261

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 62/135 (45%), Gaps = 9/135 (6%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFE-----ALSLTDRLKVAMDIAHAVAYLHVGFSRPIV 169
           L++ E    G L + +    E   +      L L D L  +  +A  +A+L    S+  +
Sbjct: 126 LVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLA---SKNCI 182
Query: 170 YRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPEN-FTTLINEQ 228
           +RD+   N+L      AK+ DF L+  I +   +I   +      ++APE+ F  +   Q
Sbjct: 183 HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ 242
Query: 229 CDVYGFGAFLFELLT 243
            DV+ +G  L+E+ +
Sbjct: 243 SDVWSYGILLWEIFS 257

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          IV E +  G+L D +     ++     L D   +A  IA 
Sbjct: 58  KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD---MAAQIAS 114
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +AY+        V+RD++  NIL  E    K+ DF L+  I D E +           +
Sbjct: 115 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKW 170
Query: 216 IAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
            APE      FT     + DV+ FG  L EL T          + R  Y   V R     
Sbjct: 171 TAPEAALYGRFTI----KSDVWSFGILLTELTT----------KGRVPYPGMVNR----- 211
Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
               E++D +   ++        +  ++   L  QC    PE+RPT
Sbjct: 212 ----EVLDQV---ERGYRMPCPPECPESLHDLMCQCWRKDPEERPT 250

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E LS  D +  A  +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I 
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 186
Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             + + +  +      ++APE  F  +   Q DV+ FG  L+E+ T
Sbjct: 187 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 48/103 (46%), Gaps = 16/103 (15%)
Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDS 208
           +A+D  H + Y+H         RD+KP NIL +     +L DF   L + +  T ++   
Sbjct: 186 IAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSV 235
Query: 209 VVGTTGFIAPENFTTL------INEQCDVYGFGAFLFELLTAQ 245
            VGT  +I+PE    +         +CD +  G  ++E+L  +
Sbjct: 236 AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 95/213 (44%), Gaps = 34/213 (15%)
Query: 59  QNIVLEDP-----FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHI 112
           + IVL++      F ++++G W+   +++  ++    +    W     +Y + M  H++I
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENI 59
Query: 113 IKLIVFESVQIGT-----LADRIHHHCEQHFEAL-----SLTDRLKVAMDIAHAVAYLHV 162
           +  I  ++   GT     L    H H    F+ L     ++   +K+A+  A  +A+LH+
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSL-FDYLNRYTVTVEGMIKLALSTASGLAHLHM 118
Query: 163 GF----SRP-IVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL--DSVVGTTGF 215
                  +P I +RD+K  NIL  +     + D  L++        I++  +  VGT  +
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 216 IAPENFTTLIN-------EQCDVYGFGAFLFEL 241
           +APE     IN       ++ D+Y  G   +E+
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 96/213 (45%), Gaps = 34/213 (15%)
Query: 59  QNIVLEDP-----FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHI 112
           + IVL++      F ++++G W+   +++  ++    +    W     +Y + M  H++I
Sbjct: 29  RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENI 85
Query: 113 IKLIVFESVQIGT-----LADRIHHHCEQHFEAL-----SLTDRLKVAMDIAHAVAYLH- 161
           +  I  ++   GT     L    H H    F+ L     ++   +K+A+  A  +A+LH 
Sbjct: 86  LGFIAADNKDNGTWTQLWLVSDYHEHGSL-FDYLNRYTVTVEGMIKLALSTASGLAHLHM 144
Query: 162 --VGF-SRP-IVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL--DSVVGTTGF 215
             VG   +P I +RD+K  NIL  +     + D  L++        I++  +  VGT  +
Sbjct: 145 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 204
Query: 216 IAPENFTTLIN-------EQCDVYGFGAFLFEL 241
           +APE     IN       ++ D+Y  G   +E+
Sbjct: 205 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          IV E +  G+L D +     ++     L D   +A  IA 
Sbjct: 69  KLRHEKLVQLYAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVD---MAAQIAS 125
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +AY+        V+RD++  NIL  E    K+ DF L+  I D E +           +
Sbjct: 126 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKW 181
Query: 216 IAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
            APE      FT     + DV+ FG  L EL T          + R  Y   V R     
Sbjct: 182 TAPEAALYGRFTI----KSDVWSFGILLTELTT----------KGRVPYPGMVNR----- 222
Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
               E++D +   ++        +  ++   L  QC    PE+RPT
Sbjct: 223 ----EVLDQV---ERGYRMPCPPECPESLHDLMCQCWRKDPEERPT 261

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 74/174 (42%), Gaps = 31/174 (17%)
Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD 207
           K+A+ I  A+ +LH   S  +++RD+KP+N+L N     K  DF +S  + D    +  D
Sbjct: 140 KIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYLVD---DVAKD 194
Query: 208 SVVGTTGFIAPENFTTLINE-----QCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEEN 262
              G   + APE     +N+     + D++  G    EL              RF Y+  
Sbjct: 195 IDAGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAIL-----------RFPYD-- 241
Query: 263 VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
                     F+++    ++E+ S      +   + F   T QC+  + ++RPT
Sbjct: 242 -----SWGTPFQQLKQ--VVEEPSPQLPADKFSAE-FVDFTSQCLKKNSKERPT 287

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/213 (23%), Positives = 96/213 (45%), Gaps = 34/213 (15%)
Query: 59  QNIVLEDP-----FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHI 112
           + IVL++      F ++++G W+   +++  ++    +    W     +Y + M  H++I
Sbjct: 4   RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENI 60
Query: 113 IKLIVFESVQIGT-----LADRIHHHCEQHFEAL-----SLTDRLKVAMDIAHAVAYLH- 161
           +  I  ++   GT     L    H H    F+ L     ++   +K+A+  A  +A+LH 
Sbjct: 61  LGFIAADNKDNGTWTQLWLVSDYHEHGSL-FDYLNRYTVTVEGMIKLALSTASGLAHLHM 119
Query: 162 --VGF-SRP-IVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL--DSVVGTTGF 215
             VG   +P I +RD+K  NIL  +     + D  L++        I++  +  VGT  +
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 179
Query: 216 IAPENFTTLIN-------EQCDVYGFGAFLFEL 241
           +APE     IN       ++ D+Y  G   +E+
Sbjct: 180 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 59  QNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKLIV 117
           Q  + +  F ++++G W+   +++  ++    +    W     +Y + M  H++I+  I 
Sbjct: 14  QESIGKGRFGEVWRGKWRGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIA 70
Query: 118 FESVQIGT-----LADRIHHHCEQHFEAL-----SLTDRLKVAMDIAHAVAYLH---VGF 164
            ++   GT     L    H H    F+ L     ++   +K+A+  A  +A+LH   VG 
Sbjct: 71  ADNKDNGTWTQLWLVSDYHEHGSL-FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 129
Query: 165 -SRP-IVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL--DSVVGTTGFIAPEN 220
             +P I +RD+K  NIL  +     + D  L++        I++  +  VGT  ++APE 
Sbjct: 130 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 189
Query: 221 FTTLIN-------EQCDVYGFGAFLFEL 241
               IN       ++ D+Y  G   +E+
Sbjct: 190 LDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 59  QNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKLIV 117
           Q  + +  F ++++G W+   +++  ++    +    W     +Y + M  H++I+  I 
Sbjct: 11  QESIGKGRFGEVWRGKWRGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIA 67
Query: 118 FESVQIGT-----LADRIHHHCEQHFEAL-----SLTDRLKVAMDIAHAVAYLH---VGF 164
            ++   GT     L    H H    F+ L     ++   +K+A+  A  +A+LH   VG 
Sbjct: 68  ADNKDNGTWTQLWLVSDYHEHGSL-FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGT 126
Query: 165 -SRP-IVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL--DSVVGTTGFIAPEN 220
             +P I +RD+K  NIL  +     + D  L++        I++  +  VGT  ++APE 
Sbjct: 127 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 186
Query: 221 FTTLIN-------EQCDVYGFGAFLFEL 241
               IN       ++ D+Y  G   +E+
Sbjct: 187 LDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/101 (27%), Positives = 51/101 (50%), Gaps = 13/101 (12%)
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            + Y+H   S  I++RD+KP+N+  NE  + ++ DF L+    +     E+   V T  +
Sbjct: 135 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADE-----EMTGYVATRWY 186
Query: 216 IAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
            APE     +  N+  D++  G  + ELL  + +   SD++
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYI 227

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E LS  D +  A  +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I 
Sbjct: 134 EQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 190
Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             + + +  +      ++APE  F  +   Q DV+ FG  L+E+ T
Sbjct: 191 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/200 (23%), Positives = 90/200 (45%), Gaps = 29/200 (14%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKLIVFESVQIGT 125
           F ++++G W+   +++  ++    +    W     +Y + M  H++I+  I  ++   GT
Sbjct: 55  FGEVWRGKWRGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAADNKDNGT 111
Query: 126 -----LADRIHHHCEQHFEAL-----SLTDRLKVAMDIAHAVAYLH---VGF-SRP-IVY 170
                L    H H    F+ L     ++   +K+A+  A  +A+LH   VG   +P I +
Sbjct: 112 WTQLWLVSDYHEHGSL-FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH 170
Query: 171 RDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL--DSVVGTTGFIAPENFTTLIN-- 226
           RD+K  NIL  +     + D  L++        I++  +  VGT  ++APE     IN  
Sbjct: 171 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMK 230
Query: 227 -----EQCDVYGFGAFLFEL 241
                ++ D+Y  G   +E+
Sbjct: 231 HFESFKRADIYAMGLVFWEI 250

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V 
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVA 189
Query: 212 TTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQEV 247
           T  + APE    ++N +      D++  G  L E+L+ + +
Sbjct: 190 TRWYRAPE---IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 227

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTT 213
             V YLH   +  +++RD+K  N+  N+  D K+ DF L+  I  DGE   +L    GT 
Sbjct: 137 QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL---CGTP 190
Query: 214 GFIAPENFTTLINE-QCDVYGFGAFLFELLTAQ 245
            +IAPE      +  + D++  G  L+ LL  +
Sbjct: 191 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 223

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/222 (20%), Positives = 91/222 (40%), Gaps = 28/222 (12%)
Query: 89  RNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQH 137
           R Q   E   N +V      H++++++           +V E ++ G L D I  H   +
Sbjct: 110 RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMN 168
Query: 138 FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI 197
            E ++      V + +  A++ LH   ++ +++RD+K  +IL       KL DF     +
Sbjct: 169 EEQIA-----AVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 220
Query: 198 PDGETHIELDSVVGTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQ-----EVSDHV 251
              +       +VGT  ++APE  + L    + D++  G  + E++  +     E     
Sbjct: 221 --SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 278
Query: 252 SFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKE 293
               R +    +K L   +   K  +D +++ D +   T  E
Sbjct: 279 MKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAE 320

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/236 (21%), Positives = 96/236 (40%), Gaps = 36/236 (15%)
Query: 89  RNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQH 137
           R Q   E   N +V      H +++ +           +V E ++ G L D I  H   +
Sbjct: 81  RKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMN 139
Query: 138 FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS----L 193
            E ++      V + +  A++YLH   ++ +++RD+K  +IL       KL DF     +
Sbjct: 140 EEQIA-----TVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQV 191
Query: 194 SLSIPDGETHIELDSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQ-----EV 247
           S  +P  +       +VGT  ++APE  + L    + D++  G  + E++  +     E 
Sbjct: 192 SKEVPKRKX------LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 245
Query: 248 SDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLT 303
                   R      VK L   +   +  +D +++ + S   T +E     F +L 
Sbjct: 246 PLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLMLVREPSQRATAQELLGHPFLKLA 301

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E LS  D +  A  +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I 
Sbjct: 137 EQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 193
Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             + + +  +      ++APE  F  +   Q DV+ FG  L+E+ T
Sbjct: 194 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 49/201 (24%), Positives = 88/201 (43%), Gaps = 22/201 (10%)
Query: 147 LKVAMDIAHAVAYLHVGF----SRP-IVYRDMKPTNILFNEQSDAKLFDFSLSLS-IPD- 199
           LK+A      + +LH        +P I +RD+K  NIL  +     + D  L++  I D 
Sbjct: 137 LKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT 196
Query: 200 GETHIELDSVVGTTGFIAPENFTTLINEQ-------CDVYGFGAFLFELLTAQEVSDHVS 252
            E  I  ++ VGT  ++ PE     +N          D+Y FG  L+E +  + VS  + 
Sbjct: 197 NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWE-VARRCVSGGIV 255
Query: 253 FESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGK---EQQLQAFKQLTLQCMDF 309
            E +  Y +    L   +  +++M + + I+    +   +   ++ L+   +L  +C   
Sbjct: 256 EEYQLPYHD----LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAH 311
Query: 310 SPEDRPTMVDVAKQLRQMYRS 330
           +P  R T + V K L +M  S
Sbjct: 312 NPASRLTALRVKKTLAKMSES 332

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 81/206 (39%), Gaps = 38/206 (18%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           IV E +  G+L D +     ++     L D   +A  IA  +AY+        V+RD++ 
Sbjct: 89  IVTEYMSKGSLLDFLKGEMGKYLRLPQLVD---MAAQIASGMAYVE---RMNYVHRDLRA 142
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE-----NFTTLINEQCD 230
            NIL  E    K+ DF L+  I D E +           + APE      FT     + D
Sbjct: 143 ANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTI----KSD 197
Query: 231 VYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCT 290
           V+ FG  L EL T          + R  Y   V R         E++D +   ++     
Sbjct: 198 VWSFGILLTELTT----------KGRVPYPGMVNR---------EVLDQV---ERGYRMP 235
Query: 291 GKEQQLQAFKQLTLQCMDFSPEDRPT 316
              +  ++   L  QC    PE+RPT
Sbjct: 236 CPPECPESLHDLMCQCWRKDPEERPT 261

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 50/102 (49%), Gaps = 8/102 (7%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS-IPDGETHIELDS 208
           A +I+  + +LH    R I+YRD+K  N++ + +   K+ DF +    + DG T  E   
Sbjct: 126 AAEISIGLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREF-- 180
Query: 209 VVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSD 249
             GT  +IAPE        +  D + +G  L+E+L  Q   D
Sbjct: 181 -CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTT 213
             V YLH   +  +++RD+K  N+  N+  D K+ DF L+  I  DGE   +L    GT 
Sbjct: 153 QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDL---CGTP 206
Query: 214 GFIAPENFTTLINE-QCDVYGFGAFLFELLTAQ 245
            +IAPE      +  + D++  G  L+ LL  +
Sbjct: 207 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/222 (20%), Positives = 91/222 (40%), Gaps = 28/222 (12%)
Query: 89  RNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQH 137
           R Q   E   N +V      H++++++           +V E ++ G L D I  H   +
Sbjct: 187 RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMN 245
Query: 138 FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI 197
            E ++      V + +  A++ LH   ++ +++RD+K  +IL       KL DF     +
Sbjct: 246 EEQIA-----AVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 297
Query: 198 PDGETHIELDSVVGTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQ-----EVSDHV 251
              +       +VGT  ++APE  + L    + D++  G  + E++  +     E     
Sbjct: 298 --SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 355
Query: 252 SFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKE 293
               R +    +K L   +   K  +D +++ D +   T  E
Sbjct: 356 MKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAE 397

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E LS  D +  A  +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             + + +  +      ++APE  F  +   Q DV+ FG  L+E+ T
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E LS  D +  A  +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             + + +  +      ++APE  F  +   Q DV+ FG  L+E+ T
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E LS  D +  A  +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I 
Sbjct: 138 EQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 194
Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             + + +  +      ++APE  F  +   Q DV+ FG  L+E+ T
Sbjct: 195 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 62/135 (45%), Gaps = 9/135 (6%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFE-----ALSLTDRLKVAMDIAHAVAYLHVGFSRPIV 169
           L++ E    G L + +    E   +      L L D L  +  +A  +A+L    S+  +
Sbjct: 118 LVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLA---SKNCI 174
Query: 170 YRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPEN-FTTLINEQ 228
           +RD+   N+L      AK+ DF L+  I +   +I   +      ++APE+ F  +   Q
Sbjct: 175 HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ 234
Query: 229 CDVYGFGAFLFELLT 243
            DV+ +G  L+E+ +
Sbjct: 235 SDVWSYGILLWEIFS 249

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E LS  D +  A  +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 201
Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             + + +  +      ++APE  F  +   Q DV+ FG  L+E+ T
Sbjct: 202 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/98 (31%), Positives = 49/98 (50%), Gaps = 8/98 (8%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
           A +IA  + +L    S+ I+YRD+K  N++ + +   K+ DF +   +I DG T      
Sbjct: 127 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKX 180
Query: 209 VVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQ 245
             GT  +IAPE        +  D + FG  L+E+L  Q
Sbjct: 181 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/222 (20%), Positives = 91/222 (40%), Gaps = 28/222 (12%)
Query: 89  RNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQH 137
           R Q   E   N +V      H++++++           +V E ++ G L D I  H   +
Sbjct: 65  RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMN 123
Query: 138 FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI 197
            E ++      V + +  A++ LH   ++ +++RD+K  +IL       KL DF     +
Sbjct: 124 EEQIA-----AVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 175
Query: 198 PDGETHIELDSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQ-----EVSDHV 251
              +       +VGT  ++APE  + L    + D++  G  + E++  +     E     
Sbjct: 176 --SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 233
Query: 252 SFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKE 293
               R +    +K L   +   K  +D +++ D +   T  E
Sbjct: 234 MKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAE 275

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 46.2 bits (108), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/222 (20%), Positives = 91/222 (40%), Gaps = 28/222 (12%)
Query: 89  RNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQH 137
           R Q   E   N +V      H++++++           +V E ++ G L D I  H   +
Sbjct: 67  RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMN 125
Query: 138 FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI 197
            E ++      V + +  A++ LH   ++ +++RD+K  +IL       KL DF     +
Sbjct: 126 EEQIA-----AVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 177
Query: 198 PDGETHIELDSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQ-----EVSDHV 251
              +       +VGT  ++APE  + L    + D++  G  + E++  +     E     
Sbjct: 178 --SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 235
Query: 252 SFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKE 293
               R +    +K L   +   K  +D +++ D +   T  E
Sbjct: 236 MKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAE 277

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V 
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 212 TTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEV 247
           T  + APE    +    +  D++  G  L E+L+ + +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V 
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 212 TTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEV 247
           T  + APE    +    +  D++  G  L E+L+ + +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V 
Sbjct: 153 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 212 TTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEV 247
           T  + APE    +    +  D++  G  L E+L+ + +
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 247

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V 
Sbjct: 135 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 212 TTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEV 247
           T  + APE    +    +  D++  G  L E+L+ + +
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 229

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V 
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 193
Query: 212 TTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEV 247
           T  + APE    +    +  D++  G  L E+L+ + +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V 
Sbjct: 138 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVA 194
Query: 212 TTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEV 247
           T  + APE    +    +  D++  G  L E+L+ + +
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 232

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V 
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 212 TTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEV 247
           T  + APE    +    +  D++  G  L E+L+ + +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 227

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V 
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 212 TTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQEV 247
           T  + APE    ++N +      D++  G  L E+L+ + +
Sbjct: 190 TRWYRAPE---IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 227

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/265 (20%), Positives = 109/265 (41%), Gaps = 38/265 (14%)
Query: 76  QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIK-----------LIVFESVQIG 124
           +K  +++ + N  + Q +++  +  I   S+  H +I+             +V + +  G
Sbjct: 39  KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 98
Query: 125 TLADRIHHHCEQHFEALSLTDRLKVAM---DIAHAVAYLHVGFSRPIVYRDMKPTNILFN 181
           ++ D I H   +      + D   +A    ++   + YLH       ++RD+K  NIL  
Sbjct: 99  SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLG 155
Query: 182 EQSDAKLFDFSLSLSIPDGETHIELDSV----VGTTGFIAPENFTTL--INEQCDVYGFG 235
           E    ++ DF +S  +  G   I  + V    VGT  ++APE    +   + + D++ FG
Sbjct: 156 EDGSVQIADFGVSAFLATG-GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG 214
Query: 236 AFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQ 295
               EL T           + +H    +K L          +++ + + +     GK   
Sbjct: 215 ITAIELATGA---------APYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGK--- 262
Query: 296 LQAFKQLTLQCMDFSPEDRPTMVDV 320
             +F+++   C+   PE RPT  ++
Sbjct: 263 --SFRKMISLCLQKDPEKRPTAAEL 285

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V 
Sbjct: 131 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 212 TTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEV 247
           T  + APE    +    +  D++  G  L E+L+ + +
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 225

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V 
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 212 TTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQEV 247
           T  + APE    ++N +      D++  G  L E+L+ + +
Sbjct: 190 TRWYRAPE---IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 227

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V 
Sbjct: 138 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 194
Query: 212 TTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEV 247
           T  + APE    +    +  D++  G  L E+L+ + +
Sbjct: 195 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 232

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V 
Sbjct: 139 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 195
Query: 212 TTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEV 247
           T  + APE    +    +  D++  G  L E+L+ + +
Sbjct: 196 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 233

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V 
Sbjct: 130 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 186
Query: 212 TTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEV 247
           T  + APE    +    +  D++  G  L E+L+ + +
Sbjct: 187 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 224

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          IV E +  G+L D +     ++     L D   +A  IA 
Sbjct: 318 KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD---MAAQIAS 374
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +AY+        V+RD++  NIL  E    K+ DF L+  I D E +           +
Sbjct: 375 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKW 430
Query: 216 IAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
            APE      FT     + DV+ FG  L EL T          + R  Y   V R     
Sbjct: 431 TAPEAALYGRFTI----KSDVWSFGILLTELTT----------KGRVPYPGMVNR----- 471
Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
               E++D +   ++        +  ++   L  QC    PE+RPT
Sbjct: 472 ----EVLDQV---ERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 510

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V 
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 212 TTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEV 247
           T  + APE    +    +  D++  G  L E+L+ + +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V 
Sbjct: 141 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 197
Query: 212 TTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEV 247
           T  + APE    +    +  D++  G  L E+L+ + +
Sbjct: 198 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 235

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V 
Sbjct: 133 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 189
Query: 212 TTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEV 247
           T  + APE    +    +  D++  G  L E+L+ + +
Sbjct: 190 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 227

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V 
Sbjct: 153 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 209
Query: 212 TTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEV 247
           T  + APE    +    +  D++  G  L E+L+ + +
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 247

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V 
Sbjct: 131 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 187
Query: 212 TTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEV 247
           T  + APE    +    +  D++  G  L E+L+ + +
Sbjct: 188 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 225

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V 
Sbjct: 135 ILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 191
Query: 212 TTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEV 247
           T  + APE    +    +  D++  G  L E+L+ + +
Sbjct: 192 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 229

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V 
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 212 TTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEV 247
           T  + APE    +    +  D++  G  L E+L+ + +
Sbjct: 194 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          IV E +  G+L D +     ++     L D   ++  IA 
Sbjct: 66  KLRHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVD---MSAQIAS 122
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +AY+        V+RD++  NIL  E    K+ DF L+  I D E +           +
Sbjct: 123 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKW 178
Query: 216 IAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
            APE      FT     + DV+ FG  L EL T          + R  Y   V R     
Sbjct: 179 TAPEAALYGRFTI----KSDVWSFGILLTELTT----------KGRVPYPGMVNR----- 219
Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
               E++D +   ++        +  ++   L  QC    PE+RPT
Sbjct: 220 ----EVLDQV---ERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 258

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 12/101 (11%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V 
Sbjct: 137 ILRGLKYIH---SANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVA 193
Query: 212 TTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQEV 247
           T  + APE    ++N +      D++  G  L E+L+ + +
Sbjct: 194 TRWYRAPE---IMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 4/104 (3%)
Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           LS  D L  +  +A  +A+L    S+  ++RD+   N+L      AK+ DF L+  I + 
Sbjct: 161 LSTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 217
Query: 201 ETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             +I   +      ++APE+ F  +   Q DV+ +G  L+E+ +
Sbjct: 218 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 8/93 (8%)
Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTT 213
             V YLH   +  +++RD+K  N+  N+  D K+ DF L+  I  DGE      ++ GT 
Sbjct: 153 QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERK---KTLCGTP 206
Query: 214 GFIAPENFTTLINE-QCDVYGFGAFLFELLTAQ 245
            +IAPE      +  + D++  G  L+ LL  +
Sbjct: 207 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 18/165 (10%)
Query: 90  NQHALEWCINHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCE--QHFEALSLTDRL 147
           N  +L+     +     ++H +I+KL  FE ++       +  +    + F+ L    R+
Sbjct: 53  NSSSLQKLFREVRIMKVLNHPNIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGRM 110
Query: 148 KVA------MDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           K          I  AV Y H  F   IV+RD+K  N+L +   + K+ DF  S     G 
Sbjct: 111 KEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN 167
Query: 202 THIELDSVVGTTGFIAPENF--TTLINEQCDVYGFGAFLFELLTA 244
              +LD+  G+  + APE F        + DV+  G  L+ L++ 
Sbjct: 168 ---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 18/165 (10%)
Query: 90  NQHALEWCINHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCE--QHFEALSLTDRL 147
           N  +L+     +     ++H +I+KL  FE ++       +  +    + F+ L    R+
Sbjct: 53  NSSSLQKLFREVRIMKVLNHPNIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGRM 110
Query: 148 KVA------MDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           K          I  AV Y H  F   IV+RD+K  N+L +   + K+ DF  S     G 
Sbjct: 111 KEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN 167
Query: 202 THIELDSVVGTTGFIAPENF--TTLINEQCDVYGFGAFLFELLTA 244
              +LD+  G+  + APE F        + DV+  G  L+ L++ 
Sbjct: 168 ---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 71/165 (43%), Gaps = 18/165 (10%)
Query: 90  NQHALEWCINHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCE--QHFEALSLTDRL 147
           N  +L+     +     ++H +I+KL  FE ++       +  +    + F+ L    R+
Sbjct: 53  NSSSLQKLFREVRIMKVLNHPNIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGRM 110
Query: 148 KVA------MDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           K          I  AV Y H  F   IV+RD+K  N+L +   + K+ DF  S     G 
Sbjct: 111 KEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN 167
Query: 202 THIELDSVVGTTGFIAPENF--TTLINEQCDVYGFGAFLFELLTA 244
              +LD+  G+  + APE F        + DV+  G  L+ L++ 
Sbjct: 168 ---KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/92 (29%), Positives = 46/92 (50%), Gaps = 10/92 (10%)
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            + Y+H   S  +V+RD+KP N+  NE  + K+ DF L+          E+   V T  +
Sbjct: 138 GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA-----RHADAEMTGYVVTRWY 189
Query: 216 IAPENFTTLI--NEQCDVYGFGAFLFELLTAQ 245
            APE   + +  N+  D++  G  + E+LT +
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 88/226 (38%), Gaps = 48/226 (21%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          IV E +  G L D +     ++     L D   +A  IA 
Sbjct: 69  KLRHEKLVQLYAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVD---MAAQIAS 125
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +AY+        V+RD++  NIL  E    K+ DF L+  I D E +           +
Sbjct: 126 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKW 181
Query: 216 IAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
            APE      FT     + DV+ FG  L EL T          + R  Y   V R     
Sbjct: 182 TAPEAALYGRFTI----KSDVWSFGILLTELTT----------KGRVPYPGMVNR----- 222
Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
               E++D +   ++        +  ++   L  QC    PE+RPT
Sbjct: 223 ----EVLDQV---ERGYRMPCPPECPESLHDLMCQCWRKDPEERPT 261

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/222 (20%), Positives = 91/222 (40%), Gaps = 28/222 (12%)
Query: 89  RNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQH 137
           R Q   E   N +V      H++++++           +V E ++ G L D I  H   +
Sbjct: 56  RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMN 114
Query: 138 FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI 197
            E ++      V + +  A++ LH   ++ +++RD+K  +IL       KL DF     +
Sbjct: 115 EEQIA-----AVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 166
Query: 198 PDGETHIELDSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQ-----EVSDHV 251
              +       +VGT  ++APE  + L    + D++  G  + E++  +     E     
Sbjct: 167 --SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 224
Query: 252 SFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKE 293
               R +    +K L   +   K  +D +++ D +   T  E
Sbjct: 225 MKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAE 266

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 53/111 (47%), Gaps = 14/111 (12%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E LS  D +  A  +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I 
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI- 200
Query: 199 DGETHIELDSVVGTTG-----FIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
               HI+      T G     ++APE  F  +   Q DV+ FG  L+E+ T
Sbjct: 201 ---HHIDXXKKT-TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 48/98 (48%), Gaps = 7/98 (7%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
             +I  A+ YLH    + +VYRD+K  N++ ++    K+ DF L    I DG T   + +
Sbjct: 257 GAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKT 311
Query: 209 VVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQ 245
             GT  ++APE           D +G G  ++E++  +
Sbjct: 312 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 27/92 (29%), Positives = 46/92 (50%), Gaps = 10/92 (10%)
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            + Y+H   S  +V+RD+KP N+  NE  + K+ DF L+          E+   V T  +
Sbjct: 156 GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLA-----RHADAEMTGYVVTRWY 207
Query: 216 IAPENFTTLI--NEQCDVYGFGAFLFELLTAQ 245
            APE   + +  N+  D++  G  + E+LT +
Sbjct: 208 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/265 (20%), Positives = 109/265 (41%), Gaps = 38/265 (14%)
Query: 76  QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIK-----------LIVFESVQIG 124
           +K  +++ + N  + Q +++  +  I   S+  H +I+             +V + +  G
Sbjct: 34  KKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGG 93
Query: 125 TLADRIHHHCEQHFEALSLTDRLKVAM---DIAHAVAYLHVGFSRPIVYRDMKPTNILFN 181
           ++ D I H   +      + D   +A    ++   + YLH       ++RD+K  NIL  
Sbjct: 94  SVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLG 150
Query: 182 EQSDAKLFDFSLSLSIPDGETHIELDSV----VGTTGFIAPENFTTL--INEQCDVYGFG 235
           E    ++ DF +S  +  G   I  + V    VGT  ++APE    +   + + D++ FG
Sbjct: 151 EDGSVQIADFGVSAFLATG-GDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG 209
Query: 236 AFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQ 295
               EL T           + +H    +K L          +++ + + +     GK   
Sbjct: 210 ITAIELATGA---------APYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGK--- 257
Query: 296 LQAFKQLTLQCMDFSPEDRPTMVDV 320
             +F+++   C+   PE RPT  ++
Sbjct: 258 --SFRKMISLCLQKDPEKRPTAAEL 280

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 88/226 (38%), Gaps = 48/226 (21%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          IV E +  G+L D +     ++     L D   +A  IA 
Sbjct: 69  KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVD---MAAQIAS 125
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +AY+        V+RD+   NIL  E    K+ DF L+  I D E +           +
Sbjct: 126 GMAYVE---RMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKW 181
Query: 216 IAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
            APE      FT     + DV+ FG  L EL T          + R  Y   V R     
Sbjct: 182 TAPEAALYGRFTI----KSDVWSFGILLTELTT----------KGRVPYPGMVNR----- 222
Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
               E++D +   ++        +  ++   L  QC    PE+RPT
Sbjct: 223 ----EVLDQV---ERGYRMPCPPECPESLHDLMCQCWRKDPEERPT 261

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 81/192 (42%), Gaps = 25/192 (13%)
Query: 67  FRKLYKGFWQKRSI-SLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLI--------- 116
           F K+YK   ++ S+ +  K    +++  LE  +  I   +   H +I+KL+         
Sbjct: 50  FGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 109
Query: 117 -VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
            +      G   D +    E+      +    K  +D   A+ YLH      I++RD+K 
Sbjct: 110 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLD---ALNYLH---DNKIIHRDLKA 163
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINE------QC 229
            NILF    D KL DF +S    +  T    DS +GT  ++APE      ++      + 
Sbjct: 164 GNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 221
Query: 230 DVYGFGAFLFEL 241
           DV+  G  L E+
Sbjct: 222 DVWSLGITLIEM 233

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/98 (30%), Positives = 47/98 (47%), Gaps = 8/98 (8%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           +A   A  H+  +  I++RD+KP+NIL +   + KL DF +S  + D    I      G 
Sbjct: 132 LATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS---IAKTRDAGC 188
Query: 213 TGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQ 245
             ++APE      + Q      DV+  G  L+EL T +
Sbjct: 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E LS  D +  A  +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I 
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIH 242
Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             + + +  +      ++APE  F  +   Q DV+ FG  L+E+ T
Sbjct: 243 HIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 48/98 (48%), Gaps = 7/98 (7%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
             +I  A+ YLH    + +VYRD+K  N++ ++    K+ DF L    I DG T   + +
Sbjct: 254 GAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKT 308
Query: 209 VVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQ 245
             GT  ++APE           D +G G  ++E++  +
Sbjct: 309 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 45/94 (47%), Gaps = 8/94 (8%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I  AV Y H  F   IV+RD+K  N+L +   + K+ DF  S     G    +LD+  G+
Sbjct: 115 IVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN---KLDTFCGS 168
Query: 213 TGFIAPENF--TTLINEQCDVYGFGAFLFELLTA 244
             + APE F        + DV+  G  L+ L++ 
Sbjct: 169 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 202

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/102 (26%), Positives = 48/102 (47%), Gaps = 8/102 (7%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           ++A A+ Y H    R +++RD+KP N+L   + + K+ DF  S+  P     +    + G
Sbjct: 123 ELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRXMCG 175
Query: 212 TTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVS 252
           T  ++ PE       +E+ D++  G   +E L      D  S
Sbjct: 176 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 217

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/102 (26%), Positives = 48/102 (47%), Gaps = 8/102 (7%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           ++A A+ Y H    R +++RD+KP N+L   + + K+ DF  S+  P     +    + G
Sbjct: 122 ELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS----LRRRXMCG 174
Query: 212 TTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVS 252
           T  ++ PE       +E+ D++  G   +E L      D  S
Sbjct: 175 TLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS 216

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 52/104 (50%), Gaps = 4/104 (3%)
Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           L L D L  +  +A  +A+L    S+  ++RD+   N+L      AK+ DF L+  I + 
Sbjct: 155 LELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 211
Query: 201 ETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             +I   +      ++APE+ F  +   Q DV+ +G  L+E+ +
Sbjct: 212 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 62/129 (48%), Gaps = 14/129 (10%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           ++A A+ Y H    + +++RD+KP N+L   + + K+ DF  S+  P     +   ++ G
Sbjct: 131 ELADALMYCH---GKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPS----LRRKTMCG 183
Query: 212 TTGFIAPENFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
           T  ++ PE     + NE+ D++  G   +ELL          FES  H  E  +R+   +
Sbjct: 184 TLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNP-----PFESASH-NETYRRIVKVD 237
Query: 271 CRFKEMVDS 279
            +F   V +
Sbjct: 238 LKFPASVPT 246

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 89/226 (39%), Gaps = 48/226 (21%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          IV E +  G+L D +     ++     L D   ++  IA 
Sbjct: 66  KLRHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVD---MSAQIAS 122
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +AY+        V+RD++  NIL  E    K+ DF L+  I D E      +      +
Sbjct: 123 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKF-PIKW 178
Query: 216 IAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
            APE      FT     + DV+ FG  L EL T          + R  Y   V R     
Sbjct: 179 TAPEAALYGRFTI----KSDVWSFGILLTELTT----------KGRVPYPGMVNR----- 219
Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
               E++D +   ++        +  ++   L  QC    PE+RPT
Sbjct: 220 ----EVLDQV---ERGYRMPCPPECPESLHDLMCQCWRKEPEERPT 258

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 46/101 (45%), Gaps = 18/101 (17%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA---KLFDFSLSLSIPDGETHIELDS 208
           DI+ A+ YLH      I++RD+KP NI+          K+ D   +  +  GE   E   
Sbjct: 130 DISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF-- 184
Query: 209 VVGTTGFIAPE-----NFTTLINEQCDVYGFGAFLFELLTA 244
            VGT  ++APE      +T  +    D + FG   FE +T 
Sbjct: 185 -VGTLQYLAPELLEQKKYTVTV----DYWSFGTLAFECITG 220

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 46/101 (45%), Gaps = 18/101 (17%)
Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA---KLFDFSLSLSIPDGETHIELDS 208
           DI+ A+ YLH      I++RD+KP NI+          K+ D   +  +  GE   E   
Sbjct: 129 DISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF-- 183
Query: 209 VVGTTGFIAPE-----NFTTLINEQCDVYGFGAFLFELLTA 244
            VGT  ++APE      +T  +    D + FG   FE +T 
Sbjct: 184 -VGTLQYLAPELLEQKKYTVTV----DYWSFGTLAFECITG 219

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/222 (20%), Positives = 91/222 (40%), Gaps = 28/222 (12%)
Query: 89  RNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQH 137
           R Q   E   N +V      H++++++           +V E ++ G L D I  H   +
Sbjct: 60  RKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMN 118
Query: 138 FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI 197
            E ++      V + +  A++ LH   ++ +++RD+K  +IL       KL DF     +
Sbjct: 119 EEQIA-----AVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQV 170
Query: 198 PDGETHIELDSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQ-----EVSDHV 251
              +       +VGT  ++APE  + L    + D++  G  + E++  +     E     
Sbjct: 171 --SKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA 228
Query: 252 SFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKE 293
               R +    +K L   +   K  +D +++ D +   T  E
Sbjct: 229 MKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAE 270

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 46/93 (49%), Gaps = 8/93 (8%)
Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTT 213
             V YLH   +  +++RD+K  N+  N+  D K+ DF L+  I  DGE    L    GT 
Sbjct: 153 QGVQYLH---NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXL---CGTP 206
Query: 214 GFIAPENFTTLINE-QCDVYGFGAFLFELLTAQ 245
            +IAPE      +  + D++  G  L+ LL  +
Sbjct: 207 NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/134 (29%), Positives = 65/134 (48%), Gaps = 15/134 (11%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +V E ++ G L D+I     Q F   S  +   V   I   V YLH   ++ +V+RD+KP
Sbjct: 93  VVTELMKGGELLDKI---LRQKF--FSEREASAVLFTITKTVEYLH---AQGVVHRDLKP 144
Query: 176 TNILFNEQS----DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCD 230
           +NIL+ ++S      ++ DF  +  +   E  + L +   T  F+APE       +  CD
Sbjct: 145 SNILYVDESGNPESIRICDFGFAKQL-RAENGL-LMTPCYTANFVAPEVLERQGYDAACD 202
Query: 231 VYGFGAFLFELLTA 244
           ++  G  L+ +LT 
Sbjct: 203 IWSLGVLLYTMLTG 216

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 90/225 (40%), Gaps = 46/225 (20%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          I+ E ++ G+L D +          L++   L +A  IA 
Sbjct: 64  QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAE 120
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +A++     R  ++RD++  NIL ++    K+ DF L+  I D E +   +       +
Sbjct: 121 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKW 176
Query: 216 IAPE--NFTTLINEQCDVYGFGAFLFELLTAQEV--SDHVSFESRFHYEENVKRLSGQNC 271
            APE  N+ T    + DV+ FG  L E++T   +      + E   + E   + +   NC
Sbjct: 177 TAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 235
Query: 272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
                                    +   QL   C    PEDRPT
Sbjct: 236 P------------------------EELYQLMRLCWKERPEDRPT 256

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 90/225 (40%), Gaps = 46/225 (20%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          I+ E ++ G+L D +          L++   L +A  IA 
Sbjct: 70  QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAE 126
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +A++     R  ++RD++  NIL ++    K+ DF L+  I D E +   +       +
Sbjct: 127 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKW 182
Query: 216 IAPE--NFTTLINEQCDVYGFGAFLFELLTAQEV--SDHVSFESRFHYEENVKRLSGQNC 271
            APE  N+ T    + DV+ FG  L E++T   +      + E   + E   + +   NC
Sbjct: 183 TAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 241
Query: 272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
                                    +   QL   C    PEDRPT
Sbjct: 242 P------------------------EELYQLMRLCWKERPEDRPT 262

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 90/225 (40%), Gaps = 46/225 (20%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          I+ E ++ G+L D +          L++   L +A  IA 
Sbjct: 69  QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAE 125
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +A++     R  ++RD++  NIL ++    K+ DF L+  I D E +   +       +
Sbjct: 126 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKW 181
Query: 216 IAPE--NFTTLINEQCDVYGFGAFLFELLTAQEV--SDHVSFESRFHYEENVKRLSGQNC 271
            APE  N+ T    + DV+ FG  L E++T   +      + E   + E   + +   NC
Sbjct: 182 TAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 240
Query: 272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
                                    +   QL   C    PEDRPT
Sbjct: 241 P------------------------EELYQLMRLCWKERPEDRPT 261

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/94 (31%), Positives = 44/94 (46%), Gaps = 8/94 (8%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I  AV Y H  F   IV+RD+K  N+L +   + K+ DF  S     G    +LD+  G 
Sbjct: 122 IVSAVQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGN---KLDAFCGA 175
Query: 213 TGFIAPENF--TTLINEQCDVYGFGAFLFELLTA 244
             + APE F        + DV+  G  L+ L++ 
Sbjct: 176 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 70/165 (42%), Gaps = 18/165 (10%)
Query: 90  NQHALEWCINHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCE--QHFEALSLTDRL 147
           N  +L+     +     ++H +I+KL  FE ++       +  +    + F+ L    R+
Sbjct: 53  NSSSLQKLFREVRIMKVLNHPNIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGRM 110
Query: 148 KVA------MDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           K          I  AV Y H  F   IV+RD+K  N+L +   + K+ DF  S     G 
Sbjct: 111 KEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN 167
Query: 202 THIELDSVVGTTGFIAPENF--TTLINEQCDVYGFGAFLFELLTA 244
              +LD+  G   + APE F        + DV+  G  L+ L++ 
Sbjct: 168 ---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 70/165 (42%), Gaps = 18/165 (10%)
Query: 90  NQHALEWCINHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCE--QHFEALSLTDRL 147
           N  +L+     +     ++H +I+KL  FE ++       +  +    + F+ L    R+
Sbjct: 53  NSSSLQKLFREVRIMKVLNHPNIVKL--FEVIETEKTLYLVMEYASGGEVFDYLVAHGRM 110
Query: 148 KVA------MDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           K          I  AV Y H  F   IV+RD+K  N+L +   + K+ DF  S     G 
Sbjct: 111 KEKEARAKFRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN 167
Query: 202 THIELDSVVGTTGFIAPENF--TTLINEQCDVYGFGAFLFELLTA 244
              +LD   G+  + APE F        + DV+  G  L+ L++ 
Sbjct: 168 ---KLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 209

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 90/225 (40%), Gaps = 46/225 (20%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          I+ E ++ G+L D +          L++   L +A  IA 
Sbjct: 59  QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAE 115
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +A++     R  ++RD++  NIL ++    K+ DF L+  I D E +   +       +
Sbjct: 116 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKW 171
Query: 216 IAPE--NFTTLINEQCDVYGFGAFLFELLTAQEV--SDHVSFESRFHYEENVKRLSGQNC 271
            APE  N+ T    + DV+ FG  L E++T   +      + E   + E   + +   NC
Sbjct: 172 TAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 230
Query: 272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
                                    +   QL   C    PEDRPT
Sbjct: 231 P------------------------EELYQLMRLCWKERPEDRPT 251

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 15/143 (10%)
Query: 109 HKHIIKLI-------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLH 161
           H HI+KLI       V+  +++ TL + +    +    +L L   +  A  ++ A+AYL 
Sbjct: 70  HPHIVKLIGVITENPVWIIMELCTLGE-LRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 162 VGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE-- 219
              S+  V+RD+   N+L +     KL DF LS  + D  T+ +         ++APE  
Sbjct: 129 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESI 184
Query: 220 NFTTLINEQCDVYGFGAFLFELL 242
           NF    +   DV+ FG  ++E+L
Sbjct: 185 NFRRFTSAS-DVWMFGVCMWEIL 206

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 90/225 (40%), Gaps = 46/225 (20%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          I+ E ++ G+L D +          L++   L +A  IA 
Sbjct: 74  QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAE 130
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +A++     R  ++RD++  NIL ++    K+ DF L+  I D E +   +       +
Sbjct: 131 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKW 186
Query: 216 IAPE--NFTTLINEQCDVYGFGAFLFELLTAQEV--SDHVSFESRFHYEENVKRLSGQNC 271
            APE  N+ T    + DV+ FG  L E++T   +      + E   + E   + +   NC
Sbjct: 187 TAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 245
Query: 272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
                                    +   QL   C    PEDRPT
Sbjct: 246 P------------------------EELYQLMRLCWKERPEDRPT 266

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N++ ++Q   K+ DF L+  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 15/143 (10%)
Query: 109 HKHIIKLI-------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLH 161
           H HI+KLI       V+  +++ TL + +    +    +L L   +  A  ++ A+AYL 
Sbjct: 75  HPHIVKLIGVITENPVWIIMELCTLGE-LRSFLQVRKYSLDLASLILYAYQLSTALAYLE 133
Query: 162 VGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE-- 219
              S+  V+RD+   N+L +     KL DF LS  + D  T+ +         ++APE  
Sbjct: 134 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESI 189
Query: 220 NFTTLINEQCDVYGFGAFLFELL 242
           NF    +   DV+ FG  ++E+L
Sbjct: 190 NFRRFTSAS-DVWMFGVCMWEIL 211

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 15/143 (10%)
Query: 109 HKHIIKLI-------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLH 161
           H HI+KLI       V+  +++ TL + +    +    +L L   +  A  ++ A+AYL 
Sbjct: 72  HPHIVKLIGVITENPVWIIMELCTLGE-LRSFLQVRKYSLDLASLILYAYQLSTALAYLE 130
Query: 162 VGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE-- 219
              S+  V+RD+   N+L +     KL DF LS  + D  T+ +         ++APE  
Sbjct: 131 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESI 186
Query: 220 NFTTLINEQCDVYGFGAFLFELL 242
           NF    +   DV+ FG  ++E+L
Sbjct: 187 NFRRFTSAS-DVWMFGVCMWEIL 208

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 15/143 (10%)
Query: 109 HKHIIKLI-------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLH 161
           H HI+KLI       V+  +++ TL + +    +    +L L   +  A  ++ A+AYL 
Sbjct: 73  HPHIVKLIGVITENPVWIIMELCTLGE-LRSFLQVRKYSLDLASLILYAYQLSTALAYLE 131
Query: 162 VGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE-- 219
              S+  V+RD+   N+L +     KL DF LS  + D  T+ +         ++APE  
Sbjct: 132 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESI 187
Query: 220 NFTTLINEQCDVYGFGAFLFELL 242
           NF    +   DV+ FG  ++E+L
Sbjct: 188 NFRRFTSAS-DVWMFGVCMWEIL 209

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 15/143 (10%)
Query: 109 HKHIIKLI-------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLH 161
           H HI+KLI       V+  +++ TL + +    +    +L L   +  A  ++ A+AYL 
Sbjct: 67  HPHIVKLIGVITENPVWIIMELCTLGE-LRSFLQVRKYSLDLASLILYAYQLSTALAYLE 125
Query: 162 VGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE-- 219
              S+  V+RD+   N+L +     KL DF LS  + D  T+ +         ++APE  
Sbjct: 126 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESI 181
Query: 220 NFTTLINEQCDVYGFGAFLFELL 242
           NF    +   DV+ FG  ++E+L
Sbjct: 182 NFRRFTSAS-DVWMFGVCMWEIL 203

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 15/143 (10%)
Query: 109 HKHIIKLI-------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLH 161
           H HI+KLI       V+  +++ TL + +    +    +L L   +  A  ++ A+AYL 
Sbjct: 70  HPHIVKLIGVITENPVWIIMELCTLGE-LRSFLQVRKYSLDLASLILYAYQLSTALAYLE 128
Query: 162 VGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE-- 219
              S+  V+RD+   N+L +     KL DF LS  + D  T+ +         ++APE  
Sbjct: 129 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESI 184
Query: 220 NFTTLINEQCDVYGFGAFLFELL 242
           NF    +   DV+ FG  ++E+L
Sbjct: 185 NFRRFTSAS-DVWMFGVCMWEIL 206

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 46/225 (20%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          I+ E ++ G+L D +          L++   L +A  IA 
Sbjct: 64  QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAE 120
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +A++     R  ++RD++  NIL ++    K+ DF L+  I D E     +       +
Sbjct: 121 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAR-EGAKFPIKW 176
Query: 216 IAPE--NFTTLINEQCDVYGFGAFLFELLTAQEV--SDHVSFESRFHYEENVKRLSGQNC 271
            APE  N+ T    + DV+ FG  L E++T   +      + E   + E   + +   NC
Sbjct: 177 TAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 235
Query: 272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
                                    +   QL   C    PEDRPT
Sbjct: 236 P------------------------EELYQLMRLCWKERPEDRPT 256

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 46/225 (20%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          I+ E ++ G+L D +          L++   L +A  IA 
Sbjct: 64  QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAE 120
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +A++     R  ++RD++  NIL ++    K+ DF L+  I D E     +       +
Sbjct: 121 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKW 176
Query: 216 IAPE--NFTTLINEQCDVYGFGAFLFELLTAQEV--SDHVSFESRFHYEENVKRLSGQNC 271
            APE  N+ T    + DV+ FG  L E++T   +      + E   + E   + +   NC
Sbjct: 177 TAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 235
Query: 272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
                                    +   QL   C    PEDRPT
Sbjct: 236 P------------------------EELYQLMRLCWKERPEDRPT 256

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 15/143 (10%)
Query: 109 HKHIIKLI-------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLH 161
           H HI+KLI       V+  +++ TL + +    +    +L L   +  A  ++ A+AYL 
Sbjct: 98  HPHIVKLIGVITENPVWIIMELCTLGE-LRSFLQVRKYSLDLASLILYAYQLSTALAYLE 156
Query: 162 VGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE-- 219
              S+  V+RD+   N+L +     KL DF LS  + D  T+ +         ++APE  
Sbjct: 157 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWMAPESI 212
Query: 220 NFTTLINEQCDVYGFGAFLFELL 242
           NF    +   DV+ FG  ++E+L
Sbjct: 213 NFRRFTSAS-DVWMFGVCMWEIL 234

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 58/131 (44%), Gaps = 12/131 (9%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +V E +  G+L D +   C    +  +      V  +   A+ +LH   S  +++RD+K 
Sbjct: 94  VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLH---SNQVIHRDIKS 144
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            NIL       KL DF     I   ++  +  ++VGT  ++APE  T      + D++  
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 202
Query: 235 GAFLFELLTAQ 245
           G    E++  +
Sbjct: 203 GIMAIEMIEGE 213

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 44.7 bits (104), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 66/142 (46%), Gaps = 21/142 (14%)
Query: 110 KHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIV 169
           KH+   +V E ++ G L D+I     Q F   S  +   V   I   V YLH   S+ +V
Sbjct: 94  KHV--YLVTELMRGGELLDKI---LRQKF--FSEREASFVLHTIGKTVEYLH---SQGVV 143
Query: 170 YRDMKPTNILFNEQSDAKL------FDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT- 222
           +RD+KP+NIL+ ++S          F F+  L   +G     L +   T  F+APE    
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENG----LLMTPCYTANFVAPEVLKR 199
Query: 223 TLINEQCDVYGFGAFLFELLTA 244
              +E CD++  G  L+ +L  
Sbjct: 200 QGYDEGCDIWSLGILLYTMLAG 221

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/132 (25%), Positives = 57/132 (43%), Gaps = 14/132 (10%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +V E +  G+L D +   C    +  +      V  +   A+ +LH   S  +++RD+K 
Sbjct: 94  VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLH---SNQVIHRDIKS 144
Query: 176 TNILFNEQSDAKLFDFSLSLSI-PDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYG 233
            NIL       KL DF     I P+     E+   VGT  ++APE  T      + D++ 
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQSKRSEM---VGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 234 FGAFLFELLTAQ 245
            G    E++  +
Sbjct: 202 LGIMAIEMIEGE 213

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 76/179 (42%), Gaps = 31/179 (17%)
Query: 79  SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIK-----------LIVFESVQIGTLA 127
           +I  M Y+G ++    +  I  + +  ++ H + I+            +V E   +G+ +
Sbjct: 83  AIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSAS 141
Query: 128 DRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAK 187
           D +    E H + L   +   V       +AYLH   S  +++RD+K  NIL +E    K
Sbjct: 142 DLL----EVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVK 194
Query: 188 LFDF-SLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQ----CDVYGFGAFLFEL 241
           L DF S S+  P        +  VGT  ++APE    +   Q     DV+  G    EL
Sbjct: 195 LGDFGSASIMAP-------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 51/104 (49%), Gaps = 4/104 (3%)
Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           L+L   +  +  +A  + +L    SR  ++RD+   NIL +E++  K+ DF L+  I   
Sbjct: 141 LTLEHLIXYSFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKD 197
Query: 201 ETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             ++          ++APE  F  +   Q DV+ FG  L+E+ +
Sbjct: 198 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 66/142 (46%), Gaps = 21/142 (14%)
Query: 110 KHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIV 169
           KH+   +V E ++ G L D+I     Q F   S  +   V   I   V YLH   S+ +V
Sbjct: 94  KHV--YLVTELMRGGELLDKI---LRQKF--FSEREASFVLHTIGKTVEYLH---SQGVV 143
Query: 170 YRDMKPTNILFNEQSDAKL------FDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT- 222
           +RD+KP+NIL+ ++S          F F+  L   +G     L +   T  F+APE    
Sbjct: 144 HRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENG----LLMTPCYTANFVAPEVLKR 199
Query: 223 TLINEQCDVYGFGAFLFELLTA 244
              +E CD++  G  L+ +L  
Sbjct: 200 QGYDEGCDIWSLGILLYTMLAG 221

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 46/225 (20%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          I+ E ++ G+L D +          L++   L +A  IA 
Sbjct: 65  QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAE 121
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +A++     R  ++RD++  NIL ++    K+ DF L+  I D E     +       +
Sbjct: 122 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKW 177
Query: 216 IAPE--NFTTLINEQCDVYGFGAFLFELLTAQEV--SDHVSFESRFHYEENVKRLSGQNC 271
            APE  N+ T    + DV+ FG  L E++T   +      + E   + E   + +   NC
Sbjct: 178 TAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 236
Query: 272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
                                    +   QL   C    PEDRPT
Sbjct: 237 P------------------------EELYQLMRLCWKERPEDRPT 257

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 46/179 (25%), Positives = 76/179 (42%), Gaps = 31/179 (17%)
Query: 79  SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIK-----------LIVFESVQIGTLA 127
           +I  M Y+G ++    +  I  + +  ++ H + I+            +V E   +G+ +
Sbjct: 44  AIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSAS 102
Query: 128 DRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAK 187
           D +    E H + L   +   V       +AYLH   S  +++RD+K  NIL +E    K
Sbjct: 103 DLL----EVHKKPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVK 155
Query: 188 LFDF-SLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQ----CDVYGFGAFLFEL 241
           L DF S S+  P        +  VGT  ++APE    +   Q     DV+  G    EL
Sbjct: 156 LGDFGSASIMAP-------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 45/94 (47%), Gaps = 8/94 (8%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I  AV Y H    + IV+RD+K  N+L +   + K+ DF  S     G    +LD+  G+
Sbjct: 120 IVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDTFCGS 173
Query: 213 TGFIAPENF--TTLINEQCDVYGFGAFLFELLTA 244
             + APE F        + DV+  G  L+ L++ 
Sbjct: 174 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 207

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 58/269 (21%), Positives = 99/269 (36%), Gaps = 48/269 (17%)
Query: 45  SAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYN-GNRNQHALEWCINHIVY 103
           +A E  +  +N     ++    +  +YKG   +R +++  ++  NR     E    +I  
Sbjct: 4   AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINE---KNIYR 60
Query: 104 ASRMSHKHIIK----------------LIVFESVQIGTLADRIHHHCEQHFEALSLTDRL 147
              M H +I +                L+V E    G+L   +  H      +  L    
Sbjct: 61  VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL---- 116
Query: 148 KVAMDIAHAVAYLHVGFSR------PIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD-- 199
             A  +   +AYLH    R       I +RD+   N+L        + DF LS+ +    
Sbjct: 117 --AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 200 ----GETHIELDSVVGTTGFIAPENFTTLIN--------EQCDVYGFGAFLFELLTAQEV 247
               GE      S VGT  ++APE     +N        +Q D+Y  G   +E+      
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF--MRC 232
Query: 248 SDHVSFESRFHYEENVKRLSGQNCRFKEM 276
           +D    ES   Y+   +   G +  F++M
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDM 261

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 46/225 (20%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          I+ E ++ G+L D +          L++   L +A  IA 
Sbjct: 66  QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAE 122
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +A++     R  ++RD++  NIL ++    K+ DF L+  I D E     +       +
Sbjct: 123 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKW 178
Query: 216 IAPE--NFTTLINEQCDVYGFGAFLFELLTAQEV--SDHVSFESRFHYEENVKRLSGQNC 271
            APE  N+ T    + DV+ FG  L E++T   +      + E   + E   + +   NC
Sbjct: 179 TAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 237
Query: 272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
                                    +   QL   C    PEDRPT
Sbjct: 238 P------------------------EELYQLMRLCWKERPEDRPT 258

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 44.7 bits (104), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 46/225 (20%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          I+ E ++ G+L D +          L++   L +A  IA 
Sbjct: 64  QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAE 120
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +A++     R  ++RD++  NIL ++    K+ DF L+  I D E     +       +
Sbjct: 121 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKW 176
Query: 216 IAPE--NFTTLINEQCDVYGFGAFLFELLTAQEV--SDHVSFESRFHYEENVKRLSGQNC 271
            APE  N+ T    + DV+ FG  L E++T   +      + E   + E   + +   NC
Sbjct: 177 TAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 235
Query: 272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
                                    +   QL   C    PEDRPT
Sbjct: 236 P------------------------EELYQLMRLCWKERPEDRPT 256

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   K+ DF  +  +  G T      +
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-KGRTW----XL 199
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 53/120 (44%), Gaps = 24/120 (20%)
Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-------------- 194
           V   +   + YLH G    +++RDMKP+NIL N +   K+ DF LS              
Sbjct: 114 VVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
Query: 195 LSIPDGETHIE-----LDSVVGTTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEV 247
           LSI +   + +     L   V T  + APE    +T   +  D++  G  L E+L  + +
Sbjct: 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 46/225 (20%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          I+ E ++ G+L D +          L++   L +A  IA 
Sbjct: 70  QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAE 126
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +A++     R  ++RD++  NIL ++    K+ DF L+  I D E     +       +
Sbjct: 127 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKW 182
Query: 216 IAPE--NFTTLINEQCDVYGFGAFLFELLTAQEV--SDHVSFESRFHYEENVKRLSGQNC 271
            APE  N+ T    + DV+ FG  L E++T   +      + E   + E   + +   NC
Sbjct: 183 TAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 241
Query: 272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
                                    +   QL   C    PEDRPT
Sbjct: 242 P------------------------EELYQLMRLCWKERPEDRPT 262

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 45/94 (47%), Gaps = 8/94 (8%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I  AV Y H  +   IV+RD+K  N+L +   + K+ DF  S     G    +LD+  G+
Sbjct: 123 IVSAVQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGN---KLDTFCGS 176
Query: 213 TGFIAPENF--TTLINEQCDVYGFGAFLFELLTA 244
             + APE F        + DV+  G  L+ L++ 
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 46/225 (20%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          I+ E ++ G+L D +          L++   L +A  IA 
Sbjct: 73  QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAE 129
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +A++     R  ++RD++  NIL ++    K+ DF L+  I D E     +       +
Sbjct: 130 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKW 185
Query: 216 IAPE--NFTTLINEQCDVYGFGAFLFELLTAQEV--SDHVSFESRFHYEENVKRLSGQNC 271
            APE  N+ T    + DV+ FG  L E++T   +      + E   + E   + +   NC
Sbjct: 186 TAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 244
Query: 272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
                                    +   QL   C    PEDRPT
Sbjct: 245 P------------------------EELYQLMRLCWKERPEDRPT 265

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   K+ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   K+ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 61/136 (44%), Gaps = 19/136 (13%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +V E  + G L D+I     Q F   S  +   V   I   V YLH   ++ +V+RD+KP
Sbjct: 93  VVTELXKGGELLDKI---LRQKF--FSEREASAVLFTITKTVEYLH---AQGVVHRDLKP 144
Query: 176 TNILFNEQSDAKL------FDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQ 228
           +NIL+ ++S          F F+  L   +G     L +   T  F+APE       +  
Sbjct: 145 SNILYVDESGNPESIRICDFGFAKQLRAENG----LLXTPCYTANFVAPEVLERQGYDAA 200
Query: 229 CDVYGFGAFLFELLTA 244
           CD++  G  L+  LT 
Sbjct: 201 CDIWSLGVLLYTXLTG 216

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 44.3 bits (103), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   K+ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 89/225 (39%), Gaps = 46/225 (20%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          I+ E ++ G+L D +          L++   L +A  IA 
Sbjct: 72  QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAE 128
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +A++     R  ++RD++  NIL ++    K+ DF L+  I D E     +       +
Sbjct: 129 GMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAR-EGAKFPIKW 184
Query: 216 IAPE--NFTTLINEQCDVYGFGAFLFELLTAQEV--SDHVSFESRFHYEENVKRLSGQNC 271
            APE  N+ T    + DV+ FG  L E++T   +      + E   + E   + +   NC
Sbjct: 185 TAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 243
Query: 272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
                                    +   QL   C    PEDRPT
Sbjct: 244 P------------------------EELYQLMRLCWKERPEDRPT 264

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 16/139 (11%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           ++ D +   + +A  + +L    S+  V+RD+   N + +E+   K+ DF L+  + D  
Sbjct: 129 TVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK- 184
Query: 202 THIELDSVVGTTGFIAPENFTTL-------INEQCDVYGFGAFLFELLT--AQEVSDHVS 252
              E DSV   TG   P  +  L          + DV+ FG  L+EL+T  A    D  +
Sbjct: 185 ---EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 241
Query: 253 FESRFHYEENVKRLSGQNC 271
           F+   +  +  + L  + C
Sbjct: 242 FDITVYLLQGRRLLQPEYC 260

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 16/139 (11%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           ++ D +   + +A  + +L    S+  V+RD+   N + +E+   K+ DF L+  + D  
Sbjct: 132 TVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK- 187
Query: 202 THIELDSVVGTTGFIAPENFTTL-------INEQCDVYGFGAFLFELLT--AQEVSDHVS 252
              E DSV   TG   P  +  L          + DV+ FG  L+EL+T  A    D  +
Sbjct: 188 ---EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 244
Query: 253 FESRFHYEENVKRLSGQNC 271
           F+   +  +  + L  + C
Sbjct: 245 FDITVYLLQGRRLLQPEYC 263

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 51/104 (49%), Gaps = 4/104 (3%)
Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           L+L   +  +  +A  + +L    SR  ++RD+   NIL +E++  K+ DF L+  I   
Sbjct: 136 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 192
Query: 201 ETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             ++          ++APE  F  +   Q DV+ FG  L+E+ +
Sbjct: 193 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 16/139 (11%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           ++ D +   + +A  + +L    S+  V+RD+   N + +E+   K+ DF L+  + D  
Sbjct: 132 TVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDK- 187
Query: 202 THIELDSVVGTTGFIAPENFTTL-------INEQCDVYGFGAFLFELLT--AQEVSDHVS 252
              E DSV   TG   P  +  L          + DV+ FG  L+EL+T  A    D  +
Sbjct: 188 ---EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 244
Query: 253 FESRFHYEENVKRLSGQNC 271
           F+   +  +  + L  + C
Sbjct: 245 FDITVYLLQGRRLLQPEYC 263

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/94 (30%), Positives = 44/94 (46%), Gaps = 8/94 (8%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I  AV Y H    + IV+RD+K  N+L +   + K+ DF  S     G    +LD+  G 
Sbjct: 123 IVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG---KLDAFCGA 176
Query: 213 TGFIAPENF--TTLINEQCDVYGFGAFLFELLTA 244
             + APE F        + DV+  G  L+ L++ 
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 16/139 (11%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           ++ D +   + +A  + +L    S+  V+RD+   N + +E+   K+ DF L+  + D  
Sbjct: 131 TVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK- 186
Query: 202 THIELDSVVGTTGFIAPENFTTL-------INEQCDVYGFGAFLFELLT--AQEVSDHVS 252
              E DSV   TG   P  +  L          + DV+ FG  L+EL+T  A    D  +
Sbjct: 187 ---EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 243
Query: 253 FESRFHYEENVKRLSGQNC 271
           F+   +  +  + L  + C
Sbjct: 244 FDITVYLLQGRRLLQPEYC 262

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 16/139 (11%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           ++ D +   + +A  + +L    S+  V+RD+   N + +E+   K+ DF L+  + D  
Sbjct: 131 TVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK- 186
Query: 202 THIELDSVVGTTGFIAPENFTTL-------INEQCDVYGFGAFLFELLT--AQEVSDHVS 252
              E DSV   TG   P  +  L          + DV+ FG  L+EL+T  A    D  +
Sbjct: 187 ---EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 243
Query: 253 FESRFHYEENVKRLSGQNC 271
           F+   +  +  + L  + C
Sbjct: 244 FDITVYLLQGRRLLQPEYC 262

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 16/139 (11%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           ++ D +   + +A  + +L    S+  V+RD+   N + +E+   K+ DF L+  + D  
Sbjct: 136 TVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK- 191
Query: 202 THIELDSVVGTTGFIAPENFTTL-------INEQCDVYGFGAFLFELLT--AQEVSDHVS 252
              E DSV   TG   P  +  L          + DV+ FG  L+EL+T  A    D  +
Sbjct: 192 ---EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 248
Query: 253 FESRFHYEENVKRLSGQNC 271
           F+   +  +  + L  + C
Sbjct: 249 FDITVYLLQGRRLLQPEYC 267

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 51/104 (49%), Gaps = 4/104 (3%)
Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           L+L   +  +  +A  + +L    SR  ++RD+   NIL +E++  K+ DF L+  I   
Sbjct: 136 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 192
Query: 201 ETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             ++          ++APE  F  +   Q DV+ FG  L+E+ +
Sbjct: 193 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 51/104 (49%), Gaps = 4/104 (3%)
Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           L+L   +  +  +A  + +L    SR  ++RD+   NIL +E++  K+ DF L+  I   
Sbjct: 190 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 201 ETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             ++          ++APE  F  +   Q DV+ FG  L+E+ +
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 15/143 (10%)
Query: 109 HKHIIKLI-------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLH 161
           H HI+KLI       V+  +++ TL + +    +    +L L   +  A  ++ A+AYL 
Sbjct: 70  HPHIVKLIGVITENPVWIIMELCTLGE-LRSFLQVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 162 VGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE-- 219
              S+  V+RD+   N+L +     KL DF LS  + D  T+ +         ++APE  
Sbjct: 129 ---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESI 184
Query: 220 NFTTLINEQCDVYGFGAFLFELL 242
           NF    +   DV+ FG  ++E+L
Sbjct: 185 NFRRFTSAS-DVWMFGVCMWEIL 206

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L +EQ   ++ DF  +  +  G T      +
Sbjct: 134 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRV-KGRTW----XL 185
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 186 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/103 (27%), Positives = 51/103 (49%), Gaps = 4/103 (3%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           S  D L  +  +A  +A+L    S+  ++RD+   N+L      AK+ DF L+  I +  
Sbjct: 162 STRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 218
Query: 202 THIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
            +I   +      ++APE+ F  +   Q DV+ +G  L+E+ +
Sbjct: 219 NYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 51/104 (49%), Gaps = 4/104 (3%)
Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           L+L   +  +  +A  + +L    SR  ++RD+   NIL +E++  K+ DF L+  I   
Sbjct: 188 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 201 ETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             ++          ++APE  F  +   Q DV+ FG  L+E+ +
Sbjct: 245 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 50/104 (48%), Gaps = 4/104 (3%)
Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           L+L   +  +  +A  + +L    SR  ++RD+   NIL +E++  K+ DF L+  I   
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201
Query: 201 ETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
              +          ++APE  F  +   Q DV+ FG  L+E+ +
Sbjct: 202 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 47/98 (47%), Gaps = 7/98 (7%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
             +I  A+ YLH    + +VYRD+K  N++ ++    K+ DF L    I DG T   +  
Sbjct: 114 GAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKX 168
Query: 209 VVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQ 245
             GT  ++APE           D +G G  ++E++  +
Sbjct: 169 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + Y+H   S  +++RD+KP+N+L N   D K+ DF L+ ++ P+ +    L   V 
Sbjct: 153 ILRGLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVA 209
Query: 212 TTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEV 247
           T  + APE    +    +  D++  G  L E+L+ + +
Sbjct: 210 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 247

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 47/98 (47%), Gaps = 7/98 (7%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
             +I  A+ YLH    + +VYRD+K  N++ ++    K+ DF L    I DG T   +  
Sbjct: 115 GAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKX 169
Query: 209 VVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQ 245
             GT  ++APE           D +G G  ++E++  +
Sbjct: 170 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 57/131 (43%), Gaps = 12/131 (9%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +V E +  G+L D +   C    +  +      V  +   A+ +LH   S  +++RD+K 
Sbjct: 94  VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLH---SNQVIHRDIKS 144
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            NIL       KL DF     I   ++  +   +VGT  ++APE  T      + D++  
Sbjct: 145 DNILLGMDGSVKLTDFGFCAQITPEQS--KRSXMVGTPYWMAPEVVTRKAYGPKVDIWSL 202
Query: 235 GAFLFELLTAQ 245
           G    E++  +
Sbjct: 203 GIMAIEMIEGE 213

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 57/131 (43%), Gaps = 12/131 (9%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +V E +  G+L D +   C    +  +      V  +   A+ +LH   S  +++RD+K 
Sbjct: 95  VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLH---SNQVIHRDIKS 145
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            NIL       KL DF     I   ++  +   +VGT  ++APE  T      + D++  
Sbjct: 146 DNILLGMDGSVKLTDFGFCAQITPEQS--KRSXMVGTPYWMAPEVVTRKAYGPKVDIWSL 203
Query: 235 GAFLFELLTAQ 245
           G    E++  +
Sbjct: 204 GIMAIEMIEGE 214

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/98 (28%), Positives = 47/98 (47%), Gaps = 7/98 (7%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
             +I  A+ YLH    + +VYRD+K  N++ ++    K+ DF L    I DG T   +  
Sbjct: 116 GAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKX 170
Query: 209 VVGTTGFIAPENF-TTLINEQCDVYGFGAFLFELLTAQ 245
             GT  ++APE           D +G G  ++E++  +
Sbjct: 171 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 51/104 (49%), Gaps = 4/104 (3%)
Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           L+L   +  +  +A  + +L    SR  ++RD+   NIL +E++  K+ DF L+  I   
Sbjct: 145 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 201
Query: 201 ETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             ++          ++APE  F  +   Q DV+ FG  L+E+ +
Sbjct: 202 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 51/104 (49%), Gaps = 4/104 (3%)
Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           L+L   +  +  +A  + +L    SR  ++RD+   NIL +E++  K+ DF L+  I   
Sbjct: 195 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 201 ETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             ++          ++APE  F  +   Q DV+ FG  L+E+ +
Sbjct: 252 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 51/104 (49%), Gaps = 4/104 (3%)
Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           L+L   +  +  +A  + +L    SR  ++RD+   NIL +E++  K+ DF L+  I   
Sbjct: 197 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 201 ETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             ++          ++APE  F  +   Q DV+ FG  L+E+ +
Sbjct: 254 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 51/104 (49%), Gaps = 4/104 (3%)
Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           L+L   +  +  +A  + +L    SR  ++RD+   NIL +E++  K+ DF L+  I   
Sbjct: 147 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 203
Query: 201 ETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             ++          ++APE  F  +   Q DV+ FG  L+E+ +
Sbjct: 204 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 52/108 (48%), Gaps = 14/108 (12%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
           + +I+ A+ YLH    R I+YRD+K  N+L + +   KL D+ +    +  G+T     +
Sbjct: 159 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TST 212
Query: 209 VVGTTGFIAPENFTTLINE----QCDVYGFGAFLFELLTAQEVSDHVS 252
             GT  +IAPE    L  E      D +  G  +FE++  +   D V 
Sbjct: 213 FCGTPNYIAPE---ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 257

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 16/139 (11%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           ++ D +   + +A  + YL    S+  V+RD+   N + +E+   K+ DF L+  + D E
Sbjct: 128 TVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184
Query: 202 THIELDSVVGTTGFIAPENFTTL-------INEQCDVYGFGAFLFELLT--AQEVSDHVS 252
            +    SV   TG   P  +  L          + DV+ FG  L+EL+T  A    D  +
Sbjct: 185 YY----SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 240
Query: 253 FESRFHYEENVKRLSGQNC 271
           F+   +  +  + L  + C
Sbjct: 241 FDITVYLLQGRRLLQPEYC 259

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 16/139 (11%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           ++ D +   + +A  + +L    S+  V+RD+   N + +E+   K+ DF L+  + D  
Sbjct: 190 TVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK- 245
Query: 202 THIELDSVVGTTGFIAPENFTTL-------INEQCDVYGFGAFLFELLT--AQEVSDHVS 252
              E DSV   TG   P  +  L          + DV+ FG  L+EL+T  A    D  +
Sbjct: 246 ---EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 302
Query: 253 FESRFHYEENVKRLSGQNC 271
           F+   +  +  + L  + C
Sbjct: 303 FDITVYLLQGRRLLQPEYC 321

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 16/139 (11%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           ++ D +   + +A  + YL    S+  V+RD+   N + +E+   K+ DF L+  + D E
Sbjct: 126 TVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182
Query: 202 THIELDSVVGTTGFIAPENFTTL-------INEQCDVYGFGAFLFELLT--AQEVSDHVS 252
            +    SV   TG   P  +  L          + DV+ FG  L+EL+T  A    D  +
Sbjct: 183 YY----SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238
Query: 253 FESRFHYEENVKRLSGQNC 271
           F+   +  +  + L  + C
Sbjct: 239 FDITVYLLQGRRLLQPEYC 257

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 51/104 (49%), Gaps = 4/104 (3%)
Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           L+L   +  +  +A  + +L    SR  ++RD+   NIL +E++  K+ DF L+  I   
Sbjct: 182 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 238
Query: 201 ETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             ++          ++APE  F  +   Q DV+ FG  L+E+ +
Sbjct: 239 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 50/104 (48%), Gaps = 4/104 (3%)
Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           L+L   +  +  +A  + +L    SR  ++RD+   NIL +E++  K+ DF L+  I   
Sbjct: 136 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 192
Query: 201 ETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
              +          ++APE  F  +   Q DV+ FG  L+E+ +
Sbjct: 193 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 50/104 (48%), Gaps = 4/104 (3%)
Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           L+L   +  +  +A  + +L    SR  ++RD+   NIL +E++  K+ DF L+  I   
Sbjct: 136 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 192
Query: 201 ETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
              +          ++APE  F  +   Q DV+ FG  L+E+ +
Sbjct: 193 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 16/139 (11%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           ++ D +   + +A  + YL    S+  V+RD+   N + +E+   K+ DF L+  + D E
Sbjct: 131 TVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 187
Query: 202 THIELDSVVGTTGFIAPENFTTL-------INEQCDVYGFGAFLFELLT--AQEVSDHVS 252
            +    SV   TG   P  +  L          + DV+ FG  L+EL+T  A    D  +
Sbjct: 188 YY----SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 243
Query: 253 FESRFHYEENVKRLSGQNC 271
           F+   +  +  + L  + C
Sbjct: 244 FDITVYLLQGRRLLQPEYC 262

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 16/139 (11%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           ++ D +   + +A  + YL    S+  V+RD+   N + +E+   K+ DF L+  + D E
Sbjct: 130 TVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 186
Query: 202 THIELDSVVGTTGFIAPENFTTL-------INEQCDVYGFGAFLFELLT--AQEVSDHVS 252
            +    SV   TG   P  +  L          + DV+ FG  L+EL+T  A    D  +
Sbjct: 187 YY----SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 242
Query: 253 FESRFHYEENVKRLSGQNC 271
           F+   +  +  + L  + C
Sbjct: 243 FDITVYLLQGRRLLQPEYC 261

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/137 (22%), Positives = 59/137 (43%), Gaps = 8/137 (5%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAY-------LHVGFSRP 167
           +++ E  + G L+  +     +     +  D  K  + + H + Y       +    SR 
Sbjct: 109 MVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 168
Query: 168 IVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPEN-FTTLIN 226
            ++RD+   NIL +E++  K+ DF L+  I      +          ++APE  F  +  
Sbjct: 169 CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYT 228
Query: 227 EQCDVYGFGAFLFELLT 243
            Q DV+ FG  L+E+ +
Sbjct: 229 IQSDVWSFGVLLWEIFS 245

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 16/139 (11%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           ++ D +   + +A  + YL    S+  V+RD+   N + +E+   K+ DF L+  + D E
Sbjct: 123 TVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 179
Query: 202 THIELDSVVGTTGFIAPENFTTL-------INEQCDVYGFGAFLFELLT--AQEVSDHVS 252
            +    SV   TG   P  +  L          + DV+ FG  L+EL+T  A    D  +
Sbjct: 180 YY----SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 235
Query: 253 FESRFHYEENVKRLSGQNC 271
           F+   +  +  + L  + C
Sbjct: 236 FDITVYLLQGRRLLQPEYC 254

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 51/104 (49%), Gaps = 4/104 (3%)
Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           L+L   +  +  +A  + +L    SR  ++RD+   NIL +E++  K+ DF L+  I   
Sbjct: 141 LTLEHLICYSFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKD 197
Query: 201 ETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             ++          ++APE  F  +   Q DV+ FG  L+E+ +
Sbjct: 198 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 16/139 (11%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           ++ D +   + +A  + YL    S+  V+RD+   N + +E+   K+ DF L+  + D E
Sbjct: 131 TVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 187
Query: 202 THIELDSVVGTTGFIAPENFTTL-------INEQCDVYGFGAFLFELLT--AQEVSDHVS 252
            +    SV   TG   P  +  L          + DV+ FG  L+EL+T  A    D  +
Sbjct: 188 YY----SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 243
Query: 253 FESRFHYEENVKRLSGQNC 271
           F+   +  +  + L  + C
Sbjct: 244 FDITVYLLQGRRLLQPEYC 262

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 69/143 (48%), Gaps = 15/143 (10%)
Query: 109 HKHIIKLI-------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLH 161
           H HI+KLI       V+  +++ TL +       + F +L L   +  A  ++ A+AYL 
Sbjct: 450 HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLE 508
Query: 162 VGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE-- 219
              S+  V+RD+   N+L +     KL DF LS  + D  T+ +         ++APE  
Sbjct: 509 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESI 564
Query: 220 NFTTLINEQCDVYGFGAFLFELL 242
           NF    +   DV+ FG  ++E+L
Sbjct: 565 NFRRFTSAS-DVWMFGVCMWEIL 586

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 47/96 (48%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T     ++
Sbjct: 133 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----TL 184
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 185 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 16/139 (11%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           ++ D +   + +A  + YL    S+  V+RD+   N + +E+   K+ DF L+  + D E
Sbjct: 129 TVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 185
Query: 202 THIELDSVVGTTGFIAPENFTTL-------INEQCDVYGFGAFLFELLT--AQEVSDHVS 252
            +    SV   TG   P  +  L          + DV+ FG  L+EL+T  A    D  +
Sbjct: 186 YY----SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 241
Query: 253 FESRFHYEENVKRLSGQNC 271
           F+   +  +  + L  + C
Sbjct: 242 FDITVYLLQGRRLLQPEYC 260

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N++ ++Q   K+ DF  +  +  G T      +
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGRTW----XL 199
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 47/96 (48%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T     ++
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----TL 199
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 15/143 (10%)
Query: 109 HKHIIKLI-------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLH 161
           H HI+KLI       V+  +++ TL + +    +    +L L   +  A  ++ A+AYL 
Sbjct: 70  HPHIVKLIGVITENPVWIIMELCTLGE-LRSFLQVRKFSLDLASLILYAYQLSTALAYLE 128
Query: 162 VGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE-- 219
              S+  V+RD+   N+L +     KL DF LS  + D  T  +         ++APE  
Sbjct: 129 ---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS-TXXKASKGKLPIKWMAPESI 184
Query: 220 NFTTLINEQCDVYGFGAFLFELL 242
           NF    +   DV+ FG  ++E+L
Sbjct: 185 NFRRFTSAS-DVWMFGVCMWEIL 206

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 47/96 (48%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N++ ++Q   ++ DF L+  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/192 (25%), Positives = 80/192 (41%), Gaps = 25/192 (13%)
Query: 67  FRKLYKGFWQKRSI-SLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLI--------- 116
           F K+YK   ++ S+ +  K    +++  LE  +  I   +   H +I+KL+         
Sbjct: 50  FGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 109
Query: 117 -VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
            +      G   D +    E+      +    K  +D   A+ YLH      I++RD+K 
Sbjct: 110 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLD---ALNYLH---DNKIIHRDLKA 163
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINE------QC 229
            NILF    D KL DF +S    +       DS +GT  ++APE      ++      + 
Sbjct: 164 GNILFTLDGDIKLADFGVSAK--NTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 221
Query: 230 DVYGFGAFLFEL 241
           DV+  G  L E+
Sbjct: 222 DVWSLGITLIEM 233

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 64/136 (47%), Gaps = 18/136 (13%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
           +++ E V  G L D +        E+L+  +  +    I   V YLH   S+ I + D+K
Sbjct: 105 VLILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLK 156
Query: 175 PTNILFNEQS----DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE--NFTTLINEQ 228
           P NI+  +++      KL DF ++  I  G    E  ++ GT  F+APE  N+  L   +
Sbjct: 157 PENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPL-GLE 212
Query: 229 CDVYGFGAFLFELLTA 244
            D++  G   + LL+ 
Sbjct: 213 ADMWSIGVITYILLSG 228

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 16/139 (11%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           ++ D +   + +A  + YL    S+  V+RD+   N + +E+   K+ DF L+  + D E
Sbjct: 150 TVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 206
Query: 202 THIELDSVVGTTGFIAPENFTTL-------INEQCDVYGFGAFLFELLT--AQEVSDHVS 252
            +    SV   TG   P  +  L          + DV+ FG  L+EL+T  A    D  +
Sbjct: 207 YY----SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 262
Query: 253 FESRFHYEENVKRLSGQNC 271
           F+   +  +  + L  + C
Sbjct: 263 FDITVYLLQGRRLLQPEYC 281

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 AGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/139 (25%), Positives = 62/139 (44%), Gaps = 16/139 (11%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           ++ D +   + +A  + YL    S+  V+RD+   N + +E+   K+ DF L+  + D E
Sbjct: 149 TVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 205
Query: 202 THIELDSVVGTTGFIAPENFTTL-------INEQCDVYGFGAFLFELLT--AQEVSDHVS 252
            +    SV   TG   P  +  L          + DV+ FG  L+EL+T  A    D  +
Sbjct: 206 YY----SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 261
Query: 253 FESRFHYEENVKRLSGQNC 271
           F+   +  +  + L  + C
Sbjct: 262 FDITVYLLQGRRLLQPEYC 280

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N++ ++Q   K+ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N++ ++Q   K+ DF  +  +  G T      +
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGRTW----XL 199
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N++ ++Q   K+ DF  +  +  G T      +
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGRTW----XL 199
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 64/136 (47%), Gaps = 18/136 (13%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
           +++ E V  G L D +        E+L+  +  +    I   V YLH   S+ I + D+K
Sbjct: 91  VLILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLK 142
Query: 175 PTNILFNEQS----DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE--NFTTLINEQ 228
           P NI+  +++      KL DF ++  I  G    E  ++ GT  F+APE  N+  L   +
Sbjct: 143 PENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPL-GLE 198
Query: 229 CDVYGFGAFLFELLTA 244
            D++  G   + LL+ 
Sbjct: 199 ADMWSIGVITYILLSG 214

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N++ ++Q   K+ DF  +  +  G T      +
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGRTW----XL 199
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N++ ++Q   K+ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/136 (27%), Positives = 64/136 (47%), Gaps = 18/136 (13%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
           +++ E V  G L D +        E+L+  +  +    I   V YLH   S+ I + D+K
Sbjct: 84  VLILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLK 135
Query: 175 PTNILFNEQS----DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE--NFTTLINEQ 228
           P NI+  +++      KL DF ++  I  G    E  ++ GT  F+APE  N+  L   +
Sbjct: 136 PENIMLLDKNVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPL-GLE 191
Query: 229 CDVYGFGAFLFELLTA 244
            D++  G   + LL+ 
Sbjct: 192 ADMWSIGVITYILLSG 207

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 47/96 (48%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T     ++
Sbjct: 168 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGATW----TL 219
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 51/108 (47%), Gaps = 14/108 (12%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
           + +I+ A+ YLH    R I+YRD+K  N+L + +   KL D+ +    +  G+T      
Sbjct: 127 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSX 180
Query: 209 VVGTTGFIAPENFTTLINE----QCDVYGFGAFLFELLTAQEVSDHVS 252
             GT  +IAPE    L  E      D +  G  +FE++  +   D V 
Sbjct: 181 FCGTPNYIAPE---ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 225

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/98 (27%), Positives = 48/98 (48%), Gaps = 13/98 (13%)
Query: 159 YLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAP 218
           Y+H      I++RD+KP N+  NE  + K+ DF L+      +   E+   V T  + AP
Sbjct: 143 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRWYRAP 194
Query: 219 ENFTTLI--NEQCDVYGFGAFLFELLTAQEV---SDHV 251
           E     +   +  D++  G  + E++T + +   SDH+
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL 232

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 50/104 (48%), Gaps = 4/104 (3%)
Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           L+L   +  +  +A  + +L    SR  ++RD+   NIL +E++  K+ DF L+  I   
Sbjct: 145 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKD 201
Query: 201 ETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
              +          ++APE  F  +   Q DV+ FG  L+E+ +
Sbjct: 202 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 50/225 (22%), Positives = 90/225 (40%), Gaps = 46/225 (20%)
Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          I+ E ++ G+L D +          L++   L +A  IA 
Sbjct: 60  QLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAE 116
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +A++     R  ++R+++  NIL ++    K+ DF L+  I D E +   +       +
Sbjct: 117 GMAFIE---ERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKW 172
Query: 216 IAPE--NFTTLINEQCDVYGFGAFLFELLTAQEV--SDHVSFESRFHYEENVKRLSGQNC 271
            APE  N+ T    + DV+ FG  L E++T   +      + E   + E   + +   NC
Sbjct: 173 TAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 231
Query: 272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
                                    +   QL   C    PEDRPT
Sbjct: 232 P------------------------EELYQLMRLCWKERPEDRPT 252

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 63/133 (47%), Gaps = 10/133 (7%)
Query: 113 IKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRD 172
           IKLI+ E +  G+L +    +  ++   ++L  +LK A+ I   + YL    SR  V+RD
Sbjct: 88  IKLIM-EFLPSGSLKE----YLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRD 139
Query: 173 MKPTNILFNEQSDAKLFDFSLSLSI-PDGETHIELDSVVGTTGFIAPENFT-TLINEQCD 230
           +   N+L   +   K+ DF L+ +I  D E     D       + APE    +      D
Sbjct: 140 LAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASD 199
Query: 231 VYGFGAFLFELLT 243
           V+ FG  L ELLT
Sbjct: 200 VWSFGVTLHELLT 212

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/143 (29%), Positives = 69/143 (48%), Gaps = 15/143 (10%)
Query: 109 HKHIIKLI-------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLH 161
           H HI+KLI       V+  +++ TL +       + F +L L   +  A  ++ A+AYL 
Sbjct: 450 HPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKF-SLDLASLILYAYQLSTALAYLE 508
Query: 162 VGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE-- 219
              S+  V+RD+   N+L +     KL DF LS  + D  T+ +         ++APE  
Sbjct: 509 ---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDS-TYYKASKGKLPIKWMAPESI 564
Query: 220 NFTTLINEQCDVYGFGAFLFELL 242
           NF    +   DV+ FG  ++E+L
Sbjct: 565 NFRRFTSAS-DVWMFGVCMWEIL 586

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 49/92 (53%), Gaps = 11/92 (11%)
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
           A+ +LH   S+ I++RD+K  N+L   + D +L DF +S    + +T  + DS +GT  +
Sbjct: 129 ALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK--NLKTLQKRDSFIGTPYW 183
Query: 216 IAPENFT------TLINEQCDVYGFGAFLFEL 241
           +APE         T  + + D++  G  L E+
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/80 (30%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 168 IVYRDMKPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFTTLIN 226
           +++RD+K  N+  NE  + K+ DF L+  +  DGE      ++ GT  +IAPE  +   +
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KTLCGTPNYIAPEVLSKKGH 194
Query: 227 E-QCDVYGFGAFLFELLTAQ 245
             + DV+  G  ++ LL  +
Sbjct: 195 SFEVDVWSIGCIMYTLLVGK 214

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 142 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 193
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 194 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/106 (25%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E ++  D +     +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I 
Sbjct: 139 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDIN 195
Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
           + + + +  +      ++APE  F  +   Q DV+ FG  ++E+ T
Sbjct: 196 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/139 (25%), Positives = 61/139 (43%), Gaps = 16/139 (11%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           ++ D +   + +A  + YL    S+  V+RD+   N + +E+   K+ DF L+  + D E
Sbjct: 130 TVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 186
Query: 202 THIELDSVVGTTGFIAPENFTTL-------INEQCDVYGFGAFLFELLT--AQEVSDHVS 252
                 SV   TG   P  +  L          + DV+ FG  L+EL+T  A    D  +
Sbjct: 187 X----XSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 242
Query: 253 FESRFHYEENVKRLSGQNC 271
           F+   +  +  + L  + C
Sbjct: 243 FDITVYLLQGRRLLQPEYC 261

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 XGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/80 (30%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 168 IVYRDMKPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFTTLIN 226
           +++RD+K  N+  NE  + K+ DF L+  +  DGE      ++ GT  +IAPE  +   +
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KTLCGTPNYIAPEVLSKKGH 194
Query: 227 E-QCDVYGFGAFLFELLTAQ 245
             + DV+  G  ++ LL  +
Sbjct: 195 SFEVDVWSIGCIMYTLLVGK 214

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/80 (30%), Positives = 43/80 (53%), Gaps = 5/80 (6%)
Query: 168 IVYRDMKPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFTTLIN 226
           +++RD+K  N+  NE  + K+ DF L+  +  DGE      ++ GT  +IAPE  +   +
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KTLCGTPNYIAPEVLSKKGH 198
Query: 227 E-QCDVYGFGAFLFELLTAQ 245
             + DV+  G  ++ LL  +
Sbjct: 199 SFEVDVWSIGCIMYTLLVGK 218

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 63/133 (47%), Gaps = 10/133 (7%)
Query: 113 IKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRD 172
           IKLI+ E +  G+L +    +  ++   ++L  +LK A+ I   + YL    SR  V+RD
Sbjct: 100 IKLIM-EFLPSGSLKE----YLPKNKNKINLKQQLKYAVQICKGMDYLG---SRQYVHRD 151
Query: 173 MKPTNILFNEQSDAKLFDFSLSLSI-PDGETHIELDSVVGTTGFIAPENFT-TLINEQCD 230
           +   N+L   +   K+ DF L+ +I  D E     D       + APE    +      D
Sbjct: 152 LAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASD 211
Query: 231 VYGFGAFLFELLT 243
           V+ FG  L ELLT
Sbjct: 212 VWSFGVTLHELLT 224

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/106 (25%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E ++  D +     +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I 
Sbjct: 141 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 197
Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
           + + + +  +      ++APE  F  +   Q DV+ FG  ++E+ T
Sbjct: 198 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/118 (26%), Positives = 49/118 (41%), Gaps = 6/118 (5%)
Query: 130 IHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLF 189
           +  HCE    +L          D   A+A+LH   S+ +V+ D+KP NI    +   KL 
Sbjct: 143 LQQHCEAWGASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLG 199
Query: 190 DFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEV 247
           DF L + +    T    +   G   ++APE          DV+  G  + E+    E+
Sbjct: 200 DFGLLVEL---GTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMEL 254

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/131 (23%), Positives = 58/131 (44%), Gaps = 12/131 (9%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +V E +  G+L D +   C    +  +      V  +   A+ +LH   S  +++R++K 
Sbjct: 95  VVMEYLAGGSLTDVVTETCMDEGQIAA------VCRECLQALEFLH---SNQVIHRNIKS 145
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGF 234
            NIL       KL DF     I   ++  +  ++VGT  ++APE  T      + D++  
Sbjct: 146 DNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSL 203
Query: 235 GAFLFELLTAQ 245
           G    E++  +
Sbjct: 204 GIMAIEMIEGE 214

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/218 (22%), Positives = 94/218 (43%), Gaps = 34/218 (15%)
Query: 49  LRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGN---------RNQHALEWCIN 99
           LR+  +  D +  +L D + K+ +G      ++  K++G          R Q   E   N
Sbjct: 34  LRMVVDQGDPR--LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFN 91
Query: 100 HIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLK 148
            +V      H +++++           ++ E +Q G L D I      + E ++      
Sbjct: 92  EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIA-----T 145
Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDS 208
           V   +  A+AYLH   ++ +++RD+K  +IL       KL DF     I   +   +   
Sbjct: 146 VCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI--SKDVPKRKX 200
Query: 209 VVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQ 245
           +VGT  ++APE  + +L   + D++  G  + E++  +
Sbjct: 201 LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 199
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/106 (25%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E ++  D +     +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
           + + + +  +      ++APE  F  +   Q DV+ FG  ++E+ T
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/106 (25%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E ++  D +     +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I 
Sbjct: 144 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 200
Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
           + + + +  +      ++APE  F  +   Q DV+ FG  ++E+ T
Sbjct: 201 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 199
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 199
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/106 (25%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E ++  D +     +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
           + + + +  +      ++APE  F  +   Q DV+ FG  ++E+ T
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 199
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 199
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 140 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 191
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 192 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 49/92 (53%), Gaps = 11/92 (11%)
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
           A+ +LH   S+ I++RD+K  N+L   + D +L DF +S    + +T  + DS +GT  +
Sbjct: 121 ALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAK--NLKTLQKRDSFIGTPYW 175
Query: 216 IAPENFT------TLINEQCDVYGFGAFLFEL 241
           +APE         T  + + D++  G  L E+
Sbjct: 176 MAPEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 168 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 219
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 148 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 199
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 200 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/127 (25%), Positives = 54/127 (42%), Gaps = 22/127 (17%)
Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDS 208
           +A+D  H + Y+H         RD+KP NIL +     +L DF   L +    T   L  
Sbjct: 173 MAIDSVHRLGYVH---------RDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSL-V 222
Query: 209 VVGTTGFIAPENFTTL--------INEQCDVYGFGAFLFELLTAQEV----SDHVSFESR 256
            VGT  +++PE    +           +CD +  G F +E+   Q      S   ++   
Sbjct: 223 AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKI 282
Query: 257 FHYEENV 263
            HY+E++
Sbjct: 283 VHYKEHL 289

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 42.7 bits (99), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/106 (25%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E ++  D +     +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
           + + + +  +      ++APE  F  +   Q DV+ FG  ++E+ T
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 51/108 (47%), Gaps = 14/108 (12%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
           + +I+ A+ YLH    R I+YRD+K  N+L + +   KL D+ +    +  G+T      
Sbjct: 112 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSX 165
Query: 209 VVGTTGFIAPENFTTLINE----QCDVYGFGAFLFELLTAQEVSDHVS 252
             GT  +IAPE    L  E      D +  G  +FE++  +   D V 
Sbjct: 166 FCGTPNYIAPE---ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 210

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/106 (25%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E ++  D +     +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
           + + + +  +      ++APE  F  +   Q DV+ FG  ++E+ T
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 140 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 191
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 192 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 75/179 (41%), Gaps = 35/179 (19%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           +A  +A+L    S+  ++RD+   NIL       K+ DF L+  I +   ++   +    
Sbjct: 172 VAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 228
Query: 213 TGFIAPEN-FTTLINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFH--YEENVKRLSG 268
             ++APE+ F  +   + DV+ +G FL+EL +        +  +S+F+   +E  + LS 
Sbjct: 229 VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP 288
Query: 269 QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
           ++    EM D                       +   C D  P  RPT     KQ+ Q+
Sbjct: 289 EHAP-AEMYD-----------------------IMKTCWDADPLKRPTF----KQIVQL 319

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 75/179 (41%), Gaps = 35/179 (19%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           +A  +A+L    S+  ++RD+   NIL       K+ DF L+  I +   ++   +    
Sbjct: 170 VAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 226
Query: 213 TGFIAPEN-FTTLINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFH--YEENVKRLSG 268
             ++APE+ F  +   + DV+ +G FL+EL +        +  +S+F+   +E  + LS 
Sbjct: 227 VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP 286
Query: 269 QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
           ++    EM D                       +   C D  P  RPT     KQ+ Q+
Sbjct: 287 EHAP-AEMYD-----------------------IMKTCWDADPLKRPTF----KQIVQL 317

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 75/179 (41%), Gaps = 35/179 (19%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           +A  +A+L    S+  ++RD+   NIL       K+ DF L+  I +   ++   +    
Sbjct: 177 VAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 233
Query: 213 TGFIAPEN-FTTLINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFH--YEENVKRLSG 268
             ++APE+ F  +   + DV+ +G FL+EL +        +  +S+F+   +E  + LS 
Sbjct: 234 VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP 293
Query: 269 QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
           ++    EM D                       +   C D  P  RPT     KQ+ Q+
Sbjct: 294 EHAP-AEMYD-----------------------IMKTCWDADPLKRPTF----KQIVQL 324

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/106 (25%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E ++  D +     +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
           + + + +  +      ++APE  F  +   Q DV+ FG  ++E+ T
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/106 (25%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E ++  D +     +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I 
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 254
Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
           + + + +  +      ++APE  F  +   Q DV+ FG  ++E+ T
Sbjct: 255 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/96 (28%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 168 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 219
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 220 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/185 (23%), Positives = 82/185 (44%), Gaps = 28/185 (15%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           IV +  + G L  RI+      F+   + D     + I  A+ ++H    R I++RD+K 
Sbjct: 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWF---VQICLALKHVH---DRKILHRDIKS 153
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELD-SVVGTTGFIAPENF-TTLINEQCDVYG 233
            NI   +    +L DF ++  +    + +EL  + +GT  +++PE       N + D++ 
Sbjct: 154 QNIFLTKDGTVQLGDFGIARVL---NSTVELARACIGTPYYLSPEICENKPYNNKSDIWA 210
Query: 234 FGAFLFELLTAQEVSDHVSFES-------------RFHYEENVKRLSGQ----NCRFKEM 276
            G  L+EL T +   +  S ++               HY  +++ L  Q    N R +  
Sbjct: 211 LGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPS 270
Query: 277 VDSII 281
           V+SI+
Sbjct: 271 VNSIL 275

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 81/206 (39%), Gaps = 38/206 (18%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           IV E +  G+L D +    +    AL L + + +A  +A  +AY+        ++RD++ 
Sbjct: 80  IVTEYMNKGSLLDFLK---DGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRS 133
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE-----NFTTLINEQCD 230
            NIL       K+ DF L+  I D E      +      + APE      FT     + D
Sbjct: 134 ANILVGNGLICKIADFGLARLIEDNEXTARQGAKF-PIKWTAPEAALYGRFTI----KSD 188
Query: 231 VYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCT 290
           V+ FG  L EL+T   V  +    +R    E V+R     C             + C  +
Sbjct: 189 VWSFGILLTELVTKGRVP-YPGMNNR-EVLEQVERGYRMPC------------PQDCPIS 234
Query: 291 GKEQQLQAFKQLTLQCMDFSPEDRPT 316
                     +L + C    PE+RPT
Sbjct: 235 --------LHELMIHCWKKDPEERPT 252

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 50/104 (48%), Gaps = 4/104 (3%)
Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           L+L   +  +  +A  + +L    SR  ++RD+   NIL +E++  K+ DF L+  I   
Sbjct: 145 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 201
Query: 201 ETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
              +          ++APE  F  +   Q DV+ FG  L+E+ +
Sbjct: 202 PDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/108 (29%), Positives = 51/108 (47%), Gaps = 14/108 (12%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL-SLSIPDGETHIELDS 208
           + +I+ A+ YLH    R I+YRD+K  N+L + +   KL D+ +    +  G+T      
Sbjct: 116 SAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSX 169
Query: 209 VVGTTGFIAPENFTTLINE----QCDVYGFGAFLFELLTAQEVSDHVS 252
             GT  +IAPE    L  E      D +  G  +FE++  +   D V 
Sbjct: 170 FCGTPNYIAPE---ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 214

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 45/94 (47%), Gaps = 6/94 (6%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA-KLFDFSLSLSIPDGETHIELDSVVG 211
           I   + +LH   + PI++RD+K  NI     + + K+ D  L+      +      +V+G
Sbjct: 138 ILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIG 192
Query: 212 TTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQ 245
           T  F APE +    +E  DVY FG    E  T++
Sbjct: 193 TPEFXAPEXYEEKYDESVDVYAFGXCXLEXATSE 226

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 42.7 bits (99), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 75/179 (41%), Gaps = 35/179 (19%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           +A  +A+L    S+  ++RD+   NIL       K+ DF L+  I +   ++   +    
Sbjct: 154 VAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210
Query: 213 TGFIAPEN-FTTLINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFH--YEENVKRLSG 268
             ++APE+ F  +   + DV+ +G FL+EL +        +  +S+F+   +E  + LS 
Sbjct: 211 VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP 270
Query: 269 QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
           ++    EM D                       +   C D  P  RPT     KQ+ Q+
Sbjct: 271 EHAP-AEMYD-----------------------IMKTCWDADPLKRPTF----KQIVQL 301

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/186 (20%), Positives = 81/186 (43%), Gaps = 26/186 (13%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           SL+  +++A +IA  +AYL+   +   V+RD+   N +  E    K+ DF ++  I + +
Sbjct: 158 SLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 214
Query: 202 THIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYE 260
            + +    +    +++PE+    +     DV+ FG  L+E+ T  E              
Sbjct: 215 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-------------- 260
Query: 261 ENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
           +  + LS +      M   ++  DK   C           +L   C  ++P+ RP+ +++
Sbjct: 261 QPYQGLSNEQVLRFVMEGGLL--DKPDNCP------DMLFELMRMCWQYNPKMRPSFLEI 312
Query: 321 AKQLRQ 326
              +++
Sbjct: 313 ISSIKE 318

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/104 (28%), Positives = 50/104 (48%), Gaps = 11/104 (10%)
Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKL--FDFSLSLSIPDGETHIE 205
           K    I + + + H   S  I++RD+KP NIL ++    KL  F F+ +L+ P GE +  
Sbjct: 128 KYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GEVY-- 181
Query: 206 LDSVVGTTGFIAPENFTTLI--NEQCDVYGFGAFLFELLTAQEV 247
            D  V T  + APE     +   +  DV+  G  + E+   + +
Sbjct: 182 -DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPL 224

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/106 (25%), Positives = 51/106 (48%), Gaps = 4/106 (3%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E ++  D +     +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
           + + +    +      ++APE  F  +   Q DV+ FG  ++E+ T
Sbjct: 209 NIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/179 (23%), Positives = 75/179 (41%), Gaps = 35/179 (19%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           +A  +A+L    S+  ++RD+   NIL       K+ DF L+  I +   ++   +    
Sbjct: 177 VAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLP 233
Query: 213 TGFIAPEN-FTTLINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFH--YEENVKRLSG 268
             ++APE+ F  +   + DV+ +G FL+EL +        +  +S+F+   +E  + LS 
Sbjct: 234 VKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP 293
Query: 269 QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
           ++    EM D                       +   C D  P  RPT     KQ+ Q+
Sbjct: 294 EHAP-AEMYD-----------------------IMKTCWDADPLKRPTF----KQIVQL 324

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 91/235 (38%), Gaps = 33/235 (14%)
Query: 98  INH--IVYASRMSHKHIIKLIVFESVQIGTLAD--RIHHHCEQHFEALSLTDRLKVAMDI 153
           +NH  IV    +S + + + I+ E +  G L    R          +L++ D L VA DI
Sbjct: 91  LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 150
Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVV 210
           A    YL        ++RD+   N L         AK+ DF ++  I     + +    +
Sbjct: 151 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 207
Query: 211 GTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
               ++ PE F   +   + D + FG  L+E+ +      ++ + S+             
Sbjct: 208 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL----GYMPYPSK------------S 251
Query: 270 NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
           N    E V S    D    C G       ++ +T QC    PEDRP    + +++
Sbjct: 252 NQEVLEFVTSGGRMDPPKNCPGP-----VYRIMT-QCWQHQPEDRPNFAIILERI 300

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 50/104 (48%), Gaps = 4/104 (3%)
Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           LS  ++L +A  +A  +AYL     R  V+RD+   N L  E    K+ DF LS +I   
Sbjct: 171 LSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSA 227
Query: 201 ETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
           + +    +      ++ PE+ F      + DV+ +G  L+E+ +
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 46/196 (23%), Positives = 85/196 (43%), Gaps = 28/196 (14%)
Query: 67  FRKLYKGFW------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLI---V 117
           F  +YKG W       K  +++M+     +  A +  ++     + + + H+ +L+   +
Sbjct: 62  FGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL 121
Query: 118 FESVQI-------GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVY 170
             +VQ+       G L D    +  +H + +     L   + IA  + YL     R +V+
Sbjct: 122 TSTVQLITQLMPFGCLLD----YVREHKDNIGSQYLLNWCVQIAKGMNYLE---DRRLVH 174
Query: 171 RDMKPTNILFNEQSDAKLFDFSLS--LSIPDGETHIELDSVVGTTGFIAPENFTTLI-NE 227
           RD+   N+L       K+ DF L+  L   + E H E   V     ++A E+    I   
Sbjct: 175 RDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PIKWMALESILHRIYTH 232
Query: 228 QCDVYGFGAFLFELLT 243
           Q DV+ +G  ++EL+T
Sbjct: 233 QSDVWSYGVTVWELMT 248

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 61/272 (22%), Positives = 108/272 (39%), Gaps = 47/272 (17%)
Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFESVQIGTL 126
            + L  G+ +K+ +  +   G   Q +     ++I+    +  K+   +I+ E ++ G L
Sbjct: 78  IKTLKAGYTEKQRVDFLGEAGIMGQFSH----HNIIRLEGVISKYKPMMIITEYMENGAL 133
Query: 127 ADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA 186
            D+     +  F  L L   L+    IA  + YL    +   V+RD+   NIL N     
Sbjct: 134 -DKFLREKDGEFSVLQLVGMLR---GIAAGMKYLA---NMNYVHRDLAARNILVNSNLVC 186
Query: 187 KLFDFSLSLSIPDGETHIELDSVVGTTG------FIAPENFT-TLINEQCDVYGFGAFLF 239
           K+ DF LS  + D     + ++   T+G      + APE  +        DV+ FG  ++
Sbjct: 187 KVSDFGLSRVLED-----DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMW 241
Query: 240 ELLTAQEVSDHVSFESRFHYE-ENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQA 298
           E++T  E         R ++E  N + +   N  F+      +     C          A
Sbjct: 242 EVMTYGE---------RPYWELSNHEVMKAINDGFR------LPTPMDCP--------SA 278
Query: 299 FKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
             QL +QC       RP   D+   L ++ R+
Sbjct: 279 IYQLMMQCWQQERARRPKFADIVSILDKLIRA 310

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 80/193 (41%), Gaps = 48/193 (24%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILF--------NEQSDAK-----LFDFSLSLSIPD 199
           IA  VA+LH   S  I++RD+KP NIL         ++Q+ A+     + DF L   +  
Sbjct: 142 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 198
Query: 200 GETHIE--LDSVVGTTGFIAP----ENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSF 253
           G+      L++  GT+G+ AP    E+    +    D++  G   + +L+  +   H  F
Sbjct: 199 GQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK---H-PF 254
Query: 254 ESRFHYEENVKR----LSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDF 309
             ++  E N+ R    L    C          + D+S      +        L  Q +D 
Sbjct: 255 GDKYSRESNIIRGIFSLDEMKC----------LHDRSLIAEATD--------LISQMIDH 296
Query: 310 SPEDRPTMVDVAK 322
            P  RPT + V +
Sbjct: 297 DPLKRPTAMKVLR 309

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/106 (25%), Positives = 51/106 (48%), Gaps = 4/106 (3%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E ++  D +     +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
           + +   +  +      ++APE  F  +   Q DV+ FG  ++E+ T
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 24/80 (30%), Positives = 42/80 (52%), Gaps = 5/80 (6%)
Query: 168 IVYRDMKPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFTTLIN 226
           +++RD+K  N+  NE  + K+ DF L+  +  DGE       + GT  +IAPE  +   +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSKKGH 192
Query: 227 E-QCDVYGFGAFLFELLTAQ 245
             + DV+  G  ++ LL  +
Sbjct: 193 SFEVDVWSIGCIMYTLLVGK 212

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 78/193 (40%), Gaps = 44/193 (22%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILF--------NEQSDAK-----LFDFSLSLSIPD 199
           IA  VA+LH   S  I++RD+KP NIL         ++Q+ A+     + DF L   +  
Sbjct: 124 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 200 GETHIE--LDSVVGTTGFIAPE------NFTT--LINEQCDVYGFGAFLFELLTAQEVSD 249
           G++     L++  GT+G+ APE      N  T   +    D++  G   + +L+  +   
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK--- 237
Query: 250 HVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDF 309
           H  F  ++  E N+ R               I       C      +     L  Q +D 
Sbjct: 238 H-PFGDKYSRESNIIR--------------GIFSLDEMKCLHDRSLIAEATDLISQMIDH 282
Query: 310 SPEDRPTMVDVAK 322
            P  RPT + V +
Sbjct: 283 DPLKRPTAMKVLR 295

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 92/235 (39%), Gaps = 33/235 (14%)
Query: 98  INH--IVYASRMSHKHIIKLIVFESVQIGTLAD--RIHHHCEQHFEALSLTDRLKVAMDI 153
           +NH  IV    +S + + + I+ E +  G L    R          +L++ D L VA DI
Sbjct: 105 LNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 164
Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVV 210
           A    YL        ++RD+   N L         AK+ DF ++  I     + +    +
Sbjct: 165 ACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 221
Query: 211 GTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
               ++ PE F   +   + D + FG  L+E+ +      ++ + S+ + E         
Sbjct: 222 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL----GYMPYPSKSNQE--------- 268
Query: 270 NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
                E V S    D    C G       ++ +T QC    PEDRP    + +++
Sbjct: 269 ---VLEFVTSGGRMDPPKNCPGP-----VYRIMT-QCWQHQPEDRPNFAIILERI 314

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 27/106 (25%), Positives = 51/106 (48%), Gaps = 4/106 (3%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E ++  D +     +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN 208
Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
           + +   +  +      ++APE  F  +   Q DV+ FG  ++E+ T
Sbjct: 209 NIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 24/80 (30%), Positives = 42/80 (52%), Gaps = 5/80 (6%)
Query: 168 IVYRDMKPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFTTLIN 226
           +++RD+K  N+  NE  + K+ DF L+  +  DGE       + GT  +IAPE  +   +
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSKKGH 216
Query: 227 E-QCDVYGFGAFLFELLTAQ 245
             + DV+  G  ++ LL  +
Sbjct: 217 SFEVDVWSIGCIMYTLLVGK 236

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 51/231 (22%), Positives = 89/231 (38%), Gaps = 31/231 (13%)
Query: 100 HIVYASRMSHKHIIKLIVFESVQIGTLAD--RIHHHCEQHFEALSLTDRLKVAMDIAHAV 157
           +IV    +S + + + I+ E +  G L    R          +L++ D L VA DIA   
Sbjct: 121 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 180
Query: 158 AYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTG 214
            YL        ++RD+   N L         AK+ DF ++  I     + +    +    
Sbjct: 181 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 237
Query: 215 FIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF 273
           ++ PE F   +   + D + FG  L+E+ +      ++ + S+             N   
Sbjct: 238 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL----GYMPYPSK------------SNQEV 281
Query: 274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
            E V S    D    C G       ++ +T QC    PEDRP    + +++
Sbjct: 282 LEFVTSGGRMDPPKNCPGP-----VYRIMT-QCWQHQPEDRPNFAIILERI 326

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 80/193 (41%), Gaps = 48/193 (24%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILF--------NEQSDAK-----LFDFSLSLSIPD 199
           IA  VA+LH   S  I++RD+KP NIL         ++Q+ A+     + DF L   +  
Sbjct: 142 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 198
Query: 200 GETHIE--LDSVVGTTGFIAP----ENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSF 253
           G+      L++  GT+G+ AP    E+    +    D++  G   + +L+  +   H  F
Sbjct: 199 GQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGK---H-PF 254
Query: 254 ESRFHYEENVKR----LSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDF 309
             ++  E N+ R    L    C          + D+S      +        L  Q +D 
Sbjct: 255 GDKYSRESNIIRGIFSLDEMKC----------LHDRSLIAEATD--------LISQMIDH 296
Query: 310 SPEDRPTMVDVAK 322
            P  RPT + V +
Sbjct: 297 DPLKRPTAMKVLR 309

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 42.0 bits (97), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/96 (27%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS--LSIPDGETHIELDSVVGTT 213
            + Y+H   S  +++RD+KP+N+L NE  + K+ DF ++  L     E    +   V T 
Sbjct: 170 GLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 214 GFIAPENFTTL--INEQCDVYGFGAFLFELLTAQEV 247
            + APE   +L    +  D++  G    E+L  +++
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQL 262

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 24/80 (30%), Positives = 42/80 (52%), Gaps = 5/80 (6%)
Query: 168 IVYRDMKPTNILFNEQSDAKLFDFSLSLSIP-DGETHIELDSVVGTTGFIAPENFTTLIN 226
           +++RD+K  N+  NE  + K+ DF L+  +  DGE       + GT  +IAPE  +   +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLSKKGH 218
Query: 227 E-QCDVYGFGAFLFELLTAQ 245
             + DV+  G  ++ LL  +
Sbjct: 219 SFEVDVWSIGCIMYTLLVGK 238

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/96 (27%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N++ ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/96 (27%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N++ ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++E+   
Sbjct: 199 CGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/186 (20%), Positives = 80/186 (43%), Gaps = 26/186 (13%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           SL+  +++A +IA  +AYL+   +   V+RD+   N +  E    K+ DF ++  I + +
Sbjct: 121 SLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETD 177
Query: 202 THIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYE 260
              +    +    +++PE+    +     DV+ FG  L+E+ T  E              
Sbjct: 178 XXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-------------- 223
Query: 261 ENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
           +  + LS +      M   ++  DK   C           +L   C  ++P+ RP+ +++
Sbjct: 224 QPYQGLSNEQVLRFVMEGGLL--DKPDNCP------DMLLELMRMCWQYNPKMRPSFLEI 275
Query: 321 AKQLRQ 326
              +++
Sbjct: 276 ISSIKE 281

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/186 (20%), Positives = 81/186 (43%), Gaps = 26/186 (13%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           SL+  +++A +IA  +AYL+   +   V+RD+   N +  E    K+ DF ++  I + +
Sbjct: 123 SLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 179
Query: 202 THIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYE 260
            + +    +    +++PE+    +     DV+ FG  L+E+ T  E              
Sbjct: 180 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-------------- 225
Query: 261 ENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
           +  + LS +      M   ++  DK   C           +L   C  ++P+ RP+ +++
Sbjct: 226 QPYQGLSNEQVLRFVMEGGLL--DKPDNCP------DMLFELMRMCWQYNPKMRPSFLEI 277
Query: 321 AKQLRQ 326
              +++
Sbjct: 278 ISSIKE 283

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 29/87 (33%), Positives = 45/87 (51%), Gaps = 6/87 (6%)
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            + YLH  F R I +RD+K  NIL N +  AKL DF ++  + D     + + V+GT  +
Sbjct: 137 GLEYLH--FMRKI-HRDIKAGNILLNTEGHAKLADFGVAGQLTD--XMAKRNXVIGTPFW 191
Query: 216 IAPENFTTL-INEQCDVYGFGAFLFEL 241
           +APE    +  N   D++  G    E+
Sbjct: 192 MAPEVIQEIGYNCVADIWSLGITAIEM 218

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 49/219 (22%), Positives = 89/219 (40%), Gaps = 31/219 (14%)
Query: 42  RIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFW------QKRSISLMKYNGNRNQHALE 95
           RI    ELR       +  ++    F  +YKG W       K  +++     N +  A +
Sbjct: 12  RILKETELR-------KVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANK 64
Query: 96  WCINHIVYASRMSHKHIIKLI---VFESVQI-------GTLADRIHHHCEQHFEALSLTD 145
             ++     + +   ++ +L+   +  +VQ+       G L D    H  ++   L   D
Sbjct: 65  EILDEAYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLD----HVRENRGRLGSQD 120
Query: 146 RLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIE 205
            L   M IA  ++YL       +V+RD+   N+L    +  K+ DF L+  +   ET   
Sbjct: 121 LLNWCMQIAKGMSYLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYH 177
Query: 206 LDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
            D       ++A E+        Q DV+ +G  ++EL+T
Sbjct: 178 ADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 4/106 (3%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           E ++  D +     +A  + YL    S+  ++RD+   N+L  E +  ++ DF L+  I 
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDIN 208
Query: 199 DGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
           + + + +  +      ++APE  F  +   Q DV+ FG  ++E+ T
Sbjct: 209 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/96 (27%), Positives = 48/96 (50%), Gaps = 7/96 (7%)
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS--LSIPDGETHIELDSVVGTT 213
            + Y+H   S  +++RD+KP+N+L NE  + K+ DF ++  L     E    +   V T 
Sbjct: 171 GLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 227
Query: 214 GFIAPENFTTL--INEQCDVYGFGAFLFELLTAQEV 247
            + APE   +L    +  D++  G    E+L  +++
Sbjct: 228 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQL 263

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/231 (22%), Positives = 89/231 (38%), Gaps = 31/231 (13%)
Query: 100 HIVYASRMSHKHIIKLIVFESVQIGTLAD--RIHHHCEQHFEALSLTDRLKVAMDIAHAV 157
           +IV    +S + + + I+ E +  G L    R          +L++ D L VA DIA   
Sbjct: 101 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 160
Query: 158 AYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTG 214
            YL        ++RD+   N L         AK+ DF ++  I     + +    +    
Sbjct: 161 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 217
Query: 215 FIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF 273
           ++ PE F   +   + D + FG  L+E+ +      ++ + S+             N   
Sbjct: 218 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL----GYMPYPSK------------SNQEV 261
Query: 274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
            E V S    D    C G       ++ +T QC    PEDRP    + +++
Sbjct: 262 LEFVTSGGRMDPPKNCPGP-----VYRIMT-QCWQHQPEDRPNFAIILERI 306

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/96 (27%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +  G T      +
Sbjct: 147 AAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW----XL 198
Query: 210 VGTTGFIAPE-NFTTLINEQCDVYGFGAFLFELLTA 244
            GT  ++APE   +   N+  D +  G  ++++   
Sbjct: 199 CGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/186 (20%), Positives = 81/186 (43%), Gaps = 26/186 (13%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           SL+  +++A +IA  +AYL+   +   V+RD+   N +  E    K+ DF ++  I + +
Sbjct: 127 SLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 183
Query: 202 THIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYE 260
            + +    +    +++PE+    +     DV+ FG  L+E+ T  E              
Sbjct: 184 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-------------- 229
Query: 261 ENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
           +  + LS +      M   ++  DK   C           +L   C  ++P+ RP+ +++
Sbjct: 230 QPYQGLSNEQVLRFVMEGGLL--DKPDNCP------DMLFELMRMCWQYNPKMRPSFLEI 281
Query: 321 AKQLRQ 326
              +++
Sbjct: 282 ISSIKE 287

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/186 (20%), Positives = 81/186 (43%), Gaps = 26/186 (13%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           SL+  +++A +IA  +AYL+   +   V+RD+   N +  E    K+ DF ++  I + +
Sbjct: 130 SLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 186
Query: 202 THIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYE 260
            + +    +    +++PE+    +     DV+ FG  L+E+ T  E              
Sbjct: 187 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-------------- 232
Query: 261 ENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
           +  + LS +      M   ++  DK   C           +L   C  ++P+ RP+ +++
Sbjct: 233 QPYQGLSNEQVLRFVMEGGLL--DKPDNCP------DMLFELMRMCWQYNPKMRPSFLEI 284
Query: 321 AKQLRQ 326
              +++
Sbjct: 285 ISSIKE 290

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 51/231 (22%), Positives = 89/231 (38%), Gaps = 31/231 (13%)
Query: 100 HIVYASRMSHKHIIKLIVFESVQIGTLAD--RIHHHCEQHFEALSLTDRLKVAMDIAHAV 157
           +IV    +S + + + I+ E +  G L    R          +L++ D L VA DIA   
Sbjct: 111 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 170
Query: 158 AYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTG 214
            YL        ++RD+   N L         AK+ DF ++  I     + +    +    
Sbjct: 171 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 227
Query: 215 FIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF 273
           ++ PE F   +   + D + FG  L+E+ +      ++ + S+             N   
Sbjct: 228 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL----GYMPYPSK------------SNQEV 271
Query: 274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
            E V S    D    C G       ++ +T QC    PEDRP    + +++
Sbjct: 272 LEFVTSGGRMDPPKNCPGP-----VYRIMT-QCWQHQPEDRPNFAIILERI 316

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 41.6 bits (96), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 38/186 (20%), Positives = 81/186 (43%), Gaps = 26/186 (13%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           SL+  +++A +IA  +AYL+   +   V+RD+   N +  E    K+ DF ++  I + +
Sbjct: 129 SLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 185
Query: 202 THIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYE 260
            + +    +    +++PE+    +     DV+ FG  L+E+ T  E              
Sbjct: 186 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-------------- 231
Query: 261 ENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
           +  + LS +      M   ++  DK   C           +L   C  ++P+ RP+ +++
Sbjct: 232 QPYQGLSNEQVLRFVMEGGLL--DKPDNCP------DMLFELMRMCWQYNPKMRPSFLEI 283
Query: 321 AKQLRQ 326
              +++
Sbjct: 284 ISSIKE 289

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/231 (22%), Positives = 89/231 (38%), Gaps = 31/231 (13%)
Query: 100 HIVYASRMSHKHIIKLIVFESVQIGTLAD--RIHHHCEQHFEALSLTDRLKVAMDIAHAV 157
           +IV    +S + + + I+ E +  G L    R          +L++ D L VA DIA   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 158 AYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTG 214
            YL        ++RD+   N L         AK+ DF ++  I     + +    +    
Sbjct: 155 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 211
Query: 215 FIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF 273
           ++ PE F   +   + D + FG  L+E+ +      ++ + S+             N   
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL----GYMPYPSK------------SNQEV 255
Query: 274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
            E V S    D    C G       ++ +T QC    PEDRP    + +++
Sbjct: 256 LEFVTSGGRMDPPKNCPGP-----VYRIMT-QCWQHQPEDRPNFAIILERI 300

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/186 (20%), Positives = 81/186 (43%), Gaps = 26/186 (13%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           SL+  +++A +IA  +AYL+   +   V+RD+   N +  E    K+ DF ++  I + +
Sbjct: 126 SLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 182
Query: 202 THIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYE 260
            + +    +    +++PE+    +     DV+ FG  L+E+ T  E              
Sbjct: 183 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-------------- 228
Query: 261 ENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
           +  + LS +      M   ++  DK   C           +L   C  ++P+ RP+ +++
Sbjct: 229 QPYQGLSNEQVLRFVMEGGLL--DKPDNCP------DMLFELMRMCWQYNPKMRPSFLEI 280
Query: 321 AKQLRQ 326
              +++
Sbjct: 281 ISSIKE 286

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 79/192 (41%), Gaps = 25/192 (13%)
Query: 67  FRKLYKGFWQKRSI-SLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLI--------- 116
           F K+YK   ++ S+ +  K    +++  LE  +  I   +   H +I+KL+         
Sbjct: 50  FGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 109
Query: 117 -VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
            +      G   D +    E+      +    K  +D   A+ YLH      I++RD+K 
Sbjct: 110 WILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLD---ALNYLH---DNKIIHRDLKA 163
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINE------QC 229
            NILF    D KL DF +S    +       D  +GT  ++APE      ++      + 
Sbjct: 164 GNILFTLDGDIKLADFGVSAK--NTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKA 221
Query: 230 DVYGFGAFLFEL 241
           DV+  G  L E+
Sbjct: 222 DVWSLGITLIEM 233

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 54/133 (40%), Gaps = 32/133 (24%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
           LIV E +  G L  RI    +Q F     ++ +K    I  A+ YLH   S  I +RD+K
Sbjct: 91  LIVMECLDGGELFSRIQDRGDQAFTEREASEIMK---SIGEAIQYLH---SINIAHRDVK 144
Query: 175 PTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDV 231
           P N+L+  +      KL DF                      GF A E      ++ CD+
Sbjct: 145 PENLLYTSKRPNAILKLTDF----------------------GF-AKETTGEKYDKSCDM 181
Query: 232 YGFGAFLFELLTA 244
           +  G  ++ LL  
Sbjct: 182 WSLGVIMYILLCG 194

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/186 (20%), Positives = 81/186 (43%), Gaps = 26/186 (13%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           SL+  +++A +IA  +AYL+   +   V+RD+   N +  E    K+ DF ++  I + +
Sbjct: 129 SLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 185
Query: 202 THIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYE 260
            + +    +    +++PE+    +     DV+ FG  L+E+ T  E              
Sbjct: 186 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-------------- 231
Query: 261 ENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
           +  + LS +      M   ++  DK   C           +L   C  ++P+ RP+ +++
Sbjct: 232 QPYQGLSNEQVLRFVMEGGLL--DKPDNCP------DMLFELMRMCWQYNPKMRPSFLEI 283
Query: 321 AKQLRQ 326
              +++
Sbjct: 284 ISSIKE 289

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/231 (22%), Positives = 90/231 (38%), Gaps = 31/231 (13%)
Query: 100 HIVYASRMSHKHIIKLIVFESVQIGTLAD--RIHHHCEQHFEALSLTDRLKVAMDIAHAV 157
           +IV    +S + + + I+ E +  G L    R          +L++ D L VA DIA   
Sbjct: 86  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 145
Query: 158 AYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTG 214
            YL        ++RD+   N L         AK+ DF ++  I     + +    +    
Sbjct: 146 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 202
Query: 215 FIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF 273
           ++ PE F   +   + D + FG  L+E+ +      ++ + S+ + E             
Sbjct: 203 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL----GYMPYPSKSNQE------------V 246
Query: 274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
            E V S    D    C G       ++ +T QC    PEDRP    + +++
Sbjct: 247 LEFVTSGGRMDPPKNCPGP-----VYRIMT-QCWQHQPEDRPNFAIILERI 291

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/231 (22%), Positives = 90/231 (38%), Gaps = 31/231 (13%)
Query: 100 HIVYASRMSHKHIIKLIVFESVQIGTLAD--RIHHHCEQHFEALSLTDRLKVAMDIAHAV 157
           +IV    +S + + + I+ E +  G L    R          +L++ D L VA DIA   
Sbjct: 94  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 158 AYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTG 214
            YL        ++RD+   N L         AK+ DF ++  I     + +    +    
Sbjct: 154 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 215 FIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF 273
           ++ PE F   +   + D + FG  L+E+ +      ++ + S+ + E             
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL----GYMPYPSKSNQE------------V 254
Query: 274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
            E V S    D    C G       ++ +T QC    PEDRP    + +++
Sbjct: 255 LEFVTSGGRMDPPKNCPGP-----VYRIMT-QCWQHQPEDRPNFAIILERI 299

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/231 (22%), Positives = 89/231 (38%), Gaps = 31/231 (13%)
Query: 100 HIVYASRMSHKHIIKLIVFESVQIGTLAD--RIHHHCEQHFEALSLTDRLKVAMDIAHAV 157
           +IV    +S + + + I+ E +  G L    R          +L++ D L VA DIA   
Sbjct: 109 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 158 AYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTG 214
            YL        ++RD+   N L         AK+ DF ++  I     + +    +    
Sbjct: 169 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 225
Query: 215 FIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF 273
           ++ PE F   +   + D + FG  L+E+ +      ++ + S+             N   
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL----GYMPYPSK------------SNQEV 269
Query: 274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
            E V S    D    C G       ++ +T QC    PEDRP    + +++
Sbjct: 270 LEFVTSGGRMDPPKNCPGP-----VYRIMT-QCWQHQPEDRPNFAIILERI 314

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/81 (32%), Positives = 43/81 (53%), Gaps = 6/81 (7%)
Query: 168 IVYRDMKPTNILFNEQSDA---KLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-T 223
           I++RD+KP  +L   + ++   KL  F +++ +  GE+ +     VGT  F+APE     
Sbjct: 153 IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTPHFMAPEVVKRE 210
Query: 224 LINEQCDVYGFGAFLFELLTA 244
              +  DV+G G  LF LL+ 
Sbjct: 211 PYGKPVDVWGCGVILFILLSG 231

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/231 (22%), Positives = 90/231 (38%), Gaps = 31/231 (13%)
Query: 100 HIVYASRMSHKHIIKLIVFESVQIGTLAD--RIHHHCEQHFEALSLTDRLKVAMDIAHAV 157
           +IV    +S + + + I+ E +  G L    R          +L++ D L VA DIA   
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 158 AYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTG 214
            YL        ++RD+   N L         AK+ DF ++  I     + +    +    
Sbjct: 154 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 210
Query: 215 FIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF 273
           ++ PE F   +   + D + FG  L+E+ +      ++ + S+ + E             
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL----GYMPYPSKSNQE------------V 254
Query: 274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
            E V S    D    C G       ++ +T QC    PEDRP    + +++
Sbjct: 255 LEFVTSGGRMDPPKNCPGP-----VYRIMT-QCWQHQPEDRPNFAIILERI 299

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 51/231 (22%), Positives = 89/231 (38%), Gaps = 31/231 (13%)
Query: 100 HIVYASRMSHKHIIKLIVFESVQIGTLAD--RIHHHCEQHFEALSLTDRLKVAMDIAHAV 157
           +IV    +S + + + I+ E +  G L    R          +L++ D L VA DIA   
Sbjct: 95  NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 154
Query: 158 AYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTG 214
            YL        ++RD+   N L         AK+ DF ++  I     + +    +    
Sbjct: 155 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVK 211
Query: 215 FIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF 273
           ++ PE F   +   + D + FG  L+E+ +      ++ + S+             N   
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL----GYMPYPSK------------SNQEV 255
Query: 274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
            E V S    D    C G       ++ +T QC    PEDRP    + +++
Sbjct: 256 LEFVTSGGRMDPPKNCPGP-----VYRIMT-QCWQHQPEDRPNFAIILERI 300

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 38/186 (20%), Positives = 80/186 (43%), Gaps = 26/186 (13%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           SL+  +++A +IA  +AYL+   +   V+RD+   N +  E    K+ DF ++  I + +
Sbjct: 130 SLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETD 186
Query: 202 THIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYE 260
              +    +    +++PE+    +     DV+ FG  L+E+ T  E              
Sbjct: 187 XXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-------------- 232
Query: 261 ENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
           +  + LS +      M   ++  DK   C           +L   C  ++P+ RP+ +++
Sbjct: 233 QPYQGLSNEQVLRFVMEGGLL--DKPDNCP------DMLFELMRMCWQYNPKMRPSFLEI 284
Query: 321 AKQLRQ 326
              +++
Sbjct: 285 ISSIKE 290

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 41.6 bits (96), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 63/140 (45%), Gaps = 21/140 (15%)
Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYL-HVGFSRPIVYRDM 173
           +IV E ++ G L   +  H +  F  + L   L+    IA  + YL  +G+    V+RD+
Sbjct: 120 MIVIEFMENGALDAFLRKH-DGQFTVIQLVGMLR---GIAAGMRYLADMGY----VHRDL 171
Query: 174 KPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTL-------IN 226
              NIL N     K+ DF LS  I D     + ++V  TTG   P  +T           
Sbjct: 172 AARNILVNSNLVCKVSDFGLSRVIED-----DPEAVYTTTGGKIPVRWTAPEAIQYRKFT 226
Query: 227 EQCDVYGFGAFLFELLTAQE 246
              DV+ +G  ++E+++  E
Sbjct: 227 SASDVWSYGIVMWEVMSYGE 246

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 48/96 (50%), Gaps = 9/96 (9%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA---KLFDFSLSLSIPDGETHIELDSV 209
           I  A+ Y H      I++RD+KP  +L   + ++   KL  F +++ +  GE+ +     
Sbjct: 139 ILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGR 193
Query: 210 VGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTA 244
           VGT  F+APE        +  DV+G G  LF LL+ 
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 81/197 (41%), Gaps = 52/197 (26%)
Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILF--------NEQSDAK-----LFDFSLSLSIPD 199
           IA  VA+LH   S  I++RD+KP NIL         ++Q+ A+     + DF L   +  
Sbjct: 124 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 200 GETHIE--LDSVVGTTGFIAPE------NFTT--LINEQCDVYGFGAFLFELLTAQEVSD 249
           G+      L++  GT+G+ APE      N  T   +    D++  G   + +L+  +   
Sbjct: 181 GQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK--- 237
Query: 250 HVSFESRFHYEENVKR----LSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQ 305
           H  F  ++  E N+ R    L    C          + D+S      +        L  Q
Sbjct: 238 H-PFGDKYSRESNIIRGIFSLDEMKC----------LHDRSLIAEATD--------LISQ 278
Query: 306 CMDFSPEDRPTMVDVAK 322
            +D  P  RPT + V +
Sbjct: 279 MIDHDPLKRPTAMKVLR 295

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 26/110 (23%), Positives = 50/110 (45%), Gaps = 4/110 (3%)
Query: 135 EQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS 194
           E+    L+  D L  A  +A  + +L     +  V+RD+   N+L       K+ DF L+
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLA 219
Query: 195 LSIPDGETHIELDSVVGTTGFIAPEN-FTTLINEQCDVYGFGAFLFELLT 243
             I     ++   +      ++APE+ F  +   + DV+ +G  L+E+ +
Sbjct: 220 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 56/127 (44%), Gaps = 12/127 (9%)
Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           IV E +  G+L D +            L   LK ++D+  A+ YL        V+RD+  
Sbjct: 83  IVTEYMAKGSLVDYLRSRGRSVLGGDCL---LKFSLDVCEAMEYLE---GNNFVHRDLAA 136
Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TTLINEQCDVYGF 234
            N+L +E + AK+ DF L+      E     D+      + APE       + + DV+ F
Sbjct: 137 RNVLVSEDNVAKVSDFGLT-----KEASSTQDTGKLPVKWTAPEALREAAFSTKSDVWSF 191
Query: 235 GAFLFEL 241
           G  L+E+
Sbjct: 192 GILLWEI 198

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/186 (20%), Positives = 81/186 (43%), Gaps = 26/186 (13%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           SL+  +++A +IA  +AYL+   +   V+RD+   N +  E    K+ DF ++  I + +
Sbjct: 136 SLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
Query: 202 THIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYE 260
            + +    +    +++PE+    +     DV+ FG  L+E+ T  E              
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-------------- 238
Query: 261 ENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
           +  + LS +      M   ++  DK   C           +L   C  ++P+ RP+ +++
Sbjct: 239 QPYQGLSNEQVLRFVMEGGLL--DKPDNCP------DMLFELMRMCWQYNPKMRPSFLEI 290
Query: 321 AKQLRQ 326
              +++
Sbjct: 291 ISSIKE 296

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 27/100 (27%), Positives = 48/100 (48%), Gaps = 10/100 (10%)
Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            + +LH   S  I++RD+KP+NI+       K+ DF L+ +     T+  +   V T  +
Sbjct: 136 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART---ASTNFMMTPYVVTRYY 189
Query: 216 IAPENFTTL-INEQCDVYGFGAFLFELLTAQEV---SDHV 251
            APE    +   E  D++  G  + EL+    +   +DH+
Sbjct: 190 RAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI 229

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 38/186 (20%), Positives = 81/186 (43%), Gaps = 26/186 (13%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           SL+  +++A +IA  +AYL+   +   V+RD+   N +  E    K+ DF ++  I + +
Sbjct: 136 SLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 192
Query: 202 THIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYE 260
            + +    +    +++PE+    +     DV+ FG  L+E+ T  E              
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-------------- 238
Query: 261 ENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
           +  + LS +      M   ++  DK   C           +L   C  ++P+ RP+ +++
Sbjct: 239 QPYQGLSNEQVLRFVMEGGLL--DKPDNCP------DMLFELMRMCWQYNPKMRPSFLEI 290
Query: 321 AKQLRQ 326
              +++
Sbjct: 291 ISSIKE 296

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 41.2 bits (95), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 51/231 (22%), Positives = 90/231 (38%), Gaps = 31/231 (13%)
Query: 100 HIVYASRMSHKHIIKLIVFESVQIGTLAD--RIHHHCEQHFEALSLTDRLKVAMDIAHAV 157
           +IV    +S + + + I+ E +  G L    R          +L++ D L VA DIA   
Sbjct: 112 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 171
Query: 158 AYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTG 214
            YL        ++RD+   N L         AK+ DF ++  I     + +    +    
Sbjct: 172 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 228
Query: 215 FIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF 273
           ++ PE F   +   + D + FG  L+E+ +      ++ + S+ + E             
Sbjct: 229 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL----GYMPYPSKSNQE------------V 272
Query: 274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
            E V S    D    C G       ++ +T QC    PEDRP    + +++
Sbjct: 273 LEFVTSGGRMDPPKNCPGP-----VYRIMT-QCWQHQPEDRPNFAIILERI 317

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 32/103 (31%), Positives = 46/103 (44%), Gaps = 10/103 (9%)
Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
           + L + + +   ++I  A++YLH   S  +VY D+KP NI+  E+   KL D      I 
Sbjct: 177 QKLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRI- 231
Query: 199 DGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFEL 241
                     + GT GF APE   T      D+Y  G  L  L
Sbjct: 232 -----NSFGYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAAL 269

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/231 (22%), Positives = 89/231 (38%), Gaps = 31/231 (13%)
Query: 100 HIVYASRMSHKHIIKLIVFESVQIGTLAD--RIHHHCEQHFEALSLTDRLKVAMDIAHAV 157
           +IV    +S + + + I+ E +  G L    R          +L++ D L VA DIA   
Sbjct: 109 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 168
Query: 158 AYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTG 214
            YL        ++RD+   N L         AK+ DF ++  I     + +    +    
Sbjct: 169 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVK 225
Query: 215 FIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF 273
           ++ PE F   +   + D + FG  L+E+ +      ++ + S+             N   
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL----GYMPYPSK------------SNQEV 269
Query: 274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
            E V S    D    C G       ++ +T QC    PEDRP    + +++
Sbjct: 270 LEFVTSGGRMDPPKNCPGP-----VYRIMT-QCWQHQPEDRPNFAIILERI 314

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 58/126 (46%), Gaps = 21/126 (16%)
Query: 147 LKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL 206
           L++  D+  A+ YL    S+  ++RD+   N L N+Q   K+ DF LS  + D     E 
Sbjct: 108 LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD----EY 160
Query: 207 DSVVGT---TGFIAPENFT-TLINEQCDVYGFGAFLFEL----------LTAQEVSDHVS 252
            S VG+     +  PE    +  + + D++ FG  ++E+           T  E ++H++
Sbjct: 161 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 220
Query: 253 FESRFH 258
              R +
Sbjct: 221 QGLRLY 226

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/120 (25%), Positives = 56/120 (46%), Gaps = 21/120 (17%)
Query: 147 LKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL 206
           L++  D+  A+ YL    S+  ++RD+   N L N+Q   K+ DF LS  + D     E 
Sbjct: 107 LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD----EY 159
Query: 207 DSVVGT---TGFIAPENFT-TLINEQCDVYGFGAFLFEL----------LTAQEVSDHVS 252
            S VG+     +  PE    +  + + D++ FG  ++E+           T  E ++H++
Sbjct: 160 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 219

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 38/186 (20%), Positives = 80/186 (43%), Gaps = 26/186 (13%)
Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE 201
           SL+  +++A +IA  +AYL+   +   V+RD+   N    E    K+ DF ++  I + +
Sbjct: 123 SLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETD 179
Query: 202 THIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYE 260
            + +    +    +++PE+    +     DV+ FG  L+E+ T  E              
Sbjct: 180 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE-------------- 225
Query: 261 ENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
           +  + LS +      M   ++  DK   C           +L   C  ++P+ RP+ +++
Sbjct: 226 QPYQGLSNEQVLRFVMEGGLL--DKPDNCP------DMLLELMRMCWQYNPKMRPSFLEI 277
Query: 321 AKQLRQ 326
              +++
Sbjct: 278 ISSIKE 283

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 51/231 (22%), Positives = 89/231 (38%), Gaps = 31/231 (13%)
Query: 100 HIVYASRMSHKHIIKLIVFESVQIGTLAD--RIHHHCEQHFEALSLTDRLKVAMDIAHAV 157
           +IV    +S + + + I+ E +  G L    R          +L++ D L VA DIA   
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 158 AYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDSVVGTTG 214
            YL        ++RD+   N L         AK+ DF ++  I     + +    +    
Sbjct: 195 QYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVK 251
Query: 215 FIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF 273
           ++ PE F   +   + D + FG  L+E+ +      ++ + S+             N   
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSL----GYMPYPSK------------SNQEV 295
Query: 274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
            E V S    D    C G       ++ +T QC    PEDRP    + +++
Sbjct: 296 LEFVTSGGRMDPPKNCPGP-----VYRIMT-QCWQHQPEDRPNFAIILERI 340

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 41.2 bits (95), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 31/120 (25%), Positives = 56/120 (46%), Gaps = 21/120 (17%)
Query: 147 LKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL 206
           L++  D+  A+ YL    S+  ++RD+   N L N+Q   K+ DF LS  + D     E 
Sbjct: 103 LEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD----EY 155
Query: 207 DSVVGT---TGFIAPENFT-TLINEQCDVYGFGAFLFEL----------LTAQEVSDHVS 252
            S VG+     +  PE    +  + + D++ FG  ++E+           T  E ++H++
Sbjct: 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 215

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	332
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-49
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	6e-45
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-43
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-42
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-32
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-32
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-31
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-31
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-30
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-29
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-29
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-28
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-28
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	9e-28
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-26
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-26
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-26
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-26
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-20
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-19
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-19
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-18
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-18
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-18
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-18
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-18
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-18
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-18
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	5e-18
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-18
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-18
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	9e-18
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-17
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-17
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-17
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-17
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-17
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-16
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-16
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-16
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-16
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-16
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-16
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-16
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-16
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	5e-16
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	8e-16
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	9e-16
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	9e-16
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-15
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-15
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-15
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-15
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-15
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-15
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-15
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-15
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-15
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-15
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	9e-15
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-14
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-14
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-14
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-14
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-14
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	3e-14
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-14
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-14
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-14
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-14
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-14
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-14
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	5e-14
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-13
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-13
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-13
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-13
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-13
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-13
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-13
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-13
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-13
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-12
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-12
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-12
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-12
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-12
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-12
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-12
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-12
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-12
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-12
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-11
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-11
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-11
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-11
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-11
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-11
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-11
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-11
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-11
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-11
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	6e-11
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	6e-11
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	7e-11
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	7e-11
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-11
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-11
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	8e-11
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-10
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-10
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-10
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-10
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-10
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-10
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-10
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-10
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-10
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-10
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-10
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-10
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-10
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-10
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-10
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-10
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-10
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-10
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-10
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-10
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-10
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-09
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-09
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-09
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-09
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-09
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-09
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-09
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-09
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-09
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-09
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-09
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-09
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-09
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-09
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-09
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-09
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-09
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-09
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-09
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-09
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-08
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-08
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-08
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-08
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-08
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-08
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-08
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-08
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-08
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-08
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-08
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-08
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-08
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-08
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-08
3fme_A	290	Dual specificity mitogen-activated protein kinase;	8e-08
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-07
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-07
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-07
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-07
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-07
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-07
3an0_A	340	Dual specificity mitogen-activated protein kinase;	6e-07
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-07
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	7e-07
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-07
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	9e-07
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-06
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-06
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-06
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-06
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	5e-06
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-06
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-06
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	9e-06
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-05
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-05
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-05
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-05
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-05
3o0g_A	292	Cell division protein kinase 5; kinase activator c	3e-05
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-05
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-05
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-05
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-05
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-05
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-05
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-05
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	6e-05
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-05
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-05
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	8e-05
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	8e-05
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	8e-05
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	9e-05
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-05
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-04
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-04
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-04
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-04
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-04
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-04
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-04
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	4e-04
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-04

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  165 bits (421), Expect = 4e-49
 Identities = 83/312 (26%), Positives = 140/312 (44%), Gaps = 37/312 (11%)

Query: 32  ASSNGKYNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQ-KRSISLMKYNGNRN 90
           +SS             +L  ATNN+D + ++    F K+YKG  +    ++L +     +
Sbjct: 17  SSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS 76

Query: 91  QHALEWCINHIVYASRMSHKHIIKLI-----------VFESVQIGTLADRIHHHCEQHFE 139
           Q   E+    I   S   H H++ LI           +++ ++ G L   ++   +    
Sbjct: 77  QGIEEF-ETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGS-DLPTM 134

Query: 140 ALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD 199
           ++S   RL++ +  A  + YLH      I++RD+K  NIL +E    K+ DF +S    +
Sbjct: 135 SMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTE 191

Query: 200 G-ETHIELDS--VVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFES 255
             +TH+   S  V GT G+I PE F    + E+ DVY FG  LFE+L A+         S
Sbjct: 192 LDQTHL---STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQ----S 244

Query: 256 RFHYEENV---KRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPE 312
                 N+      S  N + +++VD  + +          + L+ F    ++C+  S E
Sbjct: 245 LPREMVNLAEWAVESHNNGQLEQIVDPNLADKIR------PESLRKFGDTAVKCLALSSE 298

Query: 313 DRPTMVDVAKQL 324
           DRP+M DV  +L
Sbjct: 299 DRPSMGDVLWKL 310

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  155 bits (393), Expect = 6e-45
 Identities = 84/308 (27%), Positives = 146/308 (47%), Gaps = 44/308 (14%)

Query: 42  RIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQ-------KRSISLMKYNGNRNQHAL 94
           + FS  EL++A++N+  +NI+    F K+YKG          KR +   +  G   Q   
Sbjct: 18  KRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKR-LKEERTQGGELQFQT 76

Query: 95  EWCINHIVYASRMSHKHIIKLI-----------VFESVQIGTLADRIHHHCEQHFEALSL 143
           E  +  I   S   H+++++L            V+  +  G++A  +    E     L  
Sbjct: 77  E--VEMI---SMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQ-PPLDW 130

Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
             R ++A+  A  +AYLH      I++RD+K  NIL +E+ +A + DF L+  +   +TH
Sbjct: 131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH 190

Query: 204 IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEEN 262
           +    V GT G IAPE  +T   +E+ DV+G+G  L EL+T Q   D     +R   +++
Sbjct: 191 VTTA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL----ARLANDDD 245

Query: 263 ------VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
                 VK L  +  + + +VD  +  +        +++++   Q+ L C   SP +RP 
Sbjct: 246 VMLLDWVKGLLKEK-KLEALVDVDLQGNYK------DEEVEQLIQVALLCTQSSPMERPK 298

Query: 317 MVDVAKQL 324
           M +V + L
Sbjct: 299 MSEVVRML 306

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  150 bits (380), Expect = 4e-43
 Identities = 74/319 (23%), Positives = 134/319 (42%), Gaps = 54/319 (16%)

Query: 42  RIFSAEELRIATNNYDEQNIVLEDP------FRKLYKGFWQ------KRSISLMKYNGNR 89
             FS  EL+  TNN+DE+ I +         F  +YKG+        K+  +++      
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE- 71

Query: 90  NQHALEWCINHIVYASRMSHKHIIKLI-----------VFESVQIGTLADRIHHHCEQHF 138
            +   ++    I   ++  H+++++L+           V+  +  G+L D     C    
Sbjct: 72  -ELKQQF-DQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD--RLSCLDGT 127

Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSI 197
             LS   R K+A   A+ + +LH       ++RD+K  NIL +E   AK+ DF L+  S 
Sbjct: 128 PPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKISDFGLARASE 184

Query: 198 PDGETHIELDS--VVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFES 255
              +T +   +  +VGTT ++APE     I  + D+Y FG  L E++T     D    E 
Sbjct: 185 KFAQTVM---TSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVD----EH 237

Query: 256 RFHYEEN----VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSP 311
           R    +      + +  +    ++ +D   + D           ++A   +  QC+    
Sbjct: 238 R--EPQLLLDIKEEIEDEEKTIEDYIDK-KMNDAD------STSVEAMYSVASQCLHEKK 288

Query: 312 EDRPTMVDVAKQLRQMYRS 330
             RP +  V + L++M  S
Sbjct: 289 NKRPDIKKVQQLLQEMTAS 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  149 bits (377), Expect = 1e-42
 Identities = 63/323 (19%), Positives = 119/323 (36%), Gaps = 51/323 (15%)

Query: 44  FSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEW-CINHIV 102
              E L   +       +     F  ++K       +++  +     Q    W     + 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFP---IQDKQSWQNEYEVY 70

Query: 103 YASRMSHKHIIKLI---------------VFESVQIGTLADRIHHHCEQHFEALSLTDRL 147
               M H++I++ I               +    + G+L+D +  +       +S  +  
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN------VVSWNELC 124

Query: 148 KVAMDIAHAVAYLH------VGFSRP-IVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
            +A  +A  +AYLH          +P I +RD+K  N+L      A + DF L+L    G
Sbjct: 125 HIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAG 184

Query: 201 ETHIELDSVVGTTGFIAPE------NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFE 254
           ++  +    VGT  ++APE      NF      + D+Y  G  L+EL +    +D    E
Sbjct: 185 KSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE 244

Query: 255 SRFHYEENVKRLSGQNCRFKEMVDSIIIED------KSCTCTGKEQQLQAFKQLTLQCMD 308
               +EE +    GQ+   ++M + ++ +              K   +    +   +C D
Sbjct: 245 YMLPFEEEI----GQHPSLEDMQEVVVHKKKRPVLRDYWQ---KHAGMAMLCETIEECWD 297

Query: 309 FSPEDRPTMVDVAKQLRQMYRSC 331
              E R +   V +++ QM R  
Sbjct: 298 HDAEARLSAGCVGERITQMQRLT 320

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  122 bits (308), Expect = 1e-32
 Identities = 55/298 (18%), Positives = 108/298 (36%), Gaps = 47/298 (15%)

Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYA-SRMSHKHIIKLI--------- 116
           + +++ G W+   +++  +          W     +Y    M H++I+  I         
Sbjct: 50  YGEVWMGKWRGEKVAVKVF---FTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGS 106

Query: 117 ------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLH-----VGFS 165
                 + +  + G+L D +          L     LK+A      + +LH         
Sbjct: 107 WTQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGK 160

Query: 166 RPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDS--VVGTTGFIAPENFTT 223
             I +RD+K  NIL  +     + D  L++        +++     VGT  ++ PE    
Sbjct: 161 PAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220

Query: 224 LIN-------EQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM 276
            +N          D+Y FG  L+E+         V  E +  Y +    L   +  +++M
Sbjct: 221 SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE-EYQLPYHD----LVPSDPSYEDM 275

Query: 277 VDSIIIEDKS---CTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSC 331
            + + I+            ++ L+   +L  +C   +P  R T + V K L +M  S 
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ 333

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  122 bits (308), Expect = 2e-32
 Identities = 58/330 (17%), Positives = 112/330 (33%), Gaps = 56/330 (16%)

Query: 44  FSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVY 103
            +A E  +  +N     ++    +  +YKG   +R +++  +      +   +     +Y
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVF---SFANRQNFINEKNIY 59

Query: 104 A-SRMSHKHIIKLI----------------VFESVQIGTLADRIHHHCEQHFEALSLTDR 146
               M H +I + I                V E    G+L   +  H             
Sbjct: 60  RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH------TSDWVSS 113

Query: 147 LKVAMDIAHAVAYLH------VGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL----- 195
            ++A  +   +AYLH        +   I +RD+   N+L        + DF LS+     
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 196 -SIPDGETHIELDSVVGTTGFIAPENFTTLIN--------EQCDVYGFGAFLFELLTA-- 244
             +  GE      S VGT  ++APE     +N        +Q D+Y  G   +E+     
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 245 QEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDK----SCTCTGKEQQLQAFK 300
                    E +  ++  V    G +  F++M   +  E +              +++ K
Sbjct: 234 DLFPGESVPEYQMAFQTEV----GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLK 289

Query: 301 QLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
           +    C D   E R T     +++ ++   
Sbjct: 290 ETIEDCWDQDAEARLTAQXAEERMAELMMI 319

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  119 bits (301), Expect = 2e-31
 Identities = 52/302 (17%), Positives = 116/302 (38%), Gaps = 55/302 (18%)

Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYA-SRMSHKHIIKL---------- 115
           F ++++G W+   +++  +    ++    W     +Y    + H++I+            
Sbjct: 55  FGEVWRGKWRGEEVAVKIF---SSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGT 111

Query: 116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLH-----VGFS 165
                +V +  + G+L D ++ +       +++   +K+A+  A  +A+LH         
Sbjct: 112 WTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGK 165

Query: 166 RPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDS--VVGTTGFIAPENFTT 223
             I +RD+K  NIL  +     + D  L++        I++     VGT  ++APE    
Sbjct: 166 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225

Query: 224 LIN-------EQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM 276
            IN       ++ D+Y  G   +E+     +           Y+     L   +   +EM
Sbjct: 226 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE-----DYQLPYYDLVPSDPSVEEM 280

Query: 277 VDSII-------IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
              +        I ++  +C    + L+   ++  +C   +   R T + + K L Q+ +
Sbjct: 281 RKVVCEQKLRPNIPNRWQSC----EALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336

Query: 330 SC 331
             
Sbjct: 337 QE 338

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  115 bits (290), Expect = 3e-30
 Identities = 57/277 (20%), Positives = 116/277 (41%), Gaps = 46/277 (16%)

Query: 67  FRKLYKGFWQKRS--ISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL--------- 115
           F  + K  W+ +   I  ++    R    +E     +   SR++H +I+KL         
Sbjct: 21  FGVVCKAKWRAKDVAIKQIESESERKAFIVE-----LRQLSRVNHPNIVKLYGACLNPVC 75

Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +V E  + G+L + +H    +     +    +   +  +  VAYLH    + +++RD+KP
Sbjct: 76  LVMEYAEGGSLYNVLHGA--EPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKP 133

Query: 176 TNILFNEQ-SDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYG 233
            N+L     +  K+ DF  +      +    + +  G+  ++APE F  +  +E+CDV+ 
Sbjct: 134 PNLLLVAGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFS 188

Query: 234 FGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKE 293
           +G  L+E++T ++  D +   + F     V        R        +I++         
Sbjct: 189 WGIILWEVITRRKPFDEIGGPA-FRIMWAVH----NGTRPP------LIKN--LP----- 230

Query: 294 QQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
              +  + L  +C    P  RP+M ++ K +  + R 
Sbjct: 231 ---KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  113 bits (286), Expect = 1e-29
 Identities = 48/294 (16%), Positives = 115/294 (39%), Gaps = 47/294 (15%)

Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYA-SRMSHKHIIKL---------- 115
           + ++++G WQ  ++++  +    ++    W     +Y    + H++I+            
Sbjct: 21  YGEVWRGSWQGENVAVKIF---SSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHS 77

Query: 116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLH-----VGFS 165
                ++    ++G+L D +          L     L++ + IA  +A+LH         
Sbjct: 78  STQLWLITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131

Query: 166 RPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD--SVVGTTGFIAPE---- 219
             I +RD+K  NIL  +     + D  L++        +++     VGT  ++APE    
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191

Query: 220 --NFTTLI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM 276
                     ++ D++ FG  L+E+      +  V  + +  + +    +   +  F++M
Sbjct: 192 TIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE-DYKPPFYD----VVPNDPSFEDM 246

Query: 277 VDSIIIEDKS---CTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
              + ++ +          +  L +  +L  +C   +P  R T + + K L ++
Sbjct: 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI 300

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  112 bits (282), Expect = 4e-29
 Identities = 58/286 (20%), Positives = 106/286 (37%), Gaps = 55/286 (19%)

Query: 67  FRKLYKGFWQKRS----ISLMKYNGNRNQHALEWCINH----IVYASRMSHKHIIKL--- 115
           F  ++KG   K      I  +    +  +  +          +   S ++H +I+KL   
Sbjct: 32  FGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL 91

Query: 116 ------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIV 169
                 +V E V  G L  R+          +  + +L++ +DIA  + Y+    + PIV
Sbjct: 92  MHNPPRMVMEFVPCGDLYHRLLDKAHP----IKWSVKLRLMLDIALGIEYMQ-NQNPPIV 146

Query: 170 YRDMKPTNILFNEQSD-----AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT- 223
           +RD++  NI      +     AK+ DF LS      ++   +  ++G   ++APE     
Sbjct: 147 HRDLRSPNIFLQSLDENAPVCAKVADFGLS-----QQSVHSVSGLLGNFQWMAPETIGAE 201

Query: 224 --LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSII 281
                E+ D Y F   L+ +LT +   D  S+          +    +  R        I
Sbjct: 202 EESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE----EGLRPT------I 251

Query: 282 IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
            ED  C            + +   C    P+ RP    + K+L ++
Sbjct: 252 PED--C--------PPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  110 bits (277), Expect = 2e-28
 Identities = 44/286 (15%), Positives = 89/286 (31%), Gaps = 63/286 (22%)

Query: 66  PFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYA-SRMSHKHIIKL--------- 115
              +L+KG WQ   I +                N         SH +++ +         
Sbjct: 22  HSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA 81

Query: 116 ----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYR 171
               ++   +  G+L + +H   E     +  +  +K A+D+A  +A+LH      I   
Sbjct: 82  PHPTLITHWMPYGSLYNVLH---EGTNFVVDQSQAVKFALDMARGMAFLH-TLEPLIPRH 137

Query: 172 DMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF----TTLINE 227
            +   +++ +E   A++    +  S             +    ++APE            
Sbjct: 138 ALNSRSVMIDEDMTARISMADVKFSFQSP-------GRMYAPAWVAPEALQKKPEDTNRR 190

Query: 228 QCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIED--- 284
             D++ F   L+EL+T +     +S                      E+   + +E    
Sbjct: 191 SADMWSFAVLLWELVTREVPFADLSNM--------------------EIGMKVALEGLRP 230

Query: 285 ---KSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
                 +            +L   CM+  P  RP    +   L +M
Sbjct: 231 TIPPGIS--------PHVSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  109 bits (274), Expect = 5e-28
 Identities = 45/241 (18%), Positives = 93/241 (38%), Gaps = 43/241 (17%)

Query: 105 SRMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
            +  H +I+            IV +  +  +L   +H    +      +   + +A   A
Sbjct: 75  RKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASETK----FEMKKLIDIARQTA 130

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
             + YLH   ++ I++RD+K  NI  +E +  K+ DF L+          + + + G+  
Sbjct: 131 RGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187

Query: 215 FIAPE----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHY--EENVKRLSG 268
           ++APE      +   + Q DVY FG  L+EL+T Q    +++   +              
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDL 247

Query: 269 QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY 328
              R             +C         +  K+L  +C+    ++RP+   +  ++ ++ 
Sbjct: 248 SKVR------------SNC--------PKRMKRLMAECLKKKRDERPSFPRILAEIEELA 287

Query: 329 R 329
           R
Sbjct: 288 R 288

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  109 bits (274), Expect = 9e-28
 Identities = 58/248 (23%), Positives = 99/248 (39%), Gaps = 59/248 (23%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
            R+ H +I+             IV E +  G+L   +H       E L    RL +A D+
Sbjct: 89  KRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKS--GAREQLDERRRLSMAYDV 146

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT 213
           A  + YLH   + PIV+R++K  N+L +++   K+ DF LS       T +   S  GT 
Sbjct: 147 AKGMNYLH-NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTP 203

Query: 214 GFIAPENFTTLI-----NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG 268
            ++APE    ++     NE+ DVY FG  L+EL T Q+   +++                
Sbjct: 204 EWMAPE----VLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA-------------- 245

Query: 269 QNCRFKEMVDSIIIED------KSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK 322
                 ++V ++  +       ++               +   C    P  RP+   +  
Sbjct: 246 ------QVVAAVGFKCKRLEIPRNLN--------PQVAAIIEGCWTNEPWKRPSFATIMD 291

Query: 323 QLRQMYRS 330
            LR + +S
Sbjct: 292 LLRPLIKS 299

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  103 bits (260), Expect = 4e-26
 Identities = 57/285 (20%), Positives = 100/285 (35%), Gaps = 57/285 (20%)

Query: 67  FRKLYKGFWQKRSI---SLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-------- 115
           F K+Y+ FW    +   +            +E         + + H +II L        
Sbjct: 20  FGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEP 79

Query: 116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRD 172
              +V E  + G L   +          +     +  A+ IA  + YLH     PI++RD
Sbjct: 80  NLCLVMEFARGGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRD 133

Query: 173 MKPTNILFNEQSD--------AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF-TT 223
           +K +NIL  ++ +         K+ DF L+             S  G   ++APE    +
Sbjct: 134 LKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRAS 189

Query: 224 LINEQCDVYGFGAFLFELLTAQEVSDHVS-FESRFHYEENVKRLSGQNCRFKEMVDSIII 282
           + ++  DV+ +G  L+ELLT +     +      +    N   L              I 
Sbjct: 190 MFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP-------------IP 236

Query: 283 EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
               C         + F +L   C +  P  RP+  ++  QL  +
Sbjct: 237 ST--CP--------EPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  104 bits (261), Expect = 6e-26
 Identities = 39/251 (15%), Positives = 81/251 (32%), Gaps = 54/251 (21%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
            +  H++++             I+    +  TL   +          L +    ++A +I
Sbjct: 84  RQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIV----LDVNKTRQIAQEI 139

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS---LSIPDGETHIELDSVV 210
              + YLH   ++ I+++D+K  N+ ++      + DF L      +  G    +L    
Sbjct: 140 VKGMGYLH---AKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQN 195

Query: 211 GTTGFIAPENFTTLI----------NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYE 260
           G    +APE    L           ++  DV+  G   +EL   +        E+     
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA----- 250

Query: 261 ENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
             +    G   +         +              +    + L C  F  E+RPT   +
Sbjct: 251 --IIWQMGTGMKPN-------LSQIGMG--------KEISDILLFCWAFEQEERPTFTKL 293

Query: 321 AKQLRQMYRSC 331
              L ++ +  
Sbjct: 294 MDMLEKLPKRN 304

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  103 bits (260), Expect = 7e-26
 Identities = 58/257 (22%), Positives = 95/257 (36%), Gaps = 66/257 (25%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
             + H +++K             + E ++ GTL   I     Q       + R+  A DI
Sbjct: 62  RCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQ----YPWSQRVSFAKDI 117

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD------ 207
           A  +AYLH   S  I++RD+   N L  E  +  + DF L+  + D +T  E        
Sbjct: 118 ASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174

Query: 208 ------SVVGTTGFIAPE-----NFTTLINEQCDVYGFGAFLFELLTAQEV-SDHVSFES 255
                 +VVG   ++APE     ++     E+ DV+ FG  L E++       D++    
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRSYD----EKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230

Query: 256 RFH--YEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPED 313
            F       + R    NC                          +F  +T++C D  PE 
Sbjct: 231 DFGLNVRGFLDRYCPPNC------------------------PPSFFPITVRCCDLDPEK 266

Query: 314 RPTMVDVAKQLRQMYRS 330
           RP+ V +   L  +   
Sbjct: 267 RPSFVKLEHWLETLRMH 283

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 88.6 bits (220), Expect = 3e-20
 Identities = 47/264 (17%), Positives = 92/264 (34%), Gaps = 51/264 (19%)

Query: 90  NQHALEWCINHIVYASRMSHKHIIKL---------------IVFESVQIGTLADRIHHHC 134
            Q   E            +H +I++L               ++    + GTL + I    
Sbjct: 66  EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLK 125

Query: 135 EQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF-SL 193
           ++    L+    L + + I   +  +H   ++   +RD+KPTNIL  ++    L D  S+
Sbjct: 126 DKG-NFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSM 181

Query: 194 SLSIPDGETH------IELDSVVGTTGFIAPENFT----TLINEQCDVYGFGAFLFELLT 243
           + +    E         +  +   T  + APE F+     +I+E+ DV+  G  L+ ++ 
Sbjct: 182 NQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMF 241

Query: 244 AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLT 303
            +       ++  F   ++V           +                  +   A  QL 
Sbjct: 242 GE-----GPYDMVFQKGDSVALAVQNQLSIPQ----------------SPRHSSALWQLL 280

Query: 304 LQCMDFSPEDRPTMVDVAKQLRQM 327
              M   P  RP +  +  QL  +
Sbjct: 281 NSMMTVDPHQRPHIPLLLSQLEAL 304

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 85.8 bits (213), Expect = 2e-19
 Identities = 46/234 (19%), Positives = 81/234 (34%), Gaps = 34/234 (14%)

Query: 104 ASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMD 152
           A R+   H++ +           +    +    LA  +          L+    + +   
Sbjct: 88  AGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQ 142

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I  A+   H   +    +RD+KP NIL +    A L DF ++ +    E   +L + VGT
Sbjct: 143 IGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASAT-TDEKLTQLGNTVGT 198

Query: 213 TGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQE--VSDHVSFESRFHYEENVKRLSGQ 269
             ++APE F+      + D+Y     L+E LT       D +S     H  + + R S  
Sbjct: 199 LYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGA-HINQAIPRPSTV 257

Query: 270 NCRFKEMVDSIIIEDKSCTCTGKE-----QQLQAFKQLTLQCMDFSPEDRPTMV 318
                   D++I          K                   +  + +DR T +
Sbjct: 258 RPGIPVAFDAVIA-----RGMAKNPEDRYVTCGDLSAAAHAALATADQDRATDI 306

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 86.8 bits (215), Expect = 5e-19
 Identities = 39/156 (25%), Positives = 58/156 (37%), Gaps = 33/156 (21%)

Query: 104 ASRMSHKHIIKL----------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRL 147
            + + H  I+++                IV E V   +L            + L + + +
Sbjct: 133 LAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG-------QKLPVAEAI 185

Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD 207
              ++I  A++YLH   S  +VY D+KP NI+  E    KL D      I          
Sbjct: 186 AYLLEILPALSYLH---SIGLVYNDLKPENIMLTE-EQLKLIDLGAVSRI--NSF----G 235

Query: 208 SVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLT 243
            + GT GF APE   T      D+Y  G  L  L  
Sbjct: 236 YLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTL 271

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 85.1 bits (211), Expect = 2e-18
 Identities = 41/152 (26%), Positives = 70/152 (46%), Gaps = 25/152 (16%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           ++ H +I+KL           +V E    G L D I     + F   S  D  ++   + 
Sbjct: 82  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR--KRF---SEVDAARIIRQVL 136

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
             + Y+H      IV+RD+KP N+L    ++ ++ ++ DF LS      +    +   +G
Sbjct: 137 SGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIG 190

Query: 212 TTGFIAPENFTTLINEQCDVYGFGAFLFELLT 243
           T  +IAPE      +E+CDV+  G  L+ LL+
Sbjct: 191 TAYYIAPEVLHGTYDEKCDVWSTGVILYILLS 222

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 83.7 bits (207), Expect = 2e-18
 Identities = 34/164 (20%), Positives = 64/164 (39%), Gaps = 34/164 (20%)

Query: 106 RMSHKHIIKL-------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMD 152
           +++HK+I+KL             ++ E    G+L   +      +   L  ++ L V  D
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRD 120

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA----KLFDFSLSLSIPDGETHIELDS 208
           +   + +L       IV+R++KP NI+     D     KL DF  +  + D E      S
Sbjct: 121 VVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVS 174

Query: 209 VVGTTGFIAPENFTTLI---------NEQCDVYGFGAFLFELLT 243
           + GT  ++ P+ +   +             D++  G   +   T
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 51/248 (20%), Positives = 89/248 (35%), Gaps = 58/248 (23%)

Query: 109 HKHIIKL-----------IVFESVQIGTLADRI--HHHCEQHFEALSLTDRLKVAMDIAH 155
           H ++I+            I  E      L D +   +  +++ +     + + +   IA 
Sbjct: 68  HPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILF-------------NEQSDAKLFDFSLSLSIPDGET 202
            VA+LH   S  I++RD+KP NIL               E     + DF L   +  G++
Sbjct: 127 GVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQS 183

Query: 203 --HIELDSVVGTTGFIAPE--------NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVS 252
                L++  GT+G+ APE             +    D++  G   + +L+         
Sbjct: 184 SFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILS----KGKHP 239

Query: 253 FESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPE 312
           F  ++  E N+ R        K + D  +I +                 L  Q +D  P 
Sbjct: 240 FGDKYSRESNIIRGIFSLDEMKCLHDRSLIAE--------------ATDLISQMIDHDPL 285

Query: 313 DRPTMVDV 320
            RPT + V
Sbjct: 286 KRPTAMKV 293

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 25/152 (16%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
            + H +I+KL           +V E  + G L D I H     F   +  D   +   + 
Sbjct: 92  LLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR--MKF---NEVDAAVIIKQVL 146

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
             V YLH      IV+RD+KP N+L     + +  K+ DF LS    + +    +   +G
Sbjct: 147 SGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLG 200

Query: 212 TTGFIAPENFTTLINEQCDVYGFGAFLFELLT 243
           T  +IAPE      +E+CDV+  G  LF LL 
Sbjct: 201 TAYYIAPEVLRKKYDEKCDVWSIGVILFILLA 232

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 84.4 bits (209), Expect = 2e-18
 Identities = 37/156 (23%), Positives = 61/156 (39%), Gaps = 29/156 (18%)

Query: 109 HKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAV 157
           H ++I+            I  E     TL + +    EQ   A    + + +       +
Sbjct: 77  HPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV----EQKDFAHLGLEPITLLQQTTSGL 131

Query: 158 AYLHVGFSRPIVYRDMKPTNILFNEQSD-----AKLFDFSLSLSIPDGETHI-ELDSVVG 211
           A+LH   S  IV+RD+KP NIL +  +      A + DF L   +  G         V G
Sbjct: 132 AHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPG 188

Query: 212 TTGFIAPE----NFTTLINEQCDVYGFGAFLFELLT 243
           T G+IAPE    +         D++  G   + +++
Sbjct: 189 TEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVIS 224

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 84.4 bits (209), Expect = 3e-18
 Identities = 46/152 (30%), Positives = 65/152 (42%), Gaps = 25/152 (16%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
            + H +IIKL           +V E  + G L ++I +     F      D   +   I 
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR--HKF---DECDAANIMKQIL 156

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
             + YLH      IV+RD+KP NIL    N   + K+ DF LS           L   +G
Sbjct: 157 SGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLG 210

Query: 212 TTGFIAPENFTTLINEQCDVYGFGAFLFELLT 243
           T  +IAPE      NE+CDV+  G  ++ LL 
Sbjct: 211 TAYYIAPEVLKKKYNEKCDVWSCGVIMYILLC 242

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 82.4 bits (204), Expect = 4e-18
 Identities = 42/242 (17%), Positives = 81/242 (33%), Gaps = 59/242 (24%)

Query: 101 IVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKV 149
             +     H   ++L           +  E     +L      HCE    +L        
Sbjct: 108 GSHEKVGQHPCCVRLEQAWEEGGILYLQTELCG-PSLQQ----HCEAWGASLPEAQVWGY 162

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
             D   A+A+LH   S+ +V+ D+KP NI    +   KL DF L + +         +  
Sbjct: 163 LRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQ 216

Query: 210 VGTTGFIAPENFTTLINEQ----CDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKR 265
            G   ++APE    L+        DV+  G  + E+    E+          H  E    
Sbjct: 217 EGDPRYMAPE----LLQGSYGTAADVFSLGLTILEVACNMEL---------PHGGEG--- 260

Query: 266 LSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR 325
                  ++++    +  + +   +         + + +  ++  P+ R T    A+ L 
Sbjct: 261 -------WQQLRQGYLPPEFTAGLS------SELRSVLVMMLEPDPKLRAT----AEALL 303

Query: 326 QM 327
            +
Sbjct: 304 AL 305

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 82.7 bits (204), Expect = 5e-18
 Identities = 35/231 (15%), Positives = 73/231 (31%), Gaps = 32/231 (13%)

Query: 42  RIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISL------MKYNGNRNQHALE 95
            I    E ++ +      +++ E  F ++Y+      + +       +K     N     
Sbjct: 53  AIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFY 112

Query: 96  WCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLT 144
                +           +K            +V E    GTL + I+ +     + +   
Sbjct: 113 IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQG 172

Query: 145 DRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA-----------KLFDFSL 193
             +  AM + + +  +H      I++ D+KP N +                   L D   
Sbjct: 173 LVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229

Query: 194 SLSIPDGETHIELDSVVGTTGFIAPENFTTLI-NEQCDVYGFGAFLFELLT 243
           S+ +          +   T+GF   E  +    N Q D +G  A ++ +L 
Sbjct: 230 SIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLF 280

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 81.6 bits (202), Expect = 6e-18
 Identities = 49/260 (18%), Positives = 91/260 (35%), Gaps = 71/260 (27%)

Query: 105 SRMSHKHIIKL------------------------IVFESVQIGTLADRIHHHCEQHFEA 140
           + ++H+++++                         I  E  + GTL D IH         
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRD 116

Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS------ 194
                  ++   I  A++Y+H   S+ I++RD+KP NI  +E  + K+ DF L+      
Sbjct: 117 EYW----RLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRS 169

Query: 195 ------LSIPDGETHIELDSVVGTTGFIAPE--NFTTLINEQCDVYGFGAFLFELLTAQE 246
                  S     +   L S +GT  ++A E  + T   NE+ D+Y  G   FE++    
Sbjct: 170 LDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP-- 227

Query: 247 VSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQC 306
                     F                  ++  +            + +++  K++    
Sbjct: 228 ----------FSTGMER----------VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLL 267

Query: 307 MDFSPEDRPTMVDVAKQLRQ 326
           +D  P  RP     A+ L  
Sbjct: 268 IDHDPNKRPG----ARTLLN 283

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 81.5 bits (202), Expect = 7e-18
 Identities = 42/153 (27%), Positives = 73/153 (47%), Gaps = 25/153 (16%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDR--LKVAMD 152
            + H +IIK+           IV E+ + G L +RI           +L++    ++   
Sbjct: 76  SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERI---VSAQARGKALSEGYVAELMKQ 132

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           + +A+AY H   S+ +V++D+KP NILF   +  S  K+ DF L+      E      + 
Sbjct: 133 MMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNA 186

Query: 210 VGTTGFIAPENFTTLINEQCDVYGFGAFLFELL 242
            GT  ++APE F   +  +CD++  G  ++ LL
Sbjct: 187 AGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLL 219

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 82.2 bits (203), Expect = 9e-18
 Identities = 34/164 (20%), Positives = 64/164 (39%), Gaps = 34/164 (20%)

Query: 106 RMSHKHIIKL-------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMD 152
           +++HK+I+KL             ++ E    G+L   +      +   L  ++ L V  D
Sbjct: 63  KLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRD 120

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA----KLFDFSLSLSIPDGETHIELDS 208
           +   + +L       IV+R++KP NI+     D     KL DF  +  + D E      S
Sbjct: 121 VVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVS 174

Query: 209 VVGTTGFIAPENFTTLI---------NEQCDVYGFGAFLFELLT 243
           + GT  ++ P+ +   +             D++  G   +   T
Sbjct: 175 LYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 26/151 (17%), Positives = 53/151 (35%), Gaps = 22/151 (14%)

Query: 105 SRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGF 164
             M       L       + T  + +  H   H ++L    RL++ + +   +A LH   
Sbjct: 168 RDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH-KSLVHHARLQLTLQVIRLLASLH--- 223

Query: 165 SRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE----- 219
              +V+  ++P +I+ +++    L  F     + DG           + GF  PE     
Sbjct: 224 HYGLVHTYLRPVDIVLDQRGGVFLTGF--EHLVRDGARV----VSSVSRGFEPPELEARR 277

Query: 220 -------NFTTLINEQCDVYGFGAFLFELLT 243
                  +  TL+    D +  G  ++ +  
Sbjct: 278 ATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 45/152 (29%), Positives = 67/152 (44%), Gaps = 25/152 (16%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           ++ H +I+KL           IV E    G L D I     + F   S  D  ++   + 
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRF---SEHDAARIIKQVF 131

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
             + Y+H      IV+RD+KP NIL     +  D K+ DF LS           +   +G
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIG 185

Query: 212 TTGFIAPENFTTLINEQCDVYGFGAFLFELLT 243
           T  +IAPE      +E+CDV+  G  L+ LL+
Sbjct: 186 TAYYIAPEVLRGTYDEKCDVWSAGVILYILLS 217

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 80.3 bits (199), Expect = 1e-17
 Identities = 42/151 (27%), Positives = 69/151 (45%), Gaps = 25/151 (16%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
            + H +II+L           +V E    G L +R+ H   + F     +D  ++  D+ 
Sbjct: 62  SLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK--RVF---RESDAARIMKDVL 116

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
            AVAY H      + +RD+KP N LF   +  S  KL DF L+     G+    + + VG
Sbjct: 117 SAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVG 170

Query: 212 TTGFIAPENFTTLINEQCDVYGFGAFLFELL 242
           T  +++P+    L   +CD +  G  ++ LL
Sbjct: 171 TPYYVSPQVLEGLYGPECDEWSAGVMMYVLL 201

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 80.4 bits (199), Expect = 2e-17
 Identities = 39/152 (25%), Positives = 73/152 (48%), Gaps = 21/152 (13%)

Query: 104 ASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMD 152
           +S++SH++I+ +           +V E ++  TL++ I  H       LS+   +     
Sbjct: 65  SSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESH-----GPLSVDTAINFTNQ 119

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + + H      IV+RD+KP NIL +     K+FDF ++ ++    +  + + V+GT
Sbjct: 120 ILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL-SETSLTQTNHVLGT 175

Query: 213 TGFIAPENFT-TLINEQCDVYGFGAFLFELLT 243
             + +PE       +E  D+Y  G  L+E+L 
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLV 207

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 78.8 bits (195), Expect = 7e-17
 Identities = 51/253 (20%), Positives = 104/253 (41%), Gaps = 47/253 (18%)

Query: 104 ASRMSHKHIIKL---------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLK 148
           A+ ++H  I+ +               IV E V   TL D +H         ++    ++
Sbjct: 66  AAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIE 120

Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHI-ELD 207
           V  D   A+ + H      I++RD+KP NI+ +  +  K+ DF ++ +I D    + +  
Sbjct: 121 VIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177

Query: 208 SVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSF--ESRF-----HY 259
           +V+GT  +++PE      ++ + DVY  G  L+E+LT         F  +S       H 
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG-----EPPFTGDSPVSVAYQHV 232

Query: 260 EENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKE-----QQLQAFKQLTLQCMDFSPEDR 314
            E+    S ++      +D++++         K      Q     +   ++  +  P + 
Sbjct: 233 REDPIPPSARHEGLSADLDAVVL-----KALAKNPENRYQTAAEMRADLVRVHNGEPPEA 287

Query: 315 PTMVDVAKQLRQM 327
           P ++  A++   +
Sbjct: 288 PKVLTDAERTSLL 300

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 78.0 bits (193), Expect = 1e-16
 Identities = 45/151 (29%), Positives = 66/151 (43%), Gaps = 25/151 (16%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           ++ H +I+KL           IV E    G L D I     + F   S  D  ++   + 
Sbjct: 77  KLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR--KRF---SEHDAARIIKQVF 131

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
             + Y+H      IV+RD+KP NIL     +  D K+ DF LS           +   +G
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIG 185

Query: 212 TTGFIAPENFTTLINEQCDVYGFGAFLFELL 242
           T  +IAPE      +E+CDV+  G  L+ LL
Sbjct: 186 TAYYIAPEVLRGTYDEKCDVWSAGVILYILL 216

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 34/159 (21%), Positives = 62/159 (38%), Gaps = 29/159 (18%)

Query: 106 RMSHKHIIKL-----------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLK 148
           +++H +++                   +  E  + G L   ++    ++   L       
Sbjct: 68  KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLKEGPIRT 125

Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHIE 205
           +  DI+ A+ YLH      I++RD+KP NI+     ++   K+ D   +  +  GE    
Sbjct: 126 LLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL--- 179

Query: 206 LDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT 243
               VGT  ++APE           D + FG   FE +T
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECIT 218

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 77.7 bits (192), Expect = 1e-16
 Identities = 39/137 (28%), Positives = 60/137 (43%), Gaps = 24/137 (17%)

Query: 109 HKHIIKL-----------IVFESVQIGTLADRIHHHCEQHF-EALSLTDRLKVAMDIAHA 156
           H +II+L           +VF+ ++ G L D +         E     +  K+   +   
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEK----ETRKIMRALLEV 136

Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFI 216
           +  LH      IV+RD+KP NIL ++  + KL DF  S  +  GE    L  V GT  ++
Sbjct: 137 ICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTPSYL 190

Query: 217 APENFTTLINEQCDVYG 233
           APE     +N+    YG
Sbjct: 191 APEIIECSMNDNHPGYG 207

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 78.6 bits (193), Expect = 1e-16
 Identities = 23/226 (10%), Positives = 53/226 (23%), Gaps = 34/226 (15%)

Query: 115 LIVFESVQ--IGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRD 172
           L++  +    +  L   +            +     +   +    A L    S+ +V+  
Sbjct: 164 LLLMPAASVDLELLFSTLDFVYVFR-GDEGILALHILTAQLIRLAANLQ---SKGLVHGH 219

Query: 173 MKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF---TTLINEQC 229
             P N+         L D   S     G       +      +   E     T       
Sbjct: 220 FTPDNLFIMPDGRLMLGDV--SALWKVGTR---GPASSVPVTYAPREFLNASTATFTHAL 274

Query: 230 DVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTC 289
           + +  G  ++ +         + F       +   +         + +            
Sbjct: 275 NAWQLGLSIYRVWCL-----FLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLP--- 326

Query: 290 TGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVA-----KQLRQMYRS 330
                     K L  + ++F    R   ++        QL+    S
Sbjct: 327 -------DFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISS 365

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 27/160 (16%), Positives = 68/160 (42%), Gaps = 23/160 (14%)

Query: 101 IVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHH---CEQHFEALSLTDR 146
           +   + + +++ +             I++E ++  ++     +     + +   + +   
Sbjct: 94  LQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153

Query: 147 LKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL 206
             +   + ++ +Y+H    + I +RD+KP+NIL ++    KL DF  S  + D     ++
Sbjct: 154 KCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KI 207

Query: 207 DSVVGTTGFIAPE---NFTTLINEQCDVYGFGAFLFELLT 243
               GT  F+ PE   N ++    + D++  G  L+ +  
Sbjct: 208 KGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 78.2 bits (192), Expect = 3e-16
 Identities = 22/136 (16%), Positives = 50/136 (36%), Gaps = 13/136 (9%)

Query: 115 LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
           L       + T  + +  H   H ++L    RL++ + +   +A LH      +V+  ++
Sbjct: 183 LYPRMQSNLQTFGEVLLSHSSTH-KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLR 238

Query: 175 PTNILFNEQSDAKLFDFSLSLSIPDGETHI-ELDSVVGTTGFIAPENF------TTLINE 227
           P +I+ +++    L  F   +   DG + +  +          A           TL+  
Sbjct: 239 PVDIVLDQRGGVFLTGFEHLV--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTF 296

Query: 228 QCDVYGFGAFLFELLT 243
             D +  G  ++ +  
Sbjct: 297 AFDTWTLGLAIYWIWC 312

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 77.4 bits (191), Expect = 4e-16
 Identities = 40/137 (29%), Positives = 62/137 (45%), Gaps = 24/137 (17%)

Query: 109 HKHIIKL-----------IVFESVQIGTLADRIHHHCEQHF-EALSLTDRLKVAMDIAHA 156
           H HII L           +VF+ ++ G L D +         E     +   +   +  A
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK--VALSEK----ETRSIMRSLLEA 212

Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFI 216
           V++LH   +  IV+RD+KP NIL ++    +L DF  S  +  GE    L  + GT G++
Sbjct: 213 VSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYL 266

Query: 217 APENFTTLINEQCDVYG 233
           APE     ++E    YG
Sbjct: 267 APEILKCSMDETHPGYG 283

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 76.5 bits (189), Expect = 5e-16
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 39/162 (24%)

Query: 109 HKHIIKL-----------IVFESVQIGTLADRIHHHCEQHF---EALSLTDRLKVAMDIA 154
           H+++++L           +VFE ++ G++   IH    +HF   EA  +        D+A
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVV------QDVA 121

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHI-----EL 206
            A+ +LH   ++ I +RD+KP NIL    N+ S  K+ DF L   I            EL
Sbjct: 122 SALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178

Query: 207 DSVVGTTGFIAPE------NFTTLINEQCDVYGFGAFLFELL 242
            +  G+  ++APE         ++ +++CD++  G  L+ LL
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL 220

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 76.1 bits (188), Expect = 5e-16
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 28/153 (18%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHF-EALSLTDRLKVAMDI 153
           ++ H +I++L           +VF+ V  G L + I     + + EA    D       I
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEA----DASHCIQQI 114

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
             ++AY H   S  IV+R++KP N+L     + +  KL DF L++ + D E         
Sbjct: 115 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFA 168

Query: 211 GTTGFIAPENFT-TLINEQCDVYGFGAFLFELL 242
           GT G+++PE       ++  D++  G  L+ LL
Sbjct: 169 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 76.2 bits (188), Expect = 8e-16
 Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 28/153 (18%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHF-EALSLTDRLKVAMDI 153
           ++ H +I++L           +VF+ V  G L + I     + + EA    D       I
Sbjct: 84  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR--EFYSEA----DASHCIQQI 137

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
             ++AY H   S  IV+R++KP N+L     + +  KL DF L++ + D E         
Sbjct: 138 LESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFA 191

Query: 211 GTTGFIAPENFT-TLINEQCDVYGFGAFLFELL 242
           GT G+++PE       ++  D++  G  L+ LL
Sbjct: 192 GTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 224

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 75.9 bits (187), Expect = 9e-16
 Identities = 37/180 (20%), Positives = 68/180 (37%), Gaps = 33/180 (18%)

Query: 88  NRNQHALEWCINHIVYASRMSHK--HIIKLI-VFESVQI---------GTLADRIHHHCE 135
             +   L+   N I Y +++      II+L     + Q            L   +     
Sbjct: 45  EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGNIDLNSWL----- 99

Query: 136 QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL 195
           +  +++   +R     ++  AV  +H      IV+ D+KP N L  +    KL DF ++ 
Sbjct: 100 KKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVDGM-LKLIDFGIAN 155

Query: 196 SIPDGETHIELDSVVGTTGFIAPE------------NFTTLINEQCDVYGFGAFLFELLT 243
            +    T +  DS VGT  ++ PE               + I+ + DV+  G  L+ +  
Sbjct: 156 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 215

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 75.8 bits (187), Expect = 9e-16
 Identities = 38/181 (20%), Positives = 69/181 (38%), Gaps = 35/181 (19%)

Query: 88  NRNQHALEWCINHIVYASRMSHK--HIIKL-----------IVFESVQIGTLADRIHHHC 134
             +   L+   N I Y +++      II+L           +V E      L   +    
Sbjct: 64  EADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECGN-IDLNSWL---- 118

Query: 135 EQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS 194
            +  +++   +R     ++  AV  +H      IV+ D+KP N L  +    KL DF ++
Sbjct: 119 -KKKKSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIA 173

Query: 195 LSIPDGETHIELDSVVGTTGFIAPE------------NFTTLINEQCDVYGFGAFLFELL 242
             +    T +  DS VGT  ++ PE               + I+ + DV+  G  L+ + 
Sbjct: 174 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMT 233

Query: 243 T 243
            
Sbjct: 234 Y 234

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 76.3 bits (188), Expect = 1e-15
 Identities = 35/132 (26%), Positives = 52/132 (39%), Gaps = 33/132 (25%)

Query: 109 HKHIIKL---------------IVFESVQIGTLADRIHHHCEQHF---EALSLTDRLKVA 150
             HI+++               IV E +  G L  RI    +Q F   EA  +       
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIM------ 167

Query: 151 MDIAHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHIELD 207
             I  A+ YLH   S  I +RD+KP N+L+      +  KL DF  +       +   L 
Sbjct: 168 KSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LT 221

Query: 208 SVVGTTGFIAPE 219
           +   T  ++APE
Sbjct: 222 TPCYTPYYVAPE 233

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 75.7 bits (186), Expect = 1e-15
 Identities = 47/237 (19%), Positives = 86/237 (36%), Gaps = 41/237 (17%)

Query: 95  EWCINHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
            +   + V   + S   +   I  +  +   L D ++  C        +   L + + IA
Sbjct: 117 PFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVC--LHIFIQIA 174

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS----------LSIPDGETHI 204
            AV +LH   S+ +++RD+KP+NI F      K+ DF L             +     + 
Sbjct: 175 EAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231

Query: 205 ELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENV 263
                VGT  +++PE       + + D++  G  LFELL +       +   R     +V
Sbjct: 232 THTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS-----TQMERVRIITDV 286

Query: 264 KRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
           +     N +F  +                 Q+      +    +  SP +RP   D+
Sbjct: 287 R-----NLKFPLLFT---------------QKYPQEHMMVQDMLSPSPTERPEATDI 323

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 75.6 bits (186), Expect = 1e-15
 Identities = 49/272 (18%), Positives = 91/272 (33%), Gaps = 62/272 (22%)

Query: 89  RNQHALEWCINHIVYASRMS-HKHIIKLIVFESVQI------------------GTLADR 129
             +      I  + +  ++S H +I++     S+                    G L + 
Sbjct: 64  NEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEF 123

Query: 130 IHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLF 189
           +     +    LS    LK+      AV ++H     PI++RD+K  N+L + Q   KL 
Sbjct: 124 LKKMESRGP--LSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLC 180

Query: 190 DF----SLSLSIPDGETHIELDSV------VGTTGFIAPENFTTL----INEQCDVYGFG 235
           DF    ++S       +      V        T  +  PE         I E+ D++  G
Sbjct: 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG 240

Query: 236 AFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQ 295
             L+ L            +  F  +    R+   N ++                     Q
Sbjct: 241 CILYLLCF---------RQHPF-EDGAKLRI--VNGKYSIPPHD--------------TQ 274

Query: 296 LQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
              F  L    +  +PE+R ++ +V  QL+++
Sbjct: 275 YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI 306

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 75.4 bits (186), Expect = 1e-15
 Identities = 38/152 (25%), Positives = 57/152 (37%), Gaps = 21/152 (13%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
            + H HI++L           +VFE +    L   I           S          I 
Sbjct: 82  MLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKR-ADAGFVYSEAVASHYMRQIL 140

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
            A+ Y H      I++RD+KP  +L       +  KL  F +++ + +          VG
Sbjct: 141 EALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVG 195

Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELL 242
           T  F+APE        +  DV+G G  LF LL
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILL 227

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 75.1 bits (185), Expect = 2e-15
 Identities = 45/130 (34%), Positives = 61/130 (46%), Gaps = 29/130 (22%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQ-HF-EALSLTDRLKVAMD 152
           R+SH +IIKL           +V E V  G L DRI    E+ ++ E     D       
Sbjct: 104 RLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRI---VEKGYYSER----DAADAVKQ 156

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           I  AVAYLH      IV+RD+KP N+L+      +  K+ DF LS  +        + +V
Sbjct: 157 ILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTV 210

Query: 210 VGTTGFIAPE 219
            GT G+ APE
Sbjct: 211 CGTPGYCAPE 220

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 74.7 bits (184), Expect = 2e-15
 Identities = 36/173 (20%), Positives = 69/173 (39%), Gaps = 28/173 (16%)

Query: 87  GNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCE 135
              +    E     +   + M H +I++            IV +  + G L  RI+    
Sbjct: 60  SRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG 119

Query: 136 QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL 195
             F+   +   L   + I  A+ ++H    R I++RD+K  NI   +    +L DF ++ 
Sbjct: 120 VLFQEDQI---LDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIAR 173

Query: 196 SIPDGETHIELDSVVGTTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLT 243
            +    T     + +GT  +++PE    +   +      D++  G  L+EL T
Sbjct: 174 VL--NSTVELARACIGTPYYLSPE----ICENKPYNNKSDIWALGCVLYELCT 220

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 39/158 (24%), Positives = 64/158 (40%), Gaps = 35/158 (22%)

Query: 107 MSHKHIIKL---------------IVFESVQIGTLADRIHHHCEQHF---EALSLTDRLK 148
               HI+ +               I+ E ++ G L  RI    +Q F   EA  +     
Sbjct: 79  SGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIM---- 134

Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHIE 205
              DI  A+ +LH   S  I +RD+KP N+L+    + +  KL DF  +           
Sbjct: 135 --RDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN----A 185

Query: 206 LDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELL 242
           L +   T  ++APE       ++ CD++  G  ++ LL
Sbjct: 186 LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 223

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 73.9 bits (182), Expect = 4e-15
 Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 31/152 (20%)

Query: 109 HKHIIKL-----------IVFESVQIGTLADRIHHHCEQHF---EALSLTDRLKVAMDIA 154
           H +I+KL           +V E +  G L +RI     +HF   EA  +         + 
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK--KHFSETEASYIM------RKLV 116

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
            AV+++H      +V+RD+KP N+LF   N+  + K+ DF  +   P       L +   
Sbjct: 117 SAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCF 171

Query: 212 TTGFIAPENFT-TLINEQCDVYGFGAFLFELL 242
           T  + APE       +E CD++  G  L+ +L
Sbjct: 172 TLHYAAPELLNQNGYDESCDLWSLGVILYTML 203

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 73.8 bits (182), Expect = 4e-15
 Identities = 41/152 (26%), Positives = 62/152 (40%), Gaps = 26/152 (17%)

Query: 108 SHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHA 156
           S   +I L           ++ E    G +         +  E +S  D +++   I   
Sbjct: 87  SCPRVINLHEVYENTSEIILILEYAAGGEIFSLC---LPELAEMVSENDVIRLIKQILEG 143

Query: 157 VAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT 213
           V YLH      IV+ D+KP NIL        D K+ DF +S  I       EL  ++GT 
Sbjct: 144 VYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTP 197

Query: 214 GFIAPE--NFTTLINEQCDVYGFGAFLFELLT 243
            ++APE  N+   I    D++  G   + LLT
Sbjct: 198 EYLAPEILNYDP-ITTATDMWNIGIIAYMLLT 228

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 73.4 bits (181), Expect = 5e-15
 Identities = 44/154 (28%), Positives = 68/154 (44%), Gaps = 31/154 (20%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQ-HF-EALSLTDRLKVAMD 152
           ++ H++I+ L           +V + V  G L DRI    E+  + E     D   V   
Sbjct: 62  KIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRI---LERGVYTEK----DASLVIQQ 114

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           +  AV YLH      IV+RD+KP N+L+    E S   + DF LS    +G     + + 
Sbjct: 115 VLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTA 167

Query: 210 VGTTGFIAPENFT-TLINEQCDVYGFGAFLFELL 242
            GT G++APE       ++  D +  G   + LL
Sbjct: 168 CGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILL 201

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 73.7 bits (181), Expect = 7e-15
 Identities = 33/158 (20%), Positives = 58/158 (36%), Gaps = 33/158 (20%)

Query: 109 HKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAV 157
              II+L           +V E      L   +        +++   +R     ++  AV
Sbjct: 115 SDKIIRLYDYEITDQYIYMVMECGN-IDLNSWLKKK-----KSIDPWERKSYWKNMLEAV 168

Query: 158 AYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIA 217
             +H      IV+ D+KP N L  +    KL DF ++  +    T +  DS VG   ++ 
Sbjct: 169 HTIH---QHGIVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224

Query: 218 PE------------NFTTLINEQCDVYGFGAFLFELLT 243
           PE               + I+ + DV+  G  L+ +  
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 262

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 72.7 bits (179), Expect = 9e-15
 Identities = 44/184 (23%), Positives = 73/184 (39%), Gaps = 33/184 (17%)

Query: 77  KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IVFESVQIGTL 126
           KR  ++           +E     I    +++H  IIK+          IV E ++ G L
Sbjct: 45  KRKFAIGSAREADPALNVE---TEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGEL 101

Query: 127 ADRIHHHCEQHF-EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF---NE 182
            D++  +  +   EA            +  AV YLH      I++RD+KP N+L     E
Sbjct: 102 FDKVVGN--KRLKEA----TCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEE 152

Query: 183 QSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLI----NEQCDVYGFGAFL 238
               K+ DF  S  + +      + ++ GT  ++APE   ++     N   D +  G  L
Sbjct: 153 DCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

Query: 239 FELL 242
           F  L
Sbjct: 210 FICL 213

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 72.0 bits (177), Expect = 1e-14
 Identities = 47/254 (18%), Positives = 88/254 (34%), Gaps = 72/254 (28%)

Query: 105 SRMSHKHIIKL-----------------------IVFESVQIGTLADRIHHHCEQHFEAL 141
           +++ H  I++                        I  +  +   L D ++  C       
Sbjct: 58  AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117

Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS------- 194
           S+   L + + IA AV +LH   S+ +++RD+KP+NI F      K+ DF L        
Sbjct: 118 SVC--LHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 172

Query: 195 ---LSIPDGETHIELDSVVGTTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQE 246
                +     +      VGT  +++PE     I+        D++  G  LFELL    
Sbjct: 173 EEQTVLTPMPAYARHTGQVGTKLYMSPE----QIHGNSYSHKVDIFSLGLILFELLYP-- 226

Query: 247 VSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQC 306
                 F ++      +  +  +N +F       +   K                +    
Sbjct: 227 ------FSTQMERVRTLTDV--RNLKFPP-----LFTQKY----------PCEYVMVQDM 263

Query: 307 MDFSPEDRPTMVDV 320
           +  SP +RP  +++
Sbjct: 264 LSPSPMERPEAINI 277

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 71.5 bits (176), Expect = 2e-14
 Identities = 35/159 (22%), Positives = 64/159 (40%), Gaps = 27/159 (16%)

Query: 105 SRMSHKHIIKL-------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM 151
             + H +I++              IV E  + G LA  I    ++  + L     L+V  
Sbjct: 60  RELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMT 118

Query: 152 DIAHAVAYLH--VGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
            +  A+   H        +++RD+KP N+  + + + KL DF L+  +          + 
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL--NHDTSFAKTF 176

Query: 210 VGTTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLT 243
           VGT  +++PE     +N        D++  G  L+EL  
Sbjct: 177 VGTPYYMSPE----QMNRMSYNEKSDIWSLGCLLYELCA 211

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 72.4 bits (178), Expect = 2e-14
 Identities = 43/184 (23%), Positives = 75/184 (40%), Gaps = 31/184 (16%)

Query: 77  KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IVFESVQIGTL 126
           KR  ++           +E     I    +++H  IIK+          IV E ++ G L
Sbjct: 170 KRKFAIGSAREADPALNVE---TEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGEL 226

Query: 127 ADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA 186
            D++  +     + L           +  AV YLH      I++RD+KP N+L + Q + 
Sbjct: 227 FDKVVGN-----KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEED 278

Query: 187 ---KLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLI----NEQCDVYGFGAFLF 239
              K+ DF  S  + +      + ++ GT  ++APE   ++     N   D +  G  LF
Sbjct: 279 CLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF 335

Query: 240 ELLT 243
             L+
Sbjct: 336 ICLS 339

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 72.6 bits (178), Expect = 2e-14
 Identities = 29/153 (18%), Positives = 60/153 (39%), Gaps = 26/153 (16%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
            + H  ++ L           +++E +  G L +++     +  E     + ++    + 
Sbjct: 210 VLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSED----EAVEYMRQVC 265

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA--KLFDFSLSLSIPDGETHIELDSVVGT 212
             + ++H       V+ D+KP NI+F  +     KL DF L+  +   +    +    GT
Sbjct: 266 KGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGT 319

Query: 213 TGFIAPE--NFTTLINEQCDVYGFGAFLFELLT 243
             F APE       +    D++  G   + LL+
Sbjct: 320 AEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLS 351

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 71.2 bits (175), Expect = 2e-14
 Identities = 48/253 (18%), Positives = 84/253 (33%), Gaps = 75/253 (29%)

Query: 105 SRMSHKHIIKL---------------------------IVFESVQIGTLADRIHHHCEQH 137
           +++ H +I+                             I  E    GTL   I     + 
Sbjct: 59  AKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK 118

Query: 138 F-EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS 196
             + L+L    ++   I   V Y+H   S+ ++ RD+KP+NI   +    K+ DF L  S
Sbjct: 119 LDKVLAL----ELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS 171

Query: 197 IPDGETHIELDSVVGTTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQEVSDHV 251
           +   +   +     GT  +++PE     I+ Q      D+Y  G  L ELL         
Sbjct: 172 L---KNDGKRTRSKGTLRYMSPE----QISSQDYGKEVDLYALGLILAELLHVC------ 218

Query: 252 SFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSP 311
                            ++    ++ D                  +  K L  + +   P
Sbjct: 219 ---DTAFETSKFFTD-LRDGIISDIFD------------------KKEKTLLQKLLSKKP 256

Query: 312 EDRPTMVDVAKQL 324
           EDRP   ++ + L
Sbjct: 257 EDRPNTSEILRTL 269

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 71.2 bits (175), Expect = 3e-14
 Identities = 55/264 (20%), Positives = 99/264 (37%), Gaps = 48/264 (18%)

Query: 83  MKYNGNRNQHALEWCINHIVYASRMSHKHIIK-----------LIVFESVQIGTLADRIH 131
           ++     +  A   CI  I    +++H ++IK            IV E    G L+  I 
Sbjct: 65  VQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIK 124

Query: 132 HHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF 191
           H  ++    +      K  + +  A+ ++H   SR +++RD+KP N+        KL D 
Sbjct: 125 HF-KKQKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDL 180

Query: 192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQE 246
            L              S+VGT  +++PE     I+E       D++  G  L+E+     
Sbjct: 181 GLGRFF--SSKTTAAHSLVGTPYYMSPE----RIHENGYNFKSDIWSLGCLLYEMAA--- 231

Query: 247 VSDHVSFESRFHYE-ENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQ 305
                  +S F+ +  N+  L               IE         +   +  +QL   
Sbjct: 232 ------LQSPFYGDKMNLYSL------------CKKIEQCDYPPLPSDHYSEELRQLVNM 273

Query: 306 CMDFSPEDRPTMVDVAKQLRQMYR 329
           C++  PE RP +  V    ++M+ 
Sbjct: 274 CINPDPEKRPDVTYVYDVAKRMHA 297

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 71.6 bits (176), Expect = 3e-14
 Identities = 46/182 (25%), Positives = 75/182 (41%), Gaps = 29/182 (15%)

Query: 79  SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLA 127
            I   +   +R     E     +    ++ H +II L           ++ E V  G L 
Sbjct: 44  FIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELF 103

Query: 128 DRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF----NEQ 183
           D +    ++  E+LS  +       I   V YLH   ++ I + D+KP NI+        
Sbjct: 104 DFL---AQK--ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPI 155

Query: 184 SDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE--NFTTLINEQCDVYGFGAFLFEL 241
              KL DF L+  I DG    E  ++ GT  F+APE  N+   +  + D++  G   + L
Sbjct: 156 PHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYIL 211

Query: 242 LT 243
           L+
Sbjct: 212 LS 213

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 70.8 bits (174), Expect = 3e-14
 Identities = 43/236 (18%), Positives = 87/236 (36%), Gaps = 51/236 (21%)

Query: 105 SRMSHKHIIKL---------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKV 149
             + H +I++                +V E +  GTL   +     + F+ + +      
Sbjct: 80  KGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL-----KRFKVMKIKVLRSW 134

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS-DAKLFDFSLSLSIPDGETHIELDS 208
              I   + +LH   + PI++RD+K  NI     +   K+ D  L+             +
Sbjct: 135 CRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----A 189

Query: 209 VVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG 268
           V+GT  F+APE +    +E  DVY FG  + E+ T          E  +   +N  ++  
Sbjct: 190 VIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMAT---------SEYPYSECQNAAQI-- 238

Query: 269 QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
               ++       +       +  +  +   K++   C+  + ++R +     K L
Sbjct: 239 ----YR------RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYS----IKDL 280

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 36/153 (23%), Positives = 66/153 (43%), Gaps = 27/153 (17%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHF-EALSLTDRLKVAMDI 153
            + H +I++L           ++F+ V  G L + I     +++ EA    D       I
Sbjct: 66  LLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEA----DASHCIQQI 119

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
             AV + H      +V+R++KP N+L     + +  KL DF L++ +   +         
Sbjct: 120 LEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFA 174

Query: 211 GTTGFIAPENFT-TLINEQCDVYGFGAFLFELL 242
           GT G+++PE        +  D++  G  L+ LL
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVILYILL 207

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 71.1 bits (175), Expect = 4e-14
 Identities = 43/182 (23%), Positives = 74/182 (40%), Gaps = 29/182 (15%)

Query: 79  SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLA 127
            I   +   +R   + E     +     + H ++I L           ++ E V  G L 
Sbjct: 43  FIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELF 102

Query: 128 DRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF----NEQ 183
           D +        E+L+  +  +    I + V YLH   S  I + D+KP NI+       +
Sbjct: 103 DFLAEK-----ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPK 154

Query: 184 SDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE--NFTTLINEQCDVYGFGAFLFEL 241
              K+ DF L+  I  G    E  ++ GT  F+APE  N+   +  + D++  G   + L
Sbjct: 155 PRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYIL 210

Query: 242 LT 243
           L+
Sbjct: 211 LS 212

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 70.7 bits (174), Expect = 4e-14
 Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 29/182 (15%)

Query: 79  SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLA 127
            I   + + +R   + E     +     + H +II L           ++ E V  G L 
Sbjct: 37  FIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELF 96

Query: 128 DRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF----NEQ 183
           D +        E+L+  +  +    I   V YLH   S+ I + D+KP NI+        
Sbjct: 97  DFLAEK-----ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPN 148

Query: 184 SDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE--NFTTLINEQCDVYGFGAFLFEL 241
              KL DF ++  I  G    E  ++ GT  F+APE  N+   +  + D++  G   + L
Sbjct: 149 PRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYIL 204

Query: 242 LT 243
           L+
Sbjct: 205 LS 206

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 70.7 bits (174), Expect = 5e-14
 Identities = 45/182 (24%), Positives = 76/182 (41%), Gaps = 29/182 (15%)

Query: 79  SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLA 127
            I   +   +R   + E     +    ++ H ++I L           ++ E V  G L 
Sbjct: 44  FIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELF 103

Query: 128 DRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF----NEQ 183
           D +    ++  E+LS  +       I   V YLH   ++ I + D+KP NI+        
Sbjct: 104 DFL---AQK--ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPI 155

Query: 184 SDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE--NFTTLINEQCDVYGFGAFLFEL 241
              KL DF L+  I DG    E  ++ GT  F+APE  N+   +  + D++  G   + L
Sbjct: 156 PHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYIL 211

Query: 242 LT 243
           L+
Sbjct: 212 LS 213

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 71.1 bits (175), Expect = 5e-14
 Identities = 54/260 (20%), Positives = 91/260 (35%), Gaps = 80/260 (30%)

Query: 104 ASRM---SHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKV 149
           A  +   SH +I++L           IV E VQ G     +     +    L +   L++
Sbjct: 163 ARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGAR----LRVKTLLQM 218

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
             D A  + YL    S+  ++RD+   N L  E++  K+ DF +S    DG       + 
Sbjct: 219 VGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYA----AS 271

Query: 210 VGTTGF----IAPEN-----FTTLINEQCDVYGFGAFLFEL----------LTAQEVSDH 250
            G         APE      +++    + DV+ FG  L+E           L+ Q+  + 
Sbjct: 272 GGLRQVPVKWTAPEALNYGRYSS----ESDVWSFGILLWETFSLGASPYPNLSNQQTREF 327

Query: 251 VSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFS 310
           V         E   RL                      C        A  +L  QC  + 
Sbjct: 328 V---------EKGGRL-----------------PCPELCP------DAVFRLMEQCWAYE 355

Query: 311 PEDRPTMVDVAKQLRQMYRS 330
           P  RP+   + ++L+ + + 
Sbjct: 356 PGQRPSFSTIYQELQSIRKR 375

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 33/153 (21%), Positives = 60/153 (39%), Gaps = 26/153 (16%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           ++ H  +I L           ++ E +  G L DRI     +  EA    + +       
Sbjct: 104 QLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEA----EVINYMRQAC 159

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA--KLFDFSLSLSIPDGETHIELDSVVGT 212
             + ++H      IV+ D+KP NI+   +  +  K+ DF L+  +   E    +     T
Sbjct: 160 EGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTAT 213

Query: 213 TGFIAPE--NFTTLINEQCDVYGFGAFLFELLT 243
             F APE  +    +    D++  G   + LL+
Sbjct: 214 AEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLS 245

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 69.5 bits (170), Expect = 2e-13
 Identities = 41/191 (21%), Positives = 65/191 (34%), Gaps = 56/191 (29%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRI------------------------ 130
           ++ H +I +L           +V E    G L D++                        
Sbjct: 84  KLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143

Query: 131 ---------HHHCEQHFEALSLTDRL--KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNIL 179
                      H  +        ++L   +   I  A+ YLH   ++ I +RD+KP N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFL 200

Query: 180 FNEQSDA--KLFDFSLS--LSIPDGETHIELDSVVGTTGFIAPE---NFTTLINEQCDVY 232
           F+       KL DF LS      +   +  + +  GT  F+APE           +CD +
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAW 260

Query: 233 GFGAFLFELLT 243
             G  L  LL 
Sbjct: 261 SAGVLLHLLLM 271

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 25/131 (19%), Positives = 52/131 (39%), Gaps = 31/131 (23%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRI----HHHCEQHFEALSLTDRLKVA 150
              H++I+ L           ++FE +    + +RI        E+  E +S        
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNER--EIVSYV------ 108

Query: 151 MDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA--KLFDFSLSLSIPDGETHIELDS 208
             +  A+ +LH   S  I + D++P NI++  +  +  K+ +F  +  +  G+       
Sbjct: 109 HQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRL 162

Query: 209 VVGTTGFIAPE 219
           +     + APE
Sbjct: 163 LFTAPEYYAPE 173

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 34/127 (26%), Positives = 56/127 (44%), Gaps = 23/127 (18%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           ++ H ++I+L           +V E V  G L DRI    ++ +  L+  D +     I 
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRI---IDESYN-LTELDTILFMKQIC 197

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA--KLFDFSLSLSIPDGETHIELDSVVGT 212
             + ++H      I++ D+KP NIL   +     K+ DF L+      E   +L    GT
Sbjct: 198 EGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE---KLKVNFGT 251

Query: 213 TGFIAPE 219
             F+APE
Sbjct: 252 PEFLAPE 258

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 68.9 bits (169), Expect = 3e-13
 Identities = 40/153 (26%), Positives = 68/153 (44%), Gaps = 32/153 (20%)

Query: 109 HKHIIKL-----------IVFESVQIGTLADRIHHHCEQHF---EALSLTDRLKVAMDIA 154
           H +II L           +V E ++ G L D+I     + F   EA ++         I 
Sbjct: 75  HPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVL------FTIT 126

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA----KLFDFSLSLSIPDGETHIELDSVV 210
             V YLH   ++ +V+RD+KP+NIL+ ++S      ++ DF  +  +        L +  
Sbjct: 127 KTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPC 181

Query: 211 GTTGFIAPENFT-TLINEQCDVYGFGAFLFELL 242
            T  F+APE       +  CD++  G  L+ +L
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTML 214

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 69.5 bits (170), Expect = 3e-13
 Identities = 29/99 (29%), Positives = 48/99 (48%), Gaps = 17/99 (17%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + ++H   +R +VYRD+KP NIL +E    ++ D  L+      + H    + VGT
Sbjct: 301 IILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH----ASVGT 353

Query: 213 TGFIAPENFTTLINEQ------CDVYGFGAFLFELLTAQ 245
            G++APE    ++ +        D +  G  LF+LL   
Sbjct: 354 HGYMAPE----VLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 67.3 bits (165), Expect = 5e-13
 Identities = 48/257 (18%), Positives = 91/257 (35%), Gaps = 61/257 (23%)

Query: 105 SRMSHKHIIKL-------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM 151
             + H +I+K              ++ E +  G+L D +  H E+    +     L+   
Sbjct: 66  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTS 121

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
            I   + YL    ++  ++RD+   NIL   ++  K+ DF L+  +P  +        V 
Sbjct: 122 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVK 174

Query: 212 TTGFI-----APE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEE 261
             G       APE      F+       DV+ FG  L+EL T         +  +     
Sbjct: 175 EPGESPIFWYAPESLTESKFSV----ASDVWSFGVVLYELFT---------YIEKSKSPP 221

Query: 262 NVKRLSGQNCRFKEMVDSIIIE--------DKSCTCTGKEQQLQAFKQLTLQCMDFSPED 313
                   N +  +M+   +IE         +   C            +  +C + +   
Sbjct: 222 AEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCP------DEIYMIMTECWNNNVNQ 275

Query: 314 RPTMVDVAKQLRQMYRS 330
           RP+  D+A ++ Q+  +
Sbjct: 276 RPSFRDLALRVDQIRDN 292

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 68.7 bits (168), Expect = 5e-13
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 20/135 (14%)

Query: 117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKV-AMDIAHAVAYLHVGFSRPIVYRDMKP 175
           V   +  G L   I+H  +  F       R    A +I   +  LH      IVYRD+KP
Sbjct: 262 VLTLMNGGDLKFHIYHMGQAGFP----EARAVFYAAEICCGLEDLH---RERIVYRDLKP 314

Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQ-----CD 230
            NIL ++    ++ D  L++ +P+G+T   +   VGT G++APE    ++  +      D
Sbjct: 315 ENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPE----VVKNERYTFSPD 367

Query: 231 VYGFGAFLFELLTAQ 245
            +  G  L+E++  Q
Sbjct: 368 WWALGCLLYEMIAGQ 382

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 67.6 bits (166), Expect = 6e-13
 Identities = 46/256 (17%), Positives = 85/256 (33%), Gaps = 80/256 (31%)

Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
            + + H+ +L          ++ + +  G L D +  H +     +     L   + IA 
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAK 128

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG- 214
            + YL     R +V+RD+   N+L       K+ DF L+  +   E            G 
Sbjct: 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH------AEGG 179

Query: 215 -----FIAPE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVSDHVSFE 254
                ++A E      +T     Q DV+ +G  ++EL+T          A E+S  +   
Sbjct: 180 KVPIKWMALESILHRIYTH----QSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--- 232

Query: 255 SRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDR 314
                 E  +RL                  +   CT           +  +C     + R
Sbjct: 233 ------EKGERL-----------------PQPPICT------IDVYMIMRKCWMIDADSR 263

Query: 315 PTMVDVAKQLRQMYRS 330
           P   ++  +  +M R 
Sbjct: 264 PKFRELIIEFSKMARD 279

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 27/95 (28%), Positives = 48/95 (50%), Gaps = 10/95 (10%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           +  A+ YL    ++ I++RDMKP NIL +E     + DF+++  +P         ++ GT
Sbjct: 124 LVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGT 177

Query: 213 TGFIAPENFTTLI----NEQCDVYGFGAFLFELLT 243
             ++APE F++      +   D +  G   +ELL 
Sbjct: 178 KPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLR 212

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 66.6 bits (163), Expect = 1e-12
 Identities = 48/257 (18%), Positives = 91/257 (35%), Gaps = 61/257 (23%)

Query: 105 SRMSHKHIIKL-------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM 151
             + H +I+K              ++ E +  G+L D +  H E+    +     L+   
Sbjct: 97  KSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTS 152

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
            I   + YL    ++  ++RD+   NIL   ++  K+ DF L+  +P  + +      V 
Sbjct: 153 QICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYY----KVK 205

Query: 212 TTGFI-----APE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEE 261
             G       APE      F+       DV+ FG  L+EL T         +  +     
Sbjct: 206 EPGESPIFWYAPESLTESKFSV----ASDVWSFGVVLYELFT---------YIEKSKSPP 252

Query: 262 NVKRLSGQNCRFKEMVDSIIIE--------DKSCTCTGKEQQLQAFKQLTLQCMDFSPED 313
                   N +  +M+   +IE         +   C            +  +C + +   
Sbjct: 253 AEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCP------DEIYMIMTECWNNNVNQ 306

Query: 314 RPTMVDVAKQLRQMYRS 330
           RP+  D+A ++ Q+   
Sbjct: 307 RPSFRDLALRVDQIRDQ 323

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 66.1 bits (162), Expect = 2e-12
 Identities = 28/96 (29%), Positives = 49/96 (51%), Gaps = 12/96 (12%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I  A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         +S VGT
Sbjct: 139 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195

Query: 213 TGFIAPENFTTLINEQ-----CDVYGFGAFLFELLT 243
             +++PE    L+ E+      D++  G  +++L+ 
Sbjct: 196 AQYVSPE----LLTEKSACKSSDLWALGCIIYQLVA 227

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 65.8 bits (161), Expect = 2e-12
 Identities = 47/248 (18%), Positives = 88/248 (35%), Gaps = 46/248 (18%)

Query: 105 SRMSHKHIIKL-------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM 151
             + H++I+K              ++ E +  G+L + +  +  +    ++L  +LK A+
Sbjct: 78  RNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----INLKQQLKYAV 133

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
            I   + YL    SR  V+RD+   N+L   +   K+ DF L+ +I   + +      V 
Sbjct: 134 QICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT----VK 186

Query: 212 TTGFI-----APE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEE 261
                     APE      F        DV+ FG  L ELLT  +               
Sbjct: 187 DDRDSPVFWYAPECLMQSKFYI----ASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGP 242

Query: 262 NVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVA 321
              +++    R    +           C           QL  +C +F P +R +  ++ 
Sbjct: 243 THGQMT--VTRLVNTLKEGKRLPCPPNCP------DEVYQLMRKCWEFQPSNRTSFQNLI 294

Query: 322 KQLRQMYR 329
           +    + +
Sbjct: 295 EGFEALLK 302

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 65.7 bits (161), Expect = 2e-12
 Identities = 35/152 (23%), Positives = 64/152 (42%), Gaps = 26/152 (17%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHF-EALSLTDRLKVAMD 152
           S + H +I+++           ++ E    G L   +  H    F E  S      +   
Sbjct: 69  SHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRS---ATFMEE- 122

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           +A A+ Y H    R +++RD+KP N+L   + + K+ DF  S+  P         ++ GT
Sbjct: 123 LADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR----TMCGT 175

Query: 213 TGFIAPENFTT-LINEQCDVYGFGAFLFELLT 243
             ++ PE       +E+ D++  G   +E L 
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLV 207

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 65.8 bits (161), Expect = 2e-12
 Identities = 57/256 (22%), Positives = 89/256 (34%), Gaps = 62/256 (24%)

Query: 106 RMSHKHIIKL-------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMD 152
            +    I+K              +V E +  G L D +  H  +    L  +  L  +  
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASRLLLYSSQ 135

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + YL    SR  V+RD+   NIL   ++  K+ DF L+  +P  + +     VV  
Sbjct: 136 ICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYY----VVRE 188

Query: 213 TGFI-----APE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEEN 262
            G       APE      F+     Q DV+ FG  L+EL T  + S             +
Sbjct: 189 PGQSPIFWYAPESLSDNIFSR----QSDVWSFGVVLYELFTYCDKS----------CSPS 234

Query: 263 VKRLSGQNCRFKEMVDSIIIE--------DKSCTCTGKEQQLQAFKQLTLQCMDFSPEDR 314
            + L    C       S ++E             C           +L   C   SP+DR
Sbjct: 235 AEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACP------AEVHELMKLCWAPSPQDR 288

Query: 315 PTMVDVAKQLRQMYRS 330
           P+   +  QL  ++  
Sbjct: 289 PSFSALGPQLDMLWSG 304

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 65.4 bits (160), Expect = 2e-12
 Identities = 38/160 (23%), Positives = 65/160 (40%), Gaps = 28/160 (17%)

Query: 101 IVYASRMSHKHIIKL-------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRL 147
           I    ++ H +++KL             +VFE V  G + +          +A       
Sbjct: 87  IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR------ 140

Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD 207
               D+   + YLH    + I++RD+KP+N+L  E    K+ DF +S      +    L 
Sbjct: 141 FYFQDLIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL--LS 195

Query: 208 SVVGTTGFIAPENFTTLINE----QCDVYGFGAFLFELLT 243
           + VGT  F+APE+ +           DV+  G  L+  + 
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 65.3 bits (160), Expect = 2e-12
 Identities = 34/152 (22%), Positives = 67/152 (44%), Gaps = 26/152 (17%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHF-EALSLTDRLKVAMD 152
           S + H +I++L           ++ E   +GT+   +       F E  +         +
Sbjct: 64  SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTA----TYITE 117

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           +A+A++Y H   S+ +++RD+KP N+L     + K+ DF  S+  P          + GT
Sbjct: 118 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS----RRTDLCGT 170

Query: 213 TGFIAPENFTTLI-NEQCDVYGFGAFLFELLT 243
             ++ PE     + +E+ D++  G   +E L 
Sbjct: 171 LDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLV 202

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 65.8 bits (161), Expect = 3e-12
 Identities = 37/160 (23%), Positives = 62/160 (38%), Gaps = 32/160 (20%)

Query: 101 IVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKV 149
           +     ++H +I+KL           ++ E    G + D +  H       +   +    
Sbjct: 65  VRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH-----GRMKEKEARSK 119

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
              I  AV Y H    + IV+RD+K  N+L +   + K+ DF  S     G     LD+ 
Sbjct: 120 FRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAF 173

Query: 210 VGTTGFIAPENFTTLINEQC------DVYGFGAFLFELLT 243
            G   + APE    L   +       DV+  G  L+ L++
Sbjct: 174 CGAPPYAAPE----LFQGKKYDGPEVDVWSLGVILYTLVS 209

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 65.1 bits (159), Expect = 4e-12
 Identities = 55/249 (22%), Positives = 94/249 (37%), Gaps = 48/249 (19%)

Query: 105 SRMSHKHIIKL-------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM 151
             + H+HIIK              +V E V +G+L D +  H      ++ L   L  A 
Sbjct: 88  RTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH------SIGLAQLLLFAQ 141

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
            I   +AYLH   ++  ++RD+   N+L +     K+ DF L+ ++P+G  +      V 
Sbjct: 142 QICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVR 194

Query: 212 TTGFI-----APE-----NFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEE 261
             G       APE      F        DV+ FG  L+ELLT  + S     +       
Sbjct: 195 EDGDSPVFWYAPECLKEYKFYY----ASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

Query: 262 NVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVA 321
              +++    R  E+++      +   C            L   C +     RPT  ++ 
Sbjct: 251 AQGQMT--VLRLTELLERGERLPRPDKCP------AEVYHLMKNCWETEASFRPTFENLI 302

Query: 322 KQLRQMYRS 330
             L+ ++  
Sbjct: 303 PILKTVHEK 311

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 63.7 bits (156), Expect = 1e-11
 Identities = 37/99 (37%), Positives = 53/99 (53%), Gaps = 16/99 (16%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           +A A+ +LH   S  I+YRD+KP NIL +E+   KL DF LS  SI   +      S  G
Sbjct: 135 LALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCG 188

Query: 212 TTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQ 245
           T  ++APE    ++N +      D + FG  +FE+LT  
Sbjct: 189 TVEYMAPE----VVNRRGHTQSADWWSFGVLMFEMLTGT 223

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 63.9 bits (156), Expect = 1e-11
 Identities = 36/160 (22%), Positives = 66/160 (41%), Gaps = 32/160 (20%)

Query: 101 IVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKV 149
           I     ++H+H++             +V E  +  +L +          +AL+  +    
Sbjct: 92  ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-----KALTEPEARYY 146

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI-PDGETHIELDS 208
              I     YLH      +++RD+K  N+  NE  + K+ DF L+  +  DGE       
Sbjct: 147 LRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKV 200

Query: 209 VVGTTGFIAPENFTTLIN-----EQCDVYGFGAFLFELLT 243
           + GT  +IAPE    +++      + DV+  G  ++ LL 
Sbjct: 201 LCGTPNYIAPE----VLSKKGHSFEVDVWSIGCIMYTLLV 236

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 29/98 (29%), Positives = 51/98 (52%), Gaps = 14/98 (14%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I   + +LH    R I+YRD+KP N+L ++  + ++ D  L++ +  G+T        GT
Sbjct: 298 IVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT--KGYAGT 352

Query: 213 TGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQ 245
            GF+APE    L+  +      D +  G  L+E++ A+
Sbjct: 353 PGFMAPE----LLLGEEYDFSVDYFALGVTLYEMIAAR 386

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 63.4 bits (155), Expect = 1e-11
 Identities = 35/152 (23%), Positives = 64/152 (42%), Gaps = 24/152 (15%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
             ++H+H++             +V E  +  +L +          +AL+  +       I
Sbjct: 70  RSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR-----KALTEPEARYYLRQI 124

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI-PDGETHIELDSVVGT 212
                YLH      +++RD+K  N+  NE  + K+ DF L+  +  DGE       + GT
Sbjct: 125 VLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER---KKVLCGT 178

Query: 213 TGFIAPENFT-TLINEQCDVYGFGAFLFELLT 243
             +IAPE  +    + + DV+  G  ++ LL 
Sbjct: 179 PNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLV 210

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 63.3 bits (155), Expect = 1e-11
 Identities = 33/99 (33%), Positives = 50/99 (50%), Gaps = 16/99 (16%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I+ A+ +LH    + I+YRD+KP NI+ N Q   KL DF L   SI DG       +  G
Sbjct: 130 ISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---THTFCG 183

Query: 212 TTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQ 245
           T  ++APE    ++         D +  GA ++++LT  
Sbjct: 184 TIEYMAPE----ILMRSGHNRAVDWWSLGALMYDMLTGA 218

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 63.1 bits (154), Expect = 2e-11
 Identities = 46/256 (17%), Positives = 86/256 (33%), Gaps = 80/256 (31%)

Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
            + + H+ +L          ++ + +  G L D +  H +     +     L   + IA 
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDN----IGSQYLLNWCVQIAK 128

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG- 214
            + YL     R +V+RD+   N+L       K+ DF L+  +   E            G 
Sbjct: 129 GMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYH------AEGG 179

Query: 215 -----FIAPE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVSDHVSFE 254
                ++A E      +T     Q DV+ +G  ++EL+T          A E+S  +   
Sbjct: 180 KVPIKWMALESILHRIYTH----QSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL--- 232

Query: 255 SRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDR 314
                 E  +RL                  +   CT           + ++C     + R
Sbjct: 233 ------EKGERL-----------------PQPPICT------IDVYMIMVKCWMIDADSR 263

Query: 315 PTMVDVAKQLRQMYRS 330
           P   ++  +  +M R 
Sbjct: 264 PKFRELIIEFSKMARD 279

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 61.9 bits (151), Expect = 4e-11
 Identities = 46/257 (17%), Positives = 91/257 (35%), Gaps = 79/257 (30%)

Query: 105 SRMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
            ++ + +I++L          +V E    G L   +    E+    + +++  ++   ++
Sbjct: 65  HQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVS 120

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
             + YL     +  V+RD+   N+L   +  AK+ DF LS ++   +++        + G
Sbjct: 121 MGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY----TARSAG 173

Query: 215 FI-----APE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVSDHVSFE 254
                  APE      F++    + DV+ +G  ++E L+            EV   +   
Sbjct: 174 KWPLKWYAPECINFRKFSS----RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI--- 226

Query: 255 SRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPED 313
                 E  KR+     C                              L   C  +  ED
Sbjct: 227 ------EQGKRMECPPEC------------------------PPELYALMSDCWIYKWED 256

Query: 314 RPTMVDVAKQLRQMYRS 330
           RP  + V +++R  Y S
Sbjct: 257 RPDFLTVEQRMRACYYS 273

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 61.4 bits (150), Expect = 4e-11
 Identities = 34/160 (21%), Positives = 65/160 (40%), Gaps = 31/160 (19%)

Query: 101 IVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKV 149
           +    ++ H  I++L           +V E    G +   + +  +   E  +   R  +
Sbjct: 62  VKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEA---RHFM 118

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDS- 208
              I   + YLH   S  I++RD+  +N+L     + K+ DF L+       T +++   
Sbjct: 119 H-QIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLA-------TQLKMPHE 167

Query: 209 ----VVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLT 243
               + GT  +I+PE  T +    + DV+  G   + LL 
Sbjct: 168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLI 207

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 62.4 bits (152), Expect = 5e-11
 Identities = 29/102 (28%), Positives = 42/102 (41%), Gaps = 14/102 (13%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL-SIPDGETHIELDSVVG 211
           I  A+  +H       V+RD+KP NIL +     +L DF   L    DG         VG
Sbjct: 171 IVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS--LVAVG 225

Query: 212 TTGFIAPE--------NFTTLINEQCDVYGFGAFLFELLTAQ 245
           T  +++PE          T     +CD +  G F +E+   Q
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 61.9 bits (151), Expect = 5e-11
 Identities = 36/99 (36%), Positives = 50/99 (50%), Gaps = 16/99 (16%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           IA A+ YLH   S  IVYRD+KP NIL + Q    L DF L   +I    T     +  G
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCG 201

Query: 212 TTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQ 245
           T  ++APE    ++++Q      D +  GA L+E+L   
Sbjct: 202 TPEYLAPE----VLHKQPYDRTVDWWCLGAVLYEMLYGL 236

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 62.1 bits (151), Expect = 6e-11
 Identities = 27/98 (27%), Positives = 43/98 (43%), Gaps = 12/98 (12%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL-SIPDGETHIELDSVVG 211
           +  A+  +H       V+RD+KP NIL +     +L DF   L  + DG         VG
Sbjct: 184 MVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS--SVAVG 238

Query: 212 TTGFIAPENFTTLINEQ------CDVYGFGAFLFELLT 243
           T  +I+PE    +   +      CD +  G  ++E+L 
Sbjct: 239 TPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 61.7 bits (150), Expect = 6e-11
 Identities = 35/126 (27%), Positives = 54/126 (42%), Gaps = 13/126 (10%)

Query: 101 IVYASRMSHKHIIKLI-VFESVQIGTLADRIHHHCEQHFEALSLTDRL------KVAMDI 153
           I   SR+ H +IIK++ +FE+     L    H      F  +    RL       +   +
Sbjct: 80  IAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQL 139

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT 213
             AV YL     + I++RD+K  NI+  E    KL DF  +  +  G+      +  GT 
Sbjct: 140 VSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGTI 193

Query: 214 GFIAPE 219
            + APE
Sbjct: 194 EYCAPE 199

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 61.8 bits (150), Expect = 7e-11
 Identities = 43/200 (21%), Positives = 71/200 (35%), Gaps = 31/200 (15%)

Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD 207
           KV++ +   + YL       I++RD+KP+NIL N + + KL DF +S  + D       +
Sbjct: 135 KVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA----N 188

Query: 208 SVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLTAQ---EVSDHVSFESRFHYEENV 263
           S VGT  +++PE    T  + Q D++  G  L E+   +      D    E  F  +   
Sbjct: 189 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 248

Query: 264 KRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQA-----------------FKQLTLQC 306
                                 S       + L                   F+    +C
Sbjct: 249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 308

Query: 307 MDFSPEDRPTMVDVAKQLRQ 326
           +  +P +R       KQL  
Sbjct: 309 LIKNPAERAD----LKQLMV 324

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 61.5 bits (150), Expect = 7e-11
 Identities = 31/138 (22%), Positives = 56/138 (40%), Gaps = 27/138 (19%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I+ A+ YLH    R I+YRD+K  N+L + +   KL D+ +    +  G+T     +  G
Sbjct: 119 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCG 172

Query: 212 TTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRL 266
           T  +IAPE    ++  +      D +  G  +FE++  +         S F    +    
Sbjct: 173 TPNYIAPE----ILRGEDYGFSVDWWALGVLMFEMMAGR---------SPFDIVGSSDNP 219

Query: 267 SGQNCRFKEMVDSIIIED 284
                    +   I+ + 
Sbjct: 220 DQNT--EDYLFQVILEKQ 235

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 61.6 bits (150), Expect = 8e-11
 Identities = 27/99 (27%), Positives = 47/99 (47%), Gaps = 9/99 (9%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
             ++  A+  +H   S   ++RD+KP N+L ++    KL DF   + +      +  D+ 
Sbjct: 174 TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTA 229

Query: 210 VGTTGFIAPE-----NFTTLINEQCDVYGFGAFLFELLT 243
           VGT  +I+PE             +CD +  G FL+E+L 
Sbjct: 230 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 61.2 bits (149), Expect = 8e-11
 Identities = 47/263 (17%), Positives = 90/263 (34%), Gaps = 82/263 (31%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLAD-----RIHHHCEQHFEALSLTDRLK 148
              +  H+++L           ++ E +  G L       R            SL+  ++
Sbjct: 83  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142

Query: 149 VAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDS 208
           +A +IA  +AYL+   +   V+RD+   N +  E    K+ DF ++  I + + +     
Sbjct: 143 MAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----- 194

Query: 209 VVGTTGFI-----APEN-----FTTLINEQCDVYGFGAFLFELLT----------AQEVS 248
             G  G +     +PE+     FTT      DV+ FG  L+E+ T           ++V 
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTT----YSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 250

Query: 249 DHVSFESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCM 307
             V              L    NC                             +L   C 
Sbjct: 251 RFV---------MEGGLLDKPDNCP------------------------DMLFELMRMCW 277

Query: 308 DFSPEDRPTMVDVAKQLRQMYRS 330
            ++P+ RP+ +++   +++    
Sbjct: 278 QYNPKMRPSFLEIISSIKEEMEP 300

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 61.6 bits (150), Expect = 8e-11
 Identities = 31/138 (22%), Positives = 56/138 (40%), Gaps = 27/138 (19%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I+ A+ YLH    R I+YRD+K  N+L + +   KL D+ +    +  G+T     +  G
Sbjct: 162 ISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCG 215

Query: 212 TTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRL 266
           T  +IAPE    ++  +      D +  G  +FE++  +         S F    +    
Sbjct: 216 TPNYIAPE----ILRGEDYGFSVDWWALGVLMFEMMAGR---------SPFDIVGSSDNP 262

Query: 267 SGQNCRFKEMVDSIIIED 284
                    +   I+ + 
Sbjct: 263 DQNT--EDYLFQVILEKQ 278

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 45/251 (17%), Positives = 88/251 (35%), Gaps = 69/251 (27%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
            + H ++++L           I+ E +  G L D +     Q    +S    L +A  I+
Sbjct: 272 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQIS 328

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
            A+ YL     +  ++R++   N L  E    K+ DF LS  +          +      
Sbjct: 329 SAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF-PIK 384

Query: 215 FIAPE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVSDHVSFESRFHY 259
           + APE      F+     + DV+ FG  L+E+ T            +V + +        
Sbjct: 385 WTAPESLAYNKFSI----KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-------- 432

Query: 260 EENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVD 319
           E++ +    + C                         +   +L   C  ++P DRP+  +
Sbjct: 433 EKDYRMERPEGCP------------------------EKVYELMRACWQWNPSDRPSFAE 468

Query: 320 VAKQLRQMYRS 330
           + +    M++ 
Sbjct: 469 IHQAFETMFQE 479

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 60.7 bits (148), Expect = 1e-10
 Identities = 44/257 (17%), Positives = 87/257 (33%), Gaps = 82/257 (31%)

Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ + +I+++          +V E  ++G L   +  +       +   + +++   ++ 
Sbjct: 74  QLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSM 128

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG- 214
            + YL        V+RD+   N+L   Q  AK+ DF LS ++   E     +     T  
Sbjct: 129 GMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE-----NYYKAQTHG 180

Query: 215 -----FIAPE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVSDHVSFE 254
                + APE      F++    + DV+ FG  ++E  +            EV+  +   
Sbjct: 181 KWPVKWYAPECINYYKFSS----KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML--- 233

Query: 255 SRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPED 313
                 E  +R+     C                         +    L   C  +  E+
Sbjct: 234 ------EKGERMGCPAGC------------------------PREMYDLMNLCWTYDVEN 263

Query: 314 RPTMVDVAKQLRQMYRS 330
           RP    V  +LR  Y  
Sbjct: 264 RPGFAAVELRLRNYYYD 280

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 60.3 bits (147), Expect = 1e-10
 Identities = 32/136 (23%), Positives = 53/136 (38%), Gaps = 31/136 (22%)

Query: 101 IVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLK- 148
           I     ++H++++K            +  E    G L DRI                +  
Sbjct: 56  ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-----------IGMPE 104

Query: 149 -VAMD----IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
             A      +   V YLH      I +RD+KP N+L +E+ + K+ DF L+         
Sbjct: 105 PDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 161

Query: 204 IELDSVVGTTGFIAPE 219
             L+ + GT  ++APE
Sbjct: 162 RLLNKMCGTLPYVAPE 177

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 61.0 bits (148), Expect = 1e-10
 Identities = 58/255 (22%), Positives = 87/255 (34%), Gaps = 78/255 (30%)

Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          IV E +  G+L D +     ++   L L   + +A  IA 
Sbjct: 318 KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIAS 374

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +AY+        V+RD++  NIL  E    K+ DF L+  I D E              
Sbjct: 375 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY------TARQGAK 425

Query: 216 I-----APE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVSDHVSFES 255
                 APE      FT     + DV+ FG  L EL T           +EV D V    
Sbjct: 426 FPIKWTAPEAALYGRFTI----KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV---- 477

Query: 256 RFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP 315
               E   +      C                         ++   L  QC    PE+RP
Sbjct: 478 ----ERGYRMPCPPECP------------------------ESLHDLMCQCWRKEPEERP 509

Query: 316 TMVDVAKQLRQMYRS 330
           T   +   L   + S
Sbjct: 510 TFEYLQAFLEDYFTS 524

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 60.1 bits (146), Expect = 1e-10
 Identities = 25/153 (16%), Positives = 46/153 (30%), Gaps = 49/153 (32%)

Query: 104 ASRMSHKHIIK-----------LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMD 152
            SR+    + +           L+V E ++ G+L +           + S    ++    
Sbjct: 85  LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD-------TSPSPVGAIRAMQS 137

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           +A A    H      +      P+ +  +                 DG      D V+  
Sbjct: 138 LAAAADAAH---RAGVALSIDHPSRVRVS----------------IDG------DVVLAY 172

Query: 213 TGFIAPENFTTLINEQCDVYGFGAFLFELLTAQ 245
              +         N Q D+ G GA L+ LL  +
Sbjct: 173 PATMPDA------NPQDDIRGIGASLYALLVNR 199

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 51/254 (20%), Positives = 90/254 (35%), Gaps = 78/254 (30%)

Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
            + H+++I+L          +V E   +G+L DR+  H         L    + A+ +A 
Sbjct: 77  SLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQGH----FLLGTLSRYAVQVAE 132

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG- 214
            + YL    S+  ++RD+   N+L   +   K+ DF L  ++P  +     D  V     
Sbjct: 133 GMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND-----DHYVMQEHR 184

Query: 215 -----FIAPE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVSDHVSFE 254
                + APE      F+       D + FG  L+E+ T            ++   +   
Sbjct: 185 KVPFAWCAPESLKTRTFSH----ASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI--- 237

Query: 255 SRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDR 314
                ++  +RL                  +   C       Q    + +QC    PEDR
Sbjct: 238 -----DKEGERL-----------------PRPEDCP------QDIYNVMVQCWAHKPEDR 269

Query: 315 PTMVDVAKQLRQMY 328
           PT V +   L +  
Sbjct: 270 PTFVALRDFLLEAQ 283

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 60.3 bits (147), Expect = 2e-10
 Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 16/99 (16%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I  A+ YLH   SR +VYRD+K  N++ ++    K+ DF L    I DG T   + +  G
Sbjct: 114 IVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCG 167

Query: 212 TTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQ 245
           T  ++APE    ++ +       D +G G  ++E++  +
Sbjct: 168 TPEYLAPE----VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 43/263 (16%), Positives = 79/263 (30%), Gaps = 82/263 (31%)

Query: 101 IVYASRMSHKHIIK-----------LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKV 149
             +A    H H+++           LI  E    G+LAD I  +  +        +   +
Sbjct: 62  YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISEN-YRIMSYFKEAELKDL 120

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD-------------------AKLFD 190
            + +   + Y+H   S  +V+ D+KP+NI  +  S                     K+ D
Sbjct: 121 LLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGD 177

Query: 191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQ------CDVYGFGAFLFELLTA 244
                 I             G + F+A E    ++ E        D++     +     A
Sbjct: 178 LGHVTRISS------PQVEEGDSRFLANE----VLQENYTHLPKADIFALALTVVCAAGA 227

Query: 245 QEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQL-QAFKQLT 303
           + +             +    +  +  R   +                 Q L Q F +L 
Sbjct: 228 EPL---------PRNGDQWHEI--RQGRLPRI----------------PQVLSQEFTELL 260

Query: 304 LQCMDFSPEDRPTMVDVAKQLRQ 326
              +   PE RP+    A  L +
Sbjct: 261 KVMIHPDPERRPS----AMALVK 279

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 59.9 bits (146), Expect = 2e-10
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 16/99 (16%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           IA  + +L    S+ I+YRD+K  N++ + +   K+ DF +   +I DG T     +  G
Sbjct: 130 IAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCG 183

Query: 212 TTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQ 245
           T  +IAPE    +I  Q      D + FG  L+E+L  Q
Sbjct: 184 TPDYIAPE----IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 59.5 bits (145), Expect = 2e-10
 Identities = 47/160 (29%), Positives = 69/160 (43%), Gaps = 32/160 (20%)

Query: 101 IVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKV 149
           I       H HIIKL           +V E V  G L D I  H       +   +  ++
Sbjct: 62  IQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH-----GRVEEMEARRL 116

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
              I  AV Y H      +V+RD+KP N+L +   +AK+ DF LS  + DGE    L + 
Sbjct: 117 FQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTS 170

Query: 210 VGTTGFIAPENFTTLINEQ------CDVYGFGAFLFELLT 243
            G+  + APE    +I+ +       D++  G  L+ LL 
Sbjct: 171 CGSPNYAAPE----VISGRLYAGPEVDIWSCGVILYALLC 206

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 44/254 (17%), Positives = 91/254 (35%), Gaps = 75/254 (29%)

Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ + +I++L          +V E    G L   +    E+    + +++  ++   ++ 
Sbjct: 392 QLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSM 447

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            + YL     +  V+R++   N+L   +  AK+ DF LS ++   +++    +       
Sbjct: 448 GMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT--ARSAGKWP 502

Query: 216 I---APE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVSDHVSFESRF 257
           +   APE      F++    + DV+ +G  ++E L+            EV   +      
Sbjct: 503 LKWYAPECINFRKFSS----RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI------ 552

Query: 258 HYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
              E  KR+     C                              L   C  +  EDRP 
Sbjct: 553 ---EQGKRMECPPEC------------------------PPELYALMSDCWIYKWEDRPD 585

Query: 317 MVDVAKQLRQMYRS 330
            + V +++R  Y S
Sbjct: 586 FLTVEQRMRACYYS 599

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 59.9 bits (146), Expect = 2e-10
 Identities = 30/99 (30%), Positives = 47/99 (47%), Gaps = 16/99 (16%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I  A+ +LH    + I+YRD+K  N+L + +   KL DF +    I +G T     +  G
Sbjct: 133 IISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCG 186

Query: 212 TTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQ 245
           T  +IAPE    ++ E       D +  G  L+E+L   
Sbjct: 187 TPDYIAPE----ILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 59.6 bits (145), Expect = 2e-10
 Identities = 32/130 (24%), Positives = 54/130 (41%), Gaps = 19/130 (14%)

Query: 101 IVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKV 149
           I     ++H++++K            +  E    G L DRI          +   D  + 
Sbjct: 56  ICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRF 110

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
              +   V YLH      I +RD+KP N+L +E+ + K+ DF L+           L+ +
Sbjct: 111 FHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKM 167

Query: 210 VGTTGFIAPE 219
            GT  ++APE
Sbjct: 168 CGTLPYVAPE 177

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 60.2 bits (146), Expect = 3e-10
 Identities = 56/246 (22%), Positives = 87/246 (35%), Gaps = 60/246 (24%)

Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++ H+ +++L          IV E +  G+L D +     ++   L L   + +A  IA 
Sbjct: 235 KLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIAS 291

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +AY+        V+RD++  NIL  E    K+ DF L+  I D E +           +
Sbjct: 292 GMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-YTARQGAKFPIKW 347

Query: 216 IAPENFT-TLINEQCDVYGFGAFLFELLT----------AQEVSDHVSFESRFHYEENVK 264
            APE         + DV+ FG  L EL T           +EV D V        E   +
Sbjct: 348 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV--------ERGYR 399

Query: 265 RLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
                 C                         ++   L  QC    PE+RPT   +   L
Sbjct: 400 MPCPPECP------------------------ESLHDLMCQCWRKEPEERPTFEYLQAFL 435

Query: 325 RQMYRS 330
              + S
Sbjct: 436 EDYFTS 441

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 59.5 bits (145), Expect = 3e-10
 Identities = 30/99 (30%), Positives = 48/99 (48%), Gaps = 16/99 (16%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I   + +LH   S+ IVYRD+K  NIL ++    K+ DF +   ++         ++  G
Sbjct: 127 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCG 180

Query: 212 TTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQ 245
           T  +IAPE    ++  Q      D + FG  L+E+L  Q
Sbjct: 181 TPDYIAPE----ILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 59.4 bits (144), Expect = 5e-10
 Identities = 28/99 (28%), Positives = 50/99 (50%), Gaps = 15/99 (15%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVG 211
           I  A+ YLH    + +VYRD+K  N++ ++    K+ DF L    I DG T   + +  G
Sbjct: 257 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCG 311

Query: 212 TTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQ 245
           T  ++APE    ++ +       D +G G  ++E++  +
Sbjct: 312 TPEYLAPE----VLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 59.5 bits (144), Expect = 5e-10
 Identities = 56/260 (21%), Positives = 85/260 (32%), Gaps = 82/260 (31%)

Query: 104 ASRMS---HKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVA 150
           A  M    H HI+KL          I+ E   +G L   +          L L   +  A
Sbjct: 442 ALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKFS----LDLASLILYA 497

Query: 151 MDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
             ++ A+AYL    S+  V+RD+   N+L +     KL DF LS  + D           
Sbjct: 498 YQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YK 548

Query: 211 GTTGFI-----APE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVSDH 250
            + G +     APE      FT+      DV+ FG  ++E+L             +V   
Sbjct: 549 ASKGKLPIKWMAPESINFRRFTS----ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR 604

Query: 251 VSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFS 310
           +         EN +RL                      C            L  +C  + 
Sbjct: 605 I---------ENGERL-----------------PMPPNCP------PTLYSLMTKCWAYD 632

Query: 311 PEDRPTMVDVAKQLRQMYRS 330
           P  RP   ++  QL  +   
Sbjct: 633 PSRRPRFTELKAQLSTILEE 652

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 58.4 bits (142), Expect = 5e-10
 Identities = 55/257 (21%), Positives = 85/257 (33%), Gaps = 81/257 (31%)

Query: 105 SRMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
            +  H HI+KL          I+ E   +G L   +          L L   +  A  ++
Sbjct: 71  RQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRKYS----LDLASLILYAYQLS 126

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
            A+AYL    S+  V+RD+   N+L +     KL DF LS  + D            + G
Sbjct: 127 TALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY------YKASKG 177

Query: 215 FI-----APE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVSDHVSFE 254
            +     APE      FT+      DV+ FG  ++E+L             +V   +   
Sbjct: 178 KLPIKWMAPESINFRRFTS----ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--- 230

Query: 255 SRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPED 313
                 EN +RL    NC                              L  +C  + P  
Sbjct: 231 ------ENGERLPMPPNC------------------------PPTLYSLMTKCWAYDPSR 260

Query: 314 RPTMVDVAKQLRQMYRS 330
           RP   ++  QL  +   
Sbjct: 261 RPRFTELKAQLSTILEE 277

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 58.0 bits (141), Expect = 7e-10
 Identities = 47/258 (18%), Positives = 90/258 (34%), Gaps = 82/258 (31%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
            ++SH  +++L           +V E ++ G L+D +           +    L + +D+
Sbjct: 58  MKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGL----FAAETLLGMCLDV 113

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT 213
              +AYL       +++RD+   N L  E    K+ DF ++  + D       D    +T
Sbjct: 114 CEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-------DQYTSST 163

Query: 214 G------FIAPE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVSDHVS 252
           G      + +PE      +++    + DV+ FG  ++E+ +            EV + + 
Sbjct: 164 GTKFPVKWASPEVFSFSRYSS----KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI- 218

Query: 253 FESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPE 312
                       RL                  K    +          Q+   C    PE
Sbjct: 219 --------STGFRL-----------------YKPRLAS------THVYQIMNHCWRERPE 247

Query: 313 DRPTMVDVAKQLRQMYRS 330
           DRP    + +QL ++  S
Sbjct: 248 DRPAFSRLLRQLAEIAES 265

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 58.1 bits (141), Expect = 7e-10
 Identities = 49/256 (19%), Positives = 90/256 (35%), Gaps = 80/256 (31%)

Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
            + H HI++L          +V + + +G+L D +  H       L     L   + IA 
Sbjct: 71  SLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGA----LGPQLLLNWGVQIAK 126

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG- 214
            + YL       +V+R++   N+L    S  ++ DF ++  +P        D  +  +  
Sbjct: 127 GMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD------DKQLLYSEA 177

Query: 215 -----FIAPE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVSDHVSFE 254
                ++A E      +T     Q DV+ +G  ++EL+T            EV D +   
Sbjct: 178 KTPIKWMALESIHFGKYTH----QSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLL--- 230

Query: 255 SRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDR 314
                 E  +RL                  +   CT           + ++C       R
Sbjct: 231 ------EKGERL-----------------AQPQICT------IDVYMVMVKCWMIDENIR 261

Query: 315 PTMVDVAKQLRQMYRS 330
           PT  ++A +  +M R 
Sbjct: 262 PTFKELANEFTRMARD 277

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 58.1 bits (141), Expect = 9e-10
 Identities = 51/263 (19%), Positives = 87/263 (33%), Gaps = 82/263 (31%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLAD--RIHHHCEQHFEALSLTDRLKVAM 151
           S+ +H++I++            I+ E +  G L    R          +L++ D L VA 
Sbjct: 88  SKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDS 208
           DIA    YL        ++RD+   N L         AK+ DF ++  I     +     
Sbjct: 148 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY----- 199

Query: 209 VVGTTGFI-----APEN-----FTTLINEQCDVYGFGAFLFELLT----------AQEVS 248
             G    +      PE      FT+    + D + FG  L+E+ +           QEV 
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTS----KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 255

Query: 249 DHVSFESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCM 307
           + V          +  R+   +NC                             ++  QC 
Sbjct: 256 EFV---------TSGGRMDPPKNC------------------------PGPVYRIMTQCW 282

Query: 308 DFSPEDRPTMVDVAKQLRQMYRS 330
              PEDRP    + +++    + 
Sbjct: 283 QHQPEDRPNFAIILERIEYCTQD 305

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 33/102 (32%), Positives = 52/102 (50%), Gaps = 16/102 (15%)

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDS 208
           A +IA  + +L    S+ I+YRD+K  N++ + +   K+ DF +   +I DG T     +
Sbjct: 448 AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKT 501

Query: 209 VVGTTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLTAQ 245
             GT  +IAPE    +I  Q      D + FG  L+E+L  Q
Sbjct: 502 FCGTPDYIAPE----IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 54/258 (20%), Positives = 85/258 (32%), Gaps = 82/258 (31%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           +  H +II+L           IV E ++ G+L   +  H  Q     ++   + +   + 
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ----FTIMQLVGMLRGVG 161

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
             + YL        V+RD+   N+L +     K+ DF LS  + D       D+   TTG
Sbjct: 162 AGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP-----DAAYTTTG 213

Query: 215 ------FIAPE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVSDHVSF 253
                 + APE      F++      DV+ FG  ++E+L            ++V   V  
Sbjct: 214 GKIPIRWTAPEAIAFRTFSS----ASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSV-- 267

Query: 254 ESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPE 312
                  E   RL     C                          A  QL L C      
Sbjct: 268 -------EEGYRLPAPMGCP------------------------HALHQLMLDCWHKDRA 296

Query: 313 DRPTMVDVAKQLRQMYRS 330
            RP    +   L  + RS
Sbjct: 297 QRPRFSQIVSVLDALIRS 314

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 51/263 (19%), Positives = 87/263 (33%), Gaps = 82/263 (31%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLAD--RIHHHCEQHFEALSLTDRLKVAM 151
           S+ +H++I++            I+ E +  G L    R          +L++ D L VA 
Sbjct: 129 SKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDS 208
           DIA    YL        ++RD+   N L         AK+ DF ++  I     +     
Sbjct: 189 DIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY----- 240

Query: 209 VVGTTGFI-----APEN-----FTTLINEQCDVYGFGAFLFELLT----------AQEVS 248
             G    +      PE      FT+    + D + FG  L+E+ +           QEV 
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTS----KTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 296

Query: 249 DHVSFESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCM 307
           + V          +  R+   +NC                             ++  QC 
Sbjct: 297 EFV---------TSGGRMDPPKNC------------------------PGPVYRIMTQCW 323

Query: 308 DFSPEDRPTMVDVAKQLRQMYRS 330
              PEDRP    + +++    + 
Sbjct: 324 QHQPEDRPNFAIILERIEYCTQD 346

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 27/103 (26%), Positives = 43/103 (41%), Gaps = 21/103 (20%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS---LSIPDGETHIELDSV 209
           I  A+ +LH      I+YRD+K  NIL +      L DF LS   ++      +      
Sbjct: 168 IVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY----DF 220

Query: 210 VGTTGFIAPENFTTLINEQ-------CDVYGFGAFLFELLTAQ 245
            GT  ++AP+    ++           D +  G  ++ELLT  
Sbjct: 221 CGTIEYMAPD----IVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 57.3 bits (139), Expect = 2e-09
 Identities = 51/268 (19%), Positives = 88/268 (32%), Gaps = 87/268 (32%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTL----------ADRIHHHCEQHFEALSL 143
           + + H+HI++            +VFE ++ G L          A  +    +     L L
Sbjct: 98  TMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGL 157

Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
              L VA  +A  + YL        V+RD+   N L  +    K+ DF +S  I   + +
Sbjct: 158 GQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY 214

Query: 204 IELDSVVGTTGFI-----APEN-----FTTLINEQCDVYGFGAFLFELLT---------- 243
                 VG    +      PE+     FTT    + DV+ FG  L+E+ T          
Sbjct: 215 -----RVGGRTMLPIRWMPPESILYRKFTT----ESDVWSFGVVLWEIFTYGKQPWYQLS 265

Query: 244 AQEVSDHVSFESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQL 302
             E  D +            + L   + C                              +
Sbjct: 266 NTEAIDCI---------TQGRELERPRACP------------------------PEVYAI 292

Query: 303 TLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
              C    P+ R ++ DV  +L+ + ++
Sbjct: 293 MRGCWQREPQQRHSIKDVHARLQALAQA 320

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 56.8 bits (138), Expect = 2e-09
 Identities = 55/256 (21%), Positives = 85/256 (33%), Gaps = 79/256 (30%)

Query: 105 SRMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
             + H HI+KL          I+ E    G L   +  +       L +   +  ++ I 
Sbjct: 68  KNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNKNS----LKVLTLVLYSLQIC 123

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
            A+AYL    S   V+RD+   NIL       KL DF LS  I D +          +  
Sbjct: 124 KAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY------YKASVT 174

Query: 215 FI-----APE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVSDHVSFE 254
            +     +PE      FTT      DV+ F   ++E+L+           ++V   +   
Sbjct: 175 RLPIKWMSPESINFRRFTT----ASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVL--- 227

Query: 255 SRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDR 314
                 E   RL                  K   C            L  +C D+ P DR
Sbjct: 228 ------EKGDRL-----------------PKPDLCP------PVLYTLMTRCWDYDPSDR 258

Query: 315 PTMVDVAKQLRQMYRS 330
           P   ++   L  +Y+ 
Sbjct: 259 PRFTELVCSLSDVYQM 274

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 53/254 (20%), Positives = 88/254 (34%), Gaps = 76/254 (29%)

Query: 106 RMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
            + H  ++KL          I+ E +  G+L D +            L   +  +  IA 
Sbjct: 239 TLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAE 295

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +A++     R  ++RD++  NIL +     K+ DF L+  I D E      +  G    
Sbjct: 296 GMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY----TAREGAKFP 348

Query: 216 I---APE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVSDHVSFESRF 257
           I   APE     +FT     + DV+ FG  L E++T            EV   +      
Sbjct: 349 IKWTAPEAINFGSFTI----KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL------ 398

Query: 258 HYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
              E   R+   +NC                         +    + ++C    PE+RPT
Sbjct: 399 ---ERGYRMPRPENCP------------------------EELYNIMMRCWKNRPEERPT 431

Query: 317 MVDVAKQLRQMYRS 330
              +   L   Y +
Sbjct: 432 FEYIQSVLDDFYTA 445

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 56.7 bits (137), Expect = 2e-09
 Identities = 34/159 (21%), Positives = 62/159 (38%), Gaps = 32/159 (20%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
           + +S   I+ L           I  E ++ G+L   I     +    L     L      
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLI-----KQMGCLPEDRALYYLGQA 159

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQ-SDAKLFDFSLSLSIPD---GETHIELDSV 209
              + YLH   +R I++ D+K  N+L +   S A L DF  +L +     G++ +  D +
Sbjct: 160 LEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI 216

Query: 210 VGTTGFIAPENFTTLINEQ-----CDVYGFGAFLFELLT 243
            GT   +APE    ++  +      D++     +  +L 
Sbjct: 217 PGTETHMAPE----VVMGKPCDAKVDIWSSCCMMLHMLN 251

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 56.7 bits (137), Expect = 3e-09
 Identities = 40/130 (30%), Positives = 56/130 (43%), Gaps = 22/130 (16%)

Query: 101 IVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKV 149
           I       H HIIKL           +V E V  G L D I  +       L   +  ++
Sbjct: 67  IQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKN-----GRLDEKESRRL 121

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
              I   V Y H      +V+RD+KP N+L +   +AK+ DF LS  + DGE    L + 
Sbjct: 122 FQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTS 175

Query: 210 VGTTGFIAPE 219
            G+  + APE
Sbjct: 176 CGSPNYAAPE 185

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 56.1 bits (136), Expect = 4e-09
 Identities = 54/269 (20%), Positives = 91/269 (33%), Gaps = 88/269 (32%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLAD--RIH---------HHCEQHFEALS 142
           + + H+HI+K            +VFE ++ G L    R H             Q    L 
Sbjct: 72  TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131

Query: 143 LTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET 202
           L+  L +A  IA  + YL    S+  V+RD+   N L       K+ DF +S  +   + 
Sbjct: 132 LSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY 188

Query: 203 HIELDSVVGTTGFI-----APEN-----FTTLINEQCDVYGFGAFLFELLT--------- 243
           +      VG    +      PE+     FTT    + DV+ FG  L+E+ T         
Sbjct: 189 Y-----RVGGHTMLPIRWMPPESIMYRKFTT----ESDVWSFGVILWEIFTYGKQPWFQL 239

Query: 244 -AQEVSDHVSFESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQ 301
              EV + +            + L   + C                         +    
Sbjct: 240 SNTEVIECI---------TQGRVLERPRVCP------------------------KEVYD 266

Query: 302 LTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
           + L C    P+ R  + ++ K L  + ++
Sbjct: 267 VMLGCWQREPQQRLNIKEIYKILHALGKA 295

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 56.2 bits (136), Expect = 4e-09
 Identities = 53/259 (20%), Positives = 88/259 (33%), Gaps = 82/259 (31%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
            +  H +II+L           IV E ++ G+L   +  H  Q     ++   + +   I
Sbjct: 101 GQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ----FTVIQLVGMLRGI 156

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT 213
           A  + YL        V+RD+   NIL N     K+ DF L   + D       ++   T 
Sbjct: 157 ASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP-----EAAYTTR 208

Query: 214 G------FIAPE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVSDHVS 252
           G      + +PE      FT+      DV+ +G  L+E+++           Q+V   V 
Sbjct: 209 GGKIPIRWTSPEAIAYRKFTS----ASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV- 263

Query: 253 FESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSP 311
                   +   RL    +C                          A  QL L C     
Sbjct: 264 --------DEGYRLPPPMDCP------------------------AALYQLMLDCWQKDR 291

Query: 312 EDRPTMVDVAKQLRQMYRS 330
            +RP    +   L ++ R+
Sbjct: 292 NNRPKFEQIVSILDKLIRN 310

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 56.1 bits (136), Expect = 4e-09
 Identities = 25/96 (26%), Positives = 44/96 (45%), Gaps = 17/96 (17%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           I     YLH   S  ++YRD+KP N+L ++Q   ++ DF  +  +    T     ++ GT
Sbjct: 150 IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-RTW----TLCGT 201

Query: 213 TGFIAPENFTTLINEQ-----CDVYGFGAFLFELLT 243
              +APE    +I  +      D +  G  ++E+  
Sbjct: 202 PEALAPE----IILSKGYNKAVDWWALGVLIYEMAA 233

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 55.8 bits (135), Expect = 4e-09
 Identities = 32/164 (19%), Positives = 58/164 (35%), Gaps = 37/164 (22%)

Query: 101 IVYASRMSHK--HIIKL-----------IVFESVQ-IGTLADRIHHHCEQHFEALSLTDR 146
           +V   ++S     +I+L           ++ E  + +  L D I         AL     
Sbjct: 97  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-----GALQEELA 151

Query: 147 LKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN-EQSDAKLFDFSLSLSIPDGETHIE 205
                 +  AV + H   +  +++RD+K  NIL +  + + KL DF     + D      
Sbjct: 152 RSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT----V 204

Query: 206 LDSVVGTTGFIAPENFTTLINEQC------DVYGFGAFLFELLT 243
                GT  +  PE     I           V+  G  L++++ 
Sbjct: 205 YTDFDGTRVYSPPE----WIRYHRYHGRSAAVWSLGILLYDMVC 244

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 55.6 bits (135), Expect = 5e-09
 Identities = 31/96 (32%), Positives = 53/96 (55%), Gaps = 17/96 (17%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           +  A+ YLH   S+ I+YRD+KP NIL ++    K+ DF  +  +PD  T+    ++ GT
Sbjct: 115 VCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VTY----TLCGT 166

Query: 213 TGFIAPENFTTLINEQ-----CDVYGFGAFLFELLT 243
             +IAPE    +++ +      D + FG  ++E+L 
Sbjct: 167 PDYIAPE----VVSTKPYNKSIDWWSFGILIYEMLA 198

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 55.3 bits (134), Expect = 6e-09
 Identities = 51/263 (19%), Positives = 91/263 (34%), Gaps = 86/263 (32%)

Query: 104 ASRM---SHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKV 149
           A+ M    H ++++L           I+ E +  G L D +     Q    +S    L +
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYM 116

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
           A  I+ A+ YL     +  ++RD+   N L  E    K+ DF LS  +         D+ 
Sbjct: 117 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-------DTY 166

Query: 210 VGTTG------FIAPE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVS 248
               G      + APE      F+     + DV+ FG  L+E+ T            +V 
Sbjct: 167 TAHAGAKFPIKWTAPESLAYNKFSI----KSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 222

Query: 249 DHVSFESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCM 307
           + +         E   R+   + C                         +   +L   C 
Sbjct: 223 ELL---------EKDYRMERPEGC------------------------PEKVYELMRACW 249

Query: 308 DFSPEDRPTMVDVAKQLRQMYRS 330
            ++P DRP+  ++ +    M++ 
Sbjct: 250 QWNPSDRPSFAEIHQAFETMFQE 272

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 55.4 bits (134), Expect = 7e-09
 Identities = 34/138 (24%), Positives = 49/138 (35%), Gaps = 36/138 (26%)

Query: 101 IVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLK- 148
           I+    + H +I++            I+ E    G L +RI +             R   
Sbjct: 67  IINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNA-----------GRFSE 115

Query: 149 -VAMD----IAHAVAYLHVGFSRPIVYRDMKPTNILF--NEQSDAKLFDFSLSLSIPDGE 201
             A      +   V+Y H   S  I +RD+K  N L   +     K+ DF  S S     
Sbjct: 116 DEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 172

Query: 202 THIELDSVVGTTGFIAPE 219
                 S VGT  +IAPE
Sbjct: 173 Q---PKSTVGTPAYIAPE 187

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 55.0 bits (133), Expect = 8e-09
 Identities = 44/264 (16%), Positives = 86/264 (32%), Gaps = 92/264 (34%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
           S++SHKH++             +V E V+ G+L   +  +       +++  +L+VA  +
Sbjct: 67  SKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC----INILWKLEVAKQL 122

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD--------AKLFDFSLSLSIPDGETHIE 205
           A A+ +L       +++ ++   NIL   + D         KL D  +S+++   +    
Sbjct: 123 AAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD---- 175

Query: 206 LDSVVGTTGFI---APE------NFTTLINEQCDVYGFGAFLFELLT----------AQE 246
                     I    PE      N         D + FG  L+E+ +          +Q 
Sbjct: 176 -----ILQERIPWVPPECIENPKNLNL----ATDKWSFGTTLWEICSGGDKPLSALDSQR 226

Query: 247 VSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQC 306
                         E+  +L                                   L   C
Sbjct: 227 KLQFY---------EDRHQL-----------------PAPKAAE--------LANLINNC 252

Query: 307 MDFSPEDRPTMVDVAKQLRQMYRS 330
           MD+ P+ RP+   + + L  ++  
Sbjct: 253 MDYEPDHRPSFRAIIRDLNSLFTP 276

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 55.0 bits (133), Expect = 8e-09
 Identities = 48/260 (18%), Positives = 94/260 (36%), Gaps = 82/260 (31%)

Query: 105 SRMSHKHIIKL------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMD 152
              SH +++ L            +V   ++ G L + I +         ++ D +   + 
Sbjct: 81  KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQ 136

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           +A  + YL    S+  V+RD+   N + +E+   K+ DF L+  + D E      SV   
Sbjct: 137 VAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY----YSVHNK 189

Query: 213 TGF------IAPE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVSDHV 251
           TG       +A E      FTT    + DV+ FG  L+EL+T            +++ ++
Sbjct: 190 TGAKLPVKWMALESLQTQKFTT----KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245

Query: 252 SFESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFS 310
                       +RL   + C                             ++ L+C    
Sbjct: 246 ---------LQGRRLLQPEYC------------------------PDPLYEVMLKCWHPK 272

Query: 311 PEDRPTMVDVAKQLRQMYRS 330
            E RP+  ++  ++  ++ +
Sbjct: 273 AEMRPSFSELVSRISAIFST 292

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 55.0 bits (133), Expect = 9e-09
 Identities = 30/125 (24%), Positives = 44/125 (35%), Gaps = 25/125 (20%)

Query: 108 SHKHIIKL-----------IVFE-SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
            H  +I+L           +V E  +    L D I          L           +  
Sbjct: 96  GHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVA 150

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFN-EQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
           A+ + H   SR +V+RD+K  NIL +  +  AKL DF     + D           GT  
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRV 203

Query: 215 FIAPE 219
           +  PE
Sbjct: 204 YSPPE 208

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 54.6 bits (132), Expect = 1e-08
 Identities = 55/258 (21%), Positives = 89/258 (34%), Gaps = 80/258 (31%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
            + SH +II+L           I+ E ++ G L   +     +     S+   + +   I
Sbjct: 101 GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGI 156

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT 213
           A  + YL    +   V+RD+   NIL N     K+ DF LS  + D       ++   T+
Sbjct: 157 AAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-----EATYTTS 208

Query: 214 G------FIAPE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVSDHVS 252
           G      + APE      FT+      DV+ FG  ++E++T            EV   + 
Sbjct: 209 GGKIPIRWTAPEAISYRKFTS----ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI- 263

Query: 253 FESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPE 312
                    +  RL                      C        A  QL +QC      
Sbjct: 264 --------NDGFRL-----------------PTPMDCP------SAIYQLMMQCWQQERA 292

Query: 313 DRPTMVDVAKQLRQMYRS 330
            RP   D+   L ++ R+
Sbjct: 293 RRPKFADIVSILDKLIRA 310

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 54.3 bits (131), Expect = 1e-08
 Identities = 37/183 (20%), Positives = 69/183 (37%), Gaps = 35/183 (19%)

Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD 207
           K+ + I  A+ YL       +++RD+KP+NIL +E+   KL DF +S  + D       D
Sbjct: 128 KMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD---DKAKD 182

Query: 208 SVVGTTGFIAPENFTTLINEQ------CDVYGFGAFLFELLTAQEVSDHVSFESRFHYEE 261
              G   ++APE        +       DV+  G      ++  E++       +F Y  
Sbjct: 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG------ISLVELA-----TGQFPY-- 229

Query: 262 NVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVA 321
                      F+ +  + +++++     G       F+     C+      RP      
Sbjct: 230 -----KNCKTDFEVL--TKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPK----Y 278

Query: 322 KQL 324
            +L
Sbjct: 279 NKL 281

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 54.2 bits (131), Expect = 1e-08
 Identities = 38/162 (23%), Positives = 62/162 (38%), Gaps = 34/162 (20%)

Query: 105 SRMSHKHIIK-----------LIVFESVQIGTLADRIHHHCEQHFEALSLTDRL--KVAM 151
             + HK+I++            I  E V  G+L+          +  L   ++       
Sbjct: 74  KHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSAL----LRSKWGPLKDNEQTIGFYTK 129

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS-DAKLFDFSLSLSIPDGETHIELDSVV 210
            I   + YLH      IV+RD+K  N+L N  S   K+ DF  S  +       E  +  
Sbjct: 130 QILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE--TFT 184

Query: 211 GTTGFIAPENFTTLINEQCDVYGF-------GAFLFELLTAQ 245
           GT  ++APE    +I++    YG        G  + E+ T +
Sbjct: 185 GTLQYMAPE----IIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 54.2 bits (131), Expect = 1e-08
 Identities = 29/158 (18%), Positives = 54/158 (34%), Gaps = 45/158 (28%)

Query: 77  KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-------------IVFESVQI 123
           K+ I L++                     R+ HK++I+L             +V E    
Sbjct: 54  KKEIQLLR---------------------RLRHKNVIQLVDVLYNEEKQKMYMVMEYCVC 92

Query: 124 GT--LADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN 181
           G   + D +        +A            +   + YLH   S+ IV++D+KP N+L  
Sbjct: 93  GMQEMLDSVPEKRFPVCQAH------GYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLT 143

Query: 182 EQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE 219
                K+    ++ ++          +  G+  F  PE
Sbjct: 144 TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 54.3 bits (131), Expect = 1e-08
 Identities = 47/266 (17%), Positives = 81/266 (30%), Gaps = 86/266 (32%)

Query: 105 SRMSHKHIIKL-----------------IVFESVQIGTLAD--RIHHHCEQHFEALSLTD 145
               H H+ KL                 ++   ++ G L          E     L L  
Sbjct: 80  KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP-FNLPLQT 138

Query: 146 RLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIE 205
            ++  +DIA  + YL    SR  ++RD+   N +  E     + DF LS  I  G+ +  
Sbjct: 139 LVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY-- 193

Query: 206 LDSVVGTTGFI-----APEN-----FTTLINEQCDVYGFGAFLFELLT----------AQ 245
                G    +     A E+     +T       DV+ FG  ++E++T            
Sbjct: 194 ---RQGCASKLPVKWLALESLADNLYTV----HSDVWAFGVTMWEIMTRGQTPYAGIENA 246

Query: 246 EVSDHVSFESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTL 304
           E+ +++             RL     C                         +    L  
Sbjct: 247 EIYNYL---------IGGNRLKQPPECM------------------------EEVYDLMY 273

Query: 305 QCMDFSPEDRPTMVDVAKQLRQMYRS 330
           QC    P+ RP+   +  +L  +   
Sbjct: 274 QCWSADPKQRPSFTCLRMELENILGH 299

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 54.2 bits (131), Expect = 1e-08
 Identities = 28/103 (27%), Positives = 43/103 (41%), Gaps = 24/103 (23%)

Query: 109 HKHIIKL---------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
             HI+++               IV E +  G L  RI    +Q F   +  +  ++   I
Sbjct: 70  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF---TEREASEIMKSI 126

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSL 193
             A+ YLH   S  I +RD+KP N+L+      +  KL DF  
Sbjct: 127 GEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 54.2 bits (131), Expect = 1e-08
 Identities = 36/144 (25%), Positives = 57/144 (39%), Gaps = 26/144 (18%)

Query: 89  RNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHC--E 135
           + Q   E  IN I+      + +I+             +V E +  G+L D +   C  E
Sbjct: 56  QQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE 115

Query: 136 QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL 195
               A        V  +   A+ +LH   S  +++RD+K  NIL       KL DF    
Sbjct: 116 GQIAA--------VCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA 164

Query: 196 SIPDGETHIELDSVVGTTGFIAPE 219
            I       +  ++VGT  ++APE
Sbjct: 165 QI--TPEQSKRSTMVGTPYWMAPE 186

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 54.4 bits (131), Expect = 1e-08
 Identities = 44/259 (16%), Positives = 93/259 (35%), Gaps = 80/259 (30%)

Query: 105 SRMSHKHIIKL------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMD 152
              SH +++ L            +V   ++ G L + I +         ++ D +   + 
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQ 200

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           +A  + +L    S+  V+RD+   N + +E+   K+ DF L+  + D E     +    T
Sbjct: 201 VAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN---KT 254

Query: 213 TGFI-----APEN-----FTTLINEQCDVYGFGAFLFELLT----------AQEVSDHVS 252
              +     A E+     FTT    + DV+ FG  L+EL+T            +++ ++ 
Sbjct: 255 GAKLPVKWMALESLQTQKFTT----KSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL- 309

Query: 253 FESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSP 311
                      +RL   + C                             ++ L+C     
Sbjct: 310 --------LQGRRLLQPEYCP------------------------DPLYEVMLKCWHPKA 337

Query: 312 EDRPTMVDVAKQLRQMYRS 330
           E RP+  ++  ++  ++ +
Sbjct: 338 EMRPSFSELVSRISAIFST 356

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 53.8 bits (130), Expect = 2e-08
 Identities = 44/258 (17%), Positives = 88/258 (34%), Gaps = 82/258 (31%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
             +SH+ +++L           I+ E +  G L + +     +          L++  D+
Sbjct: 74  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDV 129

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT- 212
             A+ YL    S+  ++RD+   N L N+Q   K+ DF LS  + D E      S VG+ 
Sbjct: 130 CEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT----SSVGSK 182

Query: 213 -----TGFIAPE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVSDHVS 252
                +    PE      F++    + D++ FG  ++E+ +            E ++H+ 
Sbjct: 183 FPVRWS---PPEVLMYSKFSS----KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI- 234

Query: 253 FESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPE 312
                       RL                  +    +      +    +   C     +
Sbjct: 235 --------AQGLRL-----------------YRPHLAS------EKVYTIMYSCWHEKAD 263

Query: 313 DRPTMVDVAKQLRQMYRS 330
           +RPT   +   +  +   
Sbjct: 264 ERPTFKILLSNILDVMDE 281

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 53.8 bits (130), Expect = 2e-08
 Identities = 45/160 (28%), Positives = 69/160 (43%), Gaps = 33/160 (20%)

Query: 101 IVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKV 149
           I Y   + H HIIKL           +V E    G L D I        + ++  +  + 
Sbjct: 60  ISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAG-GELFDYIVEK-----KRMTEDEGRRF 113

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
              I  A+ Y H      IV+RD+KP N+L ++  + K+ DF LS  + DG     L + 
Sbjct: 114 FQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTS 167

Query: 210 VGTTGFIAPENFTTLINEQ------CDVYGFGAFLFELLT 243
            G+  + APE    +IN +       DV+  G  L+ +L 
Sbjct: 168 CGSPNYAAPE----VINGKLYAGPEVDVWSCGIVLYVMLV 203

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 52/256 (20%), Positives = 87/256 (33%), Gaps = 82/256 (32%)

Query: 106 RMSHKHIIKL------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
           ++ H ++++L            IV E +  G+L D +          L     LK ++D+
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFSLDV 298

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT 213
             A+ YL        V+RD+   N+L +E + AK+ DF L+          E  S   T 
Sbjct: 299 CEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK---------EASSTQDTG 346

Query: 214 GF----IAPE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVSDHVSFE 254
                  APE      F+T    + DV+ FG  L+E+ +           ++V   V   
Sbjct: 347 KLPVKWTAPEALREKKFST----KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV--- 399

Query: 255 SRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDR 314
                 E   ++                 D    C        A   +   C       R
Sbjct: 400 ------EKGYKM-----------------DAPDGCP------PAVYDVMKNCWHLDAATR 430

Query: 315 PTMVDVAKQLRQMYRS 330
           PT + + +QL  +   
Sbjct: 431 PTFLQLREQLEHIRTH 446

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 52.6 bits (127), Expect = 4e-08
 Identities = 58/262 (22%), Positives = 94/262 (35%), Gaps = 85/262 (32%)

Query: 104 ASRM---SHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVA 150
           A+ M    H+ +++L          I+ E ++ G+L D +          L++   L +A
Sbjct: 59  ANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMA 115

Query: 151 MDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVV 210
             IA  +A++     R  ++RD++  NIL ++    K+ DF L+  I D E      +  
Sbjct: 116 AQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT----ARE 168

Query: 211 GT------TGFIAPE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVSD 249
           G       T   APE      FT     + DV+ FG  L E++T            EV  
Sbjct: 169 GAKFPIKWT---APEAINYGTFTI----KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221

Query: 250 HVSFESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMD 308
           ++         E   R+    NC                         +   QL   C  
Sbjct: 222 NL---------ERGYRMVRPDNCP------------------------EELYQLMRLCWK 248

Query: 309 FSPEDRPTMVDVAKQLRQMYRS 330
             PEDRPT   +   L   + +
Sbjct: 249 ERPEDRPTFDYLRSVLEDFFTA 270

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 52.8 bits (127), Expect = 4e-08
 Identities = 35/144 (24%), Positives = 60/144 (41%), Gaps = 26/144 (18%)

Query: 89  RNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHC--E 135
           R Q   E   N +V      H +++++           ++ E +Q G L D +      E
Sbjct: 81  RKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNE 140

Query: 136 QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL 195
           +            V   +  A+AYLH   ++ +++RD+K  +IL       KL DF    
Sbjct: 141 EQIAT--------VCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCA 189

Query: 196 SIPDGETHIELDSVVGTTGFIAPE 219
            I   +   +  S+VGT  ++APE
Sbjct: 190 QI--SKDVPKRKSLVGTPYWMAPE 211

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 52.6 bits (127), Expect = 4e-08
 Identities = 48/261 (18%), Positives = 85/261 (32%), Gaps = 85/261 (32%)

Query: 104 ASRM---SHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKV 149
           A  M   SH  ++K            IV E +  G L +    +   H + L  +  L++
Sbjct: 54  AQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLN----YLRSHGKGLEPSQLLEM 109

Query: 150 AMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSV 209
             D+   +A+L    S   ++RD+   N L +     K+ DF ++  + D       D  
Sbjct: 110 CYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD-------DQY 159

Query: 210 VGTTG------FIAPE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVS 248
           V + G      + APE      +++    + DV+ FG  ++E+ +            EV 
Sbjct: 160 VSSVGTKFPVKWSAPEVFHYFKYSS----KSDVWAFGILMWEVFSLGKMPYDLYTNSEVV 215

Query: 249 DHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMD 308
             V             RL                  +    +          Q+   C  
Sbjct: 216 LKV---------SQGHRL-----------------YRPHLAS------DTIYQIMYSCWH 243

Query: 309 FSPEDRPTMVDVAKQLRQMYR 329
             PE RPT   +   +  +  
Sbjct: 244 ELPEKRPTFQQLLSSIEPLRE 264

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 52.6 bits (126), Expect = 6e-08
 Identities = 40/272 (14%), Positives = 72/272 (26%), Gaps = 59/272 (21%)

Query: 98  INHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFE----ALS 142
              +  +   +H +I+             +V   +  G+  D I  H          A  
Sbjct: 74  QGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI 133

Query: 143 LTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET 202
           L   LK       A+ Y+H       V+R +K ++IL +      L     +LS+     
Sbjct: 134 LQGVLK-------ALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ 183

Query: 203 -----HIELDSVVGTTGFIAPENFTTLI---NEQCDVYGFGAFLFEL------------- 241
                H      V    +++PE     +   + + D+Y  G    EL             
Sbjct: 184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT 243

Query: 242 ----LTAQE-----VSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGK 292
                         +              +    +                  S +    
Sbjct: 244 QMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYH 303

Query: 293 EQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL 324
                 F     QC+  +P+ RP+    A  L
Sbjct: 304 RTFSPHFHHFVEQCLQRNPDARPS----ASTL 331

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 51.9 bits (125), Expect = 8e-08
 Identities = 28/101 (27%), Positives = 49/101 (48%), Gaps = 14/101 (13%)

Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE--THIE 205
           K+A+ I  A+ +LH      +++RD+KP+N+L N     K+ DF +S     G     + 
Sbjct: 113 KIAVSIVKALEHLHS--KLSVIHRDVKPSNVLINALGQVKMCDFGIS-----GYLVDDVA 165

Query: 206 LDSVVGTTGFIAPENFTTLINE-----QCDVYGFGAFLFEL 241
            D   G   ++APE     +N+     + D++  G  + EL
Sbjct: 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 51.5 bits (124), Expect = 1e-07
 Identities = 50/264 (18%), Positives = 92/264 (34%), Gaps = 83/264 (31%)

Query: 105 SRMSHKHIIKL----------------IVFESVQIGTLADRI-HHHCEQHFEALSLTDRL 147
              SH ++I+L                ++   ++ G L   + +   E   + + L   L
Sbjct: 91  KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLL 150

Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD 207
           K  +DIA  + YL    +R  ++RD+   N +  +     + DF LS  I  G+ +    
Sbjct: 151 KFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY---- 203

Query: 208 SVVGTTGFI-----APEN-----FTTLINEQCDVYGFGAFLFELLT----------AQEV 247
              G    +     A E+     +T+    + DV+ FG  ++E+ T            E+
Sbjct: 204 -RQGRIAKMPVKWIAIESLADRVYTS----KSDVWAFGVTMWEIATRGMTPYPGVQNHEM 258

Query: 248 SDHVSFESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQC 306
            D++          +  RL   ++C                        L    ++   C
Sbjct: 259 YDYL---------LHGHRLKQPEDC------------------------LDELYEIMYSC 285

Query: 307 MDFSPEDRPTMVDVAKQLRQMYRS 330
               P DRPT   +  QL ++  S
Sbjct: 286 WRTDPLDRPTFSVLRLQLEKLLES 309

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 50.7 bits (122), Expect = 2e-07
 Identities = 45/259 (17%), Positives = 86/259 (33%), Gaps = 80/259 (30%)

Query: 105 SRMSHKHIIKL------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMD 152
             ++H +++ L            ++   +  G L               ++ D +   + 
Sbjct: 77  RGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDL----LQFIRSPQRNPTVKDLISFGLQ 132

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT 212
           +A  + YL     +  V+RD+   N + +E    K+ DF L+  I D E +         
Sbjct: 133 VARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQ---HR 186

Query: 213 TGFI-----APEN-----FTTLINEQCDVYGFGAFLFELLT----------AQEVSDHVS 252
              +     A E+     FTT    + DV+ FG  L+ELLT            +++  + 
Sbjct: 187 HARLPVKWTALESLQTYRFTT----KSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL- 241

Query: 253 FESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSP 311
                      +RL   + C                          +  Q+  QC +  P
Sbjct: 242 --------AQGRRLPQPEYCP------------------------DSLYQVMQQCWEADP 269

Query: 312 EDRPTMVDVAKQLRQMYRS 330
             RPT   +  ++ Q+  +
Sbjct: 270 AVRPTFRVLVGEVEQIVSA 288

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 50.7 bits (122), Expect = 2e-07
 Identities = 42/267 (15%), Positives = 85/267 (31%), Gaps = 88/267 (32%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLAD--RIHHHCEQHF---------EALS 142
           +R+ H +++ L           ++F     G L +   +                  AL 
Sbjct: 67  ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126

Query: 143 LTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET 202
             D + +   IA  + YL    S  +V++D+   N+L  ++ + K+ D  L   +   + 
Sbjct: 127 PPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY 183

Query: 203 HIELDSVVGTTGFI-----APEN-----FTTLINEQCDVYGFGAFLFELLT--------- 243
           +      +     +     APE      F+       D++ +G  L+E+ +         
Sbjct: 184 Y-----KLLGNSLLPIRWMAPEAIMYGKFSI----DSDIWSYGVVLWEVFSYGLQPYCGY 234

Query: 244 -AQEVSDHVSFESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQ 301
             Q+V + +          N + L    +C                              
Sbjct: 235 SNQDVVEMI---------RNRQVLPCPDDCP------------------------AWVYA 261

Query: 302 LTLQCMDFSPEDRPTMVDVAKQLRQMY 328
           L ++C +  P  RP   D+  +LR   
Sbjct: 262 LMIECWNEFPSRRPRFKDIHSRLRAWG 288

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 50.3 bits (121), Expect = 3e-07
 Identities = 47/259 (18%), Positives = 87/259 (33%), Gaps = 88/259 (33%)

Query: 106 RMSHKHIIKL------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
           ++ H ++++L            IV E +  G+L D +          L     LK ++D+
Sbjct: 70  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFSLDV 126

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT 213
             A+ YL        V+RD+   N+L +E + AK+ DF L+            ++     
Sbjct: 127 CEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLT-----------KEASSTQD 172

Query: 214 G------FIAPE-----NFTTLINEQCDVYGFGAFLFELLT----------AQEVSDHVS 252
                  + APE      F+T    + DV+ FG  L+E+ +           ++V   V 
Sbjct: 173 TGKLPVKWTAPEALREKKFST----KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV- 227

Query: 253 FESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSP 311
                   E   ++     C                          A  ++   C     
Sbjct: 228 --------EKGYKMDAPDGCP------------------------PAVYEVMKNCWHLDA 255

Query: 312 EDRPTMVDVAKQLRQMYRS 330
             RP+ + + +QL  +   
Sbjct: 256 AMRPSFLQLREQLEHIKTH 274

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 50.3 bits (120), Expect = 3e-07
 Identities = 28/122 (22%), Positives = 53/122 (43%), Gaps = 14/122 (11%)

Query: 128 DRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAK 187
           +      + + + L+L   +  +  +A  + +L    SR  ++RD+   NIL +E++  K
Sbjct: 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVK 233

Query: 188 LFDFSLSLSIPDGETHIELDSVVGTTGFI-----APENFTTLI-NEQCDVYGFGAFLFEL 241
           + DF L+  I     +     V      +     APE     +   Q DV+ FG  L+E+
Sbjct: 234 ICDFGLARDIYKDPDY-----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288

Query: 242 LT 243
            +
Sbjct: 289 FS 290

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 50.0 bits (120), Expect = 4e-07
 Identities = 54/265 (20%), Positives = 79/265 (29%), Gaps = 91/265 (34%)

Query: 109 HKHIIKL-----------IVFESVQIGTL-----------ADRIHHHCEQHFEALSLTDR 146
           H +II L           +  E    G L            D            LS    
Sbjct: 85  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 147 LKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL 206
           L  A D+A  + YL     +  ++RD+   NIL  E   AK+ DF LS      E +   
Sbjct: 145 LHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVY--- 195

Query: 207 DSVVGTTGFI-----APE-----NFTTLINEQCDVYGFGAFLFELLT----------AQE 246
             V  T G +     A E      +TT      DV+ +G  L+E+++            E
Sbjct: 196 --VKKTMGRLPVRWMAIESLNYSVYTT----NSDVWSYGVLLWEIVSLGGTPYCGMTCAE 249

Query: 247 VSDHVSFESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQ 305
           + + +             RL    NC                              L  Q
Sbjct: 250 LYEKL---------PQGYRLEKPLNCD------------------------DEVYDLMRQ 276

Query: 306 CMDFSPEDRPTMVDVAKQLRQMYRS 330
           C    P +RP+   +   L +M   
Sbjct: 277 CWREKPYERPSFAQILVSLNRMLEE 301

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 49.6 bits (119), Expect = 5e-07
 Identities = 47/264 (17%), Positives = 84/264 (31%), Gaps = 88/264 (33%)

Query: 108 SHKHIIKL-----------IVFESVQIGTL-----------ADRIHHHCEQHFEALSLTD 145
            HK+II L           ++ E    G L            +  +       E ++  D
Sbjct: 99  KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158

Query: 146 RLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIE 205
            +     +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I + + +  
Sbjct: 159 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY-- 213

Query: 206 LDSVVGTTGFI-----APEN-----FTTLINEQCDVYGFGAFLFELLT----------AQ 245
                 T G +     APE      +T     Q DV+ FG  ++E+ T           +
Sbjct: 214 ---KKTTNGRLPVKWMAPEALFDRVYTH----QSDVWSFGVLMWEIFTLGGSPYPGIPVE 266

Query: 246 EVSDHVSFESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTL 304
           E+   +         +   R+    NC                              +  
Sbjct: 267 ELFKLL---------KEGHRMDKPANCT------------------------NELYMMMR 293

Query: 305 QCMDFSPEDRPTMVDVAKQLRQMY 328
            C    P  RPT   + + L ++ 
Sbjct: 294 DCWHAVPSQRPTFKQLVEDLDRIL 317

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 49.2 bits (118), Expect = 7e-07
 Identities = 52/277 (18%), Positives = 88/277 (31%), Gaps = 96/277 (34%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTL-------------------ADRIHHHC 134
           +   + +I+KL           ++FE +  G L                           
Sbjct: 105 AEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164

Query: 135 EQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS 194
                 LS  ++L +A  +A  +AYL     R  V+RD+   N L  E    K+ DF LS
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLS 221

Query: 195 LSIPDGETHIELDSVVGTTGFI-----APEN-----FTTLINEQCDVYGFGAFLFELLT- 243
            +I   + +            I      PE+     +TT    + DV+ +G  L+E+ + 
Sbjct: 222 RNIYSADYY-----KADGNDAIPIRWMPPESIFYNRYTT----ESDVWAYGVVLWEIFSY 272

Query: 244 ---------AQEVSDHVSFESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKE 293
                     +EV  +V          +   L+  +NC                      
Sbjct: 273 GLQPYYGMAHEEVIYYV---------RDGNILACPENCP--------------------- 302

Query: 294 QQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
                   L   C    P DRP+   + + L++M   
Sbjct: 303 ---LELYNLMRLCWSKLPADRPSFCSIHRILQRMCER 336

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 49.2 bits (118), Expect = 7e-07
 Identities = 47/262 (17%), Positives = 82/262 (31%), Gaps = 77/262 (29%)

Query: 108 SHKHIIKL-----------IVFESVQIGTL-------------ADRIHHHCEQHFEALSL 143
           +H +I+ L           ++ E    G L             +       E    AL L
Sbjct: 85  NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144

Query: 144 TDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
            D L  +  +A  +A+L    S+  ++RD+   NIL       K+ DF L+  I +   +
Sbjct: 145 EDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 204 IELDSVVGTTGFI-----APEN-----FTTLINEQCDVYGFGAFLFELLTA-----QEVS 248
                VV     +     APE+     +T     + DV+ +G FL+EL +        + 
Sbjct: 202 -----VVKGNARLPVKWMAPESIFNCVYTF----ESDVWSYGIFLWELFSLGSSPYPGMP 252

Query: 249 DHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMD 308
               F   +   +   R+                                   +   C D
Sbjct: 253 VDSKF---YKMIKEGFRM-----------------LSPEHAP------AEMYDIMKTCWD 286

Query: 309 FSPEDRPTMVDVAKQLRQMYRS 330
             P  RPT   + + + +    
Sbjct: 287 ADPLKRPTFKQIVQLIEKQISE 308

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 49.3 bits (118), Expect = 8e-07
 Identities = 47/264 (17%), Positives = 84/264 (31%), Gaps = 88/264 (33%)

Query: 108 SHKHIIKL-----------IVFESVQIGTL-----------ADRIHHHCEQHFEALSLTD 145
            HK+II L           ++ E    G L            +  +       E ++  D
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204

Query: 146 RLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIE 205
            +     +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I + + +  
Sbjct: 205 LVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY-- 259

Query: 206 LDSVVGTTGFI-----APEN-----FTTLINEQCDVYGFGAFLFELLT----------AQ 245
                 T G +     APE      +T     Q DV+ FG  ++E+ T           +
Sbjct: 260 ---KKTTNGRLPVKWMAPEALFDRVYTH----QSDVWSFGVLMWEIFTLGGSPYPGIPVE 312

Query: 246 EVSDHVSFESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTL 304
           E+   +         +   R+    NC                              +  
Sbjct: 313 ELFKLL---------KEGHRMDKPANCT------------------------NELYMMMR 339

Query: 305 QCMDFSPEDRPTMVDVAKQLRQMY 328
            C    P  RPT   + + L ++ 
Sbjct: 340 DCWHAVPSQRPTFKQLVEDLDRIL 363

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 48.8 bits (117), Expect = 9e-07
 Identities = 44/268 (16%), Positives = 84/268 (31%), Gaps = 90/268 (33%)

Query: 108 SHKHIIKL------------IVFESVQIGTL-----------ADRIHHHCEQHFEALSLT 144
            H +++ L            ++ E  + G L                   + + + L+L 
Sbjct: 89  HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 145 DRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHI 204
             +  +  +A  + +L    SR  ++RD+   NIL +E++  K+ DF L+  I     + 
Sbjct: 149 HLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY- 204

Query: 205 ELDSVVGTTGFI-----APEN-----FTTLINEQCDVYGFGAFLFELLT----------- 243
               V      +     APE      +T     Q DV+ FG  L+E+ +           
Sbjct: 205 ----VRKGDARLPLKWMAPETIFDRVYTI----QSDVWSFGVLLWEIFSLGASPYPGVKI 256

Query: 244 AQEVSDHVSFESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQL 302
            +E    +         +   R+                                   Q 
Sbjct: 257 DEEFCRRL---------KEGTRMRAPDYTT------------------------PEMYQT 283

Query: 303 TLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
            L C    P  RPT  ++ + L  + ++
Sbjct: 284 MLDCWHGEPSQRPTFSELVEHLGNLLQA 311

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 51/267 (19%), Positives = 85/267 (31%), Gaps = 88/267 (32%)

Query: 108 SHKHIIKL-----------IVFESVQIGTL-----------ADRIHHHCEQHFEALSLTD 145
            HK+II L           ++ E    G L            +  ++      E LS  D
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192

Query: 146 RLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIE 205
            +  A  +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I   + +  
Sbjct: 193 LVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY-- 247

Query: 206 LDSVVGTTGFI-----APEN-----FTTLINEQCDVYGFGAFLFELLT----------AQ 245
                 T G +     APE      +T     Q DV+ FG  L+E+ T           +
Sbjct: 248 ---KKTTNGRLPVKWMAPEALFDRIYTH----QSDVWSFGVLLWEIFTLGGSPYPGVPVE 300

Query: 246 EVSDHVSFESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTL 304
           E+   +         +   R+    NC                              +  
Sbjct: 301 ELFKLL---------KEGHRMDKPSNCT------------------------NELYMMMR 327

Query: 305 QCMDFSPEDRPTMVDVAKQLRQMYRSC 331
            C    P  RPT   + + L ++    
Sbjct: 328 DCWHAVPSQRPTFKQLVEDLDRIVALT 354

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 34/137 (24%), Positives = 55/137 (40%), Gaps = 28/137 (20%)

Query: 98  INHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHC----EQHFEALS 142
           I  I    +    H++K            IV E    G+++D I        E       
Sbjct: 72  IKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT-- 129

Query: 143 LTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET 202
                 +       + YLH       ++RD+K  NIL N +  AKL DF ++  + D  T
Sbjct: 130 ------ILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD--T 178

Query: 203 HIELDSVVGTTGFIAPE 219
             + ++V+GT  ++APE
Sbjct: 179 MAKRNTVIGTPFWMAPE 195

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 47.6 bits (114), Expect = 2e-06
 Identities = 35/166 (21%), Positives = 64/166 (38%), Gaps = 42/166 (25%)

Query: 108 SHKHIIKL-----------IVFESVQIGTLAD--RIHHHCEQHF-------EALSLTDRL 147
            H++I+ L           ++ E    G L +  R      +            S  D L
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167

Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD 207
             +  +A  +A+L    S+  ++RD+   N+L      AK+ DF L+  I +   +    
Sbjct: 168 HFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY---- 220

Query: 208 SVVGTTGFI-----APEN-----FTTLINEQCDVYGFGAFLFELLT 243
            +V     +     APE+     +T     Q DV+ +G  L+E+ +
Sbjct: 221 -IVKGNARLPVKWMAPESIFDCVYTV----QSDVWSYGILLWEIFS 261

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 47.3 bits (113), Expect = 3e-06
 Identities = 28/103 (27%), Positives = 45/103 (43%), Gaps = 18/103 (17%)

Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF----SLSLSIPDGETH 203
           K+ +    A+ +L    +  I++RD+KP+NIL +   + KL DF     L  SI      
Sbjct: 129 KITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD- 185

Query: 204 IELDSVVGTTGFIAPENFTTLINE-----QCDVYGFGAFLFEL 241
                  G   ++APE      +      + DV+  G  L+EL
Sbjct: 186 ------AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYEL 222

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 46.5 bits (111), Expect = 5e-06
 Identities = 41/202 (20%), Positives = 76/202 (37%), Gaps = 46/202 (22%)

Query: 62  VLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-IVFES 120
           V++DP  +        R + +M+     + H     +    Y      +  I L +V E 
Sbjct: 56  VIQDPRFR-------NRELQIMQDLAVLH-HPNIVQLQSYFYTLGERDRRDIYLNVVMEY 107

Query: 121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH----------AVAYLHVGFSRPIVY 170
           V   TL     ++            R +VA               ++  LH+  S  + +
Sbjct: 108 VP-DTLHRCCRNYY-----------RRQVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCH 154

Query: 171 RDMKPTNILFNEQS-DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE------NFTT 223
           RD+KP N+L NE     KL DF  +  +   E ++     + +  + APE      ++TT
Sbjct: 155 RDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY---ICSRYYRAPELIFGNQHYTT 211

Query: 224 LINEQCDVYGFGAFLFELLTAQ 245
            +    D++  G    E++  +
Sbjct: 212 AV----DIWSVGCIFAEMMLGE 229

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 46.2 bits (110), Expect = 6e-06
 Identities = 28/92 (30%), Positives = 48/92 (52%), Gaps = 14/92 (15%)

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
             + YLH   S   ++RD+K  N+L +E  + KL DF ++  + D  T I+ ++ VGT  
Sbjct: 130 KGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPF 184

Query: 215 FIAPENFTTLI-----NEQCDVYGFGAFLFEL 241
           ++APE    +I     + + D++  G    EL
Sbjct: 185 WMAPE----VIKQSAYDSKADIWSLGITAIEL 212

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 45.8 bits (109), Expect = 9e-06
 Identities = 24/96 (25%), Positives = 47/96 (48%), Gaps = 11/96 (11%)

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
           +I   +++LH      +++RD+K  N+L  E ++ KL DF +S  +    T    ++ +G
Sbjct: 137 EILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIG 191

Query: 212 TTGFIAPE------NFTTLINEQCDVYGFGAFLFEL 241
           T  ++APE      N     + + D++  G    E+
Sbjct: 192 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEM 227

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 45.8 bits (109), Expect = 9e-06
 Identities = 23/65 (35%), Positives = 37/65 (56%), Gaps = 5/65 (7%)

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
            A+ +LH   S+ I++RD+K  N+L   + D +L DF +S       T  + DS +GT  
Sbjct: 128 EALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--TLQKRDSFIGTPY 182

Query: 215 FIAPE 219
           ++APE
Sbjct: 183 WMAPE 187

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 45.0 bits (107), Expect = 2e-05
 Identities = 36/156 (23%), Positives = 62/156 (39%), Gaps = 25/156 (16%)

Query: 98  INHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDR 146
           +  I   S+  H +I+             +V + +  G++ D I H   +      + D 
Sbjct: 61  LKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDE 120

Query: 147 LKVAM---DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH 203
             +A    ++   + YLH       ++RD+K  NIL  E    ++ DF +S  +  G   
Sbjct: 121 STIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 177

Query: 204 IEL---DSVVGTTGFIAPENFTTLINEQCDVYGFGA 236
                  + VGT  ++APE     + EQ   Y F A
Sbjct: 178 TRNKVRKTFVGTPCWMAPE-----VMEQVRGYDFKA 208

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 45.1 bits (107), Expect = 2e-05
 Identities = 23/89 (25%), Positives = 39/89 (43%), Gaps = 7/89 (7%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            + +LH   S  I++RD+KP+NI+       K+ DF L+ +             V T  +
Sbjct: 139 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYY 192

Query: 216 IAPE-NFTTLINEQCDVYGFGAFLFELLT 243
            APE        E  D++  G  + E++ 
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMIK 221

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 44.4 bits (106), Expect = 2e-05
 Identities = 26/109 (23%), Positives = 45/109 (41%), Gaps = 39/109 (35%)

Query: 107 MSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           + H +I+KL           +VFE             H +Q  +   L D  +  ++   
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFE-------------HLDQDLK--KLLDVCEGGLESVT 101

Query: 156 ----------AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS 194
                      +AY H    R +++RD+KP N+L N + + K+ DF L+
Sbjct: 102 AKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLA 147

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 44.5 bits (105), Expect = 3e-05
 Identities = 22/93 (23%), Positives = 40/93 (43%), Gaps = 15/93 (16%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            + +LH   S  I++RD+KP+NI+       K+ DF L+ +             V T  +
Sbjct: 176 GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPY---VVTRYY 229

Query: 216 IAPE-----NFTTLINEQCDVYGFGAFLFELLT 243
            APE      +   +    D++  G  + E++ 
Sbjct: 230 RAPEVILGMGYKENV----DIWSVGCIMGEMVR 258

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 44.1 bits (105), Expect = 3e-05
 Identities = 25/117 (21%), Positives = 39/117 (33%), Gaps = 34/117 (29%)

Query: 107 MSHKHIIKLIVFESVQIGTLADRIHHHCEQH--FEALSLT-----DRLKVAMDIAH---- 155
           + H +++ L+           +        H  FE    T     DR +  +        
Sbjct: 59  LKHPNLVNLL-----------EVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSI 107

Query: 156 ------AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL--SLSIPDGE-TH 203
                 AV + H       ++RD+KP NIL  + S  KL DF     L+ P      
Sbjct: 108 TWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD 161

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 44.0 bits (105), Expect = 3e-05
 Identities = 27/121 (22%), Positives = 46/121 (38%), Gaps = 42/121 (34%)

Query: 107 MSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           + HK+I++L           +VFE              C+Q  +     D     +D   
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFE-------------FCDQDLK--KYFDSCNGDLDPEI 102

Query: 156 ----------AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL--SLSIPDGE-T 202
                      + + H   SR +++RD+KP N+L N   + KL +F L  +  IP    +
Sbjct: 103 VKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS 159

Query: 203 H 203
            
Sbjct: 160 A 160

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 43.8 bits (104), Expect = 4e-05
 Identities = 32/162 (19%), Positives = 58/162 (35%), Gaps = 33/162 (20%)

Query: 106 RMSHKHIIKL---IVFESVQIGTLADRIH---HHCEQHFEALSLTDRLKVAMDIAH---- 155
            + H++++ L      ++         I+     CE       L   + V   ++     
Sbjct: 72  LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA--GLLSNVLVKFTLSEIKRV 129

Query: 156 ------AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL--SLSIPDGETHIELD 207
                  + Y+H      I++RDMK  N+L       KL DF L  + S+          
Sbjct: 130 MQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186

Query: 208 SVVGTTGFIAPE------NFTTLINEQCDVYGFGAFLFELLT 243
           + V T  +  PE      ++   I    D++G G  + E+ T
Sbjct: 187 NRVVTLWYRPPELLLGERDYGPPI----DLWGAGCIMAEMWT 224

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 43.8 bits (104), Expect = 4e-05
 Identities = 57/274 (20%), Positives = 99/274 (36%), Gaps = 96/274 (35%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLAD--RIHHHCEQHF------------- 138
            +++H H+IKL           ++ E  + G+L    R        +             
Sbjct: 81  KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140

Query: 139 ----EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS 194
                AL++ D +  A  I+  + YL       +V+RD+   NIL  E    K+ DF LS
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLS 197

Query: 195 LSIPDGETHIELDSVVGTTGFI-----APEN-----FTTLINEQCDVYGFGAFLFELLT- 243
             + + +++     V  + G I     A E+     +TT    Q DV+ FG  L+E++T 
Sbjct: 198 RDVYEEDSY-----VKRSQGRIPVKWMAIESLFDHIYTT----QSDVWSFGVLLWEIVTL 248

Query: 244 ---------AQEVSDHVSFESRFHYEENVKRLSG-QNCRFKEMVDSIIIEDKSCTCTGKE 293
                     + + + +         +   R+    NC                      
Sbjct: 249 GGNPYPGIPPERLFNLL---------KTGHRMERPDNCS--------------------- 278

Query: 294 QQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
              +   +L LQC    P+ RP   D++K L +M
Sbjct: 279 ---EEMYRLMLQCWKQEPDKRPVFADISKDLEKM 309

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 43.7 bits (104), Expect = 4e-05
 Identities = 25/110 (22%), Positives = 40/110 (36%), Gaps = 39/110 (35%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
            + H +I+ L           +VFE               E+  +   + D  K  +  +
Sbjct: 75  ELHHPNIVSLIDVIHSERCLTLVFE-------------FMEKDLK--KVLDENKTGLQDS 119

Query: 155 H----------AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS 194
                       VA+ H      I++RD+KP N+L N     KL DF L+
Sbjct: 120 QIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLA 166

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 43.8 bits (104), Expect = 4e-05
 Identities = 36/175 (20%), Positives = 63/175 (36%), Gaps = 51/175 (29%)

Query: 108 SHKHIIKL-----------IVFESVQIGTL------------------ADRIHHHCEQHF 138
           SH++I+ L           ++FE    G L                   ++     E+  
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166

Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
             L+  D L  A  +A  + +L     +  V+RD+   N+L       K+ DF L+  I 
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223

Query: 199 DGETHIELDSVVGTTGFI-----APE-----NFTTLINEQCDVYGFGAFLFELLT 243
               +     VV     +     APE      +T     + DV+ +G  L+E+ +
Sbjct: 224 SDSNY-----VVRGNARLPVKWMAPESLFEGIYTI----KSDVWSYGILLWEIFS 269

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 43.3 bits (103), Expect = 5e-05
 Identities = 18/50 (36%), Positives = 23/50 (46%), Gaps = 5/50 (10%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL--SLSIPDGETH 203
            + +LH   +  IV+RD+KP NIL       KL DF L    S     T 
Sbjct: 132 GLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 43.5 bits (103), Expect = 5e-05
 Identities = 40/175 (22%), Positives = 68/175 (38%), Gaps = 58/175 (33%)

Query: 106 RMSHKHIIKL-----------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLK 148
            + H +++ L                 +V E V   T+     H+            +LK
Sbjct: 88  IVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHY-----------AKLK 135

Query: 149 VAMDIAH----------AVAYLHVGFSRPIVYRDMKPTNILFNEQSDA-KLFDFSLSLSI 197
             M +            ++AY+H   S  I +RD+KP N+L +  S   KL DF  +  +
Sbjct: 136 QTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192

Query: 198 PDGETHIELDSVVGTTGFI-APE------NFTTLINEQCDVYGFGAFLFELLTAQ 245
             GE ++    +   + +  APE      N+TT I    D++  G  + EL+  Q
Sbjct: 193 IAGEPNVS--YIC--SRYYRAPELIFGATNYTTNI----DIWSTGCVMAELMQGQ 239

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 43.6 bits (103), Expect = 6e-05
 Identities = 26/100 (26%), Positives = 45/100 (45%), Gaps = 17/100 (17%)

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA-KLFDFSLSLSIPDGETHIELDSVVG 211
           +  AV ++H   S  I +RD+KP N+L N + +  KL DF  +  +   E  +     + 
Sbjct: 150 LFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAY---IC 203

Query: 212 TTGFIAPE------NFTTLINEQCDVYGFGAFLFELLTAQ 245
           +  + APE       +T  I    D++  G    EL+  +
Sbjct: 204 SRFYRAPELMLGATEYTPSI----DLWSIGCVFGELILGK 239

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 43.0 bits (102), Expect = 6e-05
 Identities = 28/105 (26%), Positives = 46/105 (43%), Gaps = 21/105 (20%)

Query: 107 MSHKHIIKLI-----------VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           + H++++ L+           VFE V   T+ D +    E     L      K    I +
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVD-HTILDDL----ELFPNGLDYQVVQKYLFQIIN 135

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS--LSIP 198
            + + H   S  I++RD+KP NIL ++    KL DF  +  L+ P
Sbjct: 136 GIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 43.2 bits (102), Expect = 7e-05
 Identities = 40/180 (22%), Positives = 69/180 (38%), Gaps = 68/180 (37%)

Query: 106 RMSHKHIIKL-----------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLK 148
           ++ H +I++L                 +V + V   T+     H+            R K
Sbjct: 103 KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHY-----------SRAK 150

Query: 149 VAMDIAH----------AVAYLHVGFSRPIVYRDMKPTNILFNEQSDA-KLFDFSLSLSI 197
             + + +          ++AY+H   S  I +RD+KP N+L +  +   KL DF  +  +
Sbjct: 151 QTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207

Query: 198 PDGETHIELDSVVGTTGFI------APE------NFTTLINEQCDVYGFGAFLFELLTAQ 245
             GE ++          +I      APE      ++T+ I    DV+  G  L ELL  Q
Sbjct: 208 VRGEPNVS---------YICSRYYRAPELIFGATDYTSSI----DVWSAGCVLAELLLGQ 254

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 43.2 bits (102), Expect = 7e-05
 Identities = 22/65 (33%), Positives = 33/65 (50%), Gaps = 9/65 (13%)

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
             +AYLH   S  +++RD+K  NIL +E    KL DF  +  +    +       VGT  
Sbjct: 165 QGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPY 215

Query: 215 FIAPE 219
           ++APE
Sbjct: 216 WMAPE 220

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 43.0 bits (102), Expect = 8e-05
 Identities = 28/95 (29%), Positives = 40/95 (42%), Gaps = 19/95 (20%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL--SLSIPDGETHIELDSVVGTT 213
            + +LH   S  +V+RD+KP NIL       KL DF L    S     T      VV T 
Sbjct: 132 GLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS-----VVVTL 183

Query: 214 GFIAPE-----NFTTLINEQCDVYGFGAFLFELLT 243
            + APE     ++ T +    D++  G    E+  
Sbjct: 184 WYRAPEVLLQSSYATPV----DLWSVGCIFAEMFR 214

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 43.0 bits (102), Expect = 8e-05
 Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 14/95 (14%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI-PDGETHIELDSVVGTTG 214
            + Y+H   S  +++RD+KP+N+L N   D K+ DF L+    PD +    L   V T  
Sbjct: 140 GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196

Query: 215 FIAPE------NFTTLINEQCDVYGFGAFLFELLT 243
           + APE       +T  I    D++  G  L E+L+
Sbjct: 197 YRAPEIMLNSKGYTKSI----DIWSVGCILAEMLS 227

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 43.0 bits (102), Expect = 8e-05
 Identities = 30/122 (24%), Positives = 45/122 (36%), Gaps = 42/122 (34%)

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
            +SH +II L           +VF+               E   E   +     + +  +
Sbjct: 68  ELSHPNIIGLLDAFGHKSNISLVFD-------------FMETDLE--VIIKDNSLVLTPS 112

Query: 155 H----------AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL--SLSIPDGE- 201
           H           + YLH      I++RD+KP N+L +E    KL DF L  S   P+   
Sbjct: 113 HIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY 169

Query: 202 TH 203
           TH
Sbjct: 170 TH 171

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 42.5 bits (101), Expect = 9e-05
 Identities = 23/109 (21%), Positives = 41/109 (37%), Gaps = 38/109 (34%)

Query: 107 MSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           ++H +I+KL           +VFE                Q  +   +       + +  
Sbjct: 59  LNHPNIVKLLDVIHTENKLYLVFE-------------FLHQDLKKF-MDASALTGIPLPL 104

Query: 156 ----------AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS 194
                      +A+ H   S  +++RD+KP N+L N +   KL DF L+
Sbjct: 105 IKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLA 150

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 42.7 bits (101), Expect = 9e-05
 Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 18/94 (19%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            + Y+H   +  I++RD+KP N+  NE  + K+ DF L+       T       V T  +
Sbjct: 140 GLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTG-----YVVTRWY 191

Query: 216 IAPE------NFTTLINEQCDVYGFGAFLFELLT 243
            APE       +T  +    D++  G  + E++T
Sbjct: 192 RAPEVILNWMRYTQTV----DIWSVGCIMAEMIT 221

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 42.6 bits (101), Expect = 1e-04
 Identities = 27/102 (26%), Positives = 43/102 (42%), Gaps = 21/102 (20%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGT--T 213
           AV  LH      +++RD+KP+N+L N   D K+ DF L+  I +        +   +   
Sbjct: 124 AVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180

Query: 214 GFI------APE------NFTTLINEQCDVYGFGAFLFELLT 243
            F+      APE       ++  +    DV+  G  L EL  
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFL 218

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 42.3 bits (100), Expect = 1e-04
 Identities = 26/94 (27%), Positives = 43/94 (45%), Gaps = 18/94 (19%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            + Y+H   S  +V+RD+KP N+  NE  + K+ DF L+       T       V T  +
Sbjct: 138 GLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----YVVTRWY 189

Query: 216 IAPE------NFTTLINEQCDVYGFGAFLFELLT 243
            APE      ++   +    D++  G  + E+LT
Sbjct: 190 RAPEVILSWMHYNQTV----DIWSVGCIMAEMLT 219

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 42.3 bits (100), Expect = 1e-04
 Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 18/94 (19%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+    D     E+   V T  +
Sbjct: 144 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-----EMTGYVATRWY 195

Query: 216 IAPE------NFTTLINEQCDVYGFGAFLFELLT 243
            APE      ++   +    D++  G  + ELLT
Sbjct: 196 RAPEIMLNWMHYNQTV----DIWSVGCIMAELLT 225

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 41.8 bits (99), Expect = 1e-04
 Identities = 26/121 (21%), Positives = 49/121 (40%), Gaps = 42/121 (34%)

Query: 107 MSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           + H +I+ L           +VFE             + ++  +     D     +++ +
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFE-------------YLDKDLK--QYLDDCGNIINMHN 101

Query: 156 ----------AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL--SLSIPDGE-T 202
                      +AY H    + +++RD+KP N+L NE+ + KL DF L  + SIP     
Sbjct: 102 VKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD 158

Query: 203 H 203
           +
Sbjct: 159 N 159

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 12/68 (17%), Positives = 27/68 (39%), Gaps = 5/68 (7%)

Query: 140 ALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLF--DFSLSLSI 197
            LS    L+VA  +  A+ +LH       V+ ++   NI  + +  +++    +  +   
Sbjct: 155 VLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

Query: 198 PDGETHIE 205
                H+ 
Sbjct: 212 CPSGKHVA 219

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 41.7 bits (98), Expect = 2e-04
 Identities = 16/39 (41%), Positives = 23/39 (58%), Gaps = 3/39 (7%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS 194
            V Y+H   S  I++RD+KP N L N+    K+ DF L+
Sbjct: 168 GVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLA 203

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 41.4 bits (98), Expect = 2e-04
 Identities = 15/39 (38%), Positives = 24/39 (61%), Gaps = 3/39 (7%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS 194
            +A+ H      I++RD+KP N+L N++   KL DF L+
Sbjct: 120 GLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLA 155

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 41.3 bits (97), Expect = 3e-04
 Identities = 12/61 (19%), Positives = 28/61 (45%), Gaps = 5/61 (8%)

Query: 147 LKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLF--DFSLSLSIPDGETHI 204
           L++ + +   + Y+H       V+ D+K  N+L   ++  +++  D+ LS        H 
Sbjct: 154 LQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210

Query: 205 E 205
           +
Sbjct: 211 Q 211

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 41.1 bits (97), Expect = 3e-04
 Identities = 23/94 (24%), Positives = 38/94 (40%), Gaps = 16/94 (17%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            +  LH      +V+RD+ P NIL  + +D  + DF+L+               V    +
Sbjct: 146 GLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWY 199

Query: 216 IAPE------NFTTLINEQCDVYGFGAFLFELLT 243
            APE       FT L+    D++  G  + E+  
Sbjct: 200 RAPELVMQFKGFTKLV----DMWSAGCVMAEMFN 229

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 41.3 bits (97), Expect = 3e-04
 Identities = 48/256 (18%), Positives = 81/256 (31%), Gaps = 61/256 (23%)

Query: 110 KHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVA 158
            ++I +           + FE + +  L + I    +  F+  SL    K A  I   + 
Sbjct: 159 MNVIHMLENFTFRNHICMTFELLSM-NLYELI---KKNKFQGFSLPLVRKFAHSILQCLD 214

Query: 159 YLHVGFSRPIVYRDMKPTNILFNEQSDA--KLFDFSLSLSIPDGETHIELDSVVGTTGFI 216
            LH      I++ D+KP NIL  +Q  +  K+ DF    S  + +      + + +  + 
Sbjct: 215 ALH---KNRIIHCDLKPENILLKQQGRSGIKVIDF--GSSCYEHQRVY---TYIQSRFYR 266

Query: 217 APENFTTLI-NEQCDVYGFGAFLFELLT-------------------------------A 244
           APE           D++  G  L ELLT                               +
Sbjct: 267 APEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDAS 326

Query: 245 QEVSDHVSFESRFHYEENVKRLSG----QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFK 300
           +   + VS +    Y        G       R +        E +      K      F 
Sbjct: 327 KRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFL 386

Query: 301 QLTLQCMDFSPEDRPT 316
               QC+++ P  R T
Sbjct: 387 DFLKQCLEWDPAVRMT 402

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 40.9 bits (96), Expect = 4e-04
 Identities = 13/39 (33%), Positives = 21/39 (53%), Gaps = 3/39 (7%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS 194
              ++H      I++RD+KP N L N+    K+ DF L+
Sbjct: 141 GENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLA 176

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 40.4 bits (95), Expect = 5e-04
 Identities = 19/65 (29%), Positives = 30/65 (46%), Gaps = 3/65 (4%)

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            + YLH   S  +++RDMKP+NIL N +   K+ DF LS S  +         +      
Sbjct: 121 VIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENT 177

Query: 216 IAPEN 220
              ++
Sbjct: 178 ENFDD 182

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 40.1 bits (94), Expect = 6e-04
 Identities = 15/74 (20%), Positives = 33/74 (44%), Gaps = 8/74 (10%)

Query: 134 CEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLF--DF 191
             + F   S    L++++ I   + Y+H       V+ D+K +N+L N ++  +++  D+
Sbjct: 145 NAKRF---SRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNPDQVYLVDY 198

Query: 192 SLSLSIPDGETHIE 205
            L+        H  
Sbjct: 199 GLAYRYCPEGVHKA 212

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 39.6 bits (93), Expect = 7e-04
 Identities = 21/88 (23%), Positives = 32/88 (36%), Gaps = 13/88 (14%)

Query: 134 CEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAK-----L 188
           C + F   S+      A  +   V  +H    + +VYRD+KP N L    +        +
Sbjct: 99  CGRKF---SVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYV 152

Query: 189 FDFSLSLSIPDGET--HIELDSVVGTTG 214
            DF +     D  T  HI        +G
Sbjct: 153 VDFGMVKFYRDPVTKQHIPYREKKNLSG 180

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	332
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.78
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.37
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.2
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.19
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.18
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.96
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.54
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.41
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.28
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.25
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.18
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.18
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.99
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.87
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.81
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.7
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.58
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.55
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.51
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.46
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.21
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.1
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.06
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.99
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.82
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.15
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.62
3mes_A	424	Choline kinase; malaria, structural genomics, stru	94.82
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.29
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.61
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	88.15
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	85.6

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-62  Score=433.08  Aligned_cols=257  Identities=20%  Similarity=0.314  Sum_probs=203.0

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE----------EE
Q 038681           49 LRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL----------IV  117 (332)
Q Consensus        49 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv  117 (332)
                      |++..+++.+.++||+|+||+||+|++.+ .||||+++... +....+.|.+|+.++++++|||||++          ||
T Consensus        31 Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iV  109 (307)
T 3omv_A           31 WEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIV  109 (307)
T ss_dssp             CBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEE
T ss_pred             cEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEE
Confidence            34556778889999999999999999865 59999987543 44557889999999999999999998          89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      ||||++|+|.+++....    ..+++.++..|+.||+.||+|||   +++||||||||+|||++.++.+||+|||+|+..
T Consensus       110 mEy~~gGsL~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             EECCSSCBHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             EEcCCCCCHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceec
Confidence            99999999999997541    46999999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCceeeccccccCCCcccccccCC----CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      .............||+.|||||++.+    .|+.++|||||||++|||+||+.||..........     ..+....   
T Consensus       183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~-----~~~~~~~---  254 (307)
T 3omv_A          183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII-----FMVGRGY---  254 (307)
T ss_dssp             -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH-----HHHHTTC---
T ss_pred             ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH-----HHHhcCC---
Confidence            54433333356789999999999853    68999999999999999999999998655432211     1111000   


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSC  331 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  331 (332)
                                ..+.....+..+++.+.+|+.+||+.||++|||+.||++.|+.|..++
T Consensus       255 ----------~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          255 ----------ASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             ----------CCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             ----------CCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence                      000001112245578999999999999999999999999999887653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1e-61  Score=429.87  Aligned_cols=251  Identities=20%  Similarity=0.270  Sum_probs=205.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------  115 (332)
                      .++|.+.+.||+|+||+||+|++       ++..||||+++... ....+.|.+|+.+|++++|||||++          
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC-hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            35688889999999999999987       36789999998654 3447889999999999999999998          


Q ss_pred             -EEEEeccCCChHHHHhhhhc--------ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCe
Q 038681          116 -IVFESVQIGTLADRIHHHCE--------QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA  186 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~--------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  186 (332)
                       ||||||++|+|.+++.....        .....+++.+++.++.||+.||.|||   +++|+||||||+|||++.++.+
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcE
Confidence             89999999999999986521        12246999999999999999999999   8999999999999999999999


Q ss_pred             EEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHh
Q 038681          187 KLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVK  264 (332)
Q Consensus       187 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~  264 (332)
                      ||+|||+|+...............||+.|||||++.+ .|+.++|||||||++|||+| |+.||......+...      
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~------  241 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE------  241 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH------
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH------
Confidence            9999999987765544333345679999999999987 89999999999999999999 899998765433211      


Q ss_pred             hhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          265 RLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      .+              ....   ..+.+..+++++.+|+.+||+.||++|||+++|++.|+.+.++
T Consensus       242 ~i--------------~~~~---~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          242 CI--------------TQGR---VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             HH--------------HHTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HH--------------HcCC---CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            11              0000   0111224557899999999999999999999999999998764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=7.6e-61  Score=429.91  Aligned_cols=251  Identities=19%  Similarity=0.252  Sum_probs=197.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------  115 (332)
                      ..+|.+.++||+|+||.||+|++       ++..||||+++... ....+.|.+|+.+|++++|||||++          
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~  118 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL  118 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            34677788999999999999986       36789999997654 4447889999999999999999998          


Q ss_pred             -EEEEeccCCChHHHHhhhhcc----------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC
Q 038681          116 -IVFESVQIGTLADRIHHHCEQ----------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS  184 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  184 (332)
                       ||||||++|+|.+++......          ...++++.+++.|+.||+.||+|||   +++||||||||+|||++.++
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCC
Confidence             899999999999999864221          1246999999999999999999999   89999999999999999999


Q ss_pred             CeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHH
Q 038681          185 DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEEN  262 (332)
Q Consensus       185 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~  262 (332)
                      .+||+|||+|+...............||+.|||||++.+ .++.++|||||||++|||+| |+.||......+...    
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~----  271 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID----  271 (329)
T ss_dssp             EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH----
T ss_pred             cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH----
Confidence            999999999987755443333345679999999999988 89999999999999999999 899998765433211    


Q ss_pred             HhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          263 VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                        .+              ....   ..+.+..+++++.+|+.+||+.||++|||++||++.|+.+.++
T Consensus       272 --~i--------------~~g~---~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          272 --CI--------------TQGR---ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             --HH--------------HHTC---CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --HH--------------HcCC---CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence              11              0000   1111224457899999999999999999999999999998764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.6e-61  Score=427.51  Aligned_cols=248  Identities=19%  Similarity=0.295  Sum_probs=202.5

Q ss_pred             cCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      +++++.++||+|+||+||+|.+       +++.||||++.........+.|.+|+.++++++|||||++           
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            3466678999999999999987       4578999999876665557889999999999999999998           


Q ss_pred             EEEEeccCCChHHHHhhhhc-----------ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC
Q 038681          116 IVFESVQIGTLADRIHHHCE-----------QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS  184 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  184 (332)
                      ||||||++|+|.++|.....           .....+++..++.++.|||.||+|||   +++||||||||+|||++.++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCC
Confidence            89999999999999975421           11246999999999999999999999   99999999999999999999


Q ss_pred             CeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHH
Q 038681          185 DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEEN  262 (332)
Q Consensus       185 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~  262 (332)
                      .+||+|||+|+...............||+.|||||++.+ .|+.++|||||||++|||+| |..||.+....+..     
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~-----  257 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV-----  257 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH-----
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH-----
Confidence            999999999987654433322345689999999999886 99999999999999999998 89999876543321     


Q ss_pred             HhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          263 VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                       ..+..               ..  ..+.+..++..+.+|+.+||+.||++|||++||++.|++.
T Consensus       258 -~~i~~---------------~~--~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          258 -EMIRN---------------RQ--VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             -HHHHT---------------TC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -HHHHc---------------CC--CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence             11110               00  1112234557899999999999999999999999999864

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.5e-60  Score=415.73  Aligned_cols=233  Identities=19%  Similarity=0.328  Sum_probs=192.7

Q ss_pred             CCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE---------------EEE
Q 038681           57 DEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL---------------IVF  118 (332)
Q Consensus        57 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~---------------lv~  118 (332)
                      ...++||+|+||+||+|.+  ++..||+|++.... .....+.|.+|+.++++++|||||++               |||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            5567899999999999999  78899999997543 34446789999999999999999986               799


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCCeeeCC-CCCeEEeecCCcc
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRP--IVYRDMKPTNILFNE-QSDAKLFDFSLSL  195 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~  195 (332)
                      |||++|+|.+++.+.     ..+++..+..++.||+.||+|||   +++  |+||||||+|||++. ++.+||+|||+|+
T Consensus       109 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH---~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             eCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            999999999999876     67999999999999999999999   877  999999999999974 7999999999998


Q ss_pred             ccCCCCceeeccccccCCCcccccccCCCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      .......    .+.+||+.|||||++.+.|+.++|||||||++|||+||+.||........     ....+.....    
T Consensus       181 ~~~~~~~----~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~-----~~~~i~~~~~----  247 (290)
T 3fpq_A          181 LKRASFA----KAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRVTSGVK----  247 (290)
T ss_dssp             GCCTTSB----EESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHHTTTCC----
T ss_pred             eCCCCcc----CCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH-----HHHHHHcCCC----
Confidence            6544332    45689999999999988999999999999999999999999975443221     1111111100    


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                  +...+...++++.+||.+||+.||++|||++|+++
T Consensus       248 ------------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          248 ------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                        00111123367899999999999999999999975

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1e-60  Score=429.17  Aligned_cols=236  Identities=18%  Similarity=0.285  Sum_probs=198.5

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ..|+..++||+|+||.||+|.+  +|+.||||++....... .+.+.+|+.+|++++|||||++           |||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS-GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH-HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            4599999999999999999999  79999999997654332 4668899999999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      |+||+|.+++..      ..+++.++..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.+...
T Consensus       153 ~~gg~L~~~l~~------~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  223 (346)
T 4fih_A          153 LEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  223 (346)
T ss_dssp             CTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS
T ss_pred             CCCCcHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCC
Confidence            999999999975      36999999999999999999999   999999999999999999999999999999877654


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      ...  ..+.+||+.|||||++.+ .|+.++|||||||++|||++|..||...+......      .+.            
T Consensus       224 ~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~------~i~------------  283 (346)
T 4fih_A          224 VPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK------MIR------------  283 (346)
T ss_dssp             SCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHH------------
T ss_pred             CCc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH------HHH------------
Confidence            332  246789999999999987 89999999999999999999999998755433211      110            


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                         .............++++.+||.+||+.||++|||++|+++
T Consensus       284 ---~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          284 ---DNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             ---HSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---cCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               0111111222345578999999999999999999999875

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.1e-60  Score=429.71  Aligned_cols=238  Identities=21%  Similarity=0.290  Sum_probs=193.9

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      ++|++.+.||+|+||+||+|++  +|+.||||++.... .....+.+.+|+.++++|+|||||++           ||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            5799999999999999999998  79999999997653 34457789999999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      ||+||+|.+++....   ...+++..++.++.||+.||+|||   ++||+||||||+|||++.+|.+||+|||+|+....
T Consensus       104 y~~gg~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  177 (350)
T 4b9d_A          104 YCEGGDLFKRINAQK---GVLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS  177 (350)
T ss_dssp             CCTTCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCH
T ss_pred             CCCCCcHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecC
Confidence            999999999997642   145799999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      ....  ....+||+.|||||++.+ .|+.++|||||||++|||++|+.||...+.....     .....           
T Consensus       178 ~~~~--~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~-----~~i~~-----------  239 (350)
T 4b9d_A          178 TVEL--ARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLV-----LKIIS-----------  239 (350)
T ss_dssp             HHHH--HHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-----HHHHH-----------
T ss_pred             Cccc--ccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHH-----HHHHc-----------
Confidence            3221  245689999999999998 8999999999999999999999999876543321     11111           


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                          ...+   +.+...+.++.+||.+||+.||++|||++|+++
T Consensus       240 ----~~~~---~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          240 ----GSFP---PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             ----TCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCCC---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                1110   111234578999999999999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.1e-60  Score=432.24  Aligned_cols=262  Identities=18%  Similarity=0.336  Sum_probs=218.1

Q ss_pred             ccHHHHHHHhcCCCCCCccccCCCceEEEEEeC-------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcC-CCcceE
Q 038681           44 FSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQ-------KRSISLMKYNGNRNQHALEWCINHIVYASRMSH-KHIIKL  115 (332)
Q Consensus        44 ~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~~  115 (332)
                      ++.++|++..++|++.+.||+|+||.||+|.+.       ++.||||.+.........+.|.+|+.+|.+++| ||||++
T Consensus        54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            567788888899999999999999999999972       367999999887776667889999999999975 899998


Q ss_pred             ------------EEEEeccCCChHHHHhhhhcc-----------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 038681          116 ------------IVFESVQIGTLADRIHHHCEQ-----------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRD  172 (332)
Q Consensus       116 ------------lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D  172 (332)
                                  ||||||++|+|.++|+.....           ....+++..++.++.|||.||+|||   +++|||||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCc
Confidence                        899999999999999865321           1235899999999999999999999   99999999


Q ss_pred             CCCCCeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCC
Q 038681          173 MKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDH  250 (332)
Q Consensus       173 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~  250 (332)
                      |||+|||++.++.+||+|||+|+...............||+.|||||++.+ .|+.++|||||||++|||+| |..||.+
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999998766554444456789999999999987 89999999999999999998 8999987


Q ss_pred             CCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          251 VSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      .......     ...+.               ...  ..+.+..+++++.+|+.+||+.||++|||++||++.|+.++++
T Consensus       291 ~~~~~~~-----~~~i~---------------~g~--~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          291 VKIDEEF-----CRRLK---------------EGT--RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             CCCSHHH-----HHHHH---------------HTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHH-----HHHHH---------------cCC--CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            6543221     11111               110  1111223457899999999999999999999999999999875

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.4e-61  Score=424.90  Aligned_cols=236  Identities=19%  Similarity=0.292  Sum_probs=200.2

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|++.+.||+|+||+||+|++  +++.||||++....  .....+.+.+|+++|++++|||||++           |||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5699999999999999999999  89999999997542  23336789999999999999999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      |||+||+|.+++...     +.+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus       112 Ey~~gG~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~  183 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS  183 (311)
T ss_dssp             CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecC
Confidence            999999999999876     67999999999999999999999   9999999999999999999999999999999876


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      .........+.+||+.|||||++.+ .|+.++|||||||++|||++|..||...+.....      ..+           
T Consensus       184 ~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~------~~i-----------  246 (311)
T 4aw0_A          184 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIF------AKI-----------  246 (311)
T ss_dssp             TTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHH-----------
T ss_pred             CCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHH-----------
Confidence            5444333357789999999999987 8999999999999999999999999865443221      111           


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVA  321 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl  321 (332)
                         ......    .+...++++.+||.+||+.||++|||++|++
T Consensus       247 ---~~~~~~----~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          247 ---IKLEYD----FPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ---HHTCCC----CCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ---HcCCCC----CCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence               111111    1123447899999999999999999999864

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.9e-60  Score=424.95  Aligned_cols=243  Identities=16%  Similarity=0.196  Sum_probs=198.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .+.|.+.++||+|+||.||+|++  +|+.||||++.....      ..+|+.++++++|||||++           ||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE  130 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME  130 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            34577788899999999999999  799999999976532      2479999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC-CeEEeecCCccccC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS-DAKLFDFSLSLSIP  198 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~  198 (332)
                      ||+||+|.+++...     +.+++..+..++.||+.||+|||   +++|+||||||+|||++.+| .+||+|||+|+...
T Consensus       131 y~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          131 LLEGGSLGQLIKQM-----GCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             CCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred             ccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence            99999999999876     67999999999999999999999   99999999999999999988 59999999998775


Q ss_pred             CCCce---eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          199 DGETH---IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       199 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      .....   ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||..........      .+......+.
T Consensus       203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~i~~~~~~~~  276 (336)
T 4g3f_A          203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL------KIASEPPPIR  276 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH------HHHHSCCGGG
T ss_pred             CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH------HHHcCCCCch
Confidence            43321   11234679999999999998 89999999999999999999999998765433211      1111111111


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                                     ..+..+++.+.+||.+||+.||.+|||+.|+++.|...+++
T Consensus       277 ---------------~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          277 ---------------EIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             ---------------GSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------------hcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence                           11124457899999999999999999999999999887764

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.3e-59  Score=410.43  Aligned_cols=233  Identities=25%  Similarity=0.351  Sum_probs=182.1

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|++.+.||+|+||+||+|.+  +|+.||||++....  .....+.+.+|+.++++++|||||++           |||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            6899999999999999999998  79999999997653  23336779999999999999999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||| +|+|.+++...     ..+++.++..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+...
T Consensus        93 Ey~-~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  163 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMT  163 (275)
T ss_dssp             ECC-CEEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC----
T ss_pred             eCC-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecC
Confidence            999 67999999876     67999999999999999999999   9999999999999999999999999999998765


Q ss_pred             CCCceeeccccccCCCcccccccCC-C-CChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-L-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      .....   .+.+||+.|||||++.+ . ++.++|||||||++|||+||+.||...+....      ...+......    
T Consensus       164 ~~~~~---~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~------~~~i~~~~~~----  230 (275)
T 3hyh_A          164 DGNFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVL------FKNISNGVYT----  230 (275)
T ss_dssp             --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHTCCC----
T ss_pred             CCCcc---CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHcCCCC----
Confidence            54322   45789999999999987 4 46899999999999999999999986543221      1111111111    


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                    .+...++++.+|+.+||+.||++|||++|+++
T Consensus       231 --------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          231 --------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             --------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             --------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                          11233478899999999999999999999987

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.6e-59  Score=416.62  Aligned_cols=261  Identities=18%  Similarity=0.278  Sum_probs=196.2

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------------lv~  118 (332)
                      .+|.+.+.||+|+||+||+|+++|+.||||++......  ...+..|+..+.+++|||||++               |||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~~~--~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchh--hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            35778899999999999999999999999999754322  2223456666778999999987               899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCC--------CeeecCCCCCCeeeCCCCCeEEee
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSR--------PIVYRDMKPTNILFNEQSDAKLFD  190 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~--------~ivH~Dlkp~Nill~~~~~~kl~D  190 (332)
                      |||++|+|.+++...      .+++..+..++.|++.||+|||   ++        +|+||||||+|||++.++++||+|
T Consensus        81 Ey~~~gsL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH---~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~D  151 (303)
T 3hmm_A           81 DYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLH---MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  151 (303)
T ss_dssp             ECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHH---CCBCSTTCBCCEECSCCCGGGEEECTTSCEEECC
T ss_pred             cCCCCCcHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---HhhhhccCCCCEeeccCCcccEEECCCCCEEEEe
Confidence            999999999999764      6899999999999999999999   65        999999999999999999999999


Q ss_pred             cCCccccCCCCcee--eccccccCCCcccccccCC-------CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHH
Q 038681          191 FSLSLSIPDGETHI--ELDSVVGTTGFIAPENFTT-------LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEE  261 (332)
Q Consensus       191 fg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~  261 (332)
                      ||+|+.........  ......||+.|||||++.+       .++.++|||||||++|||+||..||..........   
T Consensus       152 FGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~---  228 (303)
T 3hmm_A          152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY---  228 (303)
T ss_dssp             CTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT---
T ss_pred             CCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc---
Confidence            99998765543322  1134579999999999865       36789999999999999999998886544322111   


Q ss_pred             HHhhhhccccchhhhhhhhhhcccCCCC---CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          262 NVKRLSGQNCRFKEMVDSIIIEDKSCTC---TGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                        ............+..........+..   ......+..+.+|+.+||+.||++||||.||++.|++|.++
T Consensus       229 --~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          229 --YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             --TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --hhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence              00001111112221111111111111   11235667899999999999999999999999999998753

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.6e-59  Score=430.02  Aligned_cols=236  Identities=18%  Similarity=0.281  Sum_probs=198.7

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      +.|++.++||+|+||.||+|.+  +|+.||||++....... .+.+.+|+.+|++++|||||++           |||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~-~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR-RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS-GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH-HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            4699999999999999999999  79999999997654433 5678999999999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      |+||+|.+++..      ..+++.++..++.||+.||+|||   ++||+||||||+|||++.+|.+||+|||+|+.+...
T Consensus       230 ~~gG~L~~~i~~------~~l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~  300 (423)
T 4fie_A          230 LEGGALTDIVTH------TRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE  300 (423)
T ss_dssp             CTTEEHHHHHHH------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS
T ss_pred             CCCCcHHHHHhc------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCC
Confidence            999999999965      36999999999999999999999   999999999999999999999999999999877554


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      ...  ..+.+||+.|||||++.+ .|+.++|||||||++|||++|..||.+........      .+..           
T Consensus       301 ~~~--~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~------~i~~-----------  361 (423)
T 4fie_A          301 VPR--RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK------MIRD-----------  361 (423)
T ss_dssp             CCC--BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHH-----------
T ss_pred             Ccc--ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH------HHHc-----------
Confidence            332  256789999999999987 89999999999999999999999998655433211      1100           


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                          ............++++.+||.+||+.||++|||+.|+++
T Consensus       362 ----~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          362 ----NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             ----SCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----CCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                000111112234578999999999999999999999976

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.3e-59  Score=412.00  Aligned_cols=235  Identities=21%  Similarity=0.272  Sum_probs=187.5

Q ss_pred             cCCCCCCccccCCCceEEEEEe-----CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------E
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW-----QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------I  116 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------l  116 (332)
                      ++|++.+.||+|+||+||+|+.     +++.||||++..... ......+.+|+.++++++|||||++           |
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            5699999999999999999987     467899999976432 2224468899999999999999998           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      |||||+||+|.+++.+.     ..+++.++..++.||+.||+|||   +++|+||||||+|||++.+|.+||+|||+|+.
T Consensus       104 vmEy~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~  175 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE  175 (304)
T ss_dssp             EECCCTTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC
T ss_pred             EEEcCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEeccccccee
Confidence            99999999999999876     67999999999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      .......  ..+.+||+.|||||++.+ .|+.++|||||||++|||+||+.||...+..+...      .+         
T Consensus       176 ~~~~~~~--~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~------~i---------  238 (304)
T 3ubd_A          176 SIDHEKK--AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT------MI---------  238 (304)
T ss_dssp             -----CC--CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HH---------
T ss_pred             ccCCCcc--ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHH------HH---------
Confidence            5443322  146789999999999987 89999999999999999999999998765433211      11         


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTM-----VDVAK  322 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~-----~evl~  322 (332)
                           .....    ..+...++++.+||.+||+.||++|||+     +|+++
T Consensus       239 -----~~~~~----~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          239 -----LKAKL----GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             -----HHCCC----CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             -----HcCCC----CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence                 11111    1112345789999999999999999985     56654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.2e-57  Score=402.67  Aligned_cols=239  Identities=21%  Similarity=0.348  Sum_probs=183.1

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------------  115 (332)
                      ++|++.+.||+|+||+||+|++  +++.||||++.........+.+.+|+.+|++++|||||++                
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4589999999999999999998  7999999999877666667889999999999999999985                


Q ss_pred             -------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEE
Q 038681          116 -------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKL  188 (332)
Q Consensus       116 -------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  188 (332)
                             ||||||++|+|.+++.....  ....++..++.++.||++||+|||   +++|+||||||+|||++.++.+||
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl  159 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKV  159 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS--GGGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC--CChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEE
Confidence                   79999999999999986521  134567789999999999999999   999999999999999999999999


Q ss_pred             eecCCccccCCCCce----------eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchh
Q 038681          189 FDFSLSLSIPDGETH----------IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRF  257 (332)
Q Consensus       189 ~Dfg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~  257 (332)
                      +|||+|+........          ....+.+||+.|||||++.+ .|+.++|||||||++|||++   ||.....  ..
T Consensus       160 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~--~~  234 (299)
T 4g31_A          160 GDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME--RV  234 (299)
T ss_dssp             CCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH--HH
T ss_pred             ccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH--HH
Confidence            999999876543221          11234579999999999998 89999999999999999996   7753211  00


Q ss_pred             hhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          258 HYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .   .......  ..++               +.....++.+.+|+.+||+.||++|||+.|+++
T Consensus       235 ~---~~~~~~~--~~~p---------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          235 R---TLTDVRN--LKFP---------------PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             H---HHHHHHT--TCCC---------------HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H---HHHHHhc--CCCC---------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0   1111110  0111               111234466789999999999999999999986

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-55  Score=402.29  Aligned_cols=258  Identities=16%  Similarity=0.253  Sum_probs=197.6

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE---------------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL---------------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~---------------  115 (332)
                      ++|++.+.||+|+||+||+|.+  +|+.||||++..... ....+.+.+|+.+|++++|||||++               
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            4699999999999999999999  799999999976543 3446778999999999999999986               


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        ||||||+ |+|.+++...     ..+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+
T Consensus       134 ~~ivmE~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEeCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecce
Confidence              8999996 6899999765     67999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCc--eeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc
Q 038681          194 SLSIPDGET--HIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ  269 (332)
Q Consensus       194 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  269 (332)
                      |+.+.....  .....+.+||+.|+|||++.+  .++.++||||+||++|||++|+.||.+.+..+....  +.......
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~--I~~~~g~p  282 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQL--IMMVLGTP  282 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHH--HHHHHCCC
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHH--HHHhcCCC
Confidence            987644321  112246789999999999876  579999999999999999999999987765443221  11111111


Q ss_pred             ccchhhhh-----hhhhhcccCCCCCC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          270 NCRFKEMV-----DSIIIEDKSCTCTG----KEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       270 ~~~~~~~~-----~~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ........     ...+..........    .+..++++.+||.+||+.||++|||+.|+++
T Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          283 SPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             CGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            11110000     00000000000000    0123578899999999999999999999875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-53  Score=388.43  Aligned_cols=187  Identities=21%  Similarity=0.324  Sum_probs=160.2

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-----CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE----------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW-----QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL----------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~----------  115 (332)
                      ..+.|++.+.||+|+||+||+|++     +++.||+|++.....   ..++.+|+.+|..+ +|||||++          
T Consensus        19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            357799999999999999999986     467899999876543   45678999999998 69999987          


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC-CCeEEeecCC
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ-SDAKLFDFSL  193 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~  193 (332)
                       ||||||++|+|.+++.        .+++.++..++.||+.||+|||   ++||+||||||+|||++.+ +.+||+|||+
T Consensus        96 ~lvmE~~~g~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGl  164 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN--------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGL  164 (361)
T ss_dssp             EEEEECCCCCCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEeCCCcccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence             8999999999999983        4899999999999999999999   9999999999999999876 7999999999


Q ss_pred             ccccCCCCce--------------------------eeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCC
Q 038681          194 SLSIPDGETH--------------------------IELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQ  245 (332)
Q Consensus       194 a~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~  245 (332)
                      |+........                          ....+.+||+.|+|||++.+  .|+.++||||+||++|||++|+
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~  244 (361)
T 4f9c_A          165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR  244 (361)
T ss_dssp             CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence            9865433210                          01134579999999999976  5899999999999999999999


Q ss_pred             ccCCCCC
Q 038681          246 EVSDHVS  252 (332)
Q Consensus       246 ~p~~~~~  252 (332)
                      .||....
T Consensus       245 ~Pf~~~~  251 (361)
T 4f9c_A          245 YPFYKAS  251 (361)
T ss_dssp             SSSSCCS
T ss_pred             CCCCCCC
Confidence            9996544

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.3e-53  Score=407.20  Aligned_cols=239  Identities=17%  Similarity=0.232  Sum_probs=199.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|++.+.||+|+||.||+|.+  +|+.||+|.+...... ..+.+.+|+.+|+.++|||||++           ||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~-~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES-DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchh-hHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            36799999999999999999999  8999999999765433 36778999999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC--CCeEEeecCCcccc
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ--SDAKLFDFSLSLSI  197 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl~Dfg~a~~~  197 (332)
                      ||+||+|.+++....    ..+++.++..++.||+.||.|||   +++|+||||||+|||++.+  +.+||+|||+|+.+
T Consensus       235 ~~~gg~L~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~  307 (573)
T 3uto_A          235 FMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  307 (573)
T ss_dssp             CCCCCBHHHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEEC
T ss_pred             ecCCCcHHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEc
Confidence            999999999996531    46999999999999999999999   9999999999999999854  89999999999987


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ......   ...+||+.|||||++.+ .|+.++|||||||++|||++|..||.+....+...      .+...       
T Consensus       308 ~~~~~~---~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~------~i~~~-------  371 (573)
T 3uto_A          308 DPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR------NVKSC-------  371 (573)
T ss_dssp             CTTSEE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------HHHTT-------
T ss_pred             cCCCce---eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH------HHHhC-------
Confidence            665433   45689999999999998 89999999999999999999999998765443211      11111       


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                             ....+.......++++.+||.+||+.||.+|||+.|+++
T Consensus       372 -------~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          372 -------DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             -------CCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   111111111234578999999999999999999999986

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.5e-53  Score=404.93  Aligned_cols=237  Identities=19%  Similarity=0.298  Sum_probs=191.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHH---HHHHHHhhcCCCcceE----------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCIN---HIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~---E~~~l~~l~H~nIv~~----------  115 (332)
                      .++|++.+.||+|+||.||+|++  +|+.||||++.+...  ......+.+   ++.+++.++|||||++          
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            46799999999999999999999  899999999965321  111233334   4566677799999998          


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       ||||||+||+|.++|...     +.+++..+..++.||+.||+|||   ++|||||||||+|||++.+|.+||+|||+|
T Consensus       268 ylVmEy~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA  339 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA  339 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEeccccee
Confidence             899999999999999876     67999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCceeeccccccCCCcccccccC-C-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFT-T-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      +.......    .+.+||+.|||||++. + .|+.++|||||||++|||++|..||..........   ......     
T Consensus       340 ~~~~~~~~----~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~---i~~~i~-----  407 (689)
T 3v5w_A          340 CDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTL-----  407 (689)
T ss_dssp             EECSSCCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH---HHHHHH-----
T ss_pred             eecCCCCC----CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHhhc-----
Confidence            87765443    4678999999999996 4 79999999999999999999999997644332211   111111     


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT-----MVDVAK  322 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~  322 (332)
                               ....    ..+...++++.+||.+||+.||.+|++     ++||++
T Consensus       408 ---------~~~~----~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          408 ---------TMAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ---------HCCC----CCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ---------CCCC----CCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence                     1111    111234578999999999999999998     677754

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=4.2e-50  Score=358.20  Aligned_cols=279  Identities=25%  Similarity=0.403  Sum_probs=224.8

Q ss_pred             CCCcccccHHHHHHHhcCCCCC------CccccCCCceEEEEEeCCeeEEEEEEcCCC---ChhhHHHHHHHHHHHHhhc
Q 038681           38 YNPYRIFSAEELRIATNNYDEQ------NIVLEDPFRKLYKGFWQKRSISLMKYNGNR---NQHALEWCINHIVYASRMS  108 (332)
Q Consensus        38 ~~~~~~~~~~el~~~~~~y~~~------~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~  108 (332)
                      ......|+..++...+++|...      +.||+|+||.||+|.+++..||+|++....   .....+.+.+|+.++++++
T Consensus         9 ~~~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A            9 DTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             --CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            4467889999999999999877      899999999999999999999999997642   2344678999999999999


Q ss_pred             CCCcceE-----------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 038681          109 HKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTN  177 (332)
Q Consensus       109 H~nIv~~-----------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  177 (332)
                      ||||+++           +||||+++|+|.+++.....  ...+++..++.++.||+.||.|||   +++|+||||||+|
T Consensus        89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~N  163 (307)
T 2nru_A           89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDG--TPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSAN  163 (307)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGG--CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGG
T ss_pred             CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCCCCHHH
Confidence            9999998           89999999999999975422  246999999999999999999999   9999999999999


Q ss_pred             eeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCCCCChhhhHHHHHHHHHHHHhCCccCCCCCccchh
Q 038681          178 ILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRF  257 (332)
Q Consensus       178 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~  257 (332)
                      |+++.++.+||+|||++................||+.|+|||++.+.++.++|||||||++|+|++|..||.........
T Consensus       164 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~  243 (307)
T 2nru_A          164 ILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLL  243 (307)
T ss_dssp             EEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBT
T ss_pred             EEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHH
Confidence            99999999999999999876654433333456799999999999888899999999999999999999999865543321


Q ss_pred             hhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          258 HYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      .  ............+.+.++..+       .......+..+.+++.+||+.||.+|||+.+|++.|+++..+
T Consensus       244 ~--~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~s  307 (307)
T 2nru_A          244 L--DIKEEIEDEEKTIEDYIDKKM-------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTAS  307 (307)
T ss_dssp             T--HHHHHHHTTSCCHHHHSCSSC-------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC--
T ss_pred             H--HHHHHhhhhhhhhhhhccccc-------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhcC
Confidence            1  111122222222333322211       122346778899999999999999999999999999998653

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.9e-51  Score=368.24  Aligned_cols=277  Identities=28%  Similarity=0.417  Sum_probs=217.6

Q ss_pred             cccccHHHHHHHhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----
Q 038681           41 YRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----  115 (332)
Q Consensus        41 ~~~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----  115 (332)
                      ...++..++...+++|.+.+.||+|+||.||+|.+ +++.||||++...... ..+.+.+|+.+++.++||||+++    
T Consensus        26 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~  104 (321)
T 2qkw_B           26 SYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQ-GIEEFETEIETLSFCRHPHLVSLIGFC  104 (321)
T ss_dssp             ----CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSS-HHHHHHHHHHGGGSCCCTTBCCEEEEC
T ss_pred             ceeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChH-HHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            34566667777889999999999999999999999 7899999998766443 36789999999999999999998    


Q ss_pred             -------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEE
Q 038681          116 -------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKL  188 (332)
Q Consensus       116 -------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  188 (332)
                             +||||+++|+|.+++..... ....+++..++.++.||+.||.|||   +++|+||||||+||+++.++.+||
T Consensus       105 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl  180 (321)
T 2qkw_B          105 DERNEMILIYKYMENGNLKRHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKI  180 (321)
T ss_dssp             CCTTCCEEEEECCTTCBTGGGSSSSCC-CSCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEE
T ss_pred             cCCCeEEEEEEcCCCCcHHHHHhccCC-CccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEE
Confidence                   89999999999999976421 1235899999999999999999999   899999999999999999999999


Q ss_pred             eecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhh
Q 038681          189 FDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS  267 (332)
Q Consensus       189 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  267 (332)
                      +|||+++...............||+.|+|||++.+ .++.++|||||||++|||++|+.||.................. 
T Consensus       181 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-  259 (321)
T 2qkw_B          181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-  259 (321)
T ss_dssp             CCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH-
T ss_pred             eecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc-
Confidence            99999986544332222244568999999999876 8999999999999999999999999765543332211111000 


Q ss_pred             ccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                      .....+...+++      ..........+..+.+++.+||+.||++|||+.++++.|+.+.+
T Consensus       260 ~~~~~~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~  315 (321)
T 2qkw_B          260 HNNGQLEQIVDP------NLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALR  315 (321)
T ss_dssp             HTTTCCCSSSSS------SCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccccHHHhcCh------hhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhh
Confidence            011111111111      11223345788899999999999999999999999999998875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.9e-51  Score=368.52  Aligned_cols=264  Identities=21%  Similarity=0.303  Sum_probs=207.2

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------------E
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------------I  116 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------------l  116 (332)
                      ..++|.+.+.||+|+||.||+|.+.++.||||++.....  ....+.+|+.++.+++||||+++               +
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           22 QSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDK--QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGGGH--HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             chhhchhhheecccCceEEEEEEECCCEEEEEEeecCch--HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEE
Confidence            356799999999999999999999999999999976532  23456679999999999999987               7


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCC----------CeeecCCCCCCeeeCCCCCe
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSR----------PIVYRDMKPTNILFNEQSDA  186 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~----------~ivH~Dlkp~Nill~~~~~~  186 (332)
                      ||||+++|+|.+++...      .+++..++.++.||+.||.|||   +.          +|+||||||+|||++.++.+
T Consensus       100 v~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~  170 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKAN------VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA  170 (322)
T ss_dssp             EEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCE
T ss_pred             EEecCCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeE
Confidence            99999999999999764      5999999999999999999999   88          99999999999999999999


Q ss_pred             EEeecCCccccCCCCceeeccccccCCCcccccccCC------CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhH
Q 038681          187 KLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT------LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYE  260 (332)
Q Consensus       187 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~  260 (332)
                      ||+|||+++...............||+.|+|||++.+      .++.++|||||||++|||++|+.||..........+.
T Consensus       171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~  250 (322)
T 3soc_A          171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE  250 (322)
T ss_dssp             EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTH
T ss_pred             EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchh
Confidence            9999999987665443333345679999999999875      3566899999999999999999999876544332211


Q ss_pred             HHHhhhhccccchhhhhhhhhhcccCCC---CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          261 ENVKRLSGQNCRFKEMVDSIIIEDKSCT---CTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      ..    .........+............   .......+..+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus       251 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          251 EE----IGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             HH----HCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hh----hccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            11    0111122222221111111111   111235667899999999999999999999999999999764

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.1e-50  Score=365.00  Aligned_cols=278  Identities=28%  Similarity=0.466  Sum_probs=217.5

Q ss_pred             CCCCcccccHHHHHHHhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE
Q 038681           37 KYNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL  115 (332)
Q Consensus        37 ~~~~~~~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~  115 (332)
                      .....+.|+..++....++|.+.+.||+|+||.||+|.+ +++.||||++...........+.+|+.++++++||||+++
T Consensus        13 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~   92 (326)
T 3uim_A           13 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL   92 (326)
T ss_dssp             --CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred             ccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence            345678899999999999999999999999999999998 7899999999876544334468999999999999999987


Q ss_pred             -----------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCC---CeeecCCCCCCeeeC
Q 038681          116 -----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSR---PIVYRDMKPTNILFN  181 (332)
Q Consensus       116 -----------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~---~ivH~Dlkp~Nill~  181 (332)
                                 +||||+++|+|.+++..... ....+++..+..++.|++.||.|||   +.   +|+||||||+|||++
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~ivH~Dlkp~Nil~~  168 (326)
T 3uim_A           93 RGFCMTPTERLLVYPYMANGSVASCLRERPE-SQPPLDWPKRQRIALGSARGLAYLH---DHCDPKIIHRDVKAANILLD  168 (326)
T ss_dssp             CEEECCSSCCEEEEECCTTCBHHHHHHCCST-TCCCCCHHHHHHHHHHHHHHHHHHH---HSSSSCEECCCCSGGGEEEC
T ss_pred             EEEEecCCceEEEEEeccCCCHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCeEeCCCchhhEEEC
Confidence                       89999999999999986532 2245999999999999999999999   77   999999999999999


Q ss_pred             CCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhH
Q 038681          182 EQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYE  260 (332)
Q Consensus       182 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~  260 (332)
                      .++.+||+|||+++.......... ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.......... .
T Consensus       169 ~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~  246 (326)
T 3uim_A          169 EEFEAVVGDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDD-V  246 (326)
T ss_dssp             TTCCEEECCCSSCEECCSSSSCEE-CCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSC-S
T ss_pred             CCCCEEeccCccccccCccccccc-ccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccc-h
Confidence            999999999999987754443322 45569999999999876 88999999999999999999999996321111000 0


Q ss_pred             HHHhhhhc--cccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 038681          261 ENVKRLSG--QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQ  326 (332)
Q Consensus       261 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~  326 (332)
                      ....+...  ....+....+..      .........+..+.+++.+||+.||.+|||+.+|++.|+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          247 MLLDWVKGLLKEKKLEALVDVD------LQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             BHHHHHTTTTSSCCSTTSSCTT------CTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             hHHHHHHHHhhchhhhhhcChh------hccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            01111111  111112222211      1223345778899999999999999999999999999974

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.1e-50  Score=362.67  Aligned_cols=259  Identities=23%  Similarity=0.353  Sum_probs=199.8

Q ss_pred             cccHHHHHHHhcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE------
Q 038681           43 IFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL------  115 (332)
Q Consensus        43 ~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~------  115 (332)
                      .++..++....++|++.+.||+|+||.||+|.+++..||||++.... .....+.+.+|+.++++++||||+++      
T Consensus        26 ~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  105 (309)
T 3p86_A           26 AMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ  105 (309)
T ss_dssp             ------CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CCCcccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE
Confidence            45556666778889999999999999999999999999999997664 34446789999999999999999998      


Q ss_pred             -----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCCeeeCCCCCeEE
Q 038681          116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRP--IVYRDMKPTNILFNEQSDAKL  188 (332)
Q Consensus       116 -----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl  188 (332)
                           +||||+++|+|.+++.....  ...+++..++.++.||+.||+|||   +.+  |+||||||+|||++.++.+||
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL  180 (309)
T 3p86_A          106 PPNLSIVTEYLSRGSLYRLLHKSGA--REQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKV  180 (309)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHSTTH--HHHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEE
T ss_pred             CCceEEEEecCCCCcHHHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEE
Confidence                 89999999999999986521  124999999999999999999999   889  999999999999999999999


Q ss_pred             eecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhh
Q 038681          189 FDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS  267 (332)
Q Consensus       189 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  267 (332)
                      +|||+++........  .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..........   .... .
T Consensus       181 ~Dfg~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~---~~~~-~  254 (309)
T 3p86_A          181 CDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVA---AVGF-K  254 (309)
T ss_dssp             CCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH---HHHH-S
T ss_pred             CCCCCCccccccccc--cccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHh-c
Confidence            999999765443221  145679999999999988 78999999999999999999999998665432211   0000 0


Q ss_pred             ccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      ..                  ....+...++.+.+|+.+||+.||.+|||+.++++.|+.+.++
T Consensus       255 ~~------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          255 CK------------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             CC------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CC------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            00                  0111123447799999999999999999999999999998764

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4e-50  Score=361.83  Aligned_cols=236  Identities=21%  Similarity=0.317  Sum_probs=198.6

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      ..++|.+.+.||+|+||.||+|.+  +|+.||||++.... .....+.+.+|+.+++.++||||+++           +|
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   92 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI   92 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence            356899999999999999999998  89999999997653 34456788999999999999999998           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++...
T Consensus        93 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  164 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEF  164 (328)
T ss_dssp             ECCCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGG
T ss_pred             EECCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceec
Confidence            9999999999999876     57999999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CC-ChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      ......   ....||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.........      ..+         
T Consensus       165 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~i---------  226 (328)
T 3fe3_A          165 TVGGKL---DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELR------ERV---------  226 (328)
T ss_dssp             SSSCGG---GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHH---------
T ss_pred             CCCCcc---ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHH------HHH---------
Confidence            554432   45689999999999987 44 58999999999999999999999876543221      111         


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                           .......    +...+.++.+|+.+||+.||.+|||++|+++
T Consensus       227 -----~~~~~~~----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          227 -----LRGKYRI----PFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             -----HHCCCCC----CTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             -----HhCCCCC----CCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                 1111111    1123467899999999999999999999975

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.8e-50  Score=356.03  Aligned_cols=237  Identities=19%  Similarity=0.314  Sum_probs=197.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|++....... .+.+.+|+.++++++||||+++           +|||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH-HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            46799999999999999999998  88999999987654433 5778999999999999999997           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++|+|.+++...      .+++..+..++.|++.||.|||   ++||+||||||+|||++.++.+||+|||++.....
T Consensus        98 ~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (297)
T 3fxz_A           98 YLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (297)
T ss_dssp             CCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             CCCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC
Confidence            99999999999764      5899999999999999999999   89999999999999999999999999999987655


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      ....  .....||+.|+|||++.+ .++.++|||||||++|||++|..||..........     ......         
T Consensus       169 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----~~~~~~---------  232 (297)
T 3fxz_A          169 EQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-----LIATNG---------  232 (297)
T ss_dssp             TTCC--BCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHHHHC---------
T ss_pred             cccc--cCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhCC---------
Confidence            4332  145679999999999987 88999999999999999999999997654332211     000000         


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                             ......+...+..+.+|+.+||+.||++|||+.|+++
T Consensus       233 -------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          233 -------TPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             -------SCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -------CCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                   0011112244577999999999999999999999976

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.5e-50  Score=367.38  Aligned_cols=264  Identities=18%  Similarity=0.325  Sum_probs=215.6

Q ss_pred             ccccHHHHHHHhcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcc
Q 038681           42 RIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHII  113 (332)
Q Consensus        42 ~~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv  113 (332)
                      ..++..+++...++|.+.+.||+|+||.||+|.+       +++.||||++.........+.+.+|+.++.++ +||||+
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence            3466778888899999999999999999999984       45889999998876666678899999999999 799999


Q ss_pred             eE------------EEEEeccCCChHHHHhhhhccc--------------------------------------------
Q 038681          114 KL------------IVFESVQIGTLADRIHHHCEQH--------------------------------------------  137 (332)
Q Consensus       114 ~~------------lv~e~~~~g~L~~~l~~~~~~~--------------------------------------------  137 (332)
                      ++            +||||+++|+|.+++.......                                            
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            98            8999999999999998653210                                            


Q ss_pred             -----------------ccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          138 -----------------FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       138 -----------------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                                       ...+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.....
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                             112899999999999999999999   999999999999999999999999999999876554


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      ..........||+.|+|||++.+ .++.++|||||||++|||++ |..||..........     .....          
T Consensus       247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~-----~~~~~----------  311 (359)
T 3vhe_A          247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC-----RRLKE----------  311 (359)
T ss_dssp             TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH-----HHHHH----------
T ss_pred             ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH-----HHHHc----------
Confidence            44333356678999999999876 89999999999999999998 999997655432211     11100          


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                           ..  ....+...++++.+++.+||+.||.+|||+.++++.|+++.++
T Consensus       312 -----~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          312 -----GT--RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             -----TC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----CC--CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence                 00  0011112346799999999999999999999999999999875

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.6e-49  Score=363.74  Aligned_cols=252  Identities=18%  Similarity=0.299  Sum_probs=206.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe---------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW---------QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-------  115 (332)
                      .++|.+.+.||+|+||.||+|.+         .+..||||.+.........+.+.+|+.+++++ +||||+++       
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            46788999999999999999986         23569999998876666678899999999999 89999998       


Q ss_pred             ----EEEEeccCCChHHHHhhhhcc-----------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee
Q 038681          116 ----IVFESVQIGTLADRIHHHCEQ-----------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF  180 (332)
Q Consensus       116 ----lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill  180 (332)
                          +||||+++|+|.+++......           ....+++..++.++.||+.||.|||   +++|+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEE
Confidence                899999999999999875211           1135899999999999999999999   9999999999999999


Q ss_pred             CCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhh
Q 038681          181 NEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFH  258 (332)
Q Consensus       181 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~  258 (332)
                      +.++.+||+|||+++...............+|+.|+|||++.+ .++.++|||||||++|||++ |..||..........
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~  316 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK  316 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            9999999999999987655433222244567889999999877 89999999999999999999 999998755433211


Q ss_pred             hHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          259 YEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                            .+...               .  ....+..++..+.+|+.+||+.||.+|||+.|+++.|+++.+.
T Consensus       317 ------~~~~~---------------~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~  365 (370)
T 2psq_A          317 ------LLKEG---------------H--RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  365 (370)
T ss_dssp             ------HHHTT---------------C--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------HHhcC---------------C--CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence                  11100               0  0011123447899999999999999999999999999998764

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=355.70  Aligned_cols=249  Identities=22%  Similarity=0.323  Sum_probs=201.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|.+.+.||+|+||.||+|.+  ++..||+|++.... ....+.+.+|+.++.+++||||+++           +|||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFD-EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            46788999999999999999999  68999999986543 4447889999999999999999997           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++|+|.+++....    ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++....
T Consensus        88 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           88 YIKGGTLRGIIKSMD----SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             CCTTCBHHHHHHHCC----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             ecCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            999999999998641    46999999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCceee------------ccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhh
Q 038681          200 GETHIE------------LDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRL  266 (332)
Q Consensus       200 ~~~~~~------------~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~  266 (332)
                      ......            .....||+.|+|||++.+ .++.++|||||||++|||++|..||...........       
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~-------  233 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG-------  233 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS-------
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh-------
Confidence            332110            114579999999999988 899999999999999999999999876443222110       


Q ss_pred             hccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          267 SGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                          .......+..    .      +..+++.+.+|+.+||+.||++|||+.++++.|+++...
T Consensus       234 ----~~~~~~~~~~----~------~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          234 ----LNVRGFLDRY----C------PPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             ----BCHHHHHHHT----C------CTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----hhhhcccccc----C------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                0001111110    0      012335689999999999999999999999999998765

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.3e-50  Score=370.30  Aligned_cols=257  Identities=19%  Similarity=0.268  Sum_probs=209.2

Q ss_pred             ccHHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE------
Q 038681           44 FSAEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------  115 (332)
Q Consensus        44 ~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~------  115 (332)
                      .+.+.+....++|.+.+.||+|+||.||+|.+  ++..||||.+.........+.+.+|+.++++++||||+++      
T Consensus       104 ~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  183 (377)
T 3cbl_A          104 VPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ  183 (377)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             ccccccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec
Confidence            33345556677899999999999999999999  6899999999876655556778999999999999999998      


Q ss_pred             -----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEee
Q 038681          116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFD  190 (332)
Q Consensus       116 -----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  190 (332)
                           +||||+++|+|.+++....    ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|
T Consensus       184 ~~~~~lv~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~D  256 (377)
T 3cbl_A          184 KQPIYIVMELVQGGDFLTFLRTEG----ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISD  256 (377)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEcCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECc
Confidence                 8999999999999998652    35899999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhc
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSG  268 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  268 (332)
                      ||+++...............+++.|+|||++.+ .++.++|||||||++|||++ |..||..........      .+..
T Consensus       257 fG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~------~~~~  330 (377)
T 3cbl_A          257 FGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE------FVEK  330 (377)
T ss_dssp             GGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHH------HHHT
T ss_pred             CCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HHHc
Confidence            999986544322211122345778999999876 88999999999999999998 999998654432211      1100


Q ss_pred             cccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          269 QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                                     ..  ..+.+..++..+.+|+.+||+.||++|||+.+|++.|+++.+.
T Consensus       331 ---------------~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          331 ---------------GG--RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             ---------------TC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------------CC--CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence                           00  0111123447899999999999999999999999999998764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.4e-49  Score=352.84  Aligned_cols=262  Identities=18%  Similarity=0.286  Sum_probs=200.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      .++|++.+.||+|+||.||+|.+      +++.||||++..... ...+.+.+|+.++.+++||||+++           
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            46799999999999999999984      688999999986543 336789999999999999999997           


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        +||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~  160 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGL  160 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCS
T ss_pred             eEEEEEeCCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcc
Confidence              8999999999999997752    35999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCcee-eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc-
Q 038681          194 SLSIPDGETHI-ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN-  270 (332)
Q Consensus       194 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  270 (332)
                      ++......... ......+|..|+|||++.+ .++.++|||||||++|||++|..||.......       ........ 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-------~~~~~~~~~  233 (295)
T 3ugc_A          161 TKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEF-------MRMIGNDKQ  233 (295)
T ss_dssp             CC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHH-------HHHHCTTCC
T ss_pred             cccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHH-------HhhhcCccc
Confidence            98765443221 1133457788999999886 89999999999999999999999987543211       11111100 


Q ss_pred             c-chhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 038681          271 C-RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSC  331 (332)
Q Consensus       271 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  331 (332)
                      . .........+....  ..+.+..++.++.+|+.+||+.||++|||+.++++.|+++.+++
T Consensus       234 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          234 GQMIVFHLIELLKNNG--RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             THHHHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             cchhHHHHHHHHhccC--cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            0 00001111111111  11222345588999999999999999999999999999998764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.7e-49  Score=360.69  Aligned_cols=239  Identities=22%  Similarity=0.283  Sum_probs=197.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh-----hhHHHHHHHHHHHHhhcCCCcceE----------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ-----HALEWCINHIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~~----------  115 (332)
                      .+.|.+.+.||+|+||.||+|.+  +|..||+|.+......     ...+.+.+|+.++.+++||||+++          
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            46799999999999999999999  7899999999765432     135778999999999999999998          


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC----CeEEee
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS----DAKLFD  190 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~D  190 (332)
                       +||||+++|+|.+++...     ..+++..+..++.||+.||.|||   ++||+||||||+|||++.++    .+||+|
T Consensus        91 ~lv~e~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence             899999999999999765     57999999999999999999999   99999999999999998877    799999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ  269 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  269 (332)
                      ||++.........   ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.........      ..+...
T Consensus       163 FG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~------~~i~~~  233 (361)
T 2yab_A          163 FGLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ANITAV  233 (361)
T ss_dssp             CSSCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------HHHHTT
T ss_pred             cCCceEcCCCCcc---ccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhc
Confidence            9999877654322   45679999999999987 8999999999999999999999999876543321      111111


Q ss_pred             ccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          270 NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ...+..              ......+..+.+||.+||..||.+|||+.|+++
T Consensus       234 ~~~~~~--------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          234 SYDFDE--------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CCCCCH--------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCCc--------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111100              001123477999999999999999999999985

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.4e-49  Score=354.74  Aligned_cols=248  Identities=18%  Similarity=0.266  Sum_probs=201.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-----CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------E
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------I  116 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------l  116 (332)
                      .++|.+.+.||+|+||.||+|.+     .+..||||.+.........+.+.+|+.++++++||||+++           +
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            46688899999999999999998     2445999999887666667889999999999999999998           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ||||+++|+|.+++....    ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       128 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHD----GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EeeCCCCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            999999999999996541    46999999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCce-eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          197 IPDGETH-IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       197 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      ....... .......+|+.|+|||++.+ .++.++|||||||++|||++ |..||..........      .+..     
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~------~~~~-----  269 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVIS------SVEE-----  269 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH------HHHT-----
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHH------HHHc-----
Confidence            7554321 11133456788999999986 88999999999999999999 999997654432211      1100     


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                               .   ...+.+..++..+.+|+.+||+.||.+|||+.+|++.|+++.++
T Consensus       270 ---------~---~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~  314 (325)
T 3kul_A          270 ---------G---YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRS  314 (325)
T ss_dssp             ---------T---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ---------C---CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhC
Confidence                     0   00111123447899999999999999999999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.5e-49  Score=351.39  Aligned_cols=248  Identities=20%  Similarity=0.322  Sum_probs=197.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      .++|++.+.||+|+||.||+|.+  ++..||+|.+....  .....+.+.+|+.++.+++||||+++           +|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            35799999999999999999998  78999999986543  34446789999999999999999997           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+||+++.++.+||+|||+++..
T Consensus        90 ~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  161 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH-----GPLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKAL  161 (294)
T ss_dssp             EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred             EeCCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence            9999999999999876     57999999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ....... .....||+.|+|||++.+ .++.++|||||||++|+|++|..||........     ...............
T Consensus       162 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~-----~~~~~~~~~~~~~~~  235 (294)
T 4eqm_A          162 SETSLTQ-TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI-----AIKHIQDSVPNVTTD  235 (294)
T ss_dssp             --------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH-----HHHHHSSCCCCHHHH
T ss_pred             ccccccc-cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH-----HHHHhhccCCCcchh
Confidence            5443221 144579999999999987 889999999999999999999999987654322     111111111111000


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-TMVDVAKQLRQMY  328 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-s~~evl~~L~~l~  328 (332)
                                    .....+..+.+++.+||+.||.+|| ++.++.+.|+++.
T Consensus       236 --------------~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          236 --------------VRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             --------------SCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             --------------cccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence                          0113347899999999999999998 8999999998764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=8.3e-49  Score=352.36  Aligned_cols=248  Identities=20%  Similarity=0.301  Sum_probs=203.1

Q ss_pred             ccccHHHHHHHhcC----------CCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcC
Q 038681           42 RIFSAEELRIATNN----------YDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSH  109 (332)
Q Consensus        42 ~~~~~~el~~~~~~----------y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H  109 (332)
                      ..++.++++.++..          |...+.||+|+||.||+|.+  +|+.||||++....... .+.+.+|+.++++++|
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR-RELLFNEVVIMRDYQH  101 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS-HHHHHHHHHHHTTCCC
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH-HHHHHHHHHHHHhCCC
Confidence            46888888887764          66777999999999999998  79999999997655433 6778999999999999


Q ss_pred             CCcceE-----------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCe
Q 038681          110 KHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNI  178 (332)
Q Consensus       110 ~nIv~~-----------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  178 (332)
                      |||+++           +||||+++|+|.+++..      ..+++..+..++.||+.||.|||   +.+|+||||||+||
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~------~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NI  172 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ------VRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSI  172 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGE
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHE
Confidence            999987           89999999999999865      35999999999999999999999   89999999999999


Q ss_pred             eeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchh
Q 038681          179 LFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRF  257 (332)
Q Consensus       179 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~  257 (332)
                      |++.++.+||+|||++.........  .....||+.|+|||++.+ .++.++|||||||++|||++|..||.........
T Consensus       173 ll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~  250 (321)
T 2c30_A          173 LLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM  250 (321)
T ss_dssp             EECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             EECCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9999999999999999876544322  145679999999999987 8899999999999999999999999765432211


Q ss_pred             hhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          258 HYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                            ..+...               ...........+..+.+|+.+||+.||++|||+.++++
T Consensus       251 ------~~~~~~---------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          251 ------KRLRDS---------------PPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             ------HHHHHS---------------SCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ------HHHhcC---------------CCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  111100               00001111233477999999999999999999999986

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2e-49  Score=349.62  Aligned_cols=249  Identities=21%  Similarity=0.333  Sum_probs=194.4

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe-----CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW-----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------  115 (332)
                      ...++|.+.+.||+|+||.||+|.+     .+..||+|.+.........+.+.+|+.++++++||||+++          
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW   91 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCE
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccE
Confidence            4456799999999999999999998     2456999999877666667889999999999999999997          


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      +||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        92 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             EEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             EEEecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECcccccc
Confidence            8999999999999997641    36899999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      .......... ....+|+.|+|||++.+ .++.++|||||||++|||++ |..||..........      .+...    
T Consensus       165 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~------~i~~~----  233 (281)
T 1mp8_A          165 YMEDSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG------RIENG----  233 (281)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH------HHHTT----
T ss_pred             ccCccccccc-ccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHH------HHHcC----
Confidence            7654432211 34456789999999976 89999999999999999997 999998655433211      11000    


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                                .   ..+.+...+..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus       234 ----------~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          234 ----------E---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             ----------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------C---CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                      0   0011123447899999999999999999999999999998764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.2e-49  Score=354.37  Aligned_cols=258  Identities=22%  Similarity=0.345  Sum_probs=210.6

Q ss_pred             HHHHHHhcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----
Q 038681           47 EELRIATNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----  115 (332)
Q Consensus        47 ~el~~~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----  115 (332)
                      .++....++|.+.+.||+|+||.||+|.+       ++..||+|.+.........+.+.+|+.++++++||||+++    
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   95 (314)
T 2ivs_A           16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC   95 (314)
T ss_dssp             TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence            34445567899999999999999999987       3478999999877666667889999999999999999998    


Q ss_pred             -------EEEEeccCCChHHHHhhhhcc-------------------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 038681          116 -------IVFESVQIGTLADRIHHHCEQ-------------------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIV  169 (332)
Q Consensus       116 -------lv~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  169 (332)
                             +||||+++|+|.+++......                   ....+++..++.++.||+.||.|||   +++|+
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~iv  172 (314)
T 2ivs_A           96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLV  172 (314)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCc
Confidence                   899999999999999875321                   1134899999999999999999999   99999


Q ss_pred             ecCCCCCCeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCcc
Q 038681          170 YRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEV  247 (332)
Q Consensus       170 H~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p  247 (332)
                      ||||||+||+++.++.+||+|||+++...............+|+.|+|||++.+ .++.++|||||||++|||++ |..|
T Consensus       173 H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          173 HRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999999987765544333345567889999999877 78999999999999999999 9999


Q ss_pred             CCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          248 SDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                      |..........      .+....                 ....+...+..+.+|+.+||+.||.+|||+.++++.|+++
T Consensus       253 ~~~~~~~~~~~------~~~~~~-----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          253 YPGIPPERLFN------LLKTGH-----------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             STTCCGGGHHH------HHHTTC-----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCHHHHHH------HhhcCC-----------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            97665433211      111000                 0011123447899999999999999999999999999998


Q ss_pred             HHh
Q 038681          328 YRS  330 (332)
Q Consensus       328 ~~~  330 (332)
                      .+.
T Consensus       310 ~~~  312 (314)
T 2ivs_A          310 MVK  312 (314)
T ss_dssp             HHT
T ss_pred             Hhh
Confidence            864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.6e-49  Score=344.47  Aligned_cols=246  Identities=20%  Similarity=0.318  Sum_probs=203.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      ..++|.+.+.||+|+||.||+|.+ ++..||+|++......  .+.+.+|+.++++++||||+++           +|||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   85 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence            356789999999999999999999 8889999999876433  4678999999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++|+|.+++....    ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.....
T Consensus        86 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           86 FMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             CCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             eCCCCcHHHHHHhcC----cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence            999999999997642    46899999999999999999999   99999999999999999999999999999986654


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ..... .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||..........      .....        
T Consensus       159 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~------~~~~~--------  223 (269)
T 4hcu_A          159 DQYTS-STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE------DISTG--------  223 (269)
T ss_dssp             HHHHS-TTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------HHHTT--------
T ss_pred             ccccc-ccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHH------HHhcC--------
Confidence            32211 134557788999999986 89999999999999999999 999997654432211      11000        


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                             .  ....+...+..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus       224 -------~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          224 -------F--RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             -------C--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -------c--cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence                   0  0001112347799999999999999999999999999999875

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.7e-48  Score=349.94  Aligned_cols=265  Identities=17%  Similarity=0.234  Sum_probs=206.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-------------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-------------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-------------lv  117 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||||++.........+.+.+|+.++++++||||+++             +|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            35699999999999999999999  6899999999876555557788999999999999999987             89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee----CCCCCeEEeecCC
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF----NEQSDAKLFDFSL  193 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfg~  193 (332)
                      |||+++|+|.+++......  ..+++..++.++.||+.||.|||   +.+|+||||||+|||+    +.++.+||+|||+
T Consensus        88 ~e~~~~~~L~~~l~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             EeCCCCCCHHHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            9999999999999875221  24999999999999999999999   9999999999999999    7788899999999


Q ss_pred             ccccCCCCceeeccccccCCCcccccccC---------CCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHh
Q 038681          194 SLSIPDGETHIELDSVVGTTGFIAPENFT---------TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVK  264 (332)
Q Consensus       194 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---------~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~  264 (332)
                      ++........   ....||+.|+|||++.         ..++.++|||||||++|||++|..||.......... .....
T Consensus       163 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~  238 (319)
T 4euu_A          163 ARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNK-EVMYK  238 (319)
T ss_dssp             CEECCTTCCB---CCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCH-HHHHH
T ss_pred             ceecCCCCce---eecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhH-HHHHH
Confidence            9877655432   3457999999999874         378899999999999999999999997544322211 11111


Q ss_pred             hhhccccch-h---hhhhhhh--hcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 038681          265 RLSGQNCRF-K---EMVDSII--IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQ  326 (332)
Q Consensus       265 ~~~~~~~~~-~---~~~~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~  326 (332)
                      ...+.+... .   .......  ....+.........+..+.+|+.+||+.||++|||++|+++....
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d  306 (319)
T 4euu_A          239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD  306 (319)
T ss_dssp             HHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHH
T ss_pred             HhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHH
Confidence            111111100 0   0000000  001122233446788899999999999999999999999998764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3e-49  Score=361.60  Aligned_cols=251  Identities=18%  Similarity=0.271  Sum_probs=202.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------  115 (332)
                      .++|.+.+.||+|+||.||+|.+       ++..||||++...........+.+|+.++++++||||+++          
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            46789999999999999999995       4568999999877666667789999999999999999997          


Q ss_pred             -EEEEeccCCChHHHHhhhhc--ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC---CeEEe
Q 038681          116 -IVFESVQIGTLADRIHHHCE--QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS---DAKLF  189 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~--~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~  189 (332)
                       +||||+++|+|.+++.....  .....+++..++.++.||+.||.|||   ++||+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEEC
Confidence             89999999999999987632  11235899999999999999999999   99999999999999999555   59999


Q ss_pred             ecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhh
Q 038681          190 DFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLS  267 (332)
Q Consensus       190 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  267 (332)
                      |||+++...............||+.|+|||++.+ .++.++|||||||++|||++ |..||.........      ..+.
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~------~~i~  300 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL------EFVT  300 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH------HHHH
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHH
Confidence            9999975432222112234568999999999876 89999999999999999998 99999865443221      1111


Q ss_pred             ccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                      ..              .   ....+..++..+.+|+.+||+.||.+|||+.+|++.|+.+.+
T Consensus       301 ~~--------------~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          301 SG--------------G---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             TT--------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cC--------------C---CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            00              0   000112334679999999999999999999999999998875

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-48  Score=358.03  Aligned_cols=255  Identities=21%  Similarity=0.304  Sum_probs=208.9

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEe---------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE----
Q 038681           50 RIATNNYDEQNIVLEDPFRKLYKGFW---------QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL----  115 (332)
Q Consensus        50 ~~~~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~----  115 (332)
                      +...++|.+.+.||+|+||.||+|.+         .+..||+|++.........+.+.+|+.+++++ +||||+++    
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            44567899999999999999999996         22579999998877776678899999999999 99999998    


Q ss_pred             -------EEEEeccCCChHHHHhhhhcc-----------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCC
Q 038681          116 -------IVFESVQIGTLADRIHHHCEQ-----------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTN  177 (332)
Q Consensus       116 -------lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~N  177 (332)
                             +||||+++|+|.+++......           ....+++..++.++.||+.||.|||   +.+|+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcce
Confidence                   899999999999999875321           1135999999999999999999999   8999999999999


Q ss_pred             eeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccc
Q 038681          178 ILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFES  255 (332)
Q Consensus       178 ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~  255 (332)
                      ||++.++.+||+|||+++...............+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.......
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999987655433222245567889999999887 89999999999999999999 999997655432


Q ss_pred             hhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          256 RFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      ..      ..+....                 ....+..++.++.+|+.+||+.||++|||+.+|++.|+++...
T Consensus       302 ~~------~~~~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  353 (382)
T 3tt0_A          302 LF------KLLKEGH-----------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  353 (382)
T ss_dssp             HH------HHHHTTC-----------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HH------HHHHcCC-----------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            21      1111100                 0001113347899999999999999999999999999998754

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.1e-49  Score=353.69  Aligned_cols=238  Identities=15%  Similarity=0.212  Sum_probs=196.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|.+.+.||+|+||.||+|.+  ++..||+|.+....  ...+.+.+|+.+++.++||||+++           +|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc--ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            46799999999999999999999  78999999987553  235678899999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC--CCCeEEeecCCcccc
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE--QSDAKLFDFSLSLSI  197 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~a~~~  197 (332)
                      |+++|+|.+++....    ..+++..+..++.||+.||.|||   ++||+||||||+|||++.  ++.+||+|||+++..
T Consensus        82 ~~~g~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~  154 (321)
T 1tki_A           82 FISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             CCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             eCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeEC
Confidence            999999999997541    36999999999999999999999   999999999999999987  789999999999887


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ......   ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.........      ..+......+   
T Consensus       155 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~------~~i~~~~~~~---  222 (321)
T 1tki_A          155 KPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII------ENIMNAEYTF---  222 (321)
T ss_dssp             CTTCEE---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHTCCCC---
T ss_pred             CCCCcc---ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHH------HHHHcCCCCC---
Confidence            655432   45678999999999988 6899999999999999999999999865543221      1111100000   


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                 ........+.++.+|+.+||..||.+|||+.|+++
T Consensus       223 -----------~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          223 -----------DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -----------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----------ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                       00001133478999999999999999999999987

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=1.7e-48  Score=364.32  Aligned_cols=240  Identities=20%  Similarity=0.272  Sum_probs=196.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.+|+|++..... ....+.+.+|+.++++++||||+++           +||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            46699999999999999999998  899999999976543 3346678999999999999999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeC---CCCCeEEeecCCcc
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN---EQSDAKLFDFSLSL  195 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~a~  195 (332)
                      ||+++|+|.+++...     ..+++..+..++.||+.||.|||   ++||+||||||+|||++   .++.+||+|||++.
T Consensus        90 E~~~gg~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           90 DLVTGGELFEDIVAR-----EYYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             CCCBCCBHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EeCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            999999999999876     57999999999999999999999   99999999999999998   56789999999998


Q ss_pred             ccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ........  .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.........      ..+.       
T Consensus       162 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~------~~i~-------  226 (444)
T 3soa_A          162 EVEGEQQA--WFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLY------QQIK-------  226 (444)
T ss_dssp             CCCTTCCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHH-------
T ss_pred             EecCCCce--eecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHH------HHHH-------
Confidence            76654332  135679999999999988 8999999999999999999999999765433221      1111       


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                             ......+.+.....++.+.+|+.+||+.||.+|||+.|+++
T Consensus       227 -------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          227 -------AGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             -------HTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -------hCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                   11111111111234578999999999999999999999986

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.2e-48  Score=353.26  Aligned_cols=236  Identities=19%  Similarity=0.280  Sum_probs=195.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      .++|++.+.||+|+||.||+|.+  +++.||+|.+....  .....+.+.+|+.++..++||||+++           +|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            46799999999999999999999  78999999997542  12236678999999999999999997           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+++|+|.+++...     ..+++..+..++.||+.||.|||   ++||+||||||+|||++.+|.+||+|||+++..
T Consensus        84 ~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  155 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             EECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhc
Confidence            9999999999999876     57999999999999999999999   999999999999999999999999999999864


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ......  .....||+.|+|||++.+ .++.++|||||||++|||++|..||.........      ..+.         
T Consensus       156 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------~~i~---------  218 (337)
T 1o6l_A          156 ISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF------ELIL---------  218 (337)
T ss_dssp             CCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHH---------
T ss_pred             ccCCCc--ccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHH------HHHH---------
Confidence            333221  145689999999999987 8999999999999999999999999765432211      1111         


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~  322 (332)
                           .....    .+...+.++.+||.+||+.||.+||     +++++++
T Consensus       219 -----~~~~~----~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          219 -----MEEIR----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             -----HCCCC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -----cCCCC----CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence                 11110    1113347899999999999999999     8998875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.8e-49  Score=358.10  Aligned_cols=257  Identities=19%  Similarity=0.280  Sum_probs=207.0

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEeCC-------eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGFWQK-------RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----  115 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----  115 (332)
                      .+....++|.+.+.||+|+||.||+|.+.+       ..||+|.+.........+.+.+|+.++++++||||+++     
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            344567889999999999999999999843       78999999877666667889999999999999999998     


Q ss_pred             ------EEEEeccCCChHHHHhhhhcc-------------------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 038681          116 ------IVFESVQIGTLADRIHHHCEQ-------------------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVY  170 (332)
Q Consensus       116 ------lv~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  170 (332)
                            +||||+++|+|.+++......                   ....+++..++.++.||+.||.|||   +++|+|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeec
Confidence                  899999999999999864211                   1146899999999999999999999   999999


Q ss_pred             cCCCCCCeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccC
Q 038681          171 RDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVS  248 (332)
Q Consensus       171 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~  248 (332)
                      |||||+|||++.++.+||+|||+++...............+|+.|+|||++.+ .++.++|||||||++|||++ |..||
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            99999999999999999999999976644322222244568899999999876 89999999999999999999 99999


Q ss_pred             CCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 038681          249 DHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY  328 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~  328 (332)
                      .........      ..+...              ..   ...+..++..+.+|+.+||+.||.+|||+.++++.|+++.
T Consensus       278 ~~~~~~~~~------~~~~~~--------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~  334 (343)
T 1luf_A          278 YGMAHEEVI------YYVRDG--------------NI---LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  334 (343)
T ss_dssp             TTSCHHHHH------HHHHTT--------------CC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCChHHHH------HHHhCC--------------Cc---CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence            765443221      111100              00   0011233478999999999999999999999999999887


Q ss_pred             Hh
Q 038681          329 RS  330 (332)
Q Consensus       329 ~~  330 (332)
                      +.
T Consensus       335 ~~  336 (343)
T 1luf_A          335 ER  336 (343)
T ss_dssp             C-
T ss_pred             hh
Confidence            54

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.6e-49  Score=353.78  Aligned_cols=241  Identities=21%  Similarity=0.268  Sum_probs=194.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|++.+.||+|+||.||+|.+  +++.||+|++.........+.+.+|+.+++.++||||+++           +|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            46799999999999999999998  7899999999766554445678999999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++|+|.+++...     ..+++..++.++.||+.||.|||   +.||+||||||+|||++.++.+||+|||+++....
T Consensus        86 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           86 YCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             CCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             cCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence            99999999999765     56999999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCceeeccccccCCCcccccccCC-C-CChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-L-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ...........||+.|+|||++.+ . ++.++|||||||++|+|++|..||..........    ..+... ..      
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~----~~~~~~-~~------  226 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY----SDWKEK-KT------  226 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH----HHHHTT-CT------
T ss_pred             CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH----HHHhcc-cc------
Confidence            433333345689999999999876 4 4789999999999999999999997654432211    011000 00      


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                ........+..+.+|+.+||+.||.+|||+.|+++
T Consensus       227 ----------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          227 ----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             ----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                      00001133477889999999999999999999975

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=352.20  Aligned_cols=238  Identities=22%  Similarity=0.288  Sum_probs=195.9

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh-----hhHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ-----HALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      +.|.+.+.||+|+||.||+|.+  ++..||+|.+......     ...+.+.+|+.++++++||||+++           
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            4599999999999999999999  6899999998765332     136778999999999999999998           


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC----CeEEeec
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS----DAKLFDF  191 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Df  191 (332)
                      +||||+++|+|.+++...     ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++    .+||+||
T Consensus        91 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df  162 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF  162 (326)
T ss_dssp             EEEECCCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEcCCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEEC
Confidence            899999999999999765     57999999999999999999999   99999999999999998887    7999999


Q ss_pred             CCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc
Q 038681          192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       192 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      |+++........   ....||+.|+|||++.+ .++.++|||||||++|+|++|..||..........      ......
T Consensus       163 g~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~~~~~~  233 (326)
T 2y0a_A          163 GLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------NVSAVN  233 (326)
T ss_dssp             TTCEECCTTSCC---CCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------HHHHTC
T ss_pred             CCCeECCCCCcc---ccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH------HHHhcC
Confidence            999877544322   35679999999999987 89999999999999999999999997654432211      110000


Q ss_pred             cchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ..+..              ......+..+.+|+.+||+.||.+|||+.++++
T Consensus       234 ~~~~~--------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          234 YEFED--------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             CCCCH--------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCcCc--------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            00000              000123467899999999999999999999986

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.7e-49  Score=355.54  Aligned_cols=247  Identities=18%  Similarity=0.332  Sum_probs=195.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCe----eEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------E
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKR----SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------I  116 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------l  116 (332)
                      .++|++.+.||+|+||.||+|.+  ++.    .||+|.+.........+.+.+|+.++++++||||+++          +
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   93 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL   93 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEE
Confidence            45699999999999999999998  444    3688888766555557889999999999999999998          8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      |+||+++|+|.+++....    ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        94 v~e~~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           94 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EEECCTTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             EEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence            999999999999998642    46999999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ..............+|+.|+|||++.+ .++.++|||||||++|||++ |..||..........      .+..      
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~------~~~~------  234 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS------ILEK------  234 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH------HHHT------
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHH------HHHc------
Confidence            765544333344567889999999887 89999999999999999999 999998665433211      1100      


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                           ..      ..+.+..++..+.+|+.+||+.||.+|||+.++++.|+.+.+
T Consensus       235 -----~~------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          235 -----GE------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -----TC------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             -----CC------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                 00      001112334679999999999999999999999999998864

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.2e-48  Score=356.90  Aligned_cols=240  Identities=22%  Similarity=0.333  Sum_probs=197.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      ..++|.+.+.||+|+||.||+|.+  ++..||+|++.... .....+.+.+|+.++++++||||+++           +|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            356799999999999999999999  78999999997654 34446789999999999999999998           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC---CeEEeecCCc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS---DAKLFDFSLS  194 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~a  194 (332)
                      |||+++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++   .+||+|||++
T Consensus       107 ~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a  178 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA  178 (362)
T ss_dssp             ECCCCSCBHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcc
Confidence            9999999999999765     56999999999999999999999   99999999999999998654   5999999999


Q ss_pred             cccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      .........   ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.........      ..+..     
T Consensus       179 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~------~~i~~-----  244 (362)
T 2bdw_A          179 IEVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLY------AQIKA-----  244 (362)
T ss_dssp             BCCTTCCSC---CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHH-----
T ss_pred             eEecCCccc---ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHHh-----
Confidence            877654322   45679999999999988 8999999999999999999999999765432211      11110     


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                               .....+.+.....+.++.+|+.+||+.||.+|||+.++++
T Consensus       245 ---------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          245 ---------GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             ---------TCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ---------CCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                     0000011111234478999999999999999999999876

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.1e-48  Score=345.99  Aligned_cols=253  Identities=19%  Similarity=0.326  Sum_probs=194.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHh--hcCCCcceE---------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASR--MSHKHIIKL---------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~~---------------  115 (332)
                      .++|.+.+.||+|+||.||+|.++++.||||++....    ...+..|.+++..  ++||||+++               
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRD----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEecccc----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            4679999999999999999999999999999986542    4556677777776  799999987               


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCCeeeCCCCCeEEee
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGF-----SRPIVYRDMKPTNILFNEQSDAKLFD  190 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~Nill~~~~~~kl~D  190 (332)
                      +||||+++|+|.+++..      ..+++..++.++.||+.||.|||+..     +++|+||||||+|||++.++.+||+|
T Consensus        83 lv~e~~~~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  156 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIAD  156 (301)
T ss_dssp             EEECCCTTCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred             EehhhccCCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEee
Confidence            89999999999999964      36999999999999999999999321     57999999999999999999999999


Q ss_pred             cCCccccCCCCceee--ccccccCCCcccccccCCC-------CChhhhHHHHHHHHHHHHhC----------CccCCCC
Q 038681          191 FSLSLSIPDGETHIE--LDSVVGTTGFIAPENFTTL-------INEQCDVYGFGAFLFELLTA----------QEVSDHV  251 (332)
Q Consensus       191 fg~a~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-------~~~~sDiwSlG~~l~elltg----------~~p~~~~  251 (332)
                      ||+++..........  .....||+.|+|||++.+.       ++.++|||||||++|||++|          ..||...
T Consensus       157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence            999976654433211  1344799999999998762       34799999999999999999          7777544


Q ss_pred             CccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          252 SFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                      ....... ...........           ..............+..+.+|+.+||+.||++|||+.+|++.|+++
T Consensus       237 ~~~~~~~-~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          237 VPNDPSF-EDMRKVVCVDQ-----------QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SCSSCCH-HHHHHHHTTSC-----------CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcch-hhhhHHHhccC-----------CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            3222111 00000000000           0000000011235678899999999999999999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.5e-48  Score=341.52  Aligned_cols=245  Identities=18%  Similarity=0.283  Sum_probs=202.2

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      ..++|.+.+.||+|+||.||+|.+ ++..||+|.+......  .+.+.+|+.++.+++||||+++           +|||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS--EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence            456799999999999999999999 6778999999865433  4678999999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++|+|.+++....    ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++.....
T Consensus        84 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  156 (268)
T 3sxs_A           84 YISNGCLLNYLRSHG----KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD  156 (268)
T ss_dssp             CCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCT
T ss_pred             ccCCCcHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecch
Confidence            999999999997752    35999999999999999999999   99999999999999999999999999999987765


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ...... ....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||..........     .......       
T Consensus       157 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~-----~~~~~~~-------  223 (268)
T 3sxs_A          157 DQYVSS-VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL-----KVSQGHR-------  223 (268)
T ss_dssp             TCEEEC-CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH-----HHHTTCC-------
T ss_pred             hhhhcc-cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH-----HHHcCCC-------
Confidence            543322 34556788999999987 88999999999999999999 999997655432211     0000000       


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                                 ...+...++.+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus       224 -----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          224 -----------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             -----------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             -----------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence                       00011233679999999999999999999999999988754

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.9e-48  Score=343.00  Aligned_cols=243  Identities=23%  Similarity=0.377  Sum_probs=197.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhh------HHHHHHHHHHHHhhcCCCcceE---------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHA------LEWCINHIVYASRMSHKHIIKL---------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~------~~~~~~E~~~l~~l~H~nIv~~---------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|.+........      .+.+.+|+.++++++||||+++         
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   97 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPR   97 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTE
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCe
Confidence            46799999999999999999999  789999999876543211      2678999999999999999998         


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCCeeeCCCCC-----eEE
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRP--IVYRDMKPTNILFNEQSD-----AKL  188 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~-----~kl  188 (332)
                      +||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++  |+||||||+|||++.++.     +||
T Consensus        98 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl  170 (287)
T 4f0f_A           98 MVMEFVPCGDLYHRLLDKA----HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKV  170 (287)
T ss_dssp             EEEECCTTCBHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEE
T ss_pred             EEEEecCCCCHHHHHhccc----CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEe
Confidence            8999999999999886542    46999999999999999999999   889  999999999999988776     999


Q ss_pred             eecCCccccCCCCceeeccccccCCCcccccccCC---CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhh
Q 038681          189 FDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT---LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKR  265 (332)
Q Consensus       189 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~  265 (332)
                      +|||+++......     ....||+.|+|||++.+   .++.++|||||||++|+|++|..||...........    ..
T Consensus       171 ~Dfg~~~~~~~~~-----~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~  241 (287)
T 4f0f_A          171 ADFGLSQQSVHSV-----SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFI----NM  241 (287)
T ss_dssp             CCCTTCBCCSSCE-----ECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHH----HH
T ss_pred             CCCCccccccccc-----cccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHH----HH
Confidence            9999997544321     45679999999999843   678999999999999999999999976554332110    00


Q ss_pred             hhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          266 LSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                      ...              .  ......+..+++.+.+|+.+||+.||.+|||++++++.|++|
T Consensus       242 ~~~--------------~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          242 IRE--------------E--GLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHH--------------S--CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             Hhc--------------c--CCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            000              0  001111123457899999999999999999999999999763

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.8e-48  Score=347.03  Aligned_cols=258  Identities=19%  Similarity=0.309  Sum_probs=210.4

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----
Q 038681           49 LRIATNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----  115 (332)
Q Consensus        49 l~~~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----  115 (332)
                      +....++|.+.+.||+|+||.||+|.+       ++..||+|.+.........+.+.+|+.++.++ +||||+++     
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            344567899999999999999999985       46789999998776666678899999999999 99999998     


Q ss_pred             ------EEEEeccCCChHHHHhhhhcc-------------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 038681          116 ------IVFESVQIGTLADRIHHHCEQ-------------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPT  176 (332)
Q Consensus       116 ------lv~e~~~~g~L~~~l~~~~~~-------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~  176 (332)
                            +||||+++|+|.+++......             ....+++..++.++.||+.||.|||   +++|+||||||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~  174 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAAR  174 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccc
Confidence                  899999999999999875311             1125899999999999999999999   999999999999


Q ss_pred             CeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCcc
Q 038681          177 NILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFE  254 (332)
Q Consensus       177 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~  254 (332)
                      ||+++.++.+||+|||++................+|+.|+|||++.+ .++.++|||||||++|+|++ |..||......
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            99999999999999999987766544333345567889999999876 89999999999999999999 99999765543


Q ss_pred             chhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 038681          255 SRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSC  331 (332)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  331 (332)
                      ....     ...           ....      ....+...+..+.+|+.+||+.||.+|||+.++++.|+++.+++
T Consensus       255 ~~~~-----~~~-----------~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          255 SKFY-----KMI-----------KEGF------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             HHHH-----HHH-----------HHTC------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             hHHH-----HHh-----------ccCC------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            2211     111           0000      00011233478999999999999999999999999999998764

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.4e-48  Score=344.94  Aligned_cols=247  Identities=22%  Similarity=0.383  Sum_probs=193.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------EEEEeccC
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------IVFESVQI  123 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------lv~e~~~~  123 (332)
                      .++|++.+.||+|+||.||+|.+.++.||+|.+....   ..+.+.+|+.++++++||||+++         +||||+++
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~   83 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESES---ERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEG   83 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSSTT---HHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTT
T ss_pred             HhHeeeeeEeecCCCceEEEEEECCeeEEEEEecChh---HHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCC
Confidence            4578899999999999999999999999999986542   35778999999999999999998         89999999


Q ss_pred             CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCC-eEEeecCCccccCCCCc
Q 038681          124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD-AKLFDFSLSLSIPDGET  202 (332)
Q Consensus       124 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-~kl~Dfg~a~~~~~~~~  202 (332)
                      |+|.+++....  ....+++..++.++.|++.||.|||+...++|+||||||+||+++.++. +||+|||++....... 
T Consensus        84 ~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~-  160 (307)
T 2eva_A           84 GSLYNVLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM-  160 (307)
T ss_dssp             CBHHHHHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCHHHHHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc-
Confidence            99999997642  1134789999999999999999999211189999999999999998887 7999999997654332 


Q ss_pred             eeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhh
Q 038681          203 HIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSII  281 (332)
Q Consensus       203 ~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (332)
                          ....||+.|+|||++.+ .++.++|||||||++|||++|+.||..........   ........            
T Consensus       161 ----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~~~------------  221 (307)
T 2eva_A          161 ----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI---MWAVHNGT------------  221 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHH---HHHHHTTC------------
T ss_pred             ----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHH---HHHHhcCC------------
Confidence                34468999999999988 89999999999999999999999997543321100   00000000            


Q ss_pred             hcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          282 IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                            ........+..+.+|+.+||+.||.+|||+.++++.|+.+.+.
T Consensus       222 ------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  264 (307)
T 2eva_A          222 ------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY  264 (307)
T ss_dssp             ------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGG
T ss_pred             ------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence                  0011123346799999999999999999999999999998764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.5e-48  Score=366.24  Aligned_cols=244  Identities=19%  Similarity=0.333  Sum_probs=202.3

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE------------EE
Q 038681           50 RIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------------IV  117 (332)
Q Consensus        50 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~------------lv  117 (332)
                      ....++|.+.+.||+|+||.||+|.+.++.||||.++...   ..+.+.+|+.++++++||||+++            ||
T Consensus       189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv  265 (450)
T 1k9a_A          189 ALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV  265 (450)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT---TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEE
T ss_pred             ccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch---HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEE
Confidence            3456778999999999999999999999999999998654   25678999999999999999997            89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+++|+|.+++.....   ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus       266 ~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  339 (450)
T 1k9a_A          266 TEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  339 (450)
T ss_dssp             EECCTTCBHHHHHHHHCT---TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence            999999999999987521   34799999999999999999999   999999999999999999999999999999865


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      ....     ....+|+.|+|||++.+ .++.++|||||||++|||++ |..||......+...      .+..       
T Consensus       340 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~------~i~~-------  401 (450)
T 1k9a_A          340 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP------RVEK-------  401 (450)
T ss_dssp             C-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH------HHHT-------
T ss_pred             cccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HHHc-------
Confidence            4332     23367889999999987 89999999999999999998 999998665433211      1100       


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                              ..  ..+.+..+++.+.+||.+||+.||.+|||+.++++.|+.+...
T Consensus       402 --------~~--~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          402 --------GY--KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             --------TC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --------CC--CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence                    00  1111224457899999999999999999999999999998764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=5.5e-49  Score=354.09  Aligned_cols=247  Identities=19%  Similarity=0.358  Sum_probs=198.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCee----EEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------E
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRS----ISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------I  116 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------l  116 (332)
                      .++|.+.+.||+|+||.||+|.+  ++..    ||+|.+.........+.+.+|+.++.+++||||+++          +
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQL   91 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEE
Confidence            35688999999999999999998  4544    888888665544445667899999999999999998          8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ||||+++|+|.+++....    ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        92 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEECCTTCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             EEEeCCCCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence            999999999999997642    46899999999999999999999   89999999999999999999999999999988


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ..............+|..|+|||++.+ .++.++|||||||++|+|++ |..||..........      .+....    
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~------~~~~~~----  234 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPD------LLEKGE----  234 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHH------HHHTTC----
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHH------HHHcCC----
Confidence            765544333345678889999999986 89999999999999999999 999998754433211      110000    


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                                   ....+..++..+.+|+.+||+.||.+|||+.++++.|+++.+
T Consensus       235 -------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          235 -------------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             -------------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             -------------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                         000011223568899999999999999999999999998864

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-49  Score=356.14  Aligned_cols=257  Identities=17%  Similarity=0.308  Sum_probs=203.0

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----
Q 038681           49 LRIATNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----  115 (332)
Q Consensus        49 l~~~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----  115 (332)
                      ++...++|.+.+.||+|+||.||+|.+       .+..||+|.+.........+.+.+|+.++.++ +||||+++     
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            445668899999999999999999996       35679999998765555567899999999999 89999998     


Q ss_pred             ------EEEEeccCCChHHHHhhhhcc------------------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeec
Q 038681          116 ------IVFESVQIGTLADRIHHHCEQ------------------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYR  171 (332)
Q Consensus       116 ------lv~e~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~  171 (332)
                            +||||+++|+|.+++......                  ....+++..++.++.||+.||.|||   ++||+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccC
Confidence                  899999999999999865211                  0134899999999999999999999   9999999


Q ss_pred             CCCCCCeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCC
Q 038681          172 DMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSD  249 (332)
Q Consensus       172 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~  249 (332)
                      ||||+|||++.++.+||+|||++................||+.|+|||++.+ .++.++|||||||++|+|+| |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999987655443333345678899999999876 89999999999999999998 999998


Q ss_pred             CCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          250 HVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                      .........     .....           ..      ....+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       277 ~~~~~~~~~-----~~~~~-----------~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          277 GIPVDANFY-----KLIQN-----------GF------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             TCCCSHHHH-----HHHHT-----------TC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cCCcHHHHH-----HHHhc-----------CC------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            765432211     11110           00      001111334789999999999999999999999999998875


Q ss_pred             h
Q 038681          330 S  330 (332)
Q Consensus       330 ~  330 (332)
                      .
T Consensus       335 ~  335 (344)
T 1rjb_A          335 D  335 (344)
T ss_dssp             -
T ss_pred             H
Confidence            4

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.3e-48  Score=351.22  Aligned_cols=265  Identities=19%  Similarity=0.291  Sum_probs=197.6

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHH--HHhhcCCCcceE--------------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVY--ASRMSHKHIIKL--------------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~H~nIv~~--------------  115 (332)
                      ..++|.+.+.||+|+||.||+|.++++.||||++....    ...+..|..+  +..++||||+++              
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            45789999999999999999999999999999997543    3334445444  445899999987              


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCC---------CeeecCCCCCCeeeCCCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSR---------PIVYRDMKPTNILFNEQS  184 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~---------~ivH~Dlkp~Nill~~~~  184 (332)
                        +||||+++|+|.+++...      ..++..+..++.||+.||.|||   +.         +|+||||||+|||++.++
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~  157 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDG  157 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTS
T ss_pred             EEEEEecCCCCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCC
Confidence              799999999999999764      4689999999999999999999   88         999999999999999999


Q ss_pred             CeEEeecCCccccCCCCc------eeeccccccCCCcccccccCC--------CCChhhhHHHHHHHHHHHHhCCccCCC
Q 038681          185 DAKLFDFSLSLSIPDGET------HIELDSVVGTTGFIAPENFTT--------LINEQCDVYGFGAFLFELLTAQEVSDH  250 (332)
Q Consensus       185 ~~kl~Dfg~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~--------~~~~~sDiwSlG~~l~elltg~~p~~~  250 (332)
                      .+||+|||+++.......      ........||+.|+|||++.+        .++.++|||||||++|||++|..||..
T Consensus       158 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          158 TCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             CEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             cEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            999999999987654321      111234579999999999875        355789999999999999999877754


Q ss_pred             CCccchhhhHHHHhhhhccccchhhhhhhhhh----cccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 038681          251 VSFESRFHYEENVKRLSGQNCRFKEMVDSIII----EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQ  326 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~  326 (332)
                      .........  .........+...+.......    ...+.........++.+.+|+.+||+.||++|||+.|+++.|++
T Consensus       238 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          238 GESVPEYQM--AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             TSCCCCCCC--TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             ccchhHHHH--hhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            332221110  111111111111111110000    11111222234577889999999999999999999999999999


Q ss_pred             HHHhh
Q 038681          327 MYRSC  331 (332)
Q Consensus       327 l~~~~  331 (332)
                      +...+
T Consensus       316 ll~~~  320 (336)
T 3g2f_A          316 LMMIW  320 (336)
T ss_dssp             HHHCC
T ss_pred             HHHHH
Confidence            98764

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=8.5e-49  Score=345.75  Aligned_cols=249  Identities=16%  Similarity=0.257  Sum_probs=200.9

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------E
Q 038681           49 LRIATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------I  116 (332)
Q Consensus        49 l~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------l  116 (332)
                      +....++|.+.+.||+|+||.||+|.+ ++..||+|++......  .+.+.+|+.++.+++||||+++           +
T Consensus        19 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   96 (283)
T 3gen_A           19 WEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFI   96 (283)
T ss_dssp             TBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             ccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC--HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEE
Confidence            344567899999999999999999999 7778999999876433  4678999999999999999997           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+++.
T Consensus        97 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  169 (283)
T 3gen_A           97 ITEYMANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY  169 (283)
T ss_dssp             EECCCTTCBHHHHHHCGG----GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred             EEeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEcccccccc
Confidence            999999999999997642    46999999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ........ .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||..........      .+....    
T Consensus       170 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~------~~~~~~----  238 (283)
T 3gen_A          170 VLDDEYTS-SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE------HIAQGL----  238 (283)
T ss_dssp             BCCHHHHS-TTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH------HHHTTC----
T ss_pred             cccccccc-ccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH------HHhccc----
Confidence            65432211 134456788999999986 89999999999999999998 999998655432211      110000    


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                                   ....+...++.+.+|+.+||+.||.+|||+.++++.|.++.+.
T Consensus       239 -------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          239 -------------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             -------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------------CCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence                         0000112236799999999999999999999999999998753

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.9e-48  Score=344.80  Aligned_cols=251  Identities=21%  Similarity=0.378  Sum_probs=192.7

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE----------EEEE
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL----------IVFE  119 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv~e  119 (332)
                      +..++|.+.+.||+|+||.||+|.+.+ .||+|.+.... .....+.+.+|+.++++++||||+++          +|||
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e   99 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQ   99 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEE
Confidence            346789999999999999999999855 49999997654 34456789999999999999999997          8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++++|.+++....    ..+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++.....
T Consensus       100 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A          100 WCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             CCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             ecCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccc
Confidence            999999999996542    46999999999999999999999   99999999999999999999999999999976654


Q ss_pred             CCceeeccccccCCCcccccccC---C-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc--cccch
Q 038681          200 GETHIELDSVVGTTGFIAPENFT---T-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG--QNCRF  273 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~---~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~  273 (332)
                      ...........||+.|+|||++.   + .++.++|||||||++|+|++|..||.........     ......  ....+
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----~~~~~~~~~~~~~  247 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI-----IEMVGRGSLSPDL  247 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH-----HHHHHHTSCCCCT
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH-----HHHhcccccCcch
Confidence            33222224567999999999986   3 7899999999999999999999999865443221     111100  00000


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                                     ......++..+.+|+.+||+.||.+|||+.++++.|+++.+
T Consensus       248 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          248 ---------------SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             ---------------TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ---------------hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence                           00112344789999999999999999999999999998764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=4.4e-48  Score=340.92  Aligned_cols=248  Identities=23%  Similarity=0.344  Sum_probs=200.8

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-----CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------E
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW-----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------I  116 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------l  116 (332)
                      ..++|.+.+.||+|+||.||+|.+     .+..||+|.+.........+.+.+|+.++++++||||+++          +
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWI   89 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEE
Confidence            456799999999999999999987     2345999999887666667889999999999999999998          8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ||||+++|+|.+++....    ..+++..+..++.||+.||.|||   +++|+||||||+||+++.++.+||+|||++..
T Consensus        90 v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           90 IMELYPYGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             EEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             EEecCCCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            999999999999997652    45899999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ........ .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||..........      .+..      
T Consensus       163 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~------~~~~------  229 (281)
T 3cc6_A          163 IEDEDYYK-ASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIG------VLEK------  229 (281)
T ss_dssp             C----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHH------HHHH------
T ss_pred             cccccccc-cccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHH------HHhc------
Confidence            65443221 134567889999999976 89999999999999999998 999997654433211      0000      


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                              ..   ..+.+...++.+.+++.+||+.||.+|||+.++++.|+++.+.
T Consensus       230 --------~~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          230 --------GD---RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             --------TC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------CC---CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence                    00   0001112347799999999999999999999999999998753

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.5e-48  Score=349.22  Aligned_cols=263  Identities=18%  Similarity=0.331  Sum_probs=214.3

Q ss_pred             cccHHHHHHHhcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcce
Q 038681           43 IFSAEELRIATNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIK  114 (332)
Q Consensus        43 ~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~  114 (332)
                      .+...++....++|.+.+.||+|+||.||+|.+       +++.||||.+.........+.+.+|+.++.++ +||||++
T Consensus        16 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~   95 (316)
T 2xir_A           16 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN   95 (316)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             cccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeee
Confidence            356667777788999999999999999999984       45889999998876666677899999999999 7999998


Q ss_pred             E------------EEEEeccCCChHHHHhhhhccc-----------ccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeec
Q 038681          115 L------------IVFESVQIGTLADRIHHHCEQH-----------FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYR  171 (332)
Q Consensus       115 ~------------lv~e~~~~g~L~~~l~~~~~~~-----------~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~  171 (332)
                      +            +||||+++|+|.+++.......           ...+++..++.++.||+.||.|||   +++|+||
T Consensus        96 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~  172 (316)
T 2xir_A           96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHR  172 (316)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCS
T ss_pred             EEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccc
Confidence            8            8999999999999998653210           122889999999999999999999   8999999


Q ss_pred             CCCCCCeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCC
Q 038681          172 DMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSD  249 (332)
Q Consensus       172 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~  249 (332)
                      ||||+||+++.++.+||+|||+++...............+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.
T Consensus       173 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~  252 (316)
T 2xir_A          173 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  252 (316)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCc
Confidence            9999999999999999999999987655444333355678999999999876 89999999999999999998 999997


Q ss_pred             CCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          250 HVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                      ........     ...+..               ..  ....+...+..+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus       253 ~~~~~~~~-----~~~~~~---------------~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  310 (316)
T 2xir_A          253 GVKIDEEF-----CRRLKE---------------GT--RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  310 (316)
T ss_dssp             TCCCSHHH-----HHHHHH---------------TC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ccchhHHH-----HHHhcc---------------Cc--cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            65433221     111100               00  000111234679999999999999999999999999999987


Q ss_pred             h
Q 038681          330 S  330 (332)
Q Consensus       330 ~  330 (332)
                      +
T Consensus       311 ~  311 (316)
T 2xir_A          311 A  311 (316)
T ss_dssp             H
T ss_pred             h
Confidence            5

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=9.1e-49  Score=352.10  Aligned_cols=257  Identities=18%  Similarity=0.295  Sum_probs=191.7

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEe--CCe---eEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE------
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGFW--QKR---SISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL------  115 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~---~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~------  115 (332)
                      ++....++|.+.+.||+|+||.||+|.+  ++.   .||||.+.... .....+.+.+|+.++++++||||+++      
T Consensus        17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   96 (323)
T 3qup_A           17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR   96 (323)
T ss_dssp             TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred             hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence            3444567899999999999999999998  332   79999987653 23447789999999999999999975      


Q ss_pred             -----------EEEEeccCCChHHHHhhhhcc-cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC
Q 038681          116 -----------IVFESVQIGTLADRIHHHCEQ-HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ  183 (332)
Q Consensus       116 -----------lv~e~~~~g~L~~~l~~~~~~-~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  183 (332)
                                 +||||+++|+|.+++...... ....+++..++.++.||+.||.|||   +.||+||||||+|||++.+
T Consensus        97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~  173 (323)
T 3qup_A           97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAED  173 (323)
T ss_dssp             C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTT
T ss_pred             cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCC
Confidence                       799999999999999765321 1225899999999999999999999   8999999999999999999


Q ss_pred             CCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHH
Q 038681          184 SDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEE  261 (332)
Q Consensus       184 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~  261 (332)
                      +.+||+|||+++...............+|+.|+|||++.+ .++.++|||||||++|+|++ |..||..........   
T Consensus       174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~---  250 (323)
T 3qup_A          174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN---  250 (323)
T ss_dssp             SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---
T ss_pred             CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHH---
Confidence            9999999999987655443322234567889999999887 89999999999999999999 999998655433211   


Q ss_pred             HHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          262 NVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                        ......                  ....+...+..+.+|+.+||+.||.+|||+.++++.|+++.+.
T Consensus       251 --~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~  299 (323)
T 3qup_A          251 --YLIGGN------------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH  299 (323)
T ss_dssp             --HHHTTC------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --HHhcCC------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence              000000                  0011123447899999999999999999999999999999864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.1e-48  Score=355.63  Aligned_cols=238  Identities=19%  Similarity=0.272  Sum_probs=191.4

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhh-cCCCcceE----------
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRM-SHKHIIKL----------  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~~----------  115 (332)
                      ...++|++.+.||+|+||.||+|++  +++.||+|++....  .....+.+.+|..++..+ +||||+++          
T Consensus        20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~   99 (353)
T 3txo_A           20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL   99 (353)
T ss_dssp             ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence            3457899999999999999999998  78999999997642  223356788999999998 79999997          


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       +||||+++|+|.+++...     ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       100 ~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a  171 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMC  171 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccce
Confidence             899999999999999876     57999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      +........  ....+||+.|+|||++.+ .++.++|||||||++|||++|..||.........      ..+       
T Consensus       172 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~------~~i-------  236 (353)
T 3txo_A          172 KEGICNGVT--TATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF------EAI-------  236 (353)
T ss_dssp             BCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHH-------
T ss_pred             eecccCCcc--ccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH------HHH-------
Confidence            864433221  245689999999999987 8999999999999999999999999876543321      111       


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCH------HHHHH
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTM------VDVAK  322 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~------~evl~  322 (332)
                             ......    .+...+..+.+|+.+||+.||.+||++      .++++
T Consensus       237 -------~~~~~~----~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          237 -------LNDEVV----YPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             -------HHCCCC----CCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             -------HcCCCC----CCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence                   111111    111234678999999999999999998      66664

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.9e-48  Score=346.52  Aligned_cols=259  Identities=20%  Similarity=0.291  Sum_probs=201.6

Q ss_pred             cCCCCCCccccCCCceEEEEEe------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE------------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~------------  115 (332)
                      ..|++.+.||+|+||.||+|.+      +++.||+|++.........+.+.+|+.++.+++||||+++            
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4588999999999999999983      7899999999876655557889999999999999999987            


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       +||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.+||+|||++
T Consensus       101 ~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEEeCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECccccc
Confidence             8999999999999996542    46999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCce-eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc--c
Q 038681          195 LSIPDGETH-IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ--N  270 (332)
Q Consensus       195 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~  270 (332)
                      ......... .......||..|+|||++.+ .++.++|||||||++|+|++|..|+......       ........  .
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-------~~~~~~~~~~~  246 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL-------FLKMIGPTHGQ  246 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH-------HHHHHCSCCGG
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH-------HhhccCCcccc
Confidence            877655432 12234568889999999877 7899999999999999999999986533211       01111110  0


Q ss_pred             cchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                      ........ .+....  ..+.+...++.+.+|+.+||+.||.+|||+.++++.|+++++
T Consensus       247 ~~~~~~~~-~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll~  302 (302)
T 4e5w_A          247 MTVTRLVN-TLKEGK--RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALLK  302 (302)
T ss_dssp             GHHHHHHH-HHHTTC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             cCHHHHHH-HHhccC--CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            01111111 111111  111223455789999999999999999999999999999863

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.5e-48  Score=355.23  Aligned_cols=248  Identities=20%  Similarity=0.283  Sum_probs=191.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-----CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------E
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------I  116 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------l  116 (332)
                      .++|.+.+.||+|+||.||+|.+     .+..||||.+.........+.+.+|+.++.+++||||+++           +
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            45799999999999999999987     3667999999877666667889999999999999999998           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ||||+++|+|.+++....    ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       124 v~e~~~~~sL~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKHD----AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEECCTTCBHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            999999999999997641    46899999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCcee-eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          197 IPDGETHI-ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       197 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      ........ ......+|+.|+|||++.+ .++.++|||||||++|||++ |..||.........      ..+..     
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~------~~i~~-----  265 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI------KAVDE-----  265 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHH------HHHHT-----
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHc-----
Confidence            65433211 1122345788999999986 89999999999999999998 99999765432211      11100     


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                            ..      ..+.+..++..+.+|+.+||+.||.+|||+.+|++.|+++.+.
T Consensus       266 ------~~------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          266 ------GY------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             ------TE------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ------CC------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence                  00      0011113447899999999999999999999999999998753

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=9.8e-49  Score=353.61  Aligned_cols=234  Identities=23%  Similarity=0.330  Sum_probs=193.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|++.....  ......+.+|+.+++.++||||+++           +|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46799999999999999999998  889999999865321  1224578899999999999999998           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+ +|+|.+++...     ..+++..+..++.||+.||.|||   +.||+||||||+|||++.++.+||+|||++...
T Consensus        88 ~E~~-~g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~  158 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM  158 (336)
T ss_dssp             ECCC-CEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTT
T ss_pred             EECC-CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceec
Confidence            9999 68999999876     57999999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCceeeccccccCCCcccccccCC-C-CChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-L-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      ......   ....||+.|+|||++.+ . .+.++|||||||++|+|++|..||..........      .....      
T Consensus       159 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~------~i~~~------  223 (336)
T 3h4j_B          159 TDGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK------KVNSC------  223 (336)
T ss_dssp             TTSBTT---CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC------CCCSS------
T ss_pred             cCCccc---ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH------HHHcC------
Confidence            554322   45679999999999987 4 4789999999999999999999997654322110      00000      


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                  ....+...++.+.+|+.+||+.||.+|||+.|+++
T Consensus       224 ------------~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          224 ------------VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             ------------CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             ------------CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                        01111233477899999999999999999999975

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.9e-48  Score=355.29  Aligned_cols=238  Identities=19%  Similarity=0.298  Sum_probs=195.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|.+....  .....+.+.+|+.++..++|||||++           +|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            46799999999999999999999  78899999987542  22335778999999999999999997           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+++|+|.+++...     ..+++..+..++.||+.||.|||   +.||+||||||+|||++.+|.+||+|||+++..
T Consensus        94 ~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~  165 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML  165 (384)
T ss_dssp             ECCCTTEEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeec
Confidence            9999999999999875     57999999999999999999999   999999999999999999999999999999877


Q ss_pred             CCCCceeeccccccCCCcccccccCC----CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      ......   ....||+.|+|||++.+    .++.++|||||||++|||++|..||..........   .........   
T Consensus       166 ~~~~~~---~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~---~~~~~~~~~---  236 (384)
T 4fr4_A          166 PRETQI---TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE---IVHTFETTV---  236 (384)
T ss_dssp             CTTCCB---CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH---HHHHHHHCC---
T ss_pred             cCCCce---eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH---HHHHHhhcc---
Confidence            554332   46789999999999863    58999999999999999999999997544332211   111111100   


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT-MVDVAK  322 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-~~evl~  322 (332)
                                 .    ..+...+..+.+||.+||+.||.+||+ +++|++
T Consensus       237 -----------~----~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 -----------V----TYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             -----------C----CCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             -----------c----CCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence                       0    111233478999999999999999998 666653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-48  Score=350.47  Aligned_cols=247  Identities=18%  Similarity=0.337  Sum_probs=195.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCee----EEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------E
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRS----ISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------I  116 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~----vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------l  116 (332)
                      .++|++.+.||+|+||.||+|.+  ++..    |++|.+.........+.+.+|+.++++++||||+++          +
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   93 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQL   93 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceE
Confidence            46799999999999999999998  4544    578887766555557889999999999999999987          8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      |+||+++|+|.+++....    ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        94 v~~~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           94 ITQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             EECCCSSCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             EEEecCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence            999999999999998652    46999999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ..............+|+.|+|||++.+ .++.++|||||||++|||++ |..||..........      .+..      
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~------~~~~------  234 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS------ILEK------  234 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH------HHHT------
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH------HHHc------
Confidence            655443333244567889999999987 89999999999999999999 999998765433211      1100      


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                               ..  ..+.+...+..+.+|+.+||+.||.+|||+.++++.|+++.+
T Consensus       235 ---------~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  278 (327)
T 3lzb_A          235 ---------GE--RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             ---------TC--CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHT
T ss_pred             ---------CC--CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence                     00  001112334679999999999999999999999999999874

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.5e-48  Score=347.11  Aligned_cols=257  Identities=21%  Similarity=0.296  Sum_probs=204.0

Q ss_pred             CCCCCccccCCCceEEEEEe------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-------------E
Q 038681           56 YDEQNIVLEDPFRKLYKGFW------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-------------I  116 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-------------l  116 (332)
                      |.+.+.||+|+||.||++.+      +++.||||++.........+.+.+|+.++++++||||+++             +
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            48999999999999998875      6788999999987766667889999999999999999987             8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ||||+++|+|.+++...      .+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++..
T Consensus       113 v~e~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EECCCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEecccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence            99999999999999764      4999999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCcee-eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc--c
Q 038681          197 IPDGETHI-ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC--R  272 (332)
Q Consensus       197 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--~  272 (332)
                      ........ ......+|+.|+|||++.+ .++.++|||||||++|+|++|..||........       ........  .
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-------~~~~~~~~~~~  256 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-------ELIGIAQGQMT  256 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-------HHHCSCCHHHH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-------hhhcccccchh
Confidence            76544321 1234567888999999987 889999999999999999999999875432110       00000000  0


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSC  331 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  331 (332)
                      .... ...+...  ...+.+..++..+.+|+.+||+.||.+|||+.++++.|+++.+.+
T Consensus       257 ~~~~-~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          257 VLRL-TELLERG--ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             HHHH-HHHHHTT--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHH-HHHHhcc--cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            0001 1111111  111122345578999999999999999999999999999998754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.8e-49  Score=369.51  Aligned_cols=254  Identities=19%  Similarity=0.324  Sum_probs=208.0

Q ss_pred             ccHHHHHHHhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-------
Q 038681           44 FSAEELRIATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-------  115 (332)
Q Consensus        44 ~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-------  115 (332)
                      +...++++..++|.+.+.||+|+||.||+|.+ .+..||||.+.....  ..+.+.+|+.++++++|||||++       
T Consensus       178 ~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~  255 (454)
T 1qcf_A          178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM--SVEAFLAEANVMKTLQHDKLVKLHAVVTKE  255 (454)
T ss_dssp             CCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB--CHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             ccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc--cHHHHHHHHHHHhhCCCCCEeeEEEEEeCC
Confidence            34456667778899999999999999999999 688999999986543  36789999999999999999998       


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                         +||||+++|+|.+++.....   ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG  329 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEG---SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFG  329 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTT
T ss_pred             ccEEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCC
Confidence               89999999999999986421   35899999999999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccc
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      +++......... .....+|+.|+|||++.. .++.++|||||||++|||++ |..||......+...      .+.   
T Consensus       330 ~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~------~i~---  399 (454)
T 1qcf_A          330 LARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR------ALE---  399 (454)
T ss_dssp             GGGGBCCHHHHT-TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH------HHH---
T ss_pred             CceEcCCCceec-cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHH------HHH---
Confidence            998765432111 123456788999999985 89999999999999999999 999998654432211      110   


Q ss_pred             cchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                                  ...  ..+.+..++..+.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       400 ------------~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          400 ------------RGY--RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             ------------HTC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             ------------cCC--CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                        000  011112445789999999999999999999999999998764

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6e-48  Score=346.15  Aligned_cols=263  Identities=18%  Similarity=0.250  Sum_probs=185.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ..++|++.+.||+|+||.||+|.+  +++.||+|.+.........+.+.+|+.++++++||||+++           +||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            356799999999999999999998  6899999999876554445778999999999999999998           899


Q ss_pred             EeccCCChHHHHhhhhc-ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          119 ESVQIGTLADRIHHHCE-QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      ||++ |+|.+++..... .....+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+++..
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9998 599999976532 12235899999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      ......  .....||+.|+|||++.+  .++.++|||||||++|||++|..||..........  ...............
T Consensus       159 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~i~~~~~~~~~~~~~  234 (317)
T 2pmi_A          159 GIPVNT--FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLK--LIFDIMGTPNESLWP  234 (317)
T ss_dssp             TSCCCC--CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCSCCTTTCG
T ss_pred             CCCccc--CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHHHhCCCChhHhh
Confidence            543221  134578999999999876  68999999999999999999999998765543321  111111111110000


Q ss_pred             hhhhhhh------cccCC------CCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          276 MVDSIII------EDKSC------TCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       276 ~~~~~~~------~~~~~------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .......      .....      ........+..+.+|+.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          235 SVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            0000000      00000      00000123468999999999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=4.1e-48  Score=349.07  Aligned_cols=250  Identities=16%  Similarity=0.213  Sum_probs=199.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----------EEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----------IVF  118 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv~  118 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||||.+.....   .+.+.+|+.+++++ +||||+++           +||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR---APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS---SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc---hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            46799999999999999999997  899999999876543   23578999999999 99999987           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCC-----eEEeecCC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD-----AKLFDFSL  193 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----~kl~Dfg~  193 (332)
                      ||+ +|+|.+++....    ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.     +||+|||+
T Consensus        85 e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~  156 (330)
T 2izr_A           85 ELL-GPSLEDLFDLCD----RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFAL  156 (330)
T ss_dssp             ECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTT
T ss_pred             EeC-CCCHHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEccc
Confidence            999 899999998641    46999999999999999999999   899999999999999998887     99999999


Q ss_pred             ccccCCCCcee-----eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhh
Q 038681          194 SLSIPDGETHI-----ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS  267 (332)
Q Consensus       194 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  267 (332)
                      ++.........     ......||+.|+|||++.+ .++.++|||||||++|||++|..||...................
T Consensus       157 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~  236 (330)
T 2izr_A          157 AKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK  236 (330)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred             ceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence            98764433211     1135679999999999988 89999999999999999999999998765433221111110000


Q ss_pred             ccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      . ... .+.    ..          ... +++.+|+..||+.||.+||++++|.+.|+++.+.
T Consensus       237 ~-~~~-~~~----~~----------~~~-p~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~  282 (330)
T 2izr_A          237 R-ATP-IEV----LC----------ENF-PEMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR  282 (330)
T ss_dssp             H-HSC-HHH----HT----------TTC-HHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             c-cCC-HHH----Hh----------ccC-hHHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence            0 000 000    00          012 3899999999999999999999999999988764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.1e-48  Score=357.12  Aligned_cols=241  Identities=18%  Similarity=0.261  Sum_probs=190.6

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhh-cCCCcceE-----------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRM-SHKHIIKL-----------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~H~nIv~~-----------  115 (332)
                      ..++|++.+.||+|+||.||+|++  +++.||+|++.....  ....+.+.+|..++.++ +|||||++           
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            356799999999999999999998  788999999976532  22345688999999988 89999998           


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      +||||+++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus       130 lV~E~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~  201 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK  201 (396)
T ss_dssp             EEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             EEEEcCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceee
Confidence            899999999999999876     57999999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ........  ....+||+.|+|||++.+ .++.++|||||||++|||++|..||...........           ....
T Consensus       202 ~~~~~~~~--~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~-----------~~~~  268 (396)
T 4dc2_A          202 EGLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-----------NTED  268 (396)
T ss_dssp             CCCCTTCC--BCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC-----------------CCHH
T ss_pred             ecccCCCc--cccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch-----------hhHH
Confidence            64332221  246789999999999988 899999999999999999999999975432211000           0000


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTM  317 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~  317 (332)
                      .+.........    ..+...+.++.+||.+||+.||.+||++
T Consensus       269 ~~~~~i~~~~~----~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          269 YLFQVILEKQI----RIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HHHHHHHHCCC----CCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             HHHHHHhcccc----CCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            01111111111    1112344789999999999999999996

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2e-48  Score=352.76  Aligned_cols=239  Identities=22%  Similarity=0.337  Sum_probs=194.8

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhh-cCCCcceE--------
Q 038681           49 LRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRM-SHKHIIKL--------  115 (332)
Q Consensus        49 l~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~~--------  115 (332)
                      .....++|.+.+.||+|+||.||+|++  +++.||+|++....  .....+.+..|..++..+ +||||+++        
T Consensus        12 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~   91 (345)
T 1xjd_A           12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKE   91 (345)
T ss_dssp             ----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred             CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCC
Confidence            445678899999999999999999999  78999999997642  122356788999999987 89999997        


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                         +||||+++|+|.+++...     ..+++..+..++.||+.||+|||   ++||+||||||+|||++.+|.+||+|||
T Consensus        92 ~~~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG  163 (345)
T 1xjd_A           92 NLFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFG  163 (345)
T ss_dssp             EEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred             EEEEEEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeECh
Confidence               899999999999999876     57999999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      +++........  .....||+.|+|||++.+ .++.++|||||||++|||++|..||.........      ..+.....
T Consensus       164 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------~~i~~~~~  235 (345)
T 1xjd_A          164 MCKENMLGDAK--TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------HSIRMDNP  235 (345)
T ss_dssp             TCBCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCCC
T ss_pred             hhhhcccCCCc--ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHH------HHHHhCCC
Confidence            99865433221  245689999999999987 8999999999999999999999999865543221      11111111


Q ss_pred             chhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHH-HHH
Q 038681          272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMV-DVA  321 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~-evl  321 (332)
                      .+                  +...+.++.+|+.+||+.||++||++. +|+
T Consensus       236 ~~------------------p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          236 FY------------------PRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             CC------------------CTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             CC------------------CcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            11                  112347799999999999999999987 554

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=8.3e-49  Score=352.09  Aligned_cols=266  Identities=17%  Similarity=0.321  Sum_probs=215.3

Q ss_pred             CCCcccccHHHHHHHhcCCCCCCccccCCCceEEEEEeC-------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCC
Q 038681           38 YNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQ-------KRSISLMKYNGNRNQHALEWCINHIVYASRMSHK  110 (332)
Q Consensus        38 ~~~~~~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~  110 (332)
                      ......+..++++...++|.+.+.||+|+||.||+|.+.       +..||+|.+...........+.+|+.++++++||
T Consensus         9 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~   88 (322)
T 1p4o_A            9 FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH   88 (322)
T ss_dssp             SBCCSCCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCT
T ss_pred             cccccccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCC
Confidence            344566777888888899999999999999999999873       5789999998776666677899999999999999


Q ss_pred             CcceE-----------EEEEeccCCChHHHHhhhhcc-----cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCC
Q 038681          111 HIIKL-----------IVFESVQIGTLADRIHHHCEQ-----HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK  174 (332)
Q Consensus       111 nIv~~-----------lv~e~~~~g~L~~~l~~~~~~-----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlk  174 (332)
                      ||+++           +||||+++|+|.+++......     ....+++..++.++.||+.||.|||   ++||+|||||
T Consensus        89 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dik  165 (322)
T 1p4o_A           89 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLA  165 (322)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCS
T ss_pred             CEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCc
Confidence            99998           899999999999999864211     1135799999999999999999999   8999999999


Q ss_pred             CCCeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCC
Q 038681          175 PTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVS  252 (332)
Q Consensus       175 p~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~  252 (332)
                      |+||+++.++.+||+|||+++...............+|+.|+|||++.+ .++.++|||||||++|+|++ |..||....
T Consensus       166 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~  245 (322)
T 1p4o_A          166 ARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS  245 (322)
T ss_dssp             GGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred             cceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC
Confidence            9999999999999999999986654433322244567899999999876 89999999999999999999 899997654


Q ss_pred             ccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          253 FESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                      .....      ......              .   ....+...+..+.+|+.+||+.||.+|||+.++++.|+++.+
T Consensus       246 ~~~~~------~~~~~~--------------~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          246 NEQVL------RFVMEG--------------G---LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHH------HHHHTT--------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHH------HHHHcC--------------C---cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            33211      111000              0   000112334779999999999999999999999999987643

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.7e-48  Score=353.26  Aligned_cols=243  Identities=19%  Similarity=0.252  Sum_probs=193.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC----ChhhHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR----NQHALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      .+.|++.+.||+|+||.||+|.+  +++.||||++....    .....+.+.+|+.+++.++||||+++           
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            35699999999999999999998  78999999986432    11235778999999999999999998           


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCC---eEEeecC
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFS  192 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~Dfg  192 (332)
                      +||||+++|+|.+++...... ...+++..+..++.||+.||.|||   +++|+||||||+|||++.++.   +||+|||
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg  178 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADA-GFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFG  178 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred             EEEeCCCCCCHHHHHHHhccc-CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence            899999999999988765321 135899999999999999999999   999999999999999986655   9999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      ++.........  .....||+.|+|||++.+ .++.++|||||||++|+|++|..||......       ....+.....
T Consensus       179 ~a~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-------~~~~i~~~~~  249 (351)
T 3c0i_A          179 VAIQLGESGLV--AGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-------LFEGIIKGKY  249 (351)
T ss_dssp             TCEECCTTSCB--CCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHHH-------HHHHHHHTCC
T ss_pred             ceeEecCCCee--ecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHHH-------HHHHHHcCCC
Confidence            99877654322  135679999999999987 7899999999999999999999999764211       1111100000


Q ss_pred             chhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .+              ........+..+.+|+.+||+.||++|||+.++++
T Consensus       250 ~~--------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          250 KM--------------NPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             CC--------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CC--------------CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00              00000123478999999999999999999999986

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=6.7e-48  Score=345.84  Aligned_cols=233  Identities=20%  Similarity=0.308  Sum_probs=194.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      .++|.+.+.||+|+||.||+|..  +++.||+|++.....  ....+.+.+|+.+++.++||||+++           +|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            46799999999999999999999  789999999975421  2235678899999999999999998           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+++|+|.+++...     ..+++..+..++.||+.||.|||   ++||+||||||+|||++.+|.+||+|||+++..
T Consensus        85 ~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~  156 (318)
T 1fot_A           85 MDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV  156 (318)
T ss_dssp             ECCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEEC
T ss_pred             EeCCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceec
Confidence            9999999999999875     57999999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ....     ....||+.|+|||++.+ .++.++|||||||++|||++|..||.........      ..+          
T Consensus       157 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~i----------  215 (318)
T 1fot_A          157 PDVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY------EKI----------  215 (318)
T ss_dssp             SSCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHH----------
T ss_pred             CCcc-----ccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH------HHH----------
Confidence            5432     35679999999999987 8899999999999999999999999765432211      111          


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~  322 (332)
                          ......    .+...+.++.+|+.+||+.||++||     +++++++
T Consensus       216 ----~~~~~~----~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          216 ----LNAELR----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             ----HHCCCC----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ----HhCCCC----CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence                111100    1112347799999999999999999     8888874

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.5e-47  Score=337.64  Aligned_cols=251  Identities=14%  Similarity=0.179  Sum_probs=200.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----------EEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----------IVF  118 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv~  118 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|.+.....   .+.+.+|+.++..+ +|+||+++           +||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc---cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            46799999999999999999997  899999999875543   24578899999999 78998887           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCC-----eEEeecCC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD-----AKLFDFSL  193 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-----~kl~Dfg~  193 (332)
                      ||+ +|+|.+++....    ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.     +||+|||+
T Consensus        86 e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             ECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             Eec-CCCHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            999 899999998651    35999999999999999999999   999999999999999987776     99999999


Q ss_pred             ccccCCCCce-----eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhh
Q 038681          194 SLSIPDGETH-----IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS  267 (332)
Q Consensus       194 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  267 (332)
                      ++........     .......||+.|+|||++.+ .++.++|||||||++|||++|..||...................
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  237 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence            9876544321     11245679999999999987 88999999999999999999999998754432221110100000


Q ss_pred             ccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                       ........               ...+++.+.+|+.+||+.||++|||+++|++.|+++.+.
T Consensus       238 -~~~~~~~~---------------~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~  284 (298)
T 1csn_A          238 -QSTPLREL---------------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  284 (298)
T ss_dssp             -HHSCHHHH---------------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -cCccHHHH---------------HhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHh
Confidence             00000000               012347899999999999999999999999999999865

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=5.2e-48  Score=340.03  Aligned_cols=251  Identities=20%  Similarity=0.340  Sum_probs=205.6

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------E
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------I  116 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------l  116 (332)
                      +++...++|.+.+.||+|+||.||+|.+ .+..||+|.+......  .+.+.+|+.++++++||||+++          +
T Consensus         7 ~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (279)
T 1qpc_A            7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYI   84 (279)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred             hcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc--HHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEE
Confidence            3445567899999999999999999999 6778999999765432  5778999999999999999998          8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ||||+++|+|.+++.....   ..+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||++..
T Consensus        85 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  158 (279)
T 1qpc_A           85 ITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARL  158 (279)
T ss_dssp             EEECCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEecCCCCCHHHHHhcCCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCccccc
Confidence            9999999999999976421   25999999999999999999999   99999999999999999999999999999987


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ......... ....+|+.|+|||++.+ .++.++|||||||++|||++ |..||.........      ..+...     
T Consensus       159 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~------~~~~~~-----  226 (279)
T 1qpc_A          159 IEDNEYTAR-EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI------QNLERG-----  226 (279)
T ss_dssp             CSSSCEECC-TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH------HHHHTT-----
T ss_pred             ccCcccccc-cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHH------HHHhcc-----
Confidence            765433221 34567889999999976 78999999999999999999 99999765432211      111100     


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                                .  ....+...+..+.+|+.+||+.||++|||++++++.|+++..+
T Consensus       227 ----------~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          227 ----------Y--RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             ----------C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------c--CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHh
Confidence                      0  0001123347899999999999999999999999999998865

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.7e-47  Score=345.64  Aligned_cols=254  Identities=19%  Similarity=0.306  Sum_probs=206.0

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe---------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW---------QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~---------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----  115 (332)
                      ...++|.+.+.||+|+||.||+|.+         ++..||+|++.........+.+.+|+.++.++ +||||+++     
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            3457899999999999999999986         34679999998776666678899999999999 89999998     


Q ss_pred             ------EEEEeccCCChHHHHhhhhcc-----------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCe
Q 038681          116 ------IVFESVQIGTLADRIHHHCEQ-----------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNI  178 (332)
Q Consensus       116 ------lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  178 (332)
                            +||||+++|+|.+++......           ....+++..++.++.||+.||.|||   +.+|+||||||+||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NI  188 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV  188 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceE
Confidence                  899999999999999865311           1124899999999999999999999   99999999999999


Q ss_pred             eeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccch
Q 038681          179 LFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESR  256 (332)
Q Consensus       179 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~  256 (332)
                      +++.++.+||+|||+++...............+|+.|+|||++.+ .++.++|||||||++|+|++ |..||........
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  268 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  268 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence            999999999999999987765543333344567889999999876 78999999999999999999 9999976543321


Q ss_pred             hhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          257 FHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      .      ..+...              .   ....+..++..+.+|+.+||+.||.+|||+.++++.|+++.+.
T Consensus       269 ~------~~~~~~--------------~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~  319 (334)
T 2pvf_A          269 F------KLLKEG--------------H---RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTL  319 (334)
T ss_dssp             H------HHHHHT--------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H------HHHhcC--------------C---CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            1      111000              0   0001123347799999999999999999999999999998753

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-47  Score=343.67  Aligned_cols=254  Identities=19%  Similarity=0.332  Sum_probs=193.1

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh--cCCCcceE-----------
Q 038681           49 LRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRM--SHKHIIKL-----------  115 (332)
Q Consensus        49 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l--~H~nIv~~-----------  115 (332)
                      -....++|.+.+.||+|+||.||+|.++++.||||++....    ...+..|.+++..+  +||||+++           
T Consensus        32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~  107 (337)
T 3mdy_A           32 QRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSW  107 (337)
T ss_dssp             HTTHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred             ccccccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence            33445679999999999999999999999999999986542    34455666666554  89999987           


Q ss_pred             ----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCC--------CeeecCCCCCCeeeCCC
Q 038681          116 ----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSR--------PIVYRDMKPTNILFNEQ  183 (332)
Q Consensus       116 ----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~--------~ivH~Dlkp~Nill~~~  183 (332)
                          +||||+++|+|.+++...      .+++..++.++.|++.||.|||   ..        +|+||||||+|||++.+
T Consensus       108 ~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~  178 (337)
T 3mdy_A          108 TQLYLITDYHENGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKN  178 (337)
T ss_dssp             CEEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred             CceEEEEeccCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCC
Confidence                899999999999999653      5899999999999999999999   88        99999999999999999


Q ss_pred             CCeEEeecCCccccCCCCcee--eccccccCCCcccccccCC-CCCh------hhhHHHHHHHHHHHHhCCc--------
Q 038681          184 SDAKLFDFSLSLSIPDGETHI--ELDSVVGTTGFIAPENFTT-LINE------QCDVYGFGAFLFELLTAQE--------  246 (332)
Q Consensus       184 ~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~------~sDiwSlG~~l~elltg~~--------  246 (332)
                      +.+||+|||+++.........  ......||+.|+|||++.+ ..+.      ++|||||||++|||++|..        
T Consensus       179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~  258 (337)
T 3mdy_A          179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY  258 (337)
T ss_dssp             SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence            999999999997665433221  1134579999999999976 3333      4999999999999999944        


Q ss_pred             --cCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCC---CCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 038681          247 --VSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSC---TCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVA  321 (332)
Q Consensus       247 --p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl  321 (332)
                        ||........               ................   .......++..+.+|+.+||+.||.+|||+.+|+
T Consensus       259 ~~p~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell  323 (337)
T 3mdy_A          259 QLPYHDLVPSDP---------------SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK  323 (337)
T ss_dssp             CCTTTTTSCSSC---------------CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             cccHhhhcCCCC---------------chhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHH
Confidence              4433222111               0111111010000000   0111236778899999999999999999999999


Q ss_pred             HHHHHHHHh
Q 038681          322 KQLRQMYRS  330 (332)
Q Consensus       322 ~~L~~l~~~  330 (332)
                      +.|+++.++
T Consensus       324 ~~L~~l~~~  332 (337)
T 3mdy_A          324 KTLAKMSES  332 (337)
T ss_dssp             HHHHHHHHT
T ss_pred             HHHHHHHhh
Confidence            999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=7.4e-48  Score=344.66  Aligned_cols=257  Identities=21%  Similarity=0.303  Sum_probs=196.0

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEe-----CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-------
Q 038681           49 LRIATNNYDEQNIVLEDPFRKLYKGFW-----QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-------  115 (332)
Q Consensus        49 l~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-------  115 (332)
                      +....++|.+.+.||+|+||.||+|.+     ++..||+|.+.... .....+.+.+|+.++++++||||+++       
T Consensus        29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           29 VVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             TBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             cccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            334567788999999999999999987     23479999987653 34446789999999999999999975       


Q ss_pred             ---------EEEEeccCCChHHHHhhhhc-ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCC
Q 038681          116 ---------IVFESVQIGTLADRIHHHCE-QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD  185 (332)
Q Consensus       116 ---------lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  185 (332)
                               +||||+++|+|.+++..... .....+++..++.++.||+.||.|||   +++|+||||||+||+++.++.
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~  185 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMT  185 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSC
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCc
Confidence                     79999999999999964321 22256999999999999999999999   999999999999999999999


Q ss_pred             eEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHH
Q 038681          186 AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENV  263 (332)
Q Consensus       186 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~  263 (332)
                      +||+|||+++...............+++.|+|||++.+ .++.++|||||||++|+|++ |..||..........     
T Consensus       186 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~-----  260 (313)
T 3brb_A          186 VCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD-----  260 (313)
T ss_dssp             EEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH-----
T ss_pred             EEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH-----
Confidence            99999999987655433222234567889999999987 89999999999999999999 889997654432211     


Q ss_pred             hhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 038681          264 KRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSC  331 (332)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  331 (332)
                      ......                  ....+...+..+.+|+.+||+.||.+|||+.++++.|+++.+++
T Consensus       261 ~~~~~~------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          261 YLLHGH------------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             HHHTTC------------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHcCC------------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence            000000                  00111234478999999999999999999999999999998764

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=7.9e-48  Score=354.06  Aligned_cols=239  Identities=19%  Similarity=0.209  Sum_probs=195.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|.+....... ...+.+|+.++.+++||||+++           +|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~-~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH-HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhh-HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence            46799999999999999999999  78899999987654333 5678999999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC--CCCeEEeecCCcccc
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE--QSDAKLFDFSLSLSI  197 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~a~~~  197 (332)
                      |+++|+|.+++....    ..+++..+..++.||+.||.|||   ++||+||||||+|||++.  ++.+||+|||+++..
T Consensus       129 ~~~gg~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~  201 (387)
T 1kob_A          129 FLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  201 (387)
T ss_dssp             CCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             cCCCCcHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceec
Confidence            999999999997541    36899999999999999999999   999999999999999974  577999999999877


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ......   ....||+.|+|||++.+ .++.++|||||||++|||++|..||..........      .+..        
T Consensus       202 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~------~i~~--------  264 (387)
T 1kob_A          202 NPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ------NVKR--------  264 (387)
T ss_dssp             CTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------HHHH--------
T ss_pred             CCCcce---eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHH------HHHh--------
Confidence            654432   34579999999999987 89999999999999999999999998754332211      1100        


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                            .............+.++.+||.+||+.||.+|||+.++++
T Consensus       265 ------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          265 ------CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             ------CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ------CCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                  0000011111234478999999999999999999999986

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=7.1e-48  Score=350.08  Aligned_cols=233  Identities=18%  Similarity=0.253  Sum_probs=195.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|++....  .....+.+.+|+.++..++||||+++           +|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            36799999999999999999999  78999999986542  12336778999999999999999987           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+++|+|.+++...     ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+++..
T Consensus       120 ~e~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~  191 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV  191 (350)
T ss_dssp             EECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EcCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceec
Confidence            9999999999999876     56999999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ....     ....||+.|+|||++.+ .++.++|||||||++|||++|..||........      ...+......    
T Consensus       192 ~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~------~~~i~~~~~~----  256 (350)
T 1rdq_E          192 KGRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI------YEKIVSGKVR----  256 (350)
T ss_dssp             SSCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCC----
T ss_pred             cCCc-----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHH------HHHHHcCCCC----
Confidence            5432     35679999999999987 889999999999999999999999986543221      1111100000    


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT-----MVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~  322 (332)
                                    .+...+..+.+|+.+||+.||.+||+     +++|++
T Consensus       257 --------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          257 --------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence                          11133478999999999999999998     788764

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.9e-48  Score=341.58  Aligned_cols=237  Identities=21%  Similarity=0.337  Sum_probs=188.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh-------------------------hhHHHHHHHHHHHH
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ-------------------------HALEWCINHIVYAS  105 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-------------------------~~~~~~~~E~~~l~  105 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||||++......                         ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            46799999999999999999998  7899999998754321                         12356899999999


Q ss_pred             hhcCCCcceE-------------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 038681          106 RMSHKHIIKL-------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRD  172 (332)
Q Consensus       106 ~l~H~nIv~~-------------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D  172 (332)
                      +++||||+++             +||||+++|+|.+++..      ..+++..+..++.||+.||.|||   +++|+|||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~D  162 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRD  162 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccC
Confidence            9999999987             89999999999887543      46999999999999999999999   89999999


Q ss_pred             CCCCCeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-C---CChhhhHHHHHHHHHHHHhCCccC
Q 038681          173 MKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-L---INEQCDVYGFGAFLFELLTAQEVS  248 (332)
Q Consensus       173 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~---~~~~sDiwSlG~~l~elltg~~p~  248 (332)
                      |||+|||++.++.+||+|||+++.........  ....||+.|+|||++.+ .   ++.++|||||||++|+|++|..||
T Consensus       163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  240 (298)
T 2zv2_A          163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF  240 (298)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECSSSSCEE--CCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CCHHHEEECCCCCEEEecCCCccccccccccc--cCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCC
Confidence            99999999999999999999998765543321  45679999999999976 3   478999999999999999999999


Q ss_pred             CCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          249 DHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ........      ...+.....                ..+.....++.+.+|+.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~------~~~~~~~~~----------------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          241 MDERIMCL------HSKIKSQAL----------------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             CCSSHHHH------HHHHHHCCC----------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCccHHHH------HHHHhcccC----------------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            76543221      111100000                00111133477999999999999999999999875

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.9e-48  Score=340.75  Aligned_cols=245  Identities=18%  Similarity=0.325  Sum_probs=196.6

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE------------E
Q 038681           49 LRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------------I  116 (332)
Q Consensus        49 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~------------l  116 (332)
                      +....++|.+.+.||+|+||.||+|.++++.||+|.+....   ..+.+.+|+.++.+++||||+++            +
T Consensus        16 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l   92 (278)
T 1byg_A           16 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   92 (278)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             ccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh---HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence            33446789999999999999999999999999999997653   25778999999999999999987            8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ||||+++|+|.+++.....   ..+++..+..++.|++.||.|||   +++|+||||||+||+++.++.+||+|||++..
T Consensus        93 v~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~  166 (278)
T 1byg_A           93 VTEYMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE  166 (278)
T ss_dssp             EECCCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC---
T ss_pred             EEecCCCCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeecccccc
Confidence            9999999999999976521   24899999999999999999999   99999999999999999999999999999976


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      .....     ....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.........      ..+...     
T Consensus       167 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~------~~~~~~-----  230 (278)
T 1byg_A          167 ASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------PRVEKG-----  230 (278)
T ss_dssp             --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH------HHHTTT-----
T ss_pred             ccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHhcC-----
Confidence            54432     23467889999999876 89999999999999999998 99999765443221      111000     


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                                .  ....+...++.+.+++.+||+.||.+|||+.++++.|+++...
T Consensus       231 ----------~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          231 ----------Y--KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             ----------C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------C--CCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence                      0  0011123447899999999999999999999999999998764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.9e-48  Score=349.42  Aligned_cols=258  Identities=19%  Similarity=0.286  Sum_probs=208.2

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEe--CC-----eeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE----
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGFW--QK-----RSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL----  115 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~----  115 (332)
                      +++...++|.+.+.||+|+||.||+|.+  .+     ..||+|.+.........+.+.+|+.++.++ +||||+++    
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            4555678899999999999999999998  23     379999998877666678899999999999 89999998    


Q ss_pred             -------EEEEeccCCChHHHHhhhhcc---------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCee
Q 038681          116 -------IVFESVQIGTLADRIHHHCEQ---------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNIL  179 (332)
Q Consensus       116 -------lv~e~~~~g~L~~~l~~~~~~---------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil  179 (332)
                             +||||+++|+|.+++......         ....+++..++.++.||+.||.|||   +++|+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEE
Confidence                   899999999999999865321         0135899999999999999999999   899999999999999


Q ss_pred             eCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchh
Q 038681          180 FNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRF  257 (332)
Q Consensus       180 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~  257 (332)
                      ++.++.+||+|||++................+|+.|+|||++.+ .++.++|||||||++|||++ |..||.........
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence            99999999999999986654433323345567889999999876 89999999999999999998 99999765433221


Q ss_pred             hhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          258 HYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      .     ...           ....      ....+...+..+.+|+.+||+.||.+|||+.+|++.|+++.++
T Consensus       277 ~-----~~~-----------~~~~------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          277 Y-----KLV-----------KDGY------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             H-----HHH-----------HHTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             H-----HHH-----------hcCC------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence            1     110           0000      0001112346799999999999999999999999999988754

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-47  Score=338.85  Aligned_cols=241  Identities=25%  Similarity=0.318  Sum_probs=192.3

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ++|.+.+.||+|+||.||+|.+  ++..||+|++.........+.+.+|+.++++++||||+++           +||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            3599999999999999999998  7889999999876655557889999999999999999997           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee---CCCCCeEEeecCCcccc
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~a~~~  197 (332)
                      +++|+|.+++...... ...+++..++.++.||+.||.|||   +.+|+||||||+||++   +.++.+||+|||++...
T Consensus       102 ~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          102 CEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CSCCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             CCCCcHHHHHHhhhhc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            9999999999764222 256999999999999999999999   9999999999999999   55688999999999776


Q ss_pred             CCCCceeeccccccCCCcccccccCCCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ......   ....||+.|+|||++.+.++.++|||||||++|+|++|..||..........      ........+.   
T Consensus       178 ~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~------~~~~~~~~~~---  245 (285)
T 3is5_A          178 KSDEHS---TNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ------KATYKEPNYA---  245 (285)
T ss_dssp             ------------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCCCCCC---
T ss_pred             CCcccC---cCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh------hhccCCcccc---
Confidence            544322   4567899999999998889999999999999999999999998765433211      1100000000   


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                  ......++.+.+|+.+||+.||++|||+.|+++
T Consensus       246 ------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          246 ------------VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             ------------C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             ------------cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                        000012367889999999999999999999985

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.9e-47  Score=339.63  Aligned_cols=249  Identities=19%  Similarity=0.304  Sum_probs=199.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-----CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~------------  115 (332)
                      ...|.+.+.||+|+||.||+|.+     ....||+|.+.........+.+.+|+.++++++||||+++            
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            34588899999999999999997     2235899999887776667889999999999999999987            


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      +||||+++|+|.+++....    ..+++..++.++.|++.||.|||   +++|+||||||+||+++.++.+||+|||+++
T Consensus       104 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             EEEECCTTCBHHHHHHCTT----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             EEEeCCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccc
Confidence            8999999999999997541    46899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCce--eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          196 SIPDGETH--IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       196 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      ........  .......+|+.|+|||++.+ .++.++|||||||++|+|++ |.+||..........     ....... 
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~-----~~~~~~~-  250 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-----YLLQGRR-  250 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH-----HHHTTCC-
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH-----HHhcCCC-
Confidence            66543211  11234567889999999976 89999999999999999999 555665443322111     0110000 


Q ss_pred             chhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 038681          272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSC  331 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  331 (332)
                                       ...+...+..+.+++.+||+.||.+|||+.++++.|+++.+++
T Consensus       251 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~  293 (298)
T 3f66_A          251 -----------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  293 (298)
T ss_dssp             -----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTS
T ss_pred             -----------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                             0011123467999999999999999999999999999998765

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2e-47  Score=337.05  Aligned_cols=239  Identities=22%  Similarity=0.337  Sum_probs=197.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      .++|.+.+.||+|+||.||+|.+  ++..||+|++.... .....+.+.+|+.++++++||||+++           +||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            46799999999999999999998  68999999997654 34446778999999999999999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCC---eEEeecCCcc
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSL  195 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~Dfg~a~  195 (332)
                      ||+++|+|.+++...     ..+++..+..++.|++.||.|||   +.+|+||||||+||+++.++.   +||+|||++.
T Consensus        85 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR-----EFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             CCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             ecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            999999999999876     57999999999999999999999   999999999999999986655   9999999998


Q ss_pred             ccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ........   ....||+.|+|||++.+ .++.++||||||+++|+|++|..||..........      ...       
T Consensus       157 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~------~~~-------  220 (284)
T 3kk8_A          157 EVNDSEAW---HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYA------QIK-------  220 (284)
T ss_dssp             ECCSSCBC---CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHH-------
T ss_pred             EcccCccc---cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHH------HHH-------
Confidence            76654432   34679999999999988 78999999999999999999999997654332211      110       


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                             ......+.+.....++.+.+|+.+||+.||++|||+.|+++
T Consensus       221 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          221 -------AGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             -------HTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -------hccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                   00000111111233477999999999999999999999986

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.2e-47  Score=348.46  Aligned_cols=240  Identities=20%  Similarity=0.233  Sum_probs=183.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ..++|.+.+.||+|+||.||+|.+  +++.||+|++......  .+.+.+|+.+++.++||||+++           +||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   95 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM   95 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS--CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc--cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence            356799999999999999999999  7899999999765432  3568899999999999999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCC--eEEeecCCccc
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD--AKLFDFSLSLS  196 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~a~~  196 (332)
                      ||+++|+|.+++...     ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.  +||+|||+++.
T Consensus        96 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           96 EYASGGELYERICNA-----GRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            999999999999776     57999999999999999999999   999999999999999987765  99999999975


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCCh-hhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINE-QCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~-~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      .......   ....||+.|+|||++.+ .++. ++|||||||++|+|++|+.||..........  ......        
T Consensus       168 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~--~~~~~~--------  234 (361)
T 3uc3_A          168 SVLHSQP---KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR--KTIQRI--------  234 (361)
T ss_dssp             ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHH--HHHHHH--------
T ss_pred             ccccCCC---CCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHH--HHHHHH--------
Confidence            4333221   45579999999999876 5554 5999999999999999999997654322211  011111        


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                            .....  ..+.....+..+.+|+.+||+.||++|||+.|+++
T Consensus       235 ------~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~  274 (361)
T 3uc3_A          235 ------LSVKY--SIPDDIRISPECCHLISRIFVADPATRISIPEIKT  274 (361)
T ss_dssp             ------HTTCC--CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ------hcCCC--CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHh
Confidence                  11110  00111123477899999999999999999999986

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.5e-48  Score=356.79  Aligned_cols=268  Identities=18%  Similarity=0.231  Sum_probs=208.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-------------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-------------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-------------lv  117 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||||++.........+.+.+|+.++++++||||+++             +|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            35699999999999999999999  6899999999876555557788999999999999999987             89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee----CCCCCeEEeecCC
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF----NEQSDAKLFDFSL  193 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfg~  193 (332)
                      |||+++|+|.+++......  ..+++..++.++.||+.||+|||   +.+|+||||||+|||+    +.++.+||+|||+
T Consensus        88 ~e~~~~g~L~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGT--TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             EecCCCCCHHHHHHhhhcc--cCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            9999999999999865221  23999999999999999999999   9999999999999999    7778899999999


Q ss_pred             ccccCCCCceeeccccccCCCcccccccCC---------CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHh
Q 038681          194 SLSIPDGETHIELDSVVGTTGFIAPENFTT---------LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVK  264 (332)
Q Consensus       194 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---------~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~  264 (332)
                      ++........   ....||+.|+|||++.+         .++.++|||||||++|||++|..||......... ......
T Consensus       163 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~-~~~~~~  238 (396)
T 4eut_A          163 ARELEDDEQF---VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN-KEVMYK  238 (396)
T ss_dssp             CEECCCGGGS---SCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC-HHHHHH
T ss_pred             ceEccCCCcc---ccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch-HHHHHH
Confidence            9876554322   35679999999998752         5678999999999999999999999754432211 111222


Q ss_pred             hhhccccchhhhh----hhhh--hcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          265 RLSGQNCRFKEMV----DSII--IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       265 ~~~~~~~~~~~~~----~~~~--~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                      ...+.+......+    +...  ....+............+.+++.+||+.||++|||+.++++.+..+++
T Consensus       239 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~  309 (396)
T 4eut_A          239 IITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH  309 (396)
T ss_dssp             HHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHT
T ss_pred             HhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhh
Confidence            2222111110000    0000  001122233446788899999999999999999999999999998875

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=5.6e-48  Score=338.28  Aligned_cols=240  Identities=22%  Similarity=0.350  Sum_probs=187.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCC---hhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRN---QHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      .++|.+.+.||+|+||.||+|.+.+..||||++.....   ....+.+.+|+.+++.++||||+++           +||
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            46799999999999999999999999999999876533   2235778999999999999999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCC---eeecCCCCCCeeeCC--------CCCeE
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRP---IVYRDMKPTNILFNE--------QSDAK  187 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~---ivH~Dlkp~Nill~~--------~~~~k  187 (332)
                      ||+++|+|.+++..      ..+++..++.++.|++.||.|||   +++   |+||||||+||+++.        ++.+|
T Consensus        86 e~~~~~~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH---~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k  156 (271)
T 3dtc_A           86 EFARGGPLNRVLSG------KRIPPDILVNWAVQIARGMNYLH---DEAIVPIIHRDLKSSNILILQKVENGDLSNKILK  156 (271)
T ss_dssp             ECCTTEEHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHH---HSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred             EcCCCCCHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHH---hCCCCceeecCCchHHEEEecccccccccCcceE
Confidence            99999999999864      36999999999999999999999   777   999999999999986        77899


Q ss_pred             EeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhh
Q 038681          188 LFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRL  266 (332)
Q Consensus       188 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~  266 (332)
                      |+|||++........    ....||+.|+|||++.+ .++.++||||||+++|+|++|..||..........     ...
T Consensus       157 l~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-----~~~  227 (271)
T 3dtc_A          157 ITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY-----GVA  227 (271)
T ss_dssp             ECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH-----HHH
T ss_pred             EccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----hhh
Confidence            999999976654432    34578999999999887 79999999999999999999999998654332211     000


Q ss_pred             hccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          267 SGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                      ..               .  ...+.+..+++.+.+++.+||+.||.+|||+.++++.|++|
T Consensus       228 ~~---------------~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          228 MN---------------K--LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             TS---------------C--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             cC---------------C--CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            00               0  00111123447899999999999999999999999999864

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.1e-47  Score=337.56  Aligned_cols=238  Identities=22%  Similarity=0.322  Sum_probs=197.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|.+.+.||+|+||.||+|.+  ++..||+|++....... .+.+.+|+.++++++||||+++           +|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED-VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            45699999999999999999999  67789999987654433 6789999999999999999997           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee---CCCCCeEEeecCCccc
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLS  196 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~a~~  196 (332)
                      |+++++|.+++...     ..+++..+..++.|++.||.|||   +++|+||||||+||++   +.++.+||+|||++..
T Consensus        87 ~~~~~~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~  158 (277)
T 3f3z_A           87 LCTGGELFERVVHK-----RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR  158 (277)
T ss_dssp             CCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred             ccCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEeccccee
Confidence            99999999999876     56999999999999999999999   9999999999999999   7889999999999987


Q ss_pred             cCCCCceeeccccccCCCcccccccCCCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      .......   ....||+.|+|||++.+.++.++|||||||++|+|++|..||..........     ..... ...+.  
T Consensus       159 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-----~~~~~-~~~~~--  227 (277)
T 3f3z_A          159 FKPGKMM---RTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVML-----KIREG-TFTFP--  227 (277)
T ss_dssp             CCTTSCB---CCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----HHHHC-CCCCC--
T ss_pred             ccCccch---hccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHH-----HHHhC-CCCCC--
Confidence            6554432   4567999999999998889999999999999999999999998755432211     11111 00000  


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                  .......++.+.+|+.+||+.||.+|||+.++++
T Consensus       228 ------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          228 ------------EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             ------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ------------chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                        0000123478999999999999999999999986

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.2e-47  Score=338.37  Aligned_cols=258  Identities=16%  Similarity=0.214  Sum_probs=193.0

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      ++|++.+.||+|+||+||+|.+  +++.||+|++..... ....+.+.+|+.++++++||||+++           +|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            5789999999999999999999  789999999976543 3445778999999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++ +|.+++....    ..+++..+..++.||+.||+|||   ++||+||||||+|||++.++.+||+|||+++....
T Consensus        82 ~~~~-~l~~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  153 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             CCSE-EHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred             cCCC-CHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence            9986 6666665431    56999999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-cccchhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-QNCRFKEM  276 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  276 (332)
                      ....  .....||+.|+|||++.+  .++.++|||||||++|+|++|..||........ ........... ....+...
T Consensus       154 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~-~~~~i~~~~~~~~~~~~~~~  230 (292)
T 3o0g_A          154 PVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSM  230 (292)
T ss_dssp             CCSC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTG
T ss_pred             cccc--ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH-HHHHHHHHhCCCChhhhhhh
Confidence            3322  145678999999999876  489999999999999999998888643332211 11111111111 11111111


Q ss_pred             hhhhhhcc------cCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIED------KSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ........      ...........+..+.+|+.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            00000000      00000111234578899999999999999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-47  Score=337.51  Aligned_cols=248  Identities=17%  Similarity=0.270  Sum_probs=204.1

Q ss_pred             hcCCCCCC-ccccCCCceEEEEEe----CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------EE
Q 038681           53 TNNYDEQN-IVLEDPFRKLYKGFW----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IV  117 (332)
Q Consensus        53 ~~~y~~~~-~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv  117 (332)
                      .++|.+.+ .||+|+||.||+|.+    ++..||+|.+.........+.+.+|+.++.+++||||+++          +|
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv   87 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLV   87 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEE
Confidence            35566666 899999999999986    5778999999887666667889999999999999999998          89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+++|+|.+++...    ...+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++...
T Consensus        88 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           88 MEMAGGGPLHKFLVGK----REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EECCTTEEHHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEeCCCCCHHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            9999999999999653    146999999999999999999999   999999999999999999999999999999877


Q ss_pred             CCCCcee-eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          198 PDGETHI-ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       198 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ....... ......+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.........      ..+...     
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~~i~~~-----  229 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM------AFIEQG-----  229 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH------HHHHTT-----
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH------HHHhcC-----
Confidence            5443321 1133456889999999976 88999999999999999998 99999765443221      111100     


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                               .   ....+...+..+.+++.+||+.||.+|||+.++++.|++++.+
T Consensus       230 ---------~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  273 (287)
T 1u59_A          230 ---------K---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  273 (287)
T ss_dssp             ---------C---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------C---cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                     0   0011123447899999999999999999999999999999865

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=7.9e-48  Score=341.08  Aligned_cols=254  Identities=17%  Similarity=0.290  Sum_probs=201.9

Q ss_pred             HHHHHHHhcCCCCCC-ccccCCCceEEEEEe----CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE----
Q 038681           46 AEELRIATNNYDEQN-IVLEDPFRKLYKGFW----QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL----  115 (332)
Q Consensus        46 ~~el~~~~~~y~~~~-~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~----  115 (332)
                      ..++....++|.+.+ .||+|+||.||+|.+    .+..||||.+..... ....+.+.+|+.+++.++||||+++    
T Consensus         8 ~~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   87 (291)
T 1xbb_A            8 PKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC   87 (291)
T ss_dssp             ---CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            344444567788888 999999999999965    468899999986543 3336789999999999999999997    


Q ss_pred             ------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEe
Q 038681          116 ------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLF  189 (332)
Q Consensus       116 ------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  189 (332)
                            +||||+++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+||+++.++.+||+
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~  159 (291)
T 1xbb_A           88 EAESWMLVMEMAELGPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKIS  159 (291)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEEC
T ss_pred             CCCCcEEEEEeCCCCCHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEc
Confidence                  899999999999999875     56999999999999999999999   9999999999999999999999999


Q ss_pred             ecCCccccCCCCceee-ccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhh
Q 038681          190 DFSLSLSIPDGETHIE-LDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRL  266 (332)
Q Consensus       190 Dfg~a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~  266 (332)
                      |||++........... .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.........      ..+
T Consensus       160 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~  233 (291)
T 1xbb_A          160 DFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT------AML  233 (291)
T ss_dssp             CCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH------HHH
T ss_pred             cCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH------HHH
Confidence            9999987755443221 123346788999999976 78999999999999999999 99999865443211      111


Q ss_pred             hccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          267 SGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      ....                 ....+..++..+.+++.+||+.||.+|||+.++++.|++++.+
T Consensus       234 ~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          234 EKGE-----------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             HTTC-----------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HcCC-----------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            1000                 0011123447899999999999999999999999999999865

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.1e-47  Score=340.65  Aligned_cols=258  Identities=19%  Similarity=0.232  Sum_probs=195.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|++.+.||+|+||+||+|.+ +++.||+|++..... ....+.+.+|+.++++++||||+++           +|||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   99 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE   99 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence            46799999999999999999999 889999999976543 3335678999999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++ +|.+++....    ..+++..+..++.||+.||.|||   +.||+||||||+|||++.++.+||+|||+++....
T Consensus       100 ~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  171 (311)
T 3niz_A          100 FMEK-DLKKVLDENK----TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGI  171 (311)
T ss_dssp             CCSE-EHHHHHHTCT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred             CCCC-CHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence            9985 8888887542    45999999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-cccchhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-QNCRFKEM  276 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  276 (332)
                      ....  .....||+.|+|||++.+  .++.++|||||||++|+|++|..||..........  ........ ....+...
T Consensus       172 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          172 PVRS--YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP--KIFSILGTPNPREWPQV  247 (311)
T ss_dssp             CCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH--HHHHHHCCCCTTTSGGG
T ss_pred             Cccc--ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHHHHCCCChHHhhhh
Confidence            3322  134578999999999875  68999999999999999999999998766544322  11111111 11111111


Q ss_pred             hhhhhhcc--cCCCC-----CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIED--KSCTC-----TGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~--~~~~~-----~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .+......  .....     ......++++.+|+.+||+.||++|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            10000000  00000     000123467899999999999999999999986

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.3e-48  Score=340.90  Aligned_cols=250  Identities=19%  Similarity=0.345  Sum_probs=206.7

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           49 LRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        49 l~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      ++...++|.+.+.||+|+||.||+|.+  ++..||+|.+.....  ..+.+.+|+.++++++||||+++           
T Consensus         8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A            8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM--EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST--HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            334567899999999999999999999  589999999976543  35788999999999999999998           


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      +||||+++|+|.+++....   ...+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++.
T Consensus        86 ~v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~  159 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR  159 (288)
T ss_dssp             EEEECCTTEEHHHHHHHCC---TTTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGG
T ss_pred             EEEEcCCCCcHHHHHHhcc---cCCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccce
Confidence            8999999999999997642   145899999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      .......... ....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||..........      ....     
T Consensus       160 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~------~~~~-----  227 (288)
T 3kfa_A          160 LMTGDTYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE------LLEK-----  227 (288)
T ss_dssp             TSCSSSSEEE-TTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH------HHHT-----
T ss_pred             eccCCccccc-cCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HHhc-----
Confidence            7765443322 45567889999999986 89999999999999999999 999997655433211      1100     


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                            ..      ....+...++.+.+|+.+||+.||.+|||+.++++.|+++.++
T Consensus       228 ------~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          228 ------DY------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             ------TC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------cC------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence                  00      0011123347899999999999999999999999999998764

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.7e-47  Score=345.72  Aligned_cols=240  Identities=18%  Similarity=0.268  Sum_probs=191.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhh-cCCCcceE-----------E
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRM-SHKHIIKL-----------I  116 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------l  116 (332)
                      .++|.+.+.||+|+||.||+|++  +++.||+|++....  .....+.+.+|..++.++ +||||+++           +
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            45799999999999999999999  78999999997653  334467788999999998 89999998           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ||||+++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++.
T Consensus        88 v~e~~~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~  159 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  159 (345)
T ss_dssp             EECCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBC
T ss_pred             EEeCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEecccccc
Confidence            99999999999999876     57999999999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      .......  .....||+.|+|||++.+ .++.++|||||||++|||++|..||...........           .....
T Consensus       160 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-----------~~~~~  226 (345)
T 3a8x_A          160 GLRPGDT--TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-----------NTEDY  226 (345)
T ss_dssp             SCCTTCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC------------------CHHH
T ss_pred             ccCCCCc--ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc-----------ccHHH
Confidence            4332221  245689999999999988 889999999999999999999999975322111000           00000


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTM  317 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~  317 (332)
                      +..........    .+...+..+.+|+.+||+.||.+||++
T Consensus       227 ~~~~i~~~~~~----~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          227 LFQVILEKQIR----IPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             HHHHHHHCCCC----CCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             HHHHHHcCCCC----CCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            11111111111    112344789999999999999999996

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9.3e-48  Score=351.38  Aligned_cols=258  Identities=12%  Similarity=0.138  Sum_probs=197.2

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-C------CeeEEEEEEcCCCChhh----------HHHHHHHHHHHHhhcCCCcce
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW-Q------KRSISLMKYNGNRNQHA----------LEWCINHIVYASRMSHKHIIK  114 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~-~------~~~vavK~~~~~~~~~~----------~~~~~~E~~~l~~l~H~nIv~  114 (332)
                      ..++|.+.+.||+|+||.||+|.+ .      ++.||||.+........          ...+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            456799999999999999999988 2      47899999876642110          112345566677778999997


Q ss_pred             E---------------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCee
Q 038681          115 L---------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNIL  179 (332)
Q Consensus       115 ~---------------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil  179 (332)
                      +               |||||+ +|+|.+++....    ..+++..++.++.||+.||.|||   +++|+||||||+|||
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nil  184 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA----KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLL  184 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEE
Confidence            6               899999 999999997641    46999999999999999999999   899999999999999


Q ss_pred             eC--CCCCeEEeecCCccccCCCCcee-----eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCC
Q 038681          180 FN--EQSDAKLFDFSLSLSIPDGETHI-----ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHV  251 (332)
Q Consensus       180 l~--~~~~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~  251 (332)
                      ++  .++.+||+|||+++.........     ......||+.|+|||++.+ .++.++|||||||++|||++|..||...
T Consensus       185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            98  88999999999997664332111     1133459999999999988 8999999999999999999999999864


Q ss_pred             CccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          252 SFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      .........    ........+...++..+..         ...+.++.+|+..||+.||.+||++.+|++.|+.+.+.
T Consensus       265 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~  330 (364)
T 3op5_A          265 LKDPKYVRD----SKIRYRENIASLMDKCFPA---------ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKA  330 (364)
T ss_dssp             TTCHHHHHH----HHHHHHHCHHHHHHHHSCT---------TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccCHHHHHH----HHHHhhhhHHHHHHHhccc---------ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHH
Confidence            332221100    0000111223333322210         12247899999999999999999999999999998865

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=9.7e-48  Score=336.32  Aligned_cols=242  Identities=18%  Similarity=0.235  Sum_probs=199.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-------------EEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-------------IVF  118 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-------------lv~  118 (332)
                      .++|.+.+.||+|+||.||+|.+++..||+|++.... .....+.+.+|+.++++++||||+++             +||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            4679999999999999999999999999999998764 34446789999999999999999998             899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRP--IVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ||+++|+|.+++....   ...+++..++.++.||+.||.|||   +++  |+||||||+||+++.++.++|+|||++..
T Consensus        89 e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             ECCTTCBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             cccCCCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence            9999999999998641   125899999999999999999999   888  99999999999999999999999988755


Q ss_pred             cCCCCceeeccccccCCCcccccccCC----CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      ...       ....||+.|+|||++.+    .++.++|||||||++|||++|..||..........     .....    
T Consensus       163 ~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~-----~~~~~----  226 (271)
T 3kmu_A          163 FQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGM-----KVALE----  226 (271)
T ss_dssp             TSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHH-----HHHHS----
T ss_pred             ecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHH-----HHHhc----
Confidence            332       23468999999999875    34458999999999999999999998654432211     11000    


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                                 ..  ....+...+..+.+++.+||+.||++|||++++++.|+++.+
T Consensus       227 -----------~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          227 -----------GL--RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             -----------CC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             -----------CC--CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                       00  001112344789999999999999999999999999998864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2e-47  Score=359.56  Aligned_cols=235  Identities=24%  Similarity=0.331  Sum_probs=196.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      .++|.+.+.||+|+||.||+|.+  +|+.||||++.....  ....+.+.+|+.+++.++||||+++           +|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            36799999999999999999999  799999999975421  2235678999999999999999998           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++...
T Consensus        95 ~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~  166 (476)
T 2y94_A           95 MEYVSGGELFDYICKN-----GRLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM  166 (476)
T ss_dssp             EECCSSEEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence            9999999999999765     57999999999999999999999   999999999999999999999999999999877


Q ss_pred             CCCCceeeccccccCCCcccccccCC-C-CChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-L-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      ......   ....||+.|+|||++.+ . .+.++|||||||++|+|++|..||........      ...+...      
T Consensus       167 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~------~~~i~~~------  231 (476)
T 2y94_A          167 SDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTL------FKKICDG------  231 (476)
T ss_dssp             CTTCCB---CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHH------HHHHHTT------
T ss_pred             cccccc---cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHH------HHHHhcC------
Confidence            654322   45679999999999987 3 47899999999999999999999986543221      1111110      


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                              ...    .+...++.+.+|+.+||+.||.+|||+.++++
T Consensus       232 --------~~~----~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          232 --------IFY----TPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             --------CCC----CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --------CcC----CCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence                    000    01123367899999999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.7e-48  Score=345.31  Aligned_cols=247  Identities=21%  Similarity=0.319  Sum_probs=190.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-------------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||||++....  .......+.+|+.++.+++||||+++             
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46799999999999999999998  88999999998653  33446778999999999999999986             


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        +||||+++|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~  162 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGI  162 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred             cEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence              899999999999999876     57999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCce-eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          194 SLSIPDGETH-IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       194 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      ++........ .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.........     .........
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~-----~~~~~~~~~  237 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA-----YQHVREDPI  237 (311)
T ss_dssp             C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-----HHHHHCCCC
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHhcCCCC
Confidence            9876543221 11234578999999999987 8999999999999999999999999866543221     111111100


Q ss_pred             chhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHH-HHHHHHHH
Q 038681          272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVD-VAKQLRQM  327 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e-vl~~L~~l  327 (332)
                      ....               .....+.++.+|+.+||+.||.+||++.+ +...|.++
T Consensus       238 ~~~~---------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          238 PPSA---------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CHHH---------------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             Cccc---------------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            0000               00123477999999999999999997655 44555544

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.3e-48  Score=337.10  Aligned_cols=246  Identities=20%  Similarity=0.309  Sum_probs=202.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      ..++|.+.+.||+|+||.||+|.+ ++..||+|.+......  .+.+.+|+.++++++||||+++           +|||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE   83 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC--HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred             chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence            456799999999999999999999 8889999999876433  4678999999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++|+|.+++....    ..+++..+..++.|++.||.|||   +++|+|+||||+||+++.++.+||+|||++.....
T Consensus        84 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           84 FMEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             CCTTCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             CCCCCcHHHHHhhCc----ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccc
Confidence            999999999997642    45899999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      .... ......+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.........      ..+...        
T Consensus       157 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~i~~~--------  221 (267)
T 3t9t_A          157 DQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV------EDISTG--------  221 (267)
T ss_dssp             HHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHTT--------
T ss_pred             cccc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHH------HHHhcC--------
Confidence            3211 1134457789999999986 88999999999999999999 89999765432211      111100        


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                             .  ....+...+..+.+++.+||+.||++|||+.++++.|+++.++
T Consensus       222 -------~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          222 -------F--RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             -------C--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -------C--cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence                   0  0000112346789999999999999999999999999999875

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=8e-48  Score=349.84  Aligned_cols=239  Identities=24%  Similarity=0.295  Sum_probs=179.9

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      ...++|.+.+.||+|+||.||+|.+  +++.||||++.....   .+.+.+|+.++.+++||||+++           +|
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD---KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC-------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh---HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            3456799999999999999999999  678899999986542   4567899999999999999998           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC---CCCeEEeecCCc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE---QSDAKLFDFSLS  194 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~a  194 (332)
                      |||+++|+|.+++...     ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.   ++.+||+|||++
T Consensus       127 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a  198 (349)
T 2w4o_A          127 LELVTGGELFDRIVEK-----GYYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLS  198 (349)
T ss_dssp             ECCCCSCBHHHHHTTC-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--
T ss_pred             EEeCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccc
Confidence            9999999999999765     56999999999999999999999   899999999999999975   889999999999


Q ss_pred             cccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      +........   ....||+.|+|||++.+ .++.++|||||||++|||++|..||........     ....+..     
T Consensus       199 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~~~~i~~-----  265 (349)
T 2w4o_A          199 KIVEHQVLM---KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-----MFRRILN-----  265 (349)
T ss_dssp             -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-----HHHHHHT-----
T ss_pred             cccCccccc---ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-----HHHHHHh-----
Confidence            876543321   34678999999999988 899999999999999999999999976543221     1111111     


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                               .......+.....+..+.+|+.+||+.||++|||+.++++
T Consensus       266 ---------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          266 ---------CEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             ---------TCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---------CCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                     0000011111234478999999999999999999999986

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.1e-48  Score=352.30  Aligned_cols=246  Identities=19%  Similarity=0.311  Sum_probs=189.6

Q ss_pred             CCCCCccccCCCceEEEEEe--C---CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE------------EEE
Q 038681           56 YDEQNIVLEDPFRKLYKGFW--Q---KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------------IVF  118 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~--~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~------------lv~  118 (332)
                      |.+.+.||+|+||.||+|.+  .   +..||+|.+.........+.+.+|+.++++++||||+++            +||
T Consensus        91 ~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~  170 (373)
T 3c1x_A           91 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  170 (373)
T ss_dssp             EEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEE
T ss_pred             eecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEE
Confidence            56678899999999999997  2   246899998876666667889999999999999999987            899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++|+|.+++....    ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++...
T Consensus       171 e~~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          171 PYMKHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             ECCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             ECCCCCCHHHHHhhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999999997542    45889999999999999999999   9999999999999999999999999999998664


Q ss_pred             CCCce--eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          199 DGETH--IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       199 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      .....  .......+|+.|+|||++.+ .++.++|||||||++|||++ |.+||..........     ....+.     
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~-----~~~~~~-----  313 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-----YLLQGR-----  313 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH-----HHHTTC-----
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH-----HHHcCC-----
Confidence            43211  11133467889999999876 89999999999999999999 677776554332211     000000     


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSC  331 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  331 (332)
                                   ....+..++..+.+++.+||+.||++|||+.++++.|+++..++
T Consensus       314 -------------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~  357 (373)
T 3c1x_A          314 -------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  357 (373)
T ss_dssp             -------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             -------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence                         00011233477999999999999999999999999999998764

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-47  Score=336.32  Aligned_cols=247  Identities=20%  Similarity=0.297  Sum_probs=198.8

Q ss_pred             CCCCCCccccCCCceEEEEEe--CC---eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE------------EE
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QK---RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------------IV  117 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~------------lv  117 (332)
                      .|...+.||+|+||.||+|.+  ++   ..||+|.+.........+.+.+|+.++++++||||+++            +|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            356678999999999999997  22   36999999887766667889999999999999999987            89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+.+|+|.+++....    ..+++..+..++.|++.||.|||   +.||+||||||+||+++.++.+||+|||+++..
T Consensus       102 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  174 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSPQ----RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDI  174 (298)
T ss_dssp             ECCCTTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTT
T ss_pred             EecccCCCHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccc
Confidence            99999999999997631    46899999999999999999999   899999999999999999999999999999765


Q ss_pred             CCCCce--eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccC-CCCCccchhhhHHHHhhhhccccch
Q 038681          198 PDGETH--IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVS-DHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       198 ~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      ......  .......+|+.|+|||.+.+ .++.++|||||||++|+|++|..|+ ........      .......    
T Consensus       175 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~------~~~~~~~----  244 (298)
T 3pls_A          175 LDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL------THFLAQG----  244 (298)
T ss_dssp             TTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH------HHHHHTT----
T ss_pred             cCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH------HHHhhcC----
Confidence            443211  11134567899999999988 8999999999999999999965554 43322211      1111000    


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSC  331 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  331 (332)
                                 .  ..+.+...+..+.+|+.+||+.||.+|||+.++++.|+++.+++
T Consensus       245 -----------~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          245 -----------R--RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             -----------C--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             -----------C--CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence                       0  00111233467999999999999999999999999999998765

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.7e-47  Score=343.80  Aligned_cols=238  Identities=21%  Similarity=0.283  Sum_probs=196.0

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChh-----hHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQH-----ALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-----~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      ++|.+.+.||+|+||.||+|.+  ++..||+|.+.......     ..+.+.+|+.++.+++||||+++           
T Consensus        12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   91 (321)
T 2a2a_A           12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV   91 (321)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            4599999999999999999999  78999999987654321     36779999999999999999987           


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC----CeEEeec
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS----DAKLFDF  191 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Df  191 (332)
                      +||||+++|+|.+++...     ..+++..+..++.||+.||.|||   +.+|+||||||+||+++.++    .+||+||
T Consensus        92 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df  163 (321)
T 2a2a_A           92 LILELVSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDF  163 (321)
T ss_dssp             EEECCCCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred             EEEEcCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence            899999999999999765     56899999999999999999999   89999999999999999888    7999999


Q ss_pred             CCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc
Q 038681          192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       192 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      |++.........   ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.........      ..+....
T Consensus       164 g~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~i~~~~  234 (321)
T 2a2a_A          164 GLAHEIEDGVEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ANITSVS  234 (321)
T ss_dssp             TTCEECCTTCCC---CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH------HHHHTTC
T ss_pred             ccceecCccccc---cccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHHhcc
Confidence            999877654332   34579999999999987 8899999999999999999999999765443221      1111110


Q ss_pred             cchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ..+...              .....+..+.+|+.+||+.||++|||+.++++
T Consensus       235 ~~~~~~--------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          235 YDFDEE--------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             CCCCHH--------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             cccChh--------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            010000              00123367899999999999999999999986

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.2e-48  Score=361.66  Aligned_cols=247  Identities=17%  Similarity=0.262  Sum_probs=198.3

Q ss_pred             HHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE------
Q 038681           46 AEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL------  115 (332)
Q Consensus        46 ~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~------  115 (332)
                      ..++....++|.+.+.||+|+||.||+|.+  +++.||+|++.....  ....+.+.+|+.++..++|||||++      
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~  140 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  140 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence            345556678899999999999999999999  788999999865311  1113447899999999999999997      


Q ss_pred             -----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEee
Q 038681          116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFD  190 (332)
Q Consensus       116 -----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  190 (332)
                           |||||+++|+|.+++...      .+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|
T Consensus       141 ~~~~~lV~E~~~gg~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~D  211 (410)
T 3v8s_A          141 DRYLYMVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLAD  211 (410)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEec
Confidence                 899999999999999653      5899999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccCC-C----CChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhh
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-L----INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKR  265 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~----~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~  265 (332)
                      ||+++......... ....+||+.|+|||++.+ .    ++.++|||||||++|||++|..||..........     ..
T Consensus       212 FG~a~~~~~~~~~~-~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~-----~i  285 (410)
T 3v8s_A          212 FGTCMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS-----KI  285 (410)
T ss_dssp             CTTCEECCTTSEEE-CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-----HH
T ss_pred             cceeEeeccCCccc-ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH-----HH
Confidence            99998766544322 246789999999999875 3    7899999999999999999999998665433211     00


Q ss_pred             hhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 038681          266 LSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPED--RPTMVDVAK  322 (332)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~evl~  322 (332)
                      .           .....    ...+.....+.++.+||.+||+.+|.+  ||+++||++
T Consensus       286 ~-----------~~~~~----~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          286 M-----------NHKNS----LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             H-----------THHHH----CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             H-----------hcccc----ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            0           00000    001111133478999999999999988  999999875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.5e-48  Score=363.20  Aligned_cols=252  Identities=21%  Similarity=0.307  Sum_probs=200.2

Q ss_pred             HHHHHHHhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------
Q 038681           46 AEELRIATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------  115 (332)
Q Consensus        46 ~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------  115 (332)
                      ...+++..++|.+.+.||+|+||.||+|.+ .+..||||.+......  .+.+.+|+.++++++||||+++         
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  253 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI  253 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEcCCce
Confidence            445566677899999999999999999999 5678999999865432  4679999999999999999998         


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       |||||+++|+|.+++.....   ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a  327 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLA  327 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTT
T ss_pred             EEEehhhcCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccc
Confidence             89999999999999975421   35899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      +......... .....+|+.|+|||++.+ .++.++|||||||++|||++ |..||......+...      .+..    
T Consensus       328 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~------~i~~----  396 (452)
T 1fmk_A          328 RLIEDNEYTA-RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD------QVER----  396 (452)
T ss_dssp             C---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH------HHHT----
T ss_pred             eecCCCceec-ccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHH------HHHc----
Confidence            8765433221 134457889999999876 89999999999999999999 999998654332211      1100    


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                                 ..  ..+.+..++..+.+|+.+||+.||++|||+++|++.|+.+..
T Consensus       397 -----------~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          397 -----------GY--RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             -----------TC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             -----------CC--CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence                       00  011112445789999999999999999999999999998764

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.8e-47  Score=356.92  Aligned_cols=254  Identities=18%  Similarity=0.261  Sum_probs=190.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE--------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL--------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~--------------  115 (332)
                      .++|++.+.||+|+||.||+|.+  +++.||||++.... .....+.+.+|+.+++.++|||||++              
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            46799999999999999999998  79999999997653 34446788999999999999999975              


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                         |||||+++ +|.+.+..       .+++..+..++.||+.||+|||   +.||+||||||+|||++.++.+||+|||
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG  209 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  209 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCC
T ss_pred             eEEEEEeCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEE
Confidence               89999976 57776643       4899999999999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      +++........   ....||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.+......  .....+.....
T Consensus       210 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~--~i~~~lg~p~~  284 (464)
T 3ttj_A          210 LARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN--KVIEQLGTPCP  284 (464)
T ss_dssp             CC-----CCCC-------CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCSCCH
T ss_pred             eeeecCCCccc---CCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcCCCCH
Confidence            99876544322   45689999999999988 89999999999999999999999998765443221  11111111111


Q ss_pred             chhhh----hhhhhhcccC----------------CCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          272 RFKEM----VDSIIIEDKS----------------CTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       272 ~~~~~----~~~~~~~~~~----------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .+...    ..........                .........+.++.+|+.+||+.||++|||++|+++
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            10000    0000000000                000111233678999999999999999999999986

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=7e-48  Score=346.92  Aligned_cols=237  Identities=22%  Similarity=0.301  Sum_probs=169.8

Q ss_pred             CCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-CCCcceE-----------EEEEeccCC
Q 038681           59 QNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKL-----------IVFESVQIG  124 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~~-----------lv~e~~~~g  124 (332)
                      .+.||+|+||.||+|.+  +++.||||++...    ....+.+|+.++..+. ||||+++           +||||+++|
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence            47899999999999999  6899999999654    2466789999999997 9999998           899999999


Q ss_pred             ChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC---CeEEeecCCccccCCCC
Q 038681          125 TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS---DAKLFDFSLSLSIPDGE  201 (332)
Q Consensus       125 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~a~~~~~~~  201 (332)
                      +|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++   .+||+|||+++......
T Consensus        92 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~  163 (325)
T 3kn6_A           92 ELFERIKKK-----KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN  163 (325)
T ss_dssp             BHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--
T ss_pred             cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC
Confidence            999999875     57999999999999999999999   99999999999999997765   79999999998665443


Q ss_pred             ceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhh
Q 038681          202 THIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSI  280 (332)
Q Consensus       202 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (332)
                      ..  .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..........             ...+.....
T Consensus       164 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~-------------~~~~~~~~i  228 (325)
T 3kn6_A          164 QP--LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCT-------------SAVEIMKKI  228 (325)
T ss_dssp             ----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CC-------------CHHHHHHHH
T ss_pred             Cc--ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccc-------------cHHHHHHHH
Confidence            22  145678999999999987 89999999999999999999999997654321100             001111111


Q ss_pred             hhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          281 IIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ...............++++.+|+.+||+.||.+|||++++++
T Consensus       229 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          229 KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             TTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             HcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            111111111111234578999999999999999999998863

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.5e-47  Score=349.49  Aligned_cols=233  Identities=20%  Similarity=0.212  Sum_probs=186.5

Q ss_pred             CCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEeccCCC
Q 038681           59 QNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGT  125 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~~~~g~  125 (332)
                      .+.||+|+||.||+|.+  ++..||+|++...... ..+.+.+|+.++.+++||||+++           |||||+++|+
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK-DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHH-HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCc
Confidence            56799999999999998  7899999999876433 36789999999999999999998           8999999999


Q ss_pred             hHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee--CCCCCeEEeecCCccccCCCCce
Q 038681          126 LADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF--NEQSDAKLFDFSLSLSIPDGETH  203 (332)
Q Consensus       126 L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill--~~~~~~kl~Dfg~a~~~~~~~~~  203 (332)
                      |.+++....    ..+++..++.++.||+.||.|||   +.+|+||||||+|||+  +.++.+||+|||+++........
T Consensus       173 L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~  245 (373)
T 2x4f_A          173 LFDRIIDES----YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL  245 (373)
T ss_dssp             EHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBC
T ss_pred             HHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccc
Confidence            999987542    45899999999999999999999   9999999999999999  56788999999999877654432


Q ss_pred             eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhh
Q 038681          204 IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIII  282 (332)
Q Consensus       204 ~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (332)
                         ....||+.|+|||++.+ .++.++|||||||++|||++|..||..........     .....              
T Consensus       246 ---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~-----~i~~~--------------  303 (373)
T 2x4f_A          246 ---KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLN-----NILAC--------------  303 (373)
T ss_dssp             ---CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-----HHHHT--------------
T ss_pred             ---ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-----HHHhc--------------
Confidence               34579999999999987 89999999999999999999999998765433211     11110              


Q ss_pred             cccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          283 EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                       ............++++.+|+.+||+.||.+|||+.|+++
T Consensus       304 -~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          304 -RWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             -CCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -cCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             000000111133478999999999999999999999987

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=6.6e-48  Score=365.85  Aligned_cols=250  Identities=19%  Similarity=0.356  Sum_probs=204.7

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------  115 (332)
                      +++....+|.+.+.||+|+||.||+|.+  .+..||||.+......  .+.+.+|+.++++++|||||++          
T Consensus       214 ~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             CCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc--hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence            3445566788899999999999999999  5899999999765432  5789999999999999999998          


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       |||||+++|+|.+++.....   ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a  365 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLS  365 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCT---TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCE
T ss_pred             EEEEEccCCCCHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccc
Confidence             89999999999999976421   45899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      +......... .....+|+.|+|||++.+ .++.++|||||||++|||++ |..||..........      .+..    
T Consensus       366 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~------~~~~----  434 (495)
T 1opk_A          366 RLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE------LLEK----  434 (495)
T ss_dssp             ECCTTCCEEC-CTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH------HHHT----
T ss_pred             eeccCCceee-cCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHH------HHHc----
Confidence            8765443222 134456789999999876 89999999999999999999 999998765432211      1110    


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                                 ..  ....+..++..+.+||.+||+.||.+|||+.+|++.|+.+.+
T Consensus       435 -----------~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          435 -----------DY--RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             -----------TC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             -----------CC--CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence                       00  111112345789999999999999999999999999987653

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.7e-47  Score=361.14  Aligned_cols=238  Identities=23%  Similarity=0.335  Sum_probs=195.3

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      ++|.+.+.||+|+||+||+|.+  +++.||||++.... .......+.+|+.++++++||||+++           +|||
T Consensus        22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  101 (486)
T 3mwu_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE  101 (486)
T ss_dssp             HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence            5599999999999999999999  78999999986432 12236778999999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeC---CCCCeEEeecCCccc
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN---EQSDAKLFDFSLSLS  196 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~a~~  196 (332)
                      |+++|+|.+++...     ..+++..+..++.||+.||.|||   ++||+||||||+|||++   .++.+||+|||+++.
T Consensus       102 ~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          102 LYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             cCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            99999999999876     57999999999999999999999   99999999999999995   456799999999987


Q ss_pred             cCCCCceeeccccccCCCcccccccCCCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      .......   ....||+.|+|||++.+.++.++|||||||++|+|++|..||..........      .+.         
T Consensus       174 ~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~i~---------  235 (486)
T 3mwu_A          174 FQQNTKM---KDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK------RVE---------  235 (486)
T ss_dssp             BCCC-------CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHH---------
T ss_pred             CCCCCcc---CCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHH---------
Confidence            6554332   4567999999999999899999999999999999999999998765433211      111         


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                           ........+.....++.+.+|+.+||+.||.+|||+.++++
T Consensus       236 -----~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          236 -----TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             -----HTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----hCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 11111111111234578999999999999999999999987

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.8e-47  Score=343.03  Aligned_cols=240  Identities=20%  Similarity=0.334  Sum_probs=191.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcce----------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIK----------------  114 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~----------------  114 (332)
                      .++|++.+.||+|+||.||+|.+  +++.||||++.........+.+.+|+.++++++||||++                
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            45699999999999999999999  789999999987666656788999999999999999996                


Q ss_pred             ----------------------------------------------------EEEEEeccCCChHHHHhhhhcccccCCC
Q 038681          115 ----------------------------------------------------LIVFESVQIGTLADRIHHHCEQHFEALS  142 (332)
Q Consensus       115 ----------------------------------------------------~lv~e~~~~g~L~~~l~~~~~~~~~~l~  142 (332)
                                                                          ++||||+++|+|.+++.....  ....+
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~  162 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS--LEDRE  162 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS--GGGSC
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC--ccchh
Confidence                                                                378999999999999987532  23467


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCce----------eeccccccC
Q 038681          143 LTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH----------IELDSVVGT  212 (332)
Q Consensus       143 ~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~~~gt  212 (332)
                      +..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++........          .......||
T Consensus       163 ~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt  239 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT  239 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred             hHHHHHHHHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence            7789999999999999999   999999999999999999999999999999877654211          111345799


Q ss_pred             CCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCC
Q 038681          213 TGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTG  291 (332)
Q Consensus       213 ~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (332)
                      +.|+|||++.+ .++.++|||||||++|||++|..|+.....        ........  .+               ...
T Consensus       240 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~~--------~~~~~~~~--~~---------------~~~  294 (332)
T 3qd2_B          240 KLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR--------IITDVRNL--KF---------------PLL  294 (332)
T ss_dssp             GGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHHH--------HHHHHHTT--CC---------------CHH
T ss_pred             cCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHHH--------HHHHhhcc--CC---------------Ccc
Confidence            99999999987 899999999999999999998766431100        11100000  00               011


Q ss_pred             hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          292 KEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       292 ~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ....++.+.+|+.+||+.||.+|||+.|+++
T Consensus       295 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          295 FTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             cccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            1244567899999999999999999999986

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2e-47  Score=347.35  Aligned_cols=238  Identities=17%  Similarity=0.234  Sum_probs=193.8

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhh-cCCCcceE----------
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRM-SHKHIIKL----------  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~~----------  115 (332)
                      ...++|.+.+.||+|+||.||+|.+  +++.||+|++....  .....+.+.+|..++..+ +||||+++          
T Consensus        17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~   96 (353)
T 2i0e_A           17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL   96 (353)
T ss_dssp             --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred             CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence            3457899999999999999999999  57889999997642  122356788999999988 79999987          


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       +||||+++|+|.+++...     ..+++..++.++.||+.||.|||   ++||+||||||+|||++.+|.+||+|||++
T Consensus        97 ~lv~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a  168 (353)
T 2i0e_A           97 YFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC  168 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence             899999999999999876     57999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      +........  .....||+.|+|||++.+ .++.++|||||||++|||++|..||........      ...+.      
T Consensus       169 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~------~~~i~------  234 (353)
T 2i0e_A          169 KENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------FQSIM------  234 (353)
T ss_dssp             BCCCCTTCC--BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHH------
T ss_pred             cccccCCcc--cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH------HHHHH------
Confidence            864332221  245689999999999987 899999999999999999999999986543322      11111      


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT-----MVDVAK  322 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~  322 (332)
                              .....    .+...+.++.+|+.+||+.||.+||+     +.+|++
T Consensus       235 --------~~~~~----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          235 --------EHNVA----YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             --------HCCCC----CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             --------hCCCC----CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence                    11110    11133478999999999999999995     466654

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.6e-47  Score=361.84  Aligned_cols=239  Identities=22%  Similarity=0.294  Sum_probs=194.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh------------hhHHHHHHHHHHHHhhcCCCcceE---
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ------------HALEWCINHIVYASRMSHKHIIKL---  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~------------~~~~~~~~E~~~l~~l~H~nIv~~---  115 (332)
                      .++|.+.+.||+|+||+||+|.+  ++..||+|++......            ...+.+.+|+.++++++||||+++   
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            56799999999999999999999  7889999998765321            235678999999999999999998   


Q ss_pred             --------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC---
Q 038681          116 --------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS---  184 (332)
Q Consensus       116 --------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---  184 (332)
                              +|||||++|+|.+++...     ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++   
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~  186 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLL  186 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCS
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCc
Confidence                    899999999999999876     57999999999999999999999   99999999999999998776   


Q ss_pred             CeEEeecCCccccCCCCceeeccccccCCCcccccccCCCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHh
Q 038681          185 DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVK  264 (332)
Q Consensus       185 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~  264 (332)
                      .+||+|||++.........   ....||+.|+|||++.+.++.++|||||||++|+|++|..||..........      
T Consensus       187 ~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------  257 (504)
T 3q5i_A          187 NIKIVDFGLSSFFSKDYKL---RDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIK------  257 (504)
T ss_dssp             SEEECCCTTCEECCTTSCB---CCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------
T ss_pred             cEEEEECCCCEEcCCCCcc---ccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH------
Confidence            6999999999877654332   4567999999999998899999999999999999999999998765433211      


Q ss_pred             hhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          265 RLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .+......+              ..+.....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       258 ~i~~~~~~~--------------~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          258 KVEKGKYYF--------------DFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHCCCCC--------------CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHcCCCCC--------------CccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            111100000              00001123478999999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5.4e-47  Score=335.94  Aligned_cols=252  Identities=17%  Similarity=0.192  Sum_probs=196.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE------------EE
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------------IV  117 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~------------lv  117 (332)
                      ..++|.+.+.||+|+||.||+|.+  +++.||+|.+......   ..+.+|+.++..++|++++..            +|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C---CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc---hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            346799999999999999999997  8899999987655332   347889999999998887653            89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee---CCCCCeEEeecCCc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLS  194 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~a  194 (332)
                      |||+ +|+|.+++....    ..+++..++.++.||+.||.|||   +++|+||||||+|||+   +.++.+||+|||++
T Consensus        84 ~e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a  155 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  155 (296)
T ss_dssp             EECC-CCBHHHHHHHTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEcc-CCCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccc
Confidence            9999 899999997542    46999999999999999999999   9999999999999999   78899999999999


Q ss_pred             cccCCCCce-----eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc
Q 038681          195 LSIPDGETH-----IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG  268 (332)
Q Consensus       195 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  268 (332)
                      +........     .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||................    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----  231 (296)
T 4hgt_A          156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS----  231 (296)
T ss_dssp             EECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH----
T ss_pred             eeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhh----
Confidence            876544321     11235679999999999988 89999999999999999999999998755433221110000    


Q ss_pred             cccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          269 QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                               ........   .......++.+.+|+.+||+.||++|||+++|++.|+++.++
T Consensus       232 ---------~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          232 ---------EKKMSTPI---EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             ---------HHHHHSCH---HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ---------cccccchh---hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence                     00000000   000012247899999999999999999999999999999865

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.8e-47  Score=338.46  Aligned_cols=257  Identities=18%  Similarity=0.231  Sum_probs=192.9

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      ++|.+.+.||+|+||.||+|.+  +++.||+|++..... ....+.+.+|+.++.+++||||+++           +|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            6799999999999999999999  689999999876544 3335678899999999999999987           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++++|.+++...     ..+++..+..++.|++.||.|||   +.||+||||||+||+++.++.+||+|||++.....
T Consensus        83 ~~~~~~l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           83 YCDHTVLHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             CCSEEHHHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             eCCCchHHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            99999999988765     56999999999999999999999   99999999999999999999999999999987654


Q ss_pred             CCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      .....  ....||+.|+|||++.+  .++.++|||||||++|+|++|..||...........  .........+......
T Consensus       155 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  230 (311)
T 4agu_A          155 PSDYY--DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYL--IRKTLGDLIPRHQQVF  230 (311)
T ss_dssp             -------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--HHHHHCSCCHHHHHHH
T ss_pred             ccccc--CCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHHhccccccccccc
Confidence            33221  34578999999999865  689999999999999999999999987665433221  1111111111111111


Q ss_pred             hhhh-hcccCCCCC--------ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 DSII-IEDKSCTCT--------GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~~~~-~~~~~~~~~--------~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .... ......+.+        .....+..+.+|+.+||+.||.+|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          231 STNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             HTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0000 000000000        00134567899999999999999999999985

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-46  Score=347.19  Aligned_cols=259  Identities=22%  Similarity=0.286  Sum_probs=186.9

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhc-CCCcceE------------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMS-HKHIIKL------------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-H~nIv~~------------  115 (332)
                      ..++|.+.+.||+|+||.||+|.+  +++.||||++.... .....+.+.+|+.++..+. ||||+++            
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            457899999999999999999998  78999999986542 3444677899999999997 9999987            


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       +||||++ |+|.+++...      .+++..+..++.||+.||+|||   +.||+||||||+|||++.++.+||+|||+|
T Consensus        87 ~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN------ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEecccC-cCHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence             8999997 5999998753      6899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCc-------------------eeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCc
Q 038681          195 LSIPDGET-------------------HIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSF  253 (332)
Q Consensus       195 ~~~~~~~~-------------------~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~  253 (332)
                      +.......                   ........||+.|+|||++.+  .++.++|||||||++|||++|+.||.+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            86543110                   111234679999999999875  789999999999999999999999987665


Q ss_pred             cchhhhHHHHhhhhcccc---------chhhhhhhhhhcc---c-CCCCC------------ChHHHHHHHHHHHHHccc
Q 038681          254 ESRFHYEENVKRLSGQNC---------RFKEMVDSIIIED---K-SCTCT------------GKEQQLQAFKQLTLQCMD  308 (332)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~---~-~~~~~------------~~~~~~~~~~~li~~cl~  308 (332)
                      .....  .....+.....         .....+.......   . .....            .....++++.+|+.+||+
T Consensus       237 ~~~~~--~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~  314 (388)
T 3oz6_A          237 MNQLE--RIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ  314 (388)
T ss_dssp             HHHHH--HHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred             HHHHH--HHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence            43322  11111111000         0000000000000   0 00000            001234679999999999


Q ss_pred             CCCCCCCCHHHHHH
Q 038681          309 FSPEDRPTMVDVAK  322 (332)
Q Consensus       309 ~dP~~RPs~~evl~  322 (332)
                      .||++|||++|+++
T Consensus       315 ~dP~~R~t~~e~l~  328 (388)
T 3oz6_A          315 FNPNKRISANDALK  328 (388)
T ss_dssp             SSGGGSCCHHHHTT
T ss_pred             cCcccCCCHHHHhC
Confidence            99999999999975

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1e-47  Score=345.96  Aligned_cols=262  Identities=20%  Similarity=0.267  Sum_probs=203.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      .++|++.+.||+|+||.||+|.+      ++..||||++..... ...+.+.+|+.++++++||||+++           
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP-DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH-HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            45799999999999999999984      688999999987643 336779999999999999999987           


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        +||||+++|+|.+++....    ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             EEEEEeecCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEccccc
Confidence              8999999999999998642    35999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCcee-eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          194 SLSIPDGETHI-ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       194 a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      +.......... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||..........     ........
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~-----~~~~~~~~  248 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRM-----MGCERDVP  248 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHH-----CC----CC
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhh-----cccccccc
Confidence            98776544322 2234568888999999887 78999999999999999999999987543221100     00000111


Q ss_pred             chhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      .......... ...  ..+.+..+++.+.+|+.+||+.||.+|||+.++++.|+.++.+
T Consensus       249 ~~~~~~~~~~-~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          249 ALSRLLELLE-EGQ--RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             HHHHHHHHHH-TTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             cHHHHHHHhh-ccc--CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            1111111111 111  1122234557899999999999999999999999999988753

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-46  Score=339.93  Aligned_cols=248  Identities=21%  Similarity=0.307  Sum_probs=194.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--C----CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--Q----KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  +    +..||+|.+...........+.+|+.++.+++||||+++           
T Consensus        43 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  122 (333)
T 1mqb_A           43 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM  122 (333)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence            45677789999999999999988  2    235999999877666667789999999999999999998           


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      +||||+++|+|.+++....    ..+++..++.++.||+.||.|||   +++|+||||||+||+++.++.+||+|||+++
T Consensus       123 lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          123 IITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             EEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEeCCCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcch
Confidence            8999999999999997641    46899999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCcee-eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          196 SIPDGETHI-ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       196 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      ......... ......+|+.|+|||++.+ .++.++|||||||++|||++ |..||.........      ..+...   
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~------~~~~~~---  266 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM------KAINDG---  266 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHTT---
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHH------HHHHCC---
Confidence            765432211 1123346788999999986 89999999999999999999 99999765432211      111000   


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                                  .  ..+.+..++..+.+|+.+||+.||.+|||+.++++.|+++.+.
T Consensus       267 ------------~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          267 ------------F--RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             ------------C--CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ------------C--cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                        0  0011123447799999999999999999999999999998754

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.5e-47  Score=334.80  Aligned_cols=235  Identities=19%  Similarity=0.368  Sum_probs=191.9

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------E
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------I  116 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------l  116 (332)
                      ..++|.+.+.||+|+||.||+|.+  ++..||+|.+.....  ......+.+|+.++++++||||+++           +
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            356799999999999999999999  677899999865432  2225678899999999999999997           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ||||+++|+|.+++...     ..+++..+..++.||+.||.|||   +.||+||||||+||+++.++.++|+|||++..
T Consensus        87 v~e~~~~~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~  158 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVH  158 (279)
T ss_dssp             EECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred             EEecCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEecccccc
Confidence            99999999999999876     56999999999999999999999   99999999999999999999999999999865


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      ......    ....||+.|+|||++.+ .++.++||||||+++|+|++|..||..........      ........   
T Consensus       159 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~~~---  225 (279)
T 3fdn_A          159 APSSRR----TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK------RISRVEFT---  225 (279)
T ss_dssp             C------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHTCCC---
T ss_pred             CCcccc----cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHH------HHHhCCCC---
Confidence            544332    34578999999999987 78999999999999999999999998654432211      11100000   


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                     .+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       226 ---------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  257 (279)
T 3fdn_A          226 ---------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLE  257 (279)
T ss_dssp             ---------------CCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ---------------CCCcCCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                           11123367899999999999999999999987

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.7e-47  Score=341.26  Aligned_cols=236  Identities=18%  Similarity=0.239  Sum_probs=184.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-----CCeeEEEEEEcCCCC---hhhHHHHHHHHHHHHhhcCCCcceE---------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-----QKRSISLMKYNGNRN---QHALEWCINHIVYASRMSHKHIIKL---------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~~---------  115 (332)
                      .++|++.+.||+|+||.||+|..     +++.||+|++.....   ......+.+|+.++++++||||+++         
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46799999999999999999987     678999999986532   2235568899999999999999997         


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        +||||+++|+|.+++...     ..+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  167 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGL  167 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred             EEEEEeCCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCc
Confidence              899999999999999876     57999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          194 SLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       194 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      ++........  .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.........      ..+.     
T Consensus       168 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~i~-----  234 (327)
T 3a62_A          168 CKESIHDGTV--THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI------DKIL-----  234 (327)
T ss_dssp             C------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHH-----
T ss_pred             ccccccCCcc--ccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH------HHHH-----
Confidence            9765433221  145679999999999987 8899999999999999999999999865443221      1110     


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAK  322 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~  322 (332)
                               .....    .+...+..+.+|+.+||+.||.+||     ++.++++
T Consensus       235 ---------~~~~~----~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          235 ---------KCKLN----LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             ---------HTCCC----CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             ---------hCCCC----CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence                     00000    1112347799999999999999999     6777765

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.9e-46  Score=331.98  Aligned_cols=235  Identities=19%  Similarity=0.322  Sum_probs=193.2

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE---------------E
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL---------------I  116 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~---------------l  116 (332)
                      .|.+.+.||+|+||.||+|.+  ++..||+|.+.... .....+.+.+|+.++++++||||+++               +
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            377788999999999999999  78889999987653 34446789999999999999999986               8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCCeeeC-CCCCeEEeecCC
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRP--IVYRDMKPTNILFN-EQSDAKLFDFSL  193 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfg~  193 (332)
                      ||||+++|+|.+++...     ..+++..++.++.||+.||.|||   +.+  |+||||||+|||++ .++.+||+|||+
T Consensus       107 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~  178 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL  178 (290)
T ss_dssp             EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTG
T ss_pred             EEEecCCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCC
Confidence            99999999999999875     57999999999999999999999   888  99999999999997 789999999999


Q ss_pred             ccccCCCCceeeccccccCCCcccccccCCCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          194 SLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       194 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      +........    ....||+.|+|||++.+.++.++|||||||++|+|++|..||........     ..........  
T Consensus       179 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-----~~~~~~~~~~--  247 (290)
T 1t4h_A          179 ATLKRASFA----KAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRVTSGVK--  247 (290)
T ss_dssp             GGGCCTTSB----EESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHHTTTCC--
T ss_pred             ccccccccc----ccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH-----HHHHHhccCC--
Confidence            976554432    34578999999999988999999999999999999999999976443222     1111111000  


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                    +.......++.+.+|+.+||+.||.+|||+.++++
T Consensus       248 --------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          248 --------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             --------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                          00011122367999999999999999999999986

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.1e-47  Score=346.05  Aligned_cols=238  Identities=21%  Similarity=0.323  Sum_probs=190.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----------EEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----------IVF  118 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv~  118 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|.+......     ..+|+.++.++ +||||+++           +||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            45699999999999999999999  7899999999765432     35788899888 79999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC-C---CeEEeecCCc
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ-S---DAKLFDFSLS  194 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~---~~kl~Dfg~a  194 (332)
                      ||+++|+|.+++...     ..+++..+..++.||+.||.|||   ++||+||||||+|||+..+ +   .+||+|||++
T Consensus        96 E~~~gg~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a  167 (342)
T 2qr7_A           96 ELMKGGELLDKILRQ-----KFFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFA  167 (342)
T ss_dssp             CCCCSCBHHHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred             eCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence            999999999999765     56999999999999999999999   9999999999999998543 3   4999999999


Q ss_pred             cccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      +........  .....||+.|+|||++.+ .++.++|||||||++|||++|..||..........   ....+.      
T Consensus       168 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~---~~~~i~------  236 (342)
T 2qr7_A          168 KQLRAENGL--LMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE---ILARIG------  236 (342)
T ss_dssp             EECBCTTCC--BCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHH---HHHHHH------
T ss_pred             ccCcCCCCc--eeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHH---HHHHHc------
Confidence            876543322  145678999999999987 78999999999999999999999997643222111   111111      


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                              ..............+..+.+|+.+||+.||++|||+.++++
T Consensus       237 --------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          237 --------SGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             --------HCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             --------cCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                    11111111111234578999999999999999999999876

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=4.3e-47  Score=333.39  Aligned_cols=241  Identities=21%  Similarity=0.269  Sum_probs=197.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|++.+.||+|+||.||+|.+  +++.||+|.+.........+.+.+|+.+++.++||||+++           +|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            46799999999999999999998  6899999999766555557889999999999999999997           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+|+||||+||+++.++.+||+|||++.....
T Consensus        86 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           86 YCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             CCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             ecCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            99999999999765     56999999999999999999999   99999999999999999999999999999976644


Q ss_pred             CCceeeccccccCCCcccccccCC-C-CChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-L-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ...........||+.|+|||++.+ . ++.++|||||||++|+|++|..||.........    ...+... ...     
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~-~~~-----  227 (276)
T 2yex_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE----YSDWKEK-KTY-----  227 (276)
T ss_dssp             TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH----HHHHHTT-CTT-----
T ss_pred             CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH----HHHhhhc-ccc-----
Confidence            332222245678999999999987 4 478999999999999999999999765443211    0011100 000     


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                 .......+..+.+|+.+||+.||.+|||+.++++
T Consensus       228 -----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          228 -----------LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -----------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----------cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                       0001133467899999999999999999999975

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.2e-47  Score=360.56  Aligned_cols=238  Identities=21%  Similarity=0.308  Sum_probs=191.6

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      +.|.+.+.||+|+||.||+|.+  ++..||+|++..... ......+.+|+.+++.++||||+++           +|||
T Consensus        37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            4599999999999999999999  788999999876532 2235678999999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC---CCeEEeecCCccc
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ---SDAKLFDFSLSLS  196 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~a~~  196 (332)
                      ||++|+|.+++...     ..+++..+..++.||+.||.|||   ++||+||||||+|||++..   +.+||+|||++..
T Consensus       117 ~~~~g~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~  188 (494)
T 3lij_A          117 CYKGGELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV  188 (494)
T ss_dssp             CCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             cCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeE
Confidence            99999999999876     57999999999999999999999   9999999999999999764   4599999999987


Q ss_pred             cCCCCceeeccccccCCCcccccccCCCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      .......   ....||+.|+|||++.+.++.++|||||||++|+|++|..||..........      .+..        
T Consensus       189 ~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~i~~--------  251 (494)
T 3lij_A          189 FENQKKM---KERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILR------KVEK--------  251 (494)
T ss_dssp             CBTTBCB---CCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHH--------
T ss_pred             CCCCccc---cccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHh--------
Confidence            6554322   4567999999999998899999999999999999999999998765433211      1110        


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                            .......+.....++.+.+|+.+||+.||.+|||+.++++
T Consensus       252 ------~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          252 ------GKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             ------TCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ------CCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence                  0110111111234478999999999999999999999986

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.5e-48  Score=361.21  Aligned_cols=251  Identities=17%  Similarity=0.206  Sum_probs=199.7

Q ss_pred             cHHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----
Q 038681           45 SAEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----  115 (332)
Q Consensus        45 ~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----  115 (332)
                      ...++....++|++.+.||+|+||.||+|.+  +++.||+|++.....  ......+.+|+.++..++||||+++     
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            3455566678999999999999999999999  689999999875321  1112347899999999999999997     


Q ss_pred             ------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEe
Q 038681          116 ------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLF  189 (332)
Q Consensus       116 ------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  189 (332)
                            |||||+++|+|.+++....    ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~~----~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~  217 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKFE----DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLA  217 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEEC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEc
Confidence                  8999999999999997631    46999999999999999999999   9999999999999999999999999


Q ss_pred             ecCCccccCCCCceeeccccccCCCcccccccC-----C-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHH
Q 038681          190 DFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-----T-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENV  263 (332)
Q Consensus       190 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~  263 (332)
                      |||+|+.......... ....||+.|+|||++.     . .++.++|||||||++|||++|..||......+...     
T Consensus       218 DFGla~~~~~~~~~~~-~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~-----  291 (437)
T 4aw2_A          218 DFGSCLKLMEDGTVQS-SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG-----  291 (437)
T ss_dssp             CCTTCEECCTTSCEEC-CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH-----
T ss_pred             chhhhhhcccCCCccc-ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHH-----
Confidence            9999987655443322 4568999999999986     3 68999999999999999999999998765433211     


Q ss_pred             hhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCC--CCCHHHHHH
Q 038681          264 KRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPED--RPTMVDVAK  322 (332)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~evl~  322 (332)
                      ..+           ........  + ......++++.+||.+||..+|++  ||+++|+++
T Consensus       292 ~i~-----------~~~~~~~~--p-~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          292 KIM-----------NHKERFQF--P-TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             HHH-----------THHHHCCC--C-SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             hhh-----------hccccccC--C-cccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            000           00000000  0 000123478999999999998888  999999875

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.2e-47  Score=359.94  Aligned_cols=237  Identities=18%  Similarity=0.267  Sum_probs=186.5

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCC--CChhhHHHHHHHHHHHHhhcCCCcceE-----------E
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGN--RNQHALEWCINHIVYASRMSHKHIIKL-----------I  116 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------l  116 (332)
                      ..++|++.+.||+|+||.||+|.+  +++.||||++...  ........+.+|+.++..++||||+++           |
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            346799999999999999999998  7899999998754  223335678899999999999999998           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFS-RPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      ||||+++|+|.+++...     ..+++..+..++.||+.||+|||   + +||+||||||+|||++.++.+||+|||+++
T Consensus       226 v~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~  297 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLH---SEKNVVYRDLKLENLMLDKDGHIKITDFGLCK  297 (446)
T ss_dssp             EECCCSSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCCCGGGEEECSSSCEEECCCCCCC
T ss_pred             EEeeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHh---hcCCEEECCCCHHHEEECCCCCEEEccCCCce
Confidence            99999999999999876     57999999999999999999999   7 899999999999999999999999999998


Q ss_pred             ccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ........  .....||+.|+|||++.+ .++.++|||||||++|||++|..||.........      ..+.       
T Consensus       298 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~------~~i~-------  362 (446)
T 4ejn_A          298 EGIKDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF------ELIL-------  362 (446)
T ss_dssp             TTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHH-------
T ss_pred             eccCCCcc--cccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH------HHHH-------
Confidence            64433222  245689999999999987 8999999999999999999999999765443221      1111       


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAK  322 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~  322 (332)
                             .....    .+...++.+.+||.+||+.||.+||     |+.|+++
T Consensus       363 -------~~~~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          363 -------MEEIR----FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             -------HCCCC----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             -------hCCCC----CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence                   11110    1112347799999999999999999     9999875

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.1e-47  Score=337.88  Aligned_cols=257  Identities=18%  Similarity=0.250  Sum_probs=192.3

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ++|.+.+.||+|+||.||+|.+ +++.||+|++..... ....+.+.+|+.++++++||||+++           +||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            5789999999999999999999 789999999976543 2234678899999999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++ +|.+++....    ..+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (288)
T ss_dssp             CSE-EHHHHHHTST----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             cCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcc
Confidence            985 9999987542    46899999999999999999999   999999999999999999999999999999776543


Q ss_pred             CceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-cccchhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-QNCRFKEMV  277 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  277 (332)
                      ...  .....||+.|+|||++.+  .++.++|||||||++|||++|..||..........  ........ ....+....
T Consensus       154 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  229 (288)
T 1ob3_A          154 VRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM--RIFRILGTPNSKNWPNVT  229 (288)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCCTTTSTTGG
T ss_pred             ccc--cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHHCCCChhhchhhh
Confidence            221  134578999999999875  68999999999999999999999998765433221  11111111 111111100


Q ss_pred             -----hhhhhcccCCC-CCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 -----DSIIIEDKSCT-CTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 -----~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                           ++......+.+ .......+..+.+|+.+||+.||++|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                 00000000000 0001134578899999999999999999999975

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.3e-47  Score=340.08  Aligned_cols=247  Identities=21%  Similarity=0.255  Sum_probs=192.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|.+.....  ....+.+.+|+.++.+++||||+++           +|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            57899999999999999999998  789999999976532  3335779999999999999999987           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+++++|.+++...     ..+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++...
T Consensus       113 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EECCCCEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEecCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            9999999999999876     56999999999999999999999   999999999999999999999999999999766


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ....... .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.......      ...........    
T Consensus       185 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~~~~~~~~~~~----  253 (309)
T 2h34_A          185 TDEKLTQ-LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV------MGAHINQAIPR----  253 (309)
T ss_dssp             -------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH------HHHHHHSCCCC----
T ss_pred             ccccccc-ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH------HHHHhccCCCC----
Confidence            5433221 135578999999999987 88999999999999999999999997654321      11111111000    


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-TMVDVAKQLRQMYR  329 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-s~~evl~~L~~l~~  329 (332)
                                 ........+..+.+++.+||+.||++|| |++++++.|+++..
T Consensus       254 -----------~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          254 -----------PSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             -----------GGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             -----------ccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence                       0011123346799999999999999999 99999999987653

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.4e-46  Score=333.51  Aligned_cols=251  Identities=17%  Similarity=0.194  Sum_probs=199.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE------------EEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------------IVF  118 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~------------lv~  118 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|.+......   +.+.+|+.++..++|++++..            +||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC---CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch---hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            46799999999999999999997  8999999998765432   457899999999998886643            899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee---CCCCCeEEeecCCcc
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSL  195 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~a~  195 (332)
                      ||+ +|+|.+++....    ..+++..++.++.||+.||.|||   +++|+||||||+|||+   +.++.+||+|||++.
T Consensus        85 e~~-~~~L~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  156 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             ECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             Eec-CCCHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcc
Confidence            999 899999997542    46999999999999999999999   9999999999999999   488899999999998


Q ss_pred             ccCCCCcee-----eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc
Q 038681          196 SIPDGETHI-----ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ  269 (332)
Q Consensus       196 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  269 (332)
                      .........     ......||+.|+|||++.+ .++.++|||||||++|+|++|+.||................     
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-----  231 (296)
T 3uzp_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS-----  231 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHH-----
T ss_pred             cccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhc-----
Confidence            765543211     1135679999999999988 89999999999999999999999998754332211100000     


Q ss_pred             ccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          270 NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                              ........   .......++.+.+|+.+||+.||.+|||+.+|++.|+++.+.
T Consensus       232 --------~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  281 (296)
T 3uzp_A          232 --------EKKMSTPI---EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             --------HHHHHSCH---HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             --------ccccCCch---HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHh
Confidence                    00000000   000012347799999999999999999999999999998865

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.5e-47  Score=339.90  Aligned_cols=255  Identities=19%  Similarity=0.270  Sum_probs=187.9

Q ss_pred             cCCCCC-CccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----------EEE
Q 038681           54 NNYDEQ-NIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv~  118 (332)
                      +.|.+. +.||+|+||.||+|.+  +++.||||++...... ..+.+.+|+.++.++ +||||+++           +||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~   90 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH-IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVF   90 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC-CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch-hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence            567774 7899999999999998  7899999999766433 367889999999995 79999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCC---eEEeecCCcc
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSL  195 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~Dfg~a~  195 (332)
                      ||+++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.   +||+|||++.
T Consensus        91 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           91 EKMRGGSILSHIHKR-----RHFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             ECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             EcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            999999999999876     57999999999999999999999   899999999999999988776   9999999997


Q ss_pred             ccCCCCc-----eeeccccccCCCcccccccCC------CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHh
Q 038681          196 SIPDGET-----HIELDSVVGTTGFIAPENFTT------LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVK  264 (332)
Q Consensus       196 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~------~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~  264 (332)
                      .......     ........||+.|+|||++.+      .++.++|||||||++|||++|..||............    
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~----  238 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR----  238 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC------
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc----
Confidence            6543221     111134569999999999862      5788999999999999999999999865433210000    


Q ss_pred             hhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          265 RLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                       ......................+.......+..+.+|+.+||+.||.+|||+.|+++
T Consensus       239 -~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          239 -GEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             ---CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -cccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence             000000000011111111111010000123478999999999999999999999987

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=3.5e-47  Score=342.48  Aligned_cols=248  Identities=20%  Similarity=0.275  Sum_probs=195.8

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeE--EEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----------EE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSI--SLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----------IV  117 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~v--avK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv  117 (332)
                      ++|.+.+.||+|+||.||+|.+  ++..+  |+|.+.........+.+.+|+.++.++ +||||+++           +|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            6799999999999999999998  66654  999988765555567799999999999 89999998           89


Q ss_pred             EEeccCCChHHHHhhhhc-----------ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCe
Q 038681          118 FESVQIGTLADRIHHHCE-----------QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA  186 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  186 (332)
                      |||+++|+|.+++.....           .....+++..++.++.||+.||.|||   ++||+||||||+||+++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeE
Confidence            999999999999976520           11246999999999999999999999   9999999999999999999999


Q ss_pred             EEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHh
Q 038681          187 KLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVK  264 (332)
Q Consensus       187 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~  264 (332)
                      ||+|||+++.......   .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.........      .
T Consensus       182 kL~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~------~  252 (327)
T 1fvr_A          182 KIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------E  252 (327)
T ss_dssp             EECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------H
T ss_pred             EEcccCcCcccccccc---ccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH------H
Confidence            9999999874432221   133457889999999876 78999999999999999998 99999765433211      1


Q ss_pred             hhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          265 RLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      .+...               .  ....+...+..+.+|+.+||+.||.+|||+.++++.|.++.+.
T Consensus       253 ~~~~~---------------~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  301 (327)
T 1fvr_A          253 KLPQG---------------Y--RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  301 (327)
T ss_dssp             HGGGT---------------C--CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HhhcC---------------C--CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            11000               0  0011113347799999999999999999999999999998764

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.4e-46  Score=352.20  Aligned_cols=182  Identities=23%  Similarity=0.364  Sum_probs=146.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE--------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL--------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~--------------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||||++.... .....+.+.+|+.++++++|||||++              
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            36799999999999999999998  78999999997643 33446789999999999999999987              


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        +||||+. |+|.+++...     ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       132 ~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGl  202 (458)
T 3rp9_A          132 LYVVLEIAD-SDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGL  202 (458)
T ss_dssp             EEEEECCCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEeccc-cchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeeccccc
Confidence              8999985 6999999765     56999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCce-------------------------eeccccccCCCcccccccC-C-CCChhhhHHHHHHHHHHHHh
Q 038681          194 SLSIPDGETH-------------------------IELDSVVGTTGFIAPENFT-T-LINEQCDVYGFGAFLFELLT  243 (332)
Q Consensus       194 a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~-~-~~~~~sDiwSlG~~l~ellt  243 (332)
                      |+........                         ......+||+.|+|||++. + .++.++|||||||++|||++
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            9876432210                         1124567899999999864 4 79999999999999999999

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7e-47  Score=337.64  Aligned_cols=259  Identities=19%  Similarity=0.219  Sum_probs=191.9

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC----hhhHHHHHHHHHHHHhhc---CCCcceE-------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN----QHALEWCINHIVYASRMS---HKHIIKL-------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~---H~nIv~~-------  115 (332)
                      ..++|++.+.||+|+||+||+|.+  +++.||+|++.....    ......+.+|+.+++.++   ||||+++       
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467899999999999999999997  889999999864321    111345667887777765   9999986       


Q ss_pred             ---------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCe
Q 038681          116 ---------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA  186 (332)
Q Consensus       116 ---------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  186 (332)
                               +||||++ |+|.+++.....   ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPP---PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCE
Confidence                     7999997 599999986521   34899999999999999999999   9999999999999999999999


Q ss_pred             EEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhh
Q 038681          187 KLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKR  265 (332)
Q Consensus       187 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~  265 (332)
                      ||+|||+++........   ....||+.|+|||++.+ .++.++|||||||++|+|++|..||..........  .....
T Consensus       160 kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--~i~~~  234 (308)
T 3g33_A          160 KLADFGLARIYSYQMAL---TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG--KIFDL  234 (308)
T ss_dssp             EECSCSCTTTSTTCCCS---GGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHH--HHHHH
T ss_pred             EEeeCccccccCCCccc---CCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHH
Confidence            99999999876544332   45678999999999976 89999999999999999999999998765543321  11111


Q ss_pred             hhc-cccchhhhh---hhhhhccc-CCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          266 LSG-QNCRFKEMV---DSIIIEDK-SCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       266 ~~~-~~~~~~~~~---~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ... ....+....   ........ ..........+..+.+|+.+||+.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          235 IGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            111 000010000   00000000 0000000134478899999999999999999999985

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.3e-47  Score=352.60  Aligned_cols=242  Identities=19%  Similarity=0.252  Sum_probs=186.0

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-------hhhHHHHHHHHHHHHhhcCCCcceE------
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-------QHALEWCINHIVYASRMSHKHIIKL------  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~H~nIv~~------  115 (332)
                      ...++|.+.+.||+|+||.||+|.+  +++.||+|++.....       ......+.+|+.++++++||||+++      
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~  211 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA  211 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence            3467899999999999999999998  789999999875421       1123357899999999999999987      


Q ss_pred             ----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC---CeEE
Q 038681          116 ----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS---DAKL  188 (332)
Q Consensus       116 ----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl  188 (332)
                          +||||+++|+|.+++...     ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++   .+||
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             CceEEEEEcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEE
Confidence                899999999999998765     57999999999999999999999   89999999999999997544   5999


Q ss_pred             eecCCccccCCCCceeeccccccCCCcccccccCC----CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHh
Q 038681          189 FDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVK  264 (332)
Q Consensus       189 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~  264 (332)
                      +|||+++........   ....||+.|+|||++.+    .++.++|||||||++|+|++|..||.........     ..
T Consensus       284 ~DFG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~-----~~  355 (419)
T 3i6u_A          284 TDFGHSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----KD  355 (419)
T ss_dssp             CCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCH-----HH
T ss_pred             eecccceecCCCccc---cccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHH-----HH
Confidence            999999876544322   45679999999999852    6889999999999999999999999765432221     11


Q ss_pred             hhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          265 RLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ........+.              .......+..+.+|+.+||+.||.+|||+.|+++
T Consensus       356 ~i~~~~~~~~--------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          356 QITSGKYNFI--------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHHTTCCCCC--------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHhcCCCCCC--------------chhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            1111100000              0000123478999999999999999999999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=9.4e-47  Score=348.77  Aligned_cols=238  Identities=20%  Similarity=0.273  Sum_probs=181.9

Q ss_pred             cCCCCC-CccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE--------------
Q 038681           54 NNYDEQ-NIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL--------------  115 (332)
Q Consensus        54 ~~y~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~--------------  115 (332)
                      ++|.+. +.||+|+||.||+|.+  +++.||||++...      ..+.+|+.++.++ +||||+++              
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            456665 6899999999999999  7899999999643      4567889887555 89999986              


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC---CCCeEEeec
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE---QSDAKLFDF  191 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Df  191 (332)
                       |||||+++|+|.+++.....   ..+++..+..++.||+.||.|||   +++|+||||||+|||++.   ++.+||+||
T Consensus       135 ~lv~E~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DF  208 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDF  208 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEeCCCCcHHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEec
Confidence             79999999999999976421   35999999999999999999999   899999999999999987   789999999


Q ss_pred             CCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc
Q 038681          192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       192 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      |+++........   ....||+.|+|||++.+ .++.++|||||||++|||++|..||...........  ....+    
T Consensus       209 G~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--~~~~i----  279 (400)
T 1nxk_A          209 GFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRI----  279 (400)
T ss_dssp             TTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCS--HHHHH----
T ss_pred             ccccccCCCCcc---ccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHH--HHHHH----
Confidence            999876543322   45678999999999987 899999999999999999999999976543221100  00000    


Q ss_pred             cchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                .......+.+.....+.++.+||.+||+.||.+|||+.++++
T Consensus       280 ----------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  321 (400)
T 1nxk_A          280 ----------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  321 (400)
T ss_dssp             ----------HHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----------HcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                      001111111111234578999999999999999999999987

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.8e-47  Score=362.19  Aligned_cols=239  Identities=21%  Similarity=0.333  Sum_probs=198.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||||++.....  ....+.+.+|+.++++++||||+++           +|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            35699999999999999999999  789999999865432  3346789999999999999999997           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee---CCCCCeEEeecCCc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLS  194 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~a  194 (332)
                      |||+++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||+   +.++.+||+|||++
T Consensus       105 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A          105 GEVYTGGELFDEIISR-----KRFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             ECCCCSCBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence            9999999999999765     57999999999999999999999   9999999999999999   56789999999999


Q ss_pred             cccCCCCceeeccccccCCCcccccccCCCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      +........   ....||+.|+|||++.+.++.++|||||||++|+|++|..||..........      .+.       
T Consensus       177 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~------~i~-------  240 (484)
T 3nyv_A          177 THFEASKKM---KDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILK------KVE-------  240 (484)
T ss_dssp             HHBCCCCSH---HHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHH-------
T ss_pred             EEccccccc---ccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHH-------
Confidence            877654432   4567999999999998899999999999999999999999998765433211      111       


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                             ........+.....++.+.+|+.+||+.||.+|||+.++++
T Consensus       241 -------~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          241 -------KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             -------HCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------cCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence                   11111111111234578999999999999999999999986

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.4e-47  Score=344.08  Aligned_cols=250  Identities=20%  Similarity=0.250  Sum_probs=192.1

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC----ChhhHHHHHHHHHHHHhhcCCCcceE--------
Q 038681           50 RIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR----NQHALEWCINHIVYASRMSHKHIIKL--------  115 (332)
Q Consensus        50 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~H~nIv~~--------  115 (332)
                      ....++|.+.+.||+|+||.||+|.+  ++..||+|.+....    .....+.+.+|+.++++++||||+++        
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~  101 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ  101 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence            34456799999999999999999998  78899999986542    23446789999999999999999997        


Q ss_pred             ---EEEEeccCCChHHHHhhhhcc-----------------------------------cccCCCHHHHHHHHHHHHHHH
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQ-----------------------------------HFEALSLTDRLKVAMDIAHAV  157 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~i~~~L  157 (332)
                         +||||+++|+|.+++......                                   ....+++..++.++.||+.||
T Consensus       102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  181 (345)
T 3hko_A          102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL  181 (345)
T ss_dssp             EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence               899999999999999632110                                   012246788899999999999


Q ss_pred             HHhhhcCCCCeeecCCCCCCeeeCCCC--CeEEeecCCccccCCCC--ceeeccccccCCCcccccccCC---CCChhhh
Q 038681          158 AYLHVGFSRPIVYRDMKPTNILFNEQS--DAKLFDFSLSLSIPDGE--THIELDSVVGTTGFIAPENFTT---LINEQCD  230 (332)
Q Consensus       158 ~~LH~~~~~~ivH~Dlkp~Nill~~~~--~~kl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~---~~~~~sD  230 (332)
                      .|||   +.+|+||||||+|||++.++  .+||+|||+++......  .........||+.|+|||++.+   .++.++|
T Consensus       182 ~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          182 HYLH---NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHH---HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHH---HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            9999   89999999999999998776  89999999998653321  1111245679999999999863   7899999


Q ss_pred             HHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCC
Q 038681          231 VYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFS  310 (332)
Q Consensus       231 iwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d  310 (332)
                      ||||||++|||++|..||..........     .....               ......+.....++.+.+|+.+||+.|
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~-----~~~~~---------------~~~~~~~~~~~~~~~~~~li~~~l~~~  318 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTIS-----QVLNK---------------KLCFENPNYNVLSPLARDLLSNLLNRN  318 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHH-----HHHHC---------------CCCTTSGGGGGSCHHHHHHHHHHSCSC
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHH-----HHHhc---------------ccccCCcccccCCHHHHHHHHHHcCCC
Confidence            9999999999999999998765433211     11111               110111111234478999999999999


Q ss_pred             CCCCCCHHHHHH
Q 038681          311 PEDRPTMVDVAK  322 (332)
Q Consensus       311 P~~RPs~~evl~  322 (332)
                      |.+|||+.++++
T Consensus       319 p~~Rps~~~~l~  330 (345)
T 3hko_A          319 VDERFDAMRALQ  330 (345)
T ss_dssp             TTTSCCHHHHHH
T ss_pred             hhHCCCHHHHhc
Confidence            999999999987

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-46  Score=344.43  Aligned_cols=253  Identities=17%  Similarity=0.228  Sum_probs=190.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE--------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL--------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~--------------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  +|+.||||++.... .....+.+.+|+.+++.++||||+++              
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46799999999999999999998  78999999996543 34446778999999999999999975              


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                         +||||+ +++|.+++..      ..+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg  173 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG  173 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             eEEEEEecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeee
Confidence               899999 7899999875      36899999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      +++......     ....+|+.|+|||++.+  .++.++|||||||++|||++|+.||.+........  ..........
T Consensus       174 ~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~--~i~~~~g~~~  246 (367)
T 1cm8_A          174 LARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK--EIMKVTGTPP  246 (367)
T ss_dssp             TCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCC
T ss_pred             ccccccccc-----CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcCCCC
Confidence            998765432     45678999999998875  78999999999999999999999998765443221  1111111111


Q ss_pred             cchhhhh-----hhhhhc----ccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          271 CRFKEMV-----DSIIIE----DKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       271 ~~~~~~~-----~~~~~~----~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ..+...+     ...+..    ............++.+.+|+.+||+.||.+|||+.++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            1110000     000000    000000011234578999999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.3e-46  Score=334.47  Aligned_cols=253  Identities=23%  Similarity=0.333  Sum_probs=191.1

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------E
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------I  116 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------l  116 (332)
                      ..++|.+.+.||+|+||.||+|.+  ++..||+|++....  .....+.+.+|+.++++++||||+++           +
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l  109 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI  109 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence            346799999999999999999998  78999999997632  34456789999999999999999998           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ||||+++|+|.+++..... ....+++..++.++.||+.||.|||   +.+|+|+||||+||+++.++.+||+|||++..
T Consensus       110 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~  185 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRF  185 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC-----
T ss_pred             EEecCCCCCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceee
Confidence            9999999999999976422 1256899999999999999999999   99999999999999999999999999999976


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      .......  .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.........    ........      
T Consensus       186 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~------  253 (310)
T 2wqm_A          186 FSSKTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS----LCKKIEQC------  253 (310)
T ss_dssp             ---------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHH----HHHHHHTT------
T ss_pred             ecCCCcc--ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHH----HHHHhhcc------
Confidence            6543321  134578999999999987 8999999999999999999999999754322110    11111100      


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                              ..  +.......+..+.+|+.+||+.||.+|||+.+|++.|+++...
T Consensus       254 --------~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~  298 (310)
T 2wqm_A          254 --------DY--PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHAC  298 (310)
T ss_dssp             --------CS--CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------cC--CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHh
Confidence                    00  0000113347899999999999999999999999999998754

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.6e-47  Score=340.68  Aligned_cols=252  Identities=18%  Similarity=0.271  Sum_probs=198.5

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------  115 (332)
                      ..++|.+.+.||+|+||.||+|.+       ++..||||.+...........+.+|+.++++++||||+++         
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            457899999999999999999984       5668999999876666667789999999999999999998         


Q ss_pred             --EEEEeccCCChHHHHhhhhcc--cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC---CCCeEE
Q 038681          116 --IVFESVQIGTLADRIHHHCEQ--HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE---QSDAKL  188 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl  188 (332)
                        +||||+++|+|.+++......  ....+++..++.++.||+.||.|||   +.+|+||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEE
Confidence              899999999999999875321  1135899999999999999999999   999999999999999984   446999


Q ss_pred             eecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhh
Q 038681          189 FDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRL  266 (332)
Q Consensus       189 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~  266 (332)
                      +|||++................+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.........      ...
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~~~  258 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL------EFV  258 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH------HHH
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH------HHH
Confidence            99999976543332222244568999999999876 89999999999999999998 99999765432211      111


Q ss_pred             hccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          267 SGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                      ...              .   ....+..++..+.+|+.+||+.||.+|||+.++++.|..+.+
T Consensus       259 ~~~--------------~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          259 TSG--------------G---RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             HTT--------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hcC--------------C---CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            100              0   000111334779999999999999999999999999998764

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.1e-46  Score=335.90  Aligned_cols=237  Identities=21%  Similarity=0.283  Sum_probs=192.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|.+....... .+.+.+|+.++.+++||||+++           +|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR-DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ   86 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence            35699999999999999999998  78999999998654322 4668899999999999999997           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee---CCCCCeEEeecCCccc
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLS  196 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~a~~  196 (332)
                      |+++|+|.+++...     ..+++..+..++.||+.||.|||   +.+|+||||||+||++   +.++.+||+|||++..
T Consensus        87 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~  158 (304)
T 2jam_A           87 LVSGGELFDRILER-----GVYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM  158 (304)
T ss_dssp             CCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred             cCCCccHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence            99999999999776     56999999999999999999999   8999999999999999   7889999999999976


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      ......    ....||+.|+|||++.+ .++.++|||||||++|+|++|..||........      ...+...      
T Consensus       159 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~i~~~------  222 (304)
T 2jam_A          159 EQNGIM----STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKL------FEKIKEG------  222 (304)
T ss_dssp             CCCBTT----HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHC------
T ss_pred             cCCCcc----ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHcC------
Confidence            543321    34568999999999987 899999999999999999999999976543221      1111100      


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                              ......+.....+..+.+|+.+||+.||.+|||+.++++
T Consensus       223 --------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          223 --------YYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             --------CCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             --------CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                    000011111234478999999999999999999999986

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.6e-46  Score=346.15  Aligned_cols=238  Identities=19%  Similarity=0.293  Sum_probs=187.1

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhc--CCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNR-NQHALEWCINHIVYASRMS--HKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~--H~nIv~~-----------lv~  118 (332)
                      ..|.+.+.||+|+||.||+|.+ .++.||||++.... .....+.+.+|+.++.+++  ||||+++           |||
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~  135 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM  135 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence            4599999999999999999999 78899999997653 3445678999999999996  5999988           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      | +.+|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++ ++.+||+|||+++...
T Consensus       136 E-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          136 E-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             E-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             e-cCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            9 5688999999876     57899999999999999999999   99999999999999995 5899999999998775


Q ss_pred             CCCceeeccccccCCCcccccccCC------------CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT------------LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRL  266 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~------------~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~  266 (332)
                      ............||+.|+|||++.+            .++.++|||||||++|||++|..||.........    ..   
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~----~~---  278 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK----LH---  278 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH----HH---
T ss_pred             CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHH----HH---
Confidence            5433222245679999999999853            6899999999999999999999999754321110    11   


Q ss_pred             hccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          267 SGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                              ..++......      .+...+..+.+|+.+||+.||.+|||+.|+++
T Consensus       279 --------~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          279 --------AIIDPNHEIE------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             --------HHHCTTSCCC------CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --------HHhCccccCC------CCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence                    1111100000      01112367899999999999999999999985

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.7e-46  Score=349.23  Aligned_cols=188  Identities=22%  Similarity=0.324  Sum_probs=159.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE--------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL--------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~--------------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||||++.... .....+.+.+|+.++++++||||+++              
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            46799999999999999999998  78999999997653 33446789999999999999999987              


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        +||||++ |+|.+++...     ..+++..+..++.||+.||.|||   +.||+||||||+|||++.++.+||+|||+
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEecCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCC
Confidence              8999986 5999999765     56999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCce--------------------eeccccccCCCcccccccC-C-CCChhhhHHHHHHHHHHHHhCCccCC
Q 038681          194 SLSIPDGETH--------------------IELDSVVGTTGFIAPENFT-T-LINEQCDVYGFGAFLFELLTAQEVSD  249 (332)
Q Consensus       194 a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~~-~-~~~~~sDiwSlG~~l~elltg~~p~~  249 (332)
                      ++........                    .......||+.|+|||++. + .++.++|||||||++|||++|..||.
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            9876543211                    1124568999999999864 3 79999999999999999998655554

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.2e-47  Score=339.98  Aligned_cols=262  Identities=18%  Similarity=0.283  Sum_probs=204.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW------QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      .++|.+.+.||+|+||.||+|.+      +++.||+|++..... ...+.+.+|+.++++++||||+++           
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE-EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS-HHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            45689999999999999999984      688999999987544 336789999999999999999987           


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        +||||+++|+|.+++....    ..+++..++.++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||+
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~  191 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGL  191 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTT
T ss_pred             eEEEEECCCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcc
Confidence              8999999999999997652    35899999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCceee-ccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          194 SLSIPDGETHIE-LDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       194 a~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      +........... .....++..|+|||++.+ .++.++|||||||++|+|++|..||......       ..........
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~-------~~~~~~~~~~  264 (326)
T 2w1i_A          192 TKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE-------FMRMIGNDKQ  264 (326)
T ss_dssp             CEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHH-------HHHHHCTTCC
T ss_pred             hhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHH-------HHHhhccccc
Confidence            987765443221 123457788999999876 7899999999999999999999998643211       0011100000


Q ss_pred             --chhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 038681          272 --RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSC  331 (332)
Q Consensus       272 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  331 (332)
                        .....+...+....  ..+.+..++.++.+|+.+||+.||++|||+.+|++.|+++.+++
T Consensus       265 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          265 GQMIVFHLIELLKNNG--RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             THHHHHHHHHHHHTTC--CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hhhhHHHHHHHhhcCC--CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence              00000111111111  11112345578999999999999999999999999999998764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=4.8e-47  Score=345.97  Aligned_cols=269  Identities=17%  Similarity=0.211  Sum_probs=202.9

Q ss_pred             CCCcccccHHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-----CC
Q 038681           38 YNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS-----HK  110 (332)
Q Consensus        38 ~~~~~~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----H~  110 (332)
                      ......++..+.....++|.+.+.||+|+||.||+|.+  +++.||||++...  ....+.+..|+.++..+.     ||
T Consensus        19 ~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~h~   96 (360)
T 3llt_A           19 DDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI--KKYTRSAKIEADILKKIQNDDINNN   96 (360)
T ss_dssp             -CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC--HHHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred             CccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc--hhhhhhhHHHHHHHHHhcccCCCCC
Confidence            34455666666666778999999999999999999999  8899999999754  233566788999999996     99


Q ss_pred             CcceE-----------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCee
Q 038681          111 HIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNIL  179 (332)
Q Consensus       111 nIv~~-----------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil  179 (332)
                      ||+++           +||||+ +++|.+++.....   ..+++..+..++.||+.||+|||   +++|+||||||+|||
T Consensus        97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIl  169 (360)
T 3llt_A           97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY---NGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENIL  169 (360)
T ss_dssp             GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEE
T ss_pred             CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEE
Confidence            99998           899999 8899999986521   35899999999999999999999   999999999999999


Q ss_pred             eCC-------------------------CCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHH
Q 038681          180 FNE-------------------------QSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYG  233 (332)
Q Consensus       180 l~~-------------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwS  233 (332)
                      ++.                         ++.+||+|||+++......     ....||+.|+|||++.+ .++.++||||
T Consensus       170 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Diws  244 (360)
T 3llt_A          170 LDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH-----GSIINTRQYRAPEVILNLGWDVSSDMWS  244 (360)
T ss_dssp             ESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSCC-----CSCCSCGGGCCHHHHTTCCCCTTHHHHH
T ss_pred             EccccccccccchhcccccccccccccCCCCEEEEeccCceecCCCC-----cCccCcccccCcHHHcCCCCCCccchHH
Confidence            975                         7899999999998655433     35678999999999988 8999999999


Q ss_pred             HHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchh-hhh--------hhh-hhcccCCCCCC------------
Q 038681          234 FGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK-EMV--------DSI-IIEDKSCTCTG------------  291 (332)
Q Consensus       234 lG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--------~~~-~~~~~~~~~~~------------  291 (332)
                      |||++|+|++|+.||...........  ........+..+. ...        +.. .....+.....            
T Consensus       245 lG~il~ell~g~~pf~~~~~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~  322 (360)
T 3llt_A          245 FGCVLAELYTGSLLFRTHEHMEHLAM--MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLP  322 (360)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHHHHHHH--HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCC
T ss_pred             HHHHHHHHHHCCCCCCCCcHHHHHHH--HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhccc
Confidence            99999999999999987654432221  1111111110000 000        000 00000000000            


Q ss_pred             --hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          292 --KEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       292 --~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                        .....+.+.+|+.+||+.||++|||+.|+++
T Consensus       323 ~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          323 LYKIIKHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence              0011267889999999999999999999975

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.7e-47  Score=342.91  Aligned_cols=229  Identities=21%  Similarity=0.270  Sum_probs=192.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh-------hhHHHHHHHHHHHHhhcCCCcceE--------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ-------HALEWCINHIVYASRMSHKHIIKL--------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-------~~~~~~~~E~~~l~~l~H~nIv~~--------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||||.+......       ...+.+.+|+.++++++||||+++        
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            46799999999999999999998  8999999999765321       124457889999999999999998        


Q ss_pred             ---EEEEeccCC-ChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeec
Q 038681          116 ---IVFESVQIG-TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF  191 (332)
Q Consensus       116 ---lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  191 (332)
                         +||||+.+| +|.+++...     ..+++..+..++.||+.||.|||   .++|+||||||+|||++.++.+||+||
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEEEEeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeec
Confidence               899999777 999999875     57999999999999999999999   899999999999999999999999999


Q ss_pred             CCccccCCCCceeeccccccCCCcccccccCC-CC-ChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc
Q 038681          192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LI-NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ  269 (332)
Q Consensus       192 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  269 (332)
                      |++.........   ....||+.|+|||++.+ .+ +.++|||||||++|+|++|..||........             
T Consensus       175 g~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~-------------  238 (335)
T 3dls_A          175 GSAAYLERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE-------------  238 (335)
T ss_dssp             TTCEECCTTCCB---CEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT-------------
T ss_pred             ccceECCCCCce---eccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh-------------
Confidence            999877655432   34679999999999987 44 8999999999999999999999975321100             


Q ss_pred             ccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          270 NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                               ....        .+...+.++.+|+.+||+.||.+|||+.++++
T Consensus       239 ---------~~~~--------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          239 ---------AAIH--------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             ---------TCCC--------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------hccC--------CCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                     0000        00113367999999999999999999999987

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=355.13  Aligned_cols=251  Identities=18%  Similarity=0.202  Sum_probs=199.3

Q ss_pred             ccHHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE----
Q 038681           44 FSAEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL----  115 (332)
Q Consensus        44 ~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~----  115 (332)
                      +.+.++....++|++.+.||+|+||.||+|.+  +++.||+|++.....  ....+.+.+|..++..++||||+++    
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~  130 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF  130 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE
Confidence            44556666788999999999999999999999  789999999975321  1223457899999999999999987    


Q ss_pred             -------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEE
Q 038681          116 -------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKL  188 (332)
Q Consensus       116 -------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  188 (332)
                             |||||+++|+|.+++....    ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||
T Consensus       131 ~~~~~~~lVmE~~~gg~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~~g~vkL  203 (412)
T 2vd5_A          131 QDENYLYLVMEYYVGGDLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRL  203 (412)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEE
T ss_pred             eeCCEEEEEEcCCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecCCCCEEE
Confidence                   8999999999999998651    36999999999999999999999   999999999999999999999999


Q ss_pred             eecCCccccCCCCceeeccccccCCCcccccccC--------CCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhH
Q 038681          189 FDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT--------TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYE  260 (332)
Q Consensus       189 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~  260 (332)
                      +|||+++......... .....||+.|+|||++.        +.++.++|||||||++|||++|..||..........  
T Consensus       204 ~DFGla~~~~~~~~~~-~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~--  280 (412)
T 2vd5_A          204 ADFGSCLKLRADGTVR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYG--  280 (412)
T ss_dssp             CCCTTCEECCTTSCEE-CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--
T ss_pred             eechhheeccCCCccc-cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHH--
Confidence            9999998776544322 13568999999999986        268999999999999999999999998765433211  


Q ss_pred             HHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCC---CCHHHHHH
Q 038681          261 ENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDR---PTMVDVAK  322 (332)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R---Ps~~evl~  322 (332)
                      ......              .....  + ......+.++.+||.+||. +|.+|   |+++|+++
T Consensus       281 ~i~~~~--------------~~~~~--p-~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          281 KIVHYK--------------EHLSL--P-LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHHTHH--------------HHCCC--C-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HHHhcc--------------cCcCC--C-ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            000000              00000  0 0011334789999999999 99998   58988864

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=8.6e-47  Score=347.97  Aligned_cols=260  Identities=14%  Similarity=0.212  Sum_probs=195.5

Q ss_pred             HhcCCCCCCccccC--CCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           52 ATNNYDEQNIVLED--PFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G--~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      ..++|++.+.||+|  +||.||+|.+  +++.||||++.... .....+.+.+|+.+++.++|||||++           
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            45679999999999  9999999999  69999999997654 34446778899999999999999998           


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      +||||+++|+|.+++.....   ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||.+.
T Consensus       103 lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~  176 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFM---DGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNL  176 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCT---TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEccCCCCHHHHHhhhcc---cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccce
Confidence            89999999999999976421   45899999999999999999999   9999999999999999999999999999886


Q ss_pred             ccCCCCce-----eeccccccCCCcccccccCC---CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhh
Q 038681          196 SIPDGETH-----IELDSVVGTTGFIAPENFTT---LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS  267 (332)
Q Consensus       196 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  267 (332)
                      ........     .......||+.|+|||++.+   .++.++|||||||++|||++|..||..........     ....
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-----~~~~  251 (389)
T 3gni_B          177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-----EKLN  251 (389)
T ss_dssp             ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH-----HC--
T ss_pred             eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-----HHhc
Confidence            54322111     11133478999999999876   68999999999999999999999998755443211     1110


Q ss_pred             ccccch------------------------hhhhhhhh---hcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 038681          268 GQNCRF------------------------KEMVDSII---IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV  320 (332)
Q Consensus       268 ~~~~~~------------------------~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ev  320 (332)
                      .....+                        .+......   ........+.....++.+.+|+.+||+.||++|||+.|+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~el  331 (389)
T 3gni_B          252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTL  331 (389)
T ss_dssp             ------------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             CCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            000000                        00000000   000000111223455789999999999999999999999


Q ss_pred             HH
Q 038681          321 AK  322 (332)
Q Consensus       321 l~  322 (332)
                      ++
T Consensus       332 l~  333 (389)
T 3gni_B          332 LN  333 (389)
T ss_dssp             TT
T ss_pred             hc
Confidence            85

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.4e-47  Score=337.37  Aligned_cols=238  Identities=20%  Similarity=0.365  Sum_probs=191.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CC-------eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE--------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QK-------RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL--------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~-------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~--------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  ++       ..||+|.+..... ...+.+.+|+.++++++||||+++        
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR-NYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG-GGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            46789999999999999999998  33       5699999876543 336789999999999999999997        


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCC-------
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD-------  185 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-------  185 (332)
                         +||||+++|+|.+++....    ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.       
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~  158 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPP  158 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCC
T ss_pred             CCEEEEECCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccc
Confidence               8999999999999998752    34999999999999999999999   999999999999999998887       


Q ss_pred             -eEEeecCCccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccC-CCCCccchhhhHH
Q 038681          186 -AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVS-DHVSFESRFHYEE  261 (332)
Q Consensus       186 -~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~-~~~~~~~~~~~~~  261 (332)
                       +||+|||++......      ....||+.|+|||++.+  .++.++|||||||++|||++|..|+ ........     
T Consensus       159 ~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-----  227 (289)
T 4fvq_A          159 FIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-----  227 (289)
T ss_dssp             EEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-----
T ss_pred             eeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-----
Confidence             999999998655332      33468999999999875  6899999999999999999965544 43322111     


Q ss_pred             HHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          262 NVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                       ......               ....+.    ..+..+.+|+.+||+.||.+|||+.++++.|+++..
T Consensus       228 -~~~~~~---------------~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          228 -LQFYED---------------RHQLPA----PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             -HHHHHT---------------TCCCCC----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             -HHHhhc---------------cCCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence             000000               000000    112568899999999999999999999999998764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.3e-47  Score=345.73  Aligned_cols=256  Identities=18%  Similarity=0.220  Sum_probs=199.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|.+.+.||+|+||.||+|.+  ++..||+|.+.........+.+.+|+.++++++||||+++           +|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            45799999999999999999999  6899999999887666667889999999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSR-PIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      |+++|+|.+++...     ..+++..+..++.|++.||.|||   +. +|+||||||+|||++.++.+||+|||++....
T Consensus       112 ~~~~~~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          112 HMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             CCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             CCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            99999999999876     57999999999999999999999   74 99999999999999999999999999986553


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHh-------------
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVK-------------  264 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~-------------  264 (332)
                      ....    ....||+.|+|||++.+ .++.++|||||||++|+|++|..||................             
T Consensus       184 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3eqc_A          184 DSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  259 (360)
T ss_dssp             HHC--------CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred             cccc----cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence            3221    34578999999999988 89999999999999999999999998655432211000000             


Q ss_pred             ---------hhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          265 ---------RLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       265 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                               ..........+.++........  .......+.++.+|+.+||+.||++|||+.++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPP--KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             --------------CCCHHHHHHHHHHSCCC--CCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCcccccccCCCCcccchhhhhHHhccCCC--CCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                     0000001111222222221111  1111234578999999999999999999999986

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=341.05  Aligned_cols=239  Identities=19%  Similarity=0.295  Sum_probs=185.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcC--CCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSH--KHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H--~nIv~~-----------lv  117 (332)
                      .+.|++.+.||+|+||.||+|.+ +++.||||++.... .....+.+.+|+.++.+++|  |||+++           +|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            45699999999999999999999 88899999987653 34446789999999999986  999998           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      || +.+|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++ ++.+||+|||+++..
T Consensus        88 ~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             EC-CCSEEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             Ee-CCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            99 5678999999876     57999999999999999999999   89999999999999997 678999999999877


Q ss_pred             CCCCceeeccccccCCCcccccccC------------CCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFT------------TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKR  265 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~------------~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~  265 (332)
                      .............||+.|+|||++.            ..++.++|||||||++|||++|..||.........    ..  
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~--  231 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK----LH--  231 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH----HH--
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHH----HH--
Confidence            5544332224567999999999974            36889999999999999999999999754321110    00  


Q ss_pred             hhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          266 LSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                               ..++....      ...+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       232 ---------~~~~~~~~------~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~  273 (343)
T 3dbq_A          232 ---------AIIDPNHE------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  273 (343)
T ss_dssp             ---------HHHCTTSC------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ---------HHhcCCcc------cCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHh
Confidence                     11110000      0011122367899999999999999999999986

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.2e-46  Score=331.82  Aligned_cols=244  Identities=21%  Similarity=0.301  Sum_probs=195.3

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh-----hhHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ-----HALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      ++|.+.+.||+|+||.||+|.+  +++.||+|.+......     ...+.+.+|+.++++++||||+++           
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            5699999999999999999999  6899999998765322     136789999999999999999998           


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC----CeEEeec
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS----DAKLFDF  191 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Df  191 (332)
                      +||||+++++|.+++...     ..+++..+..++.||+.||.|||   +.+|+||||||+||+++.++    .+||+||
T Consensus        85 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEeecCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEec
Confidence            899999999999999765     57999999999999999999999   99999999999999998877    8999999


Q ss_pred             CCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc
Q 038681          192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       192 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      |++.........   ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.........      .......
T Consensus       157 g~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~  227 (283)
T 3bhy_A          157 GIAHKIEAGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETL------TNISAVN  227 (283)
T ss_dssp             TTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHTTC
T ss_pred             ccceeccCCCcc---cccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHH------HHhHhcc
Confidence            999876554322   34578999999999987 8999999999999999999999999875543221      1111100


Q ss_pred             cchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHHH
Q 038681          271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK--QLRQMY  328 (332)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~--~L~~l~  328 (332)
                      ..+..              ......+..+.+|+.+||+.||++|||+.++++  .++.+.
T Consensus       228 ~~~~~--------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          228 YDFDE--------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             CCCCH--------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             cCCcc--------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            00000              000123367899999999999999999999997  455554

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=9.4e-47  Score=337.48  Aligned_cols=233  Identities=16%  Similarity=0.187  Sum_probs=185.7

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhh-cCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRM-SHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv~  118 (332)
                      ++|++.++||+|+||+||+|.+  +++.||||++.... .......+..|+..+.++ +||||+++           +||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            5699999999999999999999  78999999987643 233355567777777666 89999987           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+ +|+|.+++....    ..+++..++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++....
T Consensus       137 e~~-~~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~  208 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELG  208 (311)
T ss_dssp             ECC-CCBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC
T ss_pred             ecc-CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecc
Confidence            999 679999987652    46999999999999999999999   8999999999999999999999999999998765


Q ss_pred             CCCceeeccccccCCCcccccccCCCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      .....   ....||+.|+|||++.+.++.++|||||||++|||++|..|+.......         .+...  ....   
T Consensus       209 ~~~~~---~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~---------~~~~~--~~~~---  271 (311)
T 3p1a_A          209 TAGAG---EVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGEGWQ---------QLRQG--YLPP---  271 (311)
T ss_dssp             ---------CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHH---------HHTTT--CCCH---
T ss_pred             cCCCC---cccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH---------HHhcc--CCCc---
Confidence            44322   3456999999999998899999999999999999999977665321110         01000  0000   


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                 ......+..+.+|+.+||+.||++|||+.++++
T Consensus       272 -----------~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          272 -----------EFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             -----------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -----------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                       001123478999999999999999999999985

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.6e-45  Score=333.36  Aligned_cols=263  Identities=18%  Similarity=0.278  Sum_probs=202.9

Q ss_pred             cccHHHHHHHhcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHh--hcCCCcceE-----
Q 038681           43 IFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASR--MSHKHIIKL-----  115 (332)
Q Consensus        43 ~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~--l~H~nIv~~-----  115 (332)
                      ..+..--....++|.+.+.||+|+||.||+|.++++.||||.+....    ...+.+|.+++..  ++||||+++     
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGGG----HHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCchh----HHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            33444344456779999999999999999999999999999996542    4667889999988  789999987     


Q ss_pred             ----------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcC-----CCCeeecCCCCCCeee
Q 038681          116 ----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGF-----SRPIVYRDMKPTNILF  180 (332)
Q Consensus       116 ----------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----~~~ivH~Dlkp~Nill  180 (332)
                                +||||+++|+|.+++...      .+++..++.++.||+.||.|||...     +.+|+||||||+|||+
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll  180 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV  180 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE
Confidence                      899999999999999753      5899999999999999999999211     3689999999999999


Q ss_pred             CCCCCeEEeecCCccccCCCCcee--eccccccCCCcccccccCCC-------CChhhhHHHHHHHHHHHHhC-------
Q 038681          181 NEQSDAKLFDFSLSLSIPDGETHI--ELDSVVGTTGFIAPENFTTL-------INEQCDVYGFGAFLFELLTA-------  244 (332)
Q Consensus       181 ~~~~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-------~~~~sDiwSlG~~l~elltg-------  244 (332)
                      +.++.+||+|||++..........  ......||+.|+|||++.+.       ++.++|||||||++|||++|       
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  260 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  260 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence            999999999999997765543221  12445799999999998762       23689999999999999999       


Q ss_pred             ---CccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCC---ChHHHHHHHHHHHHHcccCCCCCCCCHH
Q 038681          245 ---QEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCT---GKEQQLQAFKQLTLQCMDFSPEDRPTMV  318 (332)
Q Consensus       245 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~  318 (332)
                         ..||..........               ..+.............+   .....+..+.+|+.+||+.||++|||+.
T Consensus       261 ~~~~~p~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~  325 (342)
T 1b6c_B          261 EDYQLPYYDLVPSDPSV---------------EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL  325 (342)
T ss_dssp             CCCCCTTTTTSCSSCCH---------------HHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHH
T ss_pred             cccccCccccCcCcccH---------------HHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHH
Confidence               66765543221110               01111000000000000   1236678899999999999999999999


Q ss_pred             HHHHHHHHHHHh
Q 038681          319 DVAKQLRQMYRS  330 (332)
Q Consensus       319 evl~~L~~l~~~  330 (332)
                      +|++.|+++.++
T Consensus       326 ~i~~~L~~i~~~  337 (342)
T 1b6c_B          326 RIKKTLSQLSQQ  337 (342)
T ss_dssp             HHHHHHHHHHHT
T ss_pred             HHHHHHHHHHHH
Confidence            999999999865

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.6e-47  Score=347.29  Aligned_cols=235  Identities=19%  Similarity=0.257  Sum_probs=183.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHH-HHhhcCCCcceE-----------E
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVY-ASRMSHKHIIKL-----------I  116 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~-l~~l~H~nIv~~-----------l  116 (332)
                      .++|++.+.||+|+||.||+|++  ++..||+|++.....  ......+.+|..+ ++.++||||+++           +
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            46799999999999999999999  788999999976532  2234556777777 467899999997           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ||||+++|+|.+++...     ..+++..++.++.||+.||+|||   ++||+||||||+|||++.+|.+||+|||+++.
T Consensus       117 v~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             EEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             EEeCCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            99999999999999876     57999999999999999999999   99999999999999999999999999999986


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      .......  .....||+.|+|||++.+ .++.++|||||||++|||++|..||.........      ..+         
T Consensus       189 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~------~~i---------  251 (373)
T 2r5t_A          189 NIEHNST--TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY------DNI---------  251 (373)
T ss_dssp             GBCCCCC--CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHH------HHH---------
T ss_pred             cccCCCc--cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHH------HHH---------
Confidence            4332221  146689999999999988 8999999999999999999999999765433221      111         


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVA  321 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl  321 (332)
                           +.....    .+...+..+.+|+.+||+.||.+||++.+.+
T Consensus       252 -----~~~~~~----~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          252 -----LNKPLQ----LKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             -----HHSCCC----CCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             -----HhcccC----CCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence                 111110    0112347789999999999999999985433

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=343.76  Aligned_cols=257  Identities=19%  Similarity=0.305  Sum_probs=188.6

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ++|.+.+.||+|+||.||+|.+  +++.||+|++...........+.+|+.++++++||||+++           +||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            5789999999999999999999  7899999999765543323346689999999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      ++ |+|.+++....    ..+++..+..++.||+.||.|||   +.||+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  153 (324)
T 3mtl_A           82 LD-KDLKQYLDDCG----NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP  153 (324)
T ss_dssp             CS-EEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC---
T ss_pred             cc-cCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCC
Confidence            97 59999987652    45899999999999999999999   999999999999999999999999999999765443


Q ss_pred             CceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-cccchhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-QNCRFKEMV  277 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  277 (332)
                      ...  .....||+.|+|||++.+  .++.++|||||||++|+|++|..||......+....  ....... ....+....
T Consensus       154 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~--i~~~~~~~~~~~~~~~~  229 (324)
T 3mtl_A          154 TKT--YDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHF--IFRILGTPTEETWPGIL  229 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--HHHHHCCCCTTTSTTGG
T ss_pred             ccc--cccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHHhCCCChHhchhhh
Confidence            322  134578999999999876  689999999999999999999999987665443221  1111111 111111111


Q ss_pred             hhhhhcccCCC---C----CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 DSIIIEDKSCT---C----TGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~~~~~~~~~~~---~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ..........+   .    ......+.++.+|+.+||+.||.+|||+.|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            11100000000   0    001133477899999999999999999999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=364.05  Aligned_cols=241  Identities=17%  Similarity=0.275  Sum_probs=194.1

Q ss_pred             ccccCCCceEEEEEe----CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------EEEEeccCCCh
Q 038681           61 IVLEDPFRKLYKGFW----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IVFESVQIGTL  126 (332)
Q Consensus        61 ~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv~e~~~~g~L  126 (332)
                      .||+|+||.||+|.+    ++..||||.++........+.+.+|+.++++++|||||++          |||||+++|+|
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L  422 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPL  422 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTCBH
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcH
Confidence            799999999999987    4567999999876655557889999999999999999998          89999999999


Q ss_pred             HHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceee-
Q 038681          127 ADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIE-  205 (332)
Q Consensus       127 ~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-  205 (332)
                      .+++...    ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.......... 
T Consensus       423 ~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~  495 (613)
T 2ozo_A          423 HKFLVGK----REEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTA  495 (613)
T ss_dssp             HHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------
T ss_pred             HHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeee
Confidence            9999754    146999999999999999999999   99999999999999999999999999999987654332111 


Q ss_pred             ccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhc
Q 038681          206 LDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIE  283 (332)
Q Consensus       206 ~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (332)
                      .....+|+.|+|||++.+ .++.++|||||||++|||++ |..||......+...      .+..               
T Consensus       496 ~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~------~i~~---------------  554 (613)
T 2ozo_A          496 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA------FIEQ---------------  554 (613)
T ss_dssp             ------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHH------HHHT---------------
T ss_pred             ccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH------HHHc---------------
Confidence            123345789999999986 89999999999999999998 999998765433211      1110               


Q ss_pred             ccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 038681          284 DKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSC  331 (332)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  331 (332)
                      ..  ....+..++..+.+||.+||+.||++|||+.+|++.|+.++.++
T Consensus       555 ~~--~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          555 GK--RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             TC--CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             CC--CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence            00  01111234578999999999999999999999999999987653

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=343.12  Aligned_cols=248  Identities=15%  Similarity=0.191  Sum_probs=198.5

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEE-----e--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc---CCCcceE--
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGF-----W--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS---HKHIIKL--  115 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~-----~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---H~nIv~~--  115 (332)
                      ++....++|.+.+.||+|+||.||+|.     .  .++.||+|++....    ...+..|+.++..++   |+||+++  
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~e~~~~~~l~~~~~~~iv~~~~  134 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN----PWEFYIGTQLMERLKPSMQHMFMKFYS  134 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC----HHHHHHHHHHHHHSCGGGGGGBCCEEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC----hhHHHHHHHHHHHhhhhhhhhhhhhhe
Confidence            344556779999999999999999994     3  78899999997653    456778888888876   9999987  


Q ss_pred             ---------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC----
Q 038681          116 ---------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE----  182 (332)
Q Consensus       116 ---------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~----  182 (332)
                               |||||+++|+|.+++..........+++..++.++.||+.||+|||   +++|+||||||+|||++.    
T Consensus       135 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~  211 (365)
T 3e7e_A          135 AHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLE  211 (365)
T ss_dssp             EEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTC
T ss_pred             eeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccC
Confidence                     8999999999999998654333357999999999999999999999   999999999999999998    


Q ss_pred             -------CCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCcc
Q 038681          183 -------QSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFE  254 (332)
Q Consensus       183 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~  254 (332)
                             ++.+||+|||+|+...............||+.|+|||++.+ .++.++|||||||++|||++|+.||......
T Consensus       212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~  291 (365)
T 3e7e_A          212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG  291 (365)
T ss_dssp             C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETT
T ss_pred             ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCC
Confidence                   89999999999976543222222356789999999999988 7899999999999999999999998643221


Q ss_pred             chhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHHHHHHh
Q 038681          255 SRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDR-PTMVDVAKQLRQMYRS  330 (332)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R-Ps~~evl~~L~~l~~~  330 (332)
                      ...               ....+.         ..    ...+.+.+++..||+.+|.+| |++.++.+.|+.++..
T Consensus       292 ~~~---------------~~~~~~---------~~----~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          292 ECK---------------PEGLFR---------RL----PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             EEE---------------ECSCCT---------TC----SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cee---------------echhcc---------cc----CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            100               000000         00    113567899999999999999 6788899888887754

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7.1e-47  Score=343.10  Aligned_cols=253  Identities=15%  Similarity=0.149  Sum_probs=188.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-----CCeeEEEEEEcCCCChh----------hHHHHHHHHHHHHhhcCCCcceE--
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-----QKRSISLMKYNGNRNQH----------ALEWCINHIVYASRMSHKHIIKL--  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~----------~~~~~~~E~~~l~~l~H~nIv~~--  115 (332)
                      .++|.+.+.||+|+||.||+|.+     .+..+|+|+........          ....+.+|+..+..++||||+++  
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            46799999999999999999998     45789999988764321          11236788889999999999986  


Q ss_pred             -------------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC
Q 038681          116 -------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE  182 (332)
Q Consensus       116 -------------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~  182 (332)
                                   +||||+ +++|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~  186 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN-----GTFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGY  186 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG-----GBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEES
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEcc
Confidence                         899999 99999999876     47999999999999999999999   899999999999999988


Q ss_pred             CC--CeEEeecCCccccCCCCce-----eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCcc
Q 038681          183 QS--DAKLFDFSLSLSIPDGETH-----IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFE  254 (332)
Q Consensus       183 ~~--~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~  254 (332)
                      ++  .+||+|||+++........     .......||+.|+|||++.+ .++.++|||||||++|||++|..||......
T Consensus       187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  266 (345)
T 2v62_A          187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD  266 (345)
T ss_dssp             SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred             CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence            77  9999999999776432211     11134579999999999988 7999999999999999999999999653222


Q ss_pred             chhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          255 SRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                      ...... .....   ...+...+.....         ....+..+.+|+.+||+.||++|||+.+|++.|+.+
T Consensus       267 ~~~~~~-~~~~~---~~~~~~~~~~~~~---------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          267 PVAVQT-AKTNL---LDELPQSVLKWAP---------SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHH-HHHHH---HHTTTHHHHHHSC---------TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             cHHHHH-HHHhh---cccccHHHHhhcc---------ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            211100 00000   0011111110000         002336899999999999999999999999999764

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.8e-46  Score=340.78  Aligned_cols=233  Identities=21%  Similarity=0.305  Sum_probs=190.9

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      +.|...+.||+|+||.||+|.+  +++.||||++.....  ....+.+.+|+.++++++||||+++           +||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588899999999999999998  899999999976532  3345678999999999999999997           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||++ |+|.+++....    ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||++....
T Consensus       134 e~~~-g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  205 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  205 (348)
T ss_dssp             ECCS-EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             ecCC-CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecC
Confidence            9997 68888886542    46999999999999999999999   8999999999999999999999999999997664


Q ss_pred             CCCceeeccccccCCCcccccccC----CCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFT----TLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ..      ....||+.|+|||++.    +.++.++|||||||++|||++|..||.........     .........   
T Consensus       206 ~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-----~~~~~~~~~---  271 (348)
T 1u5q_A          206 PA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-----YHIAQNESP---  271 (348)
T ss_dssp             SB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH-----HHHHHSCCC---
T ss_pred             CC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH-----HHHHhcCCC---
Confidence            32      3457999999999883    37899999999999999999999999765432221     111111000   


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                    .......+..+.+|+.+||+.||++|||+.++++
T Consensus       272 --------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~  305 (348)
T 1u5q_A          272 --------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  305 (348)
T ss_dssp             --------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                          0011133477899999999999999999999975

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.3e-46  Score=342.14  Aligned_cols=258  Identities=19%  Similarity=0.253  Sum_probs=198.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  ++..||||++.........+.+.+|+.++.+++||||+++               
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            46799999999999999999998  7899999999876666667889999999999999999975               


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       +||||++ |+|.+++...      .+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++
T Consensus       106 ~iv~e~~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a  175 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLA  175 (364)
T ss_dssp             EEEEECCS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEcccC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcce
Confidence             8999997 5999998653      6999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCcee-eccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          195 LSIPDGETHI-ELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       195 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      +......... ......||+.|+|||++.+  .++.++|||||||++|+|++|..||...........  ..........
T Consensus       176 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--i~~~~~~~~~  253 (364)
T 3qyz_A          176 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH--ILGILGSPSQ  253 (364)
T ss_dssp             EECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHH--HHHHHCSCCH
T ss_pred             EecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHH--HHHHhCCCCH
Confidence            8765432211 1234579999999998754  689999999999999999999999987665443221  1111111000


Q ss_pred             c-hhhhhhh---hhhcccCCCCC-----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          272 R-FKEMVDS---IIIEDKSCTCT-----GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       272 ~-~~~~~~~---~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      . +....+.   ......+....     .....+.++.+|+.+||+.||++|||+.|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0 0000000   00000000000     00123477999999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.3e-46  Score=330.93  Aligned_cols=243  Identities=17%  Similarity=0.289  Sum_probs=195.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-------------E
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-------------I  116 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-------------l  116 (332)
                      .++|++.+.||+|+||.||+|.+  +++.||+|.+.... .....+.+.+|+.++++++||||+++             +
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            46799999999999999999999  78999999997654 34446789999999999999999987             8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCC-----eeecCCCCCCeeeCCCCCeEEeec
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRP-----IVYRDMKPTNILFNEQSDAKLFDF  191 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~-----ivH~Dlkp~Nill~~~~~~kl~Df  191 (332)
                      ||||+++|+|.+++..... ....+++..++.++.||+.||.|||   +.+     |+||||||+||+++.++.+||+||
T Consensus        85 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECH---RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---HHC------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             EEeCCCCCCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHh---cccCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            9999999999999986522 1245999999999999999999999   777     999999999999999999999999


Q ss_pred             CCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc
Q 038681          192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       192 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      |+++........  .....||+.|+|||++.+ .++.++|||||||++|+|++|..||........      ...+... 
T Consensus       161 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~i~~~-  231 (279)
T 2w5a_A          161 GLARILNHDTSF--AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL------AGKIREG-  231 (279)
T ss_dssp             CHHHHC---CHH--HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHT-
T ss_pred             chheeecccccc--ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH------HHHHhhc-
Confidence            999876544321  134578999999999987 889999999999999999999999986543221      1111000 


Q ss_pred             cchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 038681          271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQL  324 (332)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L  324 (332)
                                   ..   ...+...+..+.+++.+||+.||.+|||+.+|++.+
T Consensus       232 -------------~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          232 -------------KF---RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             -------------CC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             -------------cc---ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence                         00   001113347899999999999999999999998754

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4e-46  Score=340.69  Aligned_cols=242  Identities=23%  Similarity=0.355  Sum_probs=195.7

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-------hhhHHHHHHHHHHHHhh-cCCCcceE----
Q 038681           50 RIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-------QHALEWCINHIVYASRM-SHKHIIKL----  115 (332)
Q Consensus        50 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l-~H~nIv~~----  115 (332)
                      ....++|.+.+.||+|+||.||+|.+  +|+.||||++.....       ....+.+.+|+.++.++ +||||+++    
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            34456799999999999999999998  689999999876532       12245688999999999 79999987    


Q ss_pred             -------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEE
Q 038681          116 -------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKL  188 (332)
Q Consensus       116 -------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  188 (332)
                             +||||+++|+|.+++...     ..+++..+..++.||+.||.|||   +.||+|+||||+|||++.++.+||
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEE
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEE
Confidence                   899999999999999865     57999999999999999999999   899999999999999999999999


Q ss_pred             eecCCccccCCCCceeeccccccCCCcccccccCC-------CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHH
Q 038681          189 FDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-------LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEE  261 (332)
Q Consensus       189 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~  261 (332)
                      +|||++.........   ....||+.|+|||++.+       .++.++|||||||++|+|++|..||.........    
T Consensus       242 ~DfG~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~----  314 (365)
T 2y7j_A          242 SDFGFSCHLEPGEKL---RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILML----  314 (365)
T ss_dssp             CCCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----
T ss_pred             EecCcccccCCCccc---ccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHH----
Confidence            999999877654332   45679999999998752       5788999999999999999999999765432211    


Q ss_pred             HHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          262 NVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                        ..+......+              ..+.....+..+.+|+.+||+.||++|||+.++++
T Consensus       315 --~~i~~~~~~~--------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          315 --RMIMEGQYQF--------------SSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             --HHHHHTCCCC--------------CHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --HHHHhCCCCC--------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              1111000000              00000122367999999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.1e-46  Score=329.63  Aligned_cols=234  Identities=20%  Similarity=0.315  Sum_probs=194.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      .++|.+.+.||+|+||.||+|.+  ++..||+|.+.....  ....+.+.+|+.++++++||||+++           +|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            46799999999999999999999  688999999865421  2225678999999999999999987           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+++|+|.+++...     ..+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||++...
T Consensus        93 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  164 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHA  164 (284)
T ss_dssp             ECCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccC
Confidence            9999999999999876     56999999999999999999999   999999999999999999999999999999765


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      .....    ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.........      ..+.....     
T Consensus       165 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~------~~~~~~~~-----  229 (284)
T 2vgo_A          165 PSLRR----RTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH------RRIVNVDL-----  229 (284)
T ss_dssp             SSSCB----CCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHTTCC-----
T ss_pred             ccccc----ccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH------HHHhcccc-----
Confidence            54322    34578999999999987 7899999999999999999999999765432211      11110000     


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                   ..+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       230 -------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          230 -------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             -------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence                         011123467899999999999999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.6e-47  Score=364.88  Aligned_cols=252  Identities=21%  Similarity=0.308  Sum_probs=205.1

Q ss_pred             HHHHHHHhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------
Q 038681           46 AEELRIATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------  115 (332)
Q Consensus        46 ~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------  115 (332)
                      .+.+++..++|.+.+.||+|+||.||+|.+ .+..||||++......  .+.+.+|+.++++++||||+++         
T Consensus       259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  336 (535)
T 2h8h_A          259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI  336 (535)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSC
T ss_pred             ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC--HHHHHHHHHHHHhCCCCCEeeEEEEEeeccc
Confidence            445666677899999999999999999999 5678999999875432  5679999999999999999998         


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       |||||+++|+|.+++.....   ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a  410 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLA  410 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred             eEeeehhcCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccc
Confidence             89999999999999975421   35899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      +........ ......++..|+|||++.+ .++.++|||||||++|||++ |..||......+...      .+..    
T Consensus       411 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~------~i~~----  479 (535)
T 2h8h_A          411 RLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLD------QVER----  479 (535)
T ss_dssp             TTCCCHHHH-TTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHH------HHHT----
T ss_pred             eecCCCcee-cccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HHHc----
Confidence            876542211 1123456789999999876 89999999999999999999 999997654332211      1100    


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                                 ..  ..+.+..++..+.+||.+||+.||++|||+.+|++.|+.+..
T Consensus       480 -----------~~--~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          480 -----------GY--RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             -----------TC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             -----------CC--CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence                       00  011112345789999999999999999999999999988754

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.9e-46  Score=331.97  Aligned_cols=237  Identities=20%  Similarity=0.315  Sum_probs=197.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      ...|.+.+.||+|+||.||+|.+  +++.||+|.+.........+.+.+|+.++.+++||||+++           +|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            35599999999999999999998  7899999999877655557889999999999999999987           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++++|.+++..      ..+++..+..++.||+.||.|||   +.||+|+||||+||+++.++.+||+|||++.....
T Consensus       101 ~~~~~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A          101 YLGGGSALDLLEP------GPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             CCTTEEHHHHHTT------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             eCCCCcHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            9999999999865      36999999999999999999999   89999999999999999999999999999977654


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      ....  .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..........     .......        
T Consensus       172 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~~--------  236 (303)
T 3a7i_A          172 TQIK--RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF-----LIPKNNP--------  236 (303)
T ss_dssp             TBCC--BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHHHSCC--------
T ss_pred             cccc--cCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH-----HhhcCCC--------
Confidence            3321  145678999999999987 88999999999999999999999997654322111     0000000        


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ  323 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~  323 (332)
                                .......+..+.+|+.+||+.||.+|||+.++++.
T Consensus       237 ----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          237 ----------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             ----------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ----------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                      00111234679999999999999999999999873

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=6.2e-46  Score=340.19  Aligned_cols=254  Identities=17%  Similarity=0.248  Sum_probs=186.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE--------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL--------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~--------------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||||++.... .....+.+.+|+.+++.++||||+++              
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            46799999999999999999998  78999999997643 34446778999999999999999976              


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                         +||||+++ +|.+++..       .+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||
T Consensus       104 ~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg  172 (371)
T 2xrw_A          104 DVYIVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFG  172 (371)
T ss_dssp             EEEEEEECCSE-EHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             ceEEEEEcCCC-CHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEee
Confidence               89999975 78888853       4899999999999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      +++........   ....||+.|+|||++.+ .++.++|||||||++|+|++|..||..........  ..........+
T Consensus       173 ~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~i~~~~~~~~~  247 (371)
T 2xrw_A          173 LARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN--KVIEQLGTPCP  247 (371)
T ss_dssp             C-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHC-CCCCCH
T ss_pred             ccccccccccc---CCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCCH
Confidence            99866543221   34679999999999988 89999999999999999999999998765433211  11111110000


Q ss_pred             chhhhhh----hhhhccc----------------CCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          272 RFKEMVD----SIIIEDK----------------SCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       272 ~~~~~~~----~~~~~~~----------------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .+...+.    .......                +.........+..+.+|+.+||+.||.+|||++|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence            0000000    0000000                0011112244678999999999999999999999987

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=7.2e-47  Score=347.10  Aligned_cols=237  Identities=13%  Similarity=0.144  Sum_probs=183.0

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCC--CChhhHHHHHHHH---HHHHhhcCCCcce------------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGN--RNQHALEWCINHI---VYASRMSHKHIIK------------  114 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~--~~~~~~~~~~~E~---~~l~~l~H~nIv~------------  114 (332)
                      ++|.+.+.||+|+||.||+|.+  +++.||||++...  ......+.+.+|+   .++++++|||||+            
T Consensus        73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~  152 (377)
T 3byv_A           73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  152 (377)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred             ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence            5688889999999999999997  6999999999743  2234467899999   5555568999963            


Q ss_pred             -----------------------EEEEEeccCCChHHHHhhhhccc--ccCCCHHHHHHHHHHHHHHHHHhhhcCCCCee
Q 038681          115 -----------------------LIVFESVQIGTLADRIHHHCEQH--FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIV  169 (332)
Q Consensus       115 -----------------------~lv~e~~~~g~L~~~l~~~~~~~--~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~iv  169 (332)
                                             +|||||+ +|+|.+++.....-.  ...+++..++.++.||+.||+|||   +++|+
T Consensus       153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iv  228 (377)
T 3byv_A          153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLV  228 (377)
T ss_dssp             ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHH---HTTEE
T ss_pred             hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHH---hCCee
Confidence                                   4899999 679999998752110  122445888899999999999999   89999


Q ss_pred             ecCCCCCCeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC------------CCChhhhHHHHHHH
Q 038681          170 YRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT------------LINEQCDVYGFGAF  237 (332)
Q Consensus       170 H~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------------~~~~~sDiwSlG~~  237 (332)
                      ||||||+|||++.++.+||+|||+++.....     .....| +.|+|||++.+            .++.++|||||||+
T Consensus       229 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          229 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             CSCCCGGGEEECTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             cCCCCHHHEEEcCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999864331     134567 99999999864            48999999999999


Q ss_pred             HHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCH
Q 038681          238 LFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTM  317 (332)
Q Consensus       238 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~  317 (332)
                      +|||++|..||..........      ..              ....        ...++.+.+|+.+||+.||++|||+
T Consensus       303 l~elltg~~Pf~~~~~~~~~~------~~--------------~~~~--------~~~~~~~~~li~~~L~~dp~~Rpt~  354 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGSE------WI--------------FRSC--------KNIPQPVRALLEGFLRYPKEDRLLP  354 (377)
T ss_dssp             HHHHHHSSCCC------CCSG------GG--------------GSSC--------CCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred             HHHHHHCCCCCcccccccchh------hh--------------hhhc--------cCCCHHHHHHHHHHcCCCchhCCCH
Confidence            999999999997654322111      00              0000        1223679999999999999999999


Q ss_pred             HHHHH--HHHHHH
Q 038681          318 VDVAK--QLRQMY  328 (332)
Q Consensus       318 ~evl~--~L~~l~  328 (332)
                      .++++  .++.+.
T Consensus       355 ~e~l~hp~f~~~~  367 (377)
T 3byv_A          355 LQAMETPEYEQLR  367 (377)
T ss_dssp             HHHHTSHHHHHHH
T ss_pred             HHHhhChHHHHHH
Confidence            99986  444443

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.6e-46  Score=364.08  Aligned_cols=241  Identities=18%  Similarity=0.297  Sum_probs=194.6

Q ss_pred             CccccCCCceEEEEEe----CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE----------EEEEeccCC
Q 038681           60 NIVLEDPFRKLYKGFW----QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL----------IVFESVQIG  124 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~----------lv~e~~~~g  124 (332)
                      +.||+|+||.||+|.+    .+..||||+++.... ....+.+.+|+.++.+++|||||++          |||||+++|
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g  454 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG  454 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCC
Confidence            3699999999999976    457899999986532 3446789999999999999999998          899999999


Q ss_pred             ChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCcee
Q 038681          125 TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHI  204 (332)
Q Consensus       125 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  204 (332)
                      +|.+++...     ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++.........
T Consensus       455 ~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          455 PLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            999999765     56999999999999999999999   9999999999999999999999999999998765443221


Q ss_pred             -eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhh
Q 038681          205 -ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSII  281 (332)
Q Consensus       205 -~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (332)
                       ......+|+.|+|||++.+ .++.++|||||||++|||++ |..||..........      .+..             
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~------~i~~-------------  587 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA------MLEK-------------  587 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH------HHHT-------------
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HHHc-------------
Confidence             1133456788999999987 89999999999999999998 999998765433211      1100             


Q ss_pred             hcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 038681          282 IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSC  331 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  331 (332)
                        ..  ....+..++.++.+||.+||+.||++|||+.+|++.|+++..++
T Consensus       588 --~~--~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          588 --GE--RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             --TC--CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             --CC--CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence              00  00111234478999999999999999999999999999998765

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.8e-47  Score=344.11  Aligned_cols=252  Identities=14%  Similarity=0.189  Sum_probs=196.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-C---------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcce--------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-Q---------KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIK--------  114 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~--------  114 (332)
                      .++|.+.+.||+|+||.||+|.+ .         ++.||+|.+...      +.+.+|+.++.+++||||++        
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~------~~~~~E~~~l~~l~h~niv~~~~~~~~~  114 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD------GRLFNEQNFFQRAAKPLQVNKWKKLYST  114 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence            46799999999999999999998 2         688999998764      35789999999999999986        


Q ss_pred             -------------------EEEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 038681          115 -------------------LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP  175 (332)
Q Consensus       115 -------------------~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  175 (332)
                                         ++||||+ +|+|.+++....   ...+++..++.++.||+.||.|||   +++|+||||||
T Consensus       115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp  187 (352)
T 2jii_A          115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTA  187 (352)
T ss_dssp             TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCG
T ss_pred             CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCH
Confidence                               2899999 999999998642   146999999999999999999999   89999999999


Q ss_pred             CCeeeCCCC--CeEEeecCCccccCCCCcee-----eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCcc
Q 038681          176 TNILFNEQS--DAKLFDFSLSLSIPDGETHI-----ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEV  247 (332)
Q Consensus       176 ~Nill~~~~--~~kl~Dfg~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p  247 (332)
                      +|||++.++  .+||+|||+++.........     ......||+.|+|||++.+ .++.++|||||||++|||++|..|
T Consensus       188 ~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p  267 (352)
T 2jii_A          188 ENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP  267 (352)
T ss_dssp             GGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred             HHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            999999998  89999999997664322110     1134579999999999988 899999999999999999999999


Q ss_pred             CCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          248 SDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                      |............ ...........+.   +         ........+..+.+|+.+||+.||++|||+++|++.|+++
T Consensus       268 f~~~~~~~~~~~~-~~~~~~~~~~~~~---~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          268 WTNCLPNTEDIMK-QKQKFVDKPGPFV---G---------PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             TGGGTTCHHHHHH-HHHHHHHSCCCEE---C---------TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cccCCcCHHHHHH-HHHhccCChhhhh---h---------hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            9865422211100 1110000000000   0         0000012347899999999999999999999999999999


Q ss_pred             HHh
Q 038681          328 YRS  330 (332)
Q Consensus       328 ~~~  330 (332)
                      .+.
T Consensus       335 ~~~  337 (352)
T 2jii_A          335 LQD  337 (352)
T ss_dssp             HHH
T ss_pred             HHh
Confidence            865

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.1e-47  Score=347.37  Aligned_cols=242  Identities=10%  Similarity=0.059  Sum_probs=180.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhh--cCCCcce------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRM--SHKHIIK------------  114 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l--~H~nIv~------------  114 (332)
                      ..+|.+.+.||+|+||.||+|.+  +++.||||++.....  ....+.+.+|+.++..+  +||||++            
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            34588999999999999999998  789999999987653  34466778886655555  5999775            


Q ss_pred             -----------------------EEEEEeccCCChHHHHhhhhcccccCCCHHHH------HHHHHHHHHHHHHhhhcCC
Q 038681          115 -----------------------LIVFESVQIGTLADRIHHHCEQHFEALSLTDR------LKVAMDIAHAVAYLHVGFS  165 (332)
Q Consensus       115 -----------------------~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~------~~i~~~i~~~L~~LH~~~~  165 (332)
                                             +|||||++ |+|.+++....    ..+++..+      ..++.||+.||+|||   +
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~  212 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQ---S  212 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHH---H
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHH---H
Confidence                                   48999999 89999998752    23455555      678899999999999   9


Q ss_pred             CCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC---CCChhhhHHHHHHHHHHHH
Q 038681          166 RPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT---LINEQCDVYGFGAFLFELL  242 (332)
Q Consensus       166 ~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~ell  242 (332)
                      ++|+||||||+|||++.++.+||+|||+++......     ....+|+.|+|||++.+   .++.++|||||||++|||+
T Consensus       213 ~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ell  287 (371)
T 3q60_A          213 KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW  287 (371)
T ss_dssp             TTEEETTCSGGGEEECTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHH
T ss_pred             CCCccCcCCHHHEEECCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHH
Confidence            999999999999999999999999999998664322     24567799999999975   6899999999999999999


Q ss_pred             hCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          243 TAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       243 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      +|+.||..........+...         ..      ..........+.....++.+.+|+.+||+.||++|||+.++++
T Consensus       288 tg~~Pf~~~~~~~~~~~~~~---------~~------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          288 CLFLPFGLVTPGIKGSWKRP---------SL------RVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             HSSCSTTBCCTTCTTCCCBC---------CT------TSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             hCCCCCCCcCcccccchhhh---------hh------hhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99999987643221110000         00      0000000011111234578999999999999999999999975

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.7e-46  Score=338.38  Aligned_cols=260  Identities=15%  Similarity=0.199  Sum_probs=186.8

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           50 RIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        50 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      ....++|.+.+.||+|+||.||+|.+  +++.||||++..... ....+.+.+|+.++++++||||+++           
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            34467899999999999999999998  899999999976543 2335667899999999999999997           


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeC-----CCCCeEEee
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN-----EQSDAKLFD  190 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-----~~~~~kl~D  190 (332)
                      +||||++ |+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++     .++.+||+|
T Consensus       110 lv~e~~~-~~L~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D  180 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGD  180 (329)
T ss_dssp             EEEECCS-EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred             EEEecCC-CCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECc
Confidence            8999998 4999999876     56999999999999999999999   89999999999999994     445599999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG  268 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  268 (332)
                      ||+++........  .....||+.|+|||++.+  .++.++|||||||++|||++|..||..........  ........
T Consensus       181 fg~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~  256 (329)
T 3gbz_A          181 FGLARAFGIPIRQ--FTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF--KIFEVLGL  256 (329)
T ss_dssp             TTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCC
T ss_pred             CCCccccCCcccc--cCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH--HHHHHhCC
Confidence            9999876543222  134578999999999976  58999999999999999999999998765433221  11111111


Q ss_pred             -cccchhhhhhhhh-hcccC-CCCC-----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          269 -QNCRFKEMVDSII-IEDKS-CTCT-----GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       269 -~~~~~~~~~~~~~-~~~~~-~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                       ....+........ ....+ ....     .....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          257 PDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             CCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence             0000000000000 00000 0000     00113477899999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=9.5e-47  Score=337.97  Aligned_cols=252  Identities=20%  Similarity=0.232  Sum_probs=197.4

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-------------
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-------------  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-------------  115 (332)
                      ...++|.+.+.||+|+||.||+|.+  +++.||+|++.... ....+.+.+|+.+++.++||||+++             
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE-QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE  104 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS-HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC-HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence            4567899999999999999999998  88999999986643 3346789999999999999999986             


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        +||||+++|+|.+++...... ...+++..++.++.||+.||.|||   +++|+||||||+||+++.++.+||+|||+
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          105 AWLLLPFFKRGTLWNEIERLKDK-GNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             eEEEEEeCCCCcHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCc
Confidence              899999999999999864222 256999999999999999999999   89999999999999999999999999999


Q ss_pred             ccccCCCCcee-------eccccccCCCcccccccCC----CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHH
Q 038681          194 SLSIPDGETHI-------ELDSVVGTTGFIAPENFTT----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEEN  262 (332)
Q Consensus       194 a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~  262 (332)
                      +..........       ......||+.|+|||++.+    .++.++|||||||++|+|++|..||.........     
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-----  255 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-----  255 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC-----
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch-----
Confidence            87654221100       0123457999999999875    3689999999999999999999998642111100     


Q ss_pred             HhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 038681          263 VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY  328 (332)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~  328 (332)
                                .......    ..  ..+.....+..+.+|+.+||+.||.+|||+.++++.|+++.
T Consensus       256 ----------~~~~~~~----~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          256 ----------VALAVQN----QL--SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             ----------HHHHHHC----C----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             ----------hhHHhhc----cC--CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence                      0000000    00  01111233478999999999999999999999999998875

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.2e-46  Score=337.86  Aligned_cols=258  Identities=20%  Similarity=0.293  Sum_probs=192.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      .++|++.+.||+|+||.||+|.+  +++.||+|++..... ....+.+.+|+.++++++||||+++           +||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            45799999999999999999999  689999999876543 3345668899999999999999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++++|.+++...     ..+++..+..++.||+.||.|||   +.||+||||||+||+++.++.+||+|||+++...
T Consensus       104 e~~~~~~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A          104 EFVDHTILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             ECCSEEHHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             ecCCcchHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence            999999998887654     56999999999999999999999   9999999999999999999999999999997665


Q ss_pred             CCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ......  ....||+.|+|||++.+  .++.++|||||||++|+|++|..||..........  ..........+.....
T Consensus       176 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~  251 (331)
T 4aaa_A          176 APGEVY--DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLY--HIMMCLGNLIPRHQEL  251 (331)
T ss_dssp             ----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCSCCHHHHHH
T ss_pred             CCcccc--CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH--HHHHHhCCCChhhhhH
Confidence            433221  34578999999999876  68999999999999999999999998765543221  1111111111111111


Q ss_pred             hhhhhhcc-c-----CCCCC---ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIED-K-----SCTCT---GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~-~-----~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      +....... .     ....+   ..+..++.+.+|+.+||+.||.+|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          252 FNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             HHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             hhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            11000000 0     00000   00134578999999999999999999999886

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=8.4e-47  Score=340.64  Aligned_cols=254  Identities=21%  Similarity=0.307  Sum_probs=185.3

Q ss_pred             ccHHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-CCCcceE-----
Q 038681           44 FSAEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKL-----  115 (332)
Q Consensus        44 ~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~~-----  115 (332)
                      +..+.++....+|.+.+.||+|+||.||+|.+  +++.||+|++..... ...+.+.+|+.++.++. ||||+++     
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~   96 (337)
T 3ll6_A           18 FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE-EKNRAIIQEVCFMKKLSGHPNIVQFCSAAS   96 (337)
T ss_dssp             STTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH-HHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             hhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch-HHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence            33344455566899999999999999999999  889999999865543 33677899999999996 9999986     


Q ss_pred             --------------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCCee
Q 038681          116 --------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRP--IVYRDMKPTNIL  179 (332)
Q Consensus       116 --------------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nil  179 (332)
                                    +||||++ |+|.+++.....  ...+++..++.++.||+.||.|||   +.+  |+||||||+|||
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl  170 (337)
T 3ll6_A           97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMES--RGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLL  170 (337)
T ss_dssp             ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHT--TCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCE
T ss_pred             ccccccccCCceEEEEEEecC-CCHHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEE
Confidence                          7999996 699999976422  146999999999999999999999   888  999999999999


Q ss_pred             eCCCCCeEEeecCCccccCCCCcee----------eccccccCCCccccccc---CC-CCChhhhHHHHHHHHHHHHhCC
Q 038681          180 FNEQSDAKLFDFSLSLSIPDGETHI----------ELDSVVGTTGFIAPENF---TT-LINEQCDVYGFGAFLFELLTAQ  245 (332)
Q Consensus       180 l~~~~~~kl~Dfg~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~-~~~~~sDiwSlG~~l~elltg~  245 (332)
                      ++.++.+||+|||+++.........          ......||+.|+|||++   .+ .++.++|||||||++|+|++|.
T Consensus       171 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~  250 (337)
T 3ll6_A          171 LSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ  250 (337)
T ss_dssp             ECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSS
T ss_pred             ECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCC
Confidence            9999999999999998765432211          11245689999999998   34 7899999999999999999999


Q ss_pred             ccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 038681          246 EVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR  325 (332)
Q Consensus       246 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~  325 (332)
                      .||.........                    ......      +.....+..+.+|+.+||+.||.+|||+.++++.|+
T Consensus       251 ~p~~~~~~~~~~--------------------~~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          251 HPFEDGAKLRIV--------------------NGKYSI------PPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             CCC--------------------------------CCC------CTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             CCCcchhHHHhh--------------------cCcccC------CcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            999754322110                    000000      000112245789999999999999999999999999


Q ss_pred             HHHHh
Q 038681          326 QMYRS  330 (332)
Q Consensus       326 ~l~~~  330 (332)
                      .+...
T Consensus       305 ~~~~~  309 (337)
T 3ll6_A          305 EIAAA  309 (337)
T ss_dssp             HHHHH
T ss_pred             HHHhc
Confidence            88753

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.9e-46  Score=329.41  Aligned_cols=236  Identities=19%  Similarity=0.288  Sum_probs=196.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|.+....  .....+.+.+|+.+++.++||||+++           +|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            45799999999999999999999  68899999987653  33446778999999999999999998           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+++++|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+||+++.++.+||+|||++...
T Consensus        94 ~e~~~~~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  165 (294)
T 2rku_A           94 LELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV  165 (294)
T ss_dssp             EECCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceec
Confidence            9999999999998775     57999999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ......  .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.........      .........    
T Consensus       166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~~~~~----  233 (294)
T 2rku_A          166 EYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY------LRIKKNEYS----  233 (294)
T ss_dssp             CSTTCC--BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHTTCCC----
T ss_pred             ccCccc--cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHhhccCC----
Confidence            543322  134578999999999987 7899999999999999999999999765433211      111100000    


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                    .+...+..+.+|+.+||+.||++|||+.++++
T Consensus       234 --------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          234 --------------IPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             --------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             --------------CccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence                          11123367899999999999999999999986

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.1e-46  Score=327.29  Aligned_cols=235  Identities=26%  Similarity=0.368  Sum_probs=186.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|.+....  .....+.+.+|+.+++.++||||+++           +|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            46799999999999999999998  68999999986542  12335678999999999999999998           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+++++|.+++...     ..+++..+..++.||+.||.|||   +++|+|+||||+||+++.++.+||+|||++...
T Consensus        90 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           90 MEYVSGGELFDYICKH-----GRVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             EECCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             EeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeeccccccc
Confidence            9999999999999876     56999999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCceeeccccccCCCcccccccCC-C-CChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-L-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      ......   ....||+.|+|||++.+ . .+.++||||||+++|+|++|..||........      ...+......   
T Consensus       162 ~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~~~~~~~~---  229 (276)
T 2h6d_A          162 SDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL------FKKIRGGVFY---  229 (276)
T ss_dssp             CC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCCC---
T ss_pred             CCCcce---ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH------HHHhhcCccc---
Confidence            554322   34578999999999987 3 36899999999999999999999976543221      1111110000   


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                     .+...+..+.+++.+||+.||.+|||+.++++
T Consensus       230 ---------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          230 ---------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             ---------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence                           01123367899999999999999999999987

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4e-46  Score=342.85  Aligned_cols=257  Identities=18%  Similarity=0.206  Sum_probs=192.0

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           49 LRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        49 l~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      ++...++|.+.+.||+|+||.||+|.+  +++.||||++......     ..+|+.+++.++||||+++           
T Consensus         2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~-----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   76 (383)
T 3eb0_A            2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY-----KNRELDIMKVLDHVNIIKLVDYFYTTGDEE   76 (383)
T ss_dssp             ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS-----CCHHHHHHTTCCCTTBCCEEEEEEEC----
T ss_pred             CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch-----HHHHHHHHHHcCCCCccchhheeeecCccc
Confidence            445678899999999999999999998  8899999998765332     2479999999999999974           


Q ss_pred             --------------------------------------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHH
Q 038681          116 --------------------------------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAV  157 (332)
Q Consensus       116 --------------------------------------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L  157 (332)
                                                            +||||++ |+|.+.+...... ...+++..+..++.||+.||
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           77 PKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS-GRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             ---------------------------------CCEEEEEECCCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHH
Confidence                                                  6899998 5888888754322 25799999999999999999


Q ss_pred             HHhhhcCCCCeeecCCCCCCeeeC-CCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHH
Q 038681          158 AYLHVGFSRPIVYRDMKPTNILFN-EQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGF  234 (332)
Q Consensus       158 ~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSl  234 (332)
                      .|||   +.||+||||||+|||++ .++.+||+|||+++........   ....||+.|+|||++.+  .++.++|||||
T Consensus       155 ~~LH---~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  228 (383)
T 3eb0_A          155 GFIH---SLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS---VAYICSRFYRAPELMLGATEYTPSIDLWSI  228 (383)
T ss_dssp             HHHH---TTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCC---CCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred             HHHH---HCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCC---cCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence            9999   99999999999999997 6889999999999876554432   45578999999999876  58999999999


Q ss_pred             HHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhh--hhhhc-ccCC------CCCChHHHHHHHHHHHHH
Q 038681          235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD--SIIIE-DKSC------TCTGKEQQLQAFKQLTLQ  305 (332)
Q Consensus       235 G~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~-~~~~------~~~~~~~~~~~~~~li~~  305 (332)
                      ||++|||++|+.||......+...  .........  ....+..  +.... ..+.      ....+...+..+.+|+.+
T Consensus       229 G~il~ell~g~~pf~~~~~~~~~~--~i~~~~g~p--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  304 (383)
T 3eb0_A          229 GCVFGELILGKPLFSGETSIDQLV--RIIQIMGTP--TKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQ  304 (383)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCC--CHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCChHHHHH--HHHHHhCCC--CHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHH
Confidence            999999999999998765543321  111111111  0000000  00000 0000      000112345779999999


Q ss_pred             cccCCCCCCCCHHHHHH
Q 038681          306 CMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       306 cl~~dP~~RPs~~evl~  322 (332)
                      ||+.||.+|||+.|+++
T Consensus       305 ~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          305 ILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HCCSSGGGSCCHHHHHT
T ss_pred             HccCChhhCCCHHHHhc
Confidence            99999999999999985

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=329.36  Aligned_cols=237  Identities=19%  Similarity=0.326  Sum_probs=174.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|.+.....  ....+.+.+|+.++.+++||||+++           +|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            46799999999999999999998  789999999865421  2225778999999999999999997           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+++++|.+++....    ..+++..++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||++...
T Consensus        90 ~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~  162 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNRV----KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQL  162 (278)
T ss_dssp             EECCTTEEHHHHHHTCS----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EecCCCCcHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeec
Confidence            99999999999997641    46899999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      .......  ....||+.|+|||++.+ .++.++|||||||++|+|++|..||..........      ..          
T Consensus       163 ~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~----------  224 (278)
T 3cok_A          163 KMPHEKH--YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN------KV----------  224 (278)
T ss_dssp             C------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------C----------
T ss_pred             cCCCCcc--eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH------HH----------
Confidence            5433211  34578999999999987 78999999999999999999999997654322110      00          


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                          .....    ..+...+.++.+|+.+||+.||++|||++++++
T Consensus       225 ----~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          225 ----VLADY----EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             ----CSSCC----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ----hhccc----CCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence                00000    011123467899999999999999999999976

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.5e-46  Score=357.35  Aligned_cols=242  Identities=20%  Similarity=0.318  Sum_probs=196.9

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------E
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------I  116 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------l  116 (332)
                      ..++|.+.+.||+|+||.||+|.+  +|+.||+|++....  .......+.+|+.++.+++|||||++           +
T Consensus       182 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  261 (576)
T 2acx_A          182 TKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCL  261 (576)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEE
Confidence            356799999999999999999999  79999999996542  12235668899999999999999998           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ||||+++|+|.+++....   ...+++..++.++.||+.||.|||   ++||+||||||+|||++.+|.+||+|||+++.
T Consensus       262 VmEy~~gg~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~  335 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVH  335 (576)
T ss_dssp             EECCCCSCBHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEcCCCCcHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEeccccee
Confidence            999999999999997642   134999999999999999999999   89999999999999999999999999999987


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      .......   ....||+.|+|||++.+ .++.++|||||||++|||++|..||..........  .....+.....    
T Consensus       336 ~~~~~~~---~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~--~i~~~i~~~~~----  406 (576)
T 2acx_A          336 VPEGQTI---KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE--EVERLVKEVPE----  406 (576)
T ss_dssp             CCTTCCE---ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHH--HHHHHHHHCCC----
T ss_pred             cccCccc---cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHH--HHHHHhhcccc----
Confidence            7655432   34589999999999988 89999999999999999999999998654321110  01111111110    


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAK  322 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~  322 (332)
                                    ..+...+.++.+||.+||+.||.+||     +++||++
T Consensus       407 --------------~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          407 --------------EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             --------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             --------------cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence                          11123447899999999999999999     7888875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=6.6e-46  Score=362.47  Aligned_cols=252  Identities=21%  Similarity=0.332  Sum_probs=203.0

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEe-----CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-------
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGFW-----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-------  115 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-------  115 (332)
                      ++....++|.+.+.||+|+||.||+|.+     .+..||+|.+.........+.+.+|+.++++++||||+++       
T Consensus       384 ~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~  463 (656)
T 2j0j_A          384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN  463 (656)
T ss_dssp             GTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            4445567788999999999999999998     2457999998877666667889999999999999999998       


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                         +||||+++|+|.+++....    ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG  536 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRK----FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFG  536 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTT----TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecC
Confidence               8999999999999997641    35899999999999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccc
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      +++.......... ....+|+.|+|||++.+ .++.++|||||||++|||++ |..||..........      .+..  
T Consensus       537 ~a~~~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~------~i~~--  607 (656)
T 2j0j_A          537 LSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG------RIEN--  607 (656)
T ss_dssp             CCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------HHHH--
T ss_pred             CCeecCCCcceec-cCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHH------HHHc--
Confidence            9987655432211 34457789999999876 89999999999999999997 999998654432211      1100  


Q ss_pred             cchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                                  ..   ..+.+..++..+.+|+.+||+.||.+|||+.+|++.|+++.+.
T Consensus       608 ------------~~---~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          608 ------------GE---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             ------------TC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------CC---CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                        00   0011123447899999999999999999999999999998754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.8e-46  Score=335.05  Aligned_cols=239  Identities=20%  Similarity=0.279  Sum_probs=189.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-------hhhHHHHHHHHHHHHhhcCCCcceE--------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-------QHALEWCINHIVYASRMSHKHIIKL--------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-------~~~~~~~~~E~~~l~~l~H~nIv~~--------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||||.+.....       ......+.+|+.++++++||||+++        
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            45699999999999999999998  789999999875421       1223458899999999999999997        


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCC---eEEee
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFD  190 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~D  190 (332)
                        +||||+++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.   +||+|
T Consensus        89 ~~lv~e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           89 YYIVLELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             EEEEEECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             eEEEEecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEcc
Confidence              899999999999999765     57999999999999999999999   999999999999999987664   99999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccC---C-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhh
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFT---T-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRL  266 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~  266 (332)
                      ||+++........   ....||+.|+|||++.   . .++.++|||||||++|+|++|..||.........     ...+
T Consensus       161 fg~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~  232 (322)
T 2ycf_A          161 FGHSKILGETSLM---RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----KDQI  232 (322)
T ss_dssp             CTTCEECCCCHHH---HHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH-----HHHH
T ss_pred             Cccceeccccccc---ccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH-----HHHH
Confidence            9999876543221   3457899999999873   3 7899999999999999999999999765433221     1111


Q ss_pred             hccccc-hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          267 SGQNCR-FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       267 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ...... ....               ....+..+.+|+.+||+.||++|||+.++++
T Consensus       233 ~~~~~~~~~~~---------------~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          233 TSGKYNFIPEV---------------WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HHTCCCCCHHH---------------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhCccccCchh---------------hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            100000 0000               0123478999999999999999999999985

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.2e-46  Score=336.08  Aligned_cols=236  Identities=19%  Similarity=0.289  Sum_probs=196.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      .++|.+.+.||+|+||.||++.+  +++.||+|.+....  .....+.+.+|+.+++.++||||+++           +|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            46799999999999999999999  68899999987543  33446788999999999999999998           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+++++|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||++...
T Consensus       120 ~e~~~~~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  191 (335)
T 2owb_A          120 LELCRRRSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKV  191 (335)
T ss_dssp             ECCCTTCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EecCCCCCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence            9999999999998775     57999999999999999999999   899999999999999999999999999999876


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ......  .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..........      ........    
T Consensus       192 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~~~~----  259 (335)
T 2owb_A          192 EYDGER--KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL------RIKKNEYS----  259 (335)
T ss_dssp             CSTTCC--BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHHTCCC----
T ss_pred             ccCccc--ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH------HHhcCCCC----
Confidence            543322  135679999999999987 78999999999999999999999997654332111      11000000    


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                    .+...+..+.+|+.+||+.||++|||+.++++
T Consensus       260 --------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          260 --------------IPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             --------------CCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             --------------CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                          01123367899999999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.7e-45  Score=326.86  Aligned_cols=240  Identities=22%  Similarity=0.315  Sum_probs=196.0

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--------hhhHHHHHHHHHHHHhhc-CCCcceE-----
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--------QHALEWCINHIVYASRMS-HKHIIKL-----  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~-H~nIv~~-----  115 (332)
                      ..++|.+.+.||+|+||.||+|.+  +++.||||.+.....        ....+.+.+|+.++.++. ||||+++     
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            357899999999999999999999  789999999976531        123567889999999995 9999997     


Q ss_pred             ------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEe
Q 038681          116 ------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLF  189 (332)
Q Consensus       116 ------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  189 (332)
                            +||||+++|+|.+++...     ..+++..+..++.||+.||.|||   ++||+|+||||+||+++.++.+||+
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~  166 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLT  166 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEe
Confidence                  899999999999999875     57999999999999999999999   9999999999999999999999999


Q ss_pred             ecCCccccCCCCceeeccccccCCCcccccccC------C-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHH
Q 038681          190 DFSLSLSIPDGETHIELDSVVGTTGFIAPENFT------T-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEEN  262 (332)
Q Consensus       190 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~  262 (332)
                      |||++.........   ....||+.|+|||++.      . .++.++|||||||++|+|++|..||.........     
T Consensus       167 dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-----  238 (298)
T 1phk_A          167 DFGFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML-----  238 (298)
T ss_dssp             CCTTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-----
T ss_pred             cccchhhcCCCccc---ccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHH-----
Confidence            99999876554332   4567899999999874      2 6789999999999999999999999765432211     


Q ss_pred             HhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          263 VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                       ..+..              .......+.....+..+.+|+.+||+.||.+|||+.++++
T Consensus       239 -~~~~~--------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          239 -RMIMS--------------GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             -HHHHH--------------TCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             -HHHhc--------------CCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence             11100              0011111111234578999999999999999999999975

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=9.6e-46  Score=326.30  Aligned_cols=234  Identities=17%  Similarity=0.230  Sum_probs=189.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhh-cCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRM-SHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv  117 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|.+.... .......+.+|+..+..+ +||||+++           +|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            46699999999999999999999  79999999998653 233467789999999999 99999998           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC--------------
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ--------------  183 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--------------  183 (332)
                      |||+++|+|.+++...... ...+++..++.++.||+.||.|||   +++|+||||||+||+++.+              
T Consensus        90 ~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRI-MSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC----------------
T ss_pred             EEecCCCcHHHHHHhhccc-ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999875321 246899999999999999999999   9999999999999999844              


Q ss_pred             -----CCeEEeecCCccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccch
Q 038681          184 -----SDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESR  256 (332)
Q Consensus       184 -----~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~  256 (332)
                           ..+||+|||.+.......      ...||+.|+|||++.+  .++.++|||||||++|+|++|..|+......  
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~--  237 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW--  237 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHH--
T ss_pred             ccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHH--
Confidence                 479999999998765543      3458999999999976  5668999999999999999998876533211  


Q ss_pred             hhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          257 FHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                            .........                  ..+...+..+.+|+.+||+.||++|||+.++++
T Consensus       238 ------~~~~~~~~~------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          238 ------HEIRQGRLP------------------RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             ------HHHHTTCCC------------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------HHHHcCCCC------------------CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                  000000000                  011123478999999999999999999999985

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-46  Score=341.22  Aligned_cols=242  Identities=18%  Similarity=0.250  Sum_probs=192.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-----CCeeEEEEEEcCCC---ChhhHHHHHHHHHHHHhh-cCCCcceE--------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-----QKRSISLMKYNGNR---NQHALEWCINHIVYASRM-SHKHIIKL--------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~H~nIv~~--------  115 (332)
                      .++|.+.+.||+|+||.||+|.+     +++.||||++....   .....+.+.+|+.++.++ .||||+++        
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36799999999999999999998     68899999987542   122245677899999999 69999987        


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                         |||||+++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG  204 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFG  204 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSS
T ss_pred             eEEEEeecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCC
Confidence               899999999999999876     56999999999999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC---CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT---LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ  269 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  269 (332)
                      +++......... .....||+.|+|||++.+   .++.++|||||||++|||++|..||..........  .....    
T Consensus       205 ~a~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~----  277 (355)
T 1vzo_A          205 LSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRR----  277 (355)
T ss_dssp             EEEECCGGGGGG-GCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHH----
T ss_pred             CCeecccCCCCc-ccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--HHHHH----
Confidence            998664433221 134679999999999975   57899999999999999999999997544322111  01111    


Q ss_pred             ccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 038681          270 NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAKQ  323 (332)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~~  323 (332)
                                ......    +.+...+..+.+|+.+||+.||.+||     |+.++++.
T Consensus       278 ----------~~~~~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          278 ----------ILKSEP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             ----------HHHCCC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ----------HhccCC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence                      111111    11123347789999999999999999     99998763

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2.4e-46  Score=331.15  Aligned_cols=249  Identities=22%  Similarity=0.372  Sum_probs=191.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEe---CC--eeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE----------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW---QK--RSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~---~~--~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~----------  115 (332)
                      .++|++.+.||+|+||.||+|.+   ++  ..||+|.+....  .....+.+.+|+.++.+++||||+++          
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   96 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK   96 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCce
Confidence            46799999999999999999986   22  368999987653  23446789999999999999999998          


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      +|+||+++|+|.+++....    ..+++..+..++.||+.||.|||   +++|+|+||||+||+++.++.+||+|||++.
T Consensus        97 ~v~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           97 MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             EEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeEecccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEccccccc
Confidence            8999999999999998652    45899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCcee-eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          196 SIPDGETHI-ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       196 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      ......... ......+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.........      ......   
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~~~~~---  240 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------HKIDKE---  240 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHTS---
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH------HHHHcc---
Confidence            776544322 1234467889999999876 78999999999999999999 99999765433211      111100   


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                                 ..  ..+.+...+..+.+++.+||+.||.+|||+.++++.|+++...
T Consensus       241 -----------~~--~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          241 -----------GE--RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             -----------CC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             -----------CC--CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence                       00  0111123457899999999999999999999999999987643

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.2e-45  Score=332.64  Aligned_cols=249  Identities=16%  Similarity=0.221  Sum_probs=191.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-CCCcceE-------------E
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKL-------------I  116 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~~-------------l  116 (332)
                      .++|++.+.||+|+||.||+|.+  +++.||+|++....    .+.+.+|+.++.+++ ||||+++             +
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            36699999999999999999998  88999999997543    467899999999997 9999987             8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC-CeEEeecCCcc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS-DAKLFDFSLSL  195 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~  195 (332)
                      ||||+++++|.+++.        .+++..+..++.||+.||.|||   +++|+||||||+|||++.++ .+||+|||+++
T Consensus       111 v~e~~~~~~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~  179 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE  179 (330)
T ss_dssp             EEECCCCCCHHHHGG--------GCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEeccCchhHHHHHH--------hCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence            999999999999884        3889999999999999999999   99999999999999999777 89999999998


Q ss_pred             ccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      ........   ....||+.|+|||++.+  .++.++|||||||++|+|++|..||......... ........  ....+
T Consensus       180 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~--~~~~~  253 (330)
T 3nsz_A          180 FYHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVL--GTEDL  253 (330)
T ss_dssp             ECCTTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHH--CHHHH
T ss_pred             EcCCCCcc---ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhc--CCchh
Confidence            76554432   45578999999999876  6899999999999999999999999644322111 00000000  00001


Q ss_pred             hhhhh-----------hhhhccc------CCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          274 KEMVD-----------SIIIEDK------SCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       274 ~~~~~-----------~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .+.++           .......      ..........+.++.+|+.+||+.||.+|||++|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            11100           0000000      0011111234578999999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=6e-46  Score=345.58  Aligned_cols=253  Identities=21%  Similarity=0.277  Sum_probs=189.0

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------------  115 (332)
                      .+|.+.+.||+|+||.||+|.+  +++.||||++.....     ...+|+.++++++|||||++                
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~  128 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL  128 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence            3589999999999999999999  689999999876432     23479999999999999986                


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC-CCeEEeecCC
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ-SDAKLFDFSL  193 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~  193 (332)
                       +||||+++ +|.+++..... ....+++..++.++.||+.||.|||   +++|+||||||+|||++.+ +.+||+|||+
T Consensus       129 ~lv~e~~~~-~l~~~~~~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          129 NLVLDYVPE-TVYRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEECCCE-EHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             Eeehhcccc-cHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchh
Confidence             69999986 77777654322 1256999999999999999999999   9999999999999999965 5689999999


Q ss_pred             ccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc-
Q 038681          194 SLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN-  270 (332)
Q Consensus       194 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  270 (332)
                      ++........   ....||+.|+|||++.+  .++.++|||||||++|||++|+.||......+..  ......+.... 
T Consensus       204 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l--~~i~~~lg~p~~  278 (420)
T 1j1b_A          204 AKQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL--VEIIKVLGTPTR  278 (420)
T ss_dssp             CEECCTTCCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCSCCH
T ss_pred             hhhcccCCCc---eeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCH
Confidence            9876544322   34678999999999875  6899999999999999999999999876543321  11111111100 


Q ss_pred             cchhhhhhhhhhc-ccCC-CC-----CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          271 CRFKEMVDSIIIE-DKSC-TC-----TGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       271 ~~~~~~~~~~~~~-~~~~-~~-----~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ..+..+ ++.... ..+. ..     ......+.++.+|+.+||+.||.+|||+.|+++
T Consensus       279 ~~~~~~-~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          279 EQIREM-NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHH-CSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhh-ChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            000000 000000 0000 00     001123478999999999999999999999985

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.2e-46  Score=342.53  Aligned_cols=253  Identities=17%  Similarity=0.231  Sum_probs=177.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE--------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL--------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~--------------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  +|+.||||++.... .....+.+.+|+.+++.++||||+++              
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            46799999999999999999998  79999999997643 34446788999999999999999975              


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                         +|+|++ +++|.+++..      ..+++..+..++.||+.||.|||   +.||+||||||+|||++.++.+||+|||
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG  177 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFG  177 (367)
T ss_dssp             CCEEEEECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC--
T ss_pred             eEEEEeccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeecc
Confidence               789998 6899998865      36999999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      +++......     ....||+.|+|||++.+  .++.++|||||||++|||++|+.||.+........  .....+....
T Consensus       178 ~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~--~i~~~~g~p~  250 (367)
T 2fst_X          178 LARHTADEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK--LILRLVGTPG  250 (367)
T ss_dssp             ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCSCC
T ss_pred             ccccccccC-----CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCC
Confidence            998754432     35679999999999876  78999999999999999999999998765433221  1111111111


Q ss_pred             cchh-hhh----hhhhhcccCCCCCCh----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          271 CRFK-EMV----DSIIIEDKSCTCTGK----EQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       271 ~~~~-~~~----~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .... .+.    ...+......+....    ...++.+.+|+.+||+.||.+|||+.++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            0000 000    000000000000000    123467899999999999999999999985

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=9.6e-46  Score=362.34  Aligned_cols=238  Identities=18%  Similarity=0.241  Sum_probs=195.4

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhh-cCCCcceE----------
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRM-SHKHIIKL----------  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~H~nIv~~----------  115 (332)
                      ...++|.+.+.||+|+||.||+|.+  +++.||||++....  .....+.+..|..++..+ +||||+++          
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            3467899999999999999999999  78889999987542  122356788999999988 79999987          


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       |||||+++|+|.+++...     ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||++
T Consensus       418 ~lV~E~~~gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla  489 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMC  489 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred             EEEEeCcCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeeccee
Confidence             899999999999999876     57999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      +........  .....||+.|+|||++.+ .++.++|||||||++|||++|..||......+.      ...+...... 
T Consensus       490 ~~~~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~~~-  560 (674)
T 3pfq_A          490 KENIWDGVT--TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL------FQSIMEHNVA-  560 (674)
T ss_dssp             EECCCTTCC--BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHSSCCC-
T ss_pred             eccccCCcc--cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH------HHHHHhCCCC-
Confidence            864433222  246789999999999987 899999999999999999999999987654332      1111111111 


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTM-----VDVAK  322 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~-----~evl~  322 (332)
                                       .+...+.++.+||.+||+.||.+||++     +||++
T Consensus       561 -----------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          561 -----------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             -----------------CCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             -----------------CCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence                             112344789999999999999999997     66653

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.6e-45  Score=345.82  Aligned_cols=251  Identities=17%  Similarity=0.257  Sum_probs=198.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcc-eE-----------EEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHII-KL-----------IVF  118 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~~-----------lv~  118 (332)
                      .++|.+.++||+|+||.||+|.+  ++..||||++......   ..+.+|+.++..++|++++ .+           |||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH---PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS---CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc---HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            46799999999999999999998  7899999988765432   3478999999999875443 33           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee---CCCCCeEEeecCCcc
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSL  195 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~a~  195 (332)
                      ||+ +++|.+++....    ..+++..++.++.||+.||.|||   .++|+||||||+|||+   +.++.+||+|||+++
T Consensus        83 e~~-g~sL~~ll~~~~----~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~  154 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFCS----RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK  154 (483)
T ss_dssp             ECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             ECC-CCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcce
Confidence            999 899999997542    46999999999999999999999   9999999999999999   688999999999998


Q ss_pred             ccCCCCcee-----eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc
Q 038681          196 SIPDGETHI-----ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ  269 (332)
Q Consensus       196 ~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  269 (332)
                      .........     ......||+.|+|||++.+ .++.++|||||||++|||++|..||.................    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~----  230 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE----  230 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHH----
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhh----
Confidence            765543211     1135679999999999988 899999999999999999999999987654332211100000    


Q ss_pred             ccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          270 NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                       ..+...+....           ..++.++.+|+..||+.||.+||++.+|++.|+.+...
T Consensus       231 -~~~~~~~~~l~-----------~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          231 -KKVATSIEALC-----------RGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             -HHHHSCHHHHH-----------TTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -ccccccHHHHh-----------cCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence             00000000000           12237899999999999999999999999999998753

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=8.8e-46  Score=326.23  Aligned_cols=236  Identities=24%  Similarity=0.374  Sum_probs=195.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|.+....     +.+.+|+.++.+++||||+++               
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            45699999999999999999999  68999999997653     346789999999999999964               


Q ss_pred             ------------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC
Q 038681          116 ------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ  183 (332)
Q Consensus       116 ------------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  183 (332)
                                  +||||+++|+|.+++.....   ..+++..++.++.||+.||.|||   +.+|+|+||||+||+++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~  158 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG---EKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDT  158 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEET
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCC
Confidence                        78999999999999976421   46899999999999999999999   8999999999999999999


Q ss_pred             CCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHH
Q 038681          184 SDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEEN  262 (332)
Q Consensus       184 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~  262 (332)
                      +.+||+|||++.........   ....||+.|+|||++.+ .++.++|||||||++|+|++|..|+.....        .
T Consensus       159 ~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--------~  227 (284)
T 2a19_B          159 KQVKIGDFGLVTSLKNDGKR---TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSK--------F  227 (284)
T ss_dssp             TEEEECCCTTCEESSCCSCC---CCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHHH--------H
T ss_pred             CCEEECcchhheeccccccc---cccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHHH--------H
Confidence            99999999999877654322   34578999999999987 789999999999999999999988742110        0


Q ss_pred             HhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          263 VKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      .....          ...      .    +...+..+.+|+.+||+.||.+|||+.++++.|..+.++
T Consensus       228 ~~~~~----------~~~------~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          228 FTDLR----------DGI------I----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             HHHHH----------TTC------C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             HHHhh----------ccc------c----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence            00000          000      0    012236788999999999999999999999999987643

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-46  Score=337.62  Aligned_cols=261  Identities=21%  Similarity=0.240  Sum_probs=189.3

Q ss_pred             HHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChh----hHHHHHHHHHHHHhhcCCCcceE--------
Q 038681           50 RIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQH----ALEWCINHIVYASRMSHKHIIKL--------  115 (332)
Q Consensus        50 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~H~nIv~~--------  115 (332)
                      ....++|.+.+.||+|+||.||+|.+  +++.||||++.......    ..+.+.+|+.++.+++||||+++        
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            34467899999999999999999999  68999999987543221    13467899999999999999998        


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                         +||||+++ +|.+++....    ..+++..+..++.|++.||.|||   +++|+||||||+|||++.++.+||+|||
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  157 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDNS----LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFG  157 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTCC----SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCG
T ss_pred             ceEEEEEcCCC-CHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecc
Confidence               89999986 8998887541    46889999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-c
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-Q  269 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~  269 (332)
                      +++........  .....||+.|+|||++.+  .++.++|||||||++|+|++|..||..........  ........ .
T Consensus       158 ~a~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~--~i~~~~~~~~  233 (346)
T 1ua2_A          158 LAKSFGSPNRA--YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT--RIFETLGTPT  233 (346)
T ss_dssp             GGSTTTSCCCC--CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCC
T ss_pred             cceeccCCccc--CCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH--HHHHHcCCCC
Confidence            99876543322  145678999999999875  58999999999999999999999998765433211  11111111 0


Q ss_pred             ccchhhhhh--hhhhcccCCCCC---ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          270 NCRFKEMVD--SIIIEDKSCTCT---GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       270 ~~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ...+.+...  ...........+   .....+..+.+|+.+||+.||.+|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          234 EEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             TTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence            111111000  000000000000   00133478999999999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=9.7e-46  Score=345.01  Aligned_cols=189  Identities=21%  Similarity=0.269  Sum_probs=163.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh------cCCCcceE---------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRM------SHKHIIKL---------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l------~H~nIv~~---------  115 (332)
                      ..+|++.+.||+|+||.||+|.+  +++.||||++....  ...+.+.+|+.++..+      +|+||+++         
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK--RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc--chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            45699999999999999999998  68999999997642  3356778899998888      56799987         


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCC--eEEeec
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD--AKLFDF  191 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Df  191 (332)
                        +||||+. |+|.+++.....   ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.  +||+||
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKF---QGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTT---CCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             EEEEEeccC-CCHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeec
Confidence              8999996 699999987521   35899999999999999999999   899999999999999999887  999999


Q ss_pred             CCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccc
Q 038681          192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFES  255 (332)
Q Consensus       192 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~  255 (332)
                      |++.......     ....||+.|+|||++.+ .++.++|||||||++|||++|..||......+
T Consensus       247 G~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~  306 (429)
T 3kvw_A          247 GSSCYEHQRV-----YTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD  306 (429)
T ss_dssp             TTCEETTCCC-----CSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ccceecCCcc-----cccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            9997654432     35678999999999987 89999999999999999999999998776543

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.9e-47  Score=335.98  Aligned_cols=257  Identities=20%  Similarity=0.325  Sum_probs=179.5

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           49 LRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        49 l~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      +....++|.+.+.||+|+||.||+|.+  +++.||||.+.........+.+.+|+.++.+++||||+++           
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            345568899999999999999999998  7899999998766544556778999999999999999997           


Q ss_pred             EEEEeccCCChHHHHhhhhcc---cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          116 IVFESVQIGTLADRIHHHCEQ---HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                      +||||+++|+|.+++......   ....+++..+..++.||+.||.|||   +.+|+||||||+||+++.++.+||+|||
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEecc
Confidence            899999999999999753211   1246899999999999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCce---eeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhh
Q 038681          193 LSLSIPDGETH---IELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS  267 (332)
Q Consensus       193 ~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  267 (332)
                      ++.........   .......||+.|+|||++.+  .++.++|||||||++|+|++|..||.........     .....
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-----~~~~~  241 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVL-----MLTLQ  241 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH-----HHHHT
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHH-----HHHhc
Confidence            98766443211   11134578999999999875  6899999999999999999999999876543321     11111


Q ss_pred             ccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ...........         ........+..+.+|+.+||+.||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          242 NDPPSLETGVQ---------DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SSCCCTTC--------------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             cCCCccccccc---------cchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            11111110000         00001123467899999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=329.79  Aligned_cols=239  Identities=22%  Similarity=0.313  Sum_probs=190.2

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      ...++|.+.+.||+|+||.||+|.+  +++.||+|.+.....   .+.+.+|+.++.+++||||+++           +|
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD---LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC---CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH---HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            3456799999999999999999999  689999999976543   4678899999999999999987           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||+++|+|.+++....    ..+++..+..++.||+.||.|||   +.+|+|+||||+||+++.++.+||+|||++...
T Consensus       103 ~e~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  175 (314)
T 3com_A          103 MEYCGAGSVSDIIRLRN----KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQL  175 (314)
T ss_dssp             EECCTTEEHHHHHHHHT----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eecCCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhh
Confidence            99999999999997431    46999999999999999999999   999999999999999999999999999999766


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ......  .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..........     ......       
T Consensus       176 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~-----~~~~~~-------  241 (314)
T 3com_A          176 TDTMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF-----MIPTNP-------  241 (314)
T ss_dssp             BTTBSC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHHHSC-------
T ss_pred             hhhccc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH-----HHhcCC-------
Confidence            543221  135578999999999987 88999999999999999999999997654322110     000000       


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                               ......+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       242 ---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          242 ---------PPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ---------CCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ---------CcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                     0011112234478999999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=7.1e-46  Score=337.18  Aligned_cols=258  Identities=19%  Similarity=0.230  Sum_probs=194.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||||++...........+.+|+.++++++||||+++               
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            46799999999999999999999  6999999999876666667788999999999999999976               


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       +||||++ |+|.+++..      ..+++..+..++.||+.||.|||   ++||+||||||+|||++.++.+||+|||++
T Consensus        90 ~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEeccC-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccc
Confidence             8999997 599999875      36999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCcee--------eccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHh
Q 038681          195 LSIPDGETHI--------ELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVK  264 (332)
Q Consensus       195 ~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~  264 (332)
                      ..........        ......||+.|+|||++.+  .++.++|||||||++|+|++|..||...........  ...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~  237 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL--IFG  237 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--HHH
T ss_pred             cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH--HHH
Confidence            8765432111        1123578999999998753  789999999999999999999999987654332210  111


Q ss_pred             hhhccc--cchhhh----hhhhhhcccCCCCC----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          265 RLSGQN--CRFKEM----VDSIIIEDKSCTCT----GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       265 ~~~~~~--~~~~~~----~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ......  ......    ..............    .....+..+.+|+.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            110000  000000    00000000000000    00134578899999999999999999999986

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.7e-45  Score=334.67  Aligned_cols=260  Identities=17%  Similarity=0.210  Sum_probs=194.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE--------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL--------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~--------------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|++..... ......+.+|+.+++.++||||+++              
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            46799999999999999999999  789999999866543 2234567899999999999999976              


Q ss_pred             -----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEee
Q 038681          116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFD  190 (332)
Q Consensus       116 -----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  190 (332)
                           +||||+++ +|.+.+....    ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~D  167 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLAD  167 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECC
T ss_pred             CceEEEEEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEcc
Confidence                 79999985 7877776542    46999999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCc--eeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhh
Q 038681          191 FSLSLSIPDGET--HIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRL  266 (332)
Q Consensus       191 fg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~  266 (332)
                      ||+++.......  ........||+.|+|||++.+  .++.++|||||||++|+|++|..||...........  .....
T Consensus       168 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--i~~~~  245 (351)
T 3mi9_A          168 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL--ISQLC  245 (351)
T ss_dssp             CTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--HHHHH
T ss_pred             chhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HHHHh
Confidence            999987653221  111245578999999999876  689999999999999999999999987655433221  11111


Q ss_pred             hccccc-hhhhhhhhhhccc----CCCCCChH-----HHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          267 SGQNCR-FKEMVDSIIIEDK----SCTCTGKE-----QQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       267 ~~~~~~-~~~~~~~~~~~~~----~~~~~~~~-----~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ...... +............    ........     ..++.+.+|+.+||+.||++|||++|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          246 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             CCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            111111 1111100000000    00000000     11356899999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.5e-45  Score=350.95  Aligned_cols=244  Identities=19%  Similarity=0.294  Sum_probs=195.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      .++|.+.+.||+|+||.||+|++  +|+.||+|++.....  ....+.+.+|+.++.+++||||+++           +|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            36788899999999999999999  789999999975421  2235678999999999999999987           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      |||++||+|.+++..... ....+++..++.++.||+.||.|||   ++||+||||||+|||++.+|.+||+|||+++..
T Consensus       264 mE~~~gg~L~~~l~~~~~-~~~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDE-DNPGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             ECCCTTCBHHHHHHTSST-TSCSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEeccCCCHHHHHHHhhc-ccccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            999999999999976421 1246999999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ......  .....||+.|+|||++.+ .++.++|||||||++|||++|..||..........  ......          
T Consensus       340 ~~~~~~--~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~--~~~~~i----------  405 (543)
T 3c4z_A          340 KAGQTK--TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRV----------  405 (543)
T ss_dssp             CTTCCC--BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH--HHHHHH----------
T ss_pred             cCCCcc--cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH--HHHHHH----------
Confidence            554332  134589999999999988 89999999999999999999999998654321100  011111          


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTM-----VDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~-----~evl~  322 (332)
                          .....    ..+...+..+.+|+.+||+.||.+||++     ++|++
T Consensus       406 ----~~~~~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          406 ----LEQAV----TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             ----HHCCC----CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             ----hhccc----CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence                11111    1112344789999999999999999975     56653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-46  Score=335.74  Aligned_cols=252  Identities=17%  Similarity=0.250  Sum_probs=192.9

Q ss_pred             CCcccccHHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE
Q 038681           39 NPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL  115 (332)
Q Consensus        39 ~~~~~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~  115 (332)
                      .+...++..++....++|.+.+.||+|+||.||+|.+  +++.||+|.+......  .+.+.+|+.++.++ +||||+++
T Consensus         9 ~~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~   86 (326)
T 2x7f_A            9 RSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE--EEEIKQEINMLKKYSHHRNIATY   86 (326)
T ss_dssp             -------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST--THHHHHHHHHHHHHCCSTTBCCE
T ss_pred             CcchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc--HHHHHHHHHHHHhccCCCCeeee
Confidence            3444556666666788999999999999999999999  8899999999765433  46788999999999 79999986


Q ss_pred             -----------------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCe
Q 038681          116 -----------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNI  178 (332)
Q Consensus       116 -----------------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  178 (332)
                                       +||||+++|+|.+++.....   ..+++..++.++.||+.||.|||   +.||+|+||||+||
T Consensus        87 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NI  160 (326)
T 2x7f_A           87 YGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNV  160 (326)
T ss_dssp             EEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGG---GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGE
T ss_pred             eeEEeeccCccccceEEEEEEcCCCCcHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHE
Confidence                             79999999999999986421   46899999999999999999999   89999999999999


Q ss_pred             eeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccC-----C-CCChhhhHHHHHHHHHHHHhCCccCCCCC
Q 038681          179 LFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-----T-LINEQCDVYGFGAFLFELLTAQEVSDHVS  252 (332)
Q Consensus       179 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~-~~~~~sDiwSlG~~l~elltg~~p~~~~~  252 (332)
                      +++.++.+||+|||++.........  .....||+.|+|||++.     + .++.++|||||||++|+|++|..||....
T Consensus       161 l~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  238 (326)
T 2x7f_A          161 LLTENAEVKLVDFGVSAQLDRTVGR--RNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  238 (326)
T ss_dssp             EECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             EEcCCCCEEEeeCcCceecCcCccc--cccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence            9999999999999999766443221  13457899999999986     3 68899999999999999999999997654


Q ss_pred             ccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          253 FESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ......     ........                 .......+..+.+|+.+||..||.+|||+.++++
T Consensus       239 ~~~~~~-----~~~~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          239 PMRALF-----LIPRNPAP-----------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHHH-----HHHHSCCC-----------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHH-----HhhcCccc-----------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            322111     00000000                 0001123478999999999999999999999987

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.9e-45  Score=323.30  Aligned_cols=240  Identities=18%  Similarity=0.243  Sum_probs=188.5

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ++|.....||+|+||.||+|.+  ++..||+|.+...... ..+.+.+|+.+++.++||||+++           +||||
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  100 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSR-YSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQ  100 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchH-HHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEe
Confidence            3455566999999999999998  7889999999776433 36778999999999999999997           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC-CCCeEEeecCCccccCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE-QSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~~  199 (332)
                      +++|+|.+++.....  ...+++..+..++.||+.||.|||   +.+|+|+||||+||+++. ++.+||+|||++.....
T Consensus       101 ~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A          101 VPGGSLSALLRSKWG--PLKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             CSEEEHHHHHHHTTC--CCTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             CCCCCHHHHHHhhcc--CCCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            999999999976521  135678999999999999999999   899999999999999987 89999999999987654


Q ss_pred             CCceeeccccccCCCcccccccCC---CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT---LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ....  .....||+.|+|||++.+   .++.++|||||||++|+|++|..||...........   .......       
T Consensus       176 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~~~-------  243 (295)
T 2clq_A          176 INPC--TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF---KVGMFKV-------  243 (295)
T ss_dssp             -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH---HHHHHCC-------
T ss_pred             CCCc--ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH---hhccccc-------
Confidence            3221  134578999999999865   389999999999999999999999975432211100   0000000       


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                 ....+...+..+.+|+.+||+.||++|||+.++++
T Consensus       244 -----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          244 -----------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             -----------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             -----------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                       00111234478999999999999999999999975

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6.4e-45  Score=324.22  Aligned_cols=239  Identities=15%  Similarity=0.206  Sum_probs=193.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC---hhhHHHHHHHHHHHHhhcCCCcceE------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN---QHALEWCINHIVYASRMSHKHIIKL------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~~~~~E~~~l~~l~H~nIv~~------------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  ++..||+|.+.....   ....+.+.+|+.++++++||||+++            
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            47899999999999999999999  788999999976421   2336779999999999999999987            


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       +||||+++| |.+++....   ...+++..+..++.||+.||.|||   +++|+||||||+||+++.++.+||+|||++
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~  156 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVA  156 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEehhccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccc
Confidence             899999876 777776542   146999999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCceeeccccccCCCcccccccCC---CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFTT---LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      ................||+.|+|||++.+   .++.++|||||||++|+|++|..||........      ...+..   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~i~~---  227 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL------FENIGK---  227 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHH---
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH------HHHHhc---
Confidence            87654333222245679999999999876   347899999999999999999999986543221      111110   


Q ss_pred             chhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                 ....    .+..++..+.+|+.+||+.||.+|||+.++++
T Consensus       228 -----------~~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  263 (305)
T 2wtk_C          228 -----------GSYA----IPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQ  263 (305)
T ss_dssp             -----------CCCC----CCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             -----------CCCC----CCCccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                       0000    11123467899999999999999999999986

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.7e-45  Score=325.49  Aligned_cols=242  Identities=17%  Similarity=0.242  Sum_probs=179.0

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHH-HHHHHHHHHhhcCCCcceE-----------EE
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEW-CINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~-~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      ..++|++.+.||+|+||.||+|.+  +++.||+|++........... +.++...++.++||||+++           +|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            457799999999999999999999  899999999987654433334 4445555777899999997           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSR-PIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      |||++ |+|.+++...... ...+++..++.++.||+.||.|||   ++ ||+||||||+||+++.++.+||+|||++..
T Consensus        85 ~e~~~-~~l~~~l~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDK-GQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             Eehhc-cchHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            99997 5898888764222 257999999999999999999999   87 999999999999999999999999999987


Q ss_pred             cCCCCceeeccccccCCCccccccc----CC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENF----TT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      .......   ....||+.|+|||++    .+ .++.++|||||||++|+|++|..||.........    ..........
T Consensus       160 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~  232 (290)
T 3fme_A          160 LVDDVAK---DIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ----LKQVVEEPSP  232 (290)
T ss_dssp             -------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH----HHHHHHSCCC
T ss_pred             ccccccc---cccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH----HHHHhccCCC
Confidence            6554322   345799999999996    33 7899999999999999999999999754322110    1111111000


Q ss_pred             chhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                       .......+..+.+|+.+||+.||++|||+.++++
T Consensus       233 -----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          233 -----------------QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -----------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----------------CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                             0011133477999999999999999999999987

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.3e-45  Score=326.26  Aligned_cols=239  Identities=23%  Similarity=0.336  Sum_probs=195.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|++.... .....+.+.+|+.++++++||||+++           +|+
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            46799999999999999999999  78999999986543 23346789999999999999999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC---CCeEEeecCCcc
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ---SDAKLFDFSLSL  195 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~a~  195 (332)
                      ||+++++|.+++...     ..+++..++.++.||+.||.|||   +.+|+|+||||+||+++.+   +.+||+|||++.
T Consensus       101 e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A          101 ELYTGGELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             CCCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            999999999999765     56999999999999999999999   8999999999999999754   469999999998


Q ss_pred             ccCCCCceeeccccccCCCcccccccCCCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      ........   ....||+.|+|||++.+.++.++||||||+++|+|++|..||.........      ..+..       
T Consensus       173 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~------~~~~~-------  236 (287)
T 2wei_A          173 CFQQNTKM---KDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL------KRVET-------  236 (287)
T ss_dssp             TBCCCSSC---SCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHH-------
T ss_pred             eecCCCcc---ccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHH------HHHHc-------
Confidence            76544322   345689999999999888999999999999999999999999865433211      11110       


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                             .......+.....+..+.+|+.+||+.||.+|||+.++++
T Consensus       237 -------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          237 -------GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             -------CCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -------CCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence                   0000011111133478999999999999999999999987

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.4e-46  Score=339.29  Aligned_cols=266  Identities=16%  Similarity=0.223  Sum_probs=194.0

Q ss_pred             ccHHHHHHHhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCC----------hhhHHHHHHHHHHHHhhcCCCc
Q 038681           44 FSAEELRIATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRN----------QHALEWCINHIVYASRMSHKHI  112 (332)
Q Consensus        44 ~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~----------~~~~~~~~~E~~~l~~l~H~nI  112 (332)
                      ....++....++|.+.+.||+|+||.||+|.+ .+..||||++.....          ....+.+.+|+.++++++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            34667888899999999999999999999998 889999999865422          2224789999999999999999


Q ss_pred             ceE----------------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCC
Q 038681          113 IKL----------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPT  176 (332)
Q Consensus       113 v~~----------------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~  176 (332)
                      +++                +||||++ |+|.+++...    ...+++..+..++.||+.||.|||   +++|+||||||+
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~  163 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLH---EAGVVHRDLHPG  163 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGG
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHH---HCcCEecCCChH
Confidence            975                8999998 5888888754    146999999999999999999999   899999999999


Q ss_pred             CeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCcc
Q 038681          177 NILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFE  254 (332)
Q Consensus       177 Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~  254 (332)
                      |||++.++.+||+|||+++........   ....||+.|+|||++.+  .++.++|||||||++|+|++|..||......
T Consensus       164 NIl~~~~~~~kl~Dfg~~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~  240 (362)
T 3pg1_A          164 NILLADNNDITICDFNLAREDTADANK---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY  240 (362)
T ss_dssp             GEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             HEEEcCCCCEEEEecCccccccccccc---ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence            999999999999999999755443322   44578999999999875  7899999999999999999999999876543


Q ss_pred             chhhhHHHHhhhhccc---------cchhhhhhhhhhcccCC-CCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          255 SRFHYEENVKRLSGQN---------CRFKEMVDSIIIEDKSC-TCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       255 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ....  ..........         ....+.+.......... ........++.+.+|+.+||+.||.+|||+.|+++
T Consensus       241 ~~~~--~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          241 NQLN--KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             HHHH--HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHH--HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            3221  1111111000         00000000000000000 00001123467999999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.4e-46  Score=330.71  Aligned_cols=240  Identities=21%  Similarity=0.268  Sum_probs=189.4

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ..++|++.+.||+|+||.||+|.+  ++..||+|.+...... ..+.+.+|+.++..++||||+++           +||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE-ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C-CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH-HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            346799999999999999999999  6889999998765433 36789999999999999999997           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++|+|.+++....    ..+++..+..++.||+.||.|||   +.||+||||||+||+++.++.+||+|||++....
T Consensus        96 e~~~~~~l~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  168 (302)
T 2j7t_A           96 EFCPGGAVDAIMLELD----RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNL  168 (302)
T ss_dssp             ECCTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHH
T ss_pred             EeCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCcccc
Confidence            9999999999987642    46999999999999999999999   8999999999999999999999999999875432


Q ss_pred             CCCceeeccccccCCCcccccccC-----C-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          199 DGETHIELDSVVGTTGFIAPENFT-----T-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~-----~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      ....  ......||+.|+|||++.     + .++.++|||||||++|+|++|..||........     .........  
T Consensus       169 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-----~~~~~~~~~--  239 (302)
T 2j7t_A          169 KTLQ--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----LLKIAKSDP--  239 (302)
T ss_dssp             HHHH--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSCC--
T ss_pred             cccc--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH-----HHHHhccCC--
Confidence            1111  113457899999999883     3 789999999999999999999999986543221     111111100  


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                    .....+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       240 --------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          240 --------------PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             --------------CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             --------------cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                          011112234578999999999999999999999975

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=9.5e-46  Score=333.27  Aligned_cols=241  Identities=21%  Similarity=0.252  Sum_probs=190.6

Q ss_pred             hcCCCCC-CccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhh-cCCCcceE-----------E
Q 038681           53 TNNYDEQ-NIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRM-SHKHIIKL-----------I  116 (332)
Q Consensus        53 ~~~y~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~H~nIv~~-----------l  116 (332)
                      .+.|.+. +.||+|+||.||+|.+  +++.||+|++..... ......+.+|+.++..+ .||||+++           +
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            4557776 8899999999999999  689999999876532 33367789999999999 56999998           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC---CCCeEEeecCC
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE---QSDAKLFDFSL  193 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~  193 (332)
                      ||||+++|+|.+++....   ...+++..++.++.||+.||+|||   +.||+||||||+|||++.   ++.+||+|||+
T Consensus       107 v~e~~~~~~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~  180 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM  180 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred             EEEecCCCcHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence            999999999999986431   146999999999999999999999   999999999999999987   78999999999


Q ss_pred             ccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          194 SLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       194 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      ++........   ....||+.|+|||++.+ .++.++|||||||++|+|++|..||..........   .....      
T Consensus       181 a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~~------  248 (327)
T 3lm5_A          181 SRKIGHACEL---REIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL---NISQV------  248 (327)
T ss_dssp             CEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHT------
T ss_pred             ccccCCcccc---ccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH---HHHhc------
Confidence            9876544322   34679999999999987 89999999999999999999999997755433211   00000      


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                 ............+..+.+|+.+||+.||.+|||++++++
T Consensus       249 -----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          249 -----------NVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             -----------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             -----------ccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence                       000011111234477999999999999999999999975

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.4e-45  Score=337.55  Aligned_cols=256  Identities=18%  Similarity=0.231  Sum_probs=193.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc--------CCCcceE-------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS--------HKHIIKL-------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--------H~nIv~~-------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||||++...  ....+.+.+|+.+++.++        ||||+++       
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA--EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC--CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            47799999999999999999998  7899999999754  334677899999999996        7789886       


Q ss_pred             --------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeeecCCCCCCeeeCCCC--
Q 038681          116 --------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSR-PIVYRDMKPTNILFNEQS--  184 (332)
Q Consensus       116 --------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlkp~Nill~~~~--  184 (332)
                              +||||+ +|+|.+++....   ...+++..++.++.||+.||.|||   ++ ||+||||||+|||++.++  
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~  186 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQY  186 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchh
Confidence                    899999 567777766541   146999999999999999999999   87 999999999999998775  


Q ss_pred             -----------------------------------------------CeEEeecCCccccCCCCceeeccccccCCCccc
Q 038681          185 -----------------------------------------------DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIA  217 (332)
Q Consensus       185 -----------------------------------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  217 (332)
                                                                     .+||+|||++.......     ....||+.|+|
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~gt~~y~a  261 (397)
T 1wak_A          187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHF-----TEDIQTRQYRS  261 (397)
T ss_dssp             HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCS-----CSCCSCGGGCC
T ss_pred             hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccC-----ccCCCCCcccC
Confidence                                                           79999999998765432     34578999999


Q ss_pred             ccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhh----hHHHHhhhhccccchh-------hhhhhhh--hc
Q 038681          218 PENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFH----YEENVKRLSGQNCRFK-------EMVDSII--IE  283 (332)
Q Consensus       218 PE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~-------~~~~~~~--~~  283 (332)
                      ||++.+ .++.++|||||||++|||++|..||..........    ...........+..+.       ..+....  ..
T Consensus       262 PE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  341 (397)
T 1wak_A          262 LEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKH  341 (397)
T ss_dssp             HHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSS
T ss_pred             ChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccc
Confidence            999987 79999999999999999999999997655332111    1111111111000000       0000000  00


Q ss_pred             c-----------cCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          284 D-----------KSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       284 ~-----------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .           ...........+..+.+|+.+||+.||++|||+.|+++
T Consensus       342 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          342 ITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            0           00011223567788999999999999999999999985

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.2e-45  Score=339.08  Aligned_cols=254  Identities=18%  Similarity=0.232  Sum_probs=188.3

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------------  115 (332)
                      .+|.+.+.||+|+||.||+|.+ .+..||+|++......     ..+|+.+++.++||||+++                 
T Consensus        40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~-----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF-----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS-----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch-----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            4699999999999999999999 6667999988765322     2379999999999999986                 


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeC-CCCCeEEeecCCc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN-EQSDAKLFDFSLS  194 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Dfg~a  194 (332)
                      +||||++++ +.+.+..... ....+++..++.++.||+.||+|||   ++||+||||||+|||++ .++.+||+|||++
T Consensus       115 lv~e~~~~~-l~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          115 LVLEYVPET-VYRASRHYAK-LKQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEECCSEE-HHHHHHHHHH-TTSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEeeccCcc-HHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            799999874 4444433211 1256999999999999999999999   99999999999999998 7899999999999


Q ss_pred             cccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      +........   ....||+.|+|||++.+  .++.++|||||||++|||++|+.||.+........  .....+......
T Consensus       190 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~--~i~~~~g~p~~~  264 (394)
T 4e7w_A          190 KILIAGEPN---VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV--EIIKVLGTPSRE  264 (394)
T ss_dssp             EECCTTCCC---CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCHH
T ss_pred             ccccCCCCC---cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCCHH
Confidence            876554432   35678999999999876  68999999999999999999999998765443321  111111111000


Q ss_pred             -hhhhhhhhhhcccCC--CC----CChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          273 -FKEMVDSIIIEDKSC--TC----TGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       273 -~~~~~~~~~~~~~~~--~~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                       +..+.........+.  ..    ......++++.+|+.+||+.||.+|||+.|+++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence             000000000000000  00    011124578999999999999999999999985

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.1e-44  Score=331.81  Aligned_cols=252  Identities=17%  Similarity=0.249  Sum_probs=190.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE--------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL--------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~--------------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||||++.... .....+.+.+|+.+++.++||||+++              
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            46799999999999999999998  79999999998653 34446778999999999999999975              


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                         +||||++ |+|.+++..       .+++..+..++.||+.||.|||   +.||+||||||+|||++.++.+||+|||
T Consensus       121 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg  189 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFG  189 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred             eEEEEEcccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecC
Confidence               8999997 589888743       4999999999999999999999   8999999999999999999999999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      +++......     ....||+.|+|||++.+  .++.++|||||||++|+|++|..||......+...  ..........
T Consensus       190 ~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~i~~~~~~~~  262 (371)
T 4exu_A          190 LARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT--QILKVTGVPG  262 (371)
T ss_dssp             CC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCC
T ss_pred             cccccccCc-----CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHH--HHHHHhCCCc
Confidence            997654432     35678999999999876  78999999999999999999999998765433221  1111111111


Q ss_pred             cchhhhh-----hhhhhcccCCCCCC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          271 CRFKEMV-----DSIIIEDKSCTCTG----KEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       271 ~~~~~~~-----~~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ..+...+     ..............    ....++.+.+|+.+||+.||++|||+.|+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            1110000     00000000000000    0123578999999999999999999999985

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.6e-45  Score=331.63  Aligned_cols=267  Identities=17%  Similarity=0.206  Sum_probs=187.6

Q ss_pred             HHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE--------
Q 038681           46 AEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL--------  115 (332)
Q Consensus        46 ~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~--------  115 (332)
                      ..+.....++|.+.+.||+|+||.||+|.+  ++..||||++......  .....+|+..+..++||||+++        
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~~l~~l~h~niv~~~~~~~~~~   92 (360)
T 3e3p_A           15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF--RNRELQIMQDLAVLHHPNIVQLQSYFYTLG   92 (360)
T ss_dssp             SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC--CCHHHHHHHHHHHHCCTTBCCEEEEEEEEC
T ss_pred             hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc--cHHHHHHHHHHHhcCCCCcccHHHhhhccc
Confidence            345667788999999999999999999998  6899999998654322  3456788888999999999986        


Q ss_pred             ----------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC-CC
Q 038681          116 ----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE-QS  184 (332)
Q Consensus       116 ----------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~  184 (332)
                                +||||+++ +|.+.+...... ...+++..+..++.|++.||.|||.. +++|+||||||+|||++. ++
T Consensus        93 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           93 ERDRRDIYLNVVMEYVPD-TLHRCCRNYYRR-QVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             SSCTTCEEEEEEEECCSC-BHHHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTT
T ss_pred             cccccceeEEEEeecccc-cHHHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCC
Confidence                      69999986 666555432211 25689999999999999999999943 689999999999999996 89


Q ss_pred             CeEEeecCCccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHH
Q 038681          185 DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEEN  262 (332)
Q Consensus       185 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~  262 (332)
                      .+||+|||+++........   ....||+.|+|||++.+  .++.++|||||||++|+|++|..||..........  ..
T Consensus       170 ~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~--~~  244 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSEPN---VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH--EI  244 (360)
T ss_dssp             EEEECCCTTCBCCCTTSCC---CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HH
T ss_pred             cEEEeeCCCceecCCCCCc---ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHH--HH
Confidence            9999999999877654432   35578999999999865  58999999999999999999999998765443321  11


Q ss_pred             Hhhhhccccchhhhhhhhhh-----cccCC-----CCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          263 VKRLSGQNCRFKEMVDSIII-----EDKSC-----TCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~-----~~~~~-----~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ..............+++...     .....     ........+.++.+|+.+||+.||.+|||+.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            11111111111100000000     00000     00011124678999999999999999999999985

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.1e-45  Score=337.38  Aligned_cols=261  Identities=18%  Similarity=0.235  Sum_probs=175.3

Q ss_pred             CCCC-CCccccCCCceEEEEEe----CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-------------E
Q 038681           55 NYDE-QNIVLEDPFRKLYKGFW----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-------------I  116 (332)
Q Consensus        55 ~y~~-~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-------------l  116 (332)
                      .|.+ .++||+|+||.||+|.+    ++..||+|++.....   ...+.+|+.++++++||||+++             +
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~l   97 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI---SMSACREIALLRELKHPNVISLQKVFLSHADRKVWL   97 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC---CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC---CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEE
Confidence            3665 56899999999999996    478899999976543   3467899999999999999986             8


Q ss_pred             EEEeccCCChHHHHhhhhcc----cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee----CCCCCeEE
Q 038681          117 VFESVQIGTLADRIHHHCEQ----HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF----NEQSDAKL  188 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl  188 (332)
                      ||||++ |+|.+++......    ....+++..++.++.||+.||.|||   +.+|+||||||+|||+    +.++.+||
T Consensus        98 v~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl  173 (405)
T 3rgf_A           98 LFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKI  173 (405)
T ss_dssp             EEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred             EEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence            999997 4898888754211    1124999999999999999999999   9999999999999999    67889999


Q ss_pred             eecCCccccCCCCc-eeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccch-------hh
Q 038681          189 FDFSLSLSIPDGET-HIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESR-------FH  258 (332)
Q Consensus       189 ~Dfg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~-------~~  258 (332)
                      +|||+++....... ........||+.|+|||++.+  .++.++|||||||++|||++|..||........       ..
T Consensus       174 ~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  253 (405)
T 3rgf_A          174 ADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ  253 (405)
T ss_dssp             CCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHH
T ss_pred             EECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHH
Confidence            99999987654321 112245679999999999886  589999999999999999999999976543210       11


Q ss_pred             hHHHHhhhhcc-ccchhhhh---h-----hhhhcccCCCCCCh-------HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          259 YEENVKRLSGQ-NCRFKEMV---D-----SIIIEDKSCTCTGK-------EQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       259 ~~~~~~~~~~~-~~~~~~~~---~-----~~~~~~~~~~~~~~-------~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .......+... ...+....   .     ..............       ...+..+.+||.+||+.||.+|||++|+++
T Consensus       254 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~  333 (405)
T 3rgf_A          254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  333 (405)
T ss_dssp             HHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11111111110 00011000   0     00000000000000       011357889999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3e-44  Score=324.03  Aligned_cols=253  Identities=21%  Similarity=0.280  Sum_probs=194.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEe---CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCC------cceE--------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW---QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKH------IIKL--------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~~--------  115 (332)
                      .++|.+.+.||+|+||.||+|.+   +++.||+|++...  ....+.+.+|+.++..++|+|      |+++        
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV--DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC--CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            35799999999999999999987   6889999999754  233577899999999997765      7765        


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC----------
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE----------  182 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~----------  182 (332)
                         +||||+ +++|.+++....   ...+++..+..++.||+.||+|||   +++|+||||||+|||++.          
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~  163 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPK  163 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC--
T ss_pred             cEEEEEcCC-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCc
Confidence               899999 789999997652   136899999999999999999999   999999999999999987          


Q ss_pred             ---------CCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCC
Q 038681          183 ---------QSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVS  252 (332)
Q Consensus       183 ---------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~  252 (332)
                               ++.+||+|||+++......     ....||+.|+|||++.+ .++.++|||||||++|||++|..||....
T Consensus       164 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          164 IKRDERTLINPDIKVVDFGSATYDDEHH-----STLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             --CEEEEESCCCEEECCCSSCEETTSCC-----CSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             cccccccccCCCceEeeCcccccCcccc-----ccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                     6789999999998754432     34578999999999988 89999999999999999999999998765


Q ss_pred             ccchhhhHHHHhhhhccccchhh-----------------------hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccC
Q 038681          253 FESRFHYEENVKRLSGQNCRFKE-----------------------MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDF  309 (332)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  309 (332)
                      .......  ........+..+..                       ...... .............++.+.+|+.+||+.
T Consensus       239 ~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~L~~  315 (339)
T 1z57_A          239 SKEHLAM--MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRAC-KPLKEFMLSQDVEHERLFDLIQKMLEY  315 (339)
T ss_dssp             HHHHHHH--HHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHC-CCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred             hHHHHHH--HHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcC-cchhhhcccchhhHHHHHHHHHHHhCc
Confidence            4432211  11111111100000                       000000 000001112235678899999999999


Q ss_pred             CCCCCCCHHHHHH
Q 038681          310 SPEDRPTMVDVAK  322 (332)
Q Consensus       310 dP~~RPs~~evl~  322 (332)
                      ||.+|||+.|+++
T Consensus       316 dP~~Rpt~~ell~  328 (339)
T 1z57_A          316 DPAKRITLREALK  328 (339)
T ss_dssp             STTTSCCHHHHTT
T ss_pred             CcccccCHHHHhc
Confidence            9999999999985

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=329.71  Aligned_cols=252  Identities=17%  Similarity=0.245  Sum_probs=190.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE--------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL--------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~--------------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  +|+.||||++.... .....+.+.+|+.+++.++||||+++              
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            36799999999999999999998  79999999997654 33446778999999999999999975              


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                         +||||++ |+|.+++..       .+++..+..++.||+.||.|||   ++||+||||||+||+++.++.+||+|||
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg  171 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFG  171 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred             eEEEEecccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecc
Confidence               8999997 588888743       4899999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      +++......     ....||+.|+|||++.+  .++.++|||||||++|+|++|..||..........  ..........
T Consensus       172 ~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~--~i~~~~~~~~  244 (353)
T 3coi_A          172 LARHADAEM-----TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT--QILKVTGVPG  244 (353)
T ss_dssp             CTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH--HHHHHHCBCC
T ss_pred             cccCCCCCc-----cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHHhCCCC
Confidence            997654332     34578999999999876  78999999999999999999999998765433211  1111111111


Q ss_pred             cchhh---------hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          271 CRFKE---------MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       271 ~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ..+..         .+..................+..+.+|+.+||+.||++|||+.++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            11100         00000000000000111244578999999999999999999999985

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.7e-45  Score=327.53  Aligned_cols=257  Identities=18%  Similarity=0.210  Sum_probs=186.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||+|++.... ....+.+.+|+.++++++||||+++               
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC-hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            36799999999999999999999  58999999987654 3447789999999999999999986               


Q ss_pred             ----------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeC-CCC
Q 038681          116 ----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN-EQS  184 (332)
Q Consensus       116 ----------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~  184 (332)
                                +||||++ |+|.+++..      ..+++..++.++.||+.||+|||   ++||+||||||+||+++ .++
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~  158 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDL  158 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTT
T ss_pred             ccccccCceeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCC
Confidence                      7999998 699999864      36899999999999999999999   99999999999999997 567


Q ss_pred             CeEEeecCCccccCCCCce-eeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHH
Q 038681          185 DAKLFDFSLSLSIPDGETH-IELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEE  261 (332)
Q Consensus       185 ~~kl~Dfg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~  261 (332)
                      .+||+|||+++........ .......+|..|+|||++.+  .++.++|||||||++|||++|+.||..........  .
T Consensus       159 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~--~  236 (320)
T 2i6l_A          159 VLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQ--L  236 (320)
T ss_dssp             EEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--H
T ss_pred             eEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHH--H
Confidence            8999999999876432211 11134567999999998754  78999999999999999999999998765433211  0


Q ss_pred             HHhhhhccc-cchhh-------hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          262 NVKRLSGQN-CRFKE-------MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       262 ~~~~~~~~~-~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ......... ....+       ....................+.++.+|+.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            111000000 00000       00000000000000000134578999999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.6e-45  Score=328.24  Aligned_cols=252  Identities=18%  Similarity=0.277  Sum_probs=190.0

Q ss_pred             CcccccHHHHHHHhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhc--CCCcceE
Q 038681           40 PYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNR-NQHALEWCINHIVYASRMS--HKHIIKL  115 (332)
Q Consensus        40 ~~~~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~--H~nIv~~  115 (332)
                      +...+..+.+....++|.+.+.||+|+||.||+|.+ +++.||+|++.... .....+.+.+|+.++.+++  ||||+++
T Consensus        14 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~   93 (313)
T 3cek_A           14 GTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL   93 (313)
T ss_dssp             ------CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCE
T ss_pred             CCCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEE
Confidence            344455555666678899999999999999999999 78899999997653 3445678999999999997  5999987


Q ss_pred             -----------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC
Q 038681          116 -----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS  184 (332)
Q Consensus       116 -----------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~  184 (332)
                                 +||| +.+|+|.+++...     ..+++..++.++.||+.||.|||   +.+|+||||||+|||+++ +
T Consensus        94 ~~~~~~~~~~~lv~e-~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~  163 (313)
T 3cek_A           94 YDYEITDQYIYMVME-CGNIDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-G  163 (313)
T ss_dssp             EEEEECSSEEEEEEC-CCSEEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-T
T ss_pred             EEEeecCCEEEEEEe-cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-C
Confidence                       8999 5678999999875     57899999999999999999999   899999999999999964 8


Q ss_pred             CeEEeecCCccccCCCCceeeccccccCCCcccccccCC------------CCChhhhHHHHHHHHHHHHhCCccCCCCC
Q 038681          185 DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT------------LINEQCDVYGFGAFLFELLTAQEVSDHVS  252 (332)
Q Consensus       185 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------------~~~~~sDiwSlG~~l~elltg~~p~~~~~  252 (332)
                      .+||+|||++................||+.|+|||++.+            .++.++|||||||++|+|++|..||....
T Consensus       164 ~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (313)
T 3cek_A          164 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  243 (313)
T ss_dssp             EEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             eEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH
Confidence            899999999987655433222245578999999999864            68889999999999999999999997543


Q ss_pred             ccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          253 FESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .....    ...           ..+....      ...+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       244 ~~~~~----~~~-----------~~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          244 NQISK----LHA-----------IIDPNHE------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             SHHHH----HHH-----------HHCTTSC------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHH----HHH-----------HHhcccc------cCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            22110    000           1110000      0001112367899999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.5e-45  Score=332.94  Aligned_cols=255  Identities=16%  Similarity=0.221  Sum_probs=194.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChh----------------hHHHHHHHHHHHHhhcCCCcceE-
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQH----------------ALEWCINHIVYASRMSHKHIIKL-  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~----------------~~~~~~~E~~~l~~l~H~nIv~~-  115 (332)
                      .++|.+.+.||+|+||.||+|.++++.||+|.+.......                ..+.+.+|+.++.+++||||+++ 
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~  109 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCE  109 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCS
T ss_pred             cCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEE
Confidence            4689999999999999999999999999999987542111                12789999999999999999987 


Q ss_pred             ----------EEEEeccCCChHHH------HhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeeecCCCCCCe
Q 038681          116 ----------IVFESVQIGTLADR------IHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFS-RPIVYRDMKPTNI  178 (332)
Q Consensus       116 ----------lv~e~~~~g~L~~~------l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Ni  178 (332)
                                +||||+++|+|.++      +...   ....+++..++.++.||+.||.|||   + +||+||||||+||
T Consensus       110 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dl~p~Ni  183 (348)
T 2pml_X          110 GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN---YTCFIPIQVIKCIIKSVLNSFSYIH---NEKNICHRDVKPSNI  183 (348)
T ss_dssp             EEEESSSEEEEEEECCTTCBSSEESSSEESSCSS---SCCCCCHHHHHHHHHHHHHHHHHHH---HTSCEECCCCCGGGE
T ss_pred             EEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc---cccCCCHHHHHHHHHHHHHHHHHHh---ccCCEeecCCChHhE
Confidence                      89999999999999      5431   1257999999999999999999999   7 9999999999999


Q ss_pred             eeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC--CCCh-hhhHHHHHHHHHHHHhCCccCCCCCccc
Q 038681          179 LFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINE-QCDVYGFGAFLFELLTAQEVSDHVSFES  255 (332)
Q Consensus       179 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~-~sDiwSlG~~l~elltg~~p~~~~~~~~  255 (332)
                      +++.++.+||+|||++.......    .....||+.|+|||++.+  .++. ++|||||||++|+|++|..||.......
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVDKK----IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBTTE----ECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             EEcCCCcEEEecccccccccccc----ccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            99999999999999998765442    145679999999999986  4555 9999999999999999999998665421


Q ss_pred             hhhhHHHHhhhhccccchhhhhhhhhhcc-cCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          256 RFHYEENVKRLSGQNCRFKEMVDSIIIED-KSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .     ....+......+........... ...........+..+.+|+.+||+.||.+|||+.++++
T Consensus       260 ~-----~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          260 E-----LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             H-----HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             H-----HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            1     11111111111110000000000 00000001234578999999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.9e-45  Score=328.39  Aligned_cols=247  Identities=15%  Similarity=0.223  Sum_probs=174.4

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHH-HHHhhcCCCcceE-----------E
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIV-YASRMSHKHIIKL-----------I  116 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~-~l~~l~H~nIv~~-----------l  116 (332)
                      ...++|.+.+.||+|+||.||+|.+  +++.||||++...........+..|+. +++.++||||+++           +
T Consensus        19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence            3457899999999999999999999  699999999987765555566777776 6677899999998           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSR-PIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      ||||+++ +|.+++..........+++..+..++.|++.||.|||   .. +|+||||||+||+++.++.+||+|||+++
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            9999985 8888887533222357999999999999999999999   77 99999999999999999999999999998


Q ss_pred             ccCCCCceeeccccccCCCcccccccC----C-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFT----T-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      ........   ....||+.|+|||++.    + .++.++|||||||++|+|++|..||.........    .........
T Consensus       175 ~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~  247 (327)
T 3aln_A          175 QLVDSIAK---TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ----LTQVVKGDP  247 (327)
T ss_dssp             C---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------CCCCCSCC
T ss_pred             eccccccc---ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH----HHHHhcCCC
Confidence            76544322   3447899999999983    3 6899999999999999999999999754321100    000000000


Q ss_pred             cchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ..              .........+..+.+|+.+||+.||.+|||+.++++
T Consensus       248 ~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          248 PQ--------------LSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CC--------------CCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CC--------------CCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            00              000011133478999999999999999999999976

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=3.4e-46  Score=334.55  Aligned_cols=257  Identities=18%  Similarity=0.294  Sum_probs=196.4

Q ss_pred             cccHHHHHHHhcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE------
Q 038681           43 IFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL------  115 (332)
Q Consensus        43 ~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~------  115 (332)
                      .....++....++|.+.+.||+|+||.||+|.+.+ .+|+|.+..... ....+.+.+|+.++.+++||||+++      
T Consensus        22 ~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (319)
T 2y4i_B           22 SIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS  100 (319)
T ss_dssp             CCCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred             ccccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            34556666778899999999999999999999865 499999875432 2234567889999999999999987      


Q ss_pred             -----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEee
Q 038681          116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFD  190 (332)
Q Consensus       116 -----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  190 (332)
                           +||||+++++|.+++...    ...+++..++.++.||+.||.|||   +++|+||||||+||+++ ++.+||+|
T Consensus       101 ~~~~~iv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~D  172 (319)
T 2y4i_B          101 PPHLAIITSLCKGRTLYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITD  172 (319)
T ss_dssp             SSCEEEECBCCCSEEHHHHTTSS----CCCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECC
T ss_pred             CCceEEEeecccCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEee
Confidence                 899999999999999764    136899999999999999999999   99999999999999998 68999999


Q ss_pred             cCCccccCCCC---ceeeccccccCCCcccccccCC----------CCChhhhHHHHHHHHHHHHhCCccCCCCCccchh
Q 038681          191 FSLSLSIPDGE---THIELDSVVGTTGFIAPENFTT----------LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRF  257 (332)
Q Consensus       191 fg~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~----------~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~  257 (332)
                      ||+++......   .........||+.|+|||++.+          .++.++|||||||++|||++|..||.........
T Consensus       173 fg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~  252 (319)
T 2y4i_B          173 FGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAII  252 (319)
T ss_dssp             CSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHH
T ss_pred             cCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99987653211   1111134568999999999863          4789999999999999999999999865543221


Q ss_pred             hhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          258 HYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      .     .........                 ......+..+.+|+.+||+.||.+|||+.++++.|+++.+.
T Consensus       253 ~-----~~~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          253 W-----QMGTGMKPN-----------------LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             H-----HHHTTCCCC-----------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             H-----HhccCCCCC-----------------CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            1     000000000                 00012235689999999999999999999999999887643

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.2e-44  Score=331.40  Aligned_cols=256  Identities=16%  Similarity=0.213  Sum_probs=190.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-----------CCCcceE----
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS-----------HKHIIKL----  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----------H~nIv~~----  115 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||||++....  ...+.+.+|+.++.+++           ||||+++    
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc--cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            46799999999999999999998  89999999997542  33567889999999886           7899875    


Q ss_pred             -----------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeeecCCCCCCeeeC--
Q 038681          116 -----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSR-PIVYRDMKPTNILFN--  181 (332)
Q Consensus       116 -----------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlkp~Nill~--  181 (332)
                                 +||||+ +++|.+++.....   ..+++..+..++.||+.||.|||   ++ ||+||||||+|||++  
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~---~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIV  168 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEE
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhhc---cCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEecc
Confidence                       799999 8899999986421   35999999999999999999999   87 999999999999994  


Q ss_pred             ----CCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccch
Q 038681          182 ----EQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESR  256 (332)
Q Consensus       182 ----~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~  256 (332)
                          ..+.+||+|||++.......     ....||+.|+|||++.+ .++.++|||||||++|||++|..||........
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  243 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSY  243 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred             CCCcCcceEEEcccccccccCCCC-----CCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCccccc
Confidence                44579999999998765432     34578999999999987 789999999999999999999999986543211


Q ss_pred             h----hhHHHHhhhhccccchh-------hhhhhh--hh-----------cccCCCCCChHHHHHHHHHHHHHcccCCCC
Q 038681          257 F----HYEENVKRLSGQNCRFK-------EMVDSI--II-----------EDKSCTCTGKEQQLQAFKQLTLQCMDFSPE  312 (332)
Q Consensus       257 ~----~~~~~~~~~~~~~~~~~-------~~~~~~--~~-----------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~  312 (332)
                      .    ........+...+..+.       ..++..  ..           .........+...+..+.+||.+||+.||.
T Consensus       244 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  323 (373)
T 1q8y_A          244 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR  323 (373)
T ss_dssp             -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred             CChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcc
Confidence            1    11111111111100000       000000  00           000001123357788999999999999999


Q ss_pred             CCCCHHHHHH
Q 038681          313 DRPTMVDVAK  322 (332)
Q Consensus       313 ~RPs~~evl~  322 (332)
                      +|||+.|+++
T Consensus       324 ~Rpt~~ell~  333 (373)
T 1q8y_A          324 KRADAGGLVN  333 (373)
T ss_dssp             TCBCHHHHHT
T ss_pred             ccCCHHHHhh
Confidence            9999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.6e-44  Score=320.82  Aligned_cols=239  Identities=22%  Similarity=0.360  Sum_probs=183.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------------  115 (332)
                      .++|++.+.||+|+||.||+|.+  +++.||+|.+...  ....+.+.+|+.++++++||||+++               
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT--EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc--HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            45699999999999999999998  7899999999643  3346788999999999999999864               


Q ss_pred             ---------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCe
Q 038681          116 ---------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA  186 (332)
Q Consensus       116 ---------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~  186 (332)
                               +||||+++|+|.+++....    ..+++..++.++.||+.||.|||   +++|+||||||+||+++.++.+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~  155 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSEN----LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNV  155 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSC----GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccc----cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCE
Confidence                     7999999999999997641    35788999999999999999999   8999999999999999999999


Q ss_pred             EEeecCCccccCCCCc------------eeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCC
Q 038681          187 KLFDFSLSLSIPDGET------------HIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVS  252 (332)
Q Consensus       187 kl~Dfg~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~  252 (332)
                      ||+|||++........            ........||+.|+|||++.+  .++.++|||||||++|+|++   ||....
T Consensus       156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~  232 (303)
T 1zy4_A          156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM  232 (303)
T ss_dssp             EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred             EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence            9999999976643211            111234578999999999875  68999999999999999998   443211


Q ss_pred             ccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          253 FESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ...     .....+......              .+.......+..+.+|+.+||+.||.+|||+.++++
T Consensus       233 ~~~-----~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          233 ERV-----NILKKLRSVSIE--------------FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             HHH-----HHHHHHHSTTCC--------------CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHH-----HHHHhccccccc--------------cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence            110     011111111000              111112234467899999999999999999999986

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.1e-43  Score=326.57  Aligned_cols=193  Identities=20%  Similarity=0.299  Sum_probs=163.0

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-CCC-----cceE-------
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKH-----IIKL-------  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~n-----Iv~~-------  115 (332)
                      ...++|.+.+.||+|+||.||+|.+  +++.||||++...  ......+.+|+.++..++ |+|     |+++       
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK--KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS--HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc--HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            3457899999999999999999998  7899999999754  233567888999999985 554     6665       


Q ss_pred             ----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeC--CCCCeEEe
Q 038681          116 ----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN--EQSDAKLF  189 (332)
Q Consensus       116 ----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~  189 (332)
                          |||||++ |+|.+++....   ...+++..+..++.||+.||.|||+. ..||+||||||+|||++  .++.+||+
T Consensus       129 ~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          129 NHLCLVFEMLS-YNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred             CceEEEEecCC-CCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEE
Confidence                8999996 59999998652   13589999999999999999999932 36899999999999994  47889999


Q ss_pred             ecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccc
Q 038681          190 DFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFES  255 (332)
Q Consensus       190 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~  255 (332)
                      |||+++......     ....||+.|+|||++.+ .++.++|||||||++|||++|..||.......
T Consensus       204 DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~  265 (382)
T 2vx3_A          204 DFGSSCQLGQRI-----YQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD  265 (382)
T ss_dssp             CCTTCEETTCCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             eccCceeccccc-----ccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999998765432     35678999999999988 89999999999999999999999998765543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.2e-44  Score=327.26  Aligned_cols=238  Identities=20%  Similarity=0.282  Sum_probs=163.1

Q ss_pred             hcCCCCCC-ccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHH-HHHHhhcCCCcceE-------------
Q 038681           53 TNNYDEQN-IVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHI-VYASRMSHKHIIKL-------------  115 (332)
Q Consensus        53 ~~~y~~~~-~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~-~~l~~l~H~nIv~~-------------  115 (332)
                      .++|.+.+ .||+|+||.||+|.+  +++.||||++....      ...+|+ ..+..+.||||+++             
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP------KARQEVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            46788854 699999999999999  68999999997542      122333 33566789999986             


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC---CCCeEEee
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE---QSDAKLFD  190 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~D  190 (332)
                        +||||+++|+|.+++.....   ..+++..++.++.||+.||.|||   +++|+||||||+|||++.   ++.+||+|
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~D  174 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGD---QAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTD  174 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-C---CCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEEEeccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEec
Confidence              79999999999999986521   36999999999999999999999   899999999999999976   45599999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ  269 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  269 (332)
                      ||+++.......    ....||+.|+|||++.+ .++.++|||||||++|+|++|..||...........  .....   
T Consensus       175 fg~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~~---  245 (336)
T 3fhr_A          175 FGFAKETTQNAL----QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--MKRRI---  245 (336)
T ss_dssp             CTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------
T ss_pred             cccceecccccc----ccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--HHHhh---
Confidence            999986654332    34578999999999976 789999999999999999999999976543221100  00000   


Q ss_pred             ccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          270 NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                 .......+.+.....+..+.+|+.+||+.||.+|||+.++++
T Consensus       246 -----------~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          246 -----------RLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ----------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -----------hccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                       000000111111234578999999999999999999999987

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.2e-45  Score=327.46  Aligned_cols=241  Identities=19%  Similarity=0.294  Sum_probs=190.3

Q ss_pred             CcccccHHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh-----hhHHHHHHHHHHHHhhc--CC
Q 038681           40 PYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ-----HALEWCINHIVYASRMS--HK  110 (332)
Q Consensus        40 ~~~~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~--H~  110 (332)
                      +....+..+.....++|.+.+.||+|+||.||+|.+  +++.||||.+......     ...+.+.+|+.++.+++  ||
T Consensus        29 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~  108 (320)
T 3a99_A           29 ATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS  108 (320)
T ss_dssp             -----------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSC
T ss_pred             hhccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCC
Confidence            334445555666678899999999999999999998  8899999999765321     11345678999999996  59


Q ss_pred             CcceE-----------EEEEeccC-CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCe
Q 038681          111 HIIKL-----------IVFESVQI-GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNI  178 (332)
Q Consensus       111 nIv~~-----------lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  178 (332)
                      ||+++           +|+|++.+ ++|.+++...     ..+++..++.++.||+.||.|||   +.+|+||||||+||
T Consensus       109 ~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NI  180 (320)
T 3a99_A          109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENI  180 (320)
T ss_dssp             SBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGE
T ss_pred             CceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHE
Confidence            99987           89999976 8999999876     57999999999999999999999   99999999999999


Q ss_pred             eeC-CCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-C-CChhhhHHHHHHHHHHHHhCCccCCCCCccc
Q 038681          179 LFN-EQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-L-INEQCDVYGFGAFLFELLTAQEVSDHVSFES  255 (332)
Q Consensus       179 ll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~sDiwSlG~~l~elltg~~p~~~~~~~~  255 (332)
                      |++ .++.+||+|||+++.......    ....||+.|+|||++.+ . ++.++|||||||++|||++|..||.....  
T Consensus       181 ll~~~~~~~kL~Dfg~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--  254 (320)
T 3a99_A          181 LIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--  254 (320)
T ss_dssp             EEETTTTEEEECCCTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--
T ss_pred             EEeCCCCCEEEeeCccccccccccc----cCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--
Confidence            998 788999999999987765432    34579999999999875 4 47899999999999999999999964311  


Q ss_pred             hhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          256 RFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                            .   ... ...                  .....+..+.+|+.+||+.||++|||+.+|++
T Consensus       255 ------~---~~~-~~~------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          255 ------I---IRG-QVF------------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ------H---HHC-CCC------------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------h---hcc-ccc------------------ccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                  0   000 000                  00123367899999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.6e-44  Score=323.23  Aligned_cols=259  Identities=20%  Similarity=0.259  Sum_probs=192.7

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe---CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhh---cCCCcceE---------
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW---QKRSISLMKYNGNRN-QHALEWCINHIVYASRM---SHKHIIKL---------  115 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~H~nIv~~---------  115 (332)
                      ..++|.+.+.||+|+||.||+|.+   +++.||+|++..... ......+.+|+.+++.+   +||||+++         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999998   578899999865432 11123466788877776   89999986         


Q ss_pred             -------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEE
Q 038681          116 -------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKL  188 (332)
Q Consensus       116 -------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl  188 (332)
                             +||||++ |+|.+++.....   ..+++..++.++.||+.||.|||   ++||+||||||+||+++.++.+||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl  161 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPE---PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKL  161 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCT---TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEE
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhccc---CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEE
Confidence                   7999998 699999976521   34899999999999999999999   999999999999999999999999


Q ss_pred             eecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhh
Q 038681          189 FDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS  267 (332)
Q Consensus       189 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  267 (332)
                      +|||+++.......   .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..........  .......
T Consensus       162 ~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--~i~~~~~  236 (326)
T 1blx_A          162 ADFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG--KILDVIG  236 (326)
T ss_dssp             CSCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHC
T ss_pred             ecCcccccccCCCC---ccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH--HHHHHcC
Confidence            99999976643321   245678999999999987 89999999999999999999999998765433211  1111111


Q ss_pred             c-cccchhhhh---hhhhhc-ccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          268 G-QNCRFKEMV---DSIIIE-DKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       268 ~-~~~~~~~~~---~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      . ....+....   ...... ............+..+.+|+.+||+.||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0 000110000   000000 000000011234578899999999999999999999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.1e-43  Score=320.63  Aligned_cols=253  Identities=18%  Similarity=0.250  Sum_probs=190.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CC-eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCC------cceE--------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QK-RSISLMKYNGNRNQHALEWCINHIVYASRMSHKH------IIKL--------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~n------Iv~~--------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  ++ ..||+|++...  ....+.+.+|+.++++++|++      ++.+        
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV--GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC--HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc--ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            46799999999999999999998  44 78999999754  233577889999999998766      6654        


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeee------------
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILF------------  180 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill------------  180 (332)
                         +||||+ +|+|.+++....   ...+++..++.++.||+.||.|||   +++|+||||||+|||+            
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~  168 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEH  168 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred             eEEEEEecc-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeccccccccccc
Confidence               899999 567888776542   136999999999999999999999   9999999999999999            


Q ss_pred             -------CCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCC
Q 038681          181 -------NEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVS  252 (332)
Q Consensus       181 -------~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~  252 (332)
                             +.++.+||+|||+++......     ....||+.|+|||++.+ .++.++|||||||++|||++|..||....
T Consensus       169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          169 KSCEEKSVKNTSIRVADFGSATFDHEHH-----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             -CCCEEEESCCCEEECCCTTCEETTSCC-----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccCCCcEEEeecCccccccccc-----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                   567899999999998654433     34579999999999987 89999999999999999999999998765


Q ss_pred             ccchhhhHHHHhhhhccccchhh-----------------------hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccC
Q 038681          253 FESRFHYEENVKRLSGQNCRFKE-----------------------MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDF  309 (332)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  309 (332)
                      .......  ........+..+..                       ...... .............+..+.+|+.+||+.
T Consensus       244 ~~~~~~~--~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~L~~  320 (355)
T 2eu9_A          244 NREHLVM--MEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC-KPLKSYMLQDSLEHVQLFDLMRRMLEF  320 (355)
T ss_dssp             HHHHHHH--HHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHC-CCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred             HHHHHHH--HHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccC-CcccccccccchhHHHHHHHHHHHhcC
Confidence            4432211  11111111100000                       000000 000000111234567899999999999


Q ss_pred             CCCCCCCHHHHHH
Q 038681          310 SPEDRPTMVDVAK  322 (332)
Q Consensus       310 dP~~RPs~~evl~  322 (332)
                      ||++|||+.|+++
T Consensus       321 dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          321 DPAQRITLAEALL  333 (355)
T ss_dssp             STTTSCCHHHHTT
T ss_pred             ChhhCcCHHHHhc
Confidence            9999999999975

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2.8e-44  Score=346.84  Aligned_cols=263  Identities=15%  Similarity=0.206  Sum_probs=197.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------------  115 (332)
                      .++|.+.+.||+|+||.||+|.+  +++.||||++.........+.+.+|+.++.+++||||+++               
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            37899999999999999999998  7899999999877666667889999999999999999987               


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCC---eEEee
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFD  190 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~---~kl~D  190 (332)
                        +||||+++|+|.+++.....  ...+++..++.++.||+.||.|||   +.||+||||||+||+++.++.   +||+|
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~--~~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~D  167 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFEN--CCGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIID  167 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSC--TTCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred             EEEEEEeCCCCCHHHHHHhccc--CCCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence              89999999999999986421  135899999999999999999999   899999999999999997765   89999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-  268 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-  268 (332)
                      ||++.........   ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.........     ...... 
T Consensus       168 FG~a~~~~~~~~~---~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~-----~~~i~~~  239 (676)
T 3qa8_A          168 LGYAKELDQGELC---TEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW-----HGKVREK  239 (676)
T ss_dssp             CCCCCBTTSCCCC---CCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHS-----STTCC--
T ss_pred             ccccccccccccc---ccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhh-----hhhhhcc
Confidence            9999877654432   45679999999999987 8999999999999999999999999754321110     000000 


Q ss_pred             --cccchhhhhhhhhh--cccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHH-----HHHHHHHH
Q 038681          269 --QNCRFKEMVDSIII--EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV-----AKQLRQMY  328 (332)
Q Consensus       269 --~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ev-----l~~L~~l~  328 (332)
                        ......+.......  ...+.+.......+..+.+|+.+||..||++|||+.++     .+.+..+.
T Consensus       240 ~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL  308 (676)
T 3qa8_A          240 SNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSIL  308 (676)
T ss_dssp             ----CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHH
T ss_pred             cchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHH
Confidence              00000000000000  00111222334567899999999999999999999884     45555544

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.2e-44  Score=322.52  Aligned_cols=253  Identities=19%  Similarity=0.260  Sum_probs=178.3

Q ss_pred             CCcccccHHHHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHH-HHHHHHHHHhhcCCCcceE
Q 038681           39 NPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEW-CINHIVYASRMSHKHIIKL  115 (332)
Q Consensus        39 ~~~~~~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~-~~~E~~~l~~l~H~nIv~~  115 (332)
                      .+...+...+.....++|.+.+.||+|+||.||+|.+  +++.||||++........... +.++..++..++||||+++
T Consensus        10 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   89 (318)
T 2dyl_A           10 TGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQC   89 (318)
T ss_dssp             CCSEEESSSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCE
T ss_pred             CceEEecchhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeE
Confidence            3444444444555567899999999999999999999  789999999987655443344 4444556788899999997


Q ss_pred             -----------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCC-CeeecCCCCCCeeeCCC
Q 038681          116 -----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSR-PIVYRDMKPTNILFNEQ  183 (332)
Q Consensus       116 -----------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~-~ivH~Dlkp~Nill~~~  183 (332)
                                 +||||+ ++.+..+....    ...+++..+..++.||+.||.|||   .. ||+|+||||+||+++.+
T Consensus        90 ~~~~~~~~~~~lv~e~~-~~~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH---~~~~i~H~dlkp~Nil~~~~  161 (318)
T 2dyl_A           90 FGTFITNTDVFIAMELM-GTCAEKLKKRM----QGPIPERILGKMTVAIVKALYYLK---EKHGVIHRDVKPSNILLDER  161 (318)
T ss_dssp             EEEEECSSEEEEEECCC-SEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHH---HHHCCCCCCCCGGGEEECTT
T ss_pred             EEEEecCCcEEEEEecc-CCcHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHH---hhCCEEeCCCCHHHEEECCC
Confidence                       899999 45565555432    146999999999999999999999   74 99999999999999999


Q ss_pred             CCeEEeecCCccccCCCCceeeccccccCCCcccccccC-----C-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchh
Q 038681          184 SDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-----T-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRF  257 (332)
Q Consensus       184 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~  257 (332)
                      +.+||+|||++.........   ....||+.|+|||++.     + .++.++|||||||++|+|++|..||.........
T Consensus       162 ~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  238 (318)
T 2dyl_A          162 GQIKLCDFGISGRLVDDKAK---DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV  238 (318)
T ss_dssp             SCEEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHH
T ss_pred             CCEEEEECCCchhccCCccc---cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHH
Confidence            99999999999766543322   3457899999999984     3 6889999999999999999999999764322110


Q ss_pred             hhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          258 HYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                          ..........                ..+.....+..+.+|+.+||+.||.+|||+.++++
T Consensus       239 ----~~~~~~~~~~----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          239 ----LTKVLQEEPP----------------LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             ----HHHHHHSCCC----------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ----HHHHhccCCC----------------CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                1111111100                00111123477999999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3e-44  Score=321.05  Aligned_cols=233  Identities=19%  Similarity=0.266  Sum_probs=186.5

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh-----hhHHHHHHHHHHHHhh----cCCCcceE-
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ-----HALEWCINHIVYASRM----SHKHIIKL-  115 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l----~H~nIv~~-  115 (332)
                      +.+...++|.+.+.||+|+||.||+|.+  +++.||+|.+......     .....+.+|+.++.++    +||||+++ 
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            3445567899999999999999999998  7889999999765321     1233467899999999    89999998 


Q ss_pred             ----------EEEEe-ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeC-CC
Q 038681          116 ----------IVFES-VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN-EQ  183 (332)
Q Consensus       116 ----------lv~e~-~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~  183 (332)
                                +|+|+ +++++|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+||+++ .+
T Consensus       105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~  176 (312)
T 2iwi_A          105 DWFETQEGFMLVLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRR  176 (312)
T ss_dssp             EEC-----CEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTT
T ss_pred             EEEecCCeEEEEEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCC
Confidence                      89999 7899999999876     56999999999999999999999   89999999999999999 88


Q ss_pred             CCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-C-CChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHH
Q 038681          184 SDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-L-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEE  261 (332)
Q Consensus       184 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~  261 (332)
                      +.+||+|||++........    ....||+.|+|||++.+ . .+.++|||||||++|+|++|+.||.....        
T Consensus       177 ~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------  244 (312)
T 2iwi_A          177 GCAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--------  244 (312)
T ss_dssp             TEEEECCCSSCEECCSSCB----CCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------
T ss_pred             CeEEEEEcchhhhcccCcc----cccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--------
Confidence            9999999999987765432    35578999999999875 4 45699999999999999999999964211        


Q ss_pred             HHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          262 NVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ..   .. ...                  .+...+..+.+|+.+||+.||++|||+.++++
T Consensus       245 ~~---~~-~~~------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          245 IL---EA-ELH------------------FPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             HH---HT-CCC------------------CCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             Hh---hh-ccC------------------CcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00   00 000                  01123467899999999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=331.12  Aligned_cols=238  Identities=19%  Similarity=0.286  Sum_probs=177.7

Q ss_pred             HhcCCCCCCccccCCCceE-EEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----------EEE
Q 038681           52 ATNNYDEQNIVLEDPFRKL-YKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----------IVF  118 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~V-y~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv~  118 (332)
                      ...+|.+.+.||+|+||+| |++..+++.||||++......    .+.+|+.+++++ +|||||++           |||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            3456899999999999985 555559999999999765432    356899999999 79999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC-----CCCeEEeecCC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE-----QSDAKLFDFSL  193 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~~kl~Dfg~  193 (332)
                      |||+ |+|.+++....    ...++..+..++.||+.||.|||   +++|+||||||+|||++.     ...+||+|||+
T Consensus        98 E~~~-g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKD----FAHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             ECCS-EEHHHHHHSSS----CCCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             ECCC-CCHHHHHHhcC----CCccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            9996 59999997652    23455567899999999999999   999999999999999953     33588999999


Q ss_pred             ccccCCCCce-eeccccccCCCcccccccCC----CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhh
Q 038681          194 SLSIPDGETH-IELDSVVGTTGFIAPENFTT----LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLS  267 (332)
Q Consensus       194 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  267 (332)
                      ++........ .......||+.|+|||++.+    .++.++|||||||++|||++ |..||.........      ....
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~------~~~~  243 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN------ILLG  243 (432)
T ss_dssp             EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH------HHTT
T ss_pred             eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH------HHhc
Confidence            9876543221 12245679999999999973    67889999999999999999 89998644322110      0000


Q ss_pred             ccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ..  ..             .........+..+.+|+.+||+.||.+|||+.+|++
T Consensus       244 ~~--~~-------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          244 AC--SL-------------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             CC--CC-------------TTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cC--Cc-------------cccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            00  00             000111245567899999999999999999999984

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=5.8e-43  Score=326.81  Aligned_cols=248  Identities=20%  Similarity=0.286  Sum_probs=177.6

Q ss_pred             HHHHHhcC-CCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE---------
Q 038681           48 ELRIATNN-YDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL---------  115 (332)
Q Consensus        48 el~~~~~~-y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~---------  115 (332)
                      ++....++ |...+.||+|+||+||.+.. +|+.||||++....    .+.+.+|+.++.++ +|||||++         
T Consensus         8 ~~~~~l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   83 (434)
T 2rio_A            8 NFEQSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF----CDIALMEIKLLTESDDHPNVIRYYCSETTDRF   83 (434)
T ss_dssp             CCSCSCSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             chhhhhhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence            33333344 44568899999999976544 89999999986542    45678999999987 89999998         


Q ss_pred             --EEEEeccCCChHHHHhhhhcccc--cCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC--------
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHF--EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ--------  183 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~--~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--------  183 (332)
                        ||||||+ |+|.+++........  ...++..++.++.||+.||+|||   +++|+||||||+|||++.+        
T Consensus        84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~  159 (434)
T 2rio_A           84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQ  159 (434)
T ss_dssp             EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCT
T ss_pred             EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccc
Confidence              8999996 699999986521110  11233456789999999999999   9999999999999999754        


Q ss_pred             -----CCeEEeecCCccccCCCCcee--eccccccCCCcccccccCC--------CCChhhhHHHHHHHHHHHHh-CCcc
Q 038681          184 -----SDAKLFDFSLSLSIPDGETHI--ELDSVVGTTGFIAPENFTT--------LINEQCDVYGFGAFLFELLT-AQEV  247 (332)
Q Consensus       184 -----~~~kl~Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--------~~~~~sDiwSlG~~l~ellt-g~~p  247 (332)
                           +.+||+|||+++.........  ......||+.|+|||++.+        .++.++|||||||++|||++ |..|
T Consensus       160 ~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~P  239 (434)
T 2rio_A          160 TGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP  239 (434)
T ss_dssp             TCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCT
T ss_pred             cCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCC
Confidence                 479999999998776543211  1234579999999999853        58899999999999999999 9999


Q ss_pred             CCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          248 SDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      |........       ...... ..           ............+.++.+|+.+||+.||.+|||+.+|++
T Consensus       240 f~~~~~~~~-------~i~~~~-~~-----------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          240 FGDKYSRES-------NIIRGI-FS-----------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             TCSTTTHHH-------HHHHTC-CC-----------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCchhhHH-------HHhcCC-CC-----------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            975432211       000000 00           000011123466788999999999999999999999985

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.8e-43  Score=344.65  Aligned_cols=231  Identities=23%  Similarity=0.324  Sum_probs=190.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEe---CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE--------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW---QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL--------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~--------------  115 (332)
                      .++|.+.+.||+|+||.||+|.+   +++.||||.+.........+.+.+|+.++.+++||||+++              
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            37899999999999999999998   5899999998876666667789999999999999999976              


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        |||||+++++|.+++..       .+++..++.++.||+.||.|||   ++||+||||||+|||++.+ .+||+|||+
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~  227 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGA  227 (681)
T ss_dssp             EEEEEECCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred             eEEEEEeCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEeccc
Confidence              89999999999987753       5899999999999999999999   9999999999999999875 899999999


Q ss_pred             ccccCCCCceeeccccccCCCcccccccCCCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          194 SLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       194 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      ++.....      ....||+.|+|||++.+.++.++|||||||++|+|++|..||........                 
T Consensus       228 a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-----------------  284 (681)
T 2pzi_A          228 VSRINSF------GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-----------------  284 (681)
T ss_dssp             CEETTCC------SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECSSC-----------------
T ss_pred             chhcccC------CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccccc-----------------
Confidence            9876543      34579999999999987679999999999999999999988864321110                 


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHHHHh
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-TMVDVAKQLRQMYRS  330 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-s~~evl~~L~~l~~~  330 (332)
                      .             ........+..+.+|+.+||+.||.+|| +++++...|..+.+.
T Consensus       285 ~-------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  329 (681)
T 2pzi_A          285 P-------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE  329 (681)
T ss_dssp             C-------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred             c-------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence            0             0000112346789999999999999999 577787888776643

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.3e-42  Score=306.87  Aligned_cols=220  Identities=15%  Similarity=0.130  Sum_probs=176.3

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|.+.+.||+|+||.||+|.+  +++.||||.+.....  ....+.+.+|+.++.+++||||+++           +||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            6799999999999999999999  589999999986643  4446789999999999999999997           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++++|.+++...       ....++..++.||+.||.|||   ++||+||||||+|||++.++.+||+++|      
T Consensus       111 e~~~g~~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPA------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCC------
T ss_pred             EecCCCCHHHHHhcC-------CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecc------
Confidence            999999999999542       456678999999999999999   9999999999999999999999998543      


Q ss_pred             CCCceeeccccccCCCcccccccCCCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                                      |++      .++.++|||||||++|||++|+.||...........  ..............   
T Consensus       175 ----------------~~~------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~--~~~~~~~~~~~~~~---  227 (286)
T 3uqc_A          175 ----------------TMP------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP--AERDTAGQPIEPAD---  227 (286)
T ss_dssp             ----------------CCT------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE--CCBCTTSCBCCHHH---
T ss_pred             ----------------ccC------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH--HHHHhccCCCChhh---
Confidence                            233      378899999999999999999999987654331100  00000000000000   


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                                  .....+..+.+|+.+||+.||.+| |+.++++.|+++..
T Consensus       228 ------------~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~  265 (286)
T 3uqc_A          228 ------------IDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATA  265 (286)
T ss_dssp             ------------HCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC
T ss_pred             ------------cccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhc
Confidence                        001334779999999999999999 99999999998763

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.6e-42  Score=320.37  Aligned_cols=230  Identities=14%  Similarity=0.143  Sum_probs=177.3

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh--hhHHHHHHHHHHHHhhcC-CCcc----------------
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ--HALEWCINHIVYASRMSH-KHII----------------  113 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~H-~nIv----------------  113 (332)
                      +|...+.||+|+||.||+|.+  +|+.||||++......  ...+.+.+|+.++..++| +|..                
T Consensus        79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  158 (413)
T 3dzo_A           79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK  158 (413)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred             eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence            467788999999999999998  6999999998844332  236778999999999977 2210                


Q ss_pred             --------------------eE-EEEEeccCCChHHHHhhhh--cccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 038681          114 --------------------KL-IVFESVQIGTLADRIHHHC--EQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVY  170 (332)
Q Consensus       114 --------------------~~-lv~e~~~~g~L~~~l~~~~--~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  170 (332)
                                          .+ ++|+++ +|+|.+++....  ......+++..++.++.||+.||+|||   +++|+|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiH  234 (413)
T 3dzo_A          159 DPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH---HYGLVH  234 (413)
T ss_dssp             CCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHH---HTTEEC
T ss_pred             cCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHH---hCCccc
Confidence                                11 455544 679999985321  111245788899999999999999999   999999


Q ss_pred             cCCCCCCeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCccccccc----------CC-CCChhhhHHHHHHHHH
Q 038681          171 RDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF----------TT-LINEQCDVYGFGAFLF  239 (332)
Q Consensus       171 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~-~~~~~sDiwSlG~~l~  239 (332)
                      |||||+|||++.++.+||+|||+++.....     .....| +.|+|||++          .+ .++.++|||||||++|
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~  308 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIY  308 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHH
Confidence            999999999999999999999998765433     145567 999999998          44 6889999999999999


Q ss_pred             HHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 038681          240 ELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVD  319 (332)
Q Consensus       240 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e  319 (332)
                      ||++|+.||..........                    .......        ..++.+.+|+.+||+.||++|||+.+
T Consensus       309 elltg~~Pf~~~~~~~~~~--------------------~~~~~~~--------~~~~~~~~li~~~l~~dP~~Rpt~~~  360 (413)
T 3dzo_A          309 WIWCADLPNTDDAALGGSE--------------------WIFRSCK--------NIPQPVRALLEGFLRYPKEDRLLPLQ  360 (413)
T ss_dssp             HHHHSSCCCCTTGGGSCSG--------------------GGGSSCC--------CCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHCCCCCCCcchhhhHH--------------------HHHhhcc--------cCCHHHHHHHHHHccCChhhCcCHHH
Confidence            9999999997654322111                    0000000        12367999999999999999999888


Q ss_pred             HHH
Q 038681          320 VAK  322 (332)
Q Consensus       320 vl~  322 (332)
                      +++
T Consensus       361 ~l~  363 (413)
T 3dzo_A          361 AME  363 (413)
T ss_dssp             HTT
T ss_pred             HHh
Confidence            754

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2e-41  Score=301.20  Aligned_cols=219  Identities=19%  Similarity=0.273  Sum_probs=169.0

Q ss_pred             hcCCCCC-CccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHH-HhhcCCCcceE-------------
Q 038681           53 TNNYDEQ-NIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYA-SRMSHKHIIKL-------------  115 (332)
Q Consensus        53 ~~~y~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l-~~l~H~nIv~~-------------  115 (332)
                      .++|.+. +.||+|+||.||+|.+  +++.||+|.+...      ..+.+|+.++ +.++||||+++             
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            3567776 7799999999999999  7899999999643      4567899888 44589999986             


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC---CCCeEEee
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE---QSDAKLFD  190 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~D  190 (332)
                        +||||+++|+|.+++.....   ..+++..++.++.||+.||.|||   +.+|+||||||+||+++.   ++.+||+|
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~D  163 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGD---QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTD  163 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTT---CCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECC
T ss_pred             EEEEEeecCCCcHHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEec
Confidence              79999999999999987521   36999999999999999999999   999999999999999998   78899999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccCCCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      ||++.....                       ..++.++|||||||++|||++|..||...........  ......   
T Consensus       164 fg~a~~~~~-----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~--~~~~~~---  215 (299)
T 3m2w_A          164 FGFAKETTG-----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTRIR---  215 (299)
T ss_dssp             CTTCEECTT-----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CC--SCCSSC---
T ss_pred             ccccccccc-----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHH--HHHHHh---
Confidence            999854321                       2467899999999999999999999976543221000  000000   


Q ss_pred             cchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                 ......+.+.....+.++.+|+.+||+.||.+|||+.|+++
T Consensus       216 -----------~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          216 -----------MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             -----------TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -----------hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                       00000000000134578999999999999999999999986

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.2e-41  Score=307.54  Aligned_cols=233  Identities=17%  Similarity=0.196  Sum_probs=179.0

Q ss_pred             hcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCC-------ChhhHHHHHHHHHHHHhhc---------CCCcce--
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNR-------NQHALEWCINHIVYASRMS---------HKHIIK--  114 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~---------H~nIv~--  114 (332)
                      .++|.+.+.||+|+||.||+|+++++.||||++....       .....+.+.+|+.+++.++         |||||+  
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            4669999999999999999999999999999997653       2233578899999999986         555542  


Q ss_pred             ---------------------------------------EEEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHH
Q 038681          115 ---------------------------------------LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH  155 (332)
Q Consensus       115 ---------------------------------------~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~  155 (332)
                                                             +|||||+++|++.+.+..      ..+++..++.++.||+.
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHH
Confidence                                                   289999999977776643      35899999999999999


Q ss_pred             HHHHhhhcCCCCeeecCCCCCCeeeCCCC--------------------CeEEeecCCccccCCCCceeeccccccCCCc
Q 038681          156 AVAYLHVGFSRPIVYRDMKPTNILFNEQS--------------------DAKLFDFSLSLSIPDGETHIELDSVVGTTGF  215 (332)
Q Consensus       156 ~L~~LH~~~~~~ivH~Dlkp~Nill~~~~--------------------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y  215 (332)
                      ||.|||+  +++|+||||||+|||++.++                    .+||+|||+|+.....       ...||+.|
T Consensus       173 aL~~lH~--~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y  243 (336)
T 2vuw_A          173 SLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHH--HHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEECCCCT
T ss_pred             HHHHHHH--hCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEEEeecc
Confidence            9999993  47999999999999999887                    8999999999876532       34799999


Q ss_pred             ccccccCCCCChhhhHHHHHHH-HHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHH
Q 038681          216 IAPENFTTLINEQCDVYGFGAF-LFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ  294 (332)
Q Consensus       216 ~aPE~~~~~~~~~sDiwSlG~~-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (332)
                      +|||++.+..+.++||||||++ .+++++|..||........     ....          +.. ...............
T Consensus       244 ~aPE~~~g~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~-----~~~~----------~~~-~~~~~~~~~~~~~~~  307 (336)
T 2vuw_A          244 MDEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHY-----LTDK----------MLK-QMTFKTKCNTPAMKQ  307 (336)
T ss_dssp             TCSGGGCCCSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHH-----HHHH----------HHH-TCCCSSCCCSHHHHH
T ss_pred             cChhhhcCCCccceehhhhhCCCCcccccccCCCcchhhhhH-----HHHh----------hhh-hhccCcccchhhhhh
Confidence            9999999855999999998777 7788899998853210000     0000          000 000011111122346


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHH
Q 038681          295 QLQAFKQLTLQCMDFSPEDRPTMVDVA  321 (332)
Q Consensus       295 ~~~~~~~li~~cl~~dP~~RPs~~evl  321 (332)
                      .++++.+||.+||+.|     |+.|++
T Consensus       308 ~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          308 IKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             cCHHHHHHHHHHhccC-----CHHHHH
Confidence            7889999999999977     999987

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2.4e-35  Score=283.20  Aligned_cols=174  Identities=14%  Similarity=0.070  Sum_probs=122.3

Q ss_pred             cccCCCceEEEEEe--CCeeEEEEEEcCCC---------ChhhHHHHHHHHHHHHhh-cCCCcceE-----------EEE
Q 038681           62 VLEDPFRKLYKGFW--QKRSISLMKYNGNR---------NQHALEWCINHIVYASRM-SHKHIIKL-----------IVF  118 (332)
Q Consensus        62 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------lv~  118 (332)
                      .+.|++|.+..++.  .|..+++|.+....         .+...+.|.+|+++|+++ .|+||+++           |||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            45566666655544  78899999997652         123356799999999999 79999997           999


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||++||+|.++|...     ++++..   .|+.||+.||+|+|   ++|||||||||+|||++.+|.+||+|||+|+...
T Consensus       322 Eyv~G~~L~d~i~~~-----~~l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          322 EKLPGRLLSDMLAAG-----EEIDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             ECCCSEEHHHHHHTT-----CCCCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             ecCCCCcHHHHHHhC-----CCCCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence            999999999999876     567654   58899999999999   9999999999999999999999999999998775


Q ss_pred             CCCceeeccccccCCCcccccccCCCCChhhhHHHHHHHHHHHHhCCccC
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVS  248 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~p~  248 (332)
                      .....  ..+.+||+.|+|||++.+.+..++|+||+|++++++.++..++
T Consensus       391 ~~~~~--~~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          391 QDCSW--PTNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             ---CC--SHHHHHHHHHHHHHHC-----------------CCCCTTHHHH
T ss_pred             CCCcc--ccCceechhhccHHHhCCCCCCcccccccccchhhhccccchh
Confidence            54332  2467899999999999998888999999999998887765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.2e-30  Score=249.10  Aligned_cols=175  Identities=14%  Similarity=0.117  Sum_probs=139.3

Q ss_pred             CCCCccccCCCceEEEEEeCCeeEEEEEEcCCCC--h-----hhHHHHHHHHHHHHhhcCCCcc--eE---------EEE
Q 038681           57 DEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRN--Q-----HALEWCINHIVYASRMSHKHII--KL---------IVF  118 (332)
Q Consensus        57 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~--~-----~~~~~~~~E~~~l~~l~H~nIv--~~---------lv~  118 (332)
                      ...+.||+|+||.||+|...+..+++|+......  .     ...+++.+|+.++++++||||+  .+         |||
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm  418 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM  418 (540)
T ss_dssp             ---------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence            4467899999999999988999999998755322  1     1245689999999999999999  33         999


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+++|+|.+++..             +..++.||+.||.|||   +++|+||||||+|||++.  .+||+|||+++...
T Consensus       419 E~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          419 SYINGKLAKDVIED-------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             ECCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             ECCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            99999999999864             4589999999999999   999999999999999998  99999999998876


Q ss_pred             CCCcee-----eccccccCCCcccccccCC---CCChhhhHHHHHHHHHHHHhCCccCC
Q 038681          199 DGETHI-----ELDSVVGTTGFIAPENFTT---LINEQCDVYGFGAFLFELLTAQEVSD  249 (332)
Q Consensus       199 ~~~~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~p~~  249 (332)
                      ......     ......||+.|+|||++..   .|+..+|+||..+-..+-+.++.+|.
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            543211     1135689999999999975   67888999999998888887776663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=1.4e-26  Score=203.52  Aligned_cols=144  Identities=15%  Similarity=0.087  Sum_probs=116.6

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCCh-----------------hhHHHHHHHHHHHHhhcC
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQ-----------------HALEWCINHIVYASRMSH  109 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-----------------~~~~~~~~E~~~l~~l~H  109 (332)
                      .+......|.+.+.||+|+||.||+|.+ +|+.||+|.+......                 .....+.+|+.++++++|
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~  163 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG  163 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC
Confidence            3444455677779999999999999999 7899999999754321                 135678999999999986


Q ss_pred             CCcceE-------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC
Q 038681          110 KHIIKL-------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE  182 (332)
Q Consensus       110 ~nIv~~-------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~  182 (332)
                      +++..+       +||||+++|+|.+ +..           .....++.|++.||.|||   +.||+||||||+|||++ 
T Consensus       164 ~~v~~~~~~~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-  227 (282)
T 1zar_A          164 LAVPKVYAWEGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-  227 (282)
T ss_dssp             SSSCCEEEEETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-
T ss_pred             CCcCeEEeccceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-
Confidence            666654       8999999999988 421           124469999999999999   99999999999999999 


Q ss_pred             CCCeEEeecCCccccCCCCceeeccccccCCCcccccccC
Q 038681          183 QSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT  222 (332)
Q Consensus       183 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~  222 (332)
                      ++.+||+|||+|+.               +..|.|||.+.
T Consensus       228 ~~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          228 EEGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence            99999999999853               44578898774

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=3e-22  Score=173.72  Aligned_cols=131  Identities=12%  Similarity=0.175  Sum_probs=103.3

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCee--EEEEEEcCCCCh-----------------------hhHHHHHHHHHHHHhh
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRS--ISLMKYNGNRNQ-----------------------HALEWCINHIVYASRM  107 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~--vavK~~~~~~~~-----------------------~~~~~~~~E~~~l~~l  107 (332)
                      -|.+.+.||+|+||.||+|.+  +|+.  ||||++......                       .....+.+|+.++.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367889999999999999998  8989  999987543211                       1123688999999999


Q ss_pred             cCCCc-----ceE----EEEEeccC-C----ChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 038681          108 SHKHI-----IKL----IVFESVQI-G----TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM  173 (332)
Q Consensus       108 ~H~nI-----v~~----lv~e~~~~-g----~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  173 (332)
                      .|++|     +.+    |||||+.+ |    +|.++...        .++..+..++.|++.||.|||.  ..||+||||
T Consensus       128 ~~~~i~~p~~~~~~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~--~~givHrDl  197 (258)
T 1zth_A          128 KEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQ--EAELVHADL  197 (258)
T ss_dssp             HHTTCCCCCEEEEETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSC
T ss_pred             HhCCCCCCeEEEcCCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCC
Confidence            87654     222    99999943 4    66665432        2345678899999999999995  589999999


Q ss_pred             CCCCeeeCCCCCeEEeecCCcccc
Q 038681          174 KPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       174 kp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      ||+|||++.  .++|+|||+|...
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEET
T ss_pred             CHHHEEEcC--cEEEEECcccccC
Confidence            999999988  8999999999654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.78  E-value=1.8e-19  Score=163.01  Aligned_cols=132  Identities=14%  Similarity=0.108  Sum_probs=100.9

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCCh-----------------h----hHHHHHHHHHHHHhhcCC
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQ-----------------H----ALEWCINHIVYASRMSHK  110 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-----------------~----~~~~~~~E~~~l~~l~H~  110 (332)
                      ..-|++.+.||.|+||.||+|.. +|+.||||+++.....                 .    ..-...+|...|.++.++
T Consensus        94 g~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           94 KDVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             TSCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CCEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            33489999999999999999998 8999999987542110                 0    011235678888888655


Q ss_pred             Ccce---------EEEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeC
Q 038681          111 HIIK---------LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN  181 (332)
Q Consensus       111 nIv~---------~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~  181 (332)
                      ++.-         +|||||++|++|.++..           ......++.||+.+|.|||   ..|||||||||.|||++
T Consensus       174 gv~vp~p~~~~~~~LVME~i~G~~L~~l~~-----------~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~  239 (397)
T 4gyi_A          174 GFPVPEPIAQSRHTIVMSLVDALPMRQVSS-----------VPDPASLYADLIALILRLA---KHGLIHGDFNEFNILIR  239 (397)
T ss_dssp             TCSCCCEEEEETTEEEEECCSCEEGGGCCC-----------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE
T ss_pred             CCCCCeeeeccCceEEEEecCCccHhhhcc-----------cHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEe
Confidence            4421         28999999988865432           1234578899999999999   89999999999999998


Q ss_pred             CCCC----------eEEeecCCccccC
Q 038681          182 EQSD----------AKLFDFSLSLSIP  198 (332)
Q Consensus       182 ~~~~----------~kl~Dfg~a~~~~  198 (332)
                      .++.          +.|+||+.+-...
T Consensus       240 ~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          240 EEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCCCcccccccccceEEEEeCCcccCC
Confidence            7763          8899999886544

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.37  E-value=1.1e-12  Score=113.39  Aligned_cols=135  Identities=11%  Similarity=0.026  Sum_probs=100.8

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-CCCcceE-----------E
Q 038681           49 LRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKL-----------I  116 (332)
Q Consensus        49 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~~-----------l  116 (332)
                      +.....+|.+...++.|+.+.||++...+..+++|......... ...+.+|+.++..+. +..+.++           +
T Consensus         9 l~~~l~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~-~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l   87 (263)
T 3tm0_A            9 LKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT-TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HHHHHTTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS-TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             HHHHhccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC-HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence            34455679888889999999999998888899999987532111 235788999999884 4333333           8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhc---------------------------------
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVG---------------------------------  163 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~---------------------------------  163 (332)
                      ||||++|.+|.+.+..          ......++.+++.+|..||+-                                 
T Consensus        88 v~e~i~G~~l~~~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T 3tm0_A           88 LMSEADGVLCSEEYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEECCSSEEHHHHCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGG
T ss_pred             EEEecCCeehhhccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccc
Confidence            9999999999876321          122347888999999999940                                 


Q ss_pred             -----------------------CCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          164 -----------------------FSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       164 -----------------------~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                                             ....++|+|++|.||+++.++.+.|+||+.+
T Consensus       158 ~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a  211 (263)
T 3tm0_A          158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS  211 (263)
T ss_dssp             GSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred             ccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence                                   0145999999999999987555679999876

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.20  E-value=3.3e-11  Score=109.04  Aligned_cols=132  Identities=14%  Similarity=0.117  Sum_probs=96.3

Q ss_pred             CCCccccCCCceEEEEEeCCeeEEEEEEc--CCCChhhHHHHHHHHHHHHhhcCCC--cceE--------------EEEE
Q 038681           58 EQNIVLEDPFRKLYKGFWQKRSISLMKYN--GNRNQHALEWCINHIVYASRMSHKH--IIKL--------------IVFE  119 (332)
Q Consensus        58 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~--~~~~~~~~~~~~~E~~~l~~l~H~n--Iv~~--------------lv~e  119 (332)
                      ..+.|+.|.++.||+....+..+++|+..  ..........+.+|+.+++.+...+  +.++              +|||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             eEEEcCCcccceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            35678999999999999877888888876  4322222456788999999986322  2222              8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcC-----------------------------------
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGF-----------------------------------  164 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~-----------------------------------  164 (332)
                      |++|.++.+...       ..++......++.+++..|..||+..                                   
T Consensus       122 ~v~G~~l~~~~~-------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          122 FVSGRVLWDQSL-------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             CCCCBCCCCTTC-------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             ecCCeecCCCcc-------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            999988754221       24778888999999999999999510                                   


Q ss_pred             --------------------CCCeeecCCCCCCeeeCCCCC--eEEeecCCccc
Q 038681          165 --------------------SRPIVYRDMKPTNILFNEQSD--AKLFDFSLSLS  196 (332)
Q Consensus       165 --------------------~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~a~~  196 (332)
                                          ...++|+|++|.||+++.++.  +.|+||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                257999999999999987753  58999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.19  E-value=2.2e-11  Score=107.68  Aligned_cols=172  Identities=13%  Similarity=0.082  Sum_probs=116.1

Q ss_pred             CCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-CCC-----cce-----------EEEEEec
Q 038681           59 QNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKH-----IIK-----------LIVFESV  121 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~n-----Iv~-----------~lv~e~~  121 (332)
                      .+.++.|.+..||+..   ..+++|.....   .....+.+|..++..+. +..     ++.           ++||+++
T Consensus        25 i~~~~~G~~n~v~~v~---~~~vlR~~~~~---~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN---RDFIFKFPKHS---RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST---TSEEEEEESSH---HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC---CEEEEEecCCc---chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999864   56888886533   33567889999998883 322     221           2789999


Q ss_pred             cCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhc--------------------------------------
Q 038681          122 QIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVG--------------------------------------  163 (332)
Q Consensus       122 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~--------------------------------------  163 (332)
                      +|.+|.+....       .++..+...++.+++..|..||+.                                      
T Consensus        99 ~G~~l~~~~~~-------~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (304)
T 3sg8_A           99 KGVPLTPLLLN-------NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK  171 (304)
T ss_dssp             CCEECCHHHHH-------TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred             CCeECCccccc-------cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence            99888754332       367777788888888888888841                                      


Q ss_pred             -----------------CCCCeeecCCCCCCeeeCC--CCCeEEeecCCccccCCCCceeeccccccCCCc---cccccc
Q 038681          164 -----------------FSRPIVYRDMKPTNILFNE--QSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF---IAPENF  221 (332)
Q Consensus       164 -----------------~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y---~aPE~~  221 (332)
                                       ....++|+|++|.||+++.  .+.+.|+||+.+.........      .....+   ..|+..
T Consensus       172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl------~~~~~~~~~~~~~~~  245 (304)
T 3sg8_A          172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF------ISLMEDDEEYGMEFV  245 (304)
T ss_dssp             HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH------HTTCCTTTSCCHHHH
T ss_pred             HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH------HHHHhhccccCHHHH
Confidence                             0135899999999999988  456789999988654321110      001111   223221


Q ss_pred             C---C------------CCChhhhHHHHHHHHHHHHhCCccCC
Q 038681          222 T---T------------LINEQCDVYGFGAFLFELLTAQEVSD  249 (332)
Q Consensus       222 ~---~------------~~~~~sDiwSlG~~l~elltg~~p~~  249 (332)
                      .   .            ......+.|++|.++|.+.+|..+|.
T Consensus       246 ~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          246 SKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            1   0            11223689999999999999987763

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.18  E-value=2e-11  Score=105.01  Aligned_cols=126  Identities=12%  Similarity=0.009  Sum_probs=87.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCc-ce-E-----------EEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHI-IK-L-----------IVF  118 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nI-v~-~-----------lv~  118 (332)
                      ..+|.+....+.|..+.||++.. +|..+++|......    ...+.+|+.++..+.+.++ |. +           +||
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~   94 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL   94 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred             cCCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence            34455443334666799999987 57789999976542    2456789999999865444 32 2           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcC----------------------------------
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGF----------------------------------  164 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~----------------------------------  164 (332)
                      ||++|.+|.  ..        ..+   ...++.+++..|..||+..                                  
T Consensus        95 e~i~G~~l~--~~--------~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (264)
T 1nd4_A           95 GEVPGQDLL--SS--------HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE  161 (264)
T ss_dssp             ECCSSEETT--TS--------CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred             EecCCcccC--cC--------cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence            999998884  21        111   1256677777788887310                                  


Q ss_pred             ---------------------CCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          165 ---------------------SRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       165 ---------------------~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                                           ...++|+|++|.||+++.++.+.|+|||.+.
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                 1129999999999999876666799999873

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.54  E-value=5.3e-07  Score=79.47  Aligned_cols=125  Identities=14%  Similarity=0.084  Sum_probs=83.6

Q ss_pred             CCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCC------Ccc---------eEEEEEeccC
Q 038681           59 QNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHK------HII---------KLIVFESVQI  123 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~------nIv---------~~lv~e~~~~  123 (332)
                      ...++.|....||+.   +..+++|....   ......+.+|..+|..+.+.      .++         .++||||++|
T Consensus        24 v~~l~~G~~n~v~~v---g~~~VlR~~~~---~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV---NGDWVFRFPKS---QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE---TTTEEEEEESS---HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE---CCEEEEEecCC---chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            345788888899988   67788888532   23356789999999999642      222         2389999999


Q ss_pred             CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhc----------------------------------------
Q 038681          124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVG----------------------------------------  163 (332)
Q Consensus       124 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~----------------------------------------  163 (332)
                      .+|.+....       .++..+...++.+++..|..||+.                                        
T Consensus        98 ~~l~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~  170 (306)
T 3tdw_A           98 QILGEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD  170 (306)
T ss_dssp             EECHHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred             eECchhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence            888763211       133333444444444444444420                                        


Q ss_pred             -----------------CCCCeeecCCCCCCeeeCC---CCCe-EEeecCCccc
Q 038681          164 -----------------FSRPIVYRDMKPTNILFNE---QSDA-KLFDFSLSLS  196 (332)
Q Consensus       164 -----------------~~~~ivH~Dlkp~Nill~~---~~~~-kl~Dfg~a~~  196 (332)
                                       ....++|+|++|.||+++.   ++.+ .|+||+.+..
T Consensus       171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                             1446799999999999987   4565 7999998754

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.25  E-value=7e-06  Score=70.62  Aligned_cols=132  Identities=11%  Similarity=0.048  Sum_probs=87.1

Q ss_pred             HHHhcCCCCCCccccCCCc-eEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc----CCCcceE-------
Q 038681           50 RIATNNYDEQNIVLEDPFR-KLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS----HKHIIKL-------  115 (332)
Q Consensus        50 ~~~~~~y~~~~~lg~G~~g-~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----H~nIv~~-------  115 (332)
                      .....+|+. ..+..|..| .||+...  .+..+++|.....    ....+.+|...|+.+.    -|.++.+       
T Consensus        21 ~~~l~g~~~-~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~   95 (272)
T 4gkh_A           21 DADLYGYRW-ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDA   95 (272)
T ss_dssp             HHHHTTCEE-EEEECSSSSCEEEEEECCTTCCCEEEEEEETH----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             hccccCCeE-EEccCCCcCCeEEEEEecCCCeEEEEEECCCC----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeE
Confidence            333444543 234455555 6998876  4567888886543    2456788999998874    2444433       


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhc-------------------------------
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVG-------------------------------  163 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-------------------------------  163 (332)
                       +|||+++|.++.+.....         ......+..+++..|.-||..                               
T Consensus        96 ~lvme~l~G~~~~~~~~~~---------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (272)
T 4gkh_A           96 WLLTTAIPGKTAFQVLEEY---------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASD  166 (272)
T ss_dssp             EEEEECCCSEEHHHHHHHC---------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGG
T ss_pred             EEEEEeeCCccccccccCC---------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhh
Confidence             899999998887765432         112234556666666666610                               


Q ss_pred             ------------------------CCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          164 ------------------------FSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       164 ------------------------~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                                              ....++|+|+.|.||+++.++.+-|+||+.+.
T Consensus       167 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          167 FDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             CCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                                    01248999999999999987766799998873

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.18  E-value=8.5e-06  Score=74.35  Aligned_cols=66  Identities=8%  Similarity=0.092  Sum_probs=43.8

Q ss_pred             CCccccCCCceEEEEEe--CCeeEEEEEEcCCCC------hhhHHHHHHHHHHHHhhcC--CCcc-eE---------EEE
Q 038681           59 QNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN------QHALEWCINHIVYASRMSH--KHII-KL---------IVF  118 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~~~~~E~~~l~~l~H--~nIv-~~---------lv~  118 (332)
                      .+.||.|.++.||++..  .++.+++|.......      ....+++..|..++..+..  |..+ ++         +||
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d~~~~~lvm  114 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM  114 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEcCCccEEEE
Confidence            45789999999999975  568899998653211      1123456789999887742  3322 22         899


Q ss_pred             EeccCC
Q 038681          119 ESVQIG  124 (332)
Q Consensus       119 e~~~~g  124 (332)
                      |++++.
T Consensus       115 E~l~g~  120 (397)
T 2olc_A          115 EDLSHL  120 (397)
T ss_dssp             CCCTTS
T ss_pred             EeCCCc
Confidence            999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.18  E-value=2.9e-05  Score=68.92  Aligned_cols=131  Identities=11%  Similarity=0.075  Sum_probs=75.6

Q ss_pred             CccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-----cCCCcce--------------EEEEEe
Q 038681           60 NIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRM-----SHKHIIK--------------LIVFES  120 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~H~nIv~--------------~lv~e~  120 (332)
                      ..|+.|..+.||+....+..+++|.....     ...+..|..++..|     ..|.++.              +++|+|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~-----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP-----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTEEEEEEEECSC-----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCCCEEEEecCCC-----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            34566778999999886667999998763     12334455555544     2466553              289999


Q ss_pred             ccCCChH-----------HH---Hhhhhccc--c-------cCCCHHH-------------------------------H
Q 038681          121 VQIGTLA-----------DR---IHHHCEQH--F-------EALSLTD-------------------------------R  146 (332)
Q Consensus       121 ~~~g~L~-----------~~---l~~~~~~~--~-------~~l~~~~-------------------------------~  146 (332)
                      ++|.++.           ..   ++......  .       ....|..                               .
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542           11   11111100  0       0011211                               0


Q ss_pred             HHHHHHHHHHHHHhhh----------cCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          147 LKVAMDIAHAVAYLHV----------GFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       147 ~~i~~~i~~~L~~LH~----------~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      ..+...+..++.+|+.          .....++|+|++|.||+++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            1111223445666652          015789999999999999888889999998763

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.99  E-value=0.00017  Score=59.33  Aligned_cols=100  Identities=11%  Similarity=0.023  Sum_probs=66.8

Q ss_pred             CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCce
Q 038681          124 GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETH  203 (332)
Q Consensus       124 g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~  203 (332)
                      -+|.+.|....    .++++.+++.++.|.+.+|.-+-.  ...-..+=+-|..|++..+|+|.+.+ +.+.        
T Consensus        33 vSL~eIL~~~~----~PlsEEqaWALc~Qc~~~L~~~~~--~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------   97 (229)
T 2yle_A           33 LSLEEILRLYN----QPINEEQAWAVCYQCCGSLRAAAR--RRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------   97 (229)
T ss_dssp             EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHH--TTCCCCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred             ccHHHHHHHcC----CCcCHHHHHHHHHHHHHHHHhhhh--cccCCceecCCcceEEecCCceeccc-cccc--------
Confidence            47899998763    689999999999999999887621  11111223446889999999888764 1110        


Q ss_pred             eeccccccCCCcccccccCCCCChhhhHHHHHHHHHHHHhC
Q 038681          204 IELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTA  244 (332)
Q Consensus       204 ~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg  244 (332)
                            .....+.|||......+.+.=|||||+++|.-+-=
T Consensus        98 ------~~~~~~~~pe~~~~~~te~~~IysLG~tLY~ALDy  132 (229)
T 2yle_A           98 ------AGEPPPVAGKLGYSQCMETEVIESLGIIIYKALDY  132 (229)
T ss_dssp             ---------------CCSSSSSCHHHHHHHHHHHHHHHHTT
T ss_pred             ------ccccCCCChhhccccchHHHHHHHHHHHHHHHhhc
Confidence                  12334668888765678899999999999998763

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.87  E-value=3.7e-05  Score=66.84  Aligned_cols=70  Identities=6%  Similarity=-0.083  Sum_probs=50.5

Q ss_pred             CCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcC------CCcceE----EEEEeccCC
Q 038681           56 YDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSH------KHIIKL----IVFESVQIG  124 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H------~nIv~~----lv~e~~~~g  124 (332)
                      ......+|.|..+.||+.+. +|+.+.+|+........ ...+..|...|+.|.-      |.++..    +||||++++
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~-~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~~~lv~e~l~~~   95 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL-DGLFRAEALGLDWLGRSFGSPVPQVAGWDDRTLAMEWVDER   95 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC-TTHHHHHHHHHHHHTCSTTCCSCCEEEEETTEEEEECCCCC
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch-hhHHHHHHHHHHHHHhhCCCCcceEEeccCceEEEEeeccc
Confidence            44567789999999999998 78999999876543221 3457789999988842      333322    899999876


Q ss_pred             Ch
Q 038681          125 TL  126 (332)
Q Consensus       125 ~L  126 (332)
                      ..
T Consensus        96 ~~   97 (288)
T 3f7w_A           96 PP   97 (288)
T ss_dssp             CC
T ss_pred             CC
Confidence            43

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.81  E-value=8.2e-05  Score=66.65  Aligned_cols=68  Identities=3%  Similarity=-0.166  Sum_probs=44.0

Q ss_pred             Ccc-ccCCCceEEEEEeC--------CeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhc------CCCcce--------
Q 038681           60 NIV-LEDPFRKLYKGFWQ--------KRSISLMKYNGNRN--QHALEWCINHIVYASRMS------HKHIIK--------  114 (332)
Q Consensus        60 ~~l-g~G~~g~Vy~~~~~--------~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~------H~nIv~--------  114 (332)
                      +.| +.|....+|+....        +..+++|.......  ......+.+|+.++..+.      -|.++.        
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            567 78888999998764        67788887654320  000134567887777663      233332        


Q ss_pred             ---EEEEEeccCCChH
Q 038681          115 ---LIVFESVQIGTLA  127 (332)
Q Consensus       115 ---~lv~e~~~~g~L~  127 (332)
                         ++||||++|.++.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence               2899999987654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.70  E-value=0.00028  Score=64.81  Aligned_cols=76  Identities=14%  Similarity=0.217  Sum_probs=48.4

Q ss_pred             CCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCceeecccccc--CCCcccccccCC----CCChhhhHHHHHHHH
Q 038681          165 SRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG--TTGFIAPENFTT----LINEQCDVYGFGAFL  238 (332)
Q Consensus       165 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~----~~~~~sDiwSlG~~l  238 (332)
                      ...++|+|++|.|||++.++ +.|+||+.+..-......   .....  ...|++|+....    .-....++.+....+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dl---a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDI---GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT  306 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHH---HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHH---HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence            78999999999999998776 999999988654321111   01111  134566654432    112345566777788


Q ss_pred             HHHHhC
Q 038681          239 FELLTA  244 (332)
Q Consensus       239 ~elltg  244 (332)
                      |+.+++
T Consensus       307 ~~~y~~  312 (420)
T 2pyw_A          307 WNLFNK  312 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            877764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.58  E-value=0.0019  Score=56.90  Aligned_cols=153  Identities=14%  Similarity=0.149  Sum_probs=88.3

Q ss_pred             CCcccccHHHHHHHhcCCCC-----CCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcC---
Q 038681           39 NPYRIFSAEELRIATNNYDE-----QNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSH---  109 (332)
Q Consensus        39 ~~~~~~~~~el~~~~~~y~~-----~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H---  109 (332)
                      .++..++.+++......|.+     ...++ |....||+... +|+.+++|.......  ....+..|..++..+..   
T Consensus         6 ~~~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~--~~~~~~~E~~~~~~L~~~g~   82 (328)
T 1zyl_A            6 FTFQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW--TADQILEEHQFALQLVNDEV   82 (328)
T ss_dssp             CCCCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS--CHHHHHHHHHHHHHHHHTTC
T ss_pred             CCCCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC--CHHHHHHHHHHHHHHHHcCC
Confidence            56778888887766555543     23466 88889999887 566899999874321  13456678888877742   


Q ss_pred             --CCcce-------------EEEEEeccCCChH-----H------H---Hhhhhcc-c---ccCCCHHHH----------
Q 038681          110 --KHIIK-------------LIVFESVQIGTLA-----D------R---IHHHCEQ-H---FEALSLTDR----------  146 (332)
Q Consensus       110 --~nIv~-------------~lv~e~~~~g~L~-----~------~---l~~~~~~-~---~~~l~~~~~----------  146 (332)
                        |.++.             +++++|++|.++.     .      .   ++..... .   ....+....          
T Consensus        83 ~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  162 (328)
T 1zyl_A           83 PVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFED  162 (328)
T ss_dssp             SBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHT
T ss_pred             eecceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhh
Confidence              33322             2589999875432     1      1   1111000 0   011221111          


Q ss_pred             ------------HHHHHHHHHHHHHhhh-cCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          147 ------------LKVAMDIAHAVAYLHV-GFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       147 ------------~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                                  ...+..++..+.-+-. .....++|+|++|.||+++ + .+.|+||+.+..
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          163 ATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             cCcCCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                        1112222222222210 0156789999999999998 4 899999987754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.55  E-value=0.00028  Score=61.58  Aligned_cols=62  Identities=11%  Similarity=0.086  Sum_probs=40.4

Q ss_pred             CCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcC----CCcceE------EEEEec-cCCCh
Q 038681           59 QNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSH----KHIIKL------IVFESV-QIGTL  126 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~~------lv~e~~-~~g~L  126 (332)
                      .+.|+.|....+|+.    ..+++|........  .-...+|+.++..+..    |.++-.      +++||+ ++.++
T Consensus        23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~~~~~~~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA----GDLCLRIPGKGTEE--YINRANEAVAAREAAKAGVSPEVLHVDPATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             CEEEESCSSEEEEEE----TTEEEEEECC------CCCHHHHHHHHHHHHHTTSSCCEEEECTTTCCEEEECCTTCEEC
T ss_pred             eeEcCCcccccccee----eeEEEECCCCCccc--eeCHHHHHHHHHHHHHcCCCCceEEEECCCCEEEEeecCCCccC
Confidence            677889999999998    66888887654211  1112467877777642    444433      899999 65444

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.51  E-value=0.0016  Score=57.16  Aligned_cols=152  Identities=16%  Similarity=0.131  Sum_probs=84.7

Q ss_pred             cccccHHHHHHHhcCCCCC-----CccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-----CC
Q 038681           41 YRIFSAEELRIATNNYDEQ-----NIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMS-----HK  110 (332)
Q Consensus        41 ~~~~~~~el~~~~~~y~~~-----~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-----H~  110 (332)
                      +..++.+++......|.+.     +.|+.|....+|+....+..+++|.......   .+.+..|+.++..|.     -|
T Consensus         4 ~~~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~---~~~l~~e~~~l~~L~~~g~~vP   80 (322)
T 2ppq_A            4 YTDITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVE---KNDLPFFLGLMQHLAAKGLSCP   80 (322)
T ss_dssp             -CCCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC------CCHHHHHHHHHHHHHHTTCCCC
T ss_pred             cccCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCccEEEEEeCCCCC---HHHHHHHHHHHHHHHHCCCCCC
Confidence            3456777777776667652     3466788889999988656788998876322   233456777777663     24


Q ss_pred             Ccce--------------EEEEEeccCCChHH-----------H---HhhhhcccccC----CC---HHHHHH-------
Q 038681          111 HIIK--------------LIVFESVQIGTLAD-----------R---IHHHCEQHFEA----LS---LTDRLK-------  148 (332)
Q Consensus       111 nIv~--------------~lv~e~~~~g~L~~-----------~---l~~~~~~~~~~----l~---~~~~~~-------  148 (332)
                      .++.              +++++|++|.++..           .   ++........+    ..   |.....       
T Consensus        81 ~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~  160 (322)
T 2ppq_A           81 LPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERAD  160 (322)
T ss_dssp             CBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGG
T ss_pred             cccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHH
Confidence            4432              27899998765311           1   11110000000    11   111000       


Q ss_pred             -----HHHHHHHHHHHhhh----cCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          149 -----VAMDIAHAVAYLHV----GFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       149 -----i~~~i~~~L~~LH~----~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                           +...+...++++..    ....+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       161 ~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          161 EVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                 00113344455542    114579999999999999877656799998763

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.46  E-value=0.00037  Score=61.28  Aligned_cols=64  Identities=2%  Similarity=-0.029  Sum_probs=48.2

Q ss_pred             CCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc------CCCcce--------EEEEEeccCC
Q 038681           59 QNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMS------HKHIIK--------LIVFESVQIG  124 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------H~nIv~--------~lv~e~~~~g  124 (332)
                      .+.|+.|....+|+....+..+++|.....    ....+..|...|+.|.      -|-++.        ++||||+++.
T Consensus        41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~  116 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDEVQTVFVKINERS----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS  116 (312)
T ss_dssp             EEEECCSSSSEEEEEESSSCEEEEEEEEGG----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred             eEEeCCccceeeeEEEECCCeEEEEeCCcc----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence            456899999999999888888889887643    2566888998888873      233332        2899999987


Q ss_pred             Ch
Q 038681          125 TL  126 (332)
Q Consensus       125 ~L  126 (332)
                      ++
T Consensus       117 ~~  118 (312)
T 3jr1_A          117 KN  118 (312)
T ss_dssp             CC
T ss_pred             CC
Confidence            64

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.21  E-value=0.0011  Score=61.02  Aligned_cols=65  Identities=15%  Similarity=0.082  Sum_probs=44.2

Q ss_pred             CCccccCCCceEEEEEeC---------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcc-eE-------EEEEec
Q 038681           59 QNIVLEDPFRKLYKGFWQ---------KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHII-KL-------IVFESV  121 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~~-------lv~e~~  121 (332)
                      .+.|+.|....||++...         +..+++|+......   .+.+.+|..++..|...+++ ++       +|+||+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~g~v~e~l  154 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET---ESHLVAESVIFTLLSERHLGPKLYGIFSGGRLEEYI  154 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC---HHHHHHHHHHHHHHHHTTSSSCEEEEETTEEEECCC
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCCCEEEEEe
Confidence            456788888999999873         46788888844221   24456899999888533332 22       799999


Q ss_pred             cCCCh
Q 038681          122 QIGTL  126 (332)
Q Consensus       122 ~~g~L  126 (332)
                      +|.+|
T Consensus       155 ~G~~l  159 (429)
T 1nw1_A          155 PSRPL  159 (429)
T ss_dssp             CEEEC
T ss_pred             CCccc
Confidence            86443

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.10  E-value=0.0039  Score=55.01  Aligned_cols=33  Identities=21%  Similarity=0.268  Sum_probs=28.3

Q ss_pred             CCCeeecCCCCCCeeeCCC----CCeEEeecCCcccc
Q 038681          165 SRPIVYRDMKPTNILFNEQ----SDAKLFDFSLSLSI  197 (332)
Q Consensus       165 ~~~ivH~Dlkp~Nill~~~----~~~kl~Dfg~a~~~  197 (332)
                      ...++|+|+.+.||+++.+    +.+.|+||+.+..-
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            5689999999999999874    67899999988554

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.06  E-value=0.0014  Score=59.00  Aligned_cols=66  Identities=17%  Similarity=0.118  Sum_probs=39.2

Q ss_pred             CCccccCCCceEEEEEeCC----------eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcc-eE-------EEEEe
Q 038681           59 QNIVLEDPFRKLYKGFWQK----------RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHII-KL-------IVFES  120 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~~~----------~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv-~~-------lv~e~  120 (332)
                      ...|+.|....+|+....+          ..+++|+...... . ......|..++..+...+++ ++       +|+||
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~-~~~~~~E~~~l~~L~~~g~~P~~~~~~~~~~v~e~  115 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-E-LYNTISEFEVYKTMSKYKIAPQLLNTFNGGRIEEW  115 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-G-TSCHHHHHHHHHHHHHTTSSCCEEEEETTEEEEEC
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-c-eecHHHHHHHHHHHHhcCCCCceEEecCCcEEEEE
Confidence            3467788888999998743          6777777654321 1 11235788888887432333 22       89999


Q ss_pred             ccCCCh
Q 038681          121 VQIGTL  126 (332)
Q Consensus       121 ~~~g~L  126 (332)
                      ++|.++
T Consensus       116 i~G~~l  121 (369)
T 3c5i_A          116 LYGDPL  121 (369)
T ss_dssp             CCSEEC
T ss_pred             ecCCcC
Confidence            987543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.99  E-value=0.002  Score=58.12  Aligned_cols=134  Identities=15%  Similarity=0.142  Sum_probs=75.7

Q ss_pred             CccccCCCceEEEEEeC---------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcC----CCcceE----EEEEecc
Q 038681           60 NIVLEDPFRKLYKGFWQ---------KRSISLMKYNGNRNQHALEWCINHIVYASRMSH----KHIIKL----IVFESVQ  122 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~~----lv~e~~~  122 (332)
                      +.|..|-...+|++...         +..+++++.....  .......+|..+++.|.-    |-++-.    +|+||++
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~--~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g~v~e~i~  133 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL--QGVDSLVLESVMFAILAERSLGPQLYGVFPEGRLEQYIP  133 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTEEEEECCS
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc--chHHHHHHHHHHHHHHHhcCCCCeEEEEcCCccEEEEec
Confidence            45777888899999873         3678888753321  124556689999988842    333333    8999999


Q ss_pred             CCChHH--------------HHhh-hh-cccc-cCC--CHHHHHHHHHHHHH-------------------HHHHhhh--
Q 038681          123 IGTLAD--------------RIHH-HC-EQHF-EAL--SLTDRLKVAMDIAH-------------------AVAYLHV--  162 (332)
Q Consensus       123 ~g~L~~--------------~l~~-~~-~~~~-~~l--~~~~~~~i~~~i~~-------------------~L~~LH~--  162 (332)
                      |.+|..              .+.+ +. .... ...  -+.++..+..++..                   .+..|..  
T Consensus       134 G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L  213 (379)
T 3feg_A          134 SRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLL  213 (379)
T ss_dssp             EEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHH
T ss_pred             CccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHH
Confidence            865431              1110 00 0000 111  13445555544322                   1223221  


Q ss_pred             ---cCCCCeeecCCCCCCeeeCCC----CCeEEeecCCcc
Q 038681          163 ---GFSRPIVYRDMKPTNILFNEQ----SDAKLFDFSLSL  195 (332)
Q Consensus       163 ---~~~~~ivH~Dlkp~Nill~~~----~~~kl~Dfg~a~  195 (332)
                         .....++|+|+.+.||+++.+    +.+.|+||..+.
T Consensus       214 ~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          214 ESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             hhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               114579999999999999876    789999998773

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.82  E-value=0.0065  Score=56.27  Aligned_cols=65  Identities=14%  Similarity=-0.012  Sum_probs=42.4

Q ss_pred             CccccCCCceEEEEEeCC--eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcce-E-------EEEEeccCCCh
Q 038681           60 NIVLEDPFRKLYKGFWQK--RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIK-L-------IVFESVQIGTL  126 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~-~-------lv~e~~~~g~L  126 (332)
                      +.|+.|-...+|++...+  ..+++|+.......- . ...+|..++..|...++++ +       +|+||++|.+|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~-i-dR~~E~~vl~~L~~~gl~P~ll~~~~~G~v~e~I~G~~l  188 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI-I-NREREKKISCILYNKNIAKKIYVFFTNGRIEEFMDGYAL  188 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC-S-CHHHHHHHHHHHTTSSSBCCEEEEETTEEEEECCCSEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh-c-CHHHHHHHHHHHHhcCCCCCEEEEeCCeEEEEeeCCccC
Confidence            457788888999999855  888888875432111 1 1258999999886544432 2       79999987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.15  E-value=0.015  Score=51.46  Aligned_cols=32  Identities=13%  Similarity=0.279  Sum_probs=28.1

Q ss_pred             CCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          165 SRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       165 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ...++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            45799999999999999888899999987754

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=94.82  E-value=0.12  Score=47.09  Aligned_cols=66  Identities=12%  Similarity=-0.002  Sum_probs=43.0

Q ss_pred             CCccccCCCceEEEEEeC---------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcC----CCcceE----EEEEec
Q 038681           59 QNIVLEDPFRKLYKGFWQ---------KRSISLMKYNGNRNQHALEWCINHIVYASRMSH----KHIIKL----IVFESV  121 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H----~nIv~~----lv~e~~  121 (332)
                      .+.+..|-...+|+....         +..+++++..... .. .-...+|..+++.+.-    |-++-.    +|+||+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~~~~I~efI  152 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GK-FYDSKVELDVFRYLSNINIAPNIIADFPEGRIEEFI  152 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--C-CCCHHHHHHHHHHHHHTTSSCCEEEEETTEEEEECC
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-ch-hcCHHHHHHHHHHHHhcCCCCCEEEEcCCCEEEEEe
Confidence            345677888899999884         5778888864432 11 1123578888888753    333322    899999


Q ss_pred             cCCCh
Q 038681          122 QIGTL  126 (332)
Q Consensus       122 ~~g~L  126 (332)
                      +|.+|
T Consensus       153 ~G~~l  157 (424)
T 3mes_A          153 DGEPL  157 (424)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            98653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.29  E-value=0.019  Score=52.13  Aligned_cols=29  Identities=31%  Similarity=0.414  Sum_probs=24.4

Q ss_pred             CeeecCCCCCCeee------CCCCCeEEeecCCcc
Q 038681          167 PIVYRDMKPTNILF------NEQSDAKLFDFSLSL  195 (332)
Q Consensus       167 ~ivH~Dlkp~Nill------~~~~~~kl~Dfg~a~  195 (332)
                      .++|+|+.+.|||+      +.+..+.++||-.|.
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~  279 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS  279 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence            46799999999999      456779999998774

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.61  E-value=0.9  Score=37.07  Aligned_cols=108  Identities=9%  Similarity=0.058  Sum_probs=74.5

Q ss_pred             cCCCcceE--------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCee
Q 038681          108 SHKHIIKL--------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNIL  179 (332)
Q Consensus       108 ~H~nIv~~--------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil  179 (332)
                      .||+.+..        +++.|-...+...|-.-      ...+....++++..|+.-..+++     .=+|--|.|+||+
T Consensus        43 ~~~~Fl~~~I~e~eD~v~~~y~~~~~~~~f~~i------k~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDAELTELRDSFQIHYDINDNHTPFDNI------KSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCEEEEECSSEEEEEECCCTTSEEGGGG------GGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEE
T ss_pred             cCCcccceEEEEcccEEEEEEEcCcccCCHHHH------HhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEE
Confidence            58888865        66666554444444332      35889999999999998886665     3478889999999


Q ss_pred             eCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCCCCChhhhHHHHHHHHHHHHhCCccCC
Q 038681          180 FNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSD  249 (332)
Q Consensus       180 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~p~~  249 (332)
                      ++.++.+++.-.|+-..+.                   |.    ..+...=.-.+=|++..+++++..|.
T Consensus       112 f~~~~~p~i~~RGik~~l~-------------------P~----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNVVD-------------------PL----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             ECTTSCEEESCCEETTTBS-------------------CC----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EcCCCCEEEEEccCccCCC-------------------CC----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999998777643321                   11    11222223366788888999888775

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=88.15  E-value=0.059  Score=49.89  Aligned_cols=56  Identities=7%  Similarity=-0.053  Sum_probs=14.4

Q ss_pred             CCCCccccCCCceEEEEEeC--CeeEEE------EEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE
Q 038681           57 DEQNIVLEDPFRKLYKGFWQ--KRSISL------MKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL  115 (332)
Q Consensus        57 ~~~~~lg~G~~g~Vy~~~~~--~~~vav------K~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~  115 (332)
                      .+.+.||   ||.||+|.+.  ..+||+      |...... ..+....+.+|..++..++|||+++.
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~  209 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKI  209 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBC
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCC
Confidence            3456676   9999999994  357888      6665432 23334568889999999999999986

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=85.60  E-value=1.5  Score=35.84  Aligned_cols=106  Identities=13%  Similarity=0.145  Sum_probs=70.3

Q ss_pred             cCCCcceE--------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHH-HhhhcCCCCeeecCCCCCCe
Q 038681          108 SHKHIIKL--------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVA-YLHVGFSRPIVYRDMKPTNI  178 (332)
Q Consensus       108 ~H~nIv~~--------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~-~LH~~~~~~ivH~Dlkp~Ni  178 (332)
                      .||++ ..        +.+.|-.......+-.-      ..++..+.++++..|+.-.. +++     .-+|--|.|+||
T Consensus        48 ~~~~f-~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI-VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENL  115 (219)
T ss_dssp             SCSSS-EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGE
T ss_pred             cCCCC-CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceE
Confidence            57888 55        55555443233333221      24788999999999888777 555     457788999999


Q ss_pred             eeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCCCCChhhhHH-HHHHHHHHHHhCCccCC
Q 038681          179 LFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVY-GFGAFLFELLTAQEVSD  249 (332)
Q Consensus       179 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiw-SlG~~l~elltg~~p~~  249 (332)
                      +++.++.+++.-.|+-..+                   +|.-    .+ ..|.| .+=|++..++.++..|.
T Consensus       116 ~f~~~~~p~i~hRGi~~~l-------------------pP~e----~~-ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKESL-------------------PPDE----WD-DERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             EECTTCCEEESCCEETTTB-------------------SSCS----CC-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EEeCCCcEEEEEcCCcccC-------------------CCCC----CC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999999887764322                   2221    11 22333 66778888888877664

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	332
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-37
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-31
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-30
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-29
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	6e-29
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-28
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-28
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	9e-28
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-27
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-27
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-27
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-27
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-27
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-26
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-26
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-26
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-25
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-25
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-25
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-25
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-25
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-24
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-24
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-24
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-24
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-24
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-24
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-23
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-23
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-23
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	3e-23
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-23
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-22
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-20
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-19
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-19
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-19
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-18
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-18
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-18
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-18
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-18
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-17
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-17
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-17
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-16
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-16
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-15
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-15
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-15
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-15
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-14
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-14
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-14
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	8e-14
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-13
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-11
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-11
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	9e-11
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-09
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-09
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-08
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-05

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (330), Expect = 8e-37
 Identities = 56/298 (18%), Positives = 106/298 (35%), Gaps = 39/298 (13%)

Query: 47  EELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASR 106
           ++  I          +    F  +YKG W       M          L+   N +    +
Sbjct: 1   DDWEIPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 60

Query: 107 MSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHA 156
             H +I+            IV +  +  +L   +H    +      +   + +A   A  
Sbjct: 61  TRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETK----FEMIKLIDIARQTAQG 116

Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFI 216
           + YLH    + I++RD+K  NI  +E    K+ DF L+          + + + G+  ++
Sbjct: 117 MDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173

Query: 217 APENFTTL----INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR 272
           APE          + Q DVY FG  L+EL+T Q    +++   +  +      LS    +
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233

Query: 273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
            +                      +A K+L  +C+    ++RP    +   +  + RS
Sbjct: 234 VRSNCP------------------KAMKRLMAECLKKKRDERPLFPQILASIELLARS 273

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (295), Expect = 2e-31
 Identities = 52/305 (17%), Positives = 119/305 (39%), Gaps = 44/305 (14%)

Query: 60  NIVLEDP-----FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIK 114
            IVL++      F ++++G W+   +++  ++    +         I     + H++I+ 
Sbjct: 4   TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFR--EAEIYQTVMLRHENILG 61

Query: 115 L---------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAY 159
                           +V +  + G+L D ++ +       +++   +K+A+  A  +A+
Sbjct: 62  FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAH 115

Query: 160 LHVGF-----SRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL--DSVVGT 212
           LH+          I +RD+K  NIL  +     + D  L++        I++  +  VGT
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 213 TGFIAPENFTTLIN-------EQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKR 265
             ++APE     IN       ++ D+Y  G   +E+     +   +  + +  Y + V  
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG-IHEDYQLPYYDLVPS 234

Query: 266 LSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLR 325
                   K + +  +  +        E  L+   ++  +C   +   R T + + K L 
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCE-ALRVMAKIMRECWYANGAARLTALRIKKTLS 293

Query: 326 QMYRS 330
           Q+ + 
Sbjct: 294 QLSQQ 298

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (285), Expect = 8e-30
 Identities = 46/306 (15%), Positives = 101/306 (33%), Gaps = 45/306 (14%)

Query: 49  LRIATNNYDEQNIVLEDPFRKLYKGFWQK--RSISLMKYNGNRNQHALEWCINHIVYASR 106
           + +  +++++ + +       ++K   +     ++    +           I  +     
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 107 MSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
            +  +I+             I  E +  G+L   +          +      KV++ +  
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIK 115

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            + YL       I++RD+KP+NIL N + + KL DF +S  + D   +    S VGT  +
Sbjct: 116 GLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSY 169

Query: 216 IAPENFTTL-INEQCDVYGFGAFLFELLT---------AQEVSDHVSFESRFHYEENVKR 265
           ++PE       + Q D++  G  L E+           A+E+      +      E   R
Sbjct: 170 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229

Query: 266 LSGQNCRFKEMVDSI-----------IIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDR 314
                                      I ++             F+    +C+  +P +R
Sbjct: 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 289

Query: 315 PTMVDV 320
             +  +
Sbjct: 290 ADLKQL 295

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 1e-29
 Identities = 53/295 (17%), Positives = 105/295 (35%), Gaps = 41/295 (13%)

Query: 47  EELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASR 106
           +E  +          +    F +++ G++   +   +K    +   + +  +       +
Sbjct: 6   DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQ 64

Query: 107 MSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHA 156
           + H+ +++L          I+ E ++ G+L D +          L++   L +A  IA  
Sbjct: 65  LQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEG 121

Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFI 216
           +A++     R  ++RD++  NIL ++    K+ DF L+  I D E     +       + 
Sbjct: 122 MAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR-EGAKFPIKWT 177

Query: 217 APENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE 275
           APE         + DV+ FG  L E++T              +       +     R   
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGR---------IPYPGMTNPEVIQNLERGYR 228

Query: 276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
           MV               +   +   QL   C    PEDRPT   +   L   + +
Sbjct: 229 MVRP-------------DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 6e-29
 Identities = 48/301 (15%), Positives = 108/301 (35%), Gaps = 46/301 (15%)

Query: 47  EELRIATNNYDEQNIVL-EDPFRKLYKGFWQKRS----ISLMKYNGNRNQHALEWCINHI 101
           ++L +  +N    +I L    F  + +G ++ R     +++        +   E  +   
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 102 VYASRMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM 151
               ++ + +I++L          +V E    G L   +    E+    + +++  ++  
Sbjct: 61  QIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLH 116

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD-SVV 210
            ++  + YL     +  V+RD+   N+L   +  AK+ DF LS ++   +++     +  
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 211 GTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ 269
               + APE       + + DV+ +G  ++E L+         ++     E       G+
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYG----QKPYKKMKGPEVMAFIEQGK 229

Query: 270 NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
                                           L   C  +  EDRP  + V +++R  Y 
Sbjct: 230 RMECPPECP------------------PELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271

Query: 330 S 330
           S
Sbjct: 272 S 272

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (269), Expect = 4e-28
 Identities = 46/270 (17%), Positives = 98/270 (36%), Gaps = 52/270 (19%)

Query: 67  FRKLYKGFW----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------- 115
           F  +Y           ++ ++                 +   S + H +I++L       
Sbjct: 19  FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA 78

Query: 116 ----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYR 171
               ++ E   +GT+   +                     ++A+A++Y H   S+ +++R
Sbjct: 79  TRVYLILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCH---SKRVIHR 130

Query: 172 DMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCD 230
           D+KP N+L     + K+ DF  S+  P         ++ GT  ++ PE     + +E+ D
Sbjct: 131 DIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHDEKVD 186

Query: 231 VYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCT 290
           ++  G   +E L  +   +  +      Y+E  KR+S     F + V             
Sbjct: 187 LWSLGVLCYEFLVGKPPFEANT------YQETYKRISRVEFTFPDFVT------------ 228

Query: 291 GKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
                 +  + L  + +  +P  RP + +V
Sbjct: 229 ------EGARDLISRLLKHNPSQRPMLREV 252

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  108 bits (270), Expect = 5e-28
 Identities = 50/316 (15%), Positives = 107/316 (33%), Gaps = 58/316 (18%)

Query: 44  FSAEELRIATNNYDE---------QNIVLEDPFRKLYKGFW-----QKRSISLMKYNGNR 89
           F+ E+   A   + +         + ++    F ++  G       ++  +++       
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 90  NQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHF 138
            +      ++      +  H ++I L           I+ E ++ G+L   +  +  Q  
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 139 EALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP 198
              ++   + +   IA  + YL        V+RD+   NIL N     K+ DF LS  + 
Sbjct: 126 ---TVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179

Query: 199 DGETHIELDSVVG---TTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHVSFE 254
           D  +     S +G      + APE           DV+ +G  ++E+++           
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS----------- 228

Query: 255 SRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDR 314
                          +   ++++++I   ++            A  QL L C       R
Sbjct: 229 --------YGERPYWDMTNQDVINAI---EQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 277

Query: 315 PTMVDVAKQLRQMYRS 330
           P    +   L +M R+
Sbjct: 278 PKFGQIVNTLDKMIRN 293

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 9e-28
 Identities = 49/271 (18%), Positives = 93/271 (34%), Gaps = 44/271 (16%)

Query: 67  FRKLYKGFWQK--RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL--------- 115
           + ++     +    ++++   +  R     E     I     ++H++++K          
Sbjct: 18  YGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI 77

Query: 116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM 173
             +  E    G L DRI          +   D  +    +   V YLH      I +RD+
Sbjct: 78  QYLFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDI 129

Query: 174 KPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDV 231
           KP N+L +E+ + K+ DF L+           L+ + GT  ++APE         E  DV
Sbjct: 130 KPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDV 189

Query: 232 YGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTG 291
           +  G  L  +L  +   D  S   +                + +  +     +       
Sbjct: 190 WSCGIVLTAMLAGELPWDQPSDSCQE---------------YSDWKEKKTYLNPWKKID- 233

Query: 292 KEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK 322
                 A   L  + +  +P  R T+ D+ K
Sbjct: 234 -----SAPLALLHKILVENPSARITIPDIKK 259

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 2e-27
 Identities = 47/276 (17%), Positives = 97/276 (35%), Gaps = 43/276 (15%)

Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           F  ++ G+W  +    +K        + E  I       ++SH  +++L           
Sbjct: 18  FGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 76

Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           +VFE ++ G L+D +                L + +D+   +AYL       +++RD+  
Sbjct: 77  LVFEFMEHGCLSDYLRTQRGLFAAE----TLLGMCLDVCEGMAYLE---EACVIHRDLAA 129

Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGF 234
            N L  E    K+ DF ++  + D +             + +PE F+    + + DV+ F
Sbjct: 130 RNCLVGENQVIKVSDFGMTRFVLDDQYTSS-TGTKFPVKWASPEVFSFSRYSSKSDVWSF 188

Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  ++E+ +  +           +   +   +         +    +             
Sbjct: 189 GVLMWEVFSEGK---------IPYENRSNSEVVEDISTGFRLYKPRLASTH--------- 230

Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
                 Q+   C    PEDRP    + +QL ++  S
Sbjct: 231 ----VYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 3e-27
 Identities = 48/274 (17%), Positives = 97/274 (35%), Gaps = 49/274 (17%)

Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           F  +  G ++   +++      +N    +  +      +++ H ++++L           
Sbjct: 20  FGDVMLGDYRGNKVAVKCI---KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76

Query: 116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
            IV E +  G+L D +          L     LK ++D+  A+ YL        V+RD+ 
Sbjct: 77  YIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLA 130

Query: 175 PTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYG 233
             N+L +E + AK+ DF L+      +             + APE       + + DV+ 
Sbjct: 131 ARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKFSTKSDVWS 185

Query: 234 FGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKE 293
           FG  L+E+ +              +    +K +          V+     D    C    
Sbjct: 186 FGILLWEIYSFGR---------VPYPRIPLKDV-------VPRVEKGYKMDAPDGCP--- 226

Query: 294 QQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
               A  ++   C       RP+ + + +QL  +
Sbjct: 227 ---PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (264), Expect = 3e-27
 Identities = 49/300 (16%), Positives = 103/300 (34%), Gaps = 55/300 (18%)

Query: 57  DEQNIVLEDP------FRKLYKGFWQKRS------ISLMKYNGNRNQHALEWCINHIVYA 104
           D + + LED       F  + KG++Q +       + ++K N   +    +  +      
Sbjct: 4   DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILK-NEANDPALKDELLAEANVM 62

Query: 105 SRMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
            ++ + +I+++          +V E  ++G L   +  +       +   + +++   ++
Sbjct: 63  QQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH-----VKDKNIIELVHQVS 117

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIEL-DSVVGTT 213
             + YL        V+RD+   N+L   Q  AK+ DF LS ++   E + +         
Sbjct: 118 MGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174

Query: 214 GFIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR 272
            + APE       + + DV+ FG  ++E  +         +      E       G+   
Sbjct: 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS----YGQKPYRGMKGSEVTAMLEKGERMG 230

Query: 273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSCM 332
                                   +    L   C  +  E+RP    V  +LR  Y   +
Sbjct: 231 CPAGCP------------------REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV 272

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  106 bits (265), Expect = 3e-27
 Identities = 51/319 (15%), Positives = 102/319 (31%), Gaps = 63/319 (19%)

Query: 47  EELRIATNNYDEQNIVLEDPFRKLYKGFWQ-------KRSISLMKYNGNRNQHALEWCIN 99
             L    NN +    + E  F ++++              +++       +         
Sbjct: 6   LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR 65

Query: 100 HIVYASRMSHKHIIK-----------LIVFESVQIGTLADRIH----------------- 131
                +   + +I+K            ++FE +  G L + +                  
Sbjct: 66  EAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125

Query: 132 --HHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLF 189
                      LS  ++L +A  +A  +AYL     R  V+RD+   N L  E    K+ 
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIA 182

Query: 190 DFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVS 248
           DF LS +I   + +    +      ++ PE+        + DV+ +G  L+E+ +     
Sbjct: 183 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL-- 240

Query: 249 DHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMD 308
                  + +Y    + +         + D  I+          E        L   C  
Sbjct: 241 -------QPYYGMAHEEV------IYYVRDGNILAC-------PENCPLELYNLMRLCWS 280

Query: 309 FSPEDRPTMVDVAKQLRQM 327
             P DRP+   + + L++M
Sbjct: 281 KLPADRPSFCSIHRILQRM 299

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 5e-27
 Identities = 58/298 (19%), Positives = 103/298 (34%), Gaps = 41/298 (13%)

Query: 44  FSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVY 103
            + +   I   +   +  + +  F +++ G W   +   +K        + E  +     
Sbjct: 7   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQV 65

Query: 104 ASRMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
             ++ H+ +++L          IV E +  G+L D +     ++     L   + +A  I
Sbjct: 66  MKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLR---LPQLVDMAAQI 122

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTT 213
           A  +AY+        V+RD++  NIL  E    K+ DF L+  I D E            
Sbjct: 123 ASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPI 178

Query: 214 GFIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR 272
            + APE         + DV+ FG  L EL T              +     + +  Q  R
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR---------VPYPGMVNREVLDQVER 229

Query: 273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
              M                 +  ++   L  QC    PE+RPT   +   L   + S
Sbjct: 230 GYRMPCP-------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 1e-26
 Identities = 49/299 (16%), Positives = 107/299 (35%), Gaps = 47/299 (15%)

Query: 49  LRIATNN-YDEQNIVLEDPFRKLYKGFWQKRS------ISLMKYNGNRNQHALEWCINHI 101
           LRI     + +  ++    F  +YKG W          +++ +     +  A +  ++  
Sbjct: 3   LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 62

Query: 102 VYASRMSHKHIIKL----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM 151
              + + + H+ +L          ++ + +  G L D +  H +           L   +
Sbjct: 63  YVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNI----GSQYLLNWCV 118

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVG 211
            IA  + YL     R +V+RD+   N+L       K+ DF L+  +   E     +    
Sbjct: 119 QIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 175

Query: 212 TTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
              ++A E+    +   Q DV+ +G  ++EL+T         F S+ +       +    
Sbjct: 176 PIKWMALESILHRIYTHQSDVWSYGVTVWELMT---------FGSKPYDGIPASEI---- 222

Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR 329
                +++      +   CT           + ++C     + RP   ++  +  +M R
Sbjct: 223 ---SSILEKGERLPQPPICT------IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 1e-26
 Identities = 51/340 (15%), Positives = 113/340 (33%), Gaps = 65/340 (19%)

Query: 29  ELIASSNGKY---NPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQKRS------ 79
           ++  SS+ +Y   +        +      N +   ++    F K+        S      
Sbjct: 9   QVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSI 68

Query: 80  -ISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----------IVFESVQIGTL 126
            +++       +    E  ++ +   +++ SH++I+ L           ++FE    G L
Sbjct: 69  QVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDL 128

Query: 127 ADRIHHHCEQHFE------------------ALSLTDRLKVAMDIAHAVAYLHVGFSRPI 168
            + +    E+  E                   L+  D L  A  +A  + +L     +  
Sbjct: 129 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSC 185

Query: 169 VYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINE 227
           V+RD+   N+L       K+ DF L+  I     ++   +      ++APE+    +   
Sbjct: 186 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTI 245

Query: 228 QCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSC 287
           + DV+ +G  L+E+ +              +    V         F +++ +    D+  
Sbjct: 246 KSDVWSYGILLWEIFSLGV---------NPYPGIPVDAN------FYKLIQNGFKMDQPF 290

Query: 288 TCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
             T      +    +   C  F    RP+  ++   L   
Sbjct: 291 YAT------EEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQ 324

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 9e-26
 Identities = 44/250 (17%), Positives = 92/250 (36%), Gaps = 42/250 (16%)

Query: 87  GNRNQHALEWCINHIVYASRMSHKHIIKL-------------IVFESVQIGTLADRIHHH 133
           G+  +   +  ++ +     + H +I++              IV E  + G LA  I   
Sbjct: 40  GSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKG 99

Query: 134 CEQHFEALSLTDRLKVAMDIAHAVAYLH--VGFSRPIVYRDMKPTNILFNEQSDAKLFDF 191
            ++  + L     L+V   +  A+   H        +++RD+KP N+  + + + KL DF
Sbjct: 100 TKER-QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDF 158

Query: 192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVSDH 250
            L+  +    +     + VGT  +++PE    +  NE+ D++  G  L+EL         
Sbjct: 159 GLARILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCA-----LM 211

Query: 251 VSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFS 310
             F +    E   K   G+  R                            ++  + ++  
Sbjct: 212 PPFTAFSQKELAGKIREGKFRRIPYRYS------------------DELNEIITRMLNLK 253

Query: 311 PEDRPTMVDV 320
              RP++ ++
Sbjct: 254 DYHRPSVEEI 263

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (254), Expect = 1e-25
 Identities = 59/272 (21%), Positives = 100/272 (36%), Gaps = 48/272 (17%)

Query: 67  FRKLYKGFWQKRSISL-MKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------- 115
           F K+YK   ++ S+    K    +++  LE  +  I   +   H +I+KL          
Sbjct: 25  FGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNL 84

Query: 116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMK 174
            I+ E    G +         +    L+ +    V      A+ YLH      I++RD+K
Sbjct: 85  WILIEFCAGGAV----DAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLK 137

Query: 175 PTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT------LINEQ 228
             NILF    D KL DF +S            DS +GT  ++APE            + +
Sbjct: 138 AGNILFTLDGDIKLADFGVSAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDYK 195

Query: 229 CDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCT 288
            DV+  G  L E+   +            H+E N  R+  +           I + +  T
Sbjct: 196 ADVWSLGITLIEMAEIE----------PPHHELNPMRVLLK-----------IAKSEPPT 234

Query: 289 CTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
                +    FK    +C++ + + R T   +
Sbjct: 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 1e-25
 Identities = 46/273 (16%), Positives = 100/273 (36%), Gaps = 50/273 (18%)

Query: 67  FRKLYKGFWQK--RSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-------- 115
           F+ +YKG   +    ++  +    +  +   +           + H +I++         
Sbjct: 22  FKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV 81

Query: 116 -------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPI 168
                  +V E +  GTL   +        + + +         I   + +LH   + PI
Sbjct: 82  KGKKCIVLVTELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTR-TPPI 135

Query: 169 VYRDMKPTNILFNEQS-DAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINE 227
           ++RD+K  NI     +   K+ D  L+             +V+GT  F+APE +    +E
Sbjct: 136 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK----AVIGTPEFMAPEMYEEKYDE 191

Query: 228 QCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSC 287
             DVY FG  + E+ T++       +    +  +  +R+   +       D + I +   
Sbjct: 192 SVDVYAFGMCMLEMATSE-----YPYSECQNAAQIYRRV--TSGVKPASFDKVAIPE--- 241

Query: 288 TCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
                       K++   C+  + ++R ++ D+
Sbjct: 242 -----------VKEIIEGCIRQNKDERYSIKDL 263

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (252), Expect = 1e-25
 Identities = 52/279 (18%), Positives = 99/279 (35%), Gaps = 47/279 (16%)

Query: 67  FRKLYKGFWQKRS-------ISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---- 115
           F  + +G W   S       +  +K +      A++  I  +     + H+++I+L    
Sbjct: 21  FGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV 80

Query: 116 ------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIV 169
                 +V E   +G+L         +H     L    + A+ +A  + YL    S+  +
Sbjct: 81  LTPPMKMVTELAPLGSL----LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SKRFI 133

Query: 170 YRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF--TTLINE 227
           +RD+   N+L   +   K+ DF L  ++P  + H  +                 T   + 
Sbjct: 134 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH 193

Query: 228 QCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSC 287
             D + FG  L+E+ T  +           +  + + ++  +  R          ED   
Sbjct: 194 ASDTWMFGVTLWEMFTYGQEPWI-----GLNGSQILHKIDKEGERLP------RPEDCP- 241

Query: 288 TCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQ 326
                    Q    + +QC    PEDRPT V +   L +
Sbjct: 242 ---------QDIYNVMVQCWAHKPEDRPTFVALRDFLLE 271

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 4e-25
 Identities = 54/299 (18%), Positives = 104/299 (34%), Gaps = 48/299 (16%)

Query: 51  IATNNYDEQNIVLEDPFRKLYKGFW------QKRSISLMKYNGNRNQHALEWCINHIVYA 104
           I  +    Q ++    F ++YKG        ++  +++        +      +      
Sbjct: 4   IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63

Query: 105 SRMSHKHIIK-----------LIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
            + SH +II+           +I+ E ++ G     +     +     S+   + +   I
Sbjct: 64  GQFSHHNIIRLEGVISKYKPMMIITEYMENGA----LDKFLREKDGEFSVLQLVGMLRGI 119

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDS-VVGT 212
           A  + YL    +   V+RD+   NIL N     K+ DF LS  + D        S     
Sbjct: 120 AAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIP 176

Query: 213 TGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC 271
             + APE  +        DV+ FG  ++E++T         +  R ++E +   +     
Sbjct: 177 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMT---------YGERPYWELSNHEV----- 222

Query: 272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
              + ++          C        A  QL +QC       RP   D+   L ++ R+
Sbjct: 223 --MKAINDGFRLPTPMDCP------SAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.4 bits (247), Expect = 6e-25
 Identities = 42/273 (15%), Positives = 91/273 (33%), Gaps = 43/273 (15%)

Query: 67  FRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------- 115
           F  +  G W+ +    +K     +    E+ I        +SH+ +++L           
Sbjct: 17  FGVVKYGKWRGQYDVAIKMIKEGSMSEDEF-IEEAKVMMNLSHEKLVQLYGVCTKQRPIF 75

Query: 116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP 175
           I+ E +  G L + +     +          L++  D+  A+ YL     +  ++RD+  
Sbjct: 76  IITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAA 128

Query: 176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTL-INEQCDVYGF 234
            N L N+Q   K+ DF LS  + D E             +  PE       + + D++ F
Sbjct: 129 RNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAF 187

Query: 235 GAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQ 294
           G  ++E+ +  +           +        +    +   +    +  +K         
Sbjct: 188 GVLMWEIYSLGK---------MPYERFTNSETAEHIAQGLRLYRPHLASEK--------- 229

Query: 295 QLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
                  +   C     ++RPT   +   +  +
Sbjct: 230 ----VYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 99.3 bits (247), Expect = 1e-24
 Identities = 50/273 (18%), Positives = 90/273 (32%), Gaps = 55/273 (20%)

Query: 67  FRKLYKGFWQKRS----ISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------- 115
           F  +Y     + S    I  M Y+G ++    +  I  + +  ++ H + I+        
Sbjct: 28  FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE 87

Query: 116 ----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYR 171
               +V E            H      + L   +   V       +AYLH   S  +++R
Sbjct: 88  HTAWLVMEYCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHR 139

Query: 172 DMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTL----INE 227
           D+K  NIL +E    KL DF  +  +    +       VGT  ++APE    +     + 
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPANS------FVGTPYWMAPEVILAMDEGQYDG 193

Query: 228 QCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSC 287
           + DV+  G    EL   +         +             ++   +    S        
Sbjct: 194 KVDVWSLGITCIELAERKP-----PLFNMNAMSALYHIAQNESPALQSGHWS-------- 240

Query: 288 TCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
                    + F+     C+   P+DRPT   +
Sbjct: 241 ---------EYFRNFVDSCLQKIPQDRPTSEVL 264

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.1 bits (246), Expect = 2e-24
 Identities = 50/306 (16%), Positives = 97/306 (31%), Gaps = 56/306 (18%)

Query: 50  RIATNNYDEQNIVLEDPFRKLYKGFW----QKRSISLMKYNGNRNQHALEWCINHIVYAS 105
            +  N+   Q+++ E  F ++ K        +   ++ +     ++         +    
Sbjct: 6   VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLC 65

Query: 106 RMS-HKHIIKL-----------IVFESVQIGTLADRIHHHC-----------EQHFEALS 142
           ++  H +II L           +  E    G L D +                     LS
Sbjct: 66  KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 125

Query: 143 LTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGET 202
               L  A D+A  + YL     +  ++RD+   NIL  E   AK+ DF LS        
Sbjct: 126 SQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 182

Query: 203 HIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEE 261
                       ++A E+    +     DV+ +G  L+E+++              +   
Sbjct: 183 K---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS---------LGGTPYCGM 230

Query: 262 NVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVA 321
               L  +  +   +   +  +D+                L  QC    P +RP+   + 
Sbjct: 231 TCAELYEKLPQGYRLEKPLNCDDE-------------VYDLMRQCWREKPYERPSFAQIL 277

Query: 322 KQLRQM 327
             L +M
Sbjct: 278 VSLNRM 283

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 98.3 bits (244), Expect = 2e-24
 Identities = 50/296 (16%), Positives = 114/296 (38%), Gaps = 41/296 (13%)

Query: 47  EELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASR 106
           ++  +   +   ++ +    + ++Y+G W+K S+++       +   +E  +        
Sbjct: 10  DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 69

Query: 107 MSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
           + H ++++L           I+ E +  G L D +     Q    +S    L +A  I+ 
Sbjct: 70  IKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISS 126

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
           A+ YL     +  ++RD+   N L  E    K+ DF LS  +                 +
Sbjct: 127 AMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKW 182

Query: 216 IAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK 274
            APE+      + + DV+ FG  L+E+ T         +    +   ++ ++        
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIAT---------YGMSPYPGIDLSQV-------Y 226

Query: 275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
           E+++     ++   C       +   +L   C  ++P DRP+  ++ +    M++ 
Sbjct: 227 ELLEKDYRMERPEGCP------EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.3 bits (244), Expect = 3e-24
 Identities = 49/323 (15%), Positives = 105/323 (32%), Gaps = 57/323 (17%)

Query: 38  YNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQK-------RSISLMKYNGNRN 90
            +P ++    +     N       +    F K+ +             ++++     + +
Sbjct: 7   IDPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH 66

Query: 91  QHALEWCINHIVYASRMS-HKHIIKL-----------IVFESVQIGTLADRIHHHCEQHF 138
               E  ++ +   S +  H +I+ L           ++ E    G L + +    +   
Sbjct: 67  LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFI 126

Query: 139 E-------------ALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD 185
                         AL L D L  +  +A  +A+L    S+  ++RD+   NIL      
Sbjct: 127 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRI 183

Query: 186 AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTA 244
            K+ DF L+  I +   ++   +      ++APE+    +   + DV+ +G FL+EL + 
Sbjct: 184 TKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSL 243

Query: 245 QEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTL 304
                          +    ++  +  R                    E        +  
Sbjct: 244 GSSPYP-----GMPVDSKFYKMIKEGFRMLS----------------PEHAPAEMYDIMK 282

Query: 305 QCMDFSPEDRPTMVDVAKQLRQM 327
            C D  P  RPT   + + + + 
Sbjct: 283 TCWDADPLKRPTFKQIVQLIEKQ 305

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.3 bits (244), Expect = 4e-24
 Identities = 42/284 (14%), Positives = 98/284 (34%), Gaps = 49/284 (17%)

Query: 67  FRKLYKGFWQKRSISLMKY-----NGNRNQHALEWCINHIVYASRMSHKHIIKL------ 115
           F  +Y G         +       N   +   +   +   +     SH +++ L      
Sbjct: 40  FGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 99

Query: 116 ------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIV 169
                 +V   ++ G L     +         ++ D +   + +A  + +L     +  V
Sbjct: 100 SEGSPLVVLPYMKHGDL----RNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFV 152

Query: 170 YRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDS--VVGTTGFIAPENFTTL-IN 226
           +RD+   N + +E+   K+ DF L+  + D E     +         ++A E+  T    
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT 212

Query: 227 EQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKS 286
            + DV+ FG  L+EL+T              + + N   ++    + + ++      D  
Sbjct: 213 TKSDVWSFGVLLWELMTRGA---------PPYPDVNTFDITVYLLQGRRLLQPEYCPDP- 262

Query: 287 CTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
                         ++ L+C     E RP+  ++  ++  ++ +
Sbjct: 263 ------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFST 294

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.4 bits (242), Expect = 6e-24
 Identities = 47/244 (19%), Positives = 88/244 (36%), Gaps = 44/244 (18%)

Query: 89  RNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQH 137
           + Q   E  IN I+      + +I+             +V E +  G+L D +   C   
Sbjct: 56  QQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-- 113

Query: 138 FEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI 197
                      V  +   A+ +LH   S  +++RD+K  NIL       KL DF     I
Sbjct: 114 ----DEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166

Query: 198 PDGETHIELDSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHVSFESR 256
              ++     ++VGT  ++APE  T      + D++  G    E++  +           
Sbjct: 167 TPEQSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE---------PP 215

Query: 257 FHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT 316
           +  E  ++ L             +I  + +      E+    F+    +C+D   E R +
Sbjct: 216 YLNENPLRALY------------LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGS 263

Query: 317 MVDV 320
             ++
Sbjct: 264 AKEL 267

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.1 bits (238), Expect = 2e-23
 Identities = 47/296 (15%), Positives = 97/296 (32%), Gaps = 56/296 (18%)

Query: 67  FRKLYKGFWQK-------RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIK----- 114
           F ++ +            R++++               ++ +     + H   +      
Sbjct: 26  FGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA 85

Query: 115 --------LIVFESVQIGTLADRIHHHCEQHFE-----------ALSLTDRLKVAMDIAH 155
                   +++ E  + G L+  +     +               L+L   +  +  +A 
Sbjct: 86  CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAK 145

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            + +L    SR  ++RD+   NIL +E++  K+ DF L+  I     ++          +
Sbjct: 146 GMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKW 202

Query: 216 IAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK 274
           +APE     +   Q DV+ FG  L+E+ +        S       +E   R   +  R  
Sbjct: 203 MAPETIFDRVYTIQSDVWSFGVLLWEIFSL-----GASPYPGVKIDEEFCRRLKEGTRM- 256

Query: 275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS 330
              D    E                 Q  L C    P  RPT  ++ + L  + ++
Sbjct: 257 RAPDYTTPE---------------MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 297

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.2 bits (236), Expect = 2e-23
 Identities = 49/277 (17%), Positives = 94/277 (33%), Gaps = 46/277 (16%)

Query: 67  FRKLYKGFWQK-----RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------ 115
           F  +++G +        ++++       +    E  +   +   +  H HI+KL      
Sbjct: 20  FGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE 79

Query: 116 ----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYR 171
               I+ E   +G L        +    +L L   +  A  ++ A+AYL    S+  V+R
Sbjct: 80  NPVWIIMELCTLGEL----RSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKRFVHR 132

Query: 172 DMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCD 230
           D+   N+L +     KL DF LS  + D   + +         ++APE+          D
Sbjct: 133 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASD 191

Query: 231 VYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCT 290
           V+ FG  ++E+L            +        +  +G+                     
Sbjct: 192 VWMFGVCMWEILMHGVKPFQGVKNNDVIG----RIENGERLPMPPNCP------------ 235

Query: 291 GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
                      L  +C  + P  RP   ++  QL  +
Sbjct: 236 ------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.7 bits (237), Expect = 3e-23
 Identities = 48/314 (15%), Positives = 118/314 (37%), Gaps = 49/314 (15%)

Query: 38  YNPYRIFSAEELRIATNNYDEQNIVLEDPFRKLYKGFWQ-------KRSISLMKYNGNRN 90
           ++   ++  +E  +A         + +  F  +Y+G  +       +  +++   N   +
Sbjct: 4   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 63

Query: 91  QHALEWCINHIVYASRMSHKHIIK-----------LIVFESVQIGTLADRIHHHCEQHFE 139
                  +N        +  H+++           L++ E +  G L   +         
Sbjct: 64  MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMAN 123

Query: 140 A-----LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS 194
                  SL+  +++A +IA  +AYL+   +   V+RD+   N +  E    K+ DF ++
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMT 180

Query: 195 LSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSF 253
             I + + + +    +    +++PE+    +     DV+ FG  L+E+ T  E       
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE------- 233

Query: 254 ESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPED 313
             + +   + +++          V    + DK   C           +L   C  ++P+ 
Sbjct: 234 --QPYQGLSNEQV-------LRFVMEGGLLDKPDNCP------DMLFELMRMCWQYNPKM 278

Query: 314 RPTMVDVAKQLRQM 327
           RP+ +++   +++ 
Sbjct: 279 RPSFLEIISSIKEE 292

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.1 bits (236), Expect = 3e-23
 Identities = 43/287 (14%), Positives = 92/287 (32%), Gaps = 48/287 (16%)

Query: 50  RIATNNYDEQNIVLEDPFRKLYKGFW----QKRSISLMKYNGNRNQHALEWCINHIVYAS 105
           +    ++    I+ E  F  +         ++ +I +++      ++ + +        S
Sbjct: 4   KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 106 RMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIA 154
           R+ H   +KL                 + G L   I         +   T       +I 
Sbjct: 64  RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-----GSFDETCTRFYTAEIV 118

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
            A+ YLH    + I++RD+KP NIL NE    ++ DF  +  +         +S VGT  
Sbjct: 119 SALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 175

Query: 215 FIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF 273
           +++PE  T     +  D++  G  +++L+                   N   +  +  + 
Sbjct: 176 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL----------PPFRAGNEYLIFQKIIKL 225

Query: 274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
           +                         + L  + +      R    ++
Sbjct: 226 EYDFPEKFFPK--------------ARDLVEKLLVLDATKRLGCEEM 258

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.2 bits (233), Expect = 8e-23
 Identities = 46/241 (19%), Positives = 84/241 (34%), Gaps = 37/241 (15%)

Query: 99  NHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEA-----------LSLTDRL 147
            +I+       +     ++ E    G L + +        E            LS  D +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELD 207
             A  +A  + YL    S+  ++RD+   N+L  E +  K+ DF L+  I   + + +  
Sbjct: 139 SCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 208 SVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRL 266
           +      ++APE     +   Q DV+ FG  L+E+ T              +    V+ L
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG---------SPYPGVPVEEL 246

Query: 267 SGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQ 326
                   +++      DK   CT           +   C    P  RPT   + + L +
Sbjct: 247 -------FKLLKEGHRMDKPSNCT------NELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293

Query: 327 M 327
           +
Sbjct: 294 I 294

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 93.3 bits (231), Expect = 1e-22
 Identities = 54/299 (18%), Positives = 120/299 (40%), Gaps = 50/299 (16%)

Query: 53  TNNYDEQNIVLEDPFRKLYKGFW----QKRSISLMKYNGNRNQHALEWCINHIVYASRMS 108
           ++ Y+   I+      +++        +  ++ +++ +  R+             A+ ++
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 109 HKHIIKL---------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
           H  I+ +               IV E V   TL D +H         ++    ++V  D 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADA 120

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHI-ELDSVVGT 212
             A+ + H      I++RD+KP NI+ +  +  K+ DF ++ +I D    + +  +V+GT
Sbjct: 121 CQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177

Query: 213 TGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC 271
             +++PE      ++ + DVY  G  L+E+LT +               ++   ++ Q+ 
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE----------PPFTGDSPVSVAYQHV 227

Query: 272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-TMVDVAKQLRQMYR 329
           R   +  S   E  S               + L+ +  +PE+R  T  ++   L +++ 
Sbjct: 228 REDPIPPSARHEGLS----------ADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 87.8 bits (217), Expect = 3e-20
 Identities = 43/252 (17%), Positives = 88/252 (34%), Gaps = 44/252 (17%)

Query: 83  MKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIH 131
            K+    ++   E     I   S + H  ++ L           +++E +  G L +++ 
Sbjct: 56  AKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVA 115

Query: 132 HHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD--AKLF 189
               +    +S  + ++    +   + ++H       V+ D+KP NI+F  +     KL 
Sbjct: 116 DEHNK----MSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLI 168

Query: 190 DFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVS 248
           DF L+  +   ++        GT  F APE      +    D++  G   + LL+     
Sbjct: 169 DFGLTAHLDPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG---- 221

Query: 249 DHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMD 308
               F    + +E ++ +   +    +   S I ED               K    + + 
Sbjct: 222 -LSPFGGE-NDDETLRNVKSCDWNMDDSAFSGISED--------------GKDFIRKLLL 265

Query: 309 FSPEDRPTMVDV 320
             P  R T+   
Sbjct: 266 ADPNTRMTIHQA 277

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 84.4 bits (208), Expect = 2e-19
 Identities = 52/256 (20%), Positives = 90/256 (35%), Gaps = 50/256 (19%)

Query: 84  KYNGNRNQHALEWCINHIVYASRMS-HKHIIKL-----------IVFESVQIGTLADRIH 131
            ++    Q   E  +  +    ++S H +II+L           +VF+ ++ G L D + 
Sbjct: 43  SFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT 102

Query: 132 HHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF 191
                    LS  +  K+   +   +  LH      IV+RD+KP NIL ++  + KL DF
Sbjct: 103 EK-----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDF 154

Query: 192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTTL-------INEQCDVYGFGAFLFELLTA 244
             S  +  GE    L  V GT  ++APE              ++ D++  G  ++ LL  
Sbjct: 155 GFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211

Query: 245 QEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTL 304
                         +      +            S   +D S             K L  
Sbjct: 212 S----------PPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS----------DTVKDLVS 251

Query: 305 QCMDFSPEDRPTMVDV 320
           + +   P+ R T  + 
Sbjct: 252 RFLVVQPQKRYTAEEA 267

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 85.1 bits (210), Expect = 3e-19
 Identities = 42/230 (18%), Positives = 77/230 (33%), Gaps = 44/230 (19%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
           +++ H  +I L           ++ E +  G L DRI     +    +S  + +      
Sbjct: 81  NQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK----MSEAEVINYMRQA 136

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA--KLFDFSLSLSIPDGETHIELDSVVG 211
              + ++H      IV+ D+KP NI+   +  +  K+ DF L+  +   E          
Sbjct: 137 CEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTA 190

Query: 212 TTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
           T  F APE      +    D++  G   + LL+         F       E ++ +   +
Sbjct: 191 TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG-----LSPFAGE-DDLETLQNVKRCD 244

Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
             F E   S +  +               K      +   P  R T+ D 
Sbjct: 245 WEFDEDAFSSVSPE--------------AKDFIKNLLQKEPRKRLTVHDA 280

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 84.0 bits (207), Expect = 7e-19
 Identities = 46/294 (15%), Positives = 95/294 (32%), Gaps = 54/294 (18%)

Query: 54  NNYDEQNIVLEDPFRKLYKGFW----QKRSISLMKYNGNRNQHALEWCINHIVYASRMS- 108
           N++    I+    F ++Y        +  ++  +     + +      +N  +  S +S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 109 --HKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAH 155
                I+ +            + + +  G L   +  H           D    A +I  
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-----EADMRFYAAEIIL 118

Query: 156 AVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
            + ++H   +R +VYRD+KP NIL +E    ++ D  L+      + H      VGT G+
Sbjct: 119 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGY 171

Query: 216 IAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF 273
           +APE        +   D +  G  LF+LL           + +    E  +         
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EIDRMTLTMAVEL 228

Query: 274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMV-DVAKQLRQ 326
            +                        + L    +      R   +   A+++++
Sbjct: 229 PDSFS------------------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.9 bits (204), Expect = 1e-18
 Identities = 56/287 (19%), Positives = 98/287 (34%), Gaps = 51/287 (17%)

Query: 54  NNYDEQNIVLEDPFRKLYKGFW----QKRSISLMKYNGNRNQHALEWCINHI-VYASRMS 108
            ++    ++ +  F K++   +    Q  +I  +K +       +E  +    V +    
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 109 HKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAV 157
           H  +  +            V E +  G L   I            L+     A +I   +
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGL 116

Query: 158 AYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIA 217
            +LH   S+ IVYRD+K  NIL ++    K+ DF +      G+     ++  GT  +IA
Sbjct: 117 QFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIA 171

Query: 218 PENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM 276
           PE       N   D + FG  L+E+L  Q        E  FH           N  +   
Sbjct: 172 PEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM------DNPFYPRW 225

Query: 277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQ 323
           ++                  +  K L ++     PE R  +    +Q
Sbjct: 226 LE------------------KEAKDLLVKLFVREPEKRLGVRGDIRQ 254

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.8 bits (204), Expect = 1e-18
 Identities = 32/230 (13%), Positives = 80/230 (34%), Gaps = 44/230 (19%)

Query: 105 SRMSHKHIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDI 153
           +   H++I+ L           ++FE +    + +RI+    +    L+  + +     +
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFE----LNEREIVSYVHQV 111

Query: 154 AHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA--KLFDFSLSLSIPDGETHIELDSVVG 211
             A+ +LH   S  I + D++P NI++  +  +  K+ +F  +  +  G+       +  
Sbjct: 112 CEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFT 165

Query: 212 TTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN 270
              + APE      ++   D++  G  ++ LL+                 E  +++    
Sbjct: 166 APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI----------NPFLAETNQQIIENI 215

Query: 271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
              +   D    ++ S                  + +    + R T  + 
Sbjct: 216 MNAEYTFDEEAFKEIS----------IEAMDFVDRLLVKERKSRMTASEA 255

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.8 bits (201), Expect = 2e-18
 Identities = 45/255 (17%), Positives = 71/255 (27%), Gaps = 27/255 (10%)

Query: 83  MKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLADRIH 131
           + +            +  I     +SH +II L           +VF+ ++         
Sbjct: 33  LGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD 92

Query: 132 HHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF 191
           +                  +     + YLH      I++RD+KP N+L +E    KL DF
Sbjct: 93  NSLVLTPS-----HIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADF 144

Query: 192 SLSLSIPDGETHIELDSVVGTTGFIAPE--NFTTLINEQCDVYGFGAFLFELLTAQEVSD 249
            L+ S             V T  + APE      +     D++  G  L ELL       
Sbjct: 145 GLAKSFGSPNRAY--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLP 202

Query: 250 HVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQA----FKQLTLQ 305
             S   +            +            +  KS           A       L   
Sbjct: 203 GDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQG 262

Query: 306 CMDFSPEDRPTMVDV 320
              F+P  R T    
Sbjct: 263 LFLFNPCARITATQA 277

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 80.3 bits (197), Expect = 8e-18
 Identities = 53/303 (17%), Positives = 91/303 (30%), Gaps = 45/303 (14%)

Query: 48  ELRIATNNYDEQNIVLEDPFRKLYKGFW----QKRSISLMKYNGNRNQHALEWCINHIVY 103
           ELR+  N Y     +    F  +Y G      ++ +I L        Q  +E  I     
Sbjct: 2   ELRVG-NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI----- 55

Query: 104 ASRMSHKHIIKLIVFESVQIGT-------LADRIHHHCEQHFEALSLTDRLKVAMDIAHA 156
              M     I  I +   +          L   +           SL   L +A  +   
Sbjct: 56  YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 115

Query: 157 VAYLHVGFSRPIVYRDMKPTNILFNEQSDAKL---FDFSLSLSIPDGETH-----IELDS 208
           + Y+H   S+  ++RD+KP N L        L    DF L+    D  TH      E  +
Sbjct: 116 IEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172

Query: 209 VVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS 267
           + GT  + +      +  + + D+   G  L            +   ++    E      
Sbjct: 173 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER----- 227

Query: 268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
                 K+M   I +  K             F      C     +D+P    + +  R +
Sbjct: 228 ---ISEKKMSTPIEVLCKGYP--------SEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276

Query: 328 YRS 330
           +  
Sbjct: 277 FHR 279

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 79.9 bits (196), Expect = 9e-18
 Identities = 29/243 (11%), Positives = 67/243 (27%), Gaps = 35/243 (14%)

Query: 99  NHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVA 158
             I        + +  ++V + +        +    +      S+      A  +   V 
Sbjct: 61  TGIPNVYYFGQEGLHNVLVIDLLGPS-----LEDLLDLCGRKFSVKTVAMAAKQMLARVQ 115

Query: 159 YLHVGFSRPIVYRDMKPTNILFNEQ-----SDAKLFDFSLSLSIPDGETH-----IELDS 208
            +H    + +VYRD+KP N L         +   + DF +     D  T       E  +
Sbjct: 116 SIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKN 172

Query: 209 VVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS 267
           + GT  +++         + + D+   G      L        +   +     E +    
Sbjct: 173 LSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI---- 228

Query: 268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM 327
                  E   S  + +            + F +      + + +  P    +     ++
Sbjct: 229 ------GEKKQSTPLRELCAGFP------EEFYKYMHYARNLAFDATPDYDYLQGLFSKV 276

Query: 328 YRS 330
              
Sbjct: 277 LER 279

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.3 bits (197), Expect = 1e-17
 Identities = 50/289 (17%), Positives = 102/289 (35%), Gaps = 24/289 (8%)

Query: 53  TNNYDEQNIVLEDPFRKLYKGFWQK--RSISLMKYNGNRNQHALEWCINHIVYASRMSHK 110
              Y   + + E  +  +   +       +++ K +   +Q   +  +  I    R  H+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 111 HIIKLI-VFESVQIGTLADRI--------HHHCEQHFEALSLTDRLKVAMDIAHAVAYLH 161
           +II +  +  +  I  + D            +     + LS          I   + Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 162 VGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-LSIPDGETHIELDSVVGTTGFIAPEN 220
              S  +++RD+KP+N+L N   D K+ DF L+ ++ PD +    L   V T  + APE 
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 221 FTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD 278
                   +  D++  G  L E+L+ + +     +  + ++   +     Q      +  
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243

Query: 279 SIIIEDKSCTCTGKEQQLQAF-------KQLTLQCMDFSPEDRPTMVDV 320
                  S     K    + F         L  + + F+P  R  +   
Sbjct: 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 78.9 bits (194), Expect = 2e-17
 Identities = 61/285 (21%), Positives = 106/285 (37%), Gaps = 48/285 (16%)

Query: 53  TNNYDEQNIVLEDPFRKLYKGFWQK--RSISLMKYNGNRNQHALEWCINHIVYASRMSHK 110
            + YD ++++    F ++     ++  + +++        +       N I    ++ H 
Sbjct: 8   RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67

Query: 111 HIIKL-----------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAY 159
           +I+ L           ++ + V  G L DRI           +  D  ++   +  AV Y
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKY 122

Query: 160 LHVGFSRPIVYRDMKPTNILF---NEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFI 216
           LH      IV+RD+KP N+L+   +E S   + DF LS     G     L +  GT G++
Sbjct: 123 LH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYV 176

Query: 217 APENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE 275
           APE       ++  D +  G   + LL                Y+EN  +L  Q  + + 
Sbjct: 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGY----------PPFYDENDAKLFEQILKAEY 226

Query: 276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
             DS   +D S           + K      M+  PE R T    
Sbjct: 227 EFDSPYWDDIS----------DSAKDFIRHLMEKDPEKRFTCEQA 261

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.4 bits (190), Expect = 9e-17
 Identities = 46/233 (19%), Positives = 80/233 (34%), Gaps = 44/233 (18%)

Query: 107 MSHKHIIKL---------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAM 151
               HI+++               IV E +  G L  RI    +Q F   +  +  ++  
Sbjct: 62  SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF---TEREASEIMK 118

Query: 152 DIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD---AKLFDFSLSLSIPDGETHIELDS 208
            I  A+ YLH   S  I +RD+KP N+L+  +      KL DF  +       +     +
Sbjct: 119 SIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL---TT 172

Query: 209 VVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS 267
              T  ++APE       ++ CD++  G  ++ LL              F+    +    
Sbjct: 173 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY---------PPFYSNHGLAISP 223

Query: 268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDV 320
           G   R +         + S          +  K L    +   P  R T+ + 
Sbjct: 224 GMKTRIRMGQYEFPNPEWSEVS-------EEVKMLIRNLLKTEPTQRMTITEF 269

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.3 bits (187), Expect = 1e-16
 Identities = 51/257 (19%), Positives = 91/257 (35%), Gaps = 47/257 (18%)

Query: 80  ISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFESVQIGTLAD 128
           I   +   +R   + E     +     + H ++I L           ++ E V  G L D
Sbjct: 43  IKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFD 102

Query: 129 RIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDA-- 186
            +        E     +  +    I + V YLH   S  I + D+KP NI+  +++    
Sbjct: 103 FLAEKESLTEE-----EATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKP 154

Query: 187 --KLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT-TLINEQCDVYGFGAFLFELLT 243
             K+ DF L+  I  G    E  ++ GT  F+APE      +  + D++  G   + LL+
Sbjct: 155 RIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 211

Query: 244 AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLT 303
                   +       +E +  +S  N  F++   S                    K   
Sbjct: 212 GASPFLGDT------KQETLANVSAVNYEFEDEYFSNTSAL--------------AKDFI 251

Query: 304 LQCMDFSPEDRPTMVDV 320
            + +   P+ R T+ D 
Sbjct: 252 RRLLVKDPKKRMTIQDS 268

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.5 bits (187), Expect = 2e-16
 Identities = 41/244 (16%), Positives = 78/244 (31%), Gaps = 32/244 (13%)

Query: 98  INHIVYASRMSHKHIIKLIVFESVQIGTLADRI------------HHHCEQHFEALSLTD 145
           +  + +     H ++++L    +V       ++             +  +     +    
Sbjct: 58  VAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET 117

Query: 146 RLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIE 205
              +   +   + +LH   S  +V+RD+KP NIL       KL DF L+           
Sbjct: 118 IKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL-- 172

Query: 206 LDSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVK 264
             SVV T  + APE           D++  G    E+           F      ++  K
Sbjct: 173 -TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRR-----KPLFRGSSDVDQLGK 226

Query: 265 RLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQL--------QAFKQLTLQCMDFSPEDRPT 316
            L       +E     +   +    +   Q +        +  K L L+C+ F+P  R +
Sbjct: 227 ILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 286

Query: 317 MVDV 320
               
Sbjct: 287 AYSA 290

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.8 bits (183), Expect = 1e-15
 Identities = 44/241 (18%), Positives = 87/241 (36%), Gaps = 33/241 (13%)

Query: 105 SRMSHKHIIKL-----------------IVFESVQIGTLADRIHHHCEQHFEALSLTDRL 147
            ++ H +I++L                 +V + V       R+  H  +  + L +    
Sbjct: 68  RKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY--RVARHYSRAKQTLPVIYVK 125

Query: 148 KVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN-EQSDAKLFDFSLSLSIPDGETHIEL 206
                +  ++AY+H   S  I +RD+KP N+L + + +  KL DF  +  +  GE +   
Sbjct: 126 LYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--- 179

Query: 207 DSVVGTTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVK 264
            S + +  + APE     T      DV+  G  L ELL  Q +    S   +      V 
Sbjct: 180 VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL 239

Query: 265 RLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQA-----FKQLTLQCMDFSPEDRPTMVD 319
               +    +   +    +          +  +         L  + ++++P  R T ++
Sbjct: 240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLE 299

Query: 320 V 320
            
Sbjct: 300 A 300

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.0 bits (181), Expect = 1e-15
 Identities = 43/286 (15%), Positives = 96/286 (33%), Gaps = 35/286 (12%)

Query: 50  RIATNNYDEQNIVLEDPFRKLYKGFW----QKRSISLMKYNGNRNQHALEWCINHIVYAS 105
           ++  N++D   ++ +  F K+         +  ++ +++      +  +   +       
Sbjct: 1   KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 106 RMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRL---KVAMDIAHAVAYLHV 162
              H  +  L               + +  + F  LS        +     A  V+ L  
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120

Query: 163 GFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFT 222
             SR +VYRD+K  N++ ++    K+ DF L            + +  GT  ++APE   
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKTFCGTPEYLAPEVLE 178

Query: 223 TL-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSII 281
                   D +G G  ++E++  +     + F ++  +E   + +  +  RF   +    
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGR-----LPFYNQ-DHERLFELILMEEIRFPRTLS--- 229

Query: 282 IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMV-DVAKQLRQ 326
                             K L    +   P+ R       AK++ +
Sbjct: 230 ---------------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 73.0 bits (178), Expect = 2e-15
 Identities = 41/287 (14%), Positives = 88/287 (30%), Gaps = 30/287 (10%)

Query: 54  NNYDEQNIVLEDPFRKLYKGFWQKRSISLMK--YNGNRNQHALEWCINHIVYASRMSHKH 111
             Y     + E  +  +YK          +K       ++      I  I     + H +
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61

Query: 112 IIKLIVFESVQIGT------LADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFS 165
           I+KL      +         L   +    +     L         + + + +AY H    
Sbjct: 62  IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---D 118

Query: 166 RPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENF--TT 223
           R +++RD+KP N+L N + + K+ DF L+ +             + T  + AP+    + 
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIVTLWYRAPDVLMGSK 176

Query: 224 LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIE 283
             +   D++  G    E++          F      ++ ++          +   ++   
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGT-----PLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231

Query: 284 DKSCTCTGKEQQL----------QAFKQLTLQCMDFSPEDRPTMVDV 320
            K        + L          ++   L  + +   P  R T    
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 71.7 bits (175), Expect = 8e-15
 Identities = 52/282 (18%), Positives = 101/282 (35%), Gaps = 38/282 (13%)

Query: 54  NNYDEQNIVLEDPFRKLYKGFW----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSH 109
            ++     +    F +++        +  ++ ++K         +E   +  +  S ++H
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63

Query: 110 KHIIKLI--VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVA-YLHVGFSR 166
             II++     ++ QI  + D I           S      VA   A  V   L    S+
Sbjct: 64  PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK 123

Query: 167 PIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTL-I 225
            I+YRD+KP NIL ++    K+ DF  +  +PD        ++ GT  +IAPE  +T   
Sbjct: 124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY-----TLCGTPDYIAPEVVSTKPY 178

Query: 226 NEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDK 285
           N+  D + FG  ++E+L                Y+ N  +   +    +        ED 
Sbjct: 179 NKSIDWWSFGILIYEMLAGY----------TPFYDSNTMKTYEKILNAELRFPPFFNED- 227

Query: 286 SCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT-MVDVAKQLRQ 326
                         K L  + +      R   + +  + ++ 
Sbjct: 228 -------------VKDLLSRLITRDLSQRLGNLQNGTEDVKN 256

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 70.3 bits (171), Expect = 3e-14
 Identities = 42/241 (17%), Positives = 84/241 (34%), Gaps = 28/241 (11%)

Query: 102 VYASRMSHKHIIKLI-VFESVQIGTLADRIHHHC----EQHFEALSLTDRLKVAMDIAHA 156
           +  +     +II L  + +     T A    H      +Q ++ L+  D      +I  A
Sbjct: 82  ILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKA 141

Query: 157 VAYLHVGFSRPIVYRDMKPTNILF-NEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGF 215
           + Y H   S  I++RD+KP N++  +E    +L D+ L+     G+ +   +  V +  F
Sbjct: 142 LDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY---NVRVASRYF 195

Query: 216 IAPENFTTL--INEQCDVYGFGAFLFELLT------------AQEVSDHVSFESRFHYEE 261
             PE        +   D++  G  L  ++              Q V       +   Y+ 
Sbjct: 196 KGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255

Query: 262 NVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQL--QAFKQLTLQCMDFSPEDRPTMVD 319
             K     + RF +++     +        + Q L          + + +  + R T  +
Sbjct: 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTARE 315

Query: 320 V 320
            
Sbjct: 316 A 316

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.9 bits (170), Expect = 3e-14
 Identities = 36/256 (14%), Positives = 72/256 (28%), Gaps = 22/256 (8%)

Query: 77  KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQ 136
            R I +++   + N   L                 I   +VF+  +        +   + 
Sbjct: 57  LREIKILQLLKHENVVNLIEICRTKASPYNRCKGSI--YLVFDFCEHDLAGLLSNVLVKF 114

Query: 137 HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS-- 194
                      ++   +   +  L+      I++RDMK  N+L       KL DF L+  
Sbjct: 115 TLS--------EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166

Query: 195 LSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVS 252
            S+          + V T  +  PE            D++G G  + E+ T   +    +
Sbjct: 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 226

Query: 253 --------FESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTL 304
                    +        V         ++++      + K         +      L  
Sbjct: 227 EQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 286

Query: 305 QCMDFSPEDRPTMVDV 320
           + +   P  R    D 
Sbjct: 287 KLLVLDPAQRIDSDDA 302

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.7 bits (167), Expect = 6e-14
 Identities = 40/247 (16%), Positives = 75/247 (30%), Gaps = 19/247 (7%)

Query: 88  NRNQHALEWCINHIVYASRMSHKHIIKLIVFES-------VQIGTLADRIHHHCEQHFEA 140
              +      I  I     ++H +I+KL+           V      D            
Sbjct: 39  TETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTG 98

Query: 141 LSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG 200
           + L         +   +A+ H   S  +++RD+KP N+L N +   KL DF L+ +    
Sbjct: 99  IPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155

Query: 201 ETHIELDSVVGTTGFIAPE--NFTTLINEQCDVYGFGAFLFELLTAQEV----SDHVSFE 254
                    V T  + APE        +   D++  G    E++T + +    S+     
Sbjct: 156 VRTY--THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 213

Query: 255 SRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQL-QAFKQLTLQCMDFSPED 313
             F        +                +      +     L +  + L  Q + + P  
Sbjct: 214 RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNK 273

Query: 314 RPTMVDV 320
           R +    
Sbjct: 274 RISAKAA 280

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.2 bits (166), Expect = 8e-14
 Identities = 41/257 (15%), Positives = 80/257 (31%), Gaps = 57/257 (22%)

Query: 80  ISLMKYNGNRNQHALEWCINHIVYASRMSHKH--IIKL-----------IVFESVQIGTL 126
           +   + +              +V   ++S     +I+L           ++ E  +    
Sbjct: 37  VEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQD 96

Query: 127 ADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN-EQSD 185
                        AL           +  AV + H   +  +++RD+K  NIL +  + +
Sbjct: 97  ----LFDFITERGALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGE 149

Query: 186 AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPE--NFTTLINEQCDVYGFGAFLFELLT 243
            KL DF     + D           GT  +  PE   +         V+  G  L++++ 
Sbjct: 150 LKLIDFGSGALLKDTVYT----DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 205

Query: 244 AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLT 303
                     +  F ++E + R       F++ V S                    + L 
Sbjct: 206 ---------GDIPFEHDEEIIR---GQVFFRQRVSS------------------ECQHLI 235

Query: 304 LQCMDFSPEDRPTMVDV 320
             C+   P DRPT  ++
Sbjct: 236 RWCLALRPSDRPTFEEI 252

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.7 bits (164), Expect = 2e-13
 Identities = 35/253 (13%), Positives = 78/253 (30%), Gaps = 31/253 (12%)

Query: 88  NRNQHALEWCINHIVYASRMSHKHIIK-----------LIVFESVQIGTLADRIHHHCEQ 136
           + ++      +  I     + HK+I++            +VFE             + + 
Sbjct: 39  DDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL 98

Query: 137 HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS 196
             E             +   + + H    R +++RD+KP N+L N   + KL +F L+ +
Sbjct: 99  DPE-----IVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARA 150

Query: 197 IPDGETHIELDSVVGTTGFIAPENF--TTLINEQCDVYGFGAFLFELLT-------AQEV 247
                      + V T  +  P+      L +   D++  G    EL           +V
Sbjct: 151 FGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV 208

Query: 248 SDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCM 307
            D +    R       ++      +  +     +    +       +     + L    +
Sbjct: 209 DDQLKRIFRLLGTPTEEQWPSMT-KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLL 267

Query: 308 DFSPEDRPTMVDV 320
             +P  R +  + 
Sbjct: 268 KCNPVQRISAEEA 280

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 62.1 bits (150), Expect = 2e-11
 Identities = 33/201 (16%), Positives = 69/201 (34%), Gaps = 19/201 (9%)

Query: 54  NNYDEQNIVLEDPFRKLYKGFW----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSH 109
           + +D    +    F ++            ++ ++          +E  +N       ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100

Query: 110 KHIIKLIVFESVQIGTLADRIHHHCEQHFE------ALSLTDRLKVAMDIAHAVAYLHVG 163
             ++KL               +    + F         S       A  I     YLH  
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLH-- 158

Query: 164 FSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT 223
            S  ++YRD+KP N+L ++Q   ++ DF  +  +          ++ GT   +APE   +
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW-----TLCGTPEALAPEIILS 212

Query: 224 L-INEQCDVYGFGAFLFELLT 243
              N+  D +  G  ++E+  
Sbjct: 213 KGYNKAVDWWALGVLIYEMAA 233

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 61.0 bits (147), Expect = 4e-11
 Identities = 42/261 (16%), Positives = 78/261 (29%), Gaps = 45/261 (17%)

Query: 82  LMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------------IVFESVQIGTLADR 129
           L K    +     E           +     +              ++ + +  G L   
Sbjct: 60  LKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTH 119

Query: 130 IHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLF 189
           +           +  +      +I  A+ +LH      I+YRD+K  NIL +      L 
Sbjct: 120 LSQRE-----RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLT 171

Query: 190 DFSLSLSIPDGETHIELDSVVGTTGFIAPENFTTL---INEQCDVYGFGAFLFELLTAQE 246
           DF LS      ET        GT  ++AP+         ++  D +  G  ++ELLT   
Sbjct: 172 DFGLSKEFVADETER-AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA- 229

Query: 247 VSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQC 306
                         +  K    +  R     +    ++ S             K L  + 
Sbjct: 230 ---------SPFTVDGEKNSQAEISRRILKSEPPYPQEMS----------ALAKDLIQRL 270

Query: 307 MDFSPEDRPTMV-DVAKQLRQ 326
           +   P+ R       A ++++
Sbjct: 271 LMKDPKKRLGCGPRDADEIKE 291

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.8 bits (144), Expect = 9e-11
 Identities = 40/258 (15%), Positives = 85/258 (32%), Gaps = 39/258 (15%)

Query: 88  NRNQHALEWCINHIVYASRMSHKHIIKLI-----------VFESVQIGTLADRIHHHCEQ 136
            +++   +     +     M H+++I L+             +   +            +
Sbjct: 55  FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK 114

Query: 137 HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS 196
           H E L       +   +   + Y+H   +  I++RD+KP N+  NE  + K+ DF L+  
Sbjct: 115 H-EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLA-- 168

Query: 197 IPDGETHIELDSVVGTTGFIAPENF--TTLINEQCDVYGFGAFLFELLTAQEVSDHVSFE 254
               +   E+   V T  + APE         +  D++  G  + E++T         F+
Sbjct: 169 ---RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITG-----KTLFK 220

Query: 255 SRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQL------------QAFKQL 302
              H ++  + +        E V  +  ++      G  +                   L
Sbjct: 221 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNL 280

Query: 303 TLQCMDFSPEDRPTMVDV 320
             + +    E R T  + 
Sbjct: 281 LEKMLVLDAEQRVTAGEA 298

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.1 bits (134), Expect = 2e-09
 Identities = 44/260 (16%), Positives = 89/260 (34%), Gaps = 34/260 (13%)

Query: 89  RNQHALEWCINHIVYASRMSHKHIIKLI-VFESVQIGTLADRI--------HHHCEQHFE 139
           +NQ   +     +V    ++HK+II L+ VF   +       +         + C+    
Sbjct: 55  QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM 114

Query: 140 ALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD 199
            L       +   +   + +LH   S  I++RD+KP+NI+       K+ DF L+ +   
Sbjct: 115 ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171

Query: 200 GETHIELDSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQ------------- 245
                 +   V T  + APE    +   E  D++  G  + E++  +             
Sbjct: 172 SFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228

Query: 246 ---EVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQL--QAFK 300
              E       E     +  V+       ++  +    +  D       +  +L     +
Sbjct: 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQAR 288

Query: 301 QLTLQCMDFSPEDRPTMVDV 320
            L  + +   P  R ++ D 
Sbjct: 289 DLLSKMLVIDPAKRISVDDA 308

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 54.7 bits (130), Expect = 5e-09
 Identities = 30/265 (11%), Positives = 76/265 (28%), Gaps = 28/265 (10%)

Query: 82  LMKYNGNRNQHALEWCINHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEAL 141
           L + N   N        NHI+      +      +    V      + +    +     +
Sbjct: 63  LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 122

Query: 142 SLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN-EQSDAKLFDFSLSLSIPDG 200
            L    +++  +   + Y+H      I++ D+KP N+L     S   L    ++      
Sbjct: 123 PLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180

Query: 201 ETHIELDSVVGTTGFIAPENFTTL-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHY 259
                  + + T  + +PE           D++     +FEL+T   + +     S    
Sbjct: 181 WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240

Query: 260 EENVKRL------------------------SGQNCRFKEMVDSIIIEDKSCTCTGKEQQ 295
           ++++ ++                         G      ++    + +  +      + +
Sbjct: 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 300

Query: 296 LQAFKQLTLQCMDFSPEDRPTMVDV 320
            +         +   P  R     +
Sbjct: 301 AKEISDFLSPMLQLDPRKRADAGGL 325

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.0 bits (126), Expect = 1e-08
 Identities = 47/240 (19%), Positives = 83/240 (34%), Gaps = 37/240 (15%)

Query: 105 SRMSHKHIIKLI-VFESVQIGTLADRI---------HHHCEQHFEALSLTDRLKVAMDIA 154
             M H+++I L+ VF   +     + +           +     + L+      +   I 
Sbjct: 72  KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 131

Query: 155 HAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTG 214
             + Y+H   S  I++RD+KP+N+  NE  + K+ DF L+       T  E+   V T  
Sbjct: 132 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRW 183

Query: 215 FIAPENF--TTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR 272
           + APE        N+  D++  G  + ELLT +       F    H ++    L      
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR-----TLFPGTDHIDQLKLILRLVGTP 238

Query: 273 FKEMVDSIIIEDKSCTCTGKEQQLQ------------AFKQLTLQCMDFSPEDRPTMVDV 320
             E++  I  E          Q  +                L  + +    + R T    
Sbjct: 239 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 43.2 bits (101), Expect = 1e-05
 Identities = 22/125 (17%), Positives = 44/125 (35%), Gaps = 11/125 (8%)

Query: 93  ALEWCINHIVYASRMSHKHIIKLIVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMD 152
           A+    N      ++    + K+  +E   +            +    + + +  +V   
Sbjct: 57  AIRSARNEFRALQKLQGLAVPKVYAWEGNAVLM-----ELIDAKELYRVRVENPDEVLDM 111

Query: 153 IAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI--PDGETHIELDSVV 210
           I   VA  +    R IV+ D+   N+L +E+    + DF  S+ +        +E D   
Sbjct: 112 ILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRN 167

Query: 211 GTTGF 215
             T F
Sbjct: 168 IITYF 172

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	332
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.51
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.98
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.85
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.3
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.25
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.38
d1cjaa_	342	Actin-fragmin kinase, catalytic domain {Physarum p	81.47

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-61  Score=421.23  Aligned_cols=255  Identities=21%  Similarity=0.342  Sum_probs=203.6

Q ss_pred             HHHHhcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE----------EE
Q 038681           49 LRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL----------IV  117 (332)
Q Consensus        49 l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv  117 (332)
                      +++..++|.+.+.||+|+||+||+|++.+ .||||++.... +....+.|.+|+.++++++|||||++          ||
T Consensus         3 wei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv   81 (276)
T d1uwha_           3 WEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIV   81 (276)
T ss_dssp             CBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEE
T ss_pred             cccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEE
Confidence            34556789999999999999999998765 59999987553 34557889999999999999999998          89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      ||||++|+|.+++....    ..+++..+..++.||++||+|||   +++||||||||+|||++.++.+||+|||+|+..
T Consensus        82 ~Ey~~~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~  154 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVK  154 (276)
T ss_dssp             EECCCEEEHHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred             EecCCCCCHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeec
Confidence            99999999999997541    46999999999999999999999   899999999999999999999999999999877


Q ss_pred             CCCCceeeccccccCCCcccccccCC----CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc--ccc
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG--QNC  271 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~  271 (332)
                      .............||+.|+|||++.+    .++.++|||||||++|||+||+.||..........     .....  ..+
T Consensus       155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~-----~~~~~~~~~p  229 (276)
T d1uwha_         155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII-----FMVGRGYLSP  229 (276)
T ss_dssp             -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH-----HHHHHTSCCC
T ss_pred             cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHH-----HHHhcCCCCC
Confidence            65443333356689999999999863    58999999999999999999999998765433211     11110  000


Q ss_pred             chhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 038681          272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSC  331 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  331 (332)
                      .+.               ..+..+++++.+|+.+||+.||++|||++||++.|+.|.+++
T Consensus       230 ~~~---------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         230 DLS---------------KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             CGG---------------GSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             cch---------------hccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence            000               111234578999999999999999999999999999998864

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-60  Score=413.73  Aligned_cols=241  Identities=21%  Similarity=0.275  Sum_probs=195.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|++.+.||+|+||+||+|++  +|+.||||++......+..+.+.+|+.++++++|||||++           ||||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            35799999999999999999998  7899999999876555556779999999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      ||++|+|.+++...     ..+++.+++.++.||+.||+|||   ++||+||||||+|||++.++.+||+|||+|+....
T Consensus        84 y~~gg~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~  155 (271)
T d1nvra_          84 YCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRY  155 (271)
T ss_dssp             CCTTEEGGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             ccCCCcHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeecc
Confidence            99999999999765     57999999999999999999999   99999999999999999999999999999987755


Q ss_pred             CCceeeccccccCCCcccccccCC-C-CChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-L-INEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~-~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ...........||+.|+|||++.+ . ++.++|||||||++|||++|+.||..........     ........      
T Consensus       156 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~-----~~~~~~~~------  224 (271)
T d1nvra_         156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY-----SDWKEKKT------  224 (271)
T ss_dssp             TTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH-----HHHHTTCT------
T ss_pred             CCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHH-----HHHhcCCC------
Confidence            443333356789999999999976 4 4678999999999999999999997654432211     00000000      


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                ........++++.+|+.+||+.||++|||++|+++
T Consensus       225 ----------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         225 ----------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ----------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ----------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                      00111233477899999999999999999999875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-58  Score=407.66  Aligned_cols=236  Identities=19%  Similarity=0.318  Sum_probs=198.2

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ++|++.+.||+|+||+||+|.+  +|+.||||++....... .+.+.+|+.++++++|||||++           |||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK-KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH-HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            4699999999999999999998  79999999987654433 5789999999999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      |++|+|.+++...      .+++.+++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+|+.....
T Consensus        99 ~~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~  169 (293)
T d1yhwa1          99 LAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (293)
T ss_dssp             CTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             cCCCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccc
Confidence            9999999987653      6999999999999999999999   999999999999999999999999999999877554


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDS  279 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (332)
                      ...  .....||+.|+|||++.+ .++.++|||||||++|+|++|..||..........     ......          
T Consensus       170 ~~~--~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~-----~~~~~~----------  232 (293)
T d1yhwa1         170 QSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-----LIATNG----------  232 (293)
T ss_dssp             TCC--BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-----HHHHHC----------
T ss_pred             ccc--ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH-----HHHhCC----------
Confidence            322  145689999999999988 78999999999999999999999997654332211     111110          


Q ss_pred             hhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          280 IIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                            ......+...++.+.+||.+||+.||.+|||++|+++
T Consensus       233 ------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         233 ------TPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             ------SCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ------CCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  0111222345578999999999999999999999975

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-58  Score=402.24  Aligned_cols=245  Identities=20%  Similarity=0.329  Sum_probs=191.2

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      .++|++.+.||+|+||+||+|.+ ++..||||++......  .+.+.+|+.++++++|||||++           +||||
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc--HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            35788999999999999999999 7888999999765433  4679999999999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++|+|.+++....    ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        82 ~~~g~L~~~l~~~~----~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  154 (263)
T d1sm2a_          82 MEHGCLSDYLRTQR----GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD  154 (263)
T ss_dssp             CTTCBHHHHHHTTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC--------
T ss_pred             cCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCC
Confidence            99999999987542    46899999999999999999999   999999999999999999999999999999877554


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhC-CccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTA-QEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      ..... ....||+.|+|||++.+ .++.++|||||||++|||+|+ .+||........      ...+..          
T Consensus       155 ~~~~~-~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~------~~~i~~----------  217 (263)
T d1sm2a_         155 QYTSS-TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV------VEDIST----------  217 (263)
T ss_dssp             -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHH------HHHHHH----------
T ss_pred             Cceee-cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHH------HHHHHh----------
Confidence            43222 34678999999999987 899999999999999999995 555544332221      111110          


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                          . .  ....+..+++++.+|+.+||+.||++|||++||++.|+++.++
T Consensus       218 ----~-~--~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         218 ----G-F--RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             ----T-C--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----c-C--CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence                0 0  0011123347899999999999999999999999999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-59  Score=404.14  Aligned_cols=233  Identities=19%  Similarity=0.380  Sum_probs=197.8

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|++.+.||+|+||+||+|++  +++.||+|++....  .....+.+.+|+.++++++|||||++           |||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            5699999999999999999999  78899999986542  22336678999999999999999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      |||++|+|.+++...     ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+...
T Consensus        86 Ey~~~g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~  157 (263)
T d2j4za1          86 EYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP  157 (263)
T ss_dssp             ECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC
T ss_pred             eecCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecC
Confidence            999999999999876     57999999999999999999999   9999999999999999999999999999998766


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ....    ....||+.|+|||++.+ .++.++|||||||++|||++|+.||...+.....      ..+......     
T Consensus       158 ~~~~----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~~~~~~-----  222 (263)
T d2j4za1         158 SSRR----TTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY------KRISRVEFT-----  222 (263)
T ss_dssp             CCCC----EETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHTTCCC-----
T ss_pred             CCcc----cccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHH------HHHHcCCCC-----
Confidence            5433    35679999999999998 7899999999999999999999999765443221      111111111     


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                   .+...++++.+|+.+||+.||++|||++|+++
T Consensus       223 -------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         223 -------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             -------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence                         11233478999999999999999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-58  Score=404.69  Aligned_cols=252  Identities=20%  Similarity=0.342  Sum_probs=204.9

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------E
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------I  116 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------l  116 (332)
                      ++++..++|++.+.||+|+||.||+|.+ ++..||||++......  .+.|.+|+.++++++|||||++          |
T Consensus         7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~--~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~i   84 (272)
T d1qpca_           7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS--PDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYI   84 (272)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred             CeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCC--HHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEE
Confidence            3445567899999999999999999999 6788999999765432  4679999999999999999998          8


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      ||||+++|+|.+++.....   ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.
T Consensus        85 v~Ey~~~g~L~~~~~~~~~---~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~  158 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARL  158 (272)
T ss_dssp             EEECCTTCBHHHHTTSHHH---HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEeCCCCcHHHHHhhcCC---CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEE
Confidence            9999999999998865522   35999999999999999999999   89999999999999999999999999999988


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      ......... ....||+.|+|||++.+ .++.++|||||||++|||+||..|+........     ....+..       
T Consensus       159 ~~~~~~~~~-~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-----~~~~i~~-------  225 (272)
T d1qpca_         159 IEDNEYTAR-EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-----VIQNLER-------  225 (272)
T ss_dssp             CSSSCEECC-TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHHT-------
T ss_pred             ccCCccccc-cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-----HHHHHHh-------
Confidence            765543322 45678999999999886 899999999999999999996655543322111     1111110       


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                              ..  ....+..+++++.+|+.+||+.||++|||+++|++.|+.+..+
T Consensus       226 --------~~--~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         226 --------GY--RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             --------TC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------cC--CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence                    00  1111123457899999999999999999999999999988764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-59  Score=404.50  Aligned_cols=243  Identities=18%  Similarity=0.279  Sum_probs=187.8

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-------------EE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-------------IV  117 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-------------lv  117 (332)
                      ++|++.+.||+|+||+||+|++  +|+.||||.+.... +....+.+.+|+.++++++|||||++             ||
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5699999999999999999998  78999999997764 34456779999999999999999987             79


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcC--CCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGF--SRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      ||||++|+|.+++...... ...+++..++.++.||+.||.|||+..  .++|+||||||+|||++.++.+||+|||+|+
T Consensus        84 mEy~~~g~L~~~i~~~~~~-~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          84 MEYCEGGDLASVITKGTKE-RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EecCCCCcHHHHHHhcccc-CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            9999999999999765322 257999999999999999999999311  1349999999999999999999999999998


Q ss_pred             ccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ........  .....||+.|+|||++.+ .++.++|||||||++|||+||+.||...+..+...     ....+...   
T Consensus       163 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~-----~i~~~~~~---  232 (269)
T d2java1         163 ILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG-----KIREGKFR---  232 (269)
T ss_dssp             HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH-----HHHHTCCC---
T ss_pred             ecccCCCc--cccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHH-----HHHcCCCC---
Confidence            87654332  145689999999999987 89999999999999999999999998654432211     00110000   


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                     ..+...++++.+|+.+||+.||.+|||++|+++
T Consensus       233 ---------------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 ---------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ---------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                           111234578999999999999999999999975

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-58  Score=407.29  Aligned_cols=251  Identities=20%  Similarity=0.325  Sum_probs=205.5

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------  115 (332)
                      ++++..++|++.+.||+|+||+||+|.+  +++.||||++......  .+.+.+|+.++++++|||||++          
T Consensus        11 ~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          11 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME--VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             TTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             ccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch--HHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence            3455667899999999999999999999  6899999998765432  5779999999999999999998          


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       ||||||++|+|.+++....   ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|
T Consensus        89 ~iv~E~~~~g~l~~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a  162 (287)
T d1opja_          89 YIITEFMTYGNLLDYLRECN---RQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLS  162 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCT
T ss_pred             EEEeecccCcchHHHhhhcc---ccchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccce
Confidence             8999999999999997642   246899999999999999999999   899999999999999999999999999999


Q ss_pred             cccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      +.......... ....||+.|+|||++.+ .++.++|||||||++|||++|..||........     ....+..     
T Consensus       163 ~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-----~~~~i~~-----  231 (287)
T d1opja_         163 RLMTGDTYTAH-AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-----VYELLEK-----  231 (287)
T ss_dssp             TTCCSSSSEEE-TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----HHHHHHT-----
T ss_pred             eecCCCCceee-ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-----HHHHHhc-----
Confidence            87766544332 45568999999999876 899999999999999999997776643322111     1111110     


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                                ..  ..+.+..+++++.+|+.+||+.||++|||++||++.|+.+.+
T Consensus       232 ----------~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         232 ----------DY--RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             ----------TC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             ----------CC--CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                      00  111122345789999999999999999999999999988754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.3e-58  Score=404.39  Aligned_cols=247  Identities=18%  Similarity=0.268  Sum_probs=192.6

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CC---eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QK---RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      ++|++.++||+|+||+||+|.+  ++   ..||||.+.........+.|.+|+.+|++++|||||++           +|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            4577788999999999999998  33   35899998877777667889999999999999999998           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      ||||++|+|.+++....    ..+++.+++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus       106 ~Ey~~~g~L~~~~~~~~----~~l~~~~~~~i~~qia~gl~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             EECCTTEEHHHHHHTTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEecCCCcceeeecccc----CCCCHHHHHHHHHHHHHHHHHHh---hCCCccCccccceEEECCCCcEEECCcccceEc
Confidence            99999999999987642    46999999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCceee---ccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          198 PDGETHIE---LDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       198 ~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      ........   .....||+.|+|||++.+ .++.++|||||||++|||+| |..||......+..      ..+..    
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~------~~i~~----  248 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVI------NAIEQ----  248 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHT----
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHH------HHHHc----
Confidence            54432211   123457899999999987 89999999999999999998 89999876543221      11110    


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                                 ..  ..+.+..++..+.+|+.+||+.||++|||+.||++.|++++++
T Consensus       249 -----------~~--~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         249 -----------DY--RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             -----------TC--CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -----------CC--CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence                       00  1111224457899999999999999999999999999998753

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-57  Score=396.41  Aligned_cols=233  Identities=19%  Similarity=0.329  Sum_probs=192.4

Q ss_pred             CCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE---------------EEE
Q 038681           57 DEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL---------------IVF  118 (332)
Q Consensus        57 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~---------------lv~  118 (332)
                      +..++||+|+||+||+|.+  ++..||+|++.... .....+.+.+|++++++++|||||++               |||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            5667899999999999999  78899999987653 34446789999999999999999987               799


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCC--eeecCCCCCCeeeC-CCCCeEEeecCCcc
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRP--IVYRDMKPTNILFN-EQSDAKLFDFSLSL  195 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nill~-~~~~~kl~Dfg~a~  195 (332)
                      |||++|+|.+++...     ..+++..++.++.||+.||+|||   +++  |+||||||+|||++ .++.+||+|||+|+
T Consensus        92 E~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH---~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             ECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             eCCCCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHH---HCCCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            999999999999876     57999999999999999999999   777  99999999999996 57899999999998


Q ss_pred             ccCCCCceeeccccccCCCcccccccCCCCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      .......    ....||+.|+|||++.+.++.++|||||||++|||++|+.||........     ....+.....    
T Consensus       164 ~~~~~~~----~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-----~~~~i~~~~~----  230 (270)
T d1t4ha_         164 LKRASFA----KAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-----IYRRVTSGVK----  230 (270)
T ss_dssp             GCCTTSB----EESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-----HHHHHTTTCC----
T ss_pred             eccCCcc----CCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-----HHHHHHcCCC----
Confidence            6554432    35689999999999988999999999999999999999999975443221     1111111100    


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                  +...+...++++.+|+.+||+.||++|||++|+++
T Consensus       231 ------------~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         231 ------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------------CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                        00111123367899999999999999999999975

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-58  Score=401.16  Aligned_cols=247  Identities=18%  Similarity=0.277  Sum_probs=204.0

Q ss_pred             cCCCCCC-ccccCCCceEEEEEe----CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------EEE
Q 038681           54 NNYDEQN-IVLEDPFRKLYKGFW----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IVF  118 (332)
Q Consensus        54 ~~y~~~~-~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv~  118 (332)
                      ++|.+.+ +||+|+||+||+|.+    ++..||||.++........+.|.+|+.++++++|||||++          |||
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm   87 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM   87 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEE
Confidence            4566666 499999999999987    3457999999887776668889999999999999999998          899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      |||++|+|.+++....    ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+...
T Consensus        88 E~~~~g~L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~  160 (285)
T d1u59a_          88 EMAGGGPLHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG  160 (285)
T ss_dssp             ECCTTEEHHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred             EeCCCCcHHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence            9999999999986541    46999999999999999999999   8999999999999999999999999999998776


Q ss_pred             CCCcee-eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          199 DGETHI-ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       199 ~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      ...... ......||+.|+|||++.+ .++.++|||||||++|||+| |..||......+..      ..+..       
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~------~~i~~-------  227 (285)
T d1u59a_         161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM------AFIEQ-------  227 (285)
T ss_dssp             TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH------HHHHT-------
T ss_pred             ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH------HHHHc-------
Confidence            544322 2234568999999999886 89999999999999999998 89999876543221      11110       


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                              ..  ..+.+..+++++.+|+.+||+.||++|||+.+|++.|+..+.+
T Consensus       228 --------~~--~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         228 --------GK--RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             --------TC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------CC--CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                    00  1111224557899999999999999999999999999987754

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-59  Score=416.22  Aligned_cols=255  Identities=18%  Similarity=0.237  Sum_probs=200.7

Q ss_pred             HhcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ..++|++.+.||+|+||+||+|++  +|+.||+|++.........+.+.+|+.+|++++|||||++           |||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            457899999999999999999998  7899999999877666657789999999999999999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCC-CCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFS-RPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~-~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      ||+++|+|.+++.+.     ..+++..+..++.||+.||.|||   + ++|+||||||+|||++.++.+||+|||+|+..
T Consensus        84 Ey~~gg~L~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH---~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~  155 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLR---EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  155 (322)
T ss_dssp             ECCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred             EcCCCCcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---HhCCEEccccCHHHeeECCCCCEEEeeCCCcccc
Confidence            999999999999876     57999999999999999999999   6 58999999999999999999999999999866


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc--------
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG--------  268 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------  268 (332)
                      .....    .+.+||+.|+|||++.+ .|+.++||||+||++|||++|+.||...........  ......+        
T Consensus       156 ~~~~~----~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~--~~~~~~~~~~~~~~~  229 (322)
T d1s9ja_         156 IDSMA----NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM--FGCQVEGDAAETPPR  229 (322)
T ss_dssp             HHHTC-------CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHH--C--------------
T ss_pred             CCCcc----ccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH--HHHHhcCCcccCCcc
Confidence            43322    45689999999999988 899999999999999999999999976543321100  0000000        


Q ss_pred             ----------------cccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          269 ----------------QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       269 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                      ......+..+.......  +.......+.++.+|+.+||+.||.+|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ----------------CCCCHHHHHHHHHTSCC--CCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccccccchhHHHHHhhhhccCC--ccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                            00001111111111111  11111134578999999999999999999999987

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-58  Score=408.03  Aligned_cols=239  Identities=22%  Similarity=0.309  Sum_probs=182.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .+.|++.+.||+|+||+||+|.+  +++.||||.+.........+.+.+|+.++++++|||||++           ||||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            35699999999999999999998  7899999999876554445678899999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeC---CCCCeEEeecCCccc
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN---EQSDAKLFDFSLSLS  196 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~a~~  196 (332)
                      ||+||+|.+++...     ..+++.++..++.||+.||+|||   +++|+||||||+|||+.   .++.+||+|||+|+.
T Consensus        88 ~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          88 LVSGGELFDRIVEK-----GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             CCCSCBHHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             ccCCCcHHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEE
Confidence            99999999999765     57999999999999999999999   99999999999999994   578999999999987


Q ss_pred             cCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      .......   ....||+.|+|||++.+ .++.++|||||||++|||++|..||.........      ..          
T Consensus       160 ~~~~~~~---~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~------~~----------  220 (307)
T d1a06a_         160 EDPGSVL---STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF------EQ----------  220 (307)
T ss_dssp             ----------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HH----------
T ss_pred             ccCCCee---eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHH------HH----------
Confidence            6554332   45679999999999988 8999999999999999999999999865443221      11          


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                          ..........+.....++++.+|+.+||+.||++|||++|+++
T Consensus       221 ----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         221 ----ILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             ----HHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ----HhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                1111111122222345578999999999999999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-58  Score=404.23  Aligned_cols=238  Identities=22%  Similarity=0.281  Sum_probs=196.7

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      +.|++.+.||+|+||.||+|.+  ++..||||++....... .+.+.+|+.++++++|||||++           |||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEE-LEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGG-GGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHH-HHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEec
Confidence            3589999999999999999999  78899999997664433 6788999999999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      |++|+|.+++....    ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        91 ~~~g~L~~~~~~~~----~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          91 CAGGAVDAVMLELE----RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             CTTEEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             CCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            99999999987641    46999999999999999999999   999999999999999999999999999999765332


Q ss_pred             CceeeccccccCCCcccccccC-----C-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          201 ETHIELDSVVGTTGFIAPENFT-----T-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~-----~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      ..  ......||+.|+|||++.     + .|+.++|||||||++|||++|+.||......+..     .......     
T Consensus       164 ~~--~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~-----~~i~~~~-----  231 (288)
T d2jfla1         164 IQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL-----LKIAKSE-----  231 (288)
T ss_dssp             HH--HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH-----HHHHHSC-----
T ss_pred             cc--cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH-----HHHHcCC-----
Confidence            11  124568999999999984     2 6889999999999999999999999876543321     1111111     


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                 ......+...++++.+||.+||+.||++|||++|+++
T Consensus       232 -----------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         232 -----------PPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             -----------CCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----------CCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                       0111222345578999999999999999999999976

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-58  Score=404.06  Aligned_cols=237  Identities=19%  Similarity=0.283  Sum_probs=194.9

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|++.+.||+|+||+||+|.+  +++.||||++....  .....+.+.+|+.++++++|||||++           |||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5699999999999999999998  78999999987542  23336779999999999999999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      |||++|+|.+++...     +.+++..++.++.|++.||+|||   +++|+||||||+|||++.++.+||+|||+|+...
T Consensus        88 Ey~~gg~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~  159 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLS  159 (288)
T ss_dssp             CCCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EccCCCCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecc
Confidence            999999999999876     67999999999999999999999   9999999999999999999999999999998876


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ............||+.|+|||++.+ .++.++|||||||++|||++|..||...+.....      ..+......     
T Consensus       160 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~------~~i~~~~~~-----  228 (288)
T d1uu3a_         160 PESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF------QKIIKLEYD-----  228 (288)
T ss_dssp             ----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHTTCCC-----
T ss_pred             cCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH------HHHHcCCCC-----
Confidence            5443333355689999999999987 8999999999999999999999999865433221      111111111     


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                   .+...++++.+||.+||+.||++|||++|+++
T Consensus       229 -------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         229 -------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             -------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             -------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence                         11233477999999999999999999998754

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-57  Score=396.16  Aligned_cols=240  Identities=18%  Similarity=0.299  Sum_probs=194.9

Q ss_pred             CccccCCCceEEEEEe----CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE----------EEEEeccCC
Q 038681           60 NIVLEDPFRKLYKGFW----QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL----------IVFESVQIG  124 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv~e~~~~g  124 (332)
                      ++||+|+||+||+|.+    .++.||||++.... +....+.+.+|+.++++++|||||++          ||||||++|
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g   92 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG   92 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCC
Confidence            4699999999999987    34679999997653 33446789999999999999999998          899999999


Q ss_pred             ChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCCcee
Q 038681          125 TLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHI  204 (332)
Q Consensus       125 ~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~  204 (332)
                      +|.+++...     ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+.........
T Consensus        93 ~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          93 PLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             cHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            999999876     57999999999999999999999   8999999999999999999999999999998776544332


Q ss_pred             e-ccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhhhhh
Q 038681          205 E-LDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVDSII  281 (332)
Q Consensus       205 ~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (332)
                      . .....||+.|+|||++.+ .++.++|||||||++|||+| |+.||......+..      ..+..             
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~------~~i~~-------------  225 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT------AMLEK-------------  225 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH------HHHHT-------------
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHH------HHHHc-------------
Confidence            2 234578999999999876 89999999999999999998 89999875543221      11110             


Q ss_pred             hcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          282 IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                        ..  ..+.+..+++++.+|+.+||+.||++|||+++|++.|+..+.+
T Consensus       226 --~~--~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         226 --GE--RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             --TC--CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             --CC--CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence              00  1111224457899999999999999999999999999887654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-56  Score=387.70  Aligned_cols=241  Identities=17%  Similarity=0.265  Sum_probs=201.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      .++|++.++||+|+||+||+|++ +++.||||+++.....  .+.+.+|+.++++++|||||++           +||||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~--~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC--HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC--HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence            46899999999999999999999 7789999999876443  4679999999999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +++|+|.+++....    ..+++..++.++.||++||+|||   ++||+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~~~g~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~  153 (258)
T d1k2pa_          81 MANGCLLNYLREMR----HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD  153 (258)
T ss_dssp             CTTEEHHHHHHSGG----GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS
T ss_pred             cCCCcHHHhhhccc----cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCC
Confidence            99999999976542    46899999999999999999999   899999999999999999999999999999876554


Q ss_pred             CceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      ..... ....||+.|+|||++.+ .++.++|||||||++|||+| |+.||......+...      .+..          
T Consensus       154 ~~~~~-~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~------~i~~----------  216 (258)
T d1k2pa_         154 EYTSS-VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE------HIAQ----------  216 (258)
T ss_dssp             SCCCC-CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH------HHHT----------
T ss_pred             Cceee-cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHH------HHHh----------
Confidence            33322 45678999999999986 89999999999999999998 899998765443211      1111          


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQ  326 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~  326 (332)
                           ..  ....+...++++.+|+.+||+.||++|||+++|++.|..
T Consensus       217 -----~~--~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         217 -----GL--RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             -----TC--CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             -----CC--CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence                 00  011112344789999999999999999999999998854

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-57  Score=396.33  Aligned_cols=249  Identities=21%  Similarity=0.333  Sum_probs=195.7

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe-----CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW-----QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------  115 (332)
                      +..++|++.+.||+|+||.||+|.+     .+..||||.+.........+.+.+|+.++++++|||||++          
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~   83 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW   83 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCE
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEE
Confidence            3456799999999999999999998     2356899998877777667889999999999999999998          


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      +||||+++|+|.+++....    ..+++..++.++.||++||.|||   +++|+||||||+||+++.++.+||+|||+|+
T Consensus        84 iv~E~~~~g~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~  156 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSR  156 (273)
T ss_dssp             EEEECCTTEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             EEEEeccCCcHHhhhhccC----CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhhe
Confidence            8999999999999886542    46899999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      .......... ....||+.|+|||++.+ .++.++|||||||++|||+| |.+||......+...      .+..     
T Consensus       157 ~~~~~~~~~~-~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~------~i~~-----  224 (273)
T d1mp8a_         157 YMEDSTYYKA-SKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG------RIEN-----  224 (273)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH------HHHT-----
T ss_pred             eccCCcceec-cceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHH------HHHc-----
Confidence            7654433222 45578999999999986 89999999999999999998 899998765443211      1110     


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                               ..   ..+.+..+++.+.+||.+||+.||++|||+.||++.|+++++.
T Consensus       225 ---------~~---~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         225 ---------GE---RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             ---------TC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------CC---CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence                     00   0111224457899999999999999999999999999998753

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-57  Score=406.78  Aligned_cols=251  Identities=18%  Similarity=0.319  Sum_probs=200.0

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe--CC-----eeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-------
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW--QK-----RSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-------  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~-----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-------  115 (332)
                      +..++|++.+.||+|+||+||+|++  .+     ..||+|.+...........+.+|+.++.++ +|||||++       
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            4456799999999999999999998  22     369999998766555567899999999999 89999998       


Q ss_pred             ----EEEEeccCCChHHHHhhhhcc------------------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCC
Q 038681          116 ----IVFESVQIGTLADRIHHHCEQ------------------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDM  173 (332)
Q Consensus       116 ----lv~e~~~~g~L~~~l~~~~~~------------------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl  173 (332)
                          ||||||++|+|.+++......                  ....+++..++.++.||+.||+|||   +++|+||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccC
Confidence                899999999999999765211                  1235899999999999999999999   899999999


Q ss_pred             CCCCeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCC
Q 038681          174 KPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHV  251 (332)
Q Consensus       174 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~  251 (332)
                      ||+|||++.++.+||+|||+|+...............||+.|+|||++.+ .++.++|||||||++|||+| |..||.+.
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987765554433356678999999999876 89999999999999999998 89999876


Q ss_pred             CccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 038681          252 SFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQ  326 (332)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~  326 (332)
                      +.....     ...+..               ..  ..+.+..+++++.+||.+||+.||++|||++||++.|..
T Consensus       271 ~~~~~~-----~~~~~~---------------~~--~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         271 PVDANF-----YKLIQN---------------GF--KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             CCSHHH-----HHHHHT---------------TC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHHHHH-----HHHHhc---------------CC--CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            543321     111111               00  111122445789999999999999999999999999853

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-57  Score=394.80  Aligned_cols=249  Identities=21%  Similarity=0.299  Sum_probs=194.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEeC--C----eeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFWQ--K----RSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~~--~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      .+.|+..++||+|+||.||+|.+.  +    ..||||++...........|.+|+.++++++|||||++           
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            456888999999999999999982  2    46999999877766667789999999999999999998           


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      +||||+.+|++.+++....    ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+
T Consensus        86 ~v~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~  158 (283)
T d1mqba_          86 IITEYMENGALDKFLREKD----GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSR  158 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTT----TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEEecccCcchhhhhccc----ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhh
Confidence            8999999999999887652    46999999999999999999999   9999999999999999999999999999998


Q ss_pred             ccCCCCce-eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          196 SIPDGETH-IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       196 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      ........ .......||+.|+|||++.+ .++.++|||||||++|||++|..|+........     ....+..     
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~-----~~~~i~~-----  228 (283)
T d1mqba_         159 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-----VMKAIND-----  228 (283)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-----HHHHHHT-----
T ss_pred             cccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHH-----HHHHHhc-----
Confidence            76554322 12234568999999999987 899999999999999999997666543322111     1111110     


Q ss_pred             hhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          274 KEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                                ..  ..+.+..++..+.+|+.+||+.||++|||+.||++.|+++.++
T Consensus       229 ----------~~--~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         229 ----------GF--RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             ----------TC--CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ----------cC--CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence                      00  1112224457899999999999999999999999999998753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.3e-56  Score=404.12  Aligned_cols=239  Identities=17%  Similarity=0.227  Sum_probs=198.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|++.+.||+|+||.||+|.+  +|+.||||++...... ..+.+.+|+.++++++|||||++           ||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES-DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH-HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchh-hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            35799999999999999999998  7999999999766433 36788999999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeC--CCCCeEEeecCCcccc
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN--EQSDAKLFDFSLSLSI  197 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~Dfg~a~~~  197 (332)
                      ||++|+|.+++....    ..+++..+..++.||+.||.|||   ++||+||||||+|||++  .++.+||+|||+|+..
T Consensus       104 ~~~gg~L~~~l~~~~----~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~  176 (350)
T d1koaa2         104 FMSGGELFEKVADEH----NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL  176 (350)
T ss_dssp             CCCSCBHHHHHTCTT----SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEEC
T ss_pred             cCCCCCHHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheec
Confidence            999999999996431    46999999999999999999999   99999999999999995  4678999999999887


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ......   ....||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.+..+...      .+.         
T Consensus       177 ~~~~~~---~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~------~i~---------  238 (350)
T d1koaa2         177 DPKQSV---KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLR------NVK---------  238 (350)
T ss_dssp             CTTSCE---EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHH---------
T ss_pred             cccccc---ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHH------HHH---------
Confidence            655433   45689999999999988 89999999999999999999999998665433211      111         


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                           ..............++++.+||.+||+.||++|||++|+++
T Consensus       239 -----~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         239 -----SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             -----HTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             -----hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 11111111111234578999999999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-56  Score=397.25  Aligned_cols=262  Identities=18%  Similarity=0.335  Sum_probs=202.8

Q ss_pred             ccHHHHHHHhcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE
Q 038681           44 FSAEELRIATNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL  115 (332)
Q Consensus        44 ~~~~el~~~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~  115 (332)
                      ++.+++++..++|++.+.||+|+||.||+|.+       +++.||||++.........+.+.+|..++.++ +|+|||.+
T Consensus         3 ~~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~   82 (299)
T d1ywna1           3 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   82 (299)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEe
Confidence            35667777778899999999999999999997       24679999998776666678889999999888 68899887


Q ss_pred             ------------EEEEeccCCChHHHHhhhhcc-----------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecC
Q 038681          116 ------------IVFESVQIGTLADRIHHHCEQ-----------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRD  172 (332)
Q Consensus       116 ------------lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D  172 (332)
                                  +|||||++|+|.+++......           ....+++.+++.++.||+.||.|||   +++|+|||
T Consensus        83 ~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrD  159 (299)
T d1ywna1          83 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRD  159 (299)
T ss_dssp             EEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSC
T ss_pred             eeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCc
Confidence                        899999999999999865321           1235899999999999999999999   99999999


Q ss_pred             CCCCCeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCC-ccCCC
Q 038681          173 MKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQ-EVSDH  250 (332)
Q Consensus       173 lkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~-~p~~~  250 (332)
                      |||+|||++.++.+||+|||+|+...............||+.|+|||++.+ .++.++|||||||++|||+||. .||..
T Consensus       160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987765544433356689999999999987 8999999999999999999974 57765


Q ss_pred             CCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          251 VSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      .......     ...+.               ...  ....+...++++.+|+.+||+.||++|||++||++.|+.++++
T Consensus       240 ~~~~~~~-----~~~~~---------------~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         240 VKIDEEF-----CRRLK---------------EGT--RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             CCCSHHH-----HHHHH---------------HTC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHH-----HHHHh---------------cCC--CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            4433221     11110               000  0111123447899999999999999999999999999999865

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.6e-57  Score=398.74  Aligned_cols=232  Identities=21%  Similarity=0.264  Sum_probs=193.7

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .|+..+.||+|+||+||+|++  +++.||||++.....  ....+.+.+|+.++++++|||||++           ||||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            389999999999999999998  789999999876542  3446779999999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      ||++|+|..++...     ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||+|+....
T Consensus        96 ~~~~g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (309)
T d1u5ra_          96 YCLGSASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP  167 (309)
T ss_dssp             CCSEEHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred             ecCCCchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCC
Confidence            99999998776655     57999999999999999999999   99999999999999999999999999999986544


Q ss_pred             CCceeeccccccCCCcccccccCC----CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT----LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      .      ....||+.|+|||++.+    .|+.++|||||||++|||++|..||........     .........+    
T Consensus       168 ~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~-----~~~i~~~~~~----  232 (309)
T d1u5ra_         168 A------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----LYHIAQNESP----  232 (309)
T ss_dssp             B------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH-----HHHHHHSCCC----
T ss_pred             C------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH-----HHHHHhCCCC----
Confidence            3      34579999999999863    589999999999999999999999976543322     1111111110    


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                   ......+++++.+|+.+||+.||++|||++|+++
T Consensus       233 -------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         233 -------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             -------------CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -------------CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence                         0111234578999999999999999999999975

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-56  Score=394.23  Aligned_cols=238  Identities=22%  Similarity=0.276  Sum_probs=198.0

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-----hhhHHHHHHHHHHHHhhcCCCcceE-----------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-----QHALEWCINHIVYASRMSHKHIIKL-----------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~H~nIv~~-----------  115 (332)
                      +.|++.+.||+|+||+||+|++  +|+.||||++.....     ....+.+.+|+.+|++++|||||++           
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5699999999999999999998  789999999865422     2236789999999999999999998           


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC----CeEEeec
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS----DAKLFDF  191 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Df  191 (332)
                      ||||||++|+|.+++...     ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++    .+||+||
T Consensus        90 iv~E~~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~Df  161 (293)
T d1jksa_          90 LILELVAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDF  161 (293)
T ss_dssp             EEEECCCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEcCCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecch
Confidence            899999999999999876     57999999999999999999999   99999999999999998776    4999999


Q ss_pred             CCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc
Q 038681          192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       192 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      |+|+........   ....||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.+..+...      .+....
T Consensus       162 G~a~~~~~~~~~---~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~------~i~~~~  232 (293)
T d1jksa_         162 GLAHKIDFGNEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA------NVSAVN  232 (293)
T ss_dssp             TTCEECTTSCBC---SCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHTTC
T ss_pred             hhhhhcCCCccc---cccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHH------HHHhcC
Confidence            999887655432   45679999999999988 79999999999999999999999998765433211      111111


Q ss_pred             cchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ..+.              .......+..+.+||.+||+.||++|||++|+++
T Consensus       233 ~~~~--------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         233 YEFE--------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             CCCC--------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCCC--------------chhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1111              0111133477899999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9e-57  Score=398.26  Aligned_cols=255  Identities=20%  Similarity=0.276  Sum_probs=206.4

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEeC-------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGFWQ-------KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----  115 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----  115 (332)
                      +++...++|++.+.||+|+||+||+|++.       ++.||||++.........+.+.+|+.++++++||||+++     
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            45556778999999999999999999873       478999999887777667889999999999999999998     


Q ss_pred             ------EEEEeccCCChHHHHhhhhc-------------------ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeee
Q 038681          116 ------IVFESVQIGTLADRIHHHCE-------------------QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVY  170 (332)
Q Consensus       116 ------lv~e~~~~g~L~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH  170 (332)
                            +||||+++|+|.+++.....                   .....+++..++.++.||+.||+|||   +++|||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEe
Confidence                  89999999999999975321                   11235899999999999999999999   999999


Q ss_pred             cCCCCCCeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCC-ccC
Q 038681          171 RDMKPTNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQ-EVS  248 (332)
Q Consensus       171 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~-~p~  248 (332)
                      |||||+|||++.++.+||+|||+|+...............||+.|+|||.+.+ .++.++|||||||++|||++|. +||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            99999999999999999999999987655443333345678999999999987 8999999999999999999986 567


Q ss_pred             CCCCccchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHH
Q 038681          249 DHVSFESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMY  328 (332)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~  328 (332)
                      ......+...      .+...              .   ..+.+..+++++.+|+.+||+.||++||||.||++.|++|.
T Consensus       244 ~~~~~~e~~~------~v~~~--------------~---~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         244 YGMAHEEVIY------YVRDG--------------N---ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTSCHHHHHH------HHHTT--------------C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCHHHHHH------HHHcC--------------C---CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            6654433211      11110              0   01111234478999999999999999999999999999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2.7e-56  Score=402.33  Aligned_cols=239  Identities=19%  Similarity=0.208  Sum_probs=199.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|++.+.||+|+||.||+|.+  +|+.||||++....... .+.+.+|+.++++++|||||++           ||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH-HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH-HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            35699999999999999999998  79999999987665333 5678899999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeC--CCCCeEEeecCCcccc
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN--EQSDAKLFDFSLSLSI  197 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~Dfg~a~~~  197 (332)
                      ||++|+|.+++....    ..+++.+++.++.||+.||.|||   ++||+||||||+|||++  .++.+||+|||+|+..
T Consensus       107 ~~~gg~L~~~~~~~~----~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~  179 (352)
T d1koba_         107 FLSGGELFDRIAAED----YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL  179 (352)
T ss_dssp             CCCCCBHHHHTTCTT----CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEEC
T ss_pred             cCCCChHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceec
Confidence            999999999876541    46999999999999999999999   99999999999999997  6789999999999887


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ......   ....||+.|+|||++.+ .++.++|||||||++|||+||..||.+........                  
T Consensus       180 ~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~------------------  238 (352)
T d1koba_         180 NPDEIV---KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ------------------  238 (352)
T ss_dssp             CTTSCE---EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------------------
T ss_pred             CCCCce---eeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH------------------
Confidence            665433   45679999999999988 89999999999999999999999998765433211                  


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                        .........+.......++++.+||.+||+.||.+|||+.|+++
T Consensus       239 --~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         239 --NVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             --HHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             --HHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              11111111111112244578999999999999999999999976

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=5.2e-56  Score=388.93  Aligned_cols=249  Identities=21%  Similarity=0.328  Sum_probs=198.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-------------  115 (332)
                      .++|++.+.||+|+||.||+|.+  +++.||||++....  +....+.+.+|+.+++.++|||||++             
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            35699999999999999999998  79999999997653  34446789999999999999999986             


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        ||||||+||+|.+++...     ..+++.+++.++.||+.||+|||   ++||+||||||+|||++.++.++|+|||.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~  157 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGI  157 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred             EEEEEECCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhh
Confidence              899999999999998876     67999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCce-eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          194 SLSIPDGETH-IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       194 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      +......... .......||+.|+|||++.+ .++.++|||||||++|||+||..||......+.     ....+..   
T Consensus       158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-----~~~~~~~---  229 (277)
T d1o6ya_         158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-----AYQHVRE---  229 (277)
T ss_dssp             CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-----HHHHHHC---
T ss_pred             hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH-----HHHHHhc---
Confidence            8765443221 12245679999999999988 899999999999999999999999986544322     1111111   


Q ss_pred             chhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHHHH
Q 038681          272 RFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-TMVDVAKQLRQMYR  329 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-s~~evl~~L~~l~~  329 (332)
                                  ....+.......++++.+|+.+||+.||.+|| |+++++..|.++.+
T Consensus       230 ------------~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n  276 (277)
T d1o6ya_         230 ------------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  276 (277)
T ss_dssp             ------------CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred             ------------CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHhC
Confidence                        11111111123457899999999999999999 89999999988753

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-56  Score=395.93  Aligned_cols=246  Identities=18%  Similarity=0.344  Sum_probs=197.5

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCe----eEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------EE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKR----SISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------IV  117 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------lv  117 (332)
                      .+|++.+.||+|+||+||+|.+  +|+    .||+|++.........+.+.+|+.++++++|||||++          ++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v   88 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI   88 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEE
Confidence            4699999999999999999998  443    5899998876666667889999999999999999998          89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      +||+.+|+|.+++....    ..+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+|+..
T Consensus        89 ~e~~~~~~l~~~~~~~~----~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          89 TQLMPFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EECCTTCBHHHHHHHTS----SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEeccCCcccccccccc----cCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceec
Confidence            99999999999887652    57999999999999999999999   899999999999999999999999999999887


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKE  275 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (332)
                      .............||+.|+|||++.+ .++.++|||||||++|||+| |..||...+......      .+..       
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~------~i~~-------  228 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS------ILEK-------  228 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH------HHHH-------
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHH------HHHc-------
Confidence            65544433345578999999999876 89999999999999999998 788887665433211      1100       


Q ss_pred             hhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          276 MVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                              ..  ..+.+..+++.+.+|+.+||+.||.+|||+.||++.|..+.+
T Consensus       229 --------~~--~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         229 --------GE--RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             --------TC--CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --------CC--CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence                    00  011122445789999999999999999999999999988764

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-56  Score=386.52  Aligned_cols=241  Identities=19%  Similarity=0.332  Sum_probs=194.3

Q ss_pred             HhcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE------------EEEE
Q 038681           52 ATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------------IVFE  119 (332)
Q Consensus        52 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~------------lv~e  119 (332)
                      ..++|++.+.||+|+||.||+|.++|..||||+++...   ..+.+.+|+.++++++|||||++            +|||
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA---TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence            45678889999999999999999999999999997653   25678999999999999999998            8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+++|+|.+++.....   ..+++..++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        82 y~~~g~L~~~l~~~~~---~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~  155 (262)
T d1byga_          82 YMAKGSLVDYLRSRGR---SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  155 (262)
T ss_dssp             CCTTEEHHHHHHHHHH---HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             ccCCCCHHHHHHhcCC---CCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCC
Confidence            9999999999976522   35899999999999999999999   89999999999999999999999999999987654


Q ss_pred             CCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ..     ....+|+.|+|||++.+ .++.++|||||||++|||+| |..||.........      ..+..         
T Consensus       156 ~~-----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~------~~i~~---------  215 (262)
T d1byga_         156 TQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------PRVEK---------  215 (262)
T ss_dssp             -----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH------HHHTT---------
T ss_pred             CC-----ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH------HHHHc---------
Confidence            33     34568999999999876 89999999999999999998 67777665433321      11110         


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                            .  ...+.+...++++.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       216 ------~--~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         216 ------G--YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             ------T--CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------C--CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence                  0  0111222344789999999999999999999999999999875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-55  Score=394.63  Aligned_cols=236  Identities=19%  Similarity=0.273  Sum_probs=198.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IV  117 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv  117 (332)
                      .++|++.+.||+|+||.||+|++  +|+.||||++....  .....+.+.+|+.+|++++|||||++           +|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            46799999999999999999998  89999999997542  22336778999999999999999998           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      ||||++|+|.+++...     ..+++..++.++.||+.||+|||   ++||+||||||+|||++.+|.+||+|||+|+..
T Consensus        84 ~ey~~gg~L~~~~~~~-----~~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~  155 (337)
T d1o6la_          84 MEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG  155 (337)
T ss_dssp             EECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred             eeccCCCchhhhhhcc-----cCCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeeccccccc
Confidence            9999999999999887     67999999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ......  ....+||+.|+|||++.+ .|+.++|||||||++|||++|..||...+.....      .........    
T Consensus       156 ~~~~~~--~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~------~~i~~~~~~----  223 (337)
T d1o6la_         156 ISDGAT--MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF------ELILMEEIR----  223 (337)
T ss_dssp             CCTTCC--BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCCCC----
T ss_pred             ccCCcc--cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHH------HHHhcCCCC----
Confidence            543322  245789999999999988 8999999999999999999999999876543321      111111111    


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT-----MVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~  322 (332)
                                    .+...++++.+||.+||+.||.+||+     ++|+++
T Consensus       224 --------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         224 --------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             --------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence                          11234578899999999999999995     788775

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-56  Score=390.80  Aligned_cols=252  Identities=22%  Similarity=0.314  Sum_probs=197.3

Q ss_pred             HHHHHHhcCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----------
Q 038681           47 EELRIATNNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        47 ~el~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----------  115 (332)
                      +++++..++|++.+.||+|+||.||+|.+ ++..||||++......  .+.|.+|+.++++++|||||++          
T Consensus        10 ~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~--~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~   87 (285)
T d1fmka3          10 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS--PEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIY   87 (285)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC--HHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred             cceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCC--HHHHHHHHHHHHhcccCCEeEEEEEEecCCeE
Confidence            34445567899999999999999999999 6678999999765433  4679999999999999999998          


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      +||||+++|+|..++.....   ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++++||+|||+|+
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~---~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~  161 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETG---KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLAR  161 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHH---TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC
T ss_pred             EEEEecCCCchhhhhhhccc---ccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhh
Confidence            89999999999999876522   46999999999999999999999   8999999999999999999999999999998


Q ss_pred             ccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchh
Q 038681          196 SIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFK  274 (332)
Q Consensus       196 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (332)
                      .......... ....||+.|+|||++.+ .++.++|||||||++|||++|..||........     ....+.       
T Consensus       162 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-----~~~~i~-------  228 (285)
T d1fmka3         162 LIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-----VLDQVE-------  228 (285)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-----HHHHHH-------
T ss_pred             hccCCCceee-ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH-----HHHHHH-------
Confidence            7654433222 45678999999999986 899999999999999999997666554332211     111110       


Q ss_pred             hhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          275 EMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                             ..   ...+.+..+++++.+|+.+||+.||++|||+++|++.|+....
T Consensus       229 -------~~---~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         229 -------RG---YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             -------TT---CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             -------hc---CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhc
Confidence                   00   0111222445789999999999999999999999998876543

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.2e-55  Score=381.11  Aligned_cols=238  Identities=22%  Similarity=0.325  Sum_probs=198.2

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--------hhhHHHHHHHHHHHHhhc-CCCcceE-------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--------QHALEWCINHIVYASRMS-HKHIIKL-------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--------~~~~~~~~~E~~~l~~l~-H~nIv~~-------  115 (332)
                      ++|++.+.||+|+||+||+|++  +++.||||++.....        ....+.+.+|+.++++++ |||||++       
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            5799999999999999999998  889999999876532        122456889999999997 9999998       


Q ss_pred             ----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeec
Q 038681          116 ----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDF  191 (332)
Q Consensus       116 ----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  191 (332)
                          ||||||++|+|.+++...     ..+++.+++.++.||+.||+|||   ++||+||||||+|||++.++.+||+||
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             cceEEEEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccc
Confidence                899999999999999876     67999999999999999999999   999999999999999999999999999


Q ss_pred             CCccccCCCCceeeccccccCCCcccccccCC-------CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHh
Q 038681          192 SLSLSIPDGETHIELDSVVGTTGFIAPENFTT-------LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVK  264 (332)
Q Consensus       192 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~  264 (332)
                      |+++........   ....||+.|+|||.+.+       .++.++||||+||++|||++|+.||...+......     .
T Consensus       155 G~a~~~~~~~~~---~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~-----~  226 (277)
T d1phka_         155 GFSCQLDPGEKL---REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR-----M  226 (277)
T ss_dssp             TTCEECCTTCCB---CCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH-----H
T ss_pred             hheeEccCCCce---eeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHH-----H
Confidence            999887654432   45679999999998752       46889999999999999999999998765433211     1


Q ss_pred             hhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          265 RLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                     ........+.+.....++++.+|+.+||+.||++|||++||++
T Consensus       227 ---------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         227 ---------------IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             ---------------HHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ---------------HHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                           1111111122222355688999999999999999999999875

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.3e-55  Score=389.15  Aligned_cols=232  Identities=20%  Similarity=0.313  Sum_probs=196.4

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|++.+.||+|+||+||+|++  +|+.||||++....  .....+.+.+|+.++++++|||||++           +||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            5799999999999999999998  78999999987542  22336789999999999999999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      |||+||+|..++...     ..+++..+..++.||+.||+|||   ++||+||||||+|||++.+|.+||+|||+|+...
T Consensus        84 E~~~gg~l~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~  155 (316)
T d1fota_          84 DYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP  155 (316)
T ss_dssp             CCCCSCBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             eecCCcccccccccc-----ccccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEec
Confidence            999999999999876     67899999999999999999999   9999999999999999999999999999998875


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ...     ....||+.|+|||++.+ .++.++|||||||++|||++|+.||...+......      .+           
T Consensus       156 ~~~-----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~i-----------  213 (316)
T d1fota_         156 DVT-----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYE------KI-----------  213 (316)
T ss_dssp             SCB-----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HH-----------
T ss_pred             ccc-----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHH------HH-----------
Confidence            543     45689999999999988 79999999999999999999999998755432211      11           


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAK  322 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~  322 (332)
                         ......    .+...++++.+++.+||+.||.+||     |++++++
T Consensus       214 ---~~~~~~----~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         214 ---LNAELR----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ---HHCCCC----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---HcCCCC----CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence               111111    1113347799999999999999996     8999875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=383.45  Aligned_cols=264  Identities=18%  Similarity=0.281  Sum_probs=195.8

Q ss_pred             cCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------------lv~  118 (332)
                      ..|.+.+.||+|+||.||+|+++|+.||||++......  ......|+..+.+++|||||++               +||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~~~--~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER--SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGGHH--HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccchh--HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            34677889999999999999999999999998654321  1223345555667899999997               899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhc-----CCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVG-----FSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                      ||+++|+|.+++.+.      .+++..++.++.|++.||+|||+.     ..++|+||||||+|||++.++.+||+|||+
T Consensus        81 Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          81 DYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             ECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             ecccCCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            999999999999764      589999999999999999999931     126999999999999999999999999999


Q ss_pred             ccccCCCCcee--eccccccCCCcccccccCC-------CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHh
Q 038681          194 SLSIPDGETHI--ELDSVVGTTGFIAPENFTT-------LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVK  264 (332)
Q Consensus       194 a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~  264 (332)
                      ++.........  ......||+.|+|||++.+       .++.++|||||||++|||+||..||...........     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~-----  229 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY-----  229 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT-----
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchh-----
Confidence            98775543322  1235679999999999875       257799999999999999999988865443322110     


Q ss_pred             hhhccccchhhhhhhhhhcccCC---CCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          265 RLSGQNCRFKEMVDSIIIEDKSC---TCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      .............+........+   ...........+.+|+.+||+.||++|||+.||++.|+++.++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         230 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            00011111111111111111111   1111235667899999999999999999999999999998764

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2e-54  Score=392.02  Aligned_cols=237  Identities=19%  Similarity=0.304  Sum_probs=191.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC--hhhHHHHHH---HHHHHHhhcCCCcceE----------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN--QHALEWCIN---HIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~---E~~~l~~l~H~nIv~~----------  115 (332)
                      .++|++.+.||+|+||.||+|++  +|+.||||++.....  ......+.+   |+.+++.++|||||++          
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~   82 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL   82 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence            36799999999999999999999  799999999864321  111233444   4666777789999997          


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCc
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLS  194 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  194 (332)
                       ||||||++|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.+|.+||+|||+|
T Consensus        83 ~ivmE~~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla  154 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA  154 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTC
T ss_pred             EEEEEecCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeecee
Confidence             899999999999999876     67899999999999999999999   999999999999999999999999999999


Q ss_pred             cccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      +.......    ....||+.|+|||++.+  .++.++|||||||++|||+||+.||..........   ........   
T Consensus       155 ~~~~~~~~----~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~---~~~~~~~~---  224 (364)
T d1omwa3         155 CDFSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE---IDRMTLTM---  224 (364)
T ss_dssp             EECSSSCC----CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHH---HHHHSSSC---
T ss_pred             eecCCCcc----cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHhcccC---
Confidence            87765433    45689999999999864  68999999999999999999999998655433211   11111111   


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT-----MVDVAK  322 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~  322 (332)
                                     ....+...++++.+||.+||+.||++|||     |+|+++
T Consensus       225 ---------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         225 ---------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             ---------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence                           11111234478999999999999999999     688764

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-54  Score=391.52  Aligned_cols=232  Identities=17%  Similarity=0.246  Sum_probs=196.2

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL-----------IVF  118 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~  118 (332)
                      ++|++.+.||+|+||.||+|++  +|+.||||++....  .....+.+.+|+.+|+.++|||||++           +||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            4799999999999999999998  79999999986532  22336779999999999999999998           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIP  198 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~  198 (332)
                      ||+.+|+|.+++...     ..+++..++.++.||+.||.|||   +++|+||||||+|||++.+|.+||+|||+|+...
T Consensus       121 e~~~~g~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~  192 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK  192 (350)
T ss_dssp             ECCTTCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             ccccccchhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeecc
Confidence            999999999999876     57999999999999999999999   9999999999999999999999999999998875


Q ss_pred             CCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhh
Q 038681          199 DGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMV  277 (332)
Q Consensus       199 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (332)
                      ...     ....||+.|+|||++.+ .++.++|||||||++|||+||..||........      ...+..         
T Consensus       193 ~~~-----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~~---------  252 (350)
T d1rdqe_         193 GRT-----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI------YEKIVS---------  252 (350)
T ss_dssp             SCB-----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHH---------
T ss_pred             ccc-----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHH------HHHHhc---------
Confidence            432     45689999999999988 899999999999999999999999986543221      111111         


Q ss_pred             hhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 038681          278 DSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRP-----TMVDVAK  322 (332)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~  322 (332)
                           ...    ..+...++++.+|+.+||+.||.+|+     |++++++
T Consensus       253 -----~~~----~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         253 -----GKV----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             -----CCC----CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             -----CCC----CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence                 111    01123447899999999999999994     8999875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-54  Score=387.81  Aligned_cols=239  Identities=20%  Similarity=0.263  Sum_probs=191.6

Q ss_pred             hcCCCCCC-ccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-------------
Q 038681           53 TNNYDEQN-IVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-------------  115 (332)
Q Consensus        53 ~~~y~~~~-~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-------------  115 (332)
                      .++|.+.. .||+|+||.||+|.+  +++.||||++...      ..+.+|+.++.++ +|||||++             
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            46798765 599999999999998  7899999998643      4577899997766 79999986             


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC---CCCeEEee
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE---QSDAKLFD  190 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~D  190 (332)
                        ||||||+||+|.+++....   ...+++.+++.++.||+.||+|||   ++||+||||||+|||++.   ++.+||+|
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~---~~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~D  157 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTD  157 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCS---CCCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred             EEEEEECCCCCcHHHHHHhcC---CCCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccc
Confidence              8999999999999997642   146999999999999999999999   999999999999999975   56799999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcc
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQ  269 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  269 (332)
                      ||+|+........   ....||+.|+|||++.+ .|+.++|||||||++|+|+||+.||.+.........  ....    
T Consensus       158 FG~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~--~~~~----  228 (335)
T d2ozaa1         158 FGFAKETTSHNSL---TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG--MKTR----  228 (335)
T ss_dssp             CTTCEECCCCCCC---CCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------C----
T ss_pred             cceeeeccCCCcc---ccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHH--HHHH----
Confidence            9999877654432   45689999999999988 899999999999999999999999976543322110  0000    


Q ss_pred             ccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          270 NCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                                ........+.+.....++++.+||.+||+.||++|||+.|+++
T Consensus       229 ----------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         229 ----------IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             ----------CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ----------HhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                      0011111111222345688999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-55  Score=381.22  Aligned_cols=246  Identities=23%  Similarity=0.383  Sum_probs=191.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEe---C--CeeEEEEEEcCCC--ChhhHHHHHHHHHHHHhhcCCCcceE----------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW---Q--KRSISLMKYNGNR--NQHALEWCINHIVYASRMSHKHIIKL----------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~---~--~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~H~nIv~~----------  115 (332)
                      .++|++.+.||+|+||.||+|++   +  ...||||++....  .....+.|.+|+.++++++|||||++          
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~   86 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMK   86 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchh
Confidence            35699999999999999999987   2  2468999987653  34446789999999999999999998          


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                      +||||+++|++.+++....    ..+++..++.++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+++
T Consensus        87 lv~e~~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             eeeeeecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhh
Confidence            8999999999999887652    46999999999999999999999   8999999999999999999999999999999


Q ss_pred             ccCCCCceee-ccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccchhhhHHHHhhhhccccc
Q 038681          196 SIPDGETHIE-LDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESRFHYEENVKRLSGQNCR  272 (332)
Q Consensus       196 ~~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  272 (332)
                      .......... .....||..|+|||++.+ .++.++|||||||++|||+| |..||...+..+..      ..+..    
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~------~~i~~----  229 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL------HKIDK----  229 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH------HHHHT----
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHH------HHHHh----
Confidence            8766543322 234467889999999987 89999999999999999998 89999866544321      11111    


Q ss_pred             hhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHH
Q 038681          273 FKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQM  327 (332)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l  327 (332)
                                ...  ..+.+..++..+.+|+.+||+.||++|||+++|.+.|.+.
T Consensus       230 ----------~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         230 ----------EGE--RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             ----------SCC--CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------CCC--CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                      100  1111224457899999999999999999999999988865

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=386.94  Aligned_cols=238  Identities=14%  Similarity=0.203  Sum_probs=196.3

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      .++|++.+.||+|+||+||+|.+  +++.||||.+......  ...+.+|+.+|+.++|||||++           ||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~--~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD--QVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH--HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc--HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            36799999999999999999998  7899999999876433  3568899999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC--CCeEEeecCCcccc
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ--SDAKLFDFSLSLSI  197 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl~Dfg~a~~~  197 (332)
                      ||+||+|.+++....    ..+++.++..++.||+.||+|||   ++||+||||||+|||++.+  +.+||+|||+++..
T Consensus        82 ~~~gg~L~~~i~~~~----~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~  154 (321)
T d1tkia_          82 FISGLDIFERINTSA----FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQL  154 (321)
T ss_dssp             CCCCCBHHHHHTSSS----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEEC
T ss_pred             cCCCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhcc
Confidence            999999999997651    36999999999999999999999   9999999999999999854  58999999999887


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      ......   ....+|+.|+|||.+.+ .++.++|||||||++|+|++|..||..........      .+.         
T Consensus       155 ~~~~~~---~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~------~i~---------  216 (321)
T d1tkia_         155 KPGDNF---RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE------NIM---------  216 (321)
T ss_dssp             CTTCEE---EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHH---------
T ss_pred             ccCCcc---cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHH------HHH---------
Confidence            655433   45678999999999987 89999999999999999999999998765433211      111         


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                           ......+.......++++.+|+.+||+.||.+|||++|+++
T Consensus       217 -----~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         217 -----NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -----HTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----hCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                 11110010011123477899999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-54  Score=382.31  Aligned_cols=253  Identities=21%  Similarity=0.297  Sum_probs=202.9

Q ss_pred             HHhcCCCCCCccccCCCceEEEEEe--C-------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----
Q 038681           51 IATNNYDEQNIVLEDPFRKLYKGFW--Q-------KRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----  115 (332)
Q Consensus        51 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----  115 (332)
                      +..++|++.+.||+|+||.||+|+.  .       +..||||++...........+.+|...+.++ +|||||++     
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            4557899999999999999999987  2       2469999998887777678899999999999 79999998     


Q ss_pred             ------EEEEeccCCChHHHHhhhhcc-----------cccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCe
Q 038681          116 ------IVFESVQIGTLADRIHHHCEQ-----------HFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNI  178 (332)
Q Consensus       116 ------lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Ni  178 (332)
                            +|||||++|+|.+++......           ....+++.+++.++.||+.||+|||   +++|+||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccce
Confidence                  899999999999999765311           1245899999999999999999999   99999999999999


Q ss_pred             eeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCccch
Q 038681          179 LFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSFESR  256 (332)
Q Consensus       179 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~~~~  256 (332)
                      |++.++.+||+|||+++...............||+.|+|||.+.+ .|+.++|||||||++|||++ |..||........
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~  246 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  246 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence            999999999999999987765544333355678999999999876 99999999999999999998 6888876554321


Q ss_pred             hhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          257 FHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                            ...+..               ..  ..+.+...++++.+|+.+||+.||++|||+.||++.|+++..
T Consensus       247 ------~~~i~~---------------~~--~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         247 ------FKLLKE---------------GH--RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             ------HHHHHT---------------TC--CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------HHHHHc---------------CC--CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence                  111110               00  111112344789999999999999999999999999999864

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-54  Score=382.91  Aligned_cols=249  Identities=20%  Similarity=0.261  Sum_probs=196.5

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCe--eEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE-----------E
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKR--SISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL-----------I  116 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~-----------l  116 (332)
                      .++|++.+.||+|+||.||+|.+  ++.  .||||++.........+.+.+|+.+|+++ +|||||++           +
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            36788899999999999999999  454  57888887665555577899999999999 79999998           8


Q ss_pred             EEEeccCCChHHHHhhhh-----------cccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCC
Q 038681          117 VFESVQIGTLADRIHHHC-----------EQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD  185 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~-----------~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~  185 (332)
                      ||||+++|+|.+++....           ......+++..+..++.||+.||.|||   +++|+||||||+|||++.++.
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGC
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCc
Confidence            999999999999997541           122356999999999999999999999   999999999999999999999


Q ss_pred             eEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCc-cCCCCCccchhhhHHHH
Q 038681          186 AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQE-VSDHVSFESRFHYEENV  263 (332)
Q Consensus       186 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~-p~~~~~~~~~~~~~~~~  263 (332)
                      +||+|||+|+........   ....||..|+|||.+.+ .++.++|||||||++|||++|.. ||...+....      .
T Consensus       166 ~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~------~  236 (309)
T d1fvra_         166 AKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------Y  236 (309)
T ss_dssp             EEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------H
T ss_pred             eEEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHH------H
Confidence            999999999765543322   34568999999999976 89999999999999999999764 6665443221      1


Q ss_pred             hhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          264 KRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      ..+.              .. .  ..+.+..+++++.+||.+||+.||++|||++||++.|+++.+.
T Consensus       237 ~~i~--------------~~-~--~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         237 EKLP--------------QG-Y--RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             HHGG--------------GT-C--CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHH--------------hc-C--CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            1111              00 0  1111224457899999999999999999999999999998753

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-54  Score=382.28  Aligned_cols=258  Identities=20%  Similarity=0.321  Sum_probs=209.6

Q ss_pred             HHHHHhcCCCCCCccccCCCceEEEEEe-------CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhh-cCCCcceE----
Q 038681           48 ELRIATNNYDEQNIVLEDPFRKLYKGFW-------QKRSISLMKYNGNRNQHALEWCINHIVYASRM-SHKHIIKL----  115 (332)
Q Consensus        48 el~~~~~~y~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~H~nIv~~----  115 (332)
                      .++...++|++.+.||+|+||.||+|++       .++.||||++...........+.+|+.+++++ +|||||++    
T Consensus        17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~   96 (311)
T d1t46a_          17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (311)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence            3455567899999999999999999986       45689999998877666677899999999999 69999998    


Q ss_pred             -------EEEEeccCCChHHHHhhhhc-------------ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCC
Q 038681          116 -------IVFESVQIGTLADRIHHHCE-------------QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKP  175 (332)
Q Consensus       116 -------lv~e~~~~g~L~~~l~~~~~-------------~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp  175 (332)
                             ||||||++|+|.+++.....             .....+++..+..++.||+.||+|||   +++|+||||||
T Consensus        97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp  173 (311)
T d1t46a_          97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAA  173 (311)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSG
T ss_pred             eeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccccc
Confidence                   89999999999999986532             12236899999999999999999999   99999999999


Q ss_pred             CCeeeCCCCCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHh-CCccCCCCCc
Q 038681          176 TNILFNEQSDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLT-AQEVSDHVSF  253 (332)
Q Consensus       176 ~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~ellt-g~~p~~~~~~  253 (332)
                      +||+++.++.+||+|||.++...............||+.|+|||++.+ .++.++|||||||++|||+| |.+||...+.
T Consensus       174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~  253 (311)
T d1t46a_         174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV  253 (311)
T ss_dssp             GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred             ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999998776555444456789999999999986 89999999999999999999 5555555443


Q ss_pred             cchhhhHHHHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          254 ESRFHYEENVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                      .+..     ..           .+....      ....+...+..+.+||.+||+.||.+|||+++|++.|+++..+
T Consensus       254 ~~~~-----~~-----------~i~~~~------~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         254 DSKF-----YK-----------MIKEGF------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             SHHH-----HH-----------HHHHTC------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHH-----HH-----------HHhcCC------CCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            2221     11           111100      1111123457899999999999999999999999999987654

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=385.71  Aligned_cols=257  Identities=18%  Similarity=0.308  Sum_probs=209.8

Q ss_pred             HHHHHHhcCCCCCCccccCCCceEEEEEeC-------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE----
Q 038681           47 EELRIATNNYDEQNIVLEDPFRKLYKGFWQ-------KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL----  115 (332)
Q Consensus        47 ~el~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~----  115 (332)
                      ++|++..++|.+.+.||+|+||+||+|.+.       +..||||++...........+.+|+.++++++|||||++    
T Consensus        13 ~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~   92 (308)
T d1p4oa_          13 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV   92 (308)
T ss_dssp             CTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE
T ss_pred             cceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEE
Confidence            356666788999999999999999999873       468999999877666667789999999999999999998    


Q ss_pred             -------EEEEeccCCChHHHHhhhhc-----ccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCC
Q 038681          116 -------IVFESVQIGTLADRIHHHCE-----QHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQ  183 (332)
Q Consensus       116 -------lv~e~~~~g~L~~~l~~~~~-----~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~  183 (332)
                             +||||+++|+|.+++.....     .....+++..+..++.|++.||.|||   +++|+||||||+|||++.+
T Consensus        93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~  169 (308)
T d1p4oa_          93 SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAED  169 (308)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTT
T ss_pred             ecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCC
Confidence                   89999999999999976422     12234789999999999999999999   8999999999999999999


Q ss_pred             CCeEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCC-ccCCCCCccchhhhHH
Q 038681          184 SDAKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQ-EVSDHVSFESRFHYEE  261 (332)
Q Consensus       184 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~-~p~~~~~~~~~~~~~~  261 (332)
                      +++||+|||+|+...............||+.|+|||.+.+ .++.++|||||||++|||+||. .||......+...   
T Consensus       170 ~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~---  246 (308)
T d1p4oa_         170 FTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR---  246 (308)
T ss_dssp             CCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH---
T ss_pred             ceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH---
Confidence            9999999999987765554444455678999999999887 8999999999999999999985 6676544332211   


Q ss_pred             HHhhhhccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          262 NVKRLSGQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                         .+..              ..   ..+.+..+++.+.+|+.+||+.||++|||+++|++.|++..+
T Consensus       247 ---~i~~--------------~~---~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         247 ---FVME--------------GG---LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             ---HHHT--------------TC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ---HHHh--------------CC---CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence               1100              00   011112344789999999999999999999999999987654

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-54  Score=384.69  Aligned_cols=235  Identities=22%  Similarity=0.324  Sum_probs=194.6

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC--ChhhHHHHHHHHHHHH-hhcCCCcceE-----------EE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR--NQHALEWCINHIVYAS-RMSHKHIIKL-----------IV  117 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~H~nIv~~-----------lv  117 (332)
                      ++|++.+.||+|+||+||+|.+  +++.||||++....  .....+.+..|..++. .++|||||++           ||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5799999999999999999999  89999999997542  2233567788888776 5799999998           89


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCcccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSI  197 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~  197 (332)
                      ||||++|+|.+++...     ..+++.+++.++.||+.||+|||   +++|+||||||+|||++.++.+||+|||+++..
T Consensus        82 mEy~~~g~L~~~i~~~-----~~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~  153 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  153 (320)
T ss_dssp             EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EeecCCCcHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhc
Confidence            9999999999999876     67999999999999999999999   999999999999999999999999999999876


Q ss_pred             CCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhh
Q 038681          198 PDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEM  276 (332)
Q Consensus       198 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (332)
                      .......  ....||+.|+|||++.+ .++.++|||||||++|||++|+.||.+.+.....      ..+......    
T Consensus       154 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~------~~i~~~~~~----  221 (320)
T d1xjda_         154 MLGDAKT--NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------HSIRMDNPF----  221 (320)
T ss_dssp             CCTTCCB--CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHHCCCC----
T ss_pred             ccccccc--cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHH------HHHHcCCCC----
Confidence            5443321  45689999999999998 8999999999999999999999999876543321      111111111    


Q ss_pred             hhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 038681          277 VDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMV-DVAK  322 (332)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~-evl~  322 (332)
                                    .+...++++.+|+.+||+.||.+|||+. ++++
T Consensus       222 --------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         222 --------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             --------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             --------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence                          1113347799999999999999999985 6753

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=378.17  Aligned_cols=244  Identities=18%  Similarity=0.294  Sum_probs=197.3

Q ss_pred             CCccccCCCceEEEEEe-C----CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE------------EEEEec
Q 038681           59 QNIVLEDPFRKLYKGFW-Q----KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------------IVFESV  121 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~-~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~------------lv~e~~  121 (332)
                      .++||+|+||+||+|++ .    ...||||++.........+.|.+|++++++++|||||++            +|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46799999999999998 2    235899999876667668899999999999999999997            899999


Q ss_pred             cCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCCC
Q 038681          122 QIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDGE  201 (332)
Q Consensus       122 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~  201 (332)
                      ++|+|.+++....    ..+++..++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++......
T Consensus       112 ~~g~l~~~~~~~~----~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         112 KHGDLRNFIRNET----HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             TTCBHHHHHHCTT----CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             ecCchhhhhcccc----ccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            9999999987652    45788999999999999999999   9999999999999999999999999999998765443


Q ss_pred             cee--eccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccchhhhhh
Q 038681          202 THI--ELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRFKEMVD  278 (332)
Q Consensus       202 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (332)
                      ...  ......||+.|+|||.+.+ .++.++||||||+++|||+||..||........     ....+..          
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~-----~~~~i~~----------  249 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITVYLLQ----------  249 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHHHHT----------
T ss_pred             cccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH-----HHHHHHc----------
Confidence            221  1234578999999999876 899999999999999999998888765332211     1111110          


Q ss_pred             hhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHhh
Q 038681          279 SIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRSC  331 (332)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~~  331 (332)
                          ..   ....+..+++.+.+|+.+||+.||++|||+.||++.|+++++++
T Consensus       250 ----g~---~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~  295 (311)
T d1r0pa_         250 ----GR---RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF  295 (311)
T ss_dssp             ----TC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             ----CC---CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhh
Confidence                00   01111234478999999999999999999999999999998764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=377.82  Aligned_cols=253  Identities=21%  Similarity=0.205  Sum_probs=187.9

Q ss_pred             CCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChh----hHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           58 EQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQH----ALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        58 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~----~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      .+++||+|+||+||+|.+  +|+.||||++.......    ..+.+.+|+.++++++|||||++           |||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            356899999999999998  78999999987553221    13468899999999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      ++++++..+....     ..+++..+..++.||+.||+|||   ++||+||||||+|||++.++.+||+|||+|+.....
T Consensus        82 ~~~~~~~~~~~~~-----~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~  153 (299)
T d1ua2a_          82 METDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  153 (299)
T ss_dssp             CSEEHHHHHTTCC-----SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             hcchHHhhhhhcc-----cCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCC
Confidence            9988777666543     56999999999999999999999   999999999999999999999999999999876554


Q ss_pred             CceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-cccchhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-QNCRFKEMV  277 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  277 (332)
                      ....  ....||+.|+|||++.+  .++.++|||||||++|||++|..||......+...  ........ ....+....
T Consensus       154 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~--~i~~~~~~~~~~~~~~~~  229 (299)
T d1ua2a_         154 NRAY--THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT--RIFETLGTPTEEQWPDMC  229 (299)
T ss_dssp             CCCC--CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCTTTSSSTT
T ss_pred             cccc--cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHH--HHHHhcCCCChhhccchh
Confidence            3321  35679999999999865  68999999999999999999999998766544321  11111111 000011000


Q ss_pred             hhhhhccc-CCCCCC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 DSIIIEDK-SCTCTG----KEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~~~~~~~~-~~~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ........ ..+...    ....++++.+|+.+||+.||++||||+|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00000000 000000    0123478999999999999999999999985

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-53  Score=371.91  Aligned_cols=258  Identities=18%  Similarity=0.241  Sum_probs=192.1

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      ++|++.+.||+|+||+||+|.+  +++.||||++..... ....+.+.+|+.++++++|||||++           +|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5799999999999999999999  789999999976542 2335778999999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      |+.+ ++.+++....   ...+++..+..++.||+.||+|||   ++|||||||||+|||++.++.+||+|||+|+....
T Consensus        82 ~~~~-~~~~~~~~~~---~~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~  154 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASA---LTGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV  154 (298)
T ss_dssp             CCSE-EHHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred             ecCC-chhhhhhhhc---ccCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccC
Confidence            9976 4555554331   246999999999999999999999   99999999999999999999999999999987655


Q ss_pred             CCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc-cchhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN-CRFKEM  276 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  276 (332)
                      ....  .....||+.|+|||++..  .++.++|||||||++|+|++|+.||...+......  .......... ..+...
T Consensus       155 ~~~~--~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~--~i~~~~~~~~~~~~~~~  230 (298)
T d1gz8a_         155 PVRT--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF--RIFRTLGTPDEVVWPGV  230 (298)
T ss_dssp             CSBC--TTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCCTTTSTTG
T ss_pred             Cccc--ceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHH--HHHHhcCCCchhhcccc
Confidence            4332  245689999999998776  56899999999999999999999998765433221  1111111111 001110


Q ss_pred             hhh-hhhccc-CCCCC----ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDS-IIIEDK-SCTCT----GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~-~~~~~~-~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ... ...... .....    .....++++.+|+.+||+.||++|||++|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            000 000000 00000    00133478899999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=5.8e-53  Score=371.25  Aligned_cols=257  Identities=17%  Similarity=0.218  Sum_probs=193.6

Q ss_pred             cCCCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE-----------EEEEe
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL-----------IVFES  120 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e~  120 (332)
                      ++|++.+.||+|+||+||+|++ +|+.||||++..... ....+.+.+|+.++++++|||||++           +++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5799999999999999999999 789999999976542 3336789999999999999999998           89999


Q ss_pred             ccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCCC
Q 038681          121 VQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPDG  200 (332)
Q Consensus       121 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~  200 (332)
                      +.++.+..+....     ..+++..+..++.||+.||+|||   +++|+||||||+|||++.++.+||+|||.|......
T Consensus        82 ~~~~~~~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~  153 (286)
T d1ob3a_          82 LDQDLKKLLDVCE-----GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP  153 (286)
T ss_dssp             CSEEHHHHHHTST-----TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred             ehhhhHHHHHhhc-----CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccC
Confidence            9887776666544     57999999999999999999999   899999999999999999999999999999876544


Q ss_pred             CceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc-cccchhhhh
Q 038681          201 ETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG-QNCRFKEMV  277 (332)
Q Consensus       201 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  277 (332)
                      ...  .....+++.|+|||.+.+  .++.++|||||||++|||++|+.||......+...  ........ ....+....
T Consensus       154 ~~~--~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~--~i~~~~~~~~~~~~~~~~  229 (286)
T d1ob3a_         154 VRK--YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM--RIFRILGTPNSKNWPNVT  229 (286)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCCCCTTTSTTGG
T ss_pred             ccc--cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHH--HHHHhhCCCChhhccchh
Confidence            322  134578999999999876  67999999999999999999999998765433321  11111111 011111110


Q ss_pred             hh-----hhh-cccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          278 DS-----III-EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       278 ~~-----~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ..     ... .............++.+.+|+.+||+.||++|||++|+++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00     000 0000001111234578999999999999999999999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-53  Score=370.75  Aligned_cols=228  Identities=20%  Similarity=0.305  Sum_probs=187.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCCh-----hhHHHHHHHHHHHHhhc--CCCcceE--------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQ-----HALEWCINHIVYASRMS--HKHIIKL--------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-----~~~~~~~~E~~~l~~l~--H~nIv~~--------  115 (332)
                      .++|++.+.||+|+||+||+|++  +|+.||||++......     ....++.+|+.++++++  |||||++        
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            35799999999999999999999  7899999998754211     11234678999999996  8999998        


Q ss_pred             ---EEEEeccC-CChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC-CCCeEEee
Q 038681          116 ---IVFESVQI-GTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE-QSDAKLFD  190 (332)
Q Consensus       116 ---lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~D  190 (332)
                         +||||+.+ +++.+++...     ..+++.+++.++.||+.||+|||   +++|+||||||+|||++. ++.+||+|
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~D  154 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLID  154 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECC
T ss_pred             eEEEEEEeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECc
Confidence               89999975 6888888776     57999999999999999999999   999999999999999985 47899999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG  268 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  268 (332)
                      ||+|+.......    ....||+.|+|||++.+  .++.++|||||||++|||++|+.||.....        .   ...
T Consensus       155 FG~a~~~~~~~~----~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~--------i---~~~  219 (273)
T d1xwsa_         155 FGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------I---IRG  219 (273)
T ss_dssp             CTTCEECCSSCB----CCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------H---HHC
T ss_pred             cccceecccccc----cccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH--------H---hhc
Confidence            999987654432    45689999999999875  457789999999999999999999975311        0   000


Q ss_pred             cccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          269 QNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                       ...                  .+...++++.+|+.+||+.||++|||++|+++
T Consensus       220 -~~~------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         220 -QVF------------------FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             -CCC------------------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -ccC------------------CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence             000                  01123478999999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=373.02  Aligned_cols=258  Identities=19%  Similarity=0.227  Sum_probs=191.1

Q ss_pred             hcCCCCCCccccCCCceEEEEEe---CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhh---cCCCcceE----------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW---QKRSISLMKYNGNRN-QHALEWCINHIVYASRM---SHKHIIKL----------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l---~H~nIv~~----------  115 (332)
                      .++|++.+.||+|+||+||+|++   .++.||||++..... ......+.+|+.+++.|   +||||+++          
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999998   367799999865432 22233466788887776   79999986          


Q ss_pred             ------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEe
Q 038681          116 ------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLF  189 (332)
Q Consensus       116 ------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~  189 (332)
                            ++|||+++|++.......    ...+++..++.++.||+.||+|||   +++|+||||||+|||++.++.+||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~~----~~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~  158 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKVP----EPGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLA  158 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHSC----TTCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCceEEEEEEeccCCchhhhhhcc----CCCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeec
Confidence                  799999987665444332    256899999999999999999999   9999999999999999999999999


Q ss_pred             ecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhc
Q 038681          190 DFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSG  268 (332)
Q Consensus       190 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~  268 (332)
                      |||+++.......   .....||+.|+|||++.+ .|+.++||||+||++|||++|+.||......+...  ........
T Consensus       159 dfg~~~~~~~~~~---~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~--~i~~~~~~  233 (305)
T d1blxa_         159 DFGLARIYSFQMA---LTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG--KILDVIGL  233 (305)
T ss_dssp             SCCSCCCCCGGGG---GCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH--HHHHHHCC
T ss_pred             chhhhhhhccccc---CCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH--HHHHhhCC
Confidence            9999976544332   256789999999999987 89999999999999999999999998765443321  11111111


Q ss_pred             -cccchhhhh---hhhhhc-ccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          269 -QNCRFKEMV---DSIIIE-DKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       269 -~~~~~~~~~---~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                       ....+....   ...... ............++.+.+|+.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence             000010000   000000 000001111234578899999999999999999999976

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-52  Score=373.50  Aligned_cols=258  Identities=18%  Similarity=0.232  Sum_probs=194.8

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------------E
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------------I  116 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------------l  116 (332)
                      ++|++.++||+|+||+||+|.+  +|+.||||++.........+.+.+|+.+|++++||||+++               +
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            5699999999999999999998  7999999999876666667889999999999999999976               5


Q ss_pred             EEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccc
Q 038681          117 VFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLS  196 (332)
Q Consensus       117 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~  196 (332)
                      +++|+.+|+|.+++...      .+++..++.++.||+.||+|||   ++||+||||||+|||++.++.+||+|||+|+.
T Consensus        88 l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~  158 (345)
T d1pmea_          88 LVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARV  158 (345)
T ss_dssp             EEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEeecCCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceee
Confidence            67788899999999653      6999999999999999999999   99999999999999999999999999999976


Q ss_pred             cCCCCce-eeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccccch
Q 038681          197 IPDGETH-IELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNCRF  273 (332)
Q Consensus       197 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (332)
                      ....... .......||+.|+|||++..  .++.++||||+||++|||++|+.||............  ...........
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~  236 (345)
T d1pmea_         159 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI--LGILGSPSQED  236 (345)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCSCCHHH
T ss_pred             ccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHH--hhhccCCChhh
Confidence            6443221 11245679999999999854  7899999999999999999999999876554332211  11010000000


Q ss_pred             -h-----hhhhhhhhcccCCCCC---ChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          274 -K-----EMVDSIIIEDKSCTCT---GKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       274 -~-----~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                       .     ...............+   .....+.++.+|+.+||+.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             0     0000000000000000   00123467899999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=370.97  Aligned_cols=253  Identities=20%  Similarity=0.251  Sum_probs=188.3

Q ss_pred             CCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE-----------------
Q 038681           55 NYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL-----------------  115 (332)
Q Consensus        55 ~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~-----------------  115 (332)
                      +|...++||+|+||+||+|++  +|+.||||++......     ..+|+.+|++++|||||++                 
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~   95 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN   95 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEE
Confidence            488889999999999999999  7899999999765432     3479999999999999986                 


Q ss_pred             EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC-CeEEeecCCc
Q 038681          116 IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS-DAKLFDFSLS  194 (332)
Q Consensus       116 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a  194 (332)
                      ||||||++|. .+.+..... ....+++.+++.++.||+.||+|||   ++||+||||||+|||++.++ .+||+|||++
T Consensus        96 lv~Ey~~~~~-~~~l~~~~~-~~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a  170 (350)
T d1q5ka_          96 LVLDYVPETV-YRVARHYSR-AKQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSA  170 (350)
T ss_dssp             EEEECCSEEH-HHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTC
T ss_pred             EEEeccCCcc-HHHHHhhhh-ccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccch
Confidence            7999998754 444432211 1256999999999999999999999   99999999999999999775 8999999999


Q ss_pred             cccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc-
Q 038681          195 LSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC-  271 (332)
Q Consensus       195 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  271 (332)
                      +........   .+..||+.|+|||.+.+  .++.++||||+||++|||++|..||......+...  ........... 
T Consensus       171 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~--~i~~~~g~~~~~  245 (350)
T d1q5ka_         171 KQLVRGEPN---VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV--EIIKVLGTPTRE  245 (350)
T ss_dssp             EECCTTSCC---CSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHH--HHHHHHCCCCHH
T ss_pred             hhccCCccc---ccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHH--HHHHHhCCChHH
Confidence            877654432   45689999999998765  78999999999999999999999998765443211  11111111000 


Q ss_pred             chhhhhhhhhhcccC------CCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          272 RFKEMVDSIIIEDKS------CTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       272 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .+.............      .........++++.+|+.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            001000000000000      000011234578999999999999999999999985

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-51  Score=369.38  Aligned_cols=253  Identities=17%  Similarity=0.201  Sum_probs=189.8

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE--------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL--------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~--------------  115 (332)
                      .++|++.+.||+|+||+||+|.+  +|+.||||++.... .....+.+.+|+.+|++++|||||++              
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46799999999999999999998  79999999997653 34446789999999999999999985              


Q ss_pred             ---EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecC
Q 038681          116 ---IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFS  192 (332)
Q Consensus       116 ---lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg  192 (332)
                         +||||+ +++|..++..      ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|||
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg  166 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFG  166 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             eEEEEEecc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccc
Confidence               899999 5578777654      46999999999999999999999   9999999999999999999999999999


Q ss_pred             CccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc
Q 038681          193 LSLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       193 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      +|+......     ....||+.|+|||++.+  .++.++||||+||++|+|++|+.||...........  .........
T Consensus       167 ~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~--~~~~~~~~~  239 (346)
T d1cm8a_         167 LARQADSEM-----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE--IMKVTGTPP  239 (346)
T ss_dssp             TCEECCSSC-----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHHHHCCCC
T ss_pred             ceeccCCcc-----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHH--HHhccCCCc
Confidence            998765543     45679999999999865  678999999999999999999999987654433211  111111110


Q ss_pred             cchhh--------hhhhhhhcc-cCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          271 CRFKE--------MVDSIIIED-KSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       271 ~~~~~--------~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ..+..        ......... ...........++.+.+||.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00000        000000000 00000111234577899999999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-51  Score=363.69  Aligned_cols=260  Identities=17%  Similarity=0.175  Sum_probs=191.6

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCC-hhhHHHHHHHHHHHHhhcCCCcceE--------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRN-QHALEWCINHIVYASRMSHKHIIKL--------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~H~nIv~~--------------  115 (332)
                      .++|++.++||+|+||+||+|++  +|+.||||++..... ......+.+|+.+|++++||||+++              
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            47899999999999999999998  789999999865432 3345778999999999999999986              


Q ss_pred             -----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEee
Q 038681          116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFD  190 (332)
Q Consensus       116 -----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  190 (332)
                           +||||++++++..+....     ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~-----~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~d  160 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVL-----VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLAD  160 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTT-----CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECC
T ss_pred             CceEEEEEeccCCCccchhhhcc-----cccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeee
Confidence                 799999887666554433     57999999999999999999999   99999999999999999999999999


Q ss_pred             cCCccccCCCCce--eeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhh
Q 038681          191 FSLSLSIPDGETH--IELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRL  266 (332)
Q Consensus       191 fg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~  266 (332)
                      ||+++........  .......||+.|+|||++.+  .++.++|||||||++|||++|+.||.+.........  .....
T Consensus       161 fg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~--i~~~~  238 (318)
T d3blha1         161 FGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL--ISQLC  238 (318)
T ss_dssp             CTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--HHHHH
T ss_pred             cceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHH--HHHhc
Confidence            9999766543221  11234579999999999875  689999999999999999999999987654333221  11111


Q ss_pred             hccccchhhhhhh-----hhhcccCCCCCCh-----HHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          267 SGQNCRFKEMVDS-----IIIEDKSCTCTGK-----EQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       267 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ...........+.     .............     ...++.+.+||.+||+.||++|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            1111111000000     0000000000000     122457789999999999999999999985

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-50  Score=358.15  Aligned_cols=249  Identities=17%  Similarity=0.212  Sum_probs=191.2

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE------------EEEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL------------IVFE  119 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~------------lv~e  119 (332)
                      ++|++.+.||+|+||.||+|++  +|+.||||++......   +.+..|+++++.++|+|+|..            +|||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH---PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS---CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC---HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            4699999999999999999998  7899999998765432   347889999999988776543            7999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeC---CCCCeEEeecCCccc
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFN---EQSDAKLFDFSLSLS  196 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~a~~  196 (332)
                      |+. |+|.+.+....    ..+++..+..++.|++.||+|||   +++|+||||||+|||++   .+..+||+|||+|+.
T Consensus        84 ~~~-~~l~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~  155 (299)
T d1ckia_          84 LLG-PSLEDLFNFCS----RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  155 (299)
T ss_dssp             CCC-CBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEE
T ss_pred             EcC-Cchhhhhhhcc----CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCccee
Confidence            995 57777665431    56999999999999999999999   99999999999999975   455799999999987


Q ss_pred             cCCCCce-----eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc
Q 038681          197 IPDGETH-----IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       197 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      .......     .......||+.|+|||++.+ .++.++|||||||++|||++|..||................... ..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~-~~  234 (299)
T d1ckia_         156 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-MS  234 (299)
T ss_dssp             CBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHH-HH
T ss_pred             ccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhccc-CC
Confidence            7543321     11245679999999999998 89999999999999999999999998765443322110000000 00


Q ss_pred             cchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHH
Q 038681          271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYR  329 (332)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~  329 (332)
                      ......               ...+++++.+|+..||+.||++||+++++.+.|+.++.
T Consensus       235 ~~~~~~---------------~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         235 TPIEVL---------------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             SCHHHH---------------TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             CChhHh---------------ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            000000               01334789999999999999999999999999988764

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=355.84  Aligned_cols=258  Identities=16%  Similarity=0.188  Sum_probs=197.2

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE-----------EEEE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL-----------IVFE  119 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~-----------lv~e  119 (332)
                      ++|++.+.||+|+||+||+|++  +++.||||+++... .....+.+.+|+.++++++|||||++           +|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5799999999999999999999  78899999997654 34457889999999999999999998           8999


Q ss_pred             eccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCCccccCC
Q 038681          120 SVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSLSIPD  199 (332)
Q Consensus       120 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~  199 (332)
                      ++.+++|..++...     ..+++..+..++.|++.||+|||   +++|+||||||+|||++.++.+||+|||.|+....
T Consensus        82 ~~~~~~l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~  153 (292)
T d1unla_          82 FCDQDLKKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI  153 (292)
T ss_dssp             CCSEEHHHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             eccccccccccccc-----cccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccC
Confidence            99999998887765     67899999999999999999999   99999999999999999999999999999987765


Q ss_pred             CCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc-cchhhh
Q 038681          200 GETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN-CRFKEM  276 (332)
Q Consensus       200 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  276 (332)
                      .....  ....+++.|+|||++.+  .++.++|||||||++|||++|+.||......... ............ ..+...
T Consensus       154 ~~~~~--~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  230 (292)
T d1unla_         154 PVRCY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ-LKRIFRLLGTPTEEQWPSM  230 (292)
T ss_dssp             CCSCC--CSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH-HHHHHHHHCCCCTTTCTTG
T ss_pred             CCccc--eeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH-HHHHHhhcCCCChhhhhhh
Confidence            44322  34567889999999876  5799999999999999999999997543322211 111111111111 011100


Q ss_pred             hhhhh------hcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          277 VDSII------IEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       277 ~~~~~------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      .....      ..............++.+.+|+.+||+.||.+||||+|+++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             GGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000      00000011112244578899999999999999999999975

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.2e-50  Score=363.22  Aligned_cols=250  Identities=16%  Similarity=0.220  Sum_probs=192.1

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc-CCCcceE-------------EE
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMS-HKHIIKL-------------IV  117 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-H~nIv~~-------------lv  117 (332)
                      ++|++.++||+|+||+||+|++  +++.||||+++...    .+.+.+|+.+|.+++ ||||+++             +|
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            5799999999999999999999  79999999997543    467889999999995 9999997             79


Q ss_pred             EEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCC-CeEEeecCCccc
Q 038681          118 FESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQS-DAKLFDFSLSLS  196 (332)
Q Consensus       118 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~  196 (332)
                      ||||++|+|..+.        ..+++..++.++.||+.||+|||   ++||+||||||+|||++.++ .+||+|||+|+.
T Consensus       111 ~e~~~~~~L~~~~--------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~  179 (328)
T d3bqca1         111 FEHVNNTDFKQLY--------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  179 (328)
T ss_dssp             EECCCSCBGGGTT--------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred             EeecCCCcHHHHh--------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeeccccccee
Confidence            9999999997764        35899999999999999999999   99999999999999998665 589999999987


Q ss_pred             cCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhh-------
Q 038681          197 IPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS-------  267 (332)
Q Consensus       197 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~-------  267 (332)
                      .......   ....+|+.|+|||.+.+  .++.++||||+||++|||++|+.||.......... ......+.       
T Consensus       180 ~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~-~~i~~~~g~~~~~~~  255 (328)
T d3bqca1         180 YHPGQEY---NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL-VRIAKVLGTEDLYDY  255 (328)
T ss_dssp             CCTTCCC---CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH-HHHHHHHCHHHHHHH
T ss_pred             ccCCCcc---cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHH-HHHHHHHCCchhhhh
Confidence            7655432   45679999999999876  58999999999999999999999997654432111 00111100       


Q ss_pred             --c----cccchhhhhhhhhh--cccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          268 --G----QNCRFKEMVDSIII--EDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       268 --~----~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                        .    ....+.........  .............++++.+||.+||+.||++|||++|+++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              0    00000000000000  0000111122345678999999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=366.60  Aligned_cols=240  Identities=17%  Similarity=0.235  Sum_probs=194.0

Q ss_pred             cCCCCCCccccCCCceEEEEEe-----CCeeEEEEEEcCCC---ChhhHHHHHHHHHHHHhhcC-CCcceE---------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW-----QKRSISLMKYNGNR---NQHALEWCINHIVYASRMSH-KHIIKL---------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~H-~nIv~~---------  115 (332)
                      ++|++.+.||+|+||+||+|..     +|+.||||.+....   .....+.+.+|+.++++++| |||+++         
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6699999999999999999987     47899999987542   22235668899999999987 899998         


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        +||||+.+|+|.+++...     ..+++..+..++.||+.||.|||   +++|+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~-----~~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~  175 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGL  175 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             eeeeeecccccHHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccc
Confidence              899999999999999877     57899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccccCCCcccccccCC---CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhccc
Q 038681          194 SLSIPDGETHIELDSVVGTTGFIAPENFTT---LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQN  270 (332)
Q Consensus       194 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  270 (332)
                      |+.......... ....||+.|+|||.+.+   .++.++|||||||+||||++|+.||...........  .....    
T Consensus       176 a~~~~~~~~~~~-~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~--i~~~~----  248 (322)
T d1vzoa_         176 SKEFVADETERA-YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE--ISRRI----  248 (322)
T ss_dssp             EEECCGGGGGGG-CGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHH--HHHHH----
T ss_pred             hhhhcccccccc-cccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHHhc----
Confidence            987655433322 45689999999999865   578899999999999999999999987654433211  11100    


Q ss_pred             cchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 038681          271 CRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT-----MVDVAK  322 (332)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~  322 (332)
                                ...    ..+.+...++++.+|+.+||++||++|||     ++|+++
T Consensus       249 ----------~~~----~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         249 ----------LKS----EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ----------HHC----CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ----------ccC----CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                      000    11112245588999999999999999994     788875

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.4e-49  Score=347.95  Aligned_cols=251  Identities=14%  Similarity=0.180  Sum_probs=196.7

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcC-CCcceE-----------EEE
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSH-KHIIKL-----------IVF  118 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-~nIv~~-----------lv~  118 (332)
                      .++|++.+.||+|+||+||+|++  +|+.||||++......   ..+.+|++++..++| +||+.+           +||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA---PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS---CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc---HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            36799999999999999999998  7899999998665432   346788899999865 788776           899


Q ss_pred             EeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCC-----CCCeEEeecCC
Q 038681          119 ESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNE-----QSDAKLFDFSL  193 (332)
Q Consensus       119 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-----~~~~kl~Dfg~  193 (332)
                      ||+ +|+|.+++....    ..+++..+..++.|++.||+|||   ++||+||||||+|||++.     ++.+||+|||+
T Consensus        81 e~~-~~~l~~~~~~~~----~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~  152 (293)
T d1csna_          81 DLL-GPSLEDLLDLCG----RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  152 (293)
T ss_dssp             ECC-CCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             Eec-CCCHHHHHHhhc----cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccce
Confidence            999 679999987652    46999999999999999999999   999999999999999974     57899999999


Q ss_pred             ccccCCCCce-----eeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhh
Q 038681          194 SLSIPDGETH-----IELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLS  267 (332)
Q Consensus       194 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~  267 (332)
                      |+........     .......||+.|+|||++.+ .++.++|||||||++|||++|..||...................
T Consensus       153 a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~  232 (293)
T d1csna_         153 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  232 (293)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             eEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhcc
Confidence            9876543211     11245679999999999988 89999999999999999999999998665443322111110000


Q ss_pred             ccccchhhhhhhhhhcccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHHHHh
Q 038681          268 GQNCRFKEMVDSIIIEDKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAKQLRQMYRS  330 (332)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~l~~~  330 (332)
                       ......++.               ..+++++.+++..||..+|++||+++.+.+.|+++.+.
T Consensus       233 -~~~~~~~l~---------------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~  279 (293)
T d1csna_         233 -QSTPLRELC---------------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  279 (293)
T ss_dssp             -HHSCHHHHT---------------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -CCCChHHhc---------------CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence             000001000               12336799999999999999999999999999888754

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=358.96  Aligned_cols=253  Identities=18%  Similarity=0.256  Sum_probs=184.8

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE---------------
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL---------------  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~---------------  115 (332)
                      ++|++.++||+|+||+||+|.+  +|+.||||++.... +.....++.+|+.++++++|||||++               
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            5799999999999999999999  79999999997653 34446679999999999999999986               


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        +|||||.++ +.+.+.       ..+++..++.++.||+.||.|||   ++||+||||||+|||++.++.+|++|||+
T Consensus        97 ~~iv~Ey~~~~-l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~  165 (355)
T d2b1pa1          97 VYLVMELMDAN-LCQVIQ-------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_dssp             EEEEEECCSEE-HHHHHT-------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC
T ss_pred             eEEEEeccchH-HHHhhh-------cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhh
Confidence              899999765 444443       35899999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc-
Q 038681          194 SLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC-  271 (332)
Q Consensus       194 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  271 (332)
                      ++........   ....+|+.|+|||++.+ .++.++||||+||++|+|++|+.||...+......  ........... 
T Consensus       166 ~~~~~~~~~~---~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~--~i~~~~~~~~~~  240 (355)
T d2b1pa1         166 ARTAGTSFMM---TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN--KVIEQLGTPCPE  240 (355)
T ss_dssp             ------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCHH
T ss_pred             hhcccccccc---ccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHH--HHHHhccCCCHH
Confidence            8876554432   45679999999999988 89999999999999999999999998665433211  11111111000 


Q ss_pred             -------chhhhhhhh----------hhc--ccCCCCCChHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          272 -------RFKEMVDSI----------IIE--DKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       272 -------~~~~~~~~~----------~~~--~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                             .........          ...  ............++++.+|+.+||+.||++||||+|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                   001111100          000  001111122456788999999999999999999999985

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=359.25  Aligned_cols=254  Identities=17%  Similarity=0.230  Sum_probs=192.4

Q ss_pred             hcCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCC-ChhhHHHHHHHHHHHHhhcCCCcceE--------------
Q 038681           53 TNNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNR-NQHALEWCINHIVYASRMSHKHIIKL--------------  115 (332)
Q Consensus        53 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~H~nIv~~--------------  115 (332)
                      .++|++.+.||+|+||+||+|++  +|+.||||++.... +....+.+.+|+.+|++++|||||++              
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46799999999999999999998  79999999997654 33446678999999999999999985              


Q ss_pred             --EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEeecCC
Q 038681          116 --IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFDFSL  193 (332)
Q Consensus       116 --lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~  193 (332)
                        ++++|+.+|+|.+++..      ..+++..++.++.||+.||+|||   ++||+||||||+|||++.++.+|++|||+
T Consensus        97 ~~~i~~~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~  167 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGL  167 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred             eEEEEEeecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccch
Confidence              67888999999999864      36999999999999999999999   99999999999999999999999999999


Q ss_pred             ccccCCCCceeeccccccCCCcccccccCC--CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhhhHHHHhhhhcccc
Q 038681          194 SLSIPDGETHIELDSVVGTTGFIAPENFTT--LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFHYEENVKRLSGQNC  271 (332)
Q Consensus       194 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  271 (332)
                      +.......     ....||+.|+|||++.+  .++.++|||||||++|+|++|+.||.+.+.......  ..........
T Consensus       168 a~~~~~~~-----~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~--i~~~~~~~~~  240 (348)
T d2gfsa1         168 ARHTDDEM-----TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL--ILRLVGTPGA  240 (348)
T ss_dssp             --CCTGGG-----SSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH--HHHHHCCCCH
T ss_pred             hcccCccc-----ccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHH--HHHhcCCCCh
Confidence            97654332     45679999999998776  578999999999999999999999987654433221  1111111111


Q ss_pred             chhhhh-----hhhhhcccCCCCCC----hHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 038681          272 RFKEMV-----DSIIIEDKSCTCTG----KEQQLQAFKQLTLQCMDFSPEDRPTMVDVAK  322 (332)
Q Consensus       272 ~~~~~~-----~~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~evl~  322 (332)
                      ......     ..............    ....++++.+||.+||+.||.+|||++|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            100000     00000000000000    0123477899999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.4e-44  Score=326.35  Aligned_cols=258  Identities=14%  Similarity=0.165  Sum_probs=181.2

Q ss_pred             cCCCCCCccccCCCceEEEEEe--CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcC-----------CCcceE-----
Q 038681           54 NNYDEQNIVLEDPFRKLYKGFW--QKRSISLMKYNGNRNQHALEWCINHIVYASRMSH-----------KHIIKL-----  115 (332)
Q Consensus        54 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-----------~nIv~~-----  115 (332)
                      ++|++.++||+|+||+||+|++  +|+.||||++....  ...+.+.+|+.+++.++|           +||+++     
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~   90 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   90 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc--cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEee
Confidence            3599999999999999999998  79999999997653  234678899999988865           566665     


Q ss_pred             --------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCC--
Q 038681          116 --------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSD--  185 (332)
Q Consensus       116 --------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--  185 (332)
                              ++++++..+.........  .....+++..+..++.||+.||+|||+  ..||+||||||+|||++.++.  
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~  166 (362)
T d1q8ya_          91 HKGPNGVHVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPE  166 (362)
T ss_dssp             EEETTEEEEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTT
T ss_pred             eccccceeeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCccc
Confidence                    466665554433332222  122578999999999999999999993  389999999999999986654  


Q ss_pred             ----eEEeecCCccccCCCCceeeccccccCCCcccccccCC-CCChhhhHHHHHHHHHHHHhCCccCCCCCccchhh--
Q 038681          186 ----AKLFDFSLSLSIPDGETHIELDSVVGTTGFIAPENFTT-LINEQCDVYGFGAFLFELLTAQEVSDHVSFESRFH--  258 (332)
Q Consensus       186 ----~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~sDiwSlG~~l~elltg~~p~~~~~~~~~~~--  258 (332)
                          ++++|||.|.......     ....||+.|+|||++.+ .++.++||||+||++++|++|+.||..........  
T Consensus       167 ~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~  241 (362)
T d1q8ya_         167 NLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  241 (362)
T ss_dssp             TEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             ccceeeEeeccccccccccc-----ccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence                8999999997665433     45679999999999887 89999999999999999999999997554321111  


Q ss_pred             --hHHHHhhhhccccchh-------hhhhhhh--hc-----------ccCCCCCChHHHHHHHHHHHHHcccCCCCCCCC
Q 038681          259 --YEENVKRLSGQNCRFK-------EMVDSII--IE-----------DKSCTCTGKEQQLQAFKQLTLQCMDFSPEDRPT  316 (332)
Q Consensus       259 --~~~~~~~~~~~~~~~~-------~~~~~~~--~~-----------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs  316 (332)
                        .......+........       ...+...  ..           ............++++.+|+.+||++||.+|||
T Consensus       242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt  321 (362)
T d1q8ya_         242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  321 (362)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence              0001111110000000       0000000  00           000011233567889999999999999999999


Q ss_pred             HHHHHH
Q 038681          317 MVDVAK  322 (332)
Q Consensus       317 ~~evl~  322 (332)
                      |+|+++
T Consensus       322 a~e~L~  327 (362)
T d1q8ya_         322 AGGLVN  327 (362)
T ss_dssp             HHHHHT
T ss_pred             HHHHhc
Confidence            999986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=6.4e-28  Score=198.12  Aligned_cols=162  Identities=15%  Similarity=0.102  Sum_probs=117.4

Q ss_pred             CCCCCccccCCCceEEEEEe-CCeeEEEEEEcCCCC-----------------hhhHHHHHHHHHHHHhhcCCCcceE--
Q 038681           56 YDEQNIVLEDPFRKLYKGFW-QKRSISLMKYNGNRN-----------------QHALEWCINHIVYASRMSHKHIIKL--  115 (332)
Q Consensus        56 y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~-----------------~~~~~~~~~E~~~l~~l~H~nIv~~--  115 (332)
                      +.+.++||+|+||+||+|.+ +|+.||||++.....                 ......+.+|...+.++.|++++..  
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            35678999999999999998 899999998754211                 0112345678999999999998875  


Q ss_pred             -----EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecCCCCCCeeeCCCCCeEEee
Q 038681          116 -----IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRDMKPTNILFNEQSDAKLFD  190 (332)
Q Consensus       116 -----lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D  190 (332)
                           ++|||++++.+.+            ++...+..++.|++.||.|||   .+||+||||||+|||+++++ ++|+|
T Consensus        82 ~~~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~~-~~liD  145 (191)
T d1zara2          82 WEGNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEEG-IWIID  145 (191)
T ss_dssp             EETTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETTE-EEECC
T ss_pred             ecCCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCCC-EEEEE
Confidence                 8999998865432            444556789999999999999   99999999999999998654 99999


Q ss_pred             cCCccccCCCCceeeccccccCCCcccccccCCCCChhhhHHHHHHH
Q 038681          191 FSLSLSIPDGETHIELDSVVGTTGFIAPENFTTLINEQCDVYGFGAF  237 (332)
Q Consensus       191 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~sDiwSlG~~  237 (332)
                      ||+|.....+.........+.    .-.+.+...|+.++|+||+.--
T Consensus       146 FG~a~~~~~~~~~~~l~rd~~----~~~~~f~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         146 FPQSVEVGEEGWREILERDVR----NIITYFSRTYRTEKDINSAIDR  188 (191)
T ss_dssp             CTTCEETTSTTHHHHHHHHHH----HHHHHHHHHHCCCCCHHHHHHH
T ss_pred             CCCcccCCCCCcHHHHHHHHH----HHHHHHcCCCCCcccHHHHHHH
Confidence            999977654332100000000    0012233467888999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.51  E-value=1.9e-07  Score=78.08  Aligned_cols=138  Identities=11%  Similarity=0.044  Sum_probs=90.0

Q ss_pred             HHHHHHhcCCCCCCccccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc----CCCcceE-------
Q 038681           47 EELRIATNNYDEQNIVLEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMS----HKHIIKL-------  115 (332)
Q Consensus        47 ~el~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~----H~nIv~~-------  115 (332)
                      .|+......|...+..+-++.+.||+...++..+++|+........ ...+.+|...+..+.    -|-++..       
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~-~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT-TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS-TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc-hhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            3555556677766655555567899998888888898886553322 334677888877663    3555543       


Q ss_pred             -EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhh--------------------------------
Q 038681          116 -IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHV--------------------------------  162 (332)
Q Consensus       116 -lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~--------------------------------  162 (332)
                       +||++++|.++.+.....       .   ....++.+++..+..||+                                
T Consensus        86 ~lv~~~l~G~~~~~~~~~~-------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE-------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC-------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCG
T ss_pred             EEEEEeccccccccccccc-------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhh
Confidence             899999998876543211       1   122234444555555551                                


Q ss_pred             ------------------------cCCCCeeecCCCCCCeeeCCCCCeEEeecCCcc
Q 038681          163 ------------------------GFSRPIVYRDMKPTNILFNEQSDAKLFDFSLSL  195 (332)
Q Consensus       163 ------------------------~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~  195 (332)
                                              .....++|+|+.|.||++++++.+-|+||+.+.
T Consensus       156 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             hcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                    002248999999999999876666799998773

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.98  E-value=3.5e-05  Score=68.00  Aligned_cols=67  Identities=7%  Similarity=0.020  Sum_probs=42.8

Q ss_pred             CCccccCCCceEEEEEe--CCeeEEEEEEcCC------CChhhHHHHHHHHHHHHhhc-C-----CCcceE------EEE
Q 038681           59 QNIVLEDPFRKLYKGFW--QKRSISLMKYNGN------RNQHALEWCINHIVYASRMS-H-----KHIIKL------IVF  118 (332)
Q Consensus        59 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~~~~~E~~~l~~l~-H-----~nIv~~------lv~  118 (332)
                      .+.||.|....||++..  .++.++||.-...      .......+...|...|..+. +     |.+..+      +||
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~~~lvm  110 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVM  110 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEcCCCCEEEE
Confidence            34689999999999987  4678999875431      11122445667888887763 2     222222      899


Q ss_pred             EeccCCC
Q 038681          119 ESVQIGT  125 (332)
Q Consensus       119 e~~~~g~  125 (332)
                      |++++..
T Consensus       111 E~L~~~~  117 (392)
T d2pula1         111 EDLSHLK  117 (392)
T ss_dssp             CCCTTSE
T ss_pred             eccCCcc
Confidence            9997643

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.85  E-value=7.9e-06  Score=67.50  Aligned_cols=61  Identities=5%  Similarity=-0.066  Sum_probs=40.0

Q ss_pred             cccCC-CceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcC-----CCcceE--------EEEEeccCCCh
Q 038681           62 VLEDP-FRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMSH-----KHIIKL--------IVFESVQIGTL  126 (332)
Q Consensus        62 lg~G~-~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H-----~nIv~~--------lv~e~~~~g~L  126 (332)
                      +..|. .+.||+... .+..+++|.......    ..+..|...++.+..     |.++..        +||++++|.++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            44444 367999988 566678887665532    236678888877743     333322        89999987655

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.30  E-value=0.0022  Score=54.50  Aligned_cols=68  Identities=9%  Similarity=0.087  Sum_probs=42.8

Q ss_pred             CCcccccHHHHHHHhcCC--CCC-Cccc-cCCCceEEEEEe-CCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc
Q 038681           39 NPYRIFSAEELRIATNNY--DEQ-NIVL-EDPFRKLYKGFW-QKRSISLMKYNGNRNQHALEWCINHIVYASRMS  108 (332)
Q Consensus        39 ~~~~~~~~~el~~~~~~y--~~~-~~lg-~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~  108 (332)
                      .++..++++.+..+...+  ... +.+- .+.--.||++.. +|..+++|........  .+.+..|...+..|.
T Consensus         3 ~~f~~L~pd~i~~al~~~g~~~~~~~~~L~s~EN~vy~v~~~dg~~~VlK~~rp~~~s--~~~i~~E~~~l~~L~   75 (325)
T d1zyla1           3 FTFQTLHPDTIMDALFEHGIRVDSGLTPLNSYENRVYQFQDEDRRRFVVKFYRPERWT--ADQILEEHQFALQLV   75 (325)
T ss_dssp             CCCCCCCHHHHHHHHHHTTCCCCSCCEEECCSSSEEEEECCTTCCCEEEEEECTTTSC--HHHHHHHHHHHHHHH
T ss_pred             CCccccCHHHHHHHHHHcCCCCCcCccccccccceeEEEEcCCCCEEEEEEeCCCCCC--HHHHHHHHHHHHHHH
Confidence            456667777765444332  221 2211 222348999998 7888999998765322  466778998888875

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.25  E-value=0.00089  Score=56.63  Aligned_cols=63  Identities=14%  Similarity=0.086  Sum_probs=40.9

Q ss_pred             cccHHHHHHHhcCCCCCCccc-----cCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhc
Q 038681           43 IFSAEELRIATNNYDEQNIVL-----EDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMS  108 (332)
Q Consensus        43 ~~~~~el~~~~~~y~~~~~lg-----~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~  108 (332)
                      .++.+|++....+|.+++...     .|---+.|+...++..+++|++....+.   +.+..|+.++..|.
T Consensus         2 ~ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~---~~l~~~~~~l~~L~   69 (316)
T d2ppqa1           2 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEK---NDLPFFLGLMQHLA   69 (316)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC---C---CHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCcEEEEEcCCCCCH---HHHHHHHHHHHhhh
Confidence            357788888888898765543     4555678999886677999998654332   33445667777764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.38  E-value=0.0062  Score=53.05  Aligned_cols=64  Identities=14%  Similarity=0.081  Sum_probs=40.7

Q ss_pred             CccccCCCceEEEEEeC---------CeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcc----eE----EEEEecc
Q 038681           60 NIVLEDPFRKLYKGFWQ---------KRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHII----KL----IVFESVQ  122 (332)
Q Consensus        60 ~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv----~~----lv~e~~~  122 (332)
                      +.|+.|-.-.+|++...         ...|.+.+.- ... . .-...+|..+++.+.-.+++    -+    +|+||++
T Consensus        48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~-~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~g~I~efi~  124 (395)
T d1nw1a_          48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPE-T-ESHLVAESVIFTLLSERHLGPKLYGIFSGGRLEEYIP  124 (395)
T ss_dssp             EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCC-C-HHHHHHHHHHHHHHHHTTSSSCEEEEETTEEEECCCC
T ss_pred             EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccc-h-hhHHHHHHHHHHHHHhCCCCCeEEEEcCCceEEEEec
Confidence            46788888899999872         2345555554 322 2 23456899999888533443    22    7999998


Q ss_pred             CCCh
Q 038681          123 IGTL  126 (332)
Q Consensus       123 ~g~L  126 (332)
                      |.+|
T Consensus       125 g~~l  128 (395)
T d1nw1a_         125 SRPL  128 (395)
T ss_dssp             EEEC
T ss_pred             cccC
Confidence            7543

>d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Actin-fragmin kinase, catalytic domain
domain: Actin-fragmin kinase, catalytic domain
species: Physarum polycephalum [TaxId: 5791]

Probab=81.47  E-value=2.5  Score=34.43  Aligned_cols=124  Identities=12%  Similarity=0.065  Sum_probs=70.7

Q ss_pred             ccCCCceEEEEEeCCeeEEEEEEcCCCChhhHHHHHHHHHHHHhhcCCCcceE---------------------------
Q 038681           63 LEDPFRKLYKGFWQKRSISLMKYNGNRNQHALEWCINHIVYASRMSHKHIIKL---------------------------  115 (332)
Q Consensus        63 g~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H~nIv~~---------------------------  115 (332)
                      ..+|.+-|+-+..++..+++|...    ..+.+.+..|+...-.+.-|...-+                           
T Consensus        77 s~~Gs~Gv~FV~~e~gaiVlK~s~----tta~E~y~~eLAr~LGvpvPqmRvI~~~~~E~~~~~~~~l~~~e~d~~I~se  152 (342)
T d1cjaa_          77 SEKGTEGLFFVETESGVFIVKRST----NIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAAIDKSFRVITTL  152 (342)
T ss_dssp             CCSTTSCEEEEEESSCEEEEECCT----THHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHHHCSSSCHHHHH
T ss_pred             eecCCceEEEEEcCCceEEEecCC----chHHHHHHHHHHHHhCCCCCceEEecCCCHHHHHHHHHHhcCCChhHHHHHH
Confidence            445555555566677777777633    2335667777777666676764433                           


Q ss_pred             ------EEEEeccCCChHHHHhhhhcccccCCCHHHHHHHHHHHHHHHHHhhhcCCCCeeecC-CCCCCeeeCCCC-CeE
Q 038681          116 ------IVFESVQIGTLADRIHHHCEQHFEALSLTDRLKVAMDIAHAVAYLHVGFSRPIVYRD-MKPTNILFNEQS-DAK  187 (332)
Q Consensus       116 ------lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~D-lkp~Nill~~~~-~~k  187 (332)
                            ++|||.+|.+|.+.-.....   ..+....+..+ -.|+.-=.++++..+-++.+|+ =.+.||+++.++ .+.
T Consensus       153 l~~A~~liMeYvpG~~l~e~~~~~a~---~~fs~~~l~~L-GkIiaFDifInN~DR~PL~Wrn~GN~~Niml~~n~~~~~  228 (342)
T d1cjaa_         153 ANQANILLMELVRGITLNKLTTTSAP---EVLTKSTMQQL-GSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGATVV  228 (342)
T ss_dssp             TTCSEEEEEECCCEEESTTCCSSSHH---HHSCHHHHHHH-HHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTTCEE
T ss_pred             HhcccceeeeccCCccccccccccch---hhhcHHHHHHh-hhHHHHHHHHcCCccccccccCCCCccceEEecCCcEEE
Confidence                  89999999887655322110   11222222211 1122222356654444666663 288999998777 566


Q ss_pred             EeecCCc
Q 038681          188 LFDFSLS  194 (332)
Q Consensus       188 l~Dfg~a  194 (332)
                      .+|=|..
T Consensus       229 ~IDs~i~  235 (342)
T d1cjaa_         229 PIDSKII  235 (342)
T ss_dssp             ECSCCCC
T ss_pred             EecCCcc
Confidence            7775444